PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ciossani, G; Overlack, K; Petrovic, A; in 't Veld, PJH; Koerner, C; Wohlgemuth, S; Maffini, S; Musacchio, A				Ciossani, Giuseppe; Overlack, Katharina; Petrovic, Arsen; in 't Veld, Pim J. Huis; Koerner, Carolin; Wohlgemuth, Sabine; Maffini, Stefano; Musacchio, Andrea			The kinetochore proteins CENP-E and CENP-F directly and specifically interact with distinct BUB mitotic checkpoint Ser/Thr kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kinetochore; centromere; mitosis; checkpoint control; microtubule; Bub1; BubR1; CENP-E; CENP-F; spindle assembly checkpoint	SPINDLE ASSEMBLY CHECKPOINT; ACCURATE CHROMOSOME SEGREGATION; APICAL NUCLEAR MIGRATION; LIGHT INTERMEDIATE CHAIN; MICROTUBULE CAPTURE; DYNEIN RECRUITMENT; HUMAN-CELLS; ROUGH DEAL; ANALYTICAL ULTRACENTRIFUGATION; STRUCTURAL-ANALYSIS	The segregation of chromosomes during cell division relies on the function of the kinetochores, protein complexes that physically connect chromosomes with microtubules of the spindle. The metazoan proteins, centromere protein E (CENP-E) and CENP-F, are components of a fibrous layer of mitotic kinetochores named the corona. Several of their features suggest that CENP-E and CENP-F are paralogs: they are very large (comprising approximate to 2700 and 3200 residues, respectively), contain abundant predicted coiled-coil structures, are C-terminally prenylated, and are endowed with microtubule-binding sites at their termini. Moreover, CENP-E contains an ATP-hydrolyzing motor domain that promotes microtubule plus end-directed motion. Here, we show that both CENP-E and CENP-F are recruited to mitotic kinetochores independently of the main corona constituent, the Rod/Zwilch/ZW10 (RZZ) complex. We identified specific interactions of CENP-F and CENP-E with budding uninhibited by benzimidazole 1 (BUB1) and BUB1-related (BUBR1) mitotic checkpoint Ser/Thr kinases, respectively, paralogous proteins involved in mitotic checkpoint control and chromosome alignment. Whereas BUBR1 was dispensable for kinetochore localization of CENP-E, BUB1 was stringently required for CENP-F localization. Through biochemical reconstitution, we demonstrated that the CENP-E/BUBR1 and CENP-F/BUB1 interactions are direct and require similar determinants, a dimeric coiled-coil in CENP-E or CENP-F and a kinase domain in BUBR1 or BUB1. Our findings are consistent with the existence of structurally similar BUB1/CENP-F and BUBR1/CENP-E complexes, supporting the notion that CENP-E and CENP-F are evolutionarily related.	[Ciossani, Giuseppe; Overlack, Katharina; Petrovic, Arsen; in 't Veld, Pim J. Huis; Koerner, Carolin; Wohlgemuth, Sabine; Maffini, Stefano; Musacchio, Andrea] Max Planck Inst Mol Physiol, Dept Mechanist Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany; [Musacchio, Andrea] Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, Univ Str, D-45141 Essen, Germany	Max Planck Society; University of Duisburg Essen	Musacchio, A (corresponding author), Max Planck Inst Mol Physiol, Dept Mechanist Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	andrea.musacchio@mpi-dortmund.mpg.de	Veld, Pim J. Huis in 't/AAJ-9030-2020; Körner, Carolin/AAT-7799-2020	Veld, Pim J. Huis in 't/0000-0003-0234-6390; Musacchio, Andrea/0000-0003-2362-8784; Petrovic, Arsen/0000-0003-4448-4230; Ciossani, Giuseppe/0000-0001-5293-4292	Max Planck Society; European Research Council (ERC) Advanced Investigator Grant RECEPIANCE [669686]; European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie Grant [675737]	Max Planck Society(Max Planck Society); European Research Council (ERC) Advanced Investigator Grant RECEPIANCE(European Research Council (ERC)); European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie Grant	This work was supported by the Max Planck Society, European Research Council (ERC) Advanced Investigator Grant RECEPIANCE (Proposal 669686), and European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie Grant Agreement 675737. The authors declare that they have no conflicts of interest with the contents of this article.	Aebi U., 2006, CELL BIOL LAB HDB, P242, DOI 10.1016B978-012164730-8/50152-0; Akera T, 2015, NAT CELL BIOL, V17, P1124, DOI 10.1038/ncb3219; Ashar HR, 2000, J BIOL CHEM, V275, P30451, DOI 10.1074/jbc.M003469200; Baffet AD, 2015, DEV CELL, V33, P703, DOI 10.1016/j.devcel.2015.04.022; Barisic M, 2010, MOL BIOL CELL, V21, P1968, DOI 10.1091/mbc.E09-04-0356; Basto R, 2000, NAT CELL BIOL, V2, P939, DOI 10.1038/35046592; Basto R, 2004, CURR BIOL, V14, P56, DOI 10.1016/j.cub.2003.12.025; Berto A, 2018, EMBO REP, V19, DOI 10.15252/embr.201744742; Bolhy S, 2011, J CELL BIOL, V192, P855, DOI 10.1083/jcb.201007118; Bomont P, 2005, EMBO J, V24, P3927, DOI 10.1038/sj.emboj.7600848; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Breit C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144673; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052; Caldas GV, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150160; CASIANO CA, 1993, J CELL SCI, V106, P1045; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167; Cheerambathur DK, 2013, SCIENCE, V342, P1239, DOI 10.1126/science.1246232; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Civril F, 2010, STRUCTURE, V18, P616, DOI 10.1016/j.str.2010.02.014; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; EARNSHAW WC, 1991, CHROMOSOMA, V100, P139, DOI 10.1007/BF00337241; Earnshaw WC, 2015, NAT REV MOL CELL BIO, V16, P443, DOI 10.1038/nrm4001; Feng J, 2006, CHROMOSOMA, V115, P320, DOI 10.1007/s00412-006-0049-5; Gama JB, 2017, J CELL BIOL, V216, P943, DOI 10.1083/jcb.201610108; Gassmann R, 2008, GENE DEV, V22, P2385, DOI 10.1101/gad.1687508; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Gruber M, 2005, NUCLEIC ACIDS RES, V33, pW239, DOI 10.1093/nar/gki405; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Holland AJ, 2015, MOL BIOL CELL, V26, P1845, DOI 10.1091/mbc.E14-11-1560; Holt SV, 2005, J CELL SCI, V118, P4889, DOI 10.1242/jcs.02614; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Hu DJK, 2013, CELL, V154, P1300, DOI 10.1016/j.cell.2013.08.024; Huis In 't Veld P. J., 2016, ELIFE, V5; Hussein D, 2002, J CELL SCI, V115, P3403; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; JOKELAINEN PT, 1967, J ULTRA MOL STRUCT R, V19, P19, DOI 10.1016/S0022-5320(67)80058-3; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Krenn V, 2012, J CELL BIOL, V196, P451, DOI 10.1083/jcb.201110013; Kuhn J, 2017, J CELL BIOL, V216, P1533, DOI 10.1083/jcb.201611104; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; LIAO H, 1994, SCIENCE, V265, P394, DOI 10.1126/science.8023161; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Magidson V, 2015, NAT CELL BIOL, V17, P1134, DOI 10.1038/ncb3223; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Mao YH, 2005, J CELL BIOL, V170, P873, DOI 10.1083/jcb.200505040; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Matson DR, 2014, J CELL BIOL, V205, P541, DOI 10.1083/jcb.201307137; MCEWEN BF, 1993, J CELL BIOL, V120, P301, DOI 10.1083/jcb.120.2.301; Mische S, 2008, MOL BIOL CELL, V19, P4918, DOI 10.1091/mbc.E08-05-0483; Mosalaganti S, 2017, J CELL BIOL, V216, P961, DOI 10.1083/jcb.201611060; Moudgil DK, 2015, J CELL BIOL, V208, P881, DOI 10.1083/jcb.201412085; Musacchio A, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010005; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Musinipally V, 2013, J MOL BIOL, V425, P4427, DOI 10.1016/j.jmb.2013.07.027; Overlack K, 2017, CURR BIOL, V27, P2915, DOI 10.1016/j.cub.2017.08.033; Overlack K, 2015, ELIFE, V4, DOI 10.7554/eLife.05269; Primorac I, 2013, ELIFE, V2, DOI 10.7554/eLife.01030; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; Raaijmakers JA, 2018, CELL REP, V22, P1424, DOI 10.1016/j.celrep.2018.01.034; RATTNER JB, 1993, CELL MOTIL CYTOSKEL, V26, P214, DOI 10.1002/cm.970260305; RIEDER CL, 1982, INT REV CYTOL, V79, P1, DOI 10.1016/S0074-7696(08)61672-1; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Schafer-Hales K, 2007, MOL CANCER THER, V6, P1317, DOI 10.1158/1535-7163.MCT-06-0703; Sharp-Baker H, 2001, J CELL BIOL, V153, P1239, DOI 10.1083/jcb.153.6.1239; Silio V, 2015, DEV CELL, V35, P600, DOI 10.1016/j.devcel.2015.11.012; Simoes PA, 2018, J CELL SCI, V131, DOI 10.1242/jcs.212159; Sivaram MVS, 2009, EMBO J, V28, P902, DOI 10.1038/emboj.2009.38; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Suijkerbuijk SJE, 2012, DEV CELL, V22, P1321, DOI 10.1016/j.devcel.2012.03.009; van Hooff JJE, 2017, EMBO REP, V18, P1559, DOI 10.15252/embr.201744102; Varma D, 2008, J CELL BIOL, V182, P1045, DOI 10.1083/jcb.200710106; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Volkov VA, 2015, J CELL BIOL, V209, P813, DOI 10.1083/jcb.201408083; Weissmann F, 2016, P NATL ACAD SCI USA, V113, pE2564, DOI 10.1073/pnas.1604935113; Williams BC, 1996, J CELL BIOL, V134, P1127, DOI 10.1083/jcb.134.5.1127; Wojcik E, 2001, NAT CELL BIOL, V3, P1001, DOI 10.1038/ncb1101-1001; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Wynne DJ, 2015, J CELL BIOL, V210, P899, DOI 10.1083/jcb.201506020; Yamamoto TG, 2008, J CELL BIOL, V183, P187, DOI 10.1083/jcb.200805185; Yang ZY, 2005, MOL CELL BIOL, V25, P4062, DOI 10.1128/MCB.25.10.4062-4074.2005; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0; Zhang G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8162; ZHU XL, 1995, J BIOL CHEM, V270, P19545, DOI 10.1074/jbc.270.33.19545; ZHU XL, 1995, MOL CELL BIOL, V15, P5017; Zhu XL, 1999, MOL CELL BIOL, V19, P1016	102	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10084	10101		10.1074/jbc.RA118.003154	http://dx.doi.org/10.1074/jbc.RA118.003154			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29748388	Green Published, hybrid			2022-12-26	WOS:000437096700013
J	Keable, SM; Zadvornyy, OA; Johnson, LE; Ginovska, B; Rasmussen, AJ; Danyal, K; Eilers, BJ; Prussia, GA; LeVan, AX; Raugei, S; Seefeldt, LC; Peters, JW				Keable, Stephen M.; Zadvornyy, Oleg A.; Johnson, Lewis E.; Ginovska, Bojana; Rasmussen, Andrew J.; Danyal, Karamatullah; Eilers, Brian J.; Prussia, Gregory A.; LeVan, Axl X.; Raugei, Simone; Seefeldt, Lance C.; Peters, John W.			Structural characterization of the P1+ intermediate state of the P-cluster of nitrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidation-reduction (redox); metalloprotein; nitrogenase; enzyme structure; computational biology; nitrogen fixation; nitrogen reduction; P-cluster of MoFe protein; poised states; redox mediators; redox-dependent ligand exchange; [8Fe-7S] cluster	MOLECULAR-ORBITAL METHODS; MOFE-PROTEIN; FE PROTEIN; BASIS-SETS; ELECTRON-TRANSFER; REDOX STATE; MECHANISM; SUBSTRATE; ENERGY; APPROXIMATION	Nitrogenase is the enzyme that reduces atmospheric dinitrogen (N-2) to ammonia (NH3) in biological systems. It catalyzes a series of single-electron transfers from the donor iron protein (Fe protein) to the molybdenum-iron protein (MoFe protein) that contains the iron-molybdenum cofactor (FeMo-co) sites where N-2 is reduced to NH3. The P-cluster in the MoFe protein functions in nitrogenase catalysis as an intermediate electron carrier between the external electron donor, the Fe protein, and the FeMo-co sites of the MoFe protein. Previous work has revealed that the P-cluster undergoes redox-dependent structural changes and that the transition from the all-ferrous resting (P-N) state to the two-electron oxidized P2+ state is accompanied by protein serine hydroxyl and backbone amide ligation to iron. In this work, the MoFe protein was poised at defined potentials with redox mediators in an electrochemical cell, and the three distinct structural states of the P-cluster (P2+, P1+, and P-N) were characterized by X-ray crystallography and confirmed by computational analysis. These analyses revealed that the three oxidation states differ in coordination, implicating that the P1+ state retains the serine hydroxyl coordination but lacks the backbone amide coordination observed in the P2+ states. These results provide a complete picture of the redox-dependent ligand rearrangements of the three P-cluster redox states.	[Keable, Stephen M.; Eilers, Brian J.; Prussia, Gregory A.; LeVan, Axl X.; Peters, John W.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Zadvornyy, Oleg A.; Raugei, Simone; Peters, John W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99163 USA; [Johnson, Lewis E.; Ginovska, Bojana; Raugei, Simone; Seefeldt, Lance C.; Peters, John W.] Pacific Northwest Natl Lab, Richland, WA 99352 USA; [Rasmussen, Andrew J.; Danyal, Karamatullah; Seefeldt, Lance C.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Johnson, Lewis E.] Univ Washington, Dept Chem, Seattle, WA 98195 USA	Montana State University System; Montana State University Bozeman; Washington State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Utah System of Higher Education; Utah State University; University of Washington; University of Washington Seattle	Peters, JW (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99163 USA.; Seefeldt, LC (corresponding author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA.	lance.seefeldt@usu.edu; jw.peters@wsu.edu	Zadvornyy, Oleg/P-5294-2019	Zadvornyy, Oleg A./0000-0002-5374-6856	United States Department of Energy (DOE), Office of Science, Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; DOE's Office of Biological and Environmental Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy (DOE), Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE's Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory, is supported by the United States Department of Energy (DOE), Office of Science, Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including Grant P41GM103393). Computer resources were provided by the W. R. Wiley Environmental Molecular Sciences Laboratory, a DOE Office of Science User Facility, located at Pacific Northwest National Laboratory and sponsored by DOE's Office of Biological and Environmental Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; BURGESS BK, 1980, BIOCHIM BIOPHYS ACTA, V614, P196, DOI 10.1016/0005-2744(80)90180-1; Chan JM, 1999, BIOCHEMISTRY-US, V38, P5779, DOI 10.1021/bi982866b; CHAN MK, 1993, SCIENCE, V260, P792, DOI 10.1126/science.8484118; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Danyal K, 2015, BIOCHEMISTRY-US, V54, P2456, DOI 10.1021/acs.biochem.5b00140; Danyal K, 2011, BIOCHEMISTRY-US, V50, P9255, DOI 10.1021/bi201003a; Danyal K, 2010, J AM CHEM SOC, V132, P13197, DOI 10.1021/ja1067178; Duval S, 2013, P NATL ACAD SCI USA, V110, P16414, DOI 10.1073/pnas.1311218110; HAGEMAN RV, 1978, P NATL ACAD SCI USA, V75, P2699, DOI 10.1073/pnas.75.6.2699; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; HOWARD JB, 1994, ANNU REV BIOCHEM, V63, P235, DOI 10.1146/annurev.bi.63.070194.001315; Kelly CP, 2006, J PHYS CHEM B, V110, P16066, DOI 10.1021/jp063552y; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; Lanzilotta WN, 1997, BIOCHEMISTRY-US, V36, P12976, DOI 10.1021/bi9715371; Lanzilotta WN, 1998, BIOCHEMISTRY-US, V37, P11376, DOI 10.1021/bi980048d; Li L, 2013, J CHEM THEORY COMPUT, V9, P2126, DOI 10.1021/ct400065j; LINDAHL PA, 1988, J BIOL CHEM, V263, P19412; LOWE DJ, 1993, BIOCHEM J, V292, P93, DOI 10.1042/bj2920093; Lowery TJ, 2006, P NATL ACAD SCI USA, V103, P17131, DOI 10.1073/pnas.0603223103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Pitera JW, 2001, BIOPHYS J, V80, P2546, DOI 10.1016/S0006-3495(01)76226-1; Rupnik K, 2012, J AM CHEM SOC, V134, P13749, DOI 10.1021/ja304077h; Sarma R, 2010, J INORG BIOCHEM, V104, P385, DOI 10.1016/j.jinorgbio.2009.11.009; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; Seefeldt LC, 2009, ANNU REV BIOCHEM, V78, P701, DOI 10.1146/annurev.biochem.78.070907.103812; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Tezcan FA, 2005, SCIENCE, V309, P1377, DOI 10.1126/science.1115653; TITTSWORTH RC, 1993, J AM CHEM SOC, V115, P9763, DOI 10.1021/ja00074a050; Valiev M, 2010, COMPUT PHYS COMMUN, V181, P1477, DOI 10.1016/j.cpc.2010.04.018; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang ZY, 2011, METHODS MOL BIOL, V766, P9, DOI 10.1007/978-1-61779-194-9_2; Yoo SJ, 2000, J AM CHEM SOC, V122, P4926, DOI 10.1021/ja000254k	40	25	25	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9629	9635		10.1074/jbc.RA118.002435	http://dx.doi.org/10.1074/jbc.RA118.002435			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29720402	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000436102300007
J	Chen, D; Luo, LJ; Liang, C				Chen, De; Luo, Linjie; Liang, Chao			Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER GENOME ATLAS; BREAST-CANCER; PATHWAY; PROTEIN; CHEMORESISTANCE; AMPLIFICATION; METHYLATION; BIOMARKER; INVASION	S100A16 is a conserved member of the S100 protein family in mammals. Its upregulation was observed in many tumors and is related to malignant transformation. In this study, we explored the independent prognostic value of S100A16 in terms of overall survival (OS) and recurrence-free survival (RFS) by performing a retrospective study, using data in The Cancer Genome Atlas (TCGA)-lung adenocarcinoma (LUAD). Besides, by using deep sequencing data in TCGA-LUAD, we also explored the association between S100A16 expression and its DNA methylation and copy number alterations (CNAs). Results showed that the primary LUAD tissues (N = 514) had significantly elevated S100A16 expression compared with the normal lung tissues (N = 59). Based on OS data of 502 primary LUAD cases, we found that high S100A16 expression was correlated with inferior OS. The following univariate and multivariate analysis confirmed that increased S100A16 expression was an independent prognostic indicator of unfavorable OS (HR: 1.197, 95%CI: 1.050-1.364, p = 0.007) and RFS (HR: 1.206, 95%CI: 1.045-1.393, p= 0.011). By examining the DNA methylation data in TCGA-LUAD, we found that some S100A16 DNA CpG sites were generally hypermethylated in normal tissues, but not in LUAD tissues. Regression analysis identified a moderately negative correlation between S100A16 expression and its DNA methylation. In comparison, although DNA amplification (+1/+2) was frequent (378/511, 74%) in LUAD patients, it was not associated with increased S100A16 expression. Based on findings above, we infer that aberrant S100A16 expression might be modulated by its DNA hypomethylation and serves as an independent prognostic indicator of unfavorable OS and RFS in LUAD.	[Chen, De; Luo, Linjie; Liang, Chao] First Peoples Hosp Yibin, Dept Resp Med, Yibin, Peoples R China		Luo, LJ (corresponding author), First Peoples Hosp Yibin, Dept Resp Med, Yibin, Peoples R China.	1455082558@qq.com						Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Brodie SA, 2015, RESP MED, V109, P131, DOI 10.1016/j.rmed.2014.11.004; Carney BJ, 2017, LUNG CANCER, V114, P108, DOI 10.1016/j.lungcan.2017.08.018; Chae YK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21061-1; Chang JTH, 2015, TRANSL RES, V166, P568, DOI 10.1016/j.trsl.2015.08.001; Chen HY, 2014, AM J CANCER RES, V4, P89; Dauphin M, 2013, LUNG CANCER, V81, P117, DOI 10.1016/j.lungcan.2013.03.011; Gu FF, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0296-8; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Katono K, 2017, ONCOTARGETS THER, V10, P5273, DOI 10.2147/OTT.S145072; Kuo YC, 2015, INT J BIOCHEM CELL B, V64, P229, DOI 10.1016/j.biocel.2015.04.015; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V313, P237, DOI 10.1016/j.bbrc.2003.11.115; Murata Y, 2014, CANCER SCI, V105, P490, DOI 10.1111/cas.12363; Pan Y, 2017, ONCOTARGET, V8, P33144, DOI 10.18632/oncotarget.16562; Pu WL, 2016, J CANCER, V7, P2280, DOI 10.7150/jca.15758; Saito Keita, 2015, Asian Pac J Cancer Prev, V16, P7039; Sapkota D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076058; Schlensog M, 2018, EPIGENETICS-US, V13, P214, DOI 10.1080/15592294.2016.1229730; Sun X, 2018, J SURG ONCOL, V117, P275, DOI 10.1002/jso.24822; Tanaka M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1059-6; Tessema M, 2012, ONCOGENE, V31, P4107, DOI 10.1038/onc.2011.577; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Zheng Y, 2013, INT J BIOCHEM CELL B, V45, P2369, DOI 10.1016/j.biocel.2013.07.013; Zhou SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187356; Zhou WB, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0097-8; Zhou Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0457-5; Zhu WD, 2016, TUMOR BIOL, V37, P12241, DOI 10.1007/s13277-016-5096-9	30	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197402	10.1371/journal.pone.0197402	http://dx.doi.org/10.1371/journal.pone.0197402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746588	Green Submitted, Green Published, gold			2022-12-26	WOS:000431851700108
J	Pienaarl, E; Linderman, JJ; Kirschner, DE				Pienaarl, Elsje; Linderman, Jennifer J.; Kirschner, Denise E.			Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas	PLOS ONE			English	Article							AEROSOL INFECTION MODEL; HIGH-DOSE RIFAMPICIN; MYCOBACTERIUM-TUBERCULOSIS; DRUG-RESISTANCE; ANTIBIOTIC-RESISTANCE; POPULATION-DYNAMICS; HOST IMMUNITY; MUTATION-RATE; PHENOTYPIC HETEROGENEITY; COMPENSATORY MUTATIONS	Drug resistant tuberculosis is increasing world-wide. Resistance against isoniazid (INH), rifampicin (RIF), or both (multi-drug resistant TB, MDR-TB) is of particular concern, since INH and RIF form part of the standard regimen for TB disease. While it is known that suboptimal treatment can lead to resistance, it remains unclear how host immune responses and antibiotic dynamics within granulomas (sites of infection) affect emergence and selection of drug-resistant bacteria. We take a systems pharmacology approach to explore resistance dynamics within granulomas. We integrate spatio-temporal host immunity, INH and RIF dynamics, and bacterial dynamics (including fitness costs and compensatory mutations) in a computational framework. We simulate resistance emergence in the absence of treatment, as well as resistance selection during INH and/or RIF treatment. There are four main findings. First, in the absence of treatment, the percentage of granulomas containing resistant bacteria mirrors the non-monotonic bacterial dynamics within granulomas. Second, drug-resistant bacteria are less frequently found in non-replicating states in caseum, compared to drug-sensitive bacteria. Third, due to a steeper dose response curve and faster plasma clearance of INH compared to RIF, INH-resistant bacteria have a stronger influence on treatment outcomes than RIF-resistant bacteria. Finally, under combination therapy with INH and RIF, few MDR bacteria are able to significantly affect treatment outcomes. Overall, our approach allows drug-specific prediction of drug resistance emergence and selection in the complex granuloma context. Since our predictions are based on pre-clinical data, our approach can be implemented relatively early in the treatment development process, thereby enabling pro-active rather than reactive responses to emerging drug resistance for new drugs. Furthermore, this quantitative and drug-specific approach can help identify drug-specific properties that influence resistance and use this information to design treatment regimens that minimize resistance selection and expand the useful life-span of new antibiotics.	[Pienaarl, Elsje; Kirschner, Denise E.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Pienaarl, Elsje; Linderman, Jennifer J.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Pienaarl, Elsje] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kirschner, DE (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	kirchne@umich.edu			National Institutes of Health [R01 AI123093-01, U01HL131072, R01 HL 110811]; Office of Science of the U.S. Department of Energy [ACI-1053575]; Extreme Science and Engineering Discovery Environment (XSEDE); National Science Foundation [MCB140228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL131072, R01HL110811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Extreme Science and Engineering Discovery Environment (XSEDE); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the following grants from the National Institutes of Health: R01 AI123093-01 (DEK), U01HL131072 (DEK and JJL), R01 HL 110811 (DEK and JJL). This research also used resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the U.S. Department of Energy under Contract No. ACI-1053575 and the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number MCB140228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavez-Ramirez J, 2007, MATH MED BIOL, V24, P35, DOI 10.1093/imammb/dql026; Aldridge BB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0031-2013; Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Ankomah P, 2014, P NATL ACAD SCI USA, V111, P8331, DOI 10.1073/pnas.1400352111; Ankomah P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002487; Aymanns C, 2010, CLIN J AM SOC NEPHRO, V5, P314, DOI 10.2215/CJN.03960609; Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; BELL W J, 1960, Tubercle, V41, P247; Bielecka MK, 2017, MBIO, V8, DOI 10.1128/mBio.02073-16; Bloemberg GV, 2015, NEW ENGL J MED, V373, P1986, DOI 10.1056/NEJMc1505196; Boeree MJ, 2011, INT J TUBERC LUNG D, V15, P1133, DOI 10.5588/ijtld.11.0198; Boeree MJ, 2017, LANCET INFECT DIS, V17, P39, DOI 10.1016/S1473-3099(16)30274-2; Boeree MJ, 2015, AM J RESP CRIT CARE, V191, P1058, DOI 10.1164/rccm.201407-1264OC; Borrell S, 2011, CLIN MICROBIOL INFEC, V17, P815, DOI 10.1111/j.1469-0691.2011.03556.x; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Borrell Sonia, 2013, Evolution Medicine and Public Health, P65, DOI 10.1093/emph/eot003; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Braian C, 2015, JOVE-J VIS EXP, DOI 10.3791/53084; Brandis G, 2012, MOL MICROBIOL, V85, P142, DOI 10.1111/j.1365-2958.2012.08099.x; Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Caws M, 2006, J CLIN MICROBIOL, V44, P2333, DOI 10.1128/JCM.00330-06; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chanwong S, 2007, TUBERCULOSIS, V87, P130, DOI 10.1016/j.tube.2006.06.001; Chen RY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009501; Cherkaoui I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093574; Chida N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142384; Cicchese JM, 2017, CELL MOL BIOENG, V10, P523, DOI 10.1007/s12195-017-0507-6; Cilfone NA, 2015, J IMMUNOL, V194, P664, DOI 10.4049/jimmunol.1400734; Cilfone NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068680; Cohen KA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001880; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Colijn C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018327; Connolly C, 1999, INT J TUBERC LUNG D, V3, P1081; COSTELLO HD, 1980, AM REV RESPIR DIS, V121, P313; DAVID HL, 1970, APPL MICROBIOL, V20, P810, DOI 10.1128/AEM.20.5.810-814.1970; Davies AP, 2000, J INFECTION, V41, P184, DOI 10.1053/jinf.2000.0711; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dheda K, 2017, LANCET RESP MED, V5, P291, DOI [10.1016/S2213-2600(17)30079-6, 10.1016/s2213-2600(17)30079-6]; dYvoire HJYB, 1996, CLIN DRUG INVEST, V11, P229; ELLIOTT AM, 1995, TUBERCLE LUNG DIS, V76, P463, DOI 10.1016/0962-8479(95)90016-0; Fallahi-Sichani M, 2011, J IMMUNOL, V186, P3472, DOI 10.4049/jimmunol.1003299; Fenner L, 2012, ANTIMICROB AGENTS CH, V56, P3047, DOI 10.1128/AAC.06460-11; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Gagneux S, 2009, CLIN MICROBIOL INFEC, V15, P66, DOI 10.1111/j.1469-0691.2008.02685.x; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; GARBER AM, 1987, THEOR POPUL BIOL, V32, P326, DOI 10.1016/0040-5809(87)90053-0; Gehring R, 2010, J THEOR BIOL, V262, P97, DOI 10.1016/j.jtbi.2009.09.002; GERSZTEN E, 1963, JAMA-J AM MED ASSOC, V185, P6, DOI 10.1001/jama.1963.03060010032004; Getahun H, 2015, EUR RESPIR J, V46, P1563, DOI 10.1183/13993003.01245-2015; Gillespie SH, 2002, ANTIMICROB AGENTS CH, V46, P267, DOI 10.1128/AAC.46.2.267-274.2002; Gjini E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004857; Goldberg DE, 2012, CELL, V148, P1271, DOI 10.1016/j.cell.2012.02.021; Guirado E, 2015, MBIO, V6, DOI 10.1128/mBio.02537-14; Gumbo T, 2007, ANTIMICROB AGENTS CH, V51, P3781, DOI 10.1128/AAC.01533-06; Hartkoorn RC, 2007, TUBERCULOSIS, V87, P248, DOI 10.1016/j.tube.2006.12.001; Isaac A, 2016, OPEN FORUM INFECT S1, V3, P559, DOI [10.1093/ofid/ofw172.422, DOI 10.1093/OFID/OFW172.422]; Jagielski T, 2014, J ANTIMICROB CHEMOTH, V69, P2369, DOI 10.1093/jac/dku161; Jayaram R, 2004, ANTIMICROB AGENTS CH, V48, P2951, DOI 10.1128/AAC.48.8.2951-2957.2004; Jayaram R, 2003, ANTIMICROB AGENTS CH, V47, P2118, DOI 10.1128/AAC.47.7.2118-2124.2003; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Kendall EA, 2015, LANCET RESP MED, V3, P963, DOI 10.1016/S2213-2600(15)00458-0; Khan FA, 2017, HDB ANTIMICROBIAL RE; Kirschner DE, 2014, WIRES SYST BIOL MED, V6, P225, DOI 10.1002/wsbm.1270; Kjellsson MC, 2012, ANTIMICROB AGENTS CH, V56, P446, DOI 10.1128/AAC.05208-11; Kozakiewicz L, 2013, ADV EXP MED BIOL, V783, P225, DOI 10.1007/978-1-4614-6111-1_12; Lakshminarayana SB, 2015, J ANTIMICROB CHEMOTH, V70, P857, DOI 10.1093/jac/dku457; Lenski R E, 1998, Int Microbiol, V1, P265; Levin BR, 2001, CLIN INFECT DIS, V33, pS161, DOI 10.1086/321843; Levin BR, 2017, TRENDS MICROBIOL, V25, P878, DOI 10.1016/j.tim.2017.07.005; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Lin PL, 2013, ANTIMICROB AGENTS CH, V57, P4237, DOI 10.1128/AAC.00277-13; Lin PL, 2012, P NATL ACAD SCI USA, V109, P14188, DOI 10.1073/pnas.1121497109; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Lipsitch M, 1997, ANTIMICROB AGENTS CH, V41, P363, DOI 10.1128/AAC.41.2.363; Lipsitch M, 1998, INT J TUBERC LUNG D, V2, P187; Liu YC, 2016, J EXP MED, V213, P809, DOI 10.1084/jem.20151248; Luria SE, 1943, GENETICS, V28, P491; M'Imunya JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006591.pub2; Machado D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034538; MacLean RC, 2010, NAT REV GENET, V11, P405, DOI 10.1038/nrg2778; Malik M, 2012, ANTIMICROB AGENTS CH, V56, P3879, DOI 10.1128/AAC.00474-12; Manina G, 2015, CELL HOST MICROBE, V17, P32, DOI 10.1016/j.chom.2014.11.016; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marzo E, 2014, TUBERCULOSIS, V94, P55, DOI 10.1016/j.tube.2013.09.004; McGrath M, 2014, J ANTIMICROB CHEMOTH, V69, P292, DOI 10.1093/jac/dkt364; McIvor A, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx020; Migliori GB, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020341; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Muller B, 2013, TRENDS GENET, V29, P160, DOI 10.1016/j.tig.2012.11.005; MUSSER JM, 1995, CLIN MICROBIOL REV, V8, P496, DOI 10.1128/CMR.8.4.496; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Nahid P, 2016, CLIN INFECT DIS, V63, pe147, DOI 10.1093/cid/ciw376; odany AT, 2016, F1000RES, P5, DOI [10.12688/f1000research.7403.1, DOI 10.12688/F1000RESEARCH.7403.1]; Opatowski L, 2011, CURR OPIN INFECT DIS, V24, P279, DOI 10.1097/QCO.0b013e3283462362; Pienaar E, 2016, INFECT IMMUN, V84, P1650, DOI 10.1128/IAI.01438-15; Pienaar E, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0221-8; Pienaar E, 2015, J THEOR BIOL, V367, P166, DOI 10.1016/j.jtbi.2014.11.021; PINES A, 1964, Tubercle, V45, P77; Prideaux B, 2015, NAT MED, V21, P1223, DOI 10.1038/nm.3937; Ray JCJ, 2009, J IMMUNOL, V182, P3706, DOI 10.4049/jimmunol.0802297; Roux D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1621; Sam IC, 2006, EMERG INFECT DIS, V12, P752, DOI 10.3201/eid1205.041339; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Schaaf HS, 2007, EUR J CLIN MICROBIOL, V26, P203, DOI 10.1007/s10096-007-0257-9; Schon T, 2009, J ANTIMICROB CHEMOTH, V64, P786, DOI 10.1093/jac/dkp262; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Sharma A, 2017, LANCET INFECT DIS, V17, P707, DOI 10.1016/S1473-3099(17)30247-5; SHENNAN D H, 1964, Tubercle, V45, P1, DOI 10.1016/S0041-3879(64)80080-5; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Somoskovi A, 2001, RESP RES, V2, P164, DOI 10.1186/rr54; Song T, 2014, MOL MICROBIOL, V91, P1106, DOI 10.1111/mmi.12520; Trauner A, 2014, DRUGS, V74, P1063, DOI 10.1007/s40265-014-0248-y; Van Rie A, 2000, LANCET, V356, P22, DOI 10.1016/S0140-6736(00)02429-6; Veziris N, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01719-2016; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Vilcheze C, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0014-2013; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Werngren J, 2003, J CLIN MICROBIOL, V41, P1520, DOI 10.1128/JCM.41.4.1520-1524.2003; WHO, 2016, GLOB TUB REP; Zhang Y, 2015, INT J TUBERC LUNG D, V19, P1276, DOI 10.5588/ijtld.15.0389	127	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196322	10.1371/journal.pone.0196322	http://dx.doi.org/10.1371/journal.pone.0196322			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746491	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700013
J	Carlsson, M; Hu, GZ; Ronne, H				Carlsson, Mattias; Hu, Guo-Zhen; Ronne, Hans			Gene dosage effects in yeast support broader roles for the LOG1, HAM1 and DUT1 genes in detoxification of nucleotide analogues	PLOS ONE			English	Article							INOSINE TRIPHOSPHATE PYROPHOSPHATASE; SACCHAROMYCES-CEREVISIAE; ADENINE PHOSPHORIBOSYLTRANSFERASE; CANCER-CHEMOTHERAPY; IN-VIVO; 5-FLUOROURACIL; MECHANISM; PURINE; RNA; SENSITIVITY	Purine and pyrimidine analogues have important uses in chemotherapies against cancer, and a better understanding of the mechanisms that cause resistance to these drugs is therefore of importance in cancer treatment. In the yeast Saccharomyces cerevisiae, overexpression of the HAM1 gene encoding inosine triphosphate pyrophosphatase confers resistance to both the purine analogue 6-N-hydroxylaminopurine (HAP) and the pyrimidine analogue 5-fluorouracil (5-FU) (Carlsson et al., 2013, PLoS One 8, e52094). To find out more about the mechanisms of resistance to nucleotide analogues, and possible interdependencies between purine and pyrimidine analogue resistance mechanisms, we screened a plasmid library in yeast for genes that confer HAP resistance when overexpressed. We cloned four such genes: ADE4, DUT1, APT2, and ATR1. We further looked for genetic interactions between these genes and genes previously found to confer resistance to 5-FU. We found that HMS1, LOG1 (YJL055W), HAM1, and ATR1 confer resistance to both 5-FU and HAP, whereas ADE4, DUT1 and APT2 are specific for HAP resistance, and CPA1 and CPA2 specific for 5-FU resistance. Possible mechanisms for 5-FU and HAP detoxification are discussed based on the observed genetic interactions. Based on the effect of LOG1 against both 5-FU and HAP toxicity, we propose that the original function of the LOG (LONELY GUY) family of proteins likely was to degrade non-canonical nucleotides, and that their role in cytokinin production is a later development in some organisms.	[Carlsson, Mattias; Hu, Guo-Zhen; Ronne, Hans] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Ronne, H (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden.	Hans.Ronne@slu.se		Ronne, Hans/0000-0002-1645-6091	Swedish Cancer Society [CAN 2014/910]; Knut and Alice Wallenberg Foundation [KAW 2015.0056]	Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by grants to HR from the Swedish Cancer Society (CAN 2014/910) and the Knut and Alice Wallenberg Foundation (KAW 2015.0056).; This work was supported by grants to HR from the Swedish Cancer Society (CAN 2014/910), http://www.cancerfonden.se, and the Knut and Alice Wallenberg Foundation (KAW 2015.0056), http://kaw.wallenberg.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonzo JD, 1999, J BACTERIOL, V181, P347, DOI 10.1128/JB.181.1.347-352.1999; Bashor C, 2002, BIOCHEMISTRY-US, V41, P4020, DOI 10.1021/bi0158730; Bozdag GO, 2011, BIOCHEM BIOPH RES CO, V409, P748, DOI 10.1016/j.bbrc.2011.05.080; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Burgis NE, 2007, J BIOL CHEM, V282, P3531, DOI 10.1074/jbc.M608708200; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Carlsson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052094; CHEVALLIER MR, 1975, J BACTERIOL, V122, P629, DOI 10.1128/JB.122.2.629-641.1975; Chua G, 2006, P NATL ACAD SCI USA, V103, P12045, DOI 10.1073/pnas.0605140103; Davies O, 2012, BMB REP, V45, P259, DOI 10.5483/BMBRep.2012.45.4.259; DOLLINGER MR, 1975, CLIN PHARMACOL THER, V17, P57; Fang F, 2004, MOL CELL BIOL, V24, P10766, DOI 10.1128/MCB.24.24.10766-10776.2004; Fukushima M, 1996, Gan To Kagaku Ryoho, V23, P721; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; GRENSON M, 1969, EUR J BIOCHEM, V11, P249, DOI 10.1111/j.1432-1033.1969.tb00767.x; Guetsova ML, 1997, GENETICS, V147, P383; Guillet M, 2006, NUCLEIC ACIDS RES, V34, P2056, DOI 10.1093/nar/gkl139; Gustavsson M, 2008, MOL GENET GENOMICS, V280, P233, DOI 10.1007/s00438-008-0359-9; Gustavsson M, 2008, RNA, V14, P666, DOI 10.1261/rna.966208; HEIDELBERGER C, 1957, NATURE, V179, P663, DOI 10.1038/179663a0; HEIDELBERGER C, 1967, ANNU REV PHARMACOLOG, V7, P101, DOI 10.1146/annurev.pa.07.040167.000533; Hoskins J, 2008, GENETICS, V179, P323, DOI 10.1534/genetics.107.082727; Hoskins J, 2007, YEAST, V24, P861, DOI 10.1002/yea.1516; JUND R, 1970, J BACTERIOL, V102, P607, DOI 10.1128/JB.102.3.607-615.1970; KANAZAWA S, 1988, MOL CELL BIOL, V8, P664, DOI 10.1128/MCB.8.2.664; Kaya A, 2009, MOL CELL BIOL, V29, P3665, DOI 10.1128/MCB.01646-08; Kelly DE, 2001, COMPAR FUNCT GENOM, V2, P236, DOI 10.1002/cfg.95; Kowalski D, 2008, MOL PHARMACOL, V74, P1092, DOI 10.1124/mol.108.048256; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Kuroha T, 2009, PLANT CELL, V21, P3152, DOI 10.1105/tpc.109.068676; Ladner RD, 2001, CURR PROTEIN PEPT SC, V2, P361, DOI 10.2174/1389203013380991; Li XCL, 2011, GENETICS, V187, P1031, DOI 10.1534/genetics.110.125450; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Menezes MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032313; MERKLER DJ, 1989, J BIOL CHEM, V264, P21422; Naseem M, 2015, TRENDS PLANT SCI, V20, P781, DOI 10.1016/j.tplants.2015.10.017; NEHLIN JO, 1989, GENE, V85, P313, DOI 10.1016/0378-1119(89)90423-X; Noskov VN, 1996, YEAST, V12, P17, DOI 10.1002/(SICI)1097-0061(199601)12:1<17::AID-YEA875>3.0.CO;2-I; POLAK A, 1973, EUR J BIOCHEM, V32, P276, DOI 10.1111/j.1432-1033.1973.tb02608.x; Rebora K, 2001, MOL CELL BIOL, V21, P7901, DOI 10.1128/MCB.21.23.7901-7912.2001; RONNE H, 1995, TRENDS GENET, V11, P12, DOI 10.1016/S0168-9525(00)88980-5; RUSSELL DW, 1983, J BIOL CHEM, V258, P2674; Samanovic MI, 2015, MOL CELL, V57, P984, DOI 10.1016/j.molcel.2015.01.024; SANTI DV, 1974, BIOCHEMISTRY-US, V13, P471, DOI 10.1021/bi00700a012; Simone PD, 2013, MUTAT RES-REV MUTAT, V753, P131, DOI 10.1016/j.mrrev.2013.08.001; Spedaliere CJ, 2004, RNA, V10, P192, DOI 10.1261/rna.5100104; Stepchenkova EI, 2009, RUSS J GENET+, V45, P409, DOI 10.1134/S1022795409040048; Stepchenkova EI, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-31; Stocco G, 2009, CLIN PHARMACOL THER, V85, P164, DOI 10.1038/clpt.2008.154; Takayama S, 2007, CURR GENET, V52, P203, DOI 10.1007/s00294-007-0152-z; Tchigvintsev A, 2011, BIOCHEM J, V437, P243, DOI 10.1042/BJ20110304; Tinkelenberg BA, 2002, CANCER RES, V62, P4909; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; von Ahsen N, 2005, CLIN CHEM, V51, P2282, DOI 10.1373/clinchem.2005.057158; Waisertreiger ISR, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/872180; YOSHIDA M, 1984, BIOCHEM PHARMACOL, V33, P2863, DOI 10.1016/0006-2952(84)90208-9; YOSHIOKA A, 1987, J BIOL CHEM, V262, P8235; Zhao XL, 2007, NUCLEIC ACIDS RES, V35, P550, DOI 10.1093/nar/gkl1084	63	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196840	10.1371/journal.pone.0196840	http://dx.doi.org/10.1371/journal.pone.0196840			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738539	Green Published, Green Submitted, gold			2022-12-26	WOS:000431724900022
J	Cho, CH; Choi, JW; Lam, DW; Kim, KM; Yoon, HS				Cho, Chung Hyun; Choi, Ji Won; Lam, Daryl W.; Kim, Kyeong Mi; Yoon, Hwan Su			Plastid genome analysis of three Nemaliophycidae red algal species suggests environmental adaptation for iron limited habitats	PLOS ONE			English	Article							HEME OXYGENASE; FRESH-WATER; PHYTOCHROME CHROMOPHORE; RHODOPHYTA REVEALS; ORGANELLAR GENOMES; GENE DUPLICATION; RNA GENES; SP-NOV; EVOLUTION; SEQUENCE	The red algal subclass Nemaliophycidae includes both marine and freshwater taxa that contribute to more than half of the freshwater species in Rhodophyta. Given that these taxa inhabit diverse habitats, the Nemaliophycidae is a suitable model for studying environmental adaptation. For this purpose, we characterized plastid genomes of two freshwater species, Kumanoa americana (Batrachospermales) and Thorea hispida (Thoreales), and one marine species Palmaria palmate (Palmariales). Comparative genome analysis identified seven genes (ycf34, ycf35, ycf37, ycf46, ycf91, grx, and pbsA) that were different among marine and freshwater species. Among currently available red algal plastid genomes (127), four genes (pbsA, ycf34, ycf35, ycf37) were retained in most of the marine species. Among these, the pbsA gene, known for encoding heme oxygenase, had two additional copies (HMOX1 and HMOX2) that were newly discovered and were reported from previously red algal nuclear genomes. Each type of heme oxygenase had a different evolutionary history and special modifications (e.g., plastid targeting signal peptide). Based on this observation, we suggest that the plastid-encoded pbsA contributes to the iron controlling system in iron-deprived conditions. Thus, we highlight that this functional requirement may have prevented gene loss during the long evolutionary history of red algal plastid genomes.	[Cho, Chung Hyun; Choi, Ji Won; Yoon, Hwan Su] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea; [Lam, Daryl W.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Kim, Kyeong Mi] Marine Biodivers Inst Korea, Seocheon, South Korea	Sungkyunkwan University (SKKU); University of Alabama System; University of Alabama Tuscaloosa; Marine Biodiversity Institute of Korea (MABIK)	Yoon, HS (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea.	hsyoon2011@skku.edu	Yoon, Hwan Su/ABD-7011-2020; Yoon, Hwan Su/A-2974-2013; Cho, Chung Hyun/AAM-1233-2020	Cho, Chung Hyun/0000-0003-3105-8750; Yoon, Hwan Su/0000-0001-9507-0105	Collaborative Genome Program - Ministry of Oceans and Fisheries [20140428]; National Research Foundation of Korea [NRF-2017R1A2B3001923]; Next generation BioGreen21 Program from the Rural Development Administration, Korea [PJ01389003]; National Science Foundation Assembling the Tree of Life program [DEB-0937975, 1317114]	Collaborative Genome Program - Ministry of Oceans and Fisheries; National Research Foundation of Korea(National Research Foundation of Korea); Next generation BioGreen21 Program from the Rural Development Administration, Korea; National Science Foundation Assembling the Tree of Life program(National Science Foundation (NSF))	This study was supported by the grants from the Collaborative Genome Program (20140428) funded by the Ministry of Oceans and Fisheries, the National Research Foundation of Korea (NRF-2017R1A2B3001923), the Next generation BioGreen21 Program (PJ01389003) from the Rural Development Administration, Korea, and by a grant from the National Science Foundation Assembling the Tree of Life program (DEB-0937975, 1317114) to Hwan Su Yoon and Morgan Vis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2931; Brucker G, 2005, PLANTA, V220, P864, DOI 10.1007/s00425-004-1411-6; Campbell MA, 2014, PHYCOLOGIA, V53, P109, DOI 10.2216/13-222.1; Chan CX, 2011, CURR BIOL, V21, P328, DOI 10.1016/j.cub.2011.01.037; Chevreux B, 1999, GERM C BIOINF; Collen J, 2013, P NATL ACAD SCI USA, V110, P5247, DOI 10.1073/pnas.1221259110; Costa JF, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0772-3; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DePriest MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068246; Diaz-Tapia P, 2017, J PHYCOL, V53, P920, DOI 10.1111/jpy.12553; DIXON P.S., 1973, BIOL RHODOPHYTA; Du QW, 2016, J PHYCOL, V52, P441, DOI 10.1111/jpy.12406; Duanmu D, 2013, P NATL ACAD SCI USA, V110, P3621, DOI 10.1073/pnas.1222375110; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emborg TJ, 2006, PLANT PHYSIOL, V140, P856, DOI 10.1104/pp.105.074211; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Frankenberg-Dinkel N, 2004, ANTIOXID REDOX SIGN, V6, P825, DOI 10.1089/ars.2004.6.825; Garcia-Mata C, 2013, PLANT SCI, V201, P66, DOI 10.1016/j.plantsci.2012.11.007; Gisk B, 2010, BIOCHEM J, V425, P425, DOI 10.1042/BJ20090775; Hagopian JC, 2004, J MOL EVOL, V59, P464, DOI 10.1007/s00239-004-2638-3; Halary S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-146; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hilker R, 2012, BIOINFORMATICS, V28, P2509, DOI 10.1093/bioinformatics/bts440; Hughey JR, 2017, J PHYCOL, V53, P32, DOI 10.1111/jpy.12472; Hughey JR, 2016, BOT MAR, V59, P211, DOI 10.1515/bot-2016-0036; Hughey JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep05113; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Janouskovec J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059001; Kadish KM, 2003, PORPHYRIN HDB IRON C; Kamiya M, 2016, PHYCOLOGIA, V55, P640, DOI 10.2216/16-19.1; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapraun DF, 2007, PHYCOLOGIA, V46, P54, DOI 10.2216/06-18.1; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; Kikuchi G, 2005, BIOCHEM BIOPH RES CO, V338, P558, DOI 10.1016/j.bbrc.2005.08.020; Kilpatrick ZM, 2016, MITOCHONDRIAL DNA B, V1, P456, DOI 10.1080/23802359.2016.1182452; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUGRENS P, 1973, Phycologia, V12, P175, DOI 10.2216/i0031-8884-12-3-175.1; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kushibiki A, 2012, PHYCOL RES, V60, P114, DOI 10.1111/j.1440-1835.2012.00643.x; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lam DW, 2016, MOL PHYLOGENET EVOL, V94, P730, DOI 10.1016/j.ympev.2015.10.015; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Le Gall L, 2007, MOL PHYLOGENET EVOL, V43, P1118, DOI 10.1016/j.ympev.2006.11.012; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee JH, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0259-0; Lee J, 2016, SCI REP-UK, V6, DOI 10.1038/srep23744; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; Nan FR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03235-5; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Ng PK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3453-0; Ott F.D, 2009, HDB TAXONOMIC NAMES; Paiano MO, 2018, J PHYCOL, V54, P25, DOI 10.1111/jpy.12602; Panchy N, 2016, PLANT PHYSIOL, V171, P2294, DOI 10.1104/pp.16.00523; Peredo EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068591; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Price DC, 2012, SCIENCE, V335, P843, DOI 10.1126/science.1213561; RHIE GE, 1992, J BIOL CHEM, V267, P16088; Richaud C, 1997, P NATL ACAD SCI USA, V94, P11736, DOI 10.1073/pnas.94.21.11736; Salomaki ED, 2015, J PHYCOL, V51, P217, DOI 10.1111/jpy.12283; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shekhawat GS, 2010, J EXP BOT, V61, P2255, DOI 10.1093/jxb/erq074; Sissini MN, 2016, MITOCHONDRIAL DNA B, V1, P676, DOI 10.1080/23802359.2016.1219636; Song HJ, 2016, ALGAE-SEOUL, V31, P137, DOI 10.4490/algae.2016.31.6.5; Tamayo DA, 2016, MITOCHONDRIAL DNA B, V1, P510, DOI 10.1080/23802359.2016.1192515; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; WOMERSLEY HBS, 1979, AUST J BOT, V27, P459, DOI 10.1071/BT9790459; Zuccarello Giuseppe C., 2011, Algae, V26, P21, DOI 10.4490/algae.2011.26.1.021	75	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196995	10.1371/journal.pone.0196995	http://dx.doi.org/10.1371/journal.pone.0196995			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738547	Green Published, gold, Green Submitted			2022-12-26	WOS:000431724900040
J	Alikhani, M; Alansari, S; Hamidaddin, MA; Sangsuwon, C; Alyami, B; Thirumoorthy, SN; Oliveira, SM; Nervina, JM; Teixeira, CC				Alikhani, Mani; Alansari, Sarah; Hamidaddin, Mohammad A.; Sangsuwon, Chinapa; Alyami, Bandar; Thirumoorthy, Soumya N.; Oliveira, Serafim M.; Nervina, Jeanne M.; Teixeira, Cristina C.			Vibration paradox in orthodontics: Anabolic and catabolic effects	PLOS ONE			English	Article							ACCELERATED TOOTH MOVEMENT; LOW-MAGNITUDE; INCREASES INTERLEUKIN-1-BETA; MECHANICAL VIBRATION; CREVICULAR FLUID; ALVEOLAR BONE; IN-VIVO; MICRODAMAGE; EXPRESSION; FORCES	Vibration in the form of High Frequency Acceleration (HFA) is anabolic on the craniofacial skeleton in the absence of inflammation. Orthodontic forces trigger an inflammation-dependent catabolic cascade that is crucial for tooth movement. It is unknown what effect HFA has on alveolar bone if applied during orthodontic treatment. The objectives of this study are to examine the effect of HFA on the rate of tooth movement and alveolar bone, and determine the mechanism by which HFA affects tooth movement. Adult Sprague Dawley rats were divided to control, orthodontic force alone (OTM), and different experimental groups that received the same orthodontic forces and different HFA regimens. Orthodontic tooth movement was assessed when HFA parameters, frequency, acceleration, duration of exposure, and direct or indirect application were varied. We found that HFA treatment significantly enhanced the inflammation-dependent catabolic cascade during orthodontic tooth movement. HFA treatment increased inflammatory mediators and osteoclastogenesis, and decreased alveolar bone density during orthodontic tooth movement. Each of the HFA variables produced significant changes in the rate of tooth movement and the effect was PDL-dependent. This is the first report that HFA enhances inflammation-dependent catabolic cascades in bone. The clinical implications of our study are highly significant, as HFA can be utilized to enhance the rate of orthodontic tooth movement during the catabolic phase of treatment and subsequently be utilized to enhance retention during the anabolic remodeling phase after orthodontic forces are removed.	[Alikhani, Mani] Harvard Sch Dent Med, Dept Dev Biol, Adv Grad Educ Program Orthodont, Boston, MA USA; [Alikhani, Mani; Alansari, Sarah] Forsyth Inst, Cambridge, MA USA; [Alikhani, Mani; Alansari, Sarah; Hamidaddin, Mohammad A.; Sangsuwon, Chinapa; Alyami, Bandar; Thirumoorthy, Soumya N.; Oliveira, Serafim M.; Nervina, Jeanne M.; Teixeira, Cristina C.] Consortium Translat Orthodont Res, Hoboken, NJ 07030 USA; [Hamidaddin, Mohammad A.; Sangsuwon, Chinapa; Thirumoorthy, Soumya N.; Nervina, Jeanne M.; Teixeira, Cristina C.] NYU, Coll Dent, Dept Orthodont, New York, NY 10003 USA; [Oliveira, Serafim M.] Polytech Inst Viseu, Dept Mech Engn, Viseu, Portugal; [Teixeira, Cristina C.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10003 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Forsyth Institute; New York University; Instituto Politecnico de Viseu; New York University	Teixeira, CC (corresponding author), Consortium Translat Orthodont Res, Hoboken, NJ 07030 USA.; Teixeira, CC (corresponding author), NYU, Coll Dent, Dept Orthodont, New York, NY 10003 USA.; Teixeira, CC (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10003 USA.	cristina.teixeira@nyu.edu	Thirumoorthy, Soumya Narayani/AAB-9521-2021; de Oliveira, Serafim Paulo Melo/Y-3066-2019; Hamidaddin, Mohammad/GXF-1687-2022	Thirumoorthy, Soumya Narayani/0000-0002-1792-9866; de Oliveira, Serafim Paulo Melo/0000-0002-3499-6681; Hamidaddin, Mohammad/0000-0002-5092-264X; Alyami, Bandar/0000-0002-9048-0620	Consortium for Translational Orthodontic Research	Consortium for Translational Orthodontic Research	This work was supported by Consortium for Translational Orthodontic Research.	Alikhani M, 2015, ORTHOD CRANIOFAC RES, V18, P8, DOI 10.1111/ocr.12090; Alikhani M, 2012, J DENT RES, V91, P413, DOI 10.1177/0022034512438590; Alikhani M, 2015, SEMIN ORTHOD, V21, P162, DOI 10.1053/j.sodo.2015.06.002; Andrade I, 2007, J DENT RES, V86, P1089, DOI 10.1177/154405910708601113; Arias OR, 2006, AM J ORTHOD DENTOFAC, V130, P364, DOI 10.1016/j.ajodo.2004.12.027; Nogueira AVB, 2017, J CLIN PERIODONTOL, V44, P31, DOI 10.1111/jcpe.12636; Nogueira AVB, 2013, J PERIODONTOL, V84, P1319, DOI 10.1902/jop.2012.120510; Dahlberg G, 1940, BMJ-BRIT MED J, V14, P358; Di Domenico M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/201689; Dittmer KE, 2017, J VET DIAGN INVEST; Donahue Seth W., 2006, Critical Reviews in Biomedical Engineering, V34, P215, DOI 10.1615/CritRevBiomedEng.v34.i3.20; Fuller K, 2006, ENDOCRINOLOGY, V147, P1979, DOI 10.1210/en.2005-1340; Garman R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000653; Goodship AE, 2009, J ORTHOP RES, V27, P922, DOI 10.1002/jor.20824; Knop LAH, 2012, EUR J ORTHODONT, V34, P531, DOI 10.1093/ejo/cjq173; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Jimi E, 1996, J BIOL CHEM, V271, P4605; Kennedy OD, 2017, BONE, V95, P192, DOI 10.1016/j.bone.2016.11.029; Kitaura H, 2014, SCI WORLD J, DOI 10.1155/2014/617032; Krishnan V, 2009, J DENT RES, V88, P597, DOI 10.1177/0022034509338914; Liao ZP, 2017, J BIOMECH, V60, P57, DOI 10.1016/j.jbiomech.2017.06.012; Miles P, 2012, AUST ORTHOD J, V28, P213; Nishimura M, 2008, AM J ORTHOD DENTOFAC, V133, P572, DOI 10.1016/j.ajodo.2006.01.046; Nunes L, 2017, ARCH ORAL BIOL, V76, P70, DOI 10.1016/j.archoralbio.2017.01.016; Omar H, 2008, J ORAL MAXIL SURG, V66, P1104, DOI 10.1016/j.joms.2008.01.048; Pavlin D, SEMINARS ORTHODONTIC, V21, P187; Ren YJ, 2008, EUR J ORAL SCI, V116, P89, DOI 10.1111/j.1600-0722.2007.00511.x; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Soenjaya Y, 2015, J DENT RES, V94, P1276, DOI 10.1177/0022034515592581; Teixeira CC, 2010, J DENT RES, V89, P1135, DOI 10.1177/0022034510373764; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Verna C, 2000, EUR J ORTHODONT, V22, P343, DOI 10.1093/ejo/22.4.343; Walker JB, 2001, ANN PHARMACOTHER, V35, P113, DOI 10.1345/aph.10185; Wehrle E, 2015, DIS MODEL MECH, V8, P93, DOI 10.1242/dmm.018622; Yadav S, 2016, ANGLE ORTHOD, V86, P740, DOI 10.2319/090615-599.1; Yadav S, 2015, AM J ORTHOD DENTOFAC, V148, P440, DOI 10.1016/j.ajodo.2015.03.031; Yamamoto T, 2017, J CELL COMMUNICATION; Yang Y, 2015, ANGLE ORTHOD, V85, P899, DOI 10.2319/angl-85-05-899-899.1; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	39	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196540	10.1371/journal.pone.0196540	http://dx.doi.org/10.1371/journal.pone.0196540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734391	Green Published, Green Submitted, gold			2022-12-26	WOS:000431481700017
J	Tang, YJ; Debnath, T; Choi, EJ; Kim, YW; Ryu, JP; Jang, S; Chung, SU; Choi, YJ; Kim, EK				Tang, Yujiao; Debnath, Trishna; Choi, Eun-Ju; Kim, Young Wook; Ryu, Jung Pyo; Jang, Sejin; Chung, Sang Uk; Choi, Young-Jin; Kim, Eun-Kyung			Changes in the amino acid profiles and free radical scavenging activities of Tenebrio molitor larvae following enzymatic hydrolysis	PLOS ONE			English	Article							ABSORBENCY CAPACITY ASSAY; ANTIOXIDANT ACTIVITY; EDIBLE INSECTS; IN-VITRO; PROTEIN; PEPTIDES; PURIFICATION; EXTRACT; DIGESTION; PLASMA	Tenebrio molitor (T. molitor) larvae provide food at low environmental cost and contribute positively to livelihoods. In this research, we compared the amino acids compositions and antioxidant activities of various extracts of T. molitor to enhance their quality as food. For the comparison, distilled water extracts, enzymatic hydrolysates, and condensed enzymatic hydrolysates of T. molitor larvae were prepared. Their amino acids (AAs) profiles and antioxidant activities, including ferric-reducing antioxidant power, oxygen radical absorption capacity, and DPPH, hydroxyl radical, and hydrogen peroxide radical scavenging properties assay were analyzed. DW extracts had the lowest AAs contents and antioxidant activity compared with enzymatic extracts. Condensed hydrolysates with a combination of alcalase and flavourzyme (C-A+F) exhibited the highest levels of total free AAs (11.1759 g/100 g). C-A+F produced higher total hydrolyzed AAs (32.5292 g/100 g) compared with the other groups. The C-A+F possessed the strongest antioxidant activity. Notably, the antioxidant activities of the hydrolysates and the total hydrolyzed AAs amount were correlated. Taken together, our findings showed that C-A+F was a promising technique for obtaining extracts of T. molitor larvae with antioxidant activity as potential nutritious functional food.	[Tang, Yujiao] Changchun Univ Sci & Technol, Sch Biosci & Food Engn, Changchun, Jilin, Peoples R China; [Tang, Yujiao; Debnath, Trishna; Chung, Sang Uk; Choi, Young-Jin; Kim, Eun-Kyung] Konkuk Univ, Coll Biomed & Hlth Sci, Div Food Biosci, Chungju, South Korea; [Choi, Eun-Ju] Daegu Catholic Univ, Coll Educ, Dept Phys Educ, Gyongsan, South Korea; [Kim, Young Wook; Ryu, Jung Pyo; Jang, Sejin] Knowledge Cooperat Assoc, R&D Ctr, Korean Edible Insect Lab, Seoul, South Korea	Changchun University of Science & Technology; Konkuk University; Catholic University of Daegu	Kim, EK (corresponding author), Konkuk Univ, Coll Biomed & Hlth Sci, Div Food Biosci, Chungju, South Korea.	eunkyungkim@kku.ac.kr		Kim, Eun-Kyung/0000-0002-4832-6427	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through the Agri-Bio industry Technology Development Program - Ministry of Agriculture, Food and Rural Affairs [316027-5, 116083-3]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2017R1D1A1B03036247]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through the Agri-Bio industry Technology Development Program - Ministry of Agriculture, Food and Rural Affairs; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through the Agri-Bio industry Technology Development Program (316027-5 & 116083-3) funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA to E-K Kim), and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2017R1D1A1B03036247 to E-K Kim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerr-Nissen J, 1986, ENZYMATIC HYDROLYSIS; Aehle W, 2007, ENZYMES IND PRODUCTI, P143; AOAC, 2005, OFFICIAL METHODS ANA; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Binsan W, 2008, FOOD CHEM, V106, P185, DOI 10.1016/j.foodchem.2007.05.065; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; CAO GH, 1993, FREE RADICAL BIO MED, V14, P303, DOI 10.1016/0891-5849(93)90027-R; CHEN ST, 1991, BIOMED BIOCHIM ACTA, V50, pS181; Chung SK, 1997, BIOSCI BIOTECH BIOCH, V61, P118, DOI 10.1271/bbb.61.118; DAVIS GRF, 1975, J NUTR, V105, P1071, DOI 10.1093/jn/105.8.1071; Debnath T, 2011, FOOD CHEM, V128, P697, DOI 10.1016/j.foodchem.2011.03.090; DEFOLIART G, 1992, CROP PROT, V11, P395, DOI 10.1016/0261-2194(92)90020-6; DeFoliart GR, 1997, ECOL FOOD NUTR, V36, P109, DOI 10.1080/03670244.1997.9991510; Dust JM, 2005, J ANIM SCI, V83, P2414; Elias RJ, 2008, CRIT REV FOOD SCI, V48, P430, DOI 10.1080/10408390701425615; Huis A., 2013, EDIBLE INSECTS FUTUR; Jongema Y, 2012, LIST EDIBLE INSECTS; Kim EK, 2009, FOOD CHEM, V114, P1365, DOI 10.1016/j.foodchem.2008.11.035; Kim SY, 2007, J NUTR BIOCHEM, V18, P31, DOI 10.1016/j.jnutbio.2006.02.006; Kristinsson HG, 2000, CRIT REV FOOD SCI, V40, P43, DOI 10.1080/10408690091189266; Lee KG, 2000, J AGR FOOD CHEM, V48, P4817, DOI 10.1021/jf000237e; Ma Y., 2014, ADV J FOOD SCI TECHN, V6, P1027, DOI [10.19026/ajfst.6.153, DOI 10.19026/AJFST.6.153]; Merz M, 2015, J AGR FOOD CHEM, V63, P5682, DOI 10.1021/acs.jafc.5b01665; Mizani M, 2005, FOOD SCI TECHNOL INT, V11, P49, DOI 10.1177/1082013205051271; Nchienzia HA, 2010, POULTRY SCI, V89, P2273, DOI 10.3382/ps.2008-00558; Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o; Park PJ, 2005, J AGR FOOD CHEM, V53, P6666, DOI 10.1021/jf050582+; Park SC, 1995, European patent (EP), Patent No. [0631778 A1, 0631778]; Power O, 2013, AMINO ACIDS, V44, P797, DOI 10.1007/s00726-012-1393-9; Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256; Ramakrishnan V.V., 2013, J BIOPROCESS BIOTECH, V3, P2, DOI DOI 10.4172/2155-9821.1000130; Rao SQ, 2012, FOOD CHEM, V135, P1245, DOI 10.1016/j.foodchem.2012.05.059; Rumpold BA, 2013, MOL NUTR FOOD RES, V57, P802, DOI 10.1002/mnfr.201200735; Ruzzo EK, 2013, NEURON, V80, P429, DOI 10.1016/j.neuron.2013.08.013; SHAHIDI F, 1995, FOOD CHEM, V53, P285, DOI 10.1016/0308-8146(95)93934-J; Shyamkumar Rajaram, 2014, Avicenna Journal of Medical Biotechnology, V6, P163; Van Huis A, 2013, EDIBLE INSECTS FUTUR, P75; Vercruysse L, 2009, FOOD CHEM, V114, P38, DOI 10.1016/j.foodchem.2008.09.011; Wu JL, 2013, FOOD HYDROCOLLOID, V32, P42, DOI 10.1016/j.foodhyd.2012.11.029; Xiaoming C., 2010, REV NUTRITIVE VALUE; Zhou KQ, 2012, FOOD CHEM, V135, P1192, DOI 10.1016/j.foodchem.2012.05.063	41	24	26	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2018	13	5							e0196218	10.1371/journal.pone.0196218	http://dx.doi.org/10.1371/journal.pone.0196218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE7ZR	29727456	Green Published, gold, Green Submitted			2022-12-26	WOS:000431452100004
J	Cheddani, L; Radulescu, C; Chaignon, M; Karras, A; Neuzillet, Y; Duong, JP; Tabibzadeh, N; Letavernier, E; Delahousse, M; Haymann, JP				Cheddani, Lynda; Radulescu, Camelia; Chaignon, Michel; Karras, Alexandre; Neuzillet, Yann; Duong, Jean-Paul; Tabibzadeh, Nahid; Letavernier, Emmanuel; Delahousse, Michel; Haymann, Jean-Philippe			From arterial stiffness to kidney graft microvasculature: Mortality and graft survival within a cohort of 220 kidney transplant recipients	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; AORTIC STIFFNESS; INDEPENDENT PREDICTOR; RENAL-TRANSPLANTATION; ALL-CAUSE; DIALYSIS; DISEASE; DIET	Background Aortic stiffness assessed by carotid-femoral pulse wave velocity (CF-PWV) is a predictor of mortality in several populations. However, little is known in kidney transplant recipients. Our objectives were to evaluate the ability of CF-PWV measured 3 months following transplantation to predict mortality, graft loss and its potential links to measured Glomerular Filtration Rate (mGFR) or kidney graft microvasculature parameters. Methods The study is based on a monocentric retrospective cohort including 220 adult kidney graft recipients evaluated three months after transplantation. CF-PWV measures, clinical, laboratory and histological data performed at 3 (M3) and 12 months (M12) following transplantation were retrospectively collected. The two primary endpoints were all-cause mortality and occurrence of end stage renal disease (ESRD) defined by initiation of dialysis. Results After a median follow up of 5.5 years [1.9; 8.8], death and graft loss occurred in 10 and 12 patients respectively. M3 CF-PWV was an independent mortality risk factor (HR = 1.29 [1.03; 1.61]; p = 0.03), despite no aortic stiffness variation during the first year of transplantation. Of notice, M3 CF-PWV was not associated with M12 mGFR or ESRD outcome. Graft microcirculation assessed by Banff vascular fibrous intimal thickening score (cv) worsened between M3 and M12 (p = 0.01), but no link was found with CF-PWV, mGFR or ESRD outcome. Surprisingly, acute rejections at M3 were associated after adjustment with mortality (p = 0.03) but not ESRD. Conclusion Aortic stiffness measured 3 months after kidney transplantation is a strong predictor of mortality with no obvious influence on kidney graft microvasculature or graft loss.	[Cheddani, Lynda; Chaignon, Michel; Tabibzadeh, Nahid; Letavernier, Emmanuel; Haymann, Jean-Philippe] Hop Tenon, AP HP, Serv Explorat Fonctionnelles Multidisciplinaires, Paris, France; [Cheddani, Lynda; Tabibzadeh, Nahid; Letavernier, Emmanuel; Haymann, Jean-Philippe] Sorbonne Univ, Hop Tenon, AP HP, UMR S 1155,INSERM, Paris, France; [Radulescu, Camelia] Hop Foch, Serv Anatomopathol, Suresnes, France; [Karras, Alexandre] Hop Europeen Georges Pompidou, AP HP, Serv Nephrol, Paris, France; [Karras, Alexandre] Univ Paris 05, Paris, France; [Karras, Alexandre] INSERM, U970, PARCC, Paris, France; [Neuzillet, Yann] Hop Foch, Serv Urol, Suresnes, France; [Duong, Jean-Paul] Hop Necker Enfants Malad, AP HP, Serv Anatomopathol, Paris, France; [Delahousse, Michel] Hop Foch, Serv Nephrol & Transplantat Renale, Suresnes, France; [Delahousse, Michel] INSERM, U1018, Villejuif, France; [Delahousse, Michel] EpReC, Renal & Cardiovasc Epidemiol, CESP Team 5, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Haymann, JP (corresponding author), Hop Tenon, AP HP, Serv Explorat Fonctionnelles Multidisciplinaires, Paris, France.; Haymann, JP (corresponding author), Sorbonne Univ, Hop Tenon, AP HP, UMR S 1155,INSERM, Paris, France.	jean-philippe.haymann@aphp.fr		Tabibzadeh, Nahid/0000-0001-5803-0163; RADULESCU, Camelia/0000-0002-3704-8679	Agence Regionale de Sante, Normandie, France; ARS Normandie	Agence Regionale de Sante, Normandie, France; ARS Normandie	This work was supported by Agence Regionale de Sante, Normandie, France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank ARS Normandie for providing a personal research fellowship to Lynda Cheddani. We do thank very much Mrs Canan Herel and Mrs Alice Perchenet for their expert technical assistance.	ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485; Bachelet-Rousseau C, 2011, NEPHROL DIAL TRANSPL, V26, P3386, DOI 10.1093/ndt/gfr058; Bahous SA, 2015, AM J NEPHROL, V41, P57, DOI 10.1159/000371858; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Blacher J, 1998, HYPERTENSION, V32, P570, DOI 10.1161/01.HYP.32.3.570; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; Briet M, 2006, KIDNEY INT, V69, P350, DOI 10.1038/sj.ki.5000047; Covic A, 2003, TRANSPLANTATION, V76, P1573, DOI 10.1097/01.TP.0000086343.32903.A8; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Dahle DO, 2015, TRANSPLANTATION, V99, P1730, DOI 10.1097/TP.0000000000000660; Delahousse M, 2008, J AM SOC NEPHROL, V19, P798, DOI 10.1681/ASN.2007060634; Ferro CJ, 2002, KIDNEY INT, V62, P166, DOI 10.1046/j.1523-1755.2002.00407.x; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; Halloran PF, 1999, J AM SOC NEPHROL, V10, P167; Karras A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006078; Laurent S, 2003, STROKE, V34, P1203, DOI 10.1161/01.STR.0000065428.03209.64; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; London GM, 1997, KIDNEY INT, V51, P1678, DOI 10.1038/ki.1997.233; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Ojo AO, 2006, TRANSPLANTATION, V82, P603, DOI 10.1097/01.tp.0000235527.81917.fe; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Tabibzadeh N, 2016, CLIN TRANSPLANT, V30, P1480, DOI 10.1111/ctr.12843; Van Bortel LM, 2012, J HYPERTENS, V30, P445, DOI 10.1097/HJH.0b013e32834fa8b0; Verbeke F, 2011, HYPERTENSION, V58, P833, DOI 10.1161/HYPERTENSIONAHA.111.176594; Vincenti F, 2016, NEW ENGL J MED, V374, P333, DOI 10.1056/NEJMoa1506027; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	27	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5								10.1371/journal.pone.0195928	http://dx.doi.org/10.1371/journal.pone.0195928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723212	Green Published, Green Submitted, gold			2022-12-26	WOS:000431305100010
J	Heather, FJ; Childs, DZ; Darnaude, AM; Blanchard, JL				Heather, F. J.; Childs, D. Z.; Darnaude, A. M.; Blanchard, J. L.			Using an integral projection model to assess the effect of temperature on the growth of gilthead seabream Sparus aurata	PLOS ONE			English	Article							MASS MORTALITY; CLIMATE-CHANGE; THAU LAGOON; BODY-SIZE; AGE; EVOLUTION; SHRINKING; OTOLITH	Accurate information on the growth rates of fish is crucial for fisheries stock assessment and management. Empirical life history parameters (von Bertalanffy growth) are widely fitted to cross-sectional size-at-age data sampled from fish populations. This method often assumes that environmental factors affecting growth remain constant over time. The current study utilized longitudinal life history information contained in otoliths from 412 juveniles and adults of gilthead seabream, Sparus aurata, a commercially important species fished and farmed throughout the Mediterranean. Historical annual growth rates over 11 consecutive years (2002-2012) in the Gulf of Lions (NW Mediterranean) were reconstructed to investigate the effect of temperature variations on the annual growth of this fish. S. aurata growth was modelled linearly as the relationship between otolith size at year t against otolith size at the previous year t-1. The effect of temperature on growth was modelled with linear mixed effects models and a simplified linear model to be implemented in a cohort Integral Projection Model (cIPM). The cIPM was used to project S. aurata growth, year to year, under different temperature scenarios. Our results determined current increasing summer temperatures to have a negative effect on S. aurata annual growth in the Gulf of Lions. They suggest that global warming already has and will further have a significant impact on S. aurata size-at-age, with important implications for age-structured stock assessments and reference points used in fisheries.	[Heather, F. J.; Childs, D. Z.] Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield, S Yorkshire, England; [Darnaude, A. M.] Univ Montpellier, IFREMER, CNRS, MARBEC,IRD Montpellier, Pl Eugene Bataillon, Montpellier, France; [Blanchard, J. L.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	University of Sheffield; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Tasmania	Heather, FJ (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield, S Yorkshire, England.	freddieheather@gmail.com	Darnaude, Audrey M/D-1745-2014; Darnaude, Audrey M/AAH-9026-2020; Blanchard, Julia L/E-4919-2010; Heather, Freddie J./ABG-8120-2020; Childs, Dylan/P-7388-2018	Darnaude, Audrey M/0000-0001-7129-3902; Blanchard, Julia L/0000-0003-0532-4824; Heather, Freddie J./0000-0002-1650-2617; Childs, Dylan/0000-0002-0675-4933	French Government; TOTAL Foundation [ANR 07-JCJC-0135]; French National Research Agency; European Research Fund; French Languedoc-Roussillon Region [FEDER_C_137776 / REGION_CT_126549]; Australian Research Council [DP170104240]	French Government; TOTAL Foundation(Total SA); French National Research Agency(French National Research Agency (ANR)); European Research Fund; French Languedoc-Roussillon Region(Region Occitanie); Australian Research Council(Australian Research Council)	For fish collection, the funding bodies were the French Government and the TOTAL Foundation through the research project LAGUNEX: Export de carbone par les poissons lagunaires a l'interface mer-continent: caracterisation et quantification (ANR 07-JCJC-0135, PI = Audrey Darnaude). For otolith preparations, the funding bodies were the French National Research Agency and the TOTAL Foundation through the research project LAGUNEX: Export de carbone par les poissons lagunaires a ('interface mer-continent: caracterisation et quantification (ANR 07-JCJC-0135, PI = Audrey Darnaude) and the European Research Fund and the French Languedoc-Roussillon Region through the research project BOUCLEDOR: Boucler le cycle de vie de la dorade royale dans le Golfe du Lion (FEDER_C_137776 / REGION_CT_126549, PI = Audrey Darnaude). URL: http://www.agence.nationale-recherche.fr; http://fondation.total/; http://en.europe-en-france.gouv.fr/; http://www.laregion.fr/. For otolith imaging, the funding body was the Australian Research Council Discovery Grant (DP170104240, PI=Julia Blanchard). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTRALDI M, 1995, OCEANOL ACTA, V18, P139; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Audouin J., 1962, Revues des Travaux Inst Peches Marit, V26, P105; Audzijonyte A, 2016, FISH FISHERIES; Basset A., 2013, Transitional Waters Bulletin, V7, P1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baudron AR, 2014, GLOBAL CHANGE BIOL; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; Blanchard JL, 2011, OIKOS, V120, P481, DOI 10.1111/j.1600-0706.2010.19564.x; Brett J., 1979, FISH PHYSIOL, V8, P279, DOI DOI 10.1016/S1546-5098(08)60029-1; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; Campana SE, 2005, MAR FRESHWATER RES, V56, P485, DOI 10.1071/MF04147; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Childs DZ, 2003, P ROY SOC B-BIOL SCI, V270, P1829, DOI 10.1098/rspb.2003.2399; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Crespi V, 2002, FISHERIES MANAG ECOL, V9, P19, DOI 10.1046/j.1365-2400.2002.00275.x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Ellner S. P., 2016, DATA DRIVEN MODELLIN; European Commision, GILTH SEABR 2014; FAO, 2016, STATE WORLD FISHERIE; FAO, 2013, FISHSTATJ SOFTW FISH; Feidantsis K, 2009, MAR BIOL, V156, P797, DOI 10.1007/s00227-009-1135-z; FORD E., 1933, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V19, P305; FRANCIS RICC, 1990, J FISH BIOL, V36, P883, DOI 10.1111/j.1095-8649.1990.tb05636.x; Fry F.E.J., 1971, FISH PHYSL, V6, P1; Gallardo MA, 2003, AQUACULTURE, V223, P15, DOI 10.1016/S0044-8486(03)00164-9; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Giorgi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025734; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Goulletquer P, 2005, CULT AQ SPEC INF PRO; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Ibarz A, 2010, REV FISH BIOL FISHER, V20, P539, DOI 10.1007/s11160-010-9159-5; Isnard E, 2012, COMPARISON CONDITION; Ivleva I., 1973, POL ARCH HYDROBIOL, V20, P283; Jennings S., 2001, MARINE FISHERIES ECO; Katsanevakis S, 2008, FISH FISH, V9, P178, DOI 10.1111/j.1467-2979.2008.00279.x; Lasserre G, 1976, DYNAMIQUE POPULATION; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Magnoni LJ, 2017, BIOL OPEN; Mercier L, 2012, MAR ECOL PROG SER, V444, P175, DOI 10.3354/meps09444; Mercier L, 2011, ESTUAR COAST SHELF S, V92, P534, DOI 10.1016/j.ecss.2011.02.001; Miller John M., 1990, PRINCIPLES HYDRAULIC; Minghelli-Roman A, 2011, INT J REMOTE SENS, V32, P909, DOI 10.1080/01431160903485794; Moore J, 2014, C 99 ESA ANN CONV 20; Morrongiello JR, 2012, NAT CLIM CHANGE, V2, P849, DOI [10.1038/NCLIMATE1616, 10.1038/nclimate1616]; Munro IL., 1983, FISHBYTE ICLARM, V1, P5; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neuheimer AB, 2007, CAN J FISH AQUAT SCI, V64, P375, DOI 10.1139/F07-003; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; Okte E, 2002, TURKISH J FISHERIES; Okte E., 2002, TURKISH J FISHERIES, V2; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Parsons TR, 2013, BIOL OCEANOGRAPHIC P; Pauly D., 1984, ICLARM Technical Reports, P1; Perry SF, 2009, FISH PHYSIOL, V27, P193, DOI 10.1016/S1546-5098(08)00005-8; Pineiro C, 2003, ICES J MAR SCI, V60, P1086, DOI 10.1016/S1054-3139(03)00086-9; PORTNER HO, 1993, VERTEBRATE GAS TRANSPORT CASCADE, P330; RCore Team, 2020, R LANG ENV STAT COMP; Remen M, 2015, EFFECT TEMPERATURE M; Rijnsdorp AD, 2010, ICES J MAR SCI, V67, P1931, DOI 10.1093/icesjms/fsq049; Sara G, 2005, J MAR BIOL ASSOC UK, V85, P191, DOI 10.1017/S0025315405011057h; SECOR DH, 1989, CAN J FISH AQUAT SCI, V46, P113, DOI 10.1139/f89-015; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Steffani CN, 2003, MAR ECOL PROG SER, V246, P197, DOI 10.3354/meps246197; Tournois J, 2017, LIMNOL OCEANOGR, V62, P1219, DOI 10.1002/lno.10496; Tournois J, 2013, ESTUAR COAST SHELF S, V131, P182, DOI 10.1016/j.ecss.2013.07.006; Ulltang O, 2003, SCI MAR, V67, P5, DOI 10.3989/scimar.2003.67s15; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; WALFORD LA, 1946, BIOL BULL, V90, P141, DOI 10.2307/1538217; Weiss R, 1970, DEEP SEA RES OCEANOG	71	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196092	10.1371/journal.pone.0196092	http://dx.doi.org/10.1371/journal.pone.0196092			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723211	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000431305100012
J	Tran-Duy, A; Smerdon, DC; Clarke, PM				Tran-Duy, An; Smerdon, David C.; Clarke, Philip M.			Longevity of outstanding sporting achievers: Mind versus muscle	PLOS ONE			English	Article							CHESS PLAYERS; LIVE LONGER; INTELLIGENCE; HEALTH; PERFORMANCE; EXPERTISE; IMPACT; BRAIN	Background While there is strong evidence showing the survival advantage of elite athletes, much less is known about those engaged in mind sports such as chess. This study aimed to examine the overall as well as regional survival of International Chess Grandmasters (GMs) with a reference to the general population, and compare relative survival (RS) of GMs with that of Olympic medallists (OMs). Methods Information on 1,208 GMs and 15,157 OMs, respectively, from 28 countries were extracted from the publicly available data sources. The Kaplan-Meier method was used to estimate the survival rates of the GMs. A Cox proportional hazards model was used to adjust the survival for region, year at risk, age at risk and sex, and to estimate the life expectancy of the GMs. The RS rate was computed by matching each GM or OM by year at risk, age at risk and sex to the life table of the country the individual represented. Results The survival rates of GMs at 30 and 60 years since GM title achievement were 87% and 15%, respectively. The life expectancy of GMs at the age of 30 years (which is near the average age when they attained a GM title) was 53.6 ([95% CI]: 47.7-58.5) years, which is significantly greater than the overall weighted mean life expectancy of 45.9 years for the general population. Compared to Eastern Europe, GMs in North America (HR [95% CI]: 0.51 [0.29-0.88]) and Western Europe (HR [95% CI]: 0.53 [0.34-0.83]) had a longer lifespan. The RS analysis showed that both GMs and OMs had a significant survival advantage over the general population, and there was no statistically significant difference in the RS of GMs (RS [95% CI]: 1.14 [1.08-1.20]) compared to OMs: (RS [95% CI]: 1.09 [1.07-1.11]) at 30 years. Conclusion Elite chess players live longer than the general population and have a similar survival advantage to elite competitors in physical sports.	[Tran-Duy, An; Clarke, Philip M.] Univ Melbourne, Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia; [Smerdon, David C.] Univ Queensland, Sch Econ, Brisbane, Qld, Australia	University of Melbourne; University of Queensland	Tran-Duy, A (corresponding author), Univ Melbourne, Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia.	an.tran@unimelb.edu.au	Smerdon, David/ABA-1992-2020	Smerdon, David/0000-0002-2418-9069; Tran-Duy, An/0000-0003-0224-2858	Centre of Excellence in Population Ageing Research, Australian Research Council [CE170100005]; Australian Research Council Centre of Excellence in Population Ageing Research [CE170100005]	Centre of Excellence in Population Ageing Research, Australian Research Council; Australian Research Council Centre of Excellence in Population Ageing Research(Australian Research Council)	This work was supported by the Centre of Excellence in Population Ageing Research, Australian Research Council (CE170100005 awarded to Prof. Philip M Clarke). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Bill Mallon for his compilation and provision of the OlyMADMen database, and Simon Walter for his provision of the R code which was adapted for the relative survival analysis in the present study. This research was financially supported by the Australian Research Council Centre of Excellence in Population Ageing Research (project number CE170100005). Our study was approved by the Human Research Ethics Committee of Melbourne School of Population and Global Health (MSPGH), the University of Melbourne (Ethics ID: 1851109.1).	Addley E., 2014, GUARDIAN; Amidzic O, 2001, NATURE, V412, P603, DOI 10.1038/35088119; Antero-Jacquemin J, 2015, AM J SPORT MED, V43, P1505, DOI 10.1177/0363546515574691; Asimov I, 1987, FANTASTIC VOYAGE; BARRY H, 1969, J GENET PSYCHOL, V115, P143, DOI 10.1080/00221325.1969.10533881; Bergland, 2013, PSYCHOL TODAY; Bernstein S, 2012, KRITIKA, V13, P395, DOI 10.1353/kri.2012.0030; Bilalic M, 2007, INTELLIGENCE, V35, P457, DOI 10.1016/j.intell.2006.09.005; Chen XC, 2003, COGNITIVE BRAIN RES, V16, P32, DOI 10.1016/S0926-6410(02)00206-9; Clarke PM, 2015, BMJ-BRIT MED J, V345, pe8308; Eysenck W, 2009, SOC BEHAV PERSONAL, V37, P149, DOI 10.2224/sbp.2009.37.2.149; FEINSTEIN JS, 1993, MILBANK Q, V71, P279, DOI 10.2307/3350401; FIDE, 2017, WORLD CHESS FED; FIELLER EC, 1954, J ROY STAT SOC B, V16, P175; FINE R, 1967, PSYCHOL CHESS PLAYER; Fornal-Urban Agnieszka, 2009, Pediatr Endocrinol Diabetes Metab, V15, P177; Garatachea N, 2014, MAYO CLIN PROC, V89, P1195, DOI 10.1016/j.mayocp.2014.06.004; Glickman M. E., 1995, AM CHESS J, V3, P59; Gottfredson LS, 2004, CURR DIR PSYCHOL SCI, V13, P1, DOI 10.1111/j.0963-7214.2004.01301001.x; Grabner RH, 2007, ACTA PSYCHOL, V124, P398, DOI 10.1016/j.actpsy.2006.07.008; Grabner RH, 2014, INTELLIGENCE, V45, P26, DOI 10.1016/j.intell.2013.07.023; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hanggi J, 2014, NEUROPSYCHOLOGIA, V62, P152, DOI 10.1016/j.neuropsychologia.2014.07.019; HAKULINEN T, 1982, BIOMETRICS, V38, P933, DOI 10.2307/2529873; Kamper E., 1992, GOLDEN BOOK OLYMPIC; Langan F, 2012, GLOBE MAIL; Lemez S, 2016, THESIS; Lemez S, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0024-x; Li KM, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.44; Markham I., 2014, TELEGRAPH; Nejati Majid, 2012, Acta Med Iran, V50, P311; Rupert G Miller, 1981, SURVIVAL ANAL; SIMONTON DK, 1988, PSYCHOL BULL, V104, P251, DOI 10.1037/0033-2909.104.2.251; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; Stefani R, 2011, J QUANTITATIVE ANAL, V7, P1; Sylvestre MP, 2006, ANN INTERN MED, V145, P361, DOI 10.7326/0003-4819-145-5-200609050-00009; TALLIS GM, 1988, STAT MED, V7, P483, DOI 10.1002/sim.4780070405; Teramoto M, 2010, J SCI MED SPORT, V13, P410, DOI 10.1016/j.jsams.2009.04.010; The International Olympic Committee, 2018, ATHL; Troubat N, 2009, EUR J APPL PHYSIOL, V105, P343, DOI 10.1007/s00421-008-0908-2; Unterrainer JM, 2011, AM J PSYCHOL, V124, P213, DOI 10.5406/amerjpsyc.124.2.0213; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Waters AJ, 2002, BRIT J PSYCHOL, V93, P557, DOI 10.1348/000712602761381402; TITLE ERROR, DOI DOI 10.1172/JCI58813	44	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196938	10.1371/journal.pone.0196938	http://dx.doi.org/10.1371/journal.pone.0196938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE6AF	29723296	Green Published, Green Submitted, gold			2022-12-26	WOS:000431305100093
J	Zhang, B; Chen, MN; Zhang, YM; Chen, W; Zhang, LH; Chen, L				Zhang, Bo; Chen, Mingna; Zhang, Youming; Chen, Wei; Zhang, Lihua; Chen, Lv			An ultrasonic nanobubble-mediated PNP/fludarabine suicide gene system: A new approach for the treatment of hepatocellular carcinoma	PLOS ONE			English	Article							NUCLEOSIDE PHOSPHORYLASE GENE; IN-VITRO; DRUG-DELIVERY; RISK-FACTORS; THERAPY; MICROBUBBLES; EXPRESSION; CELLS; EPIDEMIOLOGY; OPTIMIZATION	Objective The purpose of this study is to generate an ultrasonic nanobubble (NB)-mediated purine nucleoside phosphorylase (PNP)/fludarabine suicide gene system for the treatment of human hepatocellular carcinoma (HCC). Methods NBs were prepared from a mixture the phospholipids 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1,2-dipalmitoyl-sn-glycero-3-phosphate (DPPA), perfluoropropane gas and other materials using the high shear dispersion method. NBs treated with ultrasound irradiation functioned as a gene-transfer system, and a self-constructed suicide gene expression plasmid, pcDNA3.1(+)/PNP, treated with fludarabine functioned as a therapeutic gene. This system was used to determine the cytotoxic effects of PNP/fludarabine on HepG2 cells and SMMC7721 cells. Results 1. NBs with a small diameter (208-416 nm) and at a high concentration and fine homogeneity were prepared under the optimal method. 2. The pcDNA3.1(+)/PNP plasmid was efficiently transfected into HCC cells using ultrasonic NBs. 3. At 0.75 mu g/ml fludarabine, PNP/fludarabine showed marked cytotoxic effects toward HepG2 and SMMC7721 cells. PNP/fludarabine achieved the same effect against both SMMC7721 and HepG2 cells but at a lower concentration of fludarabine for the latter. 4. Bystander effects: a 10-20% decrease in the cell survival rate was observed when only 5-10% of transfected cells were PNP positive. Conclusions NBs constitute a non-toxic, stable and effective gene-delivery platform. The PNP/fludarabine suicide gene system inhibited the growth of HCC cells, induced HCC cell apoptosis, and caused a notable bystander effect at a low fludarabine concentration. This study establishes an important new method for miniaturizing microbubbles and improving a new NB-mediated approach for gene therapy of HCC.	[Zhang, Bo; Chen, Mingna] Cent S Univ, Xiangya Hosp, Dept Ultrason Imaging, Changsha, Hunan, Peoples R China; [Zhang, Youming] Cent S Univ, Xiangya Hosp, Dept Radiol, Changsha, Hunan, Peoples R China; [Chen, Wei; Zhang, Lihua] Cent S Univ, Hepatobiliary & Enter Surg Res Ctr, Dept Radiol, Changsha, Hunan, Peoples R China; [Chen, Lv] Cent S Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Chen, L (corresponding author), Cent S Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Changsha, Hunan, Peoples R China.	chenlv@csu.edu.cn						Abou-Saleh RH, 2013, LANGMUIR, V29, P4096, DOI 10.1021/la304093t; BI WL, 1993, HUM GENE THER, V4, P725, DOI 10.1089/hum.1993.4.6-725; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Chacko S, 2016, BIOMED PHARMACOTHER; Deng LW, 2014, J NANOSCI NANOTECHNO, V14, P2947, DOI 10.1166/jnn.2014.8633; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; Eisenbrey JR, 2010, J CONTROL RELEASE, V143, P38, DOI 10.1016/j.jconrel.2009.12.021; Fu S, 2017, CLIN RES HEPATOL GAS; Fujii H, 2011, EUR HEART J, V32, P2075, DOI 10.1093/eurheartj/ehq475; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Guo ZH, 2011, MOL BIOTECHNOL, V48, P138, DOI 10.1007/s12033-010-9354-6; Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Kikuchi E, 2007, CANCER GENE THER, V14, P279, DOI 10.1038/sj.cgt.7701013; Lai CY, 2006, ULTRASOUND MED BIOL, V32, P1931, DOI 10.1016/j.ultrasmedbio.2006.06.020; Lo CW, 2014, ULTRASON SONOCHEM, V21, P833, DOI 10.1016/j.ultsonch.2013.10.017; Mao CY, 2015, ONCOTARGET, V6, P5707, DOI 10.18632/oncotarget.3302; Mohr L, 2000, HEPATOLOGY, V31, P606, DOI 10.1002/hep.510310310; Perera RH, 2017, NANOMED-NANOTECHNOL, V13, P59, DOI 10.1016/j.nano.2016.08.020; Qiu Y., 2010, INT J CHEM ENG, V2010, P10, DOI DOI 10.1016/J.BI0MATERIALS.2010.06.051; Qu LL, 2013, ONCOL REP, V29, P1435, DOI 10.3892/or.2013.2248; Shi LX, 2016, VIRUS RES, V223, P131, DOI 10.1016/j.virusres.2016.06.008; Sia KC, 2012, GENE THER, V19, P532, DOI 10.1038/gt.2011.131; Suzuki M, 2008, MOL THER, V16, P1727, DOI 10.1038/mt.2008.175; Tai CK, 2010, CANCER GENE THER, V17, P614, DOI 10.1038/cgt.2010.17; Tardy I, 2010, INVEST RADIOL, V45, P573, DOI 10.1097/RLI.0b013e3181ee8b83; Toaldo MB, 2015, MOL IMAGING BIOL, V17, P29, DOI 10.1007/s11307-014-0764-x; Wang LF, 2013, PROSTATE, V73, P1147, DOI 10.1002/pros.22663; Zhou SJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-170	29	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196686	10.1371/journal.pone.0196686	http://dx.doi.org/10.1371/journal.pone.0196686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718963	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900070
J	Liu, XJ; Wu, XY; Wang, H; Wang, SX; Kong, W; Zhang, L; Liu, G; Huang, W				Liu, Xue-Jing; Wu, Xiao-Yue; Wang, Huan; Wang, Su-Xia; Kong, Wei; Zhang, Ling; Liu, George; Huang, Wei			Renal injury in Seipin-deficient lipodystrophic mice and its reversal by adipose tissue transplantation or leptin administration alone: adipose tissue-kidney crosstalk	FASEB JOURNAL			English	Article						fatty acid oxidation; glucolipotoxicity; glycosuria; Glut2	FATTY-ACID OXIDATION; CONGENITAL GENERALIZED LIPODYSTROPHY; INSULIN-RESISTANCE; MOUSE MODEL; GLUCOSE-TOLERANCE; IMMUNE-RESPONSE; GLYCOSURIA; BSCL2/SEIPIN; NEPHROPATHY; ADIPONECTIN	Seipin deficiency is responsible for type 2 congenital generalized lipodystrophy with severe loss of adipose tissue (AT) and could lead to renal failure in humans. However, the effect of Seipin on renal function is poorly understood. Here we report that Seipin knockout (SKO) mice exhibited impaired renal function, enlarged glomerular and mesangial surface areas, renal depositions of lipid, and advanced glycation end products. Elevated glycosuria and increased electrolyte excretion were also detected. Relative renal gene expression in fatty acid oxidation and reabsorption pathways were impaired in SKO mice. Elevated glycosuria might be associated with reduced renal glucose transporter 2 levels. To improve renal function, AT transplantation or leptin administration alone was performed. Both treatments effectively ameliorated renal injury by improving all of the parameters that were measured in the kidney. The treatments also rescued insulin resistance and low plasma leptin levels in SKO mice. Our findings demonstrate for the first time that Seipin deficiency induces renal injury, which is closely related to glucolipotoxicity and impaired renal reabsorption in SKO mice, and is primarily caused by the loss of AT and especially the lack of leptin. AT transplantation and leptin administration are two effective treatments for renal injury in Seipin-deficient mice.Liu, X.-J., Wu, X.-Y., Wang, H., Wang, S.-X., Kong, W., Zhang, L., Liu, G., Huang, W. Renal injury in Seipin-deficient lipodystrophic mice and its reversal by adipose tissue transplantation or leptin administration alone: adipose tissue-kidney crosstalk.	[Liu, Xue-Jing; Wu, Xiao-Yue; Wang, Huan; Zhang, Ling; Liu, George; Huang, Wei] Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Cardiovasc Sci, Beijing 100191, Peoples R China; [Liu, Xue-Jing; Wu, Xiao-Yue; Wang, Huan; Kong, Wei; Zhang, Ling; Liu, George; Huang, Wei] Peking Univ, Hlth Sci Ctr, Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China; [Wang, Su-Xia] Peking Univ, Hosp 1, Dept Med, Renal Div, Beijing, Peoples R China; [Wang, Su-Xia] Minist Hlth China, Key Lab Renal Dis, Beijing, Peoples R China; [Wang, Su-Xia] Peking Univ, Inst Nephrol, Sch Basic Med Sci, Beijing, Peoples R China; [Kong, Wei] Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University	Huang, W (corresponding author), Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Cardiovasc Sci, Beijing 100191, Peoples R China.; Huang, W (corresponding author), Peking Univ, Hlth Sci Ctr, Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China.	huangwei@bjmu.edu.cn		Liu, Xuejing/0000-0002-3931-0191	National Science Foundation of China [81470553, 81770448]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (81470553 and 81770448). The authors are grateful to Prof. H. Liu (Peking University) for assistance in describing the pathologic changes. The authors declare no conflicts of interest.	Antuna-Puente B, 2010, J CLIN ENDOCR METAB, V95, P1463, DOI 10.1210/jc.2009-1824; Azeloglu EU, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004621; Capeau J, 2010, ENDOCR DEV, V19, P1, DOI 10.1159/000316893; Chhabra KH, 2017, MOL METAB, V6, P1274, DOI 10.1016/j.molmet.2017.07.005; Chhabra KH, 2016, DIABETES, V65, P660, DOI 10.2337/db15-0804; Chong AY, 2010, DIABETOLOGIA, V53, P27, DOI 10.1007/s00125-009-1502-9; Colombo C, 2002, DIABETES, V51, P2727, DOI 10.2337/diabetes.51.9.2727; Cortes VA, 2014, J LIPID RES, V55, P276, DOI 10.1194/jlr.M045799; Cui X, 2011, HUM MOL GENET, V20, P3022, DOI 10.1093/hmg/ddr205; Ebihara K, 2001, DIABETES, V50, P1440, DOI 10.2337/diabetes.50.6.1440; Faria CA, 2009, EUROPACE, V11, P763, DOI 10.1093/europace/eup095; Fink L, 1998, NAT MED, V4, P1329, DOI 10.1038/3327; Friedman JM, 2010, NAT MED, V16, P1100, DOI 10.1038/nm1010-1100; Garfield AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045790; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Gomes KB, 2005, J INHERIT METAB DIS, V28, P1123, DOI 10.1007/s10545-005-0038-5; Goto K, 2016, INT IMMUNOL, V28, P197, DOI 10.1093/intimm/dxv067; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Huang W, 2001, P NATL ACAD SCI USA, V98, P13330, DOI 10.1073/pnas.231476798; Javor ED, 2004, J CLIN ENDOCR METAB, V89, P3199, DOI 10.1210/jc.2003-032140; Joubert M, 2017, DIABETES, V66, P1030, DOI 10.2337/db16-0733; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Liu L, 2014, DIABETES, V63, P2320, DOI 10.2337/db13-0729; Momken I, 2017, BIOCHEM J, V474, P149, DOI 10.1042/BCJ20160804; MOORHEAD JF, 1982, LANCET, V2, P1309; Musso C, 2006, CLIN J AM SOC NEPHRO, V1, P616, DOI 10.2215/CJN.01271005; Nasrallah MP, 2013, SEMIN NEPHROL, V33, P54, DOI 10.1016/j.semnephrol.2012.12.005; O'Neill HM, 2014, DIABETOLOGIA, V57, P1693, DOI 10.1007/s00125-014-3273-1; Park HK, 2015, METABOLISM, V64, P24, DOI 10.1016/j.metabol.2014.08.004; Payne VA, 2008, DIABETES, V57, P2055, DOI 10.2337/db08-0184; Prie D, 2014, DIABETES METAB, V40, pS12, DOI 10.1016/S1262-3636(14)72690-4; Rahmouni K, 2003, J NEUROSCI, V23, P5998, DOI 10.1523/JNEUROSCI.23-14-05998.2003; Routh RE, 2002, KIDNEY INT, V61, P1365, DOI 10.1046/j.1523-1755.2002.00277.x; Salo VT, 2016, EMBO J, V35, P2699, DOI 10.15252/embj.201695170; Scerbo D, 2017, J LIPID RES, V58, P1132, DOI 10.1194/jlr.M074427; Shi S, 2015, KIDNEY INT, V88, P479, DOI 10.1038/ki.2015.103; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Steinbrekera B, 2016, J ENDOCRINOL, V231, pR47, DOI 10.1530/JOE-16-0273; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Suganami T, 2004, FASEB J, V18, P127, DOI 10.1096/fj.04-2183fje; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tschop J, 2010, J NEUROSCI, V30, P6036, DOI 10.1523/JNEUROSCI.4875-09.2010; Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722; Wang Y, 2017, METHODS MOL BIOL, V1614, P69, DOI 10.1007/978-1-4939-7030-8_6; Xu PF, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0054-x; Yang WL, 2014, HUM MOL GENET, V23, P502, DOI 10.1093/hmg/ddt444	49	15	15	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5550	5562		10.1096/fj.201701427R	http://dx.doi.org/10.1096/fj.201701427R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29738274				2022-12-26	WOS:000447972500029
J	Dai, L; Del Valle, L; Miley, W; Whitby, D; Ochoa, AC; Flemington, EK; Qin, ZQ				Dai, Lu; Del Valle, Luis; Miley, Wendell; Whitby, Denise; Ochoa, Augusto C.; Flemington, Erik K.; Qin, Zhiqiang			Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's sarcoma development	ONCOGENE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MELANOMA-CELL LINES; ENDOTHELIAL-CELLS; NUCLEAR ANTIGEN; IN-VIVO; ANTIRETROVIRAL THERAPY; DNA-SEQUENCES; CYCLE ARREST; HTDV/HERV-K; KAPPA-B	Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of several human cancers such as Kaposi's sarcoma (KS), which represents the most common AIDS-associated malignancy that lacks effective treatment options. Despite its clear role in AIDS malignancies, the fact that only a small set of KSHV-infected patients will eventually develop these tumors implies that additional co-factors are required for the development of KSHV-related cancers. In the current study, we demonstrate for the first time that KSHV de novo infection or viral latent proteins are able to transactivate human endogenous retrovirus K (HERV-K) through a variety of cellular signaling pathways and transcriptional factors. Moreover, we found that HERV-K transactivation, particularly activation of its encoded oncogenic NP9 protein, plays an important role in KSHV pathogenesis and tumorigenesis in vitro and in vivo. Our data provide innovative insights into the mechanisms of HERV-K transactivation contributing to viral oncogenesis, which may represent a promising target for KS treatment.	[Dai, Lu; Qin, Zhiqiang] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Genet, 1700 Tulane Ave, New Orleans, LA 70112 USA; [Dai, Lu; Qin, Zhiqiang] Tongji Univ, Sch Med, East Hosp, Dept Pediat,Res Ctr Translat Med, Shanghai 200120, Peoples R China; [Dai, Lu; Qin, Zhiqiang] Tongji Univ, Sch Med, East Hosp, Key Lab Arrhythmias, Shanghai 200120, Peoples R China; [Del Valle, Luis] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Pathol, 1700 Tulane Ave, New Orleans, LA 70112 USA; [Miley, Wendell; Whitby, Denise] Frederick Natl Lab Canc Res, Viral Oncol Sect, AIDS & Canc Virus Program, Leidos Biomed Res, POB B, Frederick, MD 21702 USA; [Ochoa, Augusto C.] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Pediat, 1700 Tulane Ave, New Orleans, LA 70112 USA; [Flemington, Erik K.] Tulane Univ, Hlth Sci Ctr, Tulane Canc Ctr, Dept Pathol, 1700 Tulane Ave, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tongji University; Tongji University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tulane University	Qin, ZQ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Genet, 1700 Tulane Ave, New Orleans, LA 70112 USA.; Qin, ZQ (corresponding author), Tongji Univ, Sch Med, East Hosp, Dept Pediat,Res Ctr Translat Med, Shanghai 200120, Peoples R China.; Qin, ZQ (corresponding author), Tongji Univ, Sch Med, East Hosp, Key Lab Arrhythmias, Shanghai 200120, Peoples R China.	zqin@lsuhsc.edu	Del Valle, Luis/J-4085-2015	Del Valle, Luis/0000-0003-3894-9206	DOD Career Development Award [CA140437]; Louisiana Clinical and Translational Science Center Pilot grant [U54GM104940]; LSU LIFT2 funding; NIH [P20-GM121288-01, RO1-AI101046, R01-AI106676, P01CA214091]; Department of Defense [W81XWH-16-1-0318]; National Cancer Institute, NIH [HHSN261200800001E]; National Natural Science Foundation of China [81472547, 81672924, 81400164, 81772930]; NATIONAL CANCER INSTITUTE [P01CA214091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101046, R01AI106676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM121288, P30GM114732, U54GM104940] Funding Source: NIH RePORTER	DOD Career Development Award; Louisiana Clinical and Translational Science Center Pilot grant; LSU LIFT2 funding; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Rolf Renne at the University of Florida for his kind gifts of TIVE-LTC and TIVE cells and Dr. Friedrich A. Grasser from Universitatsklinikum des Saarlandes, Germany for kindly providing HERV-K NP9 plasmids and antibody. This work was supported by grants from a DOD Career Development Award to (CA140437 to ZQ); a Louisiana Clinical and Translational Science Center Pilot grant (U54GM104940 from NIH), a LSU LIFT2 funding, and NIH P20-GM121288-01 (PI: Krzysztof Reiss) subproject to ZQ; NIH RO1-AI101046, R01-AI106676, and P01CA214091 and Department of Defense W81XWH-16-1-0318 to EKF; the federal funds from the National Cancer Institute, NIH, under Contract No. HHSN261200800001E to DW; and the awards from the National Natural Science Foundation of China (81472547, 81672924 to ZQ and 81400164, 81772930 to LD). Funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An FQ, 2006, J VIROL, V80, P4833, DOI 10.1128/JVI.80.10.4833-4846.2006; An FQ, 2005, J BIOL CHEM, V280, P3862, DOI 10.1074/jbc.M407435200; Angelova M, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0218-8; Ariza-Heredia EJ, 2011, TRANSPLANTATION, V92, P837, DOI 10.1097/TP.0b013e31823104ec; Armbruester V, 2002, CLIN CANCER RES, V8, P1800; Benavente Y, 2011, BRIT J CANCER, V105, P1768, DOI 10.1038/bjc.2011.392; Bonnet F, 2004, CANCER-AM CANCER SOC, V101, P317, DOI 10.1002/cncr.20354; Buscher K, 2006, MELANOMA RES, V16, P223; Buscher K, 2005, CANCER RES, V65, P4172, DOI 10.1158/0008-5472.CAN-04-2983; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen T, 2013, LEUKEMIA, V27, P1469, DOI 10.1038/leu.2013.8; Contreras-Galindo R, 2008, J VIROL, V82, P9329, DOI 10.1128/JVI.00646-08; Dai L, 2016, ONCOTARGET, V7, P10459, DOI 10.18632/oncotarget.7227; Dai L, 2015, BLOOD, V126, P2821, DOI 10.1182/blood-2015-07-658823; Dai L, 2015, CANCER LETT, V362, P158, DOI 10.1016/j.canlet.2015.03.034; Dai L, 2012, INT J CANCER, V131, P834, DOI 10.1002/ijc.26428; Depil S, 2002, LEUKEMIA, V16, P254, DOI 10.1038/sj.leu.2402355; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Di Bartolo DL, 2008, BLOOD, V111, P4731, DOI 10.1182/blood-2007-09-110544; Do Kim J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-85; Downey RF, 2015, INT J CANCER, V137, P1249, DOI 10.1002/ijc.29003; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Friborg J, 1999, NATURE, V402, P889, DOI 10.1038/47266; Fuchs NV, 2011, J VIROL, V85, P3436, DOI 10.1128/JVI.02539-10; Gonzalez-Cao M, 2016, CANCER BIOL MED, V13, P483, DOI 10.20892/j.issn.2095-3941.2016.0080; Gonzalez-Hernandez MJ, 2012, J VIROL, V86, P7790, DOI 10.1128/JVI.07215-11; Gross H, 2011, INT J CANCER, V129, P1105, DOI 10.1002/ijc.25760; Grossmann C, 2006, J VIROL, V80, P7179, DOI 10.1128/JVI.01603-05; He ML, 2012, CANCER RES, V72, P3582, DOI 10.1158/0008-5472.CAN-11-2876; Hohn O, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00246; Hsiao FC, 2006, J IMMUNOL, V177, P2056, DOI 10.4049/jimmunol.177.4.2056; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; Jenkins FJ, 2002, J INFECT DIS, V185, P1238, DOI 10.1086/340237; Kellam P, 1997, J Hum Virol, V1, P19; Kim KY, 2013, J VIROL, V87, P6782, DOI 10.1128/JVI.00011-13; Kraus B, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-21; Labo N, 2015, AIDS, V29, P1217, DOI 10.1097/QAD.0000000000000682; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010; Li SS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005900; Li W, 2016, ONCOTARGET, V7, P32286, DOI 10.18632/oncotarget.8591; Li ZW, 2010, CANCER INVEST, V28, P1031, DOI 10.3109/07357907.2010.512604; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; LOWER R, 1995, J VIROL, V69, P141; Luppi M, 2000, BLOOD, V96, P3279; Magin C, 1999, J VIROL, V73, P9496, DOI 10.1128/JVI.73.11.9496-9507.1999; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; Mangeney M, 1998, P NATL ACAD SCI USA, V95, P14920, DOI 10.1073/pnas.95.25.14920; Manghera M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-16; Mbisa GL, 2010, J IMMUNOL METHODS, V356, P39, DOI 10.1016/j.jim.2010.02.015; Mesri EA, 2014, CELL HOST MICROBE, V15, P266, DOI 10.1016/j.chom.2014.02.011; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Qian LW, 2007, J VIROL, V81, P7001, DOI 10.1128/JVI.00016-07; Qin ZQ, 2013, J VIROL, V87, P621, DOI 10.1128/JVI.01441-12; Qin ZQ, 2010, CANCER RES, V70, P3884, DOI 10.1158/0008-5472.CAN-09-4663; Qin ZQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000742; Shamay M, 2006, P NATL ACAD SCI USA, V103, P14554, DOI 10.1073/pnas.0604469103; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Sutkowski N, 2001, IMMUNITY, V15, P579, DOI 10.1016/S1074-7613(01)00210-2; Sutkowski N, 2004, J VIROL, V78, P7852, DOI 10.1128/JVI.78.14.7852-7860.2004; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Verma SC, 2004, J VIROL, V78, P10348, DOI 10.1128/JVI.78.19.10348-10359.2004; Wang-Johanning F, 2012, JNCI-J NATL CANCER I, V104, P189, DOI 10.1093/jnci/djr540; Wong JP, 2017, BIOL CHEM, V398, P911, DOI 10.1515/hsz-2017-0101; Ye FC, 2011, ADV VIROL, V2011, DOI 10.1155/2011/193860	67	19	19	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 16	2018	37	33					4534	4545		10.1038/s41388-018-0282-4	http://dx.doi.org/10.1038/s41388-018-0282-4			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GQ5OV	29743595	Green Accepted			2022-12-26	WOS:000441736700004
J	Hossain, D; Barbosa, JAF; Cohen, EA; Tsang, WY				Hossain, Delowar; Barbosa, Jeremy A. Ferreira; Cohen, Eric A.; Tsang, William Y.			HIV-1 Vpr hijacks EDD-DYRK2-DDB1(DCAF1) to disrupt centrosome homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						centrosome; centriole; ubiquitin ligase; human immunodeficiency virus (HIV); viral protein; microtubule; Cep78; CP110	E3 UBIQUITIN LIGASE; HUMAN-IMMUNODEFICIENCY-VIRUS; DEFICIENCY-SYNDROME AIDS; HUMANIZED MICE; CELL-CYCLE; INHIBITS TELOMERASE; PROTEIN-INTERACTION; GENE-TRANSCRIPTION; DEGRADATION; DAMAGE	Viruses exploit the host cell machinery for their own profit. To evade innate immune sensing and promote viral replication, HIV type 1 (HIV-1) subverts DNA repair regulatory proteins and induces G(2)/M arrest. The preintegration complex of HIV-1 is known to traffic along microtubules and accumulate near the microtubule-organizing center. The centrosome is the major microtubule-organizing center in most eukaryotic cells, but precisely how HIV-1 impinges on centrosome biology remains poorly understood. We report here that the HIV-1 accessory protein viral protein R (Vpr) localized to the centrosome through binding to DCAF1, forming a complex with the ubiquitin ligase EDD-DYRK2-DDB1(DCAF1) and Cep78, a resident centrosomal protein previously shown to inhibit EDD-DYRK2-DDB1(DCAF1). Vpr did not affect ubiquitination of Cep78. Rather, it enhanced ubiquitination of an EDD-DYRK2-DDB1(DCAF1) substrate, CP110, leading to its degradation, an effect that could be overcome by Cep78 expression. The down-regulation of CP110 and elongation of centrioles provoked by Vpr were independent of G(2)/M arrest. Infection of T lymphocytes with HIV-1, but not with HIV-1 lacking Vpr, promoted CP110 degradation and centriole elongation. Elongated centrioles recruited more -tubulin to the centrosome, resulting in increased microtubule nucleation. Our results suggest that Vpr is targeted to the centrosome where it hijacks a ubiquitin ligase, disrupting organelle homeostasis, which may contribute to HIV-1 pathogenesis.	[Hossain, Delowar; Barbosa, Jeremy A. Ferreira; Cohen, Eric A.; Tsang, William Y.] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Hossain, Delowar; Cohen, Eric A.; Tsang, William Y.] McGill Univ, Div Expt Med, Montreal, PQ H4A 3J1, Canada; [Cohen, Eric A.] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Tsang, William Y.] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal	Tsang, WY (corresponding author), Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.; Tsang, WY (corresponding author), McGill Univ, Div Expt Med, Montreal, PQ H4A 3J1, Canada.; Tsang, WY (corresponding author), Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada.	william.tsang@ircm.qc.ca		Tsang, William/0000-0002-1584-616X	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research (CIHR)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (to W. Y. T.) and a grant from the Canadian Institutes of Health Research (CIHR) (to E. A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonso PV, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-27; Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Aprea S, 2006, J NEUROSCI, V26, P4054, DOI 10.1523/JNEUROSCI.0603-06.2006; Barbelanne M, 2015, HUM MOL GENET, V24, P2185, DOI 10.1093/hmg/ddu738; Barbelanne M, 2013, HUM MOL GENET, V22, P2482, DOI 10.1093/hmg/ddt100; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Bolton DL, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-17; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Bregnard C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00176; Chang F, 2004, MOL BIOL CELL, V15, P1793, DOI 10.1091/mbc.E03-09-0691; Chen D, 2002, EMBO J, V21, P6801, DOI 10.1093/emboj/cdf683; Coffin JM, 1997, RETROVIRUSES INTERAC; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Das A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006791; Dave VP, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-128; de Mareuil J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-5; Dumas A, 2015, J CELL BIOL, V211, P359, DOI 10.1083/jcb.201503124; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Forget J, 1998, J MOL BIOL, V284, P915, DOI 10.1006/jmbi.1998.2206; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Fregoso OI, 2016, MBIO, V7, DOI 10.1128/mBio.01433-16; GALLO RC, 1983, SCIENCE, V220, P865, DOI 10.1126/science.6601823; Gaynor EM, 2001, EXP CELL RES, V267, P243, DOI 10.1006/excr.2001.5247; Gerard FCA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089195; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hossain D, 2017, EMBO REP, V18, P632, DOI 10.15252/embr.201642377; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2016, P NATL ACAD SCI USA, V113, pE3921, DOI 10.1073/pnas.1605023113; Jung HY, 2013, J BIOL CHEM, V288, P7252, DOI 10.1074/jbc.M112.416792; Kim K, 2013, MOL CELL, V52, P459, DOI 10.1016/j.molcel.2013.09.017; Kim K, 2012, MOL CELL BIOL, V32, P783, DOI 10.1128/MCB.06037-11; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Krisko JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003242; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Lahouassa H, 2016, P NATL ACAD SCI USA, V113, P5311, DOI 10.1073/pnas.1600485113; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lukic Z, 2014, J VIROL, V88, P13613, DOI 10.1128/JVI.02219-14; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Minemoto Y, 1999, BIOCHEM BIOPH RES CO, V258, P379, DOI 10.1006/bbrc.1999.0640; Mullee LI, 2016, CHROMOSOME RES, V24, P35, DOI 10.1007/s10577-015-9503-7; Nakagawa T, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-22; Romani B, 2012, CURR OPIN VIROL, V2, P755, DOI 10.1016/j.coviro.2012.09.010; Sabo Y, 2013, CELL HOST MICROBE, V14, P535, DOI 10.1016/j.chom.2013.10.012; Sato K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004453; Sato K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003812; Sato K, 2012, J VIROL, V86, P5000, DOI 10.1128/JVI.07062-11; Sato K, 2010, J VIROL, V84, P9546, DOI 10.1128/JVI.00823-10; Sawaya BE, 1998, J BIOL CHEM, V273, P20052, DOI 10.1074/jbc.273.32.20052; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; Wang X, 2013, J BIOL CHEM, V288, P15474, DOI 10.1074/jbc.M112.416735; Watanabe N, 2000, EXP CELL RES, V258, P261, DOI 10.1006/excr.2000.4908; Watkins RL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-125; Wen XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030939; Zamborlini A, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-63; Zhang SG, 2001, GENE, V263, P131, DOI 10.1016/S0378-1119(00)00583-7; ZHAO LJ, 1994, J BIOL CHEM, V269, P15577; Zhou XH, 2017, J BIOL CHEM, V292, P21117, DOI 10.1074/jbc.M117.798801; Zou W, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-44	69	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9448	9460		10.1074/jbc.RA117.001444	http://dx.doi.org/10.1074/jbc.RA117.001444			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29724823	Green Published, hybrid			2022-12-26	WOS:000435441400028
J	Virgile, C; Hauk, P; Wu, HC; Shang, W; Tsao, CY; Payne, GF; Bentley, WE				Virgile, Chelsea; Hauk, Pricila; Wu, Hsuan-Chen; Shang, Wu; Tsao, Chen-Yu; Payne, Gregory F.; Bentley, William E.			Engineering bacterial motility towards hydrogen-peroxide	PLOS ONE			English	Article							OXYR TRANSCRIPTION FACTOR; DISULFIDE BOND FORMATION; ESCHERICHIA-COLI; REDOX REGULATION; MAMMALIAN GUT; GENE; COMPUTATION; CHEMOTAXIS; EXPRESSION; MOLECULES	Synthetic biologists construct innovative genetic/biological systems to treat environmental, energy, and health problems. Many systems employ rewired cells for non-native product synthesis, while a few have employed the rewired cells as 'smart' devices with programmable function. Building on the latter, we developed a genetic construct to control and direct bacterial motility towards hydrogen peroxide, one of the body's immune response signaling molecules. A motivation for this work is the creation of cells that can target and autonomously treat disease, the latter signaled by hydrogen peroxide release. Bacteria naturally move towards a variety of molecular cues (e.g., nutrients) in the process of chemotaxis. In this work, we engineered bacteria to recognize and move towards hydrogen peroxide, a non-native chemoattractant and potential toxin. Our system exploits oxyRS, the native oxidative stress regulon of E. coll. We first demonstrated H2O2 -mediated upregulation motility regulator, CheZ. Using transwell assays, we showed a two-fold increase in net motility towards H2O2. Then, using a 2D cell tracking system, we quantified bacterial motility descriptors including velocity, % running (of tumble/run motions), and a dynamic net directionality towards the molecular cue. In CheZ mutants, we found that increased H2O2 concentration (0-200 mu M) and induction time resulted in increased running speeds, ultimately reaching the native E. coli wild-type speed of similar to 22 mu m/s with a similar to 45-65% ratio of running to tumbling. Finally, using a microfluidic device with stable H2O2 gradients, we characterized responses and the potential for "programmed" directionality towards H(2)O(2 )in quiescent fluids. Overall, the synthetic biology framework and tracking analysis in this work will provide a framework for investigating controlled motility of E. coli and other 'smart' probiotics for signal-directed treatment.	[Virgile, Chelsea; Hauk, Pricila; Shang, Wu; Tsao, Chen-Yu; Payne, Gregory F.; Bentley, William E.] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [Virgile, Chelsea; Hauk, Pricila; Shang, Wu; Tsao, Chen-Yu; Payne, Gregory F.; Bentley, William E.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA; [Wu, Hsuan-Chen] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei, Taiwan	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Taiwan University	Bentley, WE (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA.; Bentley, WE (corresponding author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.	bentley@umd.edu	Hauk, Pricila/C-8559-2013; Hauk, Pricila/AAS-9424-2021	Hauk, Pricila/0000-0002-4761-1920; 	Defense Threat Reduction Agency [HDTRA1-13-0037]; National Science Foundation [DMREF1435957]; National Institutes of Health [R21EB024102]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB024102] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors would like to acknowledge partial funding of this work from the Defense Threat Reduction Agency (HDTRA1-13-0037 to WEB and GFP), the National Science Foundation (DMREF1435957 to WEB and GFP) and the National Institutes of Health (R21EB024102 to WEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; Ames P, 1996, MOL MICROBIOL, V19, P737, DOI 10.1046/j.1365-2958.1996.408930.x; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Aurand TC, 2016, BIOTECHNOL BIOENG, V113, P492, DOI 10.1002/bit.25832; Benov L, 1996, P NATL ACAD SCI USA, V93, P4999, DOI 10.1073/pnas.93.10.4999; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Brynildsen MP, 2013, NAT BIOTECHNOL, V31, P160, DOI 10.1038/nbt.2458; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Division C and MSDR, 1967, AD819081 HYDR PER MA; Gonzalez-Flecha B, 1999, J BACTERIOL, V181, P3833; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Hwang IY, 2014, ACS SYNTH BIOL, V3, P228, DOI 10.1021/sb400077j; IMLAY JA, 1986, J BACTERIOL, V166, P519, DOI 10.1128/jb.166.2.519-527.1986; Kanta Jiri, 2011, Acta Medica (Hradec Kralove), V54, P97; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Loo AEK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049215; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; McKay R, 2017, BIOTECHNOL BIOENG; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Pottash AE, 2017, BIOTECHNIQUES, V62, P31, DOI 10.2144/000114493; Ravichandar JD, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Riglar DT, 2017, NAT BIOTECHNOL, V35, P653, DOI 10.1038/nbt.3879; Roy S, 2006, MOL THER, V13, P211, DOI 10.1016/j.ymthe.2005.07.684; Roy S, 2008, FREE RADICAL BIO MED, V44, P180, DOI 10.1016/j.freeradbiomed.2007.01.025; Rubens JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11658; Saeidi N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.55; Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006; Servinsky MD, 2015, ISME J, V10, P1, DOI [10.1038/ismej.2015.92, DOI 10.1038/ISMEJ.2015.92]; Shang W, 2017, BIOMICROFLUIDICS, V11, DOI 10.1063/1.4993438; Strus M, 2009, J PHYSIOL PHARMACOL, V60, P49; Terrell JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9500; Terrell JL, 2012, BIOTECHNOL J, V7, P428, DOI 10.1002/biot.201100181; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Topp S, 2007, J AM CHEM SOC, V129, P6807, DOI 10.1021/ja0692480; Tschirhart T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14030; Turner L, 2010, J BACTERIOL, V192, P3259, DOI 10.1128/JB.00083-10; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; Wu HC, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.71; Zargar A, 2016, ACS SYNTH BIOL, V5, P923, DOI 10.1021/acssynbio.5b00261; Zhang AX, 1998, EMBO J, V17, P6061, DOI 10.1093/emboj/17.20.6061; Zhang RJ, 2010, P NATL ACAD SCI USA, V107, P288, DOI 10.1073/pnas.0912804107; Zheng M, 2001, J BACTERIOL, V183, P4571, DOI 10.1128/JB.183.15.4571-4579.2001; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	47	16	16	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0196999	10.1371/journal.pone.0196999	http://dx.doi.org/10.1371/journal.pone.0196999			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750783	Green Published, gold, Green Submitted			2022-12-26	WOS:000431856300011
J	Liu, J; Zhang, YD; Chen, XL; Zhu, XL; Chen, X; Wu, JH; Guo, NF				Liu, Jing; Zhang, Yi-de; Chen, Xiao-lan; Zhu, Xue-ling; Chen, Xu; Wu, Jian-hua; Guo, Nai-feng			The protective effect of the EP2 receptor on TGF-beta 1 induced podocyte injury via the PI3K/Akt signaling pathway	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CD2-ASSOCIATED PROTEIN; KIDNEY-DISEASE; APOPTOSIS; PGE(2); CYTOSKELETON; 3-KINASE; NEPHRIN	Transforming growth factor beta 1 (TGF-beta 1) plays a central role in chronic kidney diseases. TGF-beta 1 induction causes podocyte injury, which results in proteinuria and renal failure. However, the effect of the prostaglandin E2/E-prostanoid receptor (EP2) on TGF-beta 1-induced podocyte injury remains unknown. Previous studies have shown that phosphoinositide 3-OH kinase (PI3K)/Akt is widespread in cells, and is vital for the regulation of cell proliferation, differentiation, apoptosis and metabolism. In this study, we cultured immortalized mouse podocytes in vitro in different groups: control group; TGF-beta 1 (5ng/ml) group; EP2 agonist Butaprost treatment (10(-7), 10 (-6), or 10(-5) mol/L) +TGF-beta 1 group; EP2 antagonist AH6809 treatment (10(-7), 10(-6), or 10(-5 )mol/L) + TGF-beta 1 group. We found that compared with the control group, proliferation of podocytes in the TGF-beta 1 group significantly decreased and apoptosis increased. Expression of cAMP decreased, whereas PGE2 increased. Meanwhile, expressions of nephrin, podocin and CD2AP mRNA and protein were dramatically downregulated, activated caspase-3 was increased, and activated PI3K/Akt activity were depressed. Butaprost intervention promoted podocyte proliferation with reduced apoptosis. Conversely, AH6809 intervention led to opposite results (P<0.05). Our findings suggested that EP2 agonist protects podocytes by increasing expression of cAMP, which creates feedback of inhibiting PGE2 expression. This causes the interaction of nephrin, podocin and CD2AP resulting the inhibition of apoptosis induced by activation of the PI3K/Akt signaling pathway.	[Liu, Jing; Zhang, Yi-de; Chen, Xiao-lan; Zhu, Xue-ling; Chen, Xu; Wu, Jian-hua; Guo, Nai-feng] Nantong Univ, Dept Nephrol, Affiliated Hosp, Nantong, Peoples R China	Nantong University	Chen, XL (corresponding author), Nantong Univ, Dept Nephrol, Affiliated Hosp, Nantong, Peoples R China.	chenxl8448@sina.com			National Natural Science Foundation of China [81170656]; Key Projects of Science and Technology Development Funds of Nantong [MS32015018]; fifth "226 project" research projects of Nantong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects of Science and Technology Development Funds of Nantong; fifth "226 project" research projects of Nantong	This work was supported by the National Natural Science Foundation of China (81170656; Key Projects of Science and Technology Development Funds of Nantong(MS32015018); and the fifth "226 project" research projects of Nantong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen S, 2003, SEMIN NEPHROL, V23, P532, DOI 10.1053/S0270-9295(03)00132-3; Das R, 2015, J BIOL CHEM, V290, P30830, DOI 10.1074/jbc.M115.703116; Faour WH, 2008, CELL SIGNAL, V20, P2156, DOI 10.1016/j.cellsig.2008.08.007; Grahammer F, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86177; Gu LY, 2012, KIDNEY INT, V81, P458, DOI 10.1038/ki.2011.406; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Lal MA, 2015, DRUG DISCOV TODAY, V20, P1228, DOI 10.1016/j.drudis.2015.06.003; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Li NN, 2014, BIOSCIENCE REP, V34, P797, DOI 10.1042/BSR20140130; Loeffler I, 2014, NEPHROL DIAL TRANSPL, V29, pI37, DOI 10.1093/ndt/gft267; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nasrallah R, 2014, AM J PHYSIOL-RENAL, V307, pF243, DOI 10.1152/ajprenal.00224.2014; Park HY, 2016, INT J BIOCHEM CELL B, V79, P370, DOI 10.1016/j.biocel.2016.08.042; Perico L, 2016, NAT REV NEPHROL, V12, P692, DOI 10.1038/nrneph.2016.127; Ren Q, 2016, J RECEPT SIG TRANSD, V36, P288, DOI 10.3109/10799893.2015.1101137; Rinschen MM, 2017, J AM SOC NEPHROL, V28, P2867, DOI 10.1681/ASN.2016101119; Saleem MA, 2015, NEPHROL DIAL TRANSPL, V30, P1266, DOI 10.1093/ndt/gfu363; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Sellers ZM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189894; Song ZX, 2014, METABOLISM, V63, P1324, DOI 10.1016/j.metabol.2014.06.013; Stitt-Cavanagh EM, 2010, J AM SOC NEPHROL, V21, P1678, DOI 10.1681/ASN.2009121234; Wang J, 2018, PROSTAG OTH LIPID M, V134, P1, DOI 10.1016/j.prostaglandins.2017.10.006; Wang N, 2016, J RENIN-ANGIO-ALDO S, V17, DOI 10.1177/1470320316646884; Xi PP, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160038; Yang C, 2011, LIFE SCI, V88, P201, DOI 10.1016/j.lfs.2010.11.015; Yu J, 2017, APOPTOSIS, V22, P1431, DOI 10.1007/s10495-017-1418-7; Yu J, 2016, AM J PHYSIOL-RENAL, V310, pF492, DOI 10.1152/ajprenal.00499.2015; Zhang YD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142456; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	30	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							0197158	10.1371/journal.pone.0197158	http://dx.doi.org/10.1371/journal.pone.0197158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746568	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700076
J	Hart, A; Cortes, MP; Latorre, M; Martinez, S				Hart, Andrew; Paz Cortes, Maria; Latorre, Mauricio; Martinez, Servet			Codon usage bias reveals genomic adaptations to environmental conditions in an acidophilic consortium	PLOS ONE			English	Article							ACIDITHIOBACILLUS-FERROOXIDANS; DRAFT GENOME; MICROBIAL COMMUNITY; PROVIDES INSIGHTS; BACTERIUM; SEQUENCE; STRAIN; IDENTIFICATION; EXPRESSION; EVOLUTION	The analysis of codon usage bias has been widely used to characterize different communities of microorganisms. In this context, the aim of this work was to study the codon usage bias in a natural consortium of five acidophilic bacteria used for biomining. The codon usage bias of the consortium was contrasted with genes from an alternative collection of acidophilic reference strains and metagenome samples. Results indicate that acidophilic bacteria preferentially have low codon usage bias, consistent with both their capacity to live in a wide range of habitats and their slow growth rate, a characteristic probably acquired independently from their phylogenetic relationships. In addition, the analysis showed significant differences in the unique sets of genes from the autotrophic species of the consortium in relation to other acidophilic organisms, principally in genes which code for proteins involved in metal and oxidative stress resistance. The lower values of codon usage bias obtained in this unique set of genes suggest higher transcriptional adaptation to living in extreme conditions, which was probably acquired as a measure for resisting the elevated metal conditions present in the mine.	[Hart, Andrew] Univ Chile, Ctr Modelamiento Matemat, Fac Ciencias Fis & Matemat, UMI CNRS UCHILE 2071, Casilla 170,Correo 3, Santiago, Chile; [Paz Cortes, Maria; Latorre, Mauricio] Univ Chile, Ctr Modelamiento Matemat, Math, Santiago, Chile; [Paz Cortes, Maria; Latorre, Mauricio] Univ Chile, Fac Ciencias, Fondap Ctr Genome Regulat, Santiago, Chile; [Latorre, Mauricio] Univ Chile, INTA, Lab Bioinformat & Expres Gen, Santiago, Chile; [Latorre, Mauricio] Univ OHiggins, Inst Ciencias Ingn, Rancagua, Chile; [Martinez, Servet] Univ Chile, Ctr Modelamiento Matemat, Fac Ciencias Fis & Maternat, Dept Ingn Matemat,UMI CNRS UCHILE 2071, Casilla 170,Correo 3, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de O'Higgins; Universidad de Chile	Latorre, M (corresponding author), Univ Chile, Ctr Modelamiento Matemat, Math, Santiago, Chile.; Latorre, M (corresponding author), Univ Chile, Fac Ciencias, Fondap Ctr Genome Regulat, Santiago, Chile.; Latorre, M (corresponding author), Univ Chile, INTA, Lab Bioinformat & Expres Gen, Santiago, Chile.; Latorre, M (corresponding author), Univ OHiggins, Inst Ciencias Ingn, Rancagua, Chile.; Martinez, S (corresponding author), Univ Chile, Ctr Modelamiento Matemat, Fac Ciencias Fis & Maternat, Dept Ingn Matemat,UMI CNRS UCHILE 2071, Casilla 170,Correo 3, Santiago, Chile.	mauricio.latorre@uoh.cl; smartine@dim.uchile.cl			FONDAPof the Center for Genome Regulation (CGR) [15090007]; Apoyo a la Formacion de Redes Internacionales para Investigadores [REDI170193]; FONDECYT [11150679]; CONICYT Basal of the Center for Mathematical Modeling (CMM) [PFB 03, UM12807 UCHILE-CNRS]; National Laboratory of High Performance Computing (NLHPC) at the CMM [PIA ECM-02.-CONICYT]	FONDAPof the Center for Genome Regulation (CGR); Apoyo a la Formacion de Redes Internacionales para Investigadores; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT Basal of the Center for Mathematical Modeling (CMM); National Laboratory of High Performance Computing (NLHPC) at the CMM	This work was supported by FONDAP Grant 15090007 of the Center for Genome Regulation (CGR), Apoyo a la Formacion de Redes Internacionales para Investigadores REDI170193 and FONDECYT Grant No 11150679 to Mauricio Latorre. CONICYT Basal Grant PFB 03 of the Center for Mathematical Modeling (CMM) UMI2807 UCHILE-CNRS to Servet Martinez and Mauricio Latorre. All the authors also acknowledge the support of the National Laboratory of High Performance Computing (NLHPC) at the CMM (PIA ECM-02.-CONICYT).; All the authors also acknowledge the support of the National Laboratory of High Performance Computing (NLHPC) at the CMM (PIA ECM-02.-CONICYT).	Acuna LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078237; Anderson I, 2012, STAND GENOMIC SCI, V6, P293, DOI 10.4056/sigs.2736042; Arsene-Ploetze F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000859; Botzman M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r109; Brandis G, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005926; Carbone A, 2005, MOL BIOL EVOL, V22, P547, DOI 10.1093/molbev/msi040; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Clum A, 2009, STAND GENOMIC SCI, V1, P38, DOI 10.4056/sigs.1463; COLMER AR, 1950, J BACTERIOL, V59, P317, DOI 10.1128/JB.59.3.317-328.1950; Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384; Farah C, 2005, APPL ENVIRON MICROB, V71, P7033, DOI 10.1128/AEM.71.11.7033-7040.2005; Frankel ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148682; Fujimura R, 2012, J BACTERIOL, V194, P4122, DOI 10.1128/JB.00696-12; GOEBEL BM, 1994, APPL ENVIRON MICROB, V60, P1614, DOI 10.1128/AEM.60.5.1614-1621.1994; Hart A, 2017, J GERONTOL A-BIOL, V72, P965, DOI 10.1093/gerona/glw223; Hodar C, 2012, BIOMETALS, V25, P75, DOI 10.1007/s10534-011-9484-8; Hu Q, 2015, RES MICROBIOL, V166, P525, DOI 10.1016/j.resmic.2015.06.005; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Kelly DP, 2000, INT J SYST EVOL MICR, V50, P511, DOI 10.1099/00207713-50-2-511; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Latorre M, 2016, BIORESOURCE TECHNOL, V218, P659, DOI 10.1016/j.biortech.2016.07.012; Latorre M, 2016, BIORESOURCE TECHNOL, V200, P29, DOI 10.1016/j.biortech.2015.09.110; Li B, 2011, J BACTERIOL, V193, P5555, DOI 10.1128/JB.05684-11; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li SZ, 2014, BIORESOURCE TECHNOL, V153, P300, DOI 10.1016/j.biortech.2013.12.018; Liljeqvist M, 2011, J BACTERIOL, V193, P4304, DOI 10.1128/JB.05373-11; Liu Y, 2011, BIORESOURCE TECHNOL, V102, P8092, DOI 10.1016/j.biortech.2011.06.012; Magnuson TS, 2010, BIOMETALS, V23, P1129, DOI 10.1007/s10534-010-9360-y; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mi S, 2011, J MICROBIOL, V49, P890, DOI 10.1007/s12275-011-1099-9; Moeck GS, 1998, MOL MICROBIOL, V28, P675, DOI 10.1046/j.1365-2958.1998.00817.x; Navarro CA, 2009, APPL ENVIRON MICROB, V75, P6102, DOI 10.1128/AEM.00308-09; Okabe S, 2007, APPL ENVIRON MICROB, V73, P971, DOI 10.1128/AEM.02054-06; Okibe N, 2004, BIOTECHNOL BIOENG, V87, P574, DOI 10.1002/bit.20138; Orell A, 2010, BIOTECHNOL ADV, V28, P839, DOI 10.1016/j.biotechadv.2010.07.003; Orellana LH, 2011, APPL MICROBIOL BIOT, V92, P761, DOI 10.1007/s00253-011-3494-x; Panda S, 2015, BIORESOURCE TECHNOL, V196, P694, DOI 10.1016/j.biortech.2015.08.064; Pellegrino S, 2012, STRUCTURE, V20, P2076, DOI 10.1016/j.str.2012.09.010; Peng TJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178008; Pester M, 2012, J BACTERIOL, V194, P6300, DOI 10.1128/JB.01392-12; Prakash T, 2012, BRIEF BIOINFORM, V13, P711, DOI 10.1093/bib/bbs033; Ramirez P, 2004, APPL ENVIRON MICROB, V70, P4491, DOI 10.1128/AEM.70.8.4491-4498.2004; Ran WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051652; Rawlings DE, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-13; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Roller M, 2013, NUCLEIC ACIDS RES, V41, P8842, DOI 10.1093/nar/gkt673; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; San Martin-Uriz P, 2011, J BACTERIOL, V193, P5585, DOI 10.1128/JB.05386-11; Scholz FW, 1987, J AM STAT ASSOC, V82, P6; Shen XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144473; Szekli R, 1995, STOCHASTIC ORDERING; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Travisany D, 2014, RES MICROBIOL, V165, P743, DOI 10.1016/j.resmic.2014.08.004; Travisany D, 2012, J BACTERIOL, V194, P6327, DOI 10.1128/JB.01622-12; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Valdes J, 2011, J BACTERIOL, V193, P7003, DOI 10.1128/JB.06281-11; Valdes J, 2009, J BACTERIOL, V191, P5877, DOI 10.1128/JB.00843-09; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; WAKAO N, 1994, J GEN APPL MICROBIOL, V40, P143, DOI 10.2323/jgam.40.143; Wang HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166260; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909; Yang HL, 2014, BIORESOURCE TECHNOL, V154, P185, DOI 10.1016/j.biortech.2013.12.036; You XY, 2011, J GENET GENOMICS, V38, P243, DOI 10.1016/j.jgg.2011.04.006; Zhang X, 2017, APPL ENVIRON MICROB, V17, P83; Zhang X, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0330-4	66	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0195869	10.1371/journal.pone.0195869	http://dx.doi.org/10.1371/journal.pone.0195869			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742107	Green Published, Green Submitted, gold			2022-12-26	WOS:000431757400016
J	Obinata, H; Sugimoto, A; Niwa, S				Obinata, Hiroyuki; Sugimoto, Asako; Niwa, Shinsuke			Streptothricin acetyl transferase 2 (Sat2): A dominant selection marker for Caenorhabditis elegans genome editing	PLOS ONE			English	Article							AXONAL-TRANSPORT; C. ELEGANS; GENE-TRANSFER; PROTEIN; TRANSGENESIS; RESISTANCE; CASSETTES; INSERTION; DYNAMICS; SYSTEM	Studies on Caenorhabditis elegans would benefit from the introduction of new selectable markers to allow more complex types of experiments to be conducted with this model animal. We established a new antibiotic selection marker for C. elegans transformation based on nourseothricin (NTC) and its resistance-encoding gene, streptothricin-acetyl transferase 2 (Sat2). NTC was able to efficiently prevent worm development at very low concentrations, and the worms expressing Sat2 were able to survive on the selection plates without any developmental defects. Using CRISPR/Cas9 and NTC selection, we were able to easily insert a 13-kb expression cassette into a defined locus in C. elegans. The structure and spectrum of NTC differs from other antibiotics like hygromycin B and geneticin, making it possible to use NTC alongside them. Indeed, we confirmed NTC-sat2 selection could work with the hygromycin B selection system simultaneously. Thus, the new NTC-Sat2 system can act as a useful dominant marker for gene transfer and genome editing in C. elegans.	[Obinata, Hiroyuki; Sugimoto, Asako; Niwa, Shinsuke] Tohoku Univ, Grad Sch Life Sci, Div Dev Dynam, Aoba Ku, Sendai, Miyagi, Japan; [Niwa, Shinsuke] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci FRIS, Aoba Ku, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Niwa, S (corresponding author), Tohoku Univ, Grad Sch Life Sci, Div Dev Dynam, Aoba Ku, Sendai, Miyagi, Japan.; Niwa, S (corresponding author), Tohoku Univ, Frontier Res Inst Interdisciplinary Sci FRIS, Aoba Ku, Sendai, Miyagi, Japan.	shinsuke.niwa.c8@tohoku.ac.jp	Sugimoto, Asako/U-3707-2019; Sugimoto, Asako/I-7239-2015	Sugimoto, Asako/0000-0001-6001-4293; Sugimoto, Asako/0000-0001-6001-4293; NIWA, SHINSUKE/0000-0002-8367-9228	Japan Society for the Promotion of Science [16H06536, 17H05010]; Naito Foundation; Brain Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Brain Science Foundation	This work was supported by the Japan Society for the Promotion of Science, Grant numbers: 16H06536 and 17H05010 (https: www.go.jp); the Naito Foundation (https://www. naito-f.or.jp/jp/index.php); and the Brain Science Foundation (http //www bs-f.jp/kenjo html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; BRENNER S, 1974, GENETICS, V77, P71; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Dickinson DJ, 2015, GENETICS, V200, P1035, DOI 10.1534/genetics.115.178335; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Frokjaer-Jensen C, 2014, NAT METHODS, V11, P529, DOI [10.1038/NMETH.2889, 10.1038/nmeth.2889]; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Giordano-Santini R, 2011, CELL MOL LIFE SCI, V68, P1917, DOI 10.1007/s00018-011-0670-1; Giordano-Santini R, 2010, NAT METHODS, V7, P721, DOI 10.1038/nmeth.1494; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; HAUPT I, 1978, J ANTIBIOT, V31, P1137, DOI 10.7164/antibiotics.31.1137; Kim H, 2014, GENETICS, V197, P1069, DOI 10.1534/genetics.114.166389; Klassen MP, 2010, NEURON, V66, P710, DOI 10.1016/j.neuron.2010.04.033; Kochupurakkal BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068509; MADURO M, 1995, GENETICS, V141, P977; Maeder CI, 2014, TRAFFIC, V15, P273, DOI 10.1111/tra.12142; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mizumoto K, 2013, CELL REP, V5, P389, DOI 10.1016/j.celrep.2013.09.011; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Namai S, 2018, DEV GENES EVOL, V228, P75, DOI 10.1007/s00427-018-0605-z; Nawa M, 2012, METHOD BODY BENDING, V2, DOI [10.21769/BieProtoc.253, DOI 10.21769/BIEPROTOC.253]; Niwa S, 2017, JOVE-J VIS EXP, DOI 10.3791/56690; Niwa S, 2017, CURR BIOL, V27, P2569, DOI 10.1016/j.cub.2017.07.013; Niwa S, 2016, CELL REP, V16, P2129, DOI 10.1016/j.celrep.2016.07.043; Norris AD, 2015, GENETICS, V201, P449, DOI 10.1534/genetics.115.180679; Radman I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076019; Ramos B, 2013, MOL PLANT PATHOL, V14, P44, DOI 10.1111/j.1364-3703.2012.00826.x; Redemann S, 2011, NAT METHODS, V8, P250, DOI [10.1038/nmeth.1565, 10.1038/NMETH.1565]; Semple JI, 2010, NAT METHODS, V7, P725, DOI 10.1038/nmeth.1495; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; TIETZE E, 1990, NUCLEIC ACIDS RES, V18, P1283, DOI 10.1093/nar/18.5.1283; Yogev S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15063; Yogev S, 2016, NEURON, V92, P449, DOI 10.1016/j.neuron.2016.09.036	38	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0197128	10.1371/journal.pone.0197128	http://dx.doi.org/10.1371/journal.pone.0197128			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742140	Green Published, gold, Green Submitted			2022-12-26	WOS:000431757400063
J	Kastrin, A; Ferk, P; Leskosek, B				Kastrin, Andrej; Ferk, Polonca; Leskosek, Brane			Predicting potential drug-drug interactions on topological and semantic similarity features using statistical learning	PLOS ONE			English	Article							LINK-PREDICTION; NETWORK	Drug-drug interaction (DDI) is a change in the effect of a drug when patient takes another drug. Characterizing DDIs is extremely important to avoid potential adverse drug reactions. We represent DDIs as a complex network in which nodes refer to drugs and links refer to their potential interactions. Recently, the problem of link prediction has attracted much consideration in scientific community. We represent the process of link prediction as a binary classification task on networks of potential DDIs. We use link prediction techniques for predicting unknown interactions between drugs in five arbitrary chosen large-scale DDI databases, namely DrugBank, KEGG, NDF-RT, SemMedDB, and Twosides. We estimated the performance of link prediction using a series of experiments on DDI networks. We performed link prediction using unsupervised and supervised approach including classification tree, k-nearest neighbors, support vector machine, random forest, and gradient boosting machine classifiers based on topological and semantic similarity features. Supervised approach clearly outperforms unsupervised approach. The Twosides network gained the best prediction performance regarding the area under the precision-recall curve (0.93 for both random forests and gradient boosting machine). The applied methodology can be used as a tool to help researchers to identify potential DDIs. The supervised link prediction approach proved to be promising for potential DDIs prediction and may facilitate the identification of potential DDIs in clinical research.	[Kastrin, Andrej; Ferk, Polonca; Leskosek, Brane] Univ Ljubljana, Fac Med, Inst Biostat & Med Informat, Ljubljana, Slovenia	University of Ljubljana	Leskosek, B (corresponding author), Univ Ljubljana, Fac Med, Inst Biostat & Med Informat, Ljubljana, Slovenia.	brane.leskosek@mf.uni-lj.si	Kastrin, Andrej/AAH-9234-2021	Kastrin, Andrej/0000-0002-3495-0165	ELIXIR-SI	ELIXIR-SI	The authors would like to thanks the anonymous reviewers for their valuable comments. This study was partially supported by ELIXIR-SI.; This study was partially supported by ELIXIR-SI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaziz I, 2017, J WEB SEMANT, V44, P104, DOI 10.1016/j.websem.2017.06.002; Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Ayvaz S, 2015, J BIOMED INFORM, V55, P206, DOI 10.1016/j.jbi.2015.04.006; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown SH, 2004, STUD HEALTH TECHNOL, V107, P477; Cami A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061468; Cheng FX, 2014, J AM MED INFORM ASSN, V21, pE278, DOI 10.1136/amiajnl-2013-002512; Conde-Estevez D, 2015, ANN ONCOL, V26, P1272, DOI 10.1093/annonc/mdv151; Demsar J, 2006, J MACH LEARN RES, V7, P1; Duke JD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002614; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Ferdousi R, 2017, J BIOMED INFORM, V70, P54, DOI 10.1016/j.jbi.2017.04.021; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gottlieb A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.26; Guimera R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003374; Hamed AA, 2015, J BIOMED INFORM, V56, P157, DOI 10.1016/j.jbi.2015.05.015; Hameed PN, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1546-7; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Herrero-Zazo M, 2013, J BIOMED INFORM, V46, P914, DOI 10.1016/j.jbi.2013.07.011; Holliday JD, 2003, J CHEM INF COMP SCI, V43, P819, DOI 10.1021/ci034001x; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang JL, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002998; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jamal S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00908-z; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Kastrin A, 2016, METHOD INFORM MED, V55, P340, DOI 10.3414/ME15-01-0108; Kilicoglu H, 2012, BIOINFORMATICS, V28, P3158, DOI 10.1093/bioinformatics/bts591; Kuhn M, 2016, NUCLEIC ACIDS RES, V44, pD1075, DOI 10.1093/nar/gkv1075; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Li P, 2015, BIOINFORMATICS, V31, P2007, DOI 10.1093/bioinformatics/btv080; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Liu RF, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0153-6; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lopes P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083016; Lu YD, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1460-z; Lu Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173548; Lu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17357; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.025102; Percha B, 2013, TRENDS PHARMACOL SCI, V34, P178, DOI 10.1016/j.tips.2013.01.006; Scheife RT, 2015, DRUG SAFETY, V38, P197, DOI 10.1007/s40264-014-0262-8; Shahreza ML, 2018, BRIEF BIOINFORM, V19, P878, DOI 10.1093/bib/bbx017; Sridhar D, 2016, BIOINFORMATICS, V32, P3175, DOI 10.1093/bioinformatics/btw342; Takarabe M, 2011, J CHEM INF MODEL, V51, P2977, DOI 10.1021/ci200367w; Takeda T, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0200-8; Tari L, 2010, BIOINFORMATICS, V26, pi547, DOI 10.1093/bioinformatics/btq382; Tatonetti NP, 2018, CLIN PHARMACOL THER, V103, P177, DOI 10.1002/cpt.949; Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377; Udrescu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32745; Vilar S, 2016, BRIEF BIOINFORM, V2017, P1; Vilar S, 2017, BRIEF BIOINFORM, V18, P670, DOI 10.1093/bib/bbw048; Vilar S, 2012, J AM MED INFORM ASSN, V19, P1066, DOI 10.1136/amiajnl-2012-000935; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Zhang P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12339; Zhang W, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1415-9; Zhao J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12261; Zhu Y, 2018, BRIEF BIOINFORM	61	43	43	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196865	10.1371/journal.pone.0196865	http://dx.doi.org/10.1371/journal.pone.0196865			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF1VY	29738537	Green Submitted, gold, Green Published			2022-12-26	WOS:000431724900024
J	Rassovsky, Y; Dunn, W; Wynn, JK; Wu, AD; Iacoboni, M; Hellemann, G; Green, MF				Rassovsky, Yuri; Dunn, Walter; Wynn, Jonathan K.; Wu, Allan D.; Iacoboni, Marco; Hellemann, Gerhard; Green, Michael F.			Single transcranial direct current stimulation in schizophrenia: Randomized, cross-over study of neurocognition, social cognition, ERPs, and side effects	PLOS ONE			English	Article							NONINVASIVE BRAIN-STIMULATION; IMPROVE COGNITION; AFFECTIVE PROSODY; HEALTHY-SUBJECTS; TDCS; MATRICS; DEFICITS; BATTERY; HALLUCINATIONS; RECOGNITION	Over the last decades, the treatment of schizophrenia has shifted fundamentally from a focus on symptom reduction to a focus on recovery and improving aspects of functioning. In this study, we examined the effect of transcranial direct current stimulation (tDCS) on social cognitive and nonsocial neurocognitive functions, as well as on electroencephalogram (EEG) measures, in individuals with schizophrenia. Thirty-seven individuals with schizophrenia were administered one of three different tDCS conditions (cathodal, anodal, and sham) per visit over the course of three visits, with approximately one week between each visit. Order of conditions was randomized and counterbalanced across subjects. For the active conditions, the electrode was placed over the left dorsolateral prefrontal cortex with the reference electrode over right supraorbital cortex. Current intensity was 2 mA and was maintained for two 20-minute sessions, with a one hour break between the sessions. Assessments were conducted immediately following each session, in a counterbalanced order of administration. No systematic effects were found across the social and nonsocial cognitive domains, and no significant effects were detected on event-related potentials (ERPs). The very small effect sizes, further validated by post-hoc power analyses (large Critical Ns), demonstrated that these findings were not due to lack of statistical power. Except for mild local discomfort, no significant side effects were reported. Findings demonstrate the safety and ease of administration of this procedure, but suggest that a single dose of tDCS over these areas does not yield a therapeutic effect on cognition in schizophrenia.	[Rassovsky, Yuri] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel; [Rassovsky, Yuri; Hellemann, Gerhard; Green, Michael F.] Bar Ilan Univ, Gonda Multidisciplinary Brain Res Ctr, Ramat Gan, Israel; [Rassovsky, Yuri; Dunn, Walter; Wynn, Jonathan K.; Green, Michael F.] UCLA Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Dunn, Walter; Wynn, Jonathan K.] VISN 22 Mental Illness Res Educ & Clin Ctr, Dept Vet Affairs, Los Angeles, CA USA; [Wu, Allan D.; Iacoboni, Marco] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Iacoboni, Marco] Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA USA	Bar Ilan University; Bar Ilan University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Rassovsky, Y (corresponding author), Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel.; Rassovsky, Y (corresponding author), Bar Ilan Univ, Gonda Multidisciplinary Brain Res Ctr, Ramat Gan, Israel.; Rassovsky, Y (corresponding author), UCLA Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA.	yurir@biu.ac.il	Wynn, Jonathan/H-3749-2014	Wynn, Jonathan/0000-0002-1763-8540; Rassovsky, Yuri/0000-0002-6362-9944	NARSAD Independent Investigator Grant from the Brain & Behavior Research Foundation [22017]	NARSAD Independent Investigator Grant from the Brain & Behavior Research Foundation	This study was supported by a NARSAD Independent Investigator Grant from the Brain & Behavior Research Foundation (22017).	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andreasen N., 1984, SCALE ASSESSMENT POS; Au J, 2016, J COGNITIVE NEUROSCI, V28, P1419, DOI 10.1162/jocn_a_00979; Brunelin J, 2012, BRAIN STIMUL, V5, P431, DOI 10.1016/j.brs.2011.03.010; Brunelin J, 2012, AM J PSYCHIAT, V169, P719, DOI 10.1176/appi.ajp.2012.11071091; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Buchanan RW, 2005, SCHIZOPHRENIA BULL, V31, P5, DOI 10.1093/schbul/sbi020; Dedoncker J, 2016, J NEURAL TRANSM, V123, P1159, DOI 10.1007/s00702-016-1558-x; Dresler M, 2013, NEUROPHARMACOLOGY, V64, P529, DOI 10.1016/j.neuropharm.2012.07.002; Dunn W, 2016, SCHIZOPHR RES, V174, P189, DOI 10.1016/j.schres.2016.04.021; Edwards J, 2002, CLIN PSYCHOL REV, V22, P789, DOI 10.1016/S0272-7358(02)00130-7; Ekman P., 2004, SUBTLE EXPRESSION TR; Ekman P., 1976, PICTURES FACIAL AFFE; First M. B., 1997, STRUCTURED CLIN INTE; Fitzgerald PB, 2014, BRAIN STIMUL, V7, P813, DOI 10.1016/j.brs.2014.08.002; Gold J. M., 2004, COMPREHENSIVE TXB PS, P1436; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; Green MF, 2005, SCHIZOPHRENIA BULL, V31, P882, DOI 10.1093/schbul/sbi049; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Green MF, 1996, AM J PSYCHIAT, V153, P321; Hasan A, 2016, SCHIZOPHRENIA BULL, V42, pS95, DOI 10.1093/schbul/sbv158; Hoy KE, 2014, SCHIZOPHR RES, V155, P96, DOI 10.1016/j.schres.2014.03.006; Jahshan C, 2013, SCHIZOPHR RES, V143, P348, DOI 10.1016/j.schres.2012.11.025; Kee KS, 2003, SCHIZOPHRENIA BULL, V29, P487, DOI 10.1093/oxfordjournals.schbul.a007021; Kern RS, 2008, AM J PSYCHIAT, V165, P214, DOI 10.1176/appi.ajp.2007.07010043; Koenigs M, 2009, CLIN NEUROPHYSIOL, V120, P80, DOI 10.1016/j.clinph.2008.10.010; Lee J, 2011, PSYCHOL MED, V41, P2297, DOI 10.1017/S0033291711000614; Marder SR, 2004, SCHIZOPHR RES, V72, P5, DOI 10.1016/j.schres.2004.09.010; Mattai A, 2011, BRAIN STIMUL, V4, P275, DOI 10.1016/j.brs.2011.01.001; Mayer J. D., 2002, TECHNICAL MANUAL MSC; McDonald S, 2002, AWARENESS SOCIAL INF; Mondino M, 2015, SCHIZOPHR RES, V161, P515, DOI 10.1016/j.schres.2014.10.054; Nitsche MA, 2009, NEUROTHERAPEUTICS, V6, P244, DOI 10.1016/j.nurt.2009.01.003; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; Oldrati V, 2018, BRAIN RES, V1678, P32, DOI 10.1016/j.brainres.2017.10.002; Pinkham AE, 2003, AM J PSYCHIAT, V160, P815, DOI 10.1176/appi.ajp.160.5.815; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Rassovsky Y, 2015, SCHIZOPHR RES, V165, P171, DOI 10.1016/j.schres.2015.04.016; Ruf SP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01055-1; Smith RC, 2015, SCHIZOPHR RES, V168, P260, DOI 10.1016/j.schres.2015.06.011; Stover EL, 2007, SCHIZOPHRENIA BULL, V33, P1093, DOI 10.1093/schbul/sbm085; VENTURA J, 1993, INT J METH PSYCH RES, V3, P221; Vercammen A, 2011, SCHIZOPHR RES, V131, P198, DOI 10.1016/j.schres.2011.06.021; Wynn JK, 2013, PSYCHOL MED, V43, P109, DOI 10.1017/S0033291712001006; Wynn JK, 2008, SCHIZOPHRENIA BULL, V34, P679, DOI 10.1093/schbul/sbn047; Zaghi S, 2010, NEUROSCIENTIST, V16, P285, DOI 10.1177/1073858409336227	49	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0197023	10.1371/journal.pone.0197023	http://dx.doi.org/10.1371/journal.pone.0197023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734347	Green Published, Green Submitted, gold			2022-12-26	WOS:000431481700041
J	Duarte-Garcia, A; Romero-Diaz, J; Juarez, S; Cicero-Casarrubias, A; Fragoso-Loyo, H; Nunez-Alvarez, C; Llorente, L; Sanchez-Guerrero, J				Duarte-Garcia, Ali; Romero-Diaz, Juanita; Juarez, Sandra; Cicero-Casarrubias, Alba; Fragoso-Loyo, Hilda; Nunez-Alvarez, Carlos; Llorente, Luis; Sanchez-Guerrero, Jorge			Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with Systemic Lupus Erythematosus and Cognitive Dysfunction	PLOS ONE			English	Article							BODY-MASS INDEX; NEUROPSYCHIATRIC SYNDROMES; RECEPTOR ANTIBODIES; GLUTAMATE-RECEPTOR; EMPLOYMENT STATUS; REVISED CRITERIA; INCEPTION COHORT; RISK-FACTORS; LIGAND 2; IMPAIRMENT	Objective To determine if cognitive dysfunction in patients with systemic lupus erythematosus (SLE) derives from an inflammatory process with continuing disease activity, and increased levels of autoantibodies and inflammatory molecules in serum and cerebrospinal fluid (CSF). Methods 100 randomly selected patients participating in an inception SLE cohort were studied. At entry into the cohort, a standardized medical history and extensive laboratory tests profile, including autoantibodies were completed. Follow-up occurred every 3-6 months with assessment of lupus characteristics, comorbidities, and treatment. After a mean follow-up of six-years, cross-sectional evaluation of cognitive function was done with standardized tests, and in a subset of patients an extended profile of autoantibodies, cytokines and chemokines was measured in serum and CSF. Results At enrollment into the cohort, patients were 26.4 +/- 8.2 years of age and lupus duration 5.3 +/- 3.7 months. Moderate/severe cognitive dysfunction was diagnosed in 16 patients; in comparison to patients with normal cognitive function, they had lower education 9 vs. 12 years (P = 0.006), higher body mass index 26.7 vs. 24.3 (P = 0.03), positive IgG anticardiolipin antibodies 50% vs 18% (P = 0.009), and a higher median number of concomitant NPSLE syndromes 3 vs. 1, (P = 0.04). The prevalence of cardiovascular-risk factors, other auto-antibodies, lupus activity, treatment, and incidence of critical events did not differ. In serum and CSF, the levels of auto-antibodies, cytokines and chemokine were similar, only CCL2 was elevated in CSF [886.1 (374.9-1439.7) vs. 515.8 (3.2-1958.2) pg/mL, P = 0.04]. Conclusion Scant evidence of inflammation in SLE patients with cognitive dysfunction was observed. Only a higher prevalence of IgG anticardiolipin antibodies in serum and increased levels of CCL2 in CSF were detected.	[Duarte-Garcia, Ali] Mayo Clin, Dept Med, Div Rheumatol, Rochester, MN USA; [Duarte-Garcia, Ali] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA; [Romero-Diaz, Juanita; Cicero-Casarrubias, Alba; Fragoso-Loyo, Hilda; Nunez-Alvarez, Carlos; Llorente, Luis] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico; [Juarez, Sandra] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Neurol, Mexico City, DF, Mexico; [Sanchez-Guerrero, Jorge] Mt Sinai Hosp, Div Rheumatol, Dept Med, Toronto, ON, Canada; [Sanchez-Guerrero, Jorge] Univ Hlth Network, Toronto, ON, Canada	Mayo Clinic; Mayo Clinic; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Sanchez-Guerrero, J (corresponding author), Mt Sinai Hosp, Div Rheumatol, Dept Med, Toronto, ON, Canada.; Sanchez-Guerrero, J (corresponding author), Univ Hlth Network, Toronto, ON, Canada.	Jorge.Sanchez-Guerrero@sinaihealthsystem.ca	Llorente, Luis/GQP-7202-2022	Llorente, Luis/0000-0002-3464-3747; Cicero-Casarrubias, Alba/0000-0001-9202-3629	Department of Immunology and Rheumatology, Institute Nacional de Ciencias Medicas y Nutricion Salvador Zubiran	Department of Immunology and Rheumatology, Institute Nacional de Ciencias Medicas y Nutricion Salvador Zubiran	This work was supported with resources from the Department of Immunology and Rheumatology, Institute Nacional de Ciencias Medicas y Nutricion Salvador Zubiran. There were no sponsors or funders.	Ainiala H, 2001, NEUROLOGY, V57, P496, DOI 10.1212/WNL.57.3.496; Appenzeller S, 2005, ARTHRITIS RHEUM-US, V52, P2783, DOI 10.1002/art.21271; Appenzeller S, 2009, ARTHRIT RHEUM-ARTHR, V61, P680, DOI 10.1002/art.24346; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; CARBOTTE RM, 1986, J NERV MENT DIS, V174, P357, DOI 10.1097/00005053-198606000-00008; Cournot M, 2006, NEUROLOGY, V67, P1208, DOI 10.1212/01.wnl.0000238082.13860.50; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; DENBURG SD, 1987, J CLIN EXP NEUROPSYC, V9, P323, DOI 10.1080/01688638708405054; Filley CM, 2009, COGN BEHAV NEUROL, V22, P38, DOI 10.1097/WNN.0b013e318190d174; Fragoso-Loyo H, 2007, ARTHRITIS RHEUM-US, V56, P1242, DOI 10.1002/art.22451; Fragoso-Loyo H, 2013, RHEUMATOLOGY, V52, P2218, DOI 10.1093/rheumatology/ket294; Fragoso-Loyo H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003347; GINSBURG KS, 1992, ARTHRITIS RHEUM, V35, P776, DOI 10.1002/art.1780350711; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2002, J RHEUMATOL, V29, P288; Glanz BI, 1997, NEUROPSY NEUROPSY BE, V10, P232; Gustafson D, 2004, NEUROLOGY, V63, P1876, DOI 10.1212/01.WNL.0000141850.47773.5F; Hanly JG, 2010, ANN RHEUM DIS, V69, P529, DOI 10.1136/ard.2008.106351; Hanly JG, 1999, ARTHRITIS RHEUM, V42, P728, DOI 10.1002/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O; HANLY JG, 1992, J RHEUMATOL, V19, P562; Harrison MJ, 2006, ARTHRITIS RHEUM, V54, P2515, DOI 10.1002/art.22030; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Ibanez D, 2005, J RHEUMATOL, V32, P824; Isenberg DA, 2011, LUPUS, V20, P1426, DOI 10.1177/0961203311421501; Karlson EW, 2003, LUPUS, V12, P280, DOI 10.1191/0961203303lu332oa; Kimura A, 2018, J ALZHEIMERS DIS, V61, P581, DOI 10.3233/JAD-170519; Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; Kozora E, 1996, ARTHRITIS RHEUM, V39, P2035, DOI 10.1002/art.1780391213; Kozora E, 2005, COGN BEHAV NEUROL, V18, P159, DOI 10.1097/01.wnn.0000181543.05064.4b; Lapteva L, 2006, ARTHRITIS RHEUM, V54, P2505, DOI 10.1002/art.22031; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Little AR, 2002, NEUROSCIENCE, V115, P307, DOI 10.1016/S0306-4522(02)00359-7; Madrigal JLM, 2014, ADV EXP MED BIOL, V824, P209, DOI 10.1007/978-3-319-07320-0_15; Menon S, 1999, ARTHRITIS RHEUM-US, V42, P735, DOI 10.1002/1529-0131(199904)42:4<735::AID-ANR17>3.0.CO;2-L; Mikdashi J, 2004, RHEUMATOLOGY, V43, P1555, DOI 10.1093/rheumatology/keh384; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Murray SG, 2012, ARTHRIT CARE RES, V64, P1328, DOI 10.1002/acr.21691; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Panopalis P, 2007, ARTHRIT RHEUM-ARTHR, V57, P1453, DOI 10.1002/art.23090; Romero-Diaz J, 2012, RHEUMATOLOGY, V51, P110, DOI 10.1093/rheumatology/ker307; Saczynski JS, 2008, AM J EPIDEMIOL, V168, P1132, DOI 10.1093/aje/kwn228; Selnes OA, 2012, NEW ENGL J MED, V366, P250, DOI 10.1056/NEJMra1100109; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tiffin-Richards FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106700; Tomietto P, 2007, ARTHRIT RHEUM-ARTHR, V57, P1461, DOI 10.1002/art.23098; Urowitz MB, 2010, ARTHRIT CARE RES, V62, P881, DOI 10.1002/acr.20122; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Yoshio T, 2006, ARTHRITIS RHEUM, V54, P675, DOI 10.1002/art.21547	49	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196487	10.1371/journal.pone.0196487	http://dx.doi.org/10.1371/journal.pone.0196487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723220	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100034
J	Hoving, LR; van der Zande, HJP; Pronk, A; Guigas, B; van Dijk, KW; van Harmelen, V				Hoving, Lisa R.; van der Zande, Hendrik J. P.; Pronk, Amanda; Guigas, Bruno; van Dijk, Ko Willems; van Harmelen, Vanessa			Dietary yeast-derived mannan oligosaccharides have immune-modulatory properties but do not improve high fat diet-induced obesity and glucose intolerance	PLOS ONE			English	Article							ADIPOSE-TISSUE; MACROPHAGES; SUPPLEMENTATION; INFLAMMATION; ACTIVATION	The indigestible mannan oligosaccharides (MOS) derived from the outer cell wall of yeast Saccharomyces cerevisiae have shown potential to reduce inflammation. Since inflammation is one of the underlying mechanisms involved in the development of obesity-associated metabolic dysfunctions, we aimed to determine the effect of dietary supplementation with MOS on inflammation and metabolic homeostasis in lean and diet-induced obese mice. Male C57BL/6 mice were fed either a low fat diet (LFD) or a high fat diet (HFD) with, respectively, 10% or 45% energy derived from lard fat, with or without 1% MOS for 17 weeks. Body weight and composition were measured throughout the study. After 12 weeks of intervention, whole-body glucose tolerance was assessed and in week 17 immune cell composition was determined in mesenteric white adipose tissue (mWAT) and liver by flow cytometry and RT-qPCR. In LFD-fed mice, MOS supplementation induced a significant increase in the abundance of macrophages and eosinophils in mWAT. A similar trend was observed in hepatic macrophages. Although HFD feeding induced a classical shift from the anti-inflammatory M2-like macrophages towards the pro-inflammatory M1-like macrophages in both mWAT and liver from control mice, MOS supplementation had no effect on this obesity-driven immune response. Finally, MOS supplementation did not improve whole-body glucose homeostasis in both lean and obese mice. Altogether, our data showed that MOS had extra-intestinal immune modulatory properties in mWAT and liver. However these effects were not substantial enough to significantly ameliorate HFD-induced glucose intolerance or inflammation.	[Hoving, Lisa R.; Pronk, Amanda; van Dijk, Ko Willems; van Harmelen, Vanessa] Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands; [Hoving, Lisa R.; Pronk, Amanda; van Dijk, Ko Willems; van Harmelen, Vanessa] Leiden Univ, Einthoven Lab Expt Vasc Med, Med Ctr, Leiden, Netherlands; [van der Zande, Hendrik J. P.; Guigas, Bruno] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands; [Guigas, Bruno] Leiden Univ, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands; [van Dijk, Ko Willems] Leiden Univ, Dept Med, Med Ctr, Div Endocrinol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hoving, LR (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands.; Hoving, LR (corresponding author), Leiden Univ, Einthoven Lab Expt Vasc Med, Med Ctr, Leiden, Netherlands.	l.r.having@lumc.nl	Hoving, Lisa/S-4167-2018; Guigas, Bruno/M-2515-2015; van Dijk, Ko Willems/A-1798-2008; van Dijk, Ko Willems/AAT-4681-2021	Hoving, Lisa/0000-0002-3096-7533; Guigas, Bruno/0000-0002-8856-5799; van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; van Harmelen, Vanessa/0000-0003-0111-9858	Netherlands Cardiovascular Research Committee IN-CONTROL Grant [CVON 2012-03]; Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation; Dutch Federation of University Medical Centres; Netherlands Organisation for Health Research and Development; Royal Netherlands Academy of Sciences	Netherlands Cardiovascular Research Committee IN-CONTROL Grant; Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation; Dutch Federation of University Medical Centres; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Sciences	This research was supported by The Netherlands Cardiovascular Research Committee IN-CONTROL Grant (CVON 2012-03). We acknowledge the support from the Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation, Dutch Federation of University Medical Centres, the Netherlands Organisation for Health Research and Development and the Royal Netherlands Academy of Sciences.	Acosta JR, 2016, DIABETOLOGIA, V59, P560, DOI 10.1007/s00125-015-3810-6; Baurhoo B, 2007, POULTRY SCI, V86, P1070, DOI 10.1093/ps/86.6.1070; Baurhoo B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030323; Bavington CD, 2004, COMP BIOCHEM PHYS B, V139, P607, DOI 10.1016/j.cbpc.2004.07.008; Berge AC, 2012, ANIMAL, V6, P557, DOI 10.1017/S1751731111002217; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Che TM, 2012, J ANIM SCI, V90, P657, DOI 10.2527/jas.2011-4310; Che TM, 2011, J ANIM SCI, V89, P3016, DOI 10.2527/jas.2010-3366; Gomez B, 2017, J AGR FOOD CHEM, V65, P2019, DOI 10.1021/acs.jafc.6b05409; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huh JY, 2014, MOL CELLS, V37, P365, DOI 10.14348/molcells.2014.0074; Hussaarts L, 2015, FASEB J, V29, P3027, DOI 10.1096/fj.14-266239; Johnson AMF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122195; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Morinaga H, 2015, DIABETES, V64, P1120, DOI 10.2337/db14-1238; Munyaka PM, 2012, POULTRY SCI, V91, P2164, DOI 10.3382/ps.2012-02306; Ndumele CE, 2011, ARTERIOSCL THROM VAS, V31, P1927, DOI 10.1161/ATVBAHA.111.228262; Nijhuis J, 2009, OBESITY, V17, P2014, DOI 10.1038/oby.2009.113; Smith DL, 2010, OBESITY, V18, P995, DOI 10.1038/oby.2009.308; Takao I, 2006, J HEALTH SCI, V52, P333, DOI 10.1248/jhs.52.333; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Torrecillas S, 2014, FISH SHELLFISH IMMUN, V36, P525, DOI 10.1016/j.fsi.2013.12.029; van Beek L, 2015, DIABETOLOGIA, V58, P1601, DOI 10.1007/s00125-015-3594-8; Wang WW, 2016, BRIT J NUTR, V116, P1878, DOI 10.1017/S0007114516004116; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; ZHANG YQ, 2015, INT J ENDOCRINOL, V10, DOI DOI 10.1155/2015/565760	27	13	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196165	10.1371/journal.pone.0196165	http://dx.doi.org/10.1371/journal.pone.0196165			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723205	gold, Green Published, Green Submitted			2022-12-26	WOS:000431305100014
J	Man, XF; Arroyo, E; Dunbar, M; Reed, DM; Shah, N; Kagemann, L; Kim, W; Moroi, SE; Argento, A				Man, Xiaofei; Arroyo, Elizabeth; Dunbar, Martha; Reed, David M.; Shah, Neil; Kagemann, Larry; Kim, Wonsuk; Moroi, Sayoko E.; Argento, Alan			Perilimbal sclera mechanical properties: Impact on intraocular pressure in porcine eyes	PLOS ONE			English	Article							TRABECULAR MESHWORK STIFFNESS; COLLAGEN CROSS-LINKING; HUMOR OUTFLOW FACILITY; BIOMECHANICAL PROPERTIES; PERIPAPILLARY SCLERA; AQUEOUS OUTFLOW; BEHAVIOR; INHIBITOR; PERFUSION; GLAUCOMA	There is extensive knowledge on the relationship of posterior scleral biomechanics and intraocular pressure (IOP) load on glaucomatous optic neuropathy; however, the role for biomechanical influence of the perilimbal scleral tissue on the aqueous humor drainage pathway, including the distal venous outflow system, and IOP regulation is not fully understood. The purpose of this work is to study the outflow characteristics of perfused porcine eyes relative to the biomechanical properties of the perilimbal sclera, the posterior sclera and the cornea. Enucleated porcine eyes from eleven different animals were perfused with surrogate aqueous at two fixed flow rates while monitoring their IOP. After perfusion, mechanical stress-strain and relaxation tests were conducted on specimens of perilimbal sclera, posterior sclera, and cornea from the same perfused eyes. Statistical analysis of the data demonstrated a strong correlation between increased tangent modulus of the perilimbal sclera tissues and increased perfusion IOP (R-2 = 0.74, p = 0.0006 at lower flow rate and R-2 = 0.71, p = 0.0011 at higher flow rate). In contrast, there were no significant correlations between IOP and the tangent modulus of the other tissues (Posterior sclera: R-2 = 0.17 at lower flow rate and R-2 = 0.30 at higher flow rate; cornea: R-2 = 0.02 at lower flow rate and R-2<0.01 at higher flow rate) nor the viscoelastic properties of any tissue (R-2 <= 0.08 in all caes). Additionally, the correlation occurred for IOP and not net outflow facility (R-2 <= 0.12 in all cases). These results provide new evidence that IOP in perfused porcine eyes is strongly influenced by the tangent modulus, sometimes called the tissue stiffness, of the most anterior portion of the sclera, i.e. the limbus.	[Man, Xiaofei; Reed, David M.; Shah, Neil; Moroi, Sayoko E.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Man, Xiaofei] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Arroyo, Elizabeth; Dunbar, Martha; Kim, Wonsuk; Argento, Alan] Univ Michigan, Dept Mech Engn, Dearborn, MI 48128 USA; [Dunbar, Martha] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Shah, Neil] Loyola Univ, Med Ctr, Dept Ophthalmol, 2160 S 1st Ave, Maywood, IL 60153 USA; [Kagemann, Larry] NYU, Dept Ophthalmol, Langone Med Ctr, Sch Med, 550 1St Ave, New York, NY 10016 USA; [Kagemann, Larry] US FDA, Div Ophthalm & Ear Nose & Throat Devices, Off Device Evaluat, Ctr Devices & Radiol Hlth, Silver Spring, MD USA	University of Michigan System; University of Michigan; Shanghai Jiao Tong University; University of Michigan System; University of Michigan; Northwestern University; Loyola University Chicago; New York University; NYU Langone Medical Center; US Food & Drug Administration (FDA)	Argento, A (corresponding author), Univ Michigan, Dept Mech Engn, Dearborn, MI 48128 USA.	aargento@umich.edu	Reed, David Millard/AFQ-5520-2022; Reed, David M/S-7063-2019	Reed, David M/0000-0002-4772-6138; Moroi, Sayoko E/0000-0002-0418-0657; Kagemann, Larry/0000-0001-8961-0187; Kim, Wonsuk/0000-0002-4351-0321	National Science Foundation [CMMI 1130275]; National Institutes of Health NEI Vision Core Grant [P30 EY007003]; MCubed research seed-funding program for faculty at the University of Michigan; Research to Prevent Blindness (Department of Ophthalmology and Visual Sciences, The University of Michigan)	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health NEI Vision Core Grant; MCubed research seed-funding program for faculty at the University of Michigan; Research to Prevent Blindness (Department of Ophthalmology and Visual Sciences, The University of Michigan)	This paper is supported in part upon work supported by the National Science Foundation under grant CMMI 1130275 (A.A.), the National Institutes of Health NEI Vision Core Grant P30 EY007003 (Department of Ophthalmology and Visual Sciences, The University of Michigan), MCubed research seed-funding program for faculty at the University of Michigan (S.E.M.), an unrestricted research grant from Research to Prevent Blindness (Department of Ophthalmology and Visual Sciences, The University of Michigan), and grateful patient donors (S.E.M.). This support is gratefully acknowledged. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the sponsors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2013, MOL VIS, V19, P1526; Argento A, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027615; Billiar KL, 1997, J BIOMECH, V30, P753, DOI 10.1016/S0021-9290(97)00019-5; Boschetti F, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006089; Boyce BL, 2007, J BIOMECH, V40, P2367, DOI 10.1016/j.jbiomech.2006.12.001; BURNS ML, 1984, J BIOMECH, V17, P113, DOI 10.1016/0021-9290(84)90129-5; Camras LJ, 2012, INVEST OPHTH VIS SCI, V53, P5242, DOI [10.1167/iovs.12-9825, 10.1167/iovs.12-9825a]; Carreon T, 2017, PROG RETIN EYE RES, V57, P108, DOI 10.1016/j.preteyeres.2016.12.004; Cha EDK, 2016, EXP EYE RES, V146, P354, DOI 10.1016/j.exer.2016.01.008; Chakraborty N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165520; Cowin S.C., 2007, TISSUE MECH, DOI 10.1007/978-0-387-49985-7; Cruz-Perez B, 2013, J BIOMECHANICS; Downs JC, 2003, J BIOMECH ENG-T ASME, V125, P124, DOI 10.1115/1.1536930; Elsheikh A, 2009, EXP EYE RES, V88, P1084, DOI 10.1016/j.exer.2009.01.010; Epstein DL, 1999, INVEST OPHTH VIS SCI, V40, P74; Geraghty B, 2012, J MECH BEHAV BIOMED, V16, P181, DOI 10.1016/j.jmbbm.2012.10.011; Girard M, 2007, CURR EYE RES, V32, P465, DOI 10.1080/02713680701273792; Girard MJA, 2015, CURR EYE RES, V40, P1, DOI 10.3109/02713683.2014.914543; GRANT WM, 1963, ARCH OPHTHALMOL-CHIC, V69, P783; Hatami-Marbini H, 2014, ANN BIOMED ENG, V42, P1740, DOI 10.1007/s10439-014-0996-6; Ivers KM, 2016, INVEST OPHTH VIS SCI, V57, pOCT388, DOI 10.1167/iovs.15-18666; Jacobs NT, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023503; Jonas JB, 2017, LANCET, V390, P2183, DOI 10.1016/S0140-6736(17)31469-1; Kim W, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006847; Kimball EC, 2014, EXP EYE RES, V128, P129, DOI 10.1016/j.exer.2014.08.016; Lanchares E, 2011, GRAEF ARCH CLIN EXP, V249, P1223, DOI 10.1007/s00417-011-1674-0; Lari DR, 2012, EXP EYE RES, V94, P128, DOI 10.1016/j.exer.2011.11.017; Li PC, 2017, BRIT J OPHTHALMOL, V101, P808, DOI 10.1136/bjophthalmol-2016-309295; Liu BY, 2018, SURV OPHTHALMOL, V63, P56, DOI 10.1016/j.survophthal.2017.06.007; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Matsumoto T, 2007, BIOMECHANICS MICRO N, P14; Meek K. M., 2008, P359, DOI 10.1007/978-0-387-73906-9_13; Meek KM, 2013, OPHTHAL PHYSL OPT, V33, P78, DOI 10.1111/opo.12032; Norman RE, 2011, EXP EYE RES, V93, P4, DOI 10.1016/j.exer.2010.09.014; Perez Benjamin Cruz, 2013, J Biomed Sci Eng, V6, P29; Puxkandl R, 2002, PHILOS T R SOC B, V357, P191, DOI 10.1098/rstb.2001.1033; Rao PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; ROHEN JW, 1994, PROG RETIN EYE RES, V13, P653, DOI 10.1016/1350-9462(94)90026-4; Romanyk DL, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024631; ROSENQUIST R, 1989, CURR EYE RES, V8, P1233, DOI 10.3109/02713688909013902; SAS Institute, 2016, JMP 13 MULT METH; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Spoerl E, 2005, INVEST OPHTH VIS SCI, V46, P1286, DOI 10.1167/iovs.04-0978; Spoerl E, 2004, OPHTHALMOLOGICA, V218, P136, DOI 10.1159/000076150; Stamper RL., 2009, BECKER SHAFFERS DIAG, V8th ed; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; Tanaka K., 2014, RECENT ADV STRUCTURA, P311; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Wang K, 2017, EXP EYE RES, V158, P3, DOI 10.1016/j.exer.2016.07.011; WILK MB, 1968, BIOMETRIKA, V55, P1; Wineman A.S., 2000, MECH RESPONSE POLYM; Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032; Xu W, 2010, CAN J OPHTHALMOL, V45, P632, DOI 10.3129/i10-056; Zeng YJ, 2001, J BIOMECH, V34, P533, DOI 10.1016/S0021-9290(00)00219-0; Zhang M, 2005, INVEST OPHTH VIS SCI, V46, P4130, DOI 10.1167/iovs.05-0164	55	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195882	10.1371/journal.pone.0195882	http://dx.doi.org/10.1371/journal.pone.0195882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718942	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900036
J	Peng, H; Chen, L; Chen, YP; Li, WF; Tang, LL; Lin, AH; Sun, Y; Ma, J				Peng, Hao; Chen, Lei; Chen, Yu-Pei; Li, Wen-Fei; Tang, Ling-Long; Lin, Ai-Hua; Sun, Ying; Ma, Jun			The current status of clinical trials focusing on nasopharyngeal carcinoma: A comprehensive analysis of ClinicalTrials.gov database	PLOS ONE			English	Article							BARR-VIRUS DNA; NEOADJUVANT CHEMOTHERAPY; DISTANT METASTASIS; SURVIVAL; RADIOTHERAPY; EPIDEMIOLOGY; CELLS	Purpose Clinical Trials have emerged as the main force in driving the development of medicine. However, little is known about the current status of clinical trials regarding nasopharyngeal carcinoma (NPC). This study aimed at providing a comprehensive landscape of NPC-related trials on the basis of ClinicalTrials.gov database. Patients and methods We used the keyword "nasopharyngeal carcinoma" to search the ClinicalTrials.gov database and assessed the characteristics of these trials. Results Up to December 30, 2016, 462 eligible trials in total were identified, of which 222 (48.0%) recruited only NPC (NPC trials) and the other 240 (52.0%) recruited both NPC and other cancers (multiple cancer trials). Moreover, 47 (10.2%) were Epstein-Barr virus (EBV)-related trials and 267 (57.8%) focused on metastatic/recurrent disease. Compared with NPC trials, the multiple cancer trials had a higher percentage of phase 1 (26.7% vs. 6.7%, P < 0.001) studies and more patients with metastatic/recurrent disease (72.5% vs. 41.9%, P < 0.001). Notably, non-EBV trials had more phase 2 or 3 (78.4% vs. 48.8%, P < 0.001) and interventional studies (89.5% vs. 70.7%, P = 0.002) than EBV trials. Obviously, more phase 2/3 or 3 trials were conducted in patients with non-metastatic/recurrent disease (29.4% vs. 4.9%, P < 0.001); however, metastatic/recurrent trials were more likely to be anticancer (94.6% vs. 63.6%, P < 0.001). Conclusions The role of plasma EBV DNA in clinical trials is underestimated, and high-level randomized clinical trials should be performed for patients with metastatic/recurrent disease.	[Peng, Hao; Chen, Lei; Chen, Yu-Pei; Li, Wen-Fei; Tang, Ling-Long; Sun, Ying; Ma, Jun] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med,Canc Ctr, Dept Radiat Oncol,State Key Lab Oncol Southern Ch, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, Guangzhou, Guangdong, Peoples R China; [Lin, Ai-Hua] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Ma, J (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med,Canc Ctr, Dept Radiat Oncol,State Key Lab Oncol Southern Ch, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, Guangzhou, Guangdong, Peoples R China.	majun2@mail.sysu.edu.cn	Chen, Yu-Pei/AAY-9539-2020	Chen, Yu-Pei/0000-0002-0010-3494; Ma, Jun/0000-0002-1137-9349	National Science & Technology Pillar Program [2014BA109B10]; Health & Medical Collaborative Innovation Project of Guangzhou City, China [201400000001]; Science and Technology Project of Guangzhou City, China [14570006]	National Science & Technology Pillar Program; Health & Medical Collaborative Innovation Project of Guangzhou City, China; Science and Technology Project of Guangzhou City, China	This work was supported by grants from the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2014BA109B10); the Health & Medical Collaborative Innovation Project of Guangzhou City, China (201400000001) and the Science and Technology Project of Guangzhou City, China (14570006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X, 2011, CANCER-AM CANCER SOC, V117, P3750, DOI 10.1002/cncr.25932; Anderson ML, 2015, NEW ENGL J MED, V372, P1031, DOI 10.1056/NEJMsa1409364; Chan ATC, 2002, JNCI-J NATL CANCER I, V94, P1614, DOI 10.1093/jnci/94.21.1614; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; CHANG YS, 1990, J CLIN MICROBIOL, V28, P2398, DOI 10.1128/JCM.28.11.2398-2402.1990; CHEN CL, 1993, INTERVIROLOGY, V36, P91, DOI 10.1159/000150327; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; Du XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16664; Jin Y, 2012, EUR J CANCER, V48, P882, DOI 10.1016/j.ejca.2011.09.004; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Leung SF, 2014, ANN ONCOL, V25, P1204, DOI 10.1093/annonc/mdu117; Leung SF, 2003, CANCER, V98, P288, DOI 10.1002/cncr.11496; Leung SF, 2006, J CLIN ONCOL, V24, P5414, DOI 10.1200/JCO.2006.07.7982; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Lin JC, 2001, J CLIN ONCOL, V19, P2607, DOI 10.1200/JCO.2001.19.10.2607; Lin JC, 2007, INT J RADIAT ONCOL, V68, P1342, DOI 10.1016/j.ijrobp.2007.02.012; Ma BBY, 2006, INT J RADIAT ONCOL, V66, P714, DOI 10.1016/j.ijrobp.2006.05.064; Peng H, 2016, J CANCER, V7, P1465, DOI 10.7150/jca.15736; Peng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22000; Razak ARA, 2010, EUR J CANCER, V46, P1967, DOI 10.1016/j.ejca.2010.04.004; SHAM JST, 1990, BRIT J RADIOL, V63, P108, DOI 10.1259/0007-1285-63-746-108; SHANMUGARATNAM K, 1979, CANCER, V44, P1029, DOI 10.1002/1097-0142(197909)44:3<1029::AID-CNCR2820440335>3.0.CO;2-5; Sun XM, 2014, RADIOTHER ONCOL, V110, P398, DOI 10.1016/j.radonc.2013.10.020; Teo PML, 1996, CANCER-AM CANCER SOC, V77, P2423, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2423::AID-CNCR2>3.0.CO;2-N; Tsai ST, 1996, CANCER, V77, P231, DOI 10.1002/(SICI)1097-0142(19960115)77:2<231::AID-CNCR2>3.0.CO;2-P; Twu CW, 2014, INT J RADIAT ONCOL, V89, P21, DOI 10.1016/j.ijrobp.2014.01.052; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Yang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15638; Yi JL, 2006, INT J RADIAT ONCOL, V65, P161, DOI 10.1016/j.ijrobp.2005.12.003; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; Zhang L, 2016, LANCET, V388, P1883, DOI 10.1016/S0140-6736(16)31388-5; Zhang MX, 2015, EUR J CANCER, V51, P2587, DOI 10.1016/j.ejca.2015.08.006	32	16	19	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196730	10.1371/journal.pone.0196730	http://dx.doi.org/10.1371/journal.pone.0196730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718970	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900076
J	Munoz-Vargas, L; Opiyo, SO; Digianantonio, R; Williams, ML; Wijeratne, A; Habing, G				Munoz-Vargas, Lohendy; Opiyo, Stephen O.; Digianantonio, Rose; Williams, Michele L.; Wijeratne, Asela; Habing, Gregory			Fecal microbiome of periparturient dairy cattle and associations with the onset of Salmonella shedding	PLOS ONE			English	Article							ESCHERICHIA-COLI; COMMUNITIES; IMPACT; FECES; RUMEN; SILVA; HERD	Non-typhoidal Salmonella enterica is a zoonotic pathogen with critical importance in animal and public health. The persistence of Salmonella on farms affects animal productivity and health, and represents a risk for food safety. The intestinal microbiota plays a fundamental role in the colonization and invasion of this ubiquitous microorganism. To overcome the colonization resistance imparted by the gut microbiome, Salmonella uses invasion strategies and the host inflammatory response to survive, proliferate, and establish infections with diverse clinical manifestations. Cattle serve as reservoirs of Salmonella, and periparturient cows have high prevalence of Salmonella shedding; however, little is known about the association between the gut microbiome and the onset of Salmonella shedding during the periparturient period. Thus, the objective of this study was to assess the association between changes in bacterial communities and the onset of Salmonella shedding in cattle approaching parturition. In a prospective cohort study, fecal samples from 98 dairy cows originating from four different farms were collected at four time points relative to calving (-3 wks, -1 wk, +1 wk, +3 wks). All 392 samples were cultured for Salmonella. Sequencing of the V4 region of the 16S rRNA gene using the Illumina platform was completed to evaluate the fecal microbiome in a selected sample subset. Analyses of microbial composition, diversity, and structure were performed according to time points, farm, and Salmonella onset status. Individual cow fecal microbiomes, predominated by Bacteroidetes, Firmicutes, Spirochaetes, and Proteobacteria phyla, significantly changed before and after parturition. Microbial communities from different farms were distinguishable based on multivariate analysis. Although there were significant differences in some bacterial taxa between Salmonella positive and negative samples, our results did not identify differences in the fecal microbial diversity or structure for cows with and without the onset of Salmonella shedding. These data suggest that determinants other than the significant changes in the fecal microbiome influence the periparturient onset of Salmonella shedding in dairy cattle.	[Munoz-Vargas, Lohendy; Digianantonio, Rose; Habing, Gregory] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Opiyo, Stephen O.; Williams, Michele L.; Wijeratne, Asela] Ohio State Univ, Ohio Agr Res & Dev Ctr, Wooster, OH 44691 USA; [Opiyo, Stephen O.; Williams, Michele L.; Wijeratne, Asela] Ohio State Univ, Mol & Cellular Imaging Ctr, Wooster, OH USA; [Digianantonio, Rose] Colorado State Univ, Coll Vet Med, Ft Collins, CO 80523 USA; [Williams, Michele L.] Jacksonville Univ, Dept Biol & Marine Sci, Jacksonville, FL USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Colorado State University; Jacksonville University	Munoz-Vargas, L (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA.	lohendymv@gmail.com; habing.4@osu.edu	Habing, Gregory Georg/A-1606-2013		Intramural Unites States Department of Agriculture Formula Grant in the College of Veterinary Medicine at The Ohio State University	Intramural Unites States Department of Agriculture Formula Grant in the College of Veterinary Medicine at The Ohio State University	This study was supported by the Intramural Unites States Department of Agriculture Formula Grant in the College of Veterinary Medicine at The Ohio State University. The grant was awarded to Dr. Greg Habing at the Department of Veterinary Preventive Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmer BMM, 2011, FRONT MICROBIOL, P2, DOI [10.3389/fmicb.2011.00101/abstract, DOI 10.3389/FMICB.2011.00101/ABSTRACT]; Andino A, 2015, SCI WORLD J; Baron S, 2016, VET MICROBIOL, V185, P29, DOI 10.1016/j.vetmic.2016.01.020; Behnsen J, 2015, TRENDS IMMUNOL, V36, P112, DOI 10.1016/j.it.2014.12.003; Boetl B., 2017, CATTLE MARKETS DAIRY; Borewicz KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139106; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cardenal-Munoz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026930; CDC, 2016, MULT OUTBR MULT RES; Centers for Disease Control and Prevention (Cdc), 2013, MULT OUTBR SALM TYPH; Cummings KJ, 2012, EMERG INFECT DIS, V18, P1929, DOI 10.3201/eid1812.110831; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Digianantonio R., 2015, THESIS; Dong HJ, 2016, FOODBORNE PATHOG DIS, V13, P502, DOI 10.1089/fpd.2016.2121; Drumo R, 2016, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00106; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edrington TS, 2008, EPIDEMIOL INFECT, V136, P381, DOI 10.1017/S0950268807008680; Fecteau ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160353; Fossler CP, 2005, PREV VET MED, V70, P279, DOI 10.1016/j.prevetmed.2005.04.002; Frey JC, 2010, J APPL MICROBIOL, V108, P1982, DOI 10.1111/j.1365-2672.2009.04602.x; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Habing GG, 2012, FOODBORNE PATHOG DIS, V9, P815, DOI 10.1089/fpd.2012.1149; Haley BJ, 2016, FRONT MICROBIOL, P7; Huston CL, 2002, J AM VET MED ASSOC, V220, P645, DOI 10.2460/javma.2002.220.645; Juricova H, 2013, APPL ENVIRON MICROB, V79, P745, DOI 10.1128/AEM.02628-12; Klein-Jobstl D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00622; Lewerin SS, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-51; Manyi-Loh CE, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090843; Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116; Meyer C, 2010, J FOOD PROTECT, V73, P1780, DOI 10.4315/0362-028X-73.10.1780; Munoz-Vargas L, 2017, FOODBORNE PATHOG DIS, V14, P678, DOI 10.1089/fpd.2017.2303; Nollet N, 2005, VET RES, V36, P645, DOI 10.1051/vetres:2005022; Patton TG, 2009, VET MICROBIOL, V136, P285, DOI 10.1016/j.vetmic.2008.10.032; Pitta DW, 2014, J ANIM SCI, V92, P4014, DOI 10.2527/jas.2014-7621; Proudfoot KL, 2009, J DAIRY SCI, V92, P3116, DOI 10.3168/jds.2008-1718; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Santos RL, 2014, FRONT IMMUNOL, P5, DOI [10.3389/fimmu.2014.00252/abstract, DOI 10.3389/FIMMU.2014.00252/ABSTRACT]; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shanks OC, 2011, APPL ENVIRON MICROB, V77, P2992, DOI 10.1128/AEM.02988-10; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Strawn LK, 2014, APPL ENVIRON MICROB, V80, P3982, DOI 10.1128/AEM.00348-14; Vogtmann E, 2017, AM J EPIDEMIOL, V185, P115, DOI 10.1093/aje/kww177; Wang DL, 2014, COMMUN STAT-THEOR M, V43, P1979, DOI 10.1080/03610926.2012.681418; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weese JS, 2015, EQUINE VET J, V47, P641, DOI 10.1111/evj.12361; Zhang CJ, 2016, ANAEROBE, V42, P188, DOI 10.1016/j.anaerobe.2016.10.016; Zhao WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117441	51	10	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0196171	10.1371/journal.pone.0196171	http://dx.doi.org/10.1371/journal.pone.0196171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750790	Green Published, gold, Green Submitted			2022-12-26	WOS:000431856300001
J	Zhu, SY; Wang, YZ; Xu, XM; Liu, TM; Wu, DQ; Zheng, X; Tang, SW; Dai, QZ				Zhu, Siyuan; Wang, Yanzhou; Xu, Xiaomin; Liu, Touming; Wu, Duanqing; Zheng, Xia; Tang, Shouwei; Dai, Qiuzhong			Potential use of high-throughput sequencing of soil microbial communities for estimating the adverse effects of continuous cropping on ramie (Boehmeria nivea L. Gaud)	PLOS ONE			English	Article							BACTERIAL DIVERSITY; RHIZOSPHERE SOIL; PYROSEQUENCING REVEALS; FUNGAL COMMUNITIES; REPLANT DISEASE; PLANT; MANAGEMENT; POTATO; DYNAMICS; FERTILIZATION	Ramie (Boehmeria nivea L. Gaud) fiber, one of the most important natural fibers, is extracted from stem bark. Continuous cropping is the main obstacle to ramie stem growth and a major cause of reduced yields. Root-associated microbes play crucial roles in plant growth and health. In this study, we investigated differences between microbial communities in the soil of healthy and continuously cropped ramie plants, and sought to identify potential mechanisms whereby these communities could counteract the problems posed by continuous cropping. Paired-end Illumina MiSeq analysis of 16S rRNA and ITS gene amplicons was employed to study bacterial and fungal communities. Long-term monoculture of ramie significantly decreased fiber yields and altered soil microbial communities. Our findings revealed how microbial communities and functional diversity varied according to the planting year and plant health status. Soil bacterial diversity increased with the period of ramie monoculture, whereas no significant differences were observed for fungi. Sequence analyses revealed that Firmicutes, Proteobacteria, and Acidobacteria were the most abundant bacterial phyla. Firmicutes abundance decreased with the period of ramie monoculture and correlated positively with the stem length, stem diameter, and fiber yield. The Actinobacteria, Chloroflexi, and Zygomycota phyla exhibited a significant (P < 0.05) negative correlation with yields during continuous cultivation. Some Actinobacteria members showed reduced microbial diversity, which prevented continuous ramie cropping. Ascomycota, Zygomycota, and Basidiomycota were the main fungal phyla. The relatively high abundance of Bacillus observed in healthy ramie may contribute to disease suppression, thereby promoting ramie growth. In summary, soil weakness and increased disease in ramie plants after long-term continuous cropping can be attributed to changes in soil microbes, a reduction in beneficial microbes, and an accumulation of harmful microbes.	[Zhu, Siyuan; Wang, Yanzhou; Xu, Xiaomin; Liu, Touming; Wu, Duanqing; Zheng, Xia; Tang, Shouwei; Dai, Qiuzhong] Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Bast Fiber Crops, CAAS	Zhu, SY; Dai, QZ (corresponding author), Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China.	zhusiyuan@caas.cn; daiqiuzhong@gmail.com	Wu, Duanqin/GLR-0201-2022		National Natural Science Foundation of China [31571618, 31771734]; Agricultural Science and Technology Innovation Program [ASTIP]; National Modern Agro-industry Technology Research System [nycytx-19-E16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program; National Modern Agro-industry Technology Research System	The authors acknowledge the National Natural Science Foundation of China (Grant No. 31571618 and 31771734), the Agricultural Science and Technology Innovation Program (Grant No. ASTIP), and the National Modern Agro-industry Technology Research System (Grant No. nycytx-19-E16) for supporting this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Alvey S, 2003, BIOL FERT SOILS, V37, P73, DOI 10.1007/s00374-002-0573-2; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Buee M, 2009, PLANT SOIL, V321, P189, DOI 10.1007/s11104-009-9991-3; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen MJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040659, 10.1371/journal.pone.0034651]; Dias ACF, 2012, SOIL BIOL BIOCHEM, V50, P85, DOI 10.1016/j.soilbio.2012.03.006; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Filion M, 2004, APPL ENVIRON MICROB, V70, P3541, DOI 10.1128/AEM.70.6.3541-3551.2004; Fu QL, 2012, J SOIL SEDIMENT, V12, P1134, DOI 10.1007/s11368-012-0544-7; Garbeva P, 2008, PLANT SOIL, V302, P19, DOI 10.1007/s11104-007-9432-0; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Gil SV, 2009, WORLD J MICROB BIOT, V25, P439, DOI 10.1007/s11274-008-9908-y; Gomes NCM, 2003, APPL ENVIRON MICROB, V69, P3758, DOI 10.1128/AEM.69.7.3758-3766.2003; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Hannula SE, 2012, NEW PHYTOL, V194, P784, DOI 10.1111/j.1469-8137.2012.04089.x; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; He JZ, 2008, J SOIL SEDIMENT, V8, P349, DOI 10.1007/s11368-008-0025-1; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Jayasekhar M., 2008, Agricultural Science Digest, V28, P109; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Li CG, 2010, PLANT SOIL, V330, P423, DOI 10.1007/s11104-009-0216-6; Li JG, 2014, PLANT SOIL, V380, P337, DOI 10.1007/s11104-014-2097-6; Li XG, 2014, SOIL BIOL BIOCHEM, V72, P11, DOI 10.1016/j.soilbio.2014.01.019; Li YC, 2016, J APPL MICROBIOL, V121, P787, DOI 10.1111/jam.13225; Lin WX, 2013, BMC MICROBIOL, V13, DOI [10.1186/1471-2180-13-135, 10.1186/1472-6882-13-144]; Lin WenXiong, 2012, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V20, P253, DOI 10.3724/SP.J.1011.2012.00253; Liu TM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-125; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lu HH, 2010, J SOIL SEDIMENT, V10, P1598, DOI 10.1007/s11368-010-0264-9; Lu LH, 2013, SOIL BIOL BIOCHEM, V65, P186, DOI 10.1016/j.soilbio.2013.05.025; Lu YH, 2004, FEMS MICROBIOL ECOL, V48, P179, DOI 10.1016/j.femsec.2004.01.004; Mahaffee WF, 1997, MICROB ECOL, V34, P210, DOI 10.1007/s002489900050; Manici LM, 2013, APPL SOIL ECOL, V72, P207, DOI 10.1016/j.apsoil.2013.07.011; Martin-Rueda I, 2007, SOIL TILL RES, V92, P1, DOI 10.1016/j.still.2005.10.006; Mazzola M, 2012, ANNU REV PHYTOPATHOL, V50, P45, DOI 10.1146/annurev-phyto-081211-173005; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Meriles JM, 2008, BIOL AGRIC HORTIC, V26, P193, DOI 10.1080/01448765.2008.9755080; Nobuta K, 2010, METHODS MOL BIOL, V592, P89, DOI 10.1007/978-1-60327-005-2_7; Oberauner L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01413; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Phillips RP, 2008, SOIL SCI SOC AM J, V72, P453, DOI 10.2136/sssaj2006.0389; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Santoyo G, 2012, BIOCONTROL SCI TECHN, V22, P855, DOI 10.1080/09583157.2012.694413; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Shang QH, 2014, PLANT DIS, V98, P999, DOI 10.1094/PDIS-11-13-1146-PDN; Shang QH, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2051-2; Sharma S, 2005, MICROB ECOL, V49, P407, DOI 10.1007/s00248-004-0041-7; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Squibb RL, 1957, GRASS FORAGE SCI, V9, P313; Sun J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111744; Tian YQ, 2014, MICROB ECOL, V68, P794, DOI 10.1007/s00248-014-0461-y; Uroz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055929; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; van Bruggen AHC, 2000, APPL SOIL ECOL, V15, P13, DOI 10.1016/S0929-1393(00)00068-8; Vandenkoornhuyse P, 2007, P NATL ACAD SCI USA, V104, P16970, DOI 10.1073/pnas.0705902104; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xiong H., 2005, PLANT FIBERS PROD, V27, P1; Xiong W, 2015, MICROB ECOL, V70, P209, DOI 10.1007/s00248-014-0516-0; Xu YX, 2009, SOIL BIOL BIOCHEM, V41, P919, DOI 10.1016/j.soilbio.2008.10.027; Zhang N, 2011, PLANT SOIL, V344, P87, DOI 10.1007/s11104-011-0729-7; Zhang W, 2013, MICROB ECOL, V66, P385, DOI 10.1007/s00248-012-0160-5; Zhao J, 2014, MICROB ECOL, V67, P443, DOI 10.1007/s00248-013-0322-0; Zhao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085301; Zhou XG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048288; Zhu Si-yuan, 2012, Journal of Hunan Agricultural University, V38, P360, DOI 10.3724/SP.J.1238.2012.00360	75	35	36	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0197095	10.1371/journal.pone.0197095	http://dx.doi.org/10.1371/journal.pone.0197095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750808	Green Submitted, Green Published, gold			2022-12-26	WOS:000431856300016
J	Niazi, MKK; Abas, FS; Senaras, C; Pennell, M; Sahiner, B; Chen, WJ; Opfer, J; Hasserjian, R; Louissaint, A; Shana'ah, A; Lozanski, G; Gurcan, MN				Niazi, Muhammad Khalid Khan; Abas, Fazly Salleh; Senaras, Cagler; Pennell, Michael; Sahiner, Berkman; Chen, Weijie; Opfer, John; Hasserjian, Robert; Louissaint, Abner, Jr.; Shana'ah, Arwa; Lozanski, Gerard; Gurcan, Metin N.			Nuclear IHC enumeration: A digital phantom to evaluate the performance of automated algorithms in digital pathology	PLOS ONE			English	Article							LYMPHOMA	Automatic and accurate detection of positive and negative nuclei from images of immunostained tissue biopsies is critical to the success of digital pathology. The evaluation of most nuclei detection algorithms relies on manually generated ground truth prepared by pathologists, which is unfortunately time-consuming and suffers from inter-pathologist variability. In this work, we developed a digital immunohistochemistry (IHC) phantom that can be used for evaluating computer algorithms for enumeration of IHC positive cells. Our phantom development consists of two main steps, 1) extraction of the individual as well as nuclei clumps of both positive and negative nuclei from real WSI images, and 2) systematic placement of the extracted nuclei clumps on an image canvas. The resulting images are visually similar to the original tissue images. We created a set of 42 images with different concentrations of positive and negative nuclei. These images were evaluated by four board certified pathologists in the task of estimating the ratio of positive to total number of nuclei. The resulting concordance correlation coefficients (CCC) between the pathologist and the true ratio range from 0.86 to 0.95 (point estimates). The same ratio was also computed by an automated computer algorithm, which yielded a CCC value of 0.99. Reading the phantom data with known ground truth, the human readers show substantial variability and lower average performance than the computer algorithm in terms of CCC. This shows the limitation of using a human reader panel to establish a reference standard for the evaluation of computer algorithms, thereby highlighting the usefulness of the phantom developed in this work. Using our phantom images, we further developed a function that can approximate the true ratio from the area of the positive and negative nuclei, hence avoiding the need to detect individual nuclei. The predicted ratios of 10 held-out images using the function (trained on 32 images) are within +/- 2.68% of the true ratio. Moreover, we also report the evaluation of a computerized image analysis method on the synthetic tissue dataset.	[Niazi, Muhammad Khalid Khan; Senaras, Cagler; Gurcan, Metin N.] Wake Forest Sch Med, Ctr Biomed Informat, Winston Salem, NC 27101 USA; [Abas, Fazly Salleh] Multimedia Univ, Fac Engn & Technol, Melaka, Malaysia; [Pennell, Michael] Ohio State Univ, Coll Publ Hlth, Dept Biostat, Columbus, OH 43210 USA; [Sahiner, Berkman; Chen, Weijie] US FDA, Silver Spring, MD USA; [Opfer, John] Ohio State Univ, Dept Psychol, 1885 Neil Ave Mall, Columbus, OH 43210 USA; [Hasserjian, Robert; Louissaint, Abner, Jr.] Harvard Med Sch, Dept Pathol, Boston, MA USA; [Shana'ah, Arwa; Lozanski, Gerard] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA	Wake Forest University; Multimedia University; University System of Ohio; Ohio State University; US Food & Drug Administration (FDA); University System of Ohio; Ohio State University; Harvard University; Harvard Medical School; University System of Ohio; Ohio State University	Niazi, MKK (corresponding author), Wake Forest Sch Med, Ctr Biomed Informat, Winston Salem, NC 27101 USA.	Mniazi@wakehealth.edu	Opfer, John E/B-6454-2008; Sahiner, Berkman/Y-2482-2019; Sahiner, Berkman/Z-1134-2018; Opfer, John/M-9668-2019	Opfer, John E/0000-0001-8406-3196; Opfer, John/0000-0001-8406-3196; CHEN, WEIJIE/0000-0001-7437-7829; Gurcan, Metin/0000-0002-2421-8229; Niazi, Muhammad Khalid Khan/0000-0002-1278-7512	National Cancer Institute [R01CA134451, U24CA199374, U01 CM 98945]; OSU CCC Pelotonia Award	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OSU CCC Pelotonia Award	This work was supported by R01CA134451 (PIs: MG, GL), U24CA199374 (PIs: MG, AMadabhushi, AMartel), U01 CM 98945 (PI: AB) from the National Cancer Institute. The work was also supported by OSU CCC Pelotonia Award (PI: Gurcan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belhomme P, 2015, COMPUT MED IMAG GRAP, V42, P51, DOI 10.1016/j.compmedimag.2014.11.006; Chefd'hotel c, 2014, INT WORKSH MACH LEAR; de Matos LL, 2010, BIOMARK INSIGHTS, V5, P9; Di Cataldo S, 2010, COMPUT METH PROG BIO, V100, P1, DOI 10.1016/j.cmpb.2010.02.002; FRITH CD, 1972, PERCEPT PSYCHOPHYS, V11, P409, DOI 10.3758/BF03206279; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; HERMANS J, 1995, BLOOD, V86, P1460, DOI 10.1182/blood.V86.4.1460.bloodjournal8641460; MANDLER G, 1982, J EXP PSYCHOL GEN, V111, P1, DOI 10.1037/0096-3445.111.1.1; Mao Y, 2015, IEEE 12 INT S BIOM I; METTER GE, 1985, J CLIN ONCOL, V3, P25, DOI 10.1200/JCO.1985.3.1.25; Niazi MKK, 2014, SPIE MED IMAGING; Niazi MKK, 2013, SPIE MED IMAGING; Niazi MKK, 2017, J PUBLICATION UNPUB; Patraucean V, 2012, LECT NOTES COMPUT SC, V7573, P572, DOI 10.1007/978-3-642-33709-3_41; Pennell C., 2017, SPIE MED IMAGING 201; Revkin SK, 2008, PSYCHOL SCI, V19, P607, DOI 10.1111/j.1467-9280.2008.02130.x; Sirinukunwattana K, 2016, IEEE T MED IMAGING, V35, P1196, DOI 10.1109/TMI.2016.2525803; Taylor CR, 2006, HISTOPATHOLOGY, V49, P411, DOI 10.1111/j.1365-2559.2006.02513.x; Xu HM, 2017, IEEE J BIOMED HEALTH, V21, P826, DOI 10.1109/JBHI.2016.2544245; Zaha DC, 2014, WORLD J CLIN ONCOL, V5, P382, DOI 10.5306/wjco.v5.i3.382	20	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196547	10.1371/journal.pone.0196547	http://dx.doi.org/10.1371/journal.pone.0196547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746503	gold, Green Published, Green Submitted			2022-12-26	WOS:000431851700023
J	White, SK; Mavian, C; Salemi, M; Morris, JG; Elbadry, MA; Okech, BA; Lednicky, JA; Dunford, JC				White, Sarah Keller; Mavian, Carla; Salemi, Marco; Morris, John Glenn, Jr.; Elbadry, Maha A.; Okech, Bernard A.; Lednicky, John A.; Dunford, James C.			A new "American" subgroup of African-lineage Chikungunya virus detected in and isolated from mosquitoes collected in Haiti, 2016	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; AEDES-ALBOPICTUS; MOLECULAR CLOCK; REUNION ISLAND; IQ-TREE; DENGUE; VECTOR; INFECTION; ACCURACY; OUTBREAK	As part of on-going arboviral surveillance activity in a semi-rural region in Haiti, Chikungunya virus (CHIKV)-positive mosquito pools were identified in 2014 (the peak of the Caribbean Asian-clade epidemic), and again in 2016 by RT-PCR. In 2014, CHIKV was only identified in Aedes aegypti (11 positive pools/124 screened). In contrast, in sampling in 2016, CHIKV was not identified in Ae. aegypti, but, rather, in (a) a female Aedes albopictus pool, and (b) a female Culex quinquefasciatus pool. Genomic sequence analyses indicated that the CHIKV viruses in the 2016 mosquito pools were from the East-Central-South African (ECSA) lineage, rather than the Asian lineage. In phylogenetic studies, these ECSA lineage strains form a new ECSA subgroup (subgroup 11a) together with Brazilian ECSA lineage strains from an isolated human outbreak in 2014, and a mosquito pool in 2016. Additional analyses date the most recent common ancestor of the ECSA I la subgroup around May 2007, and the 2016 Haitian CHIKV genomes around December 2015. Known CHIKV mutations associated with improved Ae. albopictus vector competence were not identified. Isolation of this newly identified lineage from Ae. albopictus is of concern, as this vector has a broader geographic range than Ae. aegypti, especially in temperate areas of North America, and stresses the importance for continued vector surveillance.	[White, Sarah Keller; Mavian, Carla; Salemi, Marco; Morris, John Glenn, Jr.; Elbadry, Maha A.; Okech, Bernard A.; Lednicky, John A.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [White, Sarah Keller; Elbadry, Maha A.; Okech, Bernard A.; Lednicky, John A.] Univ Florida, Dept Environm & Global Hlth, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA; [Mavian, Carla; Salemi, Marco] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA; [Morris, John Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA; [Dunford, James C.] US Navy, Portsmouth, VA USA; [Dunford, James C.] Marine Corps Publ Hlth Ctr, Portsmouth, VA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	White, SK (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.; White, SK (corresponding author), Univ Florida, Dept Environm & Global Hlth, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA.	sek0005@epi.ufl.edu	Lednicky, John A/C-5678-2012; Elbadry, Maha Adel/AAH-4444-2020; mavian, carla/H-3410-2019	Elbadry, Maha Adel/0000-0002-6089-4523; mavian, carla/0000-0003-3819-5520; Lednicky, John/0000-0003-4069-0539	Armed Forces Health Surveillance Branch Global Emerging Infections Surveillance (GEIS) Section, [P014517E2]; National Center for Emerging and Zoonotic Infectious Diseases (CDC) [CDC/HHS U01 CK000510]; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI126357] Funding Source: NIH RePORTER	Armed Forces Health Surveillance Branch Global Emerging Infections Surveillance (GEIS) Section,; National Center for Emerging and Zoonotic Infectious Diseases (CDC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by the Armed Forces Health Surveillance Branch Global Emerging Infections Surveillance (GEIS) Section, (PROMIS ID P014517E2 to JCD) (https://urldefense.proofpoint.com/v2/url?u=https-3A_health.mil_Military-2DHealth-2DTopics_Health-2DReadiness_Armed-2DForces-2DHealth-2DSurveillance-2DBranch_Global-2DEmerging-2DInfections-2DSurveillance-2Dand-2DResponse&d=DwIGaQ&c=pZJPUDQ3SB9JplYbifm4nt2lEVG5pWx2KikqINpWlZMr=Ve6E ldqWejwMbm2ADbtjgM-3vIGcddjo18T0wf_wJys&m=40dKywmWfBLR5r_AQAgJxJdFwsVRiQ3OtIbV5DHxua&s=BR-UiD7JZ5Q bOa8Ve2-ql_2jTeTWEHZDup9cj6UkuEs&e=), a grant from the National Center for Emerging and Zoonotic Infectious Diseases (CDC) (CDC/HHS U01 CK000510 to JAL), and a grant from the National Institutes of Health to JGM (R01 AI26357- 01S1 to JGM, https://urldefense.proofpoint.com/ v2/url?u=https-3A_www.niaid.nih.gov_&d= DwIGaQ&c=pZJPUDQ3SB9JplYbifm4nt2lEVG5pWx2KikqINpWlZM&r=Ve6EldqWejwMbm2ADbtjgM-3vIGcddjo18T0wf_ wJys&m=40dKywmWfBLR5r_AQAgJxJdFwsVRiQ3OtIbV5DHxuaE&s=mslyvsCDd2Tz_SqkbfnhbHhNsDMOemaw_ 6piYwkdM1c&e=). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], UN WRB MOSQ ID CUL C; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Beau de Rochars VM, 2017, CLIN FINDINGS LAB CO; Bessaud M, 2006, EMERG INFECT DIS, V12, P1604, DOI 10.3201/eid1210.060596; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Caglioti C, 2013, NEW MICROBIOL, V36, P211; Cherabuddi K, 2016, JMM CASE REPORTS; Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630; Crowder CD, 2010, J MED ENTOMOL, V47, P89, DOI 10.1603/033.047.0112; Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855; da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307; Das B, 2012, TROP MED INT HEALTH, V17, P235, DOI 10.1111/j.1365-3156.2011.02899.x; De Rochars VEMB, 2015, AM J TROP MED HYG, V92, P752, DOI 10.4269/ajtmh.14-0059; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gu WD, 2004, AM J TROP MED HYG, V71, P636, DOI 10.4269/ajtmh.2004.71.636; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Jones JE, 2017, MBIO, V8, DOI 10.1128/mBio.01456-17; JUPP PG, 1981, T ROY SOC TROP MED H, V75, P15, DOI 10.1016/0035-9203(81)90005-5; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015; Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Nasci RS, 2014, EMERG INFECT DIS, V20, P1394, DOI 10.3201/eid2008.140333; Organization PAH, 2015, NUMB REP CAS CHIK FE; Organization PAH, 2016, NUMB REP CAS CHIK FE; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521; Rueda LM, 2004, PICTORIAL KEYS IDENT, P33; Salvemini M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-41; Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007; Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339; Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402; Strimmer K, 2001, MOL BIOL EVOL, V18, P2298, DOI 10.1093/oxfordjournals.molbev.a003776; Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727; Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x; Thavara U, 2009, SE ASIAN J TROP MED, V40, P951; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035; White SK, 2017, GENOME ANNOUNC 5, V5; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	52	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196857	10.1371/journal.pone.0196857	http://dx.doi.org/10.1371/journal.pone.0196857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746539	Green Submitted, Green Published, gold			2022-12-26	WOS:000431851700044
J	Walling, JG; Zalapa, LA; Vinje, MA				Walling, Jason G.; Zalapa, Leslie A.; Vinje, Marcus A.			Evaluation and selection of internal reference genes from two- and six-row US malting barley varieties throughout micromalting for use in RT-qPCR	PLOS ONE			English	Article							TRANSCRIPTION-QUANTITATIVE-PCR; REAL-TIME PCR; HOUSEKEEPING GENES; NORMALIZATION; EXPRESSION; PUBLICATION; MIQE	Reverse transcription quantitative polymerase chain reaction (RT-qPCR) is a popular method for measuring transcript abundance. The most commonly used method of interpretation is relative quantification and thus necessitates the use of normalization controls (i.e. reference genes) to standardize transcript abundance. The most popular gene targets for RT-qPCR are housekeeping genes because they are thought to maintain a static transcript level among a variety of samples. However, more recent studies have shown, several housekeeping genes are not reliably stable. This is the first study to examine the potential of several reference genes for use in RT-qPCR normalization during barley malting. The process of malting barley mechanizes the imbibition and subsequent germination of barley seeds under controlled conditions. Malt quality is controlled by many pleiotropic genes that are determined by examining the result of physiological changes the barley seed undergoes during the malting process. We compared the stability of 13 reference genes across both two-and six-row malting barleys (Conrad and Legacy, respectfully) throughout the entirety of the malting process. Initially, primer target specificity, amplification efficiency and average Ct values were determined for each of the selected primer pairs. Three statistical programs (geNorm, NormFinder, and BestKeeper) were used to rank the stability of each reference gene. Rankings were similar between the two- and six-row with the exception of BestKeeper's ranking of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). A consensus ranking among programs was determined using RefFinder. Our results show that Actin (ACT) and Heat Shock Protein 70 (HSP70) were the most stable throughout micromalting, while GAPDH and Cyclophilin (CYP) were the least stable. Two reference genes are necessary for stable transcript normalization according to geNorm and the best two reference genes (ACT and HSP70) provided a sufficient level of stability.	[Walling, Jason G.; Zalapa, Leslie A.; Vinje, Marcus A.] ARS, Cereal Crops Res Unit, USDA, Madison, WI 53726 USA	United States Department of Agriculture (USDA)	Vinje, MA (corresponding author), ARS, Cereal Crops Res Unit, USDA, Madison, WI 53726 USA.	marcus.vinje@ars.usda.gov	Vinje, Marcus A./F-5704-2019	Vinje, Marcus A./0000-0003-3302-6808	United States Department of Agriculture-Agriculture Research Service	United States Department of Agriculture-Agriculture Research Service(United States Department of Agriculture (USDA))	This work was funded by the United States Department of Agriculture-Agriculture Research Service.	American Malting Barley Association Inc. (AMBA), MALT BARL BREED GUID; American Malting Barley Association Inc. AMBA., MALT BARL N AM; American Malting Barley Association Inc. AMBA, NAT BARL IMPR COMM 2; Briggs DE, 1978, BARLEY, P526; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chervoneva I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-253; De Spiegelaere W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122515; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Ferdous J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118503; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hua W, 2015, PLANT MOL BIOL REP, V33, P1002, DOI 10.1007/s11105-014-0807-0; Huang BQ, 2014, PLANT PHYSIOL, V164, P596, DOI 10.1104/pp.113.231605; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kaczmarczyk A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-184; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Koppolu R, 2013, P NATL ACAD SCI USA, V110, P13198, DOI 10.1073/pnas.1221950110; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Niu LJ, 2015, INT J MOL SCI, V16, P12513, DOI 10.3390/ijms160612513; Ovesna J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041886; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rapacz M, 2012, ACTA PHYSIOL PLANT, V34, P1723, DOI 10.1007/s11738-012-0967-1; Reddy PS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00529; Remans T, 2014, PLANT CELL, V26, P3829, DOI 10.1105/tpc.114.130641; Schwarz, 2012, MASTER BREWERS ASS A, V49, P103; Schwarz P. B., 1996, BREWING TECHNIQUES, V4, P48; Taylor CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148300; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; van Esse GW, 2017, PLANT PHYSIOL, V174, P2397, DOI 10.1104/pp.17.00108; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vinje MA, 2015, J AM SOC BREW CHEM, V73, P195, DOI 10.1094/ASBCJ-2015-0318-01; Vinje MA, 2011, PLANT PHYSIOL BIOCH, V49, P39, DOI 10.1016/j.plaphy.2010.09.019; Wu JY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00780	37	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196966	10.1371/journal.pone.0196966	http://dx.doi.org/10.1371/journal.pone.0196966			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738567	gold, Green Submitted, Green Published			2022-12-26	WOS:000431724900035
J	Stanford, KR; Taylor-Clark, TE				Stanford, Katherine R.; Taylor-Clark, Thomas E.			Mitochondrial modulation-induced activation of vagal sensory neuronal subsets by antimycin A, but not CCCP or rotenone, correlates with mitochondrial superoxide production	PLOS ONE			English	Article							ION-CHANNEL TRPA1; BRONCHOPULMONARY C-FIBERS; RECEPTOR POTENTIAL A1; CAPSAICIN RECEPTOR; NERVE-TERMINALS; TRPV1 CHANNELS; COMPLEX-III; VANILLOID 1; TNF-ALPHA; DYSFUNCTION	Inflammation causes nociceptive sensory neuron activation, evoking debilitating symptoms and reflexes. Inflammatory signaling pathways are capable of modulating mitochondrial function, resulting in reactive oxygen species (ROS) production, mitochondrial depolarization and calcium release. Previously we showed that mitochondrial modulation with antimycin A, a complex III inhibitor, selectively stimulated nociceptive bronchopulmonary C-fibers via the activation of transient receptor potential (TRP) ankyrin 1 (A1) and vanilloid 1 (V1) cation channels. TRPA1 is ROS-sensitive, but there is little evidence that TRPV1 is activated by ROS. Here, we used dual imaging of dissociated vagal neurons to investigate the correlation of mitochondrial superoxide production (mitoSOX) or mitochondrial depolarization (JC-1) with cytosolic calcium (Fura-2AM), following mitochondrial modulation by antimycin A, rotenone (complex I inhibitor) and carbonyl cyanide m-chlorophenyl hydrazone (CCCP, mitochondrial uncoupling agent). Mitochondrial modulation by all agents selectively increased cytosolic calcium in a subset of TRPA1/TRPV1-expressing (A1/V1+) neurons. There was a significant correlation between antimycin A-induced calcium responses and mitochondrial superoxide in wild-type 'responding' A1/V1+ neurons, which was eliminated in TRPA1(-/-) neurons, but not TRPV1(-/-) neurons. Nevertheless, antimycin A-induced superoxide production did not always increase calcium in A1/V1+ neurons, suggesting a critical role of an unknown factor. CCCP caused both superoxide production and mitochondrial depolarization but neither correlated with calcium fluxes in A1/V1+ neurons. Rotenone-induced calcium responses in 'responding' A1/V1+ neurons correlated with mitochondrial depolarization but not superoxide production. Our data are consistent with the hypothesis that mitochondrial dysfunction causes calcium fluxes in a subset of A1/V1+ neurons via ROS-dependent and ROS-independent mechanisms.	[Stanford, Katherine R.; Taylor-Clark, Thomas E.] Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Taylor-Clark, TE (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Morsani Coll Med, Tampa, FL 33620 USA.	ttaylorc@health.usf.edu			National Heart Lung and Blood Institute [R01HL119802]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119802] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This manuscript, and the work performed during its creation, was entirely funded by the National Heart Lung and Blood Institute (R01HL119802; PI: Taylor-Clark). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chinopoulos C, 1999, J NEUROCHEM, V73, P220, DOI 10.1046/j.1471-4159.1999.0730220.x; Cuchillo-Ibanez I, 2004, J PHYSIOL-LONDON, V560, P63, DOI 10.1113/jphysiol.2004.064063; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Gouin O, 2017, PROTEIN CELL, V8, P644, DOI 10.1007/s13238-017-0395-5; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; HUNG KS, 1973, J ULTRA MOL STRUCT R, V43, P426, DOI 10.1016/S0022-5320(73)90019-1; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Kollarik M, 2003, J PHYSIOL-LONDON, V551, P869, DOI 10.1113/jphysiol.2003.042028; Lai B, 2005, EXP NEUROL, V194, P484, DOI 10.1016/j.expneurol.2005.03.005; Li NY, 2014, TOXICOL SCI, V142, P261, DOI 10.1093/toxsci/kfu176; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P1011, DOI 10.1016/j.joca.2006.03.008; Lopez-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003; Mabalirajan U, 2008, J IMMUNOL, V181, P3540, DOI 10.4049/jimmunol.181.5.3540; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Mandadi S, 2006, PAIN, V123, P106, DOI 10.1016/j.pain.2006.02.016; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; McMahon SB, 2015, NAT REV NEUROSCI, V16, P389, DOI 10.1038/nrn3946; Meents JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170097; Michael GJ, 1999, J NEUROSCI, V19, P1844; Morrison SF, 2001, AM J PHYSIOL-REG I, V281, pR683, DOI 10.1152/ajpregu.2001.281.3.R683; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Nassenstein C, 2008, J PHYSIOL-LONDON, V586, P1595, DOI 10.1113/jphysiol.2007.148379; Nesuashvili L, 2013, MOL PHARMACOL, V83, P1007, DOI 10.1124/mol.112.084319; Ogawa N, 2016, CELL CALCIUM, V60, P115, DOI 10.1016/j.ceca.2016.02.009; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Raby BA, 2007, J ALLERGY CLIN IMMUN, V120, P351, DOI 10.1016/j.jaci.2007.05.029; Riccio MM, 1996, J PHYSIOL-LONDON, V496, P521, DOI 10.1113/jphysiol.1996.sp021703; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rohacs T, 2015, PFLUG ARCH EUR J PHY, V467, P1851, DOI 10.1007/s00424-015-1695-3; Sawada Y, 2008, EUR J NEUROSCI, V27, P1131, DOI 10.1111/j.1460-9568.2008.06093.x; Shishkin V, 2002, CELL CALCIUM, V32, P121, DOI 10.1016/S0143-4160(02)00095-7; Sipos I, 2003, NEUROCHEM RES, V28, P1575, DOI 10.1023/A:1025634728227; Spahn V, 2014, MOL PHARMACOL, V85, P335, DOI 10.1124/mol.113.088997; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; STADLER J, 1992, ANN SURG, V216, P539, DOI 10.1097/00000658-199211000-00003; Starkov AA, 2001, BIOCHEM BIOPH RES CO, V281, P645, DOI 10.1006/bbrc.2001.4409; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]; Susankova K, 2006, MOL PHARMACOL, V70, P383, DOI 10.1124/mol.106.023069; Suski JM, 2012, METHODS MOL BIOL, V810, P183, DOI 10.1007/978-1-61779-382-0_12; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; TATAR M, 1988, J PHYSIOL-LONDON, V402, P411, DOI 10.1113/jphysiol.1988.sp017212; Taylor-Clark TE, 2008, J PHYSIOL-LONDON, V586, P3447, DOI 10.1113/jphysiol.2008.153585; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Taylor-Clark TE, 2009, MOL PHARMACOL, V75, P820, DOI 10.1124/mol.108.054445; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; van Tilburg MAL, 2014, DIGEST DIS SCI, V59, P1392, DOI 10.1007/s10620-014-3045-2; von During M, 1988, Prog Brain Res, V74, P139; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Wen HR, 2012, J BIOL CHEM, V287, P13868, DOI 10.1074/jbc.M111.334896; Weng HJ, 2015, NEURON, V85, P833, DOI 10.1016/j.neuron.2014.12.065; Zell R, 1997, MOL CELL BIOCHEM, V177, P61, DOI 10.1023/A:1006896832582	65	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0197106	10.1371/journal.pone.0197106	http://dx.doi.org/10.1371/journal.pone.0197106			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734380	Green Published, Green Submitted, gold			2022-12-26	WOS:000431481700046
J	Fang, HY; Hung, MY; Lin, YM; Pandey, S; Chang, CC; Lin, KH; Shen, CY; Viswanadha, VP; Kuo, WW; Huang, CY				Fang, Hsin-Yuan; Hung, Meng-Yu; Lin, Yueh-Min; Pandey, Sudhir; Chang, Chia-Chien; Lin, Kuan-Ho; Shen, Chia-Yao; Viswanadha, Vijaya Padma; Kuo, Wei-Wen; Huang, Chih-Yang			17 beta-Estradiol and/or estrogen receptor alpha signaling blocks protein phosphatase 1 mediated ISO induced cardiac hypertrophy	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; TROPONIN-I PHOSPHORYLATION; HEART-FAILURE; DILATED CARDIOMYOPATHY; HUMAN MYOCARDIUM; CELLS; SUPPRESSION; MICE; AUTOANTIBODIES; PHOSPHOLAMBAN	Earlier studies have shown that estrogen possess protective function against the development of pathological cardiac hypertrophy. However, the molecular mechanisms of estrogens (E2) protective effect are poorly understood. Additionally, abnormal activation of beta-adrenergic signaling have been implicated in the development of pathological cardiac remodeling. However, the role of serine/threonine protein phosphatase 1 (PP1) in pathological cardiac remodeling under the influence of -adrenergic signaling have been sparsely investigated. In this study, we assessed the downstream effects of abnormal activation of PP1 upon isoproterenol (ISO) induced pathological cardiac changes. We found that pre-treatment of 17 beta-estradiol (E2), tet-on estrogen receptor-alpha, or both significantly inhibited ISO-induced increase in cell size, hypertrophy marker gene expression and cytosolic calcium accumulation in H9c2 cells. Additionally, treatment with estrogen receptor inhibitor (ICI) reversed those effects, implicating role of E2 in inhibiting pathological cardiac remodeling. However, specific inhibition of ER alpha using melatonin, reduced ISO-induced PP1c expression and enhanced the level of ser-16 phosphorylated phospholamban (PLB), responsible for regulation of sarcoplasmic reticulum Ca2+-ATPase (SERCA) activity. Furthermore, hypertrophic effect caused by overexpression of PP1c alpha was reduced by treatment with specific inhibitor of ER alpha. Collectively, we found that estrogen and estrogen receptor-a have protective effect against pathological cardiac changes by suppressing PP1 expression and its downstream signaling pathway, which further needs to be elucidated.	[Fang, Hsin-Yuan] China Med Univ Hosp, Dept Thorac Surg, Taichung, Taiwan; [Hung, Meng-Yu; Pandey, Sudhir; Huang, Chih-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Lin, Yueh-Min] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan; [Lin, Yueh-Min] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Chang, Chia-Chien] Taipei City Hosp, Renai Branch, Dept Dermatol, Taipei, Taiwan; [Lin, Kuan-Ho] China Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Shen, Chia-Yao] Meiho Univ, Dept Nursing, Pingtung, Taiwan; [Viswanadha, Vijaya Padma] Bharathiar Univ, Dept Biotechnol, Coimbatore, Tamil Nadu, India; [Kuo, Wei-Wen] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Huang, Chih-Yang] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Huang, Chih-Yang] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Changhua Christian Hospital; Taipei City Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Bharathiar University; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Huang, CY (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.; Huang, CY (corresponding author), China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan.; Huang, CY (corresponding author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan.	cyhuang@mail.cmu.edu.tw	Viswanadha, Vijaya Padma/ABG-4936-2020	Viswanadha, Vijaya Padma/0000-0001-9154-027X; Huang, Chih-Yang/0000-0003-2347-0411; Pandey, Sudhir/0000-0002-6663-9056	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study was supported by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence MOHW105-TDU-B-212-133019. There was no additional external funding received for this study.	Agabiti-Rosei E, 2002, J HYPERTENS, V20, pS34; Babiker FA, 2006, ARTERIOSCL THROM VAS, V26, P1524, DOI 10.1161/01.ATV.0000223344.11128.23; Bodor GS, 1997, CIRCULATION, V96, P1495, DOI 10.1161/01.CIR.96.5.1495; Boknik P, 2000, N-S ARCH PHARMACOL, V362, P222, DOI 10.1007/s002100000283; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002; Chen GL, 2010, BASIC RES CARDIOL, V105, P573, DOI 10.1007/s00395-010-0106-3; Chen YF, 2018, J CELL PHYSIOL, V233, P3660, DOI 10.1002/jcp.26235; Gergs U, 2004, J BIOL CHEM, V279, P40827, DOI 10.1074/jbc.M405770200; Herzig S, 2000, PHYSIOL REV, V80, P173, DOI 10.1152/physrev.2000.80.1.173; Houser SR, 2003, CIRC RES, V92, P350, DOI 10.1161/01.RES.0000060027.40275.A6; HUANG FL, 1976, EUR J BIOCHEM, V70, P419, DOI 10.1111/j.1432-1033.1976.tb11032.x; Jahns R, 1999, CIRCULATION, V99, P649, DOI 10.1161/01.CIR.99.5.649; Kirchhefer U, 2005, CARDIOVASC RES, V68, P98, DOI 10.1016/j.cardiores.2005.05.019; LIMAS CJ, 1989, CIRC RES, V64, P97, DOI 10.1161/01.RES.64.1.97; Lin TY, 2015, BIOMEDICINE-TAIWAN, V5, P33, DOI 10.7603/s40681-015-0005-x; Liu CJ, 2008, MOL CELL BIOCHEM, V313, P167, DOI 10.1007/s11010-008-9754-0; Liu CJ, 2009, J CELL MOL MED, V13, P3655, DOI 10.1111/j.1582-4934.2009.00669.x; Liu SP, 2015, BIOMEDICINE-TAIWAN, V5, P19, DOI 10.7603/s40681-015-0003-z; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Miya Y, 2002, HYPERTENS RES, V25, P153, DOI 10.1291/hypres.25.153; Osborne CK, 2000, J CLIN ONCOL, V18, P3172, DOI 10.1200/JCO.2000.18.17.3172; Pathak A, 2005, CIRC RES, V96, P756, DOI 10.1161/01.RES.0000161256.85833.fa; Pedram A, 2005, J BIOL CHEM, V280, P26339, DOI 10.1074/jbc.M414409200; Pieske B, 1999, CIRC RES, V85, P38; Pikkarainen S, 2003, J BIOL CHEM, V278, P23807, DOI 10.1074/jbc.M302719200; Sande JB, 2002, CARDIOVASC RES, V53, P382, DOI 10.1016/S0008-6363(01)00489-8; Schwinger RHG, 1999, J MOL CELL CARDIOL, V31, P479, DOI 10.1006/jmcc.1998.0897; Shin SY, 2011, J CELL SCI, V124, P82, DOI 10.1242/jcs.076034; van Eickels M, 2001, CIRCULATION, V104, P1419, DOI 10.1161/hc3601.095577; Williams RS, 2002, CIRCULATION, V105, P2242, DOI 10.1161/01.CIR.0000017141.01845.FA; Wu CH, 2005, LIFE SCI, V78, P347, DOI 10.1016/j.lfs.2005.04.077; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Zakhary DR, 1999, CIRCULATION, V99, P505, DOI 10.1161/01.CIR.99.4.505; Zhou SS, 2012, EXP CELL RES, V318, P1480, DOI 10.1016/j.yexcr.2012.03.030	35	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196569	10.1371/journal.pone.0196569	http://dx.doi.org/10.1371/journal.pone.0196569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723269	Green Submitted, Green Published, gold			2022-12-26	WOS:000431305100039
J	Morales, Y; Olsen, KJ; Bulcher, JM; Johnson, SJ				Morales, Yalemi; Olsen, Keith J.; Bulcher, Jacqueline M.; Johnson, Sean J.			Structure of frequency-interacting RNA helicase from Neurospora crassa reveals high flexibility in a domain critical for circadian rhythm and RNA surveillance	PLOS ONE			English	Article							WHITE COLLAR-1; ARCH DOMAIN; CLOCK; MTR4; PHOSPHORYLATION; FEEDBACK; FEATURES; COMPLEX; BINDING; EXOSOME	The FRH (frequency-interacting RNA helicase) protein is the Neurospora crassa homolog of yeast Mtr4, an essential RNA helicase that plays a central role in RNA metabolism as an activator of the nuclear RNA exosome. FRH is also a required component of the circadian clock, mediating protein interactions that result in the rhythmic repression of gene expression. Here we show that FRH unwinds RNA substrates in vitro with a kinetic profile similar to Mtr4, indicating that while FRH has acquired additional functionality, its core helicase function remains intact. In contrast with the earlier FRH structures, a new crystal form of FRH results in an ATP binding site that is undisturbed by crystal contacts and adopts a conformation consistent with nucleotide binding and hydrolysis. Strikingly, this new FRH structure adopts an arch domain conformation that is dramatically altered from previous structures. Comparison of the existing FRH structures reveals conserved hinge points that appear to facilitate arch motion. Regions in the arch have been previously shown to mediate a variety of protein-protein interactions critical for RNA surveillance and circadian clock functions. The conformational changes highlighted in the FRH structures provide a platform for investigating the relationship between arch dynamics and Mtr4/FRH function.	[Morales, Yalemi; Olsen, Keith J.; Bulcher, Jacqueline M.; Johnson, Sean J.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Johnson, SJ (corresponding author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA.	sean.johnson@usu.edu	Johnson, Sean/G-8191-2012	Johnson, Sean/0000-0001-7992-2494; Olsen, Keith/0000-0002-2248-9789	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; National Science Foundation [MCB0952920, DBI1228874]; National Institute of Health [R01GM117311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117311] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Stanford Synchrotron Radiation Lightsource, SLAG National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). Support for this work was provided by National Science Foundation MCB0952920 (SJJ) and DBI1228874 (SJJ), and National Institute of Health R01GM117311 (SJJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson JT, 2009, CRIT REV BIOCHEM MOL, V44, P16, DOI [10.1080/10409230802640218 , 10.1080/10409230802640218]; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Conrad KS, 2016, EMBO J, V35, P1707, DOI 10.15252/embj.201694327; Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falk S, 2017, RNA, V23, P1780, DOI 10.1261/rna.062901.117; Falk S, 2014, MOL CELL, V55, P856, DOI 10.1016/j.molcel.2014.07.020; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; Harding SE, 1992, ANAL ULTRACENTRIFUGA, Vxiii; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Hurley JM, 2013, MOL CELL, V52, P832, DOI 10.1016/j.molcel.2013.11.005; Jackson RN, 2010, EMBO J, V29, P2205, DOI 10.1038/emboj.2010.107; Jia HJ, 2012, P NATL ACAD SCI USA, V109, P7292, DOI 10.1073/pnas.1201085109; Johnson SJ, 2013, RNA BIOL, V10, P33, DOI 10.4161/rna.22101; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lauinger L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4598; Li Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148090; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Querfurth C, 2011, MOL CELL, V43, P713, DOI 10.1016/j.molcel.2011.06.033; Schmidt C, 2016, SCIENCE, V354, P1431, DOI 10.1126/science.aaf7520; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shi M, 2010, GENETICS, V184, P351, DOI 10.1534/genetics.109.111393; Tang CT, 2009, P NATL ACAD SCI USA, V106, P10722, DOI 10.1073/pnas.0904898106; Taylor LL, 2014, NUCLEIC ACIDS RES, V42, P13861, DOI 10.1093/nar/gku1208; Thoms M, 2015, CELL, V162, P1029, DOI 10.1016/j.cell.2015.07.060; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196642	10.1371/journal.pone.0196642	http://dx.doi.org/10.1371/journal.pone.0196642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718972	gold, Green Submitted, Green Published			2022-12-26	WOS:000431281900067
J	Huang, J; Montani, JP; Verrey, F; Feraille, E; Ming, XF; Yang, ZH				Huang, Ji; Montani, Jean-Pierre; Verrey, Francois; Feraille, Eric; Ming, Xiu-Fen; Yang, Zhihong			Arginase-II negatively regulates renal aquaporin-2 and water reabsorption	FASEB JOURNAL			English	Article						collecting duct; copeptin; vasopressin; urine; osmolality	COLLECTING DUCT; MOUSE MODEL; RAT-KIDNEY; EXPRESSION; MICE; LOCALIZATION; GENE	Type-II l-arginine:ureahydrolase, arginase-II (Arg-II), is abundantly expressed in the kidney. The physiologic role played by Arg-II in the kidney remains unknown. Herein, we report that in mice that are deficient in Arg-II (Arg-II-/-), total and membrane-associated aquaporin-2 (AQP2) protein levels were significantly higher compared with wild-type (WT) controls. Water deprivation enhanced Arg-II expression, AQP2 levels, and membrane association in collecting ducts. Effects of water deprivation on AQP2 were stronger in Arg-II-/- mice than in WT mice. Accordingly, a decrease in urine volume and an increase in urine osmolality under water deprivation were more pronounced in Arg-II-/- mice than in WT mice, which correlated with a weaker increase in plasma osmolality in Arg-II-/- mice. There was no difference in vasopressin release under water deprivation conditions between either genotype of mice. Although total AQP2 and phosphorylated AQP2-S256 levels (mediated by PKA) in kidneys under water deprivation conditions were significantly higher in Arg-II-/- mice compared with WT animals, there is no difference in the ratio of AQP2-S256:AQP2. In cultured mouse collecting duct principal mCCD(cl1) cells, expression of both Arg-II and AQP2 were enhanced by the vasopressin type 2 receptor agonist, desamino-d-arginine vasopressin (dDAVP). Silencing Arg-II enhanced the expression and membrane association of AQP2 by dDAVP without influencing cAMP levels. In conclusion, in vivo and in vitro experiments demonstrate that Arg-II negatively regulates AQP2 and the urine-concentrating capability in kidneys via a mechanism that is not associated with the modulation of the cAMP pathway.Huang, J., Montani, J.-P., Verrey, F., Feraille, E., Ming, X.-F., Yang, Z. Arginase-II negatively regulates renal aquaporin-2 and water reabsorption.	[Huang, Ji; Montani, Jean-Pierre; Ming, Xiu-Fen; Yang, Zhihong] Univ Fribourg, Dept Med Cardiovasc & Aging Res, Div Physiol, Fribourg, Switzerland; [Huang, Ji; Montani, Jean-Pierre; Verrey, Francois; Feraille, Eric; Ming, Xiu-Fen; Yang, Zhihong] Natl Ctr Competence Res, Kidney Control Homeostasis, Zurich, Switzerland; [Verrey, Francois] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Feraille, Eric] Univ Geneva, Dept Cell Biol & Metab, Geneva, Switzerland	University of Fribourg; University of Zurich; University of Geneva	Ming, XF; Yang, ZH (corresponding author), Univ Fribourg, Dept Med, Chemin Musee 5, CH-1700 Fribourg, Switzerland.	xiu-fen.ming@unifr.ch; zhihong.yang@unifr.ch		Verrey, Francois/0000-0003-3250-9824; Feraille, Eric/0000-0003-1656-8365	Swiss National Science Foundation [31003A_159582/1]; Swiss Heart Foundation; National Centre of Competence in Research Program (NCCR-Kidney.CH)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Heart Foundation; National Centre of Competence in Research Program (NCCR-Kidney.CH)	This work was supported by the Swiss National Science Foundation (31003A_159582/1), Swiss Heart Foundation, and the National Centre of Competence in Research Program (NCCR-Kidney.CH). The authors declare no conflicts of interest.	Borghese MFA, 2011, NEPHRON EXTRA, V1, P124, DOI 10.1159/000333066; Ash DE, 2004, J NUTR, V134, p2760S, DOI 10.1093/jn/134.10.2760S; Bjelakovic G, 2010, AMINO ACIDS, V39, P29, DOI 10.1007/s00726-010-0489-3; Boone M, 2008, PFLUG ARCH EUR J PHY, V456, P1005, DOI 10.1007/s00424-008-0498-1; Choi S, 2012, ACTA HISTOCHEM, V114, P487, DOI 10.1016/j.acthis.2011.09.002; Choi YH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-31; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Huang J, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00560; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kwon TH, 2013, KIDNEY RES CLIN PRAC, V32, P96, DOI 10.1016/j.krcp.2013.07.005; Lange PS, 2004, J NUTR, V134, p2812S, DOI 10.1093/jn/134.10.2812S; Levillain O, 2005, PFLUG ARCH EUR J PHY, V449, P491, DOI 10.1007/s00424-004-1336-8; MARPLES D, 1995, J CLIN INVEST, V95, P1838, DOI 10.1172/JCI117863; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; McDonough AA, 2015, AM J PHYSIOL-CELL PH, V308, pC426, DOI 10.1152/ajpcell.00400.2014; Ming XF, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000992; Morgenthaler NG, 2008, TRENDS ENDOCRIN MET, V19, P43, DOI 10.1016/j.tem.2007.11.001; Morris SM, 2011, DIABETES, V60, P3015, DOI 10.2337/db11-0901; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Nikolaeva S, 2016, J AM SOC NEPHROL, V27, P2997, DOI 10.1681/ASN.2015091055; Noro T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.93; Ortiz MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104923; Pillai SM, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008025; Rojek A, 2006, P NATL ACAD SCI USA, V103, P6037, DOI 10.1073/pnas.0511324103; Shi O, 2001, MOL CELL BIOL, V21, P811, DOI 10.1128/MCB.21.3.811-813.2001; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Stempin CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/683485; Takata K, 2008, HISTOCHEM CELL BIOL, V130, P197, DOI 10.1007/s00418-008-0457-0; van Balkom BWM, 2004, AM J PHYSIOL-RENAL, V286, pF216, DOI 10.1152/ajprenal.00307.2003; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Wu F, 1999, AM J PHYSIOL-RENAL, V276, pF874, DOI 10.1152/ajprenal.1999.276.6.F874; Yang ZH, 2006, CURR HYPERTENS REP, V8, P54, DOI 10.1007/s11906-006-0041-8; Yepuri G, 2012, AGING CELL, V11, P1005, DOI 10.1111/acel.12001; You HN, 2013, KIDNEY INT, V84, P1189, DOI 10.1038/ki.2013.215	34	7	8	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5520	5531		10.1096/fj.201701209R	http://dx.doi.org/10.1096/fj.201701209R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29718707	Green Published, hybrid			2022-12-26	WOS:000447972500027
J	White, MC; Schroeder, RD; Zhu, K; Xiong, K; McConkey, DJ				White, Matthew C.; Schroeder, Rebecca D.; Zhu, Keyi; Xiong, Katherine; McConkey, David J.			HRI-mediated translational repression reduces proteotoxicity and sensitivity to bortezomib in human pancreatic cancer cells	ONCOGENE			English	Article							INITIATION-FACTOR 2; REGULATED EIF-2-ALPHA KINASE; PROTEASOME INHIBITION LEADS; UNFOLDED PROTEIN RESPONSE; MULTIPLE-MYELOMA CELLS; HEAT-SHOCK PROTEINS; EIF2-ALPHA KINASE; OXIDATIVE STRESS; PARKINSONS-DISEASE; ACTIVATION LOOP	Human cancer cells display extensive heterogeneity in their sensitivities to the proteasome inhibitor bortezomib (Velcade). The molecular mechanisms underlying this heterogeneity remain unclear, and strategies to overcome resistance are limited. Here, we discover that inherent differences in eIF2 alpha phosphorylation among a panel of ten human pancreatic cancer cell lines significantly impacts bortezomib sensitivity, and implicate the HRI (heme-regulated inhibitor) eIF2 alpha kinase as a novel therapeutic target. Within our panel, we identified a subset of cell lines with defective induction of eIF2 alpha phosphorylation, conferring a high degree of sensitivity to bortezomib. These bortezomib-sensitive cells exhibited impaired translation attenuation followed by toxic accumulation of protein aggregates and reactive oxygen species (ROS), whereas the bortezomib-resistant cell lines displayed increased phosphorylation of eIF2 alpha, decreased translation, few protein aggregates, and minimal ROS production. Importantly, we identified HRI as the primary bortezomib-activated eIF2 alpha kinase, and demonstrated that HRI knockdown promoted cell death in the bortezomib-resistant cells. Overall, our data implicate inducible HRI-mediated phosphorylation of eIF2 alpha as a central cytoprotective mechanism following exposure to bortezomib and provide proof-of-concept for the development of HRI inhibitors to overcome proteasome inhibitor resistance.	[White, Matthew C.; Zhu, Keyi; Xiong, Katherine; McConkey, David J.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [White, Matthew C.; Zhu, Keyi; Xiong, Katherine; McConkey, David J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [White, Matthew C.; Schroeder, Rebecca D.; McConkey, David J.] Univ Texas Grad Sch Biomed Sci, Program Expt Therapeut, Houston, TX 77030 USA; [McConkey, David J.] Johns Hopkins Greenberg Bladder Canc Inst, Baltimore, MD 21287 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University	McConkey, DJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA.; McConkey, DJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.; McConkey, DJ (corresponding author), Univ Texas Grad Sch Biomed Sci, Program Expt Therapeut, Houston, TX 77030 USA.; McConkey, DJ (corresponding author), Johns Hopkins Greenberg Bladder Canc Inst, Baltimore, MD 21287 USA.	djmcconkey@jhmi.edu		Xiong, Katherine/0000-0002-1603-2037; White, Matthew/0000-0002-8274-0453; Schroeder, Rebecca/0000-0002-7336-1857	NIH/NCI [R01 CA127494]; M.D. Anderson Cancer Center Support Grant [P30 CA016672-38]; Albert Schweitzer Fellowship; Tzu-Chi Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA127494] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); M.D. Anderson Cancer Center Support Grant; Albert Schweitzer Fellowship; Tzu-Chi Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from NIH/NCI (R01 CA127494), and the M.D. Anderson Cancer Center Support Grant P30 CA016672-38 (D.J.M.). M.C.W. would like to acknowledge awards from The Albert Schweitzer Fellowship and the Tzu-Chi Foundation	Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Burwick N, 2017, LEUKEMIA RES, V55, P23, DOI 10.1016/j.leukres.2017.01.007; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chauhan D, 2005, ANNU REV PHARMACOL, V45, P465, DOI 10.1146/annurev.pharmtox.45.120403.100037; Chen SQ, 2010, CANCER RES, V70, P4318, DOI 10.1158/0008-5472.CAN-09-4428; Fournier MJ, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-12; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Goldberg AL, 2000, NAT BIOTECHNOL, V18, P494, DOI 10.1038/75349; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; He Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024855; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kane RC, 2007, CLIN CANCER RES, V13, P5291, DOI 10.1158/1078-0432.CCR-07-0871; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Knutsen JHJ, 2015, J CELL SCI, V128, P4420, DOI 10.1242/jcs.176545; Lee DH, 1998, MOL CELL BIOL, V18, P30, DOI 10.1128/MCB.18.1.30; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; MATTS RL, 1992, J BIOL CHEM, V267, P18160; MATTS RL, 1993, BIOCHEMISTRY-US, V32, P7323, DOI 10.1021/bi00080a001; Meister S, 2007, CANCER RES, V67, P1783, DOI 10.1158/0008-5472.CAN-06-2258; Miller CP, 2007, BLOOD, V110, P267, DOI 10.1182/blood-2006-03-013128; Mittal SPK, 2014, INT J BIOCHEM CELL B, V54, P186, DOI 10.1016/j.biocel.2014.07.016; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Rafie-Kolpin M, 2003, BIOCHEMISTRY-US, V42, P6536, DOI 10.1021/bi034005v; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schewe DM, 2009, CANCER RES, V69, P1545, DOI 10.1158/0008-5472.CAN-08-3858; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Vilas-Boas FDS, 2016, J NEURO-ONCOL, V127, P253, DOI 10.1007/s11060-015-2043-3; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Tabner BJ, 2002, FREE RADICAL BIO MED, V32, P1076, DOI 10.1016/S0891-5849(02)00801-8; Taniuchi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32886; Uma S, 1999, MOL CELL BIOL, V19, P5861; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wengrod J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0899; Weniger MA, 2011, CLIN CANCER RES, V17, P5101, DOI 10.1158/1078-0432.CCR-10-3367; WU DL, 2011, JOVE J VIS EXP NOV, P14220, DOI DOI 10.3791/3357; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Xu WP, 2011, CANCER CELL, V20, P281, DOI 10.1016/j.ccr.2011.08.020; Yefidoff-Freedman R, 2017, J MED CHEM, V60, P5392, DOI 10.1021/acs.jmedchem.7b00059; Yerlikaya A, 2008, BIOCHEM J, V412, P579, DOI 10.1042/BJ20080324; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343; Zhu KY, 2009, CANCER RES, V69, P1836, DOI 10.1158/0008-5472.CAN-08-4103	57	12	12	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 9	2018	37	32					4413	4427		10.1038/s41388-018-0227-y	http://dx.doi.org/10.1038/s41388-018-0227-y			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP8FA	29720726	Green Accepted			2022-12-26	WOS:000441144300006
J	Chiu, YH; Yang, MR; Wang, LJ; Chen, MH; Chang, GD; Chen, HW				Chiu, Yueh-Ho; Yang, Ming-Ren; Wang, Liang-Jie; Chen, Ming-Hon; Chang, Geen-Dong; Chen, Hungwen			New insights into the regulation of placental growth factor gene expression by the transcription factors GCM1 and DLX3 in human placenta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						placenta; gene transcription; growth factor; transcription factor; acetylation; DLX3; GCM1; MTF1; PGF; trophoblast	FACTOR-I MTF-1; HUMAN TROPHOBLAST; CELL-DIFFERENTIATION; MISSING 1; PREECLAMPSIA; HYPOXIA; STIMULATION; CONTRIBUTES; MECHANISMS; SYNCYTIN	Expression of placental growth factor (PGF) is closely associated with placental perfusion in early pregnancy. PGF is primarily expressed in placental trophoblasts, and its expression decreases in preeclampsia, associated with placental hypoxia. The transcription factors glial cells missing 1 (GCM1) and metal-regulatory transcription factor 1 (MTF1) have been implicated in the regulation of PGF gene expression through regulatory elements upstream and downstream of the PGF transcription start site, respectively. Here, we clarified the mechanism underlying placenta-specific PGF expression. We demonstrate that GCM1 up-regulates PGF expression through three downstream GCM1-binding sites (GBSs) but not a previously reported upstream GBS. Interestingly, we also found that these downstream GBSs also harbor metal-response elements for MTF1. Surprisingly, however, we observed that MTF1 is unlikely to regulate PGF expression in the placenta because knockdown or overexpression of GCM1, but not MTF1, dramatically decreased PGF expression or reversed the suppression of PGF expression under hypoxia, respectively. We also demonstrate that another transcription factor, Distal-less homeobox 3 (DLX3), interacts with the DNA-binding domain and the first transactivation domain of GCM1 and that this interaction inhibits GCM1-mediated PGF expression. Moreover, the GCM1-DLX3 interaction interfered with CREB-binding protein-mediated GCM1 acetylation and activation. In summary, we have identified several GBSs in the PGF promoter that are highly responsive to GCM1, have demonstrated that MTF1 does not significantly regulate PGF expression in placental cells, and provide evidence that DLX3 inhibits GCM1-mediated PGF expression. Our findings revise the mechanism for GCM1- and DLX3-mediated regulation of PGF gene expression.	[Chiu, Yueh-Ho; Wang, Liang-Jie; Chen, Hungwen] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Yang, Ming-Ren; Chen, Ming-Hon; Chang, Geen-Dong; Chen, Hungwen] Natl Taiwan Univ, Grad Inst Biochem Sci, Taipei 106, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Chen, HW (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan.	hwchen@gate.sinica.edu.tw	Chen, Hungwen/AAC-1394-2022	Chen, Hungwen/0000-0001-7928-0006	Ministry of Science and Technology [103-2311-B-001-024, 106-2311-B-001-013]; Academia Sinica, Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by Ministry of Science and Technology Grants 103-2311-B-001-024 and 106-2311-B-001-013 and Academia Sinica, Taiwan (to H.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Baczyk D, 2009, CELL DEATH DIFFER, V16, P719, DOI 10.1038/cdd.2009.1; Baumwell S, 2007, NEPHRON CLIN PRACT, V106, pC72, DOI 10.1159/000101801; Benirschke K., 2001, PATHOLOGY HUMAN PLAC, P42; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Cerdeira AS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006585; Chang CW, 2011, MOL CELL BIOL, V31, P3820, DOI 10.1128/MCB.05582-11; Chang CW, 2005, MOL CELL BIOL, V25, P8401, DOI 10.1128/MCB.25.19.8401-8414.2005; Chang M, 2008, BIOL REPROD, V78, P841, DOI 10.1095/biolreprod.107.065599; Chau K, 2017, J HUM HYPERTENS, V31, P782, DOI 10.1038/jhh.2017.61; Cheong ML, 2016, MOL CELL BIOL, V36, P197, DOI 10.1128/MCB.00655-15; Chui A, 2012, J MOL MED, V90, P273, DOI 10.1007/s00109-011-0836-1; Cramer M, 2005, BIOL CHEM, V386, P865, DOI 10.1515/BC.2005.101; De Falco S, 2012, EXP MOL MED, V44, P1, DOI 10.3858/emm.2012.44.1.025; Depoix C, 2011, REPROD SCI, V18, P219, DOI 10.1177/1933719110389337; Dewerchin M, 2014, EXPERT OPIN THER TAR, V18, P1339, DOI 10.1517/14728222.2014.948420; Dube A, 2011, BIOCHEM CELL BIOL, V89, P562, DOI [10.1139/O11-063, 10.1139/o11-063]; GEHRING WJ, 1990, TRENDS GENET, V6, P323, DOI 10.1016/0168-9525(90)90253-3; Gobble RM, 2009, PLACENTA, V30, P869, DOI 10.1016/j.placenta.2009.08.003; Green CJ, 2001, CANCER RES, V61, P2696; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Keryer G, 1998, J CELL SCI, V111, P995; Khaliq A, 1996, GROWTH FACTORS, V13, P243, DOI 10.3109/08977199609003225; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Laity JH, 2007, ARCH BIOCHEM BIOPHYS, V463, P201, DOI 10.1016/j.abb.2007.03.019; Li S, 2017, J CELL PHYSIOL, V232, P2900, DOI 10.1002/jcp.25752; Li S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02120-5; Makris A, 2016, HYPERTENSION, V67, P1263, DOI 10.1161/HYPERTENSIONAHA.116.07286; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; Nishimoto F, 2009, ENDOCRINOLOGY, V150, P1801, DOI 10.1210/en.2008-0949; Schreiber J, 1998, NUCLEIC ACIDS RES, V26, P2337, DOI 10.1093/nar/26.10.2337; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Spradley FT, 2016, HYPERTENSION, V67, P740, DOI 10.1161/HYPERTENSIONAHA.115.06783; Wang LJ, 2012, MOL CELL BIOL, V32, P3707, DOI 10.1128/MCB.00223-12; Welch PC, 2006, AM J OBSTET GYNECOL, V194, P1625, DOI 10.1016/j.ajog.2006.01.012; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7; Yang CS, 2005, J BIOL CHEM, V280, P10083, DOI 10.1074/jbc.M413986200; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Zhang H, 2003, CURR BIOL, V13, P1625, DOI 10.1016/j.cub.2003.08.054	38	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9801	9811		10.1074/jbc.RA117.001384	http://dx.doi.org/10.1074/jbc.RA117.001384			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29743241	Green Published, hybrid			2022-12-26	WOS:000436102300023
J	Freund, JR; Mansfield, CJ; Doghramji, LJ; Adappa, ND; Palmer, JN; Kennedy, DW; Reed, DR; Jiang, PH; Lee, RJ				Freund, Jenna R.; Mansfield, Corrine J.; Doghramji, Laurel J.; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Reed, Danielle R.; Jiang, Peihua; Lee, Robert J.			Activation of airway epithelial bitter taste receptors by Pseudomonas aeruginosa quinolones modulates calcium, cyclic-AMP, and nitric oxide signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cilia; mucosal immunology; lung; protein kinase A (PKA); G protein-coupled receptor (GPCR); air-liquid interface; airway surface liquid; chronic rhinosinusitis; mucociliary clearance	UPPER RESPIRATORY-INFECTION; NONPOLYPOID CHRONIC RHINOSINUSITIS; QUORUM-SENSING MOLECULE; SEROUS ACINAR-CELLS; G-PROTEIN; IN-VITRO; FLUID SECRETION; SWEET TASTE; CILIARY MOTILITY; CYSTIC-FIBROSIS	Bitter taste receptors (taste family 2 bitter receptor proteins; T2Rs), discovered in many tissues outside the tongue, have recently become potential therapeutic targets. We have shown previously that airway epithelial cells express several T2Rs that activate innate immune responses that may be important for treatment of airway diseases such as chronic rhinosinusitis. It is imperative to more clearly understand what compounds activate airway T2Rs as well as their full range of functions. T2R isoforms in airway motile cilia (T2R4, -14, -16, and -38) produce bactericidal levels of nitric oxide (NO) that also increase ciliary beating, promoting clearance of mucus and trapped pathogens. Bacterial quorum-sensing acyl-homoserine lactones activate T2Rs and stimulate these responses in primary airway cells. Quinolones are another type of quorum-sensing molecule used by Pseudomonas aeruginosa. To elucidate whether bacterial quinolones activate airway T2Rs, we analyzed calcium, cAMP, and NO dynamics using a combination of fluorescent indicator dyes and FRET-based protein biosensors. T2R-transfected HEK293T cells, several lung epithelial cell lines, and primary sinonasal cells grown and differentiated at the air-liquid interface were tested with 2-heptyl-3-hydroxy-4-quinolone (known as Pseudomonas quinolone signal; PQS), 2,4-dihydroxyquinolone, and 4-hydroxy-2-heptylquinolone (HHQ). In HEK293T cells, PQS activated T2R4, -16, and -38, whereas HHQ activated T2R14. 2,4-Dihydroxyquinolone had no effect. PQS and HHQ increased calcium and decreased both baseline and stimulated cAMP levels in cultured and primary airway cells. In primary cells, PQS and HHQ activated levels of NO synthesis previously shown to be bactericidal. This study suggests that airway T2R-mediated immune responses are activated by bacterial quinolones as well as acyl-homoserine lactones.	[Freund, Jenna R.; Doghramji, Laurel J.; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Lee, Robert J.] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lee, Robert J.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mansfield, Corrine J.; Reed, Danielle R.; Jiang, Peihua] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Monell Chemical Senses Center	Lee, RJ (corresponding author), Hosp Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, 5th Fl,Ste A,3400 Spruce St, Philadelphia, PA 19104 USA.	rjl@pennmedicine.upenn.edu	Lee, Robert J./L-4397-2017	Lee, Robert J./0000-0001-5826-6686; Freund, Jenna/0000-0001-8264-8318	National Institutes of Health [R03DC013862, R01DC016309, P30DC011735, S10OD018125]; Cystic Fibrosis Foundation [LEER16G0]; Department of Otorhinolaryngology at the University of Pennsylvania; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC016309, R03DC013862, P30DC011735] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Department of Otorhinolaryngology at the University of Pennsylvania; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by National Institutes of Health Grants R03DC013862 and R01DC016309, Cystic Fibrosis Foundation Grant LEER16G0, and the Department of Otorhinolaryngology at the University of Pennsylvania (to R.J.L.). Genotyping of patient samples was supported by National Institutes of Health Grants P30DC011735 and S10OD018125 (to D.R.R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdalla MY, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00176-17; Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P783, DOI 10.1002/alr.21803; Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P356, DOI 10.1002/alr.21675; Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P25, DOI 10.1002/alr.21666; Adappa ND, 2014, INT FORUM ALLERGY RH, V4, P3, DOI 10.1002/alr.21253; Adappa ND, 2013, INT FORUM ALLERGY RH, V3, P184, DOI 10.1002/alr.21140; An SS, 2017, CELL SIGNAL, V41, P82, DOI 10.1016/j.cellsig.2017.02.002; Bedford FL, 2011, PERCEPTION, V40, P1265, DOI 10.1068/p7119; Behrens M, 2018, CHEM BIOL DRUG DES, V91, P422, DOI 10.1111/cbdd.13089; Blalock JE, 2007, BRAIN BEHAV IMMUN, V21, P23, DOI 10.1016/j.bbi.2006.09.004; Blalock JE, 2005, J INTERN MED, V257, P126, DOI 10.1111/j.1365-2796.2004.01441.x; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Calfee MW, 2005, INFECT IMMUN, V73, P878, DOI 10.1128/IAI.73.2.878-882.2005; Cantone E, 2018, LARYNGOSCOPE, V128, pE339, DOI 10.1002/lary.27175; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Cohen SP, 2012, J BIOL CHEM, V287, P41706, DOI 10.1074/jbc.M112.423806; Denning GM, 1998, INFECT IMMUN, V66, P5777, DOI 10.1128/IAI.66.12.5777-5784.1998; Depry C, 2011, MOL BIOSYST, V7, P52, DOI 10.1039/c0mb00079e; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Diggle SP, 2006, INT J MED MICROBIOL, V296, P83, DOI 10.1016/j.ijmm.2006.01.038; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Diggle SP, 2006, CHEM BIOL, V13, P701, DOI 10.1016/j.chembiol.2006.05.006; Dimova S, 2005, TOXICOL IN VITRO, V19, P107, DOI 10.1016/j.tiv.2004.07.003; Doerner JF, 2015, ELIFE, V4, DOI 10.7554/eLife.11066; Dubern JF, 2008, MOL BIOSYST, V4, P882, DOI 10.1039/b803796p; Dzaman Karolina, 2016, Otolaryngol Pol, V70, P13, DOI 10.5604/00306657.1209438; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Ferencik M, 1997, Bratisl Lek Listy, V98, P187; Ferre S, 2015, TRENDS PHARMACOL SCI, V36, P145, DOI 10.1016/j.tips.2015.01.002; Fowler CJ, 1997, CLIN CHIM ACTA, V265, P247, DOI 10.1016/S0009-8981(97)00139-3; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Gahbauer S, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00494; Gaida MM, 2016, ONCOTARGET, V7, P12623, DOI 10.18632/oncotarget.7206; Gaida MM, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw004; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Greene TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020123; Gruber JD, 2016, PEERJ, V4, DOI 10.7717/peerj.1495; Guina T, 2003, P NATL ACAD SCI USA, V100, P2771, DOI 10.1073/pnas.0435846100; Ha DG, 2011, J BACTERIOL, V193, P6770, DOI 10.1128/JB.05929-11; Hansch GM, 2014, J APPL BIOMATER FUNC, V12, P21, DOI 10.5301/jabfm.5000204; Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166; Hariri BM, 2017, J BIOL CHEM, V292, P8484, DOI [10.1074/jbc.M116.771949, 10.1074/jbc.m116.771949]; Hariri BM, 2016, AM J RHINOL ALLERGY, V30, P261, DOI 10.2500/ajra.2016.30.4331; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; HINGLEY ST, 1986, INFECT IMMUN, V51, P254, DOI 10.1128/IAI.51.1.254-262.1986; Holban AM, 2014, VIRULENCE, V5, P303, DOI 10.4161/viru.27571; HOON MA, 1995, BIOCHEM J, V309, P629, DOI 10.1042/bj3090629; Hotterbeekx A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00106; Huang WK, 2016, SCI REP-UK, V6, DOI 10.1038/srep23450; JAIN B, 1995, AM J PHYSIOL-LUNG C, V268, pL911, DOI 10.1152/ajplung.1995.268.6.L911; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; KANTHAKUMAR K, 1993, INFECT IMMUN, V61, P2848, DOI 10.1128/IAI.61.7.2848-2853.1993; Karaman R, 2016, CHEM BIOL DRUG DES, V88, P66, DOI 10.1111/cbdd.12734; Kim DW, 2017, AM J RESP CELL MOL, V56, P762, DOI 10.1165/rcmb.2016-0373OC; Kim D, 2016, J BIOL CHEM, V291, P17616, DOI 10.1074/jbc.M116.722736; Klarenbeek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122513; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; Kuhn C, 2013, METHOD CELL BIOL, V117, P229, DOI 10.1016/B978-0-12-408143-7.00013-X; Kuhn C, 2010, CHEM SENSES, V35, P395, DOI 10.1093/chemse/bjq027; Lai YY, 2011, J ALLERGY CLIN IMMUN, V128, P1207, DOI 10.1016/j.jaci.2011.09.001; Langan KM, 2015, CURR OPIN INFECT DIS, V28, P547, DOI 10.1097/QCO.0000000000000217; Lee RJ, 2007, J PHYSIOL-LONDON, V582, P1099, DOI 10.1113/jphysiol.2007.131995; Lee RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33221; Lee RJ, 2015, CELL MOL LIFE SCI, V72, P217, DOI 10.1007/s00018-014-1736-7; Lee RJ, 2015, CURR OPIN ALLERGY CL, V15, P14, DOI 10.1097/ACI.0000000000000120; Lee RJ, 2014, J MOL MED, V92, P1235, DOI 10.1007/s00109-014-1222-6; Lee RJ, 2014, INNATE IMMUN-LONDON, V20, P606, DOI 10.1177/1753425913503386; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2013, FASEB J, V27, P5094, DOI 10.1096/fj.13-234476; Lee RJ, 2013, AM J RHINOL ALLERGY, V27, P283, DOI 10.2500/ajra.2013.27.3911; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Lee RJ, 2010, AM J PHYSIOL-LUNG C, V298, pL210, DOI 10.1152/ajplung.00342.2009; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Levit A, 2014, FASEB J, V28, P1181, DOI 10.1096/fj.13-242594; Li F, 2013, MOL HUM REPROD, V19, P349, DOI 10.1093/molehr/gat009; Lin JS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14888; Lin S, 2000, J BIOL CHEM, V275, P17979, DOI 10.1074/jbc.275.24.17979; Liu AMF, 2003, J BIOMOL SCREEN, V8, P39, DOI 10.1177/1087057102239665; Liu YC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01226; Lossow K, 2016, J BIOL CHEM, V291, P15358, DOI 10.1074/jbc.M116.718544; Mangmool S, 2011, TOXINS, V3, P884, DOI 10.3390/toxins3070884; Maniscalco M, 2007, INFLAMM RES, V56, P58, DOI 10.1007/s00011-006-6111-1; Marcinkiewicz J, 1997, IMMUNOPHARMACOLOGY, V37, P35, DOI 10.1016/S0162-3109(96)00168-3; Maurer S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00369; McGrath S, 2004, FEMS MICROBIOL LETT, V230, P27, DOI 10.1016/S0378-1097(03)00849-8; MCLAUGHLIN SK, 1994, PHYSIOL BEHAV, V56, P1157, DOI 10.1016/0031-9384(94)90360-3; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; McMahon DB, 2018, FASEB J, V32, P155, DOI 10.1096/fj.201700114RRR; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mfuna Endam L, 2014, INT FORUM ALLERGY RH, V4, P200, DOI 10.1002/alr.21275; Miyamoto S, 2000, BRIT J PHARMACOL, V130, P650, DOI 10.1038/sj.bjp.0703358; Mody SM, 2000, MOL PHARMACOL, V57, P13; Morales-Soto N, 2018, J BIOL CHEM, V293, P9544, DOI 10.1074/jbc.RA118.002605; Odaka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100252; Oliphant CM, 2002, AM FAM PHYSICIAN, V65, P455; Ozeck M, 2004, EUR J PHARMACOL, V489, P139, DOI 10.1016/j.ejphar.2004.03.004; Paczkowski JE, 2017, J BIOL CHEM, V292, P4064, DOI 10.1074/jbc.M116.770552; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; Pydi SP, 2014, J BIOL CHEM, V289, P25054, DOI 10.1074/jbc.M114.576975; Reed DR, 2010, HUM MOL GENET, V19, P4278, DOI 10.1093/hmg/ddq324; Reen FJ, 2011, FEMS MICROBIOL ECOL, V77, P413, DOI 10.1111/j.1574-6941.2011.01121.x; Robbins RA, 1997, AM J RESP CRIT CARE, V155, P268, DOI 10.1164/ajrccm.155.1.9001323; Rom DI, 2017, RHINOLOGY, V55, P90, DOI [10.4193/Rhino16.181, 10.4193/Rhin16.181]; Sandau MM, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0170-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; SISSON JH, 1995, AM J PHYSIOL-LUNG C, V268, pL596, DOI 10.1152/ajplung.1995.268.4.L596; Sisson JH, 1999, ALCOHOL CLIN EXP RES, V23, P1528, DOI 10.1111/j.1530-0277.1999.tb04677.x; Sisson JH, 2009, ALCOHOL CLIN EXP RES, V33, P610, DOI 10.1111/j.1530-0277.2008.00875.x; Stevens WW, 2015, J ALLERGY CLIN IMMUN, V136, P1442, DOI 10.1016/j.jaci.2015.10.009; Storch U, 2017, PFLUG ARCH EUR J PHY, V469, P725, DOI 10.1007/s00424-017-1975-1; Stout SL, 2007, J HISTOCHEM CYTOCHEM, V55, P433, DOI 10.1369/jhc.6A7089.2007; Tan J, 2012, J CHEM INF MODEL, V52, P1875, DOI 10.1021/ci300133a; Tan XH, 2014, BRIT J PHARMACOL, V171, P646, DOI 10.1111/bph.12460; Tashiro Y, 2013, MICROBES ENVIRON, V28, P13, DOI 10.1264/jsme2.ME12167; Thomas A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07256-y; Tipton KA, 2015, MOL MICROBIOL, V96, P670, DOI 10.1111/mmi.12963; Verbeurgt C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181302; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; WEIGENT DA, 1995, J LEUKOCYTE BIOL, V58, P137, DOI 10.1002/jlb.58.2.137; Wen XX, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0183-9; WILSON R, 1987, J CLIN INVEST, V79, P221, DOI 10.1172/JCI112787; Wolfle U, 2016, MOLECULES, V21, DOI 10.3390/molecules21030306; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Woodworth BA, 2007, AM J RHINOL, V21, P533, DOI 10.2500/ajr.2007.21.3068; Workman AD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00624; Workman AD, 2018, J ALLER CL IMM-PRACT, V6, P1078, DOI 10.1016/j.jaip.2017.09.014; Workman AD, 2017, INT FORUM ALLERGY RH, V7, P770, DOI 10.1002/alr.21966; Yamamoto K, 2013, SEMIN CELL DEV BIOL, V24, P240, DOI 10.1016/j.semcdb.2012.08.005; Yan CH, 2017, AM J RHINOL ALLERGY, V31, P85, DOI 10.2500/ajra.2017.31.4424; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zhao KQ, 2012, FASEB J, V26, P3178, DOI 10.1096/fj.11-202184	139	54	54	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9824	9840		10.1074/jbc.RA117.001005	http://dx.doi.org/10.1074/jbc.RA117.001005			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29748385	hybrid, Green Published			2022-12-26	WOS:000436102300025
J	Posner, MG; Upadhyay, A; Ishima, R; Kalli, AC; Harris, G; Kremerskothen, J; Sansom, MSP; Crennell, SJ; Bagby, S				Posner, Mareike G.; Upadhyay, Abhishek; Ishima, Rieko; Kalli, Antreas C.; Harris, Gemma; Kremerskothen, Joachim; Sansom, Mark S. P.; Crennell, Susan J.; Bagby, Stefan			Distinctive phosphoinositide- and Ca2+-binding properties of normal and cognitive performance-linked variant forms of KIBRA C2 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); crystallography; phosphoinositide; molecular dynamics; analytical ultracentrifugation; calcium-binding protein; Alzheimer disease; -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA receptor; AMPAR); Hippo pathway; membrane trafficking; C2 domain; human cognition; KIBRA; WWC protein family	MOLECULAR-DYNAMICS; STRUCTURE VALIDATION; ALZHEIMERS-DISEASE; MEMBRANE-BINDING; CA2+ BINDING; FORCE-FIELD; MEMORY; ASSOCIATION; POLYMORPHISM; PROTEINS	Kidney- and brain-expressed protein (KIBRA), a multifunctional scaffold protein with around 20 known binding partners, is involved in memory and cognition, organ size control via the Hippo pathway, cell polarity, and membrane trafficking. KIBRA includes tandem N-terminal WW domains, a C2 domain, and motifs for binding atypical PKC and PDZ domains. A naturally occurring human KIBRA variant involving residue changes at positions 734 (Met-to-Ile) and 735 (Ser-to-Ala) within the C2 domain affects cognitive performance. We have elucidated 3D structures and calcium- and phosphoinositide-binding properties of human KIBRA C2 domain. Both WT and variant C2 adopt a canonical type I topology C2 domain fold. Neither Ca2+ nor any other metal ion was bound to WT or variant KIBRA C2 in crystal structures, and Ca2+ titration produced no significant reproducible changes in NMR spectra. NMR and X-ray diffraction data indicate that KIBRA C2 binds phosphoinositides via an atypical site involving -strands 5, 2, 1, and 8. Molecular dynamics simulations indicate that KIBRA C2 interacts with membranes via primary and secondary sites on the same domain face as the experimentally identified phosphoinositide-binding site. Our results indicate that KIBRA C2 domain association with membranes is calcium-independent and involves distinctive C2 domain-membrane relative orientations.	[Posner, Mareike G.; Upadhyay, Abhishek; Crennell, Susan J.; Bagby, Stefan] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Ishima, Rieko] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Kalli, Antreas C.] Univ Leeds, Leeds Inst Canc & Pathol, Leeds LS9 7TF, W Yorkshire, England; [Kalli, Antreas C.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Harris, Gemma] Rutherford Appleton Lab, Res Complex Harwell, Didcot OX11 0FA, Oxon, England; [Kremerskothen, Joachim] Univ Hosp Munster, Internal Med D, Dept Nephrol Hypertens & Rheumatol, D-48149 Munster, Germany; [Sansom, Mark S. P.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Bath; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Leeds; University of Leeds; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Munster; University of Oxford	Bagby, S (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bsssb@bath.ac.uk	Posner, Mareike/AGK-4002-2022	Posner, Mareike/0000-0002-3156-3071; Bagby, Stefan/0000-0003-2302-9511; Kalli, Antreas/0000-0001-7156-9403; Harris, Gemma/0000-0002-4587-4620	Biotechnology and Biological Sciences Research Council [BB/J008176/1]; BBSRC [BB/J008176/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/J008176/1. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashraf A, 2015, INT J BIOCHEM CELL B, V69, P20, DOI 10.1016/j.biocel.2015.10.001; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Buther K, 2004, BIOCHEM BIOPH RES CO, V317, P703, DOI 10.1016/j.bbrc.2004.03.107; Cheignon C, 2018, REDOX BIOL, V14, P450, DOI 10.1016/j.redox.2017.10.014; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008; Corneveaux JJ, 2010, NEUROBIOL AGING, V31, P901, DOI 10.1016/j.neurobiolaging.2008.07.014; Coudevylle N, 2008, J BIOL CHEM, V283, P35918, DOI 10.1074/jbc.M804094200; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Dai H, 2004, NAT STRUCT MOL BIOL, V11, P844, DOI 10.1038/nsmb817; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duning K, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.49; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrer-Orta C, 2017, P NATL ACAD SCI USA, V114, pE5343, DOI 10.1073/pnas.1702542114; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Heitz FD, 2016, NEUROBIOL LEARN MEM, V135, P100, DOI 10.1016/j.nlm.2016.07.028; Hermann A, 2018, HEPATOLOGY, V67, P1546, DOI 10.1002/hep.29647; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Johannsen S, 2008, NEUROSCIENCE, V155, P1165, DOI 10.1016/j.neuroscience.2008.06.054; Kalli AC, 2014, BIOCHEM SOC T, V42, P1418, DOI 10.1042/BST20140144; Kawai E, 2015, NEUROMOL MED, V17, P170, DOI 10.1007/s12017-015-8348-8; Khanal P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21828-6; Kremerskothen J, 2005, J NEUROCHEM, V92, P597, DOI 10.1111/j.1471-4159.2004.02888.x; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Ling JJ, 2018, NEUROSCI LETT, V662, P77, DOI 10.1016/j.neulet.2017.08.057; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Makuch L, 2011, NEURON, V71, P1022, DOI 10.1016/j.neuron.2011.08.017; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Meliambro K, 2017, J BIOL CHEM, V292, P21137, DOI 10.1074/jbc.M117.819029; Milnik A, 2012, AM J MED GENET B, V159B, P958, DOI 10.1002/ajmg.b.32101; Montaville P, 2008, PROTEIN SCI, V17, P1025, DOI 10.1110/ps.073326608; Montaville P, 2007, J BIOL CHEM, V282, P5015, DOI 10.1074/jbc.M606746200; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Ochoa WF, 2002, J MOL BIOL, V320, P277, DOI 10.1016/S0022-2836(02)00464-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Picas L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6647; Piras IS, 2017, HIPPOCAMPUS, V27, P784, DOI 10.1002/hipo.22731; Posner MG, 2009, FEBS J, V276, P4012, DOI 10.1111/j.1742-4658.2009.07110.x; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; Rosse C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000235; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Schneider A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.004.2010; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tracy TE, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600224; Tracy TE, 2016, NEURON, V90, P245, DOI 10.1016/j.neuron.2016.03.005; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Vogt-Eisele A, 2014, J NEUROCHEM, V128, P686, DOI 10.1111/jnc.12480; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wennmann DO, 2014, MOL BIOL EVOL, V31, P1710, DOI 10.1093/molbev/msu115; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Willsey AJ, 2017, NEURON, V94, P486, DOI 10.1016/j.neuron.2017.04.024; Wilson KE, 2016, GENES-BASEL, V7, DOI 10.3390/genes7060023; Yamamoto E, 2016, STRUCTURE, V24, P1421, DOI 10.1016/j.str.2016.06.002; Yoshihama Y, 2011, CURR BIOL, V21, P705, DOI 10.1016/j.cub.2011.03.029; Yoshihama Y, 2009, BIOSCI BIOTECH BIOCH, V73, P147, DOI 10.1271/bbb.80564; Zhang L, 2014, CELL SIGNAL, V26, P1392, DOI 10.1016/j.cellsig.2014.02.023; Zhang NNN, 2017, CEREB CORTEX, V27, P4797, DOI 10.1093/cercor/bhw276	72	4	5	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9335	9344		10.1074/jbc.RA118.002279	http://dx.doi.org/10.1074/jbc.RA118.002279			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29724824	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000435441400019
J	Perron, IJ; Keenan, BT; Chellappa, K; Lahens, NF; Yohn, NL; Shockley, KR; Pack, AI; Veasey, SC				Perron, Isaac J.; Keenan, Brendan T.; Chellappa, Karthikeyani; Lahens, Nicholas F.; Yohn, Nicole L.; Shockley, Keith R.; Pack, Allan, I; Veasey, Sigrid C.			Dietary challenges differentially affect activity and sleep/wake behavior in mus musculus: Isolating independent associations with diet/energy balance and body weight	PLOS ONE			English	Article							HIGH-FAT DIET; ENERGY-BALANCE; FOOD-INTAKE; INDUCED OBESITY; HYPOTHALAMIC INFLAMMATION; MESSENGER-RNA; GLUCOSE-HOMEOSTASIS; LEPTIN RESISTANCE; THYROID AXIS; ALPHA-MSH	Background and aims Associated with numerous metabolic and behavioral abnormalities, obesity is classified by metrics reliant on body weight (such as body mass index). However, overnutrition is the common cause of obesity, and may independently contribute to these obesity-related abnormalities. Here, we use dietary challenges to parse apart the relative influence of diet and/or energy balance from body weight on various metabolic and behavioral outcomes. Materials and methods Seventy male mice (mus musculus) were subjected to the diet switch feeding paradigm, generating groups with various body weights and energetic imbalances. Spontaneous activity patterns, blood metabolite levels, and unbiased gene expression of the nutrient-sensing ventral hypothalamus (using RNA-sequencing) were measured, and these metrics were compared using standardized multivariate linear regression models. Results Spontaneous activity patterns were negatively related to body weight (p<0.0001) but not diet/energy balance (p = 0.63). Both body weight and diet/energy balance predicted circulating glucose and insulin levels, while body weight alone predicted plasma leptin levels. Regarding gene expression within the ventral hypothalamus, only two genes responded to diet/energy balance (neuropeptide y[npy] and agouti-related peptide [agrp]), while others were related only to body weight. Conclusions Collectively, these results demonstrate that individual components of obesity-specifically obesogenic diets/energy imbalance and elevated body mass-can have independent effects on metabolic and behavioral outcomes. This work highlights the shortcomings of using body mass-based indices to assess metabolic health, and identifies novel associations between blood biomarkers, neural gene expression, and animal behavior following dietary challenges.	[Perron, Isaac J.; Keenan, Brendan T.; Pack, Allan, I; Veasey, Sigrid C.] Univ Penn, Ctr Sleep & Circadian Neurobiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chellappa, Karthikeyani] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lahens, Nicholas F.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Yohn, Nicole L.] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Shockley, Keith R.] NIEHS, Biostat & Computat Biol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Perron, IJ (corresponding author), Univ Penn, Ctr Sleep & Circadian Neurobiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	iperron@pennmedicine.upenn.edu			F31 Predoctoral National Research Service Award [HL128124, P01-AG017628, HL123331, HL124576]; Intramural Research Program of the NIH, National Institute of Environmental Health Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, ZIAES103166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG054104] Funding Source: NIH RePORTER	F31 Predoctoral National Research Service Award; Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the F31 Predoctoral National Research Service Award (HL128124) to I.J.P, P01-AG017628 to A.I.P., and HL123331 and HL124576 to S.C.V. This research was also supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (https.//www.niehs.nih.gov/research/atniehs/dir/index.cfm) to KRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh CD, 2012, PANCREAS, V41, P253, DOI 10.1097/MPA.0b013e3182243107; Al Maskari Masoud Y, 2006, Sultan Qaboos Univ Med J, V6, P27; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Benoit SC, 2004, RECENT PROG HORM RES, V59, P267, DOI 10.1210/rp.59.1.267; Berenson GS, 2012, PEDIATR BLOOD CANCER, V58, P117, DOI 10.1002/pbc.23373; Berk KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160774; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Boelen A, 2008, THYROID, V18, P123, DOI 10.1089/thy.2007.0253; Choi JY, 2016, INT J OBESITY, V40, P1452, DOI 10.1038/ijo.2016.70; Coll AP, 2013, CURR OPIN PHARMACOL, V13, P970, DOI 10.1016/j.coph.2013.09.010; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; D'Agostino G, 2010, J MOL MED, V88, P1195, DOI 10.1007/s00109-010-0651-0; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorfman MD, 2015, CURR OPIN ENDOCRINOL, V22, P325, DOI 10.1097/MED.0000000000000182; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Everson CA, 2002, AM J PHYSIOL-ENDOC M, V283, pE85, DOI 10.1152/ajpendo.00558.2001; Fenselau H, 2017, NAT NEUROSCI, V20, P42, DOI 10.1038/nn.4442; Filippi BM, 2014, DIABETES, V63, P892, DOI 10.2337/db13-1044; Fisher SP, 2012, J BIOL RHYTHM, V27, P48, DOI 10.1177/0748730411431550; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gao Q, 2008, FEBS LETT, V582, P132, DOI 10.1016/j.febslet.2007.11.063; Grill HJ, 2012, CELL METAB, V16, P296, DOI 10.1016/j.cmet.2012.06.015; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; Grill M, 2015, GLIA, V63, P1738, DOI 10.1002/glia.22841; Guillemot-Legris O, 2016, SCI REP-UK, V6, DOI 10.1038/srep19694; Hall KD, 2012, AM J CLIN NUTR, V95, P989, DOI 10.3945/ajcn.112.036350; Harrold JA, 1999, BIOCHEM BIOPH RES CO, V258, P574, DOI 10.1006/bbrc.1999.0675; Henry FE, 2015, ELIFE, V4, DOI 10.7554/eLife.09800; Ishii Y, 2003, PHYSIOL BEHAV, V80, P37, DOI 10.1016/S0031-9384(03)00207-5; Jais A, 2017, J CLIN INVEST, V127, P24, DOI 10.1172/JCI88878; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Joris PJ, 2017, AM J CLIN NUTR, V105, P23, DOI 10.3945/ajcn.116.143552; Kashyap SR, 2010, CLEV CLIN J MED, V77, P468, DOI 10.3949/ccjm.77a.09135; Keating GL, 2010, NEUROPEPTIDES, V44, P241, DOI 10.1016/j.npep.2009.12.013; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kok P, 2005, J CLIN ENDOCR METAB, V90, P4659, DOI 10.1210/jc.2005-0920; Kowalski GM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27541; Lahens NF, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4011-0; Larsen PJ, 2000, OBES RES, V8, P590, DOI 10.1038/oby.2000.76; Leibowitz SF, 2004, PEPTIDES, V25, P473, DOI 10.1016/j.peptides.2004.02.006; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Longhi S, 2013, J CLIN RES PEDIATR E, V5, P40, DOI [10.4274/jcrpe.856, 10.4274/Jcrpe.856]; Mavanji V, 2010, INT J OBESITY, V34, P1576, DOI 10.1038/ijo.2010.93; Mavanji V, 2012, NEUROSCI BIOBEHAV R, V36, P1015, DOI 10.1016/j.neubiorev.2012.01.001; Mehta RK, 2015, APPL ERGON, V46, P91, DOI 10.1016/j.apergo.2014.07.007; Melvin RG, 2009, TRENDS ENDOCRIN MET, V20, P490, DOI 10.1016/j.tem.2009.09.005; Narath SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161425; Nasrallah CM, 2014, NAT REV ENDOCRINOL, V10, P650, DOI 10.1038/nrendo.2014.160; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Pack AI, 2007, PHYSIOL GENOMICS, V28, P232, DOI 10.1152/physiolgenomics.00139.2006; Panossian LA, 2012, SLEEP, V35, P605, DOI 10.5665/sleep.1812; Pasquali R, 2000, INT J OBESITY, V24, pS47, DOI 10.1038/sj.ijo.0801277; Perello M, 2010, AM J PHYSIOL-ENDOC M, V299, pE976, DOI 10.1152/ajpendo.00448.2010; Perron IJ, 2015, SLEEP, V38, P1893, DOI 10.5665/sleep.5236; Pi-Sunyer X, 2009, POSTGRAD MED, V121, P21, DOI 10.3810/pgm.2009.11.2074; Pritchard LE, 2003, ENDOCRINOLOGY, V144, P760, DOI 10.1210/en.2002-220866; Ritter S, 2000, BRAIN RES, V856, P37, DOI 10.1016/S0006-8993(99)02327-6; Rui LY, 2013, REV ENDOCR METAB DIS, V14, P387, DOI 10.1007/s11154-013-9261-9; Sainsbury A, 2002, BEST PRACT RES CL EN, V16, P623, DOI 10.1053/beem.2002.0230; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sha Y, 2015, IEEE ENG MED BIO, P6461, DOI 10.1109/EMBC.2015.7319872; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szymusiak R, 2008, ANN NY ACAD SCI, V1129, P275, DOI 10.1196/annals.1417.027; Tomiyama AJ, 2016, INT J OBESITY, V40, P883, DOI 10.1038/ijo.2016.17; Varela JE, 2007, OBES SURG, V17, P1279, DOI 10.1007/s11695-007-9228-6; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; White CL, 2010, PHYSIOL BEHAV, V100, P408, DOI 10.1016/j.physbeh.2010.04.006; Williams LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106159; Wisse BE, 2009, CELL METAB, V10, P241, DOI 10.1016/j.cmet.2009.09.003; Xia SF, 2015, METABOLISM, V64, P566, DOI 10.1016/j.metabol.2014.12.010; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	75	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196743	10.1371/journal.pone.0196743	http://dx.doi.org/10.1371/journal.pone.0196743			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746501	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700033
J	Rachik, S; Christaki, U; Li, LL; Genitsaris, S; Breton, E; Monchy, S				Rachik, Sara; Christaki, Urania; Li, Luen Luen; Genitsaris, Savvas; Breton, Elsa; Monchy, Sebastien			Diversity and potential activity patterns of planktonic eukaryotic microbes in a mesoeutrophic coastal area (eastern English Channel)	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; CLONE LIBRARIES; GROWTH-RATE; COMMUNITY STRUCTURE; SPRING BLOOM; NORTH-SEA; PHAEOCYSTIS; WATERS; PHYTOPLANKTON; RARE	The diversity of planktonic eukaryotic microbes was studied at a coastal station of the eastern English Channel (EEC) from March 2011 to July 2015 (77 samples) using high throughput sequencing (454-pyrosequencing and Illumina) of the V2-V3 hypervariable region of the 18S SSU rDNA gene. Similar estimations of OTU relative abundance and taxonomic distribution for the dominant higher taxonomic groups (contributing >1% of the total number of OTUs) were observed with the two methods (Kolmogorov-Smirnov p-value = 0.22). Eight super-groups were identified throughout all samples: Alveolata, Stramenopiles, Opisthokonta, Hacrobia, Archeaplastida, Apusozoa, Rhizaria, and Amoebozoa (ordered by decreasing OTU richness). To gain further insight into microbial activity in the EEC, ribosomal RNA was extracted for samples from 2013-2015 (30 samples). Analysis of 18S rDNA and rRNA sequences led to the detection of 696 and 700 OTUs, respectively. Cluster analysis based on OTUs' abundance indicated three major seasonal groups that were associated to spring, winter/autumn, and summer conditions. The clusters inferred from rRNA data showed a clearer seasonal representation of the community succession than the one based on rDNA. The rRNA/rDNA ratio was used as a proxy for relative cell activity. When all OTUs were considered, the average rRNA:rDNA ratio showed a linear trend around the 1:1 line, suggesting a linear relation between OTU abundance (rDNA) and activity (rRNA). However, this ratio was highly variable over time when considering individual OTUs. Interestingly, the OTU affiliated with P. globose displayed rRNA:rDNA ratio that allowed to delimit high vs low abundance and high vs low activity periods. It unveiled quite well the Phaeocystis bloom dynamic regarding cell proliferation and activity, and could even be used as early indicator of an upcoming bloom.	[Rachik, Sara; Christaki, Urania; Li, Luen Luen; Breton, Elsa; Monchy, Sebastien] Univ Lille, Univ Littoral Cote Opale, CNRS, LOG,UMR, Lille, France; [Genitsaris, Savvas] Int Hellen Univ, Sch Econ Business Adm & Legal Studies, Thessaloniki, Greece	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; International Hellenic University	Monchy, S (corresponding author), Univ Lille, Univ Littoral Cote Opale, CNRS, LOG,UMR, Lille, France.	sebastien.monchy@univ-littoral.fr	Genitsaris, Savvas/L-5302-2019; elsa, Breton/J-4996-2013	Genitsaris, Savvas/0000-0003-0585-2571; MONCHY, Sebastien/0000-0001-5808-4700; Breton, Elsa/0000-0002-9569-5436	region Nord Pas de Calais (France); FRB DEMO (FRB) program from region "Nord Pas de Calais" (France);; SOMLIT network	region Nord Pas de Calais (France)(Region Hauts-de-France); FRB DEMO (FRB) program from region "Nord Pas de Calais" (France);; SOMLIT network	This work was supported by a PhD grant from region Nord Pas de Calais (France); FRB DEMO (FRB 2013) program from region "Nord Pas de Calais" (France); SOMLIT network (http://somlit.epoc.u-bordeaux1.fr/fr/).; This study was supported by a PhD grant from region Nord Pas de Calais (France), FRB DEMO (FRB 2013) program from region "Nord Pas de Calais" (France) and the SOMLIT network.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Aminot A, 2004, DEEP-SEA RES PT I, V51, P1975, DOI 10.1016/j.dsr.2004.07.016; Barnard RL, 2013, ISME J, V7, P2229, DOI 10.1038/ismej.2013.104; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brate J, 2012, PROTIST, V163, P767, DOI 10.1016/j.protis.2012.04.004; Bremer H, 1996, ESCHERICHIA COLI SAL; Breton E, 2000, J PLANKTON RES, V22, P1423, DOI 10.1093/plankt/22.8.1423; Breton E, 2006, LIMNOL OCEANOGR, V51, P1401, DOI 10.4319/lo.2006.51.3.1401; Campbell BJ, 2011, P NATL ACAD SCI USA, V108, P12776, DOI 10.1073/pnas.1101405108; Caron DA, 2013, J EUKARYOT MICROBIOL, V60, P407, DOI 10.1111/jeu.12044; Caron DA, 2012, ANNU REV MAR SCI, V4, P467, DOI 10.1146/annurev-marine-120709-142802; Charvet S, 2014, FEMS MICROBIOL ECOL, V88, P550, DOI 10.1111/1574-6941.12324; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Christaki U, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00416; Christaki U, 2014, MICROB ECOL, V67, P13, DOI 10.1007/s00248-013-0290-4; Countway P, 2011, DEPTH MATTERS MICROB; Countway PD, 2010, LIMNOL OCEANOGR, V55, P2381, DOI 10.4319/lo.2010.55.6.2381; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; EGGE JK, 1992, MAR ECOL PROG SER, V83, P281, DOI 10.3354/meps083281; Ferrera I, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00147; Genitsaris S, 2016, MAR ECOL PROG SER, V548, P61, DOI 10.3354/meps11647; Genitsaris S, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv034; Gentile G, 2006, ENVIRON MICROBIOL, V8, P2150, DOI 10.1111/j.1462-2920.2006.01097.x; Godhe A, 2008, APPL ENVIRON MICROB, V74, P7174, DOI 10.1128/AEM.01298-08; Gong J, 2013, PROTIST, V164, P369, DOI 10.1016/j.protis.2012.11.006; Gorley C.K., 2006, GETTING STARTED PRIM; Grattepanche JD, 2011, J EXP MAR BIOL ECOL, V404, P87, DOI 10.1016/j.jembe.2011.04.004; Grattepanche JD, 2011, J PLANKTON RES, V33, P37, DOI 10.1093/plankt/fbq097; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hu SK, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw050; Hugoni M, 2013, P NATL ACAD SCI USA, V110, P6004, DOI 10.1073/pnas.1216863110; JAHNKE J, 1989, NETH J SEA RES, V23, P15, DOI 10.1016/0077-7579(89)90038-0; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; KARL DM, 1989, LIMNOL OCEANOGR, V34, P543, DOI 10.4319/lo.1989.34.3.0543; KEMP PF, 1993, APPL ENVIRON MICROB, V59, P2594, DOI 10.1128/AEM.59.8.2594-2601.1993; KERKHOF L, 1993, APPL ENVIRON MICROB, V59, P1303, DOI 10.1128/AEM.59.5.1303-1309.1993; Kuhn M., 2016, CARET CLASSIFICATION; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lepp PW, 1998, ARCH MICROBIOL, V170, P201, DOI 10.1007/s002030050634; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Lopez-Garcia P, 2003, P NATL ACAD SCI USA, V100, P697, DOI 10.1073/pnas.0235779100; Massana R, 2008, CURR OPIN MICROBIOL, V11, P213, DOI 10.1016/j.mib.2008.04.004; Massana R, 2015, ENVIRON MICROBIOL, V17, P4035, DOI 10.1111/1462-2920.12955; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Mills HJ, 2005, APPL ENVIRON MICROB, V71, P3235, DOI 10.1128/AEM.71.6.3235-3247.2005; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Moeseneder MM, 2005, FEMS MICROBIOL ECOL, V51, P341, DOI 10.1016/j.femsec.2004.09.012; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Orsi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056335; Peperzak L, 1998, J PLANKTON RES, V20, P517, DOI 10.1093/plankt/20.3.517; POULSEN LK, 1993, APPL ENVIRON MICROB, V59, P1354, DOI 10.1128/AEM.59.5.1354-1360.1993; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Development Core Team, 2014, R LANG ENV STAT COMP; RILEY GA, 1957, LIMNOL OCEANOGR, V2, P252, DOI 10.1002/lno.1957.2.3.0252; Rousseau V, 2007, BIOGEOCHEMISTRY, V83, P29, DOI 10.1007/s10533-007-9085-3; Schapira M, 2008, J MAR BIOL ASSOC UK, V88, P649, DOI 10.1017/S0025315408001306; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sherr BF, 2007, OCEANOGRAPHY, V20, P130, DOI 10.5670/oceanog.2007.57; Stoeck T, 2007, MICROB ECOL, V53, P328, DOI 10.1007/s00248-006-9166-1; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Verity PG, 2007, BIOGEOCHEMISTRY, V83, P311, DOI 10.1007/s10533-007-9090-6; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Xu DP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01121; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135	75	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196987	10.1371/journal.pone.0196987	http://dx.doi.org/10.1371/journal.pone.0196987			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746519	gold, Green Published, Green Submitted			2022-12-26	WOS:000431851700053
J	Fenton, A; Jesky, MD; Webster, R; Stringer, SJ; Yadav, P; Chapple, I; Dasgupta, I; Harding, SJ; Ferro, CJ; Cockwell, P				Fenton, Anthony; Jesky, Mark D.; Webster, Rachel; Stringer, Stephanie J.; Yadav, Punit; Chapple, Iain; Dasgupta, Indranil; Harding, Stephen J.; Ferro, Charles J.; Cockwell, Paul			Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; MOLECULAR-WEIGHT PROTEINS; COLLABORATIVE METAANALYSIS; HIGHER ALBUMINURIA; QUANTITATIVE ASSESSMENT; ALL-CAUSE; RISK; SERUM; MORTALITY; MARKER	Background Patients with chronic kidney disease (CKD) are at an increased risk of developing end-stage renal disease (ESRD). We assessed for the first time whether urinary free light chains (FLC) are independently associated with risk of ESRD in patients with CKD, and whether they offer incremental value in risk stratification. Materials and methods We measured urinary FLCs in 556 patients with CKD from a prospective cohort study. The association between urinary kappa/creatinine (KCR) and lambda/creatinine (LCR) ratios and development of ESRD was assessed by competing-risks regression (to account for the competing risk of death). The change in C-statistic and integrated discrimination improvement were used to assess the incremental value of adding KCR or LCR to the Kidney Failure Risk Equation (KFRE). Results 136 participants developed ESRD during a median follow-up time of 51 months. Significant associations between KCR and LCR and risk of ESRD became non-significant after adjustment for estimated glomerular filtration rate (eGFR) and albumin/creatinine ratio (ACR), although having a KCR or LCR >75th centile remained independently associated with risk of ESRD. Neither KCR nor LCR as continuous or categorical variables provided incremental value when added to the KFRE for estimating risk of ESRD at two years. Conclusions Urinary FLCs have an association with progression to ESRD in patients with CKD which appears to be explained to a degree by their correlation with eGFR and ACR. Levels above the 75th centile do have an independent association with ESRD, but do not improve upon a current model for risk stratification.	[Fenton, Anthony; Jesky, Mark D.; Stringer, Stephanie J.; Yadav, Punit; Ferro, Charles J.; Cockwell, Paul] Univ Hosp Birmingham NHS Fdn Trust, Dept Renal Med, Birmingham, W Midlands, England; [Fenton, Anthony; Cockwell, Paul] Univ Birmingham, Inst Inflammat & Ageing, Birmingham, W Midlands, England; [Webster, Rachel] Univ Hosp Birmingham NHS Fdn Trust, Dept Biochem, Birmingham, W Midlands, England; [Chapple, Iain] Univ Birmingham, Inst Clin Sci, Periodontal Res Grp, Birmingham, W Midlands, England; [Chapple, Iain] Birmingham Community Healthcare Fdn Trust, Birmingham, W Midlands, England; [Dasgupta, Indranil] Heart England NHS Fdn Trust, Dept Renal Med, Birmingham, W Midlands, England; [Harding, Stephen J.] Binding Site, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; Heart of England NHS Foundation Trust	Fenton, A (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Dept Renal Med, Birmingham, W Midlands, England.; Fenton, A (corresponding author), Univ Birmingham, Inst Inflammat & Ageing, Birmingham, W Midlands, England.	anthony.fenton@uhb.nhs.uk	Chapple, Iain L C/T-2986-2017; Dasgupta, Indranil/ABC-3409-2020; ferro, charles/L-7250-2019; Ferro, Charles J./O-8912-2016	Chapple, Iain L C/0000-0003-2697-7082; ferro, charles/0000-0003-0577-7081; Ferro, Charles J./0000-0003-0577-7081; Cockwell, Paul/0000-0003-1975-266X; Fenton, Anthony/0000-0003-2665-6924	Jabbs Foundation	Jabbs Foundation	The Jabbs Foundation provided funding towards the RIISC study. The Jabbs Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Binding Site, Birmingham, provided support in the form of salaries for author SJH and the measurement of urinary and serum free light chains for the cohort. SJH played a role in study conceptualization and revision of the draft, but did not receive fees, bonuses, or other benefits for the work described in the manuscript. The Binding Site did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Brothwell S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-218; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Hanaoka M, 2013, RHEUMATOLOGY, V52, P2149, DOI 10.1093/rheumatology/ket108; Hassan SB, 2011, J CLIN LAB ANAL, V25, P229, DOI 10.1002/jcla.20463; Haynes R, 2011, CLIN J AM SOC NEPHRO, V6, P2829, DOI 10.2215/CJN.03350411; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hutchison CA, 2008, CLIN J AM SOC NEPHRO, V3, P1684, DOI 10.2215/CJN.02290508; Hutchison CA, 2008, EXPERT OPIN THER TAR, V12, P667, DOI [10.1517/14728222.12.6.667, 10.1517/14728222.12.6.667 ]; Hutchison CA, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-11; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; MAACK T, 1979, KIDNEY INT, V16, P251, DOI 10.1038/ki.1979.128; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Ritchie J, 2015, CLIN J AM SOC NEPHRO, V10, P740, DOI 10.2215/CJN.09660914; Rocchetti MT, 2013, CLIN J AM SOC NEPHRO, V8, P1115, DOI 10.2215/CJN.05950612; SOLOMON A, 1985, METHOD ENZYMOL, V116, P101; Stringer S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-95; Tangri N, 2016, JAMA-J AM MED ASSOC, V315, P164, DOI 10.1001/jama.2015.18202; Tangri N, 2013, ANN INTERN MED, V158, P596, DOI 10.7326/0003-4819-158-8-201304160-00004; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Turin TC, 2012, J AM SOC NEPHROL, V23, P1569, DOI 10.1681/ASN.2012020164; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; WALDMANN TA, 1972, J CLIN INVEST, V51, P2162, DOI 10.1172/JCI107023; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499	29	5	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0197043	10.1371/journal.pone.0197043	http://dx.doi.org/10.1371/journal.pone.0197043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742142	Green Published, gold, Green Submitted			2022-12-26	WOS:000431757400056
J	Kordbacheh, F; Carruthers, TJ; Bezos, A; Oakes, M; Du Fall, L; Hocart, CH; Parish, CR; Djordjevic, MA				Kordbacheh, Farzaneh; Carruthers, Thomas J.; Bezos, Anna; Oakes, Marie; Du Fall, Lauren; Hocart, Charles H.; Parish, Christopher R.; Djordjevic, Michael A.			Promotion of mammalian angiogenesis by neolignans derived from soybean extracellular fluids	PLOS ONE			English	Article							IN-VITRO ASSAYS; DRUG DISCOVERY; MASS-SPECTROMETRY; LIGNIN BIOSYNTHESIS; ANTITUMOR AGENTS; NATURAL-PRODUCTS; ISCHEMIC-STROKE; GROWTH-FACTOR; TUMOR-GROWTH; THERAPY	Excessive or insufficient angiogenesis is associated with major classes of chronic disease. Although less studied, small molecules which can promote angiogenesis are being sought as potential therapeutics for cardiovascular and peripheral arterial disease and stroke. Here we describe a bioassay-directed discovery approach utilising size exclusion and liquid chromatography to purify components of soybean xylem sap that have pro-angiogenic activity. Using high resolution accurate mass spectrometry and nuclear magnetic resonance spectroscopy, the structure of two pro-angiogenic molecules (FK1 and FK2) were identified as erythro-guaiacylglycerol-8-O-4'-(coniferyl alcohol) ether (eGGCE), and threo-guaiacylglycerol-8-O-4'-(coniferyl alcohol) ether (tGGCE). These two molecules, which are coniferyl neolignan stereoisomers, promoted in vitro angiogenesis in the mu M to nM range. Independently sourced samples of eGGCE and tGGCE exhibited comparable pro-angiogenic activity to the soybean derived molecules. The cellular mode of action of these molecules was investigated by studying their effect on endothelial cell proliferation, migration, tube formation and adhesion to the extracellular matrix (ECM) components, fibronectin and vitronectin. They were found to enhance endothelial cell proliferation and endothelial cell tube formation on Matrigel, but did not affect endothelial cell migration or adhesion to fibronectin and vitronectin. Thus, this study has identified two coniferyl neolignan stereoisomers, eGGCE and tGGCE, as pro-angiogenic molecules, with eGGCE being less active than tGGCE.	[Kordbacheh, Farzaneh; Oakes, Marie; Du Fall, Lauren; Hocart, Charles H.; Djordjevic, Michael A.] Australian Natl Univ, Res Sch Biol, Dept Plant Sci, Canberra, ACT, Australia; [Kordbacheh, Farzaneh; Bezos, Anna; Parish, Christopher R.] Australian Natl Univ, John Curtin Sch Med Res, ACRF Dept Canc Biol & Therapeut, Canberra, ACT, Australia; [Carruthers, Thomas J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia	Australian National University; Australian National University; John Curtin School of Medical Research; Australian National University	Kordbacheh, F (corresponding author), Australian Natl Univ, Res Sch Biol, Dept Plant Sci, Canberra, ACT, Australia.; Kordbacheh, F (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, ACRF Dept Canc Biol & Therapeut, Canberra, ACT, Australia.	farzaneh.kordbacheh@anu.edu.au	Hocart, Charles H/F-2630-2011; Djordjevic, Michael/C-9945-2009	Hocart, Charles H/0000-0002-6167-2295; Parish, Christopher/0000-0001-7740-0430; Kordbacheh, Farzaneh/0000-0003-2208-1414; Djordjevic, Michael/0000-0002-9819-1372	ARC [DP1096299]; ARC Centre of Excellence [CEO348212]; NHMRC Program [455395]	ARC(Australian Research Council); ARC Centre of Excellence(Australian Research Council); NHMRC Program(National Health and Medical Research Council (NHMRC) of Australia)	MAD and CRP received research funding for this project, i.e., ARC Discovery Grant DP1096299 Dr MA Djordjevic; Prof LN Mander; Prof CR Parish "New functions for bioactive flavonoids in plants and mammals"; ARC Centre of Excellence Grant (CEO348212) and NHMRC Program Grant 455395 M. Berndt, C. Chesterman, B. Chong, P. Hogg, L. Khachigian, C. Parish and R. Stocker. Program entitled: "Vascular Biology". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhusban A, 2015, J HYPERTENS, V33, P170, DOI 10.1097/HJH.0000000000000364; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Baumgartner L, 2011, J NAT PROD, V74, P1779, DOI 10.1021/np200343t; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; BROWN KJ, 1995, EXP CELL RES, V217, P132, DOI 10.1006/excr.1995.1072; Brown KJ, 1996, LAB INVEST, V75, P539; Buckler JN, 2017, ACS OMEGA, V2, P7375, DOI 10.1021/acsomega.7b01459; Butler MS, 2004, J NAT PROD, V67, P2141, DOI 10.1021/np040106y; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Costa F, 2009, LIFE SCI, V84, P785, DOI 10.1016/j.lfs.2009.03.002; Dembinska-Kiec A, 2004, EUR HEART J, V25, P471; Deshane J, 2007, J EXP MED, V204, P605, DOI 10.1084/jem.20061609; Djordjevic MA, 2007, J PROTEOME RES, V6, P3771, DOI 10.1021/pr0606833; Djordjevic MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112635; Folkman J, 2000, CLIN CANCER RES, V6; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Font MA, 2010, CURR CARDIOL REV, V6, P238, DOI 10.2174/157340310791658802; Goodwin AM, 2007, MICROVASC RES, V74, P172, DOI 10.1016/j.mvr.2007.05.006; Gupta R, 2009, CIRC RES, V105, P724, DOI 10.1161/CIRCRESAHA.109.200386; Hallund J, 2008, NUTR METAB CARDIOVAS, V18, P497, DOI 10.1016/j.numecd.2007.05.007; Herridge DF, 1997, CARBON NITROGEN NUTR; Hodges TW, 2004, J NAT PROD, V67, P767, DOI 10.1021/np030514m; Kancheva VD, 2012, BIOCHIMIE, V94, P403, DOI 10.1016/j.biochi.2011.08.008; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Li QY, 2006, CURR MED CHEM, V13, P2021, DOI 10.2174/092986706777585004; Lin CM, 2010, J NUTR BIOCHEM, V21, P627, DOI 10.1016/j.jnutbio.2009.04.001; Liu CJ, 2009, J HEPATOL, V50, P958, DOI 10.1016/j.jhep.2008.12.023; Lourith N, 2005, J WOOD SCI, V51, P370, DOI 10.1007/s10086-004-0660-0; Mac Gabhann F, 2010, WIRES SYST BIOL MED, V2, P694, DOI 10.1002/wsbm.92; Morimoto N, 2008, J SURG RES, V145, P199, DOI 10.1016/j.jss.2007.05.031; Morreel K, 2010, ANAL CHEM, V82, P8095, DOI 10.1021/ac100968g; Morreel K, 2010, PLANT PHYSIOL, V153, P1464, DOI 10.1104/pp.110.156489; Mousa S, 2006, J CELL BIOCHEM, V97, P1370, DOI 10.1002/jcb.20741; Newman DJ, 2011, ABSTR PAP AM CHEM S, V241; NICOSIA RF, 1990, LAB INVEST, V63, P115; ONEILL HC, 1983, J IMMUNOL METHODS, V64, P257, DOI 10.1016/0022-1759(83)90433-7; Pandya NM, 2006, VASC PHARMACOL, V44, P265, DOI 10.1016/j.vph.2006.01.005; Parish CR, 1999, CANCER RES, V59, P3433; Patel N, 2018, MOL CELL PROTEOMICS, V17, P160, DOI [10.1074/mcp.RA117.000168, 10.1074/mcp.ra117.000168]; Pezzuto JM, 1997, BIOCHEM PHARMACOL, V53, P121, DOI 10.1016/S0006-2952(96)00654-5; Qu HY, 2005, J NUTR, V135, P598, DOI 10.1093/jn/135.3.598; Ribatti D, 1999, BLOOD, V93, P2627, DOI 10.1182/blood.V93.8.2627.408k21_2627_2636; SCHAFER AI, 1995, J CLIN PHARMACOL, V35, P209, DOI 10.1002/j.1552-4604.1995.tb04050.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silvestre JS, 2012, THROMB RES, V130, pS90, DOI 10.1016/j.thromres.2012.08.287; Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Tu Y, 2010, J NAT PROD, V73, P751, DOI 10.1021/np9007359; Vessecchi R, 2007, MINI-REV ORG CHEM, V4, P75, DOI 10.2174/157019307779815910; Wang JN, 2011, ARTERIOSCL THROM VAS, V31, pE19, DOI 10.1161/ATVBAHA.111.230706; Wang ZW, 2015, SEMIN CANCER BIOL, V35, pS224, DOI 10.1016/j.semcancer.2015.01.001; WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; WHETTEN R, 1995, PLANT CELL, V7, P1001, DOI 10.2307/3870053; Zhou YJ, 2009, CLIN CANCER RES, V15, P5161, DOI 10.1158/1078-0432.CCR-09-0661	57	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196843	10.1371/journal.pone.0196843	http://dx.doi.org/10.1371/journal.pone.0196843			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738532	Green Submitted, Green Published, gold			2022-12-26	WOS:000431724900023
J	Sirois, AR; Deny, DA; Baierl, SR; George, KS; Moore, SJ				Sirois, Allison R.; Deny, Daniela A.; Baierl, Samantha R.; George, Katia S.; Moore, Sarah J.			Fn3 proteins engineered to recognize tumor biomarker mesothelin internalize upon binding	PLOS ONE			English	Article							YEAST SURFACE DISPLAY; GROWTH-FACTOR RECEPTOR; HUMAN MONOCLONAL-ANTIBODY; CYSTINE KNOT PEPTIDES; HIGH-AFFINITY; BREAST-CANCER; DIRECTED EVOLUTION; LUNG ADENOCARCINOMA; FIBRONECTIN DOMAIN; AFFIBODY MOLECULES	Mesothelin is a cell surface protein that is overexpressed in numerous cancers, including breast, ovarian, lung, liver, and pancreatic tumors. Aberrant expression of mesothelin has been shown to promote tumor progression and metastasis through interaction with established tumor biomarker CA125. Therefore, molecules that specifically bind to mesothelin have potential therapeutic and diagnostic applications. However, no mesothelin-targeting molecules are currently approved for routine clinical use. While antibodies that target mesothelin are in development, some clinical applications may require a targeting molecule with an alternative protein fold. For example, non-antibody proteins are more suitable for molecular imaging and may facilitate diverse chemical conjugation strategies to create drug delivery complexes. In this work, we engineered variants of the fibronectin type III domain (Fn3) non-antibody protein scaffold to bind to mesothelin with high affinity, using directed evolution and yeast surface display. Lead engineered Fn3 variants were solubly produced and purified from bacterial culture at high yield. Upon specific binding to mesothelin on human cancer cell lines, the engineered Fn3 proteins internalized and co-localized to early endosomes. To our knowledge, this is the first report of non-antibody proteins engineered to bind mesothelin. The results validate that non-antibody proteins can be engineered to bind to tumor biomarker mesothelin, and encourage the continued development of engineered variants for applications such as targeted diagnostics and therapeutics.	[Sirois, Allison R.; Moore, Sarah J.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Sirois, Allison R.; Baierl, Samantha R.; Moore, Sarah J.] Smith Coll, Picker Engn Program, Northampton, MA 01063 USA; [Deny, Daniela A.; George, Katia S.] Smith Coll, Dept Biochem, Northampton, MA 01063 USA; [Moore, Sarah J.] Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA	University of Massachusetts System; University of Massachusetts Amherst; Smith College; Smith College; Smith College	Moore, SJ (corresponding author), Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA.; Moore, SJ (corresponding author), Smith Coll, Picker Engn Program, Northampton, MA 01063 USA.; Moore, SJ (corresponding author), Smith Coll, Dept Biol Sci, Northampton, MA 01063 USA.	sjmoore@smith.edu		Moore, Sarah/0000-0002-2633-4020	National Institutes of Health, National Cancer Institute [R15CA198927-01]; Smith College Wilens Teaching Fellowship; Schultz Foundation Research Fellowship; Schultz Foundation Undergraduate Research Fellowship; NATIONAL CANCER INSTITUTE [R15CA198927] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Smith College Wilens Teaching Fellowship; Schultz Foundation Research Fellowship; Schultz Foundation Undergraduate Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Institutes of Health, National Cancer Institute (www.cancer.gov) grant R15CA198927-01 to S.J. M.A.R.S. was supported by a Smith College Wilens Teaching Fellowship and by a Schultz Foundation Research Fellowship. K.S.G. received a Schultz Foundation Undergraduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elkacem L, 2016, THERANOSTICS, V6, P1740, DOI 10.7150/thno.15169; Abramson R., 2017, OVERVIEW TARGETED TH; Ackerman M, 2009, BIOTECHNOL PROGR, V25, P774, DOI 10.1002/btpr.174; Argani P, 2001, CLIN CANCER RES, V7, P3862; Arruebo Manuel, 2011, Cancers (Basel), V3, P3279, DOI 10.3390/cancers3033279; Berger GK, 2017, CRIT REV ONCOL HEMAT, V109, P42, DOI 10.1016/j.critrevonc.2016.11.009; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Bloom L, 2009, DRUG DISCOV TODAY, V14, P949, DOI 10.1016/j.drudis.2009.06.007; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; CHANG K, 1992, INT J CANCER, V50, P373, DOI 10.1002/ijc.2910500308; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Chao G, 2004, J MOL BIOL, V342, P539, DOI 10.1016/j.jmb.2004.07.053; Chen SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01870; Chen TF, 2013, METHOD ENZYMOL, V523, P303, DOI 10.1016/B978-0-12-394292-0.00014-X; Cherf GM, 2015, METHODS MOL BIOL, V1319, P155, DOI 10.1007/978-1-4939-2748-7_8; Colby DW, 2004, METHOD ENZYMOL, V388, P348; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; Feng Y, 2009, MOL CANCER THER, V8, P1113, DOI 10.1158/1535-7163.MCT-08-0945; Friedman M, 2009, BIOTECHNOL APPL BIOC, V53, P1, DOI 10.1042/BA20080287; Gera N, 2013, METHODS, V60, P15, DOI 10.1016/j.ymeth.2012.03.014; Getmanova EV, 2006, CHEM BIOL, V13, P549, DOI 10.1016/j.chembiol.2005.12.009; Glass JP, 2011, INT J SURG PATHOL, V19, P588, DOI 10.1177/1066896911409575; Gordon MR, 2015, BIOCONJUGATE CHEM, V26, P2198, DOI 10.1021/acs.bioconjchem.5b00399; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Hackel BJ, 2012, PROTEIN ENG DES SEL, V25, P639, DOI 10.1093/protein/gzs036; Hackel BJ, 2012, RADIOLOGY, V263, P179, DOI 10.1148/radiol.12111504; Hackel BJ, 2010, J MOL BIOL, V401, P84, DOI 10.1016/j.jmb.2010.06.004; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hausammann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060688; Ho M, 2005, CLIN CANCER RES, V11, P3814, DOI 10.1158/1078-0432.CCR-04-2304; Ho M, 2011, INT J CANCER, V128, P2020, DOI 10.1002/ijc.25557; Huang M, 2014, TRENDS PHARMACOL SCI, V35, P41, DOI 10.1016/j.tips.2013.11.004; Kachala SS, 2014, CLIN CANCER RES, V20, P1020, DOI 10.1158/1078-0432.CCR-13-1862; Kaneko O, 2009, J BIOL CHEM, V284, P3739, DOI 10.1074/jbc.M806776200; Kimura RH, 2012, CLIN CANCER RES, V18, P839, DOI 10.1158/1078-0432.CCR-11-1116; Kimura RH, 2009, PROTEINS, V77, P359, DOI 10.1002/prot.22441; Kimura RH, 2009, CANCER RES, V69, P2435, DOI 10.1158/0008-5472.CAN-08-2495; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Koide S, 2012, METHOD ENZYMOL, V503, P135, DOI 10.1016/B978-0-12-396962-0.00006-9; Kolmar H, 2011, CURR PHARM DESIGN, V17, P4329, DOI 10.2174/138161211798999465; Kruziki MA, 2016, MOL PHARMACEUT, V13, P3747, DOI 10.1021/acs.molpharmaceut.6b00538; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014; Lutz S, 2010, CURR OPIN BIOTECH, V21, P734, DOI 10.1016/j.copbio.2010.08.011; Mankoff DA, 2007, J NUCL MED, V48, p18N; Miao Z, 2011, AMINO ACIDS, V41, P1037, DOI 10.1007/s00726-010-0503-9; Moore SJ, 2013, P NATL ACAD SCI USA, V110, P14598, DOI 10.1073/pnas.1311333110; Moore SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060498; Natarajan A, 2013, CLIN CANCER RES, V19, P6820, DOI 10.1158/1078-0432.CCR-13-0626; Nord K, 1997, NAT BIOTECHNOL, V15, P772, DOI 10.1038/nbt0897-772; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; Park SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132976; Parker MH, 2005, PROTEIN ENG DES SEL, V18, P435, DOI 10.1093/protein/gzi050; Perez HL, 2014, DRUG DISCOV TODAY, V19, P869, DOI 10.1016/j.drudis.2013.11.004; Pham TN, 1998, NAT STRUCT BIOL, V5, P115, DOI 10.1038/nsb0298-115; Pirie CM, 2011, J BIOL CHEM, V286, P4165, DOI 10.1074/jbc.M110.186973; Rasool M, 2017, CURR PHARM DESIGN, V23, P1610, DOI 10.2174/1381612822666161208121829; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; SHEN DW, 1986, J BIOL CHEM, V261, P7762; Shimizu A, 2012, CANCER SCI, V103, P739, DOI 10.1111/j.1349-7006.2012.02214.x; Sievers EL, 2013, ANNU REV MED, V64, P15, DOI 10.1146/annurev-med-050311-201823; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Stern LA, 2017, ACS COMB SCI, V19, P315, DOI 10.1021/acscombsci.6b00191; Stern LA, 2016, BIOTECHNOL BIOENG, V113, P2328, DOI 10.1002/bit.26001; Stern LA, 2013, CURR OPIN CHEM ENG, V2, P425, DOI 10.1016/j.coche.2013.08.009; Tang ZW, 2013, MOL CANCER THER, V12, P416, DOI 10.1158/1535-7163.MCT-12-0731; Tchou J, 2012, BREAST CANCER RES TR, V133, P799, DOI 10.1007/s10549-012-2018-4; Thomas A, 2015, ONCOTARGET, V6, P11694, DOI 10.18632/oncotarget.3429; Tolmachev V, 2009, J NUCL MED, V50, P274, DOI 10.2967/jnumed.108.055525; Traxlmayr MW, 2017, METHODS MOL BIOL, V1575, P45, DOI 10.1007/978-1-4939-6857-2_4; Uehara N, 2008, MOL CANCER RES, V6, P186, DOI 10.1158/1541-7786.MCR-07-0254; Vazquez-Lombardi R, 2015, DRUG DISCOV TODAY, V20, P1271, DOI 10.1016/j.drudis.2015.09.004; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Wang XX, 2005, J IMMUNOL METHODS, V304, P30, DOI 10.1016/j.jim.2005.05.006; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793; Woldring DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138956; Wu AM, 2014, METHODS, V65, P139, DOI 10.1016/j.ymeth.2013.09.015; Xu LH, 2002, CHEM BIOL, V9, P933, DOI 10.1016/S1074-5521(02)00187-4; Yu LP, 2010, J CANCER, V1, P141; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724; Zhang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep25424; Zhang YJ, 2007, P NATL ACAD SCI USA, V104, P17099, DOI 10.1073/pnas.0708101104; Zhang YJ, 2012, ONCOTARGET, V3, P114; Zhao Xiao-Yan, 2016, Clin Cancer Drugs, V3, P76; Zieba A, 2012, NEW BIOTECHNOL, V29, P634, DOI 10.1016/j.nbt.2012.05.004	90	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0197029	10.1371/journal.pone.0197029	http://dx.doi.org/10.1371/journal.pone.0197029			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738555	Green Published, gold, Green Submitted			2022-12-26	WOS:000431724900043
J	Wang, ZX; Ng, KS; Chen, TH; Kim, TB; Wang, F; Shaw, K; Scott, KL; Meric-Bernstam, F; Mills, GB; Chen, K				Wang, Zixing; Ng, Kwok-Shing; Chen, Tenghui; Kim, Tae-Beom; Wang, Fang; Shaw, Kenna; Scott, Kenneth L.; Meric-Bernstam, Funda; Mills, Gordon B.; Chen, Ken			Cancer driver mutation prediction through Bayesian integration of multi-omic data	PLOS ONE			English	Article							SOMATIC MUTATIONS; VARIANTS; REVEALS; SIFT	Identification of cancer driver mutations is critical for advancing cancer research and personalized medicine. Due to inter-tumor genetic heterogeneity, many driver mutations occur at low frequencies, which make it challenging to distinguish them from passenger mutations. Here, we show that a novel Bayesian hierarchical modeling approach, named rDriver can achieve enhanced prediction accuracy by identifying mutations that not only have high functional impact scores but also are associated with systemic variation in gene expression levels. In examining 3,080 tumor samples from 8 cancer types in The Cancer Genome Atlas, rDriver predicted 1,389 driver mutations. Compared with existing tools, rDriver identified more low frequency mutations associated with lineage specific functional properties, timing of occurrence and patient survival. Evaluation of rDriver predictions using engineered cell-line models resulted in a positive predictive value of 0.94 in PIK3CA genes. Our study highlights the importance of integrating multi-omic data in predicting cancer driver mutations and provides a statistically rigorous solution for cancer target discovery and development.	[Wang, Zixing; Chen, Tenghui; Kim, Tae-Beom; Wang, Fang; Chen, Ken] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Wang, Zixing; Ng, Kwok-Shing; Shaw, Kenna; Meric-Bernstam, Funda; Mills, Gordon B.; Chen, Ken] Univ Texas MD Anderson Canc Ctr, Inst Personalized Canc Therapy, Houston, TX 77030 USA; [Scott, Kenneth L.] Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; [Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapy, Houston, TX 77030 USA; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Chen, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.; Chen, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Inst Personalized Canc Therapy, Houston, TX 77030 USA.	kchen3@mdanderson.org	Chen, Ken/AAU-1432-2021	Chen, Ken/0000-0003-4013-5279; Mills, Gordon/0000-0002-0144-9614	NIH [R01 CA172652, U01 CA217842, UL1 TR000371]; MD Anderson Cancer Center Sheikh Khalifa Ben Zayed Al Nahyan Institute of Personalized Cancer Therapy grant [U54 CM 12970]; Andrew Sabin Family Foundation; Bosarge Family Foundation; Mary K. Chapman Foundation; Michael & Susan Dell Foundation; NCI Cancer Center Support Grant [P30 CA016672]; NATIONAL CANCER INSTITUTE [U01CA217842, R01CA172652, P30CA016672] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Center Sheikh Khalifa Ben Zayed Al Nahyan Institute of Personalized Cancer Therapy grant; Andrew Sabin Family Foundation; Bosarge Family Foundation; Mary K. Chapman Foundation; Michael & Susan Dell Foundation; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the NIH [R01 CA172652, U01 CA217842, UL1 TR000371], the MD Anderson Cancer Center Sheikh Khalifa Ben Zayed Al Nahyan Institute of Personalized Cancer Therapy grant [U54 CM 12970], the Andrew Sabin Family Foundation, the Bosarge Family Foundation, the Mary K. Chapman Foundation, the Michael & Susan Dell Foundation (honoring Lorraine Dell), and the NCI Cancer Center Support Grant [P30 CA016672]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bashashati A, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r124; Berger AH, 2016, CANCER CELL, V30, P214, DOI 10.1016/j.ccell.2016.06.022; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Chen TH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2727-x; Combs SE, 2011, RADIAT ONCOL, V6, P1; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Darman RB, 2015, CELL REP, V13, P1033, DOI 10.1016/j.celrep.2015.09.053; Das A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9555; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Ding JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9554; Dogruluk T, 2015, CANCER RES, V75, P5341, DOI 10.1158/0008-5472.CAN-15-1654; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Gerstung M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6901; Gonzalez-Perez A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks743; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horn H, 2015, BIORXIV; Khurana E, 2016, NAT REV GENET, V17, P93, DOI 10.1038/nrg.2015.17; Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Logsdon BA, 2015, NUCLEIC ACIDS RES; Mao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077945; Martelotto LG, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0484-1; Masica DL, 2011, CANCER RES, V71, P4550, DOI 10.1158/0008-5472.CAN-11-0180; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Rausell A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003757; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rivas MA, 2015, SCIENCE, V348, P666, DOI 10.1126/science.1261877; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Takiar V, 2017, ONCOGENE, V36, P1607, DOI 10.1038/onc.2016.312; Tibshirani R., 1996, J ROYAL STAT SOC B, P22; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LL, 2016, CANCER CELL, V30, P750, DOI 10.1016/j.ccell.2016.10.005	44	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196939	10.1371/journal.pone.0196939	http://dx.doi.org/10.1371/journal.pone.0196939			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738578	gold, Green Published			2022-12-26	WOS:000431724900030
J	Yoshida, T; Ri, M; Kinoshita, S; Narita, T; Totani, H; Ashour, R; Ito, A; Kusumoto, S; Ishida, T; Komatsu, H; Iida, S				Yoshida, Takashi; Ri, Masaki; Kinoshita, Shiori; Narita, Tomoko; Totani, Haruhito; Ashour, Reham; Ito, Asahi; Kusumoto, Shigeru; Ishida, Takashi; Komatsu, Hirokazu; Iida, Shinsuke			Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma	PLOS ONE			English	Article							MEDIATED DRUG-RESISTANCE; MARKER; NCAM; INHIBITOR; OVEREXPRESSION; TRANSLOCATION; CHEMOTHERAPY; SENSITIVITY; INDUCTION; APOPTOSIS	Bortezomib (Btz) is an active agent used to treat multiple myeloma (MM). Not all patients who receive Btz-containing therapy show a favorable response. Interaction of cellular adhesion molecules with MM and bone marrow stromal cells is crucial for the survival of MM cells. However, little is known about the role of these molecules in the sensitivity of MM to Btz-containing therapy. Thus, we evaluated the correlation between the level of cellular adhesion molecules in MM cells and the efficacy of Btz plus dexamethasone (Bd) therapy. The expression of the neural cell adhesion molecule gene (NCAM, also known as CD56), ITGA4, CXCR4, and other genes were analyzed in 74 samples of primary MM cells collected from patients before they received Bd therapy. Of the eight genes tested, expression of NCAM was lower among patients who responded poorly to Bd therapy. In vitro expression of NCAM induced by transfection of MM cells enhanced their sensitivity to Btz treatment by causing accumulation of polyubiquitinated proteins. Our results indicate that expression of NCAM is associated with better response to Btz treatment and is a promising candidate biomarker for predicting response to therapies involving Btz.	[Yoshida, Takashi; Ri, Masaki; Kinoshita, Shiori; Narita, Tomoko; Totani, Haruhito; Ashour, Reham; Ito, Asahi; Kusumoto, Shigeru; Ishida, Takashi; Komatsu, Hirokazu; Iida, Shinsuke] Nagoya City Univ, Grad Sch Med Sci, Dept Hematol & Oncol, Nagoya, Aichi, Japan		Ri, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Hematol & Oncol, Nagoya, Aichi, Japan.	rrmasaki@ybb.ne.jp	石田, 高司/GRS-3184-2022	石田, 高司/0000-0002-1060-0777; Yoshida, Takashi/0000-0002-1516-9613	Ministry of Education, Culture, Sports, Science and Technology [16K07179, 16K09855]; National Cancer Center Research and Development Fund [26-A-4]; Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED [15ck0106077h0002]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by Grant-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (M.R: 16K07179, S.I: 16K09855); National Cancer Center Research and Development Fund (S.I.: 26-A-4); and Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED (S.I.: 15ck0106077h0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Chiori Fukuyama for her skillful technical assistance. This study was partly supported by a Grant-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (16K07179 & 16K09855), National Cancer Center Research and Development Fund (26-A-4), and by the Practical Research for Innovative Cancer Control project from Japan Agency for Medical Research and Development, AMED (15ck0106077h0002).	Azab AK, 2012, BLOOD, V119, P5782, DOI 10.1182/blood-2011-09-380410; Bataille R, 2006, HAEMATOLOGICA, V91, P1234; Chang H, 2006, LEUKEMIA LYMPHOMA, V47, P43, DOI 10.1080/10428190500272549; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Durie BGM, 2017, LANCET, V389, P519, DOI 10.1016/S0140-6736(16)31594-X; Francavilla C, 2009, J CELL BIOL, V187, P1101, DOI 10.1083/jcb.200903030; Gambella M, 2014, HAEMATOLOGICA, V99, pE14, DOI 10.3324/haematol.2013.090142; Hundemer M, 2007, BONE MARROW TRANSPL, V40, P1033, DOI 10.1038/sj.bmt.1705857; Inagaki A, 2013, LEUKEMIA RES, V37, P1648, DOI 10.1016/j.leukres.2013.09.026; Jagannath S, 2006, HAEMATOL-HEMATOL J, V91, P929; Kaiser U, 1996, ANN HEMATOL, V73, P121, DOI 10.1007/s002770050212; Kaiser U, 1996, LEUKEMIA LYMPHOMA, V20, P389, DOI 10.3109/10428199609052420; Kremer M, 2005, J PATHOL, V205, P92, DOI 10.1002/path.1680; Kuhn DJ, 2012, BLOOD, V120, P3260, DOI 10.1182/blood-2011-10-386789; Leiba M, 2014, BRIT J HAEMATOL, V166, P702, DOI 10.1111/bjh.12946; Ling SCW, 2012, HAEMATOL-HEMATOL J, V97, P64, DOI 10.3324/haematol.2011.043331; Mateos MV, 2010, J CLIN ONCOL, V28, P2259, DOI 10.1200/JCO.2009.26.0638; Mitsiades N, 2003, BLOOD, V101, P2377, DOI 10.1182/blood-2002-06-1768; Miyazaki K.S., 2015, INT J MYELOM, V5, P30; Mizuno S, 2015, INT J HEMATOL, V102, P569, DOI 10.1007/s12185-015-1859-0; Narita T, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.98; Narita T, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.6; Noborio-Hatano K, 2009, ONCOGENE, V28, P231, DOI 10.1038/onc.2008.385; Paiva B, 2015, BLOOD, V125, P3059, DOI 10.1182/blood-2014-11-568907; Pan Y, 2016, LEUKEMIA RES, V40, P77, DOI 10.1016/j.leukres.2015.11.003; Pellat-Deceunynck C, 1998, LEUKEMIA, V12, P1977, DOI 10.1038/sj.leu.2401211; Rawstron AC, 2008, HAEMATOLOGICA, V93, P431, DOI 10.3324/haematol.11080; Ri M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.26; Ri M, 2010, LEUKEMIA, V24, P1506, DOI 10.1038/leu.2010.137; Ri M, 2009, CANCER SCI, V100, P341, DOI 10.1111/j.1349-7006.2008.01038.x; Sahara N, 2004, LEUKEMIA LYMPHOMA, V45, P61, DOI 10.1080/1042819031000149377; Sahara N, 2002, BRIT J HAEMATOL, V117, P882, DOI 10.1046/j.1365-2141.2002.03513.x; Sonneveld P, 2012, J CLIN ONCOL, V30, P2946, DOI 10.1200/JCO.2011.39.6820; Yano H, 2008, CANCER SCI, V99, P2309, DOI 10.1111/j.1349-7006.2008.00936.x; Yin L, 2014, BLOOD, V123, P2997, DOI 10.1182/blood-2013-11-539395	35	13	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196780	10.1371/journal.pone.0196780	http://dx.doi.org/10.1371/journal.pone.0196780			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738534	Green Published, Green Submitted, gold			2022-12-26	WOS:000431724900019
J	Chaloupkova, H; Svobodova, I; Vapenik, P; Bartos, L				Chaloupkova, Helena; Svobodova, Ivona; Vapenik, Pavel; Bartos, Ludek			Increased resistance to sudden noise by audio stimulation during early ontogeny in German shepherd puppies	PLOS ONE			English	Article							BEHAVIOR	The period of early ontogeny constitutes a time when the physical immaturity of an organism is highly susceptible to external stimuli. Thus, early development plays a major role in shaping later adult behavior. The aim of the study was to check whether stimulating puppies at this early stage in life with sound would improve their responsiveness towards unfamiliar noises during the selection process of the police behavioral test for puppies. The cohort comprised 37 puppies from the litters of three mothers. At the commencement of the experiment the dogs were aged 16 days, rising to the age of 32 days at its close. The mothers and litters of the treatment group were either exposed to radio broadcasts, (see below; three litters totaling 19 puppies), while the control group was not exposed to any radio programs (eight litters totaling 18 puppies). All three mothers had previously experienced both auditory circumstances, as described herein. Ordinary radio broadcasts were played to the puppies in the treatment group three times a day for 20 minute periods, always during feeding time. The cohort was subjected to the so-called Puppy Test, i.e. analysis of the potential of each animal, once the dogs had reached the age of 7 weeks. Such tests included exposure to a sudden noise caused by a shovel (100 dB), noise when alone in a room, and response to loud distracting stimuli (the latter two at 70 dB). Said tasks were rated by the same analyst on a scale of 0-5 points; the better the response of the dog, the higher the score given. The differences between the treatment and control groups were analyzed via Mixed Models (PROC MIXED) in SAS. The animals comprising the treatment group responded with a higher score to the sudden noise caused by the shovel than the control dogs (P<0.01). Interestingly, gender was seen to affect response, with the males scoring more than the females (P<0.1). In conclusion, the results suggested that audio stimulation early in life improved the response of the dogs to intense sudden noise, as caused by the shovel. Therefore, acoustic stimulation during the very early period of life has the potential to raise the necessary skills of dogs for military and police purposes, or civilian life.	[Chaloupkova, Helena; Svobodova, Ivona; Vapenik, Pavel; Bartos, Ludek] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Anim Sci & Ethol, Prague, Czech Republic; [Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science	Chaloupkova, H (corresponding author), Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Anim Sci & Ethol, Prague, Czech Republic.	chaloupkovah@af.czu.cz	Chaloupková, Helena/A-7683-2019; Svobodova, Ivona/U-7957-2018	Chaloupková, Helena/0000-0003-4894-0600; Svobodova, Ivona/0000-0003-3303-981X	Ministerstvo vnitra Ceske Republiky [VI20172020088]	Ministerstvo vnitra Ceske Republiky	This work was supported by Ministerstvo vnitra Ceske Republiky - VI20172020088, http://www.mvcr.cz/ - HC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barnard S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01992-x; Battaglia CL, 2009, J VET BEHAV, V4, P203, DOI 10.1016/j.jveb.2009.03.003; Blackwell EJ, 2013, APPL ANIM BEHAV SCI, V145, P15, DOI 10.1016/j.applanim.2012.12.004; Braastad Bjarne O., 2002, P173, DOI 10.1079/9780851996028.0173; Chaloupkova H, 2007, J ANIM SCI, V85, P1741, DOI 10.2527/jas.2006-504; Chapillon P, 2002, DEV PSYCHOBIOL, V41, P373, DOI 10.1002/dev.10066; FOX MW, 1964, ANIM BEHAV, V12, P301, DOI 10.1016/0003-3472(64)90016-8; FOX MW, 1966, ANIM BEHAV, V14, P273, DOI 10.1016/S0003-3472(66)80083-0; FREEDMAN DG, 1961, SCIENCE, V133, P1016, DOI 10.1126/science.133.3457.1016; Gazzano A, 2008, APPL ANIM BEHAV SCI, V110, P294, DOI 10.1016/j.applanim.2007.05.007; Lay DC, 2000, BIOLOGY OF ANIMAL STRESS, P249, DOI 10.1079/9780851993591.0249; LEVINE S, 1956, J PERS, V24, P475, DOI 10.1111/j.1467-6494.1956.tb01283.x; Littell RC, 2000, STAT MED, V19, P1793, DOI 10.1002/1097-0258(20000715)19:13<1793::AID-SIM482>3.3.CO;2-H; Lord K, 2013, ETHOLOGY, V119, P110, DOI 10.1111/eth.12044; Meerlo P, 1999, J NEUROENDOCRINOL, V11, P925; Overall K. L., 1997, CLIN BEHAV MED SMALL; Pluijmakers JJTM, 2010, APPL ANIM BEHAV SCI, V126, P51, DOI 10.1016/j.applanim.2010.05.006; Roy V, 2002, BEHAV BRAIN RES, V136, P67, DOI 10.1016/S0166-4328(02)00095-5; Schoon A, 2011, J VET BEHAV, V6, P150, DOI 10.1016/j.jveb.2010.09.017; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Serpell James, 1995, P79; Svobodova I, 2008, APPL ANIM BEHAV SCI, V113, P139, DOI 10.1016/j.applanim.2007.09.010; Svobodova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090820; Wilsson E, 1998, APPL ANIM BEHAV SCI, V58, P151, DOI 10.1016/S0168-1591(97)00093-2; Wilsson E, 1998, APPL ANIM BEHAV SCI, V56, P245, DOI 10.1016/S0168-1591(97)00094-4	26	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196553	10.1371/journal.pone.0196553	http://dx.doi.org/10.1371/journal.pone.0196553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723300	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100038
J	Choi, JY; Jang, JH; Lim, YS; Jang, JY; Lee, G; Yang, HJ; Cho, JS; Hyun, SY				Choi, Jea Yeon; Jang, Jae Ho; Lim, Yong Su; Jang, Jee Yong; Lee, Gun; Yang, Hyuk Jun; Cho, Jin Seong; Hyun, Sung Youl			Performance on the APACHE II, SAPS II, SOFA and the OHCA score of post-cardiac arrest patients treated with therapeutic hypothermia	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; INTERNATIONAL LIAISON COMMITTEE; AMERICAN-HEART-ASSOCIATION; RANDOMIZED CLINICAL-TRIAL; HOSPITAL MORTALITY; ACUTE PHYSIOLOGY; SURVIVAL; RESUSCITATION; SEVERITY; CARDIOPULMONARY	Objective This study assessed the ability of the Acute Physiologic and Chronic Health Evaluation (APACHE) II score, Simplified Acute Physiology Score (SAPS) II, Sequential Organ Failure Assessment (SOFA) score, and out-of-hospital cardiac arrest (OHCA) score to predict the outcome of OHCA patients who underwent therapeutic hypothermia (TH). Methods This study included OHCA patients treated with TH between January 2010 and December 2013. The APACHE II score, SAPS II, and SOFA score were calculated at the time of admission and 24 h and 48 h after intensive care unit admission. The OHCA score was calculated at the time of admission. The area under the curve (AUC) of the receiver operating characteristic curve and logistic regression analysis were used to evaluate outcome predictability. Results Data from a total of 173 patients were included in the analysis. The APACHE II score at 0 h and 48 h, SAPS II at 48 h, and OHCA score had moderate discrimination for mortality (AUC: 0.715, 0.750, 0.720, 0.740). For neurologic outcomes, the APACHE II score at 0 h and 48 h, SAPS II at 0 h and 48 h, and OHCA score showed moderate discrimination (AUC: 0.752, 0.738, 0.771, 0.771, 0.764). The APACHE II score, SAPS II and SOFA score at various time points, in addition to the OHCA score, were independent predictors of mortality and a poor neurologic outcome. Conclusions The APACHE II score, SAPS II, SOFA score, and OHCA score have different capabilities in discriminating and estimating hospital mortality and neurologic outcomes. The OHCA score, APACHE II score and SAPS II at time zero and 48 h offer moderate predictive accuracy. Other scores at 0 h and 48 h, except for the SOFA score, are independently associated with 30-day mortality and poor cerebral performance.	[Choi, Jea Yeon; Jang, Jae Ho; Lim, Yong Su; Lee, Gun; Yang, Hyuk Jun; Cho, Jin Seong] Gachon Univ, Dept Emergency Med, Gil Med Ctr, Incheon, South Korea; [Jang, Jee Yong] Mokpo Hankook Hosp, Dept Emergency Med, Mokpo, Jeollanam Do, South Korea; [Hyun, Sung Youl] Gachon Univ, Dept Thorac & Cardiovasc Surg, Gil Med Ctr, Incheon, South Korea	Gachon University; Gachon University	Jang, JH (corresponding author), Gachon Univ, Dept Emergency Med, Gil Med Ctr, Incheon, South Korea.	giljhjang@gmail.com						Adrie C, 2006, EUR HEART J, V27, P2840, DOI 10.1093/eurheartj/ehl335; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bisbal M, 2014, RESUSCITATION, V85, P939, DOI 10.1016/j.resuscitation.2014.03.302; Coppler PJ, 2015, RESUSCITATION, V89, P86, DOI 10.1016/j.resuscitation.2015.01.020; Donnino MW, 2013, RESUSCITATION, V84, P651, DOI 10.1016/j.resuscitation.2012.10.024; Donnino MW, 2012, CIRCULATION, V126, P1478, DOI 10.1161/CIRCULATIONAHA.111.067256; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hunziker S, 2011, CRIT CARE MED, V39, P1670, DOI 10.1097/CCM.0b013e318218a05b; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; JENNETT B, 1975, LANCET, V1, P480; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; Kirkegaard H, 2017, JAMA-J AM MED ASSOC, V318, P341, DOI 10.1001/jama.2017.8978; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Livingston BM, 2000, CRIT CARE MED, V28, P389, DOI 10.1097/00003246-200002000-00017; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Oddo M, 2011, CURR OPIN CRIT CARE, V17, P254, DOI 10.1097/MCC.0b013e328344f2ae; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Roberts BW, 2013, CRIT CARE MED, V41, P1492, DOI 10.1097/CCM.0b013e31828a39e9; Salciccioli JD, 2012, MINERVA ANESTESIOL, V78, P1341; Skrifvars MB, 2012, RESUSCITATION, V83, P728, DOI 10.1016/j.resuscitation.2011.11.036; Sunde K, 2007, RESUSCITATION, V73, P29, DOI 10.1016/j.resuscitation.2006.08.016; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	28	25	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196197	10.1371/journal.pone.0196197	http://dx.doi.org/10.1371/journal.pone.0196197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723201	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100016
J	Hochman, S; Henik, A; Kalanthroff, E				Hochman, Shachar; Henik, Avishai; Kalanthroff, Eyal			Stopping at a red light: Recruitment of inhibitory control by environmental cues	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; RESPONSE-INHIBITION; SIGNAL; TASK; BEHAVIOR; MECHANISMS; ATTENTION; ALCOHOL; ABILITY	Environmental cues can influence basic perceptual and attentional processes especially in an emotional context. In the current study, we aimed to investigate the effect of a non-emotional common environmental cue-a traffic light-on a higher cognitive operation-inhibition. In two experiments, we administered a novel version of the stop-signal task, in which the go task was to determine the color of a traffic light. In order to investigate the influence of each of the cues on inhibitory processes, separate tracking procedures (one for each cue) were applied simultaneously to the stop-signal delay. In Experiment 1, we found that reaction time in no-stop-signal trials was faster when a green traffic light was present, whereas stop-signal reaction time was longer when a red traffic light was present. In Experiment 2, neutral control cues were used in addition to a red and green light. The results indicate that the differences between red and green stem from an association between the color red and stop processes (rather than from the green-go association). These results strengthen previous findings showing the effect of environmental cues on attentional processes and go beyond them by showing that the effect is not restricted to emotional cues. Most importantly, the current study results suggest that environmental cues can also influence complex cognitive operations such as inhibitory control. These results might have specific implications for our understanding of the processes that underlie specific psychiatric disorders characterized by inhibitory deficit.	[Hochman, Shachar; Henik, Avishai] Ben Gurion Univ Negev, Dept Psychol, Beer Sheva, Israel; [Henik, Avishai] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel; [Kalanthroff, Eyal] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel	Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem	Hochman, S (corresponding author), Ben Gurion Univ Negev, Dept Psychol, Beer Sheva, Israel.	shacharh@past.bgu.ac.il		Henik, Avishai/0000-0002-5665-6004	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC [295644]; Rothschild foundation; Molberger Scholar award; Israel Science Foundation [79/15]	European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); Rothschild foundation; Molberger Scholar award; Israel Science Foundation(Israel Science Foundation)	This work was supported by the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement 295644 to AH. Dr. Kalanthroff is supported by the Rothschild foundation, the Molberger Scholar award, and The Israel Science Foundation (grant No. 79/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allom V, 2016, HEALTH PSYCHOL REV, V10, P168, DOI 10.1080/17437199.2015.1051078; Chamberlain SR, 2006, AM J PSYCHIAT, V163, P1282, DOI 10.1176/appi.ajp.163.7.1282; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Claes Laurence, 2006, Eat Behav, V7, P196, DOI 10.1016/j.eatbeh.2006.05.001; de Wit SJ, 2012, AM J PSYCHIAT, V169, P1100, DOI 10.1176/appi.ajp.2012.12010073; Eastwood JD, 2001, PERCEPT PSYCHOPHYS, V63, P1004, DOI 10.3758/BF03194519; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fazio RH, 2001, COGNITION EMOTION, V15, P115, DOI 10.1080/02699930125908; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; GIBSON James J., 1979, ECOLOGICAL APPROACH; Goudriaan AE, 2006, ADDICTION, V101, P534, DOI 10.1111/j.1360-0443.2006.01380.x; Hietanen JK, 2006, NEUROIMAGE, V33, P406, DOI 10.1016/j.neuroimage.2006.06.048; Hommel B, 2001, PSYCHOL SCI, V12, P360, DOI 10.1111/1467-9280.00367; Jasinska AJ, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00025; Johnsen BH., 1994, PSYCHOL ADDICT BEHAV, V8, P111, DOI [10.1037/0893-164X.8.2.111, DOI 10.1037/0893-164X.8.2.111]; Jones A, 2016, APPETITE, V97, P16, DOI 10.1016/j.appet.2015.11.013; Kalanthroff E, 2013, CONSCIOUS COGN, V22, P413, DOI 10.1016/j.concog.2013.01.010; Kalanthroff E, 2016, DEPRESS ANX IN PRESS; Kalanthroff E, 2018, PSYCHOTHER PSYCHOSOM; Kalanthroff E, 2014, PSYCHIAT RES, V219, P322, DOI 10.1016/j.psychres.2014.05.050; Kalanthroff E, 2014, PSYCHOL RES-PSYCH FO, V78, P276, DOI 10.1007/s00426-013-0495-7; Kalanthroff E, 2013, J EXP PSYCHOL HUMAN, V39, P579, DOI 10.1037/a0027429; Kalanthroff E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00078; Klauer KC, 2003, PSYCHOLOGY OF EVALUATION, P7; Linkovski O, 2013, J BEHAV THER EXP PSY, V44, P30, DOI 10.1016/j.jbtep.2012.07.002; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan Gordon D., 1994, P189; Makris S, 2011, BRAIN COGNITION, V77, P257, DOI 10.1016/j.bandc.2011.08.002; Menzies L, 2007, BRAIN, V130, P3223, DOI 10.1093/brain/awm205; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Neumann R, 2000, J PERS SOC PSYCHOL, V79, P39, DOI 10.1037//0022-3514.79.1.39; Nigg JT, 2006, J AM ACAD CHILD PSY, V45, P468, DOI 10.1097/01.chi.0000199028.76452.a9; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Purkis HM, 2011, EMOTION, V11, P1484, DOI 10.1037/a0024415; Robbins TW, 2015, CURR OPIN NEUROBIOL, V30, P66, DOI 10.1016/j.conb.2014.09.005; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; SCHACHAR R, 1990, DEV PSYCHOL, V26, P710, DOI 10.1037/0012-1649.26.5.710; Tipples J, 2002, PSYCHON B REV, V9, P314, DOI 10.3758/BF03196287; Verbruggen F, 2004, ACTA PSYCHOL, V116, P21, DOI 10.1016/j.actpsy.2003.12.011; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Verbruggen F, 2008, J EXP PSYCHOL GEN, V137, P649, DOI 10.1037/a0013170; Verbruggen F, 2007, COGNITION EMOTION, V21, P391, DOI 10.1080/02699930600625081; Verbruggen F, 2015, COGNITION, V142, P81, DOI 10.1016/j.cognition.2015.05.014; Verbruggen F, 2014, NEUROPSYCHOLOGIA, V65, P263, DOI 10.1016/j.neuropsychologia.2014.08.014; Verbruggen F, 2013, PSYCHOL SCI, V24, P352, DOI 10.1177/0956797612457390; Verbruggen F, 2009, J EXP PSYCHOL LEARN, V35, P1381, DOI 10.1037/a0016645; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Waszak F, 2003, COGNITIVE PSYCHOL, V46, P361, DOI 10.1016/S0010-0285(02)00520-0; Wiers RW, 2011, PSYCHOL SCI, V22, P490, DOI 10.1177/0956797611400615	52	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196199	10.1371/journal.pone.0196199	http://dx.doi.org/10.1371/journal.pone.0196199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE6AF	29723204	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100017
J	Yu, Z; Boehm, CR; Hibber, JM; Abell, C; Haseloff, J; Burgess, SJ; Reyna-Llorens, I				Yu, Ziyi; Boehm, Christian R.; Hibber, Julian M.; Abell, Chris; Haseloff, Jim; Burgess, Steven J.; Reyna-Llorens, Ivan			Droplet-based microfluidic analysis and screening of single plant cells	PLOS ONE			English	Article							ARABIDOPSIS MESOPHYLL PROTOPLASTS; TRANSIENT GENE-EXPRESSION; MARCHANTIA-POLYMORPHA; TRANSFORMATION; TOBACCO; ELECTROPORATION; DNA; ENCAPSULATION; SELECTION; VERSATILE	Droplet-based microfluidics has been used to facilitate high-throughput analysis of individual prokaryote and mammalian cells. However, there is a scarcity of similar workflows applicable to rapid phenotyping of plant systems where phenotyping analyses typically are time-consuming and low-throughput. We report on-chip encapsulation and analysis of protoplasts isolated from the emergent plant model Marchantia polymorpha at processing rates of >100,000 cells per hour. We use our microfluidic system to quantify the stochastic properties of a heat-inducible promoter across a population of transgenic protoplasts to demonstrate its potential for assessing gene expression activity in response to environmental conditions. We further demonstrate on-chip sorting of droplets containing YFP-expressing protoplasts from wild type cells using dielectrophoresis force. This work opens the door to droplet-based microfluidic analysis of plant cells for applications ranging from high-throughput characterisation of DNA parts to single-cell genomics to selection of rare plant phenotypes.	[Yu, Ziyi; Abell, Chris] Univ Cambridge, Dept Chem, Cambridge, England; [Boehm, Christian R.; Hibber, Julian M.; Haseloff, Jim; Burgess, Steven J.; Reyna-Llorens, Ivan] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Boehm, Christian R.] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Burgess, Steven J.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA	University of Cambridge; University of Cambridge; Max Planck Society; University of Illinois System; University of Illinois Urbana-Champaign	Burgess, SJ; Reyna-Llorens, I (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.; Burgess, SJ (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.	sjb287@illinois.edu; iar28@cam.ac.uk	Burgess, Steven/AAA-1201-2021; Reyna-Llorens, Ivan/GPP-1718-2022	Burgess, Steven/0000-0003-2353-7794; Reyna-Llorens, Ivan/0000-0001-7964-7306; Boehm, Christian R./0000-0002-6633-7998	UK Biotechnological and Biological Sciences Research Council (BBSRC) via the OpenPlant Fund [BB/L014130/1]; UK Engineering and Physical Sciences Research Council (EPSRC) via the OpenPlant Fund [BB/L014130/1]; University of Cambridge Synthetic Biology Strategic Research Initiative via the SynBio Fund; BBSRC [BB/L014130/1] Funding Source: UKRI	UK Biotechnological and Biological Sciences Research Council (BBSRC) via the OpenPlant Fund; UK Engineering and Physical Sciences Research Council (EPSRC) via the OpenPlant Fund; University of Cambridge Synthetic Biology Strategic Research Initiative via the SynBio Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the UK Biotechnological and Biological Sciences Research Council (BBSRC) and Engineering and Physical Sciences Research Council (EPSRC) joint-funded OpenPlant Synthetic Biology Research Centre, grant award BB/L014130/1 via the OpenPlant Fund. This work was also supported by the University of Cambridge Synthetic Biology Strategic Research Initiative via the SynBio Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalde-Cela S, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0216; Althoff F, 2014, TRANSGENIC RES, V23, P235, DOI 10.1007/s11248-013-9746-z; Autebert J, 2012, METHODS, V57, P297, DOI 10.1016/j.ymeth.2012.07.002; Bargmann Bastiaan O R, 2010, J Vis Exp, DOI 10.3791/1673; Bascom CS, 2016, PLANT PHYSIOL, V172, P28, DOI 10.1104/pp.16.00879; Best RJ, 2016, ANAL CHEM, V88, P10445, DOI 10.1021/acs.analchem.6b02364; Boehm CR, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023887; BOPP M, 1988, PLANT CELL PHYSIOL, V29, P497; Bowman JL, 2017, CELL, V171, P287, DOI 10.1016/j.cell.2017.09.030; Davey MR, 2005, BIOTECHNOL ADV, V23, P131, DOI 10.1016/j.biotechadv.2004.09.008; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; FROMM M, 1985, P NATL ACAD SCI USA, V82, P5824, DOI 10.1073/pnas.82.17.5824; Gach PC, 2016, ACS SYNTH BIOL, V5, P426, DOI 10.1021/acssynbio.6b00011; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gronlund JT, 2012, JOVE-J VIS EXP, DOI 10.3791/4214; Gulati S, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0083.focus; HAUPTMANN RM, 1987, PLANT CELL REP, V6, P265, DOI 10.1007/BF00271995; He MY, 2005, ANAL CHEM, V77, P1539, DOI 10.1021/ac0480850; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Huang FC, 2002, MOL GENET GENOMICS, V268, P19, DOI 10.1007/s00438-002-0738-6; Huebner A, 2007, CHEM COMMUN, P1218, DOI 10.1039/b618570c; Hung MS, 2012, PROC I MECH ENG PART, V226, P15, DOI 10.1177/1740349912444511; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Ishizaki K, 2016, PLANT CELL PHYSIOL, V57, P262, DOI 10.1093/pcp/pcv097; JONES H, 1989, PLANT MOL BIOL, V13, P503, DOI 10.1007/BF00027310; Ju J, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/1/015004; Ko JM, 2006, PROTOPLASMA, V227, P237, DOI 10.1007/s00709-005-0142-2; KRENS FA, 1982, NATURE, V296, P72, DOI 10.1038/296072a0; Landenberger B, 2012, LAB CHIP, V12, P3177, DOI 10.1039/c2lc21099a; Lim JW, 2016, ANAL CHEM, V88, P5234, DOI 10.1021/acs.analchem.6b00317; Martin K, 2003, LAB CHIP, V3, P202, DOI 10.1039/b301258c; Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NEGRUTIU I, 1987, PLANT MOL BIOL, V8, P363, DOI 10.1007/BF00015814; NISHIGUCHI M, 1987, PLANT CELL REP, V6, P90, DOI 10.1007/BF00276660; Nishihama R, 2016, PLANT CELL PHYSIOL, V57, P271, DOI 10.1093/pcp/pcv102; Oh HJ, 2006, J MICROMECH MICROENG, V16, P285, DOI 10.1088/0960-1317/16/2/013; OULEE TM, 1986, P NATL ACAD SCI USA, V83, P6815, DOI 10.1073/pnas.83.18.6815; POTRYKUS I, 1985, MOL GEN GENET, V199, P169, DOI 10.1007/BF00330255; Qin D, 1996, ADV MATER, V8, P917, DOI 10.1002/adma.19960081110; Redenbaugh K, 1994, Z PFLANZENPHYSIOL, V107, P65, DOI [10.1016/S0044-328X(11)80010-3, DOI 10.1016/S0044-328X(11)80010-3]; ROEST S, 1989, ACTA BOT NEERL, V38, P1; Sakai S, 2005, BIOTECHNOL PROGR, V21, P994, DOI 10.1021/bp049600i; Sambrook J., 2001, MOL CLONING LAB MANU; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Shields CW, 2015, LAB CHIP, V15, P1230, DOI 10.1039/c4lc01246a; Terekhov SS, 2017, P NATL ACAD SCI USA, V114, P2550, DOI 10.1073/pnas.1621226114; Vinuselvi P, 2011, INT J MOL SCI, V12, P3576, DOI 10.3390/ijms12063576; WAARA S, 1995, EUPHYTICA, V85, P217, DOI 10.1007/BF00023951; Wang BL, 2014, NAT BIOTECHNOL, V32, P473, DOI 10.1038/nbt.2857; Wu H, 2011, MICROFLUID NANOFLUID, V10, P867, DOI 10.1007/s10404-010-0720-2; Yamato K.T., 2012, BSJ REV, V3, P71; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zaban B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05852	54	21	23	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196810	10.1371/journal.pone.0196810	http://dx.doi.org/10.1371/journal.pone.0196810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723275	Green Published, Green Submitted, gold			2022-12-26	WOS:000431305100067
J	Goel, R; Garcia, LMT; Goodman, A; Johnson, R; Aldred, R; Murugesan, M; Brage, S; Bhalla, K; Woodcock, J				Goel, Rahul; Garcia, Leandro M. T.; Goodman, Anna; Johnson, Rob; Aldred, Rachel; Murugesan, Manoradhan; Brage, Soren; Bhalla, Kavi; Woodcock, James			Estimating city-level travel patterns using street imagery: A case study of using Google Street View in Britain	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BETA REGRESSION; AUDIT; RELIABILITY	Background Street imagery is a promising and growing big data source providing current and historical images in more than 100 countries. Studies have reported using this data to audit road infrastructure and other built environment features. Here we explore a novel application, using Google Street View (GSV) to predict travel patterns at the city level. Methods We sampled 34 cities in Great Britain. In each city, we accessed 2000 GSV images from 1000 random locations. We selected archived images from time periods overlapping with the 2011 Census and the 2011-2013 Active People Survey (APS). We manually annotated the images into seven categories of road users. We developed regression models with the counts of images of road users as predictors. The outcomes included Census-reported commute shares of four modes (combined walking plus public transport, cycling, motorcycle, and car), as well as APS-reported past-month participation in walking and cycling. Results We found high correlations between GSV counts of cyclists ('GSV-cyclists') and cycle commute mode share (r = 0.92)/past-month cycling (r = 0.90). Likewise, GSV-pedestrians was moderately correlated with past-month walking for transport (r = 0.46), GSV-motorcycles was moderately correlated with commute share of motorcycles (r = 0.44), and GSV-buses was highly correlated with commute share of walking plus public transport (r = 0.81). GSV-car was not correlated with car commute mode share (r = -0.12). However, in multivariable regression models, all outcomes were predicted well, except past-month walking. The prediction performance was measured using cross-validation analyses. GSV-buses and GSV-cyclists are the strongest predictors for most outcomes. Conclusions GSV images are a promising new big data source to predict urban mobility patterns. Predictive power was the greatest for those modes that varied the most (cycle and bus). With its ability to identify mode of travel and capture street activity often excluded in routinely carried out surveys, GSV has the potential to be complementary to new and traditional data. With half the world's population covered by street imagery, and with up to 10 years historical data available in GSV, further testing across multiple settings is warranted both for cross-sectional and longitudinal assessments.	[Goel, Rahul; Garcia, Leandro M. T.; Johnson, Rob; Woodcock, James] Univ Cambridge, UKCRC Ctr Diet & Act Res CEDAR, Epidemiol Unit, MRC, Cambridge, England; [Goodman, Anna] London Sch Hyg & Trop Med, London, England; [Aldred, Rachel] Westminster Univ, Fac Architecture & Built Environm, Dept Planning & Transport, London, England; [Murugesan, Manoradhan; Bhalla, Kavi] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA; [Brage, Soren] Univ Cambridge, Epidemiol Unit, MRC, Cambridge, England	University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; University of Westminster; University of Chicago; University of Cambridge	Goel, R (corresponding author), Univ Cambridge, UKCRC Ctr Diet & Act Res CEDAR, Epidemiol Unit, MRC, Cambridge, England.	rg574@medschl.cam.ac.uk	Woodcock, James/AAH-6753-2021; Brage, Soren/C-6415-2013; PAN, ZEQIANG/X-6341-2018; Garcia, Leandro MT/I-7520-2013	Brage, Soren/0000-0002-1265-7355; Garcia, Leandro MT/0000-0001-5947-2617; Murugesan, Manoradhan/0000-0002-8625-9237; Goel, Rahul/0000-0002-4189-021X; Aldred, Rachel/0000-0001-7413-7251	TIGTHAT; MRC Global Challenges Project [MR/P024408/1]; METAHIT; MRC Methodology Panel project [MR/ P02663X/1]; Centre for Diet and Activity Research (CEDAR); British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research (NIHR); Wellcome Trust [MR/K023187/1]; MRC grant [MR/U105260566]; UK Medical Research Council [MC_UU_12015/3]; MRC [MR/P02663X/1, MC_UU_12015/3, MC_UU_00002/11, MR/K023187/1, MR/P024408/1] Funding Source: UKRI	TIGTHAT; MRC Global Challenges Project(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); METAHIT; MRC Methodology Panel project(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre for Diet and Activity Research (CEDAR); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); MRC grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RG, LG, MM, KB, and JW were supported by TIGTHAT, an MRC Global Challenges Project MR/P024408/1. JW and AG were also supported by METAHIT, an MRC Methodology Panel project (MR/ P02663X/1). Contributions from RJ were directly funded by and RG, LG and JW's work was undertaken under the auspices of the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence funded by the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research (NIHR) and the Wellcome Trust (MR/K023187/1) and (MR/K023187/1). RJ's work was partially supported by MRC grant (MR/U105260566). SB was supported by UK Medical Research Council [MC_UU_12015/3]. This work was completed in part with resources provided by the University of Chicago Research Computing Center.	Aldred R, 2017, INJURY PREVENTION; Aldred R, 2016, TRANSPORT REV, V36, P28, DOI 10.1080/01441647.2015.1014451; ALLEN DM, 1974, TECHNOMETRICS, V16, P125, DOI 10.2307/1267500; Althoff T, 2017, NATURE, V547, P336, DOI 10.1038/nature23018; [Anonymous], 2016, TRAVEL LONDON REPORT; Badland HM, 2010, J URBAN HEALTH, V87, P1007, DOI 10.1007/s11524-010-9505-x; Banister D, 2008, TRANSPORT POLICY, V15, P73, DOI 10.1016/j.tranpol.2007.10.005; Calabrese F, 2013, TRANSPORT RES C-EMER, V26, P301, DOI 10.1016/j.trc.2012.09.009; Clarke P, 2010, HEALTH PLACE, V16, P1224, DOI 10.1016/j.healthplace.2010.08.007; Cribari-Neto F, 2009, BETA REGRESSION IN R; Curtis JW, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-53; de Sa TH, 2017, ENVIRON INT, V108, P22, DOI 10.1016/j.envint.2017.07.009; Espinheira PL, 2008, J APPL STAT, V35, P407, DOI 10.1080/02664760701834931; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Goodman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071790; Hipp JA, 2013, AM J PREV MED, V44, P96, DOI 10.1016/j.amepre.2012.09.051; Hwang J, 2017, AM J EPIDEMIOL, V186, P274, DOI 10.1093/aje/kwx005; Jestico B, 2016, J TRANSP GEOGR, V52, P90, DOI 10.1016/j.jtrangeo.2016.03.006; Kelly CM, 2013, ANN BEHAV MED, V45, pS108, DOI 10.1007/s12160-012-9419-9; Kung KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096180; Letchford A, GITHUB REPOSITORY 20; Long Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171110; National Travel Survey 2002-2016, 2017, NAT TRAV SURV 2002 2; Nguyen QC, 2018, J EPIDEMIOL COMMUNIT; Nitsche P, 2014, TRANSPORT RES C-EMER, V43, P212, DOI 10.1016/j.trc.2013.11.005; Reddy S, 2010, ACM T SENSOR NETWORK, V6, DOI 10.1145/1689239.1689243; Rundle AG, 2011, AM J PREV MED, V40, P94, DOI 10.1016/j.amepre.2010.09.034; Smith A., 2013, SMARTPHONE OWNERSHIP; Sport England, 2013, ACT PEOPL SURV 5 7 T; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; Vanwolleghem G, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0069-1; Wang Z, 2017, APPL MOBILE PHONE DA; Wilson JS, 2012, AM J PREV MED, V42, P193, DOI 10.1016/j.amepre.2011.09.029; Yin L, 2015, APPL GEOGR, V63, P337, DOI 10.1016/j.apgeog.2015.07.010	35	37	37	7	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196521	10.1371/journal.pone.0196521	http://dx.doi.org/10.1371/journal.pone.0196521			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718953	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900056
J	Li, JZ; Guo, ZL; Sato, T; Yuan, B; Ma, YY; Qian, D; Zhong, JY; Jin, MM; Huang, P; Che, LY; Wang, Y; Lei, Y; Liu, CZ				Li, JingZhe; Guo, ZhiLan; Sato, Takashi; Yuan, Bo; Ma, YanYan; Qian, Dan; Zhong, JuYing; Jin, MengMeng; Huang, Peng; Che, LuYang; Wang, Yi; Lei, Yan; Liu, ChangZhen			Optimized application of the secreted Nano-luciferase reporter system using an affinity purification strategy	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; IN-VIVO BIOLUMINESCENCE; GAUSSIA LUCIFERASE; EX-VIVO; EXPRESSION; CELLS; PROGRESSION; ASSAYS; MOUSE	Secreted Nano-luciferase (secNluc) is a newly engineered secreted luciferase that possesses advantages of high structural stability, long half-life, and glow-type kinetics together with high light emission intensity, and thus would become one of the most valuable tools for bioluminescence assays. However, like other secreted luciferases, secNluc has to mix with the components in the conditioned medium surrounding test cells, or in the biological samples such as blood or urine after being secreted. These components may interfere with secNluc-catalyzed bioluminescence reactions and thus limit the application of the secNluc reporter system. In this study, we first examined the effects of three factors, pH, serum and residual reagents, on secNluc-catalyzed bioluminescence reactions, finding that these factors could interfere with bioluminescence reactions and result in background signal. To resolve these problems, we applied a simple affinity purification strategy in which secNluc was fused with a FLAG-tag, and anti-FLAG magnetic beads were used to catch and transfer the fusion protein to PBST, an optimal buffer for secNluc-catalyzed bioluminescence reactions that was identified in this study. The results indicated that this strategy could not only negate the interferences from serum or residual reagents and enhance the stability of light emission but also greatly increase signal intensity through enzyme enrichment. This strategy may contribute to biomedical studies that utilize secNluc and other secreted luciferases, especially those requiring superior sensitivity, low background noise and high reproducibility.	[Li, JingZhe; Guo, ZhiLan; Ma, YanYan; Qian, Dan; Zhong, JuYing; Wang, Yi; Lei, Yan; Liu, ChangZhen] China Acad Chinese Med Sci, Expt Res Ctr, Beijing Key Lab Res Chinese Med Prevent & Trea, Beijing, Peoples R China; [Li, JingZhe; Sato, Takashi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Biochem, Hachioji, Tokyo, Japan; [Yuan, Bo] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Appl Biochem, Hachioji, Tokyo, Japan; [Jin, MengMeng] Gen Hosp Chinese Peoples Liberat Army, Dept Geriatr Endocrinol, Beijing, Peoples R China; [Huang, Peng; Che, LuYang] Gen Hosp Chinese Peoples Liberat Army, Dept Orthopaed, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Experimental Research Center, CACMS; Tokyo University of Pharmacy & Life Sciences; Tokyo University of Pharmacy & Life Sciences	Lei, Y; Liu, CZ (corresponding author), China Acad Chinese Med Sci, Expt Res Ctr, Beijing Key Lab Res Chinese Med Prevent & Trea, Beijing, Peoples R China.	leiy999@163.com; lcz0220@163.com	MA, YAN/HHN-2912-2022		National Natural Science Foundation of China [31170829, 81550017]; Research Project of CACMS [ZZ2015015]; Natural Science Foundation of Beijing Municipality grant [7172150]; National Natural Science Foundation of China grant [81171762]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Project of CACMS; Natural Science Foundation of Beijing Municipality grant; National Natural Science Foundation of China grant(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China grant 31170829 to CZL, Research Project of CACMS grant ZZ2015015 to JZL, Natural Science Foundation of Beijing Municipality grant 7172150 to CZL, National Natural Science Foundation of China grant 81171762 to PH, National Natural Science Foundation of China grant 81550017 to PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandrini F, 2016, J CANCER, V7, P1791, DOI 10.7150/jca.15564; Badr CE, 2014, METHODS MOL BIOL, V1098, P1, DOI 10.1007/978-1-62703-718-1_1; Badr CE, 2011, ASSAY DRUG DEV TECHN, V9, P281, DOI 10.1089/adt.2010.0324; Bhang HEC, 2011, NAT MED, V17, P123, DOI 10.1038/nm.2269; Charles JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4981; Chung E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008316; Degeling MH, 2013, ANAL CHEM, V85, P3006, DOI 10.1021/ac4003134; El-Amouri SS, 2013, MOL BIOTECHNOL, V53, P63, DOI 10.1007/s12033-012-9519-6; England CG, 2016, BIOCONJUGATE CHEM, V27, P1175, DOI 10.1021/acs.bioconjchem.6b00112; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Geisse Sabine, 2005, V308, P87; Germain-Genevois C, 2016, MOL IMAGING BIOL, V18, P62, DOI 10.1007/s11307-015-0864-2; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Kaskova ZM, 2016, CHEM SOC REV, V45, P6048, DOI 10.1039/c6cs00296j; Liu MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090382; Machleidt T, 2015, ACS CHEM BIOL, V10, P1797, DOI 10.1021/acschembio.5b00143; Massoud TF, 2007, CURR OPIN BIOTECH, V18, P31, DOI 10.1016/j.copbio.2007.01.007; Michelini E, 2014, ANAL BIOANAL CHEM, V406, P5531, DOI 10.1007/s00216-014-7925-2; Morita N, 2016, ANAL BIOCHEM, V497, P24, DOI 10.1016/j.ab.2015.12.007; Naciri M, 2008, CYTOTECHNOLOGY, V57, P245, DOI 10.1007/s10616-008-9160-1; Niers JM, 2011, MOL THER, V19, P1090, DOI 10.1038/mt.2011.17; Pichler A, 2008, P NATL ACAD SCI USA, V105, P15932, DOI 10.1073/pnas.0801075105; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schaub FX, 2015, CANCER RES, V75, P5023, DOI 10.1158/0008-5472.CAN-14-3538; Song G, 2015, J PHOTOCH PHOTOBIO B, V153, P311, DOI 10.1016/j.jphotobiol.2015.10.014; Stacer AC, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2013.00062; Tannous BA, 2011, BIOTECHNOL ADV, V29, P997, DOI 10.1016/j.biotechadv.2011.08.021; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Yamashita H, 2014, METHODS MOL BIOL, V1098, P145, DOI 10.1007/978-1-62703-718-1_12; Zhao Hui, 2004, Mol Imaging, V3, P43, DOI 10.1162/153535004773861714	31	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196617	10.1371/journal.pone.0196617	http://dx.doi.org/10.1371/journal.pone.0196617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29719001	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900065
J	Lin, J; Xia, J; Zhang, T; Zhang, KY; Yang, Q				Lin, Jian; Xia, Jing; Zhang, Tian; Zhang, Keyun; Yang, Qian			Genome-wide profiling of microRNAs reveals novel insights into the interactions between H9N2 avian influenza virus and avian dendritic cells	ONCOGENE			English	Article							LONG NONCODING RNA; NF-KAPPA-B; IMMUNE-RESPONSES; NUCLEAR IMPORT; INNATE IMMUNITY; A(H7N9) VIRUS; BINDING-SITE; INFECTION; HOST; REPLICATION	The antigen-presenting ability of dendritic cells (DCs) plays an important and irreplaceable role in recognising and clearing viruses. Antiviral responses must rapidly defend against infection while minimising inflammatory damage, but the mechanisms that regulate the magnitude of response within an infected cell are not well understood. MicroRNAs (microRNAs), small non-coding RNAs, can regulate mouse or avian DCs to inhibit the infection and replication of avian influenza virus (AIV). Here, we performed a global analysis to understand how avian DCs respond to H9N2 AIV and provide a potential mechanism to explain how avian microRNAs can defend against H9N2 AIV replication. First, we found that both active and inactive H9N2 AIV enhanced the ability of DCs to present antigens and activate T lymphocytes. Next, total microarray analyses suggested that H9N2 AIV stimulation involved protein localisation, nucleotide binding, leucocyte transendothelial migration and MAPK signalling. Moreover, we constructed 551 transcription factor (TF)-miRNA-mRNA loops based on the above analyses. Furthermore, we found that the haemagglutinin (HA) fragment, neither H5N1-HA or H9N2-HA, could not activate DCs, while truncated HA greatly increased the immune function of DCs by activating ERK and STAT3 signalling pathways. Lastly, our results not only suggested that gga-miR1644 targets muscleblind-like protein 2 (MBNL2) to enhance the ability of avian DCs to inhibit virus replication, but also suggested that gga-miR6675 targets the nuclear localisation sequence of polymerase basic protein 1 (PB1) to trigger the silencing of PB1 genes, resulting in the inhibition of H9N2 AIV replication. Altogether, our innovative study will shed new light on the role of avian microRNAs in evoking avian DCs and inhibiting virus replication.	[Lin, Jian; Xia, Jing; Zhang, Tian; Zhang, Keyun] Nanjing Agr Univ, Coll Life Sci, Weigang 1, Nanjing 210095, Jiangsu, Peoples R China; [Lin, Jian; Yang, Qian] Nanjing Agr Univ, Coll Vet Med, Wei Gang 1, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Yang, Q (corresponding author), Nanjing Agr Univ, Coll Vet Med, Wei Gang 1, Nanjing 210095, Jiangsu, Peoples R China.	zxbyq@njau.edu.cn		Zhang, Keyun/0000-0001-7208-8572; Lin, Jian/0000-0003-0455-9736	National Key Research and Development Program of China [2017YFD500706]; National Natural Science Grant of P. R. China [31702197, 31172302]; National Science Grant of Jiangsu Province [BK20150666]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Key Research and Development Program of China; National Natural Science Grant of P. R. China(National Natural Science Foundation of China (NSFC)); National Science Grant of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Key Research and Development Program of China (2017YFD500706), the National Natural Science Grant of P. R. China (No. 31702197), the National Natural Science Grant of P. R. China (No. 31172302), the National Science Grant of Jiangsu Province (No. BK20150666) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Bandyopadhyay S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-163; Barik S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-104; Bel M, 2011, VIRUSES-BASEL, V3, P312, DOI 10.3390/v3040312; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Cilloniz C, 2010, J VIROL, V84, P7613, DOI 10.1128/JVI.00553-10; Contreras J, 2012, LEUKEMIA, V26, P404, DOI 10.1038/leu.2011.356; den Brouw MLO, 2009, IMMUNOLOGY, V126, P280, DOI 10.1111/j.1365-2567.2008.02896.x; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; Droebner K, 2011, ANTIVIR RES, V92, P195, DOI 10.1016/j.antiviral.2011.08.002; Fan NN, 2016, BIOMED PHARMACOTHER, V83, P1464, DOI 10.1016/j.biopha.2016.08.049; Hofer CT, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12679; Hofer U, 2013, NAT REV MICROBIOL, V11, P298, DOI 10.1038/nrmicro3012; Hutchinson EC, 2011, J GEN VIROL, V92, P1859, DOI 10.1099/vir.0.032813-0; Imam H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08639; Ingle H, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3183; Jiang M, 2014, J VIRAL HEPATITIS, V21, P99, DOI 10.1111/jvh.12126; Jin Y, 2017, J INFECTION, V75, P179, DOI 10.1016/j.jinf.2017.05.006; JONES IM, 1986, EMBO J, V5, P2371, DOI 10.1002/j.1460-2075.1986.tb04506.x; Ke CW, 2017, EMERG INFECT DIS, V23, P1332, DOI 10.3201/eid2308.170600; Khongnomnan K, 2015, EXP BIOL MED, V240, P1630, DOI 10.1177/1535370215589051; Langlois RA, 2012, P NATL ACAD SCI USA, V109, P12117, DOI 10.1073/pnas.1206039109; Le Negrate G, 2012, CELL MICROBIOL, V14, P168, DOI 10.1111/j.1462-5822.2011.01720.x; Li ZH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00017; Liang JF, 2013, VET IMMUNOL IMMUNOP, V155, P205, DOI 10.1016/j.vetimm.2013.06.014; Lin J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00287; Lin J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3157-5; Lin J, 2016, ONCOTARGET, V7, P48978, DOI 10.18632/oncotarget.9832; Lin TN, 2017, EMERG INFECT DIS, V23, P1041, DOI 10.3201/eid2306.161902; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loucaides EM, 2009, VIROLOGY, V394, P154, DOI 10.1016/j.virol.2009.08.015; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Marjuki H, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-134; Metwally A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040766; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Nakada R, 2017, PROTEIN SCI, V26, P1231, DOI 10.1002/pro.3173; Othumpangat S, 2014, VIROLOGY, V468, P256, DOI 10.1016/j.virol.2014.08.007; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Perrone LA, 2010, J INFECT DIS, V202, P1161, DOI 10.1086/656365; Pichulik T, 2016, EUR J IMMUNOL, V46, P167, DOI 10.1002/eji.201444970; Pizzolla A, 2017, J LEUKOCYTE BIOL, V101, P851, DOI 10.1189/jlb.4MR0716-290R; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Pu J, 2017, J VIROL, V91, DOI [10.1128/jvi.02055-16, 10.1128/JVI.02055-16]; Pu J, 2015, P NATL ACAD SCI USA, V112, P548, DOI 10.1073/pnas.1422456112; Pumroy RA, 2015, STRUCTURE, V23, P374, DOI 10.1016/j.str.2014.11.015; Ramos I, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00361; Rivera A, 2016, VIRAL IMMUNOL, V29, P212, DOI 10.1089/vim.2015.0074; Rosenberger CM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006305; Rosenberger CM, 2012, J IMMUNOL, V189, P5965, DOI 10.4049/jimmunol.1201437; Samir M, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00086; Severin C, 2016, ACTA CRYSTALLOGR D, V72, P245, DOI 10.1107/S2059798316000085; Shen XY, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/976575; Sprokholt JK, 2017, J IMMUNOL, V198, P4764, DOI 10.4049/jimmunol.1602121; Tang XY, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.25; Terrier O, 2016, SCI REP-UK, V6, DOI 10.1038/srep29006; Terrier O, 2012, VIROLOGY, V432, P204, DOI 10.1016/j.virol.2012.05.019; Turner JCM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.142; Tzarum N, 2017, J VIROL, V91, DOI 10.1128/JVI.00046-17; Valadkhan S, 2016, VIRUS RES, V212, P127, DOI 10.1016/j.virusres.2015.09.023; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Westenius V, 2014, VIROLOGY, V471, P38, DOI 10.1016/j.virol.2014.10.002; Xiang B, 2017, J INFECTION, V75, P274, DOI 10.1016/j.jinf.2017.05.002; Xu W, 2014, CELL HOST MICROBE, V16, P187, DOI 10.1016/j.chom.2014.07.008; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060; Yin Y, 2015, MUCOSAL IMMUNOL, V8, P799, DOI 10.1038/mi.2014.110; York A, 2014, J VIROL, V88, P13284, DOI 10.1128/JVI.01813-14; Yuan SF, 2016, ANTIVIR RES, V125, P34, DOI 10.1016/j.antiviral.2015.11.005; Zhang Y, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.38; Zhao Chunling, 2012, BMC Res Notes, V5, P91, DOI 10.1186/1756-0500-5-91; Zhou A, 2014, VIRUS RES, V184, P1, DOI 10.1016/j.virusres.2014.01.019; Zhou Z, 2015, CELL RES, V25, P39, DOI 10.1038/cr.2014.130; Zhu W, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.19.30533	71	7	7	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 16	2018	37	33					4562	4580		10.1038/s41388-018-0279-z	http://dx.doi.org/10.1038/s41388-018-0279-z			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GQ5OV	29743596				2022-12-26	WOS:000441736700006
J	Lundsgaard-Nielsen, SM; Pors, A; Banke, SO; Henriksen, JE; Hepp, DK; Weber, A				Lundsgaard-Nielsen, Signe M.; Pors, Anders; Banke, Stefan O.; Henriksen, Jan E.; Hepp, Dietrich K.; Weber, Anders			Critical-depth Raman spectroscopy enables home-use non-invasive glucose monitoring	PLOS ONE			English	Article							BLOOD-GLUCOSE; DEVICE	One of the most ambitious endeavors in the field of diabetes technology is non-invasive glucose sensing. In the past decades, a number of different technologies have been assessed, but none of these have found its entry into general clinical use. We report on the development of a table-top confocal Raman spectrometer that was used in the home of patients with diabetes and operated for extended periods of time unsupervised and without recalibration. The system is based on measurement of glucose levels at a 'critical depth' in the skin, specifically in the interstitial fluid located below the stratum corneum but above the underlying adipose tissue layer. The region chosen for routine glucose measurements was the base of the thumb (the thenar). In a small clinical study, 35 patients with diabetes analyzed their interstitial fluid glucose for a period of 60 days using the new critical-depth Raman (CD-Raman) method and levels were correlated to reference capillary blood glucose values using a standard finger-stick and test strip product. The calibration of the CD-Raman system was stable for > 10 days. Measurement performance for glucose levels present at, or below, a depth of similar to 250 mu m below the skin surface was comparable to that reported for currently available invasive continuous glucose monitors. In summary, using the CD-Raman technology we have demonstrated the first successful use of a non-invasive glucose monitor in the home.	[Lundsgaard-Nielsen, Signe M.; Pors, Anders; Banke, Stefan O.; Weber, Anders] RSP Syst, Odense, Denmark; [Henriksen, Jan E.] Odense Univ Hosp, Dept Endocrinol, Odense, Denmark; [Hepp, Dietrich K.] Endocrinol & Diabetol, Munich, Germany	University of Southern Denmark; Odense University Hospital	Weber, A (corresponding author), RSP Syst, Odense, Denmark.	andersw@rspsystems.com			RSP Systems; European Union [738973]	RSP Systems; European Union(European Commission)	RSP Systems funded this work and the decision to publish was made by the company. RSP Systems provided support in the form of salaries for authors SMLN, AP, SOB and AW, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 738973.	Barman I, 2010, ANAL CHEM, V82, P9719, DOI 10.1021/ac101754n; Berger AJ, 1997, SPECTROCHIM ACTA A, V53, P287, DOI 10.1016/S0584-8539(96)01779-5; Byrne HJ, 2016, CHEM SOC REV, V45, P1865, DOI 10.1039/c5cs00440c; Cengiz E, 2009, DIABETES TECHNOL THE, V11, pS11, DOI 10.1089/dia.2009.0002; do Amaral CEF, 2008, MED ENG PHYS, V30, P541, DOI 10.1016/j.medengphy.2007.06.003; Dungel P, 2008, J BIOMED MATER RES A, V85A, P699, DOI 10.1002/jbm.a.31593; Enejder AMK, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1920212; Henyey LG, 1941, ASTROPHYS J, V93, P70, DOI 10.1086/144246; International Diabetes Federation, 2020, IDF DIABETES ATLAS; Kong CR, 2011, AIP ADV, V1, DOI 10.1063/1.3646524; Kos S, 2012, CLIN CHEM LAB MED, V50, P1573, DOI 10.1515/cclm-2011-0900; Lipson Jan, 2009, J Diabetes Sci Technol, V3, P233; MARTENS H, 1991, J PHARMACEUT BIOMED, V9, P625, DOI 10.1016/0731-7085(91)80188-F; Nielsen Jannik K, 2009, J Diabetes Sci Technol, V3, P98; Parkes JL, 2000, DIABETES CARE, V23, P1143, DOI 10.2337/diacare.23.8.1143; Rebel Annette, 2012, J Diabetes Sci Technol, V6, P396; Rodbard D, 2016, DIABETES TECHNOL THE, V18, P3, DOI 10.1089/dia.2015.0417; Scholtes-Timmerman Maarten J, 2014, J Diabetes Sci Technol, V8, P974, DOI 10.1177/1932296814543104; Steil GM, 2005, DIABETOLOGIA, V48, P1833, DOI 10.1007/s00125-005-1852-x; TROWBRIDGE TS, 1975, J OPT SOC AM, V65, P531, DOI 10.1364/JOSA.65.000531; Tura A, 2007, DIABETES RES CLIN PR, V77, P16, DOI 10.1016/j.diabres.2006.10.027; Vashist SK, 2013, DIAGNOSTICS, V3, P385, DOI 10.3390/diagnostics3040385; Vashist SK, 2012, ANAL CHIM ACTA, V750, P16, DOI 10.1016/j.aca.2012.03.043; Wentholt IME, 2007, DIABETES TECHNOL THE, V9, P169, DOI 10.1089/dia.2006.0007; Wrobel MS, 2015, IOP C SERIES MAT SCI, V104	25	36	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0197134	10.1371/journal.pone.0197134	http://dx.doi.org/10.1371/journal.pone.0197134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750797	Green Published, gold			2022-12-26	WOS:000431856300020
J	Galvez, JM; Castillo, D; Herrera, LJ; San Roman, B; Valenzuela, O; Ortuno, FM; Rojas, I				Manuel Galvez, Juan; Castillo, Daniel; Javier Herrera, Luis; San Roman, Belen; Valenzuela, Olga; Ortuno, Francisco Manuel; Rojas, Ignacio			Multiclass classification for skin cancer profiling based on the integration of heterogeneous gene expression series	PLOS ONE			English	Article							CUTANEOUS MELANOMA; RNA-SEQ; TRENDS; DIAGNOSIS; OMNIBUS; RISK; GEO	Most of the research studies developed applying microarray technology to the characterization of different pathological states of any disease may fail in reaching statistically significant results. This is largely due to the small repertoire of analysed samples, and to the limitation in the number of states or pathologies usually addressed. Moreover, the influence of potential deviations on the gene expression quantification is usually disregarded. In spite of the continuous changes in omic sciences, reflected for instance in the emergence of new Next-Generation Sequencing-related technologies, the existing availability of a vast amount of gene expression microarray datasets should be properly exploited. Therefore, this work proposes a novel methodological approach involving the integration of several heterogeneous skin cancer series, and a later multiclass classifier design. This approach is thus a way to provide the clinicians with an intelligent diagnosis support tool based on the use of a robust set of selected biomarkers, which simultaneously distinguishes among different cancerrelated skin states. To achieve this, a multi-platform combination of microarray datasets from Affymetrix and Illumina manufacturers was carried out. This integration is expected to strengthen the statistical robustness of the study as well as the finding of highly-reliable skin cancer biomarkers. Specifically, the designed operation pipeline has allowed the identification of a small subset of 17 differentially expressed genes (DEGs) from which to distinguish among 7 involved skin states. These genes were obtained from the assessment of a number of potential batch effects on the gene expression data. The biological interpretation of these genes was inspected in the specific literature to understand their underlying information in relation to skin cancer. Finally, in order to assess their possible effectiveness in cancer diagnosis, a cross-validation Support Vector Machines (SVM)-based classification including feature ranking was performed. The accuracy attained exceeded the 92% in overall recognition of the 7 different cancer-related skin states. The proposed integration scheme is expected to allow the co-integration with other state-of-the-art technologies such as RNA-seq.	[Manuel Galvez, Juan; Castillo, Daniel; Javier Herrera, Luis; San Roman, Belen; Rojas, Ignacio] Univ Granada, Dept Comp Architecture & Comp Technol, Granada, Spain; [Valenzuela, Olga] Univ Granada, Dept Appl Math, Granada, Spain; [Ortuno, Francisco Manuel] Univ Chicago, Ctr Data Intens Sci, Chicago, IL 60637 USA; [Manuel Galvez, Juan; Castillo, Daniel] Univ Granada, Res Ctr Informat & Commun Technol, CIT UGR, C Periodista Rafael Gomez Montero 2,D1-7 Off, E-18071 Granada, Spain	University of Granada; University of Granada; University of Chicago; University of Granada	Galvez, JM (corresponding author), Univ Granada, Dept Comp Architecture & Comp Technol, Granada, Spain.; Galvez, JM (corresponding author), Univ Granada, Res Ctr Informat & Commun Technol, CIT UGR, C Periodista Rafael Gomez Montero 2,D1-7 Off, E-18071 Granada, Spain.	jmgg@ugr.es	Gálvez, Juan M./J-6149-2018; Herrera, Luis/GMW-6727-2022; Rojas, Ignacio/B-7481-2013; Valenzuela, Olga/L-9356-2014; Herrera, Luis J/L-2392-2014; Galvez, Juan Manuel/AAB-9172-2019; Guzman, Francisco Manuel Ortuno/I-4667-2012	Gálvez, Juan M./0000-0003-2139-0565; Herrera, Luis/0000-0003-3220-9389; Rojas, Ignacio/0000-0002-1033-5635; Valenzuela, Olga/0000-0001-6034-9392; Herrera, Luis J/0000-0003-3220-9389; Galvez, Juan Manuel/0000-0003-2139-0565; Guzman, Francisco Manuel Ortuno/0000-0001-7424-1753; Castillo-Secilla, Daniel/0000-0002-7380-1023	Government of Andalusia [P12 TIC-2082]; research project "Progress in Computer Architectures for Automatic Learning using Heterogeneous Sources: Health and Well-Being Applications" [TIN2015-71873-R]	Government of Andalusia; research project "Progress in Computer Architectures for Automatic Learning using Heterogeneous Sources: Health and Well-Being Applications"	This work has been partially supported by the Government of Andalusia and its development is part of the research project "Advanced Computer Systems in Applications in the field of Biotechnology and Bioinformatics" (reference P12 TIC-2082), in collaboration with the research project "Progress in Computer Architectures for Automatic Learning using Heterogeneous Sources: Health and Well-Being Applications" (reference TIN2015-71873-R). There was no additional external funding received for this study.	Andrade-navarro, 2016, GENOMICS COMPUTATION, V2, P1, DOI [10.18547/gcb.2016.vol2.iss1.e33, DOI 10.18547/GCB.2016.VOL2.ISS1.E33]; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Calin MA, 2013, J CANCER RES CLIN, V139, P1083, DOI 10.1007/s00432-013-1423-3; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Castillo D, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1925-0; Choudhury Debabani, 2015, 2015 IEEE MTT-S International Microwave Symposium (IMS2015), P1, DOI 10.1109/MWSYM.2015.7167093; Dai HJ, 2016, J AM ACAD DERMATOL, V75, P731, DOI 10.1016/j.jaad.2016.05.021; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Doyle S, 2011, I S BIOMED IMAGING, P715, DOI 10.1109/ISBI.2011.5872506; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferlay J, 2014, GLOBOCAN 2012 V1 0 C, V11; Ferrandiz C, 2017, ACTAS DERMO-SIFILOGR, V108, P31, DOI 10.1016/j.ad.2016.07.016; Foster Russell G, 2007, Methods Mol Biol, V362, P3; Fuchs A, 2007, DERMATOL SURG, V33, P1099, DOI 10.1111/j.1524-4725.2007.33224.x; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75; Goh WWB, 2017, TRENDS BIOTECHNOL, V35, P498, DOI 10.1016/j.tibtech.2017.02.012; Gohlmann H, 2009, GENE EXPRESSION STUD; Han ZY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04075-z; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Harms PW, 2013, J INVEST DERMATOL, V133, P936, DOI 10.1038/jid.2012.445; Heider A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-75; Hoffmann R, 2008, NAT GENET, V40, P1047, DOI 10.1038/ng.f.217; Hofherr SE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017076, 10.1371/journal.pone.0023376]; Hornik K, 2012, WIRES COMPUT STAT, V4, P394, DOI 10.1002/wics.1212; Hoshyar AN, 2014, PROCEDIA COMPUT SCI, V42, P25, DOI 10.1016/j.procs.2014.11.029; Illumina Inc. Illumina, 2009, ILL ILL GEN EXPR ARR; Jaworek-Korjakowska J, 2014, IEEE ENG MED BIO, P6459, DOI [10.1109/EMBC.2014.6945107, 10.1109/EMBC.2015.7318940]; Jenefer BM, CLUSTER COMPUTING, P1; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Katalinic A, 2003, BRIT J DERMATOL, V149, P1200, DOI 10.1111/j.1365-2133.2003.05554.x; Kather JN, 2016, SCI REP-UK, V6, DOI 10.1038/srep27988; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kieslich PJ, 2016, PACKAGE READBULK; Koscielny G, 2017, NUCLEIC ACIDS RES, V45, pD985, DOI 10.1093/nar/gkw1055; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Lazar C, 2013, BRIEF BIOINFORM, V14, P469, DOI 10.1093/bib/bbs037; Le Cao KA, 2009, APPL BIOINF BIOSTAT, P55, DOI 10.1007/978-1-4419-0811-7_3; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li Y, 2016, ARXIV161201074; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; Martinez R, 2008, BIOINFORMATICS, V24, P2643, DOI 10.1093/bioinformatics/btn490; Maryam, 2017, AIP CONF PROC, V1867, DOI 10.1063/1.4994451; Maurya R, 2014, 2014 INTERNATIONAL CONFERENCE ON COMPUTING FOR SUSTAINABLE GLOBAL DEVELOPMENT (INDIACOM), P444, DOI 10.1109/IndiaCom.2014.6828177; Misganaw Burook, 2015, IEEE Life Science Letters, V1, P15, DOI 10.1109/LLS.2015.2451291; Mitsui H, 2014, J INVEST DERMATOL, V134, P1418, DOI 10.1038/jid.2013.494; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Perez-Ortiz M, 2016, IEEE IJCNN, P2156, DOI 10.1109/IJCNN.2016.7727466; Pletscher-Frankild S, 2015, METHODS, V74, P83, DOI 10.1016/j.ymeth.2014.11.020; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Ray PJ, 2015, NUCL SEGMENTATION SK, P397; Refaeilzadeh P., 2009, ENCYCL DATABASE SYST, P532, DOI [10.1007/978-0-387-39940-9, DOI 10.1007/978-0-387-39940-9_565]; Rigel DS, 2005, ARCH DERMATOL, V141, P1032, DOI 10.1001/archderm.141.8.1032; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Romo-Bucheli D, 2015, I S BIOMED IMAGING, P1008, DOI 10.1109/ISBI.2015.7164041; Rutherford A., 2001, INTRO ANOVA ANCOVA G; Salah B, 2011, CANCER INFORM, V10, P1, DOI 10.4137/CIN.S5950; Sand M, 2012, J DERMATOL SCI, V68, P119, DOI 10.1016/j.jdermsci.2012.09.004; Sattlecker M, 2014, TRAC-TREND ANAL CHEM, V59, P17, DOI 10.1016/j.trac.2014.02.016; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328; Sharma G, 2009, INT J PARALLEL PROG, V37, P3, DOI 10.1007/s10766-008-0082-5; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sims AH, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-42; Staples MP, 2006, MED J AUSTRALIA, V184, P6, DOI 10.5694/j.1326-5377.2006.tb00086.x; Strauss T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168288; Sundar R. S., 2016, 2016 INT C CIRC POW, P1; Taminau J, 2013, BIOCGENERICS S PACKA; Taminau J, 2011, BIOINFORMATICS, V27, P3204, DOI 10.1093/bioinformatics/btr529; Team RC, 2014, R LANG ENV STAT COMP; Tejera-Vaquerizo A, 2016, ACTAS DERMO-SIFILOGR, V107, P318, DOI 10.1016/j.ad.2015.12.008; van der Geer S, 2015, DERMATOLOGY, V230, P161, DOI 10.1159/000369790; Volkov A, 2013, AUST NZ J PUBL HEAL, V37, P63, DOI 10.1111/1753-6405.12012; Vuong K, 2014, JAMA DERMATOL, V150, P434, DOI 10.1001/jamadermatol.2013.8890; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watson M, 2016, AM J TRANSPLANT, V16, P717, DOI 10.1111/ajt.13720; Yang JS, 2016, J BIOL RES-THESSALON, V23, DOI 10.1186/s40709-016-0045-8	86	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0196836	10.1371/journal.pone.0196836	http://dx.doi.org/10.1371/journal.pone.0196836			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750795	Green Submitted, Green Published, gold			2022-12-26	WOS:000431856300006
J	Del Pasqua, M; Schulze, A; Tovar-Hernandez, MA; Keppel, E; Lezzi, M; Gambi, MC; Giangrande, A				Del Pasqua, Michela; Schulze, Anja; Ana Tovar-Hernandez, Maria; Keppel, Erica; Lezzi, Marco; Gambi, Maria Cristina; Giangrande, Adriana			Clarifying the taxonomic status of the alien species Branchiomma bairdi and Branchiomma boholense (Annelida: Sabellidae) using molecular and morphological evidence	PLOS ONE			English	Article							GREAT-BARRIER-REEF; 1ST RECORD; MEDITERRANEAN SEA; GENETIC-VARIATION; POLYCHAETA SABELLIDAE; LIZARD ISLAND; INVASION; POPULATION; ATLANTIC; BIOLOGY	This study was performed to analyse the genetic and morphological diversity of the sabellid annelid genus Branchiomma, with special emphasis on a taxon so far identified as Branchiomma bairdi. This species, originally described from Bermuda, has frequently been reported as an invader in the Mediterranean, the Atlantic and the Eastern Pacific, but recent observations have raised some taxonomic questions. Samples of this taxon were collected from five sites in the Mediterranean Sea, two sites in the original distribution area of B. bairdi in the Gulf of Mexico and four localities in the east Pacific and Atlantic Oceans where B. bairdi has been reported as invasive. The molecular results revealed a conspicuous genetic divergence (18.5% K2P) between the sampled Mediterranean populations and all the other ones that led to a re-evaluation of their morphological characters. The latter showed that the Mediterranean and extra-Mediterranean populations also differ in some discrete morphological and reproductive features. Consequently, the Mediterranean samples were re-designated as B. boholense, another non-indigenous species originally described from Philippines. Branchiomma bairdiand B. boholense differ in body size, development and shape of micro and macrostylodes, size of radiolar eyes and body pigmentation. Genetic diversity was high in B. boholense from the Mediterranean as well as in B. bairdi from the Gulf of Mexico, but low in B. bairdi populations outside their native range. The phylogenetic analysis revealed the presence of connections between the Mediterranean localities as well as between native and introduced B. bairdi populations that focus the attention on the Panama Canal as important passage for the introduction of the species from the Gulf of Mexico to the north-east Pacific Ocean.	[Del Pasqua, Michela; Giangrande, Adriana] Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, CoNISMa Unit, Lecce, Italy; [Schulze, Anja] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Ana Tovar-Hernandez, Maria] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Lab Biosistemat, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Keppel, Erica] Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA; [Lezzi, Marco] Environm Protect Agcy Tuscany, ARPAT, AV Costa, UO Biol,Lab Sect, Pisa, Italy; [Gambi, Maria Cristina] Villa Dohrn Benth Ecol Ctr, Stn Zool Anton Dohrn Napoli, Dept Integrat Marine Ecol, Naples, Italy; [Giangrande, Adriana] Stn Zool Anton Dohrn Napoli, Naples, Italy	University of Salento; Texas A&M University System; Universidad Autonoma de Nuevo Leon; Smithsonian Institution; Smithsonian Environmental Research Center; Regional Environmental Protection Agency - Italy; Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli	Del Pasqua, M (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol DiSTeBA, CoNISMa Unit, Lecce, Italy.	michela.delpasqua@unisalento.it	lezzi, marco/AAA-5969-2020; Tovar-Hernández, María/F-3490-2019; Gambi, Maria Cristina/AFO-0958-2022; Keppel, Erica/E-9215-2016	lezzi, marco/0000-0002-6888-7790; Tovar-Hernández, María/0000-0002-5263-2830; Keppel, Erica/0000-0002-3969-7947; Del Pasqua, Michela/0000-0003-0711-0117	National Science Foundation [DEB-1036186]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant DEB-1036186, Dr Anja Schulze. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahyong ST, 2017, J MAR BIOL ASSOC UK, V97, P985, DOI 10.1017/S0025315417000261; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Albert RJ, 2013, ECOL APPL, V23, P289, DOI 10.1890/12-0669.1; Tovar-Hernandez MA, 2011, MAR BIOL RES, V7, P710, DOI 10.1080/17451000.2010.547201; Ana Tovar-Hernandez Maria, 2009, Marine Biodiversity Records, V2, pe43, DOI 10.1017/S1755267209000463; Tovar-Hernandez MA, 2009, SYST BIODIVERS, V7, P319, DOI 10.1017/S1477200009990041; Arias A, 2013, MEDITERR MAR SCI, V14, P162, DOI 10.12681/mms.363; Arvanitidis C, 2000, B MAR SCI, V66, P73; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barroso R, 2010, MAR BIOL, V157, P69, DOI 10.1007/s00227-009-1296-9; Bax N, 2003, MAR POLICY, V27, P313, DOI 10.1016/S0308-597X(03)00041-1; Bianchi C.N., 1983, ANN MUS CIV ST NAT G, V84, P231; Blakeslee AMH, 2010, DIVERS DISTRIB, V16, P879, DOI 10.1111/j.1472-4642.2010.00703.x; Blanchet S, 2012, FISHERIES MANAG ECOL, V19, P120, DOI 10.1111/j.1365-2400.2011.00832.x; BURDON JJ, 1981, J APPL ECOL, V18, P649, DOI 10.2307/2402423; Calosi P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0444; Capa M, 2013, ZOOL SCR, V42, P637, DOI 10.1111/zsc.12028; Capa M, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.622.9420; Capa M, 2015, ZOOTAXA, V4019, P98, DOI 10.11646/zootaxa.4019.1.8; Capa M, 2010, ORG DIVERS EVOL, V10, P351, DOI 10.1007/s13127-010-0033-z; Carlton JT, 1996, BIOL CONSERV, V78, P97, DOI 10.1016/0006-3207(96)00020-1; Carr CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022232; Cepeda D, 2018, J MAR BIOL ASSOC UK, V98, P1955, DOI 10.1017/S0025315417001618; Cinar ME, 2005, CAH BIOL MAR, V46, P143; Cinar ME, 2013, J MAR BIOL ASSOC UK, V93, P1257, DOI 10.1017/S0025315412001646; Cinar ME, 2009, J NAT HIST, V43, P2283, DOI 10.1080/00222930903094654; Cognetti G, 2005, MAR POLLUT BULL, V50, P119, DOI 10.1016/j.marpolbul.2004.11.042; Cohen Andrew N., 2006, V83, P127, DOI 10.1007/978-1-4020-5047-3_5; Corriero G, 2016, AQUAT CONSERV, V26, P392, DOI 10.1002/aqc.2550; Cossu P, 2015, MAR ECOL-EVOL PERSP, V36, P1088, DOI 10.1111/maec.12203; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Darling JA, 2015, BIOL INVASIONS, V17, P951, DOI 10.1007/s10530-014-0726-x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Carvalho MR, 2008, EVOL BIOL, V35, P150, DOI 10.1007/s11692-008-9018-7; Del Pasqua M, 2017, INVERTEBR BIOL, V136, P207, DOI 10.1111/ivb.12171; Dupont L, 2007, DIVERS DISTRIB, V13, P808, DOI 10.1111/j.1472-4642.2007.00405.x; El Haddad M, 2008, MARINE BIODIVERSITY, V1, pe61, DOI [10.1017/S1755267207006604, DOI 10.1017/S1755267207006604]; Eldridge MDB, 1999, CONSERV BIOL, V13, P531, DOI 10.1046/j.1523-1739.1999.98115.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Giangrande A., 2014, Biologia Marina Mediterranea, V21, P93; Giangrande A, 2004, BIODIVERS CONSERV, V13, P1633, DOI 10.1023/B:BIOC.0000029327.63397.6b; Giangrande A, 2012, MEDITERR MAR SCI, V13, P283, DOI 10.12681/mms.310; Goldstien SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016755; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Herre EA, 2006, P NATL ACAD SCI USA, V103, P3949, DOI 10.1073/pnas.0600550103; Hewitt CL, 2007, MAR POLLUT BULL, V55, P395, DOI 10.1016/j.marpolbul.2007.01.005; Hewitt CL, 2004, NEW ZEAL J MAR FRESH, V38, P429, DOI 10.1080/00288330.2004.9517250; HILDEBRAND SAMUEL F., 1939, ZOOLOGICA [NEW YORK], V24, P15; Hilliard J, 2016, INVERTEBR BIOL, V135, P415, DOI 10.1111/ivb.12152; Holland BS, 2000, HYDROBIOLOGIA, V420, P63, DOI 10.1023/A:1003929519809; Holloway MG, 2002, MAR ECOL PROG SER, V236, P137, DOI 10.3354/meps236137; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kelly MW, 2012, P ROY SOC B-BIOL SCI, V279, P349, DOI 10.1098/rspb.2011.0542; Keppel E, 2015, ZOOTAXA, V4058, P499, DOI 10.11646/zootaxa.4058.4.3; Khedhri I, 2017, BIOINVASIONS REC, V6, P139, DOI 10.3391/bir.2017.6.2.09; Langerhans P, 1884, Z WISSENSCHAFTLICHE, V40, P247; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Lezzi M, 2018, BIOL INVASIONS, V20, P937, DOI 10.1007/s10530-017-1601-3; Lezzi M, 2016, MAR BIOL RES, V12, P830, DOI 10.1080/17451000.2016.1206940; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Licciano M, 2002, INVERTEBR BIOL, V121, P55; Licciano M, 2008, SCI MAR, V72, P383; Licciano M, 2007, MAR ENVIRON RES, V63, P291, DOI 10.1016/j.marenvres.2006.11.003; Lopez E, 2017, HELGOLAND MAR RES, V71, DOI 10.1186/s10152-017-0499-6; Lopez-Legentil S, 2015, BIOL INVASIONS, V17, P1623, DOI 10.1007/s10530-014-0821-z; Lucey NM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12009; Maltagliati F, 2016, MAR ECOL-EVOL PERSP, V37, P492, DOI 10.1111/maec.12261; Mastrototaro F, 2015, MAR ECOL-EVOL PERSP, V36, P517, DOI 10.1111/maec.12160; McIntosh WC, 1885, REPORT SCI RESULTS V, V12, P1, DOI DOI 10.5962/BHL.TITLE.6513; MONRO C. C. A., 1933, ANN AND MAG NAT HIST, V12, P244; Nygren A, 2011, MOL PHYLOGENET EVOL, V58, P132, DOI 10.1016/j.ympev.2010.10.010; Ojaveer H, 2014, MAR POLICY, V44, P160, DOI 10.1016/j.marpol.2013.08.019; Patti FP, 2001, MAR ECOL PROG SER, V215, P169, DOI 10.3354/meps215169; Perez-Portela R, 2013, SCI REP-UK, V3, DOI 10.1038/srep03197; Perez-Portela R, 2012, MAR ECOL PROG SER, V451, P93, DOI 10.3354/meps09560; PHYLLIS, 1991, J NAT HIST, V25, P837, DOI 10.1080/00222939100770561; Pineda MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025495; Pineda MC, 2016, PEERJ, V4, DOI 10.7717/peerj.2158; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Ramalhosa P, 2014, BIOINVASIONS REC, V3, P235, DOI 10.3391/bir.2014.3.4.04; Ricevuto E, 2015, J EXP MAR BIOL ECOL, V468, P105, DOI 10.1016/j.jembe.2015.03.016; Rioja E, 1951, I BIOL UNAM Z, V22, P513; RIOJA ENRIQUE, 1958, AN INST BIOL [MEXICO], V29, P219; RIOJA ENRIQUE, 1960, AN INST BIOL UNIV MEXICO, V31, P289; Rius M, 2015, BIOL INVASIONS, V17, P869, DOI 10.1007/s10530-014-0792-0; Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003; Bastida-Zavala JR, 2016, ZOOTAXA, V4184, P401, DOI 10.11646/zootaxa.4184.3.1; Roman S, 2009, CAH BIOL MAR, V50, P241; Rubinoff I, 1965, NAT HIST, V74, P69; RUBINOFF RW, 1969, COPEIA, P395; Ruiz GM, 1999, LIMNOL OCEANOGR, V44, P950, DOI 10.4319/lo.1999.44.3_part_2.0950; Ruiz GM, BIOINVASIONS REC; Ruiz Gregory M., 2009, Smithsonian Contributions to the Marine Sciences, P291; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schloder C, 2013, AQUAT INVASIONS, V8, P443, DOI 10.3391/ai.2013.8.4.08; Schulze A, 2015, ZOOTAXA, V4019, P695, DOI 10.11646/zootaxa.4019.1.23; Schulze SR, 2000, EVOLUTION, V54, P1247; Sheth BP, 2017, GENOME, V60, P618, DOI 10.1139/gen-2015-0167; Simboura N., 2001, Monografies Thalassion Epistemon, V4, P1; Sordino P., 1992, OEBALIA S, V17, P425; Sun YA, 2017, MAR BIOL, V164, DOI 10.1007/s00227-016-3058-9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tovar-Hernandez M, 2006, ZOOTAXA, P1; Tovar-Hernandez MA, 2012, INVERTEBRADOS MARINO, P167; Tovar-Hernandez MA, 2014, ESPECIES INVASORAS A, P381; Virgilio M, 2009, MOL ECOL, V18, P1980, DOI 10.1111/j.1365-294X.2009.04170.x; Voisin M, 2005, P NATL ACAD SCI USA, V102, P5432, DOI 10.1073/pnas.0501754102; Waege Janine, 2017, Marine Biology (Berlin), V164, P199; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Zenetos A, 2011, MEDITERR MAR SCI, V12, P509, DOI 10.12681/mms.49; Zenetos A, 2017, ESTUAR COAST SHELF S, V191, P171, DOI 10.1016/j.ecss.2017.03.031	116	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197104	10.1371/journal.pone.0197104	http://dx.doi.org/10.1371/journal.pone.0197104			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746553	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700071
J	Hogan, LE; Hanhauser, E; Hobbs, KS; Palmer, CD; Robles, Y; Jost, S; LaCasce, AS; Abramson, J; Hamdan, A; Marty, FM; Kuritzkes, DR; Henrich, TJ				Hogan, Louise E.; Hanhauser, Emily; Hobbs, Kristen S.; Palmer, Christine D.; Robles, Yvonne; Jost, Stephanie; LaCasce, Anne S.; Abramson, Jeremy; Hamdan, Ayad; Marty, Francisco M.; Kuritzkes, Daniel R.; Henrich, Timothy J.			Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; MULTICENTRIC CASTLEMAN-DISEASE; CLASSIC KAPOSIS-SARCOMA; HIV-NEGATIVE PATIENT; TIME PCR ASSAY; LIPOSOMAL DOXORUBICIN; RITUXIMAB; DNA; HUMAN-HERPESVIRUS-8; PROGRESSION	Background Human Herpes Virus 8 (HHV8) can cause Kaposi's Sarcoma (KS) in immunosuppressed individuals. However, little is known about the association between chemotherapy or hematopoietic stem cell transplantation (HSCT), circulating HHV8 DNA levels, and clinical KS in HIV-1-infected individuals with various malignancies. Therefore, we examined the associations between various malignancies, systemic cancer chemotherapy, T cell phenotypes, and circulating HHV8 DNA in 29 HIV-1-infected participants with concomitant KS or other cancer diagnoses. Methods We quantified HHV8 plasma viral loads and cell-associated HHV8 DNA and determined the relationship between circulating HHV8 DNA and lymphocyte counts, and markers of early and late lymphocyte activation, proliferation and exhaustion. Results There were no significant differences in plasma HHV8 DNA levels between baseline and post-chemotherapy time points or with the presence or absence of clinical KS. However, in two participants circulating HHV8 DNA increased following treatment for KS or HSCT for lymphoma,. We observed an approximately 2-log(10) reduction in plasma HHV8 DNA in an individual with KS and multicentric Castleman disease following rituximab monotherapy. Although individuals with clinical KS had lower mean CD4(+) T cell counts and percentages as expected, there were no significant associations with these factors and plasma HHV8 levels. We identified increased proportions of CD8(+) and CD4(+) T cells expressing CD69 (P = 0.01 & P = 0.04 respectively), and increased CD57 expression on CD4(+) T cells (P = 0.003) in participants with detectable HHV8. Conclusion These results suggest there is a complex relationship between circulating HHV8 DNA and tissue-based disease in HIV-1 and HHV8 co-infected individuals with various malignancies.	[Hogan, Louise E.; Hanhauser, Emily; Hobbs, Kristen S.; Henrich, Timothy J.] UCSF, Dept Expt Med, San Francisco, CA 94143 USA; [Hogan, Louise E.; Hanhauser, Emily; Hobbs, Kristen S.; Robles, Yvonne; Marty, Francisco M.; Kuritzkes, Daniel R.; Henrich, Timothy J.] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA; [Hogan, Louise E.; LaCasce, Anne S.; Abramson, Jeremy; Hamdan, Ayad; Marty, Francisco M.; Kuritzkes, Daniel R.; Henrich, Timothy J.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Palmer, Christine D.; Jost, Stephanie] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Jost, Stephanie; Hamdan, Ayad] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [LaCasce, Anne S.; Marty, Francisco M.] Dana Faber Canc Inst, Dept Med, Boston, MA USA; [Abramson, Jeremy] Massachusetts Gen Hosp, Boston, MA 02114 USA	University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital	Hogan, LE; Henrich, TJ (corresponding author), UCSF, Dept Expt Med, San Francisco, CA 94143 USA.; Hogan, LE; Henrich, TJ (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.; Hogan, LE; Henrich, TJ (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	lou.hogan3@gmail.com; timothy.henrich@ucsf.edu	Marty, Francisco M./H-7088-2019; Palmer, Christine/GXH-4415-2022; Abramson, Jeremy/N-5178-2019	Marty, Francisco M./0000-0002-3708-8734; Palmer, Christine Denise/0000-0003-3213-0398; Hobbs, Kristen S./0000-0001-8912-7398; Hogan, Louise/0000-0001-5526-954X	Federal funds from NIH/NIAID [K23A1098480, UM1 068636]; Foundation for AIDS Research (amfAR) ARCHE grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI098480] Funding Source: NIH RePORTER	Federal funds from NIH/NIAID; Foundation for AIDS Research (amfAR) ARCHE grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Federal funds from NIH/NIAID K23A1098480 (to T.J.H), UM1 068636 (AIDS Clinical Trials Group Virology Support Laboratory), and by the Foundation for AIDS Research (amfAR) ARCHE grant to T.J.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broccolo F, 2002, J CLIN MICROBIOL, V40, P4652, DOI 10.1128/JCM.40.12.4652-4658.2002; Bruno B, 2006, EUR J HAEMATOL, V76, P342, DOI 10.1111/j.1600-0609.2005.00601.x; Casquero A, 2006, ANN HEMATOL, V85, P185, DOI 10.1007/s00277-005-0038-4; Clifford KS, 2005, J AM ACAD DERMATOL, V53, P155, DOI 10.1016/j.jaad.2004.12.048; Engels EA, 2003, AIDS, V17, P1847, DOI 10.1097/00002030-200308150-00015; Gerard L, 2012, BLOOD, V119, P2228, DOI 10.1182/blood-2011-08-376012; Henrich TJ, 2014, ANN INTERN MED, V161, P319, DOI 10.7326/M14-1027; Henrich TJ, 2012, J VIROL METHODS, V186, P68, DOI 10.1016/j.jviromet.2012.08.019; Laney AS, 2004, AIDS, V18, P1819, DOI 10.1097/00002030-200409030-00011; Lin L, 2009, J CLIN ONCOL, V27, P2496, DOI 10.1200/JCO.2008.20.1707; Malnati MS, 2008, NAT PROTOC, V3, P1240, DOI 10.1038/nprot.2008.108; Martin-Carbonero L, 2008, CLIN INFECT DIS, V47, P410, DOI 10.1086/589865; Moore PS, 2000, NEW ENGL J MED, V343, P1411, DOI 10.1056/NEJM200011093431912; Murphy C, 2017, J CLIN PHARM THER, V42, P111, DOI 10.1111/jcpt.12472; Pantanowitz L, 2008, BMC CLIN PATHOL, V8, DOI 10.1186/1472-6890-8-7; Shiels MS, 2011, JAMA-J AM MED ASSOC, V305, P1450, DOI 10.1001/jama.2011.396; Stratigos AJ, 2005, ARCH DERMATOL, V141, P1421, DOI 10.1001/archderm.141.11.1421; Ureshino H, 2015, INTERNAL MED, V54, P3205, DOI 10.2169/internalmedicine.54.5103; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9	19	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197298	10.1371/journal.pone.0197298	http://dx.doi.org/10.1371/journal.pone.0197298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746555	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700098
J	Kim, B; Lee, HJ; Im, NR; Lee, Y; Kim, HK; Kang, CY; Park, IH; Lee, SH; Lee, HM; Lee, SH; Baek, SK; Kim, TH				Kim, Byoungjae; Lee, Hyun-Ji; Im, Nu-Ri; Lee, Young; Kim, Ha Kyun; Kang, Cha Young; Park, Il-Ho; Lee, Seung Hoon; Lee, Heung-Man; Lee, Sang Hag; Baek, Seung-Kuk; Kim, Tae Hoon			Decreased expression of CCL17 in the disrupted nasal polyp epithelium and its regulation by IL-4 and IL-5	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; CHRONIC RHINOSINUSITIS; E-CADHERIN; T-CELLS; INFLAMMATION; CHEMOKINES; ASTHMA; TARC; ASSOCIATION; ACTIVATION	Background In airway epithelium, thymus and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) are induced by defective epithelial barriers such as E-cadherin and attract the effector cells of Th2 immunity. However, the association between the epithelial barrier and CCL17 expression has not been studied in chronic rhinosinusitis with nasal polyp (CRSwNP). Thus, we aimed to evaluate the expression of CCL17 and its regulation by Th cytokines in nasal polyp (NP) epithelial cells. Methods The expression and distribution of CCL17, CCL22, E-cadherin and/or epidermal growth factor receptor (EGFR) were measured using real-time PCR, western blot, and immunohistochemistry and compared between normal ethmoid sinus epithelium and NP epithelium. In addition, the expression level of CCL17 was determined in cultured epithelial cells treated with IL-4, IL-5, IL-13, TNF-alpha, and IFN-gamma. Results The expression of CCL17 was decreased in the NP epithelium compared to the epithelium of normal ethmoid sinus, whereas the expression of CCL22 was not decreased. E-cadherin was differentially distributed between the epithelium of normal ethmoid sinus and NP epithelium. EGFR was also decreased in NPs. Interestingly, the stimulation of cultured epithelial cells with Th2 cytokines, IL-4 and IL-5, resulted in an upregulation of CCL17 expression only in NP epithelial cells whereas the expression of CCL17 was increased in both normal epithelial cells and NP epithelial cells by Th1 cytokines. Conclusion Our results suggest that the decreased expression of CCL17 in defective NP epithelium may be closely connected to NP pathogenesis and can be differentially regulated by cytokines in the NP epithelium of patients with CRSwNP.	[Kim, Byoungjae; Lee, Hyun-Ji; Im, Nu-Ri; Lee, Young; Kim, Ha Kyun; Kang, Cha Young; Park, Il-Ho; Lee, Seung Hoon; Lee, Heung-Man; Lee, Sang Hag; Baek, Seung-Kuk; Kim, Tae Hoon] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Byoungjae] Korea Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Baek, SK; Kim, TH (corresponding author), Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	mdskbaek@gmail.com; doctorth@korea.ac.kr		PARK, IL-HO/0000-0002-7011-6071	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Ministry of Science, ICT & Future Planning [2014R1A1A1002131, 2016R1E1A2020731, 2017R1A2B2003575]; Clinical Trial Center of Korea University Anam Hospital [I1500931]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) by the Ministry of Health Welfare [HI17C0387, HI14C0748]; Korea University grant; Korea University Medical Center; Anam Hospital, Seoul, Republic of Korea [01700021, K1620151]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Clinical Trial Center of Korea University Anam Hospital; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) by the Ministry of Health Welfare; Korea University grant; Korea University Medical Center; Anam Hospital, Seoul, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology and the Ministry of Science, ICT & Future Planning (2014R1A1A1002131, 2016R1E1A2020731, 2017R1A2B2003575), the Clinical Trial Center of Korea University Anam Hospital (I1500931), and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) by the Ministry of Health & Welfare (HI17C0387, HI14C0748). This research was also supported by a Korea University grant and a grant of Korea University Medical Center and Anam Hospital, Seoul, Republic of Korea (01700021, K1620151).	Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Araujo-Pires AC, 2015, J BONE MINER RES, V30, P400, DOI 10.1002/jbmr.2376; Baba S, 2014, LARYNGOSCOPE, V124, pE115, DOI 10.1002/lary.24462; Banerji A, 2007, AM J RHINOL, V21, P19, DOI 10.2500/ajr.2007.21.2979; Burgel PR, 2000, J ALLERGY CLIN IMMUN, V106, P705, DOI 10.1067/mai.2000.109823; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Chin D, 2013, CURR OPIN OTOLARYNGO, V21, P23, DOI 10.1097/MOO.0b013e32835bc3f9; Ding GQ, 2007, ARCH OTOLARYNGOL, V133, P1097, DOI 10.1001/archotol.133.11.1097; Edward JA, 2017, CLIN IMMUNOL, V179, P66, DOI 10.1016/j.clim.2017.02.002; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fukumoto A, 2008, INT ARCH ALLERGY IMM, V145, P291, DOI 10.1159/000110085; Heijink IH, 2010, EUR RESPIR J, V36, P1016, DOI 10.1183/09031936.00125809; Heijink IH, 2007, J IMMUNOL, V178, P7678, DOI 10.4049/jimmunol.178.12.7678; Heijink IH, 2007, AM J RESP CELL MOL, V36, P351, DOI 10.1165/rcmb.2006-0160OC; Heijink IH, 2010, AM J RESP CELL MOL, V42, P69, DOI 10.1165/rcmb.2008-0449OC; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Kim DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111352; Kim YM, 2010, CLIN IMMUNOL, V137, P111, DOI 10.1016/j.clim.2010.05.013; Kimura S, 2011, ALLERGY ASTHMA IMMUN, V3, P186, DOI 10.4168/aair.2011.3.3.186; Lam M, 2015, AM J RHINOL ALLERGY, V29, P175, DOI 10.2500/ajra.2015.29.4176; Lam M, 2013, INT FORUM ALLERGY RH, V3, P121, DOI 10.1002/alr.21082; Lanza DC, 1997, OTOLARYNG HEAD NECK, V117, pS1, DOI 10.1016/S0194-5998(97)70001-9; Li HB, 2008, CLIN IMMUNOL, V129, P394, DOI 10.1016/j.clim.2008.07.031; Lund VJ, 1997, OTOLARYNG HEAD NECK, V117, pS35, DOI 10.1016/S0194-5998(97)70005-6; Mahdavinia M, 2015, J ALLERGY CLIN IMMUN, V135, P576, DOI 10.1016/j.jaci.2014.08.031; Meng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082373; Miljkovic D, 2014, ALLERGY, V69, P1154, DOI 10.1111/all.12440; Nagarkar DR, 2013, J ALLERGY CLIN IMMUN, V132, P593, DOI 10.1016/j.jaci.2013.04.005; Piccirillo JF., 2002, OTOLARYNG HEAD NECK, V126, P41, DOI [10.1067/mhn.2002.121022, DOI 10.1067/mhn.2002.121022]; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Shikani AH, 2014, AM J OTOLARYNG, V35, P377, DOI 10.1016/j.amjoto.2013.11.011; Shin HW, 2015, J ALLERGY CLIN IMMUN, V135, P1476, DOI 10.1016/j.jaci.2015.01.003; Song JF, 2013, TOXICOL LETT, V220, P8, DOI 10.1016/j.toxlet.2013.03.033; Terada N, 2001, CLIN EXP ALLERGY, V31, P1923, DOI 10.1046/j.1365-2222.2001.01152.x; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Wu DW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002998; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Zhang N, 2006, AM J RHINOL, V20, P445, DOI 10.2500/ajr.2006.20.2887; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	42	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197355	10.1371/journal.pone.0197355	http://dx.doi.org/10.1371/journal.pone.0197355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746583	gold, Green Published, Green Submitted			2022-12-26	WOS:000431851700106
J	Yin, ZY; Zeng, L; Luo, SM; Chen, P; He, X; Guo, W; Li, BL				Yin, Zuo-Yun; Zeng, Lu; Luo, Shao-Ming; Chen, Ping; He, Xiao; Guo, Wei; Li, Bailian			Examining the patterns and dynamics of species abundance distributions in succession of forest communities by model selection	PLOS ONE			English	Article							CANONICAL DISTRIBUTION; PLANT-COMMUNITIES; RANK-ABUNDANCE; DIVERSITY; AREA; COMMONNESS	There are a few common species and many rare species in a biological community or a multi-species collection in given space and time. This hollow distribution curve is called species abundance distribution (SAD). Few studies have examined the patterns and dynamics of SADs during the succession of forest communities by model selection. This study explored whether the communities in different successional stages followed different SAD models and whether there existed a best SAD model to reveal their intrinsic quantitative features of structure and dynamics in succession. The abundance (the number of individuals) of each vascular plant was surveyed by quadrat sampling method from the tree, shrub and herb layers in two typical communities (i.e., the evergreen needle- and broadleaved mixed forest and the monsoon evergreen broad-leaved forest) in southern subtropical Dinghushan Biosphere Reserve, South China. The sites of two forest communities in different successional stages are both 1 ha in area. We collected seven widely representative SAD models with obviously different function forms and transformed them into the same octave (log 2 ) scale. These models are simultaneously confronted with eight datasets from four layers of two communities, and their goodness-of-fits to the data were evaluated by the chi-squared test, the adjusted coefficient of determination and the information criteria. The results indicated that: (1) the logCauchy model followed all the datasets and was the best among seven models; (2) the fitness of each model to the data was not directly related to the successional stage of forest community; (3) according to the SAD curves predicted by the best model (i.e., the logCauchy), the proportion of rare species decreased but that of common ones increased in the upper layers with succession, while the reverse was true in the lower layers; and (4) the difference of the SADs increased between the upper and the lower layers with succession. We concluded that the logCauchy model had the widest applicability in describing the SADs, and could best mirror the SAD patterns and dynamics of communities and their different layers in the succession of forests. The logCauchy-modeled SADs can quantitatively guide the construction of ecological forests and the restoration of degraded vegetation.	[Yin, Zuo-Yun; Chen, Ping; Guo, Wei] Zhongkai Univ Agr & Engn, Coll Hort & Landscape Architecture, Guangzhou, Guangdong, Peoples R China; [Yin, Zuo-Yun] Guangdong Prov Key Lab Forest Breeding Protect &, Guangzhou, Guangdong, Peoples R China; [Yin, Zuo-Yun] Guangdong Acad Forestry, Guangdong Forest Res Inst, Guangzhou, Guangdong, Peoples R China; [Yin, Zuo-Yun] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Yin, Zuo-Yun; Li, Bailian] Univ Calif Riverside, Dept Bot & Plant Sci, Ecol Complex & Modeling Lab, Riverside, CA 92521 USA; [Zeng, Lu] Guangdong Ecol Engn Vocat Coll, Guangzhou, Guangdong, Peoples R China; [Luo, Shao-Ming] Zhongkai Univ Agr & Engn, Fac Mech & Elect Engn, Guangzhou, Guangdong, Peoples R China; [He, Xiao] Guangdong Univ Finance & Econ, Coll Econ, Guangzhou, Guangdong, Peoples R China	Zhongkai University of Agriculture & Engineering; Chinese Academy of Sciences; South China Botanical Garden, CAS; University of California System; University of California Riverside; Zhongkai University of Agriculture & Engineering; Guangdong University of Finance & Economics	Yin, ZY (corresponding author), Zhongkai Univ Agr & Engn, Coll Hort & Landscape Architecture, Guangzhou, Guangdong, Peoples R China.; Yin, ZY (corresponding author), Guangdong Prov Key Lab Forest Breeding Protect &, Guangzhou, Guangdong, Peoples R China.; Yin, ZY (corresponding author), Guangdong Acad Forestry, Guangdong Forest Res Inst, Guangzhou, Guangdong, Peoples R China.; Yin, ZY (corresponding author), Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.; Yin, ZY (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Ecol Complex & Modeling Lab, Riverside, CA 92521 USA.; Luo, SM (corresponding author), Zhongkai Univ Agr & Engn, Fac Mech & Elect Engn, Guangzhou, Guangdong, Peoples R China.; He, X (corresponding author), Guangdong Univ Finance & Econ, Coll Econ, Guangzhou, Guangdong, Peoples R China.	yinzuoyun@163.com; smluo@gdut.edu.cn; 807933187@qq.com		Yin, Zuo-Yun/0000-0001-9169-4447	Education Department of Guangdong Province, China [2016KZDXM002]; Ministry of Science and Technology of the People's Republic of China [2012BAD22B05]; Science and Technology Department of Guangdong Province, China [2015A040404045, 2016A020207003]	Education Department of Guangdong Province, China; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Science and Technology Department of Guangdong Province, China	This work was supported by the Education Department of Guangdong Province, China, Award Number: 2016KZDXM002 (Recipient: Zuo-Yun Yin, Ph.D.); Ministry of Science and Technology of the People's Republic of China, Award Number: 2012BAD22B05 (Recipient: Lu Zeng); Science and Technology Department of Guangdong Province, China, Award Number: 2015A040404045 (Recipient: Ping Chen); and Science and Technology Department of Guangdong Province, China, Award Number: 2016A020207003 (Recipient: Ping Chen).	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; AOKI I, 1995, ECOL MODEL, V82, P21, DOI 10.1016/0304-3800(94)00076-T; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; Eliazar I, 2015, ANN PHYS-NEW YORK, V355, P322, DOI 10.1016/j.aop.2015.02.016; Eliazar II, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052104; Engen S, 1996, MATH BIOSCI, V132, P169, DOI 10.1016/0025-5564(95)00054-2; Ferreri L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003931; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Forster MA, 2007, ECOGRAPHY, V30, P449, DOI [10.1111/j.2007.0906-7509.04899.x, 10.1111/j.0906-7590.2007.04899.x]; Guo QF, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00023; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; Jackson CR, 2001, ECOLOGY, V82, P555, DOI 10.2307/2679879; Jiang RY, 2015, INTRO QUALITY RELIAB, P79; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Jost Lou, 2011, P66; KEMPTON RA, 1974, J ANIM ECOL, V43, P381, DOI 10.2307/3371; Krebs CJ, 2001, ECOLOGY EXPT ANAL DI; Li B., 2002, ENCY ENV, P821; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111500; Loehle C, 2006, ECOLOGY, V87, P2221, DOI 10.1890/0012-9658(2006)87[2221:SADRFB]2.0.CO;2; LONGUET-HIGGINS M S, 1971, Theoretical Population Biology, V2, P271, DOI 10.1016/0040-5809(71)90020-7; MACARTHUR R, 1960, AM NAT, V94, P25, DOI 10.1086/282106; May R.M., 1975, P81; McGill B, 2003, OIKOS, V102, P679, DOI 10.1034/j.1600-0706.2003.12617.x; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; MILLER RI, 1989, ECOLOGY, V70, P16, DOI 10.2307/1938408; Molles M., 1999, ECOLOGY CONCEPTS APP; Peng Shao-Lin, 2003, Acta Ecologica Sinica, V23, P1590; PIELOU EC, 1966, SCIENCE, V151, P592, DOI 10.1126/science.151.3710.592; Plotkin JB, 2002, ECOLOGY, V83, P3344, DOI 10.1890/0012-9658(2002)083[3344:STSCOA]2.0.CO;2; PRESTON FW, 1962, ECOLOGY, V43, P410, DOI 10.2307/1933371; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Quinn GP, 2002, EXPT DESIGN DATA ANA, P144; Rocchini D, 2012, INT J REMOTE SENS, V33, P4458, DOI 10.1080/01431161.2011.648286; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Scott D., 2014, Journal of Plant Studies, V3, P58; Sizling AL, 2009, THEOR ECOL-NETH, V2, P89, DOI 10.1007/s12080-008-0031-3; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; [殷祚云 Yin Zuoyun], 2013, [生态环境学报, Ecology and Environmental Sciences], V22, P189; [殷祚云 Yin Zuoyun], 2009, [生态环境学报, Ecology and Environmental Sciences], V18, P222; Yin ZY, 2005, J INTEGR PLANT BIOL, V47, P801, DOI 10.1111/j.1744-7909.2005.00095.x; Yin ZY, 2005, ECOL MODEL, V184, P329, DOI 10.1016/j.ecolmodel.2004.10.011; Yin ZY, 2005, THESIS; Yin ZY, 1999, GUIHAIA, V19, P221; Zeng LH, 2013, MANAGEMENT SECONDARY; Zhang Feng, 2013, Yingyong Shengtai Xuebao, V24, P511; Zhang JT, 2004, QUANTITATIVE ECOLOGY, DOI DOI 10.1186/1472-6785-4-8; Zhang QM, 2002, TROPICAL SUBTROPICAL, V9, P18	53	1	1	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196898	10.1371/journal.pone.0196898	http://dx.doi.org/10.1371/journal.pone.0196898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746516	gold, Green Published, Green Submitted			2022-12-26	WOS:000431851700046
J	Aharaz, A; Pottegard, A; Henriksen, DP; Hallas, J; Beck-Nielsen, H; Lassen, AT				Aharaz, Abdellatif; Pottegard, Anton; Henriksen, Daniel Pilsgaard; Hallas, Jesper; Beck-Nielsen, Henning; Lassen, Annmarie Touborg			Risk of lactic acidosis in type 2 diabetes patients using metformin: A case control study	PLOS ONE			English	Article							RENAL IMPAIRMENT; LACTATE; MORTALITY; QUALITY	Background Metformin constitutes first-line treatment of type 2 diabetes mellitus. It is presumed to have lactic acidosis as a dangerous, but rare, side effect. Objectives To estimate the incidence rate of lactic acidosis in patients with type 2 diabetes mellitus as well as to estimate the relative risk of lactic acidosis associated with metformin treatment. Methods This is a population-based combined cohort and case-control study among patients with type 2 diabetes mellitus who were acutely admitted with lactic acidosis at Odense University Hospital, Denmark; in the period from 1st June 2009 to 1st October 2013. The patients included as cases were all acutely hospitalized with lactic acidosis (pH <7.35 and lactate >= 2.0 mmol/l). For each case, we identified 24 age- and sex-matched controls sampled from the same cohort with type 2 diabetes mellitus. The use of metformin identified by using a prescription database. Analyses included multivariable logistic regression and adjusting for predefined confounding: renal function, HbA1c, comorbidity and diabetes duration. Results Our cohort included 10,652 patients with type 2 diabetes mellitus with a median age of 74 years, and 51.5% were male. During follow-up, 163 individuals were hospitalized with lactic acidosis, corresponding to an incidence rate of 391/100,000 person years. Use of metformin was not associated with lactic acidosis: adjusted odds ratio was 0.79 (95%CI 0.54-1.17). Conclusion Among patients with type 2 diabetes mellitus, the incidence rate of acute hospitalization with lactic acidosis was 391/100,000 person years. Use of metformin did not increase the risk of lactic acidosis. However, comorbidity seems to be an important risk factor.	[Aharaz, Abdellatif; Beck-Nielsen, Henning] Odense Univ Hosp, Dept Endocrinol, Odense, Denmark; [Pottegard, Anton; Hallas, Jesper] Univ Southern Denmark, Clin Pharmacol & Pharm, Odense, Denmark; [Henriksen, Daniel Pilsgaard] Odense Univ Hosp, Dept Resp Med, Odense, Denmark; [Lassen, Annmarie Touborg] Odense Univ Hosp, Dept Emergency Med, Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Aharaz, A (corresponding author), Odense Univ Hosp, Dept Endocrinol, Odense, Denmark.	abaha@regionsjaelland.dk	Lassen, Annmarie/AAA-5816-2019	Pottegard, Anton/0000-0001-9314-5679; Henriksen, Daniel Pilsgaard/0000-0003-1303-6195; Lassen, Annmarie/0000-0003-4942-6152	Novo Nordisk; University of Southern Denmark; Nordic Bioscience via Danish PhD School of Endocrinology	Novo Nordisk(Novo Nordisk); University of Southern Denmark; Nordic Bioscience via Danish PhD School of Endocrinology	Professor Henning Beck-Nielsen received reimbursement of travel expenses from Novo Nordisk in connection with an invited lecture, but received no honorarium. Novo Nordisk had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Abdellatif Aharaz has received a PhD stipendiate funded by The University of Southern Denmark and Nordic Bioscience via Danish PhD School of Endocrinology. The University of Southern Denmark and Nordic Bioscience had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2012, WHO COLL CTR DRUG ST; Bodmer M, 2008, DIABETES CARE, V31, P2086, DOI 10.2337/dc08-1171; Brown JB, 1998, DIABETES CARE, V21, P1659, DOI 10.2337/diacare.21.10.1659; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dujic T, 2015, DIABETES, V64, P1786, DOI 10.2337/db14-1388; Ekstrom N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001076; Eppenga WL, 2014, DIABETES CARE, V37, P2218, DOI 10.2337/dc13-3023; Friesecke S, 2010, CRIT CARE, V14, DOI 10.1186/cc9376; Guelho D, 2014, ACTA MEDICA PORT, V27, P196, DOI 10.20344/amp.4071; Haidl F, 2015, EUR J EMERG MED, V22, P282, DOI 10.1097/MEJ.0000000000000210; Hallas J, 2001, PHARMACOEPIDEM DR S, V10, P619, DOI 10.1002/pds.638; Hloch O, 2012, NEUROENDOCRINOL LETT, V33, P792; International Diabetes Federation, IDF DIAB ATL 2015; Inzucchi SE, 2014, JAMA-J AM MED ASSOC, V312, P2668, DOI 10.1001/jama.2014.15298; Kajbaf F, 2013, DIABETIC MED, V30, P345, DOI 10.1111/dme.12017; Kajbaf F, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-22; Keller G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023200; Kraut JA, 2014, NEW ENGL J MED, V371, P2309, DOI 10.1056/NEJMra1309483; Krzymien J, 2013, POL ARCH MED WEWN, V123, P91, DOI 10.20452/pamw.1619; Lepelley M, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/3545914; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Pedersen M, 2015, EMERG MED J, V32, P678, DOI 10.1136/emermed-2014-204305; Richy FF, 2014, DIABETES CARE, V37, P2291, DOI 10.2337/dc14-0464; Salpeter SR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002967.pub3; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Stang M, 1999, DIABETES CARE, V22, P925, DOI 10.2337/diacare.22.6.925; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; van Berlo-van de Laar IRF, 2011, J CLIN PHARM THER, V36, P376, DOI 10.1111/j.1365-2710.2010.01192.x	30	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196122	10.1371/journal.pone.0196122	http://dx.doi.org/10.1371/journal.pone.0196122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738540	Green Published, Green Submitted, gold			2022-12-26	WOS:000431724900006
J	Andreis, ME; Polito, U; Veronesi, MC; Faustini, M; Di Giancamillo, M; Modina, SC				Andreis, Maria Elena; Polito, Umberto; Veronesi, Maria Cristina; Faustini, Massimo; Di Giancamillo, Mauro; Modina, Silvia C.			Novel contributions in canine craniometry: Anatomic and radiographic measurements in newborn puppies	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; SKULL SHAPE; BREEDS; DOGS; TYPOLOGY	The largest differences in intraspecific head shape among the Carnivora order are to be found in dogs. Based on their skull morphotypes, dog breeds are currently classified as dolichocephalic, mesaticephalic and brachycephalic. Due to the fact that some breeds have not been yet defined, this classification is incomplete; moreover, multi-breed studies on the skull morphology of puppies have never been performed. The aim of this work was to verify (i) whether differences in the skull conformation of purebred puppies are already present within the first week of age; (ii) whether radiographic and anatomic measures could be considered interchangeable, and (iii) to possibly classify puppies from non-categorized breeds thanks to their radiographic cranial measurements using neural nets. One hundred and thirty-seven dead puppies aged 0-7 days were examined considering their anatomic and radiographic measures. All linear measures and anatomic indices significantly differed among brachycephalic and non-brachycephalic puppies. Radiographic indices, with the exception of CI, identified the three skull morphotypes (p<0.05, for all comparisons). Radiographic and anatomic measures proved to be non-interchangeable in newborn puppies. Finally, nineteen puppies belonging to 5 non-categorized breeds could be classified thanks to neural nets in the three skull morphotypes with different probability (P between 0,66 and 0,95).	[Andreis, Maria Elena; Polito, Umberto; Modina, Silvia C.] Univ Milan, Dept Hlth Anim Sci & Food Safety, Milan, Italy; [Veronesi, Maria Cristina; Faustini, Massimo; Di Giancamillo, Mauro] Univ Milan, Dept Vet Med, Milan, Italy	University of Milan; University of Milan	Di Giancamillo, M (corresponding author), Univ Milan, Dept Vet Med, Milan, Italy.	mauro.digiancamillo@unimi.it	Di Giancamillo, Mauro/M-4877-2017; VERONESI, MARIA CRISTINA/L-1033-2017	Di Giancamillo, Mauro/0000-0003-3128-4619; VERONESI, MARIA CRISTINA/0000-0002-6062-6692; POLITO, UMBERTO/0000-0002-4503-8155	Universita degli Studi di Milano (UNIMI) - Piano di Sostegno alla Ricerca [LINEA2CVER0_2017_AZB]	Universita degli Studi di Milano (UNIMI) - Piano di Sostegno alla Ricerca	Funded by Universita degli Studi di Milano (UNIMI) - Piano di Sostegno alla Ricerca 2015-2017 - LINEA2CVER0_2017_AZB.	Alpak H, 2004, ANN ANAT, V186, P323, DOI 10.1016/S0940-9602(04)80050-5; Bannasch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009632; Bourdelle E., 1953, ANATOMIE REGIONALE A; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; BREHM H, 1985, Anatomia Histologia Embryologia, V14, P324, DOI 10.1111/j.1439-0264.1985.tb00828.x; Carrasco JJ, 2014, J VET BEHAV, V9, P43, DOI 10.1016/j.jveb.2013.09.004; Contri A, 2012, REPRODUCTION, V144, P339, DOI 10.1530/REP-12-0125; Cross C. L., 2016, BSAVA Congress 2016 Proceedings, 7-10 April 2016, Birmingham, UK, P542; Di Giancamillo A, 2016, EUR J HISTOCHEM, V60, P189, DOI 10.4081/ejh.2016.2701; Drake AG, 2010, AM NAT, V175, P289, DOI 10.1086/650372; Dyce K.M., 2010, TXB VET ANATOMY, V4th ed.; Ellenberger W, 1932, HDB VERGLEICHENDEN A; Evans H.E., 2013, MILLERS ANATOMY DOG; Fogel GB, 2008, BRIEF BIOINFORM, V9, P307, DOI 10.1093/bib/bbn021; Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31; Georgevsky D, 2014, J VET BEHAV, V9, P228, DOI 10.1016/j.jveb.2014.04.007; Getty R, 1975, SISSON GROSSMANS ANA; Helton WS, 2009, BEHAV PROCESS, V82, P355, DOI 10.1016/j.beproc.2009.08.004; Knowler SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151280; Koch DA, 2012, SCHWEIZ ARCH TIERH, V154, P217, DOI 10.1024/0036-7281/a000331; LIGNEREUX Y, 1991, REV MED VET-TOULOUSE, V142, P469; Marchant TW, 2017, CURR BIOL, V27, P1573, DOI 10.1016/j.cub.2017.04.057; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; McGreevy PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080529; Meola SD, 2013, TOP COMPANION ANIM M, V28, P91, DOI 10.1053/j.tcam.2013.06.004; Modina SC, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1092-6; Onar V, 2003, ANAT REC PART A, V272A, P460, DOI 10.1002/ar.a.10052; Onar V, 1999, ANAT HISTOL EMBRYOL, V28, P253, DOI 10.1046/j.1439-0264.1999.00202.x; Onar V, 2001, ANAT HISTOL EMBRYOL, V30, P41, DOI 10.1046/j.1439-0264.2001.00292.x; Pilegaard AM, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00030; Pouliakis A, 2016, BIOMED ENG COMPUT BI, V7, P1, DOI 10.4137/BECB.S31601; REGODON S, 1993, ANN ANAT, V175, P361, DOI 10.1016/S0940-9602(11)80043-9; Roberts T, 2010, VET J, V183, P266, DOI 10.1016/j.tvjl.2009.11.005; Saber A.S., 2015, Journal of Veterinary Anatomy, V8, P13; Schmidt MJ, 2011, VET RADIOL ULTRASOUN, V52, P436, DOI 10.1111/j.1740-8261.2011.01825.x; Schmidt MJ, 2014, ACTA VET SCAND, V56, DOI 10.1186/1751-0147-56-30; Schoenebeck JJ, 2013, GENETICS, V193, P317, DOI 10.1534/genetics.112.145284; SEIFERLE E, 1966, ACTA ANAT, V63, P346, DOI 10.1159/000142799; Shearin AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000310; STARCK D., 1962, ZEIT TIERZUCHT UNG ZUCHTUNGS BIOL, V77, P129; Stockard CR, 1941, AM ANATOMY MEMOIR, V19; Stone HR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149403; Sutter NB, 2008, MAMM GENOME, V19, P713, DOI 10.1007/s00335-008-9153-6; Teng Kendy T, 2016, Canine Genet Epidemiol, V3, P2, DOI 10.1186/s40575-016-0032-2; Trangerud C, 2007, J ANIM SCI, V85, P76, DOI 10.2527/jas.2006-354; TROUTH CO, 1977, ACTA ANAT, V98, P469, DOI 10.1159/000144826	46	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196959	10.1371/journal.pone.0196959	http://dx.doi.org/10.1371/journal.pone.0196959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738556	Green Published, gold			2022-12-26	WOS:000431724900033
J	Landau, D; London, L; Bandach, I; Segev, Y				Landau, Daniel; London, Lital; Bandach, Inbar; Segev, Yael			The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia	PLOS ONE			English	Article							STIMULATING AGENTS; IRON-METABOLISM; ERYTHROPOIETIN; RESISTANCE; HEPCIDIN; HIF-2-ALPHA; CHILDREN	Objectives Anemia is a known driver for hypoxia inducible factor (HIF) which leads to increased renal erythropoietin (EPO) synthesis. Bone marrow (BM) EPO receptor (EPOR) signals are transduced through a JAK2-STAT5 pathway. The origins of anemia of chronic kidney disease (CKD) are multifactorial, including impairment of both renal EPO synthesis as well as intestinal iron absorption. We investigated the HIF- EPO- EPOR axis in kidney, BM and proximal tibia in anemic juvenile CKD rats. Methods CKD was induced by 5/6 nephrectomy in young (20 days old) male Sprague-Dawley rats while C group was sham operated. Rats were sacrificed 4 weeks after CKD induction and 5 minutes after a single bolus of IV recombinant human EPO. An additional control anemic (C-A) group was daily bled for 7 days. Results Hemoglobin levels were similarly reduced in CKD and C-A (11.4 +/- 0.3 and 10.8 +/- 0.2 Vs 13.5 +/- 0.3 g/dL in C, p<0.0001). Liver hepcidin mRNA was decreased in CA but increased in CKD. Serum iron was unchanged while transferrin levels were mildly decreased in CKD. Kidney HIF2 alpha protein was elevated in C-A but unchanged in CKD. Kidney EPO protein and mRNA levels were unchanged between groups. However, BM EPO protein (which reflects circulating EPO) was increased in C-A but remained unchanged in CKD. BM and proximal tibia EPOR were unchanged in C-A but decreased in CKD. Proximal tibial phospho-STAT5 increased after the EPO bolus in C but not in CKD. Conclusions Compared to blood loss, anemia in young CKD rats is associated with inappropriate responses in the HIF-EPO-EPO-R axis: kidney HIF2 alpha and renal EPO are not increased, BM and bone EPOR levels, as well as bone pSTAT5 response to EPO are reduced. Thus, anemia of CKD may be treated with additional therapeutic avenues beyond iron and EPO supplementation.	[Landau, Daniel] Schneider Childrens Med Ctr Israel, Dept Pediat B, Petah Tiqwa, Israel; [Landau, Daniel; Segev, Yael] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [London, Lital; Bandach, Inbar; Segev, Yael] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol, Beer Sheva, Israel	Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University	Landau, D (corresponding author), Schneider Childrens Med Ctr Israel, Dept Pediat B, Petah Tiqwa, Israel.; Landau, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.	danny_L@clalit.org.il	Landau, Daniel/ABB-8166-2020	Landau, Daniel/0000-0001-6347-7891				Abed M, 2014, J MOL MED, V92, P871, DOI 10.1007/s00109-014-1151-4; Atkinson MA, 2011, NAT REV NEPHROL, V7, P635, DOI 10.1038/nrneph.2011.115; Bamgbola O, 2012, PEDIATR NEPHROL, V27, P195, DOI 10.1007/s00467-011-1839-4; Bamgbola OF, 2011, KIDNEY INT, V80, P464, DOI 10.1038/ki.2011.179; Barrett TD, 2015, BRIT J PHARMACOL, V172, P4078, DOI 10.1111/bph.13188; Chen R, 2012, J BIOL CHEM, V287, P30800, DOI 10.1074/jbc.M111.244780; Ditting T, 2007, AM J PHYSIOL-RENAL, V293, pF1099, DOI 10.1152/ajprenal.00267.2007; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Fadrowski JJ, 2008, CLIN J AM SOC NEPHRO, V3, P457, DOI 10.2215/CJN.03020707; Farsijani NM, 2016, J CLIN INVEST, V126, P1425, DOI 10.1172/JCI74997; Fehr T, 2004, KIDNEY INT, V66, P1206, DOI 10.1111/j.1523-1755.2004.00880.x; Garrido P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124048; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kuhrt D, 2015, BLOOD, V125, P3536, DOI 10.1182/blood-2014-11-575357; Landau D, 2009, ENDOCRINE, V36, P126, DOI 10.1007/s12020-009-9190-2; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Macdougall IC, 2009, ADV CHRONIC KIDNEY D, V16, P117, DOI 10.1053/j.ackd.2008.12.010; Madan A, 1997, BLOOD CELL MOL DIS, V23, P169, DOI 10.1006/bcmd.1997.0134; Marquez-Ibarra A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152625; Mastrogiannaki M, 2013, BLOOD, V122, P885, DOI 10.1182/blood-2012-11-427765; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Means RT, 2013, AM J MED SCI, V345, P57, DOI 10.1097/MAJ.0b013e318253caf1; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Ribeiro S, 2016, BIOCHIMIE, V125, P150, DOI 10.1016/j.biochi.2016.03.012; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Schaefer F, 2001, J CLIN INVEST, V108, P467, DOI 10.1172/JCI200111895; Singh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029064; Souma T, 2016, J AM SOC NEPHROL, V27, P428, DOI 10.1681/ASN.2014121184; Suzuki N, 2015, TOHOKU J EXP MED, V235, P233, DOI 10.1620/tjem.235.233; Tan QL, 2013, J BIOL CHEM, V288, P17134, DOI 10.1074/jbc.M112.444059; Troib A, 2013, KIDNEY INT, V84, P940, DOI 10.1038/ki.2013.196; Wiezel D, 2014, NEPHROL DIAL TRANSPL, V29, P791, DOI 10.1093/ndt/gfu003	36	19	20	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196684	10.1371/journal.pone.0196684	http://dx.doi.org/10.1371/journal.pone.0196684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738538	Green Published, gold, Green Submitted			2022-12-26	WOS:000431724900012
J	Pro, SC; Arlehamn, CSL; Dhanda, SK; Carpenter, C; Lindvall, M; Faruqi, AA; Santee, CA; Renz, H; Sidney, J; Peters, B; Sette, A				Pro, Sebastian Carrasco; Arlehamn, Cecilia S. Lindestam; Dhanda, Sandeep K.; Carpenter, Chelsea; Lindvall, Mikaela; Faruqi, Ali A.; Santee, Clark A.; Renz, Harald; Sidney, John; Peters, Bjoern; Sette, Alessandro			Microbiota epitope similarity either dampens or enhances the immunogenicity of disease-associated antigenic epitopes	PLOS ONE			English	Article							REGULATORY T-CELLS; MOLECULAR MIMICRY; CONSERVATION; VALIDATION; REACTIVITY; BACTERIA; PROTEIN	The microbiome influences adaptive immunity and molecular mimicry influences T cell reactivity. Here, we evaluated whether the sequence similarity of various antigens to the micro biota dampens or increases immunogenicity of T cell epitopes. Sets of epitopes and control sequences derived from 38 antigenic categories (infectious pathogens, allergens, autoantigens) were retrieved from the Immune Epitope Database (IEDB). Their similarity to micro biome sequences was calculated using the BLOSUM62 matrix. We found that sequence similarity was associated with either dampened (tolerogenic; e.g. most allergens) or increased (inflammatory; e.g. Dengue and West Nile viruses) likelihood of a peptide being immunogenic as a function of epitope source category. Ten-fold cross-validation and validation using sets of manually curated epitopes and non-epitopes derived from allergens were used to confirm these initial observations. Furthermore, the genus from which the micro biome homologous sequences were derived influenced whether a tolerogenic versus inflammatory modulatory effect was observed, with Fusobacterium most associated with inflammatory influences and Bacteroides most associated with tolerogenic influences. We validated these effects using PBMCs stimulated with various sets of microbiome peptides. "Tolerogenic" microbiome peptides elicited IL-10 production, "inflammatory" peptides elicited mixed IL-10/IFN gamma production, while microbiome epitopes homologous to self were completely unreactive for both cytokines. We also tested the sequence similarity of cockroach epitopes to specific microbiome sequences derived from households of cockroach allergic individuals and non-allergic controls. Microbiomes from cockroach allergic households were less likely to contain sequences homologous to previously defined cockroach allergens. These results are compatible with the hypothesis that microbiome sequences may contribute to the tolerization of T cells for allergen epitopes, and lack of these sequences might conversely be associated with increased likelihood of T cell reactivity against the cockroach epitopes. Taken together this study suggests that microbiome sequence similarity influences immune reactivity to homologous epitopes encoded by pathogens, allergens and auto-antigens.	[Pro, Sebastian Carrasco; Arlehamn, Cecilia S. Lindestam; Dhanda, Sandeep K.; Carpenter, Chelsea; Lindvall, Mikaela; Sidney, John; Peters, Bjoern; Sette, Alessandro] La Jolla Inst Allergy & Immunol, Dept Vaccine Discovery, La Jolla, CA 92037 USA; [Faruqi, Ali A.; Santee, Clark A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Renz, Harald] Philipps Univ Marburg, Inst Lab Med, Marburg, Germany; [Peters, Bjoern; Sette, Alessandro] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	La Jolla Institute for Immunology; University of California System; University of California San Francisco; Philipps University Marburg; University of California System; University of California San Diego	Sette, A (corresponding author), La Jolla Inst Allergy & Immunol, Dept Vaccine Discovery, La Jolla, CA 92037 USA.; Sette, A (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	alex@iji.org	Pro, Sebastian Carrasco/AAF-8868-2020; Sette, Alessandro/AFO-8916-2022; Dhanda, Sandeep Kumar/J-8471-2016	Pro, Sebastian Carrasco/0000-0003-3388-3789; Dhanda, Sandeep Kumar/0000-0003-1381-7434; Lindvall, Mikaela/0000-0002-0042-1353; Lindestam Arlehamn, Cecilia/0000-0001-7302-8002	National Institutes of Health, National Institute of Allergy and Infectious Disease [UM1 AI114271, HHSN272201200010C]	National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health, National Institute of Allergy and Infectious Disease (UM1 AI114271 and HHSN272201200010C) to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archila LD, 2014, CLIN EXP ALLERGY, V44, P986, DOI 10.1111/cea.12324; Arlehamn CSL, 2015, P NATL ACAD SCI USA, V112, pE147, DOI 10.1073/pnas.1416537112; Atarashi K, 2017, SCIENCE, V358, P359, DOI 10.1126/science.aan4526; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Brehm MA, 2002, NAT IMMUNOL, V3, P627, DOI 10.1038/ni806; Bresciani A, 2016, IMMUNOLOGY, V148, P34, DOI 10.1111/imm.12585; Burns JC, 2015, AUTOIMMUNITY, V48, P181, DOI 10.3109/08916934.2015.1027817; Pro SC, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/763461; Chiu C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004008; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Cusick MF, 2012, CLIN REV ALLERG IMMU, V42, P102, DOI [10.1007/s12016-011-8293-8, 10.1007/s12016-011-8294-7]; D'Orsogna LJA, 2010, TRANSPL IMMUNOL, V23, P149, DOI 10.1016/j.trim.2010.06.008; De Groot AS, 2008, BLOOD, V112, P3303, DOI 10.1182/blood-2008-02-138073; Dillon MBC, 2015, CLIN EXP ALLERGY, V45, P1856, DOI 10.1111/cea.12643; FUJINAMI RS, 1983, P NATL ACAD SCI-BIOL, V80, P2346, DOI 10.1073/pnas.80.8.2346; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hinz D, 2015, CLIN EXP ALLERGY, V45, P1601, DOI 10.1111/cea.12507; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; McKinney DM, 2015, HUM IMMUNOL, V76, P917, DOI 10.1016/j.humimm.2015.04.007; McMaster SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115725; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; O'Connor GT, 2018, J ALLERGY CLIN IMMUN, V141, P1468, DOI 10.1016/j.jaci.2017.06.040; Okuda S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2203; Oseroff C, 2010, J IMMUNOL, V185, P943, DOI 10.4049/jimmunol.1000405; Paul S, 2015, J IMMUNOL METHODS, V422, P28, DOI 10.1016/j.jim.2015.03.022; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; Schulten V, 2013, P NATL ACAD SCI USA, V110, P3459, DOI 10.1073/pnas.1300512110; Scriba TJ, 2017, AM J RESP CRIT CARE, V196, P772, DOI 10.1164/rccm.201706-1208OC; Skevaki C, 2017, J ALLERGY C IN PRESS; Smolinska S, 2017, GASTROENTEROL CLIN N, V46, P19, DOI 10.1016/j.gtc.2016.09.004; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Westernberg L, 2016, J ALLERGY CLIN IMMUN, V138, P571, DOI 10.1016/j.jaci.2015.11.034; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8	40	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196551	10.1371/journal.pone.0196551	http://dx.doi.org/10.1371/journal.pone.0196551			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734356	Green Submitted, Green Published, gold			2022-12-26	WOS:000431481700020
J	Hamouda, E; El-Metwally, S; Tarek, M				Hamouda, Eslam; El-Metwally, Sara; Tarek, Mayada			Ant Lion Optimization algorithm for kidney exchanges	PLOS ONE			English	Article							PAIRED DONATION; CHAINS	The kidney exchange programs bring new insights in the field of organ transplantation. They make the previously not allowed surgery of incompatible patient-donor pairs easier to be performed on a large scale. Mathematically, the kidney exchange is an optimization problem for the number of possible exchanges among the incompatible pairs in a given pool. Also, the optimization modeling should consider the expected quality-adjusted life of transplant candidates and the shortage of computational and operational hospital resources. In this article, we introduce a bio-inspired stochastic-based Ant Lion Optimization, ALO, algorithm to the kidney exchange space to maximize the number of feasible cycles and chains among the pool pairs. Ant Lion Optimizer-based program achieves comparable kidney exchange results to the deterministic-based approaches like integer programming. Also, ALO outperforms other stochastic-based methods such as Genetic Algorithm in terms of the efficient usage of computational resources and the quantity of resulting exchanges. Ant Lion Optimization algorithm can be adopted easily for on-line exchanges and the integration of weights for hard-to-match patients, which will improve the future decisions of kidney exchange programs. A reference implementation for ALO algorithm for kidney exchanges is written in MATLAB and is GPL licensed. It is available as free open-source software from: https://github.com/SaraEl-Metwally/ALO algorithm for Kidney Exchange.	[Hamouda, Eslam; El-Metwally, Sara; Tarek, Mayada] Mansoura Univ, Fac Comp & Informat, Comp Sci Dept, Mansoura, Dakahlia, Egypt	Egyptian Knowledge Bank (EKB); Mansoura University	Hamouda, E (corresponding author), Mansoura Univ, Fac Comp & Informat, Comp Sci Dept, Mansoura, Dakahlia, Egypt.	eslam_foad@mans.edu.eg	Hamouda, Eslam/AAO-3773-2020; El-Metwally, Sara/H-6580-2017	Hamouda, Eslam/0000-0001-5716-6819; El-Metwally, Sara/0000-0003-4496-7080; Tarek, Mayada/0000-0001-5593-8416				Abraham D, 2009, MATCHING MARKETS DES; Abraham DJ, 2007, EC'07: PROCEEDINGS OF THE EIGHTH ANNUAL CONFERENCE ON ELECTRONIC COMMERCE, P295; Akbarpour M, 2014, 15 ACM C EC COMP CAL; Anderson R, 2015, P NATL ACAD SCI USA, V112, P663, DOI 10.1073/pnas.1421853112; Ashlagi I, 2011, AM J TRANSPLANT, V11, P984, DOI 10.1111/j.1600-6143.2011.03481.x; Blum C, 2011, APPL SOFT COMPUT, V11, P4135, DOI 10.1016/j.asoc.2011.02.032; Boussaid I, 2013, INFORM SCIENCES, V237, P82, DOI 10.1016/j.ins.2013.02.041; Chen YH, 2012, IEEE T BIO-MED ENG, V59, P1985, DOI 10.1109/TBME.2012.2195663; Constantino M, 2013, EUR J OPER RES, V231, P45, DOI [10.1016/1.ejsr.2013.05.025, DOI 10.1016/1.EJSR.2013.05.025]; Crawford B, 2017, COMPLEXITY, DOI 10.1155/2017/8404231; Dickerson J.P., 2013, P EC, P323, DOI DOI 10.1145/2482540.2482596; Ellison D, 2014, SYSTEMATIC REV KIDNE; Ferrari P, 2015, NEPHROL DIAL TRANSPL, V30, P1276, DOI 10.1093/ndt/gfu309; Ferrari P, 2009, MED J AUSTRALIA, V190, P700, DOI 10.5694/j.1326-5377.2009.tb02642.x; Gentry SE, 2007, AM J TRANSPLANT, V7, P2361, DOI 10.1111/j.1600-6143.2007.01935.x; Gentry SE, 2009, AM J TRANSPLANT, V9, P1330, DOI 10.1111/j.1600-6143.2009.02622.x; Goezinne S, 2016, GENETIC ALGORITHM KI; Johnson RJ, 2008, TRANSPLANTATION, V86, P1672, DOI 10.1097/TP.0b013e3181901a3d; Kalbfleisch D, 2012, OPTIMIZATION SIMULAT; Leeser DB, 2012, CLIN TRANSPLANT, V26, pE213, DOI 10.1111/j.1399-0012.2012.01606.x; Malik Shafi, 2014, Can J Kidney Health Dis, V1, P6, DOI 10.1186/2054-3581-1-6; Mirjalili S, 2015, ADV ENG SOFTW, V83, P80, DOI 10.1016/j.advengsoft.2015.01.010; Rai Deepak, 2013, Software Engineering Notes, V38, P96, DOI 10.1145/2492248.2492271; Rees Michael A, 2009, Clin Transpl, P235; Roth AE, 2005, AM ECON REV, V95, P376, DOI 10.1257/000282805774669989; Roth AE, 2004, Q J ECON, V119, P457, DOI 10.1162/0033553041382157; Roth AE, 2007, AM ECON REV, V97, P828, DOI 10.1257/aer.97.3.828; Saidman S. L., 2006, AM J TRANSPLANT, V6, P2694; Saidman SL, 2006, TRANSPLANTATION, V81, P773, DOI 10.1097/01.tp.0000195775.77081.25; Sakthivel S, 2013, INT J ADV RES, V3; Segev DL, 2005, JAMA-J AM MED ASSOC, V293, P1883, DOI 10.1001/jama.293.15.1883; U.S department of Health, ORG PROC TRANSPL NET; Yogarajan G., 2016, MIDDLE E J SCI RES, V24, P3113, DOI DOI 10.5829/ID0SI.MEJSR.2016.3113.3120; Zawbaa HM, 2015, PROCEEDINGS OF 2015 THIRD IEEE WORLD CONFERENCE ON COMPLEX SYSTEMS (WCCS); Zawbaa HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150652	35	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196707	10.1371/journal.pone.0196707	http://dx.doi.org/10.1371/journal.pone.0196707			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723232	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100055
J	da Silva, VMF; Freitas, CEC; Dias, RL; Martin, AR				da Silva, Vera M. F.; Freitas, Carlos E. C.; Dias, Rodrigo L.; Martin, Anthony R.			Both cetaceans in the Brazilian Amazon show sustained, profound population declines over two decades	PLOS ONE			English	Article							INIA-GEOFFRENSIS; RIVER DOLPHINS; SOTALIA-FLUVIATILIS; FISHERIES; BAIT; BOTO	Obligate river dolphins occur only in the rivers of Asia and South America, where they are increasingly subject to damaging pressures such as habitat degradation, food competition and entanglement in fishing gear as human populations expand. The Amazon basin hosts two, very different, dolphins-the boto or Amazon river dolphin (Inia geoffrensis) and the smaller tucuxi (Sotalia fluviatilis). Both species have wide geographical ranges and were once considered to be relatively abundant. Their IUCN Red List conservation status of Data Deficient (DD), due to limited information on threats, ecology, population numbers and trends, did not initially cause alarm. However, the development of dolphin hunting to provide fish bait at around the beginning of this millennium broadly coincided with the onset of a widespread perception that numbers of both species were in decline. Consequently, the need for population trend data to inform conservation advice and measures became urgent. This paper presents a 22-year time series of standardised surveys for both dolphins within the Mamiraua A Reserve, Amazonas State, Brazil. Analysis of these data show that both species are in steep decline, with their populations halving every 10 years (botos) and 9 years (tucuxis) at current rates. These results are consistent with published, independent information on survival rates of botos in this area, which demonstrated a substantial drop in annual survival, commencing at around the year 2000. Mamiraua A is a protected area, and is subject to fewer environmental pressures than elsewhere in the region, so there is no reason to suspect that the decline in dolphins within the Reserve is more pronounced than outside it. If South America's freshwater cetaceans are to avoid following their Asian counterparts on the path to a perilous conservation status, effective conservation measures are required immediately. Enforcement of existing fishery laws would greatly assist in achieving this.	[da Silva, Vera M. F.; Dias, Rodrigo L.] Inst Nacl de Pesquisas da Amazonia, Lab Mamiferos Aquat, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Freitas, Carlos E. C.] Univ Fed Amazonas, Fac Ciencias Agr, Dept Ciencias Pesqueiras, Manaus, Amazonas, Brazil; [Martin, Anthony R.] Univ Dundee, Ctr Remote Environm, Dundee, Scotland	Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Amazonas; University of Dundee	da Silva, VMF (corresponding author), Inst Nacl de Pesquisas da Amazonia, Lab Mamiferos Aquat, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil.	tucuxi@inpa.gov.br	Freitas, Carlos/I-5386-2012; da Silva, Vera Maria Ferreira/AAE-8126-2021	Freitas, Carlos/0000-0001-5406-0998; da Silva, Vera Maria Ferreira/0000-0002-1774-0393	AMPA/Petrobras Ambiental Program, INPA/MCTIC; AMPA/MPF-TC [02/2015-TAC, 003/2014]; INPA/PCI	AMPA/Petrobras Ambiental Program, INPA/MCTIC; AMPA/MPF-TC; INPA/PCI	Projeto Boto receives the sponsorship of the AMPA/Petrobras Ambiental Program, INPA/MCTIC and by the AMPA/MPF-TC No. 02/2015-TAC, No. 003/2014. RLD received an INPA/PCI scholarship during part of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, REV AMAZONIA; Best RC, 1996, AMAZONIANA, V14, P165; Best Robin C., 1993, Mammalian Species, V426, P1; Brum SM, 2015, J APPL ICHTHYOL, V31, P675, DOI 10.1111/jai.12772; Castello L, 2016, ENVIRON MANAGE, V42, P197; Civil Society Mamiraua A, 1996, MAM MAN PLAN MAN; da Silva V.M.F., 2011, IUCN SPECIES MAGAZIN, V53, P10; da Silva V. M. F., 2000, BIOL CONSERVATION FR, P121; da Silva V. M. F., 2010, ACTION PLAN S AM RIV; Fernandes Valdelira Lia Araújo, 2009, Acta Amaz., V39, P405, DOI 10.1590/S0044-59672009000200020; Fox J., 2019, R COMPANION APPL REG, V.; Gomez C, 2008, FAUNA ACUATICA AMENA, P39; Huang SL, 2012, FRESHWATER BIOL, V57, P1266, DOI 10.1111/j.1365-2427.2012.02772.x; Iriarte V., 2013, Journal of Cetacean Research and Management, V13, P163; Iriarte V, 2013, AQUAT MAMM, V39, P116, DOI 10.1578/AM.39.2.2013.116; IUCN-International Union for Conservation of Nature, 2022, GUIDELINES USING IUC; Loch C, 2009, BIODIVERS CONSERV, V18, P3979, DOI 10.1007/s10531-009-9693-4; Mamiraua IDS, BANC DAD FLUV RES DE; Martin AR, 2018, BIOL J LINN SOC, V123, P666, DOI 10.1093/biolinnean/bly005; Martin AR, 2004, J ZOOL, V263, P295, DOI 10.1017/S095283690400528X; Martin AR, 2017, SC67ASM13 INT WHAL C; Mintzer VJ, 2015, BIODIVERS CONSERV, V24, P247, DOI 10.1007/s10531-014-0805-4; Mintzer VJ, 2013, BIOL CONSERV, V158, P280, DOI 10.1016/j.biocon.2012.10.006; Moura EAF, 2016, SOCIO DEMOGRAFIA RES; PACIFICI M, 2013, NAT CONSERV-BULGARIA, P87, DOI DOI 10.3897/NATURECONSERVATION.5.5734; Paradis E., ape: Analyses of Phylogenetics and Evolution; Alves LCPD, 2012, ZOOLOGIA-CURITIBA, V29, P420, DOI 10.1590/S1984-46702012000500005; Reeves RR, 2011, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2011-1.RLTS.T10831A3220342.en, DOI 10.2305/IUCN.UK.2011-1.RLTS.T10831A3220342.EN]; Ripley B, 2013, MASS MODERN APPL STA; Secchi E, 2012, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2012.RLTS.T190871A17583369.EN; Smith BD, 2012, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2012.RLTS.T41758A17355810.en, DOI 10.2305/IUCN.UK.2012.RLTS.T41758A17355810.EN]; Trujillo F., 2010, ACTION PLAN S AM RIV, P145; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; WORSLEY KJ, 1982, BIOMETRIKA, V69, P297, DOI 10.1093/biomet/69.2.297; Zuur Alain F., 2009, P1	35	15	16	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0191304	10.1371/journal.pone.0191304	http://dx.doi.org/10.1371/journal.pone.0191304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718917	gold, Green Published, Green Submitted			2022-12-26	WOS:000431281900002
J	Heberling, JM; Mason, NWH				Heberling, J. Mason; Mason, Norman W. H.			Are endemics functionally distinct? Leaf traits of native and exotic woody species in a New Zealand forest	PLOS ONE			English	Article							INVASIVE PLANTS; ECONOMICS SPECTRUM; SOIL FERTILITY; USE EFFICIENCY; RAIN-FOREST; PHOTOSYNTHESIS; CHRONOSEQUENCE; STRATEGIES; NITROGEN; BIOMASS	Recent studies have concluded that native and invasive species share a common set of trait relationships. However, native species in isolated regions might be functionally constrained by their unique evolutionary histories such that they follow different carbon capture strategies than introduced species. We compared leaf traits relating to resource investment, carbon return, and resource-use efficiency in 16 native (endemic) and three non-native (invasive) species in a temperate forest in Canterbury, South Island, New Zealand. Trait differences were more closely associated with leaf habit than nativity. Deciduous species (including invaders) exhibited greater maximum photosynthetic rates at similar resource costs, which resulted in greater nitrogen-and energy-use efficiencies than evergreen natives. Leaf area was the only trait that differed significantly by nativity (over two-fold larger in invaders). Invaders and deciduous natives both occupied the 'fast return' end of the leaf economics spectrum in contrast to the native evergreens which had comparatively slow return on investment. Dominant woody invaders in this forest are physiologically distinct from many New Zealand endemic species, which are overwhelmingly evergreen. It remains unclear whether these trait differences translate to an ecological divergence in plant strategy, but these results suggest that ecophysiological tradeoffs are likely constrained by biogeography.	[Heberling, J. Mason] Carnegie Museum Nat Hist, Sect Bot, Pittsburgh, PA 15213 USA; [Heberling, J. Mason] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Heberling, J. Mason] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Mason, Norman W. H.] Landcare Res, Hamilton, New Zealand	University of Tennessee System; University of Tennessee Knoxville; Syracuse University; Landcare Research - New Zealand	Heberling, JM (corresponding author), Carnegie Museum Nat Hist, Sect Bot, Pittsburgh, PA 15213 USA.; Heberling, JM (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.; Heberling, JM (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	heberlingm@carnegiemnh.org	Heberling, Mason/I-4506-2019	Heberling, Mason/0000-0003-0756-5090	US National Science Foundation Graduate Research Fellowship	US National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This material is based upon work supported by a US National Science Foundation Graduate Research Fellowship to JMH. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2000, PERSPECT PLANT ECOL, V3, P52, DOI DOI 10.1078/1433-8319-00004; Atkin OK, 2013, PLANT SOIL, V367, P163, DOI 10.1007/s11104-013-1686-0; Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; BUSSELL W. T., 1968, N Z J BOT, V6, P63; Cieraad E, 2015, N Z J ECOL, V39; Craine JM, 2006, ECOL STU AN, V186, P167; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Donovan LA, 2011, TRENDS ECOL EVOL, V26, P88, DOI 10.1016/j.tree.2010.11.011; Dungan RJ, 2004, FUNCT ECOL, V18, P34, DOI 10.1111/j.1365-2435.2004.00809.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; Fadzly N, 2009, NEW PHYTOL, V184, P495, DOI 10.1111/j.1469-8137.2009.02926.x; Fridley JD, 2014, GLOBAL ECOL BIOGEOGR, V23, P1157, DOI 10.1111/geb.12221; Fridley JD, 2012, NATURE, V485, P359, DOI 10.1038/nature11056; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Funk JL, 2017, BIOL INVASIONS, V19, P1143, DOI 10.1007/s10530-016-1297-9; Funk JL, 2013, ECOLOGY, V94, P1893, DOI 10.1890/12-1602.1; Grubb PJ, 2016, PLANT ECOL DIVERS, V9, P3, DOI 10.1080/17550874.2015.1048761; Gulias J, 2003, ANN BOT-LONDON, V92, P215, DOI 10.1093/aob/mcg123; Heberling JM, 2017, GLOBAL ECOL BIOGEOGR, V26, P447, DOI 10.1111/geb.12551; Heberling JM, 2013, NEW PHYTOL, V200, P523, DOI 10.1111/nph.12388; Heberling JM, 2012, GLOBAL ECOL BIOGEOGR, V21, P1137, DOI 10.1111/j.1466-8238.2012.00761.x; Howell CJ, 2002, FUNCT ECOL, V16, P232, DOI 10.1046/j.1365-2435.2002.00613.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Lee W., 1998, ROYAL SOC NZ MISCELL, V48, P91; Leishman MR, 2010, J ECOL, V98, P28, DOI 10.1111/j.1365-2745.2009.01608.x; Lusk CH, 2015, J ECOL, V103, P479, DOI 10.1111/1365-2745.12368; Mack RN, 2003, INT J PLANT SCI, V164, pS185, DOI 10.1086/368399; MARSHALL B, 1980, J EXP BOT, V31, P29, DOI 10.1093/jxb/31.1.29; Matzek V, 2011, BIOL INVASIONS, V13, P3005, DOI 10.1007/s10530-011-9985-y; Mcalpine KG, 2008, AUSTRAL ECOL, V33, P10, DOI 10.1111/j.1442-9993.2007.01784.x; McDowell SCL, 2002, AM J BOT, V89, P1431, DOI 10.3732/ajb.89.9.1431; McGlone MS, 2010, NEW ZEAL J ECOL, V34, P137; McGlone MS, 2004, NEW ZEAL J BOT, V42, P1, DOI 10.1080/0028825X.2004.9512887; MILLARD P, 1991, NEW PHYTOL, V117, P587, DOI 10.1111/j.1469-8137.1991.tb00963.x; Niinemets U, 2005, PLANT CELL ENVIRON, V28, P1552, DOI 10.1111/j.1365-3040.2005.01392.x; Ordonez A, 2013, GLOBAL ECOL BIOGEOGR, V22, P648, DOI 10.1111/geb.12019; Ordonez A, 2010, FUNCT ECOL, V24, P1353, DOI 10.1111/j.1365-2435.2010.01739.x; Pattison RR, 1998, OECOLOGIA, V117, P449, DOI 10.1007/s004420050680; Plummer M., 2003, P 3 INT WORKSH DISTR; Poorter Hendrik, 1994, P111; Richardson SJ, 2010, NEW ZEAL J ECOL, V34, P306; Thompson K, 2011, TRENDS ECOL EVOL, V26, P155, DOI 10.1016/j.tree.2011.01.007; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; VERTREGT N, 1987, J THEOR BIOL, V128, P109, DOI 10.1016/S0022-5193(87)80034-6; WARDLE P, 1985, NEW ZEAL J BOT, V23, P773, DOI 10.1080/0028825X.1985.10434242; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zhu JJ, 2012, CAN J SOIL SCI, V92, P645, DOI [10.4141/CJSS2011-100, 10.4141/cjss2011-100]; [No title captured]	49	4	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196746	10.1371/journal.pone.0196746	http://dx.doi.org/10.1371/journal.pone.0196746			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718966	gold, Green Submitted, Green Published			2022-12-26	WOS:000431281900078
J	Islam, MZ; Khalequzzaman, M; Prince, MFRK; Siddique, MA; Rashid, ESMH; Ahmed, MSU; Pittendrigh, BR; Ali, MP				Islam, M. Z.; Khalequzzaman, M.; Prince, M. F. R. K.; Siddique, M. A.; Rashid, E. S. M. H.; Ahmed, M. S. U.; Pittendrigh, B. R.; Ali, M. P.			Diversity and population structure of red rice germplasm in Bangladesh	PLOS ONE			English	Article							GENETIC DIVERSITY; MOLECULAR CHARACTERIZATION; ACCESSIONS; VARIETIES; IDENTIFICATION; CULTIVARS; INFERENCE; EXTRACTS; CYANIDIN; MARKERS	While the functionality and healthy food value of red rice have increased its popularity, such that market demand for it is expected to rise, most strains suffer from low grain yield. To perform diversity and population structure analyses of red rice germplasm, therefore, becomes essential for improving yields for commercial production. In this study, fifty red rice germplasm from the Bangladesh Rice Research Institute (BRRI) genebank were characterized both morphologically and genetically using fifty simple sequence repeat (SSR) markers. Overall, 162 alleles were detected by the markers with the detected allele number varying from two to seven. Additionally, 22 unique alleles were identified for use as a germplasm diagnostic tool. The highest and lowest polymorphic information content (PIC) indices were 0.75 and 0.04 found in markers RM282 and RM304, respectively, and genetic diversity was moderate, varying from 0.05 to 0.78 (average: 0.35). While phylogenetic cluster analysis of the fifteen distance-based agro-morphological traits divided the germplasm into five clusters (I, II, III, IV and V), a similar SSR analysis yielded only three major groups (I, II, and III), and a model-based population structure analysis yielded four (A, B, C and D). Both principal component and neighbors joining tree analysis from the population structure method showed the tested germplasm as highly diverse in structure. Moreover, an analysis of molecular variance (AMOVA), as well as a pairwise FST analysis, both indicated significant differentiation (ranging from 0.108 to 0.207) among all pairs of populations, suggesting that all four population structure groups differed significantly. Populations A and D were the most differentiated from each other by FST. Findings from this study suggest that the diverse germplasm and polymorphic trait-linked SSR markers of red rice are suitable for the detection of economically desirable trait loci/genes for use in future molecular breeding programs.	[Islam, M. Z.; Khalequzzaman, M.; Prince, M. F. R. K.; Siddique, M. A.; Rashid, E. S. M. H.; Ahmed, M. S. U.] Bangladesh Rice Res Inst, Genet Resources & Seed Div, Gazipur, Bangladesh; [Pittendrigh, B. R.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Ali, M. P.] Bangladesh Rice Res Inst, Entomol Div, Gazipur, Bangladesh	Bangladesh Rice Research Institute (BRRI); Michigan State University; Bangladesh Rice Research Institute (BRRI)	Islam, MZ (corresponding author), Bangladesh Rice Res Inst, Genet Resources & Seed Div, Gazipur, Bangladesh.; Ali, MP (corresponding author), Bangladesh Rice Res Inst, Entomol Div, Gazipur, Bangladesh.	zahid.grs@gmail.com; panna_ali@yahoo.com	ALI, PANNA/P-1625-2017; Siddique, Abubakar/AAX-1888-2020	ALI, PANNA/0000-0001-8197-7064; 	Bangladesh Rice Research Institute (BRRI) through the Ministry of Agriculture, Bangladesh	Bangladesh Rice Research Institute (BRRI) through the Ministry of Agriculture, Bangladesh	The authors are grateful for the financial support provided by the Bangladesh Rice Research Institute (BRRI) through the Ministry of Agriculture, Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for the financial support provided by the Bangladesh Rice Research Institute (BRRI) through the Ministry of Agriculture, Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also greatly appreciate Mr Rakib Ahmed for making Fig 1 showing germplasm collection sites.	Adom KK, 2002, J AGR FOOD CHEM, V50, P6182, DOI 10.1021/jf0205099; Ahmed MSU, 2016, RICE SCI, V23, P211, DOI 10.1016/j.rsci.2016.06.004; Akkaya MS, 2004, EUPHYTICA, V135, P179, DOI 10.1023/B:EUPH.0000014908.02499.41; Allhgholipour M, 2014, GENETIKA-BELGRADE, V46, P187, DOI 10.2298/GENSR1401187A; Ashim Chakravorty, 2013, American Journal of Experimental Agriculture, V3, P110; Australian Bureau of Statistics, 2017, 65030 HOUS EXP SURV; Babu BK, 2014, MOL BIOL REP, V41, P4329, DOI 10.1007/s11033-014-3304-5; BBS, 2015, YB AGR STAT; Behera L, 2012, AUSTR J CROP SCI, V6; Belamkar V, 2011, GENETICA, V139, P411, DOI 10.1007/s10709-011-9556-2; Bhakal M, 2015, J PLANT SCI RES, V2, P1; BRRI, 2016, ANN REP 2014 15; Chakhonkaen S, 2012, RICE, V5, DOI 10.1186/1939-8433-5-19; Choudhury B, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-228; Chutipaijit S, 2011, AUST J CROP SCI, V5, P1191; Cornelious BK, 2002, CROP SCI, V42, P642, DOI 10.2135/cropsci2002.0642; Das B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-71; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Giarrocco LE, 2007, CROP SCI, V47, P853, DOI 10.2135/cropsci2005.07.0198; Gramene, GRAM PORT 2017; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Huang YP, 2016, J FOOD DRUG ANAL, V24, P564, DOI 10.1016/j.jfda.2016.01.004; Hyun JW, 2004, J AGR FOOD CHEM, V52, P2213, DOI 10.1021/jf030370h; Islam M, 2011, BANGLADESH J PLANT B, V22, P51; Islam M., 2014, VARIABILITY ASSESSME; Islam M. M., 2017, SAARC Journal of Agriculture, V15, P123, DOI 10.3329/sja.v15; Jayamani P, 2007, CROP SCI, V47, P879, DOI 10.2135/cropsci2006.04.0236; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Kim D, 2012, COMPUT GEOTECH, V44, P9, DOI 10.1016/j.compgeo.2012.03.005; Kristamtini, 2012, Journal of Agricultural and Biological Science, V7, P982; Kushwaha, 2016, BLACK RICE RES HIST, P21, DOI DOI 10.1007/978-3-319-30153-2; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RH, 2000, EUPHYTICA, V114, P1, DOI 10.1023/A:1003664528131; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lv J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046919; Mau Y. S., 2017, Biodiversitas: Journal of Biological Diversity, V18, P197, DOI 10.13057/biodiv/d180127; Mian MA, 2016, SCI WORLD J, DOI [10.1155/2016/2796720, DOI 10.1155/2016/2796720]; de Mira NVM, 2009, J FOOD COMPOS ANAL, V22, P405, DOI 10.1016/j.jfca.2008.06.012; Nam SH, 2006, FOOD CHEM, V94, P613, DOI 10.1016/j.foodchem.2004.12.010; Patzak J, 2012, GENOME, V55, P647, DOI [10.1139/g2012-054, 10.1139/G2012-054]; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rana MK, 2004, J PLANT BIOCHEM BIOT, V13, P19, DOI 10.1007/BF03263185; Rao C.R., 1964, SANKHYA A, V26, P329, DOI DOI 10.1214/AOMS/1177704248; RAO CR, 1952, ADV STAT METHODS BIO; Ren XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088091; Rohlf F.J., 2002, NTSYS PC NUMERICAL T; Roy S, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0414-1; Saini N, 2004, EUPHYTICA, V140, P133, DOI 10.1007/s10681-004-2510-y; Salgotra RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131858; SatueGracia MT, 1997, J AGR FOOD CHEM, V45, P3362, DOI 10.1021/jf970234a; Shah SM, 2013, PAK J BOT, V45, P423; Siddique MA, 2016, BRAZ J BOT, V39, P631, DOI 10.1007/s40415-016-0271-1; Siddique M. A., 2013, Bangladesh Journal of Plant Breeding and Genetics, V26, P19; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084136; Sohrabi M, 2012, SCI WORLD J, DOI 10.1100/2012/416291; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JA, 1998, CROP SCI, V38, P1348, DOI [10.2135/cropsci1998.0011183X003800050034x, 10.2135/cropsci1998.0011183X003800050035x]; Thomson MJ, 2007, THEOR APPL GENET, V114, P559, DOI 10.1007/s00122-006-0457-1; Thudi M, 2011, J PLANT BIOCHEM BIOT, V20, P74, DOI 10.1007/s13562-010-0028-z; Travis AJ, 2015, RICE, V8, DOI 10.1186/s12284-015-0068-z; Tsuda T, 2002, J NUTR SCI VITAMINOL, V48, P305, DOI 10.3177/jnsv.48.305; Upadhyay P, 2012, BIOCHEM GENET, V50, P770, DOI 10.1007/s10528-012-9519-z; Wang ML, 2009, THEOR APPL GENET, V120, P13, DOI 10.1007/s00122-009-1155-6; Wang ML, 2011, THEOR APPL GENET, V123, P1307, DOI 10.1007/s00122-011-1668-7; Wong S. C., 2009, American Journal of Agricultural and Biological Sciences, V4, P298; Yadav S, 2013, J GENET, V92, P545, DOI 10.1007/s12041-013-0312-5; Zhang Jun, 2008, Acta Agronomica Sinica, V34, P1529, DOI 10.3724/SP.J.1006.2008.01529; Zhang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027565; Zhang T, 2010, RICE SCI, V17, P288, DOI 10.1016/S1672-6308(09)60029-9; Zhao C, 2004, J AGR FOOD CHEM, V52, P6122, DOI 10.1021/jf049517a; Zhao X., 2016, SCI REP, V6; Zheng K., 1995, RICE GENET NEWSLETT, V12, P255	75	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196096	10.1371/journal.pone.0196096	http://dx.doi.org/10.1371/journal.pone.0196096			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718936	Green Submitted, gold, Green Published			2022-12-26	WOS:000431281900047
J	Rodriguero, MS; Wirth, SA; Alberghina, JS; Lanteri, AA; Confalonieri, VA				Rodriguero, Marcela S.; Wirth, Sonia A.; Alberghina, Josefina S.; Lanteri, Analia A.; Confalonieri, Viviana A.			A tale of swinger insects: Signatures of past sexuality between divergent lineages of a parthenogenetic weevil revealed by ribosomal intraindividual variation	PLOS ONE			English	Article							TRIBE NAUPACTINI COLEOPTERA; HYBRID ORIGIN; RNA GENE; EVOLUTION; CURCULIONIDAE; WIDESPREAD; IDENTIFICATION; JMODELTEST; CLOCK; ZONE	Naupactus cervinus (Boheman) (Curculionidae, Naupactini) is a parthenogenetic weevil native to the Paranaense Forest which displays high levels of genetic variation. Two divergent clades were identified, one ranging in forest areas (Forest clade), and the other in open vegetation areas (Grassland clade). Both of them have individuals with high levels of heterozygosity in ribosomal sequences. Investigation of intraindividual variation in ITS1 sequences through cloning and posterior sequencing suggested that mating between both groups most likely occurred in the Paranaense Forest after a secondary contact, which led to fixed heterozygotes as a consequence of parthenogenesis. Otherwise, sexual segregation would have disrupted multilocus genotypes. Only a small number of heterozygous genotypes of all the possible combinations are found in nature. We propose the occurrence of a hybrid zone in the Paranaense Forest. The fact that it is one of the most important biodiversity hotspots of the world, together with its key role for investigating evolutionary processes, makes it worthy of conservation. This is the first genetic evidence of bisexuality in N. cervinus.	[Rodriguero, Marcela S.; Alberghina, Josefina S.; Confalonieri, Viviana A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, EGEBA, Dept Ecol Genet & Evoluc,CONICET, Buenos Aires, DF, Argentina; [Wirth, Sonia A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Agrobiotecnol, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina; [Wirth, Sonia A.] UBA, CONICET, IBBEA, Buenos Aires, DF, Argentina; [Lanteri, Analia A.] Univ Nacl La Plata, CONICET, Fac Ciencias Nat & Museo, Div Entomol,Museo La Plata, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata	Rodriguero, MS (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, EGEBA, Dept Ecol Genet & Evoluc,CONICET, Buenos Aires, DF, Argentina.	rodriguero@ege.fcen.uba.ar		Wirth, Sonia/0000-0003-2930-9979; Rodriguero, Marcela/0000-0001-5967-2045; Confalonieri, Viviana Andrea/0000-0003-4499-9816	Agencia Nacional de Promocion Cientifica y Tecnologica (Fondo para la Investigacion Cientifica y Tecnologica) [0962, 1468]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [112-201101-00586]; Universidad de Buenos Aires [20020100100186]; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas	Agencia Nacional de Promocion Cientifica y Tecnologica (Fondo para la Investigacion Cientifica y Tecnologica); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires(University of Buenos Aires); University of Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (Fondo para la Investigacion Cientifica y Tecnologica), grant No. 0962, http://www.agencia. mincyt.gob.ar/frontend/agencia/fondo/foncyt (awarded to MSR); Agencia Nacional de Promocion Cientifica y Tecnologica (Fondo para la Investigacion Cientifica y Tecnologica), grant No. 1468, http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt (awarded to VAC); Consejo Nacional de Investigaciones Cientificas y Tecnicas, grant No. 112-201101-00586, http://proyectosinv.conicetgov.ar/ (awarded to VAC); Universidad de Buenos Aires, grant no. 20020100100186, http://cyt.rec.uba.ar/Pagnas/Financiarniento/Subsidies.aspx (awarded to VAC), and a travel grant from the University of Buenos Aires (awarded to MSR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks are due to Pablo Colombo, Jerson Guedes, Noelia Guzman, Mauricio Lovadina, Patricia Perez Barros and Glauber Stiirmer for field assistance. We are also indebted to two anonymous reviewers for their critical reading and helpful comments on an earlier version of this manuscript, to Visitacion Conforti and Angela Juarez for allowing us to use their laminar flux, to L. Chifflet, F. Cunha Almeida and A. Sanchez Restrepo for helpful discussion and to C. Tomatis and P. Rodriguero for their valuable suggestions for designing Figs 1 and 3, respectively. MSR was awarded a postdoctoral scholarship from Consejo Nacional de Investigaciones Cientificas y Tecnicas and a travel grant from the University of Buenos Aires. MSR, SAW, AAL, and VAC are members of the Research Career of Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina.	ANDERSON E, 1953, BIOL REV, V28, P280, DOI 10.1111/j.1469-185X.1953.tb01379.x; ANDERSON E, 1948, EVOLUTION, V2, P1, DOI 10.2307/2405610; ANDERSON E., 1949, Introgressive hybridization.; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; Brelsford A, 2011, MOL ECOL, V20, P2380, DOI 10.1111/j.1365-294X.2011.05055.x; Buchanan L. L., 1939, Miscellaneous Publications United States Department of Agriculture Washington, VNo. 341; Buggs RJA, 2007, HEREDITY, V99, P301, DOI 10.1038/sj.hdy.6800997; Campagna L, 2014, BIOL J LINN SOC, V111, P863, DOI 10.1111/bij.12272; Chifflet L, 2016, J EVOLUTION BIOL, V29, P790, DOI 10.1111/jeb.12827; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Gomez-Zurita J, 2006, EVOLUTION, V60, P328, DOI 10.1111/j.0014-3820.2006.tb01110.x; Guedes JVC, 2005, NEOTROP ENTOMOL, V34, P577, DOI 10.1590/S1519-566X2005000400007; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hancock JM, 2000, MOL PHYLOGENET EVOL, V14, P366, DOI 10.1006/mpev.1999.0709; HUBBS CLARK, 1960, COPEIA, V1960, P1, DOI 10.2307/1439836; JUNQUEIRA G. M., 1952, Solo, V44, P51; Kajtoch L, 2012, INSECT SCI, V19, P183, DOI 10.1111/j.1744-7917.2011.01448.x; Kajtoch L, 2009, FOLIA BIOL-KRAKOW, V57, P149, DOI 10.3409/fb57_3-4.149-156; Krieger J, 2002, J APPL ICHTHYOL, V18, P290, DOI 10.1046/j.1439-0426.2002.00377.x; Krieger J, 2006, J HERED, V97, P218, DOI 10.1093/jhered/esj035; Lachowska D, 2008, GENETICA, V134, P235, DOI 10.1007/s10709-007-9230-x; Lanteri A.A., 1987, Revista de la Asociacion de Ciencias Naturales del Litoral, V17, P161; LANTERI AA, 1995, ANN ENTOMOL SOC AM, V88, P722, DOI 10.1093/aesa/88.6.722; Lanteri AA, 1989, NATURA NEOTROPICALIS, V20, P41; LANTERI ANALÍA A., 2002, Neotrop. entomol., V31, P561, DOI 10.1590/S1519-566X2002000400008; Lanteri Analia A., 1993, Revista Sociedad Entomologica Argentina, V52, P100; Lavinia PD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186845; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Lokki J., 1980, Basic Life Sciences, V13, P277; Lundmark M, 2010, HEREDITAS, V147, P278, DOI 10.1111/j.1601-5223.2010.02198.x; Moritz C, 2009, P ROY SOC B-BIOL SCI, V276, P1235, DOI 10.1098/rspb.2008.1622; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Piper RW, 2001, BIOL CONSERV, V101, P9, DOI 10.1016/S0006-3207(01)00048-9; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; REMINGTON C L, 1968, Evolutionary Biology (New York), P321; Rodriguero MS, 2013, MOL PHYLOGENET EVOL, V68, P644, DOI 10.1016/j.ympev.2013.04.011; Rodriguero MS, 2010, INSECT MOL BIOL, V19, P631, DOI 10.1111/j.1365-2583.2010.01018.x; Rodriguero MS, 2016, ECOL EVOL, V6, P5431, DOI 10.1002/ece3.2180; Rodriguero MS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-340; Rodriguero MS, 2015, 9 C ARG ENT; Rozek M, 2009, MICRON, V40, P881, DOI 10.1016/j.micron.2009.06.006; Saetre GP, 1997, NATURE, V387, P589; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; Smith S, 1978, ANIMAL CYTOGENETICS; Smith SG, 1978, ANIMAL CYTOGENETICS, V3; Stenberg P, 2003, MOL BIOL EVOL, V20, P1626, DOI 10.1093/molbev/msg180; Suomalainen E., 1969, P261; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; TAJIMA F, 1993, GENETICS, V135, P599; TAKENOUCHI Y, 1976, P JPN ACAD, V52, P126, DOI 10.2183/pjab1945.52.126; TAKENOUCHI Y, 1980, Journal of the Hokkaido University of Education Section II B, V31, P1; TAKENOUCHI Y, 1981, Zoological Magazine (Tokyo), V90, P39; TAKENOUCHI Y, 1965, CAN J GENET CYTOL, V7, P663, DOI 10.1139/g65-088; TAKENOUCHI Y, 1981, Zoological Magazine (Tokyo), V90, P231; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMIUK J, 1992, HEREDITY, V68, P391, DOI 10.1038/hdy.1992.58; VANDEL A., 1928, BULL BIOL FRANCE ET BELGIQUE, V62, P164	62	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195551	10.1371/journal.pone.0195551	http://dx.doi.org/10.1371/journal.pone.0195551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718921	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900022
J	Xue, YF; Cheng, LL; Chen, X; Zhai, XM; Wang, W; Zhang, WJ; Bai, Y; Tian, HZ; Nie, L; Zhang, SH; Wei, T				Xue, Yifeng; Cheng, Linglong; Chen, Xi; Zhai, Xiaoman; Wang, Wei; Zhang, Wenjie; Bai, Yan; Tian, Hezhong; Nie, Lei; Zhang, Shihao; Wei, Tong			Emission characteristics of harmful air pollutants from cremators in Beijing, China	PLOS ONE			English	Article							MUNICIPAL WASTE INCINERATOR; HEALTH-RISKS; VICINITY; DIOXINS; PCDD/FS; EXPOSURE; METALS; FURANS; JAPAN; VOCS	The process of corpse cremation generates numerous harmful air pollutants, including particulate matter (PM), sulfur dioxide (SO2), nitrogen oxides (NOx), volatile organic compounds (VOCs), and heavy metals. These pollutants could have severe effects on the surrounding environment and human health. Currently, the awareness of the emission levels of harmful air pollutants from cremators and their emission characteristics is insufficient. In this study, we obtained the emission characteristics of flue gas from cremators in Beijing and determined the localized emission factors and emission levels of harmful air pollutants based on actual monitoring data from nine typical cremators. The results show that the emissions of air pollutants from the cremators that directly discharge flue gas exceed the emission standards of China and Beijing. The installation of a flue gas post-treatment system could effectively reduce gaseous pollutants and the emission levels of PM. After being equipped with a flue gas post-treatment system, the emission concentrations of PM10, PM2.5, CO, SO2 and VOCs from the cremators are reduced by 97.6, 99.2, 19.6, 85.2 and 70.7%, respectively. Moreover, the emission factors of TSP, PM10, PM2.5, CO, SO2 and VOCs are also reduced to 12.5, 9.3, 3.0, 164.1, 8.8 and 19.8 g/body. Although the emission concentration of VOCs from the cremators is not high, they are one of major sources of "odor" in the crematories and demand more attention. Benzene, a chemical that can seriously harm human health, constitutes the largest proportion (similar to 50%) of the chemical components of VOCs in the flue gas from the cremators.	[Xue, Yifeng; Cheng, Linglong; Nie, Lei; Zhang, Shihao] Beijing Municipal Res Inst Environm Protect, Natl Engn Res Ctr Urban Environm Pollut Control, Beijing, Peoples R China; [Chen, Xi; Zhai, Xiaoman; Wang, Wei] Minist Civil Affairs, Inst 101, Key Lab Pollut Control, Beijing, Peoples R China; [Zhang, Wenjie] Chinese Res Inst Environm Sci, Beijing, Peoples R China; [Bai, Yan; Wei, Tong] Babaoshan Funeral Parlor, Beijing, Peoples R China; [Tian, Hezhong] Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Co, Beijing, Peoples R China; [Zhang, Shihao] Capital Normal Univ, Coll Resource Environm & Tourism, Beijing, Peoples R China	Beijing Municipal Research Institute of Environment; Chinese Research Academy of Environmental Sciences; Beijing Normal University; Capital Normal University	Wang, W (corresponding author), Minist Civil Affairs, Inst 101, Key Lab Pollut Control, Beijing, Peoples R China.; Tian, HZ (corresponding author), Beijing Normal Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Co, Beijing, Peoples R China.	wangwei67626@126.com; hztian@bnu.edu.cn	Xue, Yifeng/R-4416-2019; Tian, HZ/B-8413-2013; Hezhong, Tian/AAE-6878-2019	Hezhong, Tian/0000-0002-3638-8495; Xue, Yifeng/0000-0001-6132-6213	National Science and Technology Support Program of the Ministry of Science and Technology of China [2014BAC23602]; National Key Research and Development Program of China [2016YFC0201106]; Science Foundation of Beijing Municipal Research Institute of Environmental Protection [2017601]; Beijing Excellent Personnel Training Project [2017000021733G105]	National Science and Technology Support Program of the Ministry of Science and Technology of China; National Key Research and Development Program of China; Science Foundation of Beijing Municipal Research Institute of Environmental Protection; Beijing Excellent Personnel Training Project	This work was funded by the National Science and Technology Support Program of the Ministry of Science and Technology of China (2014BAC23602), the National Key Research and Development Program of China (2016YFC0201106), the Science Foundation of Beijing Municipal Research Institute of Environmental Protection (2017601), and the Beijing Excellent Personnel Training Project (2017000021733G105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agramunt MC, 2005, J EXPO ANAL ENV EPID, V15, P29, DOI 10.1038/sj.jea.7500339; Ben YJ, 2017, ENVIRON POLLUT, V224, P532, DOI 10.1016/j.envpol.2017.02.036; Chen SJ, 2004, CHEMOSPHERE, V55, P1197, DOI 10.1016/j.chemosphere.2003.12.020; Domingo JL, 2002, ARCH ENVIRON CON TOX, V43, P461, DOI 10.1007/s00244-002-1280-6; Domingo JL, 2015, SCI TOTAL ENVIRON, V518, P363, DOI 10.1016/j.scitotenv.2015.03.010; Kamal MS, 2016, ATMOS ENVIRON, V140, P117, DOI 10.1016/j.atmosenv.2016.05.031; Kim KH, 2008, CHEMOSPHERE, V73, P1632, DOI 10.1016/j.chemosphere.2008.07.068; Liu WB, 2013, ENVIRON SCI TECHNOL, V47, P9774, DOI 10.1021/es402136s; Mari M, 2010, ENVIRON INT, V36, P131, DOI 10.1016/j.envint.2009.09.006; Nansai K, 2012, ENVIRON SCI TECHNOL, V46, P4933, DOI 10.1021/es203687r; [任玥 REN Yue], 2009, [环境科学研究, Research of Environmental Sciences], V22, P1245; Rovira J, 2015, WASTE MANAGE, V43, P168, DOI 10.1016/j.wasman.2015.05.039; Santarsiero A, 2005, MICROCHEM J, V79, P299, DOI 10.1016/j.microc.2004.10.016; Schuhmacher M, 2004, CHEMOSPHERE, V57, P43, DOI 10.1016/j.chemosphere.2004.05.007; Takaoka M, 2010, ATMOS CHEM PHYS, V10, P3665, DOI 10.5194/acp-10-3665-2010; Takeda N, 2014, CHEMOSPHERE, V98, P91, DOI 10.1016/j.chemosphere.2013.09.114; Trozzi C, 2016, EMEP EEA EMISSION IN; Wang LC, 2003, ENVIRON SCI TECHNOL, V37, P62, DOI 10.1021/es0208714; Wang W, 2006, ENV POLLUTION CONTRO, V28, P795; [王玮 Wang Wei], 2006, [环境污染与防治, Environmental Pollution & Control], V28, P786; [王玮 WANG Wei], 2006, [环境科学学报, Acta Scientiae Circumstantiae], V26, P1246; Xi Jin-ying, 2012, China Environmental Science, V32, P1955; Xiong ChengCheng, 2013, Environmental Science & Technology (China), V36, P192; Xue Y, 2016, ATMOS ENVIRON, V124, P36; Xue YF, 2015, HUAN JING KE XUE, V36, P28; Yin Wen-hua, 2015, Huanjing Kexue, V36, P3596; Zheng JY, 2013, SCI TOTAL ENVIRON, V456, P127, DOI 10.1016/j.scitotenv.2013.03.055	27	14	18	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0194226	10.1371/journal.pone.0194226	http://dx.doi.org/10.1371/journal.pone.0194226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718907	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900004
J	Gates, LA; Gu, GW; Chen, Y; Rohira, AD; Lei, JT; Hamilton, RA; Yu, Y; Lonard, DM; Wang, J; Wang, SP; Edwards, DG; Lavere, PF; Shao, JY; Yi, P; Jain, A; Jung, SY; Malovannaya, A; Li, SQ; Shao, JY; Roeder, RG; Ellis, MJ; Qin, J; Fuqua, SAW; O'Malley, BW; Foulds, CE				Gates, Leah A.; Gu, Guowei; Chen, Yue; Rohira, Aarti D.; Lei, Jonathan T.; Hamilton, Ross A.; Yu, Yang; Lonard, David M.; Wang, Jin; Wang, Shu-Ping; Edwards, David G.; Lavere, Philip F.; Shao, Jiangyong; Yi, Ping; Jain, Antrix; Jung, Sung Yun; Malovannaya, Anna; Li, Shunqiang; Shao, Jieya; Roeder, Robert G.; Ellis, Matthew J.; Qin, Jun; Fuqua, Suzanne A. W.; O'Malley, Bert W.; Foulds, Charles E.			Proteomic profiling identifies key coactivators utilized by mutant ER alpha proteins as potential new therapeutic targets	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER CELLS; ESR1 MUTATIONS; ENDOCRINE RESISTANCE; GENETIC SCREENS; PROTEASOME; RECRUITMENT; INHIBITOR; REVEALS; DNA	Approximately 75% of breast cancers are estrogen receptor alpha (ER alpha)-positive and are treatable with endocrine therapies, but often patients develop lethal resistant disease. Frequent mutations (10-40%) in the ligand-binding domain (LBD) codons in the gene encoding ER alpha (ESR1) have been identified, resulting in ligand-independent, constitutively active receptors. In addition, ESR1 chromosomal translocations can occur, resulting in fusion proteins that lack the LBD and are entirely unresponsive to all endocrine treatments. Thus, identifying coactivators that bind to these mutant ERa proteins may offer new therapeutic targets for endocrine-resistant cancer. To define coactivator candidate targets, a proteomics approach was performed profiling proteins recruited to the two most common ER alpha LBD mutants, Y537S and D538G, and an ESR1-YAP1 fusion protein. These mutants displayed enhanced coactivator interactions as compared to unliganded wild-type ER alpha. Inhibition of these coactivators decreased the ability of ESR1 mutants to activate transcription and promote breast cancer growth in vitro and in vivo. Thus, we have identified specific coactivators that may be useful as targets for endocrine-resistant breast cancers.	[Gates, Leah A.; Gu, Guowei; Rohira, Aarti D.; Hamilton, Ross A.; Yu, Yang; Lonard, David M.; Wang, Jin; Lavere, Philip F.; Shao, Jiangyong; Yi, Ping; Jain, Antrix; Malovannaya, Anna; Qin, Jun; O'Malley, Bert W.; Foulds, Charles E.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Gates, Leah A.] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Gu, Guowei; Lei, Jonathan T.; Edwards, David G.; Ellis, Matthew J.; Fuqua, Suzanne A. W.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Chen, Yue] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA 70130 USA; [Lei, Jonathan T.; Ellis, Matthew J.] Baylor Coll Med, Interdept Grad Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Wang, Jin] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Wang, Jin] Baylor Coll Med, Ctr Drug Discovery, Houston, TX 77030 USA; [Wang, Shu-Ping; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10065 USA; [Jung, Sung Yun; Malovannaya, Anna; Qin, Jun] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Li, Shunqiang; Shao, Jieya] Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Ellis, Matthew J.; Fuqua, Suzanne A. W.; O'Malley, Bert W.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Foulds, Charles E.] Baylor Coll Med, Ctr Precis Environm Hlth, Houston, TX 77030 USA	Baylor College of Medicine; Rockefeller University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Rockefeller University; Baylor College of Medicine; Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine	Foulds, CE (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Foulds, CE (corresponding author), Baylor Coll Med, Ctr Precis Environm Hlth, Houston, TX 77030 USA.	foulds@bcm.edu	Jain, Antrix/AEB-7319-2022; Wang, Jin/AAC-7292-2019; Wang, Shu-Ping/S-4379-2018	Jain, Antrix/0000-0002-2815-3645; Wang, Jin/0000-0003-3625-7919; Wang, Shu-Ping/0000-0002-5895-1269; Lei, Jonathan/0000-0002-0209-8051; Jung, Sung Yun/0000-0003-1521-7977; Malovannaya, Anna/0000-0003-2953-6485	NCI [P30 CA125123]; CPRIT [RP170005, RP150578, RR140033, RP150440, RP120732-P2, RP110784]; NIH [DK56338, CA125123, R01 HD008188, R01 HD007857, R01 CA207270, R01 CA072038, R01 GM115622, R01 CA207701, R21 CA213535, R01 DK071900, R01 CA178765, 1F31CA210385-01, T32 GM088129]; Susan G. Komen Foundation [PG12220321, CCR14300139]; Breast Cancer Research Foundation [17-055]; DOD [W81XWH-13-1-0285, W81XWH-16-1-0539]; Human Frontier Science Program Fellowship [LT000538/2011-L]; McNair Medical Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD007857, R01HD008188] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [F31CA210385, R01CA207701, R21CA213535, R01CA178765, R01CA072038, R01CA207270, P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900, P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129, R01GM115622] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CPRIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; DOD(United States Department of Defense); Human Frontier Science Program Fellowship(Human Frontier Science Program); McNair Medical Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following BCM cores (Tissue Culture, Monoclonal Antibody/Recombinant Protein and Mass Spectrometry Proteomics (funded by NCI P30 CA125123 and CPRIT RP170005), Gene Vector, Integrated Microscopy (funded by NIH (DK56338 and CA125123) and CPRIT (RP150578))), David Bader, Doug Chan, and Rainer Lanz. We acknowledge the joint participation with the Adrienne Helis Malvin Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with BCM and the Cancer Program. This work was supported by the NIH ((R01 HD008188 and R01 HD007857 to B.W.O.), (R01 CA207270 and R01 CA072038 to S.A.W.F), (R01 GM115622, R01 CA207701, and R21 CA213535 to J.W.), (R01 DK071900 and R01 CA178765 to R.G.R.), (1F31CA210385-01 to L.A.G.), and (T32 GM088129 to J.T.L.)), CPRIT ((RR140033 to M.J.E), (RP150440 and RP120732-P2 to S.A.W.F.), and (RP110784 to J.Q.)), Susan G. Komen Foundation ((PG12220321 to M.J.E.) and (CCR14300139 to Jieya Shao)), Breast Cancer Research Foundation (17-055 to S.A.W.F.), DOD ((W81XWH-13-1-0285 to B.W.O.) and (W81XWH-16-1-0539 to M.J.E.)), the Human Frontier Science Program Fellowship (LT000538/2011-L to S.P.W.), and the McNair Medical Foundation (M.J.E.).	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Alluri PG, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.AM2016-2156; Boney-Montoya J, 2010, MOL ENDOCRINOL, V24, P346, DOI 10.1210/me.2009-0429; Bossi D, 2016, CANCER DISCOV, V6, P650, DOI 10.1158/2159-8290.CD-15-1200; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chandarlapaty S, 2016, JAMA ONCOL, V2, P1310, DOI 10.1001/jamaoncol.2016.1279; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Ciruelos E, 2014, BREAST, V23, P201, DOI 10.1016/j.breast.2014.01.016; Clatot F, 2016, ONCOTARGET, V7, P74448, DOI 10.18632/oncotarget.12950; Dawkins JBN, 2016, CANCER RES, V76, P4861, DOI 10.1158/0008-5472.CAN-16-0481; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Fan MY, 2004, MOL ENDOCRINOL, V18, P2603, DOI 10.1210/me.2004-0164; Fanning Sean W, 2016, Elife, V5, DOI 10.7554/eLife.12792; Foulds CE, 2013, MOL CELL, V51, P185, DOI 10.1016/j.molcel.2013.06.007; Foulds Charles E, 2010, Mol Endocrinol, V24, P1090, DOI 10.1210/me.2009-0427; Fribbens C, 2016, J CLIN ONCOL, V34, P2961, DOI 10.1200/JCO.2016.67.3061; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Gelsomino L, 2016, BREAST CANCER RES TR, V157, P253, DOI 10.1007/s10549-016-3829-5; Gu GW, 2015, BREAST CANCER RES TR, V150, P535, DOI 10.1007/s10549-015-3354-y; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Harrod A, 2017, ONCOGENE, V36, P2286, DOI 10.1038/onc.2016.382; Hartmaier RJ, 2018, ANN ONCOL, V29, P872, DOI 10.1093/annonc/mdy025; Jeong KW, 2012, MOL ENDOCRINOL, V26, P955, DOI 10.1210/me.2012-1066; Jeselsohn R, 2018, CANCER CELL, V33, P173, DOI 10.1016/j.ccell.2018.01.004; Jeselsohn R, 2014, CLIN CANCER RES, V20, P1757, DOI 10.1158/1078-0432.CCR-13-2332; Johnson AB, 2012, MOL CELL ENDOCRINOL, V348, P430, DOI 10.1016/j.mce.2011.04.021; Joseph JD, 2016, ELIFE, V5, DOI 10.7554/eLife.15828; Jozwik KM, 2016, CELL REP, V17, P2715, DOI 10.1016/j.celrep.2016.11.028; Kinyamu HK, 2008, MOL CARCINOGEN, V47, P845, DOI 10.1002/mc.20440; Lake MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044160; Lazennec G, 1997, MOL ENDOCRINOL, V11, P1375, DOI 10.1210/me.11.9.1375; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Long WW, 2012, J CLIN INVEST, V122, P1869, DOI 10.1172/JCI61492; Mao CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34753; Massarweh S, 2007, CLIN CANCER RES, V13, P1950, DOI 10.1158/1078-0432.CCR-06-2540; Merenbakh-Lamin K, 2013, CANCER RES, V73, P6856, DOI 10.1158/0008-5472.CAN-13-1197; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Powers GL, 2010, ONCOGENE, V29, P1509, DOI 10.1038/onc.2009.434; Prenzel T, 2011, CANCER RES, V71, P5739, DOI 10.1158/0008-5472.CAN-11-1896; Raj GV, 2017, ELIFE, V6, DOI 10.7554/eLife.26857; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Scott GK, 2017, ONCOTARGET, V8, P83432, DOI 10.18632/oncotarget.12735; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Song XZ, 2016, P NATL ACAD SCI USA, V113, P4970, DOI 10.1073/pnas.1604274113; Spoerke JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11579; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Symmans WF, 2010, J CLIN ONCOL, V28, P4111, DOI 10.1200/JCO.2010.28.4273; Thaler S, 2015, INT J CANCER, V137, P686, DOI 10.1002/ijc.29404; Toska E, 2017, SCIENCE, V355, P1324, DOI 10.1126/science.aah6893; Toy W, 2017, CANCER DISCOV, V7, P277, DOI 10.1158/2159-8290.CD-15-1523; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Van Asten K, 2014, ENDOCR-RELAT CANCER, V21, pR31, DOI 10.1530/ERC-13-0269; Wang SP, 2017, MOL CELL, V67, P308, DOI 10.1016/j.molcel.2017.06.028; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wardell SE, 2015, CLIN CANCER RES, V21, P5121, DOI 10.1158/1078-0432.CCR-15-0360; Weir HM, 2016, CANCER RES, V76, P3307, DOI 10.1158/0008-5472.CAN-15-2357; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; Wierer M, 2013, CELL REP, V3, P2021, DOI 10.1016/j.celrep.2013.05.024; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940; Zhang QX, 1997, CANCER RES, V57, P1244; Zhao YC, 2017, CANCER RES, V77, P5602, DOI 10.1158/0008-5472.CAN-17-1265	66	36	36	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 16	2018	37	33					4581	4598		10.1038/s41388-018-0284-2	http://dx.doi.org/10.1038/s41388-018-0284-2			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GQ5OV	29748621	Green Published, hybrid			2022-12-26	WOS:000441736700007
J	Yoon, S; Lee, EJ; Choi, JH; Chung, T; Kim, DY; Im, JY; Bae, MH; Kwon, JH; Kim, HH; Kim, HC; Park, YN; Wang, HJ; Woo, HG				Yoon, Sarah; Lee, Eun-Ju; Choi, Ji-Hye; Chung, Taek; Kim, Do Young; Im, Jong-Yeop; Bae, Myung-Ho; Kwon, Jung-Hee; Kim, Hyuk-Hoon; Kim, Hyung Chul; Park, Young Nyun; Wang, Hee-Jung; Woo, Hyun Goo			Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer	ONCOGENE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; LIPOCALIN 2; RESISTANCE; PROGRESSION; EXPRESSION; ANGIOGENESIS; SENSITIVITY; INDUCTION; MECHANISM; HUMANS	Gene mutations play critical roles during cancer development and progression, and therefore represent targets for precision medicine. Here we recapitulated the pharmacogenomic data to delineate novel candidates for actionable mutations and therapeutic target drugs. As a proof-of-concept, we demonstrated that the loss-of-function of SULF2 by mutation (N491K) or inhibition enhanced sorafenib sensitivity in liver cancer cells and in vivo mouse models. This effect was mediated by deregulation of EGFR signaling and downstream expression of LCN2. We also report that the liver cancer patients non-responding to sorafenib treatment exhibit higher expression of SULF2 and LCN2. In conclusion, we suggest that SULF2 plays a key role in sorafenib susceptibility and resistance in liver cancer via deregulation of LCN2. Diagnostic or therapeutic targeting of SULF2 (e.g., OKN-007) and/or LCN2 can be a novel precision strategy for sorafenib treatment in cancer patients.	[Yoon, Sarah; Lee, Eun-Ju; Choi, Ji-Hye; Im, Jong-Yeop; Woo, Hyun Goo] Ajou Univ, Sch Med, Dept Physiol, Suwon, South Korea; [Choi, Ji-Hye; Im, Jong-Yeop; Woo, Hyun Goo] Ajou Univ, Dept Biomed Sci, Grad Sch, Suwon, South Korea; [Chung, Taek; Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Chung, Taek; Park, Young Nyun] Yonsei Univ, Coll Med, PLUS Project Med Sci BK21, Seoul, South Korea; [Kim, Do Young] Yonsei Univ, Coll Med, Dept Gastroenterol, Seoul, South Korea; [Bae, Myung-Ho; Kwon, Jung-Hee] CbsBioscience Inc, Daejeon, South Korea; [Kim, Hyuk-Hoon] Ajou Univ, Sch Med, Dept Emergency Med, Suwon, South Korea; [Kim, Hyung Chul] NCI, Dev Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wang, Hee-Jung] Ajou Univ, Sch Med, Dept Surg, Suwon, South Korea	Ajou University; Ajou University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Ajou University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ajou University	Woo, HG (corresponding author), Ajou Univ, Sch Med, Dept Physiol, Suwon, South Korea.; Woo, HG (corresponding author), Ajou Univ, Dept Biomed Sci, Grad Sch, Suwon, South Korea.	hg@ajou.ac.kr	Woo, Hyun Goo | 우현구/I-8954-2019; Woo, Hyun Goo/AEJ-7372-2022	Woo, Hyun Goo | 우현구/0000-0002-0916-893X; Woo, Hyun Goo/0000-0002-0916-893X	Korea Healthcare Technology R&D Project, Ministry of Health Welfare [HI15C1551, HI14C3392]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2017M3A9B6061509, NRF-2017R1E1A1A01074733, NRF-2015R1D1A4A01020022]	Korea Healthcare Technology R&D Project, Ministry of Health Welfare; National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by grants from the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare (HI15C1551 and HI14C3392) and from the National Research Foundation of Korea (NRF) funded by the Korea government (MSIP) (NRF-2017M3A9B6061509, NRF-2017R1E1A1A01074733, and NRF-2015R1D1A4A01020022).	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Berasain C, 2013, GUT, V62, P1674, DOI 10.1136/gutjnl-2013-304564; Blivet-Van Eggelpoel MJ, 2012, J HEPATOL, V57, P108, DOI 10.1016/j.jhep.2012.02.019; Chen G, 2017, CANCER RES, V77, P632, DOI 10.1158/0008-5472.CAN-15-2556; Chen HA, 2016, HEPATOLOGY, V64, P1637, DOI 10.1002/hep.28773; Ding GX, 2015, PROSTATE, V75, P957, DOI 10.1002/pros.22978; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2010, HEPATOLOGY, V52, P1680, DOI 10.1002/hep.23848; Leung L, 2012, PLOS ONE, V7; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nishida N, 2015, DIGEST DIS, V33, P771, DOI 10.1159/000439102; Park JG, 2015, CLIN MOL HEPATOL, V21, P287, DOI 10.3350/cmh.2015.21.3.287; Peng S, 2014, HEPATOLOGY, V60, P1264, DOI 10.1002/hep.27236; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Rudalska R, 2014, NAT MED, V20, P1138, DOI 10.1038/nm.3679; Shiiba M, 2013, INT J ONCOL, V42, P1197, DOI 10.3892/ijo.2013.1815; Sun XF, 2016, HEPATOLOGY, V64, P488, DOI 10.1002/hep.28574; Tang RH, 2009, J BIOL CHEM, V284, P21505, DOI 10.1074/jbc.M109.028472; Tovar V, 2017, GUT, V66, P530, DOI 10.1136/gutjnl-2015-309501; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Yonesaka K, 2008, CLIN CANCER RES, V14, P6963, DOI 10.1158/1078-0432.CCR-08-0957; Yoo J, 2012, AM J PHYSIOL-GASTR L, V302, pG805, DOI 10.1152/ajpgi.00522.2011; Zhang Y, 2012, CANCER EPIDEMIOL, V36, pE294, DOI 10.1016/j.canep.2012.05.012; Zhao P, 2013, MOL METAB, V2, P161, DOI 10.1016/j.molmet.2013.04.003	31	10	10	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 9	2018	37	32					4443	4454		10.1038/s41388-018-0291-3	http://dx.doi.org/10.1038/s41388-018-0291-3			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP8FA	29720727				2022-12-26	WOS:000441144300008
J	Chi, H; Chung, CH; Lin, YJ; Lin, CH				Chi, Hsin; Chung, Ching-Hu; Lin, Yuh-Jyh; Lin, Chyi-Her			Seasonal peaks and risk factors of respiratory syncytial virus infections related hospitalization of preterm infants in Taiwan	PLOS ONE			English	Article							WEEKS GESTATION; YOUNG-CHILDREN; BRONCHOPULMONARY DYSPLASIA; BRONCHIOLITIS; PALIVIZUMAB; DURATION; BURDEN; BORN; CARE; AGE	Objectives To assess the nationwide seasonal peaks, risk factors, and utilization of medical resources of respiratory syncytial virus-associated hospitalization (RSVH) in preterm infants in Taiwan. Study design A Taiwan nationwide birth cohort was extracted from the Birth Certificate Application Database during 2007-2009 and prospectively linked to the National Health Insurance database. We evaluated the seasonal peaks and risk factors (gestational age [GA], chronologic age [CA], and bronchopulmonary dysplasia [BPD]) associated with the RSVH of preterm infants. The length of hospital stays (LOS), care in intensive care unit (ICU), and use of mechanical ventilation (MV) were also analyzed. Results There is a total duration of 9 months of RSVH season in Taiwan, three seasonal peaks and two seasonal peaks of RSVH in preterm infants with BPD and without BPD, respectively. Preterm infants had significantly higher RSVH rate than term infants (2.6% vs 0.9%, p<0.0001). Preterm infants born at 29-35 weeks of gestational age (wGA) with BPD had significantly higher RSVH rate than those without BPD (p<0.0001). Preterm infants without BPD born at < 32 wGA had higher RSVH rate than those born at 33-35 wGA (p<0.0001). Overall, 56.4% of RSVH occurred within 9 months of CA. Preterm infants with BPD had significantly higher ICU admission rate within 18 months of CA (p<0.0001), MV usage within 12 months of CA (p<0.0001) and LOS within 18 months of CA (p<0.001) than those without BPD. RSVH occurred within 6 months of CA was significantly associated with higher ICU admission rate (p<0.0001), MV usage (p = 0.0002) and longer LOS (p<0.001) in preterm infants without BPD. Conclusions There is a total duration of 9 months of RSVH season in Taiwan. Preterm < 32 wGA, BPD, and CA within 6 months were risk factors of RSVH which also contribute to higher utilization of medical resources.	[Chi, Hsin] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Chi, Hsin] Mackay Childrens Hosp, Taipei, Taiwan; [Chi, Hsin; Chung, Ching-Hu] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Lin, Yuh-Jyh; Lin, Chyi-Her] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan, Taiwan; [Lin, Yuh-Jyh; Lin, Chyi-Her] Natl Cheng Kung Univ, Coll Med, Tainan, Taiwan	Mackay Memorial Hospital; Mackay Medical College; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Lin, CH (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan, Taiwan.; Lin, CH (corresponding author), Natl Cheng Kung Univ, Coll Med, Tainan, Taiwan.	neonate@mail.ncku.edu.tw	Lin, Yuh Jyh/AAK-4314-2020					Abraha HY, 2015, EXPERT REV RESP MED, V9, P779, DOI 10.1586/17476348.2015.1098536; Abramson JS, 2003, PEDIATRICS, V112, P1442; Anderson EJ, 2017, AM J PERINAT, V34, P51, DOI 10.1055/s-0036-1584147; Behrendt CE, 1998, EUR J PEDIATR, V157, P215, DOI 10.1007/s004310050798; Bocchini JA, 2009, PEDIATRICS, V124, P1216, DOI [10.1542/peds.2009-1806, 10.1542/peds.2009-2345]; Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Breese C, 2013, PEDIATRICS, V132, pE341, DOI 10.1542/peds.2013-0303; Carbonell-Estrany X, 2000, PEDIATR INFECT DIS J, V19, P592, DOI 10.1097/00006454-200007000-00002; Chi H, 2011, J FORMOS MED ASSOC, V110, P388, DOI 10.1016/S0929-6646(11)60057-0; Cilla G, 2006, EPIDEMIOL INFECT, V134, P506, DOI 10.1017/S0950268805005571; Flaherman VJ, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-144; Gouyon JB, 2013, EPIDEMIOL INFECT, V141, P816, DOI 10.1017/S0950268812001069; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Halsey NA, 1998, PEDIATRICS, V102, P1211, DOI 10.1542/peds.102.5.1211; Helfrich AM, 2015, EARLY HUM DEV, V91, P541, DOI 10.1016/j.earlhumdev.2015.06.009; Hervas D, 2012, EUR J CLIN MICROBIOL, V31, P1975, DOI 10.1007/s10096-011-1529-y; Homaira N, 2016, EPIDEMIOL INFECT, V144, P1612, DOI 10.1017/S0950268815003015; Howard TS, 2000, J PEDIATR-US, V137, P227, DOI 10.1067/mpd.2000.107525; Hsu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110166; Kneyber MCJ, 2002, PEDIATR PULM, V33, P453, DOI 10.1002/ppul.10099; Landry JS, 2012, CHRON DIS INJ CAN, V33, P47; Lee Jian-Te, 2007, Journal of Microbiology Immunology and Infection, V40, P293; Mauskopf J, 2016, PEDIATR INFECT DIS J, V35, pE229, DOI 10.1097/INF.0000000000001163; Murray J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089186; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Panozzo CA, 2007, PEDIATR INFECT DIS J, V26, pS41, DOI 10.1097/INF.0b013e318157da82; Robbie GJ, 2012, ANTIMICROB AGENTS CH, V56, P4927, DOI 10.1128/AAC.06446-11; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Sommer Constanze, 2011, Open Microbiol J, V5, P144, DOI 10.2174/1874285801105010144; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; Stevens TP, 2000, ARCH PEDIAT ADOL MED, V154, P55; Stockman LJ, 2012, PEDIATR INFECT DIS J, V31, P5, DOI 10.1097/INF.0b013e31822e68e6; Tang JLW, 2014, REV MED VIROL, V24, P15, DOI 10.1002/rmv.1771; Weisman LE, 2003, PEDIATR INFECT DIS J, V22, pS33, DOI 10.1097/00006454-200302001-00005; Winterstein AG, 2013, JAMA PEDIATR, V167, P1118, DOI 10.1001/jamapediatrics.2013.2636; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X	37	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197410	10.1371/journal.pone.0197410	http://dx.doi.org/10.1371/journal.pone.0197410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746578	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700110
J	Li, MX; Lee, D; Obi, CR; Freeberg, JK; Farr-Jones, S; Tomic, MT				Li, Mingxiang; Lee, Dennis; Obi, Chidi R.; Freeberg, Joel K.; Farr-Jones, Shauna; Tomic, Milan T.			An ambient temperature-stable antitoxin of nine co-formulated antibodies for botulism caused by serotypes A, B and E	PLOS ONE			English	Article							DOMAIN-BASED ASSAYS; MONOCLONAL-ANTIBODIES; MOLECULAR EVOLUTION; NEUROTOXIN; AFFINITY; BINDING; SUBTYPES; MIXTURE; TOXIN	Safe and effective antitoxins to treat and prevent botulism are needed for biodefense. We have developed recombinant antibody-based therapeutics for botulinum neurotoxin (BoNT) serotypes A, B, and E. The mechanism of action of this antitoxin requires that three mAbs bind one toxin molecule to achieve clearance. Here we present a co-formulation of an antitoxin to the three most important serotypes. Combining these antibodies obviates the need to identify the serotype causing intoxication prior to drug administration, which would facilitate administration. The lyophilized powder formulation contains nine mAbs, three mAbs for each of the three serotypes (A, B, E). The formulation was stored as a liquid and lyophilized powder for up to one year, and characterized by binding affinity and multiple physicochemical methods. No significant increase in soluble higher order aggregates, cleavage products, or change in charge isoforms was measured after storage as a lyophilized powder at 50 degrees C for one year. Furthermore, toxin-domain binding ELISA data indicated that each of the individual antibodies in the lyophilized drug product showed essentially full binding capability to their respective toxin domains after being stored at 50 degrees C for one year. Physicochemical characterization of the formulation demonstrated the nine individual mAbs were remarkably stable. This work demonstrates feasibility of lyophilized, oligoclonal antibody therapies for biodefense with ambient temperature stability, that would facilitate stockpiling, distribution, and administration.	[Li, Mingxiang; Lee, Dennis; Obi, Chidi R.; Freeberg, Joel K.; Tomic, Milan T.] Xoma Corp, Berkeley, CA 94710 USA; [Farr-Jones, Shauna] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Li, Mingxiang] Sutro Biopharma Inc, San Francisco, CA USA; [Lee, Dennis] Samsung BioL, Incheon, South Korea; [Obi, Chidi R.; Freeberg, Joel K.] Portola Pharmaceut Inc, San Francisco, CA USA; [Tomic, Milan T.] Ology Bioserv Inc, Berkeley, CA 94710 USA	University of California System; University of California San Francisco	Tomic, MT (corresponding author), Xoma Corp, Berkeley, CA 94710 USA.; Tomic, MT (corresponding author), Ology Bioserv Inc, Berkeley, CA 94710 USA.	milan.tomic@ologybio.com		Farr-Jones, Shauna/0000-0003-4130-6332	National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200800028C]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This was supported by the National Institute of Allergy and Infectious Diseases (NIAID) under the contract number HHSN272200800028C. The content of the manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors MTT, SFJ, ML, DL, CO but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Arena S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5640; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; Botulism in the United States, 1998, BOT US 1899 1998 HDB; Cangene Corp. BAT &REG, 2013, BAT BOT ANT HEPT A B; Carvalho S, 2016, BRIT J PHARMACOL, V173, P1407, DOI 10.1111/bph.13450; Chao TY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006133; Derman Y, 2016, TOXINS, V8, DOI 10.3390/toxins8090257; Garcia-Rodriguez C, 2011, PROTEIN ENG DES SEL, V24, P321, DOI 10.1093/protein/gzq111; Garcia-Rodriguez C, 2018, TOXINS, V10, pE105; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Kalb SR, 2008, INT J MASS SPECTROM, V278, P101, DOI 10.1016/j.ijms.2008.04.004; Kalb SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005355; Li M, 2011, [No title captured], Patent No. [US20110059079 A1, 20110059079]; Lou J, 2010, PROTEIN ENG DES SEL, V23, P311, DOI 10.1093/protein/gzq001; Meng Q, 2012, ANAL BIOCHEM, V430, P141, DOI 10.1016/j.ab.2012.08.005; Meng Q, 2012, ANAL BIOCHEM, V421, P351, DOI 10.1016/j.ab.2011.09.030; Nayak SU, 2014, ANTIMICROB AGENTS CH, V58, P5047, DOI 10.1128/AAC.02830-14; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Pless DD, 2001, INFECT IMMUN, V69, P570, DOI 10.1128/IAI.69.1.570-574.2001; Rao AKJK, 2013, CONFIRMED CASES BOTU; Rasetti-Escargueil C, 2017, TOXINS, V9, DOI 10.3390/toxins9100309; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Schwimmer LJ, 2013, J IMMUNOL METHODS, V391, P60, DOI 10.1016/j.jim.2013.02.010; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Teshima G, 2011, J CHROMATOGR A, V1218, P2091, DOI 10.1016/j.chroma.2010.10.107; Woodard J, 2013, ANAL CHEM, V85, P6429, DOI 10.1021/ac401455f; Yao GR, 2017, TOXINS, V9, DOI 10.3390/toxins9030093	29	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197011	10.1371/journal.pone.0197011	http://dx.doi.org/10.1371/journal.pone.0197011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746518	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700056
J	Ryskaliyeva, A; Henry, C; Miranda, G; Faye, B; Konuspayeva, G; Martin, P				Ryskaliyeva, Alma; Henry, Celine; Miranda, Guy; Faye, Bernard; Konuspayeva, Gaukhar; Martin, Patrice			Combining different proteomic approaches to resolve complexity of the milk protein fraction of dromedary, Bactrian camels and hybrids, from different regions of Kazakhstan	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; MOLECULAR CHARACTERIZATION; RENNETING PROPERTIES; SEQUENCE-ANALYSIS; BETA-CASEIN; BOVINE; PHOSPHORYLATION; LACTOFERRIN; ALPHA(S1)-CASEIN; EXPRESSION	Nutritional suitability of milk is not only related to gross composition, but is also strongly affected by the microheterogeniety of the protein fraction. Hence, to go further into the evaluation of the potential suitability of non-bovine milks in human/infant nutrition it is necessary to have a detailed characterization of their protein components. Combining proven proteomic approaches (SDS-PAGE, LC-MS/MS and LC-ESI-MS) and cDNA sequencing, we provide here in depth characterization of the milk protein fraction of dromedary and Bactrian camels, and their hybrids, from different regions of Kazakhstan. A total 391 functional groups of proteins were identified from 8 camel milk samples. A detailed characterization of 50 protein molecules, relating to genetic variants and isoforms arising from post-translational modifications and alternative splicing events, belonging to nine protein families (K-, alpha(s1)-, alpha(s2)-, beta-; and gamma-CN, WAP, alpha-LAC, PGRP, CSA/LPO) was achieved by LC-ESI-MS. The presence of two unknown proteins UP1 (22,939 Da) and UP2 (23,046 Da) was also reported as well as the existence of ap-CN short isoform (946 Da lighter than the full-length beta-CN), arising very likely in both genetic variants (A and B) from proteolysis by plasmin. In addition, we report, for the first time to our knowledge, the occurrence of a alpha(s2)-CN phosphorylation isoform with 12P groups within two recognition motifs, suggesting thereby the existence of two kinase systems involved in the phosphorylation of caseins in the mammary gland. Finally, we demonstrate that genetic variants, which hitherto seemed to be species- specific (e.g. beta-CN A for Bactrian and beta-CN B for dromedary), are in fact present both in Camel dromedarius and C. bactrianus.	[Ryskaliyeva, Alma; Miranda, Guy; Martin, Patrice] Univ Paris Saclay, AgroParisTech, UMR GABI, INRA, Jouy En Josas, France; [Henry, Celine] Univ Paris Saclay, MICALIS Inst, Plateforme Anal Prote Paris Sud Ouest PAPPSO, INRA, Jouy En Josas, France; [Faye, Bernard] CIRAD, UMR SELMET, Montpellier, France; [Konuspayeva, Gaukhar] Al Farabi Kazakh State Natl Univ, Biol Dept, Alma Ata, Kazakhstan	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CIRAD; Al-Farabi Kazakh National University	Ryskaliyeva, A (corresponding author), Univ Paris Saclay, AgroParisTech, UMR GABI, INRA, Jouy En Josas, France.	alma.ryskaliyeva@inra.fr	, faye/CAG-0441-2022; Konuspayeva, Gaukhar/A-8484-2016; Ryskaliyeva, Alma/AAR-3009-2020	Konuspayeva, Gaukhar/0000-0003-0171-3582; Ryskaliyeva, Alma/0000-0001-7892-0665; Henry, Celine/0000-0002-2355-1791	JSC <<Center for International Programs>> (Kazakhstan); Ministry of Education and Science of the Republic of Kazakhstan [1729/GF4]	JSC <<Center for International Programs>> (Kazakhstan); Ministry of Education and Science of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	The study was carried out within the Bolashak International Scholarship of the first author, funded by the JSC << Center for International Programs >> (Kazakhstan). The research was partly supported by a grant from the Ministry of Education and Science of the Republic of Kazakhstan under name "Proteomic investigation of camel milk" #1729/GF4, which is duly appreciated. The authors thank all Kazakhstani camel milk farms for rendering help in sample collection, as well as PAPPSO and @BRIDGe teams at INRA (Jouy-en-Josas, France) for providing necessary facilities and technical support.r The study was carried out within the Bolashak International Scholarship of the first author, funded by the JSC << Center for International Programs >> (Kazakhstan). The research was partly supported by a grant from the Ministry of Education and Science of the Republic of Kazakhstan under name "Proteomic investigation of camel milk" #1729/GF4, which is duly appreciated. INRA (Jouy-en-Josas, France) for providing necessary facilities and technical support.	Agrawal RP, 2003, J CAMEL PRACT RES, V10, P45; Al Haj OA, 2010, INT DAIRY J, V20, P811, DOI 10.1016/j.idairyj.2010.04.003; Al-Ayadhi LY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/602834; Alhaider A, 2013, J MASS SPECTROM, V48, P779, DOI 10.1002/jms.3213; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Balteanu VA, 2013, MOL BIOL REP, V40, P4311, DOI 10.1007/s11033-013-2518-2; BEG OU, 1986, REGUL PEPTIDES, V15, P55, DOI 10.1016/0167-0115(86)90075-3; BEG OU, 1987, FEBS LETT, V216, P270, DOI 10.1016/0014-5793(87)80704-4; Bijl E, 2014, J DAIRY SCI, V97, P7240, DOI 10.3168/jds.2014-8061; Bijl E, 2014, INT DAIRY J, V34, P135, DOI 10.1016/j.idairyj.2013.08.001; Bornaz S, 2009, INT J DAIRY TECHNOL, V62, P505, DOI 10.1111/j.1471-0307.2009.00535.x; Bouchard D, 2006, LANCET ONCOL, V7, P167, DOI 10.1016/S1470-2045(06)70579-4; Boumahrou N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-80; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenaut P, 2012, J DAIRY SCI, V95, P6130, DOI 10.3168/jds.2012-5604; Chianese L, 1996, J DAIRY RES, V63, P49, DOI 10.1017/S0022029900031538; Cunsolo V, 2017, FOOD RES INT, V99, P41, DOI 10.1016/j.foodres.2017.07.002; Davoodi SH, 2016, IRAN J PHARM RES, V15, P573; De Kruif C.G., 2003, ADV DAIRY CHEM A, V4th, P185, DOI [10.1007/978-1-4614-4714-6_6, DOI 10.1007/978-1-4614-4714-6_6]; DULL TJ, 1990, DNA CELL BIOL, V9, P499, DOI 10.1089/dna.1990.9.499; Dziarski R, 2012, MICROB DRUG RESIST, V18, P280, DOI 10.1089/mdr.2012.0002; El-Agamy E. I, 2009, BIOACTIVE COMPONENTS, P159; El-Agamy EI, 2009, SMALL RUMINANT RES, V82, P1, DOI 10.1016/j.smallrumres.2008.12.016; El-Fakharany EM, 2017, EXP THER MED, V13, P1313, DOI 10.3892/etm.2017.4159; Elrobh MS, 2011, INT J MOL SCI, V12, P4214, DOI 10.3390/ijms12074214; Ereifej KI, 2011, FOOD CHEM, V127, P282, DOI 10.1016/j.foodchem.2010.12.112; Erhardt G, 2016, TROP ANIM HEALTH PRO, V48, P879, DOI 10.1007/s11250-016-0997-6; Fang ZH, 2016, J DAIRY SCI, V99, P8168, DOI 10.3168/jds.2016-11250; Felfoul I, 2017, FOOD CHEM, V216, P161, DOI 10.1016/j.foodchem.2016.08.007; Ferranti P, 1999, J PROTEIN CHEM, V18, P595, DOI 10.1023/A:1020659518748; FERRANTI P, 1995, J DAIRY RES, V62, P281, DOI 10.1017/S0022029900030983; Girardet JM, 2000, BIOCHEM CELL BIOL, V78, P19, DOI 10.1139/bcb-78-1-19; Habib HM, 2013, FOOD CHEM, V141, P148, DOI 10.1016/j.foodchem.2013.03.039; HENNIGHAUSEN LG, 1982, NUCLEIC ACIDS RES, V10, P2677, DOI 10.1093/nar/10.8.2677; Hinz K, 2012, J DAIRY RES, V79, P185, DOI 10.1017/S0022029912000015; Hsieh ChiaChien, 2015, BioMed Research International, V2015, P146840; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; Kanwar JR, 2015, MOLECULES, V20, P9703, DOI 10.3390/molecules20069703; Kappeler S, 1998, J DAIRY RES, V65, P209, DOI 10.1017/S0022029997002847; Kappeler S, 1999, J DAIRY SCI, V82, P2084, DOI 10.3168/jds.S0022-0302(99)75450-0; Kappeler SR, 2004, J DAIRY SCI, V87, P2660, DOI 10.3168/jds.S0022-0302(04)73392-5; Kappeler SR, 2003, J DAIRY SCI, V86, P498, DOI 10.3168/jds.S0022-0302(03)73628-5; Kappeler SR, 1999, INT DAIRY J, V9, P481, DOI 10.1016/S0958-6946(99)00117-X; Konuspayeva G, 2005, NATO SCI SER I LIFE, V362, P158; Konuspayeva G, 2009, J FOOD COMPOS ANAL, V22, P95, DOI 10.1016/j.jfca.2008.09.008; Konuspayeva G, 2007, J DAIRY SCI, V90, P38, DOI 10.3168/jds.S0022-0302(07)72606-1; Korashy Hesham M, 2012, J Biomed Biotechnol, V2012, P593195, DOI 10.1155/2012/593195; Larsen MR, 2006, BIOTECHNIQUES, V40, P790, DOI 10.2144/000112201; Legrand D, 2004, BIOMETALS, V17, P225, DOI 10.1023/B:BIOM.0000027696.48707.42; LEROUX C, 1992, J BIOL CHEM, V267, P6147; Manaer T, 2015, J ETHNOPHARMACOL, V169, P269, DOI 10.1016/j.jep.2015.04.032; Martin P., 2013, ADV DAIRY CHEM A, V1A, P387, DOI [DOI 10.1007/978-1-4614-4714-6_13, 10.1007/978-1-4614-4714-6]; Mati A, 2017, INT DAIRY J, V73, P25, DOI 10.1016/j.idairyj.2016.12.001; MERCIER JC, 1981, BIOCHIMIE, V63, P1, DOI 10.1016/S0300-9084(81)80141-1; Merin U, 2001, LIVEST PROD SCI, V67, P297, DOI 10.1016/S0301-6226(00)00198-6; Miranda G, 2004, PROTEOMICS, V4, P2496, DOI 10.1002/pmic.200300765; Mohandesan E, 2017, MOL ECOL RESOUR, V17, P300, DOI 10.1111/1755-0998.12551; Nurseitova M, 2014, EMIR J FOOD AGR, V26, P366, DOI 10.9755/ejfa.v26i4.17271; Ochirkhuyag B, 1997, LAIT, V77, P601, DOI 10.1051/lait:1997543; Ostersen S, 1997, J DAIRY RES, V64, P207, DOI 10.1017/S0022029996002099; Pauciullo A, 2014, GENE, V547, P159, DOI 10.1016/j.gene.2014.06.055; Pauciullo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124963; Restani P, 1999, CLIN EXP ALLERGY, V29, P997, DOI 10.1046/j.1365-2222.1999.00563.x; Rhoads RP, 2013, ADV NUTR, V4, P267, DOI 10.3945/an.112.003376; Saadaoui B, 2014, ELECTROPHORESIS, V35, P1406, DOI 10.1002/elps.201300383; Saadaoui B, 2013, PROTEOMICS, V13, P1180, DOI 10.1002/pmic.201200113; Sakono M, 2011, BIOCHEM BIOPH RES CO, V404, P494, DOI 10.1016/j.bbrc.2010.12.009; Salmen SH, 2012, SAUDI J BIOL SCI, V19, P177, DOI 10.1016/j.sjbs.2011.12.002; Sboui A, 2010, J ANIM PHYSIOL AN N, V94, P540, DOI 10.1111/j.1439-0396.2009.00941.x; Sds-page L., 1970, NATURE, P5; Sharma P, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228163; Sharma S, 2013, SMALL RUMINANT RES, V112, P216, DOI 10.1016/j.smallrumres.2012.12.008; Shuiep ES, 2013, INT DAIRY J, V28, P88, DOI 10.1016/j.idairyj.2012.09.002; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; SORENSEN ES, 1993, J DAIRY RES, V60, P189, DOI 10.1017/S0022029900027503; Tagliabracci VS, 2015, CELL, V161, P1619, DOI 10.1016/j.cell.2015.05.028; Tydell CC, 2002, J BIOL CHEM, V277, P19658, DOI 10.1074/jbc.M200659200; Wangoh J, 1998, INT DAIRY J, V8, P617, DOI 10.1016/S0958-6946(98)00092-2; Yang YX, 2013, J PROTEOME RES, V12, P1660, DOI 10.1021/pr301001m; Youcef N., 2009, American Journal of Applied Sciences, V6, P1448; Zhao DB, 2015, SMALL RUMINANT RES, V127, P58, DOI 10.1016/j.smallrumres.2015.04.008	81	18	19	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197026	10.1371/journal.pone.0197026	http://dx.doi.org/10.1371/journal.pone.0197026			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746547	Green Submitted, Green Published, gold			2022-12-26	WOS:000431851700058
J	Cheng, HW; Yang, Y; Chen, YF; Chen, XQ; Cai, ZZ; Du, AF				Cheng, Haiwei; Yang, Yi; Chen, Yifei; Chen, Xueqiu; Cai, Zizheng; Du, Aifang			Novel monoclonal antibody-based immunochromatographic strip for detecting citrinin in fruit from Zhejiang province, China	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; INDIRECT COMPETITIVE ELISA; RAPID DETECTION; OCHRATOXIN-A; ZEARALENONE; IMMUNOASSAY; MYCOTOXINS; AFFINITY; PATULIN; SAMPLES	Citrinin (CIT) is a hepato-nephrotoxic fungal metabolite produced by the genera Penicillium, Aspergillus and Monascu. There is an increasing demand for rapid and economical methods for detection CIT residues in fruit. In this study, we developed an immunochromatographic strip (ICS) for detection of citrinin (CIT) residues in fruit for the first time. Anti-CIT monoclonal antibody (McAb) 2B9 was prepared, with a binding affinity of 9.39 x 10(8) L/moL. Conjugates CIT-BSA and McAb 2B9 were used to develop the ICS which could be completed in 5 min, with the detection limit of 50 ng/mL and no cross reactivity with other mycotoxins. Analysis of CIT in 64 fruit samples revealed that data obtained from the ICS test were in good agreement with indirect competitive enzyme-linked immunosorbent assays (ic-ELISAs) and high performance liquid chromatography (HPLC). This result demonstrated that the ICS test could be used as a rapid, reliable, cost-effective and user-friendly qualitative tool for detection of CIT residues on-site.	[Cheng, Haiwei; Yang, Yi; Chen, Yifei; Chen, Xueqiu; Du, Aifang] Zhejiang Univ, Coll Anim Sci, Inst Prevent Vet Med, Hangzhou, Zhejiang, Peoples R China; [Cheng, Haiwei; Yang, Yi; Chen, Yifei; Chen, Xueqiu; Du, Aifang] Zhejiang Univ, Coll Anim Sci, Zhejiang Prov Key Lab Prevent Vet Med, Hangzhou, Zhejiang, Peoples R China; [Cheng, Haiwei] Jiangsu Acad Agr Sci, Natl Res Ctr Engn & Technol Vet Biol, Key Lab Vet Biol Engn & Technol, Minist Agr, Nanjing, Jiangsu, Peoples R China; [Cheng, Haiwei] Jiangsu Coinnovat Ctr Prevent & Control Import An, Yangzhou, Jiangsu, Peoples R China; [Cai, Zizheng] Nanjing Agr Univ, Nanjing, Jiangsu, Peoples R China	Zhejiang University; Zhejiang University; Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Du, AF (corresponding author), Zhejiang Univ, Coll Anim Sci, Inst Prevent Vet Med, Hangzhou, Zhejiang, Peoples R China.; Du, AF (corresponding author), Zhejiang Univ, Coll Anim Sci, Zhejiang Prov Key Lab Prevent Vet Med, Hangzhou, Zhejiang, Peoples R China.	afdu@zju.edu.cn			National High Technology Research and Development Program (863 Program) [2012AA101602]; Fundamental Research Funds for the Central Universities [2011XZZX006]	National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National High Technology Research and Development Program (863 Program, No. 2012AA101602) and the Fundamental Research Funds for the Central Universities (2011XZZX006).	Abramson D, 1999, J AOAC INT, V82, P1353; Aziz NH, 2002, FOOD CONTROL, V13, P281, DOI 10.1016/S0956-7135(02)00028-2; Basab C, 2001, IVD TECHNOL, V8, P46; BEATTY JD, 1987, J IMMUNOL METHODS, V100, P173, DOI 10.1016/0022-1759(87)90187-6; BLANC PJ, 1995, BIOTECHNOL LETT, V17, P291, DOI 10.1007/BF01190639; Brenn-Struckhofova Z, 2007, ANAL CHEM, V79, P710, DOI 10.1021/ac061672w; DAVIS JM, 1982, J IMMUNOL METHODS, V50, P161, DOI 10.1016/0022-1759(82)90222-8; ELBANNA AA, 1987, SYST APPL MICROBIOL, V10, P42, DOI 10.1016/S0723-2020(87)80008-5; GB/ T, 2008, DET CITR MON PROD; GIMENO A, 1983, J ASSOC OFF ANA CHEM, V66, P85; Hayat M.A., 1989, COLLOIDAL GOLD PRINC; Hetherington AC, 1931, PHILOS T R SOC LON B, V220, P269, DOI 10.1098/rstb.1931.0025; Hua XD, 2010, BIOSENS BIOELECTRON, V26, P189, DOI 10.1016/j.bios.2010.06.005; Huang ZB, 2012, FOOD CONTROL, V28, P7, DOI 10.1016/j.foodcont.2012.04.035; Ian FR, 1983, CULTURE ANIMAL CELLS; Jin WC, 2013, J MICROBIOL METH, V92, P323, DOI 10.1016/j.mimet.2013.01.001; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kong DZ, 2017, FOOD AGR IMMUNOL, V28, P754, DOI 10.1080/09540105.2017.1312293; Li YN, 2012, FOOD AGR IMMUNOL, V23, P145, DOI 10.1080/09540105.2011.606562; Li YN, 2011, J FOOD SAFETY, V31, P497, DOI 10.1111/j.1745-4565.2011.00326.x; Ling SM, 2015, BIOSENS BIOELECTRON, V71, P256, DOI 10.1016/j.bios.2015.04.049; Liu BH, 2008, ANAL CHEM, V80, P7029, DOI 10.1021/ac800951p; Liu LQ, 2014, SENSORS-BASEL, V14, P16785, DOI 10.3390/s140916785; Manabe M., 2001, Mycotoxins, V51, P25, DOI 10.2520/myco.51.25; Martins ML, 2002, FOOD ADDIT CONTAM, V19, P568, DOI 10.1080/02652030210121320; Nigovic B, 2013, FOOD CHEM, V138, P531, DOI 10.1016/j.foodchem.2012.10.104; PHILLIPS RD, 1980, J CHROMATOGR, V190, P419, DOI 10.1016/S0021-9673(00)88247-3; Ping JF, 2014, FOOD CHEM, V151, P65, DOI 10.1016/j.foodchem.2013.11.026; RATH S, 1988, J IMMUNOL METHODS, V106, P245, DOI 10.1016/0022-1759(88)90204-9; Reinhard H, 1999, J CHROMATOGR A, V862, P147, DOI 10.1016/S0021-9673(99)00929-2; Romero T, 2014, SMALL RUMINANT RES, V121, P376, DOI 10.1016/j.smallrumres.2014.07.007; ROTH J, 1982, HISTOCHEM J, V14, P791, DOI 10.1007/BF01033628; Shaker EM, 2015, ENVIRON TOXICOL PHAR, V39, P433, DOI 10.1016/j.etap.2014.12.005; Shu PY, 2002, ANAL SCI, V18, P283, DOI 10.2116/analsci.18.283; Sun YN, 2014, J AGR FOOD CHEM, V62, P11116, DOI 10.1021/jf503092j; Tuomi T, 2001, ANALYST, V126, P1545, DOI 10.1039/b103790k; Wang S, 2006, J AGR FOOD CHEM, V54, P2491, DOI 10.1021/jf0530401; Wang YK, 2013, FOOD CONTROL, V31, P180, DOI 10.1016/j.foodcont.2012.09.048; Xu Y, 2010, FOOD CHEM, V119, P834, DOI 10.1016/j.foodchem.2009.08.049; Zhang G, 2008, FOOD ADDIT CONTAM A, V25, P413, DOI 10.1080/02652030701561452; Zhao YL, 2008, J AGR FOOD CHEM, V56, P12138, DOI 10.1021/jf802648z; Zhou Y, 2009, BIOSENS BIOELECTRON, V24, P2744, DOI 10.1016/j.bios.2009.01.034; Zhu Y, 2008, J AGR FOOD CHEM, V56, P5469, DOI 10.1021/jf800274f	43	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0197179	10.1371/journal.pone.0197179	http://dx.doi.org/10.1371/journal.pone.0197179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742170	gold, Green Published, Green Submitted			2022-12-26	WOS:000431757400066
J	Alsayegh, KN; Sheridan, SD; Lyer, S; Rao, RR				Alsayegh, Khaled N.; Sheridan, Steven D.; Lyer, Shilpa; Rao, Raj Raghavendra			Knockdown of CDK2AP1 in human embryonic stem cells reduces the threshold of differentiation	PLOS ONE			English	Article							G(2) CHECKPOINT; PROTEIN; CYCLIN; EXPRESSION; GENE; P53; PLURIPOTENCY; PROPAGATION; P12(DOC-1); APOPTOSIS	Recent studies have suggested a role for the Cyclin Dependent Kinase-2 Associated Protein 1 (CDK2AP1) in stem cell differentiation and self-renewal. In studies with mouse embryonic stem cells (mESCs) derived from generated mice embryos with targeted deletion of the Cdk2ap1 gene, CDK2AP1 was shown to be required for epigenetic silencing of Oct4 during differentiation, with deletion resulting in persistent self-renewal and reduced differentiation potential. Differentiation capacity was restored in these cells following the introduction of a non-phosphorylatible form of the retinoblastoma protein (pRb) or exogenous Cdk2ap1. In this study, we investigated the role of CDK2AP1 in human embryonic stem cells (hESCs). Using a shRNA to reduce its expression in hESCs, we found that CDK2AP1 knockdown resulted in a significant reduction in the expression of the pluripotency genes, OCT4 and NANOG. We also found that CDK2AP1 knockdown increased the number of embryoid bodies (EBs) formed when differentiation was induced. In addition, the generated EBs had significantly higher expression of markers of all three germ layers, indicating that CDK2AP1 knockdown enhanced differentiation. CDK2AP1 knockdown also resulted in reduced proliferation and reduced the percentage of cells in the S phase and increased cells in the G2/M phase of the cell cycle. Further investigation revealed that a higher level of p53 protein was present in the CDK2AP1 knockdown hESCs. In hESCs in which p53 and CDK2AP1 were simultaneously downregulated, OCT4 and NANOG expression was not affected and percentage of cells in the S phase of the cell cycle was not reduced. Taken together, our results indicate that the knockdown of CDK2AP1 in hESCs results in increased p53 and enhances differentiation and favors it over a self-renewal fate.	[Alsayegh, Khaled N.] Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Richmond, VA USA; [Alsayegh, Khaled N.] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia; [Sheridan, Steven D.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA USA; [Lyer, Shilpa] Univ Arkansas, Dept Biol Sci, Fulbright Coll Arts & Sci, Fayetteville, AR 72701 USA; [Rao, Raj Raghavendra] Univ Arkansas, Dept Biomed Engn, Coll Engn, Fayetteville, AR 72701 USA	Virginia Commonwealth University; King Saud Bin Abdulaziz University for Health Sciences; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Lyer, S (corresponding author), Univ Arkansas, Dept Biol Sci, Fulbright Coll Arts & Sci, Fayetteville, AR 72701 USA.; Rao, RR (corresponding author), Univ Arkansas, Dept Biomed Engn, Coll Engn, Fayetteville, AR 72701 USA.	si02@uark.edu; rajrao@uark.edu	Rao, Raj/AAW-4308-2021	Rao, Raj/0000-0003-0544-413X; Sheridan, Steven/0000-0003-1045-1158; Iyer, Shilpa/0000-0001-6287-2232	VCU's Center for Clinical and Translational Research [NIH-R15R15NS080157-01A1, NIH CTSA UL1TR000058]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS080157] Funding Source: NIH RePORTER	VCU's Center for Clinical and Translational Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by NIH-R15R15NS080157-01A1 (S. lyer) and NIH CTSA UL1TR000058 (R. R. Rao and S. lyer) by VCU's Center for Clinical and Translational Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2010, BIOTECHNOL PROGR, V26, P1126, DOI 10.1002/btpr.412; Abraham S, 2010, BIOCHEM BIOPH RES CO, V393, P211, DOI 10.1016/j.bbrc.2010.01.101; Adams BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010001; Bode D, 2016, MOL CELL PROTEOMICS, V15, P878, DOI 10.1074/mcp.M115.053207; Deshpande AM, 2012, STEM CELLS DEV, V21, P3010, DOI 10.1089/scd.2012.0007; Deshpande AM, 2009, J BIOL CHEM, V284, P6043, DOI 10.1074/jbc.C800158200; Dolezalova D, 2012, STEM CELLS, V30, P1362, DOI 10.1002/stem.1108; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Kim JJ, 2012, J BIOL CHEM, V287, P41103, DOI 10.1074/jbc.M112.416545; Kim Y, 2009, J BIOL CHEM, V284, P23405, DOI 10.1074/jbc.M109.026088; Kim Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004518; Matsuo K, 2000, FASEB J, V14, P1318, DOI 10.1096/fj.14.10.1318; Passalaris TM, 1999, MOL CELL BIOL, V19, P5872, DOI 10.1128/mcb.19.9.5872; PRASAD GL, 1992, CELL GROWTH DIFFER, V3, P507; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rao RR, 2004, BIOL REPROD, V71, P1772, DOI 10.1095/biolreprod.104.030395; Rao RR, 2004, BIOTECHNOL BIOENG, V88, P273, DOI 10.1002/bit.20245; Rivera A, 2006, CELL MOL LIFE SCI, V63, P1425, DOI 10.1007/s00018-006-5521-5; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharov AA, 2003, PLOS BIOL, V1, P410, DOI 10.1371/journal.pbio.0000074; Sheridan SD, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/738910; Shintani S, 2000, MOL CELL BIOL, V20, P6300, DOI 10.1128/MCB.20.17.6300-6307.2000; Soucek T, 1997, ONCOGENE, V14, P2251, DOI 10.1038/sj.onc.1201061; Van Hooser A, 1998, J CELL SCI, V111, P3497; Wong DTW, 2012, J DENT RES, V91, P235, DOI 10.1177/0022034511420723; Xia Xiaofeng, 2007, Biotechnol Genet Eng Rev, V24, P297; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhou JM, 2003, NUCLEIC ACIDS RES, V31, P3881, DOI 10.1093/nar/gkg468	32	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196817	10.1371/journal.pone.0196817	http://dx.doi.org/10.1371/journal.pone.0196817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734353	gold, Green Published, Green Submitted			2022-12-26	WOS:000431481700028
J	Green, MB; Campbell, JL; Yanai, RD; Bailey, SW; Bailey, AS; Grant, N; Halm, I; Kelsey, EP; Rustad, LE				Green, Mark B.; Campbell, John L.; Yanai, Ruth D.; Bailey, Scott W.; Bailey, Amey S.; Grant, Nicholas; Halm, Ian; Kelsey, Eric P.; Rustad, Lindsey E.			Downsizing a long-term precipitation network: Using a quantitative approach to inform difficult decisions	PLOS ONE			English	Article							AREAL RAINFALL; UNCERTAINTY; GAUGE	The design of a precipitation monitoring network must balance the demand for accurate estimates with the resources needed to build and maintain the network. If there are changes in the objectives of the monitoring or the availability of resources, network designs should be adjusted. At the Hubbard Brook Experimental Forest in New Hampshire, USA, precipitation has been monitored with a network established in 1955 that has grown to 23 gauges distributed across nine small catchments. This high sampling intensity allowed us to simulate reduced sampling schemes and thereby evaluate the effect of decommissioning gauges on the quality of precipitation estimates. We considered all possible scenarios of sampling intensity for the catchments on the south-facing slope (2047 combinations) and the north-facing slope (4095 combinations), from the current scenario with 11 or 12 gauges to only 1 gauge remaining. Gauge scenarios differed by as much as 6.0% from the best estimate (based on all the gauges), depending on the catchment, but 95% of the scenarios gave estimates within 2% of the long-term average annual precipitation. The insensitivity of precipitation estimates and the catchment fluxes that depend on them under many reduced monitoring scenarios allowed us to base our reduction decision on other factors such as technician safety, the time required for monitoring, and co-location with other hydrometeorological measurements (snow, air temperature). At Hubbard Brook, precipitation gauges could be reduced from 23 to 10 with a change of <2% in the long-term precipitation estimates. The decision-making approach illustrated in this case study is applicable to the redesign of monitoring networks when reduction of effort seems warranted.	[Green, Mark B.; Kelsey, Eric P.] Plymouth State Univ, Ctr Environm, Plymouth, NH USA; [Green, Mark B.; Campbell, John L.; Bailey, Scott W.; Bailey, Amey S.; Grant, Nicholas; Halm, Ian; Rustad, Lindsey E.] US Forest Serv, Northern Res Stn, USDA, Durham, NH USA; [Yanai, Ruth D.] SUNY Coll Environm Sci & Forestry, Dept Forest & Nat Resources Management, Syracuse, NY 13210 USA; [Kelsey, Eric P.] Plymouth State Univ, Dept Atmospher Sci & Chem, Plymouth, NH USA; [Kelsey, Eric P.] Mt Washington Observ, North Conway, NH USA	University System Of New Hampshire; Plymouth State University; United States Department of Agriculture (USDA); United States Forest Service; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; University System Of New Hampshire; Plymouth State University	Green, MB (corresponding author), Plymouth State Univ, Ctr Environm, Plymouth, NH USA.; Green, MB (corresponding author), US Forest Serv, Northern Res Stn, USDA, Durham, NH USA.	mbgreen@plymouth.edu	Kelsey, Eric/ABG-2237-2020; Brook, Hubbard/AAD-1112-2022; Yanai, Ruth D./O-3250-2019	Yanai, Ruth D./0000-0001-6987-2489; Green, Mark/0000-0002-7415-7209; Bailey, Scott/0000-0002-9160-156X; Campbell, John/0000-0003-4956-1696	Joint Venture Agreement from the Northern Research Station; Division of Environmental Biology [1257906, 1633026]; Division Of Environmental Biology [1257906] Funding Source: National Science Foundation	Joint Venture Agreement from the Northern Research Station; Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a Joint Venture Agreement from the Northern Research Station to Plymouth State University (MBG), Division of Environmental Biology grant 1257906 to RDY and Division of Environmental Biology grant 1633026 to JLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anctil F, 2006, J HYDROL, V328, P717, DOI 10.1016/j.jhydrol.2006.01.016; [Anonymous], BIOLOGIA, DOI [DOI 10.1007/S10750-015-2535-3, 10.1007/s10750-015-2535-3]; Bailey A. S., 2003, HYDROMETEOROLOGICAL, P305; BASALIRWA CPK, 1995, INT J CLIMATOL, V15, P1161, DOI 10.1002/joc.3370151008; BASIST A, 1994, J CLIMATE, V7, P1305, DOI 10.1175/1520-0442(1994)007<1305:SRBTAP>2.0.CO;2; Battles JJ, 2015, TREE INVENTORY DATA, DOI [10.6073/pasta/e15c338046c59338e5bdc2b169222c1a, DOI 10.6073/PASTA/E15C338046C59338E5BDC2B169222C1A]; Biber E, 2013, ECOL SOC, V18, DOI 10.5751/ES-06117-180468; Butler TJ, 2001, ATMOS ENVIRON, V35, P1015, DOI 10.1016/S1352-2310(00)00386-1; CALLAHAN JT, 1984, BIOSCIENCE, V34, P363, DOI 10.2307/1309727; Campbell JL, 2016, ECOSPHERE, V7; Campbell JL, 2016, HUBBARD BROOK EXPT F, DOI [10.6073/pasta/e3edeeed4f591f608739e788ac7becfd, DOI 10.6073/PASTA/E3EDEEED4F591F608739E788AC7BECFD]; Campbell JL, 2012, VEGETATION TREATMENT; Campbell JL, 2013, BIOSCIENCE, V63, P574, DOI 10.1525/bio.2013.63.7.10; Campbell JL, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009438; Cann M., 2016, PRECIPITATION HUBBAR; CASELTON WF, 1984, STAT PROBABIL LETT, V2, P223, DOI 10.1016/0167-7152(84)90020-8; Cheng KS, 2008, HYDROL PROCESS, V22, P2554, DOI 10.1002/hyp.6851; Daly C, 2017, INT J CLIMATOL, V37, P124, DOI 10.1002/joc.4986; DYER TGJ, 1975, Q J ROY METEOR SOC, V101, P1005, DOI 10.1002/qj.49710143020; Eaton J.S., 2000, NE275 USDA FOR SERV, P52, DOI DOI 10.2737/NE-GTR-275; Graler B, 2016, R J, V8, P204; HENDRICK R L, 1970, Journal of Hydrology (Amsterdam), V10, P151, DOI 10.1016/0022-1694(70)90185-X; Hornbeck JW, 1997, CAN J FOREST RES, V27, P2043, DOI 10.1139/cjfr-27-12-2043; Hrachowitz M, 2011, J HYDROL ENG, V16, P460, DOI 10.1061/(ASCE)HE.1943-5584.0000331; Huff F., 1970, J APPL METEOROL, V9, P35, DOI [DOI 10.1175/1520-0450(1970)009<0035:SEIMOM>2.0.CO;2, 10.1175/1520-0450(1970)0090035:SEIMOM2.0.CO;2]; Levine CR, 2014, ECOL INDIC, V39, P94, DOI 10.1016/j.ecolind.2013.12.010; Likens G.E., 2013, BIOGEOCHEMISTRY FORE; LIKENS GE, 1972, ENVIRONMENT, V14, P33, DOI 10.1080/00139157.1972.9933001; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Lovett GM, 2007, FRONT ECOL ENVIRON, V5, P253, DOI 10.1890/1540-9295(2007)5[253:WNEM]2.0.CO;2; Mahmood R, 2016, J GEOGR SCI, V26, P1661, DOI 10.1007/s11442-016-1351-7; MALLANTS D, 1990, J APPL METEOROL, V29, P892, DOI 10.1175/1520-0450(1990)029&lt;0892:DHPRBM&gt;2.0.CO;2; McRoberts DB, 2011, J APPL METEOROL CLIM, V50, P1187, DOI 10.1175/2010JAMC2626.1; Naoum S, 2004, J HYDROL ENG, V9, P79, DOI 10.1061/(ASCE)1084-0699(2004)9:2(79); Ollinger S.V., 1995, NE191 US FOR SERV; R Foundation for Statistical Computing, 2017, LANG ENV STAT COMP; Steiner M, 1996, WATER RESOUR RES, V32, P373, DOI 10.1029/95WR03396; Swift L., 1988, FOREST HYDROLOGY ECO, P35, DOI DOI 10.1007/978-1-4612-3732-7_3; Thiessen AH, 1911, MON WEATHER REV, V39, P1082, DOI [10.1175/1520-0493, DOI 10.1175/1520-0493(1911)39<1082B:PAFLA>2.0.CO;2]; Tsintikidis D, 2002, J HYDROL ENG, V7, P175, DOI 10.1061/(ASCE)1084-0699(2002)7:2(175); Turner R., 2017, DELDIR DELAUNAY TRIA; Wagner PD, 2012, J HYDROL, V464, P388, DOI 10.1016/j.jhydrol.2012.07.026; Yanai RD, 2015, HYDROL PROCESS, V29, P1793, DOI 10.1002/hyp.10265; Yang DQ, 1998, J ATMOS OCEAN TECH, V15, P54, DOI 10.1175/1520-0426(1998)015<0054:AONSNP>2.0.CO;2	44	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0195966	10.1371/journal.pone.0195966	http://dx.doi.org/10.1371/journal.pone.0195966			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734332	Green Submitted, gold, Green Published			2022-12-26	WOS:000431481700007
J	Higaki, A; Mogi, M; Iwanami, J; Min, LJ; Bai, HY; Shan, BS; Kan-No, H; Ikeda, S; Higaki, J; Horiuchi, M				Higaki, Akinori; Mogi, Masaki; Iwanami, Jun; Min, Li-Juan; Bai, Hui-Yu; Shan, Bao-Shuai; Kan-no, Harumi; Ikeda, Shuntaro; Higaki, Jitsuo; Horiuchi, Masatsugu			Recognition of early stage thigmotaxis in Morris water maze test with convolutional neural network	PLOS ONE			English	Article							CHRONIC CEREBRAL HYPOPERFUSION; MOUSE MODEL; MEMORY; MICE; CLASSIFICATION; MUTATION; BEHAVIOR; LESIONS	The Morris water maze test (MWM) is a useful tool to evaluate rodents' spatial learning and memory, but the outcome is susceptible to various experimental conditions. Thigmotaxis is a commonly observed behavioral pattern which is thought to be related to anxiety or fear. This behavior is associated with prolonged escape latency, but the impact of its frequency in the early stage on the final outcome is not clearly understood. We analyzed swim path trajectories in male C57BU6 mice with or without bilateral common carotid artery stenosis (BCAS) treatment. There was no significant difference in the frequencies of particular types of trajectories according to ischemic brain surgery. The mouse groups with thigmotaxis showed significantly prolonged escape latency and lower cognitive score on day 5 compared to those without thigmotaxis. As the next step, we made a convolutional neural network (CNN) model to recognize the swim path trajectories. Our model could distinguish thigmotaxis from other trajectories with 96% accuracy and specificity as high as 0.98. These results suggest that thigmotaxis in the early training stage is a predictive factor for impaired performance in MWM, and machine learning can detect such behavior easily and automatically.	[Higaki, Akinori; Iwanami, Jun; Min, Li-Juan; Bai, Hui-Yu; Shan, Bao-Shuai; Kan-no, Harumi; Horiuchi, Masatsugu] Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Toon, Ehime, Japan; [Higaki, Akinori; Ikeda, Shuntaro; Higaki, Jitsuo] Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Toon, Ehime, Japan; [Mogi, Masaki] Ehime Univ, Grad Sch Med, Dept Pharmacol, Toon, Ehime, Japan	Ehime University; Ehime University; Ehime University	Higaki, A (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Toon, Ehime, Japan.; Higaki, A (corresponding author), Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Toon, Ehime, Japan.	keroplant83@gmail.com	Higaki, Akinori/AAA-2551-2019	Higaki, Akinori/0000-0002-0827-874X				Acheson SK, 2011, NEUROSCI LETT, V487, P411, DOI 10.1016/j.neulet.2010.10.067; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dalm S, 2000, BEHAV RES METH INS C, V32, P134, DOI 10.3758/BF03200795; Devan BD, 1999, BEHAV BRAIN RES, V100, P5, DOI 10.1016/S0166-4328(98)00107-7; Gehring TV, 2015, SCI REP-UK, V5, DOI 10.1038/srep14562; Goodman J, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00663; Graziano A, 2003, J NEUROSCI METH, V130, P33, DOI 10.1016/S0165-0270(03)00187-0; Higaki A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191708; Huang Y, 2012, BEHAV BRAIN RES, V226, P26, DOI 10.1016/j.bbr.2011.08.043; Illouz T, 2016, BRAIN BEHAV IMMUN, V52, P132, DOI 10.1016/j.bbi.2015.10.013; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Nishio K, 2010, STROKE, V41, P1278, DOI 10.1161/STROKEAHA.110.581686; Packard MG, 2004, NEUROBIOL LEARN MEM, V82, P243, DOI 10.1016/j.nlm.2004.06.008; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sakata A, 2009, BRAIN RES, V1300, P14, DOI 10.1016/j.brainres.2009.08.068; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Tokui S., CHAINER NEXT GENERAT; TREIT D, 1988, PHARMACOL BIOCHEM BE, V31, P959, DOI 10.1016/0091-3057(88)90413-3; Tuma J, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00116; Wolfer DP, 2000, EXP PHYSIOL, V85, P627, DOI 10.1017/S0958067000020959	23	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0197003	10.1371/journal.pone.0197003	http://dx.doi.org/10.1371/journal.pone.0197003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723266	Green Submitted, gold, Green Published			2022-12-26	WOS:000431305100098
J	Phan, K; Mitchell, P; Liew, G; Plant, AJ; Wang, SB; Thiagalingam, A; Burlutsky, G; Gopinath, B				Phan, Kevin; Mitchell, Paul; Liew, Gerald; Plant, Adam J.; Wang, Sarah B.; Thiagalingam, Aravinda; Burlutsky, George; Gopinath, Bamini			Associations between retinal arteriolar and venular calibre with the prevalence of impaired fasting glucose and diabetes mellitus: A cross-sectional study	PLOS ONE			English	Article							CORONARY HEART-DISEASE; BLUE MOUNTAINS EYE; LIFE-STYLE AUSDIAB; VESSEL DIAMETERS; VASCULAR CALIBER; ATHEROSCLEROSIS RISK; MICROVASCULAR SIGNS; RETINOPATHY; COMMUNITIES; ABNORMALITIES	Background This study aims to explore retinal vessel calibre in individuals at risk of coronary artery disease (CAD), diagnosed with impaired fasting glucose (IFG) or diabetes mellitus (DM), and whether indices of CAD extent and severity modifies these associations with DM. Methods A cross-sectional study was undertaken of 1680 patients presenting to Westmead Hospital (Sydney, Australia) for evaluation of potential CAD. Baseline digital retinal photographs, cardiovascular risk factor measurements, fasting blood tests and self -reported diabetes by patient questionnaire was recorded. Extent and severity of CAD was assessed using Extent and Gensini scores from angiography findings, respectively. Multivariate analysis including age and hypertension was undertaken to assess the association between retinal vessel calibre and IFG or DM. Results A total of 748 patients were included; 96 (12.8%) and 189 (25.3%), respectively, had IFG or DM (together termed 'hyperglycaemia'). No consistent association between hyperglycaemia and retinal arteriolar calibre was apparent. Wider retinal venular calibre (second and third tertile) carried a significantly higher odds of DM in men only (multivariable-adjusted OR 2.447, p = 0.005; and OR 2.76, p = 0.002; respectively). No equivalent association was apparent in women. This association was marginally significant (p = 0.08) in patients with CAD Extent scores below the median (i.e. less diffuse CAD). Retinal vessel calibre was not associated with impaired fasting glucose. Conclusions This study reports a significant association between retinal venular widening and diabetes mellitus in men. This association was marginally stronger among participants with less diffuse CAD.	[Phan, Kevin; Mitchell, Paul; Liew, Gerald; Plant, Adam J.; Wang, Sarah B.; Burlutsky, George; Gopinath, Bamini] Univ Sydney, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW, Australia; [Phan, Kevin; Mitchell, Paul; Liew, Gerald; Plant, Adam J.; Wang, Sarah B.; Burlutsky, George; Gopinath, Bamini] Univ Sydney, Westmead Millennium Inst, Sydney, NSW, Australia; [Thiagalingam, Aravinda] Univ Sydney, Westmead Millennium Inst, Ctr Heart Res, Sydney, NSW, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Westmead Institute for Medical Research	Gopinath, B (corresponding author), Univ Sydney, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW, Australia.; Gopinath, B (corresponding author), Univ Sydney, Westmead Millennium Inst, Sydney, NSW, Australia.	bamini.gopinath@sydney.edu.au	Gopinath, Bamini/K-4286-2019; Liew, Gerald/AAB-6870-2022	Gopinath, Bamini/0000-0003-3573-359X; 	National Health and Medical Research Council (NHMRC) Project [571012]	National Health and Medical Research Council (NHMRC) Project(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) Project Grant 571012.	Benitez-Aguirre P, 2015, INVEST OPHTH VIS SCI, V56, P571, DOI 10.1167/iovs.14-15147; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Clark MG, 2008, AM J PHYSIOL-ENDOC M, V295, pE732, DOI 10.1152/ajpendo.90477.2008; Couper DJ, 2002, AM J OPHTHALMOL, V133, P78, DOI 10.1016/S0002-9394(01)01315-0; Daien V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071089; de Jongh RT, 2004, DIABETOLOGIA, V47, P978, DOI 10.1007/s00125-004-1412-9; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ikram MK, 2006, DIABETES, V55, P506, DOI 10.2337/diabetes.55.02.06.db05-0546; Jeganathan VSE, 2009, MICROCIRCULATION, V16, P534, DOI 10.1080/10739680902975222; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Kifley A, 2008, MICROCIRCULATION, V15, P373, DOI 10.1080/10739680701812220; Klein R, 2003, OPHTHALMOLOGY, V110, P2118, DOI 10.1016/S0161-6420(03)00863-7; Klein R, 2007, OPHTHALMOLOGY, V114, P1884, DOI 10.1016/j.ophtha.2007.02.023; Klein Ronald, 2006, Trans Am Ophthalmol Soc, V104, P98; Klein R, 2006, OPHTHALMOLOGY, V113, P1488, DOI 10.1016/j.ophtha.2006.03.028; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Knudtson MD, 2004, BRIT J OPHTHALMOL, V88, P57, DOI 10.1136/bjo.88.1.57; Mitchell P, 2005, NEUROLOGY, V65, P1005, DOI 10.1212/01.wnl.0000179177.15900.ca; Neeland IJ, 2012, AM HEART J, V164, P547, DOI 10.1016/j.ahj.2012.07.007; Nguyen TT, 2008, DIABETES, V57, P536, DOI 10.2337/db07-1376; Nguyen TT, 2008, DIABETES CARE, V31, P544, DOI 10.2337/dc07-1528; Norgaz T, 2005, INT HEART J, V46, P639, DOI 10.1536/ihj.46.639; Sabanayagam C, 2015, DIABETOLOGIA, V58, P2476, DOI 10.1007/s00125-015-3717-2; Sherry LM, 2002, CLIN EXP OPHTHALMOL, V30, P179, DOI 10.1046/j.1442-9071.2002.00520.x; Sianos Georgios, 2005, EuroIntervention, V1, P219; SULLIVAN DR, 1990, AM HEART J, V119, P1262, DOI 10.1016/S0002-8703(05)80173-5; Tikellis G, 2007, DIABETOLOGIA, V50, P2263, DOI 10.1007/s00125-007-0822-x; WAGENER HP, 1947, T AM OPHTHAL SOC, V45, P57; Wang JJ, 2003, HYPERTENSION, V42, P534, DOI 10.1161/01.HYP.0000090122.38230.41; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2005, ARCH INTERN MED, V165, P1060, DOI 10.1001/archinte.165.9.1060; Wong TY, 2004, INVEST OPHTH VIS SCI, V45, P2949, DOI 10.1167/iovs.04-0069; Wong TY, 2004, OPHTHALMOLOGY, V111, P1183, DOI 10.1016/j.ophtha.2003.09.039; Wong TY, 2004, DIABETES, V53, P179, DOI 10.2337/diabetes.53.1.179; Wong TY, 2003, INVEST OPHTH VIS SCI, V44, P4644, DOI 10.1167/iovs.03-0079; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P2528, DOI 10.1001/jama.287.19.2528	39	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0189627	10.1371/journal.pone.0189627	http://dx.doi.org/10.1371/journal.pone.0189627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723218	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100001
J	Elahi, LS; Shamai, KN; Abtahie, AM; Cai, AM; Padmanabhan, S; Bremer, M; Wilkinson, KA				Elahi, Lubayna S.; Shamai, Krystle N.; Abtahie, Adam M.; Cai, Adam M.; Padmanabhan, Shreejit; Bremer, Martina; Wilkinson, Katherine A.			Diet induced obesity alters muscle spindle afferent function in adult mice	PLOS ONE			English	Article							RABBIT JAW MUSCLES; SKELETAL-MUSCLE; POSTURAL STABILITY; BALANCE CONTROL; SOLEUS MUSCLE; BODY-WEIGHT; SENSITIVITY; INNERVATION; INDIVIDUALS; NONOBESE	Populations with obesity are more likely to fall and exhibit balance instability. The reason for this is likely multifactorial, but there is some evidence that sensory function is impaired during obesity. We tested the hypothesis that muscle proprioceptor function is compromised in a mouse model of diet induced obesity. An in vitro muscle-nerve preparation was used to record muscle spindle afferent responses to physiological stretch and sinusoidal vibration. We compared the responses of C57/Bl6 male and female mice on a control diet (10% kcal fat) with those eating a high fat diet (HFD; 60% kcal fat) for 10 weeks (final age 14 - 15 weeks old). Following HFD feeding, adult mice of both sexes exhibited decreased muscle spindle afferent responses to muscle movement. Muscle spindle afferent firing rates during the plateau phase of stretch were significantly lower in both male and female HFD animals as were two measures of dynamic sensitivity (dynamic peak and dynamic index). Muscle spindle afferents in male mice on a HFD were also significantly less likely to entrain to vibration. Due to the importance of muscle spindle afferents to proprioception and motor control, decreased muscle spindle afferent responsiveness may contribute to balance instability during obesity.	[Elahi, Lubayna S.; Shamai, Krystle N.; Abtahie, Adam M.; Cai, Adam M.; Padmanabhan, Shreejit; Wilkinson, Katherine A.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Bremer, Martina] San Jose State Univ, Dept Math & Stat, San Jose, CA 95192 USA	California State University System; San Jose State University; California State University System; San Jose State University	Wilkinson, KA (corresponding author), San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA.	Katherine.wilkinson@sjsu.edu		Wilkinson, Katherine A./0000-0002-2692-5533	California State University Program in Education and Research in Biotechnology (CSUPERB) New Investigator Grant; SJSU Research, Scholarly and Creative Activity Grant; NIH Research Initiative for Scientific Enhancement (RISE) Fellowship [5R25GM71381]	California State University Program in Education and Research in Biotechnology (CSUPERB) New Investigator Grant; SJSU Research, Scholarly and Creative Activity Grant; NIH Research Initiative for Scientific Enhancement (RISE) Fellowship	This work was supported by a California State University Program in Education and Research in Biotechnology (CSUPERB) New Investigator Grant (KAW; https://www2.calstate.edu/impact-of-the-csu/research/csuperb/Pages/grants-and-awards-programs-aspx), an SJSU Research, Scholarly and Creative Activity Grant (KAW), and an NIH Research Initiative for Scientific Enhancement (RISE) Fellowship (#5R25GM71381, AMA; https://www.nigms.nih.gov/Training/RISE/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Barclay CJ, 2005, J MUSCLE RES CELL M, V26, P225, DOI 10.1007/s10974-005-9013-x; BARKER D, 1981, PROC R SOC SER B-BIO, V212, P317, DOI 10.1098/rspb.1981.0042; Billot M, 2013, NEUROSCI LETT, V535, P40, DOI 10.1016/j.neulet.2012.11.022; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Carrasco DI, 2017, J NEUROPHYSIOL, V117, P1690, DOI 10.1152/jn.00889.2016; Cheung PPY, 2015, J MOTOR BEHAV, V47, P436, DOI 10.1080/00222895.2015.1007914; Corbeil P, 2001, IEEE T NEUR SYS REH, V9, P126, DOI 10.1109/7333.928572; Costello KE, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-20; D'Hondt E, 2008, NEUROSCI LETT, V440, P72, DOI 10.1016/j.neulet.2008.05.056; D'Hondt E, 2011, CLIN BIOMECH, V26, P84, DOI 10.1016/j.clinbiomech.2010.08.007; da Rocha ES, 2014, CLIN BIOMECH, V29, P822, DOI 10.1016/j.clinbiomech.2014.05.006; Davy KP, 2009, NEUROSCI BIOBEHAV R, V33, P116, DOI 10.1016/j.neubiorev.2008.05.024; DeNies MS, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.204; Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014; Finkelstein EA, 2007, AM J HEALTH PROMOT, V21, P460, DOI 10.4278/0890-1171-21.5.460; Fjeldstad Cecilie, 2008, Dyn Med, V7, P4, DOI 10.1186/1476-5918-7-4; Franco JA, 2014, JOVE-J VIS EXP, DOI 10.3791/51948; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; GARDNER RM, 1983, PERCEPT MOTOR SKILL, V57, P1111, DOI 10.2466/pms.1983.57.3f.1111; Grassi C, 1996, NEUROSCI LETT, V212, P204, DOI 10.1016/0304-3940(96)12835-4; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Griffin TM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3068; Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12; Handrigan GA, 2012, GAIT POSTURE, V35, P88, DOI 10.1016/j.gaitpost.2011.08.012; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Himes CL, 2012, J AM GERIATR SOC, V60, P124, DOI 10.1111/j.1532-5415.2011.03767.x; Hong J, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-11; HOUK J, 1967, J NEUROPHYSIOL, V30, P466, DOI 10.1152/jn.1967.30.3.466; Hue O, 2007, GAIT POSTURE, V26, P32, DOI 10.1016/j.gaitpost.2006.07.005; HUNT CC, 1960, J PHYSIOL-LONDON, V151, P332, DOI 10.1113/jphysiol.1960.sp006441; HUNT CC, 1951, J PHYSIOL-LONDON, V113, P298, DOI 10.1113/jphysiol.1951.sp004573; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; Kararizou E, 2005, ANAL QUANT CYTOL, V27, P1; Kim GH, 2007, J PHYSIOL-LONDON, V582, P525, DOI 10.1113/jphysiol.2007.130120; KNIFFKI KD, 1978, EXP BRAIN RES, V31, P511; Ko SU, 2010, J BIOMECH, V43, P1104, DOI 10.1016/j.jbiomech.2009.12.004; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Lai PPK, 2008, CLIN BIOMECH, V23, pS2, DOI 10.1016/j.clinbiomech.2008.02.004; Lee S, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0049-5; Lhomond O, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00318; Li WG, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-88; Lin SH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11460; Liu JX, 2005, J HISTOCHEM CYTOCHEM, V53, P445, DOI 10.1369/jhc.4A6257.2005; Madigan M, 2014, CURR OBES REP, V3, P348, DOI 10.1007/s13679-014-0106-y; Matter KC, 2007, OBESITY, V15, P2384, DOI 10.1038/oby.2007.283; Matthews PBC, 1981, MUSCLE SPINDLES THEI; McGraw B, 2000, ARCH PHYS MED REHAB, V81, P484, DOI 10.1053/mr.2000.3782; Menegoni F, 2009, OBESITY, V17, P1951, DOI 10.1038/oby.2009.82; Mignardot JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060491; Mignardot JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014387; Miwa T, 1995, NEUROSCI LETT, V201, P179, DOI 10.1016/0304-3940(95)12165-X; Muller KA, 2008, DIABETES, V57, P1693, DOI 10.2337/db08-0022; O'Brien PD, 2017, LANCET NEUROL, V16, P465, DOI 10.1016/S1474-4422(17)30084-4; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Opree A, 2000, J NEUROSCI, V20, P6289, DOI 10.1523/JNEUROSCI.20-16-06289.2000; Passatore M, 1996, J AUTONOM NERV SYST, V57, P163, DOI 10.1016/0165-1838(95)00074-7; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Roatta S, 2002, J PHYSIOL-LONDON, V540, P237, DOI 10.1113/jphysiol.2001.014316; Rosant C, 2007, EXP GERONTOL, V42, P301, DOI 10.1016/j.exger.2006.10.007; Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293; Simoneau M., 2012, J BIOMECH, V45, DOI [10.1016/S0021-9290(12)70234-8, DOI 10.1016/S0021-9290(12)70234-8]; Simoneau M, 2015, GAIT POSTURE, V41, P203, DOI 10.1016/j.gaitpost.2014.10.008; Stubbins RE, 2012, EUR J NUTR, V51, P861, DOI 10.1007/s00394-011-0266-4; SWASH M, 1972, J NEUROL SCI, V16, P417, DOI 10.1016/0022-510X(72)90048-2; Takase K, 2016, OBESITY, V24, P886, DOI 10.1002/oby.21441; van Deursen RWM, 1998, EXP BRAIN RES, V120, P1, DOI 10.1007/s002210050371; Wilkinson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039140; Wolff AV, 2006, MUSCLE NERVE, V34, P304, DOI 10.1002/mus.20588; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162; Wu XF, 2014, NEUROSCI LETT, V583, P49, DOI 10.1016/j.neulet.2014.09.029; Yang YB, 2014, OBESITY, V22, P2147, DOI 10.1002/oby.20811	72	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196832	10.1371/journal.pone.0196832	http://dx.doi.org/10.1371/journal.pone.0196832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718979	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900086
J	Elhakeem, A; Markovic, D; Broberg, A; Anten, NPR; Ninkovic, V				Elhakeem, Ali; Markovic, Dimitrije; Broberg, Anders; Anten, Niels P. R.; Ninkovic, Velemir			Aboveground mechanical stimuli affect belowground plant-plant communication	PLOS ONE			English	Article							KIN RECOGNITION; BEHAVIOR; ARABIDOPSIS; TOUCH; COMPETITION; RESPONSES; STRESS; GROWTH; ROOTS	Plants can detect the presence of their neighbours and modify their growth behaviour accordingly. But the extent to which this neighbour detection is mediated by abiotic stressors is not well known. In this study we tested the acclimation response of Zea mays L. seedlings through belowground interactions to the presence of their siblings exposed to brief mechano stimuli. Maize seedling simultaneously shared the growth solution of touched plants or they were transferred to the growth solution of previously touched plants. We tested the growth preferences of newly germinated seedlings toward the growth solution of touched (T_solution) or untouched plants (C_solution). The primary root of the newly germinated seedlings grew significantly less towards T_solution than to C_solution. Plants transferred to T_solution allocated more biomass to shoots and less to roots. While plants that simultaneously shared their growth solution with the touched plants produced more biomass. Results show that plant responses to neighbours can be modified by aboveground abiotic stress to those neighbours and suggest that these modifications are mediated by belowground interactions.	[Elhakeem, Ali; Markovic, Dimitrije] Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden; [Elhakeem, Ali; Anten, Niels P. R.] Wageningen Univ & Res, Ctr Crop Syst Anal, Wageningen, Netherlands; [Markovic, Dimitrije] Univ Banja Luka, Fac Agr, Banja Luka, Bosnia & Herceg; [Broberg, Anders] Swedish Univ Agr Sci, Dept Mol Sci, Uppsala, Sweden; [Ninkovic, Velemir] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Wageningen University & Research; University of Banja Luka (UNIBL); Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Ninkovic, V (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	velemir.ninkovic@slu.se	Markovic, Dimitrije/A-2513-2019; Elhakeem, Ali/U-9543-2019; Ninkovic, Velemir/E-7677-2011	Markovic, Dimitrije/0000-0003-3030-4155; Elhakeem, Ali/0000-0002-2752-1207; Ninkovic, Velemir/0000-0001-9276-7169	Swedish Research Council for Environment (FORMAS) [2014-225]	Swedish Research Council for Environment (FORMAS)(Swedish Research Council Formas)	This study was financially supported by The Swedish Research Council for Environment (FORMAS) (project number 2014-225). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, COMMUN INTEGR BIOL, DOI DOI 10.4161/CIB.3.1.10118; [Anonymous], 2006, SAS MIXED MODELS; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Baluska F, 2010, TRENDS PLANT SCI, V15, P402, DOI 10.1016/j.tplants.2010.04.007; Benton HP, 2010, BIOINFORMATICS, V26, P2488, DOI 10.1093/bioinformatics/btq441; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; Broz AK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-115; CAHN MD, 1989, PLANT SOIL, V119, P271, DOI 10.1007/BF02370419; Callaway RM, 2002, TRENDS ECOL EVOL, V17, P104, DOI 10.1016/S0169-5347(01)02438-7; Chehab EW, 2012, CURR BIOL, V22, P701, DOI 10.1016/j.cub.2012.02.061; Chen BJW, 2012, PLANT SCI, V195, P157, DOI 10.1016/j.plantsci.2012.07.006; Curtis JT, 1959, VEGETATION WISCONSIN; de Wit M, 2013, PLANT J, V75, P90, DOI 10.1111/tpj.12203; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Dudley SA, 2013, FUNCT ECOL, V27, P898, DOI 10.1111/1365-2435.12121; Falik O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023625; Fang SQ, 2013, P NATL ACAD SCI USA, V110, P2670, DOI 10.1073/pnas.1222821110; File AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045648; Franklin KA, 2009, CURR OPIN PLANT BIOL, V12, P63, DOI 10.1016/j.pbi.2008.09.007; Gagliano M, 2012, TRENDS PLANT SCI, V17, P323, DOI 10.1016/j.tplants.2012.03.002; Guerrieri E, 2002, J CHEM ECOL, V28, P1703, DOI 10.1023/A:1020553531658; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P29; Jacob CE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173758; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Karban Richard, 2015, PLANT SENSING COMMUN; LINDBERG S, 1985, PLANT SOIL, V83, P295, DOI 10.1007/BF02184300; Liu Y, 2007, ANN BOT-LONDON, V99, P121, DOI 10.1093/aob/mcl230; Markovic D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165742; Markovic D, 2014, ARTHROPOD-PLANT INTE, V8, P171, DOI 10.1007/s11829-014-9303-6; Meng SX, 2006, J ECOL, V94, P681, DOI 10.1111/j.1365-2745.2006.01121.x; Moore D., 1998, INTRO PRACTICE STAT; Ninkovic V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069431; Novoplansky A, 2016, COGN SYST MONOGR, V29, P57, DOI 10.1007/978-3-319-22599-9_5; Novoplansky A, 2009, PLANT CELL ENVIRON, V32, P726, DOI 10.1111/j.1365-3040.2009.01979.x; Penuelas J, 2014, PLANT CELL ENVIRON, V37, P1866, DOI 10.1111/pce.12340; Pigliucci M, 2002, INT J PLANT SCI, V163, P399, DOI 10.1086/339158; Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546; SAS, 2014, STAT AN SOFTW SAS ST, V9; SILVERTOWN J, 1989, ANNU REV ECOL SYST, V20, P349, DOI 10.1146/annurev.es.20.110189.002025; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Trewavas A, 2009, PLANT CELL ENVIRON, V32, P606, DOI 10.1111/j.1365-3040.2009.01929.x; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11	43	22	25	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195646	10.1371/journal.pone.0195646	http://dx.doi.org/10.1371/journal.pone.0195646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718944	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900025
J	McGreevy, PD; Wilson, B; Starling, MJ; Serpell, JA				McGreevy, Paul D.; Wilson, Bethany; Starling, Melissa J.; Serpell, James A.			Behavioural risks in male dogs with minimal lifetime exposure to gonadal hormones may complicate population-control benefits of desexing	PLOS ONE			English	Article							ANIMAL SHELTER; AGGRESSION; TEMPERAMENT; PET; STERILIZATION; TRAITS; BITE; SEX	Castration of dogs is a widespread practise with clear justification in population control and knock-on benefits for animal welfare. Deleterious behavioural consequences of castration are believed to be negligible. Gonadectomy is widely recommended as part of a multi-factorial approach to prevent problems including aggression in dogs. However, the consequences of early castration on health are still being debated. The current study focused on the reported behaviour of 6,235 male dogs castrated before 520 weeks of life for reasons other than behavioural management, and calculated their percentage lifetime exposure to gonadal hormones (PLGH) as a proportion of their age at the time of being reported to the online Canine Behavioral Assessment and Research Questionnaire (C-BARQ). Forty behaviors differed between entire and castrated dogs, of which 25 were associated with PLGH and 14 with age-at-castration (AAC). Only 2 behaviours, indoor urine marking and howling when left alone, were significantly more likely in dogs with longer PLGH. In contrast, longer PLGH was associated with significantly reduced reporting of 26 (mostly unwelcome) behaviours. Of these, 8 related to fearfulness and 7 to aggression. The current data suggest that dogs' tendency to show numerous behaviours can be influenced by the timing of castration. They indicate how dog behaviour matures when gonadal hormones are allowed to have their effect. The differences reported here between undesirable behaviours of castrated and intact dogs were in the range of 5.04% and 12.31%, suggesting that, for some dogs, partial or complete denial of puberty may reduce indoor urine-marking but have many other undesirable consequences. Veterinarians may use these data to discuss unwelcome consequences with owners of male dogs before castration.	[McGreevy, Paul D.; Wilson, Bethany; Starling, Melissa J.] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia; [Serpell, James A.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA	University of Sydney; University of Pennsylvania	McGreevy, PD (corresponding author), Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Sydney, NSW, Australia.	paul.mcgreevy@sydney.edu.au		McGreevy, Paul/0000-0001-7220-8378				Agresti A, 2002, CATEGORICAL DATA ANA, P282; Barnard S, 2012, APPL ANIM BEHAV SCI, V138, P79, DOI 10.1016/j.applanim.2012.02.017; Beauvais W, 2012, J SMALL ANIM PRACT, V53, P314, DOI 10.1111/j.1748-5827.2011.01220.x; BEAVER BV, 1994, J AM VET MED ASSOC, V204, P1953; BECK AM, 1975, PUBLIC HEALTH REP, V90, P262; Cocia RI, 2010, ANTHROZOOS, V23, P185, DOI 10.2752/175303710X12682332910097; Cooley DM, 2002, CANCER EPIDEM BIOMAR, V11, P1434; D'Onise K, 2017, INJURY PREV, V23, P212, DOI 10.1136/injuryprev-2016-042141; de la Riva GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055937; De Meester RH, 2008, J VET BEHAV, V3, P161, DOI 10.1016/j.jveb.2007.10.005; Duffy D, 2014, APPL ANIMAL BEHAV SC, V138, P99; Farhoody P., 2010, THESIS HUNTER COLL N, P1; Farhoody P, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00018; Garde E, 2016, PREV VET MED, V123, P106, DOI 10.1016/j.prevetmed.2015.11.011; Hart BL, 2016, VET MED SCI, V2, P191, DOI 10.1002/vms3.34; Hart BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102241; Hart BL, 1997, J AM VET MED ASSOC, V210, P1129; Heidenberger E, 1990, Tierarztl Prax, V18, P69; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Kass P. H., 2001, Journal of Applied Animal Welfare Science, V4, P237, DOI 10.1207/S15327604JAWS0404_01; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; LINE S, 1986, APPL ANIM BEHAV SCI, V16, P77, DOI 10.1016/0168-1591(86)90042-0; Lockwood R, 2017, DOMESTIC DOG: ITS EVOLUTION, BEHAVIOR AND INTERACTIONS WITH PEOPLE, 2ND EDITION, P160; Marston Linda C., 2005, Journal of Applied Animal Welfare Science, V8, P25, DOI 10.1207/s15327604jaws0801_3; Masters AM, 2008, AUST VET J, V86, P18, DOI 10.1111/j.1751-0813.2007.00248.x; Mattin M, 2014, VET REC, V174, P349, DOI 10.1136/vr.101950; McGreevy PD, 2010, VET J, V186, P1, DOI 10.1016/j.tvjl.2009.09.007; McGreevy PD, 2010, ANIM WELFARE, V19, P11; McGreevy PD, 2008, APPL ANIM BEHAV SCI, V109, P320, DOI 10.1016/j.applanim.2007.04.001; McGreevy PD, 2009, A MODERN DOGS LIFE; McKenzie B., 2010, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V5, P1, DOI 10.1079/PAVSNNR20105045; Miller DD, 1996, J AM VET MED ASSOC, V209, P738; Mongillo P, 2017, APPL ANIMAL IN PRESS; O'Neill DG, 2013, VET J, V198, P638, DOI 10.1016/j.tvjl.2013.09.020; O'Neill DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090501; PATRONEK GJ, 1995, ANTHROZOOS, V8, P31, DOI 10.2752/089279395787156455; Reichler IM, 2009, REPROD DOMEST ANIM, V44, P29, DOI 10.1111/j.1439-0531.2009.01437.x; Roll A, 1997, APPL ANIM BEHAV SCI, V52, P229, DOI 10.1016/S0168-1591(96)01125-2; Ru G, 1998, VET J, V156, P31, DOI 10.1016/S1090-0233(98)80059-2; SCHNEIDER R, 1969, JNCI-J NATL CANCER I, V43, P1249; Serpell JA, 2005, ANTHROZOOS, V18, P196, DOI 10.2752/089279305785594135; Shoop Stephanie Jw, 2015, Canine Genet Epidemiol, V2, P1, DOI 10.1186/2052-6687-2-1; Starling MJ, 2013, VET J, V197, P868, DOI 10.1016/j.tvjl.2013.05.019; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Takeuchi Y, 2000, J AM VET MED ASSOC, V217, P342, DOI 10.2460/javma.2000.217.342; Trevejo R, 2011, JAVMA-J AM VET MED A, V238, P898, DOI 10.2460/javma.238.7.898; van der Borg JAM, 2010, APPL ANIM BEHAV SCI, V128, P78, DOI 10.1016/j.applanim.2010.09.016	47	33	33	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196284	10.1371/journal.pone.0196284	http://dx.doi.org/10.1371/journal.pone.0196284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718954	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900050
J	An, R; Schmid, R; Klausing, A; Robering, JW; Weber, M; Bauerle, T; Detsch, R; Boccaccini, AR; Horch, RE; Boos, AM; Weigand, A				An, Ran; Schmid, Rafael; Klausing, Anne; Robering, Jan W.; Weber, Maximilian; Baeuerle, Tobias; Detsch, Rainer; Boccaccini, Aldo R.; Horch, Raymund E.; Boos, Anja M.; Weigand, Annika			Proangiogenic effects of tumor cells on endothelial progenitor cells vary with tumor type in an in vitro and in vivo rat model	FASEB JOURNAL			English	Article						cancer; neovascularization; cytokines; hydrogel	HEPATOCELLULAR-CARCINOMA; INDUCED ANGIOGENESIS; CANCER-RESEARCH; GROWTH-FACTOR; ACTIVIN-A; METASTASIS; PROGRESSION; BIOLOGY; ANGIOPOIETIN-2; EXPRESSION	Endothelial progenitor cells (EPCs) contribute to neovascularization in tumors. However, the relationship of EPCs and tumor-induced angiogenesis still remains to be clarified. The present study aimed at investigating the influence of 4 different tumor types on angiogenic properties of EPCs in an in vitro and in vivo rat model. It could be demonstrated that in vitro proliferation, migration, and angiogenic abilities and genetic modifications of EPCs are controlled in a tumor-type-dependent manner. The proangiogenic effect of mammary carcinoma, osteosarcoma, and rhabdomyosarcoma cells was more pronounced compared to colon carcinoma cells. Coinjection of encapsulated tumor cells, especially mammary carcinoma cells, and EPCs in a rat model confirmed a contributing effect of EPCs in tumor vascularization. Cytokines secreted by tumors such as monocyte chemoattractant protein 1, macrophage inflammatory protein 2, and TNF-related apoptosis-inducing ligand play a pivotal role in the tumor cell-EPC interaction, leading to enhanced migration and angiogenesis. With the present study, we were able to decipher possible underlying mechanisms by which EPCs are stimulated by tumor cells and contribute to tumor vascularization. The present study will contribute to a better understanding of tumor-induced vascularization, thus facilitating the development of therapeutic strategies targeting tumor-EPC interactions.An, R., Schmid, R., Klausing, A., Robering, J. W., Weber, M., Bauerle, T., Detsch, R., Boccaccini, A. R., Horch, R. E., Boos, A. M., Weigand, A. Proangiogenic effects of tumor cells on endothelial progenitor cells vary with tumor type in an in vitro and in vivo rat model.	[An, Ran; Schmid, Rafael; Klausing, Anne; Robering, Jan W.; Weber, Maximilian; Horch, Raymund E.; Boos, Anja M.; Weigand, Annika] Univ Hosp Erlangen, Lab Tissue Engn & Regenerat Med, Dept Plast & Hand Surg, Erlangen, Germany; [Baeuerle, Tobias] Univ Hosp Erlangen, Dept Radiol, Erlangen, Germany; [Detsch, Rainer; Boccaccini, Aldo R.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Mat Sci & Engn, Erlangen, Germany; [An, Ran] Huazhong Univ Sci & Technol, Union Plast & Aesthet Hosp, Wuhan Union Hosp, Wuhan, Hubei, Peoples R China	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Huazhong University of Science & Technology	Weigand, A (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Plast & Hand Surg, Krankenhausstr 12, D-91054 Erlangen, Germany.; Weigand, A (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Lab Tissue Engn & Regenerat Med, Krankenhausstr 12, D-91054 Erlangen, Germany.	annika.weigand@uk-erlangen.de	Boccaccini, Aldo R./N-9782-2019; Boccaccini, Aldo R/C-7905-2013	Boccaccini, Aldo R./0000-0002-7377-2955; Bauerle, Tobias/0000-0002-0206-6199; Detsch, Rainer/0000-0001-9383-428X	Staedtler Foundation (University of Erlangen-Nurnberg); Manfred Roth Foundation; Forschungsstiftung Medizin; University of Erlangen-Nurnberg; Interdisciplinary Center for Clinical Research (IZKF; Faculty of Medicine, FAU); German Research Foundation (DFG) within the Collaborative Research Center TRR225; Marohn-Stiftung; Sofie-Wallner Stiftung; Xue Hong and Hans Georg Geis Foundation	Staedtler Foundation (University of Erlangen-Nurnberg); Manfred Roth Foundation; Forschungsstiftung Medizin; University of Erlangen-Nurnberg; Interdisciplinary Center for Clinical Research (IZKF; Faculty of Medicine, FAU); German Research Foundation (DFG) within the Collaborative Research Center TRR225; Marohn-Stiftung; Sofie-Wallner Stiftung; Xue Hong and Hans Georg Geis Foundation	The authors thank J. Jordan, C. Gillmann, and L. Seyler (University Hospital of Erlangen) for their technical support with the 3D imaging; S. Reakasame [Friedrich-Alexander University Erlangen-Nurnberg (FAU)] for technical support with the 3D encapsulation of the cells; E. Nakashima (Keio University Tokyo, Japan) for providing TR-BME2 cells; A. Raabe [University Cancer Center Hamburg (UCCH)] for providing R1H cells; P. J. K. Kuppen (Leiden University Medical Center, Leiden, The Netherlands) for providing MCR86 cells; T. L. M. ten Hagen (Erasmus Medical Center, Rotterdam, The Netherlands) for providing ROS-1 cells; and S. Fleischer and I. Arnold-Herberth (both from the University Hospital of Erlangen) for their excellent technical support. This work was supported, in part, by the Staedtler Foundation (University of Erlangen-Nurnberg), the Manfred Roth Foundation, the Forschungsstiftung Medizin, University of Erlangen-Nurnberg, Interdisciplinary Center for Clinical Research (IZKF; Faculty of Medicine, FAU), the German Research Foundation (DFG) within the Collaborative Research Center TRR225 (Subproject C03), Marohn-Stiftung, Sofie-Wallner Stiftung, and the Xue Hong and Hans Georg Geis Foundation. The authors declare no conflicts of interest.	Adamcic U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053385; Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073; Ahmed TAE, 2008, TISSUE ENG PART B-RE, V14, P199, DOI 10.1089/ten.teb.2007.0435; Bidarra SJ, 2014, ACTA BIOMATER, V10, P1646, DOI 10.1016/j.actbio.2013.12.006; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8; Cantarella G, 2006, BRIT J CANCER, V94, P1428, DOI 10.1038/sj.bjc.6603092; Cartland S. P., INT J MOL SCI; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Chwalek K, 2014, ADV DRUG DELIVER REV, V79-80, P30, DOI 10.1016/j.addr.2014.05.006; de la Puente P, 2013, CLIN CANCER RES, V19, P3360, DOI 10.1158/1078-0432.CCR-13-0462; De Palma M, 2006, BBA-REV CANCER, V1766, P159, DOI 10.1016/j.bbcan.2006.06.003; Farnsworth RH, 2014, ONCOGENE, V33, P3496, DOI 10.1038/onc.2013.304; Fiedler U, 2003, J BIOL CHEM, V278, P1721, DOI 10.1074/jbc.M208550200; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gillet JP, 2013, JNCI-J NATL CANCER I, V105, P452, DOI 10.1093/jnci/djt007; Gordon MS, 2010, INT J CANCER, V126, P1777, DOI 10.1002/ijc.25026; Grellier M, 2009, J CELL BIOCHEM, V106, P390, DOI 10.1002/jcb.22018; Gupta MK, 2003, WORLD J GASTROENTERO, V9, P1144, DOI 10.3748/wjg.v9.i6.1144; Hoh BL, 2011, CIRCULATION, V124, P2243, DOI 10.1161/CIRCULATIONAHA.111.036061; Hwang CM, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014105; Ivanovska J, 2016, TISSUE ENG PART C-ME, V22, P708, DOI [10.1089/ten.TEC.2015.0452, 10.1089/ten.tec.2015.0452]; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; Leto G, 2006, CLIN EXP METASTAS, V23, P117, DOI 10.1007/s10585-006-9010-5; Li WM, 2000, CYTOKINE, V12, P1017, DOI 10.1006/cyto.1999.0678; Liao YY, 2016, ONCOTARGET, V7, P4310, DOI 10.18632/oncotarget.6708; Logsdon EA, 2014, J CELL MOL MED, V18, P1491, DOI 10.1111/jcmm.12164; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Marlicz W, 2016, ONCOL REP, V36, P3635, DOI 10.3892/or.2016.5179; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Moldobaeva A, 2005, AM J PHYSIOL-LUNG C, V288, pL1117, DOI 10.1152/ajplung.00370.2004; Nagyova M, 2014, IN VITRO CELL DEV-AN, V50, P656, DOI 10.1007/s11626-014-9750-5; Nanobashvili J., 2003, EUR SURG, V35, P214, DOI 10.1007/s10353-003-0012-0; Ochiya T, 2014, ANGIOGENESIS, V17, P17, DOI 10.1007/s10456-013-9372-7; Oikonomou E, 2013, BIOFACTORS, V39, P343, DOI 10.1002/biof.1112; Pardali E., INT J MOL SCI; Patenaude A, 2010, MICROVASC RES, V79, P217, DOI 10.1016/j.mvr.2010.01.007; Pelus LM, 2002, CRIT REV ONCOL HEMAT, V43, P257, DOI 10.1016/S1040-8428(01)00202-5; Pena B, 2017, ACS APPL MATER INTER, V9, P31645, DOI 10.1021/acsami.7b11438; Pirisi M, 2000, CANCER DETECT PREV, V24, P150; Poggio P, 2011, J CELL PHYSIOL, V226, P2139, DOI 10.1002/jcp.22549; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Russell JS, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-177; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Sarker B, 2015, INT J BIOL MACROMOL, V78, P72, DOI 10.1016/j.ijbiomac.2015.03.061; Secchiero P, 2004, NEOPLASIA, V6, P364, DOI 10.1593/neo.03421; Shih YT, 2015, GUT, V64, P1132, DOI 10.1136/gutjnl-2013-306302; Shih YT, 2012, CELL SIGNAL, V24, P779, DOI 10.1016/j.cellsig.2011.11.013; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Wang H, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0353-9; Wang Y, 2016, ACTA OCEANOL SIN, V35, P1, DOI 10.1007/s13131-016-0858-1; Wei B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039069; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; Yu Y, 2008, EXP CELL RES, V314, P3198, DOI 10.1016/j.yexcr.2008.08.001; Zecchin A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01750	60	9	9	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5587	5601		10.1096/fj.201800135RR	http://dx.doi.org/10.1096/fj.201800135RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29746168				2022-12-26	WOS:000447972500032
J	Li, NN; Zhang, Y; Sidlauskas, K; Ellis, M; Evans, I; Frankel, P; Lau, J; El-Hassan, T; Guglielmi, L; Broni, J; Richard-Loendt, A; Brandner, S				Li, Ningning; Zhang, Ying; Sidlauskas, Kastytis; Ellis, Matthew; Evans, Ian; Frankel, Paul; Lau, Joanne; El-Hassan, Tedani; Guglielmi, Loredana; Broni, Jessica; Richard-Loendt, Angela; Brandner, Sebastian			Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades	ONCOGENE			English	Article							INTEGRATED GENOMIC ANALYSIS; PROSTATE-CANCER CELLS; STEM-CELL; DOWN-REGULATION; CYCLE ARREST; HUMAN GLIOBLASTOMA; FATE DETERMINATION; TUMOR-SUPPRESSOR; EXPRESSION; MIR-449A	To identify biomarkers for glioma growth, invasion and progression, we used a candidate gene approach in mouse models with two complementary brain tumour phenotypes, developing either slow-growing, diffusely infiltrating gliomas or highly proliferative, non-invasive primitive neural tumours. In a microRNA screen we first identified microRNA-449a as most significantly differentially expressed between these two tumour types. miR-449a has a target dependent effect, inhibiting cell growth and migration by downregulation of CCND1 and suppressing neural phenotypes by inhibition of G protein coupled-receptor (GPR) 158. GPR158 promotes glioma stem cell differentiation and induces apoptosis and is highest expressed in the cerebral cortex and in oligodendrogliomas, lower in IDH mutant astrocytomas and lowest in the most malignant form of glioma, IDH wild-type glioblastoma. The correlation of GPR158 expression with molecular subtypes, patient survival and therapy response suggests a possible role of GPR158 as prognostic biomarker in human gliomas.	[Li, Ningning; Zhang, Ying; Sidlauskas, Kastytis; Ellis, Matthew; Lau, Joanne; Broni, Jessica; Richard-Loendt, Angela; Brandner, Sebastian] UCL, Inst Neurol, Dept Neurodegenerat, Queen Sq, London WC1N 3BG, England; [Li, Ningning] Sun Yat Sen Univ, Affiliated Hosp 7, Shenzhen 518107, Peoples R China; [Evans, Ian; Frankel, Paul] UCL, Div Med, Univ St, London WC1E 6JF, England; [El-Hassan, Tedani; Brandner, Sebastian] Univ Coll London Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, Div Neuropathol, Queen Sq, London WC1N 3BG, England; [Guglielmi, Loredana] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, 4 Newark St, London E1 2AT, England; [Broni, Jessica; Richard-Loendt, Angela] UCL, Inst Neurol, UCL IQPath Lab, Queen Sq, London WC1N 3BG, England	University of London; University College London; Sun Yat Sen University; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; Queen Mary University London; University of London; University College London	Li, NN; Brandner, S (corresponding author), UCL, Inst Neurol, Dept Neurodegenerat, Queen Sq, London WC1N 3BG, England.; Li, NN (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 7, Shenzhen 518107, Peoples R China.; Brandner, S (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, Div Neuropathol, Queen Sq, London WC1N 3BG, England.	linn29@mail.sysu.edu.cn; s.brandner@ucl.ac.uk	Evans, Ian/C-8533-2009; Brandner, Sebastian/J-4562-2014	Evans, Ian/0000-0002-0468-8274; Brandner, Sebastian/0000-0002-9821-0342; Zhang, Ying/0000-0003-2194-7116; Li, Ningning/0000-0002-0414-5878; Ellis, Matthew/0000-0002-5264-0531	Brain Tumour Charity UK (BTC) [8/128]; Centre grant from BTC [8/197]; Brain Tumour Research UK; Department of Health's NIHR Biomedical Research Centre's funding scheme; CRUK Accelerator Ed-UCL Grant [C416/A23615]; University College London (Overseas research scholarship, UCL ORS); UCLH Charity; Cancer Research UK [C1 15121 A 20256]	Brain Tumour Charity UK (BTC); Centre grant from BTC; Brain Tumour Research UK; Department of Health's NIHR Biomedical Research Centre's funding scheme(National Institute for Health Research (NIHR)); CRUK Accelerator Ed-UCL Grant; University College London (Overseas research scholarship, UCL ORS); UCLH Charity; Cancer Research UK(Cancer Research UK)	Part of this work was supported by a grant from the Brain Tumour Charity UK to NL and SB (BTC, 8/128) and by a Centre grant from BTC (8/197). LG and part of NL were supported by a Centre of Excellence grant to Queen May University London from Brain Tumour Research UK. SB is also supported by the Department of Health's NIHR Biomedical Research Centre's funding scheme. The tissue resource is supported by the CRUK Accelerator Ed-UCL Grant C416/A23615. YZ is supported by a PhD fellowship from University College London (Overseas research scholarship, UCL ORS) and by funds from UCLH Charity. ME is funded by a Cancer Research UK Accelerator grant C1 15121 A 20256. We thank M. Elizabeth Fini, UCSC Los Angeles for the pcDNA3.1 hGPR158 vector.	Al-Mayhani TMF, 2009, J NEUROSCI METH, V176, P192, DOI 10.1016/j.jneumeth.2008.07.022; Barca-Mayo O, 2014, CELL MOL LIFE SCI, V71, P2975, DOI 10.1007/s00018-014-1576-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bjarndottir TK, 2005, GENE, V362, P70, DOI 10.1016/j.gene.2005.07.029; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chen SH, 2014, ONCOL LETT, V7, P568, DOI 10.3892/ol.2013.1737; Chen SP, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1738-3; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Dahia PLM, 2014, NAT REV CANCER, V14, P108, DOI 10.1038/nrc3648; Fang YT, 2013, ONCOL REP, V30, P399, DOI 10.3892/or.2013.2465; Fededa JP, 2016, EMBO J, V35, P2386, DOI 10.15252/embj.201694056; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Henriquez NV, 2013, CANCER RES, V73, P5834, DOI 10.1158/0008-5472.CAN-13-1299; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Insel PA, 2007, BBA-BIOMEMBRANES, V1768, P994, DOI 10.1016/j.bbamem.2006.09.029; Jacques TS, 2010, EMBO J, V29, P222, DOI 10.1038/emboj.2009.327; JIANG W, 1992, CANCER RES, V52, P2980; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Jovicic A, 2013, J NEUROSCI, V33, P5127, DOI 10.1523/JNEUROSCI.0600-12.2013; Khrimian L, 2017, J EXP MED, V214, P2859, DOI 10.1084/jem.20171320; Kwon CH, 2008, CANCER RES, V68, P3286, DOI 10.1158/0008-5472.CAN-07-6867; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Lize M, 2011, CELL CYCLE, V10, P2874, DOI 10.4161/cc.10.17.17181; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lukaszewicz AI, 2011, P NATL ACAD SCI USA, V108, P11632, DOI 10.1073/pnas.1106230108; Ma JF, 2015, NEUROCHEM RES, V40, P1681, DOI 10.1007/s11064-015-1635-9; Mao AH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27346; Marino S, 2000, GENE DEV, V14, P994; Marino S, 2002, DEVELOPMENT, V129, P3513; Martin HC, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r51; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Orlandi C, 2012, J CELL BIOL, V197, P711, DOI 10.1083/jcb.201202123; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Patel N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117758; Patel N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057843; Pham JT, 2012, AM J STEM CELLS, V1, P182; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Pratt AJ, 2009, J BIOL CHEM, V284, P17897, DOI 10.1074/jbc.R900012200; Redshaw N, 2009, BRAIN RES, V1250, P20, DOI 10.1016/j.brainres.2008.11.020; Reuss DE, 2015, ACTA NEUROPATHOL, V130, P407, DOI 10.1007/s00401-015-1454-8; Reuss DE, 2015, ACTA NEUROPATHOL, V129, P133, DOI 10.1007/s00401-014-1370-3; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Saddiki H, 2015, BIOINFORMATICS, V31, P225, DOI 10.1093/bioinformatics/btu618; Shi W, 2016, ONCOTARGET, V7, P18906, DOI 10.18632/oncotarget.7753; Sturm D, 2016, CELL, V164, P1060, DOI 10.1016/j.cell.2016.01.015; Su WY, 2012, CELL RES, V22, P1374, DOI 10.1038/cr.2012.57; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Tan SM, 2014, CELL REP, V8, P1225, DOI 10.1016/j.celrep.2014.07.023; Thompson MD, 2014, METHODS MOL BIOL, V1175, P153, DOI 10.1007/978-1-4939-0956-8_8; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vigneswaran K, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.57; Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Weller M, 2013, LANCET ONCOL, V14, pE370, DOI 10.1016/S1470-2045(13)70168-2; Wu JW, 2014, P NATL ACAD SCI USA, V111, pE2851, DOI 10.1073/pnas.1407777111; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Yao MJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-232; Yao YL, 2015, MOL ONCOL, V9, P640, DOI 10.1016/j.molonc.2014.11.003; You JC, 2015, AM J CANCER RES, V5, P2730; ZHANG YJ, 1993, BIOCHEM BIOPH RES CO, V196, P1010, DOI 10.1006/bbrc.1993.2350; Zhao ZZ, 2015, RNA BIOL, V12, P538, DOI 10.1080/15476286.2015.1023495; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhou M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0556-3	71	19	20	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 2	2018	37	31					4313	4333		10.1038/s41388-018-0277-1	http://dx.doi.org/10.1038/s41388-018-0277-1			21	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP1HN	29720725	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000440566100009
J	Su, HB; Zhang, Z; Liu, ZJ; Peng, BZ; Kong, C; Wang, HH; Zhang, Z; Xu, Y				Su, Haibo; Zhang, Zhen; Liu, Zijian; Peng, Baozhou; Kong, Cong; Wang, Honghai; Zhang, Zhi; Xu, Ying			Mycobacterium tuberculosis PPE60 antigen drives Th1/Th17 responses via Toll-like receptor 2-dependent maturation of dendritic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; tuberculosis; dendritic cell; antigen processing; PE; PPE proteins; tuberculosis; TLR; Toll-like receptor; tuberculosis vaccine; helper T cell response; CD4(+) T cell	NECROSIS-FACTOR-ALPHA; REGULATORY T-CELLS; IMMUNE-RESPONSES; NLRP3 INFLAMMASOME; PROTECTIVE EFFICACY; VACCINE CANDIDATE; MULTIGENE FAMILY; IN-VIVO; MACROPHAGES; ACTIVATION	Targeting of Mycobacterium tuberculosis (MTB) PE/PPE antigens that induce type 1 helper T cell (Th1) and Th17 responses represents a crucial strategy for the development of tuberculosis (TB) vaccines. However, only a few PE/PPE antigens induce these responses. Here, we sought to determine how the cell wall-associated antigen PPE60 (Rv3478) activates dendritic cell (DC) maturation and T-cell differentiation. We observed that PPE60 induces DC maturation by augmenting the protein expression of cluster of differentiation 80 (CD80) and CD86 and major histocompatibility complex (MHC) class I and MHC class II on the cell surface. PPE60 also stimulated the production of tumor necrosis factor- (TNF), interleukin (IL)-1, IL-6, IL-12p70, and IL-23p19 but not IL-10. This induction was mediated by Toll-like receptor 2 (TLR2) and followed by activation of p38, c-Jun N-terminal kinase (JNK), and NF-B signaling. PPE60 enhanced MHC-II expression and promoted antigen processing by DCs in a TLR2-dependent manner. Moreover, PPE60-stimulated DCs directed naive CD4(+) T cells to produce IFN-, IL-2, and IL-17A, expanding the Th1 and Th17 responses, along with activation of T-bet and RAR-related orphan receptor C (RORt) but not GATA-3. Moreover, PPE60 activated the NLRP3 inflammasome followed by caspase-1-dependent IL-1 and IL-18 synthesis in DCs. Of note, pharmacological inhibition of NLRP3 activation specifically attenuated IFN- and IL-17A secretion into the supernatant from CD4(+) T cells cocultured with PPE60-activated DCs. These findings indicate that PPE60 induces Th1 and Th17 immune responses by activating DCs in a TLR2-dependent manner, suggesting PPE60's potential for use in MTB vaccine development.	[Su, Haibo; Liu, Zijian; Peng, Baozhou] GMU, GIBH, Joint Sch Life Sci, 195 Dongfengxi Rd, Guangzhou 510000, Guangdong, Peoples R China; [Kong, Cong; Wang, Honghai; Xu, Ying] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, 220 Handan Rd, Shanghai 200433, Peoples R China; [Su, Haibo; Zhang, Zhen; Zhang, Zhi] Guangdong Second Prov Gen Hosp, 466 Xingang Rd, Guangzhou 510220, Guangdong, Peoples R China	Fudan University	Xu, Y (corresponding author), Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, 220 Handan Rd, Shanghai 200433, Peoples R China.; Zhang, Z (corresponding author), Guangdong Second Prov Gen Hosp, 466 Xingang Rd, Guangzhou 510220, Guangdong, Peoples R China.	yalw135@126.com; yingxu2520@fudan.edu.cn			National Natural Science Foundation of China [31600747]; youth innovation talents program of the education department of Guangdong province through University Innovation Strong School Project [2016KQNCX141, Q17024049]; National Science and Technology Major Project [2018ZX10731301-004, 2018ZX10302302-002]; Guangzhou Science and Technology Innovation Committee [201804010317]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); youth innovation talents program of the education department of Guangdong province through University Innovation Strong School Project; National Science and Technology Major Project; Guangzhou Science and Technology Innovation Committee	This work was supported by National Natural Science Foundation of China Grant 31600747, the youth innovation talents program of the education department of Guangdong province through University Innovation Strong School Project Grants 2016KQNCX141 and Q17024049, National Science and Technology Major Project 2018ZX10731301-004 and 2018ZX10302302-002, and Guangzhou Science and Technology Innovation Committee Grant 201804010317. The authors declare that they have no conflicts of interest with the contents of this article.	Ade N, 2007, TOXICOL SCI, V99, P488, DOI 10.1093/toxsci/kfm178; Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Baldwin SL, 2009, VACCINE, V27, P3063, DOI 10.1016/j.vaccine.2009.03.018; Bansal K, 2010, J BIOL CHEM, V285, P36511, DOI 10.1074/jbc.M110.158055; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Basu S, 2018, MICROB PATHOGENESIS, V114, P219, DOI 10.1016/j.micpath.2017.11.044; Bertholet S, 2008, J IMMUNOL, V181, P7948, DOI 10.4049/jimmunol.181.11.7948; Brennan MJ, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00969-16, 10.1128/iai.00969-16]; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Briken V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00062; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cascioferro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027713; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; Derrick SC, 2013, VACCINE, V31, P4641, DOI 10.1016/j.vaccine.2013.07.032; Dona V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057517; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Fernandes-Alnemri T, 2013, J IMMUNOL, V191, P3995, DOI 10.4049/jimmunol.1301681; Fishbein S, 2015, MOL MICROBIOL, V96, P901, DOI 10.1111/mmi.12981; Forsyth KS, 2016, CURR OPIN IMMUNOL, V40, P123, DOI 10.1016/j.coi.2016.03.003; Jacobo REG, 2014, CELL IMMUNOL, V289, P167, DOI 10.1016/j.cellimm.2014.03.010; Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099; Gopalakrishnan A, 2016, CURR OPIN IMMUNOL, V42, P76, DOI 10.1016/j.coi.2016.06.003; Jang S, 2008, J LEUKOCYTE BIOL, V84, P1264, DOI 10.1189/jlb.1107742; Kaufmann SHE, 2012, CURR OPIN BIOTECH, V23, P900, DOI 10.1016/j.copbio.2012.03.007; Khubaib M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00719; Kim WS, 2016, IMMUNOBIOLOGY, V221, P440, DOI 10.1016/j.imbio.2015.11.006; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Kupz A, 2016, J CLIN INVEST, V126, P2109, DOI 10.1172/JCI84978; Lewinsohn DA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01262; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Mourik BC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00294; Mukhopadhyay S, 2011, TUBERCULOSIS, V91, P441, DOI 10.1016/j.tube.2011.04.004; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Nieuwenhuizen NE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00121; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Saini NK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.133, 10.1038/nmicrobiol.2016.133]; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sato K, 1998, CLIN EXP IMMUNOL, V112, P63; Sayes F, 2012, CELL HOST MICROBE, V11, P352, DOI 10.1016/j.chom.2012.03.003; Sayes F, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005770; Sia JK, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/747543; Su HB, 2015, ONCOTARGET, V6, P38517, DOI 10.18632/oncotarget.5956; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Vordermeier HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040890; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Windish HP, 2011, VACCINE, V29, P7842, DOI 10.1016/j.vaccine.2011.07.094; Xu Y, 2015, J MOL MED, V93, P645, DOI 10.1007/s00109-014-1243-1; Yuk JM, 2014, CLIN EXP VACCINE RES, V3, P155, DOI 10.7774/cevr.2014.3.2.155	57	24	26	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10287	10302		10.1074/jbc.RA118.001696	http://dx.doi.org/10.1074/jbc.RA118.001696			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29739853	Green Published, hybrid			2022-12-26	WOS:000437096700027
J	Molina, LCP; Pinto, NA; Torres, NI; Gonzalez-Cota, AL; Luque, GM; Balestrini, PA; Romarowski, A; Krapf, D; Santi, CM; Trevino, CL; Darszon, A; Buffone, MG				Puga Molina, Lis C.; Pinto, Nicolas A.; Torres, Nicolas I.; Gonzalez-Cota, Ana L.; Luque, Guillermina M.; Balestrini, Paula A.; Romarowski, Ana; Krapf, Dario; Santi, Celia M.; Trevino, Claudia L.; Darszon, Alberto; Buffone, Mariano G.			CFTR/ENaC-dependent regulation of membrane potential during human sperm capacitation is initiated by bicarbonate uptake through NBC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sperm; bicarbonate; epithelial sodium channel (ENaC); fertilization; sodium transport; Capacitation; ENaC; human sperm; membrane potential; NBC	TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; SODIUM-BICARBONATE; FERTILIZING-CAPACITY; INTRACELLULAR SODIUM; CARBONIC-ANHYDRASES; CHANNEL REGULATION; MOLECULAR-CLONING; CHLORIDE CHANNEL; HYPERPOLARIZATION	To fertilize an egg, sperm must reside in the female reproductive tract to undergo several maturational changes that are collectively referred to as capacitation. From a molecular point of view, the HCO3 -dependent activation of the atypical soluble adenylyl cyclase (ADCY10) is one of the first events that occurs during capacitation and leads to the subsequent cAMP-dependent activation of protein kinase A (PKA). Capacitation is also accompanied by hyperpolarization of the sperm plasma membrane. We previously reported that PKA activation is necessary forCFTR(cystic fibrosis transmembrane conductance regulator channel) activity and for the modulation of membrane potential (Em). However, the main HCO3 transporters involved in the initial transport and the PKA-dependent Em changes are not well known nor characterized. Here, we analyzed how the activity of CFTR regulates Em during capacitation and examined its relationship with an electrogenic Na / HCO3 cotransporter (NBC) and epithelial Na channels (ENaCs). We observed that inhibition of both CFTR and NBC decreased HCO3 influx, resulting in lower PKA activity, and that events downstream of the cAMP activation of PKA are essential for the regulation of Em. Addition of a permeable cAMP analog partially rescued the inhibitory effects caused by these inhibitors. HCO3 also produced a rapid membrane hyperpolarization mediated by ENaC channels, which contribute to the regulation of Em during capacitation. Altogether, we demonstrate for the first time, that NBC cotransporters and ENaC channels are essential in the CFTR-dependent activation of the cAMP/ PKA sig-naling pathway and Em regulation during human sperm capacitation.	[Puga Molina, Lis C.; Pinto, Nicolas A.; Torres, Nicolas I.; Luque, Guillermina M.; Balestrini, Paula A.; Romarowski, Ana; Buffone, Mariano G.] Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt IBYME, C1425FQB, Buenos Aires, DF, Argentina; [Gonzalez-Cota, Ana L.; Santi, Celia M.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Krapf, Dario] UNR, CONICET, Inst Biol Mol & Celular Rosario IBR, RA-2000 Rosario, Santa Fe, Argentina; [Trevino, Claudia L.; Darszon, Alberto] UNAM, Inst Biotechnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62210, Morelos, Mexico	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Washington University (WUSTL); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Universidad Nacional Autonoma de Mexico	Buffone, MG (corresponding author), Vuelta Obligado 2490,C1425FQB, RA-1428 Buenos Aires, DF, Argentina.	mgbuffone@ibyme.conicet.gov.ar	Puga Molina, Lis del Carmen/AFE-9171-2022; Puga Molina, Lis del Carmen/AAE-9765-2022; Luque, Guillermina/M-9237-2019; torres, nicolas/AAE-4849-2019	Puga Molina, Lis del Carmen/0000-0001-7937-4918; Puga Molina, Lis del Carmen/0000-0001-7937-4918; Luque, Guillermina/0000-0002-2745-8236; Krapf, Dario/0000-0001-7607-1954; Balestrini, Paula Ania/0000-0002-9351-1226; Gonzalez Cota, Ana L./0000-0002-1643-5805; Pinto, Nicolas Alejandro/0000-0001-9992-5692; Torres, Nicolas/0000-0001-6501-185X; Darszon, Alberto/0000-0002-2502-0505	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2015-2294, PICT 2015-3164]; CONACyT-Mexico Fronteras de la Ciencia 71; DGAPA/UNAM [IN203116, IN205516]; National Institutes of Health [R01 HD069631]; Consejo Nacional de Ciencia y Tecnologia postdoctoral fellowship [EPE-2017 291231]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069631] Funding Source: NIH RePORTER	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONACyT-Mexico Fronteras de la Ciencia 71; DGAPA/UNAM(Universidad Nacional Autonoma de Mexico); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia postdoctoral fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by Agencia Nacional de Promocion Cientifica y Tecnologica Grants PICT 2015-2294 (to M.G.B.) and PICT 2015-3164 (to D.K.), CONACyT-Mexico Fronteras de la Ciencia 71 (to A.D. and C.T.), DGAPA/UNAM Grants IN203116 (to C.T.) and IN205516 (to A.D.), and National Institutes of Health Grants R01 HD069631 (to C.M.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Consejo Nacional de Ciencia y Tecnologia postdoctoral fellowship EPE-2017 291231.	AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Baron S, 2005, J AM SOC NEPHROL, V16, P3490, DOI 10.1681/ASN.2005010075; Berdiev BK, 2009, MOL BIOSYST, V5, P123, DOI 10.1039/b810471a; Brenker C, 2014, ELIFE, V3, DOI 10.7554/eLife.01438; Briel M, 1998, J PHYSIOL-LONDON, V508, P825, DOI 10.1111/j.1469-7793.1998.825bp.x; Brown SG, 2016, HUM REPROD, V31, P1147, DOI 10.1093/humrep/dew056; Buffone MG, 2014, BBA-MOL BASIS DIS, V1842, P2610, DOI 10.1016/j.bbadis.2014.07.013; Buffone MG, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.117911; Calzada L, 1997, ARCH ANDROLOGY, V38, P151, DOI 10.3109/01485019708987892; Chavez JC, 2014, J BIOL CHEM, V289, P32266, DOI 10.1074/jbc.M114.607556; Ch'en FT, 2008, BRIT J PHARMACOL, V153, P972, DOI 10.1038/sj.bjp.0707667; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chavez JC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094037; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; Diao RY, 2013, REPRODUCTION, V146, P637, DOI 10.1530/REP-13-0146; Escoffier J, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127266; Escoffier J, 2012, J CELL SCI, V125, P473, DOI 10.1242/jcs.093344; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Geng YY, 2017, J BIOL CHEM, V292, P8978, DOI 10.1074/jbc.M117.776013; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Gunaratne HJ, 2006, GENE, V375, P37, DOI 10.1016/j.gene.2006.02.005; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hernandez-Gonzalez EO, 2007, J BIOL CHEM, V282, P24397, DOI 10.1074/jbc.M701603200; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; HINTON BT, 1981, J REPROD FERTIL, V61, P59, DOI 10.1530/jrf.0.0610059; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V246, P535, DOI 10.1006/bbrc.1998.8658; Jensen LJ, 1999, BIOL REPROD, V60, P573, DOI 10.1095/biolreprod60.3.573; Jose O, 2015, BIOCHEM BIOPH RES CO, V468, P713, DOI 10.1016/j.bbrc.2015.11.021; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kong XB, 2009, INT J ANDROL, V32, P330, DOI 10.1111/j.1365-2605.2008.00864.x; Kunzelmann K, 2003, PFLUG ARCH EUR J PHY, V445, P504, DOI 10.1007/s00424-002-0958-y; Li CY, 2010, HUM REPROD, V25, P317, DOI 10.1093/humrep/dep406; Li P, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0114-17.2017; Linares-Hernandez L, 1998, BBA-BIOMEMBRANES, V1372, P1, DOI 10.1016/S0005-2736(98)00035-2; Lopez-Gonzalez I, 2014, MOL HUM REPROD, V20, P619, DOI 10.1093/molehr/gau029; Luconi M, 2005, BIOL REPROD, V72, P22, DOI 10.1095/biolreprod.104.032490; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Mannowetz N, 2011, INT J ANDROL, V34, P153, DOI 10.1111/j.1365-2605.2010.01067.x; Mannowetz N, 2013, ELIFE, V2, DOI 10.7554/eLife.01009; Mansell SA, 2014, MOL HUM REPROD, V20, P392, DOI 10.1093/molehr/gau003; McPartlin LA, 2009, BIOL REPROD, V81, P199, DOI 10.1095/biolreprod.108.074880; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; OKAMURA N, 1985, J BIOL CHEM, V260, P9699; Owen DH, 2005, J ANDROL, V26, P459, DOI 10.2164/jandrol.04104; Patrat C, 2002, BIOL REPROD, V66, P1775, DOI 10.1095/biolreprod66.6.1775; Molina LCP, 2017, J CELL PHYSIOL, V232, P1404, DOI 10.1002/jcp.25634; Rode B, 2012, HUM MOL GENET, V21, P1287, DOI 10.1093/hmg/ddr558; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Sanchez G, 2006, MOL HUM REPROD, V12, P565, DOI 10.1093/molehr/gal062; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Sassani P, 2002, AM J PHYSIOL-CELL PH, V282, pC408, DOI 10.1152/ajpcell.00409.2001; Soleimani M, 2001, J MEMBRANE BIOL, V183, P71, DOI 10.1007/s00232-001-0055-8; Sorum B, 2015, CELL, V163, P724, DOI 10.1016/j.cell.2015.09.052; Stival C, 2016, ADV ANAT EMBRYOL CEL, V220, P93, DOI 10.1007/978-3-319-30567-7_5; Stival C, 2015, J BIOL CHEM, V290, P18855, DOI 10.1074/jbc.M115.640326; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Torres-Flores V, 2008, J ANDROL, V29, P63, DOI 10.2164/jandrol.107.003368; VISHWAKARMA P, 1962, FERTIL STERIL, V13, P481; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; Wandernoth PM, 2015, J BIOL CHEM, V290, P29202, DOI 10.1074/jbc.M115.698597; Wandernoth PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015061; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wertheimer EV, 2008, J BIOL CHEM, V283, P35539, DOI 10.1074/jbc.M804586200; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044; ZENG Y, 1995, DEV BIOL, V171, P554, DOI 10.1006/dbio.1995.1304	68	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9924	9936		10.1074/jbc.RA118.003166	http://dx.doi.org/10.1074/jbc.RA118.003166			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29743243	Green Published, hybrid			2022-12-26	WOS:000436102300034
J	Hilton, JK; Salehpour, T; Sisco, NJ; Rath, P; Van Horn, WD				Hilton, Jacob K.; Salehpour, Taraneh; Sisco, Nicholas J.; Rath, Parthasarathi; Van Horn, Wade D.			Phosphoinositide-interacting regulator of TRP (PIRT) has opposing effects on human and mouse TRPM8 ion channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transient receptor potential channels (TRP channels); phosphoinositide; membrane protein; nuclear magnetic resonance (NMR); ion channel; electrophysiology; channel modulation; phosphoinositide regulator of TRP	ANKYRIN REPEAT DOMAIN; ELECTRON CRYOMICROSCOPY; HAIR-CELLS; COLD; RECEPTOR; ACTIVATION; MECHANISM; MENTHOL; SUBUNIT; BINDING	Transient receptor potential melastatin 8 (TRPM8) is a cold-sensitive ion channel with diverse physiological roles. TRPM8 activity is modulated by many mechanisms, including an interaction with the small membrane protein phosphoinositide-interacting regulator of TRP (PIRT). Here, using comparative electrophysiology experiments, we identified species-dependent differences between the human and mouse TRPM8-PIRT complexes. We found that human PIRT attenuated human TPRM8 conductance, unlike mouse PIRT, which enhanced mouse TRPM8 conductance. Quantitative Western blot analysis demonstrates that this effect does not arise from decreased trafficking of TRPM8 to the plasma membrane. Chimeric human/mouse TRPM8 channels were generated to probe the molecular basis of the PIRT modulation, and the effect was recapitulated in a pore domain chimera, demonstrating the importance of this region for PIRT-mediated regulation of TRPM8. Moreover, recombinantly expressed and purified human TRPM8 S1-S4 domain (comprising transmembrane helices S1-S4, also known as the sensing domain, ligand-sensing domain, or voltage sensing-like domain) and full-length human PIRT were used to investigate binding between the proteins. NMR experiments, supported by a pulldown assay, indicated that PIRT binds directly and specifically to the TRPM8 S1-S4 domain. Binding became saturated as the S1-S4:PIRT mole ratio approached 1. Our results have uncovered species-specific TRPM8 modulation by PIRT. They provide evidence for a direct interaction between PIRT and the TRPM8 S1-S4 domain with a 1:1 binding stoichiometry, suggesting that a functional tetrameric TRPM8 channel has four PIRT-binding sites.	[Hilton, Jacob K.; Salehpour, Taraneh; Sisco, Nicholas J.; Rath, Parthasarathi; Van Horn, Wade D.] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA; [Hilton, Jacob K.; Salehpour, Taraneh; Sisco, Nicholas J.; Rath, Parthasarathi; Van Horn, Wade D.] Arizona State Univ, Virginia G Piper Ctr Personalized Diagnost, Tempe, AZ 85281 USA; [Hilton, Jacob K.; Salehpour, Taraneh; Sisco, Nicholas J.; Rath, Parthasarathi; Van Horn, Wade D.] Arizona State Univ, Magnet Resonance Res Ctr, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Van Horn, WD (corresponding author), Virginia G Piper Ctr Personalized Diagnost, Sch Mol Sci, Biodesign Inst, Magnet Resonance Res Ctr, POB 871604, Tempe, AZ 85281 USA.	wade.van.horn@asu.edu	Van Horn, Wade/GSN-2667-2022; Sisco, Nicholas J/ABE-3039-2021	Van Horn, Wade/0000-0002-2493-5578; Sisco, Nicholas J/0000-0003-2091-868X	Bisgrove Early Career Award from the Science Foundation Arizona [R01GM112077]; National Institutes of Health [R01GM112077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112077] Funding Source: NIH RePORTER	Bisgrove Early Career Award from the Science Foundation Arizona; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Bisgrove Early Career Award from the Science Foundation Arizona and National Institutes of Health Grant R01GM112077 (to W.V.H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott GW, 2002, FASEB J, V16, DOI 10.1096/fj.01-0520hyp; Almeida MC, 2012, J NEUROSCI, V32, P2086, DOI 10.1523/JNEUROSCI.5606-11.2012; Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Bai JP, 2011, AM J PHYSIOL-CELL PH, V300, pC435, DOI 10.1152/ajpcell.00449.2010; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Chen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3501; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding Z, 2008, EUR J PHARMACOL, V578, P201, DOI 10.1016/j.ejphar.2007.09.030; Duan JJ, 2018, P NATL ACAD SCI USA, V115, P2377, DOI 10.1073/pnas.1722038115; Gao XF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8650; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Gavva NR, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-36; Gkika D, 2015, J CELL BIOL, V208, P89, DOI 10.1083/jcb.201402076; Gracheva EO, 2015, CURR OPIN NEUROBIOL, V34, P67, DOI 10.1016/j.conb.2015.01.021; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Guo W, 2016, PURINERG SIGNAL, V12, P489, DOI 10.1007/s11302-016-9515-6; Hilton JK, 2015, BIOCHEMISTRY-US, V54, P2401, DOI 10.1021/acs.biochem.5b00071; Janssens A, 2011, J PHYSIOL-LONDON, V589, P4827, DOI 10.1113/jphysiol.2011.216523; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Khoury MK, 2010, ANAL BIOCHEM, V397, P129, DOI 10.1016/j.ab.2009.09.041; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Knowlton WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025894; Kroncke BM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501228; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Ma ST, 2012, J MOL CELL BIOL, V4, P88, DOI 10.1093/jmcb/mjs001; Manderfield LJ, 2008, FEBS J, V275, P1336, DOI 10.1111/j.1742-4658.2008.06294.x; Martinez-Espinosa PL, 2014, J GEN PHYSIOL, V144, P275, DOI 10.1085/jgp.201411253; Matos-Cruz V, 2017, CELL REP, V21, P3329, DOI 10.1016/j.celrep.2017.11.083; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Miyazaki K, 2011, METHOD ENZYMOL, V498, P399, DOI 10.1016/B978-0-12-385120-8.00017-6; Moparthi L, 2014, P NATL ACAD SCI USA, V111, P16901, DOI 10.1073/pnas.1412689111; Myers BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005741; Patel KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020559; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Peng DG, 2014, BIOCHEMISTRY-US, V53, P2032, DOI 10.1021/bi500102w; Quallo T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8150; Ramanathan K, 1999, SCIENCE, V283, P215, DOI 10.1126/science.283.5399.215; Rath P, 2016, BIOCHEMISTRY-US, V55, P114, DOI 10.1021/acs.biochem.5b00931; Rohacs T, 2014, HANDB EXP PHARMACOL, V223, P1143, DOI 10.1007/978-3-319-05161-1_18; Saito S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002041; Sun J, 2014, HYPERTENSION, V63, P1354, DOI 10.1161/HYPERTENSIONAHA.113.02573; Sun XH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00063; Survery S, 2016, J BIOL CHEM, V291, P26899, DOI 10.1074/jbc.M116.743443; Tang M, 2016, ACTA PHARMACOL SIN, V37, P98, DOI 10.1038/aps.2015.110; Tang ZX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3179; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Velisetty P, 2016, SCI REP-UK, V6, DOI 10.1038/srep27652; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang CM, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0054-x; Weng HJ, 2015, NEURON, V85, P833, DOI 10.1016/j.neuron.2014.12.065; Winkler PA, 2017, NATURE, V552, P200, DOI 10.1038/nature24674; Yang F, 2015, NAT CHEM BIOL, V11, P518, DOI [10.1038/NCHEMBIO.1835, 10.1038/nchembio.1835]; Yin Y, 2018, SCIENCE, V359, P237, DOI 10.1126/science.aan4325; Zhou JH, 2015, BIOPHYS J, V108, P2658, DOI 10.1016/j.bpj.2015.04.024	58	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9423	9434		10.1074/jbc.RA118.003563	http://dx.doi.org/10.1074/jbc.RA118.003563			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29724821	hybrid, Green Published			2022-12-26	WOS:000435441400026
J	Chen, J; Liu, LT; Wang, ZB; Sun, HC; Zhang, YJ; Lu, ZY; Li, CD				Chen, Jing; Liu, Liantao; Wang, Zhanbiao; Sun, Hongchun; Zhang, Yongjiang; Lu, Zhanyuan; Li, Cundong			Determining the effects of nitrogen rate on cotton root growth and distribution with soil cores and minirhizotrons	PLOS ONE			English	Article							LENGTH DENSITY; FINE ROOTS; FIELD; AVAILABILITY; IRRIGATION; MANAGEMENT; BIOMASS; SYSTEM; CARBON; WATER	Cotton root growth can be affected by different nitrogen fertilizer rates. The objective of the present study was to quantify the effects of nitrogen fertilization rate on cotton root growth and distribution using minirhizotron and soil coring methods. A secondary objective was to evaluate the minirhizotron method as a tool for determining nitrogen application rates using the root distribution as an index. This study was conducted on a Bt cotton cultivar (Jimian 958) under four nitrogen fertilization rates, i.e., 0, 120, 240 and 480 kg ha(-1) (control, low, moderate and high levels, respectively), in the Yellow River basin of China from 2013-2015. The sampling process, details of each method as well as the root morphology and root distribution were measured. The operational processes, time and labor needed for the soil core method were all greater than those for the minirhizotron method. The total root length density and the length density in most soil layers, especially in the upper soil layers, first increased but then decreased as nitrogen fertilization increased, and the same trend was observed for both methods. Compared with N0, the total root length density under moderate nitrogen fertilization by the soil coring method increased by more than 94.82%, in 2014 and 61.11% in 2015; while by the minirhizotron method the corresponding values were 28.24% in 2014 and 57.47%, in 2015. Most roots were distributed in the shallow soil layers (0-60 cm) in each method. However, the root distribution with the soil coring method (>73.11%) was greater than that with the minirhizotron method (>47.07%). The correlations between the root morphology indexes of shallow soil depth measured using the two methods were generally significant, with correlative coefficients greater than 0.334. We concluded that the minirhizotron method could be used for cotton root analysis and most cotton roots distributed in upper soil layers (0-60 cm). In addition, a moderate nitrogen rate (240 kg ha(-1)) could increase root growth, especially in the shallow soil layers. The differences observed with the minirhizotron method were clearer than those observed with the soil coring method.	[Chen, Jing; Liu, Liantao; Wang, Zhanbiao; Sun, Hongchun; Zhang, Yongjiang; Lu, Zhanyuan; Li, Cundong] Agr Univ Hebei, State Key Lab Cotton Biol Hebei Base, Lab Crop Growth Regulat, Dept Agron, Baoding, Hebei, Peoples R China; [Chen, Jing; Wang, Zhanbiao] Chinese Acad Agr Sci, Inst Cotton Res, Anyang, Henan, Peoples R China; [Lu, Zhanyuan] Inner Mongolia Acad Agr & Anim Husb Sci, Hohhot, Inner Mongolia, Peoples R China	Hebei Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Li, CD (corresponding author), Agr Univ Hebei, State Key Lab Cotton Biol Hebei Base, Lab Crop Growth Regulat, Dept Agron, Baoding, Hebei, Peoples R China.	auhlcd@163.com	Liu/AAR-5480-2020; Zhang, Yongjiang/R-6250-2019; Wang, Zhanbiao/AAO-7457-2020	Zhang, Yongjiang/0000-0001-5846-6004; chen, jing/0000-0003-0644-5871	National Natural Science Foundation of China [31301270]; Natural Science Foundation of Hebei [C2016204088]; Fund of Team Building of Crop Science Hebei Agricultural University [TD2016C318]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei(Natural Science Foundation of Hebei Province); Fund of Team Building of Crop Science Hebei Agricultural University	This study was supported by National Natural Science Foundation of China (31301270, LLT), Natural Science Foundation of Hebei (C2016204088, LLT) and The Fund of Team Building of Crop Science Hebei Agricultural University (TD2016C318).	Amato M, 2012, COMPUT ELECTRON AGR, V80, P50, DOI 10.1016/j.compag.2011.10.014; Bates G. H, 1937, NATURE, V139, P966; BLAND WL, 1988, AGRON J, V80, P271, DOI 10.2134/agronj1988.00021962008000020024x; BOHM W, 1977, AGRON J, V69, P415; BRAGG PL, 1983, PLANT SOIL, V73, P435, DOI 10.1007/BF02184322; Chen ZK, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00173; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Gregory P.J., 2006, PLANT ROOTS GROWTH A; GREGORY PJ, 1979, J EXP BOT, V30, P205, DOI 10.1093/jxb/30.1.205; Gregory PJ, 2007, PLANT ROOTS GROWTH A, P45; Guo DL, 2008, NEW PHYTOL, V177, P443, DOI 10.1111/j.1469-8137.2007.02242.x; HIRASAWA T, 1995, JPN J CROP SCI, V64, P78, DOI 10.1626/jcs.64.78; Jose S, 2001, AGROFOREST SYST, V52, P161, DOI 10.1023/A:1010667921970; Katayama K, 2000, JARQ-JPN AGR RES Q, V34, P81; Kiba T, 2011, J EXP BOT, V62, P1399, DOI 10.1093/jxb/erq410; Luo HH, 2015, J PLANT NUTR SOIL SC, V178, P384, DOI 10.1002/jpln.201400264; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Machado RMA, 2003, PLANT SOIL, V255, P375, DOI 10.1023/A:1026198919074; Majdi H, 1996, PLANT SOIL, V185, P255, DOI 10.1007/BF02257530; MERRILL SD, 1994, SOIL SCI SOC AM J, V58, P1061, DOI 10.2136/sssaj1994.03615995005800040009x; Min W, 2014, FIELD CROP RES, V169, P1, DOI 10.1016/j.fcr.2014.09.002; Nielsen KL, 2001, J EXP BOT, V52, P329, DOI 10.1093/jexbot/52.355.329; Pierret A, 2005, NEW PHYTOL, V166, P967, DOI 10.1111/j.1469-8137.2005.01389.x; Pregitzer KS, 2000, ECOL APPL, V10, P18, DOI 10.1890/1051-0761(2000)010[0018:IEOACA]2.0.CO;2; Pu XZ, 2016, CROP PASTURE SCI, V67, P1297, DOI 10.1071/CP16230; RADIN JW, 1990, PLANT PHYSIOL, V92, P855, DOI 10.1104/pp.92.3.855; Sainju UM, 2005, AGRON J, V97, P1279, DOI 10.2134/agronj2004.0213; SANDERS JL, 1978, AGRON J, V70, P1073, DOI 10.2134/agronj1978.00021962007000060043x; Sanguineti MC, 2007, ANN APPL BIOL, V151, P291, DOI 10.1111/j.1744-7348.2007.00198.x; Senapati N, 2014, SOIL TILL RES, V143, P38, DOI 10.1016/j.still.2014.05.009; [陶垿 Tao Xu], 2015, [棉花学报, Cotton Science], V27, P329; Tian QY, 2009, NEW PHYTOL, V184, P918, DOI 10.1111/j.1469-8137.2009.03004.x; Tierney GL, 2002, CAN J FOREST RES, V32, P1692, DOI [10.1139/x02-123, 10.1139/X02-123]; Vogt K., 1991, TECHNIQUES APPROACHE, P477; VOS J, 1983, PLANT SOIL, V74, P295, DOI 10.1007/BF02143621; Withington JM, 2003, NEW PHYTOL, V160, P533, DOI 10.1046/j.1469-8137.2003.00903.x; Wright AN, 2004, HORTTECHNOLOGY, V14, P560, DOI 10.21273/HORTTECH.14.4.0560; Yavuz MY, 2012, INT J AGRIC BIOL, V14, P11; Zeng G, 2008, NEW PHYTOL, V177, P549, DOI 10.1111/j.1469-8137.2007.02271.x; Zhang HZ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00912; Zhou GuiSheng, 2011, Agricultural Science & Technology - Hunan, V12, P1667	41	11	14	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0197284	10.1371/journal.pone.0197284	http://dx.doi.org/10.1371/journal.pone.0197284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750816	Green Submitted, Green Published, gold			2022-12-26	WOS:000431856300028
J	Offor, O; Utay, N; Reynoso, D; Somasunderam, A; Currier, J; Lake, J				Offor, Obiageli; Utay, Netanya; Reynoso, David; Somasunderam, Anoma; Currier, Judith; Lake, Jordan			Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy	PLOS ONE			English	Article							FATTY LIVER-DISEASE; HEPATIC-FIBROSIS; NONALCOHOLIC STEATOHEPATITIS; PROTEASE INHIBITOR; METABOLIC SYNDROME; RANDOMIZED-TRIAL; HYALURONIC-ACID; GROWTH-FACTOR; HIV; YKL-40	Background People with HIV are at for metabolic syndrome (MetS) and fatty liver disease, but the role of Antiretroviral therapy (ART) is poorly understood. MetS and fatty liver disease been associated with changes in adiponectin, soluble ST2 (sST2), chitinase 3-like 1 (Chi3L1), hyaluronic acid (HA), tissue inhibitor of metalloproteinase-1 (TIMP-1), lysyl oxidase-like-2 (LOXL2) and transforming growth factor beta (TGF-beta) concentrations in HIV-uninfected populations. Protease (PI) and non-nucleoside reverse transcriptase inhibitors (NNRTI) may contribute to these comorbidities, but the effects of switching from PI- or NNRTI to raltegravir (RAL) on these biomarkers is unknown. Methods Cryopreserved plasma was obtained from a completed, prospective trial of HIV-infected women with central adiposity on NNRTI- or PI-based ART during which they were randomized to remain on their current ART or switch to a RAL based regimen. Biomarker concentrations were quantified using ELISA and Multiplex assays at baseline and 24 weeks after randomization. Wilcoxon-signed rank test evaluated within-group changes, Spearman and linear regression models evaluated correlations between biomarkers and clinical covariates. Results Participants had a median age of 43 years, CD4(+) T lymphocyte count 558 cells/mm(3) and BMI 32 kg/m(2) ; 35% met criteria for MetS. At baseline, higher adiponectin levels correlated with higher Chi3L1 levels (r = 0.42, p = 0.02), as did declines after 24 weeks (r = 0.40, p = 0.03). Changes in sST2 correlated with changes in Chi3L1 (r = 0.43, p = 0.02) and adiponectin (r = 0.40, p = 0.03). Adiponectin and Chi3L1 levels decreased significantly in women switched to RAL vs continue PI/NNRTI. Conclusion In women with HIV and central obesity, the hepatic steatosis/fibrosis marker Chi3L1 and adiponectin decrease in conjunction with sST2 decreases following switch to RAL. Whether switching from NNRTI/PI-based regimens to RAL can improve hepatic steatosis and dysmetabolism requires further study.	[Offor, Obiageli] Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol, Houston, TX 77030 USA; [Utay, Netanya; Somasunderam, Anoma] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Reynoso, David] Univ Texas Med Branch Galveston, Dept Infect Dis, Galveston, TX USA; [Currier, Judith] Univ Calif Los Angeles, Dept Infect Dis, Los Angeles, CA 90024 USA; [Lake, Jordan] Univ Texas Hlth Sci Ctr Houston, Dept Infect Dis, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California Los Angeles; University of Texas System; University of Texas Health Science Center Houston	Offor, O (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol, Houston, TX 77030 USA.	Obiageli.l.offor@uth.tmc.edu	Reynoso, David/AAM-4476-2021	Reynoso, David/0000-0002-2639-4197	Merck and Co. Investigator-Initiated Studies Program; National Institutes of Health [M01-RR000865, K24 AI56933, P30-AG028748, T32 MH080634]	Merck and Co. Investigator-Initiated Studies Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Merck and Co. Investigator-Initiated Studies Program (to J.S. Currier). Additional funding was provided by the National Institutes of Health [M01-RR000865, K24 AI56933 to J.S. Currier, P30-AG028748, and T32 MH080634].	Abdelaziz R, 2015, DIGESTION, V92, P130, DOI 10.1159/000439083; Achari AE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061321; Argentou M, 2009, OBES SURG, V19, P1313, DOI 10.1007/s11695-009-9912-9; Argentou N, 2016, INFLAMM RES, V65, P355, DOI 10.1007/s00011-016-0921-6; Berg G, 2011, CLIN CHIM ACTA, V412, P1731, DOI 10.1016/j.cca.2011.06.013; Boyd MA, 2017, LANCET HIV, V4, pE13, DOI 10.1016/S2352-3018(16)30189-8; Brown TT, 2012, NAT REV ENDOCRINOL, V8, P11, DOI 10.1038/nrendo.2011.151; Cassol E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-203; Coffman F, 2008, CRIT REV CL LAB SCI, V45, P531, DOI [10.1080/10408360802334743, 10.1080/10408360802334743 ]; Domingo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089088; Domingos H, 2009, BRAZ J INFECT DIS, V13, P130, DOI 10.1590/S1413-86702009000200012; Esteghamati A, 2014, J ENDOCRINOL INVEST, V37, P1211, DOI 10.1007/s40618-014-0154-x; Falutz J, 2007, NEW ENGL J MED, V357, P2359, DOI 10.1056/NEJMoa072375; Flisiak R, 2002, HEPATO-GASTROENTEROL, V49, P1369; Haubrich RH, 2009, AIDS, V23, P1109, DOI 10.1097/QAD.0b013e32832b4377; Ikenaga N, 2017, GUT, V66, P1697, DOI 10.1136/gutjnl-2016-312473; Ikmal SIQS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/698567; Ingiliz P, 2009, HEPATOLOGY, V49, P436, DOI 10.1002/hep.22665; Ketlogetswe KS, 2014, AIDS, V28, P901, DOI 10.1097/QAD.0000000000000186; Lake JE, 2012, AIDS PATIENT CARE ST, V26, P532, DOI 10.1089/apc.2012.0135; Lesi OA, 2009, J NATL MED ASSOC, V101, P151, DOI 10.1016/S0027-9684(15)30828-2; Luo L, 2009, AIDS RES HUM RETROV, V25, P1265, DOI 10.1089/aid.2009.0072; Macias J, 2012, HEPATOLOGY, V56, P1261, DOI 10.1002/hep.25791; Martinez-Martinez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079176; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Morse CG, 2015, CLIN INFECT DIS, V60, P1569, DOI 10.1093/cid/civ101; Nobili V, 2010, TRANSL RES, V156, P229, DOI 10.1016/j.trsl.2010.05.008; Ofotokun I, 2015, CLIN INFECT DIS, V60, P1842, DOI 10.1093/cid/civ193; Omar F, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-46; Pascual-Figal DA, 2015, AM J CARDIOL, V115, p3B, DOI 10.1016/j.amjcard.2015.01.034; Perez-Matute P, 2011, CURR HIV RES, V9, P174, DOI 10.2174/157016211795945278; Persson F, 2012, DIABETES RES CLIN PR, V96, P84, DOI 10.1016/j.diabres.2011.12.008; Rathcke CN, 2006, INFLAMM RES, V55, P53, DOI 10.1007/s00011-005-0010-8; Rivero-Juarez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068953; Rostami S, 2013, HEPAT MON, V13, DOI [10.5812/hepatmon.9611, 10.5812/hepatmon.13787]; Schiavon LL, 2010, SCAND J GASTROENTERO, V45, P615, DOI 10.3109/00365521003637203; Shimada M, 2007, AM J GASTROENTEROL, V102, P1931, DOI 10.1111/j.1572-0241.2007.01322.x; Sonderup MW, 2015, HEPATOLOGY, V61, P1721, DOI 10.1002/hep.27710; Stojanovic S, 2015, VOJNOSANIT PREGL, V72, P779, DOI 10.2298/VSP140531067S; Suzuki A, 2005, LIVER INT, V25, P779, DOI 10.1111/j.1478-3231.2005.01064.x; Tajtakova Maria, 2006, Endocr Regul, V40, P15; Tan Z, 2017, CELL MOL IMMUNOL; Tao H, 2014, INFLAMM RES, V63, P249, DOI 10.1007/s00011-013-0698-9; Thomsen SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133672; van Wijk JPH, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/201027; Williams EJ, 2000, J HEPATOL, V32, P754, DOI 10.1016/S0168-8278(00)80244-5; Young L, 2015, HIV CLIN TRIALS, V16, P163, DOI 10.1179/1945577115Y.0000000002; Younossi ZM, 2011, OBES SURG, V21, P431, DOI 10.1007/s11695-010-0204-1	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196395	10.1371/journal.pone.0196395	http://dx.doi.org/10.1371/journal.pone.0196395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746485	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700017
J	Schroeder, RT; Croft, JL; Ngo, GD; Bertram, JEA				Schroeder, Ryan T.; Croft, James L.; Ngo, Giang D.; Bertram, John E. A.			Properties of traditional bamboo carrying poles have implications for user interactions	PLOS ONE			English	Article							HUMAN WALKING; STEP FREQUENCY; CONSTRAINED OPTIMIZATION; SPEED; COST; PLANTS; LOADS	Compliant bamboo poles have long been used for load carriage in Asian cultures. Although this custom differs from Western conventions of rigid body attachments (e.g. backpack), potential benefits include reduced peak shoulder forces as well as metabolic transport cost savings. Evidence that carrying a flexible pole benefits locomotion remains mixed, perhaps in part because the properties of pole design (e.g. bamboo material, structural geometry, etc.) have largely been neglected. These properties influence vibrational forces and consequently, the energy required by the user to manage the oscillations. We collected authentic bamboo poles from northern Vietnam and characterized their design parameters. Four poles were extensively studied in the lab (load-deflection testing, resonance testing, and computed tomography scans of three-dimensional geometry), and 10 others were tested at a rural Vietnamese farm site (basic measures of form and resonance). A mass-spring-damper model was used to characterize a relationship between resonant frequency (which affects the energetics of the pole-carrier system) and pole properties concerning stiffness, damping, etc. Model predictions of resonant frequencies agreed well with empirical data. Although measured properties suggest the poles are not optimally designed to reduce peak oscillation forces, resonant frequencies are within range of a typical human walking cadence, and this is likely to have a consequence on locomotion energetics.	[Schroeder, Ryan T.; Bertram, John E. A.] Univ Calgary, Biomed Engn Grad Program, Calgary, AB, Canada; [Croft, James L.; Bertram, John E. A.] Edith Cowan Univ, Ctr Exercise & Sports Res, Sch Med & Hlth Sci, Perth, WA, Australia; [Ngo, Giang D.] Thai Nguyen Univ, Agr & Forestry, Thai Nguyen, Vietnam; [Bertram, John E. A.] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada	University of Calgary; Edith Cowan University; Thai Nguyen University; University of Calgary	Schroeder, RT (corresponding author), Univ Calgary, Biomed Engn Grad Program, Calgary, AB, Canada.	ryan.schroeder@ucalgary.ca	Schroeder, Ryan T./ABC-2090-2020; Bertram, John/W-8982-2019	Schroeder, Ryan T./0000-0002-0613-3440; 	Edith Cowan University Collaboration Enhancement Scheme; Natural Sciences and Engineering Research Council (NSERC) of Canada [312117-2012, 04823-2017]; University of Calgary Biomedical Engineering Graduate Program Exchange Travel Award; University of Calgary Eyes High Doctoral Recruitment Scholarship (EHDRS)	Edith Cowan University Collaboration Enhancement Scheme; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Calgary Biomedical Engineering Graduate Program Exchange Travel Award; University of Calgary Eyes High Doctoral Recruitment Scholarship (EHDRS)	This work was supported by Edith Cowan University Collaboration Enhancement Scheme (received by author JLC), a Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant (312117-2012 and 04823-2017) (received by author JEAB), a University of Calgary Biomedical Engineering Graduate Program Exchange Travel Award (received by author RTS), and University of Calgary Eyes High Doctoral Recruitment Scholarship (EHDRS) (received by author RTS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman J, 2011, IEEE INT C INT ROBOT, P203, DOI 10.1109/IROS.2011.6048723; Amada S, 1997, J MATER SCI, V32, P2693, DOI 10.1023/A:1018683308211; [Anonymous], 2010, GROWTH QUALITY INDIG; BANKS HT, 1991, J APPL MECH-T ASME, V58, P716, DOI 10.1115/1.2897253; Bastien GJ, 2005, EUR J APPL PHYSIOL, V94, P76, DOI 10.1007/s00421-004-1286-z; Bertram JEA, 2005, J EXP BIOL, V208, P979, DOI 10.1242/jeb.01498; Bertram JEA, 2001, J THEOR BIOL, V209, P445, DOI 10.1006/jtbi.2001.2279; Bourke P., 1988, CALCULATING AREA CEN; Castillo ER, 2014, J APPL PHYSIOL, V117, P507, DOI 10.1152/japplphysiol.00119.2014; CAVAGNA GA, 1986, J PHYSIOL-LONDON, V373, P235, DOI 10.1113/jphysiol.1986.sp016044; Cavagna GA, 2015, J EXP BIOL, V218, P3276, DOI 10.1242/jeb.127142; Charteris J, 1998, ERGONOMICS, V41, P1792, DOI 10.1080/001401398185974; DALLARD P., 2001, J BRIDGE ENG, V6, P412, DOI [10.1061/(ASCE)1084-0702(2001)6:6(412), DOI 10.1061/(ASCE)1084-0702(2001)6:6(412)]; de Langre E, 2008, ANNU REV FLUID MECH, V40, P141, DOI 10.1146/annurev.fluid.40.111406.102135; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Joshi V, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2014.0662; KRAM R, 1991, J APPL PHYSIOL, V71, P1119, DOI 10.1152/jappl.1991.71.3.1119; LAKKAD SC, 1981, FIBRE SCI TECHNOL, V14, P319, DOI 10.1016/0015-0568(81)90023-3; Miller LA, 2005, J THEOR BIOL, V234, P511, DOI 10.1016/j.jtbi.2004.12.004; Potwar K, 2015, J MECH DESIGN, V137, DOI 10.1115/1.4028757; Rome LC, 2005, SCIENCE, V309, P1725, DOI 10.1126/science.1111063; Woolam WE., 1967, INT J MECH SCI, V9, P743, DOI [10.1016/0020-7403(67)90032-X, DOI 10.1016/0020-7403(67)90032-X]	23	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196208	10.1371/journal.pone.0196208	http://dx.doi.org/10.1371/journal.pone.0196208			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746480	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700010
J	Szentirmai, E; Kapas, L				Szentirmai, Eva; Kapas, Levente			Brown adipose tissue plays a central role in systemic inflammation-induced sleep responses	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; UNCOUPLING PROTEIN-1; SICKNESS BEHAVIOR; TNF-ALPHA; INTERLEUKIN 1-BETA; BODY-TEMPERATURE; MICE LACKING; THERMOGENESIS; FAT	We previously identified brown adipose tissue (BAT) as a source of sleep-inducing signals. Pharmacological activation of BAT enhances sleep while sleep loss leads to increased BAT thermogenesis. Recovery sleep after sleep loss is diminished in mice that lack uncoupling protein 1 (UCP-1), and also in wild-type (WT) mice after sensory denervation of the BAT. Systemic inflammation greatly affects metabolism and the function of adipose tissue, and also induces characteristic sleep responses. We hypothesized that sleep responses to acute inflammation are mediated by BAT-derived signals. To test this, we determined the effects of systemic inflammation on sleep and body temperature in UCP-1 knockout (KO) and WT mice. Intraperitoneal injections of lipopolysaccharide, tumor necrosis factor-a, interleukin-1 beta and clodronate containing liposomes were used to induce systemic inflammation. In WT animals, non-rapid-eye movement sleep (NREMS) was elevated in all four inflammatory models. All NREMS responses were completely abolished in UCP-1 KO animals. Systemic inflammation elicited an initial hypothermia followed by fever in WT mice. The hypothermic phase, but not the fever, was abolished in UCP-1 KO mice. The only recognized function of UCP-1 is to promote thermogenesis in brown adipocytes. Present results indicate that the presence of UCP-1 is necessary for increased NREMS but does not contribute to the development of fever in systemic inflammation.	[Szentirmai, Eva; Kapas, Levente] Washington State Univ, Elson S Floyd Coll Med, Dept Biomed Sci, Spokane, WA 99202 USA; [Szentirmai, Eva; Kapas, Levente] Washington State Univ, Sleep & Performance Res Ctr, Spokane, WA 99202 USA	Washington State University; Washington State University	Szentirmai, E (corresponding author), Washington State Univ, Elson S Floyd Coll Med, Dept Biomed Sci, Spokane, WA 99202 USA.; Szentirmai, E (corresponding author), Washington State Univ, Sleep & Performance Res Ctr, Spokane, WA 99202 USA.	eszentirmai@wsu.edu		Kapas, Levente/0000-0002-0396-816X	National Institute of Health, National Heart, Lung, and Blood Institute [R01HL122390]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122390] Funding Source: NIH RePORTER	National Institute of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health, National Heart, Lung, and Blood Institute, grant number R01HL122390, to ES. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159812; Arruda AP, 2010, ENDOCRINOLOGY, V151, P683, DOI 10.1210/en.2009-0865; Betz MJ, 2015, DIABETES, V64, P2352, DOI 10.2337/db15-0146; BLATTEIS CM, 1976, J APPL PHYSIOL, V40, P35, DOI 10.1152/jappl.1976.40.1.35; Blouet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051898; Borges BD, 2014, AM J PHYSIOL-REG I, V306, pR34, DOI 10.1152/ajpregu.00147.2013; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Commins SP, 2001, AM J PHYSIOL-ENDOC M, V280, pE372; COOMBES RC, 1987, BIOSCIENCE REP, V7, P791, DOI 10.1007/BF01116752; Copinschi G, 2014, FRONT HORM RES, V42, P59, DOI 10.1159/000358858; Crichton PG, 2017, BIOCHIMIE, V134, P35, DOI 10.1016/j.biochi.2016.12.016; DASCOMBE MJ, 1989, AM J PHYSIOL, V256, pE7, DOI 10.1152/ajpendo.1989.256.1.E7; Davis CJ, 2011, J CLIN SLEEP MED, V7, pS16, DOI 10.5664/JCSM.1346; DERIJK RH, 1994, AM J PHYSIOL, V266, pR1, DOI 10.1152/ajpregu.1994.266.1.R1; Dogan MD, 2002, PHARMACOL BIOCHEM BE, V72, P143, DOI 10.1016/S0091-3057(01)00736-5; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fang JD, 1998, AM J PHYSIOL-REG I, V274, pR655, DOI 10.1152/ajpregu.1998.274.3.R655; Fang JD, 1997, J NEUROSCI, V17, P5949; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Grunfeld C, 1996, NUTRITION, V12, pS24; Hansen MK, 1997, AM J PHYSIOL-REG I, V273, pR1246, DOI 10.1152/ajpregu.1997.273.4.R1246; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Inokuma K, 2005, DIABETES, V54, P1385, DOI 10.2337/diabetes.54.5.1385; JEPSON MM, 1988, AM J PHYSIOL, V255, pE617, DOI 10.1152/ajpendo.1988.255.5.E617; Kapas L, 1998, AM J PHYSIOL-REG I, V274, pR406, DOI 10.1152/ajpregu.1998.274.2.R406; Kelley KW, 2003, BRAIN BEHAV IMMUN, V17, pS112; Kenney MJ, 2001, AM J PHYSIOL-HEART C, V281, pH2441, DOI 10.1152/ajpheart.2001.281.6.H2441; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; KOZAK W, 1994, AM J PHYSIOL, V266, pR125, DOI 10.1152/ajpregu.1994.266.1.R125; Krueger JM, 2003, BRAIN BEHAV IMMUN, V17, pS41; Kubota T, 2001, AM J PHYSIOL-REG I, V280, pR1213, DOI 10.1152/ajpregu.2001.280.4.R1213; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; LOPEZSORIANO J, 1995, MOL CELL BIOCHEM, V143, P113, DOI 10.1007/BF01816944; Madden Christopher J, 2017, Temperature (Austin), V4, P89, DOI 10.1080/23328940.2016.1257407; Masaki T, 1999, BBA-MOL CELL BIOL L, V1436, P585, DOI 10.1016/S0005-2760(98)00173-8; Matthias A, 1999, J BIOL CHEM, V274, P28150, DOI 10.1074/jbc.274.40.28150; Mills EM, 2003, NATURE, V426, P403, DOI 10.1038/426403a; Morrow JD, 2005, BRAIN BEHAV IMMUN, V19, P40, DOI 10.1016/j.bbi.2004.04.001; Mracek T, 2004, CYTOKINE, V26, P9, DOI 10.1016/j.cyto.2003.12.001; Nadjar A, 2013, GLIA, V61, P724, DOI 10.1002/glia.22465; Nisoli E, 1997, CELL DEATH DIFFER, V4, P771, DOI 10.1038/sj.cdd.4400292; Okamatsu-Ogura Y, 2007, AM J PHYSIOL-ENDOC M, V292, pE1135, DOI 10.1152/ajpendo.00425.2006; Okamatsu-Ogura Y, 2011, EXP BIOL MED, V236, P1274, DOI 10.1258/ebm.2011.011143; Okamatsu-Ogura Y, 2007, OBES RES CLIN PRACT, V1, P233, DOI 10.1016/j.orcp.2007.08.001; Ono K, 2011, J APPL PHYSIOL, V110, P789, DOI 10.1152/japplphysiol.00128.2010; Opp MR, 1998, LIFE SCI, V62, P923, DOI 10.1016/S0024-3205(98)00010-1; Osaka T, 1998, PFLUG ARCH EUR J PHY, V437, P36, DOI 10.1007/s004240050743; Porras A, 1997, FEBS LETT, V416, P324, DOI 10.1016/S0014-5793(97)01204-0; Riley CL, 2016, J PHYSIOL-LONDON, V594, P7455, DOI 10.1113/JP272971; Romanovsky AA, 1996, AM J PHYSIOL-REG I, V270, pR693, DOI 10.1152/ajpregu.1996.270.4.R693; ROTHWELL NJ, 1989, AM J PHYSIOL, V256, pE111, DOI 10.1152/ajpendo.1989.256.1.E111; ROTHWELL NJ, 1988, BIOSCIENCE REP, V8, P345, DOI 10.1007/BF01115225; SAKAGUCHI T, 1988, EXP NEUROL, V101, P464, DOI 10.1016/0014-4886(88)90057-X; Schmid SM, 2015, LANCET DIABETES ENDO, V3, P52, DOI 10.1016/S2213-8587(14)70012-9; SHOHAM S, 1987, AM J PHYSIOL, V253, pR142, DOI 10.1152/ajpregu.1987.253.1.R142; Shukla C, 2016, NAT SCI SLEEP, V8, P9, DOI 10.2147/NSS.S62365; Simpson N, 2007, NUTR REV, V65, pS244, DOI [10.1111/j.1753-4887.2007.tb00371.x, 10.1301/nr.2007.dec.S244-S252]; SZEKELY M, 1973, ACTA PHYSIOL HUNG, V43, P85; SZEKELY M, 1979, ACTA PHYSIOL HUNG, V53, P469; SZEKELY M, 1979, ACTA PHYSIOL HUNG, V53, P265; Szelenyi Z, 2004, FRONT BIOSCI-LANDMRK, V9, P2447, DOI 10.2741/1406; Szentirmai E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01047-1; Szentirmai E, 2014, EUR J NEUROSCI, V39, P984, DOI 10.1111/ejn.12463; Szentirmai E, 2014, BRAIN BEHAV IMMUN, V36, P200, DOI 10.1016/j.bbi.2013.11.017; Toth LA, 2001, AM J PHYSIOL-REG I, V280, pR1806, DOI 10.1152/ajpregu.2001.280.6.R1806; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; vanRooijen N, 1997, TRENDS BIOTECHNOL, V15, P178, DOI 10.1016/S0167-7799(97)01019-6; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vaughan CH, 2012, AM J PHYSIOL-REG I, V302, pR1049, DOI 10.1152/ajpregu.00640.2011; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Vijgen GHEJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077221; Wang JP, 1997, NEUROIMMUNOMODULAT, V4, P230, DOI 10.1159/000097341; Wang T, 2009, FEBS LETT, V583, P3655, DOI 10.1016/j.febslet.2009.10.046; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Zielinski MR, 2013, SLEEP, V36, P1227, DOI 10.5665/sleep.2892	79	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197409	10.1371/journal.pone.0197409	http://dx.doi.org/10.1371/journal.pone.0197409			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746591	gold, Green Published, Green Submitted			2022-12-26	WOS:000431851700109
J	Mushtaq, A; Mustafa, M; Hayat, T; Alsaedi, A				Mushtaq, Ammar; Mustafa, Meraj; Hayat, Tasawer; Alsaedi, Ahmed			Buoyancy effects in stagnation-point flow of Maxwell fluid utilizing non-Fourier heat flux approach	PLOS ONE			English	Article							MIXED CONVECTION FLOW; VERTICAL STRETCHING SHEET; REACTIVE SOLUTE TRANSFER; BOUNDARY-LAYER-FLOW; THERMAL-CONDUCTIVITY; CHEMICAL-REACTION; MICROPOLAR FLUID; SHRINKING SHEET; MASS-TRANSFER; MHD FLOW	Here we utilize a non-Fourier approach to model buoyancy aiding or opposing flow of Maxwell fluid in the region of stagnation-point towards a vertical stretchable surface. Flow field is permeated by uniform transverse magnetic field. Two different heating processes namely (i) prescribed surface temperature (PST) and (ii) constant wall temperature (CWT) are analyzed. Through suitable transformations, the similarity equations are formed which are treated numerically for a broad range of magnetic interaction parameter. The obtained solutions are compared with available articles under limiting situations and such comparisons appear convincing. The structure of boundary layer depends on a parameter measuring the ratio of free stream velocity to the stretching sheet velocity. The momentum transport via stretching boundary is opposed by both fluid relaxation time and magnetic interaction parameter. Thermal boundary layer expands as the effects of transverse magnetic field and thermal relaxation time are amplified. A reduction in heat penetration depth is anticipated for increasing values of thermal relaxation time. The variation in wall slope of temperature with increasing thermal relaxation time appears similar at any assigned value of Prandtl number. A comparative study of aiding and opposition flow situations is presented and deliberated.	[Mushtaq, Ammar] NUST, RCMS, Islamabad, Pakistan; [Mustafa, Meraj] NUST, SNS, Islamabad, Pakistan; [Hayat, Tasawer] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawer; Alsaedi, Ahmed] King Abdulaziz Univ, Fac Sci, Dept Math, Jeddah, Saudi Arabia	National University of Sciences & Technology - Pakistan; National University of Sciences & Technology - Pakistan; Quaid I Azam University; King Abdulaziz University	Mushtaq, A (corresponding author), NUST, RCMS, Islamabad, Pakistan.	ammar.mushtaq@yahoo.com	Mushtaq, Ammar/O-3326-2013; Mustafa Hashmi, Meraj/P-1769-2014	Mushtaq, Ammar/0000-0001-9548-4631; 				Abbasbandy S, 2014, APPL MATH COMPUT, V242, P569, DOI 10.1016/j.amc.2014.04.102; Abbasi FM, 2016, J MOL LIQ, V220, P848, DOI 10.1016/j.molliq.2016.04.132; Abdulhameed M, 2017, COMP MATH APPL, DOI [10.1016/j.camwa.2017.07.040, DOI 10.10163.CAMWA.2017.07.040]; Abel MS, 2012, MECCANICA, V47, P385, DOI 10.1007/s11012-011-9448-7; Ali FM, 2014, APPL MATH MECH-ENGL, V35, P155, DOI 10.1007/s10483-014-1780-8; Ali L, 2017, AICHE J, DOI [10.1002/aic.15794, DOI 10.1002/ALC.15794]; Bai Y, 2016, J MOL LIQ, V224, P1172, DOI 10.1016/j.molliq.2016.10.082; Baron Fourier J. B., 1822, CHEZ FIRMIN DIDOT; Bhattacharyya K, 2015, J APPL MECH TECH PH+, V56, P464, DOI 10.1134/S0021894415030165; Bhattacharyya K., 2012, ACTA TECHNICA, V57, P1; Bhattacharyya K, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/12/124701; Bhattacharyya K, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/7/074705; Bhattacharyya K, 2012, CHEM ENG COMMUN, V199, P368, DOI 10.1080/00986445.2011.592444; Cattaneo C., 1948, ATTI SEMIN MAT FIS, V3, P83, DOI DOI 10.1007/978-3-642-11051-1_5; Christov CI, 2009, MECH RES COMMUN, V36, P481, DOI 10.1016/j.mechrescom.2008.11.003; Gireesha BJ, 2013, INT J NUMER METHOD H, V23, P598, DOI 10.1108/09615531311323764; Gul T, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7040369; Haddad SAM, 2014, INT J HEAT MASS TRAN, V68, P659, DOI 10.1016/j.ijheatmasstransfer.2013.09.039; Han SH, 2014, APPL MATH LETT, V38, P87, DOI 10.1016/j.aml.2014.07.013; Hayat T, 2009, CHAOS SOLITON FRACT, V39, P840, DOI 10.1016/j.chaos.2007.01.067; Hayat T, 2016, INT J HEAT MASS TRAN, V102, P723, DOI 10.1016/j.ijheatmasstransfer.2016.06.059; Hayat T, 2016, AIP ADV, V6, DOI 10.1063/1.4942091; Hiemenz K., 1911, DINGLERS POLYTECH J, V326, P391; Khan JA, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0137363, DOI 10.1371/J0URNALP0NE.0137363]; Khan N, 2016, INT J HEAT MASS TRAN, V92, P1090, DOI 10.1016/j.ijheatmasstransfer.2015.09.001; Khan NA, 2017, EUROPEAN PHYS J PLUS, V132, DOI [10.1140/epip/i2017-11277-3, DOI 10.1140/EPLP/12017-11277.3]; Kumari M, 2014, MECCANICA, V49, P1263, DOI 10.1007/s11012-014-9884-2; Kumari M, 2009, INT J NONLIN MECH, V44, P1048, DOI 10.1016/j.ijnonlinmec.2009.08.002; Liu L, 2017, INT J THERM SCI, V112, P421, DOI 10.1016/j.ijthermalsci.2016.11.008; Liu L, 2016, INT J HEAT MASS TRAN, V103, P1191, DOI 10.1016/j.ijheatmasstransfer.2016.07.113; Mahapatra TR, 2009, INT J NONLIN MECH, V44, P124, DOI 10.1016/j.ijnonlinmec.2008.09.005; Mahmoud MAA, 2013, J MECH, V29, P461, DOI 10.1017/jmech.2013.22; Megahed AM, 2012, CHINESE PHYS B, V22, DOI [10.1088/1674-1056/22/9/094701, DOI 10.1088/16741056/22/9/094701]; Mohammadein AA, 2010, MECCANICA, V45, P89, DOI 10.1007/s11012-009-9226-y; Motsa SS, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/290615; Mukhopadhyay S, 2012, CHINESE PHYS LETT, V29, DOI [10.1088/0256-307X/29/5/054703, DOI 10.1088/0256-307X129/5/054703]; Mushtaq A, 2016, AIP ADV, V6, DOI 10.1063/1.4940133; Mustafa M, 2017, INT J HEAT MASS TRAN, V108, P1340, DOI 10.1016/j.ijheatmasstransfer.2017.01.029; Mustafa M, 2017, INT J HEAT MASS TRAN, V106, P142, DOI 10.1016/j.ijheatmasstransfer.2016.10.051; Mustafa M, 2017, INT J NUMER METHOD H, DOI [10.1108/HFF-08-2016-0323, DOI 10.1108/HFF-08-201]; Mustafa M, 2015, AIP ADV, V5, DOI [10.1063/1.4917306, DOI 10.1063/1A917306]; Mustafa M, 2017, INT J HEAT MASS TRAN, V113, P1012, DOI 10.1016/j.ijheatmasstransfer.2017.06.002; Nandy SK, 2015, J TAIWAN INST CHEM E, V52, P22, DOI 10.1016/j.jtice.2015.01.025; Patil PM, 2010, INT J NUMER METHOD H, V20, P445, DOI 10.1108/09615531011035839; Renardy M, 2012, J NON-NEWTON FLUID, V189, P14, DOI 10.1016/j.jnnfm.2012.09.010; Rubab K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153481; Sadeghy K, 2006, INT J NONLIN MECH, V41, P1242, DOI 10.1016/j.ijnonlinmec.2006.08.005; Salahuddin T, 2016, J MAGN MAGN MATER, V401, P991, DOI 10.1016/j.jmmm.2015.11.022; Shafique Z, 2016, RESULTS PHYS, V6, P627, DOI 10.1016/j.rinp.2016.09.006; Shateyi S, 2013, BOUND VAL PROB, V196, DOI [10.1186/1687-2770-2013-196, DOI 10.1186/1687-2770-2013.196]; Straughan B, 2010, INT J HEAT MASS TRAN, V53, P95, DOI 10.1016/j.ijheatmasstransfer.2009.10.001; Tibullo V, 2011, MECH RES COMMUN, V38, P77, DOI 10.1016/j.mechrescom.2010.10.008; Turkyilmazoglu M, 2017, INT J HEAT MASS TRAN, V106, P127, DOI 10.1016/j.ijheatmasstransfer.2016.10.056	53	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0192685	10.1371/journal.pone.0192685	http://dx.doi.org/10.1371/journal.pone.0192685			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742101	Green Published, Green Submitted, gold			2022-12-26	WOS:000431757400001
J	Carson, RA; Rudine, AC; Tally, SJ; Franks, AL; Frahm, KA; Waldman, JK; Silswal, N; Burale, S; Phan, JV; Chandran, UR; Monaghan, AP; DeFranco, DB				Carson, Ross A.; Rudine, Anthony C.; Tally, Serena J.; Franks, Alexis L.; Frahm, Krystle A.; Waldman, Jacob K.; Silswal, Neerupma; Burale, Suban; Phan, James, V; Chandran, Uma R.; Monaghan, A. Paula; DeFranco, Donald B.			Statins impact primary embryonic mouse neural stem cell survival, cell death, and fate through distinct mechanisms	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; CHOLESTEROL-METABOLISM; SIMVASTATIN; PRAVASTATIN; BRAIN; MODEL; PREECLAMPSIA; EXPRESSION; NEURONS; MICE	Statins inhibit HMG-CoA reductase, the rate-limiting enzyme in the cholesterol biosynthesis pathway (CBP), and are used for the prevention of cardiovascular disease. The anti-inflammatory effects of statins may also provide therapeutic benefits and have led to their use in clinical trials for preeclampsia, a pregnancy-associated inflammatory condition, despite their current classification as category X (i.e. contraindicated during pregnancy). In the developing neocortex, products of the CBP play essential roles in proliferation and differentiation of neural stem-progenitor cells (NSPCs). To understand how statins could impact the developing brain, we studied effects of pravastatin and simvastatin on primary embryonic NSPC survival, proliferation, global transcription, and cell fate in vitro. We found that statins dose dependently decrease NSPC expansion by promoting cell death and autophagy of NSPCs progressing through the G1 phase of the cell cycle. Genome-wide transcriptome analysis demonstrates an increase in expression of CBP genes following pravastatin treatment, through activation of the SREBP2 transcription factor. Co-treatment with farnesyl pyrophosphate (FPP), a CBP metabolite downstream of HMG-CoA reductase, reduces SREBP2 activation and pravastatin-induced PARP cleavage. Finally, pravastatin and simvastatin differentially alter NSPC cell fate and mRNA expression during differentiation, through a non-CBP dependent pathway.	[Carson, Ross A.; Tally, Serena J.; DeFranco, Donald B.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Rudine, Anthony C.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat,Div Newborn Med, Pittsburgh, PA 15261 USA; [Franks, Alexis L.] Univ Pittsburgh, Sch Med, Dept Pediat, Div Child Neurol,Childrens Hosp Pittsburgh, Pittsburgh, PA 15261 USA; [Frahm, Krystle A.] Univ Pittsburgh, Sch Med, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15213 USA; [Waldman, Jacob K.; Chandran, Uma R.] Univ Pittsburgh, Sch Med, Dept Biomed Informat, Pittsburgh, PA USA; [Silswal, Neerupma; Burale, Suban; Phan, James, V; Monaghan, A. Paula] Univ Missouri, Sch Med, Dept Biomed Sci, Kansas City, MO 64108 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Missouri System; University of Missouri Kansas City	DeFranco, DB (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	dod1@pitt.edu		Silswal, Neerupma/0000-0001-7151-2378; Franks, Alexis/0000-0002-0148-3214	National Cancer Institute [P30CA047904]; NURSA Data Resource Project U24 grant [DK097748]; NIH [R01 HD087288, T32-HD071834-01A1, K12 HD052892-09]; T32 training grant from the National Institute of Diabetes and Digestive and Kidney Diseases [T32DK007052]; ACS [RSG-09-054-0 1-GMC]; G. Harold and Leila Y. Mathers Charitable Foundation Award; Magee-Womens Clinical Trainee Research Award; University of Pittsburgh Medical Center Department of Pediatrics Endowed Instructorship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD087288] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NURSA Data Resource Project U24 grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 training grant from the National Institute of Diabetes and Digestive and Kidney Diseases; ACS(American Cancer Society); G. Harold and Leila Y. Mathers Charitable Foundation Award; Magee-Womens Clinical Trainee Research Award; University of Pittsburgh Medical Center Department of Pediatrics Endowed Instructorship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project used the UPCI Cancer Bioinformatics Services, which is supported in part by the National Cancer Institute award P30CA047904. This study was supported by NURSA Data Resource Project U24 grant DK097748 (DBD, APM, URC), NIH grant R01 HD087288 (DBD, APM) a T32 training grant T32DK007052 from the National Institute of Diabetes and Digestive and Kidney Diseases (KAF), an ACS grant (RSG-09-054-0 1-GMC, APM), G. Harold and Leila Y. Mathers Charitable Foundation Award (APM), NIH T32-HD071834-01A1 (AR), NIH K12 HD052892-09 (AR), Magee-Womens Clinical Trainee Research Award (AR), the University of Pittsburgh Medical Center Department of Pediatrics Endowed Instructorship (AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer AJ, 2013, HYPERTENSION, V61, P1103, DOI 10.1161/HYPERTENSIONAHA.111.00226; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brownfoot FC, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0902-3; Carson R, 2016, STEROIDS, V114, P25, DOI 10.1016/j.steroids.2016.05.012; Carver AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100873; Carver AR, 2014, INT J DEV NEUROSCI, V33, P33, DOI 10.1016/j.ijdevneu.2013.11.004; Edison RJ, 2004, AM J MED GENET A, V131A, P287, DOI 10.1002/ajmg.a.30386; Fukui K, 2015, J BIOL CHEM, V290, P26383, DOI 10.1074/jbc.M115.664367; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; Kalabis GM, 2005, BIOL REPROD, V73, P591, DOI 10.1095/biolreprod.105.042242; Kavalipati Narasaraju, 2015, Indian J Endocrinol Metab, V19, P554, DOI 10.4103/2230-8210.163106; Kumasawa K, 2011, P NATL ACAD SCI USA, V108, P1451, DOI 10.1073/pnas.1011293108; Lankas GR, 2004, BIRTH DEFECTS RES B, V71, P111, DOI 10.1002/bdrb.20005; Li Q, 2014, J CLIN LIPIDOL, V8, P618, DOI 10.1016/j.jacl.2014.07.010; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Okamoto-Uchida Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37697; Peffer ME, 2014, MOL CELL BIOL, V34, P2611, DOI 10.1128/MCB.01121-13; Ramma W, 2014, J REPROD IMMUNOL, V101, P153, DOI 10.1016/j.jri.2013.12.120; Robin NC, 2014, STEM CELL REP, V2, P9, DOI 10.1016/j.stemcr.2013.11.002; Roy A, 2015, CELL METAB, V22, P253, DOI 10.1016/j.cmet.2015.05.022; Saad AF, 2014, REPROD SCI, V21, P138, DOI 10.1177/1933719113492207; Saito K, 2009, P NATL ACAD SCI USA, V106, P8350, DOI 10.1073/pnas.0903541106; Sakayori N, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/973508; Samarasinghe RA, 2014, NEUROBIOL DIS, V70, P252, DOI 10.1016/j.nbd.2014.06.020; Samarasinghe RA, 2011, P NATL ACAD SCI USA, V108, P16657, DOI 10.1073/pnas.1102821108; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Shehadah A, 2010, J NEUROL SCI, V294, P107, DOI 10.1016/j.jns.2010.03.020; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Su J, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0114-2; Thelen KM, 2006, J PHARMACOL EXP THER, V316, P1146, DOI 10.1124/jpet.105.094136; Tozawa R, 1999, J BIOL CHEM, V274, P30843, DOI 10.1074/jbc.274.43.30843; Uzan J, 2011, VASC HEALTH RISK MAN, V7, P467, DOI 10.2147/VHRM.S20181; Wang KW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/910260; Wood WG, 2014, MOL NEUROBIOL, V50, P214, DOI 10.1007/s12035-014-8647-3; Wu HT, 2012, BRAIN RES, V1486, P121, DOI 10.1016/j.brainres.2012.09.039; Yan JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020945; Zarek J, 2014, J OBSTET GYNAECOL CA, V36, P506, DOI 10.1016/S1701-2163(15)30565-X; Zhang J, 2015, PROTEIN CELL, V6, P254, DOI 10.1007/s13238-014-0131-3	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196387	10.1371/jorurnal.pone.0196387	http://dx.doi.org/10.1371/jorurnal.pone.0196387			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738536				2022-12-26	WOS:000431724900008
J	Komatsu, H; Fujimoto, S; Maruyama, S; Mukoyama, M; Sugiyama, H; Tsuruya, K; Sato, H; Soma, J; Yano, J; Itano, S; Nishino, T; Sato, T; Narita, I; Yokoyama, H				Komatsu, Hiroyuki; Fujimoto, Shouichi; Maruyama, Shoichi; Mukoyama, Masashi; Sugiyama, Hitoshi; Tsuruya, Kazuhiko; Sato, Hiroshi; Soma, Jun; Yano, Junko; Itano, Seiji; Nishino, Tomoya; Sato, Toshinobu; Narita, Ichiei; Yokoyama, Hitoshi			Distinct characteristics and outcomes in elderly-onset IgA vasculitis (Henoch-Schonlein purpura) with nephritis: Nationwide cohort study of data from the Japan Renal Biopsy Registry (J-RBR)	PLOS ONE			English	Article							CONSENSUS CONFERENCE NOMENCLATURE; METHYLPREDNISOLONE PULSE THERAPY; OXFORD CLASSIFICATION; ABERRANT GLYCOSYLATION; SEVERE FORMS; NEPHROPATHY; ADULTS; TONSILLECTOMY; PATHOPHYSIOLOGY; CHILDREN	Background The clinical presentation and prognosis of adult and elderly patients with IgA vasculitis (Henoch-Schonlein purpura) accompanied by nephritis (IgAV-N) have not been investigated in detail. We therefore surveyed the features and outcomes of IgAV-N based on nationwide data derived from the Japan Renal Biopsy Registry (J-RBR). Methods This multi-center cohort study compared the clinicopathological parameters at diagnosis, initial therapies and outcomes between 106 adult (age 19-64 years) and 46 elderly (>= 65 years) patients with IgAV-N who were registered in the J-RBR between 2007 and 2012. The primary end-points comprised a 50% increase in serum creatinine (sCr) values or end-stage kidney disease. Factors affecting a decrease in renal function were assessed using Cox proportional hazards models. Results Rates of hypertension, impaired renal function, hypoalbuminemia and crescentic glomerulonephritis were significantly higher among the elderly, than the adult patients. About 80% and 60% of the patients in both groups were respectively treated with corticosteroid and a renin-angiotensin system (RAS) blockade. Both groups had favorable renal survival rates for nine years (93.6% and 91.4% of the adult and elderly patients, respectively). Significantly more elderly than adult patients developed a 50% increase in sCr during a mean observation period of 3.9 years (21.7% vs. 4.7%, p = 0.012), and significantly fewer elderly, than adult patients achieved clinical remission (23.9% vs. 46.2%, p = 0.016). Multivariate analysis selected advanced age (>= 65 years) and lower serum albumin values as independent prognostic factors for a decline in renal function, whereas steroid pulse therapy helped to preserve renal function. Conclusions The renal prognosis of adult and elderly patients with IgAV-N was favorable when treated aggressively with corticosteroid and RAS blockade. However, the course of renal function should be carefully monitored in patients aged over 65 years and those with hypoalbuminemia.	[Komatsu, Hiroyuki] Univ Miyazaki Hosp, Dept Nephrol, Miyazaki, Japan; [Fujimoto, Shouichi] Univ Miyazaki, Fac Med, Dept Hemovasc Med & Artificial Organs, Miyazaki, Japan; [Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi, Japan; [Mukoyama, Masashi] Kumamoto Univ, Grad Sch Med Sci, Dept Nephrol, Kumamoto, Japan; [Sugiyama, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama, Japan; [Tsuruya, Kazuhiko] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Fukuoka, Japan; [Sato, Hiroshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Clin Pharmacol & Therapeut, Sendai, Miyagi, Japan; [Soma, Jun] Iwate Prefectural Cent Hosp, Dept Nephrol & Rheumatol, Morioka, Iwate, Japan; [Yano, Junko] Kurume Univ, Sch Med, Dept Med, Div Nephrol, Fukuoka, Japan; [Itano, Seiji] Kawasaki Med Sch, Dept Internal Med, Div Nephrol & Hypertens, Okayama, Japan; [Nishino, Tomoya] Nagasaki Univ Hosp, Dept Nephrol, Nagasaki, Japan; [Sato, Toshinobu] Sendai Shakai Hoken Hosp, Dept Nephrol, Sendai, Miyagi, Japan; [Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata, Japan; [Yokoyama, Hitoshi] Kanazawa Med Univ, Sch Med, Div Nephrol, Uchinada, Ishikawa, Japan	University of Miyazaki; University of Miyazaki; Nagoya University; Kumamoto University; Okayama University; Kyushu University; Tohoku University; Iwate Prefectural Central Hospital; Kurume University; Kawasaki Medical School; Nagasaki University; Niigata University; Kanazawa Medical University	Komatsu, H (corresponding author), Univ Miyazaki Hosp, Dept Nephrol, Miyazaki, Japan.	hiroyuki_komatsu@med.miyazaki-u.ac.jp	Sugiyama, Hitoshi/B-2252-2011; Narita, Ichiei/G-5204-2017	Sugiyama, Hitoshi/0000-0002-4127-6471; Narita, Ichiei/0000-0001-7692-3096; komatsu, hiroyuki/0000-0001-7557-2204	Japanese Society of Nephrology; Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan	Japanese Society of Nephrology; Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan	This study was supported in part by the Japanese Society of Nephrology, by a Grant-in-Aid for Intractable Renal Diseases Research, Research on Rare and Intractable Diseases, and by Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan.	[Anonymous], 2012, KIDNEY INT S2, P218; Audemard-Verger A, 2017, ARTHRITIS RHEUMATOL, V69, P1862, DOI 10.1002/art.40178; Audemard-Verger A, 2015, AUTOIMMUN REV, V14, P579, DOI 10.1016/j.autrev.2015.02.003; Coppo R, 1997, NEPHROL DIAL TRANSPL, V12, P2277, DOI 10.1093/ndt/12.11.2277; Coppo R, 2006, AM J KIDNEY DIS, V47, P993, DOI 10.1053/j.ajkd.2006.02.178; Davin JC, 2001, KIDNEY INT, V59, P823, DOI 10.1046/j.1523-1755.2001.059003823.x; Davin JC, 2014, NAT REV NEPHROL, V10, P563, DOI 10.1038/nrneph.2014.126; Davin JC, 2011, CLIN J AM SOC NEPHRO, V6, P679, DOI 10.2215/CJN.06710810; Hotta O, 2001, AM J KIDNEY DIS, V38, P736, DOI 10.1053/ajkd.2001.27690; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jennette JC, 2013, CLIN EXP NEPHROL, V17, P603, DOI 10.1007/s10157-013-0869-6; Kato-Okada S, 2015, JPN CLIN MED, V6, P5, DOI 10.4137/JCM.S23093; Kawabe M, 2017, CLIN EXP NEPHROL, V21, P714, DOI 10.1007/s10157-016-1336-y; Kawasaki Y, 2007, TOHOKU J EXP MED, V211, P291, DOI 10.1620/tjem.211.291; Kim CH, 2014, MODERN PATHOL, V27, P972, DOI 10.1038/modpathol.2013.222; Kiryluk K, 2011, KIDNEY INT, V80, P79, DOI 10.1038/ki.2011.16; Komatsu H, 2016, CLIN EXP NEPHROL, V20, P552, DOI 10.1007/s10157-015-1177-0; Lv JC, 2017, JAMA-J AM MED ASSOC, V318, P432, DOI 10.1001/jama.2017.9362; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mohey H, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-169; Niaudet P, 1998, PEDIATR NEPHROL, V12, P238, DOI 10.1007/s004670050446; Novak J, 2007, CONTRIB NEPHROL, V157, P134; Pillebout E, 2002, J AM SOC NEPHROL, V13, P1271, DOI 10.1097/01.ASN.0000013883.99976.22; Pillebout E, 2010, KIDNEY INT, V78, P495, DOI 10.1038/ki.2010.150; Rai A, 1999, J AM SOC NEPHROL, V10, P2637; Rauta V, 2002, CLIN NEPHROL, V58, P1; Shrestha S, 2006, QJM-INT J MED, V99, P253, DOI 10.1093/qjmed/hcl034; Soriano A, 2012, AGING CLIN EXP RES, V24, P559, DOI 10.3275/8476; Sugiyama H, 2005, INTERNAL MED, V44, P611, DOI 10.2169/internalmedicine.44.611; Sugiyama H, 2013, CLIN EXP NEPHROL, V17, P155, DOI 10.1007/s10157-012-0746-8; Sugiyama H, 2011, CLIN EXP NEPHROL, V15, P493, DOI 10.1007/s10157-011-0430-4; Suzuki H, 2018, KIDNEY INT, V93, P700, DOI 10.1016/j.kint.2017.10.019; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Trimarchi H, 2017, KIDNEY INT, V91, P1014, DOI 10.1016/j.kint.2017.02.003; Xu K, 2018, J NEPHROL, V31, P279, DOI 10.1007/s40620-017-0457-z; Yokoyama H, 2015, CLIN EXP NEPHROL, V19, P496, DOI 10.1007/s10157-014-1022-x; Yokoyama H, 2012, CLIN EXP NEPHROL, V16, P903, DOI 10.1007/s10157-012-0673-8	37	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196955	10.1371/journal.pone.0196955	http://dx.doi.org/10.1371/journal.pone.0196955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738576	Green Submitted, Green Published, gold			2022-12-26	WOS:000431724900032
J	van Woesik, R; Cacciapaglia, CW				van Woesik, Robert; Cacciapaglia, Christopher William			Keeping up with sea-level rise: Carbonate production rates in Palau and Yap, western Pacific Ocean	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-REEFS; CLIMATE-CHANGE; GROWTH; ACIDIFICATION; COMMUNITIES; BUDGET; UNCERTAINTY; RESILIENCE; RESPONSES	Coral reefs protect islands from tropical storm waves and provide goods and services for millions of islanders worldwide. Yet it is unknown how coral reefs in general, and carbonate production in particular, will respond to sea-level rise and thermal stress associated with climate change. This study compared the reef-building capacity of different shallow-water habitats at twenty-four sites on each of two islands, Palau and Yap, in the western Pacific Ocean. We were particularly interested in estimating the inverse problem of calculating the value of live coral cover at which net carbonate production becomes negative, and whether that value varied across habitats. Net carbonate production varied among habitats, averaging 10.2 kg CaCO3 m(-2) y(-1) for outer reefs, 12.7 kg CaCO3 m(-2) y(-1) for patch reefs, and 7.2 kg CaCO3 m(-2) y(-1) for inner reefs. The value of live coral cover at which net carbonate production became negative varied across habitats, with highest values on inner reefs. These results suggest that some inner reefs tend to produce less carbonate, and therefore need higher coral cover to produce enough carbonate to keep up with sea-level rise than outer and patch reefs. These results also suggest that inner reefs are more vulnerable to sealevel rise than other habitats, which stresses the need for effective land-use practices as the climate continues to change. Averaging across all reef habitats, the rate of carbonate production was 9.7 kg CaCO3 m(-2) y(-1), or approximately 7.9 mm y(-1) of potential vertical accretion. Such rates of vertical accretion are higher than projected averages of sea-level rise for the representative concentration pathway (RCP) climate-change scenarios 2.6, 4.5, and 6, but lower than for the RCP scenario 8.5.	[van Woesik, Robert; Cacciapaglia, Christopher William] Florida Inst Technol, Dept Biol Sci, West Univ Blvd, Melbourne, FL 32901 USA	Florida Institute of Technology	van Woesik, R (corresponding author), Florida Inst Technol, Dept Biol Sci, West Univ Blvd, Melbourne, FL 32901 USA.	rvw@fit.edu		van Woesik, Robert/0000-0002-1864-0263	National Science Foundation [NSF OCE-1657633]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation, award NSF OCE-1657633 to R. van Woesik. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEY WH, 1978, SCIENCE, V202, P831, DOI 10.1126/science.202.4370.831; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Barkley HC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500328; Bianchi C. N., 2017, MARINE ANIMAL FOREST, P1241, DOI 10. 1007/978-3-319-21012-4; Bonaldo RM, 2008, MAR ECOL PROG SER, V360, P237, DOI 10.3354/meps07413; Buddemeier R.W., 1988, P 6 INT COR REEF S, V1, P253; Dana JD, 1890, MANUAL GEOLOGY TREAT, P440; Davies P.J., 1983, Australian Institute of Marine Science Contribution, P69; Edenhofer O., 2014, CONTRIBUTION WORKING; Edinger EN, 2000, MAR POLLUT BULL, V40, P404, DOI 10.1016/S0025-326X(99)00237-4; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Glynn Peter W., 1997, P68; Golbuu Y, 2007, CORAL REEFS, V26, P319, DOI 10.1007/s00338-007-0200-7; Golbuu Y, 2011, MAR POLLUT BULL, V62, P824, DOI 10.1016/j.marpolbul.2010.12.015; Gouezo M, 2015, MAR ECOL PROG SER, V540, P73, DOI 10.3354/meps11518; Harris DL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao4350; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hubbard Dennis K., 1997, P43; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Januchowski-Hartley FA, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2533; Jevrejeva S, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104008; Kiessling W, 2014, EGU GEN ASSEM C ABST, P15790; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MARSH LM, 1984, CORAL REEFS, V2, P175; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; Montaggioni LF, 2005, EARTH-SCI REV, V71, P1, DOI 10.1016/j.earscirev.2005.01.002; Mumby PJ, 2014, CURR BIOL, V24, pR413, DOI 10.1016/j.cub.2014.04.029; Neumann A.C., 1985, PROC 5 INT CORAL REE, V3, P105; Ong L, 2010, MAR BIOL, V157, P1313, DOI 10.1007/s00227-010-1411-y; Pandolfi JM, 2015, ANNU REV ECOL EVOL S, V46, P281, DOI 10.1146/annurev-ecolsys-120213-091811; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pebesma E.J., 2005, R NEWS, V5; Perry CT, 2008, CORAL REEFS, V27, P853, DOI 10.1007/s00338-008-0418-z; Perry CT, 2017, SCI REP-UK, V7, DOI 10.1038/srep40581; Perry CT, 2012, CORAL REEFS, V31, P853, DOI 10.1007/s00338-012-0901-4; Perry CT, 2015, SCI REP-UK, V5, DOI 10.1038/srep18289; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; R Core Team, 2021, R LANGUAGE ENV STAT; Ries JB, 2011, J EXP MAR BIOL ECOL, V403, P54, DOI 10.1016/j.jembe.2011.04.006; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Roff G, 2015, CORAL REEFS, V34, P715, DOI 10.1007/s00338-015-1305-z; Roff G, 2015, GEOLOGY, V43, P343, DOI 10.1130/G36478.1; Shamberger KEF, 2014, GEOPHYS RES LETT, V41, P499, DOI 10.1002/2013GL058489; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; SMITH SV, 1976, SCIENCE, V194, P937, DOI 10.1126/science.194.4268.937; SMITH SV, 1981, PAC SCI, V35, P279; STEARN CW, 1977, B MAR SCI, V27, P479; Tanzil JTI, 2009, CORAL REEFS, V28, P519, DOI 10.1007/s00338-008-0457-5; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; van Hooidonk R, 2013, NAT CLIM CHANGE, V3, P508, DOI [10.1038/NCLIMATE1829, 10.1038/nclimate1829]; van Woesik R, 1999, MAR FRESHWATER RES, V50, P427, DOI 10.1071/MF97046; van Woesik R, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150181; van Woesik R, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044051; van Woesik R, 2013, PEERJ, V1, DOI 10.7717/peerj.208; vanWoesik R, 1997, CORAL REEFS, V16, P103, DOI 10.1007/s003380050064; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Wand MP, 2008, AUST NZ J STAT, V50, P179, DOI 10.1111/j.1467-842X.2008.00507.x; Woodroffe CD, 2012, GEOLOGY, V40, P951, DOI 10.1130/G33344.1; Wu LG, 2004, J CLIMATE, V17, P1686, DOI 10.1175/1520-0442(2004)017<1686:AIOGWO>2.0.CO;2; Zuur AF, 2014, BEGINNERS GUIDE GEN, P332	64	17	18	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0197077	10.1371/journal.pone.0197077	http://dx.doi.org/10.1371/journal.pone.0197077			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738545	Green Published, Green Submitted, gold			2022-12-26	WOS:000431724900049
J	Shin, J; Muller, KR; Hwang, HJ				Shin, Jaeyoung; Mueller, Klaus-Robert; Hwang, Han-Jeong			Eyes-closed hybrid brain-computer interface employing frontal brain activation	PLOS ONE			English	Article							EEG; NIRS; BCI; CLASSIFICATION; COMMUNICATION; OPERATE; ALS	Brain-computer interfaces (BCIs) have been studied extensively in order to establish a non-muscular communication channel mainly for patients with impaired motor functions. However, many limitations remain for BCIs in clinical use. In this study, we propose a hybrid BCI that is based on only frontal brain areas and can be operated in an eyes-closed state for end users with impaired motor and declining visual functions. In our experiment, electroenceph-alography (EEG) and near-infrared spectroscopy (NIRS) were simultaneously measured while 12 participants performed mental arithmetic (MA) and remained relaxed (baseline state: BL). To evaluate the feasibility of the hybrid BCI, we classified MA-from BL-related brain activation. We then compared classification accuracies using two unimodal BCIs (EEG and NIRS) and the hybrid BCI in an offline mode. The classification accuracy of the hybrid BCI (83.9 +/- 10.3%) was shown to be significantly higher than those of unimodal EEG-based (77.3 +/- 15.9%) and NIRS-based BCI (75.9 +/- 6.3%). The analytical results confirmed performance improvement with the hybrid BCI, particularly for only frontal brain areas. Our study shows that an eyes-closed hybrid BCI approach based on frontal areas could be applied to neurodegenerative patients who lost their motor functions, including oculomotor functions.	[Shin, Jaeyoung] Hanyang Univ, Dept Biomed Engn, Seoul, South Korea; [Mueller, Klaus-Robert] Berlin Inst Technol TU Berlin, Machine Learning Grp, Berlin, Germany; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Mueller, Klaus-Robert] Max Planck Inst Informat, Stuhlsatzenhausweg, Saarbrucken, Germany; [Hwang, Han-Jeong] Kumoh Natl Inst Technol, Dept Med IT Convergence Engn, Kumi, South Korea	Hanyang University; Technical University of Berlin; Korea University; Max Planck Society; Kumoh National University Technology	Muller, KR (corresponding author), Berlin Inst Technol TU Berlin, Machine Learning Grp, Berlin, Germany.; Muller, KR (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.; Muller, KR (corresponding author), Max Planck Inst Informat, Stuhlsatzenhausweg, Saarbrucken, Germany.; Hwang, HJ (corresponding author), Kumoh Natl Inst Technol, Dept Med IT Convergence Engn, Kumi, South Korea.	klaus-robert.mueller@tu-berlin.de; h2j@kumoh.ac.kr	Shin, Jaeyoung/T-5173-2018; Mueller, Klaus-Robert/Y-3547-2019	Shin, Jaeyoung/0000-0003-2899-6893; Mueller, Klaus-Robert/0000-0002-3861-7685	Institute for Information & Communications Technology Promotion (IITP) grant - Korea government (MSIT) [2017-0-00451]; National Research Foundation of Korea (NRF) - Ministry of Education [2017R1A6A3A01003543]; National Research Foundation of Korea (NRF) grant - Korea government (Ministry of Science, ICT & Future Planning) [2017R1C1B5017909]; Institute for Information & Communications Technology Promotion (IITP) grant - Korea government [2017-0-00451]	Institute for Information & Communications Technology Promotion (IITP) grant - Korea government (MSIT); National Research Foundation of Korea (NRF) - Ministry of Education; National Research Foundation of Korea (NRF) grant - Korea government (Ministry of Science, ICT & Future Planning); Institute for Information & Communications Technology Promotion (IITP) grant - Korea government	This work was supported by Institute for Information & Communications Technology Promotion (IITP) grant funded by the Korea government (MSIT) (No. 2017-0-00451) and by National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2017R1A6A3A01003543) and the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science, ICT & Future Planning) (No. 2017R1C1B5017909).; This work was supported by a grant from Institute for Information & Communications Technology Promotion (IITP) grant funded by the Korea government (No. 2017-0-00451), and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science, ICT & Future Planning) (No.2017R1C1B5017909). Correspondence to KRM and HJH.	Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; Blankertz B, 2007, ADV NEURAL INFORM PR; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00198; Blankertz B, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00530; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Chaudhary U, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.1002593; Dahne S, 2015, P IEEE, V103, P1507, DOI 10.1109/JPROC.2015.2425807; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Dornhege G., 2007, BRAIN COMPUTER INTER; Fazli S, 2015, P IEEE, V103, P891, DOI 10.1109/JPROC.2015.2413993; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; Fomina T, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/6/066021; Freeman WJ, 2003, CLIN NEUROPHYSIOL, V114, P1053, DOI 10.1016/S1388-2457(03)00045-2; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Friedrich EVC, 2013, CLIN NEUROPHYSIOL, V124, P61, DOI 10.1016/j.clinph.2012.05.020; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Gomez- Herrero G, 2006, 7 NORD SIGN PROC S 7; Gorner M, 2017, 7 GRAZ BCI C 2017 18; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Herff C, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00935; Herrmann MJ, 2003, BIOL PSYCHOL, V64, P255, DOI 10.1016/S0301-0511(03)00095-4; Hohne J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104854; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Hohmann MR, 2016, PROG BRAIN RES, V228, P221, DOI 10.1016/bs.pbr.2016.04.022; Hong KS, 2015, NEUROSCI LETT, V587, P87, DOI 10.1016/j.neulet.2014.12.029; Hwang HJ, 2017, PSYCHOPHYSIOLOGY, V54, P444, DOI 10.1111/psyp.12793; Hwang HJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15890; Kocsis L, 2006, PHYS MED BIOL, V51, pN91, DOI 10.1088/0031-9155/51/5/N02; Koles ZJ, 1998, ELECTROEN CLIN NEURO, V107, P343, DOI 10.1016/S0013-4694(98)00084-4; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Kubler A, 2009, ANN NY ACAD SCI, V1157, P90, DOI 10.1111/j.1749-6632.2008.04122.x; Lim JH, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/039501; Lim JH, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026021; Moghimi S, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026022; Muller-Putz G, 2015, P IEEE, V103, P926, DOI 10.1109/JPROC.2015.2411333; Naseer N, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00003; Neuper C, 2003, CLIN NEUROPHYSIOL, V114, P399, DOI 10.1016/S1388-2457(02)00387-5; Neuper C, 2006, PROG BRAIN RES, V159, P393, DOI 10.1016/S0079-6123(06)59025-9; Power SD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066004; Power SD, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026002; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Schudlo LC, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/6/066008; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Shin J, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.3; Shin J, 2017, IEEE T NEUR SYS REH, V25, P1735, DOI 10.1109/TNSRE.2016.2628057; Shin J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36203; Tichavsky P, 2008, 2008 IEEE INT C AC S; Tomita Y, 2014, IEEE T BIO-MED ENG, V61, P1274, DOI 10.1109/TBME.2014.2300492; Vansteensel MJ, 2010, ANN NEUROL, V67, P809, DOI 10.1002/ana.21985; Vidaurre C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025009; Vidaurre C, 2011, NEURAL COMPUT, V23, P791, DOI 10.1162/NECO_a_00089; Vidaurre C, 2010, BRAIN TOPOGR, V23, P194, DOI 10.1007/s10548-009-0121-6; von Luhmann A, 2017, IEEE T BIO-MED ENG, V64, P1199, DOI 10.1109/TBME.2016.2594127; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, DOI [10.1093/acprof:oso/9780195388855.001.0001, DOI 10.1093/ACPROF:OSO/9780195388855.001.0001]; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	57	7	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196359	10.1371/journal.pone.0196359	http://dx.doi.org/10.1371/journal.pone.0196359			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734383	Green Published, gold, Green Submitted			2022-12-26	WOS:000431481700013
J	Benoit, JB; Frank, DN; Bessesen, MT				Benoit, Jeanne B.; Frank, Daniel N.; Bessesen, Mary T.			Genomic evolution of Staphylococcus aureus isolates colonizing the nares and progressing to bacteremia	PLOS ONE			English	Article							GENE REGULATOR AGR; CLUMPING FACTOR-B; METHICILLIN-RESISTANT; NASAL CARRIERS; COLONIZATION; INFECTION; CARRIAGE; VIRULENCE; RISK; PATHOGENESIS	Background Nasal colonization by Staphylococcus aureus is a key risk factor for bacteremia. The objective of this study is to identify genomic modifications occurring in nasal carriage strains of S. aureus as they progress to bacteremia in a cohort of hospitalized patients. Methods Eight patients with S. aureus bacteremia were identified. Genomic sequences of the bloodstream isolates were compared with 57 nasal isolates collected longitudinally prior to the occurrence of bacteremia, which covered a timespan of up to 326 days before bacteremia. Results Within each subject, nasal colonizing strains were closely related to bacteremia strains. Within a subject, the number of single nucleotide polymorphisms (SNPs) observed between time points was greater than within a single time point. Co-colonization and strain replacement were observed in one case. In all cases colonization progressed to bacteremia without addition of new virulence genes. In one case, a mutation in the accessory gene regulator gene caused abrogation of agrfunction. Conclusion S. aureus evolves in the human nares at a variable rate. Progression of S. aureus nasal colonization to nosocomial infection is seldom associated with acquisition of new virulence determinants. Mutation in the agrgene with abrogation of function was associated with progression to bacteremia in one case.	[Benoit, Jeanne B.; Frank, Daniel N.; Bessesen, Mary T.] Univ Colorado Denver, Dept Med, Div Infect Dis, Aurora, CO 80045 USA; [Benoit, Jeanne B.; Frank, Daniel N.; Bessesen, Mary T.] Eastern Colorado Healthcare Syst, Dept Vet Affairs, Denver, CO 80220 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Bessesen, MT (corresponding author), Univ Colorado Denver, Dept Med, Div Infect Dis, Aurora, CO 80045 USA.; Bessesen, MT (corresponding author), Eastern Colorado Healthcare Syst, Dept Vet Affairs, Denver, CO 80220 USA.	Mary.Bessesen@ucdenver.edu		Bessesen, Mary/0000-0001-9305-1293	Department of Veterans Affairs: VA Merit Review Grant [I01BX007080]	Department of Veterans Affairs: VA Merit Review Grant	This work was supported by the Department of Veterans Affairs: VA Merit Review Grant I01BX007080 to MTB (https://www.research.va.gov/services/shared_docs/resources.cfm#5). The sponsor had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Albrecht VS, 2015, J CLIN MICROBIOL, V53, P3478, DOI 10.1128/JCM.01371-15; Azarian T, 2016, J INFECT DIS, V214, P895, DOI 10.1093/infdis/jiw242; Bessesen MT, 2015, J INFECTION, V71, P649, DOI 10.1016/j.jinf.2015.08.008; Bhardwaj A, 2016, P NATL ACAD SCI USA, V113, pE538, DOI 10.1073/pnas.1520045113; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Bradley P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10063; Calderwood MS, 2014, J INFECT DIS, V209, P571, DOI 10.1093/infdis/jit501; Cassat JE, 2013, CELL HOST MICROBE, V13, P759, DOI 10.1016/j.chom.2013.05.003; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dominguez SR, 2016, J PEDIAT INF DIS SOC, V5, P329, DOI 10.1093/jpids/piv020; Edwards J, 2015, FASEB J, V29; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Epstein L, 2016, CLIN INFECT DIS, V62, P45, DOI 10.1093/cid/civ777; Ferreira MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058277; Fournier B, 2001, MOL MICROBIOL, V41, P247, DOI 10.1046/j.1365-2958.2001.02515.x; Fowler VG, 1998, CLIN INFECT DIS, V27, P478, DOI 10.1086/514686; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Frank DN, 2003, J CLIN MICROBIOL, V41, P295, DOI 10.1128/JCM.41.1.295-303.2003; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hu CY, 2012, BIOCHEM BIOPH RES CO, V419, P617, DOI 10.1016/j.bbrc.2012.02.057; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jenkins A, 2015, MBIO, V6, DOI 10.1128/mBio.02272-14; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Laabei M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002229; Laabei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087270; Lahey T, 2009, MEDICINE, V88, P263, DOI 10.1097/MD.0b013e3181b8fccb; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Marth G, 2012, ARXIV12073907V2; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Oun S, 2013, RNA BIOL, V10, P157, DOI 10.4161/rna.22899; Painter KL, 2014, TRENDS MICROBIOL, V22, P676, DOI 10.1016/j.tim.2014.09.002; Papenfort K, 2015, FEMS MICROBIOL REV, V39, P362, DOI 10.1093/femsre/fuv016; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; van Belkum A, 2007, MICROBES INFECT, V9, P1471, DOI 10.1016/j.micinf.2007.08.003; Varshney AK, 2009, APPL ENVIRON MICROB, V75, P6839, DOI 10.1128/AEM.00272-09; Verkaik NJ, 2009, J INFECT DIS, V199, P625, DOI 10.1086/596743; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Votintseva AA, 2014, J CLIN MICROBIOL, V52, P1192, DOI 10.1128/JCM.03254-13; Wanner S, 2017, NAT MICROBIOL, V2, DOI [10.1038/nmicrobiol.2016.257, 10.1038/nmicrobiol.2017.48]; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109; YU VL, 1986, NEW ENGL J MED, V315, P91, DOI 10.1056/NEJM198607103150204	52	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0195860	10.1371/journal.pone.0195860	http://dx.doi.org/10.1371/journal.pone.0195860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723202	Green Published, gold			2022-12-26	WOS:000431305100009
J	Shah, AB; Nivar, I; Speelman, DL				Shah, Ami B.; Nivar, Isaac; Speelman, Diana L.			Elevated androstenedione in young adult but not early adolescent prenatally androgenized female rats	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; SYNDROME PCOS; DEFINING HYPERANDROGENISM; SERUM ANDROSTENEDIONE; DIAGNOSTIC-CRITERIA; MEDICAL PROGRESS; ADIPOSE-TISSUE; RODENT MODELS; EXCESS; WOMEN	Background Elevated testosterone (T) is routinely reported as a marker of hyperandrogenemia in rodent models for polycystic ovary syndrome (PCOS). In women with PCOS, elevated serum androstenedione (A4) is associated with more severe phenotypes, including a positive correlation with serum T, DHEAS, free androgen index (FAI), LH, and LH/FSH ratio. Furthermore, A4, along with calculated free T and FAI, was identified as one of the best predictors of PCOS in adult women of all ages (18 to > 50 y). Objective The objective of this study was to investigate serum A4 levels in early adolescent and young adult prenatally androgenized (PNA) female rats, a model for PCOS. Methods Pregnant rats were injected with 5 mg T daily during gestational days 16-19 (PNA rats, experimental group) or an equal volume of vehicle (control group). Female offspring of both groups had tail vein blood drawn for serum analysis at 8 and 16 weeks of age. ELISAs were used to quantify serum A4 and T levels. Results Serum A4 and T were elevated in 16-week-old PNA rats compared to controls. There was no significant difference in either hormone at 8 weeks of age. Conclusions The PNA rats demonstrated elevated serum A4 and T in young adulthood, as has been observed in women with PCOS, further validating this as a model for PCOS and underscoring the importance of serum A4 elevation as a parameter inherent to PCOS and a rodent model for the disorder. Significant A4 elevation develops between early adolescence and early adulthood in this PNA rat model.	[Shah, Ami B.; Nivar, Isaac; Speelman, Diana L.] Lake Erie Coll Osteopath Med, Dept Biochem, Erie, PA 16509 USA		Speelman, DL (corresponding author), Lake Erie Coll Osteopath Med, Dept Biochem, Erie, PA 16509 USA.	dspeelman@lecom.edu			Lake Erie College of Osteopathic Medicine and Lake Erie Consortium for Osteopathic Medical Training grant	Lake Erie College of Osteopathic Medicine and Lake Erie Consortium for Osteopathic Medical Training grant	This work was supported by a Lake Erie College of Osteopathic Medicine and Lake Erie Consortium for Osteopathic Medical Training grant to D.L.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2010, AM J PHYSIOL-ENDOC M, V299, pE741, DOI 10.1152/ajpendo.00058.2010; Abbott DH, 2009, AM J PRIMATOL, V71, P776, DOI 10.1002/ajp.20679; Abbott David H., 2008, V13, P145, DOI 10.1159/000134831; Agapova SE, 2014, SEMIN REPROD MED, V32, P194, DOI 10.1055/s-0034-1371091; Amalfi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037658; Anderson AD, 2014, SEMIN REPROD MED, V32, P202, DOI 10.1055/s-0034-1371092; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Barth JH, 2010, EUR J ENDOCRINOL, V162, P611, DOI 10.1530/EJE-09-0741; Caldwell ASL, 2014, ENDOCRINOLOGY, V155, P3146, DOI 10.1210/en.2014-1196; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Demissie M, 2008, AM J PHYSIOL-ENDOC M, V295, pE262, DOI 10.1152/ajpendo.90208.2008; Dunaif A., 1992, MOSBY YB, Vxviii; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Forsdike RA, 2007, J ENDOCRINOL, V192, P421, DOI 10.1677/joe.1.07097; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Gambineri A, 2012, DIABETES, V61, P2369, DOI 10.2337/db11-1360; Georgopoulos NA, 2014, HORM-INT J ENDOCRINO, V13, P213, DOI 10.1007/BF03401335; Gibson-Helm M, 2017, J CLIN ENDOCR METAB, V102, P604, DOI 10.1210/jc.2016-2963; Gibson-Helm ME, 2014, FAM PRACT, V31, P545, DOI 10.1093/fampra/cmu028; Goodarzi MO, 2015, J STEROID BIOCHEM, V145, P213, DOI 10.1016/j.jsbmb.2014.06.003; Guzel AI, 2012, ARCH GYNECOL OBSTET, V285, P767, DOI 10.1007/s00404-011-2077-5; Kosus N, 2012, GYNECOL ENDOCRINOL, V28, P611, DOI 10.3109/09513590.2011.650770; Lebron-Milad K, 2012, BIOL MOOD ANXIETY DI, V2, DOI [10.1186/2045-5380-2-7, 10.1186/2045-5380-2-3]; Leonie E, 2012, ENDOCRINOLOGY, V153, P2861, DOI 10.1210/en.2011-1754; Lerchbaum E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108263; Long JA, 1920, ANA REC, V18, P244; Lu CX, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136283; MAHAJAN DK, 1988, ENDOCRIN METAB CLIN, V17, P751, DOI 10.1016/S0889-8529(18)30408-0; Maliqueo M, 2014, SEMIN REPROD MED, V32, P183, DOI 10.1055/s-0034-1371090; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; McLean AC, 2012, JOVE-J VIS EXP, DOI 10.3791/4389; Miri M, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-37; Misichronis G, 2012, GYNECOL ENDOCRINOL, V28, P249, DOI 10.3109/09513590.2011.613965; Misso M, 2014, SEMIN REPROD MED, V32, P230, DOI 10.1055/s-0034-1371095; Moran LJ, 2015, TRENDS ENDOCRIN MET, V26, P136, DOI 10.1016/j.tem.2014.12.003; Nohara K, 2013, AM J PHYSIOL-ENDOC M, V304, pE1321, DOI 10.1152/ajpendo.00620.2012; Noroozzadeh M, 2015, J ENDOCRINOL INVEST, V38, P489, DOI 10.1007/s40618-014-0198-y; O'Reilly MW, 2014, J CLIN ENDOCR METAB, V99, P1027, DOI 10.1210/jc.2013-3399; Padmanabhan V, 2010, ENDOCRINOLOGY, V151, P595, DOI 10.1210/en.2009-1015; Paixao L, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0231-z; Pasquali R, 2016, J CLIN ENDOCR METAB, V101, P2013, DOI 10.1210/jc.2015-4009; Pinola P, 2015, J CLIN ENDOCR METAB, V100, P3400, DOI 10.1210/jc.2015-2123; Quinkler M, 2004, J ENDOCRINOL, V183, P331, DOI 10.1677/joe.1.05762; RAJ SG, 1978, OBSTET GYNECOL, V52, P169; Ressler IB, 2015, AM J PHYSIOL-ENDOC M, V308, pE1076, DOI 10.1152/ajpendo.00182.2014; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; Rosenfield RL, 1999, ENDOCRIN METAB CLIN, V28, P265, DOI 10.1016/S0889-8529(05)70070-0; Rosenfield RL, 2015, PEDIATRICS, V136, P1154, DOI 10.1542/peds.2015-1430; Sam S, 2003, TRENDS ENDOCRIN MET, V14, P365, DOI 10.1016/j.tem.2003.08.002; Scaruffi E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00185; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Staley K, 2005, NAT NEUROSCI, V8, P697, DOI 10.1038/nn0605-697; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Tehrani FR, 2014, EXP PHYSIOL, V99, P792, DOI 10.1113/expphysiol.2014.078055; Tehrani FR, 2014, INT J ENDOCRINOL MET, V12, DOI 10.5812/ijem.16502; Tyndall V, 2012, REPRODUCTION, V143, P21, DOI 10.1530/REP-11-0239; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; Ward IL, 2003, HORM BEHAV, V43, P531, DOI 10.1016/S0018-506X(03)00061-8; Welt CK, 2013, J CLIN ENDOCR METAB, V98, P4629, DOI 10.1210/jc.2013-2375; Wu XY, 2010, ENDOCR J, V57, P201, DOI 10.1507/endocrj.K09E-205; Xita N, 2006, J CLIN ENDOCR METAB, V91, P1660, DOI 10.1210/jc.2005-2757; Yan XN, 2013, J ENDOCRINOL, V217, P119, DOI 10.1530/JOE-12-0577; Yang XM, 2011, AM J PHYSIOL-REG I, V300, pR869, DOI 10.1152/ajpregu.00334.2010	65	5	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196862	10.1371/journal.pone.0196862	http://dx.doi.org/10.1371/journal.pone.0196862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723293	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100080
J	Barradas-Bautista, D; Alvarado-Mentado, M; Agostino, M; Cocho, G				Barradas-Bautista, Didier; Alvarado-Mentado, Matias; Agostino, Mark; Cocho, Germinal			Cancer growth and metastasis as a metaphor of Go gaming: An Ising model approach	PLOS ONE			English	Article							PHASE-TRANSITIONS; TUMOR-METASTASIS; CELLS; SIMULATION; GENES; CHEMOTHERAPY; NETWORKS; GAME	This work aims for modeling and simulating the metastasis of cancer, via the analogy between the cancer process and the board game Go. In the game of Go, black stones that play first could correspond to a metaphor of the birth, growth, and metastasis of cancer. Moreover, playing white stones on the second turn could correspond the inhibition of cancer invasion. Mathematical modeling and algorithmic simulation of Go may therefore benefit the efforts to deploy therapies to surpass cancer illness by providing insight into the cellular growth and expansion over a tissue area. We use the Ising Hamiltonian, that models the energy exchange in interacting particles, for modeling the cancer dynamics. Parameters in the energy function refer the biochemical elements that induce cancer birth, growth, and metastasis; as well as the biochemical immune system process of defense.	[Barradas-Bautista, Didier] CINVESTAV, ABACUS Project, Mexico City, DF, Mexico; [Alvarado-Mentado, Matias] CINVESTAV, Comp Sci Dept, Mexico City, DF, Mexico; [Agostino, Mark] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [Agostino, Mark] Curtin Univ, Curtin Inst Computat, Perth, WA, Australia; [Cocho, Germinal] Univ Nacl Autonoma Mexico, Complex Sci Ctr, Mexico City, DF, Mexico; [Cocho, Germinal] Univ Nacl Autonoma Mexico, Phys Inst, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Curtin University; Curtin University; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Alvarado-Mentado, M (corresponding author), CINVESTAV, Comp Sci Dept, Mexico City, DF, Mexico.	matias@cs.cinvestav.mx	Alvarado, Matias/D-1446-2010; Barradas-Bautista, Didier/D-3269-2018; Agostino, Mark/H-5481-2019	Barradas-Bautista, Didier/0000-0002-6464-6607; Agostino, Mark/0000-0002-1799-0392; Alvarado, Matias/0000-0003-2853-7451	ABACUS; CONACyT [EDOMEX-2011-C01-165873]; Raine Priming Grant; Curtin Institute for Computation; Curtin Research Fellowship	ABACUS; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Raine Priming Grant; Curtin Institute for Computation; Curtin Research Fellowship	This work was partially supported by ABACUS, CONACyT grant EDOMEX-2011-C01-165873. M.A. is a recipient of a Raine Priming Grant, Operational Research Support from the Curtin Institute for Computation, and a Curtin Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the warm and enthusiastic support from professor Isidoro Glitler, director of ABACUS supercomputer center. As well, thank to professor Arthur Lander, for his time to listen our research: high valuable feedback we got from. This work was partially supported by ABACUS, CONACyT grant EDOMEX-2011-001-165873. M.A. is a recipient of a Raine Priming Grant, Operational Research Support from the Curtin Institute for Computation, and a Curtin Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Alvarado M, 2017, ARXIV171007360CS; Arredondo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118611; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bethge A, 2015, J BIOMED INFORM, V57, P74, DOI 10.1016/j.jbi.2015.07.011; Bonaccorsi E, 2001, PHYS CHEM MINER, V28, P509, DOI 10.1007/s002690100179; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bouzy B, 2001, ARTIF INTELL, V132, P39, DOI 10.1016/S0004-3702(01)00127-8; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chin AR, 2016, CLIN CANCER RES, V22, P3725, DOI 10.1158/1078-0432.CCR-16-0028; Cho SH, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0341-9; Crespi B, 2005, TRENDS ECOL EVOL, V20, P545, DOI 10.1016/j.tree.2005.07.007; Curado MP, 2014, ANN GLOB HEALTH, V80, P370, DOI 10.1016/j.aogh.2014.09.009; Eftimie R, 2011, B MATH BIOL, V73, P2, DOI 10.1007/s11538-010-9526-3; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Friedl P, 2003, BIOCHEM SOC SYMP, V70, P277, DOI 10.1042/bss0700277; Graepel T, 2001, LECT NOTES COMPUTER, V2130; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Haeno H, 2012, CELL, V148, P362, DOI 10.1016/j.cell.2011.11.060; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haridas P, 2017, PEERJ, V5, DOI 10.7717/peerj.3754; Hong WS, 2015, CANCER RES, V75, P4021, DOI 10.1158/0008-5472.CAN-15-1889; Hue M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-144; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong Sh, 1994, KOREAN GO ASS LEARN; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Krieger MH, 1996, CONSTITUTIONS MATTER; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Llanos-Perez JA, 2016, PHYSICA A, V462, P560, DOI 10.1016/j.physa.2016.06.086; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; MATSUDA H, 1981, PROG THEOR PHYS, V66, P1078, DOI 10.1143/PTP.66.1078; McDougall SR, 2002, B MATH BIOL, V64, P673, DOI 10.1006/bulm.2002.0293; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Naxerova K, 2015, NAT REV CLIN ONCOL, V12, P258, DOI 10.1038/nrclinonc.2014.238; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Paget S, 1989, LANCET, V8, P98, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Parkin DM, 2011, J EPIDEMIOL COMMUN H, V65, pA143, DOI 10.1136/jech.2011.142976e.69; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Peng L, 2017, B MATH BIOL, V79, P389, DOI 10.1007/s11538-016-0237-2; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Reiter JG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14114; Retsky MW, 1997, BREAST CANCER RES TR, V45, P193, DOI 10.1023/A:1005849301420; Sartakhti JS, 2017, J THEOR BIOL, V412, P17, DOI 10.1016/j.jtbi.2016.09.019; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stewart B. W., 2003, World Cancer Report; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van de Vijver M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1687; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weiss L, 2000, METASTASIS CANC CONC; WU FY, 1982, REV MOD PHYS, V54, P235, DOI 10.1103/RevModPhys.54.235; Yee A, 2012, LECT NOTES ARTIF INT, V7637, P11, DOI 10.1007/978-3-642-34654-5_2; Young NP, 2010, P NATL ACAD SCI USA, V107, P10184, DOI 10.1073/pnas.1004796107; Zuleyha A, 2017, PHYSICA A, V486, P901, DOI 10.1016/j.physa.2017.05.096	65	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195654	10.1371/journal.pone.0195654	http://dx.doi.org/10.1371/journal.pone.0195654			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718932	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900027
J	von Martial, R; Gralla, J; Mordasini, P; El Koussy, M; Bellwald, S; Volbers, B; Kurmann, R; Jung, S; Fischer, U; Arnold, M; Sarikaya, H				von Martial, Rascha; Gralla, Jan; Mordasini, Pasquale; El Koussy, Marwan; Bellwald, Sebastian; Volbers, Bastian; Kurmann, Rebekka; Jung, Simon; Fischer, Urs; Arnold, Marcel; Sarikaya, Hakan			Impact of smoking on stroke outcome after endovascular treatment	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN-ACTIVATOR; INTERNAL CAROTID-ARTERY; FLOW RESTORATION DEVICE; MIDDLE CEREBRAL-ARTERY; INFARCTION TIMI TRIAL; INTRAARTERIAL THROMBOLYSIS; MYOCARDIAL-INFARCTION; INTRAVENOUS THROMBOLYSIS; CARDIOEMBOLIC STROKE	Background Recent studies suggest a paradoxical association between smoking status and clinical outcome after intravenous thrombolysis (IVT). Little is known about relationship between smoking and stroke outcome after endovascular treatment (EVT). Methods We analyzed data of all stroke patients treated with EVT at the tertiary stroke centre of Berne between January 2005 and December 2015. Using uni- and multivariate modeling, we assessed whether smoking was independently associated with excellent clinical outcome (modified Rankin Scale (mRS) 0-1) and mortality at 3 months. In addition, we also measured the occurrence of symptomatic intracranial hemorrhage (sICH) and recanalization. Results Of 935 patients, 204 (21.8%) were smokers. They were younger (60.5 vs. 70.1 years of age, p<0.001), more often male (60.8% vs. 52.5%, p = 0.036), had less often from hypertension (56.4% vs. 69.6%, p<0.001) and were less often treated with antithrombotics (35.3% vs. 47.7%, p = 0.004) as compared to nonsmokers. In univariate analyses, smokers had higher rates of excellent clinical outcome (39.1% vs. 23.1%, p<0.001) and arterial recanalization (85.6% vs. 79.4%, p = 0.048), whereas mortality was lower (15.6% vs. 25%, p = 0.006) and frequency of sICH similar (4.4% vs. 4.1%, p = 0.86). After correcting for confounders, smoking still independently predicted excellent clinical outcome (OR 1.758, 95% CI 1.206-2.562; p<0.001). Conclusion Smoking in stroke patients may be a predictor of excellent clinical outcome after EVT. However, these data must not be misinterpreted as beneficial effect of smoking due to the observational study design. In view of deleterious effects of cigarette smoking on cardiovascular health, cessation of smoking should still be strongly recommended for stroke prevention.	[von Martial, Rascha; Bellwald, Sebastian; Volbers, Bastian; Kurmann, Rebekka; Jung, Simon; Fischer, Urs; Arnold, Marcel; Sarikaya, Hakan] Univ Hosp Bern, Dept Neurol, Inselspital, Bern, Switzerland; [von Martial, Rascha; Gralla, Jan; Mordasini, Pasquale; El Koussy, Marwan; Bellwald, Sebastian; Volbers, Bastian; Kurmann, Rebekka; Jung, Simon; Fischer, Urs; Arnold, Marcel; Sarikaya, Hakan] Univ Bern, Bern, Switzerland; [Gralla, Jan; Mordasini, Pasquale; El Koussy, Marwan] Univ Hosp Bern, Dept Diagnost & Intervent Neuroradiol, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Sarikaya, H (corresponding author), Univ Hosp Bern, Dept Neurol, Inselspital, Bern, Switzerland.; Sarikaya, H (corresponding author), Univ Bern, Bern, Switzerland.	hakan.sarikaya@insel.ch	Volbers, Bastian/J-6154-2019; Mordasini, Pasquale/H-8321-2015	Volbers, Bastian/0000-0003-0453-1530; Fischer, Urs/0000-0003-0521-4051	Bangerter Foundation; Hermann Klaus Foundation; Swiss Heart Foundation; Swiss National Science Foundation	Bangerter Foundation; Hermann Klaus Foundation; Swiss Heart Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	HS has received research grants from Bangerter Foundation, Hermann Klaus Foundation, the Swiss Heart Foundation and the Swiss National Science Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ali SF, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000171; Arboix A, 2011, EXPERT REV CARDIOVAS, V9, P367, DOI [10.1586/ERC.10.192, 10.1586/erc.10.192]; Arboix A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-47; Aries MJH, 2009, EUR J NEUROL, V16, P819, DOI 10.1111/j.1468-1331.2009.02596.x; Arnold M, 2004, J NEUROL NEUROSUR PS, V75, P857, DOI 10.1136/jnnp.2003.020479; Arnold M, 2002, STROKE, V33, P1828, DOI 10.1161/01.STR.0000020713.89227.B7; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bhatia R, 2014, INT J STROKE, V9, P974, DOI 10.1111/j.1747-4949.2012.00890.x; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; De Silva DA, 2009, J CLIN NEUROSCI, V16, P501, DOI 10.1016/j.jocn.2008.07.068; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; ERNST E, 1987, BRIT J HAEMATOL, V65, P485, DOI 10.1111/j.1365-2141.1987.tb04155.x; Fischer U, 2013, EUR J NEUROL, V20, P1017, DOI 10.1111/ene.12094; Galimanis A, 2012, STROKE, V43, P1052, DOI 10.1161/STROKEAHA.111.639112; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Heldner MR, 2015, J NEUROL NEUROSUR PS, V86, P755, DOI 10.1136/jnnp-2014-308401; Hussein HM, 2017, NICOTINE TOB RES, V19, P871, DOI 10.1093/ntr/ntx020; Kirtane AJ, 2005, J AM COLL CARDIOL, V45, P321, DOI 10.1016/j.jacc.2004.10.018; Kufner A, 2013, STROKE, V44, P407, DOI 10.1161/STROKEAHA.112.662148; Kvistad CE, 2014, ACTA NEUROL SCAND, V130, P299, DOI 10.1111/ane.12225; Luedi R, 2014, J NEUROL, V261, P1622, DOI 10.1007/s00415-014-7401-0; MCGILL HC, 1988, AM HEART J, V115, P250, DOI 10.1016/0002-8703(88)90645-X; Medlin F, 2015, STROKE, V46, P126, DOI 10.1161/STROKEAHA.114.006408; Meseguer E, 2014, CEREBROVASC DIS EXTR, V4, P84, DOI 10.1159/000357218; Middleton ET, 2000, CHEST, V117, P758, DOI 10.1378/chest.117.3.758; Nedeltchev K, 2006, STROKE, V37, P3002, DOI 10.1161/01.STR.0000249417.24085.80; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Oesterle A, 2017, CIRC RES, V120, P229, DOI 10.1161/CIRCRESAHA.116.308537; Olsen TS, 2007, STROKE, V38, P2646, DOI 10.1161/STROKEAHA.107.490292; Ovbiagele B, 2005, NEUROLOGY, V65, P293, DOI 10.1212/01.WNL.0000168163.72351.f3; Palnum KD, 2008, AGE AGEING, V37, P90, DOI 10.1093/ageing/afm134; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Purcell IF, 1999, QJM-INT J MED, V92, P327, DOI 10.1093/qjmed/92.6.327; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Saver JL, 2014, INT J STROKE, V9, P658, DOI 10.1111/j.1747-4949.2012.00856.x; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Smith EE, 2010, CIRCULATION, V122, P1496, DOI 10.1161/CIRCULATIONAHA.109.932822; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; SPARROW D, 1978, J CHRON DIS, V31, P425, DOI 10.1016/0021-9681(78)90006-1; Tong X, 2016, STROKE, V47, P1811, DOI 10.1161/STROKEAHA.116.013124; Undas A, 2009, THROMB HAEMOSTASIS, V102, P1289, DOI 10.1160/TH09-03-0187; Urbach H, 2002, NEURORADIOLOGY, V44, P695, DOI 10.1007/s00234-002-0762-6; Vanacker P, 2015, J STROKE CEREBROVASC, V24, P1781, DOI 10.1016/j.jstrokecerebrovasdis.2015.04.002; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wang XG, 2015, CNS NEUROSCI THER, V21, P657, DOI 10.1111/cns.12421; WHO, 2015, WHO GLOB REP TRENDS; Yaghi S, 2016, NEUROHOSPITALIST, V6, P102, DOI 10.1177/1941874416641466; Zaidat OO, 2013, STROKE, V44, P2650, DOI 10.1161/STROKEAHA.113.001972	54	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0194652	10.1371/journal.pone.0194652	http://dx.doi.org/10.1371/journal.pone.0194652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718909	Green Submitted, Green Published, gold			2022-12-26	WOS:000431281900009
J	Kota, S; Hou, SR; Guerrant, W; Madoux, F; Troutman, S; Fernandez-Vega, V; Alekseeva, N; Madala, N; Scampavia, L; Kissil, J; Spicer, TP				Kota, Smitha; Hou, Shurong; Guerrant, William; Madoux, Franck; Troutman, Scott; Fernandez-Vega, Virneliz; Alekseeva, Nina; Madala, Neeharika; Scampavia, Louis; Kissil, Joseph; Spicer, Timothy P.			A novel three-dimensional high-throughput screening approach identifies inducers of a mutant KRAS selective lethal phenotype	ONCOGENE			English	Article							HUMAN CANCER-CELLS; SYNTHETIC LETHALITY; K-RAS; DRUG DISCOVERY; SMALL-MOLECULE; IN-VITRO; CULTURE; 3D; 3RD-DIMENSION; SPHEROIDS	The RAS proteins are the most frequently mutated oncogenes in cancer, with highest frequency found in pancreatic, lung, and colon tumors. Moreover, the activity of RAS is required for the proliferation and/or survival of these tumor cells and thus represents a high-value target for therapeutic development. Direct targeting of RAS has proven challenging for multiple reasons stemming from the biology of the protein, the complexity of downstream effector pathways and upstream regulatory networks. Thus, significant efforts have been directed at identifying downstream targets on which RAS is dependent. These efforts have proven challenging, in part due to confounding factors such as reliance on two-dimensional adherent monolayer cell cultures that inadequately recapitulate the physiologic context to which cells are exposed in vivo. To overcome these issues, we implemented a high-throughput screening (HTS) approach using a spheroid-based 3-dimensional culture format, thought to more closely reflect conditions experienced by cells in vivo. Using isogenic cell pairs, differing in the status of KRAS, we identified Proscillaridin A as a selective inhibitor of cells harboring the oncogenic KRas(G12v) allele. Significantly, the identification of Proscillaridin A was facilitated by the 3D screening platform and would not have been discovered employing standard 2D culturing methods.	[Kota, Smitha; Hou, Shurong; Guerrant, William; Madoux, Franck; Troutman, Scott; Fernandez-Vega, Virneliz; Alekseeva, Nina; Madala, Neeharika; Scampavia, Louis; Kissil, Joseph; Spicer, Timothy P.] Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA; [Madoux, Franck] Amgen Inc, Thousand Oaks, CA 91320 USA	Scripps Research Institute; Amgen	Kissil, J; Spicer, TP (corresponding author), Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA.	jkissil@scripps.edu; spicert@scripps.edu			National Cancer Institute of the National Institutes of Health [R33CA206949, CA124495]; NATIONAL CANCER INSTITUTE [R01CA124495, R33CA206949] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Pierre Baillargeon and Lina Deluca at Scripps for their help with compound management. This work was supported in part by the National Cancer Institute of the National Institutes of Health under Award Number R33CA206949 (TPS) and CA124495 (JK).	Alevizopoulos K, 2014, CURR DRUG TARGETS, V15, P988, DOI 10.2174/1389450115666140908125025; Antoni D, 2015, INT J MOL SCI, V16, P5517, DOI 10.3390/ijms16035517; Babij C, 2011, CANCER RES, V71, P5818, DOI 10.1158/0008-5472.CAN-11-0778; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bittker JA., 2010, SCREEN RAS SELECTIVE; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Delebinski CI, 2015, CELL PROLIFERAT, V48, P600, DOI 10.1111/cpr.12208; Denicolai E, 2014, ONCOTARGET, V5, P10934, DOI 10.18632/oncotarget.2541; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Felth J, 2009, J NAT PROD, V72, P1969, DOI 10.1021/np900210m; Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003; Foster SA, 2016, CANCER CELL, V29, P477, DOI 10.1016/j.ccell.2016.02.010; Guo W, 2008, CANCER RES, V68, P7403, DOI 10.1158/0008-5472.CAN-08-1449; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; Kim N, 2016, SCI REP-UK, V6, DOI 10.1038/srep29721; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Longati P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-95; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo TP, 2012, P NATL ACAD SCI USA, V109, P2860, DOI 10.1073/pnas.1120589109; Madoux F, 2017, SLAS DISCOV, V22, P516, DOI 10.1177/2472555216686308; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Powell K, 2017, SCIENCE, V356, P96, DOI 10.1126/science.356.6333.96; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Ramaiahgari SC, 2014, ARCH TOXICOL, V88, P1083, DOI 10.1007/s00204-014-1215-9; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shaw AT, 2011, P NATL ACAD SCI USA, V108, P8773, DOI 10.1073/pnas.1105941108; Singh A, 2009, CELL CYCLE, V8, P2676, DOI 10.4161/cc.8.17.9336; Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Verjans ET, 2018, J CELL PHYSIOL, V233, P2993, DOI 10.1002/jcp.26052; Vicent S, 2010, J CLIN INVEST, V120, P3940, DOI 10.1172/JCI44165; Wang Y, 2010, ONCOGENE, V29, P4658, DOI 10.1038/onc.2010.218; Weiwer M, 2012, ACS MED CHEM LETT, V3, P1034, DOI 10.1021/ml300246r; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zanoni M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19103; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	39	17	17	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 9	2018	37	32					4372	4384		10.1038/s41388-018-0257-5	http://dx.doi.org/10.1038/s41388-018-0257-5			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP8FA	29743592	Green Accepted			2022-12-26	WOS:000441144300003
J	Mbonye, U; Wang, BL; Gokulrangan, G; Shi, WX; Yang, SC; Karn, J				Mbonye, Uri; Wang, Benlian; Gokulrangan, Giridharan; Shi, Wuxian; Yang, Sichun; Karn, Jonathan			Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); transcription elongation factor; bromodomain-containing protein 4 (BRD4); heat-shock protein 90 (Hsp90); 7SK snRNP; proteomics; post-translational modification (PTM); Cdc37; HIV latency; P-TEFb; super-elongation complex; Tat; CDK activation loop	IMMUNODEFICIENCY-VIRUS TRANSCRIPTION; NEGATIVE ELONGATION-FACTOR; RNA-POLYMERASE-II; 7SK SNRNP; CDK9/CYCLIN T1; TYPE-1 TAT; FACTOR-B; COMPLEX; HSP90; LATENCY	The HIV trans-activator Tat recruits the host transcription elongation factor P-TEFb to stimulate proviral transcription. Phosphorylation of Thr-186 on the activation loop (T-loop) of cyclin-dependent kinase 9 (CDK9) is essential for its kinase activity and assembly of CDK9 and cyclin T1 (CycT1) to form functional P-TEFb. Phosphorylation of a second highly conserved T-loop site, Ser-175, alters the competitive binding of Tat and the host recruitment factor bromodomain containing 4 (BRD4) to P-TEFb. Here, we investigated the intracellular mechanisms that regulate these key phosphorylation events required for HIV transcription. Molecular dynamics simulations revealed that the CDK9/CycT1 interface is stabilized by intramolecular hydrogen bonding of pThr-186 by an arginine triad and Glu-96 of CycT1. Arginine triad substitutions that disrupted CDK9/CycT1 assembly accumulated Thr-186-dephosphorylated CDK9 associated with the cytoplasmic Hsp90/Cdc37 chaperone. The Hsp90/Cdc37/CDK9 complex was also present in resting T cells, which lack CycT1. Hsp90 inhibition in primary T cells blocked P-TEFb assembly, disrupted Thr-186 phosphorylation, and suppressed proviral reactivation. The selective CDK7 inhibitor THZ1 blocked CDK9 phosphorylation at Ser-175, and in vitro kinase assays confirmed that CDK7 activity is principally responsible for Ser-175 phosphorylation. Mutation of Ser-175 to Lys had no effect on CDK9 kinase activity or P-TEFb assembly but strongly suppressed both HIV expression and BRD4 binding. We conclude that the transfer of CDK9 from the Hsp90/Cdc37 complex induced by Thr-186 phosphorylation is a key step in P-TEFb biogenesis. Furthermore, we demonstrate that CDK7-mediated Ser-175 phosphorylation is a downstream nuclear event essential for facilitating CDK9 T-loop interactions with Tat.	[Mbonye, Uri; Karn, Jonathan] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Wang, Benlian; Gokulrangan, Giridharan; Shi, Wuxian; Yang, Sichun] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Wang, Benlian; Gokulrangan, Giridharan; Shi, Wuxian; Yang, Sichun] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Gokulrangan, Giridharan] Bristol Myers Squibb, Wallingford, CT 06492 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Bristol-Myers Squibb	Karn, J (corresponding author), Case Western Reserve Univ, Dept Mol Biol & Microbiol, 10900 Euclid Ave,LC4860, Cleveland, OH 44106 USA.	jonathan.karn@case.edu	Mbonye, Uri/AAG-8861-2020; Yang, Sichun/B-1608-2008	Mbonye, Uri/0000-0002-7694-0803; Yang, Sichun/0000-0002-1726-0576	National Institutes of Health Public Health Service [R01 DA043159, R01 DA036171, R01 DE025464, R01 AI120204, R33 AI110156]; American Foundation for AIDS Research (amfAR) [108266-51-RFRL, 108836-55-RGRL]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, R01AI120204, R33AI110156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA043159, R01DA036171] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); American Foundation for AIDS Research (amfAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Public Health Service Grants R01 DA043159, R01 DA036171, R01 DE025464, R01 AI120204, and R33 AI110156 and American Foundation for AIDS Research (amfAR) Grants 108266-51-RFRL and 108836-55-RGRL (to the Karn laboratory). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ammosova Tatiana, 2011, PLoS One, V6, pe18985, DOI 10.1371/journal.pone.0018985; Ammosova T, 2011, J BIOL CHEM, V286, P3798, DOI 10.1074/jbc.M110.196493; Anderson I, 2014, P NATL ACAD SCI USA, V111, pE1528, DOI 10.1073/pnas.1320178111; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Bourgeois CF, 2002, MOL CELL BIOL, V22, P1079, DOI 10.1128/MCB.22.4.1079-1093.2002; Budhiraja S, 2013, J VIROL, V87, P1211, DOI 10.1128/JVI.02413-12; Budhiraja S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-52; Calderwood Stuart K, 2015, Subcell Biochem, V78, P103, DOI 10.1007/978-3-319-11731-7_5; Case DA, 2012, AMBER 12; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Chiang K, 2012, J VIROL, V86, P3244, DOI 10.1128/JVI.05065-11; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; DINGWALL C, 1990, EMBO J, V9, P4145, DOI 10.1002/j.1460-2075.1990.tb07637.x; Dow EC, 2010, J CELL PHYSIOL, V224, P84, DOI 10.1002/jcp.22096; FEINBERG MB, 1991, P NATL ACAD SCI USA, V88, P4045, DOI 10.1073/pnas.88.9.4045; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Fisher Robert P, 2012, Genes Cancer, V3, P731, DOI 10.1177/1947601912473308; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Fujinaga K, 2012, NUCLEIC ACIDS RES, V40, P9160, DOI 10.1093/nar/gks682; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Fukuyo Y, 2010, CANCER LETT, V290, P24, DOI 10.1016/j.canlet.2009.07.010; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Gudipaty SA, 2015, MOL CELL BIOL, V35, P3810, DOI 10.1128/MCB.00226-15; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jadlowsky JK, 2014, MOL CELL BIOL, V34, P1911, DOI 10.1128/MCB.01013-13; Joshi P, 2016, J BIOL CHEM, V291, P10332, DOI 10.1074/jbc.M116.717538; Keen NJ, 1996, P NATL ACAD SCI USA, V93, P2505, DOI 10.1073/pnas.93.6.2505; Kim YK, 2011, J MOL BIOL, V410, P896, DOI 10.1016/j.jmb.2011.03.054; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Kobbi L, 2016, P NATL ACAD SCI USA, V113, P12721, DOI 10.1073/pnas.1612331113; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Margolis DM, 2016, SCIENCE, V353, P362, DOI 10.1126/science.aaf6517; Marz M, 2009, MOL BIOL EVOL, V26, P2821, DOI 10.1093/molbev/msp198; Mbonye U, 2017, ANNU REV VIROL, V4, P261, DOI 10.1146/annurev-virology-101416-041646; Mbonye U, 2014, VIROLOGY, V454, P328, DOI 10.1016/j.virol.2014.02.008; Mbonye UR, 2015, PROTEOMICS, V15, P2078, DOI 10.1002/pmic.201500038; Mbonye UR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003338; McNamara RP, 2013, CELL REP, V5, P1256, DOI 10.1016/j.celrep.2013.11.003; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Miyata Y, 2005, MOL CELL BIOCHEM, V274, P171, DOI 10.1007/s11010-005-2949-8; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Nilson KA, 2015, MOL CELL, V59, P576, DOI 10.1016/j.molcel.2015.06.032; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Passinen S, 2001, EUR J BIOCHEM, V268, P5337, DOI 10.1046/j.0014-2956.2001.02467.x; Pearson R, 2008, J VIROL, V82, P12291, DOI 10.1128/JVI.01383-08; Prasanth KV, 2010, MOL BIOL CELL, V21, P4184, DOI 10.1091/mbc.E10-02-0105; Ramakrishnan R, 2012, J CELL PHYSIOL, V227, P609, DOI 10.1002/jcp.22760; Ramakrishnan R, 2009, J LEUKOCYTE BIOL, V86, P1345, DOI 10.1189/jlb.0509309; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Schuller R, 2016, MOL CELL, V61, P305, DOI 10.1016/j.molcel.2015.12.003; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Schulze-Gahmen U, 2016, ELIFE, V5, DOI 10.7554/eLife.15910; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Siliciano JD, 2016, J CLIN INVEST, V126, P409, DOI 10.1172/JCI86047; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Suh H, 2016, MOL CELL, V61, P297, DOI 10.1016/j.molcel.2015.12.021; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tillotson B, 2010, J BIOL CHEM, V285, P39835, DOI 10.1074/jbc.M110.141580; Wang Y, 2008, J BIOL CHEM, V283, P33578, DOI 10.1074/jbc.M807495200; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681	83	29	29	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10009	10025		10.1074/jbc.RA117.001347	http://dx.doi.org/10.1074/jbc.RA117.001347			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29743242	Green Published, hybrid			2022-12-26	WOS:000437096700007
J	Thomas, MK; Fontana, S; Reyes, M; Pomati, F				Thomas, Mridul K.; Fontana, Simone; Reyes, Marta; Pomati, Francesco			Quantifying cell densities and biovolumes of phytoplankton communities and functional groups using scanning flow cytometry, machine learning and unsupervised clustering	PLOS ONE			English	Article							NEURAL-NETWORK ANALYSIS; IDENTIFICATION; ECOLOGY; TRAITS	Scanning flow cytometry (SFCM) is characterized by the measurement of time-resolved pulses of fluorescence and scattering, enabling the high-throughput quantification of phytoplankton morphology and pigmentation. Quantifying variation at the single cell and colony level improves our ability to understand dynamics in natural communities. Automated high-frequency monitoring of these communities is presently limited by the absence of repeatable, rapid protocols to analyse SFCM datasets, where images of individual particles are not available. Here we demonstrate a repeatable, semi-automated method to (1) rapidly clean SFCM data from a phytoplankton community by removing signals that do not belong to live phytoplankton cells, (2) classify individual cells into trait clusters that correspond to functional groups, and (3) quantify the biovolumes of individual cells, the total biovolume of the whole community and the total biovolumes of the major functional groups. Our method involves the development of training datasets using lab cultures, the use of an unsupervised clustering algorithm to identify trait clusters, and machine learning tools (random forests) to (1) evaluate variable importance, (2) classify data points, and (3) estimate biovolumes of individual cells. We provide example datasets and R code for our analytical approach that can be adapted for analysis of datasets from other flow cytometers or scanning flow cytometers.	[Thomas, Mridul K.; Fontana, Simone; Reyes, Marta; Pomati, Francesco] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland; [Thomas, Mridul K.] Tech Univ Denmark, Ctr Ocean Life, DTU Aqua, Lyngby, Denmark; [Fontana, Simone] Swiss Fed Res Inst WSL, Biodivers & Conservat Biol, Birmensdorf, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Technical University of Denmark; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Thomas, MK (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland.; Thomas, MK (corresponding author), Tech Univ Denmark, Ctr Ocean Life, DTU Aqua, Lyngby, Denmark.	mrit@dtu.dk	; Fontana, Simone/AFS-0846-2022	Thomas, Mridul/0000-0002-5089-5610; Fontana, Simone/0000-0003-1194-1909	Swiss National Science Foundation [CRSI12_147654]; Villum Fonden [00007178] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Villum Fonden(Villum Fonden)	This work was supported by the Swiss National Science Foundation (http://www.snf.ch/en/Pages/default.aspx) project CRSI12_147654, "In-situ Sensing Tools for Understanding Rapid Microscale Plankton Dynamics", awarded to FP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Aghaeepour N, 2011, CYTOM PART A, V79A, P6, DOI 10.1002/cyto.a.21007; Arnoldini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080117; BALFOORT HW, 1992, J PLANKTON RES, V14, P575, DOI 10.1093/plankt/14.4.575; Besmer MD, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00265; Boddy L, 2000, MAR ECOL PROG SER, V195, P47, DOI 10.3354/meps195047; Boddy L, 2001, CYTOMETRY, V44, P195, DOI 10.1002/1097-0320(20010701)44:3<195::AID-CYTO1112>3.0.CO;2-H; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Dubelaar GBJ, 2000, SCI MAR, V64, P255, DOI 10.3989/scimar.2000.64n2255; Dubelaar GBJ, 2000, SCI MAR, V64, P135, DOI 10.3989/scimar.2000.64n2135; Edwards KF, 2015, LIMNOL OCEANOGR, V60, P540, DOI 10.1002/lno.10033; Edwards KF, 2012, LIMNOL OCEANOGR, V57, P554, DOI 10.4319/lo.2012.57.2.0554; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Foladori P, 2008, WATER RES, V42, P3757, DOI 10.1016/j.watres.2008.06.026; Ge Y, 2012, BIOINFORMATICS, V28, P2052, DOI 10.1093/bioinformatics/bts300; Gluge S, 2014, COMM COM INF SC, V438, P379; Hammes F, 2010, ANAL BIOANAL CHEM, V397, P1083, DOI 10.1007/s00216-010-3646-3; Hunter-Cevera KR, 2014, P NATL ACAD SCI USA, V111, P9852, DOI 10.1073/pnas.1321421111; Hyrkas J, 2016, BIOINFORMATICS, V32, P417, DOI 10.1093/bioinformatics/btv594; Jain A., 1988, ALGORITHMS CLUSTERIN; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Lo K, 2008, CYTOM PART A, V73A, P321, DOI 10.1002/cyto.a.20531; Malkassian A, 2011, CYTOM PART A, V79A, P263, DOI 10.1002/cyto.a.21035; Newell EW, 2016, NAT IMMUNOL, V17, P890, DOI 10.1038/ni.3485; Parsons L., 2004, ACM SIGKDD EXPLORATI, V6, P90, DOI [10.1145/1007730.1007731, DOI 10.1145/1007730.1007731]; Pomati F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071677; Pomati F, 2013, ECOTOXICOLOGY, V22, P779, DOI 10.1007/s10646-013-1068-7; Pomati F, 2011, ENVIRON SCI TECHNOL, V45, P9658, DOI 10.1021/es201934n; R Core Team, 2021, R LANGUAGE ENV STAT; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Sosik HM, 2007, LIMNOL OCEANOGR-METH, V5, P204, DOI 10.4319/lom.2007.5.204; Sosik HM, 2010, DEVEL APPL PHYCOL, V4, P171, DOI 10.1007/978-90-481-9268-7_8; Steinberg CEW, 1996, ARCH TOX S, V18, P417; Stoop R, 2016, CHAOS SOLITON FRACT, V90, P81, DOI 10.1016/j.chaos.2016.02.035; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; Thomas MK, 2017, DATASET QUANTIFYING, DOI [10.5281/zenodo.977772, DOI 10.5281/ZENODO.977772]; Thomas MK, 2017, R CODE CLEANING CLUS, DOI [10.5281/zenodo.999747, DOI 10.5281/ZENODO.999747]; Utermohl H., 1931, Verhandlungen der Internationalen Vereinigung fuer Theoretische Limnologie Stuttgart, V5, P567; Wang YY, 2010, TRENDS BIOTECHNOL, V28, P416, DOI 10.1016/j.tibtech.2010.04.006	42	18	18	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196225	10.1371/journal.pone.0196225	http://dx.doi.org/10.1371/journal.pone.0196225			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746500	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700012
J	Lumsangkul, C; Fan, YK; Chang, SC; Ju, JC; Chiang, HI				Lumsangkul, Chompunut; Fan, Yang-Kwang; Chang, Shen-Chang; Ju, Jyh-Cherng; Chiang, Hain-, I			Characterizing early embryonic development of Brown Tsaiya Ducks (Anas platyrhynchos) in comparison with Taiwan Country Chicken (Gallus gallus domestics)	PLOS ONE			English	Article							CHORIOALLANTOIC MEMBRANE; ARTIFICIAL-INSEMINATION; JAPANESE-QUAIL; MODEL; SEMEN; INCUBATION; FERTILITY; SELECTION; DRAKES	Avian embryos are among the most convenient and the primary representatives for the study of classical embryology. It is well-known that the hatching time of duck embryos is approximately one week longer than that of chicken embryos. However, the key features associated with the slower embryonic development in ducks have not been adequately described. This study aimed to characterize the pattern and the speed of early embryogenesis in Brown Tsaiya Ducks (BTD) compared with those in Taiwan Country Chicken (TCC) by using growth parameters including embryonic crown-tail length (ECTL), primitive streak formation, somitogenesis, and other development-related parameters, during the first 72 h of incubation. Three hundred and sixty eggs from BTD and TCC, respectively, were incubated at 37.2 degrees C, and were then dissected hourly to evaluate their developmental stages. We found that morphological changes of TCC embryos shared a major similarity with that of the Hamburger and Hamilton staging system during early chick embryogenesis. The initial primitive streak in TCC emerged between 6 and 7 h post-incubation, but its emergence was delayed until 10 to 13 h post-incubation in BTD. Similarly, the limb primordia (wing and limb buds) were observed at 51 h post-incubation in TCC embryos compared to 64 h post-incubation in BTD embryos. The allantois first appeared around 65 to 68 h in TCC embryos, but it was not observed in BTD embryos. At the 72 h post-incubation, 40 somites were clearly formed in TCC embryos while only 32 somites in BTD embryos. Overall, the BTD embryos developed approximately 16 h slower than the chicken embryo during the first 72 h of development. To our best knowledge, this is the first study to describe two distinct developmental time courses between TCC and BTD, which would facilitate future embryogenesis-related studies of the two important avian species in Taiwan.	[Lumsangkul, Chompunut; Fan, Yang-Kwang; Ju, Jyh-Cherng; Chiang, Hain-, I] Natl Chung Hsing Univ, Dept Anim Sci, Taichung, Taiwan; [Chang, Shen-Chang] Council Agr, Livestock Res Inst, Kaohsiung Anim Propagat Stn, Pingtung, Taiwan; [Ju, Jyh-Cherng] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Ju, Jyh-Cherng] China Med Univ Hosp, Med Res Dept, Core Lab Stem Cell Res, Taichung, Taiwan; [Ju, Jyh-Cherng] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	National Chung Hsing University; Taiwan Livestock Research Institute; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Ju, JC; Chiang, HI (corresponding author), Natl Chung Hsing Univ, Dept Anim Sci, Taichung, Taiwan.; Ju, JC (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.; Ju, JC (corresponding author), China Med Univ Hosp, Med Res Dept, Core Lab Stem Cell Res, Taichung, Taiwan.; Ju, JC (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	jcju@dragon.nchu.edu.tw; samchiang@nchu.edu.tw		Lumsangkul, Chompunut/0000-0003-2014-5306				Ainsworth SJ, 2010, J ANAT, V216, P3, DOI 10.1111/j.1469-7580.2009.01173.x; Bekele M. W., 2016, African Journal of Agricultural Research, V11, P3418; Bergtold WH, 1971, STUDY INCUBATION PER; Burggren WW, 2016, REV BRAS ZOOTECN, V45, P709, DOI [10.1590/S1806-92902016001100010, 10.1590/s1806-92902016001100010]; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Cheng YS, 2002, GENET SEL EVOL, V34, P597, DOI [10.1051/gse:2002025, 10.1186/1297-9686-34-5-597]; Dias MS., 2004, FOC, V16, P1, DOI [10.3171/foc.2004.16.2.2, DOI 10.3171/FOC.2004.16.2.2]; Dupuy V, 2002, POULTRY SCI, V81, P860, DOI 10.1093/ps/81.6.860; Eleroglu H, 2016, BRAZ J POULTRY SCI, V18, P61, DOI 10.1590/1806-9061-2015-0154; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Iqbal J, 2016, J APPL ANIM RES, V44, P54, DOI 10.1080/09712119.2014.987294; Kaltofen RS, 1971, EMBRYONIC DEV EGGS P; KOECKE HANS-ULRICH, 1958, EMBRYOLOGIA, V4, P55, DOI 10.1111/j.1440-169X.1958.tb00147.x; Kue CS, 2015, EXP ANIM TOKYO, V64, P129, DOI 10.1538/expanim.14-0059; Liu HC, 2015, ASIAN AUSTRAL J ANIM, V28, P605, DOI 10.5713/ajas.14.0740; Lotvedt P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103040; Lukaszewicz E, 2017, POULTRY SCI, P1, DOI [10.3382/ps/pew282, DOI 10.3382/PS/PEW282]; Nagai H, 2011, DEV DYNAM, V240, P162, DOI 10.1002/dvdy.22520; Ng'ambi JW, 2013, S AFR J ANIM SCI, V43, pS69, DOI 10.4314/sajas.v43i5.13; Padhi MK, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/2604685; Poivey JP, 2001, POULTRY SCI, V80, P703, DOI 10.1093/ps/80.6.703; Pourquie O, 2004, MECH DEVELOP, V121, P1069, DOI 10.1016/j.mod.2004.05.002; Ramaphala N. O., 2013, Asian Journal of Animal and Veterinary Advances, V8, P885, DOI 10.3923/ajava.2013.885.892; Resende TP, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/718683; Ribatti D, 1996, INT J DEV BIOL, V40, P1189; Ribatti D, 2016, MECH DEVELOP, V141, P70, DOI 10.1016/j.mod.2016.05.003; ROUVIER R, 1984, C INRA INS ART AM GE, P360; SCHOENWOLF GC, 1992, DEV DYNAM, V193, P235, DOI 10.1002/aja.1001930304; Sellier N, 2006, J APPL POULTRY RES, V15, P219, DOI 10.1093/japr/15.2.219; Sellier N, 2005, THERIOGENOLOGY, V64, P429, DOI 10.1016/j.theriogenology.2004.12.010; Sirsat SKG, 2016, J EXP BIOL, V219, P1214, DOI 10.1242/jeb.132282; STERN CD, 1990, DEVELOPMENT, V109, P667; Tong Q, 2013, POULTRY SCI, V92, P620, DOI 10.3382/ps.2012-02509; Vasiev B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010571; WILSON HR, 1991, POULT SCI S, V22, P145	35	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196973	10.1371/journal.pone.0196973	http://dx.doi.org/10.1371/journal.pone.0196973			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742160	Green Submitted, Green Published, gold			2022-12-26	WOS:000431757400051
J	Maltz, RM; Keirsey, J; Kim, SC; Mackos, AR; Gharaibeh, RZ; Moore, CC; Xu, JY; Bakthavatchalu, V; Somogyi, A; Bailey, MT				Maltz, Ross M.; Keirsey, Jeremy; Kim, Sandra C.; Mackos, Amy R.; Gharaibeh, Raad Z.; Moore, Cathy C.; Xu, Jinyu; Bakthavatchalu, Vasudevan; Somogyi, Arpad; Bailey, Michael T.			Prolonged restraint stressor exposure in outbred CD-1 mice impacts microbiota, colonic inflammation, and short chain fatty acids	PLOS ONE			English	Article							PROBIOTIC LACTOBACILLUS-REUTERI; CHRONIC PSYCHOSOCIAL STRESS; PROTEIN-COUPLED RECEPTOR; DSS-INDUCED COLITIS; CITROBACTER-RODENTIUM; NICOTINIC-ACID; MOLECULAR-IDENTIFICATION; ENTEROENDOCRINE CELLS; GAS-CHROMATOGRAPHY; ENHANCED SEVERITY	Stressor-exposure has been shown to exacerbate inflammation and change the composition of the gastrointestinal microbiota; however stressor-induced effects on microbiota-derived metabolites and their receptors are unknown. Thus, bacterial-produced short chain fatty acids (SCFAs), as well as microbial community composition, were assessed in the colons of mice exposed to stress during infection with Citrobacter rodentium. Mice were exposed to overnight restraint on 7 consecutive nights, or left undisturbed as a control. After the first exposure of restraint, mice were orally challenged with C. rodentium or with vehicle. Microbial community composition was assessed using 16S rRNA gene sequencing and SCFA levels measured using gas chromatography-mass spectrometry (GC-MS). Pathogen levels and colonic inflammation were also assessed 6 days post-infection. Results demonstrated that the microbial community structure and SCFA production were significantly affected by both stressor exposure and C. rodentium-infection. Exposure to prolonged restraint in the absence of infection significantly reduced SCFAs (acetic acid, butyric acid, and propionic acid). Multiple bacterial taxa were affected by stressor exposure, with the relative abundance of Lactobacillus being significantly reduced and directly correlated with propionic acid. Lactobacillus abundances were inversely correlated with colonic inflammation, supporting the contention that Lactobacillus helps to regulate mucosal inflammatory responses. Our data indicates that restraint stressor can have significant effects on pathogen-induced colonic inflammation and suggest that stressor-induced changes in the microbiota, microbial-produced SCFAs and their receptors may be involved.	[Maltz, Ross M.; Kim, Sandra C.] Nationwide Childrens Hosp, Pediat Gastroenterol, Columbus, OH 43205 USA; [Maltz, Ross M.; Mackos, Amy R.; Xu, Jinyu; Bailey, Michael T.] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Res Inst, Columbus, OH 43205 USA; [Maltz, Ross M.; Bailey, Michael T.] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA; [Keirsey, Jeremy; Somogyi, Arpad] Ohio State Univ, Campus Chem Instrumentat Ctr Mass Spec & Prote, Columbus, OH 43210 USA; [Kim, Sandra C.] Univ Pittsburgh, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15261 USA; [Gharaibeh, Raad Z.; Moore, Cathy C.] Univ North Carolina Charlotte, Dept Bioinformat & Genom, Charlotte, NC USA; [Gharaibeh, Raad Z.] Univ North Carolina Charlotte, Dept Bioinformat & Genom, Bioinformat Serv Div, Kannapolis, NC USA; [Bakthavatchalu, Vasudevan] MIT, Div Comparat Med, Cambridge, MA 02139 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte; Massachusetts Institute of Technology (MIT)	Maltz, RM (corresponding author), Nationwide Childrens Hosp, Pediat Gastroenterol, Columbus, OH 43205 USA.; Maltz, RM (corresponding author), Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Res Inst, Columbus, OH 43205 USA.; Maltz, RM (corresponding author), Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA.	Ross.Maltz@nationwidechildrens.org	Sheridan, John F/E-4081-2011	Bailey, Michael/0000-0002-2222-3980; Mackos, Amy/0000-0001-9882-3854	National Center for Complementary & Integrative Health of the National Institutes of Health [R01AT006552]; National Center for Complementary & Integrative Health [R01AT006552] Funding Source: NIH RePORTER	National Center for Complementary & Integrative Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Center for Complementary & Integrative Health of the National Institutes of Health under Award Number R01AT006552 (to M.T.B.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5724; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Bailey MT, 2004, J PEDIATR GASTR NUTR, V38, P414, DOI 10.1097/00005176-200404000-00009; Bailey MT, 1999, DEV PSYCHOBIOL, V35, P146, DOI 10.1002/(SICI)1098-2302(199909)35:2<146::AID-DEV7>3.0.CO;2-G; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Bernstein CN, 2010, AM J GASTROENTEROL, V105, P1994, DOI 10.1038/ajg.2010.140; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cavigelli SA, 2003, P NATL ACAD SCI USA, V100, P16131, DOI 10.1073/pnas.2535721100; Cresci GA, 2010, J GASTROINTEST SURG, V14, P449, DOI 10.1007/s11605-009-1045-x; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Do A, 2017, J PHARMACOL EXP THER, V360, P140, DOI 10.1124/jpet.116.236711; Eaton KA, 2011, INFECT IMMUN, V79, P185, DOI 10.1128/IAI.00880-10; Galley JD, 2016, BRAIN BEHAV IMMUNITY; Galley JD, 2017, SCI REP-UK, V7, DOI 10.1038/srep45012; Galley JD, 2017, BRAIN BEHAV IMMUN, V60, P44, DOI 10.1016/j.bbi.2016.09.010; Galley JD, 2014, GUT MICROBES, V5, P748, DOI 10.4161/19490976.2014.972241; Galley JD, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-189; Garcia-Villalba R, 2012, J SEP SCI, V35, P1906, DOI 10.1002/jssc.201101121; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; GLAVIN GB, 1994, NEUROSCI BIOBEHAV R, V18, P223, DOI 10.1016/0149-7634(94)90027-2; Green BT, 2004, AM J PHYSIOL-GASTR L, V287, pG1238, DOI 10.1152/ajpgi.00471.2003; Karaki S, 2006, CELL TISSUE RES, V324, P353, DOI 10.1007/s00441-005-0140-x; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Knowles SR, 2008, BIOL PSYCHOL, V77, P132, DOI 10.1016/j.biopsycho.2007.09.010; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Lu LF, 2016, J MICROBIOL BIOTECHN, V26, P693, DOI 10.4014/jmb.1511.11063; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Mackos AR, 2016, MUCOSAL IMMUNOL, V9, P515, DOI 10.1038/mi.2015.81; Mackos AR, 2013, INFECT IMMUN, V81, P3253, DOI 10.1128/IAI.00278-13; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Masui R, 2013, INFLAMM BOWEL DIS, V19, P2848, DOI 10.1097/01.MIB.0000435444.14860.ea; Mcbee ME, 2008, INFECT IMMUN, V76, P4851, DOI 10.1128/IAI.00745-08; McCafferty J, 2013, ISME J, V7, P2116, DOI 10.1038/ismej.2013.106; Mishiro T, 2013, LAB INVEST, V93, P834, DOI 10.1038/labinvest.2013.70; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Park JS, 2017, J MICROBIOL; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Reber SO, 2007, ENDOCRINOLOGY, V148, P670, DOI 10.1210/en.2006-0983; Reber SO, 2006, ENDOCRINOLOGY, V147, P4968, DOI 10.1210/en.2006-0347; Reber SO, 2011, BRAIN BEHAV IMMUN, V25, P1153, DOI 10.1016/j.bbi.2011.03.004; Schreiber O, 2009, AM J PHYSIOL-GASTR L, V296, pG534, DOI 10.1152/ajpgi.90470.2008; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; Tazoe H, 2008, J PHYSIOL PHARMACOL, V59, P251; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Traue HC, 1999, INT J BEHAV MED, V6, P101, DOI 10.1207/s15327558ijbm0602_1; Turgeon N, 2014, AM J PHYSIOL-GASTR L, V306, pG594, DOI 10.1152/ajpgi.00393.2013; Turgeon N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073785; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Veenema AH, 2008, ENDOCRINOLOGY, V149, P2727, DOI 10.1210/en.2007-1469; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580; Zijlmans MAC, 2015, PSYCHONEUROENDOCRINO, V53, P233, DOI 10.1016/j.psyneuen.2015.01.006	61	26	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196961	10.1371/journal.pone.0196961	http://dx.doi.org/10.1371/journal.pone.0196961			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742146	Green Submitted, Green Published, gold			2022-12-26	WOS:000431757400050
J	Tahvili, S; Torngren, M; Holmberg, D; Leanderson, T; Ivars, F				Tahvili, Sahar; Torngren, Marie; Holmberg, Dan; Leanderson, Tomas; Ivars, Fredrik			Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PANCREATIC LYMPH-NODES; NECROSIS-FACTOR-ALPHA; REACTIVE T-CELLS; DENDRITIC CELLS; QUINOLINE-3-CARBOXAMIDE ABR-215757; COMBINATION THERAPY; MONOCLONAL-ANTIBODY; CYTOKINE PRODUCTION; MULTIPLE-SCLEROSIS	Quinoline-3-carboxamides (Q compounds) are immunomodulatory compounds that have shown efficacy both in autoimmune disease and cancer. We have in here investigated the impact of one such compound, paquinimod, on the development of diabetes in the NOD mouse model for type I diabetes (T1D). In cohorts of NOD mice treated with paquinimod between weeks 10 to 20 of age and followed up until 40 weeks of age, we observed dose-dependent reduction in incidence of disease as well as delayed onset of disease. Further, in contrast to untreated controls, the majority of NOD mice treated from 15 weeks of age did not develop diabetes at 30 weeks of age. Importantly, these mice displayed significantly less insulitis, which correlated with selectively reduced number of splenic macrophages and splenic Ly6C(hi) inflammatory monocytes at end point as compared to untreated controls. Collectively, these results demonstrate that paquinimod treatment can significantly inhibit progression of insulitis to T1D in the NOD mouse. We propose that the effect of paquinimod on disease progression may be related to the reduced number of these myeloid cell populations. Our finding also indicates that this compound could be a candidate for clinical development towards diabetes therapy in humans.	[Tahvili, Sahar; Holmberg, Dan; Leanderson, Tomas; Ivars, Fredrik] Lund Univ, Dept Expt Med Sci, Sect Immunol, Immunol Grp, Lund, Sweden; [Torngren, Marie; Leanderson, Tomas] Act Biotech AB, Lund, Sweden	Lund University	Ivars, F (corresponding author), Lund Univ, Dept Expt Med Sci, Sect Immunol, Immunol Grp, Lund, Sweden.	fredrik.ivars@med.lu.se		Tahvili, Sahar/0000-0002-8425-3165	Swedish Cancer Foundation [16 0653]; Greta och Johan Kocks stiftelser; Alfred Osterlund Foundation; Active Biotech AB	Swedish Cancer Foundation; Greta och Johan Kocks stiftelser; Alfred Osterlund Foundation; Active Biotech AB	This work was supported by the Swedish Cancer Foundation (Grant # 16 0653), Greta och Johan Kocks stiftelser and the Alfred Osterlund Foundation. The funder Active Biotech AB provided support in the form of salaries for authors TL and MT. FI receives a research grant from Active Biotech AB. The specific roles of TL, MT and FI are articulated in the "author contributions" section. Apart from these contributions, Active Biotech AB did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi T, 1997, INT IMMUNOL, V9, P1159, DOI 10.1093/intimm/9.8.1159; Alleva DG, 2000, DIABETES, V49, P1106, DOI 10.2337/diabetes.49.7.1106; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Ben Nasr M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam7543; BENDELAC A, 1987, J EXP MED, V166, P823, DOI 10.1084/jem.166.4.823; Bengtsson AA, 2012, ARTHRITIS RHEUM-US, V64, P1579, DOI 10.1002/art.33493; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Bonner-Weir S, 2005, NAT BIOTECHNOL, V23, P857, DOI 10.1038/nbt1115; Brauner H, 2010, J IMMUNOL, V184, P2272, DOI 10.4049/jimmunol.0804358; Brunmark C, 2002, J NEUROIMMUNOL, V130, P163, DOI 10.1016/S0165-5728(02)00225-4; Calderon B, 2006, AM J PATHOL, V169, P2137, DOI 10.2353/ajpath.2006.060539; Carrero JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059701; Cesaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045478; Chaparro RJ, 2010, EXPERT REV CLIN IMMU, V6, P939, DOI [10.1586/eci.10.68, 10.1586/ECI.10.68]; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Deronic A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2649-7; Deronic A, 2014, INT IMMUNOPHARMACOL, V18, P290, DOI 10.1016/j.intimp.2013.12.008; Diana J, 2013, NAT MED, V19, P65, DOI 10.1038/nm.3042; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Ferris ST, 2014, IMMUNITY, V41, P657, DOI 10.1016/j.immuni.2014.09.012; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Frumento D, 2017, J ENDOCRINOL INVEST, V40, P803, DOI 10.1007/s40618-017-0641-y; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; George S, 2013, CURR ONCOL REP, V15, P65, DOI 10.1007/s11912-013-0295-7; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Grewal IS, 1997, J IMMUNOL, V159, P401; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Halban PA, 2004, NAT CELL BIOL, V6, P1021, DOI 10.1038/ncb1104-1021; Hansen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144090; Haskins K, 1996, DIABETES, V45, P1299, DOI 10.2337/diabetes.45.10.1299; HAYWARD AR, 1989, J IMMUNOL, V143, P1555; Hedlund G, 2001, INT IMMUNOPHARMACOL, V1, P1123, DOI 10.1016/S1567-5769(01)00041-8; Helmersson S, 2013, AM J PATHOL, V182, P1671, DOI 10.1016/j.ajpath.2013.01.032; HEROLD KC, 1992, DIABETES, V41, P385, DOI 10.2337/diabetes.41.3.385; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Isaacs JT, 2010, EXPERT OPIN INV DRUG, V19, P1235, DOI 10.1517/13543784.2010.514262; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Jolivel V, 2013, BRAIN, V136, P1048, DOI 10.1093/brain/awt023; Kamper M, 2010, TRANSL RES, V156, P26, DOI 10.1016/j.trsl.2010.05.004; Katsarou Anastasia, 2017, Nat Rev Dis Primers, V3, P17016, DOI 10.1038/nrdp.2017.16; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; LEE KU, 1988, DIABETES, V37, P989, DOI 10.2337/diabetes.37.7.989; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Lernmark A, 2013, NAT REV ENDOCRINOL, V9, P92, DOI 10.1038/nrendo.2012.237; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Lieberman SM, 2003, TISSUE ANTIGENS, V62, P359, DOI 10.1034/j.1399-0039.2003.00152.x; Makino S, 1980, Jikken Dobutsu, V29, P1; Martin AP, 2008, DIABETES, V57, P3025, DOI 10.2337/db08-0625; Mishra MK, 2012, AM J PATHOL, V181, P642, DOI 10.1016/j.ajpath.2012.05.011; Nikolic T, 2005, LAB INVEST, V85, P487, DOI 10.1038/labinvest.3700238; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Ogawa N, 2004, DIABETES, V53, P1700, DOI 10.2337/diabetes.53.7.1700; Phillips Jenny M, 2009, Rev Diabet Stud, V6, P97, DOI 10.1900/RDS.2009.6.97; Poligone B, 2002, J IMMUNOL, V168, P188, DOI 10.4049/jimmunol.168.1.188; Pruenster M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7915; Rabinovitch A, 2002, DIABETES, V51, P638, DOI 10.2337/diabetes.51.3.638; Reed JC, 2015, NAT REV ENDOCRINOL, V11, P308, DOI 10.1038/nrendo.2014.236; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Rosmalen JGM, 2000, LAB INVEST, V80, P769, DOI 10.1038/labinvest.3780080; Saxena V, 2007, J IMMUNOL, V179, P5041, DOI 10.4049/jimmunol.179.8.5041; Schelbergen RFP, 2012, ARTHRITIS RHEUM-US, V64, P1477, DOI 10.1002/art.33495; Schulze-Topphoff U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033797; Serreze DV, 1996, J EXP MED, V184, P2049, DOI 10.1084/jem.184.5.2049; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Solomon M, 2004, ADV IMMUNOL, V84, P239, DOI 10.1016/S0065-2776(04)84007-0; Stenstrom M, 2010, INT IMMUNOPHARMACOL, V10, P837, DOI 10.1016/j.intimp.2010.04.011; Suarez-Pinzon WL, 2011, CELL TRANSPLANT, V20, P1343, DOI 10.3727/096368910X557263; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; von Herrath M, 2013, CLIN EXP IMMUNOL, V172, P186, DOI 10.1111/cei.12085; Wegner C, 2010, J NEUROIMMUNOL, V227, P133, DOI 10.1016/j.jneuroim.2010.07.009; Weiss L, 2002, CYTOKINE, V19, P85, DOI 10.1006/cyto.2002.1956; Wong FS, 1996, J EXP MED, V183, P67, DOI 10.1084/jem.183.1.67; Xiu Y, 2008, J IMMUNOL, V180, P2863, DOI 10.4049/jimmunol.180.5.2863; Yan L, 2013, ATHEROSCLEROSIS, V228, P69, DOI 10.1016/j.atherosclerosis.2013.02.023; Yang HS, 2004, J NEUROIMMUNOL, V156, P3, DOI 10.1016/j.jneuroim.2004.02.016; Yu H, 2018, IMMUNOLOGY, V153, P161, DOI 10.1111/imm.12867; Zhang XW, 2000, J LEUKOCYTE BIOL, V68, P621; Zou LP, 2002, NEUROPHARMACOLOGY, V42, P731, DOI 10.1016/S0028-3908(02)00015-1	79	10	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196598	10.1371/journal.pone.0196598	http://dx.doi.org/10.1371/journal.pone.0196598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742113	gold, Green Published, Green Submitted			2022-12-26	WOS:000431757400034
J	Matsubara, K; Iwasaki, Y; Nishiki, I; Nomura, K; Fujiwara, A				Matsubara, Kazumi; Iwasaki, Yuki; Nishiki, Issei; Nomura, Kazuharu; Fujiwara, Atushi			Identification of genetic linkage group 1-linked sequences in Japanese eel (Anguilla japonica) by single chromosome sorting and sequencing	PLOS ONE			English	Article							GENOME SEQUENCE; GLASS EEL; KARYOTYPE; LOCALIZATION; CAPTIVITY; MARKERS; MOUSE; MAP; 10K	Japanese eel (Anguilla japonica) constitutes one of the most important food fish in Japan; accordingly, genome sequencing and linkage mapping have been conducted for the purpose of artificial cultivation. In the next stage, integration of genomic sequences within linkage groups (LG) is required to construct higher-resolution genetic markers for quantitative trait loci mapping and selective breeding of beneficial traits in farming. In order to identify LG1-linked scaffolds from the draft genome assembly (323,776 scaffolds) reported previously, we attempted to isolate chromosomes corresponding to LG1 by flow sorting and subsequent analyses. Initially, single chromosomes were randomly collected by chromosome sorting and subjected to whole-genome amplification (WGA). A total of 60 WGA samples were screened by PCR with primers for a known LG1-linked scaffold, and five positive WGA samples were sequenced by next-generation sequencing (NGS). Following reference mapping analysis of the NGS reads, four of the five WGA samples were found to be enriched by LG1-linked sequences. These samples were cytogenetically assigned to chromosome 5 by fluorescence in situ hybridization. Using blastn searches with 82,081 contigs constructed from the NGS reads of the four WGA samples as queries, 2323 scaffolds were identified as putative LG1-linked scaffolds from the draft genome assembly. The total length of the putative LG1-linked scaffolds was 99.0 Mb, comparable to the estimated DNA amounts of chromosome 5 (91.1 Mb). These results suggest that the methodology developed herein is applicable to isolate specific chromosome DNAs and integrate unanchored scaffold sequences onto a particular LG and chromosome even in teleost fishes, in which isolation of specific chromosomes by flow sorting is generally difficult owing to similar morphologies, sizes, and GC-contents among chromosomes in the genome. The putative LG1-linked scaffolds of Japanese eel contain a total of 6833 short tandem repeats which will be available for higher-resolution linkage mapping.	[Matsubara, Kazumi; Iwasaki, Yuki; Nishiki, Issei; Fujiwara, Atushi] Japan Fisheries Res & Educ Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Nomura, Kazuharu] Japan Fisheries Res & Educ Agcy, Natl Res Inst Aquaculture, Minamiise, Mie, Japan; [Matsubara, Kazumi] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biomed Chem, Sanda, Hyogo, Japan; [Iwasaki, Yuki] Natl Inst Genet, Ctr Informat Biol, Genome Evolut Lab, Mishima, Shizuoka, Japan	Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Kwansei Gakuin University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Fujiwara, A (corresponding author), Japan Fisheries Res & Educ Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan.	jiwara@affrc.go.jp			Project of the Bio-oriented Technology Research Advancement Institution (NARO)	Project of the Bio-oriented Technology Research Advancement Institution (NARO)	This study was funded by Grants-in-Aid for "The special scheme project on advanced research and development for next-generation technology" from the Project of the Bio-oriented Technology Research Advancement Institution (NARO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkman PJ, 2011, PLANT BIOTECHNOL J, V9, P768, DOI 10.1111/j.1467-7652.2010.00587.x; Chen W, 2008, GENOME RES, V18, P1143, DOI 10.1101/gr.076166.108; Fantes J A, 1990, Methods Mol Biol, V5, P529, DOI 10.1385/0-89603-150-0:529; Fluch S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030784; Fujiwara A, 2001, GENETICA, V111, P77, DOI 10.1023/A:1013788626712; Fujiwara A, 1997, CHROMOSOMA, V106, P44, DOI 10.1007/s004120050223; Fujiwara A, 2007, GENETICA, V131, P267, DOI 10.1007/s10709-006-9136-z; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Henkel CV, 2012, GENE, V511, P195, DOI 10.1016/j.gene.2012.09.064; Kai W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-233; Koepfli KP, 2015, ANNU REV ANIM BIOSCI, V3, P57, DOI 10.1146/annurev-animal-090414-014900; LEBO RV, 1982, CYTOMETRY, V3, P145, DOI 10.1002/cyto.990030302; LEBO RV, 1979, P NATL ACAD SCI USA, V76, P5804, DOI 10.1073/pnas.76.11.5804; Masuda Y, 2011, NIPPON SUISAN GAKK, V77, P416, DOI 10.2331/suisan.77.416; Mayer KFX, 2009, PLANT PHYSIOL, V151, P496, DOI 10.1104/pp.109.142612; Nomura K, 2016, PLANT AN GEN C 24; Nomura K, 2011, AQUACULTURE, V310, P329, DOI 10.1016/j.aquaculture.2010.11.006; Okamura A, 2014, ECOL FRESHW FISH, V23, P95, DOI 10.1111/eff.12086; Pinthong K, 2013, CYTOLOGIA, V78, P223, DOI 10.1508/cytologia.78.223; RABBITTS P, 1995, NAT GENET, V9, P369, DOI 10.1038/ng0495-369; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SILLAR R, 1981, J HISTOCHEM CYTOCHEM, V29, P74, DOI 10.1177/29.1.6162882; Sudbery I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r112; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; Tanaka H, 2015, FISHERIES SCI, V81, P11, DOI 10.1007/s12562-014-0821-z; Vitulo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026421; Yang F, 2003, P NATL ACAD SCI USA, V100, P1062, DOI 10.1073/pnas.0335540100; Yang H, 2011, P NATL ACAD SCI USA, V108, P12, DOI 10.1073/pnas.1016725108	28	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0197040	10.1371/journal.pone.0197040	http://dx.doi.org/10.1371/journal.pone.0197040			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738551	gold, Green Submitted, Green Published			2022-12-26	WOS:000431724900044
J	Paiatto, LN; Silva, FGD; Yamada, AT; Tamashiro, WMSC; Simioni, PU				Paiatto, Lisiery N.; Silva, Fernanda G. D.; Yamada, Aureo T.; Tamashiro, Wirla M. S. C.; Simioni, Patricia U.			Adoptive transfer of dendritic cells expressing CD11c reduces the immunological response associated with experimental colitis in BALB/c mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ORAL TOLERANCE; T-CELLS; BYSTANDER SUPPRESSION; ULCERATIVE-COLITIS; TH17 CELLS; INDUCTION; MODELS; PATHOGENESIS; ANTIBODIES	Introduction In addition to conventional therapies, several new strategies have been proposed for modulating autoimmune diseases, including the adoptive transfer of immunological cells. In this context, dendritic cells (DCs) appear to be one of the most promising treatments for autoimmune disorders. The present study aimed to evaluate the effects of adoptive transfer of DCs obtained from both naive and ovalbumin (OVA)-tolerant mice on the severity of TNBS induced colitis and analyze the eventual protective mechanisms. Methods and results To induce oral tolerance, BALB/c mice were fed 4mg/mL OVA solution for seven consecutive days. Spleen DCs were isolated from tolerant (tDC) and naive (nDC) mice, and then adoptively transferred to syngeneic mice. Three days later, colitis was induced in DC treated mice by intrarectal instillation of 100 mu g2,4,6-trinitrobenzenesulfonic acid (TNBS) dissolved in 50% ethanol. Control subjects received only intrarectal instillation of either TNBS solution or a vehicle. Five days later, mice from all groups were euthanized and examined for physiological and immunological parameters. Regarding the phenotype, we observed that the frequencies of CD11(+) MHC II+ and CD11(+) MHCII+ CD86(+) cells were significantly lower in DCs isolated from tolerant mice than in those from naive mice. However, pretreatment with both types of DCs was able to significantly reduce clinical signs of colitis such as diarrhea, rectal prolapse, bleeding, and cachexia, although only treatment with tDCs was able to prevent weight loss from instillation of TNBS. In vitro proliferation of spleen cells from mice treated with either type of DCs was significantly lower than that observed in splenic cell cultures of naive mice. Although no significant difference was observed in the frequencies of Treg cells in the experimental groups, the frequency of Th17(+)CD4(+) cellsand the secretion of IL-17 were more reduced in the cultures of spleen cells from mice treated with either type of DCs. The levels of that no competing interests exist. IL-9 and IFN-gamma were lower in supernatants of cells from mice treated with nDCs. Conclusion The results allow us to conclude that the adoptive transfer of cells expressing CD11c is able to reduce the clinical and immunological signs of drug-induced colitis. Adoptive transfer of CD11c(+)DC isolated from both naive and tolerant mice altered the proliferative and T cell responses. To the best of our knowledge, there is no previously published data showing the protective effects of DCs from naive or tolerant mice in the treatment of colitis.	[Paiatto, Lisiery N.; Simioni, Patricia U.] Univ Estadual Paulista, UNESP, Inst Biosci, Rio Claro, SP, Brazil; [Silva, Fernanda G. D.] Univ Estadual Campinas, UNICAMP, Fac Food Engn, Campinas, SP, Brazil; [Silva, Fernanda G. D.] Univ Fed Ouro Preto, Sch Nutr, Dept Food, Ouro Preto, MG, Brazil; [Yamada, Aureo T.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil; [Tamashiro, Wirla M. S. C.; Simioni, Patricia U.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Genet Evolut Microbiol & Immunol, Campinas, SP, Brazil; [Simioni, Patricia U.] Fac Amer, FAM, Dept Biomed Sci, Americana, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual de Campinas; Universidade Federal de Ouro Preto; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Simioni, PU (corresponding author), Univ Estadual Paulista, UNESP, Inst Biosci, Rio Claro, SP, Brazil.; Simioni, PU (corresponding author), Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Genet Evolut Microbiol & Immunol, Campinas, SP, Brazil.; Simioni, PU (corresponding author), Fac Amer, FAM, Dept Biomed Sci, Americana, SP, Brazil.	psimioni@gmail.com	Silva, Fernanda/O-6177-2019; Simioni, Patricia/A-3169-2009; Silva, Fernanda G.D./M-2564-2017	Silva, Fernanda/0000-0002-9615-5415; Simioni, Patricia/0000-0002-6951-5040; Silva, Fernanda G.D./0000-0002-9615-5415	Sao Paulo Research Foundation (FAPESP), Brazil [2013/20258-2, 2014/086192, 2015/09326-1, 2014/167010, 2014/08591-0]; Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)	Sao Paulo Research Foundation (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work has been supported by Sao Paulo Research Foundation (FAPESP, http://tapesp.br/), Brazil (Grant No. 2013/20258-2) and fellowships (#2014/086192, #2015/09326-1 #2014/167010 and #2014/08591-0) and by Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES, http://www.capes.gov.br) (LNP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MC, 2003, BRAZ J MED BIOL RES, V36, P1227, DOI 10.1590/S0100-879X2003000900013; Arijs I, 2011, AM J GASTROENTEROL, V106, P748, DOI 10.1038/ajg.2011.27; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Defendenti C, 2015, INT J IMMUNOPATH PH, V28, P569, DOI 10.1177/0394632015600535; Duchmann R, 1996, EUR J IMMUNOL, V26, P934, DOI 10.1002/eji.1830260432; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Engel MA, 2010, J GASTROENTEROL, V45, P571, DOI 10.1007/s00535-010-0219-3; Eri R, 2008, INFLAMM BOWEL DIS, V14, P458, DOI 10.1002/ibd.20344; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Fukaya T, 2011, METHODS MOL BIOL, V677, P113, DOI 10.1007/978-1-60761-869-0_8; Gerlach K, 2014, NAT IMMUNOL, V15, P676, DOI 10.1038/ni.2920; Girard-Madoux MJH, 2016, ONCOTARGET, V7, P32015, DOI 10.18632/oncotarget.8337; Glocker EO, 2011, ANN NY ACAD SCI, V1246, P102, DOI 10.1111/j.1749-6632.2011.06339.x; Gordon JR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00007; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Guo BC, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00242; Kalantari T, 2011, IMMUNOL RES, V51, P153, DOI 10.1007/s12026-011-8255-5; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li HM, 2008, J IMMUNOL, V181, P2483, DOI 10.4049/jimmunol.181.4.2483; Lindsay J, 2002, GENE THER, V9, P1715, DOI 10.1038/sj.gt.3301841; Liu ZJ, 2009, WORLD J GASTROENTERO, V15, P5784, DOI 10.3748/wjg.15.5784; Lutz MB, 2002, J IMMUNOL, V169, P3574, DOI 10.4049/jimmunol.169.7.3574; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Matricon J, 2010, M S-MED SCI, V26, P405, DOI 10.1051/medsci/2010264405; Matteoli G, 2010, GUT, V59, P595, DOI 10.1136/gut.2009.185108; MILLER A, 1991, J EXP MED, V174, P791, DOI 10.1084/jem.174.4.791; Millington OR, 2004, J IMMUNOL, V173, P6059, DOI 10.4049/jimmunol.173.10.6059; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Muller G, 2002, J INVEST DERMATOL, V119, P836, DOI 10.1046/j.1523-1747.2002.00496.x; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Neurath MF, 1996, J EXP MED, V183, P2605, DOI 10.1084/jem.183.6.2605; Niess JH, 2006, CURR OPIN GASTROEN, V22, P354, DOI 10.1097/01.mog.0000231807.03149.54; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Owczarek D, 2009, POL ARCH MED WEWN, V119, P84, DOI 10.20452/pamw.614; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Paiatto LN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170205; Pedersen AE, 2007, IMMUNOLOGY, V121, P526, DOI 10.1111/j.1365-2567.2007.02600.x; Perrier C, 2011, IMMUNOTHERAPY-UK, V3, P1341, DOI [10.2217/imt.11.122, 10.2217/IMT.11.122]; de Mattos BRR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/493012; Randhawa PK, 2014, KOREAN J PHYSIOL PHA, V18, P279, DOI 10.4196/kjpp.2014.18.4.279; Rutella S, 2011, WORLD J GASTROENTERO, V17, P3761, DOI 10.3748/wjg.v17.i33.3761; Shen W, 2010, NEUROCHEM RES, V35, P940, DOI 10.1007/s11064-009-0091-9; Simioni PU, 2017, INT J IMMUNOPATH PH, V30, P44, DOI 10.1177/0394632016678873; Simioni PU, 2004, SCAND J IMMUNOL, V60, P257, DOI 10.1111/j.0300-9475.2004.01454.x; Strober W, 1997, IMMUNOL TODAY, V18, P61, DOI 10.1016/S0167-5699(97)01000-1; Takamatsu M, 2013, J IMMUNOL, V191, P3057, DOI 10.4049/jimmunol.1203306; Thome R, 2012, CELL IMMUNOL, V280, P113, DOI 10.1016/j.cellimm.2012.11.017; Tontini GE, 2015, WORLD J GASTROENTERO, V21, P21, DOI 10.3748/wjg.v21.i1.21; Wang LM, 2016, EUR J IMMUNOL, V46, P2454, DOI 10.1002/eji.201546274; Whittem C.G., 2010, JOVE-J VIS EXP, V35, DOI [10.3791/1652, DOI 10.3791/1652]; WILDNER G, 1995, EUR J IMMUNOL, V25, P1292, DOI 10.1002/eji.1830250524; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Wu XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083013; Yamazaki S, 2009, J DERMATOL SCI, V54, P69, DOI 10.1016/j.jdermsci.2009.02.001; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zonneveld-Huijssoon E, 2011, ANN RHEUM DIS, V70, P2199, DOI 10.1136/ard.2010.136994	57	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196994	10.1371/journal.pone.0196994	http://dx.doi.org/10.1371/journal.pone.0196994			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738575	gold, Green Submitted, Green Published			2022-12-26	WOS:000431724900039
J	Romano, MR; Ilardi, G; Ferrara, M; Cennamo, G; Allegrini, D; Pafundi, P; Costagliola, C; Staibano, S; Cennamo, G				Romano, Mario R.; Ilardi, Gennaro; Ferrara, Mariantonia; Cennamo, Gilda; Allegrini, Davide; Pafundi, Pia; Costagliola, Ciro; Staibano, Stefania; Cennamo, Giovanni			Intraretinal changes in idiopathic versus diabetic epiretinal membranes after macular peeling	PLOS ONE			English	Article							INTERNAL LIMITING MEMBRANE; FOVEAL AVASCULAR ZONE; MULLER CELLS; REMOVAL; ANGIOGRAPHY; RETINOPATHY; EYES	Introduction Epiretinal traction is not responsible only for epiretinal but also intraretinal changes. This study aims to describe structural and vascular intraretinal changes after macular peeling in idiopathic (iERM) vs diabetic ERM (dERM). Methods We conducted a prospective interventional study on forty-two eyes, 23 with iERMs and 19 with dERMs, undergoing ERM-ILM peeling. We performed SD-OCT preoperatively, 1 and 6 months postoperatively to assess central macular thickness (CMT), intraretinal cysts (IC) and/or continuous ectopic inner foveal layers (CEIFL), superficial and deep capillary free zone (CFZ) area on OCT-A. Glial fibrillary acidic protein (GFAP), as a Muller cells marker, was detected immunohistochemically on ILM specimens, to assess Muller cells iatrogenic damage. Results The CEIFLs were significantly more common in iERMs (12 (52.2%) in iERMs vs 2 (10.5%) in dERMs, p = 0.004), whereas ICs in dERMs (6 (26.1%) in iERMs vs 17 (89.5%) in dERMs, p<0.001). Median preoperative and postoperative BCVA was 20/50 [20/40-20/66] and 20/ 33 [20/25-20/40] in iERMs and 20/100 [20/66-20/200] and 20/50 [20/50-20/66] in dERMs, respectively. Median preoperative and postoperative CMT was 423 [370-488] and 364 [329-382] mu m in iERM group and 465 [447-503] and 378 [359-433] mu m in dERM group, respectively. The BCVA improvement and reduction of CMT thickness were significant in both groups (p<0.001). The presence of CEIFL was associated with lower BCVA in iERMs. Deep CFZ network significantly increased only in dERMs, passing from 0.34 [0.29-0.42] mm(2) preoperatively to 0.56 [0.46-0.6] mm(2) at 6-month follow-up (p<0.001). The GFAP expression was significantly higher in dERMs (p = 0.001). Conclusion The intraretinal changes are different in iERMs and dERMs, as increased expression of CEIFLs in iERMs vs ICs in dERMs. The CEIFLs are associated with worse anatomical and functional outcomes in iERMs, whereas GFAP espression in peeled ILMs is higher in dERMs.	[Romano, Mario R.; Allegrini, Davide] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Ilardi, Gennaro; Staibano, Stefania] Univ Federerico II, Dept Biomed Adv Sci, Naples, Italy; [Ferrara, Mariantonia; Cennamo, Gilda; Cennamo, Giovanni] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, Naples, Italy; [Pafundi, Pia] Univ Campania Luigi Vanvitelli, Dept Clin & Expt Med, Naples, Italy; [Costagliola, Ciro] Univ Molise, Dept Hlth Sci, Eye Clin, Campobasso, Italy	Humanitas University; University of Naples Federico II; Universita della Campania Vanvitelli; University of Molise	Romano, MR (corresponding author), Humanitas Univ, Dept Biomed Sci, Milan, Italy.	mario.romano.md@gmail.com	Ferrara, Mariantonia/AEC-7557-2022; Pafundi, Pia Clara/AAC-3991-2021; Ilardi, Gennaro/AAC-3589-2022	Ferrara, Mariantonia/0000-0002-1191-4989; Pafundi, Pia Clara/0000-0002-0310-3529; Ilardi, Gennaro/0000-0002-9354-4087; Romano, Mario R/0000-0003-0348-0532; ALLEGRINI, DAVIDE/0000-0002-5988-706X				Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Azuma K, 2017, RETINA-J RET VIT DIS, V37, P1813, DOI 10.1097/IAE.0000000000001537; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bu SC, 2014, RETINA-J RET VIT DIS, V34, P2317, DOI 10.1097/IAE.0000000000000349; Cheung N, 2017, BRIT J OPHTHALMOL, V101, P371, DOI 10.1136/bjophthalmol-2016-308563; Di G, 2016, GRAEF ARCH CLIN EXP, V254, P873, DOI 10.1007/s00417-015-3143-7; Freiberg FJ, 2016, GRAEF ARCH CLIN EXP, V254, P1051, DOI 10.1007/s00417-015-3148-2; Govetto A, 2019, RETINA-J RET VIT DIS, V39, P347, DOI 10.1097/IAE.0000000000001940; Govetto A, 2017, AM J OPHTHALMOL, V175, P99, DOI 10.1016/j.ajo.2016.12.006; Guidry C, 2005, PROG RETIN EYE RES, V24, P75, DOI 10.1016/j.preteyeres.2004.07.001; Junemann AGM, 2015, GRAEF ARCH CLIN EXP, V253, P2181, DOI 10.1007/s00417-015-3127-7; Kampik Anselm, 2012, Retina, V32 Suppl 2, pS194, DOI 10.1097/IAE.0b013e31825bc20a; Kenawy N, 2010, OPHTHALMOLOGY, V117, P320, DOI 10.1016/j.ophtha.2009.07.024; Kritzenberger M, 2011, HISTOPATHOLOGY, V58, P953, DOI 10.1111/j.1365-2559.2011.03820.x; Laban KG, 2015, OPHTHALMOLOGICA, V234, P119, DOI 10.1159/000438677; Lee JW, 2010, JPN J OPHTHALMOL, V54, P129, DOI 10.1007/s10384-009-0778-0; Lim JW, 2011, CLIN EXP OPHTHALMOL, V39, P9, DOI 10.1111/j.1442-9071.2010.02377.x; Minnella AM, 2018, ACTA OPHTHALMOL, V96, pE647, DOI 10.1111/aos.13099; Moein HR, 2018, RETINA-J RET VIT DIS, V38, P2277, DOI 10.1097/IAE.0000000000001902; Morescalchi F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/269787; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Ripandelli G, 2015, RETINA-J RET VIT DIS, V35, P498, DOI 10.1097/IAE.0000000000000330; Romano MR, 2017, CURR EYE RES, V42, P780, DOI 10.1080/02713683.2016.1231322; Romano MR, 2017, GRAEF ARCH CLIN EXP, V255, P681, DOI 10.1007/s00417-016-3534-4; Romano MR, 2017, GRAEF ARCH CLIN EXP, V255, P31, DOI 10.1007/s00417-016-3413-z; Romano MR, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/372564; Romano MR, 2014, RETINA-J RET VIT DIS, V34, P1182, DOI 10.1097/IAE.0000000000000076; SANDER B, 1994, ACTA OPHTHALMOL, V72, P553; Scarinci F, 2015, JAMA OPHTHALMOL, V133, P1036, DOI 10.1001/jamaophthalmol.2015.2183; Semeraro F, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/671905; Silva KC, 2009, DIABETES, V58, P1382, DOI 10.2337/db09-0166; Sohn EH, 2016, P NATL ACAD SCI USA, V113, pE2655, DOI 10.1073/pnas.1522014113; Syrbe S, 2018, EXP EYE RES, V167, P110, DOI 10.1016/j.exer.2017.12.004; Takase N, 2015, RETINA-J RET VIT DIS, V35, P2377, DOI 10.1097/IAE.0000000000000849; Tamura K, 2012, JPN J OPHTHALMOL, V56, P280, DOI 10.1007/s10384-012-0130-y; Tien T, 2017, INVEST OPHTH VIS SCI, V58, P2915, DOI 10.1167/iovs.16-21355; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Ye HH, 2015, BRIT J OPHTHALMOL, V99, P1594, DOI 10.1136/bjophthalmol-2015-307050	38	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0197065	10.1371/journal.pone.0197065	http://dx.doi.org/10.1371/journal.pone.0197065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738569	Green Published, Green Submitted, gold			2022-12-26	WOS:000431724900046
J	Akella, SS; Francis, JH; Knezevic, A; Ostrovnaya, I; Gobin, YP; Friedman, D; Guarini, E; Eibeler, L; Catalanotti, F; Abramson, DH				Akella, Sruti S.; Francis, Jasmine H.; Knezevic, Andrea; Ostrovnaya, Irina; Gobin, Y. Pierre; Friedman, Danielle; Guarini, Edith; Eibeler, Lindsey; Catalanotti, Federica; Abramson, David H.			Growth patterns of survivors of retinoblastoma treated with ophthalmic artery chemosurgery	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; LONG-TERM SURVIVORS; CRANIAL IRRADIATION; LINEAR GROWTH; CHEMOTHERAPY; CHILDREN; BONE; THERAPY; HEIGHT	Although studies from pediatric cancers (largely acute lymphoblastic leukemia) have shown that patients undergoing systemic chemotherapy may experience decreased growth velocity during the treatment phase, no such data exist for retinoblastoma patients treated with systemic chemotherapy or ophthalmic artery chemosurgery (OAC). The purpose of this study is to report growth patterns of our retinoblastoma (Rb) population who were treated with OAC in a retrospective, single center (Memorial Sloan Kettering Cancer Center) review of 341 patients treated between 2006 and 2016. Children who only received OAC were classified as naive; those who were treated initially with systemic chemotherapy and subsequently presented to our center for OAC were termed secondary; and a small group of patients who received single-agent systemic chemotherapy prior to OAC were labeled bridge. For all patients, height and weight were recorded at monthly intervals during OAC (short-term) and then annually during a follow-up period (long-term) up to 3 years after treatment. Excluded from this study were children who received external radiation therapy and those with genetic syndromes, which are independently associated with growth derangements. During OAC, there was no significant difference in growth velocity between the naive and secondary groups. In either group, number of treatments also did not affect growth rate. Three years after the end of OAC, naive patients were in the 68th percentile by height (95% CI 61.30, 74.63) compared to secondary patients in the 61st percentile (95% CI 51.1, 71.47). Both groups were in the same weight percentiles during the first two years of follow-up but at the three-year follow-up period, naive patients were in the 63rd percentile (95% CI 57.4, 69.4) and secondary patients were in the 60th percentile (95% CI 50.4, 69.7). OAC for retinoblastoma does not appear to impact short-term growth velocity, weight gain during the treatment period or after three years.	[Akella, Sruti S.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Francis, Jasmine H.; Guarini, Edith; Eibeler, Lindsey; Catalanotti, Federica; Abramson, David H.] Mem Sloan Kettering Canc Ctr, Dept Surg, Ophthalm Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [Francis, Jasmine H.; Abramson, David H.] Weill Cornell Sch Med, Dept Ophthalmol, New York, NY USA; [Knezevic, Andrea; Ostrovnaya, Irina] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Dept Radiol & Neurosurg, New York, NY USA; [Friedman, Danielle] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center	Akella, SS (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	sruti.akella@gmail.com	Friedman, Danielle Novetsky/B-7551-2016	Friedman, Danielle Novetsky/0000-0003-4668-9176; Knezevic, Andrea/0000-0002-0741-2150; Francis, Jasmine/0000-0002-7637-3108	Cancer Center Support Grant [P30 CA008748]; Fund for Ophthalmic Knowledge, Inc.	Cancer Center Support Grant; Fund for Ophthalmic Knowledge, Inc.	This study was supported by The Cancer Center Support Grant (P30 CA008748) to SSA. The Fund for Ophthalmic Knowledge, Inc. also provided partial funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson David H, 2017, Int J Retina Vitreous, V3, P40, DOI 10.1186/s40942-017-0093-8; Abramson DH, 2015, JAMA OPHTHALMOL, V133, P1341, DOI 10.1001/jamaophthalmol.2015.3108; Abramson DH, 2014, ANNU REV MED, V65, P171, DOI 10.1146/annurev-med-061312-123455; Brinkman TM, 2015, CANCER-AM CANCER SOC, V121, P123, DOI 10.1002/cncr.28924; Crofton PM, 1999, EUR J CANCER, V35, P960, DOI 10.1016/S0959-8049(99)00060-X; Desjardins L, 2002, J AAPOS, V6, P108, DOI 10.1067/mpa.2002.121451; Dickerman JD, 2007, PEDIATRICS, V119, P554, DOI 10.1542/peds.2006-2826; Dunkel IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108692; Fan C, 2011, CURR MOL MED, V11, P140, DOI 10.2174/156652411794859223; Fischer C, 2017, J PEDIAT HEMATOL ONC, V39, P555, DOI 10.1097/MPH.0000000000000968; Friedman DN, 2016, CANCER-AM CANCER SOC, V122, P773, DOI 10.1002/cncr.29704; Gobin YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044322; KATZ JA, 1991, J PEDIATR-US, V118, P575, DOI 10.1016/S0022-3476(05)83385-2; KATZ JA, 1993, J PEDIATR-US, V123, P546, DOI 10.1016/S0022-3476(05)80948-5; MOELL C, 1988, ACTA PAEDIATR SCAND, V77, P688, DOI 10.1111/j.1651-2227.1988.tb10731.x; Nahum MP, 2001, PEDIATR HEMAT ONCOL, V18, P173, DOI 10.1080/08880010151114769; Reilly JJ, 2000, INT J OBESITY, V24, P1537, DOI 10.1038/sj.ijo.0801403; Rose SR, 2004, J PEDIATR ENDOCR MET, V17, P55; Schaiquevich P, 2017, RETINA-J RET VIT DIS, V37, P1, DOI 10.1097/IAE.0000000000001275; SCHRIOCK EA, 1991, J CLIN ONCOL, V9, P400, DOI 10.1200/JCO.1991.9.3.400; Seth R, 2017, INDIAN J MED RES, V146, P216, DOI 10.4103/ijmr.IJMR_196_16; Siebler T, 2002, HORM RES, V58, P80, DOI 10.1159/000064769; Suzuki S, 2011, OPHTHALMOLOGY, V118, P2081, DOI 10.1016/j.ophtha.2011.03.013; Turck D, 2013, J PEDIATR GASTR NUTR, V57, P258, DOI 10.1097/MPG.0b013e318298003f; van Dijk J, 2009, PSYCHO-ONCOLOGY, V18, P87, DOI 10.1002/pon.1381; van Dijk J, 2009, PSYCHO-ONCOLOGY, V18, P1281, DOI 10.1002/pon.1507; Vandecruys E, 2013, J PEDIATR-US, V163, P268, DOI 10.1016/j.jpeds.2012.12.037; Weintraub N, 2011, PEDIATR BLOOD CANCER, V56, P590, DOI 10.1002/pbc.22790; Willard VW, 2014, J CLIN ONCOL, V32, P2788, DOI 10.1200/JCO.2013.53.1996; Yu CL, 2009, JNCI-J NATL CANCER I, V101, P581, DOI 10.1093/jnci/djp046	30	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0197052	10.1371/journal.pone.0197052	http://dx.doi.org/10.1371/journal.pone.0197052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734385	Green Submitted, gold, Green Published			2022-12-26	WOS:000431481700042
J	Han, SN; Jiang, N; Lv, QY; Kan, YM; Hao, JJ; Li, JQ; Luo, LX				Han, Sining; Jiang, Na; Lv, Qingyang; Kan, Yumin; Hao, Jianjun; Li, Jianqiang; Luo, Laixin			Detection of Clavibacter michiganensis subsp michiganensis in viable but nonculturable state from tomato seed using improved qPCR	PLOS ONE			English	Article							REAL-TIME PCR; ESCHERICHIA-COLI O157H7; PROPIDIUM MONOAZIDE; LISTERIA-MONOCYTOGENES; SSP MICHIGANENSIS; QUANTITATIVE PCR; FOOD-PRODUCTS; CELLS; BACTERIA; WATER	Clavibacter michiganensis subsp. michiganensis (Cmm) is a seed-borne pathogen that causes bacterial canker disease of tomato. Cmm is typically detected in tomato seeds using quantitative real-time polymerase chain reaction (qPCR) combined with culture-based isolation. The viable but nonculturable (VBNC) state of Cmm may result in the underestimation or false negative detection of the pathogen. In the present study, propidium monoazide (PMA) and its improved structure PMAxx were used to pretreat Cmm prior to DNA extraction, followed by qPCR. Both PMA and PMAxx could bind to the chromosomal DNA of dead bacterial cells and therefore block DNA amplification by PCR. This effect, however, does not occur in living bacterial cells, as the chemicals cannot penetrate through the undamaged cell membrane. Both viable and dead Cmm cells were treated with PMA and PMAxx at various concentrations. With this treatment, the range of the cell population was determined for effective detection. PMAxx showed a better discrimination effect than PMA on the viable and dead cells of Cmm and was therefore used throughout the present study. VBNC cells of Cmm (10(8) CFU mL(-1)) was induced by 50 mu M copper sulfate, which was detected at different sampling times up to a month by using both PMAxx-qPCR and flow cytometry assays. The optimal PMAxx concentration was 20 mu M for detecting membrane-intact Cmm cells. High specificity and sensitivity were obtained at Cmm concentrations ranging from 10(3) to 10(7) CFU mL(-1). The accurate and robust results of PMAxx-qPCR were confirmed by flow cytometry method to detect viable Cmm cells. Furthermore, the PMAxx-qPCR assay was successfully used in detecting VBNC Cmm cells in tomato seeds with as few as 10 seeds per set.	[Han, Sining; Jiang, Na; Lv, Qingyang; Kan, Yumin; Li, Jianqiang; Luo, Laixin] China Agr Univ, Coll Plant Protect, Dept Plant Pathol, Beijing, Peoples R China; [Han, Sining; Jiang, Na; Lv, Qingyang; Kan, Yumin; Li, Jianqiang; Luo, Laixin] China Agr Univ, Coll Plant Protect, MOA Key Lab Pest Monitoring & Green Management, Beijing, Peoples R China; [Han, Sining; Jiang, Na; Lv, Qingyang; Kan, Yumin; Li, Jianqiang; Luo, Laixin] China Agr Univ, Beijing Key Lab Seed Dis Testing & Control BKL SD, Beijing, Peoples R China; [Hao, Jianjun] Univ Maine, Sch Food & Agr, Hitchner Hall, Orono, ME USA; [Han, Sining; Jiang, Na; Lv, Qingyang; Kan, Yumin; Li, Jianqiang; Luo, Laixin] China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University; University of Maine System; University of Maine Orono; China Agricultural University	Luo, LX (corresponding author), China Agr Univ, Coll Plant Protect, Dept Plant Pathol, Beijing, Peoples R China.; Luo, LX (corresponding author), China Agr Univ, Coll Plant Protect, MOA Key Lab Pest Monitoring & Green Management, Beijing, Peoples R China.; Luo, LX (corresponding author), China Agr Univ, Beijing Key Lab Seed Dis Testing & Control BKL SD, Beijing, Peoples R China.; Luo, LX (corresponding author), China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China.	luolaixin@cau.edu.cn	Li, Jing/GYU-5036-2022; LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022		National Natural Science Foundation of China [31571972]; National Key Research and Development Program of China [2017YFD0201601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by the National Natural Science Foundation of China (Grant No. 31571972; the website address is http://www.nsfc.gov.cn/) and National Key Research and Development Program of China grant 2017YFD0201601 to LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported through a grant from the National Natural Science Foundation of China (Grant No. 31571972) and the National Key Research and Development Program of China (2017YFD0201601).	Cawthorn DM, 2008, J APPL MICROBIOL, V105, P1178, DOI 10.1111/j.1365-2672.2008.03851.x; DAVIS MJ, 1984, INT J SYST BACTERIOL, V34, P107, DOI 10.1099/00207713-34-2-107; de Leon L, 2008, J APPL MICROBIOL, V104, P776, DOI 10.1111/j.1365-2672.2007.03595.x; de Leon L, 2011, PLANT DIS, V95, P1328, DOI 10.1094/PDIS-02-11-0091; Dikin A., 2003, International Journal of Agriculture and Biology, V5, P507; Dinu LD, 2013, FOOD CONTROL, V31, P268, DOI 10.1016/j.foodcont.2012.10.020; Ducret A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-3; Eichenlaub R, 2011, ANNU REV PHYTOPATHOL, V49, P445, DOI 10.1146/annurev-phyto-072910-095258; Ferrentino G, 2015, PROCESS BIOCHEM, V50, P188, DOI 10.1016/j.procbio.2014.12.014; FRANKEN AAJM, 1993, NETH J PLANT PATHOL, V99, P125, DOI 10.1007/BF01974265; Frenkel O, 2016, EUR J PLANT PATHOL, V144, P569, DOI 10.1007/s10658-015-0795-4; GITAITIS RD, 1991, PLANT DIS, V75, P834, DOI 10.1094/PD-75-0834; Hadas R, 2005, PLANT PATHOL, V54, P643, DOI 10.1111/j.1365-3059.2005.01230.x; Hausbeck MK, 2000, PHYTOPATHOLOGY, V90, P38, DOI 10.1094/PHYTO.2000.90.1.38; Jiang N, 2016, PLANT PATHOL, V65, P826, DOI 10.1111/ppa.12454; Josefsen MH, 2010, APPL ENVIRON MICROB, V76, P5097, DOI 10.1128/AEM.00411-10; Kibbee RJ, 2017, J MICROBIOL METH, V132, P139, DOI 10.1016/j.mimet.2016.12.004; Li F, 2016, LWT-FOOD SCI TECHNOL, V74, P176, DOI 10.1016/j.lwt.2016.07.044; Li L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00258; Luo LX, 2008, PLANT PATHOL, V57, P332, DOI 10.1111/j.1365-3059.2007.01736.x; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; Oliver JD, 2005, J MICROBIOL, V43, P93; Ordax M, 2006, APPL ENVIRON MICROB, V72, P3482, DOI 10.1128/AEM.72.5.3482-3488.2006; Pinto D, 2015, CRIT REV MICROBIOL, V41, P61, DOI 10.3109/1040841X.2013.794127; Randazzo W, 2018, J APPL MICROBIOL, V124, P958, DOI 10.1111/jam.13519; Randazzo W, 2016, INT J FOOD MICROBIOL, V229, P1, DOI 10.1016/j.ijfoodmicro.2016.04.010; Ribero DH, 2016, SEED SCI TECHNOL, V44, P486, DOI 10.15258/sst.2016.44.3.11; RIEDY MC, 1991, CYTOMETRY, V12, P133, DOI 10.1002/cyto.990120206; Rudi K, 2005, LETT APPL MICROBIOL, V40, P301, DOI 10.1111/j.1472-765X.2005.01672.x; Santiago P, 2015, HELICOBACTER, V20, P252, DOI 10.1111/hel.12205; Sen Y, 2015, PLANT DIS, V99, P4, DOI 10.1094/PDIS-05-14-0499-FE; Smith EF., 1910, SCIENCE, V31, P794, DOI DOI 10.1126/SCIENCE.31.785.80-A; Temple TN, 2013, PLANT DIS, V97, P1585, DOI 10.1094/PDIS-03-13-0262-RE; Tian Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep35457; Ullrich S, 1996, APPL ENVIRON MICROB, V62, P4587, DOI 10.1128/AEM.62.12.4587-4593.1996; Waters C. M., 1992, Phytopathology, V82, P1072; Wu B, 2015, J MICROBIOL METH, V115, P147, DOI 10.1016/j.mimet.2015.05.016; Xiao XL, 2013, CAN J MICROBIOL, V59, P157, DOI 10.1139/cjm-2012-0577; Yasuhara-Bell J, 2013, PHYTOPATHOLOGY, V103, P1220, DOI 10.1094/PHYTO-03-13-0078-R	39	20	22	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196525	10.1371/journal.pone.0196525	http://dx.doi.org/10.1371/journal.pone.0196525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723290	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100037
J	Sanadhya, P; Bucki, P; Liarzi, O; Ezra, D; Gamliel, A; Miyara, SB				Sanadhya, Payal; Bucki, Patricia; Liarzi, Orna; Ezra, David; Gamliel, Abraham; Miyara, Sigal Braun			Caenorhabditis elegans susceptibility to Daldinia cf. concentrica bioactive volatiles is coupled with expression activation of the stress-response transcription factor daf-16, a part of distinct nematicidal action	PLOS ONE			English	Article							ROOT-KNOT NEMATODE; MELOIDOGYNE-INCOGNITA; PAECILOMYCES-LILACINUS; TRICHODERMA-HARZIANUM; BIOLOGICAL-CONTROL; ORGANIC-COMPOUNDS; ANTHELMINTIC EMODEPSIDE; SUPEROXIDE DISMUTASES; PARASITIC NEMATODE; CHLORIDE CHANNEL	The bionematicidal effect of a synthetic volatile mixture (SVM) of four volatile organic compounds (VOCs) emitted by the endophytic fungus Daldinia cf. concentrica against the devastating plant-parasitic root-knot nematode Meloidogyne javanica has been recently demonstrated in both in vitro and greenhouse experiments. However, the mode of action governing the observed irreversible paralysis of J2 larvae upon exposure to SVM is unknown. To unravel the mechanism underlying the anthelmintic and nematicidal activities, we used the tractable model worm Caenorhabditis elegans. C. elegans was also susceptible to both the fungal VOCs and SVM. Among compounds comprising SVM, 3-methyl-1-butanol, (+/-)-2-methyl-1-butanol, and 4-heptanone showed significant nematicidal activity toward L1, L4 and young adult stages. Egg hatching was only negatively affected by 4-heptanone. To determine the mechanism underlying this activity, we examined the response of C. elegans mutants for glutamate-gated chloride channel and acetylcholine transporter, targets of the nematicidal drugs ivermectin and aldicarb, respectively, to 4-heptanone and SVM. These aldicarb- and ivermectin-resistant mutants retained susceptibility upon exposure to 4-heptanone and SVM. Next, we used C. elegans TJ356 strain zIs356 (daf-16::GFP+rol-6), LD1 Idls7[skn-1B/C::GFP + pRF4(rol-6(su1006))], LD1171 Idls3 [gcs-1p::gfp; rol-6 (su1006))], CL2166 dvls19 (gst-4p::GFP) and CF1553 muls84 (sod-3p::GFP+rol-6), which have mutations in genes regulating multiple stress responses. Following exposure of L4 larvae to 4-heptanone or SVM, there was clear nuclear translocation of DAF-16::GFP, and SKN-1::GFP indicating that their susceptibility involves DAF-16 and SKN1 regulation. Application of 4-heptanone, but not SVM, induced increased expression of, gcs-1::GFP and gst-4::GFP compared to controls. In contrast, application of 4-heptanone or SVM to the sod-3::4::GFP line elicited a significant decline in overall fluorescence intensity compared to controls, indicating SOD-3 downregulation and therefore overall reduction in cellular redox machinery. Our data indicate that the mode of action of SVM and 4-heptanone from D. cf. concentrica differs from that of currently available nematicides, potentially offering new solutions for nematode management.	[Sanadhya, Payal; Bucki, Patricia; Miyara, Sigal Braun] ARO, Volcani Ctr, Dept Entomol, Rishon Leziyyon, Israel; [Sanadhya, Payal; Bucki, Patricia; Miyara, Sigal Braun] ARO, Volcani Ctr, Nematol Unit, Rishon Leziyyon, Israel; [Sanadhya, Payal; Bucki, Patricia; Miyara, Sigal Braun] ARO, Volcani Ctr, Chem Unit, Rishon Leziyyon, Israel; [Liarzi, Orna; Ezra, David] ARO, Volcani Ctr, Dept Plant Pathol & Weed Res, Rishon Leziyyon, Israel; [Gamliel, Abraham] ARO, Volcani Ctr, Lab Pest Management Res, Agr Engn Growing Prod & Environm Engn, Rishon Leziyyon, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Miyara, SB (corresponding author), ARO, Volcani Ctr, Dept Entomol, Rishon Leziyyon, Israel.; Miyara, SB (corresponding author), ARO, Volcani Ctr, Nematol Unit, Rishon Leziyyon, Israel.; Miyara, SB (corresponding author), ARO, Volcani Ctr, Chem Unit, Rishon Leziyyon, Israel.	sigalhor@volcani.agri.gov.il	Sanadhya, Payal/F-4750-2011		Israeli Ministry of Agriculture and Rural Development Grant [301-0865-16]	Israeli Ministry of Agriculture and Rural Development Grant	This research was funded by the Israeli Ministry of Agriculture and Rural Development Grant No. 301-0865-16.	Affokpon A, 2011, SOIL BIOL BIOCHEM, V43, P600, DOI 10.1016/j.soilbio.2010.11.029; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Ando H, 2015, J APPL MICROBIOL, V118, P873, DOI 10.1111/jam.12764; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; Back P, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/608478; Barros AF, 2014, APPL SOIL ECOL, V80, P34, DOI 10.1016/j.apsoil.2014.02.011; Bird DM, 2004, CURR OPIN PLANT BIOL, V7, P372, DOI 10.1016/j.pbi.2004.05.005; Brownlee DJA, 1997, PARASITOLOGY, V115, P553, DOI 10.1017/S0031182097001601; Bull K, 2007, INT J PARASITOL, V37, P627, DOI 10.1016/j.ijpara.2006.10.013; Caboni P, 2012, J AGR FOOD CHEM, V60, P1146, DOI 10.1021/jf2044586; Chitwood DJ, 2002, ANNU REV PHYTOPATHOL, V40, P221, DOI 10.1146/annurev.phyto.40.032602.130045; Chitwood DJ, 2003, NEMATICIDES ENCY AGR, P1104, DOI [10.1002/047126363X.agr171, DOI 10.1002/047126363X.AGR171]; Crisford A, 2011, MOL PHARMACOL, V79, P1031, DOI 10.1124/mol.111.071043; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Fialho Mauricio Batista, 2012, Summa phytopathol., V38, P152, DOI 10.1590/S0100-54052012000200008; Fleming JT, 1997, J NEUROSCI, V17, P5843; Freire ES, 2012, J NEMATOL, V44, P321; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Garbeva P, 2014, FEMS MICROBIOL ECOL, V87, P639, DOI 10.1111/1574-6941.12252; Grimme E, 2007, PLANT DIS, V91, P220, DOI 10.1094/PDIS-91-2-0220; Gu YQ, 2007, SOIL BIOL BIOCHEM, V39, P2567, DOI 10.1016/j.soilbio.2007.05.011; Guest M, 2007, INT J PARASITOL, V37, P1577, DOI 10.1016/j.ijpara.2007.05.006; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hu Y, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000499; Huang WK, 2016, BIOL CONTROL, V92, P31, DOI 10.1016/j.biocontrol.2015.09.008; Kaminsky R, 2008, NATURE, V452, P176, DOI 10.1038/nature06722; Kearn J, 2014, PESTIC BIOCHEM PHYS, V109, P44, DOI 10.1016/j.pestbp.2014.01.004; Khan MR, 2011, PHYTOPATHOL MEDITERR, V50, P257; Kiewnick S, 2006, BIOL CONTROL, V38, P179, DOI 10.1016/j.biocontrol.2005.12.006; Kiewnick S, 2006, NEMATOLOGY, V8, P69, DOI 10.1163/156854106776179926; Liarzi O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168437; Liarzi O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168242; Link CD, 2002, METHOD ENZYMOL, V353, P497; Maehara N, 1997, FUND APPL NEMATOL, V20, P611; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Mercier J, 2004, POSTHARVEST BIOL TEC, V31, P1, DOI 10.1016/j.postharvbio.2003.08.004; MEYER SLF, 1990, J NEMATOL, V22, P532; Mulcahy B, 2013, J EXP BIOL, V216, P492, DOI 10.1242/jeb.068734; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; NGUYEN M, 1995, GENETICS, V140, P527; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Porta-de-la-Riva M, 2012, JOVE-J VIS EXP, DOI 10.3791/4019; Przybysz AJ, 2009, MECH AGEING DEV, V130, P357, DOI 10.1016/j.mad.2009.02.004; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Reddy P. P., 1996, Nematologia Mediterranea, V24, P265; Rogers S, 2015, SAGE OPEN MED, V3, DOI 10.1177/2050312115575387; Saifullah T, 1996, AFRO ASIAN J NEMATOL, V6, P23; Sanchez-Ortiz BL, 2016, J APPL MICROBIOL, V120, P1313, DOI 10.1111/jam.13101; Sharon E, 2001, PHYTOPATHOLOGY, V91, P687, DOI 10.1094/PHYTO.2001.91.7.687; Suarez B, 2004, APPL MICROBIOL BIOT, V65, P46, DOI 10.1007/s00253-004-1610-x; Tawe WN, 1998, NUCLEIC ACIDS RES, V26, P1621, DOI 10.1093/nar/26.7.1621; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Wang Y, 2012, B ENVIRON CONTAM TOX, V89, P704, DOI 10.1007/s00128-012-0760-2; Wolstenholme AJ, 2005, PARASITOLOGY, V131, pS85, DOI 10.1017/S0031182005008218; Yang ZS, 2012, J ASIA-PAC ENTOMOL, V15, P647, DOI 10.1016/j.aspen.2012.08.002; Yates DM, 2003, INT J PARASITOL, V33, P1183, DOI 10.1016/S0020-7519(03)00172-3	62	7	7	6	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196870	10.1371/journal.pone.0196870	http://dx.doi.org/10.1371/journal.pone.0196870			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723292	Green Published, Green Submitted, gold			2022-12-26	WOS:000431305100083
J	Ilha, P; Schiesari, L; Yanagawa, FI; Jankowski, K; Navas, CA				Ilha, Paulo; Schiesari, Luis; Yanagawa, Fernando, I; Jankowski, Kathijo; Navas, Carlos A.			Deforestation and stream warming affect body size of Amazonian fishes	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMUNITY STRUCTURE; RIPARIAN ZONE; GROWTH-RATE; TEMPERATURE; IMPACTS; ENERGY; CONSERVATION; ASSEMBLAGES; POPULATIONS	Declining body size has been suggested to be a universal response of organisms to rising temperatures, manifesting at all levels of organization and in a broad range of taxa. However, no study to date evaluated whether deforestation-driven warming could trigger a similar response. We studied changes in fish body size, from individuals to assemblages, in streams in Southeastern Amazonia. We first conducted sampling surveys to validate the assumption that deforestation promoted stream warming, and to test the hypothesis that warmer deforested streams had reduced fish body sizes relative to cooler forest streams. As predicted, deforested streams were up to 6 degrees C warmer and had fish 36% smaller than forest streams on average. This body size reduction could be largely explained by the responses of the four most common species, which were 43-55% smaller in deforested streams. We then conducted a laboratory experiment to test the hypothesis that stream warming as measured in the field was sufficient to cause a growth reduction in the dominant fish species in the region. Fish reared at forest stream temperatures gained mass, whereas those reared at deforested stream temperatures lost mass. Our results suggest that deforestation-driven stream warming is likely to be a relevant factor promoting observed body size reductions, although other changes in stream conditions, like reductions in organic matter inputs, can also be important. A broad scale reduction in fish body size due to warming may be occurring in streams throughout the Amazonian Arc of Deforestation, with potential implications for the conservation of Amazonian fish biodiversity and food supply for people around the Basin.	[Ilha, Paulo; Schiesari, Luis] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, SP, Brazil; [Schiesari, Luis; Yanagawa, Fernando, I] Univ Sao Paulo, Gestao Ambiental, Escola Artes Ciencias & Humanidades, Sao Paulo, SP, Brazil; [Jankowski, Kathijo] US Geol Survey, Upper Midwest Environm Sci Ctr, La Crosse, WI USA; [Navas, Carlos A.] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, SP, Brazil; [Ilha, Paulo] Inst Pesquisa Ambiental Amazonia, Canarana, Mato Grosso, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; United States Department of the Interior; United States Geological Survey; Universidade de Sao Paulo	Ilha, P (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, SP, Brazil.; Ilha, P (corresponding author), Inst Pesquisa Ambiental Amazonia, Canarana, Mato Grosso, Brazil.	ilha@ib.usp.br	Ilha, Paulo/K-8026-2019; Ilha, Paulo/U-3355-2019; Schiesari, Luis C/E-8624-2012	Ilha, Paulo/0000-0003-3431-908X; Schiesari, Luis C/0000-0003-0814-591X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Post-doc Fellowship [88887.136288/2017-00]; Conselho Nacional de Desenvolvimento Cientifico e TecnologicoCNPq; PIBIC Undergraduate Fellowship; PELD/TANG Post-doc Fellowship [23038.000452/2017-16]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; PhD Fellowship [2011/20458-6]; Young Researcher Award [612 2008/57939-9]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Post-doc Fellowship; Conselho Nacional de Desenvolvimento Cientifico e TecnologicoCNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PIBIC Undergraduate Fellowship; PELD/TANG Post-doc Fellowship; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PhD Fellowship; Young Researcher Award	Funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br), Post-doc Fellowship 88887.136288/2017-00 to PI; Conselho Nacional de Desenvolvimento Cientifico e TecnologicoCNPq (www.cnpq.br), PIBIC Undergraduate Fellowship to FIY, PELD/TANG Post-doc Fellowship 23038.000452/2017-16 to PI; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br), PhD Fellowship 2011/20458-6 to PI, and Young Researcher Award 612 2008/57939-9 to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho AA, 2005, CONSERV BIOL, V19, P646, DOI 10.1111/j.1523-1739.2005.00701.x; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; ATKINSON D, 1995, J THERM BIOL, V20, P61, DOI 10.1016/0306-4565(94)00028-H; Atkinson D, 1997, TRENDS ECOL EVOL, V12, P235, DOI 10.1016/S0169-5347(97)01058-6; Azevedo PA, 1998, AQUAT LIVING RESOUR, V11, P227, DOI 10.1016/S0990-7440(98)89005-0; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baudron AR, 2014, GLOBAL CHANGE BIOL, V20, P1023, DOI 10.1111/gcb.12514; Belk MC, 2005, ECOL FRESHW FISH, V14, P177, DOI 10.1111/j.1600-0633.2005.00091.x; Benejam L, 2016, CAN J FISH AQUAT SCI, V73, P547, DOI 10.1139/cjfas-2015-0025; BERRIGAN D, 1994, OIKOS, V70, P474, DOI 10.2307/3545787; Blanck A, 2007, J BIOGEOGR, V34, P862, DOI 10.1111/j.1365-2699.2006.01654.x; Bojsen BH, 2002, FRESHWATER BIOL, V47, P2246, DOI 10.1046/j.1365-2427.2002.00956.x; Brander K, 2013, ICES J MAR SCI, V70, P1065, DOI 10.1093/icesjms/fst055; BRETT JR, 1969, J FISH RES BOARD CAN, V26, P2363, DOI 10.1139/f69-230; Britz PJ, 1997, AQUACULTURE, V152, P191, DOI 10.1016/S0044-8486(97)00002-1; Brown L, 2004, OUTGROWING EARTH FOO; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Caruso NM, 2014, GLOBAL CHANGE BIOL, V20, P1751, DOI 10.1111/gcb.12550; Casatti L, 2012, NEOTROP ICHTHYOL, V10, P205, DOI 10.1590/S1679-62252012000100020; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Chown SL, 2003, ECOGRAPHY, V26, P445, DOI 10.1034/j.1600-0587.2003.03479.x; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Clarke K.R., 2006, PRIMER V6 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Costa WJEM, 2011, ICHTHYOL EXPLOR FRES, V22, P233; da Fonseca AP, 2013, NEOTROP ICHTHYOL, V11, P837, DOI 10.1590/S1679-62252013000400012; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; de Melo CE, 2009, NEOTROP ICHTHYOL, V7, P251, DOI 10.1590/S1679-62252009000200017; Desai AS, 2009, J THERM BIOL, V34, P276, DOI 10.1016/j.jtherbio.2009.03.005; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; DODSON SI, 1974, LIMNOL OCEANOGR, V19, P721, DOI 10.4319/lo.1974.19.5.0721; Donelson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097223; Evans EC, 1998, HYDROL PROCESS, V12, P575; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Forster J, 2012, P NATL ACAD SCI USA, V109, P19310, DOI 10.1073/pnas.1210460109; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Ilha P., 2015, THESIS; ISA, 2011, ALM SOC PARQ INCL XI; Isaac V, 2011, CONSUMO PESCADO AMAZ; Jeppesen E, 2010, HYDROBIOLOGIA, V646, P73, DOI 10.1007/s10750-010-0171-5; Kamdem Toham A, 1999, HYDROBIOLOGIA, V397, P29, DOI 10.1023/A:1003605801875; Kausar R., 2006, Pakistan Veterinary Journal, V26, P105; Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014; Lefevre S, 2018, GLOBAL CHANGE BIOL, V24, P553, DOI 10.1111/gcb.13978; Lefevre S, 2017, GLOBAL CHANGE BIOL, V23, P3449, DOI 10.1111/gcb.13652; Leitao RP, 2017, ECOGRAPHY, V125, P336, DOI DOI 10.1111/ECOG.02845; Leveque C, 2008, HYDROBIOLOGIA, V595, P545, DOI 10.1007/s10750-007-9034-0; Lorion CM, 2009, ECOL APPL, V19, P468, DOI 10.1890/08-0050.1; Lynch AJ, 2016, ENVIRON REV, V24, P115, DOI 10.1139/er-2015-0064; Macedo Marcia N, 2013, Philos Trans R Soc Lond B Biol Sci, V368, P20120153, DOI 10.1098/rstb.2012.0153; Malmquist HJ, 2004, ACIA INT SCI S CLIM, V8, P45; Myers BJE, 2017, REV FISH BIOL FISHER, V27, P339, DOI 10.1007/s11160-017-9476-z; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Navas CA, 1996, PHYSIOL ZOOL, V69, P1481, DOI 10.1086/physzool.69.6.30164271; Neuheimer AB, 2011, NAT CLIM CHANGE, V1, P110, DOI [10.1038/NCLIMATE1084, 10.1038/nclimate1084]; O'Gorman EJ, 2016, GLOBAL CHANGE BIOL, V22, P3206, DOI 10.1111/gcb.13233; Ohlberger J, 2013, FUNCT ECOL, V27, P991, DOI 10.1111/1365-2435.12098; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pusey BJ, 2003, MAR FRESHWATER RES, V54, P1, DOI 10.1071/MF02041; R Core Team, 2021, R LANGUAGE ENV STAT; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; REZNICK D, 1982, AM NAT, V120, P181, DOI 10.1086/283981; Rypel AL, 2014, AM NAT, V183, P147, DOI 10.1086/674094; Sandblom E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1490; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Silverio D, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/10/104015; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Todd CD, 2008, GLOBAL CHANGE BIOL, V14, P958, DOI 10.1111/j.1365-2486.2007.01522.x; Velasquez C, 2010, FIQUE DENTRO BACIA R; Venne H, 1989, PHYSL ECOLOGY JAPAN, V1, P239; Volcan MV, 2013, J APPL ICHTHYOL, V29, P648, DOI 10.1111/jai.12013	77	29	30	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196560	10.1371/journal.pone.0196560	http://dx.doi.org/10.1371/journal.pone.0196560			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718960	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900061
J	Sato, K; Harb, S; Kumar, A; Kapadia, SR; Mick, S; Krishnaswamy, A; Desai, MY; Griffin, BP; Rodriguez, LL; Tuzcu, EM; Svensson, LG; Popovic, ZB				Sato, Kimi; Harb, Serge; Kumar, Arnav; Kapadia, Samir R.; Mick, Stephanie; Krishnaswamy, Amar; Desai, Milind Y.; Griffin, Brian P.; Rodriguez, L. Leonardo; Tuzcu, E. Murat; Svensson, Lars G.; Popovic, Zoran B.			Impact of left ventricular diastolic function and survival in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement	PLOS ONE			English	Article							MITRAL REGURGITATION; FILLING PRESSURES; AMERICAN-SOCIETY; EUROPEAN-ASSOCIATION; DOPPLER ESTIMATION; RECOMMENDATIONS; ECHOCARDIOGRAPHY; DYSFUNCTION; RELAXATION; VELOCITY	In year 2016, the American Society of Echocardiography (ASE) and the European Association of Cardiovascular Imaging (EACVI) updated Recommendations for the assessment and grading of diastolic dysfunction (DD). We aimed to assess the applicability of this DD grading method and its association with prognosis in patients with severe aortic stenosis (AS) who underwent transcatheter aortic valve implantation (TAVI). We retrospectively identified 237 consecutive patients with severe AS who underwent trans-femoral TAVI. Baseline transthoracic echocardiography was evaluated to assess pre-and post-TAVI diastolic function according to the current ASE/EACVI Recommendations. Prior to TAVI, 41 (17%) patients were diagnosed as having grade I DD, 111 (47%) patients had grade II DD, 80 (34%) had grade III DD. DD grade after TAVI decreased (p < 0.001) with 75 patients (32%) reclassified to a lower DD grade. During the median follow-up of 1,320 days, 136 (57%) patients died. In univariable Cox proportional hazards model analysis, neither pre-nor post-TAVI DD grade were associated with prognosis. However, patients with grade III DD detected before TAVI and AR >= 2 after TAVI had poorer survival (p<0.008). Patients with grade III DD detected after TAVI and AR >= 2 after TAVI had poorer prognosis (p = 0.002). TAVI improves DD grade. While poor DD grade was not associated with mortality after treatment of AS by TAVI, concomitant presence of DD and post-procedural AR carried a poor prognosis.	[Sato, Kimi; Harb, Serge; Kumar, Arnav; Kapadia, Samir R.; Mick, Stephanie; Krishnaswamy, Amar; Desai, Milind Y.; Griffin, Brian P.; Rodriguez, L. Leonardo; Tuzcu, E. Murat; Svensson, Lars G.; Popovic, Zoran B.] Cleveland Clin, Heart & Vasc Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Popovic, ZB (corresponding author), Cleveland Clin, Heart & Vasc Inst, Cleveland, OH 44106 USA.	popoviz@ccf.org	Kumar, Arnav/AAM-1602-2020					Ariza J, 2015, EUR HEART J CARDIOVA; Ariza J, 2016, EUR HEART J-CARD IMG, V17, P804, DOI 10.1093/ehjci/jev219; Barbanti M, 2013, CIRCULATION, V128, P2776, DOI 10.1161/CIRCULATIONAHA.113.003885; Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; Bedogni F, 2013, CIRCULATION, V128, P2145, DOI 10.1161/CIRCULATIONAHA.113.001822; Blair JEA, 2017, J AM SOC ECHOCARDIOG, V30, P541, DOI 10.1016/j.echo.2017.01.003; Diwan A, 2005, CIRCULATION, V111, P3281, DOI 10.1161/CIRCULATIONAHA.104.508812; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; HESS OM, 1984, CIRCULATION, V69, P855, DOI 10.1161/01.CIR.69.5.855; Iwataki M, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000136; Jassal DS, 2008, EUR HEART J, V29, P1542, DOI 10.1093/eurheartj/ehn172; Kampaktsis PN, 2017, CATHETER CARDIO INTE, V89, P445, DOI 10.1002/ccd.26582; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1016/j.jacc.2012.09.001, 10.1093/ejcts/ezs533]; LABOVITZ AJ, 1985, AM J CARDIOL, V55, P133, DOI 10.1016/0002-9149(85)90314-5; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Nagueh SF, 1996, CIRCULATION, V94, P2138, DOI 10.1161/01.CIR.94.9.2138; Nagueh SF, 1999, CIRCULATION, V99, P254, DOI 10.1161/01.CIR.99.2.254; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Olson JJ, 2006, J AM SOC ECHOCARDIOG, V19, P83, DOI 10.1016/j.echo.2005.07.005; Popovic ZB, 2006, AM J PHYSIOL-HEART C, V290, pH1454, DOI 10.1152/ajpheart.00902.2005; Rossi A, 2001, J AM SOC ECHOCARDIOG, V14, P562, DOI 10.1067/mje.2001.111475; Sato K, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005798; Sato K, 2017, AM HEART J, V189, P28, DOI 10.1016/j.ahj.2017.03.022; Soeki T, 2002, Eur J Echocardiogr, V3, P128, DOI 10.1053/euje.2001.0137; Toggweiler S, 2012, J AM COLL CARDIOL, V59, P2068, DOI 10.1016/j.jacc.2012.02.020; Unger P, 2011, HEART, V97, P272, DOI 10.1136/hrt.2010.212282; Zoghbi WA, 2017, J AM SOC ECHOCARDIOG, V30, P303, DOI 10.1016/j.echo.2017.01.007	28	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196031	10.1371/journal.pone.0196031	http://dx.doi.org/10.1371/journal.pone.0196031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718948	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900043
J	Clarke, SG				Clarke, Steven G.			The ribosome: A hot spot for the identification of new types of protein methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						protein methylation; post-translational modification (PTM); translation elongation factor; ribosome; ribosome structure; protein methyltransferase	SET DOMAIN METHYLTRANSFERASE; MASS-SPECTROMETRIC ANALYSIS; N-TERMINAL METHYLATION; ARGININE METHYLATION; SACCHAROMYCES-CEREVISIAE; S-ADENOSYLMETHIONINE; CYSTEINE METHYLTRANSFERASE; LYSINE METHYLATION; ESCHERICHIA-COLI; DNA-DAMAGE	Cellular physiology depends on the alteration of protein structures by covalent modification reactions. Using a combination of bioinformatic, genetic, biochemical, and mass spectrometric approaches, it has been possible to probe ribosomal proteins from the yeast Saccharomyces cerevisiae for post-translationally methylated amino acid residues and for the enzymes that catalyze these modifications. These efforts have resulted in the identification and characterization of the first protein histidine methyltransferase, the first N-terminal protein methyltransferase, two unusual types of protein arginine methyltransferases, and a new type of cysteine methylation. Two of these enzymes may modify their substrates during ribosomal assembly because the final methylated histidine and arginine residues are buried deep within the ribosome with contacts only with RNA. Two of these modifications occur broadly in eukaryotes, including humans, whereas the others demonstrate a more limited phylogenetic range. Analysis of strains where the methyltransferase genes are deleted has given insight into the physiological roles of these modifications. These reactions described here add diversity to the modifications that generate the typical methylated lysine and arginine residues previously described in histones and other proteins.	[Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Clarke, Steven G.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.; Clarke, SG (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu	Moffitt, Terrie E/D-5295-2011; caspi, avshalom/D-5294-2011	Moffitt, Terrie E/0000-0002-8589-6760; caspi, avshalom/0000-0003-0082-4600; Clarke, Steven/0000-0002-7303-6632	National Science Foundation [MCB-1714569]; National Institutes of Health [GM026020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB-1714569 and National Institutes of Health Grant GM026020. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afjehi-Sadat L, 2013, CURR OPIN CHEM BIOL, V17, P12, DOI 10.1016/j.cbpa.2012.12.023; Al-Hadid Q, 2016, RNA, V22, P489, DOI 10.1261/rna.054569.115; Al-Hadid Q, 2016, BIOCHEM BIOPH RES CO, V470, P552, DOI 10.1016/j.bbrc.2016.01.107; Al-Hadid Q, 2014, MOL CELL BIOL, V34, P2903, DOI 10.1128/MCB.01634-13; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Black JC, 2013, BIOPOLYMERS, V99, P127, DOI 10.1002/bip.22136; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Bonsignore LA, 2015, ONCOTARGET, V6, P12248, DOI 10.18632/oncotarget.3653; Bonsignore LA, 2015, MECH AGEING DEV, V146, P42, DOI 10.1016/j.mad.2015.03.012; Carlson SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026435; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Castillo-Aguilera O., 2017, BIOMOLECULES, V7, pE3, DOI DOI 10.3390/BI0M7010003; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; Chern MK, 2002, J BIOL CHEM, V277, P15345, DOI 10.1074/jbc.M111379200; Clarke S., 2006, PROTEIN METHYLTRANSF, V24, P1; Clarke SG, 2013, TRENDS BIOCHEM SCI, V38, P243, DOI 10.1016/j.tibs.2013.02.004; Cloutier P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003210; Couttas TA, 2012, PROTEOMICS, V12, P960, DOI 10.1002/pmic.201100570; Dai XX, 2013, J PROTEOME RES, V12, P4167, DOI 10.1021/pr400498y; Demirci H, 2007, EMBO J, V26, P567, DOI 10.1038/sj.emboj.7601508; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; DOGNIN MJ, 1980, EUR J BIOCHEM, V112, P131, DOI 10.1111/j.1432-1033.1980.tb04995.x; Dong C, 2015, GENE DEV, V29, P2343, DOI 10.1101/gad.270611.115; Drozak J, 2015, J BIOL CHEM, V290, P17190, DOI 10.1074/jbc.M115.640037; Dzialo MC, 2014, J BIOL CHEM, V289, P30511, DOI 10.1074/jbc.M114.605527; Erce MA, 2013, PROTEOMICS, V13, P1059, DOI 10.1002/pmic.201200477; Erce MA, 2012, PROTEOMICS, V12, P564, DOI 10.1002/pmic.201100397; Falnes PO, 2016, BIOCHEM J, V473, P1995, DOI 10.1042/BCJ20160117; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; GOTTSCHLING H, 1962, NATURE, V196, P829, DOI 10.1038/196829a0; Grabarse WG, 2000, J MOL BIOL, V303, P329, DOI 10.1006/jmbi.2000.4136; Gratenstein K, 2005, GENOMICS, V85, P762, DOI 10.1016/j.ygeno.2005.02.010; Hamey JJ, 2018, TRENDS BIOCHEM SCI, V43, P211, DOI 10.1016/j.tibs.2018.01.004; Hamey JJ, 2016, MOL CELL PROTEOMICS, V15, P164, DOI 10.1074/mcp.M115.052449; Horowitz S, 2012, J BIOL CHEM, V287, P41576, DOI 10.1074/jbc.R112.418574; Hyun K, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.11; Jakobsson ME, 2018, RNA BIOL, V15, P314, DOI 10.1080/15476286.2018.1440875; Kalhor HR, 1999, ARCH BIOCHEM BIOPHYS, V370, P105, DOI 10.1006/abbi.1999.1370; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; Louie DF, 1996, J BIOL CHEM, V271, P28189, DOI 10.1074/jbc.271.45.28189; Low JKK, 2012, FEBS J, V279, P4423, DOI 10.1111/febs.12039; Lv FJ, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.37; Medvar B, 2016, PHYSIOL GENOMICS, V48, P502, DOI 10.1152/physiolgenomics.00031.2016; Meng FY, 2004, ANAL CHEM, V76, P2852, DOI 10.1021/ac0354903; Meskauskas A, 2010, NUCLEIC ACIDS RES, V38, P7800, DOI 10.1093/nar/gkq641; Mielecki D, 2015, MUTAT RES-REV MUTAT, V763, P294, DOI 10.1016/j.mrrev.2014.12.001; Migliori V, 2010, EPIGENOMICS-UK, V2, P119, DOI [10.2217/epi.09.39, 10.2217/EPI.09.39]; Niewmierzycka A, 1999, J BIOL CHEM, V274, P814, DOI 10.1074/jbc.274.2.814; Olsson I, 2007, EXP CELL RES, V313, P1778, DOI 10.1016/j.yexcr.2007.03.007; Petkowski JJ, 2013, BIOCHEM J, V456, P453, DOI 10.1042/BJ20131163; Petkowski JJ, 2012, BIOCHEMISTRY-US, V51, P5942, DOI 10.1021/bi300278f; Petrossian T, 2009, EPIGENOMICS-UK, V1, P163, DOI 10.2217/EPI.09.3; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Porras-Yakushi TR, 2008, J BIOL CHEM, V283, P15512; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; Raposo AE, 2018, CELL DIV, V13, DOI 10.1186/s13008-018-0036-2; Rendon OZ, 2014, HUM MOL GENET, V23, P5159, DOI 10.1093/hmg/ddu239; Revenkova E, 1999, EMBO J, V18, P490, DOI 10.1093/emboj/18.2.490; Rhein VF, 2013, J BIOL CHEM, V288, P33016, DOI 10.1074/jbc.M113.518803; Richardson SL, 2015, J BIOL CHEM, V290, P11601, DOI 10.1074/jbc.M114.626846; Rouillon A, 1999, J BIOL CHEM, V274, P28096, DOI 10.1074/jbc.274.40.28096; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Sathyan KM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14678; Sayegh J, 2008, BIOCHEM BIOPH RES CO, V372, P811, DOI 10.1016/j.bbrc.2008.05.121; Schwalm EL, 2016, SCIENCE, V352, P309, DOI 10.1126/science.aad5367; Sengupta S, 2014, BBA-GEN SUBJECTS, V1840, P1861, DOI 10.1016/j.bbagen.2014.01.005; Shields KM, 2017, PROTEIN SCI, V26, P1639, DOI 10.1002/pro.3202; Shin HS, 2009, BIOCHEM BIOPH RES CO, V385, P273, DOI 10.1016/j.bbrc.2009.05.055; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Tooley CES, 2010, NATURE, V466, P1125, DOI 10.1038/nature09343; Tooley JG, 2014, PROTEIN SCI, V23, P1641, DOI 10.1002/pro.2547; VANET A, 1994, MOL MICROBIOL, V14, P947, DOI 10.1111/j.1365-2958.1994.tb01330.x; Vlaming H, 2014, EMBO REP, V15, P1077, DOI 10.15252/embr.201438793; Walsh C. T., 2006, POSTTRANSLATIONAL MO, P121; Wang CY, 2017, FEBS LETT, V591, P433, DOI 10.1002/1873-3468.12533; Webb KJ, 2011, J BIOL CHEM, V286, P18405, DOI 10.1074/jbc.M110.200410; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Webb KJ, 2008, J BIOL CHEM, V283, P35561, DOI 10.1074/jbc.M806006200; Wilson LJ, 2018, CANCER RES, V78, P15, DOI 10.1158/0008-5472.CAN-17-2291; Winter DL, 2018, J MOL BIOL, V430, P102, DOI 10.1016/j.jmb.2017.11.009; Wlodarski T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023168; Wu RX, 2015, GENE DEV, V29, P2337, DOI 10.1101/gad.270926.115; Wu ZR, 2017, FEBS J, V284, P2732, DOI 10.1111/febs.14056; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yang YZ, 2012, MOL CELL, V48, P487, DOI 10.1016/j.molcel.2012.11.007; Yao Q, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004522; Yao XY, 1999, J BIOL CHEM, V274, P37443, DOI 10.1074/jbc.274.52.37443; Yesselman JD, 2015, PROTEINS, V83, P403, DOI 10.1002/prot.24724; Young BD, 2012, BIOCHEMISTRY-US, V51, P5091, DOI 10.1021/bi300186g; Zhang G, 2015, ORG BIOMOL CHEM, V13, P4149, DOI 10.1039/c5ob00120j; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690; Zhang TY, 2015, EMBO REP, V16, P1467, DOI 10.15252/embr.201540945; Zhang Y, 2016, J BIOL CHEM, V291, P20149, DOI 10.1074/jbc.M116.734079; Zobel-Thropp P, 1998, J BIOL CHEM, V273, P29283, DOI 10.1074/jbc.273.45.29283	100	13	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10438	10446		10.1074/jbc.AW118.003235	http://dx.doi.org/10.1074/jbc.AW118.003235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29743234	Green Published, hybrid			2022-12-26	WOS:000437828400004
J	Knight, JM; Mandal, P; Morlacchi, P; Mak, G; Li, E; Madison, M; Landers, C; Saxton, B; Felix, E; Gilbert, B; Sederstrom, J; Varadhachary, A; Singh, MM; Chatterjee, D; Corry, DB; McMurray, JS				Knight, J. Morgan; Mandal, Pijus; Morlacchi, Pietro; Mak, Garbo; Li, Evan; Madison, Matthew; Landers, Cameron; Saxton, Brandon; Felix, Ed; Gilbert, Brian; Sederstrom, Joel; Varadhachary, Atul; Singh, Melissa M.; Chatterjee, Dev; Corry, David B.; McMurray, John S.			Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						asthma; STAT transcription factor; allergen; fungi; cytokine; peptidomimetic; SH2 domain; STAT5; STAT6	DOSE INHALED FLUTICASONE; INNATE LYMPHOID-CELLS; SIGNAL-TRANSDUCTION; CARNITINE HOMEOSTASIS; PHOSPHATASE SHP-1; INFLUENZA-VIRUS; ASTHMA; THERAPY; IL-4; INFLAMMATION	Asthma is a chronic inflammatory disease of the lungs and airways and one of the most burdensome of all chronic maladies. Previous studies have established that expression of experimental and human asthma requires the IL-4/IL-13/IL-4 receptor (IL-4R) signaling pathway, which activates the transcription factor STAT6. However, no small molecules targeting this important pathway are currently in clinical development. To this end, using a preclinical asthma model, we sought to develop and test a small-molecule inhibitor of the Src homology 2 domains in mouse and human STAT6. We previously developed multiple peptidomimetic compounds on the basis of blocking the docking site of STAT6 to IL-4R and phosphorylation of Tyr(641) in STAT6. Here, we expanded the scope of our initial in vitro structure-activity relationship studies to include central and C-terminal analogs of these peptides to develop a lead compound, PM-43I. Conducting initial dose range, toxicity, and pharmacokinetic experiments with PM-43I, we found that it potently inhibits both STAT5- and STAT6-dependent allergic airway disease in mice. Moreover, PM-43I reversed preexisting allergic airway disease in mice with a minimum ED50 of 0.25 g/kg. Of note, PM-43I was efficiently cleared through the kidneys with no long-term toxicity. We conclude that PM-43I represents the first of a class of small molecules that may be suitable for further clinical development against asthma.	[Knight, J. Morgan; Mak, Garbo; Li, Evan; Corry, David B.] Baylor Coll Med, Dept Med, 1 Baylor Plaza,BCM285, Houston, TX 77030 USA; [Knight, J. Morgan; Corry, David B.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Saxton, Brandon; Gilbert, Brian] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Madison, Matthew; Landers, Cameron; Corry, David B.] Baylor Coll Med, Translat Biol & Mol Med Program, Houston, TX 77030 USA; [Li, Evan; Corry, David B.] Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA; [Mandal, Pijus; Morlacchi, Pietro; Felix, Ed; McMurray, John S.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA; [Sederstrom, Joel] Baylor Coll Med, Flow Cytometry Core Facil, Houston, TX USA; [Corry, David B.] Michael E Debakey Vet Affairs Ctr Translat Res In, Houston, TX 77030 USA; [Varadhachary, Atul; Singh, Melissa M.; Chatterjee, Dev] Fannin Innovat Studio & Atrapos Therapeut LLC, Houston, TX 77027 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Knight, JM; Corry, DB (corresponding author), Baylor Coll Med, Dept Med, 1 Baylor Plaza,BCM285, Houston, TX 77030 USA.	JMK@bcm.edu; dcorry@bcm.edu		Madison, Matthew/0000-0001-8143-7471; Landers, Cameron/0000-0002-1507-282X	National Institutes of Health [R41AI25007, R01 HL117181]; Veterans Affairs Office of Research and Development [I01BX002221, I01 CX001673]; American Asthma Foundation; Biology of Inflammation Center, Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI125007] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Office of Research and Development; American Asthma Foundation; Biology of Inflammation Center, Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This study was funded by National Institutes of Health Grants R41AI25007 and R01 HL117181, Veterans Affairs Office of Research and Development Grants I01BX002221 and I01 CX001673, the American Asthma Foundation, and the Biology of Inflammation Center, Baylor College of Medicine. J.M.K., P. Mandal, P. Morlacchi, D.B.C., and Atrapos Therapeutics, LLC hold intellectual property rights in compound PM-43I. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed CMI, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00183; Arima K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000567; Bhattacharjee A, 2013, FREE RADICAL BIO MED, V54, P1, DOI 10.1016/j.freeradbiomed.2012.10.553; Board on Environmental Studies and Toxicology Division on Earth and Life Sciences National Research Council, 2014, REV FORM ASS NAT TOX; Brass EP, 2002, PHARMACOL REV, V54, P589, DOI 10.1124/pr.54.4.589; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; Cates C. J., 2012, COCHRANE DATABASE SY; Chang GH, 2013, AM J OTOLARYNG, V34, P743, DOI 10.1016/j.amjoto.2013.07.016; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Delbridge ARD, 2015, CELL DEATH DIFFER, V22, P1071, DOI 10.1038/cdd.2015.50; Duerr CU, 2016, CYTOKINE, V87, P1, DOI 10.1016/j.cyto.2016.01.018; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; Fairfax AJ, 1999, THORAX, V54, P860, DOI 10.1136/thx.54.9.860; Gavino AC, 2016, ALLERGY, V71, P1684, DOI 10.1111/all.12937; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; HALLER O, 1979, J EXP MED, V149, P601, DOI 10.1084/jem.149.3.601; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hao YH, 2014, INFECT IMMUN, V82, P5246, DOI 10.1128/IAI.01989-14; Haque SJ, 1998, J BIOL CHEM, V273, P33893, DOI 10.1074/jbc.273.51.33893; Helman D, 1998, FEBS LETT, V441, P287, DOI 10.1016/S0014-5793(98)01555-5; Hoffmann F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00107; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; Isaksen DE, 1999, J IMMUNOL, V163, P5971; Jia YY, 2013, BASIC CLIN PHARMACOL, V113, P431, DOI 10.1111/bcpt.12112; Kabata H, 2015, ALLERGOL INT, V64, P227, DOI 10.1016/j.alit.2015.03.004; Knight JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142212; Knight JM, 2014, J ALLERGY CLIN IMMUN, V133, P189, DOI 10.1016/j.jaci.2013.03.049; KNIGHT V, 1988, EUR J CLIN MICROBIOL, V7, P721, DOI 10.1007/BF01975037; Knight V, 1987, Infect Dis Clin North Am, V1, P441; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; LAVROV SV, 1968, NATURE, V217, P856, DOI 10.1038/217856a0; Leav BA, 2000, NEW ENGL J MED, V343, P586, DOI 10.1056/NEJM200008243430818; Lee SH, 2008, J IMMUNOL, V180, P4656, DOI 10.4049/jimmunol.180.7.4656; Losman JA, 1999, J IMMUNOL, V162, P3770; Mandal PK, 2015, J MED CHEM, V58, P8970, DOI 10.1021/acs.jmedchem.5b01321; Mandal PK, 2011, J MED CHEM, V54, P3549, DOI 10.1021/jm2000882; Mandal PK, 2009, ORG LETT, V11, P3394, DOI 10.1021/ol9012662; McDonald VM, 2017, RESPIROLOGY, V22, P53, DOI 10.1111/resp.12957; McMurray John S, 2012, JAKSTAT, V1, P263, DOI 10.4161/jkst.22682; Mitkus RJ, 2013, VACCINE, V31, P2738, DOI 10.1016/j.vaccine.2013.03.071; Miyata S, 1999, CLIN EXP ALLERGY, V29, P114; Morlacchi P, 2014, ACS MED CHEM LETT, V5, P69, DOI 10.1021/ml4003919; Patnaik A, 2002, CLIN CANCER RES, V8, P2142; Peter E, 2002, CLIN INFECT DIS, V35, pE54, DOI 10.1086/341971; Peters MC, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0651-4; PHALEN RF, 1984, INHALATION STUDIES F, P211; Porter P, 2009, MUCOSAL IMMUNOL, V2, P504, DOI 10.1038/mi.2009.102; Porter PC, 2014, J ALLERGY CLIN IMMUN, V134, P325, DOI 10.1016/j.jaci.2014.04.028; Ram PA, 1997, J BIOL CHEM, V272, P17694, DOI 10.1074/jbc.272.28.17694; Reich Nancy C, 2013, JAKSTAT, V2, pe27080, DOI 10.4161/jkst.27080; SCHLESINGER RB, 1985, J TOXICOL ENV HEALTH, V15, P197, DOI 10.1080/15287398509530647; Simeone-Penney MC, 2007, J IMMUNOL, V178, P6191, DOI 10.4049/jimmunol.178.10.6191; Tan HTT, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0650-5; Uehara Y, 2015, CIRC J, V79, P2523, DOI 10.1253/circj.CJ-15-0960; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077795; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Zhu JF, 2010, IMMUNOL CELL BIOL, V88, P244, DOI 10.1038/icb.2009.114	63	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10026	10040		10.1074/jbc.RA117.000567	http://dx.doi.org/10.1074/jbc.RA117.000567			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29739850	hybrid, Green Published			2022-12-26	WOS:000437096700008
J	Galan, JMGY; Murciano, A; Sirvent, L; Sanchez, A; Watkins, JE				Maria Gabriel y Galan, Jose; Murciano, Antonio; Sirvent, Laure; Sanchez, Abel; Watkins, James E.			Germination fitness of two temperate epiphytic ferns shifts under increasing temperatures and forest fragmentation	PLOS ONE			English	Article							SIMULATED CLIMATE-CHANGE; VASCULAR EPIPHYTES; SEED-GERMINATION; NONVASCULAR EPIPHYTES; SPORE GERMINATION; RAIN-FOREST; DIVERSITY; CONSERVATION; PLANTS; WORLD	Ferns are an important component of ecosystems around the world. Studies of the impacts that global changes may have on ferns are scarce, yet emerging studies indicate that some species may be particularly sensitive to climate change. The lack of research in this subject is much more aggravated in the case of epiphytes, and especially those that live under temperate climates. A mathematical model was developed for two temperate epiphytic ferns in order to predict potential impacts on spore germination kinetics, in response to different scenarios of global change, coming from increasing temperature and forest fragmentation. Our results show that an increasing temperature will have a negative impact over the populations of these temperate epiphytic ferns. Under unfragmented forests the germination percentage was comparatively less influenced than in fragmented patches. This study highlight that, in the long term, populations of the studied epiphytic temperate ferns may decline due to climate change. Overall, epiphytic fern communities will suffer changes in diversity, richness and dominance. Our study draws attention to the role of ferns in epiphytic communities of temperate forests, emphasizing the importance of considering these plants in any conservation strategy, specifically forest conservation. From a methodological point of view, the model we propose could be easily used to dynamically monitor the status of ecosystems, allowing the quick prediction of possible future scenarios, which is a crucial issue in biodiversity conservation decision-making.	[Maria Gabriel y Galan, Jose] Univ Complutense, Fac Biol, Dept Biodivers Ecol & Evolut, Unit Bot, Madrid, Spain; [Murciano, Antonio; Sanchez, Abel] Univ Complutense, Fac Biol, Dept Biodivers Ecol & Evolut, Neural Plast Res Grp,IdISSC,Unit Biomath, Madrid, Spain; [Murciano, Antonio; Sanchez, Abel] Univ Complutense, Fac Biol, Dept Biodivers Ecol & Evolut, Neurocomp & Neurorobot Res Grp,UCM Unit Biomat, Madrid, Spain; [Sirvent, Laure] Natl Museum Nat Hist, Paris, France; [Watkins, James E.] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; Museum National d'Histoire Naturelle (MNHN); Colgate University	Galan, JMGY (corresponding author), Univ Complutense, Fac Biol, Dept Biodivers Ecol & Evolut, Unit Bot, Madrid, Spain.	jmgabrie@ucm.es	Sanchez, Abel/L-8032-2014; Gabriel y Galan, Jose Maria/L-2263-2014	Sanchez, Abel/0000-0002-7978-3436; Gabriel y Galan, Jose Maria/0000-0003-2786-0062; MURCIANO CESPEDOSA, ANTONIO/0000-0001-6644-8420	Universidad Complutense Research Groups (Biodiversity and Taxonomy of Cryptogamic Plants) [UCM-CM 910801]; Fundacion Santander [JPI2014]	Universidad Complutense Research Groups (Biodiversity and Taxonomy of Cryptogamic Plants); Fundacion Santander	The authors thank the following Institutions for supporting part of this research: Universidad Complutense Research Groups (Biodiversity and Taxonomy of Cryptogamic Plants, UCM-CM 910801 to JMGG; www.ucm.es), and Fundacion Santander fora research mobility grant to Chile (JPI2014 to JMGG; https://www.bancosantander.es/es/universidades). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119952; [Anonymous], 2013, CONTRIBUTION WORKING, P1535; Armesto J, 1996, ECOLOGIA BOSQUES NAT; Ashworth L, 2011, BIOTROPICA, V43, P496, DOI 10.1111/j.1744-7429.2010.00721.x; Barthlott W, 2001, PLANT ECOL, V152, P145, DOI 10.1023/A:1011483901452; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Benzing DH, 1998, CLIMATIC CHANGE, V39, P519, DOI 10.1023/A:1005312307709; Bruna EM, 1999, NATURE, V402, P139, DOI 10.1038/45963; Bystriakova N, 2014, ANN BOT-LONDON, V113, P453, DOI 10.1093/aob/mct274; Cardelus CL, 2006, J ECOL, V94, P144, DOI 10.1111/j.1365-2745.2005.01052.x; Cardelus CL, 2005, BIOTROPICA, V37, P238, DOI 10.1111/j.1744-7429.2005.00032.x; Castillo C, 2001, ESTAD STICA CLIMATOL, VII; DYER A., 1979, EXPT BIOL FERNS, P254; Echeverria C, 2006, BIOL CONSERV, V130, P481, DOI 10.1016/j.biocon.2006.01.017; Ellis CJ, 2009, J BIOGEOGR, V36, P302, DOI 10.1111/j.1365-2699.2008.01989.x; Gradstein S.R., 2008, BIODIVER ECOLOG SERI, V2, P51; Gutierrez AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103226; Hiendlmeyer R, 2010, AM FERN J, V100, P207, DOI 10.1640/0002-8444-100.4.207; Hietz P, 1998, PURE APPL CHEM, V70, P1; HIETZ P., 2010, FERN ECOLOGY, P140, DOI DOI 10.1017/CB09780511844898; Hietz P, 2012, BIOTROPICA, V44, P197, DOI 10.1111/j.1744-7429.2011.00791.x; Hsu RCC, 2014, PLANT ECOL, V215, P889, DOI 10.1007/s11258-014-0340-0; Hsu RCC, 2012, DIVERS DISTRIB, V18, P334, DOI 10.1111/j.1472-4642.2011.00819.x; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Kessler M., 2010, FERN ECOLOGY, P22, DOI DOI 10.1017/CBO9780511844898.003; Koster N, 2009, CONSERV BIOL, V23, P911, DOI 10.1111/j.1523-1739.2008.01164.x; Li S, 2011, FOREST ECOL MANAG, V261, P1760, DOI 10.1016/j.foreco.2011.01.037; Lindsay S., 1990, TAXONOMIA BIOGEOGRAF, P243; Lu HZ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00416; Galan JMGY, 2015, AN JARDIN BOT MADRID, V72, DOI 10.3989/ajbm.2405; Galan JMGY, 2011, WORKING WITH FERNS: ISSUES AND APPLICATIONS, P193, DOI 10.1007/978-1-4419-7162-3_14; Milbau A, 2009, ANN BOT-LONDON, V104, P287, DOI 10.1093/aob/mcp117; Nadkarni NM, 2002, OECOLOGIA, V131, P580, DOI 10.1007/s00442-002-0899-3; Nadkarni NM, 1992, SELBYANA, V13, P140; NAUYALIS I I, 1989, Botanicheskii Zhurnal (St. Petersburg), V74, P844; Neto LM, 2009, BIODIVERS CONSERV, V18, P3785, DOI 10.1007/s10531-009-9679-2; Oishi Y, 2015, LANDSC ECOL ENG, V11, P283, DOI 10.1007/s11355-015-0273-3; Pajaron S, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv047; Pearson RG, 2005, BIOL CONSERV, V123, P389, DOI 10.1016/j.biocon.2004.12.006; Pouteau R, 2016, CLIMATIC CHANGE, V138, P143, DOI 10.1007/s10584-016-1734-x; Ranal MA, 1999, AM FERN J, V89, P149, DOI 10.2307/1547349; ROBERTS EH, 1988, SYM SOC EXP BIOL, V42, P109; RodrIguez-RIos R., 1995, FLORA CHILE, V1, p260 ; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sanhueza C, 2017, POLAR BIOL, V40, P449, DOI 10.1007/s00300-016-1972-4; Schuettpelz E., 2007, EVOLUTION DIVERSIFIC; Sharpe J.M, 2010, FERN ECOLOGY; Song L, 2012, BIOL CONSERV, V152, P127, DOI 10.1016/j.biocon.2012.04.002; Testo WL, 2013, AM J BOT, V100, P2261, DOI 10.3732/ajb.1300150; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Ursula H, 1995, BIOL CONSERV, V75, P103; Wade TG, 2003, ECOL SOC, V7, DOI [10.5751/ES-00530-070207, DOI 10.5751/ES-00530-070207]; Walck JL, 2011, GLOBAL CHANGE BIOL, V17, P2145, DOI 10.1111/j.1365-2486.2010.02368.x; Walther GR, 2004, PERSPECT PLANT ECOL, V6, P169, DOI 10.1078/1433-8319-00076; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Watkins JE, 2012, INT J PLANT SCI, V173, P695, DOI 10.1086/665974; Watkins JE, 2007, AM J BOT, V94, P701, DOI 10.3732/ajb.94.4.701; Werkman BR, 1996, GLOB CHANGE BIOL, V2, P59, DOI 10.1111/j.1365-2486.1996.tb00049.x; Wolf JHD, 2006, ECOL STU AN, V185, P375, DOI 10.1007/3-540-28909-7_29; Zotz G, 2005, PLANT ECOL, V176, P173, DOI 10.1007/s11258-004-0066-5; Zotz G., 2009, V70, P147, DOI 10.1007/978-3-540-68421-3_7; Zotz G, 2001, J EXP BOT, V52, P2067, DOI 10.1093/jexbot/52.364.2067	63	4	4	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0197110	10.1371/journal.pone.0197110	http://dx.doi.org/10.1371/journal.pone.0197110			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750811	Green Published, Green Submitted, gold			2022-12-26	WOS:000431856300018
J	Kunkler, B; Salamango, D; DeBruine, ZJ; Ploch, C; Dean, S; Grossens, D; Hledin, MP; Marquez, GA; Madden, J; Schnell, A; Short, M; Burnatowska-Hledin, MA				Kunkler, Bryan; Salamango, Daniel; DeBruine, Zachary J.; Ploch, Caitlin; Dean, Shirley; Grossens, David; Hledin, Michael P.; Marquez, Gabriel A.; Madden, Julie; Schnell, Abigayle; Short, Michael; Burnatowska-Hledin, Maria A.			CUL5 is required for thalidomide-dependent inhibition of cellular proliferation	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE MULTIPLE-MYELOMA; ENDOTHELIAL-CELLS; CEREBLON EXPRESSION; ADENOVIRUS E4ORF6; LIMB DEFECTS; GENE FAMILY; PROTEINS; ANGIOGENESIS	Angiogenesis is essential for cancer metastasis, thus the discovery and characterization of molecules that inhibit this process is important. Thalidomide is a teratogenic drug which is known to inhibit angiogenesis and effectively inhibit cancer metastasis, yet the specific cellular targets for its effect are not well known. We discovered that CUL5 (previously identified as VACM-1), a scaffold protein in E3 ligase complexes, is involved in thalidomide-dependent inhibition of endothelial cell growth. Our results show that in human endothelial cells (HUVEC), thalidomide-dependent decrease in cell growth was associated with decreased nuclear localization of CUL5. In HUVEC transfected with anti-VACM-1 siRNA, thalidomide failed to decrease cell growth. Previously it was established that the antiproliferative effect of CUL5 is inhibited in rat endothelial cells (RAMEC) transfected with mutated CUL5 which is constitutively modified by NEDD8, a ubiquitin-like protein. In this study, the antiproliferative response to thalidomide was compromised in RAMEC expressing mutated CUL5. These results suggest that CUL5 protein is involved in the thalidomide-dependent regulation of cellular proliferation in vitro. Consequently, CUL5 may be an important part of the mechanism for thalidomide-dependent inhibition of cellular proliferation, as well as a novel biomarker for predicting a response to thalidomide for the treatment of disorders such as multiple myeloma and HIV infection.	[Kunkler, Bryan; Salamango, Daniel; DeBruine, Zachary J.; Ploch, Caitlin; Dean, Shirley; Grossens, David; Hledin, Michael P.; Marquez, Gabriel A.; Madden, Julie; Schnell, Abigayle; Short, Michael; Burnatowska-Hledin, Maria A.] Hope Coll, Dept Chem, Paul A Schaap Sci Ctr, Holland, MI 49423 USA; [Burnatowska-Hledin, Maria A.] Hope Coll, Dept Biol, Paul A Schaap Sci Ctr, Holland, MI 49423 USA	Hope College; Hope College	Burnatowska-Hledin, MA (corresponding author), Hope Coll, Dept Chem, Paul A Schaap Sci Ctr, Holland, MI 49423 USA.; Burnatowska-Hledin, MA (corresponding author), Hope Coll, Dept Biol, Paul A Schaap Sci Ctr, Holland, MI 49423 USA.	hledin@hope.edu			National Cancer Institute [R15CA104014]; Arnold and Mabel Beckman Foundation Beckman Foundation Award; American Society for Biochemistry and Molecular Biology (US) undergraduate award; Hope College's REACH program for high school students	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Arnold and Mabel Beckman Foundation Beckman Foundation Award; American Society for Biochemistry and Molecular Biology (US) undergraduate award; Hope College's REACH program for high school students	This work was supported in part by the National Cancer Institute grant R15CA104014 (MABH), the Arnold and Mabel Beckman Foundation Beckman Foundation Award to SD, American Society for Biochemistry and Molecular Biology (US) undergraduate award to BK, and Hope College's REACH program for high school students (GAM and MPH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030019; Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Baxter SS, 2009, IN VITRO CELL DEV-AN, V45, P264, DOI 10.1007/s11626-008-9163-4; Bradley SE, 2010, J BIOL CHEM, V285, P4883, DOI 10.1074/jbc.M109.085225; Broyl A, 2013, BLOOD, V121, P624, DOI 10.1182/blood-2012-06-438101; Buchwalter A, 2008, MICROVASC RES, V75, P155, DOI 10.1016/j.mvr.2007.08.004; Burnatowska-Hledin M, 2001, ENDOTHELIUM-J ENDOTH, V8, P49, DOI 10.3109/10623320109063157; Burnatowska-Hledin M, 1998, AM J PHYSIOL, V276, pF199; Burnatowska-Hledin MA, 2004, BIOCHEM BIOPH RES CO, V319, P817, DOI 10.1016/j.bbrc.2004.05.057; BURNATOWSKAHLEDIN MA, 1995, AM J PHYSIOL-RENAL, V268, pF1198, DOI 10.1152/ajprenal.1995.268.6.F1198; Byrd PJ, 1997, GENOME RES, V7, P71, DOI 10.1101/gr.7.1.71; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Ehrlich ES, 2009, P NATL ACAD SCI USA, V106, P20330, DOI 10.1073/pnas.0810571106; Fay Michael J, 2003, Mol Cancer, V2, P40, DOI 10.1186/1476-4598-2-40; Feng L, 2007, GENE DEV, V21, P2717, DOI 10.1101/gad.1604207; Heuze ML, 2005, J BIOL CHEM, V280, P5468, DOI 10.1074/jbc.M413040200; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Huang Y, 2009, EUR UROL, V56, P690, DOI 10.1016/j.eururo.2008.10.014; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Johnson AE, 2012, CELL TISSUE RES, V349, P527, DOI 10.1007/s00441-012-1419-3; Kaczmarczyk-Sedlak I, 2013, ACTA POL PHARM, V70, P323; Kalla C, 2007, EUR J CANCER, V43, P1328, DOI 10.1016/j.ejca.2007.02.005; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Knobloch J, 2007, FASEB J, V21, P1410, DOI 10.1096/fj.06-7603com; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Laszlo GS, 2009, CURR BIOL, V19, P157, DOI 10.1016/j.cub.2008.12.007; Lee RHK, 2007, EMBO J, V26, P3592, DOI 10.1038/sj.emboj.7601781; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Luo K, 2007, FASEB J, V21, P1742, DOI 10.1096/fj.06-7241com; Maeda Y, 2008, J BIOL CHEM, V283, P16084, DOI 10.1074/jbc.M710223200; MAKONKAWKEYOON S, 1993, P NATL ACAD SCI USA, V90, P5974, DOI 10.1073/pnas.90.13.5974; Mathias N, 1996, MOL CELL BIOL, V16, P6634; Mobasheri A, 2005, INT J ONCOL, V26, P1149; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Rafiee P, 2010, AM J PHYSIOL-GASTR L, V298, pG167, DOI 10.1152/ajpgi.00385.2009; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Samant RS, 2014, P NATL ACAD SCI USA, V111, P6834, DOI 10.1073/pnas.1322412111; Shortal J., 2013, ORG DEV JOINT CHIEFS, P1; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stephens TD, 2009, BIRTH DEFECTS RES A, V85, P725, DOI 10.1002/bdra.20597; Swords RT, 2010, BLOOD, V1, P2009; Tamilarasan KP, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-17; Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106; Vacca A, 2005, J CLIN ONCOL, V23, P5334, DOI 10.1200/JCO.2005.03.723; Vacca A, 2001, BRIT J HAEMATOL, V113, P415, DOI 10.1046/j.1365-2141.2001.02738.x; Van Dort C, 2003, AM J PHYSIOL-CELL PH, V285, pC1386, DOI 10.1152/ajpcell.00338.2002; Vargesson N, 2009, BIOESSAYS, V31, P1327, DOI 10.1002/bies.200900103; Xu XM, 2012, CANCER LETT, V322, P148, DOI 10.1016/j.canlet.2012.02.038; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhao X, 2014, HUM MOL GENET, V10, P1; Zhu YX, 2011, BLOOD, V118, P4771, DOI 10.1182/blood-2011-05-356063	56	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196760	10.1371/journal.pone.0196760	http://dx.doi.org/10.1371/journal.pone.0196760			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746508	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700035
J	Cortes, V; Gonzalez-Solis, J				Cortes, Veronica; Gonzalez-Solis, Jacob			Seabird bycatch mitigation trials in artisanal demersal longliners of the Western Mediterranean	PLOS ONE			English	Article							INTEGRATED WEIGHT LONGLINES; BY-CATCH; PUFFINUS-MAURETANICUS; PELAGIC SEABIRDS; FISHERIES; MORTALITY; SHEARWATERS; PATTERNS; AREAS; CONSERVATION	High numbers of seabirds are killed annually worldwide in longline fisheries. In the Mediterranean, this mortality is seriously affecting the viability of seabird populations, in particular of the three endemic shearwaters. Even so, there is currently no specific seabird mitigation requirements for the longline fleet operating in this area. From 2013 to 2014, we assessed the efficiency and practical applicability of four mitigation measures on artisanal demersal longliners targeting European hake (Merluccius merluccius) in the western Mediterranean: night setting, tori line, weighted lines and artificial baits. We performed fifty-two pairs of experimental (with the tested mitigation measure) and control settings (without any measure), and compared their effects on seabird interactions and fish catches. In addition, we estimated the longline sink rates and the seabird access area to baited hooks in different longline configurations. Night setting reduced bycatch risk without affecting target and noncommercial fish catches. The tori line may have reduced the bycatch risk by displacing bait attacks beyond the end of the line, but at this distance shearwaters could still access to the baits and the streamers did not deter birds under calm wind conditions. Weighted lines increased sink rate, but it resulted in only a minor reduction of the seabird access window to baited hooks and led to some operational problems during the setting. Artificial baits substantially reduced commercial catches. Moreover, the seabird access to the baited hooks was influenced by the longline configuration, the setting speed and the relative position to the floats and weights. So far, night setting stands out as the best mitigation measure for reducing bycatch levels without compromising target catches in demersal longliners. Ideally, these results should be confirmed in longliners targeting species other than European hake.	[Cortes, Veronica; Gonzalez-Solis, Jacob] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Cortes, Veronica; Gonzalez-Solis, Jacob] Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambiental, Barcelona, Spain	University of Barcelona; University of Barcelona	Cortes, V (corresponding author), Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain.; Cortes, V (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambiental, Barcelona, Spain.	vecorse@gmail.com	Gonzalez-Solis, Jacob/AAZ-5338-2021; González-Solís, Jacob/AAB-1161-2019; Gonzalez-Solis, Jacob/C-3942-2008; Fennell, Hannah/AAI-1408-2019	Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gonzalez-Solis, Jacob/0000-0002-8691-9397; 	Generalitat de Catalunya [FI/DGR/2011]; Fundacion Biodiversidad [18PCA4328]; Ministerio de Agricultura, Alimentacion y Medio Ambiente [18PCA4328]; AP Project Application [2013-09]	Generalitat de Catalunya(Generalitat de Catalunya); Fundacion Biodiversidad(European Commission); Ministerio de Agricultura, Alimentacion y Medio Ambiente(Spanish Government); AP Project Application	This work was supported by (VC) FI/DGR/2011 http://agaur.gencat.cat/es/inici/, Generalitat de Catalunya; 18PCA4328: 2013-14, 2014-15, http://fundacion-biodiversidad.es/, Fundacion Biodiversidad and Ministerio de Agricultura, Alimentacion y Medio Ambiente; ACAP Project Application 2013-09, https://www.acap.aq/en, Agreement on the Conservation of Albatrosses and Petrels. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACAP, 2014, BYC MIT FACT SHEETS; ACAP, 2016, SUMM ADV RED IMP DEM, DOI [10.1016/i.tree.2008.10.008, DOI 10.1016/I.TREE.2008.10.008]; Aguilar JS, 2003, SCI MAR, V67, P129, DOI 10.3989/scimar.2003.67s2129; Anastasopoulou A, 2013, J FISH BIOL, V83, P1637, DOI 10.1111/jfb.12269; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; [Anonymous], 1999, INC CATCH SEAB LONGL; [Anonymous], 1998, ICES J MAR SCI, V55, P145; [Anonymous], 2003, FISH RES, V60, P11; [Anonymous], 2011, MAR ECOL PROG SER, V435, P285; Ashford J.R., 1995, CCAMLR Science, V2, P111; Becares J, MONOGRAFIA SEO, V1; Belda EJ, 2001, BIOL CONSERV, V98, P357, DOI 10.1016/S0006-3207(00)00178-6; Boggs CH, 2001, UASGCP REP, V2001, P79; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boyd C, 2014, ANIM CONSERV, V17, P530, DOI 10.1111/acv.12179; Brothers N, 1999, BIOL CONSERV, V88, P85, DOI 10.1016/S0006-3207(98)00085-8; CAREY FG, 1981, FISH B-NOAA, V79, P277; Cartamil DP, 2004, MAR ECOL PROG SER, V266, P245, DOI 10.3354/meps266245; Cherel Y, 1996, BIOL CONSERV, V75, P63, DOI 10.1016/0006-3207(95)00037-2; Cianchetti-Benedetti M, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3106-0; Cortes V, 2018, MAR ECOL PROG SER, V588, P229, DOI 10.3354/meps12427; Cortes V, 2017, MAR ECOL PROG SER, V565, P1, DOI 10.3354/meps12026; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Dietrich KS, 2008, BIOL CONSERV, V141, P1793, DOI 10.1016/j.biocon.2008.04.023; Dimech M, 2009, INT COMMISSION CONSE; FAO, 2016, STAT MED BLACK SEA F; Barcelona SG, 2010, AQUAT LIVING RESOUR, V23, P363, DOI 10.1051/alr/2010022; Genovart M, 2017, GLOBAL CHANGE BIOL, V23, P3012, DOI 10.1111/gcb.13670; Genovart M, 2016, J APPL ECOL, V53, P1158, DOI 10.1111/1365-2664.12622; Gilman E, 2005, FISH FISH, V6, P35, DOI 10.1111/j.1467-2679.2005.00175.x; Gilman EL, 2011, MAR POLICY, V35, P590, DOI 10.1016/j.marpol.2011.01.021; Gladics AJ, 2017, FISH RES, V196, P85, DOI 10.1016/j.fishres.2017.08.015; Gothel H, 1992, FAUNA MARINA MEDITER; Inchausti P, 2001, BIOL CONSERV, V100, P377, DOI 10.1016/S0006-3207(01)00044-1; Karris G, 2013, MEDITERR MAR SCI, V14, P19, DOI 10.12681/mms.541; Laneri K, 2010, MAR ECOL PROG SER, V420, P241, DOI 10.3354/meps08847; Lewison RL, 2003, ECOL APPL, V13, P743, DOI 10.1890/1051-0761(2003)013[0743:EFBAEO]2.0.CO;2; Linden A, 2011, ECOLOGY, V92, P1414, DOI 10.1890/10-1831.1; Lokkeborg S, 1997, FISH RES, V32, P213, DOI 10.1016/S0165-7836(97)00070-2; Arcos JM, 2012, BIOL CONSERV, V156, P30, DOI 10.1016/j.biocon.2011.12.011; Meier RE, 2015, BIOL CONSERV, V190, P87, DOI 10.1016/j.biocon.2015.05.012; Melvin EF, 2014, FISH RES, V149, P5, DOI 10.1016/j.fishres.2013.07.012; Melvin EF, 2001, AFP72001; Moreno CA, 2006, BIOL CONSERV, V127, P27, DOI 10.1016/j.biocon.2005.07.011; Oppel S, 2011, BIOL CONSERV, V144, P2255, DOI 10.1016/j.biocon.2011.05.017; Peron C, 2013, BIOL CONSERV, V168, P210, DOI 10.1016/j.biocon.2013.09.006; Pon JPS, 2007, FISH RES, V85, P101, DOI 10.1016/j.fishres.2007.01.002; Robertson G, 2003, FISH RES, V62, P385, DOI 10.1016/S0165-7836(02)00276-X; Robertson G, 2008, AQUAT CONSERV, V17, P102; Robertson GG, 2000, CCAMLR SCI, V7, P133; Robertson G, 2006, BIOL CONSERV, V132, P458, DOI 10.1016/j.biocon.2006.05.003; Rubolini D, 2015, ETHOLOGY, V121, P284, DOI 10.1111/eth.12338; Sanchez A, 2003, FISH RES, V60, P99, DOI 10.1016/S0165-7836(02)00055-3; Soriano-Redondo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep37373; Stevens JD, 2010, MAR BIOL, V157, P575, DOI 10.1007/s00227-009-1343-6; Wanless RM, 2009, BIOL CONSERV, V142, P1710, DOI 10.1016/j.biocon.2009.03.008; Weimerskirch H, 2000, POLAR BIOL, V23, P236, DOI 10.1007/s003000050440; Zuur Alain F., 2009, P1	58	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196731	10.1371/journal.pone.0196731	http://dx.doi.org/10.1371/journal.pone.0196731			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742148	gold, Green Submitted, Green Published			2022-12-26	WOS:000431757400038
J	Dou, XL; Shirahata, S; Sugimoto, H				Dou, Xiaoling; Shirahata, Shingo; Sugimoto, Hiroki			Functional clustering of mouse ultrasonic vocalization data	PLOS ONE			English	Article							MICE; REPERTOIRE	Mouse ultrasonic vocalizations (USVs) are studied in many fields of science. However, various noise and varied USV patterns in observed signals make complete automatic analysis difficult. We improve several methods to reduce noise, detect USV calls and automatically cluster USV calls. After reduction of noise and detection of USV calls, we consider USV calls as functional data and characterize them as USV functions with B-spline basis functions. For discontinuous USV calls, breakpoints in the USV functions are defined using multiple knots in the construction of the B-spline basis functions, and a hierarchical method is used to cluster the USV functions by shape. We finally show the performance of the proposed methods with USV data recorded for laboratory mice.	[Dou, Xiaoling] Waseda Univ, Fac Sci & Engn, Tokyo, Japan; [Shirahata, Shingo] Osaka Univ, Grad Sch Engn Sci, Osaka, Japan; [Sugimoto, Hiroki] Jichi Med Univ, Div Biol, Shimotsuke, Tochigi, Japan	Waseda University; Osaka University; Jichi Medical University	Dou, XL (corresponding author), Waseda Univ, Fac Sci & Engn, Tokyo, Japan.	xiaoling@aoni.waseda.jp			Transdisciplinary Research Integration Center, Research Organization of Information and Systems, Japan	Transdisciplinary Research Integration Center, Research Organization of Information and Systems, Japan	This work was supported by Transdisciplinary Research Integration Center, Research Organization of Information and Systems, Japan (Dr. Xiaoling Dou) (http://www.. rois.ac.ip).	Abraham C, 2003, SCAND J STAT, V30, P581, DOI 10.1111/1467-9469.00350; Asaba A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087186; Chiou JM, 2007, J ROY STAT SOC B, V69, P679, DOI 10.1111/j.1467-9868.2007.00605.x; Curry T, 2013, GENES BRAIN BEHAV, V12, P397, DOI 10.1111/gbb.12037; De Boor C, 2000, PRACTICAL GUIDE SPLI; Dou X, 2015, ASTE FINANCIAL PEN B, VB12, P71; Ferraty T, 2006, NONPARAMETRIC FUNCTI; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Hahn ME, 2005, BEHAV GENET, V35, P31, DOI 10.1007/s10519-004-0854-7; Heckman J, 2016, NEUROSCI BIOBEHAV R, V65, P313, DOI 10.1016/j.neubiorev.2016.03.029; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; James GM, 2003, J AM STAT ASSOC, V98, P397, DOI 10.1198/016214503000189; MAGGIO JC, 1985, J COMP PSYCHOL, V99, P420, DOI 10.1037/0735-7036.99.4.420; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Ramsay J. O, 2006, FUNCTIONAL DATA ANAL; Ramsay J. O., 2002, APPL FUNCTIONAL DATA, DOI 10.1111/j.1467-985x.2004.t01-5-.x; Ramsay JO., 1997, FUNCTIONAL DATA ANAL, DOI 10.1007/978-1-4757-7107-7; Rivlin T.J., 1990, CHEBYSHEV POLYNOMIAL; Sani R., 2006, EXPT DESIGN STAT PSY; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; SMOTHERMAN WP, 1974, BEHAV BIOL, V12, P55, DOI 10.1016/S0091-6773(74)91026-8; Sugimoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022093; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	25	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196834	10.1371/journal.pone.0196834	http://dx.doi.org/10.1371/journal.pone.0196834			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742174	Green Published, gold			2022-12-26	WOS:000431757400044
J	Eusemann, BK; Baulain, U; Schrader, L; Thone-Reineke, C; Patt, A; Petow, S				Eusemann, Beryl Katharina; Baulain, Ulrich; Schrader, Lars; Thoene-Reineke, Christa; Patt, Antonia; Petow, Stefanie			Radiographic examination of keel bone damage in living laying hens of different strains kept in two housing systems	PLOS ONE			English	Article							EGG QUALITY; FURNISHED CAGES; BREAKING STRENGTH; PLUMAGE CONDITION; DEFORMITIES; FRACTURES; WELFARE; PREVALENCE; PERCHES; BEHAVIOR	A high prevalence of deviations and fractures of the keel bone is a widespread welfare problem in laying hens. The aim of this study was to experimentally investigate this multifactorial problem throughout the laying period and to compare the prevalence and severity in different layer lines and different housing systems. High performing white (WLA) and brown (BLA) pure bred layer lines and low performing white (R11, G11) and brown layer lines (L68) were kept in both single cages and a floor housing system. A total of 97 hens (19 or 20 from each line, respectively) were repeatedly radiographed in the 35th, 51st and 72nd week of age. Fracture prevalence increased with age (p<0.001). The proportion of deviated keel bone area increased only for caged BLA, WLA and R11 hens (p<0.05) and was significantly higher for caged WLA and R11 hens compared to floor-housed WLA and R11 hens in the 72nd week of age (p<0.05). In the 72nd week of age hens in the floor housing system showed significantly more fractures than hens kept in cages (p<0.05). Prevalence of keel bone deviations was significantly higher in the white layer line R11 but significantly lower in the white layer line G11 compared to both brown layer lines and WLA (p<0.05). Brown layers showed significantly more fractures than white layers (p<0.05) in the 51st and 72nd week of age. Within the brown layers there was a significantly lower prevalence of deviations (p<0.05) and fractures (p<0.05) in the low performing (L68) compared to the high performing line (BLA). Our results show a different development of keel bone damage in caged compared to floor-housed hens under experimental conditions. Additionally, they indicate genetic effects on keel bone damage.	[Eusemann, Beryl Katharina; Schrader, Lars; Patt, Antonia; Petow, Stefanie] Friedrich Loeffler Inst, Inst Anim Welf & Anim Husb, Celle, Germany; [Baulain, Ulrich] Friedrich Loeffler Inst, Inst Farm Anim Genet, Mariensee, Germany; [Thoene-Reineke, Christa] Free Univ Berlin, Inst Anim Welf Anim Behav & Lab Anim Sci, Berlin, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Free University of Berlin	Eusemann, BK (corresponding author), Friedrich Loeffler Inst, Inst Anim Welf & Anim Husb, Celle, Germany.	beryl.eusemann@fli.de		Eusemann, Beryl/0000-0003-1367-0372; Schrader, Lars/0000-0003-1696-1562	Friedrich-Loeffler-Institut	Friedrich-Loeffler-Institut	All costs were covered by budget resources of the Friedrich-Loeffler-Institut.	Barnett JL, 1997, AUST J EXP AGR, V37, P523, DOI 10.1071/EA97024; Candelotto L, 2017, POULTRY SCI, V96, P3517, DOI 10.3382/ps/pex146; Casey-Trott T, 2015, POULTRY SCI, V94, P2339, DOI 10.3382/ps/pev223; Clark WD, 2008, POULTRY SCI, V87, P1964, DOI 10.3382/ps.2008-00115; EFSA, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4191; EFSA, 2005, EFSA J, V197, P1, DOI DOI 10.2903/J.EFSA.2005.197; ETCHES RJ, 1987, J NUTR, V117, P619, DOI 10.1093/jn/117.3.619; FAWC, 2010, OP OST BON FRACT LAY; FAWC, 2013, OP LETT GREAT BRIT G; FLEMING RH, 1994, BRIT POULTRY SCI, V35, P651, DOI 10.1080/00071669408417731; Fleming RH, 2004, BRIT POULTRY SCI, V45, P320, DOI 10.1080/00071660410001730815; Habig C, 2013, BRIT POULTRY SCI, V54, P413, DOI 10.1080/00071668.2013.792405; Heerkens JLT, 2016, POULTRY SCI, V95, P2479, DOI 10.3382/ps/pew157; Hocking PM, 2003, BRIT POULTRY SCI, V44, P365, DOI [10.1080/0007166031000085535, NO_DOI]; Jendral MJ, 2008, POULTRY SCI, V87, P828, DOI 10.3382/ps.2007-00192; Jones PJ, 2016, 16 INT C PROD DIS FA, P148; Kappeli S, 2011, BRIT POULTRY SCI, V52, P531, DOI 10.1080/00071668.2011.615059; Kappeli S, 2011, POULTRY SCI, V90, P1637, DOI 10.3382/ps.2011-01379; Keutgen H., 1999, DTSCH TIERARTZLICHE, V106, P125; Lay DC, 2011, POULTRY SCI, V90, P278, DOI 10.3382/ps.2010-00962; Lieboldt MA, 2015, EUR POULTRY SCI, V79, DOI 10.1399/eps.2015.89; Moinard C, 2004, WELFARE LAYING HEN P, V27, P417; Nasr MAF, 2013, APPL ANIM BEHAV SCI, V147, P127, DOI 10.1016/j.applanim.2013.04.015; Nasr MAF, 2013, BRIT POULTRY SCI, V54, P165, DOI 10.1080/00071668.2013.767437; Nasr MAF, 2012, ANIM WELFARE, V21, P127, DOI 10.7120/096272812799129376; Nasr MAF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042420; Petrik MT, 2015, POULTRY SCI, V94, P579, DOI 10.3382/ps/pev039; Pickel T, 2011, POULTRY SCI, V90, P715, DOI 10.3382/ps.2010-01025; Richards GJ, 2012, VET REC, V170, P494, DOI 10.1136/vr.100489; Richards GJ, 2011, VET REC, V169, P279, DOI 10.1136/vr.d4404; Riczu CM, 2004, POULTRY SCI, V83, P375, DOI 10.1093/ps/83.3.375; Rodenburg TB, 2008, ANIM WELFARE, V17, P363; Sandilands V, 2009, BRIT POULTRY SCI, V50, P395, DOI 10.1080/00071660903110844; Scholz B, 2014, BRIT POULTRY SCI, V55, P419, DOI 10.1080/00071668.2014.933175; Scholz B, 2008, ARCH TIERZUCHT, V51, P179, DOI 10.5194/aab-51-179-2008; Sherwin CM, 2010, BRIT POULTRY SCI, V51, P488, DOI 10.1080/00071668.2010.502518; Sirovnik KJ, 2017, 10 EUR S POULTR WELF, P162; Stratmann A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122568; Vits A, 2005, POULTRY SCI, V84, P1511, DOI 10.1093/ps/84.10.1511; Wahlstrom A, 2001, POULTRY SCI, V80, P266, DOI 10.1093/ps/80.3.266; Whitehead CC, 2004, POULTRY SCI, V83, P193, DOI 10.1093/ps/83.2.193; Wilkins LJ, 2011, VET REC, V169, P414, DOI 10.1136/vr.d4831; Wilkins LJ, 2004, VET REC, V155, P547, DOI 10.1136/vr.155.18.547	43	38	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0194974	10.1371/journal.pone.0194974	http://dx.doi.org/10.1371/journal.pone.0194974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742164	gold, Green Published, Green Submitted			2022-12-26	WOS:000431757400008
J	Oudeman, J; Verhamme, C; Engbersen, MP; Caan, MWA; Maas, M; Froeling, M; Nederveen, AJ; Strijkers, GJ				Oudeman, Jos; Verhamme, Camiel; Engbersen, Maurits P.; Caan, Mattan W. A.; Maas, Mario; Froeling, Martijn; Nederveen, Aart J.; Strijkers, Gustav J.			Diffusion tensor MRI of the healthy brachial plexus	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; FIELD-OF-VIEW; NERVE ROOTS; PERIPHERAL-NERVES; SKELETAL-MUSCLE; FAT-SUPPRESSION; ULNAR NERVES; NEUROGRAPHY; DTI; TRACTOGRAPHY	Introduction Diffusion Tensor MRI (DT-MRI) is a promising tool for the evaluation of brachial plexus pathology. Therefore, we introduce and evaluate a fast DT-MRI protocol (8min33s scanning with 5-10 min postprocessing time) for the brachial plexus. Materials and methods Thirty healthy volunteers within three age-groups (18-35, 36-55, and > 56) received DT-MRI of the brachial-plexus twice. Means of fractional-anisotropy (FA), mean-diffusivity (MD), axial-diffusivity (AD), and radial-diffusivity (RD) for the individual roots and trunks were evaluated. A stepwise forward approach was applied to test for correlations with age, sex, body-mass-index (BMI), bodysurface, height, and bodyweight. Within-subject, intra-rater, and inter-rater repeatability were assessed using Bland-Altman analysis, coefficient of variation (CV), intraclass-correlation (ICC), and minimal detectable difference (MDD). Results No differences between sides and root levels were found. MD, AD, and RD correlated (P < 0.05) with bodyweight. Within-subject quantification proved repeatable with CVs for FA, MD, AD, and RD of 16%, 12%, 11%, and 14%, respectively. Discussion The DT-MRI protocol was fast and repeatable. Found correlations should be considered in future studies of brachial plexus pathology.	[Oudeman, Jos; Engbersen, Maurits P.; Caan, Mattan W. A.; Maas, Mario; Nederveen, Aart J.] Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Verhamme, Camiel] Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Froeling, Martijn] Univ Med Ctr, Dept Radiol, Utrecht, Netherlands; [Strijkers, Gustav J.] Acad Med Ctr, Biomed Engn & Phys, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Oudeman, J (corresponding author), Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands.	J.Oudeman@amc.uva.nl	Engbersen, Maurits/AAI-3198-2021; Froeling, Martijn/E-7865-2012	Engbersen, Maurits/0000-0002-4523-2345; Froeling, Martijn/0000-0003-3841-0497; Strijkers, Gustav/0000-0001-6700-5058; Caan, Matthan W.A./0000-0002-5162-8880; Verhamme, Anne/0000-0002-2201-1865; Nederveen, Aart/0000-0002-5477-973X	Nuts-Ohra Foundation (Amsterdam, The Netherlands) [1203055]; European Union COST Action [BM1304]	Nuts-Ohra Foundation (Amsterdam, The Netherlands)(Netherlands Government); European Union COST Action	This work was supported by grant 1203055 from the Nuts-Ohra Foundation (Amsterdam, The Netherlands). This work was also supported by the European Union COST Action BM1304, "Applications of MR imaging and spectroscopy techniques in neuromuscular disease: collaboration on outcome measures and pattern recognition for diagnostics and therapy development." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Budzik JF, 2013, EUR RADIOL, V23, P1361, DOI 10.1007/s00330-012-2710-0; Caan MWA, 2011, IEEE T BIO-MED ENG, V58, P2431, DOI 10.1109/TBME.2010.2095009; Chappell KE, 2004, AM J NEURORADIOL, V25, P431; Chen YY, 2014, ACAD RADIOL, V21, P338, DOI 10.1016/j.acra.2013.11.005; Chhabra A, 2013, AM J NEURORADIOL, V34, P802, DOI 10.3174/ajnr.A3316; Chhabra A, 2013, AM J NEURORADIOL, V34, P486, DOI 10.3174/ajnr.A3287; Chhabra A, 2013, RADIOL RES PRACT, V2013, DOI 10.1155/2013/809568; Damon BM, 2016, NMR BIOMED, V31, P1252, DOI [10.1002/NBRN.3563, DOI 10.1002/NBRN.3563]; Damon BM, 2008, MAGN RESON MED, V60, P934, DOI 10.1002/mrm.21707; Froeling M, 2015, RADIOLOGY, V274, P548, DOI 10.1148/radiol.14140702; Froeling M, 2013, NMR BIOMED, V26, P1339, DOI 10.1002/nbm.2959; Froeling M, 2012, J MAGN RESON IMAGING, V36, P237, DOI 10.1002/jmri.23608; Galban CJ, 2005, NMR BIOMED, V18, P489, DOI 10.1002/nbm.975; Galban CJ, 2007, J GERONTOL A-BIOL, V62, P453, DOI 10.1093/gerona/62.4.453; Gasparotti R, 2013, INVEST RADIOL, V48, P104, DOI 10.1097/RLI.0b013e3182775267; Gooch CL, 2007, NEUROL CLIN, V25, P1, DOI 10.1016/j.ncl.2007.01.011; Guggenberger R, 2012, RADIOLOGY, DOI [10.1148/RADOL.12111403, DOI 10.1148/RADOL.12111403]; Haakma W, 2017, EUR RADIOL, V27, P2216, DOI 10.1007/s00330-016-4575-0; Haun DW, 2010, ULTRASOUND MED BIOL, V36, P1422, DOI 10.1016/j.ultrasmedbio.2010.05.012; Hilgenfeld T, 2017, INVEST RADIOL, V52, P741, DOI 10.1097/RLI.0000000000000401; Hooijmans MT, 2015, NMR BIOMED, V28, P1589, DOI 10.1002/nbm.3427; Irfanoglu MO, 2012, NEUROIMAGE, V61, P275, DOI 10.1016/j.neuroimage.2012.02.054; Jengojan S, 2015, EUR RADIOL, V25, P1678, DOI 10.1007/s00330-014-3562-6; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kakuda T, 2011, NEURORADIOLOGY, V53, P955, DOI 10.1007/s00234-010-0833-z; Kerasnoudis A, 2013, CLIN NEUROPHYSIOL, V124, P1881, DOI 10.1016/j.clinph.2013.03.007; Khalil C, 2010, EUR J RADIOL, V76, P391, DOI 10.1016/j.ejrad.2010.03.012; Kronlage Moritz, 2018, Eur Radiol, V28, P1801, DOI 10.1007/s00330-017-5134-z; Kwee RM, 2014, AM J ROENTGENOL, V203, P1303, DOI 10.2214/AJR.13.12403; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Lee G, 2015, J MAGN RESON IMAGING, V41, P684, DOI 10.1002/jmri.24581; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lehmann HC, 2010, EXP NEUROL, V223, P238, DOI 10.1016/j.expneurol.2009.10.012; Lozeron P, 2016, J NEUROL SCI, V360, P170, DOI 10.1016/j.jns.2015.11.048; Madhuranthakam AJ, 2015, SEMIN MUSCULOSKEL R, V19, P86, DOI 10.1055/s-0035-1547370; Maehara M, 2014, MAGN RESON IMAGING, V32, P440, DOI 10.1016/j.mri.2014.01.011; Marciniak C, 2013, J ULTRAS MED, V32, P2091, DOI 10.7863/ultra.32.12.2091; Markvardsen LH, 2016, NEURORADIOLOGY, V58, P745, DOI 10.1007/s00234-016-1692-z; Mathys C, 2013, MUSCLE NERVE, V48, P889, DOI 10.1002/mus.23855; Moriyama H, 2007, J PERIPHER NERV SYST, V12, P205, DOI 10.1111/j.1529-8027.2007.00140.x; Oikawa Y, 2015, MAGN RESON IMAGING, V33, P956, DOI 10.1016/j.mri.2015.05.002; Oudeman J, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13012; Oudeman J, 2016, J MAGN RESON IMAGING, V43, P644, DOI 10.1002/jmri.25025; Padua L, 2013, NEUROLOGY, V80, P1626, DOI 10.1212/WNL.0b013e3182905017; Shibuya K, 2015, ANN NEUROL, V77, P333, DOI 10.1002/ana.24314; Sugimoto T, 2013, ULTRASOUND MED BIOL, V39, P1560, DOI 10.1016/j.ultrasmedbio.2013.03.031; Tagliafico A, 2011, EUR RADIOL, V21, P1764, DOI 10.1007/s00330-011-2100-z; Takagi T, 2009, NEUROIMAGE, V44, P884, DOI 10.1016/j.neuroimage.2008.09.022; Takahara T, 2008, RADIOLOGY, V249, P653, DOI 10.1148/radiol.2492071826; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; van der Jagt PKN, 2012, NEUROIMAGE, V62, P1792, DOI 10.1016/j.neuroimage.2012.06.001; Vargas MI, 2015, SEMIN MUSCULOSKEL R, V19, P137, DOI 10.1055/s-0035-1546300; Vargas MI, 2010, NEURORADIOLOGY, V52, P237, DOI 10.1007/s00234-009-0643-3; Vo T, 2017, INT J BIOMATER, P1, DOI DOI 10.1097/FILI.0000000000000363; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Williams SE, 2013, J MAGN RESON IMAGING, V38, P1292, DOI 10.1002/jmri.24045; Yoneyama M, 2013, MAGN RESON MED SCI, V12, P111, DOI 10.2463/mrms.2012-0063; Zijta FM, 2011, EUR RADIOL, V21, P1243, DOI 10.1007/s00330-010-2044-8	60	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196975	10.1371/journal.pone.0196975	http://dx.doi.org/10.1371/journal.pone.0196975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742154	Green Published, gold, Green Submitted			2022-12-26	WOS:000431757400052
J	Steffens, TS; Lehman, SM				Steffens, Travis S.; Lehman, Shawn M.			Lemur species-specific metapopulation responses to habitat loss and fragmentation	PLOS ONE			English	Article							BROWN-MOUSE LEMUR; ALOUATTA-PALLIATA-MEXICANA; LITTORAL FOREST FRAGMENTS; PATCH-OCCUPANCY; RAIN-FOREST; LANDSCAPE ATTRIBUTES; MICROCEBUS-MURINUS; PRIMATE; POPULATION; DISPERSAL	Determining what factors affect species occurrence is vital to the study of primate biogeography. We investigated the metapopulation dynamics of a lemur community consisting of eight species (Avahi occidentalis, Propithecus coquereli, Microcebus murinus, Microcebus ravelobensis, Lepilemur edwardsi, Cheirogaleus medius, Eulemur mongoz, and Eulemur fulvus) within fragmented tropical dry deciduous forest habitat in Ankarafantsika National Park, Madagascar. We measured fragment size and isolation of 42 fragments of forest ranging in size from 0.23 to 117.7 ha adjacent to continuous forest. Between June and November 2011, we conducted 1218 surveys and observed six of eight lemur species (M. murinus, M. ravelobensis, C. medius, E. fulvus, P. coquereli, and L. edwardsi) in the 42 fragments. We applied among patch incidence function models (IFMs) with various measures of dispersal and a mainland-island IFM to lemur species occurrence, with the aim of answering the following questions: 1) Do lemur species in dry deciduous forest fragments form metapopulations? 2) What are the separate effects of area (extinction risk) and connectivity/isolation (colonization potential) within a lemur metapopulation? 3) Within simulated metapopulations over time, how do area and connectivity/isolation affect occurrence? and 4) What are the conservation implications of our findings? We found that M. murinus formed either a mainland-island or an among patch metapopulation, M. ravelobensis formed a mainland-island metapopulation, C. medius and E. fulvus formed among patch metapopulations, and neither P. coquereli or L. edwardsi formed a metapopulation. Metapopulation dynamics and simulations suggest that area was a more consistent positive factor determining lemur species occurrence than fragment isolation and is crucial to the maintenance of lemur populations within this fragmented landscape. Using a metapopulation approach to lemur biogeography is critical for understanding how lemur species respond to forest loss and fragmentation.	[Steffens, Travis S.] Planet Madagascar, Toronto, ON, Canada; [Lehman, Shawn M.] Univ Toronto, Dept Anthropol, Toronto, ON, Canada	University of Toronto	Steffens, TS (corresponding author), Planet Madagascar, Toronto, ON, Canada.	Travis@planetmadagascar.org		Lehman, Shawn/0000-0003-0191-7139	Sigma Xi Grants in Aid of Research; American Society of Primatology (Conservation Small Grant); Calgary and Edmonton Valley Zoos; Primate Conservation, Inc.	Sigma Xi Grants in Aid of Research; American Society of Primatology (Conservation Small Grant); Calgary and Edmonton Valley Zoos; Primate Conservation, Inc.	Financial support for this work was provided by the following intuitions and organizations: Sigma Xi Grants in Aid of Research (https://www.sigmaxi.org), American Society of Primatology (Conservation Small Grant; https://www.asp.org), Calgary and Edmonton Valley Zoos (https/www.calgaryzoo.com and https://www.edmorton.ca/attractions_everts/edmonton-valley-zooaspx), Primate Conservation, Inc. (http://www.primate.org), The Explorers Club (Exploration Fund; https://explorers.org), and the University of Toronto School of Graduate Studies Travel Grant to TS, and the Natural Sciences and Engineering Research Council of Canada (Discovery Grant; http://www.nserc-crsng.gc.ca/index_eng.asp) to SL.	Alonso LE, 2002, RAP B BIOL ASSESS, V23; Anzures-Dadda A, 2007, ANIM CONSERV, V10, P69, DOI 10.1111/j.1469-1795.2006.00074.x; Arroyo-Rodriguez V, PRIMATES FRAGMENTS E; Arroyo-Rodriguez V, 2010, AM J PRIMATOL, V72, P1, DOI 10.1002/ajp.20753; Arroyo-Rodriguez V, 2008, AM J PRIMATOL, V70, P69, DOI 10.1002/ajp.20458; Arroyo-Rodriguez V, 2013, LANDSCAPE ECOL, V28, P1717, DOI 10.1007/s10980-013-9929-2; Bannar-Martin KH, 2014, INT J PRIMATOL, V35, P1122, DOI 10.1007/s10764-014-9792-2; Bloesch U, 1999, APPL VEG SCI, V2, P117, DOI 10.2307/1478888; Bodin O, 2007, LANDSCAPE ECOL, V22, P31, DOI 10.1007/s10980-006-9015-0; Bowman J, 2002, ECOLOGY, V83, P2049, DOI 10.2307/3071786; Boyle SA, 2010, BIOL CONSERV, V143, P1134, DOI 10.1016/j.biocon.2010.02.008; Burke RJ, 2014, FOLIA PRIMATOL, V85, P277, DOI 10.1159/000360082; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Chapman CA, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P63; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; Craul M, 2009, BIOL CONSERV, V142, P2862, DOI 10.1016/j.biocon.2009.05.026; Cristobal-Azkarate J, 2005, AM J PRIMATOL, V67, P209, DOI 10.1002/ajp.20178; Crowley BE, 2013, NATURWISSENSCHAFTEN, V100, P943, DOI 10.1007/s00114-013-1094-6; Curtis DJ, 1998, INT J PRIMATOL, V19, P811, DOI 10.1023/A:1020341312735; Dausmann KH, 2005, J COMP PHYSIOL B, V175, P147, DOI 10.1007/s00360-004-0470-0; Dolrenry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088081; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Farris ZJ, 2014, INT J PRIMATOL, V35, P859, DOI 10.1007/s10764-014-9786-0; Fietz J, 1999, OECOLOGIA, V121, P157, DOI 10.1007/s004420050917; Ganzhorn JU, 1998, INT J PRIMATOL, V19, P785, DOI 10.1023/A:1020337211827; Ganzhorn JU, 2003, ANIM CONSERV, V6, P147, DOI 10.1017/S1367943003003196; Garcia G, 2003, ORYX, V37, P115, DOI 10.1017/S0030605303000206; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; HANSKI I, 1994, TRENDS ECOL EVOL, V9, P131, DOI 10.1016/0169-5347(94)90177-5; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; Hanski I., 1999, METAPOPULATION ECOLO; Hanski I, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P186; Hanski K, 2003, THEOR POPUL BIOL, V64, P119, DOI 10.1016/S0040-5809(03)00022-4; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; HARRISON S, 1991, BIOL J LINN SOC, V42, P73, DOI 10.1111/j.1095-8312.1991.tb00552.x; Irwin MT, 2009, ANIM CONSERV, V12, P220, DOI 10.1111/j.1469-1795.2009.00243.x; Irwin MT, 2008, BIOTROPICA, V40, P231, DOI 10.1111/j.1744-7429.2007.00368.x; Irwin MT, 2010, BIOL CONSERV, V143, P2351, DOI 10.1016/j.biocon.2010.01.023; Kun-Rodrigues C, 2014, AM J PRIMATOL, V76, P515, DOI 10.1002/ajp.22243; Lawes MJ, 2000, CONSERV BIOL, V14, P1088, DOI 10.1046/j.1523-1739.2000.99120.x; Lehman SM, 2006, AM J PHYS ANTHROPOL, V129, P232, DOI 10.1002/ajpa.20241; Lehman SM, 2006, AM J PRIMATOL, V68, P293, DOI 10.1002/ajp.20224; MAC ARTHUR ROBERT H., 1967; Mandujano S, 2008, TROP CONSERV SCI, V1, P43, DOI 10.1177/194008290800100104; Marsh LK, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P1; Marshall AR, 2010, AM J PRIMATOL, V72, P325, DOI 10.1002/ajp.20787; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; MCGOOGAN KC, 2011, THESIS; Mittermeier R. A., 2010, LEMURS MADAGASCAR, V3rd; Muller AE, 1998, FOLIA PRIMATOL, V69, P160; Norscia I, 2008, PRIMATES, V49, P85, DOI 10.1007/s10329-007-0061-2; Oksanen J., 2004, INCIDENCE FUNCTION M; Olivieri GL, 2008, BIOL CONSERV, V141, P1257, DOI 10.1016/j.biocon.2008.02.025; Quemere E, 2010, MOL ECOL, V19, P1606, DOI 10.1111/j.1365-294X.2010.04581.x; Rabesandratana Andriatahiana Z., 2012, Lemur News, V16, P57; Raboy BE, 2010, BIOTROPICA, V42, P388, DOI 10.1111/j.1744-7429.2009.00595.x; Radespiel L, 2003, ANIM BEHAV, V65, P709, DOI 10.1006/anbe.2003.2121; Radespiel U, 2000, AM J PRIMATOL, V51, P21, DOI 10.1002/(SICI)1098-2345(200005)51:1<21::AID-AJP3>3.0.CO;2-C; Radespiel U, 2009, BEHAVIOUR, V146, P607, DOI 10.1163/156853909X426372; Radespiel U, 2008, AM J PRIMATOL, V70, P860, DOI 10.1002/ajp.20574; Rakotondravony R, 2009, AM J PRIMATOL, V71, P928, DOI 10.1002/ajp.20732; Ramanankirahina R, 2016, AM J PHYS ANTHROPOL, V159, P466, DOI 10.1002/ajpa.22898; Rasoloharijaona S, 2006, AM J PHYS ANTHROPOL, V129, P591, DOI 10.1002/ajpa.20342; Razafy Fara L., 2003, RAPPORT ACTUALISATIO, P26; Richard AF, 1985, PRIMATES NATURE; Rodriguez-Toledo EM, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P79; Salmona J, 2014, ENDANGER SPECIES RES, V25, P175, DOI 10.3354/esr00622; Schad J, 2004, CONSERV GENET, V5, P299, DOI 10.1023/B:COGE.0000031137.50239.d3; Schliehe-Diecks S, 2012, BEHAV ECOL SOCIOBIOL, V66, P1175, DOI 10.1007/s00265-012-1371-y; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Schwitzer C., 2013, LEMURS MADAGASCAR ST, P185; Schwitzer C, 2014, SCIENCE, V344, P358, DOI 10.1126/science.344.6182.358-c; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Steffens TS, 2016, CAM S BIO EVOL ANTHR, V73, P477; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Swart J, 1996, ECOL MODEL, V93, P57, DOI 10.1016/0304-3800(95)00211-1; Team R Development Core, 2007, R LANG ENV STAT COMP; Valenta K, 2016, EVOL BIOL, V43, P344, DOI 10.1007/s11692-016-9374-7; Warren RD, 1997, J ZOOL, V243, P397, DOI 10.1111/j.1469-7998.1997.tb02790.x; Weidt A, 2004, AM J PHYS ANTHROPOL, V123, P40, DOI 10.1002/ajpa.10296; Zeigler SL, 2013, BIOTROPICA, V45, P528, DOI 10.1111/btp.12037	83	24	25	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0195791	10.1371/journal.pone.0195791	http://dx.doi.org/10.1371/journal.pone.0195791			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF2GV	29742108	Green Published, gold, Green Submitted			2022-12-26	WOS:000431757400014
J	Takiguchi, H; Takeuchi, T; Niimi, K; Tomomatsu, H; Tomomatsu, K; Hayama, N; Oguma, T; Aoki, T; Urano, T; Asai, S; Miyachi, H; Asano, K				Takiguchi, Hiroto; Takeuchi, Tomoe; Niimi, Kyoko; Tomomatsu, Hiromi; Tomomatsu, Katsuyoshi; Hayama, Naoki; Oguma, Tsuyoshi; Aoki, Takuya; Urano, Tetsuya; Asai, Satomi; Miyachi, Hayato; Asano, Koichiro			Proportion and clinical characteristics of non-asthmatic non-smokers among adults with airflow obstruction	PLOS ONE			English	Article							PULMONARY-DISEASE; NEVER-SMOKERS; CIGARETTE-SMOKING; BIOMASS SMOKE; LUNG-DISEASE; COPD; JAPAN; WOMEN	Background and objectives Chronic obstructive pulmonary disease (COPD) mainly develops after long-term exposure to cigarette or biomass fuel smoke, but also occurs in non-smokers with or without a history of asthma. We investigated the proportion and clinical characteristics of non-smokers among middle-aged to elderly subjects with airflow obstruction. Methods We retrospectively analyzed 1,892 subjects aged 40-89 years who underwent routine preoperative spirometry at a tertiary university hospital in Japan. Airflow obstruction was defined as a forced expiratory volume in 1 second (FEV1)/forced vital capacity < 0.7 or as the lower limit of the normal. Results Among 323 patients presenting with FEV1/forced vital capacity < 0.7, 43 had asthma and 280 did not. Among the non-asthmatic patients with airflow obstruction, 94 (34%) were nonsmokers. A larger number of women than men with airflow obstruction had asthma (26% vs. 7.6%, p < 0.001), or were non-smokers among non-asthmatics (72% vs. 20%, p < 0.001). Non-asthmatic non-smokers, rather than non-asthmatic smokers, asthmatic non-smokers, and asthmatic smokers, exhibited better pulmonary function (median FEV1: 79% of predicted FEV1 vs. 73%, 69%, and 66%, respectively, p = 0.005) and less dyspnea on exertion (1% vs. 12%, 12%, and 28%, respectively, p = 0.001). Pulmonary emphysema on thoracic computed tomography was less common in non-smokers (p < 0.001). Using the lower limit of the normal to define airflow obstruction yielded similar results. Conclusions There are a substantial number of non-smokers with airflow obstruction compatible with COPD in Japan. In this study, airflow obstruction in non-smokers was more common in women and likelier to result in mild functional and pathological abnormalities than in smokers. Further studies are warranted to investigate the long-term prognosis and appropriate management of this population in developed countries, especially in women.	[Takiguchi, Hiroto; Takeuchi, Tomoe; Niimi, Kyoko; Tomomatsu, Hiromi; Tomomatsu, Katsuyoshi; Hayama, Naoki; Oguma, Tsuyoshi; Aoki, Takuya; Asano, Koichiro] Tokai Univ, Sch Med, Dept Med, Div Pulm Med, Isehara, Kanagawa, Japan; [Urano, Tetsuya] Tokai Univ, Sch Med, Dept Basic Med, Div Med Educ, Isehara, Kanagawa, Japan; [Asai, Satomi; Miyachi, Hayato] Tokai Univ, Sch Med, Dept Lab Med, Isehara, Kanagawa, Japan	Tokai University; Tokai University; Tokai University	Asano, K (corresponding author), Tokai Univ, Sch Med, Dept Med, Div Pulm Med, Isehara, Kanagawa, Japan.	ko-asano@tokai-u.jp		AOKI, TAKUYA/0000-0002-1299-4220	Tokai University	Tokai University	This study is funded by an educational grant from Tokai University. No grant number was added to this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshabanat A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136065; Camp PG, 2014, EUR RESPIR J, V43, P725, DOI 10.1183/09031936.00206112; Castaldi PJ, 2011, THORAX, V66, P903, DOI 10.1136/thx.2010.146118; Ehrlich RI, 2004, INT J TUBERC LUNG D, V8, P369; Ekici A, 2005, ENVIRON RES, V99, P93, DOI 10.1016/j.envres.2005.01.004; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; Hagstad S, 2012, RESP MED, V106, P980, DOI 10.1016/j.rmed.2012.03.010; Hansen JE, 2007, CHEST, V131, P349, DOI 10.1378/chest.06-1349; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Katanoda K, 2008, J EPIDEMIOL, V18, P251, DOI 10.2188/jea.JE2007429; Kubota M, 2014, RESPIR INVESTIG, V52, P242, DOI 10.1016/j.resinv.2014.03.003; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; Osaka D, 2010, INTERNAL MED, V49, P1489, DOI 10.2169/internalmedicine.49.3364; OSWALD NC, 1955, LANCET, V2, P843; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Sezer H, 2006, ANN EPIDEMIOL, V16, P59, DOI 10.1016/j.annepidem.2004.12.014; Smith M, 2014, EUR RESPIR J, V44, P66, DOI 10.1183/09031936.00152413; Takiguchi Hiroto, 2014, Tokai J Exp Clin Med, V39, P151; Thomsen M, 2013, LANCET RESP MED, V1, P543, DOI 10.1016/S2213-2600(13)70137-1; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; WHITTEMORE AS, 1995, AM J PUBLIC HEALTH, V85, P702, DOI 10.2105/AJPH.85.5.702; Zhang J, 2014, INT J CHRONIC OBSTR, V9, P57, DOI 10.2147/COPD.S52416; Zhou Y, 2009, EUR RESPIR J, V33, P509, DOI 10.1183/09031936.00084408	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196132	10.1371/journal.pone.0196132	http://dx.doi.org/10.1371/journal.pone.0196132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742176	Green Submitted, Green Published, gold			2022-12-26	WOS:000431757400021
J	Haque, ME; Han, B; Wang, B; Wang, Y; Liu, AZ				Haque, Mohammad Enamul; Han, Bing; Wang, Bin; Wang, Yue; Liu, Aizhong			Development of an efficient chromatin immunoprecipitation method to investigate protein-DNA interaction in oleaginous castor bean seeds	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; ONE-HYBRID SYSTEM; HISTONE MODIFICATIONS; REVEALS DIFFERENCES; CROSS-LINKING; CHIP-SEQ; ARABIDOPSIS; OIL; BIOSYNTHESIS; METABOLISM	Chromatin immunoprecipitation (ChIP) is usually a reliable technique to find the binding sites of a transcription factor. In the current study, we developed a suitable ChIP method using developing castor bean seeds. A castor bean seed with large and persistent endosperm contains high amounts of storage lipids (ca. 50-60%) and is often considered as a model material to studying seed biology. In oleaginous seeds, due to the rich oils which could seriously affect immunoprecipitation and DNA isolation, it is often difficult to carry out a successful ChIP experiment. Thus, the development of an efficient ChIP method for oleaginous seeds is required. In this study, we modified different steps, including tissue preparation for cross-linking, chromatin washing, sonication and immunoprecipitation of other existing methods. As exemplified by the targeted gene identification of a master regulator WRI1, which regulates fatty acid biosynthesis, we found that the improved ChIP method worked well. We analyzed percentage input and fold changes of the ChIPed DNA. We also made successful ChIP-seq libraries using this method. This method provides a technical support not only for use on castor bean seeds; it might be used equally to analyze protein-DNA interaction in vivo in other oleaginous seeds.	[Haque, Mohammad Enamul; Han, Bing; Wang, Bin; Wang, Yue; Liu, Aizhong] Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Yunnan Key Lab Wild Plant Resources, Kunming, Yunnan, Peoples R China; [Haque, Mohammad Enamul; Han, Bing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Bin; Liu, Aizhong] Southwest Forestry Univ, Key Lab Forest Resources Conservat & Utilizat Sou, Minist Educ, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Southwest Forestry University - China	Liu, AZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Econ Plants & Biotechnol, Yunnan Key Lab Wild Plant Resources, Kunming, Yunnan, Peoples R China.; Liu, AZ (corresponding author), Southwest Forestry Univ, Key Lab Forest Resources Conservat & Utilizat Sou, Minist Educ, Kunming, Yunnan, Peoples R China.	liuaizhong@mail.kib.ac.cn	Haque, Enamul/AFR-5446-2022	Liu, Aizhong/0000-0002-3197-5535	Chinese National Key Technology R D Program [2015BAD15B02]; National Natural Science Foundation of China [31661143002, 31701465, 31771839]; Yunnan Applied Basic Research Projects [2016FA011]	Chinese National Key Technology R D Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Applied Basic Research Projects	This work was financially supported by Chinese National Key Technology R & D Program (2015BAD15B02), National Natural Science Foundation of China (31661143002, 31701465 and 31771839) and Yunnan Applied Basic Research Projects (2016FA011).	Baud S, 2009, PLANT J, V60, P933, DOI 10.1111/j.1365-313X.2009.04011.x; Bhardwaj HL, 2003, IND CROP PROD, V17, P47, DOI 10.1016/S0926-6690(02)00058-4; Bowler C, 2004, PLANT J, V39, P776, DOI 10.1111/j.1365-313X.2004.02169.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cagliari A, 2010, PLANT SCI, V179, P499, DOI 10.1016/j.plantsci.2010.07.015; Das PM, 2004, BIOTECHNIQUES, V37, P961, DOI 10.2144/04376RV01; Deplancke B, 2004, GENOME RES, V14, P2093, DOI 10.1101/gr.2445504; Fido Roger J, 2004, Methods Mol Biol, V244, P21; Focks N, 1998, PLANT PHYSIOL, V118, P91, DOI 10.1104/pp.118.1.91; Fukuda N, 2013, PLANT MOL BIOL, V82, P473, DOI 10.1007/s11103-013-0075-7; Hajduch M, 2011, PROTEOMICS, V11, P1619, DOI 10.1002/pmic.201000644; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Houston NL, 2009, PLANT PHYSIOL, V151, P857, DOI 10.1104/pp.109.141622; Kanai M, 2016, PLANT BIOTECHNOL J, V14, P1241, DOI 10.1111/pbi.12489; Kaufmann K, 2010, NAT PROTOC, V5, P457, DOI 10.1038/nprot.2009.244; Kim HU, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2805-0; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lan TY, 2013, ANAL BIOCHEM, V438, P11, DOI 10.1016/j.ab.2013.03.012; Lee JH, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0192-4; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li W, 2014, NAT PROTOC, V9, P2180, DOI 10.1038/nprot.2014.146; Lin X, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-48; Maeo K, 2009, PLANT J, V60, P476, DOI 10.1111/j.1365-313X.2009.03967.x; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; Monke G, 2012, NUCLEIC ACIDS RES, V40, P8240, DOI 10.1093/nar/gks594; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; Ogunniyi DS, 2006, BIORESOURCE TECHNOL, V97, P1086, DOI 10.1016/j.biortech.2005.03.028; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Ricardi MM, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-11; Routaboul JM, 1999, PLANT PHYSIOL BIOCH, V37, P831, DOI 10.1016/S0981-9428(99)00115-1; Saleh A, 2008, NAT PROTOC, V3, P1018, DOI 10.1038/nprot.2008.66; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Santos CD, 2013, GENET MOL RES, V12, P3128, DOI 10.4238/2013.February.28.23; Schmid KM, 2008, N COMP BIOC, P97, DOI 10.1016/B978-044453219-0.50006-4; Strenkert D, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-35; Xu RH, 2011, BIOMASS BIOENERG, V35, P1683, DOI 10.1016/j.biombioe.2011.01.001; Xu W, 2016, PLANT PHYSIOL, V171, P1242, DOI 10.1104/pp.16.00056; Yamaguchi Nobutoshi, 2014, Arabidopsis Book, V12, pe0170, DOI 10.1199/tab.0170; Yang H, 2016, PLANT CELL, V28, P629, DOI 10.1105/tpc.15.00691; Zhang Y, 2016, PHOTOSYNTH RES, V128, P125, DOI 10.1007/s11120-015-0206-x	43	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0197126	10.1371/journal.pone.0197126	http://dx.doi.org/10.1371/journal.pone.0197126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738563	Green Submitted, Green Published, gold			2022-12-26	WOS:000431724900052
J	Yildirimoglu, M; Kahraman, O				Yildirimoglu, Mehmet; Kahraman, Osman			Searching for empirical evidence on traffic equilibrium	PLOS ONE			English	Article							ROUTE CHOICE; SCALE	Cities around the world are inundated by cars and suffer traffic congestion that results in excess delays, reduced safety and environmental pollution. The interplay between road infrastructure and travel choices defines the level and the spatio-temporal extent of congestion. Given the existing infrastructure, understanding how the route choice decisions are made and how travellers interact with each other is a crucial first step in mitigating traffic congestion. This is a problem with fundamental importance, as it has implications for other limited supply systems where agents compete for resources and reach an equilibrium. Here, we observe the route choice decisions and the traffic conditions through an extensive data set of GPS trajectories. We compare the actual paths followed by travellers to those implied by equilibrium conditions (i) at a microscopic scale, where we focus on individual path similarities, and (ii) at a macroscopic scale, where we perform network level comparison of the traffic loads. We present that non-cooperative or selfish equilibrium replicates the actual traffic (to a certain extent) at the macroscopic scale, while the majority of individual decisions cannot be reproduced by neither selfish nor cooperative equilibrium models.	[Yildirimoglu, Mehmet] Univ Queensland, Sch Civil Engn, St Lucia, Qld 4072, Australia; [Kahraman, Osman] Univ Southern Calif, Dept Phys & Astron, Los Angeles, CA 90089 USA; [Kahraman, Osman] Arcelik AS, R&D Ctr, TR-34950 Istanbul, Turkey	University of Queensland; University of Southern California; Arcelik AS	Yildirimoglu, M (corresponding author), Univ Queensland, Sch Civil Engn, St Lucia, Qld 4072, Australia.	m.yildirimoglu@uq.edu.au	Kahraman, Osman/O-7988-2019; Yildirimoglu, Mehmet/F-7317-2017	Kahraman, Osman/0000-0001-9244-5143; Yildirimoglu, Mehmet/0000-0002-6534-4053				AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Bekhor S, 2002, TRANSPORT RES REC, P78, DOI 10.3141/1805-10; Bekhor S, 2006, ANN OPER RES, V144, P235, DOI 10.1007/s10479-006-0009-8; Berinde V, 2007, LECT NOTES MATH, V1912, P1; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bierlaire M, 2006, TRANSPORT SCI, V40, P44, DOI 10.1287/trsc.1050.0119; Buhl J, 2006, EUR PHYS J B, V49, P513, DOI 10.1140/epjb/e2006-00085-1; Cardillo A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066107; Cascetta E, 1996, TRANSPORTATION AND TRAFFIC THEORY, P697; Colak S, 2016, NATURE COMMUNICATION, P7; Daganzo C. F., 1977, Transportation Science, V11, P338, DOI 10.1287/trsc.11.4.338; Dixit VV, 2014, TRANSPORT RES C-EMER, V48, P301, DOI 10.1016/j.trc.2014.09.002; Eliasson J, 2009, TRANSPORT RES A-POL, V43, P468, DOI 10.1016/j.tra.2008.11.014; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Fujita M, 1999, SPATIAL EC CITIES RE, V213; Gabaix X, 2006, AM ECON REV, V96, P1043, DOI 10.1257/aer.96.4.1043; Gao S, 2011, TRANSPORT RES A-POL, V45, P916, DOI 10.1016/j.tra.2011.04.008; Habitat U.N., 2016, WORLD CIT REP 2016 U; Helbing D, 2004, HUMAN BEHAVIOUR AND TRAFFIC NETWORKS, P47; Helbing D, 2010, QUANTITATIVE SOCIODYNAMICS: STOCHASTIC METHODS AND MOODELS OF SOCIAL INTERACTION PROCESSES, SECOND EDITION, P1, DOI 10.1007/978-3-642-11546-2; Higham DJ, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.161063; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; Kurant M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.138701; Loreto V, 2007, NAT PHYS, V3, P758, DOI 10.1038/nphys770; Lou Y., 2009, P 17 ACM SIGSPATIAL, P352, DOI DOI 10.1145/1653771.1653820; MAHMASSANI HS, 1987, TRANSPORT SCI, V21, P89, DOI 10.1287/trsc.21.2.89; McFadden D, 2001, AM ECON REV, V91, P351, DOI 10.1257/aer.91.3.351; Morikawa T, 2005, OPER RES COMPUT SCI, V31, P341; Nisan N, 2007, ALGORITHMIC GAME THEORY, P1, DOI 10.1017/CBO9780511800481; Peeta S, 2001, NETW SPAT ECON, V1, P233, DOI [DOI 10.1023/A:1012827724856, 10.1023/A:1012827724856]; Prato CG, 2006, TRANSPORT RES REC, P19, DOI 10.3141/1985-03; Prato CG, 2009, J CHOICE MODEL, V2, P65; Roughgarden T., 2005, SELFISH ROUTING PRIC, V174; Selten R, 2007, GAME ECON BEHAV, V58, P394, DOI 10.1016/j.geb.2006.03.012; Sheffi Y., 1985, URBAN TRANSPORTATION; SMITH MJ, 1979, TRANSPORT RES B-METH, V13, P295, DOI 10.1016/0191-2615(79)90022-5; Toledo T, 2007, TRANSPORT RES C-EMER, V15, P96, DOI 10.1016/j.trc.2007.02.002; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed; Vovsha P, 1998, TRANSPORT RES REC, P133, DOI 10.3141/1645-17; Wardrop JG, 1952, P I CIVIL ENG, P325, DOI [10.1680/ipeds.1952.11362, DOI 10.1680/IPEDS.1952.11259]; WEIDLICH W, 1991, PHYS REP, V204, P1, DOI 10.1016/0370-1573(91)90024-G; Youn H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.128701; Zhu SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134322	47	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196997	10.1371/journal.pone.0196997	http://dx.doi.org/10.1371/journal.pone.0196997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE8KX	29734394	gold, Green Published, Green Submitted			2022-12-26	WOS:000431481700040
J	Siegler, JC; Marshall, PWM; Finn, H; Cross, R; Mudie, K				Siegler, Jason C.; Marshall, Paul W. M.; Finn, Harrison; Cross, Rebecca; Mudie, Kurt			Acute attenuation of fatigue after sodium bicarbonate supplementation does not manifest into greater training adaptations after 10-weeks of resistance training exercise	PLOS ONE			English	Article							FORCE DEVELOPMENT; METABOLIC ALKALOSIS; INTENSITY; INGESTION; STRENGTH; PERFORMANCE; POWER; MECHANISMS; CAFFEINE; NAHCO3	Purpose In two concurrent studies, we aimed to a) confirm the acute effect of 0.3 g.kg(-1) body weight (BW) sodium bicarbonate (NaHCO3) supplementation on central and peripheral mechanisms associated with explosive power (Study 1) and b) determine whether chronic NaHCO3 supplementation would improve the adaptive response of the neuromuscular system during a 10-week resistance training program (Study 2). Methods Eight resistance trained participants volunteered after providing written consent. The experimental design consisted of a week of baseline testing, followed by ten weeks of training with progress measures performed in Week 5. Study 1 involved neuromuscular measurements before and after the leg extension portion of a power based training session performed in Week 1. Changes in maximal torque (MVT) and rates of torque development (RTD), along with other variables derived from femoral nerve stimulation (e.g. voluntary activation, neural recruitment) were analysed to determine the extent of fatigue under NaHCO3 or placebo conditions. Changes in these same variables, coupled with functional 1-repetition maximum leg extension strength, were measured in Study 2 from baseline (Week 0) to Week 5, and again at Week 10. Results and conclusion In Study 1, we observed a decline after the leg extension task in both MVT (similar to 30%) and rates of torque production (RTD) irrespective of acid-base status, however the decline in maximal RTD (RTDMAX) was nearly 20% less in the NaHCO3 condition when compared to placebo (mean difference of 294.8 +/- 133.4 Nm.s(-1) (95% CI -583.1 to -6.5 Nm, p < 0.05)). The primary finding in Study 2, however, suggests that introducing NaHCO3 repeatedly during a 10-week RT program does not confer any additional benefit to the mechanisms (and subsequent adaptive processes) related to explosive power production.	[Siegler, Jason C.; Marshall, Paul W. M.; Finn, Harrison; Cross, Rebecca; Mudie, Kurt] Western Sydney Univ, Sch Sci & Hlth, Sport & Exercise Sci, Sydney, NSW, Australia; [Finn, Harrison] Neurosci Res Australia, Sydney, NSW, Australia; [Mudie, Kurt] Victoria Univ, ISEAL, Melbourne, Vic, Australia	Western Sydney University; Neuroscience Research Australia; Victoria University	Siegler, JC (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Sport & Exercise Sci, Sydney, NSW, Australia.	j.siegler@westernsydney.edu.au	Finn, Harrison/AGI-9875-2022	Mudie, Kurt/0000-0001-9328-4759; Cross, Rebecca/0000-0002-3966-9313; Siegler, Jason/0000-0003-1346-4982	University of Western Sydney: School of Science and Health's Seed Grant scheme; Western Sydney University's School of Science and Health's Seed Grant scheme	University of Western Sydney: School of Science and Health's Seed Grant scheme; Western Sydney University's School of Science and Health's Seed Grant scheme	This work was supported by the University of Western Sydney: School of Science and Health's Seed Grant scheme (Dr. Jason C Siegler). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Bulk Nutrients (TM) for supplying the carbohydrate and protein powders for the standardized pre-exercise meal replacement shake. Additional support was also provided by the Western Sydney University's School of Science and Health's Seed Grant scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Broch-Lips M, 2007, J APPL PHYSIOL, V103, P494, DOI 10.1152/japplphysiol.00049.2007; Carr AJ, 2011, SPORTS MED, V41, P801, DOI 10.2165/11591440-000000000-00000; Carr BM, 2013, EUR J APPL PHYSIOL, V113, P743, DOI 10.1007/s00421-012-2484-8; Coombes J., 1993, J STRENGTH COND RES, V7, P241, DOI DOI 10.1519/1533-4287(1993)007<0241; Davis JK, 2009, SPORTS MED, V39, P813, DOI 10.2165/11317770-000000000-00000; Douroudos II, 2006, MED SCI SPORT EXER, V38, P1746, DOI 10.1249/01.mss.0000230210.60957.67; Duncan MJ, 2014, J STRENGTH COND RES, V28, P1358, DOI 10.1519/JSC.0000000000000277; Fyfe JJ, 2014, SPORTS MED, V44, P743, DOI 10.1007/s40279-014-0162-1; Gough LA, 2017, SPORTS MED, P1; Higgins MF, 2013, EUR J APPL PHYSIOL, V113, P1331, DOI 10.1007/s00421-012-2557-8; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; Jones RL, 2016, INT J SPORT NUTR EXE, V26, P445, DOI 10.1123/ijsnem.2015-0286; Kreider RB, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0173-z; Mangine GT, 2016, EUR J APPL PHYSIOL, V116, P2367, DOI 10.1007/s00421-016-3488-6; Marshall PWM, 2011, EUR J APPL PHYSIOL, V111, P3007, DOI 10.1007/s00421-011-1944-x; McMaster DT, 2013, SPORTS MED, V43, P367, DOI 10.1007/s40279-013-0031-3; McNaughton L, 1999, EUR J APPL PHYSIOL O, V80, P333, DOI 10.1007/s004210050600; McNaughton LR, 2008, CURR SPORT MED REP, V7, P230, DOI 10.1249/JSR.0b013e31817ef530; MERTON PA, 1954, J PHYSIOL-LONDON, V123, P553, DOI 10.1113/jphysiol.1954.sp005070; Mitchell CJ, 2012, J APPL PHYSIOL, V113, P71, DOI 10.1152/japplphysiol.00307.2012; Peart DJ, 2012, J STRENGTH COND RES, V26, P1975, DOI 10.1519/JSC.0b013e3182576f3d; Portington KJ, 1998, MED SCI SPORT EXER, V30, P523, DOI 10.1097/00005768-199804000-00009; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Rhea MR, 2002, J STRENGTH COND RES, V16, P525; Siegler JC, 2016, EXP PHYSIOL, V101, P1383, DOI 10.1113/EP085933; Siegler JC, 2015, EXP PHYSIOL, V100, P519, DOI 10.1113/EP085054; Siegler JC, 2015, EUR J APPL PHYSIOL, V115, P565, DOI 10.1007/s00421-014-3027-2; Siegler JC, 2013, J APPL PHYSIOL, V115, P1634, DOI 10.1152/japplphysiol.00688.2013; Siegler JC, 2016, SPORTS MED OPEN, P1; Strojnik V, 1998, J APPL PHYSIOL, V84, P344, DOI 10.1152/jappl.1998.84.1.344; Tarnopolsky MA, 2010, ANN NUTR METAB, V57, P1, DOI 10.1159/000322696; Volek JS, 2004, MED SCI SPORT EXER, V36, P689, DOI 10.1249/01.MSS.0000121944.19275.C4; WEBSTER MJ, 1993, MED SCI SPORT EXER, V25, P960; Zhang SJ, 2006, J PHYSIOL-LONDON, V572, P551, DOI 10.1113/jphysiol.2005.104521	35	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196677	10.1371/journal.pone.0196677	http://dx.doi.org/10.1371/journal.pone.0196677			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718968	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000431281900068
J	Shi, LY; Ma, Y; Zhu, GY; Liu, JW; Zhou, CX; Chen, LJ; Wang, Y; Li, RC; Yang, ZX; Zhang, D				Shi, Li-Ya; Ma, Yang; Zhu, Gang-Yi; Liu, Jin-Wei; Zhou, Chun-Xiang; Chen, Liang-Jian; Wang, Yang; Li, Rui-Chao; Yang, Zhi-Xia; Zhang, Dong			Placenta-specific 1 regulates oocyte meiosis and fertilization through furin	FASEB JOURNAL			English	Article						Plac1; IGF1R; microvillus; Akt	FACTOR-I RECEPTOR; GROWTH-FACTOR; PROPROTEIN CONVERTASES; PLAC1; INHIBITION; EXPRESSION; PATHWAY; GENES; CELLS; ACTIVATION	Placenta-specific 1 (Plac1) has been found to be essential for placentation, and abnormal Plac1 expression and distribution is highly correlated with preeclampsia and implantation failure; however, its function in mammalian oocytes has not been elucidated. Here, we report that Plac1 was more prominent in mouse oocytes and enriched at the membrane region throughout meiosis. On the one hand, Plac1 knockdown severely disrupted microvillus organization; however, on the other hand, Plac1 significantly decreased oocyte maturation and increased aneuploidy, consequently disrupting normal fertilization. On the basis of immunoprecipitate matrix-assisted laser desorption/ionization, we established a working model, then verified and suggested that, at the germinal vesicle stage, Plac1 enriches the membrane to activate furin, and active furin subsequently activates IGF-1 receptor to maintain regular microvillus organization. Upon meiosis onset, active furin/IGF-1 receptor relocates into the cytoplasm to activate (phosphorylate) Akt to promote meiosis. In summary, our finding suggests that Plac1, a protein that is crucial for placentation, is also essential for oocyte meiosis and fertilization.Shi, L.-Y., Ma, Y., Zhu, G.-Y., Liu, J.-W., Zhou, C.-X., Chen, L.-J., Wang, Y., Li, R.-C., Yang, Z.-X., Zhang, D. Placenta-specific 1 regulates oocyte meiosis and fertilization through furin.	[Shi, Li-Ya; Ma, Yang; Zhu, Gang-Yi; Chen, Liang-Jian; Wang, Yang; Yang, Zhi-Xia; Zhang, Dong] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Liu, Jin-Wei] Zhejiang Prov Peoples Hosp, Dept Gynecol, Hangzhou, Zhejiang, Peoples R China; [Zhou, Chun-Xiang] Nanjing Univ, Med Sch, Affiliated Drum Tower Hosp, Prenatal Diag Ctr Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Li, Rui-Chao] Liuzhou Workers Hosp, Liuzhou, Peoples R China	Nanjing Medical University; Zhejiang Provincial People's Hospital; Nanjing University	Zhang, D (corresponding author), Nanjing Med Univ, 101 Longmiandadao, Nanjing 211166, Jiangsu, Peoples R China.	dong.ray.zhang@njmu.edu.cn	shi, liya/HDM-6854-2022; Zhang, Dong/AAM-8146-2021		National Basic Research Program of China (973 Program) [2013CB945504]; General Program of the National Natural Science Foundation of China [31471406, 31671561]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); General Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Hui Li and Xin Xie (Nanjing Medical University) for help with electron microscopy. This work was supported by the National Basic Research Program of China (973 Program; Grant 2013CB945504) and the General Program of the National Natural Science Foundation of China (Grants 31471406 and 31671561). The authors declare no conflicts of interest.	Benammar A, 2017, REPROD SCI, V24, P1062, DOI 10.1177/1933719116678688; Blakesley VA, 1998, J BIOL CHEM, V273, P18411, DOI 10.1074/jbc.273.29.18411; Chang WL, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.148932; Chang WL, 2016, REPROD BIOL, V16, P218, DOI 10.1016/j.repbio.2016.07.001; Chang WL, 2014, REPRODUCTION, V148, P343, DOI 10.1530/REP-14-0052; Chen Y, 2011, PLACENTA, V32, P877, DOI 10.1016/j.placenta.2011.08.011; Cocchia M, 2000, GENOMICS, V68, P305, DOI 10.1006/geno.2000.6302; DONATH MY, 1994, P NATL ACAD SCI USA, V91, P1686, DOI 10.1073/pnas.91.5.1686; Fant M, 2002, MOL REPROD DEV, V63, P430, DOI 10.1002/mrd.10200; Fant M, 2007, MOL REPROD DEV, V74, P922, DOI 10.1002/mrd.20673; Galaviz-Hernandez C, 2003, GENE, V309, P81, DOI 10.1016/S0378-1119(03)00508-0; Gusscott S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161158; Hiraoka D, 2016, J CELL SCI, V129, P3153, DOI 10.1242/jcs.182170; Hoshino Y, 2008, DEV BIOL, V314, P215, DOI 10.1016/j.ydbio.2007.12.005; Iams WT, 2015, CLIN CANCER RES, V21, P4270, DOI 10.1158/1078-0432.CCR-14-2518; Jaaks P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161396; Jin Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150462; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Kim TR, 2012, FEBS LETT, V586, P303, DOI 10.1016/j.febslet.2011.12.036; Koslowski M, 2007, CANCER RES, V67, P9528, DOI 10.1158/0008-5472.CAN-07-1350; Koslowski M, 2009, J BIOL CHEM, V284, P28607, DOI 10.1074/jbc.M109.031120; Li RC, 2016, PEERJ, V4, DOI 10.7717/peerj.1849; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Matteo M, 2013, PLACENTA, V34, P335, DOI 10.1016/j.placenta.2013.01.006; Meng TG, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.231; MOTLIK J, 1990, MOL REPROD DEV, V27, P366, DOI 10.1002/mrd.1080270411; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Paillisson A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-76; Purwosunu Y, 2007, PRENATAL DIAG, V27, P772, DOI 10.1002/pd.1780; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Runge KE, 2007, DEV BIOL, V304, P317, DOI 10.1016/j.ydbio.2006.12.041; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Stawowy P, 2004, BIOCHEM BIOPH RES CO, V321, P531, DOI 10.1016/j.bbrc.2004.07.001; Tchabo Nana E, 2009, Cancer Immun, V9, P6; Turpeinen H, 2013, CURR GENOMICS, V14, P453, DOI 10.2174/1389202911314050010; Wetsel WC, 2013, P NATL ACAD SCI USA, V110, P17362, DOI 10.1073/pnas.1314698110; Wu Y, 2017, ONCOL REP, V37, P465, DOI 10.3892/or.2016.5272; Yoon SO, 2017, MOL CELL, V67, P512, DOI 10.1016/j.molcel.2017.06.033; Zhou Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.106; Zylkiewicz E, 2010, ZYGOTE, V18, P195, DOI 10.1017/S0967199409990189	40	11	11	2	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5483	5494		10.1096/fj.201700922RR	http://dx.doi.org/10.1096/fj.201700922RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29723063				2022-12-26	WOS:000447972500024
J	Abou El Hassan, M; Huang, K; Xu, ZD; Yu, T; Bremner, R				Abou El Hassan, Mohamed; Huang, Katherine; Xu, Zhaodong; Yu, Tao; Bremner, Rod			Frequent interferon regulatory factor 1 (IRF1) binding at remote elements without histone modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; histone modification; interferon regulatory factor (IRF); STAT transcription factor; histone acetylase; interferon; transcription enhancer; gene regulation	GENE-EXPRESSION; ORDERED RECRUITMENT; ALPHA CISTROME; CIITA LOCUS; TRANSCRIPTION; ENHANCERS; ACTIVATION; DISTINCT; BRG1; ACETYLATION	Transcriptional activators bind DNA and recruit cofactors to modify chromatin. The extent to which these two events are separable is unclear. Here, using a custom ChIP tiling array to map chromatin modifications, we show that interferon--induced DNA binding of signal transducer and activator of transcription 1 (STAT1), typically associated with the transcription factor interferon regulatory factor 1 (IRF1), causes histone acetylation (H3ac, H4ac). In contrast, among IRF1 sites lacking concomitant STAT1 recruitment, only 25% underwent inducible histone acetylation, 31% exhibited constitutive histone acetylation, and 44% had no histone acetylation. These latter orphan sites also lacked other activating modifications (e.g. H3K4me1, H3K4me2) and were typically remote from transcription start sites. In these cases the closest gene was typically an IFN-inducible locus that did not respond to IFN in this setting. Orphan sites were detected in different cell types, suggesting broad relevance. Despite an atypical downstream response (i.e. no histone modifications), IRF1 binding depended on SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4 (SMARCA4 or BRG1), as is typical of active IRF1 enhancers. Although SMARCA4 permitted IRF1 access to the orphan sites, there was no corecruitment of the histone acetyltransferases CREB-binding protein (CBP) and p300. Orphan sites were constitutively unacetylated, and several were marked with repressive chromatin modifications (e.g. H3K27me3). In conclusion, although IRF1 can trigger enhanceosome formation independently of STAT1, its ability to do so depends on local chromatin cues.	[Abou El Hassan, Mohamed; Huang, Katherine; Xu, Zhaodong; Yu, Tao; Bremner, Rod] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Abou El Hassan, Mohamed] Queen Elizabeth Hosp, Prov Lab Serv, Clin Chem Div, Charlottetown, PE C1A 8T5, Canada; [Abou El Hassan, Mohamed] Dalhousie Univ, Fac Med, Dept Pathol, Halifax, NS B3H 4R2, Canada; [Bremner, Rod] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Bremner, Rod] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; McGill University; Dalhousie University; University of Toronto; University of Toronto	Bremner, R (corresponding author), Mt Sinai Hosp, Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	bremner@lunenfeld.ca	Bremner, Rod/I-6490-2012	Bremner, Rod/0000-0001-9184-7212	Krembil Foundation; Canadian Cancer Society Research Institute	Krembil Foundation; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by funding from the Krembil Foundation (to R. B.) and from the Canadian Cancer Society Research Institute (to R. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Abou El Hassan M, 2017, BMC MOL BIOL, V18, DOI 10.1186/s12867-017-0084-1; Abou El Hassan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126466; Bemer M, 2018, METHODS MOL BIOL, V1675, P205, DOI 10.1007/978-1-4939-7318-7_13; Carrascosa LC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15366; Chow NA, 2014, CELL REP, V9, P1718, DOI 10.1016/j.celrep.2014.11.011; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Eklund EA, 1999, J IMMUNOL, V163, P6095; El Hassan MA, 2015, J IMMUNOL, V194, P5007, DOI 10.4049/jimmunol.1403247; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Leung YT, 2015, EPIGENETICS-US, V10, P191, DOI 10.1080/15592294.2015.1009764; Lupien M, 2010, GENE DEV, V24, P2219, DOI 10.1101/gad.1944810; Lupien M, 2009, MOL CELL BIOL, V29, P3413, DOI 10.1128/MCB.00020-09; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Negishi H, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028423; Ni ZY, 2008, NAT IMMUNOL, V9, P785, DOI 10.1038/ni.1619; Ni ZY, 2005, P NATL ACAD SCI USA, V102, P14611, DOI 10.1073/pnas.0503070102; Pattenden SG, 2002, EMBO J, V21, P1978, DOI 10.1093/emboj/21.8.1978; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Suzuki K, 2017, ADV PROTEIN CHEM STR, V106, P71, DOI 10.1016/bs.apcsb.2016.08.002; Varinou L, 2003, IMMUNITY, V19, P793, DOI 10.1016/S1074-7613(03)00322-4; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Zakharova N, 2003, J BIOL CHEM, V278, P43067, DOI 10.1074/jbc.M308166200; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092	29	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10353	10362		10.1074/jbc.RA118.002889	http://dx.doi.org/10.1074/jbc.RA118.002889			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29748386	Green Published, hybrid			2022-12-26	WOS:000437096700033
J	Mueller, JW; Idkowiak, J; Gesteira, TF; Vallet, C; Hardman, R; van den Boom, J; Dhir, V; Knauer, SK; Rosta, E; Arlt, W				Mueller, Jonathan W.; Idkowiak, Jan; Gesteira, Tarsis F.; Vallet, Cecilia; Hardman, Rebecca; van den Boom, Johannes; Dhir, Vivek; Knauer, Shirley K.; Rosta, Edina; Arlt, Wiebke			Human DHEA sulfation requires direct interaction between PAPS synthase 2 and DHEA sulfotransferase SULT2A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						steroid hormone; sulfotransferase; molecular docking; enzyme kinetics; protein-protein interaction; dehydroepiandrosterone; DHEAS; PAPS synthase; steroid sulfation pathway	PROTEIN-PROTEIN DOCKING; CYTOSOLIC SULFOTRANSFERASES; QUINARY STRUCTURE; CRYSTAL-STRUCTURE; LOCALIZATION; EXPRESSION; MUTATIONS; EVOLUTION; ENZYMES; DOMAIN	The high-energy sulfate donor 3-phosphoadenosine-5-phosphosulfate (PAPS), generated by human PAPS synthase isoforms PAPSS1 and PAPSS2, is required for all human sulfation pathways. Sulfotransferase SULT2A1 uses PAPS for sulfation of the androgen precursor dehydroepiandrosterone (DHEA), thereby reducing downstream activation of DHEA to active androgens. Human PAPSS2 mutations manifest with undetectable DHEA sulfate, androgen excess, and metabolic disease, suggesting that ubiquitous PAPSS1 cannot compensate for deficient PAPSS2 in supporting DHEA sulfation. In knockdown studies in human adrenocortical NCI-H295R1 cells, we found that PAPSS2, but not PAPSS1, is required for efficient DHEA sulfation. Specific APS kinase activity, the rate-limiting step in PAPS biosynthesis, did not differ between PAPSS1 and PAPSS2. Co-expression of cytoplasmic SULT2A1 with a cytoplasmic PAPSS2 variant supported DHEA sulfation more efficiently than co-expression with nuclear PAPSS2 or nuclear/cytosolic PAPSS1. Proximity ligation assays revealed protein-protein interactions between SULT2A1 and PAPSS2 and, to a lesser extent, PAPSS1. Molecular docking studies showed a putative binding site for SULT2A1 within the PAPSS2 APS kinase domain. Energy-dependent scoring of docking solutions identified the interaction as specific for the PAPSS2 and SULT2A1 isoforms. These findings elucidate the mechanistic basis for the selective requirement for PAPSS2 in human DHEA sulfation.	[Mueller, Jonathan W.; Idkowiak, Jan; Hardman, Rebecca; Dhir, Vivek; Arlt, Wiebke] Univ Birmingham, IMSR, Birmingham B15 2TT, W Midlands, England; [Mueller, Jonathan W.; Idkowiak, Jan; Arlt, Wiebke] Birmingham Hlth Partners, CEDAM, Birmingham B15 2TH, W Midlands, England; [Gesteira, Tarsis F.; Rosta, Edina] Kings Coll London, Dept Chem, London SE1 1DB, England; [Vallet, Cecilia; Knauer, Shirley K.] Univ Duisburg Essen, Dept Mol Biol 2, Ctr Med Biotechnol ZMB, D-45141 Essen, Germany; [van den Boom, Johannes] Univ Duisburg Essen, Dept Mol Biol 1, Ctr Med Biotechnol ZMB, D-45141 Essen, Germany	University of Birmingham; University of London; King's College London; University of Duisburg Essen; University of Duisburg Essen	Mueller, JW (corresponding author), Univ Birmingham, Coll Med & Dent Sci, IMSR, Birmingham B15 2TT, W Midlands, England.	j.w.mueller@bham.ac.uk	Arlt, Wiebke/B-6310-2009; Idkowiak, Jan/R-9990-2019; Knauer, Shirley K/E-7931-2012; Mueller, Jonathan Wolf/D-1632-2010	Arlt, Wiebke/0000-0001-5106-9719; Knauer, Shirley K/0000-0003-4321-0924; Vallet, Cecilia/0000-0002-9413-846X; Mueller, Jonathan Wolf/0000-0003-1212-189X; Idkowiak, Jan/0000-0001-9181-3995; Rosta, Edina/0000-0002-9823-4766	European Commission Marie Curie Fellowship [SUPA-HD 625451]; Wellcome Trust [092283]; ISSF award; Medical Research Council UK Research Training Fellowship [G1001964]; Biotechnology and Biological Sciences Research Council UK Grant [BB/N007700/1]; Society for Endocrinology Early Career Grant; BBSRC [BB/N007700/1] Funding Source: UKRI; EPSRC [EP/L000253/1, EP/M022609/1] Funding Source: UKRI; MRC [G1001964] Funding Source: UKRI	European Commission Marie Curie Fellowship(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); ISSF award; Medical Research Council UK Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council UK Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Society for Endocrinology Early Career Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Commission Marie Curie Fellowship SUPA-HD 625451 (to J. W. M.), Wellcome Trust Project Grant 092283 (to W. A.), ISSF award (to J. W. M.), Medical Research Council UK Research Training Fellowship G1001964 (to J. I.), the Biotechnology and Biological Sciences Research Council UK Grant BB/N007700/1 (to E. R.), and a Society for Endocrinology Early Career Grant (to J. W. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmadian A, 2006, CLIN CHIM ACTA, V363, P83, DOI 10.1016/j.cccn.2005.04.038; Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Barlow K. A., 2018, J PHYS CHEM B, DOI [10.1021/acs.jcpb.7b11367, DOI 10.1021/ACS.JCPB.7B11367]; Bernstein RM, 2012, AM J PHYS ANTHROPOL, V147, P389, DOI 10.1002/ajpa.22001; Besset S, 2000, FASEB J, V14, P345, DOI 10.1096/fasebj.14.2.345; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chan KX, 2016, P NATL ACAD SCI USA, V113, pE4567, DOI 10.1073/pnas.1604936113; Cohen RD, 2017, PROTEIN SCI, V26, P403, DOI 10.1002/pro.3092; Coughtrie MWH, 2016, CHEM-BIOL INTERACT, V259, P2, DOI 10.1016/j.cbi.2016.05.005; Dajani R, 1999, J BIOL CHEM, V274, P37862, DOI 10.1074/jbc.274.53.37862; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; FEHER T, 1977, ACTA ENDOCRINOL-COP, V85, P126; Fuda H, 2002, BIOCHEM J, V365, P497, DOI 10.1042/BJ20020044; Gesteira TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070880; Goettsch S, 2006, J MOL BIOL, V361, P436, DOI 10.1016/j.jmb.2006.06.023; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Grum D, 2010, BIOCHEM BIOPH RES CO, V395, P420, DOI 10.1016/j.bbrc.2010.04.039; Herrero J, 2016, DATABASE OXFORD, V2016; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hirschmann F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04539-2; Hudson Benjamin H, 2012, Adv Biol Regul, V52, P229; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kauffman FC, 2004, DRUG METAB REV, V36, P823, DOI 10.1081/DMR-200033496; Kalsch J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13058; Kessler D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-37; Knapp B, 2011, J COMPUT BIOL, V18, P997, DOI 10.1089/cmb.2010.0237; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Lansdon EB, 2004, BIOCHEMISTRY-US, V43, P4356, DOI 10.1021/bi049827m; LIPMANN F, 1958, SCIENCE, V128, P575, DOI 10.1126/science.128.3324.575; Lu LY, 2009, DRUG METAB DISPOS, V37, P1083, DOI 10.1124/dmd.108.025395; Matena A, 2013, STRUCTURE, V21, P1769, DOI 10.1016/j.str.2013.07.016; MCCONKEY EH, 1982, P NATL ACAD SCI-BIOL, V79, P3236, DOI 10.1073/pnas.79.10.3236; Mueller JW, 2015, ENDOCR REV, V36, P526, DOI 10.1210/er.2015-1036; Mueller JW, 2013, FEBS J, V280, P3050, DOI 10.1111/febs.12252; Nagai N, 2004, J CELL SCI, V117, P3331, DOI 10.1242/jcs.01191; Noordam C, 2009, NEW ENGL J MED, V360, P2310, DOI 10.1056/NEJMoa0810489; Oostdijk W, 2015, J CLIN ENDOCR METAB, V100, pE672, DOI 10.1210/jc.2014-3556; Patron NJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-39; Pedersen LC, 2000, FEBS LETT, V475, P61, DOI 10.1016/S0014-5793(00)01479-4; Rai BK, 2006, BIOINFORMATICS, V22, P2691, DOI 10.1093/bioinformatics/btl449; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; Schroder E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029559; Schuler G, 2018, J STEROID BIOCHEM, V179, P55, DOI 10.1016/j.jsbmb.2017.10.006; Sekulic N, 2007, J MOL BIOL, V367, P488, DOI 10.1016/j.jmb.2007.01.025; Sircar A, 2010, PROTEINS, V78, P3115, DOI 10.1002/prot.22765; Stelzer C, 2007, DEV DYNAM, V236, P1313, DOI 10.1002/dvdy.21137; Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040; Sundqvist A, 2013, ONCOGENE, V32, P3606, DOI 10.1038/onc.2012.370; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; van den Boom J, 2012, J BIOL CHEM, V287, P17645, DOI 10.1074/jbc.M111.325498; Wang T, 2016, BIOCHEMISTRY-US, V55, P4036, DOI 10.1021/acs.biochem.6b00401; Wang T, 2014, BIOCHEMISTRY-US, V53, P6893, DOI 10.1021/bi501120p; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Weitzner B, 2009, PROTEINS, V75, P289, DOI 10.1002/prot.22347; Yang G, 2016, BIOCHEMISTRY-US, V55, P4583, DOI 10.1021/acs.biochem.6b00561	56	21	22	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9724	9735		10.1074/jbc.RA118.002248	http://dx.doi.org/10.1074/jbc.RA118.002248			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29743239	Green Published, hybrid			2022-12-26	WOS:000436102300017
J	Prakash, D; Walters, KA; Martinie, RJ; McCarver, AC; Kumar, AK; Lessner, DJ; Krebs, C; Golbeck, JH; Ferry, JG				Prakash, Divya; Walters, Karim A.; Martinie, Ryan J.; McCarver, Addison C.; Kumar, Adepu K.; Lessner, Daniel J.; Krebs, Carsten; Golbeck, John H.; Ferry, James G.			Toward a mechanistic and physiological understanding of a ferredoxin:disulfide reductase from the domains Archaea and Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						archaea; stress; enzyme mechanism; disulfide; thioredoxin	METHANOSARCINA-ACETIVORANS; THIOREDOXIN REDUCTASE; FERREDOXINTHIOREDOXIN REDUCTASE; SPECTROSCOPIC CHARACTERIZATION; DISULFIDE REDUCTION; CATALYTIC MECHANISM; CLUSTER CHEMISTRY; 4FE-4S CLUSTER; SITE; METHANE	Disulfide reductases reduce other proteins and are critically important for cellular redox signaling and homeostasis. Methanosarcina acetivorans is a methane-producing microbe from the domain Archaea that produces a ferredoxin:disulfide reductase (FDR) for which the crystal structure has been reported, yet its biochemical mechanism and physiological substrates are unknown. FDR and the extensively characterized plant-type ferredoxin:thioredoxin reductase (FTR) belong to a distinct class of disulfide reductases that contain a unique active-site [4Fe-4S] cluster. The results reported here support a mechanism for FDR similar to that reported for FTR with notable exceptions. Unlike FTR, FDR contains a rubredoxin [1Fe-0S] center postulated to mediate electron transfer from ferredoxin to the active-site [4Fe-4S] cluster. UV-visible, EPR, and Mossbauer spectroscopic data indicated that two-electron reduction of the active-site disulfide in FDR involves a one-electron-reduced [4Fe-4S](1+) intermediate previously hypothesized for FTR. Our results support a role for an active-site tyrosine in FDR that occupies the equivalent position of an essential histidine in the active site of FTR. Of note, one of seven Trxs encoded in the genome (Trx5) and methanoredoxin, a glutaredoxin-like enzyme from M. acetivorans, were reduced by FDR, advancing the physiological understanding of FDR's role in the redox metabolism of methanoarchaea. Finally, bioinformatics analyses show that FDR homologs are widespread in diverse microbes from the domain Bacteria.	[Prakash, Divya; Walters, Karim A.; Kumar, Adepu K.; Krebs, Carsten; Golbeck, John H.; Ferry, James G.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Martinie, Ryan J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [McCarver, Addison C.; Lessner, Daniel J.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [McCarver, Addison C.] ImmunoVision Inc, 1820 Ford Ave, Springdale, AR 72764 USA; [Kumar, Adepu K.] Sardar Patel Renewable Energy Res Inst, Post Box 2,Near BVM Engn Coll, Vallabh Vidyanagar 388120, Gujarat, India	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Arkansas System; University of Arkansas Fayetteville	Ferry, JG (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	jgf3@psu.edu	Prakash, Divya/Z-5061-2019; Krebs, Carsten/D-4773-2009; Kiran Kumar, Dr. Adepu/AAD-2089-2019	Prakash, Divya/0000-0003-0080-2583; Krebs, Carsten/0000-0002-3302-7053; Kiran Kumar, Dr. Adepu/0000-0001-6612-1823; Martinie, Ryan/0000-0003-1257-2850	National Science Foundation Graduate Research Fellowship Program Grant [DGE1255832]; NASA Exobiology Grant [NNX12AR60G]; Arkansas Biosciences Institute, major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000; National Science Foundation [MCB-1613022, MCB-1359578]; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-95ER20198 MOD16, DE-FG02-95ER20198 MOD17]; Person Endowment; Div Of Molecular and Cellular Bioscience [1359578] Funding Source: National Science Foundation	National Science Foundation Graduate Research Fellowship Program Grant; NASA Exobiology Grant(National Aeronautics & Space Administration (NASA)); Arkansas Biosciences Institute, major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000; National Science Foundation(National Science Foundation (NSF)); Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Person Endowment; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by National Science Foundation Graduate Research Fellowship Program Grant DGE1255832.; Supported by NASA Exobiology Grant NNX12AR60G and the Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000.; Supported by National Science Foundation Grants MCB-1613022 and MCB-1359578 for the EPR spectroscopy and redox titrations, respectively.; Supported by the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy through Grants DE-FG02-95ER20198 MOD16 and 17 (90%) and the Person Endowment (10%). To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania 16802. Tel.: 814-863-5721; E-mail: jgf3@psu.edu.	Balsera M, 2013, PLANTA, V237, P619, DOI 10.1007/s00425-012-1803-y; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Conrad R, 2009, ENV MICROBIOL REP, V1, P285, DOI 10.1111/j.1758-2229.2009.00038.x; Dai SD, 2007, NATURE, V448, P92, DOI 10.1038/nature05937; Eidsness MK, 1999, BIOCHEMISTRY-US, V38, P14803, DOI 10.1021/bi991661f; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Fahey RC, 2013, BBA-GEN SUBJECTS, V1830, P3182, DOI 10.1016/j.bbagen.2012.10.006; Gilmore SP, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4036-4; Glauser DA, 2004, J BIOL CHEM, V279, P16662, DOI 10.1074/jbc.M313851200; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Jacquot JP, 2009, TRENDS PLANT SCI, V14, P336, DOI 10.1016/j.tplants.2009.03.005; Jameson GNL, 2003, J AM CHEM SOC, V125, P1146, DOI 10.1021/ja029338e; Kumar AK, 2015, BIOCHEMISTRY-US, V54, P3122, DOI 10.1021/acs.biochem.5b00137; Lessner DJ, 2006, P NATL ACAD SCI USA, V103, P17921, DOI 10.1073/pnas.0608833103; Li LY, 2007, J PROTEOME RES, V6, P759, DOI 10.1021/pr060383l; McCarver AC, 2017, MICROBIOL-SGM, V163, P62, DOI 10.1099/mic.0.000406; McCarver AC, 2014, FEBS J, V281, P4598, DOI 10.1111/febs.12964; MCFARLAN SC, 1992, J BIOL CHEM, V267, P10561; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; MIDDLETON P, 1978, EUR J BIOCHEM, V88, P135, DOI 10.1111/j.1432-1033.1978.tb12430.x; Munck E., 2000, PHYS METHODS BIOINOR, P287; NEWMAN DJ, 1968, EUR J BIOCHEM, V7, P45, DOI 10.1111/j.1432-1033.1968.tb19571.x; ONATE YA, 1989, J BIOL CHEM, V264, P18386; ONDARZA RN, 1983, J MOL EVOL, V19, P371, DOI 10.1007/BF02101641; Pandelia ME, 2015, BBA-MOL CELL RES, V1853, P1395, DOI 10.1016/j.bbamcr.2014.12.005; Schurmann P, 1995, PHOTOSYNTH RES, V46, P309, DOI 10.1007/BF00020445; Sheehan R, 2015, J IND MICROBIOL BIOT, V42, P965, DOI 10.1007/s10295-015-1592-y; Staples CR, 1998, BIOCHEMISTRY-US, V37, P4612, DOI 10.1021/bi9729763; Susanti D, 2014, P NATL ACAD SCI USA, V111, P2608, DOI 10.1073/pnas.1324240111; Wagner T, 2017, SCIENCE, V357, P699, DOI 10.1126/science.aan0425; Walters EM, 2009, BIOCHEMISTRY-US, V48, P1016, DOI 10.1021/bi802074p; Walters EM, 2005, J AM CHEM SOC, V127, P9612, DOI 10.1021/ja051909q; Walters EM, 2004, PHOTOSYNTH RES, V79, P249, DOI 10.1023/B:PRES.0000017195.05870.61; Wei YF, 2015, BIOCHEMISTRY-US, V54, P7019, DOI 10.1021/acs.biochem.5b01092; Yenugudhati D, 2016, BIOCHEMISTRY-US, V55, P313, DOI 10.1021/acs.biochem.5b00823	37	6	6	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9198	9209		10.1074/jbc.RA118.002473	http://dx.doi.org/10.1074/jbc.RA118.002473			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29720404	Green Published, hybrid			2022-12-26	WOS:000435441400006
J	Ul Husna, A; Wang, N; Cobbold, SA; Newton, HJ; Hocking, DM; Wilksch, JJ; Scott, TA; Davies, MR; Hinton, JC; Tree, JJ; Lithgow, T; McConville, MJ; Strugnell, RA				Ul Husna, Asma; Wang, Nancy; Cobbold, Simon A.; Newton, Hayley J.; Hocking, Dianna M.; Wilksch, Jonathan J.; Scott, Timothy A.; Davies, Mark R.; Hinton, Jay C.; Tree, Jai J.; Lithgow, Trevor; McConville, Malcolm J.; Strugnell, Richard A.			Methionine biosynthesis and transport are functionally redundant for the growth and virulence of Salmonella Typhimurium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						methionine; S-adenosylmethionine (SAM); biosynthesis; transporter; Salmonella enterica; peptidoglycan; in vivo infection; virulence	ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; S-ADENOSYLMETHIONINE; CONTAINING VACUOLE; ABC TRANSPORTER; IN-VITRO; GENE; METABOLISM; INFECTION; MUTANTS	Methionine (Met) is an amino acid essential for many important cellular and biosynthetic functions, including the initiation of protein synthesis and S-adenosylmethionine-mediated methylation of proteins, RNA, and DNA. The de novo biosynthetic pathway of Met is well conserved across prokaryotes but absent from vertebrates, making it a plausible antimicrobial target. Using a systematic approach, we examined the essentiality of de novo methionine biosynthesis in Salmonella enterica serovar Typhimurium, a bacterial pathogen causing significant gastrointestinal and systemic diseases in humans and agricultural animals. Our data demonstrate that Met biosynthesis is essential for S. Typhimurium to grow in synthetic medium and within cultured epithelial cells where Met is depleted in the environment. During systemic infection of mice, the virulence of S. Typhimurium was not affected when either de novo Met biosynthesis or high-affinity Met transport was disrupted alone, but combined disruption in both led to severe in vivo growth attenuation, demonstrating a functional redundancy between de novo biosynthesis and acquisition as a mechanism of sourcing Met to support growth and virulence for S. Typhimurium during infection. In addition, our LC-MS analysis revealed global changes in the metabolome of S. Typhimurium mutants lacking Met biosynthesis and also uncovered unexpected interactions between Met and peptidoglycan biosynthesis. Together, this study highlights the complexity of the interactions between a single amino acid, Met, and other bacterial processes leading to virulence in the host and indicates that disrupting the de novo biosynthetic pathway alone is likely to be ineffective as an antimicrobial therapy against S. Typhimurium.	[Ul Husna, Asma; Wang, Nancy; Newton, Hayley J.; Hocking, Dianna M.; Wilksch, Jonathan J.; Scott, Timothy A.; Davies, Mark R.; Tree, Jai J.; Strugnell, Richard A.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3000, Australia; [Cobbold, Simon A.; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, Parkville, Vic 3052, Australia; [Hinton, Jay C.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England; [Tree, Jai J.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Lithgow, Trevor] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Scott, Timothy A.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England; [Lithgow, Trevor] Australian Res Council, Canberra, ACT, Australia	University of Melbourne; University of Melbourne; University of Liverpool; University of New South Wales Sydney; Monash University; University of London; London School of Hygiene & Tropical Medicine	Wang, N; Strugnell, RA (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3000, Australia.	nancyw@unimelb.edu.au; rastru@unimelb.edu.au	Wang, Nancy/K-4949-2019; Wang, Nancy/C-1518-2016; Hinton, Jay C. D./B-2142-2008; Davies, Mark R/J-2128-2014; Lithgow, Trevor/H-5925-2017	Wang, Nancy/0000-0001-7623-1858; Hinton, Jay C. D./0000-0003-2671-6026; Davies, Mark R/0000-0001-6141-5179; Cobbold, Simon/0000-0002-9927-8998; Lithgow, Trevor/0000-0002-0102-7884; Strugnell, Richard/0000-0003-0614-5641; Scott, Timothy/0000-0001-7042-8609; Husna, Asma Ul/0000-0001-7740-9849; Tree, Jai/0000-0001-8233-0975; Newton, Hayley/0000-0002-9240-2001	Australian National Health and Medical Research Council Program (NHMRC) Program [606788]; International Postgraduate Research Scholarship in Australia	Australian National Health and Medical Research Council Program (NHMRC) Program(National Health and Medical Research Council (NHMRC) of Australia); International Postgraduate Research Scholarship in Australia	This work was supported by Australian National Health and Medical Research Council Program (NHMRC) Program Grant 606788 (to T.L. and R.A.S.). This work was also supported by an International Postgraduate Research Scholarship in Australia (to A.U.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Augustus AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-558; AYLING PD, 1972, J GEN MICROBIOL, V73, P127, DOI 10.1099/00221287-73-1-127; AYLING PD, 1979, J GEN MICROBIOL, V114, P227, DOI 10.1099/00221287-114-2-227; BANERJEE RV, 1989, J BIOL CHEM, V264, P13888; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Berney M, 2015, P NATL ACAD SCI USA, V112, P10008, DOI 10.1073/pnas.1513033112; Bertrand EM, 2013, LIMNOL OCEANOGR, V58, P1431, DOI 10.4319/lo.2013.58.4.1431; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bogard RW, 2012, MBIO, V3, DOI 10.1128/mBio.00236-12; Bourne CR, 2014, ANTIBIOTICS-BASEL, V3, P1, DOI 10.3390/antibiotics3010001; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; Coates ARM, 2007, BRIT J PHARMACOL, V152, P1147, DOI 10.1038/sj.bjp.0707432; Cobbold SA, 2016, J INFECT DIS, V213, P276, DOI 10.1093/infdis/jiv372; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ejim LJ, 2004, INFECT IMMUN, V72, P3310, DOI 10.1128/IAI.72.6.3310-3314.2004; Ferla MP, 2014, MICROBIOL-SGM, V160, P1571, DOI 10.1099/mic.0.077826-0; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Gal J, 2002, J BACTERIOL, V184, P4930, DOI 10.1128/JB.184.17.4930-4932.2002; Gonzalez JC, 1996, BIOCHEMISTRY-US, V35, P12228, DOI 10.1021/bi9615452; GONZALEZ JC, 1992, BIOCHEMISTRY-US, V31, P6045, DOI 10.1021/bi00141a013; Gordon MA, 2011, CURR OPIN INFECT DIS, V24, P484, DOI 10.1097/QCO.0b013e32834a9980; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Harada E, 2010, J BACTERIOL, V192, P2892, DOI 10.1128/JB.01535-09; Hernandez SB, 2015, ENVIRON MICROBIOL, V17, P1081, DOI 10.1111/1462-2920.12491; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jelsbak L, 2016, INFECT IMMUN, V84, P2076, DOI 10.1128/IAI.00182-16; JETER RM, 1984, J BACTERIOL, V159, P206, DOI 10.1128/JB.159.1.206-213.1984; KALAN EB, 1954, J BACTERIOL, V68, P293, DOI 10.1128/JB.68.3.293-298.1954; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; KATZEN HM, 1965, J BIOL CHEM, V240, P825; Knodler LA, 2003, TRAFFIC, V4, P587, DOI 10.1034/j.1600-0854.2003.00118.x; KOZAK M, 1983, MICROBIOL REV, V47, P1; Kroger C, 2013, CELL HOST MICROBE, V14, P683, DOI 10.1016/j.chom.2013.11.010; Kwon YK, 2008, NAT CHEM BIOL, V4, P602, DOI 10.1038/nchembio.108; LEUNG KY, 1991, P NATL ACAD SCI USA, V88, P11470, DOI 10.1073/pnas.88.24.11470; LISSNER CR, 1983, J IMMUNOL, V131, P3006; MANDELL GL, 1973, J CLIN INVEST, V52, P1673, DOI 10.1172/JCI107348; Mastroeni P., 2006, SALMONELLA INFECTION; MAXON ME, 1989, P NATL ACAD SCI USA, V86, P85, DOI 10.1073/pnas.86.1.85; Merlin C, 2002, J BACTERIOL, V184, P5513, DOI 10.1128/JB.184.19.5513-5517.2002; Morowitz MJ, 2011, SURG CLIN N AM, V91, P771, DOI 10.1016/j.suc.2011.05.001; Murima P, 2014, CHEM BIOL, V21, P1423, DOI 10.1016/j.chembiol.2014.08.020; Nairz M, 2009, CELL MICROBIOL, V11, P1365, DOI 10.1111/j.1462-5822.2009.01337.x; Neis EPJG, 2015, NUTRIENTS, V7, P2930, DOI 10.3390/nu7042930; OLD IG, 1991, PROG BIOPHYS MOL BIO, V56, P145, DOI 10.1016/0079-6107(91)90012-H; Pitchandi P, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-29; PRATS R, 1989, J BACTERIOL, V171, P3740, DOI 10.1128/jb.171.7.3740-3745.1989; Raman SB, 2013, INFECT IMMUN, V81, P1430, DOI 10.1128/IAI.00743-12; Richardson AR, 2011, CELL HOST MICROBE, V10, P33, DOI 10.1016/j.chom.2011.06.004; RICHAUD C, 1993, J BIOL CHEM, V268, P26827; Rossi M, 2011, NUTRIENTS, V3, P118, DOI 10.3390/nu3010118; Shah DH, 2007, VET MICROBIOL, V119, P352, DOI 10.1016/j.vetmic.2006.09.002; SHAW NA, 1991, FEMS MICROBIOL LETT, V78, P127, DOI 10.1016/0378-1097(91)90145-Z; Sikora M, 2009, MICROBIOL-SGM, V155, P1858, DOI 10.1099/mic.0.026609-0; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; Srikumar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005262; Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; Struck AW, 2012, CHEMBIOCHEM, V13, P2642, DOI 10.1002/cbic.201200556; SUSSKIND MM, 1978, MICROBIOL REV, V42, P385, DOI 10.1128/MMBR.42.2.385-413.1978; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Tuite NL, 2005, J BACTERIOL, V187, P4362, DOI 10.1128/JB.187.13.4362-4371.2005; TURNER SJ, 1993, INFECT IMMUN, V61, P5374, DOI 10.1128/IAI.61.12.5374-5380.1993; VAUDAUX P, 1979, ANTIMICROB AGENTS CH, V16, P743, DOI 10.1128/AAC.16.6.743; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380	72	11	11	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9506	9519		10.1074/jbc.RA118.002592	http://dx.doi.org/10.1074/jbc.RA118.002592			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29720401	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000435441400033
J	Yan, JY; Li, J; Hu, J; Zhang, L; Wei, CG; Sultana, N; Cai, XQ; Zhang, WJ; Cai, CL				Yan, Jianyun; Li, Jun; Hu, Jun; Zhang, Lu; Wei, Chengguo; Sultana, Nishat; Cai, Xiaoqiang; Zhang, Weijia; Cai, Chen-Leng			Smad4 deficiency impairs chondrocyte hypertrophy via the Runx2 transcription factor in mouse skeletal development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondrocyte; chondrogenesis; development; SMAD transcription factor; signaling; bone; mouse; Chondrocyte differentiation; Chondrocyte hypertrophy; Endochondral bone formation; Runx2; Smad4	ENDOCHONDRAL BONE-DEVELOPMENT; GROWTH-PLATE CHONDROCYTES; II COLLAGEN GENE; CLEIDOCRANIAL DYSPLASIA; INDIAN-HEDGEHOG; MORPHOGENETIC PROTEIN; CBFA1-DEFICIENT MICE; FACTOR RECEPTOR-3; CRE RECOMBINASE; FACTOR-BETA	Chondrocyte hypertrophy is the terminal step in chondrocyte differentiation and is crucial for endochondral bone formation. How signaling pathways regulate chondrocyte hypertrophic differentiation remains incompletely understood. In this study, using a Tbx18:Cre (Tbx18(Cre/+)) gene-deletion approach, we selectively deleted the gene for the signaling protein SMAD family member 4 (Smad4(f/f)) in the limbs of mice. We found that the Smad4-deficient mice develop a prominent shortened limb, with decreased expression of chondrocyte differentiation markers, including Col2a1 and Acan, in the humerus at mid-to-late gestation. The most striking defects in these mice were the absence of stylopod elements and failure of chondrocyte hypertrophy in the humerus. Moreover, expression levels of the chondrocyte hypertrophy-related markers Col10a1 and Panx3 were significantly decreased. Of note, we also observed that the expression of runt-related transcription factor 2 (Runx2), a critical mediator of chondrocyte hypertrophy, was also down-regulated in Smad4-deficient limbs. To determine how the skeletal defects arose in the mouse mutants, we performed RNA-Seq with ChIP-Seq analyses and found that Smad4 directly binds to regulatory elements in the Runx2 promoter. Our results suggest a new mechanism whereby Smad4 controls chondrocyte hypertrophy by up-regulating Runx2 expression during skeletal development. The regulatory mechanism involving Smad4-mediated Runx2 activation uncovered here provides critical insights into bone development and pathogenesis of chondrodysplasia.	[Yan, Jianyun; Li, Jun; Hu, Jun; Zhang, Lu; Sultana, Nishat; Cai, Xiaoqiang; Cai, Chen-Leng] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, Mindich Child Hlth & Dev Inst, One Gustave L Levy Pl, New York, NY 10029 USA; [Yan, Jianyun; Li, Jun; Hu, Jun; Zhang, Lu; Sultana, Nishat; Cai, Xiaoqiang; Cai, Chen-Leng] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, One Gustave L Levy Pl, New York, NY 10029 USA; [Yan, Jianyun] Southern Med Univ, Sino Japanese Cooperat Platform Translat Res Hear, Guangdong Prov Biomed Engn Technol Res Ctr Cardio, Lab Heart Ctr,Zhujiang Hosp,Heart Ctr, Guangzhou 510280, Guangdong, Peoples R China; [Yan, Jianyun] Southern Med Univ, Sino Japanese Cooperat Platform Translat Res Hear, Guangdong Prov Biomed Engn Technol Res Ctr Cardio, Dept Cardiol,Zhujiang Hosp,Heart Ctr, Guangzhou 510280, Guangdong, Peoples R China; [Wei, Chengguo; Zhang, Weijia] Icahn Sch Med Mt Sinai, Div Renal, New York, NY 10029 USA; [Wei, Chengguo; Zhang, Weijia] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Southern Medical University - China; Southern Medical University - China; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Cai, CL (corresponding author), Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, Mindich Child Hlth & Dev Inst, One Gustave L Levy Pl, New York, NY 10029 USA.; Cai, CL (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, One Gustave L Levy Pl, New York, NY 10029 USA.	chenleng.cai@mssm.edu	Yan, Jianyun/AAX-4510-2020	Yan, Jianyun/0000-0002-6962-1169	National Institutes of Health [1R01HL131735, 1R01HL095810, 1R56HL129807, 1K02HL094688]; American Heart Association [15GRNT25710153, 0855808D]; March of Dimes Foundation [5-FY07-642]; National Natural Science Foundation of China [81470488, 81770280, 81728004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL129807, T32HL007824, R01HL131735, R01HL095810, K02HL094688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); March of Dimes Foundation(March of Dimes); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants 1R01HL131735, 1R01HL095810, 1R56HL129807, and 1K02HL094688, American Heart Association Grants 15GRNT25710153 and 0855808D, and March of Dimes Foundation Grant 5-FY07-642 (to C. L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Natural Science Foundation of China Grants 81470488, 81770280, and 81728004.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2007, MATRIX BIOL, V26, P224, DOI 10.1016/j.matbio.2006.12.002; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Benazet JD, 2012, DEVELOPMENT, V139, P4250, DOI 10.1242/dev.084822; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bond SR, 2011, J BONE MINER RES, V26, P2911, DOI 10.1002/jbmr.509; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cai XQ, 2013, DEVELOPMENT, V140, P3176, DOI 10.1242/dev.092502; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Domowicz MS, 2009, DEV BIOL, V329, P242, DOI 10.1016/j.ydbio.2009.02.024; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Iwamoto T, 2010, J BIOL CHEM, V285, P18948, DOI 10.1074/jbc.M110.127027; Iwata T, 2000, HUM MOL GENET, V9, P1603, DOI 10.1093/hmg/9.11.1603; Jeon J, 2011, J BIOL CHEM, V286, P27206, DOI 10.1074/jbc.M111.218065; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Li FF, 2011, J BONE MINER RES, V26, P2899, DOI 10.1002/jbmr.504; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Long FX, 2001, DEVELOPMENT, V128, P5099; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nishimura R, 2012, J BIOL CHEM, V287, P33179, DOI 10.1074/jbc.M111.337063; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Qin HX, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-73; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Saito A, 2014, MOL CELL, V53, P127, DOI 10.1016/j.molcel.2013.11.008; Salazar VS, 2013, J CELL SCI, V126, P4974, DOI 10.1242/jcs.131953; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shu B, 2011, J CELL SCI, V124, P3428, DOI 10.1242/jcs.083659; Shukunami C, 1999, INT J DEV BIOL, V43, P39; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.03466; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; WARMAN ML, 1993, NAT GENET, V5, P79, DOI 10.1038/ng0993-79; Yan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104503; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Yoon BS, 2006, DEVELOPMENT, V133, P4667, DOI 10.1242/dev.02680; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zhang JH, 2005, DEV BIOL, V284, P311, DOI 10.1016/j.ydbio.2005.05.036; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	69	15	16	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9162	9175		10.1074/jbc.RA118.001825	http://dx.doi.org/10.1074/jbc.RA118.001825			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29735531	Green Published, hybrid			2022-12-26	WOS:000435441400003
J	Na, MK; Won, YD; Kim, CH; Kim, JM; Cheong, JH; Ryu, JI; Han, MH				Na, Min Kyun; Won, Yu Deok; Kim, Choong Hyun; Kim, Jae Min; Cheong, Jin Hwan; Ryu, Je Il; Han, Myung-Hoon			Opportunistic osteoporosis screening via the measurement of frontal skull Hounsfield units derived from brain computed tomography images	PLOS ONE			English	Article							BONE-MINERAL DENSITY; MANAGEMENT; SCANS; FRACTURES; TOOL	Background and purpose Osteoporosis is one of the most common chronic metabolic diseases, but detection and treatment rates are low. The aim of the current study was to evaluate the correlation between frontal skull Hounsfield unit (HU) values from brain computed tomography (CT) scans and T-scores of the lumbar spine and femoral neck from dual-energy X-ray absorptiometry (DXA) scans. Methods Patients with < 1 year between brain CT and DXA scans were included in the study. The average frontal skull HU value used for analysis was defined as the average of four HU values of the frontal bone. A receiver operating characteristic curve was generated, and area under the curve (AUC) was used to determine the HU values of the frontal skull for predicting osteoporosis. The frontal skull HU value with the highest sensitivity and specificity was considered the optimal cutoff value. Results In total, 899 patients who underwent both brain CT and DXA scans at a single institution were enrolled. Average skull HU values differed significantly among patients in different bone mineral density categories (p < 0.001). There was a positive correlation between skull HU value and T-score (beta = 105.06, p < 0.001, R-2 = 0.343). The mean HU value in subjects with osteoporosis was 515, and the optimal cutoff value for the prediction of osteoporosis was 610 HU (AUC = 0.775, 95% CI 0.744-0.806, p < 0.001). Conclusions Clinical brain CT scans can assist in the detection of osteoporosis, and patients with an HU value < 610 as determined via brain CT may be considered for further evaluation for possible osteoporosis.	[Na, Min Kyun; Won, Yu Deok; Kim, Choong Hyun; Kim, Jae Min; Cheong, Jin Hwan; Ryu, Je Il; Han, Myung-Hoon] Hanyang Univ, Guri Hosp, Dept Neurosurg, Seoul, South Korea	Hanyang University	Han, MH (corresponding author), Hanyang Univ, Guri Hosp, Dept Neurosurg, Seoul, South Korea.	gksmh80@gmail.com	Won, Yu Deok/CAF-2646-2022	Won, Yu Deok/0000-0002-8822-6631				Baba T, 2015, OSTEOPOROSIS INT, V26, P1959, DOI 10.1007/s00198-015-3103-4; Birnbaum BA, 2007, RADIOLOGY, V242, P109, DOI 10.1148/radiol.2421052066; Blume SW, 2011, OSTEOPOROSIS INT, V22, P1835, DOI 10.1007/s00198-010-1419-7; Burke CJ, 2016, CLIN CASES MINER BON, V13, P135, DOI 10.11138/ccmbm/2016.13.2.135; Chai J, 2014, INT J ORAL MAX IMPL, V29, P667, DOI 10.11607/jomi.3354; Emohare O, 2015, J NEUROSURG-SPINE, V23, P1, DOI 10.3171/2014.10.SPINE14233; Gausden EB, 2017, J BONE JOINT SURG AM, V99, P1580, DOI 10.2106/JBJS.16.00749; Goldman LW, 2007, J NUCL MED TECHNOL, V35, P115, DOI 10.2967/jnmt.107.042978; Nguyen HS, 2016, WORLD NEUROSURG, V93, P50, DOI 10.1016/j.wneu.2016.05.069; Johnson CC, 2016, J HAND SURG-AM, V41, P767, DOI 10.1016/j.jhsa.2016.04.016; Lee HT, 2015, CLIN EXP HYPERTENS, V37, P212, DOI 10.3109/10641963.2014.933971; Lee IJ, 2013, J CRANIOFAC SURG, V24, P428, DOI 10.1097/SCS.0b013e3182801333; Paschou SA, 2017, J CLIN ENDOCR METAB, V102, P3621, DOI 10.1210/jc.2017-00042; Pervaiz K, 2013, J SHOULDER ELB SURG, V22, pE1, DOI 10.1016/j.jse.2012.05.029; Pickhardt PJ, 2013, ANN INTERN MED, V158, P588, DOI 10.7326/0003-4819-158-8-201304160-00003; Schreiber JJ, 2015, J BONE JOINT SURG AM, V97A, P1095, DOI 10.2106/JBJS.N.01230; Schreiber JJ, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.5.FOCUS1483; Schreiber JJ, 2011, J BONE JOINT SURG AM, V93A, P1057, DOI 10.2106/JBJS.J.00160; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815; Wagner SC, 2017, J BONE JOINT SURG AM, V99, DOI 10.2106/JBJS.15.01244	20	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197336	10.1371/journal.pone.0197336	http://dx.doi.org/10.1371/journal.pone.0197336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746570	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700104
J	Zinyemba, C; Archer, E; Rother, HA				Zinyemba, Cliff; Archer, Emma; Rother, Hanna-Andrea			Climate variability, perceptions and political ecology: Factors influencing changes in pesticide use over 30 years by Zimbabwean smallholder cotton producers	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; PEST-MANAGEMENT; FARMERS PERCEPTIONS; WESTERN-CAPE; BT COTTON; RESISTANCE; HEALTH; IMPACT; AGRICULTURE; STRATEGIES	Pesticides represent a potential public health hazard of note in farming communities. Accumulating evidence indicates that some pesticides used in agriculture act as hormone disrupters, with the potential to result in chronic health effects. Despite such a growing evidence base, pesticides remain the preferred method of pest control in agriculture worldwide. In many parts of Sub-Saharan Africa, usage is on the increase. This qualitative study assessed changes in the usage of pesticides by Zimbabwean smallholder cotton farmers in the past 30 years. Farmers reported an increase in the usage of pesticides, specifically insecticides, since the early 1980s. An increase in pest populations was also reported. The findings suggested a bi-directional causal relationship between the increase in pest population and the increase in pesticide use. Factors which emerged to have collectively impacted on the changes include climate variability, limited agency on the part of farmers, power dynamics involving the government and private cotton companies and farmers' perceptions and practices. An Integrated Pest Management Policy for Zimbabwe is recommended to facilitate integration of chemical controls with a broad range of other pest control tactics. Continuous farmer education and awareness raising is further recommended, since farmers' perceptions can influence their practices.	[Zinyemba, Cliff; Rother, Hanna-Andrea] Univ Cape Town, Environm Hlth Div, Ctr Occupat & Environm Hlth Res, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Archer, Emma] CSIR, Nat Resources & Environm, Johannesburg, South Africa; [Archer, Emma] Univ Witwatersrand, Global Change Inst, Johannesburg, South Africa	University of Cape Town; Council for Scientific & Industrial Research (CSIR) - South Africa; University of Witwatersrand	Rother, HA (corresponding author), Univ Cape Town, Environm Hlth Div, Ctr Occupat & Environm Hlth Res, Sch Publ Hlth & Family Med, Cape Town, South Africa.	andrea.rother@uct.ac.za	Archer, Emma/V-5736-2019; Rother, Hanna-Andrea/ABB-1037-2020	Rother, Hanna-Andrea/0000-0001-5292-8909; Archer, Emma/0000-0002-5374-3866; Zinyemba, Cliff/0000-0003-1592-0005	Applied Centre for Climate and Earth Systems Sciences (ACCESS) of South Africa; African Climate and Development Institute (ACDI) of the University of Cape Town; South African National Research Foundation (NRF)	Applied Centre for Climate and Earth Systems Sciences (ACCESS) of South Africa; African Climate and Development Institute (ACDI) of the University of Cape Town; South African National Research Foundation (NRF)(National Research Foundation - South Africa)	This work was funded by the Applied Centre for Climate and Earth Systems Sciences (ACCESS) of South Africa and the African Climate and Development Institute (ACDI) of the University of Cape Town as a PhD bursary and field work funding (respectively) for CZ. We also acknowledge the South African National Research Foundation (NRF) for additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate T, 2000, ANNU REV ENTOMOL, V45, P631, DOI 10.1146/annurev.ento.45.1.631; Ajayi O. C., 2011, Health, V3, P631, DOI 10.4236/health.2011.310107; Bebber DP, 2013, NAT CLIM CHANGE, V3, P985, DOI [10.1038/nclimate1990, 10.1038/NCLIMATE1990]; Bergman A, 2013, ENVIRON HEALTH PERSP, V121, pA104, DOI 10.1289/ehp.1205448; Bloomfield JP, 2006, SCI TOTAL ENVIRON, V369, P163, DOI 10.1016/j.scitotenv.2006.05.019; Bollmohr S, 2007, CHEMOSPHERE, V68, P479, DOI 10.1016/j.chemosphere.2006.12.078; Brevault T, 2009, CROP PROT, V28, P968, DOI 10.1016/j.cropro.2009.07.004; Brown D, 2012, CLIMATE CHANGE IMPAC; Creswell J.W., 2015, RES DESIGN QUALITATI, V4th ed.; Dalvie MA, 2014, SCI TOTAL ENVIRON, V466, P1078, DOI 10.1016/j.scitotenv.2013.07.099; Damalas CA, 2008, SCI TOTAL ENVIRON, V390, P341, DOI 10.1016/j.scitotenv.2007.10.028; Delcour I, 2015, FOOD RES INT, V68, P7, DOI 10.1016/j.foodres.2014.09.030; English RG, 2012, ENVIRON INT, V47, P73, DOI 10.1016/j.envint.2012.06.006; Field C.B., 2012, MANAGING RISKS EXTRE, P555; Foti R, 2005, J SUSTAINABLE DEV AF, V7, P116; Galt RE, 2009, J POLIT ECOL, V16, P1; Galt RE, 2013, ANTIPODE, V45, P336, DOI 10.1111/j.1467-8330.2012.01000.x; Galt RE, 2010, ANN ASSOC AM GEOGR, V100, P327, DOI 10.1080/00045601003595388; Galt RE, 2008, GLOBAL ENVIRON CHANG, V18, P786, DOI 10.1016/j.gloenvcha.2008.07.003; Garry VF, 2004, TOXICOL APPL PHARM, V198, P152, DOI 10.1016/j.taap.2003.11.027; Gesesew HA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162527; GROSSMAN LS, 1992, HUM ECOL, V20, P315, DOI 10.1007/BF00889900; Han P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102980; Handiseni T, 2017, ZIMBABWE J SCI TECHN, V12, P41; Hashemi SM, 2011, J SUSTAIN AGR, V35, P69, DOI 10.1080/10440046.2011.530511; Heong KL, 1999, CROP PROT, V18, P315, DOI 10.1016/S0261-2194(99)00030-7; Hwang HM, 2008, SCI TOTAL ENVIRON, V404, P26, DOI 10.1016/j.scitotenv.2008.05.031; Karavina C., 2012, RES J AGR SCI, V3, P607; Kattwinkel M, 2011, ECOL APPL, V21, P2068, DOI 10.1890/10-1993.1; Keikotlhaile BM, 2010, FOOD CHEM TOXICOL, V48, P1, DOI 10.1016/j.fct.2009.10.031; Kortenkamp A, 2011, STATE ART ASSESSMENT; Kouser S, 2011, ECOL ECON, V70, P2105, DOI 10.1016/j.ecolecon.2011.06.008; Kuye RA, 2008, J AGROMEDICINE, V12, P57, DOI DOI 10.1080/10599240801887876; Lekei EE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-389; Mancini F, 2005, INT J OCCUP ENV HEAL, V11, P221; Mapuranga R., 2015, INT J AGRON AGR RES, V7, P23; Masuka G, 2013, SINGAPORE J TROP GEO, V34, P103, DOI 10.1111/sjtg.12016; Masuka G, 2012, GEOFORUM, V43, P573, DOI 10.1016/j.geoforum.2011.11.001; Maumbe BM, 2003, SOC SCI MED, V57, P1559, DOI 10.1016/S0277-9536(03)00016-9; Mesnage R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/179691; Meyer L., 2014, CLIMATE CHANGE 2014; Midega CAO, 2012, CROP PROT, V42, P193, DOI 10.1016/j.cropro.2012.07.010; Mostafalou S, 2013, TOXICOL APPL PHARM, V268, P157, DOI 10.1016/j.taap.2013.01.025; Mubvekeri W., 2014, Journal of Ecology and the Natural Environment, V6, P342; Muchadeyi FC, 2004, LIVEST RES RURAL DEV, V16; Mudimu GD., 1995, PESTICIDE USE POLICI, P30419; Ngowi A, 2007, CROP PROT, V26, P1617, DOI 10.1016/j.cropro.2007.01.008; Nolan BT, 2008, PEST MANAG SCI, V64, P933, DOI 10.1002/ps.1587; Nyakudya IW, 2011, AGR WATER MANAGE, V98, P1649, DOI 10.1016/j.agwat.2011.06.002; Petrelli G, 2000, EUR J EPIDEMIOL, V16, P391, DOI 10.1023/A:1007630610911; Pimentel D, 2014, INTEGRATED PEST MANAGEMENT: CURRENT CONCEPTS AND ECOLOGICAL PERSPECTIVE, P111, DOI 10.1016/B978-0-12-398529-3.00008-7; Poulton C, 2009, COMP ANAL ORG PERFOR; Saldana J, 2013, CODING MANUAL QUALIT, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CB09781107415324.004]; Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007; Seeger B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147490; Settle W, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0277; Silvie PJ, 2013, CROP PROT, V43, P157, DOI 10.1016/j.cropro.2012.09.006; Steffens K, 2015, SCI TOTAL ENVIRON, V514, P239, DOI 10.1016/j.scitotenv.2014.12.049; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tibugari H., 2012, Archives of Phytopathology and Plant Protection, V45, P2395, DOI 10.1080/03235408.2012.727327; Tonderai N, 2014, EUR J BUSINESS EC AC, V2; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Unganai L, 2009, IOP C SERIES EARTH E, V6, DOI [10.1088/1755-1307/6/1/, DOI 10.1088/1755-1307/6/1/412045]; Weidner IS, 1998, ENVIRON HEALTH PERSP, V106, P793, DOI 10.2307/3434122; Weiss B, 2011, J NEUROL SCI, V305, P11, DOI 10.1016/j.jns.2011.03.014; Whalon ME, 2008, GLOBAL PESTICIDE RESISTANCE IN ARTHROPODS, P5, DOI 10.1079/9781845933531.0005; Williamson Bruce, 1969, IRISH TIMES 0524; Williamson S, 2008, CROP PROT, V27, P1327, DOI 10.1016/j.cropro.2008.04.006; Yang YH, 2013, J ECON ENTOMOL, V106, P375, DOI 10.1603/EC12286; Zimbabwe National Statistics Agency, 2012, ZIMB POP CENS PROV R	70	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196901	10.1371/journal.pone.0196901	http://dx.doi.org/10.1371/journal.pone.0196901			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF3JM	29746510	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700047
J	Ashari, ZE; Dasgupta, N; Brayton, KA; Broschat, SL				Ashari, Zhila Esna; Dasgupta, Nairanjana; Brayton, Kelly A.; Broschat, Shira L.			An optimal set of features for predicting type IV secretion system effector proteins for a subset of species based on a multi-level feature selection approach	PLOS ONE			English	Article							LARGE-SCALE IDENTIFICATION; LEGIONELLA-PNEUMOPHILA; TRANSLOCATED SUBSTRATE; MACROPHAGES; REGULATOR; FAMILY	Type IV secretion systems (T4SS) are multi-protein complexes in a number of bacterial pathogens that can translocate proteins and DNA to the host. Most T4SSs function in conjugation and translocate DNA; however, approximately 13% function to secrete proteins, delivering effector proteins into the cytosol of eukaryotic host cells. Upon entry, these effectors manipulate the host cell's machinery for their own benefit, which can result in serious illness or death of the host. For this reason recognition of T4SS effectors has become an important subject. Much previous work has focused on verifying effectors experimentally, a costly endeavor in terms of money, time, and effort. Having good predictions for effectors will help to focus experimental validations and decrease testing costs. In recent years, several scoring and machine learning-based methods have been suggested for the purpose of predicting T4SS effector proteins. These methods have used different sets of features for prediction, and their predictions have been inconsistent. In this paper, an optimal set of features is presented for predicting T4SS effector proteins using a statistical approach. A thorough literature search was performed to find features that have been proposed. Feature values were calculated for datasets of known effectors and non-effectors for T4SS-containing pathogens for four genera with a sufficient number of known effectors, Legionella pneumophila, Coxiella burnetii, Brucella spp, and Bartonella spp. The features were ranked, and less important features were filtered out. Correlations between remaining features were removed, and dimensional reduction was accomplished using principal component analysis and factor analysis. Finally, the optimal features for each pathogen were chosen by building logistic regression models and evaluating each model. The results based on evaluation of our logistic regression models confirm the effectiveness of our four optimal sets of features, and based on these an optimal set of features is proposed for all T4SS effector proteins.	[Ashari, Zhila Esna; Brayton, Kelly A.; Broschat, Shira L.] Washington State Univ, Sch Elect Engn & Comp Sci, Washington, DC 99164 USA; [Dasgupta, Nairanjana] Washington State Univ, Dept Math & Stat, Washington, DC USA; [Brayton, Kelly A.; Broschat, Shira L.] Washington State Univ, Dept Vet Microbiol & Pathol, Washington, DC USA; [Brayton, Kelly A.; Broschat, Shira L.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Washington, DC USA	Washington State University; Washington State University; Washington State University; Washington State University	Ashari, ZE (corresponding author), Washington State Univ, Sch Elect Engn & Comp Sci, Washington, DC 99164 USA.	z.esnaashariesfahan@wsu.edu		Esna Ashari, Zhila/0000-0003-0454-7794	National Institutes of Health [R01A1042792]; Carl M. Hansen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carl M. Hansen Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant R01A1042792 by National Institutes of Health and by the Carl M. Hansen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abby SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23080; Altman E, 2008, J BACTERIOL, V190, P1985, DOI 10.1128/JB.01493-07; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; Burstein D, 2009, INT J BIOCH CELL BIO, V5; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; Campodonico EM, 2005, MOL MICROBIOL, V56, P918, DOI 10.1111/j.1365-2958.2005.04595.x; Carey KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002056; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chen C, 2010, P NATL ACAD SCI USA, V107, P21755, DOI 10.1073/pnas.1010485107; Chen J, 2004, SCIENCE, V7, P507; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Esna Ashari Z, 2017, P 8 ACM C BIONF COMP; Habyarimana F, 2008, ENVIRON MICROBIOL, V10, P1460, DOI 10.1111/j.1462-2920.2007.01560.x; Han N, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/9415459; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; Ke YH, 2015, FRONT CELL INFECT MI, V5, DOI [10.3389/fcimb.2015.00072, 10.3389/famb.2015.00072]; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Lifshitz Z, 2014, INFECT IMMUN, V82, P3740, DOI 10.1128/IAI.01729-14; Lockwood S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027724; Meyer DF, 2013, NUCLEIC ACIDS RES, V41, P9218, DOI 10.1093/nar/gkt718; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Myeni S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003556; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Ninio S, 2005, MOL MICROBIOL, V55, P912, DOI 10.1111/j.1365-2958.2004.04435.x; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Price CTD, 2010, J EXP MED, V207, P1712, DOI 10.1084/jem.20100771; Pulliainen AT, 2009, INT J BIOCHEM CELL B, V41, P507, DOI 10.1016/j.biocel.2008.10.018; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Shohdy N, 2005, P NATL ACAD SCI USA, V102, P4866, DOI 10.1073/pnas.0501315102; Sinclair S, 2015, FUTURE MICROBIOLOGY, V6; Suwwan de Felipe K, 2008, PLOS PATHOG, V4, DOI [10.1111/j.1462-5822.2008.01249.x, DOI 10.1111/J.1462-5822.2008.01249.XPMID]; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Voth DE, 2011, J BACTERIOL, V193, P1493, DOI 10.1128/JB.01359-10; Voth DE, 2009, J BACTERIOL, V191, P4232, DOI 10.1128/JB.01656-08; Wei QZ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1158; Yu LZ, 2010, J THEOR BIOL, V267, P1, DOI 10.1016/j.jtbi.2010.08.001; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zou LY, 2013, BIOINFORMATICS, V29, P3135, DOI 10.1093/bioinformatics/btt554; Zusman T, 2008, INFECT IMMUN, V76, P4581, DOI 10.1128/IAI.00337-08; Zusman T, 2007, MOL MICROBIOL, V63, P1508, DOI 10.1111/j.1365-2958.2007.05604.x	48	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0197041	10.1371/journal.pone.0197041	http://dx.doi.org/10.1371/journal.pone.0197041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742157	gold, Green Submitted, Green Published			2022-12-26	WOS:000431757400055
J	Blomqvist, BRH; Mann, RP; Sumpter, DJT				Blomqvist, Bjorn R. H.; Mann, Richard P.; Sumpter, David J. T.			Using Bayesian dynamical systems, model averaging and neural networks to determine interactions between socio-economic indicators	PLOS ONE			English	Article							COUPLING FUNCTIONS; LINEAR-REGRESSION; DEMOCRACY; NONLINEARITY	Social and economic systems produce complex and nonlinear relationships in the indicator variables that describe them. We present a Bayesian methodology to analyze the dynamical relationships between indicator variables by identifying the nonlinear functions that best describe their interactions. We search for the 'best' explicit functions by fitting data using Bayesian linear regression on a vast number of models and then comparing their Bayes factors. The model with the highest Bayes factor, having the best trade-off between explanatory power and interpretability, is chosen as the 'best' model. To be able to compare a vast number of models, we use conjugate priors, resulting in fast computation times. We check the robustness of our approach by comparison with more prediction oriented approaches such as model averaging and neural networks. Our modelling approach is illustrated using the classical example of how democracy and economic growth relate to each other. We find that the best dynamical model for democracy suggests that long term democratic increase is only possible if the economic situation gets better. No robust model explaining economic development using these two variables was found.	[Blomqvist, Bjorn R. H.; Sumpter, David J. T.] Uppsala Univ, Dept Math, Uppsala, Sweden; [Mann, Richard P.] Univ Leeds, Sch Math, Leeds, W Yorkshire, England	Uppsala University; University of Leeds	Blomqvist, BRH (corresponding author), Uppsala Univ, Dept Math, Uppsala, Sweden.	bjorn.blomqvist@math.uu.se	Mann, Richard/N-9779-2014	Mann, Richard/0000-0003-0701-1274				Barro RJ, 1999, J POLIT ECON, V107, pS158, DOI 10.1086/250107; Denison D.G., 2002, BAYESIAN METHODS NON; Durlauf SN, 2005, HANDB ECON, V22, P555; Epstein JM., 1997, NONLINEAR DYNAMICS M; Fedor P, 2008, B ENTOMOL RES, V98, P437, DOI 10.1017/S0007485308005750; FreedomHouse, 2010, FREED WORLD; Gelman A., 2014, BAYESIAN DATA ANAL, V2; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hoeting JA, 1998, P AAAI WORKSH INT MU, V335, P77; Hoff PD, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-92407-6_1; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Iatsenko D, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0622; Inglehart R, 2000, WASH QUART, V23, P215, DOI 10.1162/016366000560665; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kiel LD, 1997, CHAOS THEORY SOCIAL; Kiss IZ, 2007, SCIENCE, V316, P1886, DOI 10.1126/science.1140858; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Kralemann B, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/8/085013; Kralemann B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3418; Krieckhaus J, 2004, BRIT J POLIT SCI, V34, P635, DOI 10.1017/S0007123404000225; Lek S, 1999, ECOL MODEL, V120, P65, DOI 10.1016/S0304-3800(99)00092-7; Liang F, 2008, J AM STAT ASSOC, V103, P410, DOI 10.1198/016214507000001337; Lindenfors P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028270; LIPSET SM, 1959, AM POLIT SCI REV, V53, P69, DOI 10.2307/1951731; Losada M, 2004, AM BEHAV SCI, V47, P740, DOI 10.1177/0002764203260208; Manski CF, 2000, J ECON PERSPECT, V14, P115, DOI 10.1257/jep.14.3.115; Marks G, 1992, REEXAMINING DEMOCRAC; Miyazaki J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.194101; Moral-Benito E, 2015, J ECON SURV, V29, P46, DOI 10.1111/joes.12044; Nelles O., 2013, NONLINEAR SYSTEM IDE; Opp KD, 2011, J MATH SOCIOL, V35, P209, DOI 10.1080/0022250X.2010.532257; Raftery AE, 2005, MON WEATHER REV, V133, P1155, DOI 10.1175/MWR2906.1; Raftery AE, 1997, J AM STAT ASSOC, V92, P179, DOI 10.2307/2291462; Ranganathan S, 2015, PALGRAVE COMMUNICATI, P1, DOI [10.1057/palcornms.2015.33, DOI 10.1057/PALCORNMS.2015.33]; Ranganathan S, 2015, PALGR COMMUN, V1, DOI 10.1057/palcomms.2015.33; Ranganathan S, 2015, BIG DATA-US, V3, P22, DOI 10.1089/big.2014.0066; Ranganathan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086468; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Ruths D, 2014, SCIENCE, V346, P1063, DOI 10.1126/science.346.6213.1063; Saftoiu A, 2012, CLIN GASTROENTEROL H, V10, P84, DOI 10.1016/j.cgh.2011.09.014; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Skilling J, 2006, BAYESIAN ANAL, V1, P833, DOI 10.1214/06-BA127; Spaiser V, 2016, SOCIOLOGICAL METHODS; Spaiser V, 2017, INT J SUST DEV WORLD, V24, P457, DOI 10.1080/13504509.2016.1235624; Spaiser V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097856; Spiegelhalter DJ., 2004, BAYESIAN APPROACHES, V13; Stankovski T, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.045001; Stankovski T, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00033; Stankovski T, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/3/035002; Stankovski T, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.011026; Suykens JA, 2012, ARTIFICIAL NEURAL NE; Taormina R, 2012, ENG APPL ARTIF INTEL, V25, P1670, DOI 10.1016/j.engappai.2012.02.009; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Tokuda IT, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.064101; Welzel C, 2013, FREEDOM RISING: HUMAN EMPOWERMENT AND THE QUEST FOR EMANCIPATION, P1; Wetzel C, 2005, INT REV SOCIOLOGY, V15, P81, DOI [10.1080/03906700500038579, DOI 10.1080/03906700500038579]; Wintle BA, 2003, CONSERV BIOL, V17, P1579, DOI 10.1111/j.1523-1739.2003.00614.x; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; World Bank, WORLD DEV IND	62	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196355	10.1371/journal.pone.0196355	http://dx.doi.org/10.1371/journal.pone.0196355			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF2GV	29742126	gold, Green Published, Green Submitted			2022-12-26	WOS:000431757400027
J	Gebreyes, YF; Goshu, DY; Geletew, TK; Argefa, TG; Zemedu, TG; Lemu, KA; Waka, FC; Mengesha, AB; Degefu, FS; Deghebo, AD; Wubie, HT; Negeri, MG; Tesema, TT; Tessema, YG; Regassa, MG; Eba, GG; Beyene, MG; Yesu, KM; Zeleke, GT; Mengistu, YT; Belayneh, AB				Gebreyes, Yeweyenhareg Feleke; Goshu, Dejuma Yadeta; Geletew, Tedia Kebede; Argefa, Terefe Gelibo; Zemedu, Theodros Getachew; Lemu, Kassahun Amenu; Waka, Feyissa Challa; Mengesha, Alemayehu Bekele; Degefu, Fasil Shiferaw; Deghebo, Atkure Defar; Wubie, Habtamu Teklie; Negeri, Mussie Gebremichael; Tesema, Tefera Tadele; Tessema, Yabetse Girma; Regassa, Mulugeta Guta; Eba, Geremew Gonfa; Beyene, Misrak Getnet; Yesu, Kissi Mudie; Zeleke, Girum Taye; Mengistu, Yewondwossen Tadesse; Belayneh, Abebe Bekele			Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: Evidences from the National NCDs STEPS Survey, 2015	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; CARDIOVASCULAR-DISEASE; SYSTOLIC HYPERTENSION; SYSTEMATIC ANALYSIS; BLOOD-PRESSURE; ASSOCIATION; POPULATION; HEALTH; GLUCOSE	The prevalence of diabetes, dyslipidemias, and high blood pressure is increasing worldwide especially in low and middle income countries. World Health Organization has emphasized the importance of the assessment of the magnitude of the specific disease in each country. We determined the prevalence and determinant factors of high blood pressure, hyperglycemia, dyslipidemias and metabolic syndrome in Ethiopia. A community based survey was conducted from -April to June 2015 using WHO NOD STEPS instrument version 3.1.2008. Multistage stratified systemic random sampling was used to select representative samples from 9 regions of the country. A total of 10,260 people aged 15-69 years participated in the study. Blood pressure (BP) was measured for 9788 individuals. A total of 9141 people underwent metabolic screening. The prevalence of raised blood pressure (SBP >= 140 and/or DBP >= 90 mmHg) was 15.8% (16.3% in females and 15.5% in males). The prevalence of diabetes mellitus (FBS >= 126 mg/dl) including those on medication was 3.2% (3.5% males and 3.0% females). The prevalence of impaired fasting glucose was 9.1% with ADA criteria and 3.8% with WHO criteria. Hypercholesterolemia was found in 5.2%, hypertriglyceridemia in 21.0%, high LDL cholesterol occurred in 14.1% and low HDL cholesterol occurred in 68.7%. The prevalence of metabolic syndrome using IDF definition was 4.8% (8.6% in females and vs. 1.8% in males). Advanced age, urban residence, lack of physical exercise, raised waist circumference, raised waist hip ratio, overweight or obesity, and total blood cholesterol were significantly associated with raised blood pressure (BP) and diabetes mellitus. Increased waist- hip ratio was an independent predictor of raised blood pressure, hyperglycemia and raised total cholesterol. Our study showed significantly high prevalence of raised blood pressure, hyperglycemia and dyslipidemia in Ethiopia. Community based interventions are recommended to control these risk factors.	[Gebreyes, Yeweyenhareg Feleke; Goshu, Dejuma Yadeta; Geletew, Tedia Kebede; Mengistu, Yewondwossen Tadesse] Addis Ababa Univ, Coll Hlth Sci, Addis Ababa, Ethiopia; [Gebreyes, Yeweyenhareg Feleke] Ethiopian Med Assoc, Addis Ababa, Ethiopia; [Argefa, Terefe Gelibo; Zemedu, Theodros Getachew; Lemu, Kassahun Amenu; Waka, Feyissa Challa; Deghebo, Atkure Defar; Wubie, Habtamu Teklie; Tesema, Tefera Tadele; Tessema, Yabetse Girma; Regassa, Mulugeta Guta; Eba, Geremew Gonfa; Beyene, Misrak Getnet; Yesu, Kissi Mudie; Zeleke, Girum Taye; Belayneh, Abebe Bekele] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Mengesha, Alemayehu Bekele] Ethiopian Publ Hlth Assoc, Addis Ababa, Ethiopia; [Degefu, Fasil Shiferaw] WHO, Addis Ababa, Ethiopia; [Negeri, Mussie Gebremichael] Fed Minist Hlth, Addis Ababa, Ethiopia	Addis Ababa University; World Health Organization; Federal Ministry of Health - Ethiopia (FMOH)	Gebreyes, YF (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Addis Ababa, Ethiopia.	yeweyenharegf@yahoo.com.mail	Zemedu, Theodros G/AAJ-3682-2020	Zemedu, Theodros G/0000-0002-6486-0531; Feleke, Yeweyenhareg/0000-0001-7365-6025; Beyene, Misrak Getnet/0000-0002-6629-756X; Tessema, Yabetse Girma/0000-0001-5265-0919; Gelibo, Terefe/0000-0001-7591-9669	World Health Organization (WHO); United Nation International Children's Emergency Fund (UNICEF)	World Health Organization (WHO)(World Health Organization); United Nation International Children's Emergency Fund (UNICEF)	Both World Health Organization (WHO) and United Nation International Children's Emergency Fund (UNICEF) supported the The WHO STEPS, Ethiopia, in terms of financial support, in kind and as Expert support. We have applied the Standard format of WHO STEPS Survey with minor modification. But the funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The overall organizer of the funding is the Federal Ministry Health Of Ethiopia. Mr. Abebe Belayneh, the head of the Health System and Reproductive Health Research Directorate is responsible for grant related activities.	Abdissa Senbeta Guteta, 2014, Ethiop Med J, V52, P9; Abdissa SG, 2015, ETHIOP J HEALTH DEV, P29; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Alberti G, 2006, IDF CONS WORLDW DEF, P2; Alemayehu C.M., 2013, CLIN MED RES, V2, P94, DOI [10.11648/j.cmr.20130205.11, DOI 10.11648/J.CMR.20130205.11]; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; [Anonymous], EPIDEMIOLOGY CARDIOV; [Anonymous], 2017, NONC DIS; Anteneh ZA, 2015, INT J GEN MED, V8, P175, DOI 10.2147/IJGM.S81513; Balkau B, 1999, DIABETES CARE, V22, P696, DOI 10.2337/diacare.22.5.696; Bee Ying Tan Jr, 2008, Malays J Nutr, V14, P65; Belayneh AB, 2015, AM SCI RES J ENG TEC, V13, P34; Brown CD, 2000, OBES RES, V8, P605, DOI 10.1038/oby.2000.79; Dasappa Hemavathi, 2015, J Family Med Prim Care, V4, P399, DOI 10.4103/2249-4863.161336; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Ethiopian Federal Ministry of Health, 2014, NAT STRAT ACT PLAN P; Ethiopian Federal Ministry of Health, 2016, NAT COMPR GUID CLIN, P160; Ethiopian Federal Ministry of Health, 2016, NAT TRAIN GUID DIAB; Everett B, 2015, BIODEMOGR SOC BIOL, V61, P1, DOI 10.1080/19485565.2014.929488; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Franklin SS, 2001, HYPERTENSION, V37, P869, DOI 10.1161/01.HYP.37.3.869; Franklin SS, 2001, CIRCULATION, V103, P1245; Franklin SS, 2005, CIRCULATION, V111, P1121, DOI 10.1161/01.CIR.0000157159.39889.EC; Gabir MM, 2000, DIABETES CARE, V23, P1108, DOI 10.2337/diacare.23.8.1108; Garcez MR, 2014, ARQ BRAS CARDIOL, V103, P476, DOI 10.5935/abc.20140156; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Joshi SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096808; Kibret KT, 2015, PUBLIC HEALTH REV, V36, DOI 10.1186/s40985-015-0014-z; Kishore J, 2016, INT J HYPERTENS, V2016, DOI 10.1155/2016/7962595; Kuller LH, 2007, HYPERTENSION, V50, P1004, DOI 10.1161/HYPERTENSIONAHA.107.095620; Levitan EB, 2004, ARCH INTERN MED, V164, P2147, DOI 10.1001/archinte.164.19.2147; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mengesha AB, 2015, THESIS; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Ministry of Health Malawi and WHO, 2009, MAL NAT STEPS SURV C; Muluneh AT, 2012, ETHIOP J HEALTH SCI, V22, P7; nternational Diabetes Federation, 2015, DIABETES ATLAS; Ogah OS, 2013, HEART, V99, P1390, DOI 10.1136/heartjnl-2012-303227; Oguejiofor OC, 2012, ANN AFR MED, V11, P197, DOI 10.4103/1596-3519.102846; Okafor Christian I, 2012, Indian J Endocrinol Metab, V16, P56, DOI 10.4103/2230-8210.91191; Organization WH, 2009, GLOB HLTH RISKS MORT; Ravikiran M, 2010, DIABETES RES CLIN PR, V89, P181, DOI 10.1016/j.diabres.2010.03.010; Roberts G, 2013, VANUATU NCD RISK FAC, DOI [10.1016/j.metabol.2009.04.008, DOI 10.1016/J.METABOL.2009.04.008]; Shaw JE, 2000, DIABETES CARE, V23, P34, DOI 10.2337/diacare.23.1.34; Sola AO., 2013, J MED SCI, V4, P149; Sun GZ, 2015, INT J CARDIOL, V182, P13, DOI 10.1016/j.ijcard.2014.12.063; Tesfaye F, 2007, J HUM HYPERTENS, V21, P28, DOI 10.1038/sj.jhh.1002104; Toth PP, 2012, J CLIN LIPIDOL, V6, P325, DOI 10.1016/j.jacl.2012.05.002; Walia R, 2014, INDIAN J MED RES, V139, P252; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2016, GLOB REP PSOR; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization, 2016, ETH STEPS REP RISK F; World Health Organization, 2009, WHO STEPS INSTRUMENT; World Health Organization, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2014, OV GLOB HLTH OBS DEA; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zuo H, 2009, METABOLISM, V58, P1102, DOI 10.1016/j.metabol.2009.04.008	60	60	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0194819	10.1371/journal.pone.0194819	http://dx.doi.org/10.1371/journal.pone.0194819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742131	Green Submitted, gold, Green Published			2022-12-26	WOS:000431757400007
J	Li, JK; Liang, Z; Li, YJ; Li, P; Jiang, CB				Li, Jiake; Liang, Zheng; Li, Yajiao; Li, Peng; Jiang, Chunbo			Experimental study and simulation of phosphorus purification effects of bioretention systems on urban surface runoff	PLOS ONE			English	Article							STORM WATER RUNOFF; RAIN GARDEN; POLLUTANT REMOVAL; PHOSPHATE REMOVAL; SEDIMENT REMOVAL; FLY-ASH; FIELD; PERFORMANCE; NUTRIENT; MEDIA	Excessive phosphorus (P) contributes to eutrophication by degrading water quality and limiting human use of water resources. Identifying economic and convenient methods to control soluble reactive phosphorus (SRP) pollution in urban runoff is the key point of rainwater management strategies. Through three series of different tests involving influencing factors, continuous operation and intermittent operation, this study explored the purification effects of bioretention tanks under different experimental conditions, it included nine intermittent tests, single field continuous test with three groups of different fillers (Fly ash mixed with sand, Blast furnace slag, and Soil), and eight intermittent tests with single filler (Blast furnace slag mixed with sand). Among the three filler combinations studied, the filler with fly ash mixed with sand achieved the best pollution reduction efficiency. The setting of the submerged zone exerted minimal influence on the P removal of the three filler combinations. An extension of the dry period slightly promoted the P purification effect. The combination of fly ash mixed with sand demonstrated a positive purification effect on SRP during short- or long-term simulated rainfall duration. Blast furnace slag also presented a positive purification effect in the short term, although its continuous purification effect on SRP was poor in the long term. The purification abilities of soil in the short and long terms were weak. Under intermittent operations across different seasons, SRP removal was unstable, and effluent concentration processes were different. The purification effect of the bioretention system on SRP was predicted through partial least squares regression (PLS) modeling analysis. The event mean concentration removal of SRP was positively related to the adsorption capacity of filler and rainfall interval time and negatively related to submerged zones, influent concentration and volume.	[Li, Jiake; Liang, Zheng; Li, Peng; Jiang, Chunbo] Xian Univ Technol, State Key Lab Ecohydraul Northwes Arid Reg China, Xian, Shaanxi, Peoples R China; [Li, Yajiao] Xian Univ Sci & Technol, Sch Architecture & Civil Engn, Xian, Shaanxi, Peoples R China	Xi'an University of Technology; Xi'an University of Science & Technology	Li, JK (corresponding author), Xian Univ Technol, State Key Lab Ecohydraul Northwes Arid Reg China, Xian, Shaanxi, Peoples R China.	xaut_ljk@163.com			Natural Science Foundation of Shaanxi Province [2015JZ013]; National Natural Science Foundation of China [51279158, 51209168]	Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the Natural Science Foundation of Shaanxi Province (Grant no. 2015JZ013) and the National Natural Science Foundation of China (Grant nos. 51279158 and 51209168).	Blecken GT, 2010, J HYDROL, V394, P507, DOI 10.1016/j.jhydrol.2010.10.010; Bratieres K, 2008, WATER RES, V42, P3930, DOI 10.1016/j.watres.2008.06.009; Brown RA, 2011, J ENVIRON ENG, V137, P1082, DOI 10.1061/(ASCE)EE.1943-7870.0000437; Brown RA, 2011, J IRRIG DRAIN ENG, V137, P132, DOI 10.1061/(ASCE)IR.1943-4774.0000167; Chahal MK, 2016, SCI TOTAL ENVIRON, V556, P302, DOI 10.1016/j.scitotenv.2016.02.125; Davis AP, 2007, ENVIRON ENG SCI, V24, P1048, DOI 10.1089/ees.2006.0190; Davis AP, 2006, WATER ENVIRON RES, V78, P284, DOI 10.2175/106143005X94376; Davis AP, 2001, WATER ENVIRON RES, V73, P5, DOI 10.2175/106143001X138624; Deletic A, 2006, J HYDROL, V317, P261, DOI 10.1016/j.jhydrol.2005.05.021; Dietz ME, 2006, ENVIRON SCI TECHNOL, V40, P1335, DOI 10.1021/es051644f; Dietz ME, 2005, WATER AIR SOIL POLL, V167, P123, DOI 10.1007/s11270-005-8266-8; Dietz ME, 2007, WATER AIR SOIL POLL, V186, P351, DOI 10.1007/s11270-007-9484-z; Ghane E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167834; Hatt E, 2007, WATER SCI TECHNOL, V56, P11, DOI 10.2166/wst.2007.751; Hsieh CH, 2005, WATER SCI TECHNOL, V51, P177, DOI 10.2166/wst.2005.0589; Hsieh CH, 2005, J ENVIRON ENG, V131, P1521, DOI 10.1061/(ASCE)0733-9372(2005)131:11(1521); Hunt WF, 2008, J ENVIRON ENG-ASCE, V134, P403, DOI 10.1061/(ASCE)0733-9372(2008)134:5(403); Hunt WF, 2006, J IRRIG DRAIN ENG, V132, P600, DOI 10.1061/(ASCE)0733-9437(2006)132:6(600); Hwang V, 2017, CONSTR BUILD MATER, V132, P161, DOI 10.1016/j.conbuildmat.2016.11.134; Komlos J, 2012, J ENVIRON ENG, V138, P991, DOI 10.1061/(ASCE)EE.1943-7870.0000566; Lau AYT, 2017, CHEMOSPHERE, V169, P89, DOI 10.1016/j.chemosphere.2016.11.048; Li H, 2009, J ENVIRON ENG, V135, P567, DOI 10.1061/(ASCE)EE.1943-7870.0000026; Li JK, 2016, ECOL ENG, V91, P74, DOI 10.1016/j.ecoleng.2016.01.061; Li JK, 2016, WATER RES, V90, P141, DOI 10.1016/j.watres.2015.12.015; Liu JY, 2014, ENVIRON SCI TECHNOL, V48, P607, DOI 10.1021/es404022b; [卢金锁 Lu Jinsuo], 2010, [中国给水排水, China Water & Wastewater], V26, P82; Lucke T, 2015, SCI TOTAL ENVIRON, V536, P784, DOI 10.1016/j.scitotenv.2015.07.142; Lucke T, 2011, BUILD RES INF, V39, P603, DOI 10.1080/09613218.2011.602182; Lurling M, 2014, WATER RES, V54, P78, DOI 10.1016/j.watres.2014.01.059; Manka BN, 2016, ECOL ENG, V94, P622, DOI 10.1016/j.ecoleng.2016.06.024; Mullane JM, 2015, SCI TOTAL ENVIRON, V537, P294, DOI 10.1016/j.scitotenv.2015.07.157; O'Neill SW, 2012, J ENVIRON ENG-ASCE, V138, P318, DOI 10.1061/(ASCE)EE.1943-7870.0000409; Paerl HW, 2011, WATER RES, V45, P1973, DOI 10.1016/j.watres.2010.09.018; Palmer ET, 2013, WATER ENVIRON RES, V85, P823, DOI 10.2175/106143013X13736496908997; Passeport E, 2009, J IRRIG DRAIN ENG, V135, P505, DOI 10.1061/(ASCE)IR.1943-4774.0000006; Payne EGI, 2014, CRIT REV ENV SCI TEC, V44, P796, DOI 10.1080/10643389.2012.741310; Sharma R, 2017, SCI TOTAL ENVIRON, V577, P33, DOI 10.1016/j.scitotenv.2016.09.182; Soleimanifar H, 2016, CHEMOSPHERE, V154, P289, DOI 10.1016/j.chemosphere.2016.03.101; State Environmental Protection Administration of China, 2002, MON AN METH WAT WAST, V4th ed.; Sun XL, 2007, CHEMOSPHERE, V66, P1601, DOI 10.1016/j.chemosphere.2006.08.013; Takaijudin H, 2016, POLLUTION, V2, P489, DOI 10.7508/pj.2016.04.010; Takaijudin H, 2016, IOP C SERIES MAT SCI, P136; Takaijudin H, 2015, 36 IAHR WORLD C HAG; Trowsdale SA, 2011, J HYDROL, V397, P167, DOI 10.1016/j.jhydrol.2010.11.023; Vijayaraghavan K, 2015, ENVIRON TECHNOL, V37, p1 ; Wallace S, 2001, WATER SCI TECHNOL, V44, P259, DOI 10.2166/wst.2001.0838; Wang Y, 2016, J ENVIRON SCI-CHINA, V50, P79, DOI 10.1016/j.jes.2016.04.025	47	20	22	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196339	10.1371/journal.pone.0196339	http://dx.doi.org/10.1371/journal.pone.0196339			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742120	gold, Green Published, Green Submitted			2022-12-26	WOS:000431757400026
J	Oberle, B; Ogle, K; Zanne, AE; Woodall, CW				Oberle, Brad; Ogle, Kiona; Zanne, Amy E.; Woodall, Christopher W.			When a tree falls: Controls on wood decay predict standing dead tree fall and new risks in changing forests	PLOS ONE			English	Article							NORTHERN HARDWOOD FORESTS; PONDEROSA PINE FORESTS; UNITED-STATES; SNAG DYNAMICS; CARBON-CYCLE; LITTER DECOMPOSITION; SEVERE DROUGHT; CLIMATE-CHANGE; RATES; MODEL	When standing dead trees (snags) fall, they have major impacts on forest ecosystems. Snag fall can redistribute wildlife habitat and impact public safety, while governing important carbon (C) cycle consequences of tree mortality because ground contact accelerates C emissions during deadwood decay. Managing the consequences of altered snag dynamics in changing forests requires predicting when snags fall as wood decay erodes mechanical resistance to breaking forces. Previous studies have pointed to common predictors, such as stem size, degree of decay and species identity, but few have assessed the relative strength of underlying mechanisms driving snag fall across biomes. Here, we analyze nearly 100,000 repeated snag observations from boreal to subtropical forests across the eastern United States to show that wood decay controls snag fall in ways that could generate previously unrecognized forest-climate feedback. Warmer locations where wood decays quickly had much faster rates of snag fall. The effect of temperature on snag fall was so strong that in a simple forest C model, anticipated warming by mid-century reduced snag C by 22%. Furthermore, species-level differences in wood decay resistance (durability) accurately predicted the timing of snag fall. Differences in half-life for standing dead trees were similar to expected differences in the service lifetimes of wooden structures built from their timber. Strong effects of temperature and wood durability imply future forests where dying trees fall and decay faster than at present, reducing terrestrial C storage and snag-dependent wildlife habitat. These results can improve the representation of forest C cycling and assist forest managers by helping predict when a dead tree may fall.	[Oberle, Brad; Zanne, Amy E.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Oberle, Brad; Zanne, Amy E.] Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO 63110 USA; [Oberle, Brad] New Coll Florida, Div Nat Sci, Sarasota, FL 34243 USA; [Ogle, Kiona] No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ USA; [Woodall, Christopher W.] Northern Forest Sci & Applicat, Northern Res Stn, Durham, NH USA	George Washington University; Missouri Botanical Gardens; State University System of Florida; New College Florida; Northern Arizona University	Oberle, B (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.; Oberle, B (corresponding author), Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO 63110 USA.; Oberle, B (corresponding author), New Coll Florida, Div Nat Sci, Sarasota, FL 34243 USA.	boberle@ncf.edu		Woodall, Christopher/0000-0001-8076-6214; Oberle, Brad/0000-0002-4227-3352	National Science Foundation Division of Environmental Biology [1302797]	National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation Division of Environmental Biology 1302797 to A. E. Z. https://www.nsf.gov/div/index.jsp?div=DEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair EC, 2008, GLOBAL CHANGE BIOL, V14, P2636, DOI 10.1111/j.1365-2486.2008.01674.x; Anderegg WRL, 2016, ECOSYSTEMS, V19, P1133, DOI 10.1007/s10021-016-9982-1; Angers VA, 2012, CAN J FOREST RES, V42, P157, DOI [10.1139/X11-167, 10.1139/x11-167]; [Anonymous], 2010, SUST AM HARDW GUID S; [Anonymous], 1994, 3501 EN; Bennett AC, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.139, 10.1038/nplants.2015.139]; Berner LT, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6f94; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Brazee NJ, 2011, FORESTRY, V84, P33, DOI 10.1093/forestry/cpq040; Brischke C, 2009, EUR J WOOD WOOD PROD, V67, P329, DOI 10.1007/s00107-009-0329-x; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Buettel JC, 2017, LOOK SEE WHATS SYSTE, V8; Chambers CL, 2014, FOREST SCI, V60, P713, DOI 10.5849/forsci.13-018; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Christophersen N, 1996, SCOPE 51 BIOGEOCHEMI, P285; Cornwell WK, 2009, GLOBAL CHANGE BIOL, V15, P2431, DOI 10.1111/j.1365-2486.2009.01916.x; Covey KR, 2016, BIOGEOCHEMISTRY, V130, P215, DOI 10.1007/s10533-016-0253-1; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Dechnik-Vazquez YA, 2016, J TROP ECOL, V32, P89, DOI 10.1017/S0266467416000092; Donato DC, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1410; Edburg SL, 2012, FRONT ECOL ENVIRON, V10, P416, DOI 10.1890/110173; Fassnacht KS, 2016, FOREST ECOL MANAG, V363, P267, DOI 10.1016/j.foreco.2015.12.003; Finer L, 2016, FOREST ECOL MANAG, V372, P10, DOI 10.1016/j.foreco.2016.03.060; Forest Products Laboratory, WOOD PROP TECHSH; Forest Products Laboratory, 2010, FPLGTR1902010; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Ganey J.L., 2012, INT J FOR RES, V2012; Ganey JL, 2015, J WILDLIFE MANAGE, V79, P1369, DOI 10.1002/jwmg.947; Gelman A, 2007, POLICY ANAL; Gelman A, 2007, SOCIOL METHODOL, V37, P23, DOI 10.1111/j.1467-9531.2007.00181.x; Hansen E. M., 2014, FOREST SCI, V60, P1; Harmon ME, 2001, HJ ANDREWS RES REP, V2; Harris NL, 2016, CARBON BAL MANAGE, V11, DOI 10.1186/s13021-016-0066-5; Hilger AB, 2012, ECOL APPL, V22, P2078, DOI 10.1890/11-2277.1; Holm JA, 2014, BIOGEOSCIENCES, V11, P5773, DOI 10.5194/bg-11-5773-2014; Kuhns M, 2016, USU TREE BROWER VERS; Lloyd JD, 2012, FIRE ECOL, V8, P18, DOI 10.4996/fireecology.0803018; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Materials ASFT and. Standard D, 2017, ANN BOOK ASTM STAND, P344; Matton WR, 1925, FOREST TREES FLORIDA; McRoberts RE, 2005, J FOREST, V103, P304; Meier CL, 2010, SOIL BIOL BIOCHEM, V42, P1083, DOI 10.1016/j.soilbio.2010.03.005; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Michaelian M, 2011, GLOBAL CHANGE BIOL, V17, P2084, DOI 10.1111/j.1365-2486.2010.02357.x; Miles P.D., 2009, NRS38, DOI DOI 10.2737/NRS-RN-38; Moore DJP, 2013, ECOL LETT, V16, P731, DOI 10.1111/ele.12097; MORRISON ML, 1993, ECOL APPL, V3, P322, DOI 10.2307/1941835; Mortimer M. J., 2004, Urban Forestry & Urban Greening, V2, P159, DOI 10.1078/1618-8667-00032; Oberle B, 2016, DIRECT ESTIMATES DOW, V361, P351; Oberle B, 2018, ECOSYSTEMS, V21, P85, DOI 10.1007/s10021-017-0136-x; Oberle B, 2014, FOREST ECOL MANAG, V323, P1, DOI 10.1016/j.foreco.2014.03.026; Ogle K, 2014, MODEL BASED METAANAL, P194; Ogle K, 2006, HIERARCHICAL MODELIN; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peltola HM, 2006, AM J BOT, V93, P1501, DOI 10.3732/ajb.93.10.1501; Pelz KA, 2013, FOREST ECOL MANAG, V299, P60, DOI 10.1016/j.foreco.2013.01.008; Pietsch KA, 2014, GLOBAL ECOL BIOGEOGR, V23, P1046, DOI 10.1111/geb.12172; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Russell MB, 2014, BIOGEOSCIENCES, V11, P6417, DOI 10.5194/bg-11-6417-2014; Russell MB, 2014, ECOSYSTEMS, V17, P765, DOI 10.1007/s10021-014-9757-5; Russell MB, 2012, FOREST ECOL MANAG, V284, P230, DOI 10.1016/j.foreco.2012.08.004; Scheffer TC, 1998, TECHNICAL REPORT, P1; Schmidlin TW, 2009, NAT HAZARDS, V50, P13, DOI 10.1007/s11069-008-9314-7; Song ZW, 2017, FOREST ECOL MANAG, V385, P206, DOI 10.1016/j.foreco.2016.11.033; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Taylor AM, 2002, WOOD FIBER SCI, V34, P587; Hogg EH, 2015, GLOBAL CHANGE BIOL, V21, P1968, DOI 10.1111/gcb.12805; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; USDA Forest Service. Forest Inventory and Analysis National Core Field Guide, 2016, VERS 7, VI, P68; Valette N, 2016, FUNGAL BIOL REV, P1; Vanderwel MC, 2006, CAN J FOREST RES, V36, P2769, DOI 10.1139/X06-173; Venugopal P, 2016, FOREST ECOL MANAG, V360, P341, DOI 10.1016/j.foreco.2015.10.023; Vogt Jess, 2015, Arboriculture & Urban Forestry, V41, P293; Westfall JA, 2006, CAN J FOREST RES, V36, P1551, DOI 10.1139/X06-045; Wilson Barry Tyler, 2013, Carbon Balance Manag, V8, P1, DOI 10.1186/1750-0680-8-1; Woodall CW, 2012, FORESTRY, V85, P125, DOI 10.1093/forestry/cpr065; Woodall Christopher W, 2008, Carbon Balance Manag, V3, P5, DOI 10.1186/1750-0680-3-5; Zanne AE, 2015, J ECOL, V103, P1421, DOI 10.1111/1365-2745.12474; Zhang DQ, 2008, J PLANT ECOL, V1, P85, DOI 10.1093/jpe/rtn002; Zhu K, 2014, GLOBAL CHANGE BIOL, V20, P251, DOI 10.1111/gcb.12382; Zipser EJ, 2006, B AM METEOROL SOC, V87, P1057, DOI 10.1175/BAMS-87-8-1057	82	20	21	7	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196712	10.1371/journal.pone.0196712	http://dx.doi.org/10.1371/journal.pone.0196712			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742158	Green Published, gold, Green Submitted			2022-12-26	WOS:000431757400036
J	Lee, BH; Stallcup, MR				Lee, Brian H.; Stallcup, Michael R.			Different chromatin and DNA sequence characteristics define glucocorticoid receptor binding sites that are blocked or not blocked by coregulator Hic-5	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; PROSTATE TUMORIGENESIS; PHYSICAL INTERACTION; ANDROGEN RECEPTOR; READ ALIGNMENT; LIM PROTEIN; KAPPA-B; GENE; ETS; ACTIVATION	The glucocorticoid receptor (GR) regulates genes in many physiological pathways by binding to enhancer and silencer elements of target genes, where it recruits coregulator proteins that remodel chromatin and regulate the assembly of transcription complexes. The coregulator Hydrogen peroxide-inducible clone 5 (Hic-5) is necessary for glucocorticoid (GC) regulation of one group of GR target genes, is irrelevant for a second group, and inhibits GR binding to a third gene set, thereby blocking their regulation by GC. Gene-specific characteristics that distinguish GR binding regions (GBR) at Hic-5 blocked genes from GBR at other GC-regulated genes are unknown. Here we show genome-wide that blocked GBR generally require CHD9 and BRM for GR occupancy in contrast to GBR that are not blocked by Hic-5. Hic-5 blocked GBR are enriched near Hic-5 blocked GR target genes but not near GR target genes that are not blocked by Hic-5. Furthermore blocked GBR are in a closed conformation prior to Hic-5 depletion, and require Hic-5 depletion and glucocorticoid treatment to create an open conformation necessary for GR occupancy. A transcription factor binding motif characteristic of the ETS family was enriched near blocked GBR and blocked genes but not near non-blocked GBR or non-blocked GR target genes. Thus, we identify specific differences in chromatin conformation, chromatin remodeler requirements, and local DNA sequence motifs that contribute to gene-specific actions of transcription factors and coregulators. These findings shed light on mechanisms that contribute to binding site selection by transcription factors, which vary in a cell type-specific manner.	[Lee, Brian H.; Stallcup, Michael R.] Univ Southern Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Med, Los Angeles, CA 90007 USA	University of Southern California	Stallcup, MR (corresponding author), Univ Southern Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Med, Los Angeles, CA 90007 USA.	stallcup@usc.edu			National Institutes of Health [R37DK055274, R01DK043093]; Cancer Center Support Grant [P30CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093, R37DK055274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grants R37DK055274 and R01DK043093 to M.R.S. and Cancer Center Support Grant P30CA014089 to the USC Norris Comprehensive Cancer Center, which supported the Molecular Genomics, Bioreagent, Biostatistics, and Molecular and Cell Biology Core Facilities used in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanova L, 2009, ENDOCRINOLOGY, V150, P3863, DOI 10.1210/en.2009-0008; Biddie SC, 2012, RHEUMATOLOGY, V51, P403, DOI 10.1093/rheumatology/ker215; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burd CJ, 2013, MOL CELL ENDOCRINOL, V380, P25, DOI 10.1016/j.mce.2013.03.020; Burd CJ, 2012, MOL CELL BIOL, V32, P1805, DOI 10.1128/MCB.06206-11; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Chodankar R, 2015, MOL ENDOCRINOL, V29, P716, DOI 10.1210/me.2014-1403; Chodankar R, 2014, P NATL ACAD SCI USA, V111, P4007, DOI 10.1073/pnas.1400522111; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; Dittmer J, 2015, SEMIN CANCER BIOL, V35, P20, DOI 10.1016/j.semcancer.2015.09.010; Drori S, 2005, GENE DEV, V19, P362, DOI 10.1101/gad.1240705; Engel KB, 2011, MOL CELL BIOL, V31, P3267, DOI 10.1128/MCB.05351-11; Esnault C, 2017, MOL CELL, V65, P1081, DOI 10.1016/j.molcel.2017.02.005; Fletcher TM, 2002, MOL CELL BIOL, V22, P3255, DOI 10.1128/MCB.22.10.3255-3263.2002; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Garrett-Sinha LA, 2013, CELL MOL LIFE SCI, V70, P3375, DOI 10.1007/s00018-012-1243-7; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glass CK, 2000, GENE DEV, V14, P121; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herrlich P, 2001, ONCOGENE, V20, P2465, DOI 10.1038/sj.onc.1204388; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kim-Kaneyama J, 2012, J ATHEROSCLER THROMB, V19, P601, DOI 10.5551/jat.10736; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leach DA, 2014, MOL CELL ENDOCRINOL, V384, P185, DOI 10.1016/j.mce.2014.01.004; Lee BH, 2017, J BIOL CHEM, V292, P9320, DOI 10.1074/jbc.M117.782607; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li X, 2011, ONCOGENE, V30, P167, DOI 10.1038/onc.2010.400; Lonard DM, 2012, NAT REV ENDOCRINOL, V8, P598, DOI 10.1038/nrendo.2012.100; Love MI, 2017, NUCLEIC ACIDS RES, V45, P1805, DOI 10.1093/nar/gkw1163; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Morris SA, 2014, NAT STRUCT MOL BIOL, V21, P73, DOI 10.1038/nsmb.2718; Mullick J, 2001, J BIOL CHEM, V276, P18007, DOI 10.1074/jbc.M100671200; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Rameil P, 2000, ONCOGENE, V19, P2086, DOI 10.1038/sj.onc.1203542; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Shibanuma M, 2004, J CELL BIOCHEM, V91, P633, DOI 10.1002/jcb.10754; Starick SR, 2015, GENOME RES, V25, P825, DOI 10.1101/gr.185157.114; Stempor Przemyslaw, 2016, Wellcome Open Res, V1, P14, DOI 10.12688/wellcomeopenres.10004.1; STRAHLE U, 1987, P NATL ACAD SCI USA, V84, P7871, DOI 10.1073/pnas.84.22.7871; Swinstead EE, 2016, BIOESSAYS, V38, P1150, DOI 10.1002/bies.201600137; Telorac J, 2016, NUCLEIC ACIDS RES, V44, P6142, DOI 10.1093/nar/gkw203; Thomas RS, 1997, ONCOGENE, V14, P2845, DOI 10.1038/sj.onc.1201125; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Wai PY, 2006, J BIOL CHEM, V281, P18973, DOI 10.1074/jbc.M511962200; Wang H, 2008, ONCOGENE, V27, P6791, DOI 10.1038/onc.2008.291; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wu Dai-Ying, 2014, Nucl Recept Signal, V12, pe002, DOI 10.1621/nrs.12002; Yang L, 2000, MOL BIOL CELL, V11, P2007, DOI 10.1091/mbc.11.6.2007; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	60	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196965	10.1371/journal.pone.0196965	http://dx.doi.org/10.1371/journal.pone.0196965			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738565	Green Published, Green Submitted, gold			2022-12-26	WOS:000431724900034
J	Jideonwo, V; Hou, Y; Ahn, M; Surendran, S; Morral, N				Jideonwo, Victoria; Hou, Yongyong; Ahn, Miwon; Surendran, Sneha; Morral, Nuria			Impact of silencing hepatic SREBP-1 on insulin signaling	PLOS ONE			English	Article							DEPENDENT ADENOVIRAL VECTORS; GLUCOKINASE GENE-EXPRESSION; ELEMENT-BINDING PROTEIN-1; MAMMALIAN TARGET; KINASE-B; TRANSCRIPTIONAL REGULATION; MTOR COMPLEX; TUMOR-GROWTH; CELL-GROWTH; FATTY LIVER	Sterol Regulatory Element Binding Protein-1 (SREBP-1) is a conserved transcription factor of the basic helix-loop-helix leucine zipper family (bHLH-Zip) that plays a central role in regulating expression of genes of carbohydrate and fatty acid metabolism in the liver. SREBP-1 activity is essential for the control of insulin-induced anabolic processes during the fed state. In addition, SREBP-1 regulates expression of key molecules in the insulin signaling pathway, including insulin receptor substrate 2 (IRS2) and a subunit of the phosphatidylinositol 3-kinase (PI3K) complex, PIK3R3, suggesting that feedback mechanisms exist between SREBP-1 and this pathway. Nevertheless, the overall contribution of SREBP-1 activity to maintain insulin signal transduction is unknown. Furthermore, Akt is a known activator of mTORC1, a sensor of energy availability that plays a fundamental role in metabolism, cellular growth and survival. We have silenced SREBP-1 and explored the impact on insulin signaling and mTOR in mice under fed, fasted and refed conditions. No alterations in circulating levels of insulin were observed. The studies revealed that depletion of SREBP-1 had no impact on IRS1(Y612), Akt(S473), and downstream effectors GSK3 alpha(S21) and FoxO1(S256) during the fed state. Nevertheless, reduced levels of these molecules were observed under fasting conditions. These effects were not associated with changes in phosphorylation of mTOR. Overall, our data indicate that the contribution of SREBP-1 to maintain insulin signal transduction in liver is modest.	[Jideonwo, Victoria; Hou, Yongyong; Ahn, Miwon; Surendran, Sneha; Morral, Nuria] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Morral, Nuria] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Morral, N (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.; Morral, N (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	nmorralc@iu.edu	Morral, Nuria/AAC-7149-2020	Morral, Nuria/0000-0002-8932-2887	National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK078595, P30-DK097512]; American Diabetes Association [1-08-RA-135]; Biomedical Research Grant from Indiana University School of Medicine; National Center for Research Resources, National Institutes of Health [C06 RR020128-01]; Indiana University Presidents Diversity Dissertation Fellowship; American Heart Association pre-doctoral fellowship; IUPUI Open Access Fund;  [R01-DK078595-05S1]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); Biomedical Research Grant from Indiana University School of Medicine; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Indiana University Presidents Diversity Dissertation Fellowship; American Heart Association pre-doctoral fellowship(American Heart Association); IUPUI Open Access Fund; 	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK078595 and P30-DK097512), by the American Diabetes Association (1-08-RA-135), and by a Biomedical Research Grant from Indiana University School of Medicine. This research was conducted in a facility constructed with support from Research Facilities Improvement Program Grant Number C06 RR020128-01 from the National Center for Research Resources, National Institutes of Health. Victoria Jideonwo was supported by grant R01-DK078595-05S1 and by an Indiana University Presidents Diversity Dissertation Fellowship; Sneha Surendran was supported by an American Heart Association pre-doctoral fellowship. Support for article processing charges provided by the IUPUI Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius L, 2016, ANNU REV NUTR, V36, P389, DOI 10.1146/annurev-nutr-071715-051145; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bechmann LP, 2012, HEPATOLOGY, V55, P1083, DOI 10.1002/hep.24793; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Boulay Anne, 2007, V172, P99; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; Dolganiuc A, 2011, WORLD J GASTROENTERO, V17, P2520, DOI 10.3748/wjg.v17.i20.2520; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; GRAHAM FL, 1995, MOL BIOTECHNOL, V3, P207, DOI 10.1007/BF02789331; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kallin A, 2007, J LIPID RES, V48, P1628, DOI 10.1194/jlr.M700136-JLR200; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Kim TH, 2009, J BIOL CHEM, V284, P15071, DOI 10.1074/jbc.M109.006742; Li C, 2014, INT J MOL SCI, V15, P7124, DOI 10.3390/ijms15057124; Lu BB, 2014, DIABETES, V63, P2935, DOI 10.2337/db13-1531; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Morral N, 1998, HUM GENE THER, V9, P2709, DOI 10.1089/hum.1998.9.18-2709; Morral N, 1999, P NATL ACAD SCI USA, V96, P12816, DOI 10.1073/pnas.96.22.12816; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nie LY, 2013, ONCOL REP, V30, P1346, DOI 10.3892/or.2013.2575; Oosterveer MH, 2012, J CLIN INVEST, V122, P2817, DOI 10.1172/JCI62368; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Park Jae-Seung, 2011, BMC Res Notes, V4, P8, DOI 10.1186/1756-0500-4-8; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Pettinelli P, 2009, BBA-MOL BASIS DIS, V1792, P1080, DOI 10.1016/j.bbadis.2009.08.015; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Ricoult SJH, 2016, ONCOGENE, V35, P1250, DOI 10.1038/onc.2015.179; Roth U, 2004, J BIOL CHEM, V279, P2623, DOI 10.1074/jbc.M308391200; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Ruiz R, 2014, J BIOL CHEM, V289, P5510, DOI 10.1074/jbc.M113.541110; Ruiz R, 2009, HUM GENE THER, V20, P87, DOI 10.1089/hum.2008.081; Sandig V, 2000, P NATL ACAD SCI USA, V97, P1002, DOI 10.1073/pnas.97.3.1002; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Schiedner G, 1998, NAT GENET, V18, P180, DOI 10.1038/ng0298-180; Sekulic A, 2000, CANCER RES, V60, P3504; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shulman GI, 2014, NEW ENGL J MED, V371, P2237; Streicher R, 1996, J BIOL CHEM, V271, P7128, DOI 10.1074/jbc.271.12.7128; Surendran S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18958; Yamauchi Y, 2011, CANCER RES, V71, P4989, DOI 10.1158/0008-5472.CAN-10-4108; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	59	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196704	10.1371/journal.pone.0196704	http://dx.doi.org/10.1371/journal.pone.0196704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723221	Green Submitted, gold, Green Published			2022-12-26	WOS:000431305100054
J	Li, X; Lu, ZQ; Song, CM; Chen, PF; He, L; Jin, Q; Mu, GH; Deng, YJ				Li Xing; Lu Zhongqian; Song Chunmei; Chen Pingfa; He Lei; Jin Qin; Mu Genhua; Deng Yijun			Activation of M1 macrophages in sepsis-induced acute kidney injury in response to heparin-binding protein	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; PATHOGENESIS; INFLAMMATION; CONTRIBUTE; MARKER; HBP	Background In the early stage of sepsis, M1 macrophages result in the production of inflammatory mediators and AKI. Heparin-binding protein (HBP) have been shown to play important roles in sepsis-induced AKI. In this study, we investigate the association of HBP with M1 macrophages in sepsis-induced AKI. Methods Male C57BL6 mice were subjected to cecal ligation and puncture (CLP) or sham surgery. Biochemical and histological renal damage was assessed. Macrophage infiltration was assessed by immunohistochemistry. RT-PCR was used to investigate the expression of heparin-binding protein (HBP), the inducible nitric oxide synthase (iNOS) and arginase 1 (Arg-1) mRNAs. Western blots were performed to assay the tissue levels of HBP, tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6). Results High levels of HBP were obviously detected 24 h after sepsis-induced AKI. Heparin inhibited HBP expression during sepsis-induced AKI. The suppression of HBP expression by heparin injection after the establishment of sepsis-induced AKI resulted in a reduction in renal injury severity accompanied with a significant repression of M1 macrophage activation and expression of TNF-alpha and IL-6. Conclusions HBP plays an important role in the initial inflammatory reaction associated with sepsisinduced AKI, presumably by activating M1 macrophages and suppressing TNF-alpha and IL-6 secretion.	[Li Xing; Lu Zhongqian; Chen Pingfa; He Lei; Jin Qin; Mu Genhua; Deng Yijun] Yancheng City 1 Peoples Hosp, Dept ICU, Yancheng, Peoples R China; [Song Chunmei] Nantong Univ, Nursing Coll, Nantong, Peoples R China	Nantong University	Deng, YJ (corresponding author), Yancheng City 1 Peoples Hosp, Dept ICU, Yancheng, Peoples R China.	dengyj2003@163.com		Jin, Qin/0000-0002-7246-4651				Bentzer P, 2017, INTENS CARE MED EXP, V5, DOI 10.1186/s40635-017-0119-4; Chang A, 2014, CURR OPIN NEPHROL HY, V23, P204, DOI 10.1097/01.mnh.0000444814.49755.90; Fisher J, 2017, SHOCK, V48, P313, DOI 10.1097/SHK.0000000000000862; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Heo KS, 2014, CIRCULATION, V130, P180, DOI 10.1161/CIRCULATIONAHA.113.005991; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Inoue T, 2017, KIDNEY INT, V91, P526, DOI 10.1016/j.kint.2016.11.026; Jo SK, 2006, NEPHROL DIAL TRANSPL, V21, P1231, DOI 10.1093/ndt/gfk047; Klenzak J, 2005, CRIT CARE CLIN, V21, P211, DOI 10.1016/j.ccc.2005.01.002; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Li X, 2018, SHOCK, V50, P233, DOI 10.1097/SHK.0000000000001006; Linder A, 2009, CLIN INFECT DIS, V49, P1044, DOI 10.1086/605563; Lundie RJ, 2016, IMMUNOL CELL BIOL, V94, P400, DOI 10.1038/icb.2015.114; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Pahlman LI, 2006, J IMMUNOL, V177, P1221, DOI 10.4049/jimmunol.177.2.1221; Pereira HA, 2003, GLIA, V41, P64, DOI 10.1002/glia.10167; Ricci Z, 2009, CURR DRUG TARGETS, V10, P1179, DOI 10.2174/138945009789753192; Ristagno G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1412-4; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Soehnlein O, 2008, J CLIN INVEST, V118, P3491, DOI 10.1172/JCI35740; Tverring J, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0330-1; Wang L, 2014, EXP THER MED, V8, P1764, DOI 10.3892/etm.2014.2004; Wu XH, 2015, INT J IMMUNOPATH PH, V28, P351, DOI 10.1177/0394632015593228; Zarjou A, 2011, J AM SOC NEPHROL, V22, P999, DOI 10.1681/ASN.2010050484; Zhang XL, 2014, ENDOCRINOLOGY, V155, P4939, DOI 10.1210/en.2014-1020	28	22	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196423	10.1371/journal.pone.0196423	http://dx.doi.org/10.1371/journal.pone.0196423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723248	gold, Green Submitted, Green Published			2022-12-26	WOS:000431305100030
J	Zhang, X; Yan, F; Feng, J; Qian, H; Cheng, Z; Yang, Q; Wu, Y; Zhao, Z; Li, A; Xiao, H				Zhang, Xiaobao; Yan, Fang; Feng, Jiying; Qian, Haitao; Cheng, Zhi; Yang, Qianqian; Wu, Yong; Zhao, Zhibin; Li, Aimin; Xiao, Hang			Dexmedetomidine inhibits inflammatory reaction in the hippocampus of septic rats by suppressing NF-kappa B pathway	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; ISCHEMIA/REPERFUSION INJURY; ISCHEMIA-REPERFUSION; ALZHEIMERS-DISEASE; LUNG INJURY; AGED RATS; LIPOPOLYSACCHARIDE; NEUROINFLAMMATION; PROPOFOL; NEUROPROTECTION	Dexmedetomidine (DEX) is known to provide neuroprotective effect in the central nervous system. However, the detailed mechanism remains far more elusive. This study was designed to investigate the relevant mechanisms of DEX's neuroprotective effect. Sprague-Dawley (SD) rats were injected with dexmedetomidine and/or Lipopolysaccharide (LPS) intraperitoneally, and inflammatory cytokines in serum and in the hippocampus were measured by enzyme linked immunosorbent assay (ELISA). NF-kappa B in the brain tissue extracts was analyzed with western-blot. Then, we investigated whether NF-kappa B inhibitor prevents the elevation of inflammatory cytokines in rats injected with LPS. Our results indicated that compared with the control group, the rats exposed to LPS showed significant cognitive dysfunction. When compared to controls, the levels of TNF-alpha and IL-6 in the serum and hippocampus homogenate were increased in rats treated with LPS. DEX pretreatment inhibited the rats' TNF-alpha, IL-6 and NF-kappa B levels induced by LPS. In response to LPS, PDTC pretreatment restrains the production of proinflammatory cytokines (TNF-alpha and IL-6). Rats treated with PDTC and DEX alongside LPS exhibited less TNF-alpha and IL-6 than the LPS treated group. In combination, PDTC and DEX showed addictive effects. Our data suggest that DEX exerts a neuroprotective effect through NF-kappa B in part after LPS-induced cognitive dysfunction.	[Zhang, Xiaobao; Feng, Jiying; Qian, Haitao; Cheng, Zhi; Yang, Qianqian; Wu, Yong; Zhao, Zhibin; Li, Aimin] Nanjing Med Univ, Lianyungang Clin Coll, Dept Anesthesiol, Lianyungang, Peoples R China; [Yan, Fang] Nanjing Med Univ, Kangda Coll, Dept Basic Med Sci, Lianyungang, Peoples R China; [Xiao, Hang] Nanjing Med Univ, Sch Publ Hlth, Dept Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Li, A (corresponding author), Nanjing Med Univ, Lianyungang Clin Coll, Dept Anesthesiol, Lianyungang, Peoples R China.; Xiao, H (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Toxicol, Nanjing, Jiangsu, Peoples R China.	jiesun1999@126.com; hxiao@njmu.edu.cn			National Natural Science Foundation of China [81701050]; National Natural Science Foundation of Jiangsu Province, China [BK20160423]; Lianyungang Science and Technology Project [SH1528]; Kangda Research and Development Fund [KD2017KYJJY6001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Lianyungang Science and Technology Project; Kangda Research and Development Fund	The present study was supported by the National Natural Science Foundation of China (grant nos. 81701050), National Natural Science Foundation of Jiangsu Province, China (grant nos. BK20160423) and Lianyungang Science and Technology Project (grant nos. SH1528). Kangda Research and Development Fund (KD2017KYJJY6001) to Fang Yan.	Arai K, 2001, JPN J PHARMACOL, V87, P195, DOI 10.1254/jjp.87.195; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Balko JA, 2017, J ZOO WILDLIFE MED, V48, P48, DOI 10.1638/2016-0079.1; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; Chen Z, 2017, BIOMED PHARMACOTHER, V93, P1018, DOI 10.1016/j.biopha.2017.06.050; Cheng P, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00547; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Chrysostomou C, 2008, EXPERT OPIN DRUG MET, V4, P619, DOI [10.1517/17425255.4.5.619, 10.1517/17425255.4.5.619 ]; Colin PJ, 2017, BRIT J ANAESTH, V119, P200, DOI 10.1093/bja/aex085; Gu J, 2011, ACTA ANAESTH SCAND, V55, P1272, DOI 10.1111/j.1399-6576.2011.02526.x; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hirsch Etienne C, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS210, DOI 10.1016/S1353-8020(11)70065-7; Hovens IB, 2014, BRAIN BEHAV IMMUN, V38, P202, DOI 10.1016/j.bbi.2014.02.002; Hsing CH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/163140; Hu MH, 2014, CLIN EXP IMMUNOL, V175, P268, DOI 10.1111/cei.12219; Kim E, 2017, NEUROSCI LETT, V649, P20, DOI 10.1016/j.neulet.2017.04.011; Kunisawa T, 2012, J ANESTH, V26, P254, DOI 10.1007/s00540-011-1312-3; Li X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170757; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Linden A, 2005, EUR RESPIR J, V25, P159, DOI 10.1183/09031936.04.00032904; Liu H, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6352159; Luo C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00197; Lv J, 2017, ENVIRON TOXICOL PHAR, V52, P121, DOI 10.1016/j.etap.2017.03.017; Maccioni RB, 2009, ANN NY ACAD SCI, V1153, P240, DOI 10.1111/j.1749-6632.2008.03972.x; Mahmoud M, 2013, J CLIN ANESTH, V25, P529, DOI 10.1016/j.jclinane.2013.04.011; Peng M, 2013, J SURG RES, V179, pE219, DOI 10.1016/j.jss.2012.05.047; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Sun J, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0394-5; Wang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132638; Xiong B, 2016, AM J TRANSL RES, V8, P70; Yang CL, 2011, J SURG RES, V167, pE273, DOI 10.1016/j.jss.2010.02.020; Zhang XF, 2014, MATER RES INNOV, V18, P244, DOI 10.1179/1432891714Z.000000000829	33	28	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196897	10.1371/journal.pone.0196897	http://dx.doi.org/10.1371/journal.pone.0196897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723264	Green Published, Green Submitted, gold			2022-12-26	WOS:000431305100089
J	Smit, EA; Sadakata, M				Smit, Eline Adrianne; Sadakata, Makiko			The effect of handedness on spatial and motor representation of pitch patterns in pianists	PLOS ONE			English	Article							CEREBRAL LATERALIZATION; AUDITORY-FEEDBACK; PERFORMANCE; PIANO; MUSICIANS; HEIGHT; MEMORY	This study investigated the effect of handedness on pianists' abilities to adjust their keyboard performance skills to new spatial and motor mappings. Left- and right-handed pianists practiced simple melodies on a regular MIDI piano keyboard (practice) and were then asked to perform these with modified melodic contours (the same or reversed melodic contour causing a change of fingering) and on a reversed MIDI piano keyboard (test). The difference of performance duration between the practice and the test phase as well as the amount of errors played were used as test measures. Overall, a stronger effect for modified melodic contours than for the reversed keyboard was observed. Furthermore, we observed a trend of left-handed pianists to be quicker and more accurate in playing melodies when reversing their fingering with reversed contours in their left-hand performances. This suggests that handedness may influence pianists' skill to adjust to new spatial and motor mappings.	[Smit, Eline Adrianne] Western Sydney Univ, MARCS Inst Brain Behav & Dev, Milperra, NSW, Australia; [Smit, Eline Adrianne; Sadakata, Makiko] Univ Amsterdam, Mus Dept, Amsterdam, Netherlands; [Sadakata, Makiko] Univ Amsterdam, Inst Log Language & Computat, Amsterdam, Netherlands; [Sadakata, Makiko] Radboud Univ Nijmegen, Artificial Intelligence Dept, Nijmegen, Netherlands	Western Sydney University; University of Amsterdam; University of Amsterdam; Radboud University Nijmegen	Sadakata, M (corresponding author), Univ Amsterdam, Mus Dept, Amsterdam, Netherlands.; Sadakata, M (corresponding author), Univ Amsterdam, Inst Log Language & Computat, Amsterdam, Netherlands.; Sadakata, M (corresponding author), Radboud Univ Nijmegen, Artificial Intelligence Dept, Nijmegen, Netherlands.	m.sadakata@uva.nl		Smit, Eline/0000-0003-0250-378X; Sadakata, Makiko/0000-0002-3931-0642				Annett M, 2009, LANGUAGE LATERALIZATION AND PSYCHOSIS, P73, DOI 10.1017/CBO9780511576744.006; APA, 2009, APA CONC DICT PSYCH, P532; Banich M. T., 1997, NEUROPSYCHOLOGY NEUR; Brown SG, 2006, LATERALITY, V11, P1, DOI 10.1080/1357650054200000440; Busch D, 2010, LATERALITY, V15, P610, DOI 10.1080/13576500903081806; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Cheng FPH, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00868; Cohen M.S., 2008, HANDEDNESS QUESTIONN; COREN S, 1978, BRIT J PSYCHOL, V69, P207, DOI 10.1111/j.2044-8295.1978.tb01649.x; Cuzzocreo JL, 2009, HUM BRAIN MAPP, V30, P1271, DOI 10.1002/hbm.20596; DEUTSCH D, 1985, MUSIC PERCEPT, V3, P127; Deutsch D, 1980, NEUROPSYCHOLOGY LEFT, P263; Finney SA, 2003, MEM COGNITION, V31, P51, DOI 10.3758/BF03196082; GILBERT AN, 1992, NEUROPSYCHOLOGIA, V30, P601, DOI 10.1016/0028-3932(92)90065-T; Giles, 1982, ATTITUDES LANGUAGE V, P132; Good JMM., 1994, PSYCHOL MUSIC, V22, P148, DOI DOI 10.1177/0305735694222004; GOTESTAM KO, 1990, PERCEPT MOTOR SKILL, V70, P1323, DOI 10.2466/PMS.70.4.1323-1327; Grafton ST, 1998, J NEUROSCI, V18, P9420; HASSLER M, 1988, DEV NEUROPSYCHOL, V4, P129, DOI 10.1080/87565648809540399; Hepper PG, 2005, NEUROPSYCHOLOGIA, V43, P313, DOI 10.1016/j.neuropsychologia.2004.08.009; Jancke L, 2006, NEUROREPORT, V17, P447; Jancke L, 2002, NEUROREPORT, V13, P1579; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Kopiez R, 2006, NEUROPSYCHOLOGIA, V44, P1079, DOI 10.1016/j.neuropsychologia.2005.10.023; Kopiez R, 2012, PSYCHOL MUSIC, V40, P357, DOI 10.1177/0305735610394708; Kopiez R, 2010, LATERALITY, V15, P385, DOI 10.1080/13576500902885975; Laeng B, 1999, Laterality, V4, P363, DOI 10.1080/135765099396917; Lega C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00250; Lidji P, 2007, J EXP PSYCHOL HUMAN, V33, P1189, DOI 10.1037/0096-1523.33.5.1189; MACKAY DG, 1969, AM J PSYCHOL, V82, P23, DOI 10.2307/1420605; MACKAY DG, 1982, PSYCHOL REV, V89, P483, DOI 10.1037/0033-295X.89.5.483; Meyer RK, 2003, MUSIC PERCEPT, V21, P81, DOI 10.1525/mp.2003.21.1.81; Mullensiefen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101091; Nishimura A, 2009, PSYCHON B REV, V16, P666, DOI 10.3758/PBR.16.4.666; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palmer C, 2000, PSYCHOL SCI, V11, P63, DOI 10.1111/1467-9280.00216; Perkins D. N., 1992, CONTRIBUTION INT ENC; Pfordresher P. Q., 2006, ADV COGN PSYCHOL, V2, P183, DOI [10.2478/v10053-008-0054-8, DOI 10.2478/V10053-008-0054-8]; Pfordresher PQ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00914; Pratt CC, 1930, J EXP PSYCHOL, V13, P278, DOI 10.1037/h0072651; Repp BH, 1999, MUSIC PERCEPT, V16, P409; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; Rusconi E, 2005, ANN NY ACAD SCI, V1060, P195, DOI 10.1196/annals.1360.056; Semjen A, 2001, J EXP PSYCHOL HUMAN, V27, P251, DOI 10.1037//0096-1523.27.2.251; Stumpf C, 1883, TONPSYCHOLOGIE; Szaflarski JP, 2002, NEUROLOGY, V59, P238, DOI 10.1212/WNL.59.2.238; Thorndike EL, 1901, PSYCHOL REV, V8, P247, DOI 10.1037/h0071363; Vingerhoets G, 2012, HUM BRAIN MAPP, V33, P763, DOI 10.1002/hbm.21247; Willems RM, 2010, CEREB CORTEX, V20, P1719, DOI 10.1093/cercor/bhp234	49	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195831	10.1371/journal.pone.0195831	http://dx.doi.org/10.1371/journal.pone.0195831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5SH	29718946	Green Published, gold			2022-12-26	WOS:000431281900034
J	Tauler-Ametller, H; Hernandez-Matias, A; Pares, F; Pretus, JLI; Real, J				Tauler-Ametller, Helena; Hernandez-Matias, Antonio; Pares, Francesc; Pretus, Joan L., I; Real, Joan			Assessing the applicability of stable isotope analysis to determine the contribution of landfills to vultures' diet	PLOS ONE			English	Article							EGYPTIAN VULTURE; POPULATION DECLINE; MIXING MODELS; GYPS-FULVUS; LAND-USE; ECOLOGY; CONSEQUENCES; DICLOFENAC; REDUCTION; RESIDUES	Human activities cause changes to occur in the environment that affect resource availability for wildlife. The increase in the human population of cities has led to a rise in the amount of waste deposited in landfills, installations that have become a new food resource for both pest and threatened species such as vultures. In this study we used stable isotope analysis (SIA) and conventional identification of food remains from Egyptian Vultures (Neophron percnopterus) to assess the applicability of SIA as a new tool for determining the composition of the diets of vultures, a group of avian scavengers that is threatened worldwide. We focused on an expanding Egyptian Vulture population in NE Iberian Peninsula to determine the part played by landfills and livestock in the diet of these species, and aimed to reduce the biases associated with conventional ways of identifying food remains. We compared proportions of diet composition obtained with isotope mixing models and conventional analysis for five main prey. The greatest agreement between the two methods was in the categories 'landfills' and 'birds' and the greatest differences between the results from the two methods were in the categories 'livestock', 'carnivores' and 'wild herbivores'. Despite uncertainty associated to SIA, our results showed that stable isotope analysis can help to distinguish between animals that rely on waste and so present enriched levels of delta C-13 than those that feed on the countryside. Indeed, a high proportion of food derived from landfills (nearly 50%) was detected in some breeding pairs. Furthermore we performed GLMM analyses that showed that high values of delta C-13 in Egyptian Vulture feathers (a proxy of feeding in landfills) are related with high levels of humanization of territories. This method has the potential to be applied to other threatened vulture species for which there is a lack of information regarding resources they are consuming, being especially important as the main causes of vultures decline worldwide are related to the consumption and availability of food resources.	[Tauler-Ametller, Helena; Hernandez-Matias, Antonio; Pares, Francesc; Pretus, Joan L., I; Real, Joan] Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Catalunya, Spain; [Tauler-Ametller, Helena; Hernandez-Matias, Antonio; Pares, Francesc; Pretus, Joan L., I; Real, Joan] Univ Barcelona, Inst Recerca Biodiversitat IRBIO, Barcelona, Catalunya, Spain; [Tauler-Ametller, Helena; Hernandez-Matias, Antonio; Pares, Francesc; Real, Joan] Univ Barcelona, Equip Biol Conservacio, Barcelona, Catalunya, Spain; [Hernandez-Matias, Antonio] Univ Girona, Fac Ciencies, Dept Ciencies Ambientals, Campus Montilivi, Girona, Catalunya, Spain	University of Barcelona; University of Barcelona; University of Barcelona; Universitat de Girona	Tauler-Ametller, H (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Catalunya, Spain.; Tauler-Ametller, H (corresponding author), Univ Barcelona, Inst Recerca Biodiversitat IRBIO, Barcelona, Catalunya, Spain.; Tauler-Ametller, H (corresponding author), Univ Barcelona, Equip Biol Conservacio, Barcelona, Catalunya, Spain.	htauler@ub.edu	Real, Joan/L-1590-2017	Pretus, Joan Lluis/0000-0002-4375-8626; Real, Joan/0000-0003-1355-8938; HERNANDEZ-MATIAS, ANTONIO/0000-0001-9810-8121	Red Electrica the Espana-SA; Universitat de Barcelona; Servei de Biodiversitat de la Generalitat de Catalunya; natural park of Sant Llorenc del Munt (Diputacio de Barcelona); natural park of Muntanya de Montserrat (Diputacio de Barcelona); La Garrotxa Volcanic Zone Natural Park (Generalitat de Catalunya); Grup de Naturalistes d'Osona-ICHN	Red Electrica the Espana-SA; Universitat de Barcelona; Servei de Biodiversitat de la Generalitat de Catalunya; natural park of Sant Llorenc del Munt (Diputacio de Barcelona); natural park of Muntanya de Montserrat (Diputacio de Barcelona); La Garrotxa Volcanic Zone Natural Park (Generalitat de Catalunya)(Generalitat de Catalunya); Grup de Naturalistes d'Osona-ICHN	Red Electrica the Espana-SA (http:www.ree.es/en) financed the project, and Universitat de Barcelona (http:/www.ub.edu/web/ub/ca/) supported HTA with a predoctoral grant (APIF 2014).; We would like to thank the Grup de Suport de Muntanya belonging to the Cos d'Agents Rurals (Departament d'Agricultura, Generalitat de Catalunya) for help with the fieldwork and for climbing the nest-cliffs. We are also grateful for the support received from the Servei de Biodiversitat de la Generalitat de Catalunya, the natural parks of Sant Llorenc del Munt and Muntanya de Montserrat (Diputacio de Barcelona) and La Garrotxa Volcanic Zone Natural Park (Generalitat de Catalunya). We would also like to thank F. Fontelles for helping with the conventional diet analysis and the Barcelona Museum of Natural Sciences for allowing us to use their reference collections. Thanks are also due to I. Peragon and the Scientific and Technological Centres of the University of Barcelona for the Stable Isotope Analysis and to J. Resano for his help with the statistical analysis. We are also grateful to Mercedes Gil from Red Electrica de Espana SA and the support received from Grup de Naturalistes d'Osona-ICHN (J. Baucells, C. Martorell). Finally, we are grateful to J. A. Donazar, S. Oppel, two anonymous reviewers and editor A. Margalida for their help in improving the manuscript. All applicable institutional and/or national guidelines for the care and use of animals were followed. We are also grateful to Mercedes Gil from Red Electrica de Espana SA.	[Anonymous], 1993, LOS BUITRES IBERICOS; Bino G, 2010, J APPL ECOL, V47, P1262, DOI 10.1111/j.1365-2664.2010.01882.x; BirdLife International, 2016, NEOPHR PERCN, DOI [10.2305/IUCN.UK.2016-3.RLTS.T22695180A90559652.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22695180A90559652.EN]; Blanco G, 1998, J APPL ECOL, V35, P232, DOI 10.1046/j.1365-2664.1998.00296.x; Boarman WI, 2006, J ARID ENVIRON, V67, P248, DOI 10.1016/j.jaridenv.2006.09.024; Boner M, 2004, ANAL BIOANAL CHEM, V378, P301, DOI 10.1007/s00216-003-2347-6; Bosch M, 2000, J APPL ECOL, V37, P369, DOI 10.1046/j.1365-2664.2000.00501.x; Bosch Marc, 1994, Avocetta, V18, P135; Brown R, 2003, HUELLAS SERIALES AYE; Blazquez MC, 2016, ECOL INDIC, V63, P332, DOI 10.1016/j.ecolind.2015.12.015; Carneiro M, 2015, ECOTOX ENVIRON SAFE, V113, P295, DOI 10.1016/j.ecoenv.2014.12.016; Carrete M, 2007, BIOL CONSERV, V136, P143, DOI 10.1016/j.biocon.2006.11.025; Carrete M, 2009, BIOL CONSERV, V142, P2954, DOI 10.1016/j.biocon.2009.07.027; Casas-Diaz E, 2016, SCI TOTAL ENVIRON, V557, P620, DOI 10.1016/j.scitotenv.2016.03.083; CEBALLOS O, 1990, Journal of Raptor Research, V24, P19; Chamberlain CP, 2005, P NATL ACAD SCI USA, V102, P16707, DOI 10.1073/pnas.0508529102; Ciucci P, 1997, J ZOOL, V243, P803, DOI 10.1111/j.1469-7998.1997.tb01977.x; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; De Bolas O, 2015, FLORA DELS PEISOS CA, VI-IV; de la Casa-Resino I, 2014, ECOTOXICOLOGY, V23, P1377, DOI 10.1007/s10646-014-1280-0; Dobrev V, 2016, BIRD CONSERV INT, V26, P273, DOI 10.1017/S0959270915000155; DONAZAR JA, 1993, J APPL ECOL, V30, P515, DOI 10.2307/2404191; Donazar JA, 2010, EUR J WILDLIFE RES, V56, P613, DOI 10.1007/s10344-009-0358-0; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Donazar Sancho J.A., 1988, Ardeola, V35, P3; Duhem C, 2008, POPUL ECOL, V50, P91, DOI 10.1007/s10144-007-0059-z; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gangoso L, 2013, CONSERV LETT, V6, P172, DOI 10.1111/j.1755-263X.2012.00289.x; Gonzalez-Martin I, 1999, MEAT SCI, V52, P437, DOI 10.1016/S0309-1740(99)00027-3; Healy K, 2018, ECOGRAPHY, V41, P1393, DOI 10.1111/ecog.03371; Heaton K, 2008, FOOD CHEM, V107, P506, DOI 10.1016/j.foodchem.2007.08.010; Hebert CE, 2001, ENVIRON SCI TECHNOL, V35, P3482, DOI 10.1021/es001970p; Hernandez M, 2009, EUR J WILDLIFE RES, V55, P415, DOI 10.1007/s10344-009-0255-6; Hidalgo S., 2005, BUTEO, V14, P23; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Jose M., 2010, RAPID COMMUN MASS SP, V24, P3567; Katzenberger J, 2019, BIRD CONSERV INT, V29, P71, DOI 10.1017/S0959270917000326; Koenig R, 2006, SCIENCE, V312, P1591, DOI 10.1126/science.312.5780.1591; Laiolo P, 2004, J APPL ECOL, V41, P294, DOI 10.1111/j.0021-8901.2004.00893.x; Lieury N, 2015, BIOL CONSERV, V191, P349, DOI 10.1016/j.biocon.2015.07.008; Lopez-Lopez P, 2014, ECOL APPL, V24, P938, DOI 10.1890/13-2000.1; Margalida A, 2014, SCIENCE, V346, P1296, DOI 10.1126/science.1260260; Margalida A., 2007, Animal Biodiversity and Conservation, V30, P189; Margalida A, 2007, J WILDLIFE MANAGE, V71, P1621, DOI 10.2193/2006-049; Margalida A, 2012, IBIS, V154, P184, DOI 10.1111/j.1474-919X.2011.01189.x; Margalida A, 2009, IBIS, V151, P235; Martina Aldo, 1997, Hystrix, V9, P23; Martinez-Abrain A, 2012, J APPL ECOL, V49, P109, DOI 10.1111/j.1365-2664.2011.02080.x; Milchev B, 2012, NORTH-WEST J ZOOL, V8, P315; Mundy P., 1992, VULTURES AFRICA; Nadjafzadeh M, 2016, IBIS, V158, P1, DOI 10.1111/ibi.12311; Navarro J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159974; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Ogada D, 2016, CONSERV LETT, V9, P89, DOI 10.1111/conl.12182; Oro D, 2013, ECOL LETT, V16, P1501, DOI 10.1111/ele.12187; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Osborne CP, 2014, NEW PHYTOL, V204, P441, DOI 10.1111/nph.12942; Osorio MT, 2011, J AGR FOOD CHEM, V59, P3285, DOI 10.1021/jf1040433; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Payo-Payo A, 2015, ECOL APPL, V25, P2228, DOI [10.1890/14-2090.1.sm, 10.1890/14-2090.1]; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Piasentier E, 2003, MEAT SCI, V64, P239, DOI 10.1016/S0309-1740(02)00183-3; Polito MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026642; Quarles W, 2013, COMMON SENSE PEST CO, VXXVII, P1; Ramos R, 2009, MAR ECOL PROG SER, V377, P289, DOI 10.3354/meps07792; Real J, 1996, J WILDLIFE MANAGE, V60, P632, DOI 10.2307/3802082; Resano J, 2011, RAPID COMMUN MASS SP, V45, P342, DOI DOI 10.1002/RCM; Resano J, 2011, J RAPTOR RES, V45, P342, DOI 10.3356/JRR-11-13.1; Resano-Mayor J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095320; Resano-Mayor J, 2014, IBIS, V156, P176, DOI 10.1111/ibi.12095; Robinson BG, 2018, AUK, V135, P60, DOI 10.1642/AUK-17-143.1; Russo G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183333; Sanz-Aguilar A, 2015, BIOL CONSERV, V187, P10, DOI 10.1016/j.biocon.2015.03.029; Schmidt O, 2005, FOOD CHEM, V91, P545, DOI 10.1016/j.foodchem.2004.08.036; Swan GE, 2006, BIOL LETT-UK, V2, P279, DOI 10.1098/rsbl.2005.0425; Tauler H, 2015, BIRD CONSERV INT, V25, P426, DOI 10.1017/S0959270914000392; Tauler-Ametller H, 2017, IBIS, V159, P757, DOI 10.1111/ibi.12495; The IUCN Red List,, IUCN RED LIST THREAT; Viada Carlota, 1994, Bolleti de la Societat d'Historia Natural de les Balears, V37, P101; Vidal E, 1998, BIODIVERS CONSERV, V7, P1013, DOI 10.1023/A:1008805030578; Votier SC, 2003, POLAR BIOL, V26, P20, DOI 10.1007/s00300-002-0446-z; Weiser EL, 2011, J FIELD ORNITHOL, V82, P297, DOI 10.1111/j.1557-9263.2011.00333.x; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wooller MJ, 2007, ARCT ANTARCT ALP RES, V39, P318, DOI 10.1657/1523-0430(2007)39[318:SCICOE]2.0.CO;2; Zuberogoitia I, 2008, ANIM CONSERV, V11, P313, DOI 10.1111/j.1469-1795.2008.00184.x	85	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196044	10.1371/journal.pone.0196044	http://dx.doi.org/10.1371/journal.pone.0196044			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718940	gold, Green Published, Green Submitted			2022-12-26	WOS:000431281900044
J	Rademaker, G; Hennequiere, V; Brohee, L; Nokin, MJ; Lovinfosse, P; Durieux, F; Gofflot, S; Bellier, J; Costanza, B; Herfs, M; Peiffer, R; Bettendorff, L; Deroanne, C; Thiry, M; Delvenne, P; Hustinx, R; Bellahcene, A; Castronovo, V; Peulen, O				Rademaker, Gilles; Hennequiere, Vincent; Brohee, Laura; Nokin, Marie-Julie; Lovinfosse, Pierre; Durieux, Florence; Gofflot, Stephanie; Bellier, Justine; Costanza, Brunella; Herfs, Michael; Peiffer, Raphael; Bettendorff, Lucien; Deroanne, Christophe; Thiry, Marc; Delvenne, Philippe; Hustinx, Roland; Bellahcene, Akeila; Castronovo, Vincent; Peulen, Olivier			Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness	ONCOGENE			English	Article							CANCER-CELLS; DETERMINES; AUTOPHAGY; SURVIVAL; FUSION; PHOSPHORYLATION; HETEROGENEITY; PROGRESSION; METABOLISM; PLASTICITY	Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related death. Therapeutic options remain very limited and are based on classical chemotherapies. Energy metabolism reprogramming appears as an emerging hallmark of cancer and is considered a therapeutic target with considerable potential. Myoferlin, a ferlin family member protein overexpressed in PDAC, is involved in plasma membrane biology and has a tumor-promoting function. In the continuity of our previous studies, we investigated the role of myoferlin in the context of energy metabolism in PDAC. We used selected PDAC tumor samples and PDAC cell lines together with small interfering RNA technology to study the role of myoferlin in energetic metabolism. In PDAC patients, we showed that myoferlin expression is negatively correlated with overall survival and with glycolytic activity evaluated by F-18-deoxyglucose positron emission tomography. We found out that myoferlin is more abundant in lipogenic pancreatic cancer cell lines and is required to maintain a branched mitochondrial structure and a high oxidative phosphorylation activity. The observed mitochondrial fission induced by myoferlin depletion led to a decrease of cell proliferation, ATP production, and autophagy induction, thus indicating an essential role of myoferlin for PDAC cell fitness. The metabolic phenotype switch generated by myoferlin silencing could open up a new perspective in the development of therapeutic strategies, especially in the context of energy metabolism.	[Rademaker, Gilles; Hennequiere, Vincent; Nokin, Marie-Julie; Durieux, Florence; Bellier, Justine; Costanza, Brunella; Peiffer, Raphael; Bellahcene, Akeila; Castronovo, Vincent; Peulen, Olivier] Univ Liege, Metastasis Res Lab, GIGA Canc, Liege, Belgium; [Brohee, Laura; Deroanne, Christophe] Univ Liege, Lab Connect Tissue Biol, GIGA Canc, Liege, Belgium; [Lovinfosse, Pierre; Hustinx, Roland] Univ Liege, Dept Nucl Med & Oncol Imaging, Univ Hosp Ctr, Liege, Belgium; [Gofflot, Stephanie] Univ Liege, Univ Hosp, Tissue Biobank, Liege, Belgium; [Herfs, Michael; Delvenne, Philippe] Univ Liege, Lab Expt Pathol, GIGA Canc, Liege, Belgium; [Bettendorff, Lucien] Univ Liege, Neurophysiol Lab, GIGA Neurosci, Liege, Belgium; [Thiry, Marc] Univ Liege, Lab Cellular & Tissular Biol, GIGA Neurosci, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; University of Liege; University of Liege	Peulen, O (corresponding author), Univ Liege, Metastasis Res Lab, GIGA Canc, Liege, Belgium.	olivier.peulen@uliege.be	Peulen, Olivier/C-1250-2018; Rademaker, Gilles/X-1386-2019; Costanza, Brunella/AAB-6354-2022	Peulen, Olivier/0000-0002-6933-0134; Rademaker, Gilles/0000-0003-0170-781X; Costanza, Brunella/0000-0001-8279-805X; Brohee, Laura/0000-0001-8498-1579; Peiffer, Raphael/0000-0001-5839-8849	FNRS Televie grant	FNRS Televie grant(Fonds de la Recherche Scientifique - FNRS)	We acknowledge Dr Chantal Humblet and Mrs Alice Marquet (GIGA-histology platform, ULg), Dr Sandra Ormenese and Dr Jean-Jacques Goval (GIGA-imaging platform, ULg), Dr Emmanuel Di Valentin (GIGA-viral vector platform, ULg), Mrs Patricia Piscicelli (Laboratory of Cellular and Tissular Biology), Mrs Naima Maloujahmoum, and Selina Nuchtern (Metastasis Research Laboratory) for their respective experimental support. We thank Mrs Caroline Ziane for proofreading and English editing. We are also thankful to the institutional Biobank of the University Hospital Liege for providing patient material. The results shown in this work are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/. Akeila Bellahcene and Lucien Bettendorff are Research Directors (FNRS). Christophe Deroanne is a Research Associate (FNRS). Dr Michael Herfs, Dr Marie-Julie Nokin, Dr Brunella Costanza, Mrs Laura Brohee, Mrs Florence Durieux, and Mrs Justine Bellier are supported by an FNRS Televie grant. M. Raphael Peiffer is student-researcher supported by the ULg Medicine Faculty. The sponsor had no other roles in the study.	Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600; Baek G, 2014, CELL REP, V9, P2233, DOI 10.1016/j.celrep.2014.11.025; Bernatchez PN, 2009, AM J PHYSIOL-CELL PH, V297, pC484, DOI 10.1152/ajpcell.00498.2008; Blomme A, 2016, ONCOGENE, V4, P1151; Blomme A, 2016, ONCOTARGET, V7, P83669, DOI 10.18632/oncotarget.13276; Boudreau A, 2016, NAT CHEM BIOL, V12, P779, DOI 10.1038/nchembio.2143; Cao YL, 2017, NATURE, V542, P372, DOI 10.1038/nature21077; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Daemen A, 2015, P NATL ACAD SCI USA, V112, pE4410, DOI 10.1073/pnas.1501605112; Denise C, 2015, ONCOTARGET, V6, P41706, DOI 10.18632/oncotarget.5991; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; ELSASSER HP, 1992, VIRCHOWS ARCH B, V61, P295, DOI 10.1007/BF02890431; Eng CH, 2016, P NATL ACAD SCI USA, V113, P182, DOI 10.1073/pnas.1515617113; Fahmy K, 2016, INT J CANCER, V138, P652, DOI 10.1002/ijc.29820; Gangolf M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013616; Habrook CJ, 2017, CANCER CELL, V31, P5, DOI 10.1016/j.ccell.2016.12.006; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Higashi T, 1997, J NUCL MED, V38, P1337; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hyun SH, 2016, EUR J NUCL MED MOL I, V43, P1461, DOI 10.1007/s00259-016-3316-6; Ippolito L, 2016, ONCOTARGET, V7, P61890, DOI 10.18632/oncotarget.11301; Jahani-Asl A, 2007, EMBO REP, V8, P912, DOI 10.1038/sj.embor.7401077; Jones P, 2017, CLIN CANC RES, V23; Kim SE, 2015, BIOCHEM BIOPH RES CO, V463, P205, DOI 10.1016/j.bbrc.2015.05.022; Kosinski M, 2015, RTCGA CANC GENOME AT; Larson Steven M., 1999, Clin Positron Imaging, V2, P159, DOI 10.1016/S1095-0397(99)00016-3; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lee JW, 2014, J NUCL MED, V55, P898, DOI 10.2967/jnumed.113.131847; Mao K, 2013, CELL CYCLE, V12, P3131, DOI 10.4161/cc.26352; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Neuzillet C, 2017, PHARMACOL THERAPEUT, V174, P145, DOI 10.1016/j.pharmthera.2017.02.028; Peixoto P, 2012, CELL DEATH DIFFER, V19, P1239, DOI 10.1038/cdd.2012.3; Protopopova M, 2016, MOL CANCER RES, V14, DOI 10.1158/1557-3125.METCA15-A65; R Core Team, 2021, R LANGUAGE ENV STAT; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Sancho P, 2015, CELL METAB, V22, P590, DOI 10.1016/j.cmet.2015.08.015; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Turtoi A, 2013, CANCER RES, V73, P5438, DOI 10.1158/0008-5472.CAN-13-1142; Turtoi A, 2011, J PROTEOME RES, V10, P4302, DOI 10.1021/pr200527z; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Yamano K, 2011, NAT CELL BIOL, V13, P1026, DOI 10.1038/ncb2334; Yang A, 2014, CANCER DISCOV, V4, P905, DOI 10.1158/2159-8290.CD-14-0362	51	35	35	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 9	2018	37	32					4398	4412		10.1038/s41388-018-0287-z	http://dx.doi.org/10.1038/s41388-018-0287-z			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP8FA	29720728	hybrid, Green Published			2022-12-26	WOS:000441144300005
J	Jimenez-Vicente, E; Yang, ZY; Ray, WK; Echavarri-Erasun, C; Cash, VL; Rubio, LM; Seefeldt, LC; Dean, DR				Jimenez-Vicente, Emilio; Yang, Zhi-Yong; Keith Ray, W.; Echavarri-Erasun, Carlos; Cash, Valerie L.; Rubio, Luis M.; Seefeldt, Lance C.; Dean, Dennis R.			Sequential and differential interaction of assembly factors during nitrogenase MoFe protein maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein assembly; nitrogenase; reductase; protein purification; electron paramagnetic resonance (EPR); MoFe protein; FeMo-cofactor; P-cluster; nitrogen fixation	IRON-MOLYBDENUM COFACTOR; IN-VITRO SYNTHESIS; AZOTOBACTER-VINELANDII NITROGENASE; KLEBSIELLA-PNEUMONIAE; NUCLEOTIDE-SEQUENCE; MUTATIONAL ANALYSIS; STRUCTURAL GENES; DELETION STRAIN; FIXATION; PURIFICATION	Nitrogenases reduce atmospheric nitrogen, yielding the basic inorganic molecule ammonia. The nitrogenase MoFe protein contains two cofactors, a [7Fe-9S-Mo-C-homocitrate] active-site species, designated FeMo-cofactor, and a [8Fe-7S] electron-transfer mediator called P-cluster. Both cofactors are essential for molybdenum-dependent nitrogenase catalysis in the nitrogen-fixing bacterium Azotobacter vinelandii. We show here that three proteins, NafH, NifW, and NifZ, copurify with MoFe protein produced by an A. vinelandii strain deficient in both FeMo-cofactor formation and P-cluster maturation. In contrast, two different proteins, NifY and NafY, copurified with MoFe protein deficient only in FeMo-cofactor formation. We refer to proteins associated with immature MoFe protein in the following as assembly factors. Copurifications of such assembly factors with MoFe protein produced in different genetic backgrounds revealed their sequential and differential interactions with MoFe protein during the maturation process. We found that these interactions occur in the order NafH, NifW, NifZ, and NafY/NifY. Interactions of NafH, NifW, and NifZ with immature forms of MoFe protein preceded completion of P-cluster maturation, whereas interaction of NafY/NifY preceded FeMo-cofactor insertion. Because each assembly factor could independently bind an immature form of MoFe protein, we propose that subpopulations of MoFe protein-assembly factor complexes represent MoFe protein captured at different stages of a sequential maturation process. This suggestion was supported by separate isolation of three such complexes, MoFe protein-NafY, MoFe protein-NifY, and MoFe protein-NifW. We conclude that factors involved in MoFe protein maturation sequentially bind and dissociate in a dynamic process involving several MoFe protein conformational states.	[Jimenez-Vicente, Emilio; Keith Ray, W.; Cash, Valerie L.; Dean, Dennis R.] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Yang, Zhi-Yong; Seefeldt, Lance C.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Echavarri-Erasun, Carlos; Rubio, Luis M.] UPM, Ctr Biotecnol & Genom Plantas, Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Campus Montegancedo UPM Pozuelo De Alarcon, Madrid 28223, Spain	Virginia Polytechnic Institute & State University; Utah System of Higher Education; Utah State University; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad Politecnica de Madrid	Dean, DR (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	deandr@vt.edu	Rubio, Luis M./B-5827-2009; Echavarri-Erasun, Carlos/L-5820-2014; Yang, Zhiyong/E-7834-2013	Rubio, Luis M./0000-0003-1596-2475; Yang, Zhiyong/0000-0001-8186-9450; Echavarri-Erasun, Carlos/0000-0001-8363-5199; Dean, Dennis/0000-0001-8960-6196	Fralin Life Science Institute; Agricultural Experiment Station Hatch Program; McIntire-Stennis Program at Virginia Tech	Fralin Life Science Institute; Agricultural Experiment Station Hatch Program; McIntire-Stennis Program at Virginia Tech	Mass spectrometry resources used in this work are maintained in part through funding by the Fralin Life Science Institute, the Agricultural Experiment Station Hatch Program, and the McIntire-Stennis Program at Virginia Tech and are managed by Richard F. Helm.	ALLEN RM, 1993, J BIOL CHEM, V268, P23670; Barney BM, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01534-17; BENNETT LT, 1988, MOL MICROBIOL, V2, P315, DOI 10.1111/j.1365-2958.1988.tb00034.x; BENNETT LT, 1988, J BIOL CHEM, V263, P1364; BISHOP PE, 1986, SCIENCE, V232, P92, DOI 10.1126/science.232.4746.92; BLANCO G, 1993, MOL MICROBIOL, V9, P869, DOI 10.1111/j.1365-2958.1993.tb01745.x; Broach RB, 2006, BIOCHEMISTRY-US, V45, P15039, DOI 10.1021/bi061697p; Buren S, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fnx274; BURGESS BK, 1980, BIOCHIM BIOPHYS ACTA, V614, P196, DOI 10.1016/0005-2744(80)90180-1; Chatterjee R, 1997, J BIOL CHEM, V272, P21604, DOI 10.1074/jbc.272.34.21604; CHISNELL JR, 1988, J BACTERIOL, V170, P27, DOI 10.1128/jb.170.1.27-33.1988; Christiansen J, 1998, BIOCHEMISTRY-US, V37, P12611, DOI 10.1021/bi981165b; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Curatti L, 2005, P NATL ACAD SCI USA, V102, P6291, DOI 10.1073/pnas.0501216102; Dilworth MJ, 1998, BIOCHEMISTRY-US, V37, P17495, DOI 10.1021/bi9812017; Dos Santos PC, 2011, METHODS MOL BIOL, V766, P81, DOI 10.1007/978-1-61779-194-9_6; Dos Santos PC, 2011, MOL MICROBIOL, V79, P1132, DOI 10.1111/j.1365-2958.2011.07541.x; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Hamilton TL, 2011, J BACTERIOL, V193, P4477, DOI 10.1128/JB.05099-11; Hernandez JA, 2011, J BIOL CHEM, V286, P6321, DOI 10.1074/jbc.M110.168732; HOMER MJ, 1993, J BACTERIOL, V175, P4907, DOI 10.1128/JB.175.15.4907-4910.1993; HOMER MJ, 1995, J BIOL CHEM, V270, P24745, DOI 10.1074/jbc.270.42.24745; Hu YL, 2008, BIOCHEMISTRY-US, V47, P3973, DOI 10.1021/bi7025003; Hu Y, 2007, P NATL ACAD SCI USA, V104, P10424, DOI 10.1073/pnas.0704297104; Hu YL, 2004, J BIOL CHEM, V279, P54963, DOI 10.1074/jbc.M408983200; JACOBSON MR, 1989, J BACTERIOL, V171, P1017, DOI 10.1128/jb.171.2.1017-1027.1989; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; JOERGER RD, 1988, CRIT REV MICROBIOL, V16, P1, DOI 10.3109/10408418809104465; JOERGER RD, 1990, J BACTERIOL, V172, P3400, DOI 10.1128/jb.172.6.3400-3408.1990; JOERGER RD, 1988, J BACTERIOL, V170, P1475, DOI 10.1128/jb.170.4.1475-1487.1988; Kim S, 1996, J BIOL CHEM, V271, P9764, DOI 10.1074/jbc.271.16.9764; Magnuson JK, 1997, TETRAHEDRON, V53, P11971, DOI 10.1016/S0040-4020(97)00710-2; Moser J, 2013, P NATL ACAD SCI USA, V110, P2094, DOI 10.1073/pnas.1218303110; ORMEJOHNSON WH, 1972, P NATL ACAD SCI USA, V69, P3142, DOI 10.1073/pnas.69.11.3142; PAUL W, 1989, EUR J BIOCHEM, V178, P675, DOI 10.1111/j.1432-1033.1989.tb14497.x; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Ribbe MW, 2002, J BIOL CHEM, V277, P23469, DOI 10.1074/jbc.M202061200; RIVERAORTIZ JM, 1975, J BACTERIOL, V123, P537, DOI 10.1128/JB.123.2.537-545.1975; ROBERTS GP, 1978, J BACTERIOL, V136, P267, DOI 10.1128/JB.136.1.267-279.1978; ROBINSON AC, 1987, J BIOL CHEM, V262, P14327; Rubio LM, 2004, J BIOL CHEM, V279, P19739, DOI 10.1074/jbc.M400965200; Rubio LM, 2002, J BIOL CHEM, V277, P14299, DOI 10.1074/jbc.M107289200; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Rupnik K, 2012, J AM CHEM SOC, V134, P13749, DOI 10.1021/ja304077h; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Seefeldt LC, 2012, CURR OPIN CHEM BIOL, V16, P19, DOI 10.1016/j.cbpa.2012.02.012; Seefeldt LC, 2009, ANNU REV BIOCHEM, V78, P701, DOI 10.1146/annurev.biochem.78.070907.103812; Setubal JC, 2009, J BACTERIOL, V191, P4534, DOI 10.1128/JB.00504-09; SHAH VK, 1994, J BIOL CHEM, V269, P1154; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; STRANDBERG GW, 1968, CAN J MICROBIOL, V14, P25, DOI 10.1139/m68-005; Vicente EJ, 2017, P NATL ACAD SCI USA, V114, P3009, DOI 10.1073/pnas.1701560114; WHITE TC, 1992, J BIOL CHEM, V267, P24007	54	23	23	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9812	9823		10.1074/jbc.RA118.002994	http://dx.doi.org/10.1074/jbc.RA118.002994			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29724822	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000436102300024
J	Igarashi, A; Itoh, K; Yamada, T; Adachi, Y; Kato, T; Murata, D; Sesaki, H; Iijima, M				Igarashi, Atsushi; Itoh, Kie; Yamada, Tatsuya; Adachi, Yoshihiro; Kato, Takashi; Murata, Daisuke; Sesaki, Hiromi; Iijima, Miho			Nuclear PTEN deficiency causes microcephaly with decreased neuronal soma size and increased seizure susceptibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatase and tensin homolog (PTEN); phosphatidylinositide 3-kinase (PI 3-kinase); mouse genetics; brain; cell signaling; lipid signaling; PIP3 signaling; nucleus; mouse; genome editing	HAMARTOMA TUMOR SYNDROME; LOCALIZATION; PATHWAY; BRAIN; TUMORIGENESIS; MODELS; DRP1	Defects in phosphatase and tensin homolog (PTEN) are associated with neurological disorders and tumors. PTEN functions at two primary intracellular locations: the plasma membrane and the nucleus. At the membrane, PTEN functions as a phosphatidylinositol (3,4,5)-trisphosphate phosphatase and suppresses PI 3-kinase signaling that drives cell growth and tumorigenesis. However, the in vivo function of nuclear PTEN is unclear. Here, using CRISPR/Cas9, we generated a mouse model in which PTEN levels in the nucleus are decreased. Nuclear PTEN-deficient mice were born with microcephaly and maintained a small brain during adulthood. The size of neuronal soma was significantly smaller in the cerebellum, cerebral cortex, and hippocampus. Also, these mice were prone to seizure. No changes in PI 3-kinase signaling were observed. By contrast, the size of other organs was unaffected. Therefore, nuclear PTEN is essential for the health of the brain by promoting the growth of neuronal soma size during development.	[Igarashi, Atsushi; Itoh, Kie; Yamada, Tatsuya; Adachi, Yoshihiro; Kato, Takashi; Murata, Daisuke; Sesaki, Hiromi; Iijima, Miho] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Iijima, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	miijima@jhmi.edu			National Institutes of Health [GM084015, GM123266]; Allegheny Health Network-Sidney Kimmel Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084015, R01GM123266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allegheny Health Network-Sidney Kimmel Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM084015 (to M. I.) and GM123266 (to H. S.) and the Allegheny Health Network-Sidney Kimmel Comprehensive Cancer Center (to M. I. and H. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi Y, 2016, MOL CELL, V63, P1034, DOI 10.1016/j.molcel.2016.08.013; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Ben Haim L, 2017, NAT REV NEUROSCI, V18, P31, DOI [10.1038/nrn.2016.159, 10.1038/nm.2016.159]; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chung JH, 2006, HUM MOL GENET, V15, P2553, DOI 10.1093/hmg/ddl177; Cupolillo D, 2016, NEUROPSYCHOPHARMACOL, V41, P1457, DOI 10.1038/npp.2015.339; DEDEYN PP, 1992, EPILEPSY RES, V12, P87, DOI 10.1016/0920-1211(92)90030-W; Dhir A., 2012, CURR PROT NEUROSCI, V58, p9.37.1, DOI [DOI 10.1002/0471142301.NS0937S58, 10.1002/0471142301.ns0937s58]; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Gil A, 2007, CELL DEATH DIFFER, V14, P395, DOI 10.1038/sj.cdd.4402073; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Nguyen HN, 2015, SCI REP-UK, V5, DOI 10.1038/srep12600; Nguyen HN, 2014, P NATL ACAD SCI USA, V111, pE2684, DOI 10.1073/pnas.1409433111; Hobert JA, 2009, GENET MED, V11, P687, DOI 10.1097/GIM.0b013e3181ac9aea; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Kreis P, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00023; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Leslie NR, 2016, BIOCHEM SOC T, V44, P273, DOI 10.1042/BST20150224; Lindsay Y, 2006, J CELL SCI, V119, P5160, DOI 10.1242/jcs.000133; Loscher W, 2013, NAT REV DRUG DISCOV, V12, P757, DOI 10.1038/nrd4126; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marino S, 2002, DEVELOPMENT, V129, P3513; Moncalero VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018857; Nardella C, 2011, CURR TOP MICROBIOL, V347, P135, DOI 10.1007/82_2010_62; Nguyen HN, 2014, ONCOGENE, V33, P5688, DOI 10.1038/onc.2013.507; Nguyen HN, 2015, ONCOGENE, V34, P3737, DOI 10.1038/onc.2014.293; Pilarski R, 2013, JNCI-J NATL CANCER I, V105, P1607, DOI 10.1093/jnci/djt277; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Sarnat HB, 2015, CELL TISSUE RES, V359, P279, DOI 10.1007/s00441-014-1988-4; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Veleva-Rotse BO, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00035; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Yamada T, 2016, AM J PATHOL, V186, P2798, DOI 10.1016/j.ajpath.2016.06.025; Yang M, 2017, ONCOGENE, V36, P3673, DOI 10.1038/onc.2016.493; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004	49	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9292	9300		10.1074/jbc.RA118.002356	http://dx.doi.org/10.1074/jbc.RA118.002356			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29735527	Green Published, hybrid			2022-12-26	WOS:000435441400015
J	Gong, S; Zhang, F; Norton, I; Essayed, WI; Unadkat, P; Rigolo, L; Pasternak, O; Rathi, Y; Hou, LJ; Golby, AJ; O'donnell, LJ				Gong, Shun; Zhang, Fan; Norton, Isaiah; Essayed, Walid, I; Unadkat, Prashin; Rigolo, Laura; Pasternak, Ofer; Rathi, Yogesh; Hou, Lijun; Golby, Alexandra J.; O'donnell, Lauren J.			Free water modeling of peritumoral edema using multi-fiber tractography: Application to tracking the arcuate fasciculus for neurosurgical planning	PLOS ONE			English	Article							DIFFUSION TENSOR TRACTOGRAPHY; WHITE-MATTER; FIBER TRACTOGRAPHY; CORTICOSPINAL TRACT; BRAIN-TUMORS; VISUALIZATION; LANGUAGE; DTI; MRI; MICROSTRUCTURE	Purpose Peritumoral edema impedes the full delineation of fiber tracts due to partial volume effects in image voxels that contain a mixture of cerebral parenchyma and extracellular water. The purpose of this study is to investigate the effect of incorporating a free water (FW) model of edema for white matter tractography in the presence of edema. Materials and methods We retrospectively evaluated 26 consecutive brain tumor patients with diffusion MRI and T2-weighted images acquired presurgically. Tractography of the arcuate fasciculus (AF) was performed using the two-tensor unscented Kalman filter tractography (UKFt) method, the UKFt method with a reduced fiber tracking stopping fractional anisotropy (FA) threshold (UKFt+rFA), and the UKFt method with the addition of a FW compartment (UKFt+FW). An automated white matter fiber tract identification approach was applied to delineate the AF. Quantitative measurements included tract volume, edema volume, and mean FW fraction. Visual comparisons were performed by three experts to evaluate the quality of the detected AF tracts. Results The AF volume in edematous brain hemispheres was significantly larger using the UKFt+FW method (p<0.0001) compared to UKFt, but not significantly larger (p = 0.0996) in hemispheres without edema. The AF size increase depended on the volume of edema: a significant correlation was found between AF volume affected by (intersecting) edema and AF volume change with the FW model (Pearson r = 0.806, p<0.0001). The mean FW fraction was significantly larger in tracts intersecting edema (p = 0.0271). Compared to the UKFt+rFA method, there was a significant increase of the volume of the AF tract that intersected the edema using the UKFt+FW method, while the whole AF volumes were similar. Expert judgment results, based on the five patients with the smallest AF volumes, indicated that the expert readers generally preferred the AF tract obtained by using the FW model, according to their anatomical knowledge and considering the potential influence of the final results on the surgical route. Conclusion Our results indicate that incorporating biophysical models of edema can increase the sensitivity of tractography in regions of peritumoral edema, allowing better tract visualization in patients with high grade gliomas and metastases.	[Gong, Shun; Zhang, Fan; Norton, Isaiah; Essayed, Walid, I; Unadkat, Prashin; Rigolo, Laura; Pasternak, Ofer; Rathi, Yogesh; Golby, Alexandra J.; O'donnell, Lauren J.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Gong, Shun; Hou, Lijun] Shanghai Changzheng Hosp, Shanghai Inst Neurosurg, Dept Neurosurg, Shanghai, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Naval Medical University	O'donnell, LJ (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA.	odonnell@bwh.harvard.edu	O'Donnell, Lauren J./ABA-7546-2020; Unadkat, Prashin/AAI-9799-2021	O'Donnell, Lauren J./0000-0003-0197-7801; Essayed, Walid I./0000-0003-4640-0563; Unadkat, Prashin/0000-0001-6678-9380	National Institutes of Health (NIH) [U01 CA199459, R03 NS088301, P41 EB015898, R01 MH074794, P41 EB015902, R25 CA089017, R01 MH097979, R21 CM 98740, U01 NS083223, R01 MH108574]; China Scholarship Council [201503170356]; National Nature Science Foundation of China [81371382]; Shanghai Outstanding Academic Leader Fund: [XBR2013075]; National "12th Five-Year" key issues [BWS12J025]; NATIONAL CANCER INSTITUTE [R21CA198740, U01CA199459, R25CA089017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015902, P41EB015898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074794, R01MH108574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS088301] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Outstanding Academic Leader Fund:; National "12th Five-Year" key issues; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study is supported by National Institutes of Health (NIH) grants: U01 CA199459, R03 NS088301, P41 EB015898 (National Center for Image-Guided Therapy), R01 MH074794, P41 EB015902 (Neuroimage Analysis Center), R25 CA089017, R01 MH097979, R21 CM 98740, U01 NS083223, R01 MH108574 to L.J.O.; China Scholarship Council: 201503170356 to S.G.; National Nature Science Foundation of China: 81371382 to L.H.; Shanghai Outstanding Academic Leader Fund: XBR2013075 to L.H.; National "12th Five-Year" key issues: BWS12J025 to L.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhinav K, 2015, NEURO-ONCOLOGY, V17, P1199, DOI 10.1093/neuonc/nov113; Akai H, 2005, J COMPUT ASSIST TOMO, V29, P127, DOI 10.1097/01.rct.0000148453.29579.51; Baumgartner C., 2012, COMP DIFF MRI WORKSH, P27; Bergamino M, 2016, NEUROIMAGE-CLIN, V10, P336, DOI 10.1016/j.nicl.2015.11.020; Berlot R, 2014, NEUROIMAGE, V92, P27, DOI 10.1016/j.neuroimage.2014.01.031; Brun A, 2003, LECT NOTES COMPUT SC, V2809, P518; Burgel U, 2009, CENT EUR NEUROSURG, V70, P27, DOI 10.1055/s-0028-1087212; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Caverzasi E, 2016, J NEUROSURG, V125, P33, DOI 10.3171/2015.6.JNS142203; Chamberland M, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00059; Chen ZR, 2016, INT J COMPUT ASS RAD, V11, P1475, DOI 10.1007/s11548-015-1344-5; Chen ZR, 2015, NEUROIMAGE-CLIN, V7, P815, DOI 10.1016/j.nicl.2015.03.009; Colon-Perez LM, 2016, BRAIN IMAGING BEHAV, V10, P1137, DOI 10.1007/s11682-015-9474-5; Craddock RC, 2013, NAT METHODS, V10, P524, DOI [10.1038/nmeth.2482, 10.1038/NMETH.2482]; Essayed WI, 2017, NEUROIMAGE-CLIN, V15, P659, DOI 10.1016/j.nicl.2017.06.011; Farquharson S, 2013, J NEUROSURG, V118, P1367, DOI 10.3171/2013.2.JNS121294; Farshidfar Z, 2014, NEURORADIOL J, V27, P75, DOI 10.15274/NRJ-2014-10008; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fowlkes C, 2004, IEEE T PATTERN ANAL, V26, P214, DOI 10.1109/TPAMI.2004.1262185; Gering DT, 2001, J MAGN RESON IMAGING, V13, P967, DOI 10.1002/jmri.1139; Girard G, 2014, NEUROIMAGE, V98, P266, DOI 10.1016/j.neuroimage.2014.04.074; Gorgolewski K, 2011, P INT SOC MAG RESON, P2430; Gorgolewski KJ, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00245; Hoy AR, 2015, J MAGN RESON IMAGING, V42, P1572, DOI 10.1002/jmri.24925; Jbabdi S, 2011, BRAIN CONNECT, V1, P169, DOI 10.1089/brain.2011.0033; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kipp L, 2015, NEUROLOGY, V86, pP4; Kuhnt D, 2013, NEUROSURGERY, V72, pA165, DOI 10.1227/NEU.0b013e318270d9fb; Lally PJ, 2014, NEURITE ORIENTATION, P2673; Lecoeur J, 2013, MICCAI 2013 DTI TRAC; Lecoeur J, 2014, MICCAI 2014 DTI TRAC; Li Zhixi, 2013, J Biomed Sci Eng, V6, P192; Liao R, 2017, NEUROIMAGE-CLIN, V15, P819, DOI 10.1016/j.nicl.2017.06.027; Lu S, 2004, RADIOLOGY, V232, P221, DOI 10.1148/radiol.2321030653; Maier-Hein K.H., 2016, BIORXIV, DOI 10.1101/084137; Maier-Hein KH, 2015, ALZHEIMERS DEMENT, V11, P485, DOI 10.1016/j.jalz.2014.04.518; Malcolm JG, 2010, IEEE T MED IMAGING, V29, P1664, DOI 10.1109/TMI.2010.2048121; Matthews PM, 2006, NAT REV NEUROSCI, V7, P732, DOI 10.1038/nrn1929; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; Mechtler L, 2009, NEUROL CLIN, V27, P171, DOI 10.1016/j.ncl.2008.09.015; Morita KI, 2005, J NEUROSURG, V102, P336, DOI 10.3171/jns.2005.102.2.0336; Nimsky C, 2016, ADV TECH STAND NEURO, V43, P37, DOI 10.1007/978-3-319-21359-0_2; Niu C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003189; O'Donnell LJ, 2007, IEEE T MED IMAGING, V26, P1562, DOI 10.1109/TMI.2007.906785; O'Donnell LJ, 2017, NEUROIMAGE-CLIN, V13, P138, DOI 10.1016/j.nicl.2016.11.023; O'Donnell LJ, 2012, LECT NOTES COMPUT SC, V7512, P123, DOI 10.1007/978-3-642-33454-2_16; Oestreich LKL, 2016, NEUROIMAGE-CLIN, V12, P405, DOI 10.1016/j.nicl.2016.08.004; Oguz I, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00004; Oh J, 2005, J MAGN RESON IMAGING, V21, P701, DOI 10.1002/jmri.20335; Papadopoulos MC, 2004, NEUROSCIENCE, V129, P1011, DOI 10.1016/j.neuroscience.2004.05.044; Pasternak O., 2014, VISUALIZATION PROCES, P249, DOI [10.1007/978-3-642-54301, DOI 10.1007/978-3-642-54301]; Pasternak O, 2008, MAGN RESON IMAGING, V26, P1133, DOI 10.1016/j.mri.2008.01.006; Pasternak O, 2012, LECT NOTES COMPUT SC, V7511, P305, DOI 10.1007/978-3-642-33418-4_38; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Petrella JR, 2006, RADIOLOGY, V240, P793, DOI 10.1148/radiol.2403051153; Planetta PJ, 2016, BRAIN, V139, P495, DOI 10.1093/brain/awv361; Pouratian N, 2007, NAT CLIN PRACT NEURO, V3, P628, DOI 10.1038/ncpneuro0634; Propper RE, 2010, BRAIN COGNITION, V73, P85, DOI 10.1016/j.bandc.2010.03.004; Pujol S, 2015, J NEUROIMAGING, V25, P875, DOI 10.1111/jon.12283; Qazi AA, 2009, NEUROIMAGE, V47, pT98, DOI 10.1016/j.neuroimage.2008.06.034; Radmanesh A, 2015, CLIN NEUROL NEUROSUR, V129, P44, DOI 10.1016/j.clineuro.2014.11.021; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Reddy CP, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00166; Schonberg T, 2006, NEUROIMAGE, V30, P1100, DOI 10.1016/j.neuroimage.2005.11.015; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Smits M, 2007, AM J NEURORADIOL, V28, P1354, DOI 10.3174/ajnr.A0538; Steventon JJ, 2016, J NEUROSCI METH, V265, P2, DOI 10.1016/j.jneumeth.2015.08.027; Talos IF, 2003, LECT NOTES COMPUT SC, V2878, P407; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Treiber JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152472; Tunc B, 2016, NEUROSURGERY, V79, P568, DOI 10.1227/NEU.0000000000001183; Wan EA, 2000, IEEE 2000 ADAPTIVE SYSTEMS FOR SIGNAL PROCESSING, COMMUNICATIONS, AND CONTROL SYMPOSIUM - PROCEEDINGS, P153, DOI 10.1109/ASSPCC.2000.882463; Wu JS, 2007, NEUROSURGERY, V61, P935, DOI 10.1227/01.neu.0000303189.80049.ab; Yu QW, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00228; Zhang HL, 2013, NEUROSURGERY, V73, P1044, DOI 10.1227/NEU.0000000000000146; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	77	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197056	10.1371/journal.pone.0197056	http://dx.doi.org/10.1371/journal.pone.0197056			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746544	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700061
J	Kthiri, D; Loladze, A; MacLachlan, PR; N'Diaye, A; Walkowiak, S; Nilsen, K; Dreisigacker, S; Ammar, K; Pozniak, CJ				Kthiri, Dhouha; Loladze, Alexander; MacLachlan, P. R.; N'Diaye, Amidou; Walkowiak, Sean; Nilsen, Kirby; Dreisigacker, Susanne; Ammar, Karim; Pozniak, Curtis J.			Characterization and mapping of leaf rust resistance in four durum wheat cultivars	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TRITICUM-AESTIVUM L.; PUCCINIA-TRITICINA; DISEASE-RESISTANCE; VIRULENCE PHENOTYPES; CONFERS RESISTANCE; GENETIC-ANALYSIS; HIGH-DENSITY; IDENTIFICATION; DIVERSITY	Widening the genetic basis of leaf rust resistance is a primary objective of the global durum wheat breeding effort at the International Wheat and Maize Improvement Center (CIMMYT). Breeding programs in North America are following suit, especially after the emergence of new races of Puccinia triticina such as BBG/BP and BBBQD in Mexico and the United States, respectively. This study was conducted to characterize and map previously undescribed genes for leaf rust resistance in durum wheat and to develop reliable molecular markers for marker-assisted breeding. Four recombinant inbred line (RIL) mapping populations derived from the resistance sources Amria, Byblos, Geromtel_3 and Tunsyr_2, which were crossed to the susceptible line ATRED #2, were evaluated for their reaction to the Mexican race BBG/BP of P. triticina. Genetic analyses of host reactions indicated that leaf rust resistance in these genotypes was based on major seedling resistance genes. Allelism tests among resistant parents supported that Amria and Byblos carried allelic or closely linked genes. The resistance in Geromtel_3 and Tunsyr_2 also appeared to be allelic. Bulked segregant analysis using the Infinium iSelect 90K single nucleotide polymorphism (SNP) array identified two genomic regions for leaf rust resistance; one on chromosome 6BS for Geromtel_3 and Tunsyr_2 and the other on chromosome 7BL for Amria and Byblos. Polymorphic SNPs identified within these regions were converted to kompetitive allele-specific PCR (KASP) assays and used to genotype the RIL populations. KASP markers usw215 and usw218 were the closest to the resistance genes in Geromtel_3 and Tunsyr_2, while usw260 was closely linked to the resistance genes in Amria and Byblos. DNA sequences associated with these SNP markers were anchored to the wild emmer wheat (WEW) reference sequence, which identified several candidate resistance genes. The molecular markers reported herein will be useful to effectively pyramid these resistance genes with other previously marked genes into adapted, elite durum wheat genotypes.	[Kthiri, Dhouha; MacLachlan, P. R.; N'Diaye, Amidou; Walkowiak, Sean; Nilsen, Kirby; Pozniak, Curtis J.] Univ Saskatchewan, Crop Dev Ctr, Dept Plant Sci, Saskatoon, SK, Canada; [Loladze, Alexander; Dreisigacker, Susanne; Ammar, Karim] Int Maize & Wheat Improvement Ctr CIMMYT, Mexico City, DF, Mexico	University of Saskatchewan; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Pozniak, CJ (corresponding author), Univ Saskatchewan, Crop Dev Ctr, Dept Plant Sci, Saskatoon, SK, Canada.	curtis.pozniak@usask.ca		N'Diaye, Amidou/0000-0001-7769-7801; Loladze, Alexander/0000-0001-6806-4295	Genome Canada; Genome Prairie; Western Grains Research Foundation; Saskatchewan Wheat Development Commission; Alberta Wheat Development Commission; Saskatchewan Ministry of Agriculture; Saskatchewan Innovation and Opportunity scholarship; Rene Vandeveld postgraduate scholarship; "Patronato por la Investigacion y Experimentacion Agricola del Estado de Sonora (PIEAES)" / Fundacion Produce Sonora, Mexico; "Durable Rust Resistance Wheat (DRRW)" Project, Borlaug Global Rust Initiative (BGRI)	Genome Canada(Genome Canada); Genome Prairie; Western Grains Research Foundation; Saskatchewan Wheat Development Commission; Alberta Wheat Development Commission; Saskatchewan Ministry of Agriculture; Saskatchewan Innovation and Opportunity scholarship; Rene Vandeveld postgraduate scholarship; "Patronato por la Investigacion y Experimentacion Agricola del Estado de Sonora (PIEAES)" / Fundacion Produce Sonora, Mexico; "Durable Rust Resistance Wheat (DRRW)" Project, Borlaug Global Rust Initiative (BGRI)	This research was conducted as part of the Canadian Triticum Applied Genomics (CTAG2) project. We are grateful for the financial support of Genome Canada, Genome Prairie, Western Grains Research Foundation, Saskatchewan Wheat Development Commission, Alberta Wheat Development Commission and the Saskatchewan Ministry of Agriculture. Scholarships were also provided by the Saskatchewan Innovation and Opportunity scholarship and the Rene Vandeveld postgraduate scholarship. CIMMYT's contribution to the present work has been made possible thanks to funding from (1) "Patronato por la Investigacion y Experimentacion Agricola del Estado de Sonora (PIEAES)" / Fundacion Produce Sonora, Mexico, and (2) the "Durable Rust Resistance Wheat (DRRW)" Project as part of the Borlaug Global Rust Initiative (BGRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Allen AM, 2017, PLANT BIOTECHNOL J, V15, P390, DOI 10.1111/pbi.12635; Aoun M, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2016.01.0008; Avni R, 2017, SCIENCE, V357, P93, DOI 10.1126/science.aan0032; Basnet BR, 2015, PHYTOPATHOLOGY, V105, P470, DOI 10.1094/PHYTO-01-14-0016-R; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Cloutier S, 2007, PLANT MOL BIOL, V65, P93, DOI 10.1007/s11103-007-9201-8; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DARVASI A, 1992, THEOR APPL GENET, V85, P353, DOI 10.1007/BF00222881; DARVASI A, 1994, GENETICS, V138, P1365; Deschamps S, 2010, MOL BREEDING, V25, P553, DOI 10.1007/s11032-009-9357-9; Dreisigacker S, 2016, CIMMYT WHEAT MOL GEN; DVORAK J, 1990, GENOME, V33, P892, DOI 10.1139/g90-134; DYCK P L, 1970, Canadian Journal of Genetics and Cytology, V12, P689; Edwards D, 2013, THEOR APPL GENET, V126, P1, DOI 10.1007/s00122-012-1964-x; Ellis JG, 2007, AUST J AGR RES, V58, P507, DOI 10.1071/AR06151; Ellis JG, 2007, ANNU REV PHYTOPATHOL, V45, P289, DOI 10.1146/annurev.phyto.45.062806.094331; Feuillet C, 2003, P NATL ACAD SCI USA, V100, P15253, DOI 10.1073/pnas.2435133100; Gharbi MS, 2013, BORL GLOB RUST IN TE; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Goyeau H, 2012, PLANT PATHOL, V61, P761, DOI 10.1111/j.1365-3059.2011.02554.x; Goyeau H, 2010, PLANT DIS, V94, P1068, DOI 10.1094/PDIS-94-8-1068A; Herrera-Foessel SA, 2008, PLANT DIS, V92, P469, DOI 10.1094/PDIS-92-3-0469; Herrera-Foessel SA, 2006, PLANT DIS, V90, P1065, DOI 10.1094/PD-90-1065; Herrera-Foessel SA, 2014, PLANT DIS, V98, P631, DOI 10.1094/PDIS-07-13-0741-RE; Herrera-Foessel SA, 2008, PLANT DIS, V92, P1650, DOI 10.1094/PDIS-92-12-1650; Herrera-Foessel SA, 2007, CROP SCI, V47, P1459, DOI 10.2135/cropsci2006.10.0663; Herrera-Foessel SA, 2012, THEOR APPL GENET, V124, P1475, DOI 10.1007/s00122-012-1802-1; Huang L, 2003, GENETICS, V164, P655; Huerta-Espino J, 2011, EUPHYTICA, V179, P143, DOI 10.1007/s10681-011-0361-x; Kohner JA, 2015, PLANT DIS, V99, P156, DOI 10.1094/PDIS-06-14-0667-PDN; Kolmer JA, 2015, PLANT DIS, V99, P1261, DOI 10.1094/PDIS-12-14-1277-SR; Kolmer JA, 2005, CURR OPIN PLANT BIOL, V8, P441, DOI 10.1016/j.pbi.2005.05.001; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Krattinger SG, 2016, NEW PHYTOL, V212, P320, DOI 10.1111/nph.14097; Loladze A, 2014, PHYTOPATHOLOGY, V104, P1322, DOI 10.1094/PHYTO-03-14-0065-R; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; Maccaferri M, 2010, MOL BREEDING, V26, P189, DOI 10.1007/s11032-009-9353-0; Mantovani P, 2010, PLANT DIS, V94, P420, DOI 10.1094/PDIS-94-4-0420; Marais GF, 2005, EUPHYTICA, V143, P115, DOI 10.1007/s10681-005-2911-6; McDowell JM, 2008, DEV COMP IMMUNOL, V32, P736, DOI 10.1016/j.dci.2007.11.005; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; McIntosh RA, 2015, CATALOGUE GENE SYM S; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Ordonez ME, 2007, PHYTOPATHOLOGY, V97, P344, DOI 10.1094/PHYTO-97-3-0344; Periyannan S, 2013, SCIENCE, V341, P786, DOI 10.1126/science.1239028; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Pozniak CJ, 2007, THEOR APPL GENET, V114, P525, DOI 10.1007/s00122-006-0453-5; Qureshi N, 2017, THEOR APPL GENET, V130, P495, DOI 10.1007/s00122-016-2829-5; Roelfs A.P., 1992, RUST DIS WHEAT CONCE, P34; Rosewarne GM, 2008, THEOR APPL GENET, V116, P1027, DOI 10.1007/s00122-008-0736-0; Rozen S, 2000, Methods Mol Biol, V132, P365; Saintenac C, 2013, SCIENCE, V341, P783, DOI 10.1126/science.1239022; Schnurbusch T, 2004, THEOR APPL GENET, V108, P477, DOI 10.1007/s00122-003-1444-4; Singh A, 2013, MOL BREEDING, V31, P405, DOI 10.1007/s11032-012-9798-4; SINGH RP, 1991, PLANT DIS, V75, P790, DOI 10.1094/PD-75-0790; SINGH RP, 1993, PLANT DIS, V77, P460, DOI 10.1094/PD-77-0460; Singh RP, 2004, PLANT DIS, V88, P703, DOI 10.1094/PDIS.2004.88.7.703; Soleiman NH, 2016, SPAN J AGRIC RES, V14, DOI 10.5424/sjar/2016143-9184; Terracciano I, 2013, THEOR APPL GENET, V126, P1077, DOI 10.1007/s00122-012-2038-9; Vida G, 2009, EUPHYTICA, V170, P67, DOI 10.1007/s10681-009-9945-0; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xing LF, 2014, MOL BREEDING, V33, P931, DOI 10.1007/s11032-013-0007-x; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Zhang PP, 2015, CROP J, V3, P152, DOI 10.1016/j.cj.2014.11.004; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3	71	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197317	10.1371/journal.pone.0197317	http://dx.doi.org/10.1371/journal.pone.0197317			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746580	Green Published, gold			2022-12-26	WOS:000431851700101
J	Okamura, M; Yamanaka, Y; Shigemoto, M; Kitadani, Y; Kobayashi, Y; Kambe, T; Nagao, M; Kobayashi, I; Okumura, K; Masuda, S				Okamura, Masumi; Yamanaka, Yasutaka; Shigemoto, Maki; Kitadani, Yuya; Kobayashi, Yuhko; Kambe, Taiho; Nagao, Masaya; Kobayashi, Issei; Okumura, Katsuzumi; Masuda, Seiji			Depletion of mRNA export regulator DBP5/DDX19, GLE1 or IPPK that is a key enzyme for the production of IP6, resulting in differentially altered cytoplasmic mRNA expression and specific cell defect	PLOS ONE			English	Article							BOX PROTEIN DBP5; INOSITOL HEXAKISPHOSPHATE; DNA-DAMAGE; MUTATIONS; COMPLEX; BINDING; ACTIVATION; INSP(6); HGLE1; MODEL	DBP5, also known as DDX19, GLE1 and inositol hexakisphosphate (IP6) function in messenger RNA (mRNA) export at the cytoplasmic surface of the nuclear pore complex in eukaryotic cells. DBP5 is a DEAD-box RNA helicase, and its activity is stimulated by interactions with GLE1 and IP6. In addition, these three factors also have unique role(s). To investigate how these factors influenced the cytoplasmic mRNA expression and cell phenotype change, we performed RNA microarray analysis to detect the effect and function of DBP5, GLE1 and IP6 on the cytoplasmic mRNA expression. The expression of some cytoplasmic mRNA subsets (e.g. cell cycle, DNA replication) was commonly suppressed by the knockdown of DBP5, GLE1 and IPPK (IP6 synthetic enzyme). The GLE1 knock-down selectively reduced the cytoplasmic mRNA expression required for mitotic progression, results in an abnormal spindle phenotype and caused the delay of mitotic process. Meanwhile, G1/S cell cycle arrest was observed in DBP5 and IPPK knock-down cells. Several factors that function in immune response were also down-regulated in DBP5 or IPPK knock-down cells. Thereby, IFN beta-1 mRNA transcription evoked by poly(I:C) treatment was suppressed. These results imply that DBP5, GLE1 and IP6 have a conserved and individual function in the cytoplasmic mRNA expression. Variations in phenotype are due to the difference in each function of DBP5, GLE1 and IPPK in intracellular mRNA metabolism.	[Okamura, Masumi; Yamanaka, Yasutaka; Shigemoto, Maki; Kitadani, Yuya; Kambe, Taiho; Nagao, Masaya; Masuda, Seiji] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto, Kyoto, Japan; [Kobayashi, Yuhko; Kobayashi, Issei] Mie Univ, Ctr Mol Biol & Genet, Tsu, Mie, Japan; [Okumura, Katsuzumi] Mie Univ, Grad Sch Bioresources, Dept Life Sci, Tsu, Mie, Japan	Kyoto University; Mie University; Mie University	Masuda, S (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto, Kyoto, Japan.	masuda@kais.kyoto-u.ac.jp			JSPS Kakenhi Grant [15K14919, 17K19232, 26292053]	JSPS Kakenhi Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by "grants-in-aid" from JSPS Kakenhi Grant Number 15K14919, 17K19232 and 26292053 to S.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aditi, 2015, MOL BIOL CELL, V26, P1476, DOI 10.1091/mbc.E14-11-1523; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Alcazar-Roman AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370; Aryanpur PP, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00139-17; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Bolger TA, 2011, J BIOL CHEM, V286, P39750, DOI 10.1074/jbc.M111.299321; Fellenberg J, 2016, CANCER LETT, V371, P134, DOI 10.1016/j.canlet.2015.10.039; Folkmann AW, 2013, CELL, V155, P582, DOI 10.1016/j.cell.2013.09.023; Folkmann AW, 2011, NUCLEUS-PHILA, V2, P540, DOI 10.4161/nucl.2.6.17881; Gross T, 2007, SCIENCE, V315, P646, DOI 10.1126/science.1134641; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hanakahi LA, 2002, EMBO J, V21, P2038, DOI 10.1093/emboj/21.8.2038; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Hatch AJ, 2010, CELL, V143, P1030, DOI 10.1016/j.cell.2010.11.045; HERVA R, 1988, AM J MED GENET, V29, P67, DOI 10.1002/ajmg.1320290109; Hodroj D, 2017, EMBO J; Ito Y, 2004, ANTICANCER RES, V24, P259; Jao LE, 2017, MOL BIOL CELL, V28, P120, DOI 10.1091/mbc.E16-09-0675; Jao LE, 2012, DEVELOPMENT, V139, P1316, DOI 10.1242/dev.074344; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kaneb HM, 2015, HUM MOL GENET, V24, P1363, DOI 10.1093/hmg/ddu545; Kendirgi F, 2003, J CELL BIOL, V160, P1029, DOI 10.1083/jcb.200211081; Kumar A, 2006, IMMUNOLOGY, V117, P11, DOI 10.1111/j.1365-2567.2005.02258.x; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Kutay U, 2008, CELL, V134, P564, DOI 10.1016/j.cell.2008.08.009; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Ma YM, 2002, J BIOL CHEM, V277, P10756, DOI 10.1074/jbc.C200030200; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Madabhushi R, 2014, NEURON, V83, P266, DOI 10.1016/j.neuron.2014.06.034; Mikhailova T, 2016, NUCLEIC ACIDS RES, pgkw1239; Montpetit B, 2011, NATURE, V472, P238, DOI 10.1038/nature09862; Nousiainen HO, 2008, NAT GENET, V40, P155, DOI 10.1038/ng.2007.65; Okamura M, 2015, GENES-BASEL, V6, P124, DOI 10.3390/genes6010124; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Qiu HY, 2014, J CLIN INVEST, V124, P981, DOI 10.1172/JCI72723; Rajakyla EK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6978; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Sarmah B, 2005, DEV CELL, V9, P133, DOI 10.1016/j.devcel.2005.05.002; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Seytanoglu A, 2016, NEUROSCIENCE, V322, P287, DOI 10.1016/j.neuroscience.2016.02.039; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561; Wang WY, 2013, NAT NEUROSCI, V16, P1383, DOI 10.1038/nn.3514; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Yamazaki T, 2010, MOL BIOL CELL, V21, P2953, DOI 10.1091/mbc.E09-10-0913	48	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197165	10.1371/journal.pone.0197165	http://dx.doi.org/10.1371/journal.pone.0197165			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746542	Green Submitted, Green Published, gold			2022-12-26	WOS:000431851700078
J	Daikoku, T				Daikoku, Tatsuya			Time-course variation of statistics embedded in music: Corpus study on implicit learning and knowledge	PLOS ONE			English	Article							ARTIFICIAL GRAMMARS; AUDITORY SEQUENCE; EXPECTATION; PERCEPTION; PROBABILITIES; GENERATION; LANGUAGE; MODEL	Learning and knowledge of transitional probability in sequences like music, called statistical learning and knowledge, are considered implicit processes that occur without intention to learn and awareness of what one knows. This implicit statistical knowledge can be alternatively expressed via abstract medium such as musical melody, which suggests this knowledge is reflected in melodies written by a composer. This study investigates how statistics in music vary over a composer's lifetime. Transitional probabilities of highest-pitch sequences in Ludwig van Beethoven's Piano Sonata were calculated based on different hierarchical Markov models. Each interval pattern was ordered based on the sonata opus number. The transitional probabilities of sequential patterns that are musical universal in music gradually decreased, suggesting that time-course variations of statistics in music reflect time-course variations of a composer's statistical knowledge. This study sheds new light on novel methodologies that may be able to evaluate the time-course variation of composer's implicit knowledge using musical scores.	[Daikoku, Tatsuya] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany	Max Planck Society	Daikoku, T (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany.	daikoku@cbs.mpg.de			Kao foundation for Arts and Sciences; Kawai Foundation for sound technology music	Kao foundation for Arts and Sciences; Kawai Foundation for sound technology music	This work was supported by Grant-in-Aid for Nakayama Foundation for Human Science, The Kao foundation for Arts and Sciences(http://www.kao-foundation.or.jp/english.html), and Kawai Foundation for sound technology & music(http://www.sound-zaidan.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abla D, 2008, J COGNITIVE NEUROSCI, V20, P952, DOI 10.1162/jocn.2008.20058; Adorno- Wiesengrund T., 1993, BEETHOVEN PHILOS MUS; Albrecht J, 2013, MUSIC PERCEPT, V31, P59, DOI 10.1525/MP.2013.31.1.59; Albrecht JD, 2014, MUSIC PERCEPT, V31, P223, DOI 10.1525/MP.2014.31.3.223; Backer E, 2005, PATTERN RECOGN LETT, V26, P299, DOI 10.1016/j.patrec.2004.10.016; Bains W, 2008, MED HYPOTHESES, V70, P186, DOI 10.1016/j.mehy.2007.08.004; Batterink LJ, 2015, J MEM LANG, V83, P62, DOI 10.1016/j.jml.2015.04.004; Berry D. C., 1993, IMPLICIT LEARNING TH; Bigand E, 2006, COGNITION, V100, P100, DOI 10.1016/j.cognition.2005.11.007; Blackburn P, 2005, STUDIES COMPUTATIONA; Boucourechliev A., 1963, BEETHOVEN; Chomsky N., 1957, SYNTACTIC STRUCTURES; Cilibrasi R, 2004, COMPUT MUSIC J, V28, P49, DOI 10.1162/0148926042728449; Clark A, 2012, HDB COMPUTATIONAL LI; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; Cohen H., 2003, APPL MULTIPLE REGRES; Dahlhaus C., 1991, L BEETHOVEN APPROACH; Daikoku T, 2017, BIOMAGNETIC SENDAI, V16; Daikoku T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10476-x; Daikoku T, 2017, NEUROPSYCHOLOGIA, V95, P1, DOI 10.1016/j.neuropsychologia.2016.12.006; Daikoku T, 2016, BRAIN COGNITION, V108, P1, DOI 10.1016/j.bandc.2016.06.008; Daikoku T, 2015, NEUROBIOL LEARN MEM, V118, P8, DOI 10.1016/j.nlm.2014.11.001; Daikoku T, 2014, NEUROPSYCHOLOGIA, V63, P194, DOI 10.1016/j.neuropsychologia.2014.08.028; Deliege I, 1996, MUSIC PERCEPT, V14, P117; Deliege I, 2001, MUSIC PERCEPT, V18, P371, DOI 10.1525/mp.2001.18.3.371; Dubnov S, 2010, MACHINE AUDITION PRI, P371; Ettlinger M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00211; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Furl N, 2011, NEUROIMAGE, V54, P2267, DOI 10.1016/j.neuroimage.2010.10.038; Gjerdingen RO, 2012, MUSIC PERCEPTION INT, V31, P192; Hansen N, 2014, FRONT NEUROL, V5, DOI [10.3389/fneur.2014.00080, 10.3389/fpsyg.2014.01052]; Hardoon DR, PASCAL 2005; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Huron D, 2012, TOP COGN SCI, V4, P678, DOI 10.1111/j.1756-8765.2012.01224.x; Ito JP, 2014, MUSIC PERCEPT, V31, P205, DOI 10.1525/MP.2014.31.3.205; Jackendoff R, 2006, COGNITION, V100, P33, DOI 10.1016/j.cognition.2005.11.005; Johnson D., 1985, BEETHOVEN SKETCHBOOK; Jonaitis EM, 2009, COGNITIVE SCI, V33, P951, DOI 10.1111/j.1551-6709.2009.01036.x; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19741; Koelsch S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00110; Kranenburg P., 2006, P ISMIR; London J, 2013, MUSIC PERCEPT, V31, P68, DOI 10.1525/MP.2013.31.1.68; LYNCH MP, 1991, J EXP PSYCHOL HUMAN, V17, P967, DOI 10.1037/0096-1523.17.4.967; Markov A. A., 1971, MARKOV CHAINS, V1; Norgaard M, 2014, MUSIC PERCEPT, V31, P271, DOI 10.1525/MP.2014.31.3.271; Nottebohm G., 1887, ZWEITE BEETHOVENIANA; Nottebohm G., 1872, BEETHOVENIANA; Omigie D, 2013, NEUROPSYCHOLOGIA, V51, P1749, DOI 10.1016/j.neuropsychologia.2013.05.010; Omigie D, 2012, NEUROPSYCHOLOGIA, V50, P1483, DOI 10.1016/j.neuropsychologia.2012.02.034; Paraskevopoulos E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16592-y; Paraskevopoulos E, 2012, NEUROPSYCHOLOGIA, V50, P341, DOI 10.1016/j.neuropsychologia.2011.12.007; Pearce MT, 2006, MUSIC PERCEPT, V23, P377, DOI 10.1525/mp.2006.23.5.377; Pearce MT, 2012, TOP COGN SCI, V4, P625, DOI 10.1111/j.1756-8765.2012.01214.x; Pearce MT, 2010, PERCEPTION, V39, P1365, DOI 10.1068/p6507; Pearce MT, 2004, J NEW MUSIC RES, V33, P367, DOI 10.1080/0929821052000343840; Pearce MT., 2005, THESIS; Perkovic S, 2018, PSYCHOL SCI, V29, P34, DOI 10.1177/0956797617733831; Perruchet P, 1998, J MEM LANG, V39, P246, DOI 10.1006/jmla.1998.2576; Perruchet P, 2006, TRENDS COGN SCI, V10, P233, DOI 10.1016/j.tics.2006.03.006; Pollastri E, 2001, FIRST INTERNATIONAL CONFERENCE ON WEB DELIVERING OF MUSIC, PROCEEDINGS, P88, DOI 10.1109/WDM.2001.990162; Poon H., 2007, AAAI, V7, P913; Prince JB, 2014, MUSIC PERCEPT, V31, P254, DOI 10.1525/MP.2014.31.3.254; Reber A.S., 1993, IMPLICIT LEARNING TA; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; Richardson M, 2006, MACH LEARN, V62, P107, DOI 10.1007/s10994-006-5833-1; Rohrmeier M, 2012, TOP COGN SCI, V4, P525, DOI 10.1111/j.1756-8765.2012.01223.x; Rohrmeier MA, 2014, CONSCIOUS COGN, V27, P155, DOI 10.1016/j.concog.2014.03.011; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 2005, DEVELOPMENTAL SCI, V8, P1, DOI 10.1111/j.1467-7687.2005.00387.x; SERVANSCHREIBER E, 1990, J EXP PSYCHOL LEARN, V16, P592, DOI 10.1037/0278-7393.16.4.592; Shanks D. R., 2005, HDB COGNITION, P203, DOI [10.4135/9781848608177.n8, DOI 10.4135/9781848608177.N8]; Singla P, 2006, IEEE DATA MINING, P572; Sullivan J., 1927, BEETHOVEN HIS SPIRIT; Tillmann B, 2000, PSYCHOL REV, V107, P885, DOI 10.1037/0033-295X.107.4.885; Vasuki PRM, 2017, CLIN NEUROPHYSIOL, V128, P1270, DOI 10.1016/j.clinph.2017.04.010; WAGENAAR WA, 1972, PSYCHOL BULL, V77, P65, DOI 10.1037/h0032060; Wang W., 2010, MACHINE AUDITION PRI; White CM, 2012, MUSIC PERCEPTION INT, V31, P244; Yumoto M., 2016, CLIN APPL MAGNETOENC	80	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196493	10.1371/journal.pone.0196493	http://dx.doi.org/10.1371/journal.pone.0196493			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF2GV	29742112	Green Published, gold, Green Submitted			2022-12-26	WOS:000431757400031
J	Ferrer, MD; Ketteler, M; Tur, F; Tur, E; Isern, B; Salcedo, C; Joubert, PH; Behets, GJ; Neven, E; D'Haese, PC; Perello, J				Ferrer, Miguel D.; Ketteler, Markus; Tur, Fernando; Tur, Eva; Isern, Bernet; Salcedo, Carolina; Joubert, Pieter H.; Behets, Geert J.; Neven, Ellen; D'Haese, Patrick C.; Perello, Joan			Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-ARTERY CALCIFICATION; ATOMIC-EMISSION-SPECTROMETRY; VASCULAR CALCIFICATION; HEMODIALYSIS-PATIENTS; AORTIC CALCIFICATION; PHYTIC ACID; SECONDARY HYPERPARATHYROIDISM; CALCIUM LEVELS; VITAMIN-D	End-stage renal disease is strongly associated with progressive cardiovascular calcification (CVC) and there is currently no therapy targeted to treat CVC. SNF472 is an experimental formulation under development for treatment of soft tissue calcification. We have investigated the pharmacokinetics of SNF472 administration in rats and its inhibitory effects on CVC. SNF472 was studied in three rat models: (1) prevention of vitamin D-3-induced CVC with an intravenous SNF472 bolus of 1 mg/kg SNF472, (2) inhibition of progression of vitamin D-3-induced CVC with a subcutaneous SNF472 bolus of 10 or 60 mg/kg SNF472, starting after calcification induction, (3) CVC in adenine-induced uremic rats treated with 50 mg/kg SNF472 via i.v. 4h -infusion. Uremic rats presented lower plasma levels of SNF472 than control animals after i.v. infusion. CVC in non-uremic rats was inhibited by 60-70% after treatment with SNF472 and progression of cardiac calcification completely blocked. Development of CVC in uremic rats was inhibited by up to 80% following i.v. infusion of SNF472. SNF472 inhibits the development and progression of CVC in uremic and non-uremic rats in the same range of SNF472 plasma levels but using in each case the required dose to obtain those levels. These results collectively support the development of SNF472 as a novel therapeutic option for treatment of CVC in humans.	[Ferrer, Miguel D.; Tur, Fernando; Tur, Eva; Isern, Bernet; Salcedo, Carolina; Joubert, Pieter H.; Perello, Joan] Lab Sanifit SL, Res & Dev Dept, Palma De Mallorca, Spain; [Ferrer, Miguel D.] Univ Balearic Isl, Dept Fundamental Biol & Hlth Sci, Palma De Mallorca, Spain; [Ketteler, Markus] Klinikum Coburg GmbH, Div Nephrol, Coburg, Germany; [Tur, Fernando; Perello, Joan] Univ Balearic Isl, Univ Inst Hlth Sci Res, Palma De Mallorca, Spain; [Joubert, Pieter H.] Kings Coll London, Inst Pharmaceut Sci, London, England; [Behets, Geert J.; Neven, Ellen; D'Haese, Patrick C.] Univ Antwerp, Dept Biomed Sci, Lab Pathophysiol, Antwerp, Belgium	Universitat de les Illes Balears; Klinikum Coburg; Universitat de les Illes Balears; University of London; King's College London; University of Antwerp	Perello, J (corresponding author), Lab Sanifit SL, Res & Dev Dept, Palma De Mallorca, Spain.; Perello, J (corresponding author), Univ Balearic Isl, Univ Inst Hlth Sci Res, Palma De Mallorca, Spain.	joan.perello@sanifit.com	Neven, Ellen/GVR-7948-2022; Reynés, Miguel David Ferrer/J-4206-2019; Perello, Joan/A-7387-2019; D'Haese, Patrick C/C-9599-2019	Reynés, Miguel David Ferrer/0000-0003-1924-7727; Perello, Joan/0000-0003-2671-3386; 	"Fundacion Genoma Espana/Centro para el Desarrollo Tecnologico Industrial" (CDTI) through the INNOCASH program [IC10- 129]; Laboratoris Sanifit; INNCORPORA-Torres Quevedo subprogram of the "Ministerio de Economia y Competitividad", Government of Spain [PTQ-11-04860, PTQ-09-01-00301, PTQ-11-04872]; Fundacion Genoma Espana/CDTI, Ministerio de Economia y Competitividad	"Fundacion Genoma Espana/Centro para el Desarrollo Tecnologico Industrial" (CDTI) through the INNOCASH program; Laboratoris Sanifit; INNCORPORA-Torres Quevedo subprogram of the "Ministerio de Economia y Competitividad", Government of Spain; Fundacion Genoma Espana/CDTI, Ministerio de Economia y Competitividad	This study was supported by a grant from "Fundacion Genoma Espana/Centro para el Desarrollo Tecnologico Industrial" (CDTI) through the INNOCASH program (IC10- 129) and from private funds of Laboratoris Sanifit. MF (PTQ-11-04860), ET (PTQ-09-01-00301) and CS (PTQ-11-04872) were co-funded by the INNCORPORA-Torres Quevedo subprogram of the "Ministerio de Economia y Competitividad", Government of Spain. The funders (Fundacion Genoma Espana/CDTI, Ministerio de Economia y Competitividad, the investors of Laboratoris Sanifit) provided support in the form of salaries for authors [MF, FT, ET, BI, CS, PJ, JP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Addison WN, 2010, BONE, V46, P1100, DOI 10.1016/j.bone.2010.01.367; Adragao T, 2004, NEPHROL DIAL TRANSPL, V19, P1480, DOI 10.1093/ndt/gfh217; Bas A, 2006, J BONE MINER RES, V21, P484, DOI 10.1359/JBMR.051211; Block GA, 2007, KIDNEY INT, V71, P438, DOI 10.1038/sj.ki.5002059; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Block GA, 2005, KIDNEY INT, V68, P1815, DOI 10.1111/j.1523-1755.2005.00600.x; Canan C, 2012, ACTA SCI-TECHNOL, V34, P457, DOI 10.4025/actascitechnol.v34i4.16358; Chertow GM, 2002, KIDNEY INT, V62, P245, DOI 10.1046/j.1523-1755.2002.00434.x; Conte A, 1999, Arch Esp Urol, V52, P305; Cozzolino M, 2005, KIDNEY INT, V68, P429, DOI 10.1111/j.1523-1755.2005.00421.x; Curhan GC, 2004, ARCH INTERN MED, V164, P885, DOI 10.1001/archinte.164.8.885; Arriero MD, 2012, CELL PHYSIOL BIOCHEM, V30, P974, DOI 10.1159/000341474; Ferrer MD, 2016, CKD MBD ERA EDTA M A; Fukagawa M, 2008, NEPHROL DIAL TRANSPL, V23, P328, DOI 10.1093/ndt/gfm534; GRAF E, 1987, J BIOL CHEM, V262, P11647; GRAF E, 1985, CANCER-AM CANCER SOC, V56, P717, DOI 10.1002/1097-0142(19850815)56:4<717::AID-CNCR2820560402>3.0.CO;2-4; Grases F, 2006, FRONT BIOSCI-LANDMRK, V11, P136, DOI 10.2741/1786; Grases F, 2004, ANAL CHIM ACTA, V510, P41, DOI 10.1016/j.aca.2003.12.061; Grases F, 1999, ANTICANCER RES, V19, P3717; Grases F, 1996, ANAL LETT, V29, P1193, DOI 10.1080/00032719608001468; Grases F, 2000, SCAND J UROL NEPHROL, V34, P162, DOI 10.1080/003655900750016526; Grases F, 2008, FRONT BIOSCI-LANDMRK, V13, P7115, DOI 10.2741/3214; Grases F, 2007, CIRC J, V71, P1152, DOI 10.1253/circj.71.1152; Grases F, 2010, J MED FOOD, V13, P1301, DOI 10.1089/jmf.2009.0152; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P948, DOI 10.1093/ndt/gfn571; Lomashvili KA, 2008, KIDNEY INT, V73, P1024, DOI 10.1038/ki.2008.26; Lopez-Gonzalez AA, 2008, J MED FOOD, V11, P747, DOI 10.1089/jmf.2008.0087; Lopez-Gonzalez AA, 2013, EUR J NUTR, V52, P717, DOI 10.1007/s00394-012-0377-6; Lopez-Gonzalez Angel A, 2010, Front Biosci (Elite Ed), V2, P1093; Neven E, 2007, KIDNEY INT, V72, P574, DOI 10.1038/sj.ki.5002353; Neven E, 2015, J BONE MINER RES, V30, P2313, DOI 10.1002/jbmr.2585; Neven E, 2010, ARTERIOSCL THROM VAS, V30, P1741, DOI 10.1161/ATVBAHA.110.204834; O'Neill WC, 2011, KIDNEY INT, V79, P512, DOI 10.1038/ki.2010.461; Raggi P, 2011, NEPHROL DIAL TRANSPL, V26, P1327, DOI 10.1093/ndt/gfq725; Russo D, 2004, AM J KIDNEY DIS, V44, P1024, DOI 10.1053/j.ajkd.2004.07.022; Russo D, 2013, BLOOD PURIFICAT, V36, P17, DOI 10.1159/000350580; Russo D, 2011, KIDNEY INT, V80, P112, DOI 10.1038/ki.2011.69; Schlieper G, 2007, SEMIN DIALYSIS, V20, P113, DOI 10.1111/j.1525-139X.2007.00257.x; Shantouf RS, 2010, AM J NEPHROL, V31, P419, DOI 10.1159/000294405; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; Tamura K, 2005, J PHARMACOL SCI, V99, P89, DOI 10.1254/jphs.FPJ05019X; Terai K, 2009, BRIT J PHARMACOL, V156, P1267, DOI 10.1111/j.1476-5381.2008.00108.x; Toussaint ND, 2009, CLIN J AM SOC NEPHRO, V4, P221, DOI 10.2215/CJN.02550508; Tur F, 2013, J CHROMATOGR B, V928, P146, DOI 10.1016/j.jchromb.2013.03.023; VANDENBERG CJ, 1972, CLIN SCI, V43, P377, DOI 10.1042/cs0430377; Verberckmoes SC, 2007, KIDNEY INT, V71, P298, DOI 10.1038/sj.ki.5002028	46	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							0197061	10.1371/journal.pone.0197061	http://dx.doi.org/10.1371/journal.pone.0197061			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742152	Green Published, Green Submitted, gold			2022-12-26	WOS:000431757400059
J	Clarisse, D; Van Wesemael, K; Tavernier, J; Offner, F; Beck, IM; De Bosscher, K				Clarisse, Dorien; Van Wesemael, Karlien; Tavernier, Jan; Offner, Fritz; Beck, Ilse M.; De Bosscher, Karolien			Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; INDUCED APOPTOSIS; MOLECULAR-MECHANISMS; MEDIATED APOPTOSIS; PLANT-ORIGIN; MOUSE MODEL; IN-VIVO; KAPPA-B; RESISTANCE; LIGAND	Glucocorticoids (GCs) are a cornerstone in the treatment of lymphoid malignancies such as multiple myeloma (MM) and acute lymphoblastic leukemia (ALL). Yet, prolonged GC use is hampered by deleterious GC-related side effects and the emergence of GC resistance. To tackle and overcome these GC-related problems, the applicability of selective glucocorticoid receptor agonists and modulators was studied, in search of fewer side-effects and at least equal therapeutic efficacy as classic GCs. Compound A (CpdA) is a prototypical example of such a selective glucocorticoid receptor modulator and does not support GR-mediated transactivation. Here, we examined whether the combination of CpdA with the classic GC dexamethasone (Dex) may improve GC responsiveness of MM and ALL cell lines. We find that the combination of Dex and CpdA does not substantially enhance GC-mediated cell killing. In line, several apoptosis hallmarks, such as caspase 3/7 activity, PARP cleavage and the levels of cleaved-caspase 3 remain unchanged upon combining Dex with CpdA. Moreover, we monitor no additional inhibition of cell proliferation and the homologous downregulation of GR is not counteracted by the combination of Dex and CpdA. In addition, CpdA is unable to modulate Dex-liganded GR transactivation and transrepression, yet, Dex-mediated transrepression is also aberrant in these lymphoid cell lines. Together, transrepression-favoring compounds, alone or combined with GCs, do not seem a valid strategy in the treatment of lymphoid malignancies.	[Clarisse, Dorien; Tavernier, Jan; De Bosscher, Karolien] Univ Ghent, Dept Biomol Med, VIB UGent Ctr Med Biotechnol, Receptor Res Labs,NRL, Ghent, Belgium; [Clarisse, Dorien; Tavernier, Jan; De Bosscher, Karolien] Univ Ghent, Dept Biomol Med, VIB UGent Ctr Med Biotechnol, CRL, Ghent, Belgium; [Clarisse, Dorien; Van Wesemael, Karlien; Beck, Ilse M.] Univ Ghent, LECR, Dept Radiat Oncol & Expt Canc Res, Ghent, Belgium; [Clarisse, Dorien; Tavernier, Jan; De Bosscher, Karolien] CRIG, Ghent, Belgium; [Clarisse, Dorien; Van Wesemael, Karlien; Offner, Fritz] Ghent Univ Hosp, Dept Internal Med, Hematol, Ghent, Belgium; [Beck, Ilse M.] Odisee Univ Coll, Dept Hlth Sci, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; Ghent University; Ghent University Hospital	De Bosscher, K (corresponding author), Univ Ghent, Dept Biomol Med, VIB UGent Ctr Med Biotechnol, Receptor Res Labs,NRL, Ghent, Belgium.; De Bosscher, K (corresponding author), Univ Ghent, Dept Biomol Med, VIB UGent Ctr Med Biotechnol, CRL, Ghent, Belgium.; De Bosscher, K (corresponding author), CRIG, Ghent, Belgium.	karolien.debosscher@vib-ugent.be	Tavernier, Jan/AAG-3636-2019; Clarisse, Dorien/AAS-9957-2021	Clarisse, Dorien/0000-0002-2580-2291; De Bosscher, Karolien/0000-0001-5059-9718	Flanders Innovation and Entrepreneurship (VLAIO) [131374]; Research Foundation Flanders (FWO) [1.2.405.10.N.00]; Stand up against cancer [KDB 2012-VLK-GC-MM]	Flanders Innovation and Entrepreneurship (VLAIO); Research Foundation Flanders (FWO)(FWO); Stand up against cancer	DC is funded by a predoctoral fellowship from Flanders Innovation and Entrepreneurship (VLAIO), previously agentschap voor Innovate door Wetenschap en Technologie (IWT), grant number 131374 (www.vlaio.be). IMB was a postdoctoral fellow of the Research Foundation Flanders (FWO) until September 2016, grant number 1.2.405.10.N.00 (www.fwo.be). This work was part of a research project realized with the support of 'Stand up against cancer' (Kom op tegen kanker), previously the Flemish League against Cancer (Vlaamse Liga tegen Kanker), grant number KDB 2012-VLK-GC-MM (www.komoptegenkanker.be).	Altonsy MO, 2014, J BIOL CHEM, V289, P8231, DOI 10.1074/jbc.M113.545178; Beck IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069115; Chen Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9323; Clarisse D, 2017, ONCOTARGET, V8, P109675, DOI 10.18632/oncotarget.22764; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; De Bosscher K, 2016, TRENDS PHARMACOL SCI, V37, P4, DOI 10.1016/j.tips.2015.09.002; De Bosscher K, 2010, BRAIN BEHAV IMMUN, V24, P1035, DOI 10.1016/j.bbi.2010.06.010; De Bosscher K, 2010, CURR OPIN PHARMACOL, V10, P497, DOI 10.1016/j.coph.2010.04.007; De Bosscher K, 2010, J STEROID BIOCHEM, V120, P96, DOI 10.1016/j.jsbmb.2010.02.027; Deroo BJ, 2001, MOL BIOL CELL, V12, P3365, DOI 10.1091/mbc.12.11.3365; Desmet SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07941-y; Dewint P, 2008, J IMMUNOL, V180, P2608, DOI 10.4049/jimmunol.180.4.2608; Drebert Z, 2015, J STEROID BIOCHEM, V149, P92, DOI 10.1016/j.jsbmb.2015.02.002; Gavrila A, 2015, AM J RESP CELL MOL, V53, P728, DOI 10.1165/rcmb.2014-0477OC; Gossye V, 2010, ANN RHEUM DIS, V69, P291, DOI 10.1136/ard.2008.102871; Greenstein S, 2003, EXP HEMATOL, V31, P271, DOI 10.1016/S0301-472X(03)00023-7; Greenstein S, 2002, CLIN CANCER RES, V8, P1681; Gross KL, 2009, MOL CELL ENDOCRINOL, V300, P7, DOI 10.1016/j.mce.2008.10.001; Gruver-Yates Amanda L, 2013, Cells, V2, P202, DOI 10.3390/cells2020202; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hellemans J, 2014, METHODS MOL BIOL, V1160, P19, DOI 10.1007/978-1-4939-0733-5_3; Herr I, 2007, APOPTOSIS, V12, P271, DOI 10.1007/s10495-006-0624-5; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Kfir-Erenfeld S, 2014, CANCER IMMUNOL IMMUN, V63, P37, DOI 10.1007/s00262-013-1477-8; Lesovaya EA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1242, DOI 10.1134/S000629791111006X; Lesovaya E, 2013, CELL CYCLE, V12, P133, DOI 10.4161/cc.23048; Lim HW, 2015, GENOME RES, V25, P836, DOI 10.1101/gr.188581.114; Louw A, 1997, BIOCHEM PHARMACOL, V53, P189, DOI 10.1016/S0006-2952(96)00661-2; Medh RD, 2003, GENOMICS, V81, P543, DOI 10.1016/S0888-7543(03)00045-4; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Norman M, 2002, CURR OPIN PHARMACOL, V2, P723, DOI 10.1016/S1471-4892(02)00232-1; Oh KS, 2017, IMMUNITY, V47, P298, DOI 10.1016/j.immuni.2017.07.012; Rajkumar SV, 2016, AM J HEMATOL, V91, P720, DOI 10.1002/ajh.24402; Ramamoorthy S, 2016, RHEUM DIS CLIN N AM, V42, P15, DOI 10.1016/j.rdc.2015.08.002; Ratman D, 2013, MOL CELL ENDOCRINOL, V380, P41, DOI 10.1016/j.mce.2012.12.014; Rauner M, 2011, ENDOCRINOLOGY, V152, P103, DOI 10.1210/en.2010-0456; Reber LL, 2012, J IMMUNOL, V188, P3478, DOI 10.4049/jimmunol.1004227; Robertson S, 2013, STEROIDS, V78, P182, DOI 10.1016/j.steroids.2012.10.016; Robertson S, 2010, J BIOL CHEM, V285, P8061, DOI 10.1074/jbc.M109.087866; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Schaaf MJM, 2002, J STEROID BIOCHEM, V83, P37, DOI 10.1016/S0960-0760(02)00263-7; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schlossmacher G, 2011, J ENDOCRINOL, V211, P17, DOI 10.1530/JOE-11-0135; Schmidt S, 2004, CELL DEATH DIFFER, V11, pS45, DOI 10.1038/sj.cdd.4401456; Smith LK, 2010, PROG BRAIN RES, V182, P1, DOI 10.1016/S0079-6123(10)82001-1; Sundahl N, 2016, ONCOSCIENCE, V3, P22, DOI [10.18632/oncoscience.315, DOI 10.18632/ONCOSCIENCE.315]; Sundahl N, 2015, PHARMACOL THERAPEUT, V152, P28, DOI 10.1016/j.pharmthera.2015.05.001; Talaber G, 2009, INT IMMUNOL, V21, P1269, DOI 10.1093/intimm/dxp093; Tan CK, 2016, P NATL ACAD SCI USA, V113, P1115, DOI 10.1073/pnas.1524215113; Thiele S, 2012, J BONE MINER RES, V27, P2242, DOI 10.1002/jbmr.1688; van Loo G, 2010, MOL ENDOCRINOL, V24, P310, DOI 10.1210/me.2009-0236; Vandevyver S, 2012, TRAFFIC, V13, P364, DOI 10.1111/j.1600-0854.2011.01288.x; Vettorazzi S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8796; Wust S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008202; Yang N, 2012, STEROIDS, V77, P1041, DOI 10.1016/j.steroids.2012.05.007; Yemelyanov A, 2008, CANCER RES, V68, P4763, DOI 10.1158/0008-5472.CAN-07-6104; Yemelyanov A, 2012, CELL CYCLE, V11, P395, DOI 10.4161/cc.11.2.18945; Zhang ZR, 2009, J IMMUNOL, V183, P3081, DOI 10.4049/jimmunol.0901088; Zheng YC, 2015, MOL ENDOCRINOL, V29, P1486, DOI 10.1210/me.2015-1128	60	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0197000	10.1371/journal.pone.0197000	http://dx.doi.org/10.1371/journal.pone.0197000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738549	Green Published, Green Submitted, gold			2022-12-26	WOS:000431724900041
J	Sajjadi, H; Shushtari, ZJ; Shati, M; Salimi, Y; Dejman, M; Vameghi, M; Karimi, S; Mahmoodi, Z				Sajjadi, Homeira; Shushtari, Zahra Jorjoran; Shati, Mohsen; Salimi, Yahya; Dejman, Masoomeh; Vameghi, Meroe; Karimi, Salahedin; Mahmoodi, Zohreh			An indirect estimation of the population size of students with high-risk behaviors in select universities of medical sciences: A network scale-up study	PLOS ONE			English	Article							HIV RISK	Background Network scale-up is one of the most important indirect methods of estimating the size of clandestine populations and people with high-risk behaviors. The present study is an indirect estimation of the population size of students with high-risk behaviors in select universities of medical sciences. Methods A total of 801 students from two University of Medical Sciences at Tehran and Alborz University of Medical Sciences were selected through convenience sampling. Six subgroups of high-risk behaviors were examined in the study, including Tramadol use, cannabis use, opium use, alcohol consumption, extramarital heterosexual intercourse, and heterosexual intercourse in return for money. To estimate the social network size in the study population, each participant was asked to name their close student friends from the two select universities. Data were collected using a checklist designed for this purpose. Results The participants' mean number of close friends from the selected medical universities was C = 8.14 (CI: 7.54-8.75). Within these social networks, friends with extramarital heterosexual intercourse (5.53%) and friends who consumed alcohol (4.92%) had the highest frequency, and friends who used opium (0.33%) had the lowest frequency. The variables of age, gender, marital status, type of residence and academic degree were significantly related to the likelihood of having close friends with certain high-risk behaviors (P<0.001). Conclusion According to the results obtained, alcohol consumption and extramarital heterosexual intercourse are very common among students. Special HIV prevention programs are therefore necessary for this age group.	[Sajjadi, Homeira; Shushtari, Zahra Jorjoran] Univ Social Welf & Rehabil Sci, Social Determinants Hlth Res Ctr, Tehran, Iran; [Shati, Mohsen] Univ Social Welf & Rehabil Sci, Dept Aging, Tehran, Iran; [Salimi, Yahya] Kermanshah Univ Med Sci, Social Dev & Hlth Promot Res Ctr, Kermanshah, Iran; [Salimi, Yahya] Kermanshah Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Kermanshah, Iran; [Dejman, Masoomeh] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Dejman, Masoomeh; Vameghi, Meroe] Univ Social Welf & Rehabil Sci, Social Welf Management Res Ctr, Tehran, Iran; [Karimi, Salahedin] Tabriz Univ Med Sci, Social Determinants Hlth Res Ctr, Tabriz, Iran; [Mahmoodi, Zohreh] Alborz Univ Med Sci, Social Determinants Hlth Res Ctr, Karaj, Iran	Kermanshah University of Medical Sciences; Kermanshah University of Medical Sciences; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tabriz University of Medical Science	Mahmoodi, Z (corresponding author), Alborz Univ Med Sci, Social Determinants Hlth Res Ctr, Karaj, Iran.	zohrehmahmoodi2011@gmail.com	mahmoodi, zohreh/AAM-7529-2020; karimi, salah/R-6999-2019; Salimi, Yahya/V-2626-2017; Shushtari, Zahra Jorjoran/G-9701-2019; mahmoodi, zohreh/E-9442-2015; vameghi, Meroe/AAE-8844-2021; Vameghi, Meroe/J-5324-2017	mahmoodi, zohreh/0000-0002-7868-6941; karimi, salah/0000-0002-1542-0214; Salimi, Yahya/0000-0001-9351-3208; mahmoodi, zohreh/0000-0002-7868-6941; 				[Anonymous], 2015, ISLAMIC REPUBLIC IRA; Bao Shui-Lian, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P1036; Bayrami M., 2010, Urmia Medical Journal, V21, P215; Bernard HR, 2010, SEX TRANSM INFECT, V86, pI11, DOI 10.1136/sti.2010.044446; Coordinator UtUOotGA, CONS NETW SCAL OTH S; Ege E, 2011, SEX DISABIL, V29, P229, DOI 10.1007/s11195-011-9205-9; Ezoe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031184; Farahani Farideh Khalaj Abadi, 2012, J Reprod Infertil, V13, P101; Feehan DM, 2016, SOCIOL METHODOL, V46, P153, DOI 10.1177/0081175016665425; Feehan DM, 2016, AM J EPIDEMIOL, V183, P747, DOI 10.1093/aje/kwv287; Guo WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070718; Hajian K, 2011, J GORGAN U MED SCI, V13, P53; Kadushin C, 2006, J DRUG ISSUES, V36, P417, DOI 10.1177/002204260603600209; Karami J, 2015, J WOMEN STUDIES SOCI, V13, P129; Kazemeini T., 2013, J RAFSANJAN U MED SC, V12, P15; Kazemzadeh Y., 2016, INT J HIGH RISK BEHA, V5, pe25130, DOI [https://doi.org/10.5812/ijhrba.25130, DOI 10.5812/IJHRBA.25130]; Killworth PD, 1998, EVALUATION REV, V22, P289, DOI 10.1177/0193841X9802200205; Mahboubi S., 2017, INT J ADOLESCENT MED; Mahmoodi N, 2010, J APPL SOCIOLOGY, V21, P35; McCarty C, 2001, HUM ORGAN, V60, P28, DOI 10.17730/humo.60.1.efx5t9gjtgmga73y; Paniotto V, 2009, ESTIMATING SIZE POPU; Ramezani Amitis, 2006, Arch Iran Med, V9, P315; Rastegari Azam, 2013, Glob J Health Sci, V5, P217, DOI 10.5539/gjhs.v5n4p217; Rezazadeh M., 2015, J FUNDAMENTALS MENTA, V17, P148; Salganik MJ, 2011, SOC NETWORKS, V33, P70, DOI 10.1016/j.socnet.2010.10.006; Shati M, 2014, IRAN J PUBLIC HEALTH, V43, P1079; Sheikhzadeh K, 2016, J SUBST USE, V21, P9, DOI 10.3109/14659891.2014.942401; Shokoohi M, 2012, INT J PREVENTIVE MED, V3, P471; Siam S., 2007, DRUG ABUSE PREVALENC; Smith DJ, 2007, AM J PUBLIC HEALTH, V97, P997, DOI 10.2105/AJPH.2006.088583; Snyder DK, 2007, PSYCHOL PSYCHOL, P12; Taghavi M, 2013, SCI Q RES ADDICTION, V7, P9; Trkulja V, 2003, CROAT MED J, V44, P50; Varma DS, 2010, J WOMENS HEALTH, V19, P815, DOI 10.1089/jwh.2008.0884; Zarrabi H., 2009, Acta Medica Iranica, V47, P473	35	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0195364	10.1371/journal.pone.0195364	http://dx.doi.org/10.1371/journal.pone.0195364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF1VY	29738560	Green Published, Green Submitted, gold			2022-12-26	WOS:000431724900003
J	Wang, JK; Fan, YL; Dong, Y; Ma, MY; Dong, YR; Niu, YJ; Jiang, Y; Wang, H; Wang, ZY; Wu, LZ; Sun, HQ; Cui, CL				Wang, Junkai; Fan, Yunli; Dong, Yue; Ma, Mengying; Dong, Yuru; Niu, Yajuan; Jiang, Yin; Wang, Hong; Wang, Zhiyan; Wu, Liuzhen; Sun, Hongqiang; Cui, Cailian			Combining gray matter volume in the cuneus and the cuneus-prefrontal connectivity may predict early relapse in abstinent alcohol-dependent patients	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; ANTERIOR CINGULATE CORTEX; DECISION-MAKING; RESTING BRAIN; RISK-TAKING; INDIVIDUALS; ASSOCIATION; ADDICTION	Background Developing more effective strategies to prevent relapse remains one of the major challenges of treating substance dependence. Previous studies have identified brain abnormalities in abstinent alcoholics. However, whether these persistent brain deficits in abstinence could predict early relapse to alcohol use has not been well established. This study aimed to identify biomarkers of relapse vulnerability by investigating persistent brain abnormalities in abstinent alcohol-dependent patients. Methods Brain imaging and impulsive behavior data were collected from 56 abstinent alcohol-dependent male inpatients and 33 age-matched male healthy controls. Voxel-based morphometry was used to investigate the differences of grey matter volume between the groups. The resting-state functional connectivity was examined using brain areas with gray matter deficits as seed regions. A preliminary prospective study design was used to classify patients into abstainers and relapsers after a 62-day average abstinence period. Results Compared with healthy controls, both relapsers and abstainers exhibited significantly reduced gray matter volume in the cuneus. Functional connectivity analysis revealed that relapsers relative to abstainers demonstrated increased cuneus-centered negative functional connectivity within a network of brain regions which are involved in executive control and salience. Abnormal gray matter volume in the left cuneus and the functional connectivity between the right cuneus and bilateral dorsolateral prefrontal cortex could successfully predict relapse during the 3-month follow-up period. Conclusions Findings suggest that the abnormal gray matter volume in the cuneus and resting-state cuneus-prefrontal functional connectivity may play an important role in poor treatment outcomes in alcoholics and serve as useful neural markers of relapse vulnerability.	[Wang, Junkai; Wang, Zhiyan; Wu, Liuzhen; Cui, Cailian] Peking Univ, Neurosci Res Inst, Beijing, Peoples R China; [Wang, Junkai; Wang, Zhiyan; Wu, Liuzhen; Cui, Cailian] Peking Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China; [Wang, Junkai; Wang, Zhiyan; Wu, Liuzhen; Cui, Cailian] Minist Educ, Key Lab Neurosci, Beijing, Peoples R China; [Wang, Junkai; Wang, Zhiyan; Wu, Liuzhen; Cui, Cailian] Minist Publ Hlth, Beijing, Peoples R China; [Fan, Yunli; Ma, Mengying; Niu, Yajuan] Peking Univ, Beijing Hui Long Guan Hosp, Beijing, Peoples R China; [Dong, Yue; Dong, Yuru; Wang, Hong] Gen Hosp Armed Police Forces, Dept Magnet Resonance, Beijing, Peoples R China; [Jiang, Yin] Capital Med Univ, Beijing Neurosurg Inst, Stereotact & Funct Neurosurg Lab, Beijing, Peoples R China; [Sun, Hongqiang] Peking Univ, Inst Mental Hlth, Hosp 6, Beijing, Peoples R China; [Sun, Hongqiang] Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China	Peking University; Peking University; Peking University; Beijing Neurosurgical Institute; Capital Medical University; Peking University; Peking University	Cui, CL (corresponding author), Peking Univ, Neurosci Res Inst, Beijing, Peoples R China.; Cui, CL (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China.; Cui, CL (corresponding author), Minist Educ, Key Lab Neurosci, Beijing, Peoples R China.; Cui, CL (corresponding author), Minist Publ Hlth, Beijing, Peoples R China.	clcui@bjmu.edu.cn		Wang, Zhiyan/0000-0001-7910-3245	National Natural Science Foundation [81471353, 81371462, 81571297]; National Basic Research Program [2015CB553500]; Science Fund for Creative Research Groups from the National Natural Science Foundation [81521063]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Science Fund for Creative Research Groups from the National Natural Science Foundation	This work was supported by the National Natural Science Foundation 81471353, Dr. Cailian Cui; the National Natural Science Foundation 81371462, Liuzhen Wu; the National Natural Science Foundation 81571297, Hongqiang Sun; the National Basic Research Program 2015CB553500, Dr. Cailian Cui; the Science Fund for Creative Research Groups from the National Natural Science Foundation 81521063, Dr. Cailian Cui. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bowden-Jones H, 2005, J NEUROPSYCH CLIN N, V17, P417, DOI 10.1176/appi.neuropsych.17.3.417; Camchong J, 2013, CEREB CORTEX, V23, P2086, DOI 10.1093/cercor/bhs190; Camchong J, 2011, BIOL PSYCHIAT, V69, P1117, DOI 10.1016/j.biopsych.2011.01.008; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Colibazzi T, 2010, EMOTION, V10, P377, DOI 10.1037/a0018484; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Dawson DA, 2007, ALCOHOL CLIN EXP RES, V31, P2036, DOI 10.1111/j.1530-0277.2007.00536.x; De Wilde B, 2013, EUR ADDICT RES, V19, P21, DOI 10.1159/000339290; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Demirakca T, 2011, ALCOHOL CLIN EXP RES, V35, P1678, DOI 10.1111/j.1530-0277.2011.01514.x; Fama R, 2004, ALCOHOL CLIN EXP RES, V28, P1657, DOI 10.1097/01.ALC.0000145690.48510.DA; Filbey FM, 2014, P NATL ACAD SCI USA, V111, P16913, DOI 10.1073/pnas.1415297111; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Hommer DW, 2001, AM J PSYCHIAT, V158, P198, DOI 10.1176/appi.ajp.158.2.198; Hong LE, 2009, ARCH GEN PSYCHIAT, V66, P431, DOI 10.1001/archgenpsychiatry.2009.2; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Khullar S, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00093; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liang PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep18216; Loeber S, 2009, ADDICT BIOL, V14, P194, DOI 10.1111/j.1369-1600.2009.00146.x; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Muller-Oehring Eva M, 2015, Cereb Cortex, V25, P4155, DOI 10.1093/cercor/bhu134; Pattij T, 2013, CURR OPIN NEUROBIOL, V23, P700, DOI 10.1016/j.conb.2013.01.023; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Rando K, 2011, AM J PSYCHIAT, V168, P183, DOI 10.1176/appi.ajp.2010.10020233; Segall JM, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00010; Segobin SH, 2014, ALCOHOL CLIN EXP RES, V38, P739, DOI 10.1111/acer.12300; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; Sheehan DV, 1998, J CLIN PSYCHIAT S20, V59, P22, DOI DOI 10.1016/S0924-9338(99)80239-9; Sheehan DV, 1998, J CLIN PSYCHIAT S20, V59, P4; Shi L, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00414; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sui J, 2014, NEUROIMAGE, V102, P11, DOI 10.1016/j.neuroimage.2013.09.044; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; Tomasi D, 2011, CEREB CORTEX, V21, P2003, DOI 10.1093/cercor/bhq268; van Eijk J, 2013, ALCOHOL CLIN EXP RES, V37, P67, DOI 10.1111/j.1530-0277.2012.01853.x; Wang JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161956; Wang LB, 2016, ADDICT BIOL, V21, P646, DOI 10.1111/adb.12228; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Xiao PR, 2015, DRUG ALCOHOL DEPEN, V153, P22, DOI 10.1016/j.drugalcdep.2015.05.030; Yang X, 2016, NEUROSCI BIOBEHAV R, V66, P92, DOI 10.1016/j.neubiorev.2016.03.034	50	25	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196860	10.1371/journal.pone.0196860	http://dx.doi.org/10.1371/journal.pone.0196860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE8KX	29734343	Green Published, gold, Green Submitted			2022-12-26	WOS:000431481700030
J	Gao, RJ; Xu, ZC; Deng, HX; Guan, ZB; Liao, XR; Zhao, Y; Zheng, XH; Cai, YJ				Gao, Ruijie; Xu, Zhecun; Deng, Huaxiang; Guan, Zhengbing; Liao, Xiangru; Zhao, Ye; Zheng, Xiaohui; Cai, Yujie			Enhanced hypocrellin production of Shiraia sp SUPER-H168 by overexpression of alpha-amylase gene	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; PHOTODYNAMIC THERAPY; ASPERGILLUS-ORYZAE; STARCH GRANULES; MAIZE KERNELS; BAMBUSICOLA; METABOLISM; IDENTIFICATION; BIOSYNTHESIS; GLUCOSIDASE	Relative expression levels of twenty-four amylase genes in Shiraia sp. SUPER-H168 were investigated by real-time quantitative PCR when various carbohydrates, including glucose, sucrose, maltose, amylose, amylopectin and corn flour, were used as carbon source. Genes, including an alpha-glucosidase gene Amy33 (2997 bp), an alpha-amylase gene Amy365-1 (1749 bp) and a glycogen debranching enzyme gene Amy130 (2487 bp), were overexpressed, and four overexpression transformants were constructed, respectively. When Amy365-1 and Amy130 were co-overexpressed, relative expression levels of seven hypocrellin biosynthesis genes and four related genes in central carbon catabolism were all increased. Expression of Amy33 was also increased along with increase of Amy365-1 and Amy130. Under liquid state fermentation, biomasses and hypocrellin productions were both gradually increased in four overexpression strains than those of wild type strain. Under SSF, hypocrellin production of Amy365-1 and Amy130 co-expression strain reached 71.85 mg/ gds, which was 2.83 fold than that of wild type strain, and residual sugar was decreased from 35.47% to 16.68%. These results can provide a practical approach for other secondary metabolites by filamentous fungi under SSF when raw starch material is used as carbon source.	[Gao, Ruijie; Xu, Zhecun; Deng, Huaxiang; Guan, Zhengbing; Liao, Xiangru; Cai, Yujie] Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China; [Zhao, Ye; Zheng, Xiaohui] Northwest Univ, Coll Life Sci, Xian, Shanxi, Peoples R China	Jiangnan University; Northwest University Xi'an	Cai, YJ (corresponding author), Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China.; Zhao, Y (corresponding author), Northwest Univ, Coll Life Sci, Xian, Shanxi, Peoples R China.	zhaoye@nwu.edu.cn; yjcai@jiangnan.edu.cn			National Science Foundation of China [21275066]; fundamental research of doctor of philosophy [2050205]; Project of Graduate Student Scientific Research and Innovation of Jiangsu province [205020502]; Six Talent Peak Program [SWYY-126]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); fundamental research of doctor of philosophy; Project of Graduate Student Scientific Research and Innovation of Jiangsu province; Six Talent Peak Program	This work was financially supported by the National Science Foundation of China (Grant No. 21275066), fundamental research of doctor of philosophy at 2014 (Grant No. 2050205), Project of Graduate Student Scientific Research and Innovation of Jiangsu province at 2015 (Grant No. 205020502), Six Talent Peak Program at 2016 (Grant No. SWYY-126).; This work was financially supported by the National Science Foundation of China (Grant No. 21275066), fundamental research of doctor of philosophy at 2014 (Grant No. 2050205), Project of Graduate Student Scientific Research and Innovation of Jiangsu province at 2015 (Grant No. 205020502), Six Talent Peak Program at 2016 (Grant No. SWYY-126).	Afrisham S, 2016, J MOL CATAL B-ENZYM, V132, P98, DOI 10.1016/j.molcatb.2016.07.002; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Allison Ron R, 2006, Future Oncol, V2, P53, DOI 10.2217/14796694.2.1.53; Amano N, 1980, B NATL SCI MUS B, V6, P55; Bar-Even A, 2012, NAT CHEM BIOL, V8, P509, DOI [10.1038/NCHEMBIO.971, 10.1038/nchembio.971]; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Bluhm BH, 2005, MOL PLANT MICROBE IN, V18, P1333, DOI 10.1094/MPMI-18-1333; Cai YJ, 2011, NEW BIOTECHNOL, V28, P588, DOI 10.1016/j.nbt.2011.02.001; Cai YJ, 2010, APPL BIOCHEM BIOTECH, V160, P2275, DOI 10.1007/s12010-009-8728-3; Castano AP, 2005, PHOTODIAGN PHOTODYN, V2, P1, DOI 10.1016/S1572-1000(05)00030-X; Cheng TF, 2004, J BASIC MICROB, V44, P339, DOI 10.1002/jobm.200410434; Chiba S, 1997, BIOSCI BIOTECH BIOCH, V61, P1233, DOI 10.1271/bbb.61.1233; de Castro AM, 2010, APPL BIOCHEM BIOTECH, V162, P1612, DOI 10.1007/s12010-010-8942-z; Deng H, 2012, J MED CHEM, V55, P1910, DOI 10.1021/jm2017368; Deng HX, 2016, PROCESS BIOCHEM, V51, P1357, DOI 10.1016/j.procbio.2016.07.013; Deng HX, 2016, GENE, V580, P67, DOI 10.1016/j.gene.2016.01.019; Doidy J, 2012, TRENDS PLANT SCI, V17, P413, DOI 10.1016/j.tplants.2012.03.009; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Fang LZ, 2006, J ANTIBIOT, V59, P351, DOI 10.1038/ja.2006.49; Gao RJ, 2017, ANN MICROBIOL, V67, P65, DOI 10.1007/s13213-016-1238-y; HUDSON JB, 1994, PHOTOCHEM PHOTOBIOL, V60, P253, DOI 10.1111/j.1751-1097.1994.tb05100.x; Jiang T, 2015, PROTEIN EXPRES PURIF, V114, P15, DOI 10.1016/j.pep.2015.06.002; Kirk PM, 2008, DICT FUNGI, P634; Krivoruchko A, 2015, METAB ENG, V28, P28, DOI 10.1016/j.ymben.2014.11.009; Lacerda LG, 2008, J THERM ANAL CALORIM, V93, P445, DOI 10.1007/s10973-006-8273-z; LACHMUND A, 1993, CURR MICROBIOL, V26, P47, DOI 10.1007/BF01577242; Liang XH, 2009, MICROBIOL RES, V164, P9, DOI 10.1016/j.micres.2008.08.004; Liu XY, 2016, APPL MICROBIOL BIOT, V100, P4875, DOI 10.1007/s00253-015-7222-9; MORKEBERG R, 1995, MICROBIOL-SGM, V141, P2449, DOI 10.1099/13500872-141-10-2449; Newman AG, 2016, J AM CHEM SOC, V138, P4219, DOI 10.1021/jacs.6b00633; Papagianni M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-50; Peng H, 2015, J MOL CATAL B-ENZYM, V119, P71, DOI 10.1016/j.molcatb.2015.06.005; Sandhu KS, 2007, FOOD CHEM, V101, P1499, DOI 10.1016/j.foodchem.2006.01.060; Shen XY, 2012, BANGL J PHARMACOL, V7, P249, DOI 10.3329/bjp.v7i4.12068; Srichuwong S, 2005, INT J BIOL MACROMOL, V37, P115, DOI 10.1016/j.ijbiomac.2005.09.006; Su YJ, 2011, EUR FOOD RES TECHNOL, V232, P935, DOI 10.1007/s00217-011-1461-5; Su YJ, 2010, EUR FOOD RES TECHNOL, V231, P781, DOI 10.1007/s00217-010-1322-7; Sugai-Guerios MH, 2015, ADV BIOCHEM ENG BIOT, V149, P171, DOI 10.1007/10_2014_299; Velmurugan P, 2011, J BIOSCI BIOENG, V112, P590, DOI 10.1016/j.jbiosc.2011.08.009; Woloshuk CP, 1997, PHYTOPATHOLOGY, V87, P164, DOI 10.1094/PHYTO.1997.87.2.164; Xie WL, 2014, DYES PIGMENTS, V101, P43, DOI 10.1016/j.dyepig.2013.09.038; Yang HL, 2009, DYES PIGMENTS, V82, P142, DOI 10.1016/j.dyepig.2008.12.012; Yin WB, 2011, J MICROBIOL, V49, P329, DOI 10.1007/s12275-011-1009-1; Zhao HY, 2014, PHOTODIAGN PHOTODYN, V11, P204, DOI 10.1016/j.pdpdt.2014.01.003	44	2	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196519	10.1371/journal.pone.0196519	http://dx.doi.org/10.1371/journal.pone.0196519			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723233	gold, Green Published, Green Submitted			2022-12-26	WOS:000431305100036
J	Yuan, X; Kang, Y; Zuo, J; Xie, YN; Ma, L; Ren, XL; Bien, ZY; Wei, QP; Zhou, KC; Wang, XY; Yu, ZM				Yuan, Xin; Kang, Yi; Zuo, Jun; Xie, Youneng; Ma, Li; Ren, Xuelei; Bien, Zeyu; Wei, Qiuping; Zhou, Kechao; Wang, Xiyang; Yu, Zhiming			Micro/nano hierarchical structured titanium treated by NH4OH/H2O2 for enhancing cell response	PLOS ONE			English	Article							IN-VITRO; OSTEOBLAST PROLIFERATION; GENE-EXPRESSION; DENTAL IMPLANTS; TIO2 NANOTUBES; SURFACE; BONE; ADHESION; DIFFERENTIATION; OSSEOINTEGRATION	In this paper, two kinds of titanium surfaces with novel micro/nano hierarchical structures, namely Etched (E) surface and Sandblast and etched (SE) surface, were successfully fabricated by NH4OH and H2O2 mixture. And their cellular responses of MG63 were investigated compared with Sandblast and acid-etching (SLA) surface. Scanning electron microscope (SEM), Surface profiler, X-ray photoelectron spectroscopy (XPS), and Contact angle instrument were employed to assess the surface morphologies, roughness, chemistry and wettability respectively. Hierarchical structures with micro holes of 10-30 mu m in diameter and nano pits of tens of nanometers in diameter formed on both E and SE surfaces. The size of micro holes is very close to osteoblast cell, which makes them wonderful beds for osteoblast. Moreover, these two kinds of surfaces possess similar roughness and superior hydrophilicity to SLA. Reactive oxygen species were detected on E and SE surface, and thus considerable antimicrobial performance and well fixation can be speculated on them. The cell experiments also demonstrated a boost in cell attachment, and that proliferation and osteogenic differentiation were achieved on them, especially on SE surface. The results indicate that the treatment of pure titanium with H2O2/NH4OH is an effective technique to improve the initial stability of implants and enhance the osseointegration, which may be a promising surface treatment to titanium implant.	[Yuan, Xin; Xie, Youneng; Ma, Li; Ren, Xuelei; Bien, Zeyu; Wei, Qiuping; Zhou, Kechao; Yu, Zhiming] Cent S Univ, Sch Mat Sci & Engn, State Key Lab Powder Met, Changsha, Hunan, Peoples R China; [Kang, Yi] Cent S Univ, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Zuo, Jun] Cent S Univ, Xiangya Stomatol Hosp, Changsha, Hunan, Peoples R China; [Wang, Xiyang; Yu, Zhiming] Cent S Univ, Xiangya Hosp, Hunan Prov Engn Lab High Performance Bioengn Biom, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Ma, L; Wei, QP (corresponding author), Cent S Univ, Sch Mat Sci & Engn, State Key Lab Powder Met, Changsha, Hunan, Peoples R China.	marycsupm@csu.edu.cn; qiupwei@csu.edu.cn	Wei, Qiup/N-3314-2013	Wei, Qiup/0000-0002-8109-5982	National Natural Science Foundation of China [51601226]; National Key Research and Development Program of China [2016YEB0301402]; State Key Laboratory of Powder Metallurgy; Open-End Fund for Valuable and Precision Instruments of Central South University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; State Key Laboratory of Powder Metallurgy; Open-End Fund for Valuable and Precision Instruments of Central South University	The authors gratefully acknowledge the National Natural Science Foundation of China (No. 51601226), National Key Research and Development Program of China (No. 2016YEB0301402), the State Key Laboratory of Powder Metallurgy, and the Open-End Fund for Valuable and Precision Instruments of Central South University for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the National Natural Science Foundation of China (No. 51601226), National Key Research and Development Program of China (No. 2016YEB0301402), the State Key Laboratory of Powder Metallurgy, and the Open-End Fund for Valuable and Precision Instruments of Central South University for financial support.	Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004; Bauer S, 2008, ACTA BIOMATER, V4, P1576, DOI 10.1016/j.actbio.2008.04.004; Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704; Chen J, 2007, J BIOMED MATER RES B, V82B, P360, DOI 10.1002/jbm.b.30741; de Oliveira PT, 2007, J BIOMED MATER RES A, V80A, P554, DOI 10.1002/jbm.a.30955; de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8; Deng JY, 2010, J BIOMATER APPL, V25, P179, DOI 10.1177/0885328209349316; Gittens RA, 2013, ACTA BIOMATER, V9, P6268, DOI 10.1016/j.actbio.2012.12.002; Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029; Gongadze E, 2011, INT J NANOMED, V6, P1801, DOI [10.2147/IJN.S21755, 10.2147/IJN.S16982]; Guo J, 2007, BIOMATERIALS, V28, P5418, DOI 10.1016/j.biomaterials.2007.08.032; Guo LT, 2016, MAT SCI ENG C-MATER, V61, P143, DOI 10.1016/j.msec.2015.12.030; Hayes JS, 2010, EUR CELLS MATER, V20, P98; Hori N, 2010, DENT MATER, V26, P275, DOI 10.1016/j.dental.2009.11.077; Huang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06172; Isa ZM, 2006, INT J ORAL MAX IMPL, V21, P203; Jemat A, 2015, BIO MED RES INT, V10, P1155, DOI DOI 10.1155/2015/791725; Lai YK, 2009, ADV MATER, V21, P3799, DOI 10.1002/adma.200900686; Lavenus S, 2012, NANOMEDICINE-UK, V7, P967, DOI [10.2217/NNM.11.181, 10.2217/nnm.11.181]; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Lee EJ, 2013, CURR APPL PHYS, V13, pS36, DOI 10.1016/j.cap.2012.12.023; Lee SW, 2009, CLIN ORAL IMPLAN RES, V20, P458, DOI 10.1111/j.1600-0501.2008.01671.x; Li D, 2013, J MATER SCI-MATER M, V24, P489, DOI 10.1007/s10856-012-4810-4; Lim JY, 2005, BIOMACROMOLECULES, V6, P3319, DOI 10.1021/bm0503423; Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001; Macak JM, 2007, CURR OPIN SOLID ST M, V11, P3, DOI 10.1016/j.cossms.2007.08.004; Meirelles L, 2008, CLIN IMPLANT DENT R, V10, P245, DOI 10.1111/j.1708-8208.2008.00089.x; Meirelles L, 2007, CLIN ORAL IMPLAN RES, V18, P326, DOI 10.1111/j.1600-0501.2006.01308.x; Mishra YK, 2017, MAT TODAY, DOI 10.1016/j.mattod.2017.11.003; Nanci A, 1998, J BIOMED MATER RES, V40, P324; Nasajpour A, 2017, NANO LETT, V17, P6235, DOI 10.1021/acs.nanolett.7b02929; Omori S, 2009, J DENT RES, V88, P957, DOI 10.1177/0022034509343426; Panayotov Ivan V, 2015, Folia Med (Plovdiv), V57, P11, DOI 10.1515/folmed-2015-0014; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Pisarek M, 2012, BIOMIMETIC ELECTRODE; Rolando AGI, 2010, BIOMATERIALS, V32, P3395; Shibata Y, 2004, J DENT RES, V83, P115, DOI 10.1177/154405910408300206; Shibata Y, 2010, BIOMATERIALS, V31, P8546, DOI 10.1016/j.biomaterials.2010.07.098; Verma SK, TOXICOLOGY RES; Verma SK, ACS OMEGA; Vetrone F, 2009, NANO LETT, V9, P659, DOI 10.1021/nl803051f; Wang HY, 2010, BIOMATERIALS, V31, P413, DOI 10.1016/j.biomaterials.2009.09.066; Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4; Xie YN, 2017, MATER LETT, V186, P38, DOI 10.1016/j.matlet.2016.08.079; Xie YN, 2016, MATER LETT, V176, P74, DOI 10.1016/j.matlet.2016.04.076; Yavari SA, 2014, BIOMATERIALS, V35, P6172, DOI 10.1016/j.biomaterials.2014.04.054; Yeo In-Sung, 2014, Open Biomed Eng J, V8, P114, DOI 10.2174/1874120701408010114; Yousefpour M, 2007, MATER DESIGN, V28, P2154, DOI 10.1016/j.matdes.2006.06.005; Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320; Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014; Zhou JH, 2013, ACS APPL MATER INTER, V5, P5358, DOI 10.1021/am401339n	51	8	8	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196366	10.1371/journal.pone.0196366	http://dx.doi.org/10.1371/journal.pone.0196366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723214	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100026
J	Pascall, JC; Webb, LMC; Eskelinen, EL; Innocentin, S; Attaf-Bouabdallah, N; Butcher, GW				Pascall, John C.; Webb, Louise M. C.; Eskelinen, Eeva-Liisa; Innocentin, Silvia; Attaf-Bouabdallah, Noudjoud; Butcher, Geoffrey W.			GIMAP6 is required for T cell maintenance and efficient autophagy in mice	PLOS ONE			English	Article							BB RAT; GTPASE; GENE; LYMPHOCYTES; ACTIVATION; MUTATION; TBK1; PHOSPHORYLATION; MITOCHONDRIA; EXPRESSION	The GTPases of the immunity-associated proteins (GIMAP) GTPases are a family of proteins expressed strongly in the adaptive immune system. We have previously reported that in human cells one member of this family, GIMAP6, interacts with the ATG8 family member GABARAPL2, and is recruited to autophagosomes upon starvation, suggesting a role for GIMAP6 in the autophagic process. To study this possibility and the function of GIMAP6 in the immune system, we have established a mouse line in which the Gimap6 gene can be inactivated by Cre-mediated recombination. In mice bred to carry the CD2Cre transgene such that the Gimap6 gene was deleted within the T and B cell lineages there was a 50-70% reduction in peripheral CD4(+) and CD8(+) T cells. Analysis of splenocyte-derived proteins from these mice indicated increased levels of MAP1LC3B, particularly the lipidated LC3-II form, and S405-phosphorylation of SQSTM1. Electron microscopic measurements of Gimap6(-/-) CD4(+) T cells indicated an increased mitochondrial/cytoplasmic volume ratio and increased numbers of autophagosomes. These results are consistent with autophagic disruption in the cells. However, Gimap6(-/-) T cells were largely normal in character, could be effectively activated in vitro and supported T cell-dependent antibody production. Treatment in vitro of CD4(+) splenocytes from GIMAP6(fl/fl) ERT2Cre mice with 4-hydroxytamoxifen resulted in the disappearance of GIMAP6 within five days. In parallel, increased phosphorylation of SQSTM1 and TBK1 was observed. These results indicate a requirement for GIMAP6 in the maintenance of a normal peripheral adaptive immune system and a significant role for the protein in normal autophagic processes. Moreover, as GIMAP6 is expressed in a cell-selective manner, this indicates the potential existence of a cell-restricted mode of autophagic regulation.	[Pascall, John C.; Webb, Louise M. C.; Innocentin, Silvia; Attaf-Bouabdallah, Noudjoud; Butcher, Geoffrey W.] Babraham Inst, Lab Lymphocyte Signalling & Dev, Babraham Res Campus, Cambridge, England; [Eskelinen, Eeva-Liisa] Univ Helsinki, Fac Biol & Environm Sci, Dept Biosci, Helsinki, Finland; [Eskelinen, Eeva-Liisa] Univ Turku, Inst Biomed, Turku, Finland; [Attaf-Bouabdallah, Noudjoud] Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseilles, France	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Helsinki; University of Turku; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Butcher, GW (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Babraham Res Campus, Cambridge, England.	geoff.butcher@babraham.ac.uk	Webb, Louise/V-3121-2019; Eskelinen, Eeva-Liisa/AAF-3496-2019	Eskelinen, Eeva-Liisa/0000-0003-0006-7785; ATTAF, Noudjoud/0000-0001-7254-7679; Webb, Louise/0000-0003-3417-1484	Biotechnology and Biological Sciences Research Council (UK) [BBS/E/B/000C0407, BBS/E/B/000C0427]; Academy of Finland; BBSRC [BBS/E/B/000C0427, BBS/E/B/000C0407] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Academy of Finland(Academy of Finland); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grant numbers BBS/E/B/000C0407 and BBS/E/B/000C0427 from The Biotechnology and Biological Sciences Research Council (UK) to Dr Geoffrey W Butcher. Eeva-Liisa Eskilinen was supported by the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Electron Microscopy Unit at the Institute of Biotechnology, University of Helsinki, for the availability of instruments and technical help, members of the Biological Support Unit at the Babraham Institute for animal work and members of the Babraham Institute Flow Facility for technical assistance. ELE was supported by the Academy of Finland.	Barnes MJ, 2010, J IMMUNOL, V184, P3743, DOI 10.4049/jimmunol.0903164; Biller L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-63; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Budd RC, 2001, CURR OPIN IMMUNOL, V13, P356, DOI 10.1016/S0952-7915(00)00227-2; Carter C, 2007, J IMMUNOL, V179, P1784, DOI 10.4049/jimmunol.179.3.1784; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Cousins L, 2006, GASTROENTEROLOGY, V131, P1475, DOI 10.1053/j.gastro.2006.09.023; Datta P, 2017, EUR J IMMUNOL, V47, P84, DOI 10.1002/eji.201646599; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; de Luca C, 2005, J CLIN INVEST, V115, P3484, DOI 10.1172/JCI24059; Ding WX, 2012, J BIOL CHEM, V287, P42379, DOI 10.1074/jbc.M112.413682; Ding WX, 2012, J BIOL CHEM, V287, P42373, DOI 10.1074/jbc.M112.413674; Fischer HJ, 2016, FASEB J, V30, P1724, DOI 10.1096/fj.15-277384; Hall AR, 2014, BRIT J PHARMACOL, V171, P1890, DOI 10.1111/bph.12516; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Ho CH, 2017, J BIOL CHEM, V292, P9305, DOI 10.1074/jbc.M116.768689; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Ilangumaran S, 2009, MOL IMMUNOL, V46, P1256, DOI 10.1016/j.molimm.2008.09.031; JACOB HJ, 1992, NAT GENET, V2, P56, DOI 10.1038/ng0992-56; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Keita M, 2007, BIOCHEM BIOPH RES CO, V361, P481, DOI 10.1016/j.bbrc.2007.07.048; Kim CY, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00582-17; Krucken J, 2004, GENE, V341, P291, DOI 10.1016/j.gene.2004.07.005; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Lang JA, 2004, EUR J IMMUNOL, V34, P2396, DOI 10.1002/eji.200324751; Lim J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004987; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Malik AN, 2016, MITOCHONDRION, V29, P59, DOI 10.1016/j.mito.2016.05.003; Matsumoto G, 2015, HUM MOL GENET, V24, P4429, DOI 10.1093/hmg/ddv179; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; McDowell IC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105097; Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103; Pascall JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077782; Patterson AR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02897-7; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Ramanathan S, 2001, IMMUNOL REV, V184, P161, DOI 10.1034/j.1600-065x.2001.1840115.x; Reuber TL, 1996, PLANT CELL, V8, P241, DOI 10.1105/tpc.8.2.241; Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Roy SG, 2013, AUTOPHAGY, V9, P1009, DOI 10.4161/auto.24468; Sandal T, 2003, MOL BIOL CELL, V14, P3292, DOI 10.1091/mbc.e02-10-0700; Sandal T, 2001, CELL DEATH DIFFER, V8, P754, DOI 10.1038/sj.cdd.4400873; Saunders A, 2010, BLOOD, V115, P3249, DOI 10.1182/blood-2009-08-237586; Schnell S, 2006, BLOOD, V108, P591, DOI 10.1182/blood-2005-11-4616; Schulteis RD, 2008, BLOOD, V112, P4905, DOI 10.1182/blood-2008-03-146555; Schwefel D, 2013, STRUCTURE, V21, P550, DOI 10.1016/j.str.2013.01.014; Schwefel D, 2010, P NATL ACAD SCI USA, V107, P20299, DOI 10.1073/pnas.1010322107; Serrano D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00094; Stephenson LM, 2009, AUTOPHAGY, V5, P625, DOI 10.4161/auto.5.5.8133; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Van Wesenbeeck L, 2007, J CLIN INVEST, V117, P919, DOI 10.1172/JCI30328; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wang ZJ, 2009, PLANT SIGNAL BEHAV, V4, P165, DOI 10.4161/psb.4.3.7722; Webb LMC, 2016, J IMMUNOL, V196, P207, DOI 10.4049/jimmunol.1501582; Webb LMC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110294; Weiss Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-400; Wong Vivian Wy, 2010, Self Nonself, V1, P259, DOI 10.4161/self.1.3.12819; Yano K, 2014, EUR J IMMUNOL, V44, P561, DOI 10.1002/eji.201343750; Zhang SM, 2016, DEV COMP IMMUNOL, V56, P25, DOI 10.1016/j.dci.2015.11.008	64	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196504	10.1371/journal.pone.0196504	http://dx.doi.org/10.1371/journal.pone.0196504			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718959	Green Submitted, Green Published, gold			2022-12-26	WOS:000431281900055
J	Robinson, RJ; Hensel, EC; al-Olayan, AA; Nonnemaker, JM; Lee, YO				Robinson, R. J.; Hensel, E. C.; al-Olayan, A. A.; Nonnemaker, J. M.; Lee, Y. O.			Effect of e-liquid flavor on electronic cigarette topography and consumption behavior in a 2-week natural environment switching study	PLOS ONE			English	Article							SMOKING TOPOGRAPHY; NICOTINE LEVELS; TOBACCO; SMOKERS; VAPERS; SWEET	Electronic Nicotine Delivery Systems (ENDS) offer an alternate means to consume nicotine in a variety of flavored aerosols. Data are needed to better understand the impact of flavors on use behavior. A natural environment observational study was conducted on experienced ENDS users to measure the effect of e-liquid flavor on topography and consumption behavior. The RIT wPUM (TM) monitor was used to record to record the date and time and puff topography (flow rate, volume, duration) for every puff taken by N = 34 participants over the course of two weeks. All participants used tobacco flavor for one week, and either berry or menthol flavor for one week. Results provide strong evidence that flavor affects the topography behaviors of mean puff flow rate and mean puff volume, and there is insufficient evidence to support an influence of flavor on mean puff duration and mean puff interval. There was insufficient evidence, due to the low power associated with the limited number of observation days, to establish a relationship between flavor and cumulative consumption behavior. While the results indicate that an effect may be evident, additional observation days are required to establish significance.	[Robinson, R. J.; Hensel, E. C.; al-Olayan, A. A.] Rochester Inst Technol, Rochester, NY 14623 USA; [Nonnemaker, J. M.; Lee, Y. O.] Res Triangle Int Inc, Res Triangle Pk, NC USA	Rochester Institute of Technology	Robinson, RJ (corresponding author), Rochester Inst Technol, Rochester, NY 14623 USA.	rjreme@rit.edu	Lee, Youn/ABF-9022-2021; Hensel, Edward/Q-6753-2019	Lee, Youn/0000-0001-9042-5392; Hensel, Edward/0000-0002-2682-0766; Robinson, Risa/0000-0001-8488-5448; nonnemaker, james/0000-0003-1044-7482	Rochester Institute of Technology Kate Gleason College of Engineering faculty research funds; RTI International institutional research and development funds	Rochester Institute of Technology Kate Gleason College of Engineering faculty research funds; RTI International institutional research and development funds	This work was supported by Rochester Institute of Technology Kate Gleason College of Engineering faculty research funds, and RTI International institutional research and development funds. The funder provided support in the form of salaries for authors [RJR ECH AM YOL JMN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahijevych K, 1997, RES NURS HEALTH, V20, P505, DOI 10.1002/(SICI)1098-240X(199712)20:6<505::AID-NUR5>3.0.CO;2-Q; Arndt J, 2013, HEALTH PSYCHOL, V32, P525, DOI 10.1037/a0029201; Aung AT, 2004, ADDICT BEHAV, V29, P699, DOI 10.1016/j.addbeh.2004.02.012; Barnes Andrew J, 2017, Tob Regul Sci, V3, P374, DOI 10.18001/TRS.3.4.1; Behar RZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117222; Bialous SA, 2001, AM J PUBLIC HEALTH, V91, P62; Blank MD, 2009, NICOTINE TOB RES, V11, P896, DOI 10.1093/ntr/ntp083; Brauer LH, 1996, ADDICT BEHAV, V21, P233, DOI 10.1016/0306-4603(95)00054-2; Burling TA, 1996, J SUBST ABUSE, V8, P445, DOI 10.1016/S0899-3289(96)90005-X; Czoli CD, 2016, TOB CONTROL, V25, pE30, DOI 10.1136/tobaccocontrol-2015-052422; Evans SE, 2014, TOB CONTROL, V23, P23, DOI 10.1136/tobaccocontrol-2013-051489; Farsalinos KE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11269; Goldenson NI, 2016, DRUG ALCOHOL DEPEN, V168, P176, DOI 10.1016/j.drugalcdep.2016.09.014; Goniewicz ML, 2013, NICOTINE TOB RES, V15, P158, DOI 10.1093/ntr/nts103; Hamilton CM, 2011, AM J EPIDEMIOL, V174, P253, DOI 10.1093/aje/kwr193; HATSUKAMI D, 1987, INT J ADDICT, V22, P719, DOI 10.3109/10826088709027453; HATSUKAMI DK, 1988, ADDICT BEHAV, V13, P91, DOI 10.1016/0306-4603(88)90031-7; Helen GS, 2017, DRUG ALCOHOL DEPEN, V178, P391, DOI 10.1016/j.drugalcdep.2017.05.042; HERNING RI, 1983, CLIN PHARMACOL THER, V33, P84, DOI 10.1038/clpt.1983.12; HERNING RI, 1981, BRIT MED J, V283, P187, DOI 10.1136/bmj.283.6285.187; Hsu G, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.8550; Kim H, 2016, TOB CONTROL, V25, pii55, DOI 10.1136/tobaccocontrol-2016-053221; Korzun T, 2018, ACS OMEGA, V3, P30, DOI 10.1021/acsomega.7b01521; Lawrence D, 2011, TOBACCO INDUCED D S1, V9, pS3, DOI [10.1186/1617-9625-9-S1-S3, DOI 10.1186/1617-9625-9-S1-S3]; Lee YH, 2015, ADDICT BEHAV, V48, P1, DOI 10.1016/j.addbeh.2015.04.003; Lee YO, 2018, NICOTINE TOB RES, V20, P1283, DOI 10.1093/ntr/ntx222; Lee YO, 2011, TOB CONTROL, V20, pII1, DOI 10.1136/tc.2011.043604; Lopez AA, 2016, NICOTINE TOB RES, V18, P720, DOI 10.1093/ntr/ntv182; Lopez AA, 2015, PREV MED, V80, P101, DOI 10.1016/j.ypmed.2015.07.006; Nonnemaker J, 2016, TOB CONTROL, V25, pE37, DOI 10.1136/tobaccocontrol-2015-052511; Ossip-Klein D, 1983, BEH MED ABSTR, V4, P73; Robinson DR, 2015, PLOS ONE; Robinson RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164038; Robinson R J, 2015, PLoS One, V10, pe0129296, DOI 10.1371/journal.pone.0129296; Sazonov E, 2013, J STUD ALCOHOL DRUGS, V74, P956, DOI 10.15288/jsad.2013.74.956; Siegel MB, 2011, AM J PREV MED, V40, P472, DOI 10.1016/j.amepre.2010.12.006; Spindle TR, 2015, NICOTINE TOB RES, V17, P142, DOI 10.1093/ntr/ntu186; Wagoner KG, 2016, NICOTINE TOB RES, V18, P2006, DOI 10.1093/ntr/ntw095; Y El Sayed, 2015, CHEM ANAL CONSTITUEN	39	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196640	10.1371/journal.pone.0196640	http://dx.doi.org/10.1371/journal.pone.0196640			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5SH	29718974	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900066
J	Xu, D; Luo, HWW; Hu, W; Hu, SWW; Yuan, C; Wang, GHH; Zhang, L; Yu, H; Magdalou, J; Chen, LBB; Wang, H				Xu, Dan; Luo, Hanwen W.; Hu, Wen; Hu, Shuwei W.; Yuan, Chao; Wang, Guihua H.; Zhang, Li; Yu, Hong; Magdalou, Jacques; Chen, Liaobin B.; Wang, Hui			Intrauterine programming mechanism for hypercholesterolemia in prenatal caffeine-exposed female adult rat offspring	FASEB JOURNAL			English	Article						glucocorticoids; cholesterol; epigenetic; HMGCR; C/EBP alpha	DENSITY-LIPOPROTEIN CHOLESTEROL; THRIFTY PHENOTYPE HYPOTHESIS; CARDIOVASCULAR RISK-FACTORS; METABOLIC SYNDROME; GROWTH RESTRICTION; DNA METHYLATION; EPIGENETIC MODIFICATION; PROTEIN RESTRICTION; GENE-EXPRESSION; FETAL	Clinical and animal studies have indicated that hypercholesterolemia and its associated diseases have intrauterine developmental origins. Our previous studies showed that prenatal caffeine exposure (PCE) led to fetal overexposure to maternal glucocorticoids (GCs) and increased serum total cholesterol levels in adult rat offspring. This study further confirms the intrauterine programming of PCE-induced hypercholesterolemia in female adult rat offspring. Pregnant Wistar rats were intragastrically administered caffeine (30, 60, and 120 mg/kg/d) from gestational day (GD)9 to 20. Female rat offspring were euthanized at GD20 and postnatal wk 12; several adult rat offspring were additionally subjected to ice-water swimming stimulation to induce chronic stress prior to death. The effects of GCs on cholesterol metabolism and epigenetic regulation were verified using the L02 cell line. The results showed that PCE induced hypercholesterolemia in adult offspring, which manifested as significantly higher levels of serum total cholesterol and LDL cholesterol (LDL-C) as well as higher ratios of LDL-C/HDL cholesterol. We further found that the cholesterol levels were increased in fetal livers but were decreased in fetal blood, accompanied by increased maternal blood cholesterol levels and reduced placental cholesterol transport. Furthermore, analysis of PCE offspring in the uterus and in a postnatal basal/chronic stress state and the results of in vitro experiments showed that hepatic cholesterol metabolism underwent GC-dependent changes and was associated with cholesterol synthase via abnormalities in 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) histone acetylation. We concluded that, to compensate for intrauterine placentally derived decreases in fetal blood cholesterol levels, high intrauterine GC levels activated fetal hepatic CCAAT enhancer binding protein signaling and down-regulated Sirtuin1 expression, which mediated the high levels of histone acetylation (via H3K9ac and H3K14ac) and expression of HMGCR. This GC-dependent cholesterol metabolism programming effect was sustained through adulthood, leading to the occurrence of hypercholesterolemia.Xu, D., Luo, H. W., Hu, W., Hu, S. W., Yuan, C., Wang, G. H., Zhang, L., Yu, H., Magdalou, J., Chen, L. B., Wang, H. Intrauterine programming mechanism for hypercholesterolemia in prenatal caffeine-exposed female adult rat offspring.	[Xu, Dan; Luo, Hanwen W.; Hu, Wen; Hu, Shuwei W.; Yuan, Chao; Wang, Guihua H.; Zhang, Li; Wang, Hui] Wuhan Univ, Zhongnan Hosp, Basic Med Sch, Dept Pharmacol, Wuhan, Hubei, Peoples R China; [Xu, Dan; Yu, Hong; Chen, Liaobin B.; Wang, Hui] Wuhan Univ, Zhongnan Hosp, Dept Orthoped Surg, Wuhan, Hubei, Peoples R China; [Luo, Hanwen W.; Chen, Liaobin B.] Hubei Prov Key Lab Developmentally Originated Dis, Wuhan, Hubei, Peoples R China; [Magdalou, Jacques] Univ Lorraine, UMR 7365, CNRS, Fac Med, Vandoeuvre Les Nancy, France	Wuhan University; Wuhan University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine	Chen, LBB (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Orthopaed Surg, Wuhan 430071, Hubei, Peoples R China.; Wang, H (corresponding author), Wuhan Univ, Basic Med Sch, Dept Pharmacol, 185 East Lake Rd, Wuhan 430071, Hubei, Peoples R China.	lbchen@whu.edu.cn; wanghui19@whu.edu.cn			National Key Research and Development Program of China [2017YFC1001300]; National Natural Science Foundation of China [81430089, 81673524, 81671472]; Hubei Province Health and Family Planning Scientific Research Project [WJ2017C0003]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province Health and Family Planning Scientific Research Project	This work was supported by National Key Research and Development Program of China Grant 2017YFC1001300; National Natural Science Foundation of China Grants 81430089, 81673524, and 81671472; and Hubei Province Health and Family Planning Scientific Research Project Grant WJ2017C0003. The authors declare no conflicts of interest.	Alworth LC, 2002, TOXICOL APPL PHARM, V183, P10, DOI 10.1006/taap.2002.9459; Ao Y, 2015, TOXICOL APPL PHARM, V287, P128, DOI 10.1016/j.taap.2015.05.007; Ayaori M, 2006, ARTERIOSCL THROM VAS, V26, P163, DOI 10.1161/01.ATV.0000193513.29074.52; Azadbakht L, 2014, NUTRITION, V30, P150, DOI [10.1016/j.nut.2013.06.005, 10.]; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Baumann M, 2013, PLACENTA, V34, P1079, DOI 10.1016/j.placenta.2013.06.309; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Cabrero A, 2005, MOL CELL BIOCHEM, V275, P173, DOI 10.1007/s11010-005-1353-8; Chorostowska-Wynimko J, 2004, INT J TISSUE REACT, V26, P53; Cong RH, 2012, J NUTR BIOCHEM, V23, P1647, DOI 10.1016/j.jnutbio.2011.11.007; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Duan YJ, 2014, COMP BIOCHEM PHYS A, V176, P59, DOI 10.1016/j.cbpa.2014.07.010; Efstathiou SP, 2012, CIRCULATION, V125, P902, DOI 10.1161/CIRCULATIONAHA.111.034546; Feng YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154758; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Fowden AL, 2005, EARLY HUM DEV, V81, P723, DOI 10.1016/j.earlhumdev.2005.06.007; Gale CR, 2001, J CLIN ENDOCR METAB, V86, P267, DOI 10.1210/jc.86.1.267; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Halperin RO, 2006, HYPERTENSION, V47, P45, DOI 10.1161/01.HYP.0000196306.42418.0e; Ho SM, 2007, REPROD TOXICOL, V23, P267, DOI 10.1016/j.reprotox.2007.01.004; Huang J, 2012, CLIN EXP PHARMACOL P, V39, P357, DOI 10.1111/j.1440-1681.2012.05676.x; Huang YF, 2015, CLIN ENDOCRINOL, V83, P78, DOI 10.1111/cen.12663; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kanaoka Tsuyoshi, 2012, Ann Vasc Dis, V5, P36, DOI 10.3400/avd.oa.11.00068; Kaufmann PA, 2000, J AM COLL CARDIOL, V36, P103, DOI 10.1016/S0735-1097(00)00697-5; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Lejskova M, 2012, PHYSIOL RES, V61, P587, DOI 10.33549/physiolres.932313; Li J, 2015, TOXICOL APPL PHARM, V284, P345, DOI 10.1016/j.taap.2015.03.002; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Liu J, 2006, AM J CARDIOL, V98, P1363, DOI 10.1016/j.amjcard.2006.06.032; Liu XM, 2014, J CLIN BIOCHEM NUTR, V55, P40, DOI 10.3164/jcbn.13-100; Liu YS, 2012, TOXICOL APPL PHARM, V262, P205, DOI 10.1016/j.taap.2012.05.002; Lundasen T, 2003, J BIOL CHEM, V278, P43224, DOI 10.1074/jbc.M302645200; Luo HW, 2015, SCI REP-UK, V5, DOI 10.1038/srep17746; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P403, DOI 10.1038/nrendo.2014.74; Nerlov C, 2008, CURR OPIN CELL BIOL, V20, P180, DOI 10.1016/j.ceb.2008.02.002; Ono K, 2012, J CARDIOL, V60, P339, DOI 10.1016/j.jjcc.2012.07.014; Pecks U, 2012, J PERINAT MED, V40, P287, DOI [10.1515/jpm.2011.135, 10.1515/JPM.2011.135]; Pecks U, 2012, HYPERTENS PREGNANCY, V31, P156, DOI 10.3109/10641955.2010.544805; Sohi G, 2011, SEMIN REPROD MED, V29, P246, DOI 10.1055/s-0031-1275523; Sohi G, 2011, MOL ENDOCRINOL, V25, P785, DOI 10.1210/me.2010-0395; Szostak-Wegierek Dorota, 2011, Med Wieku Rozwoj, V15, P203; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Trapani L, 2012, WORLD J HEPATOL, V4, P184, DOI 10.4254/wjh.v4.i6.184; Vaag AA, 2012, DIABETOLOGIA, V55, P2085, DOI 10.1007/s00125-012-2589-y; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Valsamakis G, 2006, ANN NY ACAD SCI, V1092, P138, DOI 10.1196/annals.1365.012; van Rossum EFC, 2002, DIABETES, V51, P3128, DOI 10.2337/diabetes.51.10.3128; Wadsack C, 2007, AM J PHYSIOL-ENDOC M, V292, pE476, DOI 10.1152/ajpendo.00547.2005; Wang LL, 2014, TOXICOL LETT, V224, P311, DOI 10.1016/j.toxlet.2013.11.006; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Woollett LA, 2011, PLACENTA, V32, pS218, DOI 10.1016/j.placenta.2011.01.011; Wu YM, 2015, TOXICOL APPL PHARM, V289, P109, DOI 10.1016/j.taap.2015.09.007; Xia LP, 2014, TOXICOL LETT, V226, P98, DOI 10.1016/j.toxlet.2014.01.023; Xn D, 2012, TOXICOL APPL PHARM, V264, P395, DOI 10.1016/j.taap.2012.08.016; Xu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044497; Zhang HT, 2007, MOL PHARMACOL, V71, P1319, DOI 10.1124/mol.106.032011; Zheng Rui-Dan, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P543; Zhou D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165224	62	13	13	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5563	5576		10.1096/fj.201701557R	http://dx.doi.org/10.1096/fj.201701557R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29718709	Bronze			2022-12-26	WOS:000447972500030
J	Fang, QQ; Wang, XF; Zhao, WY; Chen, CY; Zhang, MX; Shi, BH; Zhang, LY; Tan, WQ				Fang, Qing-Qing; Wang, Xiao-Feng; Zhao, Wan-Yi; Chen, Chun-Ye; Zhang, Min-Xia; Shi, Bang-Hui; Zhang, Li-Yun; Tan, Wei-Qiang			The source of ACE during scar formation is from both bone marrow and skin tissue	FASEB JOURNAL			English	Article						Wound healing; TGF-1; TNF-; fibrosis; transgenic mouse	ANGIOTENSIN-CONVERTING ENZYME; WOUND-HEALING DEFECT; TGF-BETA; BLOOD-PRESSURE; MICE; FIBROSIS; HYPERTENSION; SYSTEM; INHIBITION	Angiotensin-converting enzyme (ACE) has been found in the pathogenesis of various fibrosis diseases, and ACE inhibitor (ACEI) may affect wound healing and cutaneous fibrosis. However, there is no scientific evidence as to where the ACE is produced during scar formation. Whether it is from the cutaneous tissue or the bone marrow, or both remains unknown. In this study, we investigated the source of ACE using bone marrow transplantation in genetically modified mice, analyzed the inflammatory milieu and some growth factors in the middle of the wound healing period (4 d after the wound was induced). After having deleted the ACE from bone marrow or skin tissue, the wound/scar width in the low-ACE groups were narrower than those in wild-type (WT) controls. Loosely arranged collagen deposition and reduced vessel density were also detected in ACE-deficient mice. Lower ACE levels during scar formation were also accompanied by lower levels of TGF-1. In the middle of the wound healing period, ACE levels affected the inflammatory cells significantly. In the mice with a deficiency in ACE, the expression of TGF-1 and TNF- decreased, but not that of IL-4. Our findings indicate that both bone marrow and skin tissue release ACE during scar formation. Deleting either of them can affect the inflammatory cells and growth factors and reduce the expression of TGF-1, resulting in a decreased level of scarring.Fang, Q.-Q., Wang, X.-F., Zhao, W.-Y., Chen, C.-Y., Zhang, M.-X., Shi, B.-H., Zhang, L.-Y., Tan, W.-Q. The source of ACE during scar formation is from both bone marrow and skin tissue.	[Fang, Qing-Qing; Wang, Xiao-Feng; Zhao, Wan-Yi; Zhang, Li-Yun; Tan, Wei-Qiang] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Plast Surg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China; [Fang, Qing-Qing; Wang, Xiao-Feng; Zhao, Wan-Yi; Tan, Wei-Qiang] Zhejiang Univ, Sch Med, Affiliated Sir Run Run Shaw Hosp, Dept Plast Surg, Hangzhou, Zhejiang, Peoples R China; [Fang, Qing-Qing; Wang, Xiao-Feng; Zhao, Wan-Yi; Chen, Chun-Ye; Zhang, Min-Xia; Shi, Bang-Hui; Zhang, Li-Yun; Tan, Wei-Qiang] Zhejiang Univ, Sch Med, Affiliated Hosp 4, Dept Plast Surg, Yiwu, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Tan, WQ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Plast Surg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	tanweixxxx@zju.edu.cn	Tan, Wei-Qiang/GYI-8422-2022; fang, qingqing/GZK-4330-2022	Tan, Wei-Qiang/0000-0001-5610-2418; Zhao, Wanyi/0000-0001-9604-4005	National Natural Science Foundation of China [81671918, 81372072]; National Key Research Program of China [2016YFC1101004]; Zhejiang Provincial Science and Technology Project of China [2016C33134]; Zhejiang Provincial Medical and Healthy Science Foundation of China [2018KY874]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research Program of China; Zhejiang Provincial Science and Technology Project of China; Zhejiang Provincial Medical and Healthy Science Foundation of China	The authors thank Dr. Kenneth E. Bernstein (Director of Experimental Pathology, Cedars-Sinai Medical Center, Los Angeles, CA, USA) for providing laboratory facilities; Y.-Y. Hu (Zhejiang University) for helping design Figs. 1 and 7; and B. Zheng (Zhejiang University) for helping analyze the pathology shown in Fig. 1. This study was supported by the National Natural Science Foundation of China (81671918 to Q.-Q.F., C.-Y.C., M.-X.Z., L.-Y.Z., W.-Q.T., and 81372072 to L.-Y.Z., W.-Q.T.), the National Key Research Program of China (2016YFC1101004 to W.-Q.T.), Zhejiang Provincial Science and Technology Project of China (2016C33134 to W.-Q.T.), and Zhejiang Provincial Medical and Healthy Science Foundation of China (2018KY874 to W.-Q.T.). The authors declare no conflicts of interest.	Abbas G, 2011, AM J THER, V18, pE202, DOI 10.1097/MJT.0b013e3181df8df5; Bernstein KE, 2014, CURR OPIN NEPHROL HY, V23, P106, DOI 10.1097/01.mnh.0000441047.13912.56; Bernstein KE, 2013, PHARMACOL REV, V65, P1, DOI 10.1124/pr.112.006809; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Brilla CG, 2003, HERZ, V28, P744, DOI 10.1007/s00059-003-2524-6; Choi ME, 2012, SEMIN NEPHROL, V32, P244, DOI 10.1016/j.semnephrol.2012.04.003; Cogliati B, 2015, J DERMATOL SCI, V79, P50, DOI 10.1016/j.jdermsci.2015.03.019; Cole J, 2002, CIRC RES, V90, P87, DOI 10.1161/hh0102.102360; Cutroneo KR, 2007, WOUND REPAIR REGEN, V15, pS54, DOI 10.1111/j.1524-475X.2007.00226.x; Esther CR, 1996, LAB INVEST, V74, P953; FALKENHAHN M, 1995, HYPERTENSION, V25, P219, DOI 10.1161/01.HYP.25.2.219; Gaddam Ravinder Reddy, 2014, Inflammation & Allergy Drug Targets, V13, P224; Galeano M, 2008, WOUND REPAIR REGEN, V16, P208, DOI 10.1111/j.1524-475X.2008.00361.x; Hameedaldeen A, 2014, INT J MOL SCI, V15, P16257, DOI 10.3390/ijms150916257; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Iannello Silvai, 2006, MedGenMed, V8, P60; Ikushima H, 2011, CURR PHARM BIOTECHNO, V12, P2099, DOI 10.2174/138920111798808419; Kolesnyk I, 2010, NETH J MED, V68, P15; Krum H, 2007, J HYPERTENS, V25, P25, DOI 10.1097/HJH.0b013e3280113950; Morihara K, 2006, J AM ACAD DERMATOL, V54, P251, DOI 10.1016/j.jaad.2005.09.027; Myerson SG, 2001, CIRCULATION, V103, P226; Namazi MR, 2011, INT J DERMATOL, V50, P85, DOI 10.1111/j.1365-4632.2010.04678.x; NG KKF, 1967, NATURE, V216, P762, DOI 10.1038/216762a0; Nystrom A, 2013, J CLIN INVEST, V123, P3498, DOI 10.1172/JCI68127; Peters T, 2005, EMBO J, V24, P3400, DOI 10.1038/sj.emboj.7600809; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Re R, 2007, AM J PHYSIOL-HEART C, V293, pH905, DOI 10.1152/ajpheart.00552.2007; Sharifi AM, 2005, PHARMACOL RES, V52, P438, DOI 10.1016/j.phrs.2005.07.004; Shen XZ, 2007, AM J PATHOL, V170, P2122, DOI 10.2353/ajpath.2007.061205; Sindrilaru A, 2009, BLOOD, V113, P5266, DOI 10.1182/blood-2008-07-166702; Skipworth JRA, 2011, ALIMENT PHARM THER, V34, P840, DOI 10.1111/j.1365-2036.2011.04810.x; Tan WSD, 2018, CURR OPIN PHARMACOL, V40, P9, DOI 10.1016/j.coph.2017.12.002; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Thomas JR, 2012, ARCH FACIAL PLAST S, V14, P162, DOI 10.1001/archfacial.2012.223; Uzun H, 2013, PLAST RECONSTR SURG, V132, p361E, DOI 10.1097/PRS.0b013e31829acf0a; Verrecchia F, 2004, CELL SIGNAL, V16, P873, DOI 10.1016/j.cellsig.2004.02.007; Wang YW, 2014, J INVEST DERMATOL, V134, P2016, DOI 10.1038/jid.2014.84; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618	38	7	8	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5199	5208		10.1096/fj.201701575RRR	http://dx.doi.org/10.1096/fj.201701575RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29750573	Bronze			2022-12-26	WOS:000443817700046
J	Parekh, A; Das, S; Parida, S; Das, CK; Dutta, D; Mallick, SK; Wu, PH; Kumar, BNP; Bharti, R; Dey, G; Banerjee, K; Rajput, S; Bharadwaj, D; Pal, I; Dey, KK; Rajesh, Y; Jena, BC; Biswas, A; Banik, P; Pradhan, AK; Das, SK; Das, AK; Dhara, S; Fisher, PB; Wirtz, D; Mills, GB; Mandal, M				Parekh, Aditya; Das, Subhayan; Parida, Sheetal; Das, Chandan Kanta; Dutta, Debabrata; Mallick, Sanjaya K.; Wu, Pei-Hsun; Kumar, B. N. Prashanth; Bharti, Rashmi; Dey, Goutam; Banerjee, Kacoli; Rajput, Shashi; Bharadwaj, Deblina; Pal, Ipsita; Dey, Kaushik Kumar; Rajesh, Yetirajam; Jena, Bikash Chandra; Biswas, Angana; Banik, Payel; Pradhan, Anjan K.; Das, Swadesh K.; Das, Amit Kumar; Dhara, Santanu; Fisher, Paul B.; Wirtz, Denis; Mills, Gordon B.; Mandal, Mahitosh			Multi-nucleated cells use ROS to induce breast cancer chemoresistance in vitro and in vivo	ONCOGENE			English	Article							MULTINUCLEATED GIANT-CELLS; MITOTIC CATASTROPHE; REACTIVE OXYGEN; SECRETORY PHENOTYPE; TUMOR-CELLS; POLYPLOIDY; SENESCENCE; HYPOXIA; APOPTOSIS; DOXORUBICIN	Although there is a strong correlation between multinucleated cells (MNCs) and cancer chemo-resistance in variety of cancers, our understanding of how multinucleated cells modulate the tumor micro-environment is limited. We captured multinucleated cells from triple-negative chemo-resistant breast cancers cells in a time frame, where they do not proliferate but rather significantly regulate their micro-environment. We show that oxidatively stressed MNCs induce chemo-resistance in vitro and in vivo by secreting VEGF and MIF. These factors act through the RAS/MAPK pathway to induce chemoresistance by upregulating anti-apoptotic proteins. In MNCs, elevated reactive oxygen species (ROS) stabilizes HIF-1 alpha contributing to increase production of VEGF and MIF. Together the data indicate, that the ROS-HIF-1 alpha signaling axis is very crucial in regulation of chemo-resistance by MNCs. Targeting ROS-HIF-1 alpha in future may help to abrogate drug resistance in breast cancer.	[Parekh, Aditya; Das, Subhayan; Parida, Sheetal; Das, Chandan Kanta; Kumar, B. N. Prashanth; Bharti, Rashmi; Dey, Goutam; Banerjee, Kacoli; Rajput, Shashi; Bharadwaj, Deblina; Pal, Ipsita; Dey, Kaushik Kumar; Rajesh, Yetirajam; Jena, Bikash Chandra; Biswas, Angana; Banik, Payel; Dhara, Santanu; Mandal, Mahitosh] Indian Inst Technol Kharagpur, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India; [Dutta, Debabrata; Das, Amit Kumar] Indian Inst Technol Kharagpur, Dept Biotechnol, Kharagpur, W Bengal, India; [Mallick, Sanjaya K.] Univ Calcutta, BD Biosci Ctr Res Nanosci & Nanotechnol, Kolkata, W Bengal, India; [Wu, Pei-Hsun; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Pradhan, Anjan K.; Das, Swadesh K.; Fisher, Paul B.] Virginia Commonwealth Univ, Sch Med, VCU Inst Mol Med, VCU Inst Mol Med,Dept Human & Mol Genet, Richmond, VA 23298 USA; [Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Div Canc Med, Houston, TX 77030 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; University of Calcutta; Johns Hopkins University; Virginia Commonwealth University; University of Texas System; UTMD Anderson Cancer Center	Mandal, M (corresponding author), Indian Inst Technol Kharagpur, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India.	mahitosh@smst.iitkgp.ernet.in	Dey, Kaushik Kumar/H-5997-2018; Bhusetty Nagesh, Prashanth Kumar/ABH-4999-2020; das, subhayan/G-3453-2018; Dhara, Santanu/AAS-5872-2020; JAIN, SHASHI/N-8877-2017; jain, shashi/AAF-4706-2020; Pal, Ipsita/AAX-4410-2020; Mandal, Mahitosh/GMW-6195-2022; Pradhan, Anjan K/O-2555-2014	Dey, Kaushik Kumar/0000-0002-9594-6362; Bhusetty Nagesh, Prashanth Kumar/0000-0003-3518-405X; das, subhayan/0000-0002-8628-5128; JAIN, SHASHI/0000-0001-9428-0135; jain, shashi/0000-0001-9428-0135; Mandal, Mahitosh/0000-0003-3861-3323; Rajesh, Yetirajam/0000-0002-0277-3942; Biswas, Angana/0000-0002-0983-0428; Rajesh, Yetirajam/0000-0001-8882-8854; Mills, Gordon/0000-0002-0144-9614; Jena, Bikash Chandra/0000-0002-6672-9254; Dey, Goutam/0000-0002-8210-3219	Department of Biotechnology [BT/PR13996/Med/30/309/2010]; Department of Atomic Energy [35/14/05/2015-BRNS/3053]; Ministry of Human Resource Development [4-23/2014-TS]; University Grants Commission, Department of Biotechnology, and Fulbright; NATIONAL CANCER INSTITUTE [R01CA174388] Funding Source: NIH RePORTER	Department of Biotechnology; Department of Atomic Energy(Department of Atomic Energy (DAE)); Ministry of Human Resource Development; University Grants Commission, Department of Biotechnology, and Fulbright; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge Anji Anura, Bodhisatwa Das, Raunak Kumar Das, and Prof. Jyotirmoy Chaterjee from IIT Kharagpur for their help in microscopy. We also thank Hasini Jayatilaka and Michelle Karl from Johns Hopkins University for their support. We also thank Sanat Dey, Purna Patra, and other staffs of central research facility of IIT Kharagpur for technical assistance. The research was supported by Department of Biotechnology (BT/PR13996/Med/30/309/2010), Department of Atomic Energy, (35/14/05/2015-BRNS/3053), and Ministry of Human Resource Development (F. NO. 4-23/2014-TS. I). University Grants Commission, Department of Biotechnology, and Fulbright is also hereby acknowledged for scholarship support.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Balsas P, 2012, LEUKEMIA RES, V36, P212, DOI 10.1016/j.leukres.2011.09.011; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Blajeski AL, 2001, EXP CELL RES, V270, P277, DOI 10.1006/excr.2001.5349; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; Bucala R, 2000, NATURE, V408, P146, DOI 10.1038/35041654; Carloni V, 2013, ONCOGENE, V32, P2649, DOI 10.1038/onc.2012.268; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Conklin Kenneth A, 2004, Integr Cancer Ther, V3, P294, DOI 10.1177/1534735404270335; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; da Costa CET, 2005, J EXP MED, V201, P687, DOI 10.1084/jem.20041785; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dey G, 2015, SCI REP-UK, V5, DOI 10.1038/srep10316; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Erenpreisa J, 2008, CELL BIOL INT, V32, P1044, DOI 10.1016/j.cellbi.2008.06.003; FISHBACK NF, 1994, CANCER-AM CANCER SOC, V73, P2936, DOI 10.1002/1097-0142(19940615)73:12<2936::AID-CNCR2820731210>3.0.CO;2-U; Holt DJ, 2011, BIOMATERIALS, V32, P3977, DOI 10.1016/j.biomaterials.2011.02.021; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Kotchetkov R, 2003, INT J CANCER, V104, P36, DOI 10.1002/ijc.10917; Krajcovic M, 2011, NAT CELL BIOL, V13, P324, DOI 10.1038/ncb2174; Kumar BN, 2013, BMC CANCER, V13, P1; Kuo CH, 2014, BREAST CANCER-TOKYO, V21, P358, DOI 10.1007/s12282-012-0400-z; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Leikam C, 2008, ONCOGENE, V27, P7070, DOI 10.1038/onc.2008.323; Liu B, 2003, J ORAL PATHOL MED, V32, P367, DOI 10.1034/j.1600-0714.2003.00126.x; Lu YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158587; Mandal M, 1998, ONCOGENE, V17, P999, DOI 10.1038/sj.onc.1202020; Mosieniak G, 2010, CURR PHARM DESIGN, V16, P734, DOI 10.2174/138161210790883714; Mosieniak G, 2015, NEOPLASIA, V17, P882, DOI 10.1016/j.neo.2015.11.008; Most J, 1997, BLOOD, V89, P662, DOI 10.1182/blood.V89.2.662; Nakayama Y, 2015, CELL STRUCT FUNCT, V40, P51, DOI 10.1247/csf.14005; Ogden A, 2015, CANCER LETT, V367, P89, DOI 10.1016/j.canlet.2015.06.025; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pirker R, 2012, LANCET ONCOL, V13, P33, DOI 10.1016/S1470-2045(11)70318-7; Portugal J, 2010, CURR PHARM DESIGN, V16, P69, DOI 10.2174/138161210789941801; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Puig PE, 2008, CELL BIOL INT, V32, P1031, DOI 10.1016/j.cellbi.2008.04.021; Rajput S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061342; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rohnalter V, 2015, ONCOTARGET, V6, P40005, DOI 10.18632/oncotarget.5552; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Ryska A, 2001, VIRCHOWS ARCH, V439, P768, DOI 10.1007/s004280100470; Sharma S, 2013, MOL CANCER THER, V12, P725, DOI 10.1158/1535-7163.MCT-12-1079; Sliwinska MA, 2009, MECH AGEING DEV, V130, P24, DOI 10.1016/j.mad.2008.04.011; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Sundaram M, 2004, CANCER BIOL THER, V3, P207, DOI 10.4161/cbt.3.2.663; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123; Zhang S, 2014, ONCOGENE, V33, P134, DOI 10.1038/onc.2013.318; Zhang S, 2014, ONCOGENE, V33, P116, DOI 10.1038/onc.2013.96; Zhang SW, 2014, INT J CANCER, V134, P508, DOI 10.1002/ijc.28319; Zhang WH, 2011, CANCER-AM CANCER SOC, V117, P4092, DOI 10.1002/cncr.26021; Zheng L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1825	55	38	40	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 16	2018	37	33					4546	4561		10.1038/s41388-018-0272-6	http://dx.doi.org/10.1038/s41388-018-0272-6			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GQ5OV	29743594				2022-12-26	WOS:000441736700005
J	Cheng, G; Zielonka, M; Dranka, B; Kumar, SN; Myers, CR; Bennett, B; Garces, AM; Machado, LGDD; Thiebaut, D; Ouari, O; Hardy, M; Zielonka, J; Kalyanaraman, B				Cheng, Gang; Zielonka, Monika; Dranka, Brian; Kumar, Suresh N.; Myers, Charles R.; Bennett, Brian; Garces, Alexander M.; Machado, Luiz Gabriel Dias Duarte; Thiebaut, David; Ouari, Olivier; Hardy, Micael; Zielonka, Jacek; Kalyanaraman, Balaraman			Detection of mitochondria-generated reactive oxygen species in cells using multiple probes and methods: Potentials, pitfalls, and the future	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; reactive oxygen species (ROS); electron paramagnetic resonance (EPR); peroxiredoxin; superoxide ion; low-temperature EPR; mitochondrial oxidants; radical scavengers; redox probes; thiol-specific antioxidant enzymes; bioenergetics	ELECTRON-PARAMAGNETIC-RESONANCE; DIAGNOSTIC MARKER PRODUCTS; IMAGING HYDROGEN-PEROXIDE; OXIDATIVE STRESS; IN-VIVO; FLUORESCENT-PROBE; NADPH OXIDASE; INTRACELLULAR SUPEROXIDE; CATIONIC ANTIOXIDANTS; ROS GENERATION	Reactive oxygen and nitrogen species (ROS/RNS) such as superoxide (O), hydrogen peroxide, lipid hydroperoxides, peroxynitrite, and hypochlorous and hypobromous acids play a key role in many pathophysiological processes. Recent studies have focused on mitochondrial ROS as redox signaling species responsible for promoting cell division, modulating and regulating kinases and phosphatases, and activating transcription factors. Many ROS also stimulate cell death and senescence. The extent to which these processes occur is attributed to ROS levels (low or high) in cells. However, the exact nature of ROS remains unknown. Investigators have used redox-active probes that, upon oxidation by ROS, yield products exhibiting fluorescence, chemiluminescence, or bioluminescence. Mitochondria-targeted probes can be used to detect ROS generated in mitochondria. However, because most of these redox-active probes (untargeted and mitochondria-targeted) are oxidized by several ROS species, attributing redox probe oxidation to specific ROS species is difficult. It is conceivable that redox-active probes are oxidized in common one-electron oxidation pathways, resulting in a radical intermediate that either reacts with another oxidant (including oxygen to produce O) and forms a stable fluorescent product or reacts with O to form a fluorescent marker product. Here, we propose the use of multiple probes and complementary techniques (HPLC, LC-MS, redox blotting, and EPR) and the measurement of intracellular probe uptake and specific marker products to identify specific ROS generated in cells. The low-temperature EPR technique developed to investigate cellular/mitochondrial oxidants can easily be extended to animal and human tissues.	[Cheng, Gang; Zielonka, Monika; Zielonka, Jacek; Kalyanaraman, Balaraman] Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Cheng, Gang; Zielonka, Monika; Zielonka, Jacek; Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA; [Kumar, Suresh N.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Myers, Charles R.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Myers, Charles R.; Zielonka, Jacek; Kalyanaraman, Balaraman] Med Coll Wisconsin, Canc Ctr, Milwaukee, WI 53226 USA; [Dranka, Brian] Agilent Technol, Cell Anal Div, Santa Clara, CA 95051 USA; [Bennett, Brian; Garces, Alexander M.; Machado, Luiz Gabriel Dias Duarte] Marquette Univ, Dept Phys, Milwaukee, WI 53233 USA; [Thiebaut, David; Ouari, Olivier; Hardy, Micael] Aix Marseille Univ, CNRS, ICR, UMR 7273, F-13013 Marseille, France	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Agilent Technologies; Marquette University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Aix-Marseille Universite	Kalyanaraman, B (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	balarama@mcw.edu	Zielonka, Jacek/N-9546-2014; Hardy, micael/ABF-3357-2020	Zielonka, Jacek/0000-0002-2524-0145; Hardy, micael/0000-0003-2976-7785; Ouari, Olivier/0000-0003-4320-4313; Dias Duarte Machado, Luiz Gabriel/0000-0002-0960-106X	National Science Foundation [CHE-1532168]; Bruker BioSpin; Direct For Mathematical & Physical Scien [1532168] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U01CA178960, R01CA208648] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Bruker BioSpin; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	EPR was supported by National Science Foundation Major Research Instrumentation Award CHE-1532168 (to B. B.) and by Bruker BioSpin.	Abe K, 2014, J CEREBR BLOOD F MET, V34, P1907, DOI 10.1038/jcbfm.2014.160; Ahn HY, 2012, J AM CHEM SOC, V134, P4721, DOI 10.1021/ja210315x; Andreyev AY, 2015, BIOCHEMISTRY-MOSCOW+, V80, P517, DOI 10.1134/S0006297915050028; Beatty A, 2018, MOL CANCER THER, V17, P264, DOI 10.1158/1535-7163.MCT-17-0407; Beinert H, 1978, Methods Enzymol, V54, P133; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Bennett B, 2016, FREE RADICAL BIO MED, V92, P141, DOI 10.1016/j.freeradbiomed.2016.01.001; Bonini MG, 2006, FREE RADICAL BIO MED, V40, P968, DOI 10.1016/j.freeradbiomed.2005.10.042; Brand MD, 2016, FREE RADICAL BIO MED, V100, P14, DOI 10.1016/j.freeradbiomed.2016.04.001; Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979; Cerrato CP, 2015, FASEB J, V29, P4589, DOI 10.1096/fj.14-269225; Chan SHH, 2009, HYPERTENSION, V53, P217, DOI 10.1161/HYPERTENSIONAHA.108.116905; Chandran K, 2009, BIOPHYS J, V96, P1388, DOI 10.1016/j.bpj.2008.10.042; Cheng G, 2014, BRIT J CANCER, V111, P85, DOI 10.1038/bjc.2014.272; Cheng G, 2015, CANCER LETT, V365, P96, DOI 10.1016/j.canlet.2015.05.016; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Chu WH, 2014, ORG BIOMOL CHEM, V12, P4421, DOI 10.1039/c3ob42379d; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; Cox AG, 2008, FREE RADICAL BIO MED, V44, P1001, DOI 10.1016/j.freeradbiomed.2007.11.017; Cunniff B, 2013, J CELL PHYSIOL, V228, P835, DOI 10.1002/jcp.24232; Davies MJ, 2016, METHODS, V109, P21, DOI 10.1016/j.ymeth.2016.05.013; Dey S, 2016, J BIOL CHEM, V291, P11185, DOI 10.1074/jbc.M116.726968; Dhanasekaran A, 2005, FREE RADICAL BIO MED, V39, P567, DOI 10.1016/j.freeradbiomed.2005.04.016; Dickey JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070575; Dickinson BC, 2008, J AM CHEM SOC, V130, P9638, DOI 10.1021/ja802355u; Dickinson BC, 2011, CHEM BIOL, V18, P943, DOI 10.1016/j.chembiol.2011.07.005; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Esterberg R, 2016, J CLIN INVEST, V126, P3556, DOI 10.1172/JCI84939; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Ge C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03881-9; Hall DJ, 2012, J CEREBR BLOOD F MET, V32, P23, DOI 10.1038/jcbfm.2011.119; Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123; Hangauer MJ, 2017, NATURE, V551, P247, DOI 10.1038/nature24297; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; Hu JJ, 2015, J AM CHEM SOC, V137, P6837, DOI 10.1021/jacs.5b01881; Idelchik MDS, 2017, SEMIN CANCER BIOL, V47, P57, DOI 10.1016/j.semcancer.2017.04.005; JANZEN EG, 1984, METHOD ENZYMOL, V105, P188; Jayakumar S, 2017, FREE RADICAL BIO MED, V113, P530, DOI 10.1016/j.freeradbiomed.2017.10.378; Kalyanaraman B, 2018, REDOX BIOL, V15, P347, DOI 10.1016/j.redox.2017.12.012; Kalyanaraman B, 2017, ARCH BIOCHEM BIOPHYS, V617, P38, DOI 10.1016/j.abb.2016.08.021; Kalyanaraman B, 2014, BBA-GEN SUBJECTS, V1840, P739, DOI 10.1016/j.bbagen.2013.05.008; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Kotamraju S, 2004, METHOD ENZYMOL, V378, P362; Lee E, 2017, J CELL PHYSIOL, V232, P3209, DOI 10.1002/jcp.25867; Li PY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22831; Logan A, 2016, CELL METAB, V23, P379, DOI 10.1016/j.cmet.2015.11.014; Ma L, 2018, INT J CANCER, V142, P1786, DOI 10.1002/ijc.31207; Maghzal GJ, 2007, FREE RADICAL BIO MED, V43, P1095, DOI 10.1016/j.freeradbiomed.2007.06.023; McCarthy C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32683; Medvedev ES, 2010, BBA-BIOENERGETICS, V1797, P1665, DOI 10.1016/j.bbabio.2010.05.011; Michalski R, 2014, J BIOL CHEM, V289, P22536, DOI 10.1074/jbc.M114.553727; Michalski R, 2014, FREE RADICAL BIO MED, V67, P278, DOI 10.1016/j.freeradbiomed.2013.10.816; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Myers CR, 2016, FREE RADICAL BIO MED, V91, P81, DOI 10.1016/j.freeradbiomed.2015.12.008; Myers CR, 2010, FREE RADICAL BIO MED, V49, P1903, DOI 10.1016/j.freeradbiomed.2010.09.020; Myers JM, 2009, FREE RADICAL BIO MED, V47, P1477, DOI 10.1016/j.freeradbiomed.2009.08.015; Ni R, 2016, FREE RADICAL BIO MED, V90, P12, DOI 10.1016/j.freeradbiomed.2015.11.013; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Ogrunc M, 2014, CELL DEATH DIFFER, V21, P998, DOI 10.1038/cdd.2014.16; Oien DB, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00970; Pearson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096378; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pillai VB, 2017, ONCOTARGET, V8, P34082, DOI 10.18632/oncotarget.16133; Davila MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138777; Quinlan CL, 2013, METHOD ENZYMOL, V526, P189, DOI 10.1016/B978-0-12-405883-5.00012-0; Ren T, 2017, ONCOGENE, V36, P5897, DOI 10.1038/onc.2017.167; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Roelofs BA, 2015, FREE RADICAL BIO MED, V86, P250, DOI 10.1016/j.freeradbiomed.2015.05.032; Rota C, 1999, FREE RADICAL BIO MED, V27, P873, DOI 10.1016/S0891-5849(99)00137-9; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Shadel GS, 2015, CELL, V163, P560, DOI 10.1016/j.cell.2015.10.001; Shchepinova MM, 2017, CELL CHEM BIOL, V24, P1285, DOI 10.1016/j.chembiol.2017.08.003; Sikora A, 2013, CHEM RES TOXICOL, V26, P856, DOI 10.1021/tx300499c; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Skulachev VP, 2005, IUBMB LIFE, V57, P305, DOI 10.1080/15216540500092161; Smith RAJ, 2003, P NATL ACAD SCI USA, V100, P5407, DOI 10.1073/pnas.0931245100; Smulik R, 2014, J BIOL CHEM, V289, P35570, DOI 10.1074/jbc.M114.597740; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stein N, 2017, BIOCHEMISTRY-US, V56, P3068, DOI 10.1021/acs.biochem.6b00876; Szeto HH, 2006, AAPS J, V8, pE277, DOI 10.1007/BF02854898; Tampo Y, 2003, CIRC RES, V92, P56, DOI 10.1161/01.RES.0000048195.15637.AC; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Torrens-Mas M, 2017, CANCERS, V9, DOI 10.3390/cancers9070090; Tortora V, 2007, FREE RADICAL BIO MED, V42, P1075, DOI 10.1016/j.freeradbiomed.2007.01.007; Tung JN, 2018, ONCOTARGET, V9, P4637, DOI 10.18632/oncotarget.23161; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Wang H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02915-8; Wangpaichitr M, 2017, Cell Dev Biol, V6, DOI 10.4172/2168-9296.1000183; Wangpaichitr M, 2017, ONCOTARGET, V8, P49275, DOI 10.18632/oncotarget.17568; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Winterbourn CC, 2018, ANTIOXID REDOX SIGN, V29, P541, DOI 10.1089/ars.2017.7425; Xu J, 2016, ANAL CHEM, V88, P1455, DOI 10.1021/acs.analchem.5b04424; Yasui H, 2017, CANCER LETT, V390, P160, DOI 10.1016/j.canlet.2017.01.006; Yu W, 2016, J BIOL CHEM, V291, P3268, DOI 10.1074/jbc.M115.702076; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200; Zielonka J, 2005, FREE RADICAL BIO MED, V39, P853, DOI 10.1016/j.freeradbiomed.2005.05.001; Zielonka J, 2008, FREE RADICAL BIO MED, V44, P835, DOI 10.1016/j.freeradbiomed.2007.11.013; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zielonka J, 2017, CHEM REV, V117, P10043, DOI 10.1021/acs.chemrev.7b00042; Zielonka J, 2016, FREE RADICAL BIO MED, V99, P32, DOI 10.1016/j.freeradbiomed.2016.07.023; Zielonka J, 2016, J BIOL CHEM, V291, P7029, DOI 10.1074/jbc.M115.702787; Zielonka Jacek, 2015, Methods Mol Biol, V1264, P171, DOI 10.1007/978-1-4939-2257-4_16; Zielonka J, 2013, FREE RADICAL BIO MED, V65, P1310, DOI 10.1016/j.freeradbiomed.2013.09.017; Zielonka J, 2013, METHOD ENZYMOL, V526, P145, DOI 10.1016/B978-0-12-405883-5.00009-0; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031; Zou L, 2018, J BIOL CHEM, V293, P1666, DOI 10.1074/jbc.M117.798645	117	56	56	11	78	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10363	10380		10.1074/jbc.RA118.003044	http://dx.doi.org/10.1074/jbc.RA118.003044			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29739855	hybrid, Green Published			2022-12-26	WOS:000437096700034
J	Parikh, RY; Lin, HF; Gangaraju, VK				Parikh, Rasesh Y.; Lin, Haifan; Gangaraju, Vamsi K.			A critical role for nucleoporin 358 (Nup358) in transposon silencing and piRNA biogenesis in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear pore; RNA; RNA interference; RNAi; transposable element; TE; ovary; Piwi; Piwi-interacting RNA; ping-pong cycle; RAN-binding protein 2; RanBP2; Nup358	NUCLEAR-PORE COMPLEX; WIDE RNAI SCREEN; PROTEIN IMPORT; PIWI PROTEINS; NASCENT RNA; E3 LIGASE; GERMLINE; PATHWAY; MECHANISM; CHROMATIN	Piwi-interacting RNAs (piRNAs) are a class of small noncoding RNAs that bind Piwi proteins to silence transposons and to regulate gene expression. In Drosophila germ cells, the Aubergine (Aub)-Argonaute 3 (Ago3)-dependent ping-pong cycle generates most germline piRNAs. Loading of antisense piRNAs amplified by this cycle enables Piwi to enter the nucleus and silence transposons. Nuclear localization is crucial for Piwi function in transposon silencing, but how this process is regulated remains unknown. It is also not known whether any of the components of the nuclear pore complex (NPC) directly function in the piRNA pathway. Here, we show that nucleoporin 358 (Nup358) and Piwi interact with each other and that a germline knockdown (GLKD) of Nup358 with short hairpin RNA prevents Piwi entry into the nucleus. The Nup358 GLKD also activated transposons, increased genomic instability, and derailed piRNA biogenesis because of a combination of decreased piRNA precursor transcription and a collapse of the ping-pong cycle. Our results point to a critical role for Nup358 in the piRNA pathway, laying the foundation for future studies to fully elucidate the mechanisms by which Nup358 contributes to piRNA biogenesis and transposon silencing.	[Parikh, Rasesh Y.; Gangaraju, Vamsi K.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Parikh, Rasesh Y.; Gangaraju, Vamsi K.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Lin, Haifan] Yale Univ, Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Lin, Haifan] Yale Univ, Dept Cell Biol, New Haven, CT 06510 USA	Medical University of South Carolina; Medical University of South Carolina; Yale University; Yale University	Gangaraju, VK (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.; Gangaraju, VK (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA.; Lin, HF (corresponding author), Yale Univ, Yale Stem Cell Ctr, New Haven, CT 06510 USA.; Lin, HF (corresponding author), Yale Univ, Dept Cell Biol, New Haven, CT 06510 USA.	haifan.lin@yale.edu; gangaraj@musc.edu			National Institutes of Health [P30 CA138313];  [S10 OD018113]; NATIONAL CANCER INSTITUTE [P30CA138313, DP1CA174418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES021736] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Haruhiko Siomi, Mikiko Siomi, and William Theurkauf for antibodies. We thank Robert Wilson and Jennifer Schulte for preparing deep-sequencing libraries. We thank Todd Mack for generating Piwi and NNup358 expression plasmids. We acknowledge core support from the Cell and Molecular Imaging Shared Resource, Hollings Cancer Center, Medical University of South Carolina (supported by National Institutes of Health Grant P30 CA138313); Shared Instrumentation Grant S10 OD018113; and the Genomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina.	Akkouche A, 2017, MOL CELL, V66, P411, DOI 10.1016/j.molcel.2017.03.017; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; Beyret E, 2012, CELL RES, V22, P1429, DOI 10.1038/cr.2012.120; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Forler D, 2004, MOL CELL BIOL, V24, P1155, DOI 10.1128/MCB.24.3.1155-1167.2004; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; Gardini A, 2017, METHODS MOL BIOL, V1468, P111, DOI 10.1007/978-1-4939-4035-6_9; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Han BW, 2015, BIOINFORMATICS, V31, P593, DOI 10.1093/bioinformatics/btu647; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; Huang XA, 2013, DEV CELL, V24, P502, DOI 10.1016/j.devcel.2013.01.023; Hur JK, 2016, GENE DEV, V30, P840, DOI 10.1101/gad.276030.115; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Karam JA, 2017, J BIOL CHEM, V292, P6039, DOI 10.1074/jbc.C117.777730; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Klenov MS, 2014, NUCLEIC ACIDS RES, V42, P6208, DOI 10.1093/nar/gku268; Klenov MS, 2011, P NATL ACAD SCI USA, V108, P18760, DOI 10.1073/pnas.1106676108; Ku HY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005813; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Le Thomas A, 2014, GENE DEV, V28, P1667, DOI 10.1101/gad.245514.114; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mohn F, 2014, CELL, V157, P1364, DOI 10.1016/j.cell.2014.04.031; Muerdter F, 2013, MOL CELL, V50, P736, DOI 10.1016/j.molcel.2013.04.006; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Roth P, 2003, J CELL BIOL, V163, P701, DOI 10.1083/jcb.200304046; Rozhkov NV, 2013, GENE DEV, V27, P400, DOI 10.1101/gad.209767.112; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sienski G, 2015, GENE DEV, V29, P2258, DOI 10.1101/gad.271908.115; Uv AE, 2000, GENE DEV, V14, P1945; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109; Wang W, 2015, MOL CELL, V59, P819, DOI 10.1016/j.molcel.2015.08.007; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yamanaka S, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-22; Yu Y, 2015, SCIENCE, V350, P339, DOI 10.1126/science.aab0700; Zhang Z, 2011, MOL CELL, V44, P572, DOI 10.1016/j.molcel.2011.10.011	49	9	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9140	9147		10.1074/jbc.AC118.003264	http://dx.doi.org/10.1074/jbc.AC118.003264			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29735528	Green Published, hybrid			2022-12-26	WOS:000435441400001
J	Gonzalez, RG; Fell, R; He, JL; Campbell, J; Burdo, TH; Autissier, P; Annamalai, L; Taheri, F; Parker, T; Lifson, JD; Halpern, EF; Vangel, M; Masliah, E; Westmoreland, SV; Williams, KC; Ratai, EM				Gonzalez, R. Gilberto; Fell, Robert; He, Julian; Campbell, Jennifer; Burdo, Tricia H.; Autissier, Patrick; Annamalai, Lakshmanan; Taheri, Faramarz; Parker, Termara; Lifson, Jeffrey D.; Halpern, Elkan F.; Vangel, Mark; Masliah, Eliezer; Westmoreland, Susan, V; Williams, Kenneth C.; Ratai, Eva-Maria			Temporal/compartmental changes in viral RNA and neuronal injury in a primate model of NeuroAIDS	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MAGNETIC-RESONANCE-SPECTROSCOPY; CENTRAL-NERVOUS-SYSTEM; AIDS DEMENTIA COMPLEX; CHRONIC HIV-INFECTION; NEUROCOGNITIVE DISORDERS; ANTIRETROVIRAL THERAPY; CEREBROSPINAL-FLUID; RHESUS MACAQUES; COGNITIVE IMPAIRMENT	Despite the advent of highly active anti-retroviral therapy HIV-associated neurocognitive disorders (HAND) continue to be a significant problem. Furthermore, the precise pathogenesis of this neurodegeneration is still unclear. The objective of this study was to examine the relationship between infection by the simian immunodeficiency virus (SIV) and neuronal injury in the rhesus macaque using in vivo and postmortem sampling techniques. The effect of SIV infection in 23 adult rhesus macaques was investigated using an accelerated NeuroAIDS model. Disease progression was modulated either with combination anti-retroviral therapy (cART, 4 animals) or minocycline (7 animals). Twelve animals remained untreated. Viral loads were monitored in the blood and cerebral spinal fluid, as were levels of activated monocytes in the blood. Neuronal injury was monitored in vivo using magnetic resonance spectroscopy. Viral RNA was quantified in brain tissue of each animal postmortem using reverse transcription polymerase chain reaction (RT-PCR), and neuronal injury was assessed by immunohistochemistry. Without treatment, viral RNA in plasma, cerebral spinal fluid, and brain tissue appears to reach a plateau. Neuronal injury was highly correlated both to plasma viral levels and a subset of infected/activated monocytes (CD14+CD16+), which are known to traffic the virus into the brain. Treatment with either cART or minocycline decreased brain viral levels and partially reversed alterations in in vivo and immunohistochemical markers for neuronal injury. These findings suggest there is significant turnover of replicating virus within the brain and the severity of neuronal injury is directly related to the brain viral load.	[Gonzalez, R. Gilberto; Fell, Robert; He, Julian; Parker, Termara; Vangel, Mark; Ratai, Eva-Maria] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Neuroradiol Div, Charlestown, MA 02129 USA; [Gonzalez, R. Gilberto; He, Julian; Halpern, Elkan F.; Vangel, Mark; Ratai, Eva-Maria] Harvard Med Sch, Boston, MA 02115 USA; [Campbell, Jennifer; Burdo, Tricia H.; Autissier, Patrick; Williams, Kenneth C.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Annamalai, Lakshmanan; Taheri, Faramarz; Westmoreland, Susan, V] New England Primate Res Ctr, Southborough, MA USA; [Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Halpern, Elkan F.] Massachusetts Gen Hosp, Dept Radiol, Inst Technol Assessment, 32 Fruit St, Boston, MA 02114 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Fell, Robert] Univ Minnesota, Minneapolis, MN USA; [Campbell, Jennifer] Janssen Sci Affairs LLC, Horsham, PA USA; [Burdo, Tricia H.] Temple Univ, Lewis Katz Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Annamalai, Lakshmanan] Merck & Co Inc, Kenilworth, NJ USA; [Taheri, Faramarz] Univ Calif Irvine, Sch Med, Gavin Herbert Eye Inst, Irvine, CA 92717 USA; [Parker, Termara] Yale Univ, Sch Med, New Haven, CT USA; [Masliah, Eliezer] NIA, Bethesda, MD 20892 USA; [Westmoreland, Susan, V] Abbvie, Worcester, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; Johnson & Johnson; Janssen Pharmaceuticals; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Merck & Company; University of California System; University of California Irvine; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); AbbVie	Ratai, EM (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Neuroradiol Div, Charlestown, MA 02129 USA.; Ratai, EM (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	eratai@mgh.harvard.edu	Dutta, Debashis/L-4685-2019		National Institutes of Health (NIH) [R21NS059331, R01NS050041, R01NS040237, R01NS37654, R01MH62962, MH59754, MH62512, R01NS082116, RR00168]; NIH [S10RR021110, S10RR022976, S10RR019933, S10RR023401, S10RR019307, S10RR023043]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grants R21NS059331 (EMR), R01NS050041 (RGG), R01NS040237 (KCW), R01NS37654 (KCW), R01MH62962 (EM), MH59754 (EM), MH62512 (EM), R01NS082116 (THB) and RR00168 (NEPRC Base Grant). The Massachusetts General Hospital A.A. Martinos Center for Biomedical Imaging is also supported by the NIH grants S10RR021110, S10RR022976, S10RR019933, S10RR023401, S10RR019307 and S10RR023043. The depleting anti-CD8 (human recombinant, cM-807) reagent used in these studies was provided by the NIH Nonhuman Primate Reagent Resource (R24RR016001, N01AI040101). Supported in part with federal funds from the National Cancer Institute, National Institutes of Health (Contract No. HHSN261200800001E) to JDL. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Additionally, Jennifer Campbell is currently employed by Janssen Scientific Affairs, LLC. Horsham, PA, USA, and was formerly employed by Johnson and Johnson. Lakshmanan Annamalai is currently employed by Merck & Co., Inc. Susan V. Westmoreland is currently employed by AbbVie Pharmaceuticals. Dr. Jeffrey D. Lifson has been employed by the AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick. Eva-Maria Ratai is a member on the Advisory Board for BrainSpec, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adle-Biassette H, 1999, NEUROPATH APPL NEURO, V25, P123; Ancuta P, 2006, J LEUKOCYTE BIOL, V80, P1156, DOI 10.1189/jlb.0206125; Annamalai L, 2010, AM J PATHOL, V177, P777, DOI 10.2353/ajpath.2010.091248; Bellizzi MJ, 2005, J CLIN INVEST, V115, P3185, DOI 10.1172/JCI25444; Boban J, 2017, AM J NEURORADIOL, V38, P1122, DOI 10.3174/ajnr.A5160; Burdo TH, 2013, AIDS, V27, P1387, DOI 10.1097/QAD.0b013e32836010bd; Burudi EME, 2001, ADV VIRUS RES, V56, P435, DOI 10.1016/S0065-3527(01)56035-2; Campbell JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025661; Canestri A, 2010, CLIN INFECT DIS, V50, P773, DOI 10.1086/650538; Chan P, 2014, CURR HIV-AIDS REP, V11, P317, DOI 10.1007/s11904-014-0221-0; Clay CC, 2007, J VIROL, V81, P12040, DOI 10.1128/JVI.00133-07; Clifford DB, 2013, LANCET INFECT DIS, V13, P976, DOI 10.1016/S1473-3099(13)70269-X; Cysique LAJ, 2006, NEUROLOGY, V66, P1447, DOI 10.1212/01.wnl.0000210477.63851.d3; DESROSIERS RC, 1990, ANNU REV IMMUNOL, V8, P557, DOI 10.1146/annurev.iy.08.040190.003013; Eden A, 2010, J INFECT DIS, V202, P1819, DOI 10.1086/657342; Elbirt D, 2015, ISR MED ASSOC J, V17, P54; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Everall IP, 1999, BRAIN PATHOL, V9, P209; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Follstaedt SC, 2008, J NEUROVIROL, V14, P376, DOI 10.1080/13550280802199898; Gannon P, 2011, CURR OPIN NEUROL, V24, P275, DOI 10.1097/WCO.0b013e32834695fb; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; Gongvatana A, 2013, J NEUROVIROL, V19, P209, DOI 10.1007/s13365-013-0162-1; Harezlak J, 2014, J NEUROVIROL, V20, P294, DOI 10.1007/s13365-014-0246-6; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Kim JP, 2005, AM J NEURORADIOL, V26, P752; Kraft-Terry SD, 2009, NEURON, V64, P133, DOI 10.1016/j.neuron.2009.09.042; Kumar AM, 2007, J NEUROVIROL, V13, P210, DOI 10.1080/13550280701327038; Lentz MR, 2005, RADIOLOGY, V235, P461, DOI 10.1148/radiol.2352040003; Letendre SL, 2004, ANN NEUROL, V56, P416, DOI 10.1002/ana.20198; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; MASLIAH E, 1992, LAB INVEST, V66, P285; McArthur JC, 1997, ANN NEUROL, V42, P689, DOI 10.1002/ana.410420504; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; McClernon DR, 2001, NEUROLOGY, V57, P1396, DOI 10.1212/WNL.57.8.1396; McGuire JL, 2015, J NEUROVIROL, V21, P439, DOI 10.1007/s13365-015-0333-3; Mohamed MA, 2010, RADIOLOGY, V254, P577, DOI 10.1148/radiol.09081867; Nath A, 2002, J INFECT DIS, V186, pS193, DOI 10.1086/344528; Nath A, 2008, INT REV PSYCHIATR, V20, P25, DOI 10.1080/09540260701861930; NAVIA BA, 1986, ANN NEUROL, V19, P525, DOI 10.1002/ana.410190603; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Pulliam L, 1997, LANCET, V349, P692, DOI 10.1016/S0140-6736(96)10178-1; Ratai EM, 2011, MAGN RESON MED, V66, P625, DOI 10.1002/mrm.22821; Ratai EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010523; Robertson KR, 2007, J NEUROIMMUNE PHARM, V2, P105, DOI 10.1007/s11481-006-9052-0; Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257; Sacktor N, 2011, NEUROLOGY, V77, P1135, DOI 10.1212/WNL.0b013e31822f0412; Sanchez AB, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7030025; Schifitto G, 2007, AIDS, V21, P1877, DOI 10.1097/QAD.0b013e32813384e8; SCHMITT FA, 1988, NEW ENGL J MED, V319, P1573, DOI 10.1056/NEJM198812153192404; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Scutari R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7040038; Tan IL, 2012, CNS DRUGS, V26, P123, DOI 10.2165/11597770-000000000-00000; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Tozzi V, 2001, J ACQ IMMUN DEF SYND, V28, P19, DOI 10.1097/00042560-200109010-00004; Valcour VG, 2010, J LEUKOCYTE BIOL, V87, P621, DOI 10.1189/jlb.0809571; Westmoreland SV, 1998, J NEUROVIROL, V4, P260, DOI 10.3109/13550289809114527; Williams K, 2005, J CLIN INVEST, V115, P2534, DOI 10.1172/JCI22953; Williams K, 2001, GLIA, V36, P156, DOI 10.1002/glia.1105; Zhang X., 2013, J CLIN CELL IMMUNOL, V4, P005, DOI [10.4172/2155-9899.S7-005, DOI 10.4172/2155-9899.S7-005]; Zhou L, 2013, INFECT DIS REP, V5, P38, DOI 10.4081/idr.2013.s1.e8; Zink MC, 1998, J NEUROVIROL, V4, P249, DOI 10.3109/13550289809114526; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003; zur Megede J, 2008, AIDS RES HUM RETROV, V24, P1103, DOI 10.1089/aid.2008.0055	72	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0196942	10.1371/journal.pone.0196942	http://dx.doi.org/10.1371/journal.pone.0196942			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750804	gold, Green Published, Green Submitted			2022-12-26	WOS:000431856300010
J	Chaiyasitdhi, A; Miphonpanyatawichok, W; Riehle, MO; Phatthanakun, R; Surareungchai, W; Kundhikanjana, W; Kuntanawat, P				Chaiyasitdhi, Atitheb; Miphonpanyatawichok, Wirat; Riehle, Mathis Oliver; Phatthanakun, Rungrueang; Surareungchai, Werasak; Kundhikanjana, Worasom; Kuntanawat, Panwong			The biomechanical role of overall-shape transformation in a primitive multicellular organism: A case study of dimorphism in the filamentous cyanobacterium Arthrospira platensis	PLOS ONE			English	Article							POLYSACCHARIDE SECRETION; GLIDING MOTILITY; DIATOM CHAINS; SPIRULINA; MORPHOLOGY; CAULOBACTER; BACTERIUM; MODULUS; SYSTEM; MOTION	Morphological transformations in primitive organisms have long been observed; however, its biomechanical roles are largely unexplored. In this study, we investigate the structural advantages of dimorphism in Arthrospira platensis, a filamentous multicellular cyanobacterium. We report that helical trichomes, the default shape, have a higher persistence length (L-p), indicating a higher resistance to bending or a large value of flexural rigidity (k(f)), the product of the local cell stiffness (E) and the moment of inertia of the trichomes' cross-section (l). Through Atomic Force Microscopy (AFM), we determined that the Eof straight and helical trichomes were the same. In contrast, our computational model shows that l is greatly dependent on helical radii, implying that trichome morphology is the major contributor to k(f) variation. According to our estimation, increasing the helical radii alone can increase k(f) by 2 orders of magnitude. We also observe that straight trichomes have improved gliding ability, due to its structure and lower k(f). Our study shows that dimorphism provides mechanical adjustability to the organism and may allow it to thrive in different environmental conditions. The higher k(f) provides helical trichomes a better nutrient uptake through advection in aquatic environments. On the other hand, the lower k(f) improves the gliding ability of straight trichomes in aquatic environments, enabling it to chemotactically relocate to more favorable territories when it encounters certain environmental stresses. When more optimal conditions are encountered, straight trichomes can revert to their original helical form. Our study is one of the first to highlight the biomechanical role of an overall-shape transformation in cyanobacteria.	[Chaiyasitdhi, Atitheb] King Mongkuts Univ Technol Thonburi, Fac Engn, Biol Engn Program, Bangkok, Thailand; [Miphonpanyatawichok, Wirat; Surareungchai, Werasak; Kuntanawat, Panwong] King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Div Biotechnol, Bangkok, Thailand; [Riehle, Mathis Oliver] Univ Glasgow, Coll Med Vet & Life Sci, Ctr Cell Engn, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Phatthanakun, Rungrueang] Synchrotron Light Res Inst, Nakhon Ratchasima, Thailand; [Surareungchai, Werasak; Kuntanawat, Panwong] King Mongkuts Univ Technol Thonburi, Fac Sci, Nanosci & Nanotechnol Grad Program, Bangkok, Thailand; [Kundhikanjana, Worasom] Suranaree Univ Technol, Sch Phys, Inst Sci, Nakhon Ratchasima, Thailand; [Kuntanawat, Panwong] Suranaree Univ Technol, Sch Biotechnol, Inst Agr Technol, Nakhon Ratchasima, Thailand	King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi; University of Glasgow; King Mongkuts University of Technology Thonburi; Suranaree University of Technology; Suranaree University of Technology	Kuntanawat, P (corresponding author), King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Div Biotechnol, Bangkok, Thailand.; Kuntanawat, P (corresponding author), King Mongkuts Univ Technol Thonburi, Fac Sci, Nanosci & Nanotechnol Grad Program, Bangkok, Thailand.; Kuntanawat, P (corresponding author), Suranaree Univ Technol, Sch Biotechnol, Inst Agr Technol, Nakhon Ratchasima, Thailand.	panwong.kun@gmail.com	Kuntanawat, Panwong/AAQ-5135-2021; Phatthanakun, Rungrueang/AAV-6531-2021; Chaiyasitdhi, Atitheb/AAR-3573-2020	Phatthanakun, Rungrueang/0000-0002-1884-2287; Chaiyasitdhi, Atitheb/0000-0001-8293-5683; Kuntanawat, Panwong/0000-0003-3850-440X	Thailand Research Fund (TRF) [TRG5880260]; Suranaree University of Technology (SUT); Office of the Higher Education Commission under the National Research University (NRU) project	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Suranaree University of Technology (SUT); Office of the Higher Education Commission under the National Research University (NRU) project	PK received funding from Thailand Research Fund (TRF) http://www.trf.or.th/ (contract number TRG5880260). WK received funding from Suranaree University of Technology (SUT) www.sut.ac.th, and the Office of the Higher Education Commission under the National Research University (NRU) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergey DH, 2005, BERGEYS MANUAL SYSTE, DOI [10.1345/aph.1P777, DOI 10.1345/APH.1P777]; Boal D., 2012, MECH CELL; Boal D, 2010, PALEOBIOLOGY, V36, P555, DOI 10.1666/08096.1; Burriesci M, 2008, J PHOTOCH PHOTOBIO B, V91, P77, DOI 10.1016/j.jphotobiol.2008.01.012; Butenko AV, 2012, LANGMUIR, V28, P12941, DOI 10.1021/la302056j; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Chaiyasitdhi A, 2017, 8 RMUTP INT C SCI TE, P35; Chang YR, 2014, J MECH BEHAV BIOMED, V37, P209, DOI 10.1016/j.jmbbm.2014.05.027; CIFERRI O, 1983, MICROBIOL REV, V47, P551, DOI 10.1128/MMBR.47.4.551-578.1983; Dhahri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061663; Food and Agriculture Organization of the United Nations, 2008, REV CULTURE PRODUCTI; Gerbode SJ, 2012, SCIENCE, V337, P1087, DOI 10.1126/science.1223304; GOLDSTEIN SF, 1988, CELL MOTIL CYTOSKEL, V9, P101, DOI 10.1002/cm.970090202; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Hibbeler RC, 2008, STUDIES HLTH TECHNOL; Hoiczyk E, 1998, CURR BIOL, V8, P1161, DOI 10.1016/S0960-9822(07)00487-3; Hongsthong A, 2007, MOL BIOTECHNOL, V36, P123, DOI 10.1007/s12033-007-0013-5; Jeeji Bai N., 1980, ALGOL STUD, V26, P32; Jeeji Bai N, 1985, ARCH HYDROBIOL S71, V191, P38; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Karp-Boss L, 1998, LIMNOL OCEANOGR, V43, P1767, DOI 10.4319/lo.1998.43.8.1767; Khayatan B, 2015, MOL MICROBIOL, V98, P1021, DOI 10.1111/mmi.13205; Kim JS, 2009, BIOPHYS J, V96, pL47, DOI 10.1016/j.bpj.2009.02.010; Kuznetsova TG, 2007, MICRON, V38, P824, DOI 10.1016/j.micron.2007.06.011; LEWIN RA, 1980, ARCH HYDROBIOL S60, V26, P48; Ma ZL, 2009, PLANTA, V230, P329, DOI 10.1007/s00425-009-0947-x; Margolin W, 2004, CURR BIOL, V14, pR242, DOI 10.1016/j.cub.2004.02.057; Muhling M, 2003, J PHYCOL, V39, P360; Musielak MM, 2009, J FLUID MECH, V638, P401, DOI 10.1017/S0022112009991108; Nezhad AS, 2013, LAB CHIP, V13, P2599, DOI [10.1039/c3lc00012e, 10.1039/c31c00012e]; Nubel U, 2000, INT J SYST EVOL MICR, V50, P1265, DOI 10.1099/00207713-50-3-1265; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Risser DD, 2013, MOL MICROBIOL, V87, P884, DOI 10.1111/mmi.12138; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Stahl M, 2016, INFECT IMMUN, V84, P3399, DOI 10.1128/IAI.00751-16; Thammathorn S, 2001, THESIS; VANEYKELENBURG C, 1980, J THEOR BIOL, V82, P271, DOI 10.1016/0022-5193(80)90103-4; Vonshak A, 1997, SPIRULINA PLATENSIS; Wang ZP, 2005, J PHYCOL, V41, P622, DOI 10.1111/j.1529-8817.2005.00087.x; Wang ZP, 1997, J ZHEJIANG AGR U, V23, P36; Wilde A, 2015, MOL MICROBIOL, V98, P998, DOI 10.1111/mmi.13242; Wolgemuth CW, 2005, PHYS BIOL, V2, P189, DOI 10.1088/1478-3975/2/3/006; Wu HY, 2005, APPL ENVIRON MICROB, V71, P5004, DOI 10.1128/AEM.71.9.5004-5013.2005; Young AM, 2012, LIMNOL OCEANOGR, V57, P1789, DOI 10.4319/lo.2012.57.6.1789; Young KD, 2007, CURR OPIN MICROBIOL, V10, P596, DOI 10.1016/j.mib.2007.09.009; Zarrouk C, 1896, CONTRIBUTION ETUDE C	46	5	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196383	10.1371/journal.pone.0196383	http://dx.doi.org/10.1371/journal.pone.0196383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746494	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000431851700016
J	Dib, FK; Rodgers, P				Dib, Fadi K.; Rodgers, Peter			Graph drawing using tabu search coupled with path relinking	PLOS ONE			English	Article							COMMUNITY STRUCTURE; ALGORITHM; MODEL; LAYOUT	Graph drawing, or the automatic layout of graphs, is a challenging problem. There are several search based methods for graph drawing which are based on optimizing an objective function which is formed from a weighted sum of multiple criteria. In this paper, we propose a new neighbourhood search method which uses a tabu search coupled with path relinking to optimize such objective functions for general graph layouts with undirected straight lines. To our knowledge, before our work, neither of these methods have been previously used in general multi-criteria graph drawing. Tabu search uses a memory list to speed up searching by avoiding previously tested solutions, while the path relinking method generates new solutions by exploring paths that connect high quality solutions. We use path relinking periodically within the tabu search procedure to speed up the identification of good solutions. We have evaluated our new method against the commonly used neighbourhood search optimization techniques: hill climbing and simulated annealing. Our evaluation examines the quality of the graph layout (objective function's value) and the speed of layout in terms of the number of evaluated solutions required to draw a graph. We also examine the relative scalability of each method. Our experimental results were applied to both random graphs and a real-world dataset. We show that our method outperforms both hill climbing and simulated annealing by producing a better layout in a lower number of evaluated solutions. In addition, we demonstrate that our method has greater scalability as it can layout larger graphs than the state-of-the-art neighbourhood search methods. Finally, we show that similar results can be produced in a real world setting by testing our method against a standard public graph dataset.	[Dib, Fadi K.; Rodgers, Peter] Univ Kent, Sch Comp, Canterbury, Kent, England; [Dib, Fadi K.] Gulf Univ Sci & Technol, Comp Sci Dept, Hawally, Kuwait	University of Kent; Gulf University of Science & Technology	Dib, FK (corresponding author), Univ Kent, Sch Comp, Canterbury, Kent, England.; Dib, FK (corresponding author), Gulf Univ Sci & Technol, Comp Sci Dept, Hawally, Kuwait.	fkd4@kent.ac.uk; deeb.f@gust.edu.kw	Dib, Fadi/I-8331-2018	Dib, Fadi/0000-0003-2689-3305				Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Batagelj V., 2006, PAJEK DATASETS; Battista GD, 1998, GRAPH DRAWING ALGORI; Blum C, 2003, ACM COMPUT SURV, V35, P268, DOI 10.1145/937503.937505; Brank J, 2004, ZBORNIK C 7, V7, P67; Branke J, 1997, PROCEEDINGS OF THE THIRD NORDIC WORKSHOP ON GENETIC ALGORITHMS AND THEIR APPLICATIONS (3NWGA), P193; Choe Y, 2004, SOC NEUR ABSTR, V30; Cordeau JF, 1997, NETWORKS, V30, P105, DOI 10.1002/(SICI)1097-0037(199709)30:2<105::AID-NET5>3.0.CO;2-G; Daudin JJ, 2008, STAT COMPUT, V18, P173, DOI 10.1007/s11222-007-9046-7; Davidson R, 1996, ACM T GRAPHIC, V15, P301, DOI 10.1145/234535.234538; Dib FK, 2014, J VISUAL LANG COMPUT, V25, P912, DOI 10.1016/j.jvlc.2014.10.019; Dongkyung Nam, 2000, International Journal of Fuzzy Systems, V2, P87; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Eades P., 1984, C NUMERANTIUM, V42, P149; Eiben AE, 1999, IEEE T EVOLUT COMPUT, V3, P124, DOI 10.1109/4235.771166; Eloranta T., 2001, DIVULGACIONES MATEMM, V9, P155; Escobar JW, 2014, J HEURISTICS, V20, P483, DOI 10.1007/s10732-014-9247-0; FRIDEN C, 1989, COMPUTING, V42, P35, DOI 10.1007/BF02243141; Gansner ER, 2013, IEEE T VIS COMPUT GR, V19, P927, DOI 10.1109/TVCG.2012.299; GENDREAU M, 1994, MANAGE SCI, V40, P1276, DOI 10.1287/mnsc.40.10.1276; Gendreau M, 2014, SEARCH METHODOLOGIES, P243; Gibson H, 2013, INFORM VISUAL, V12, P324, DOI 10.1177/1473871612455749; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gleiser PM, 2003, ADV COMPLEX SYST, V6, P565, DOI 10.1142/S0219525903001067; Glover F, 1997, OPERAT RES COMP SCI, P1; Glover F., 1989, ORSA Journal on Computing, V1, P190, DOI [10.1287/ijoc.2.1.4, 10.1287/ijoc.1.3.190]; Glover F, 2000, CONTROL CYBERN, V29, P653; HERTZ A, 1987, COMPUTING, V39, P345, DOI 10.1007/BF02239976; Hertz A., 1995, P GIORN LAV AIRO, V95, P13; Ho SC, 2006, J HEURISTICS, V12, P55, DOI 10.1007/s10732-006-4192-1; HOLM S, 1979, SCAND J STAT, V6, P65; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; KOSAK C, 1994, IEEE T SYST MAN CYB, V24, P440, DOI 10.1109/21.278993; Kosak C, 1991, PARALLEL GENETIC ALG; Laguna M, 1997, COMPUT OPER RES, V24, P1175, DOI 10.1016/S0305-0548(96)00083-4; Laguna M, 1999, INFORMS J COMPUT, V11, P44, DOI 10.1287/ijoc.11.1.44; Lee Y.-Y., 2006, P AS PAC S INF VIS, V60, P179; Lim A., 1991, 1991 IEEE International Symposium on Circuits and Systems (Cat. No.91CH3006-4), P1164, DOI 10.1109/ISCAS.1991.176574; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Marti R, 1998, EUR J OPER RES, V106, P558, DOI 10.1016/S0377-2217(97)00291-9; Melian CJ, 2004, ECOLOGY, V85, P352, DOI 10.1890/02-0638; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Noack Andreas, 2007, Journal of Graph Algorithms and Applications, V11, P453, DOI 10.7155/jgaa.00154; Ortmann M, 2016, LECT NOTES COMPUT SC, V9801, P18, DOI 10.1007/978-3-319-50106-2_2; Pacheco J, 2006, J OPER RES SOC, V57, P29, DOI 10.1057/palgrave.jors.2601917; Peng B, 2015, COMPUT OPER RES, V53, P154, DOI 10.1016/j.cor.2014.08.006; Purchase HC, 2002, J VISUAL LANG COMPUT, V13, P501, DOI 10.1006/S1045-926X(02)00016-2; Rahimi-Vahed A, 2013, J HEURISTICS, V19, P497, DOI 10.1007/s10732-013-9221-2; Ribeiro CC, 2012, J HEURISTICS, V18, P193, DOI 10.1007/s10732-011-9167-1; Rolland E, 1996, ANN OPER RES, V63, P209, DOI 10.1007/BF02125455; Rosete-Suarez A, 1999, GECCO-99: PROCEEDINGS OF THE GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1699; Stott J, 2011, IEEE T VIS COMPUT GR, V17, P101, DOI 10.1109/TVCG.2010.24; Talbi E.-G., 1993, Proceeding of the Twenty-Sixth Hawaii International Conference on System Sciences (Cat. No.93TH0501-7), P565, DOI 10.1109/HICSS.1993.284069; Tamassia R., 2013, HDB GRAPH DRAWING VI; Upton G., 2014, DICT STAT; Ware M, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1892; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	58	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197103	10.1371/journal.pone.0197103	http://dx.doi.org/10.1371/journal.pone.0197103			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746576	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000431851700070
J	Sun, X; Guo, SY; Wang, W; Cao, ZY; Dan, JH; Cheng, JL; Cao, W; Tian, F; Cao, WW; Tian, Y				Sun, Xin; Guo, Shuyuan; Wang, Wei; Cao, Zhengyu; Dan, Juhua; Cheng, Jiali; Cao, Wei; Tian, Fang; Cao, Wenwu; Tian, Ye			Potential involvement of the 18 kDa translocator protein and reactive oxygen species in apoptosis of TH P-1 macrophages induced by sonodynamic therapy	PLOS ONE			English	Article							MITOCHONDRIAL BENZODIAZEPINE-RECEPTORS; PROTOPORPHYRIN-IX; CYTOCHROME-C; CELLS; PORPHYRINS; INTENSITY; VDAC	Sonodynamic therapy (SDT) with exogenous protoporphyrin IX (PpIX) or endogenous PpIX derived from 5-aminolevulinic acid (ALA) has been carried out to produce apoptotic effects on macrophages, indicating a potential treatment methodology for atherosclerosis. Our previous studies have found that mitochondria damage by reactive oxygen species (ROS) plays a major role in the SDT-induced apoptosis. This study aimed at investigating the potential involvement of the mitochondrial 18 kDa translocator protein (TSPO) and ROS in the pro-apoptotic effects of SDT on THP-1 macrophages. THP-1 macrophages were divided into control and SDT groups, and went through pretreatment of the specific TSPO ligand PK11195 and ROS scavengers N-Acetyl Cysteine (NAC), then compared with groups without pretreatment. Application of PK11195 reduced intracellular accumulation of endogenous PpIX. PK11195 and NAC reduced the generation of intracellular ROS and oxidation of cardiolipin induced by SDT, respectively. PK11195 and NAC also reduced SDT-induced mitochondrial membrane potential (Delta Psi(m)) loss, the translocation of cytochrome c and cell apoptosis. PpIX accumulation, ROS generation and cell apoptosis were also attenuated by siTSPO. Our findings indicate the pivotal role of TSPO and ROS in SDT-induced cardiolipin oxidation, Delta Psi(m) collapse, cytochrome c translocation and apoptosis in THP-1 macrophages.	[Sun, Xin; Cao, Wenwu] Harbin Inst Technol, Lab Photo & Sonotheranost Technol, Harbin, Heilongjiang, Peoples R China; [Sun, Xin; Guo, Shuyuan; Wang, Wei; Cao, Zhengyu; Cheng, Jiali; Cao, Wei; Tian, Fang; Tian, Ye] Harbin Med Univ, Affiliated Hosp 1, Cardiovasc Inst, Dept Cardiol, Harbin, Heilongjiang, Peoples R China; [Sun, Xin; Guo, Shuyuan; Wang, Wei; Dan, Juhua; Tian, Fang; Tian, Ye] Minist Educ, Key Lab Cardiovasc Res, Dept Pathophysiol, State Prov Key Labs Biomed Pharmaceut China, Harbin, Heilongjiang, Peoples R China; [Cao, Wenwu] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA	Harbin Institute of Technology; Harbin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cao, WW (corresponding author), Harbin Inst Technol, Lab Photo & Sonotheranost Technol, Harbin, Heilongjiang, Peoples R China.; Tian, Y (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Cardiovasc Inst, Dept Cardiol, Harbin, Heilongjiang, Peoples R China.; Tian, Y (corresponding author), Minist Educ, Key Lab Cardiovasc Res, Dept Pathophysiol, State Prov Key Labs Biomed Pharmaceut China, Harbin, Heilongjiang, Peoples R China.; Cao, WW (corresponding author), Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA.	dzk@psu.edu; yetian@ems.hrbmu.edu.cn	Cao, Wenwu/F-6091-2012	Cao, Wenwu/0000-0002-2447-1486; Tian, Ye/0000-0003-3726-7270	National Natural Science Foundation of China (NSFC) [81400339, 81701848]; State Key Program of NSFC [81530052]; Natural Science Foundation of Heilongjiang Province [QC2016121]; Medical Scientific Research Foundation of Harbin Medical University [2016LCZX57]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); State Key Program of NSFC; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Medical Scientific Research Foundation of Harbin Medical University	This study was supported by the National Natural Science Foundation of China (NSFC) (81400339 and 81701848), the State Key Program of NSFC (81530052), Natural Science Foundation of Heilongjiang Province (QC2016121), and Medical Scientific Research Foundation of Harbin Medical University (2016LCZX57). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourbeh G, 2012, J NEUROSCI, V32, P5728, DOI 10.1523/JNEUROSCI.2900-11.2012; Bisland SK, 2007, LASER SURG MED, V39, P678, DOI 10.1002/lsm.20544; Busch AWU, 2017, BIOCHEMISTRY-US, V56, P73, DOI 10.1021/acs.biochem.6b01019; Cheng JL, 2013, INT J NANOMED, V8, P669, DOI 10.2147/IJN.S39844; Ghorai A, 2015, APOPTOSIS, V20, P562, DOI 10.1007/s10495-015-1107-3; Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063; Gonzalez-Polo RA, 2005, ONCOGENE, V24, P7503, DOI 10.1038/sj.onc.1208907; Gupta R, 2017, BIOCHEM BIOPH RES CO, V490, P1221, DOI 10.1016/j.bbrc.2017.06.194; Kanter JE, 2017, CIRC RES, V121, P1109, DOI 10.1161/CIRCRESAHA.117.311973; Kavurma MM, 2017, CURR OPIN LIPIDOL, V28, P91, DOI 10.1097/MOL.0000000000000394; KRAMMER B, 2008, PHOTOCH PHOTOBIO SCI, V7, P283, DOI DOI 10.1039/B712847A; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Li ZT, 2015, THROMB HAEMOSTASIS, V114, P793, DOI [10.1160/TH114-12-1030, 10.1160/TH14-12-1030]; Liang BX, 2017, EUR J PHARMACOL, V796, P139, DOI 10.1016/j.ejphar.2016.12.030; Lv YH, 2012, CELL PHYSIOL BIOCHEM, V30, P321, DOI 10.1159/000339067; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Marginedas-Freixa I, 2016, SCI REP-UK, V6, DOI 10.1038/srep33516; McHale AP, 2016, ADV EXP MED BIOL, V880, P429, DOI 10.1007/978-3-319-22536-4_22; MOAN J, 1991, PHOTOCHEM PHOTOBIOL, V53, P549, DOI 10.1111/j.1751-1097.1991.tb03669.x; Nahum R, 2017, EXP CLIN ENDOCRINOL; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Ozaki H, 2010, SYNAPSE, V64, P649, DOI 10.1002/syn.20779; Peng CH, 2011, J PHOTOCH PHOTOBIO B, V102, P26, DOI 10.1016/j.jphotobiol.2010.09.001; Quintanilla RA, 2017, BIOCHEM BIOPH RES CO, V483, P1078, DOI 10.1016/j.bbrc.2016.09.054; Serpe L, 2011, TECHNOL CANCER RES T, V10, P85, DOI 10.7785/tcrt.2012.500182; Song W, 2011, ANTICANCER RES, V31, P39; Verma A, 1998, MOL MED, V4, P40, DOI 10.1007/BF03401728; VERMA A, 1987, P NATL ACAD SCI USA, V84, P2256, DOI 10.1073/pnas.84.8.2256; Wan GY, 2016, CANCER BIOL MED, V13, P325, DOI 10.20892/j.issn.2095-3941.2016.0068; Zhang JL, 2017, BIOENGINEERED, V8, P424, DOI 10.1080/21655979.2016.1230572	30	5	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196541	10.1371/journal.pone.0196541	http://dx.doi.org/10.1371/journal.pone.0196541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746502	gold, Green Published, Green Submitted			2022-12-26	WOS:000431851700022
J	Jimenez-Sousa, MA; Gomez-Moreno, AZ; Pineda-Tenor, D; Medrano, LM; Sanchez-Ruano, JJ; Fernandez-Rodriguez, A; Artaza-Varasa, T; Saura-Montalban, J; Vazquez-Moron, S; Ryan, P; Resino, S				Angeles Jimenez-Sousa, Maria; Zaida Gomez-Moreno, Ana; Pineda-Tenor, Daniel; Maria Medrano, Luz; Jose Sanchez-Ruano, Juan; Fernandez-Rodriguez, Amanda; Artaza-Varasa, Tomas; Saura-Montalban, Jose; Vazquez-Moron, Sonia; Ryan, Pablo; Resino, Salvador			The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements design	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; INTERLEUKIN-7 RECEPTOR-ALPHA; HIV/HCV-COINFECTED PATIENTS; MULTIPLE-SCLEROSIS; HEPATOCELLULAR-CARCINOMA; TRANSIENT ELASTOGRAPHY; LONG-TERM; ANTIRETROVIRAL THERAPY; SOLUBLE IL-7R-ALPHA; IMMUNE-RESPONSES	The polymorphisms at the alpha-chain of the IL-7 receptor (IL7RA) have been related to T-cell homeostasis and development and may contribute to immune system deregulation. In the present study, we analyzed the association between IL7RA polymorphisms and the progression of liver fibrosis in patients infected with HCV. We carried out a retrospective study with a design consisting of repeated measurements in 187 HCV-infected patients, to study the risk prediction of liver fibrosis progression using genetic factors. We genotyped the rs6897932, rs987106 and rs3194051 IL7RA polymorphisms using the Agena Bioscience's MassARRAY. Transient elastography was used to measure liver stiffness. The used cutoffs were: <7.1 kPa (F0-F1), 7.1-9.4 kPa (F2; significant fibrosis), 9.5-12.4 kPa (F3; advanced fibrosis), and >= 12.5 kPa (F4; cirrhosis). All HCV genotypes were analyzed. The median of follow-up time was 47.9 months. Baseline liver stiffness measurement (LSM) values did not show significant statistical differences for IL7RA genotypes (p>0.05). In univariate analysis, the rs6897932 T allele had a positive relationship with an increase in LSM (arithmetic mean ratio (AMR) = 1.21 (95%CI = 1.08; 1.36); p = 0.001), progression to advanced fibrosis (F >= 3) (odds ratio (OR) = 2.51 (95%CI = 1.29; 4.88); p = 0.006) and progression to cirrhosis (F4) (OR = 2.71 (95%CI = 0.94; 5.03); p = 0.069). In multivariable analysis, the rs6897932 T allele was related to a higher increase of LSM values during follow-up (adjusted AMR = 1.27 (95%CI = 1.13; 1.42); p<0.001) and higher odds of progression to advanced fibrosis [adjusted OR = 4.46 (95%CI = 1.87; 10.62); p = 0.001], and progression to cirrhosis [adjusted OR = 3.92 (95%CI = 1.30; 11.77); p = 0.015]. Regarding IL7RA rs987106 and rs3194051 polymorphisms, we did not find significant results except for the relationship between IL7RA rs987106 and the increase in LSM values [adjusted OR = 1.12 (95%CI = 1.02; 1.23); p = 0.015]. The IL7RA rs6897932 polymorphism seems to be related to increased risk of liver fibrosis progression in HCV-infected patients. Thus, the rs6897932 polymorphism could be related to the physiopathology of CHC and might be used to successfully stratify the risk of CHC progression.	[Angeles Jimenez-Sousa, Maria; Maria Medrano, Luz; Fernandez-Rodriguez, Amanda; Vazquez-Moron, Sonia; Resino, Salvador] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Infecc Viral & Inmunidad, Majadahonda, Spain; [Zaida Gomez-Moreno, Ana; Jose Sanchez-Ruano, Juan; Artaza-Varasa, Tomas] Hosp Virgen de la Salud, Serv Digest, Toledo, Spain; [Pineda-Tenor, Daniel] Hosp Univ Fuenlabrada, Serv Lab Clin, Madrid, Spain; [Saura-Montalban, Jose] Hosp Virgen de la Salud, Serv Lab Clin, Toledo, Spain; [Ryan, Pablo] Hosp Univ Infanta Leonor, Serv Med Interne, Madrid, Spain; [Ryan, Pablo] UCM, Fac Med, Madrid, Spain; [Ryan, Pablo] IiSGM, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Complejo Hospitalario de Toledo; Hospital Universitario Fuenlabrada; Complejo Hospitalario de Toledo; Hospital Universitario Infanta Leonor; Complutense University of Madrid	Resino, S (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Infecc Viral & Inmunidad, Majadahonda, Spain.	sresino@isciii.es	Ryan, Pablo/AAM-1924-2021; Resino, Salvador/B-2430-2008; Vázquez-Morón, Sonia/H-7019-2013; RYAN, PABLO/GRF-3462-2022; Rodríguez, Amanda Fernández/Q-4062-2016; Jiménez-Sousa, Maria A./I-8725-2012; de dios, luz maria medrano/K-1946-2016	Ryan, Pablo/0000-0002-4212-7419; Resino, Salvador/0000-0001-8783-0450; Vázquez-Morón, Sonia/0000-0002-0977-741X; RYAN, PABLO/0000-0002-4212-7419; Rodríguez, Amanda Fernández/0000-0002-5110-2213; Jiménez-Sousa, Maria A./0000-0002-1945-6169; de dios, luz maria medrano/0000-0003-3717-5384; Pineda-Tenor, Daniel/0000-0001-6343-5384	Fondo de Investigacion de Sanidad en Espana (FIS) [Spanish Health Founds for Research] [PI14C111/00011, PI15C111/00024, PT13/0001]; Instituto de Salud Carlos III [CD13/00013, CD14/00002, CP14/0010]	Fondo de Investigacion de Sanidad en Espana (FIS) [Spanish Health Founds for Research]; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work has been supported by grants given by Fondo de Investigacion de Sanidad en Espana (FIS) [Spanish Health Founds for Research] [grant numbers PI14C111/00011, PI15C111/00024 and PT13/0001]. MAJS, LM M, and AFR are supported by "Instituto de Salud Carlos III" [grant numbers CD13/00013, CD14/00002 and CP14/0010].	Adam R, 2012, J HEPATOL, V57, P675, DOI 10.1016/j.jhep.2012.04.015; Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Asrani SK, 2013, GASTROENTEROLOGY, V145, P375, DOI 10.1053/j.gastro.2013.04.005; Broux B, 2010, GENES IMMUN, V11, P326, DOI 10.1038/gene.2009.106; Calvaruso V, 2012, LIVER INT, V32, P2, DOI 10.1111/j.1478-3231.2011.02703.x; Capitini CM, 2009, J INTERN MED, V266, P141, DOI 10.1111/j.1365-2796.2009.02085.x; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2015, DIGEST DIS, V33, P498, DOI 10.1159/000374097; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; Crawley AM, 2010, J IMMUNOL, V184, P4679, DOI 10.4049/jimmunol.0903758; Forner A, 2018, LANCET; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Ghany MG, 2003, GASTROENTEROLOGY, V124, P97, DOI 10.1053/gast.2003.50018; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Guzman-Fulgencio M, 2015, EUR J CLIN MICROBIOL, V34, P385, DOI 10.1007/s10096-014-2245-1; Guzman-Fulgencio M, 2015, EUR J CLIN INVEST, V45, P1192, DOI 10.1111/eci.12539; Guzman-Fulgencio M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0577-y; Hartling HJ, 2014, AIDS, V28, P1739, DOI 10.1097/QAD.0000000000000354; Hartling HJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42036; Hou LF, 2013, J IMMUNOL, V190, P621, DOI 10.4049/jimmunol.1201970; Jager J, 2013, GENES IMMUN, V14, P453, DOI 10.1038/gene.2013.40; Janjua NZ, 2017, J HEPATOL, V66, P504, DOI 10.1016/j.jhep.2016.10.028; Kreft KL, 2012, GENES IMMUN, V13, P587, DOI 10.1038/gene.2012.34; Larrea E, 2014, GUT, V63, P665, DOI 10.1136/gutjnl-2012-304377; Larrubia JR, 2013, J VIRAL HEPATITIS, V20, P85, DOI 10.1111/j.1365-2893.2012.01618.x; Liang TJ, 2014, NEW ENGL J MED, V370, P2043, DOI 10.1056/NEJMe1403619; Lundstrom W, 2013, P NATL ACAD SCI USA, V110, pE1761, DOI 10.1073/pnas.1222303110; Mallet V, 2008, ANN INTERN MED, V149, P399, DOI 10.7326/0003-4819-149-6-200809160-00006; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Poynard T, 2013, J HEPATOL, V59, P675, DOI 10.1016/j.jhep.2013.05.015; Rajasuriar R, 2012, GENES IMMUN, V13, P83, DOI 10.1038/gene.2011.65; Rajasuriar R, 2010, J INFECT DIS, V202, P1254, DOI 10.1086/656369; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Santiago JL, 2008, DIABETOLOGIA, V51, P1653, DOI 10.1007/s00125-008-1070-4; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shiffman ML, 2014, ANN HEPATOL, V13, P340, DOI 10.1016/S1665-2681(19)30840-3; Shin EC, 2016, NAT REV IMMUNOL, V16, P509, DOI 10.1038/nri.2016.69; Shin EC, 2013, J VIROL, V87, P4772, DOI 10.1128/JVI.03122-12; Smith DJ, 2015, INT J DRUG POLICY, V26, P911, DOI 10.1016/j.drugpo.2015.07.004; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; van der Meer AJ, 2017, J HEPATOL, V66, P485, DOI 10.1016/j.jhep.2016.10.017; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012	49	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0197115	10.1371/journal.pone.0197115	http://dx.doi.org/10.1371/journal.pone.0197115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742149	Green Submitted, Green Published, gold			2022-12-26	WOS:000431757400061
J	Arrieta-Villegas, C; Peralvarez, T; Vidal, E; Puighibet, Z; Moll, X; Canturri, A; Sevilla, IA; Espada, Y; Juste, RA; Domingo, M; de Val, BP				Arrieta-Villegas, Claudia; Peralvarez, Tania; Vidal, Enric; Puighibet, Zoe; Moll, Xavier; Canturri, Albert; Sevilla, Iker A.; Espada, Yvonne; Juste, Ramon A.; Domingo, Mariano; Perez de Val, Bernat			Efficacy of parenteral vaccination against tuberculosis with heat-inactivated Mycobacterium bovis in experimentally challenged goats	PLOS ONE			English	Article							ENDOBRONCHIAL INFECTION; BCG VACCINE; WILD BOAR; RESPONSES; CATTLE; IMMUNITY; BADGERS; FIELD; DEER	Tuberculosis (TB) in animals is a re-emerging disease with a wide range of hosts that causes large economic losses in livestock. Goats are particularly susceptible to TB and, in endemic areas, vaccination may be a valuable measure to control the disease. The main aim of this study was to evaluate the efficacy of parenteral vaccination of goats with a heat-inactivated Mycobacterium bovis (HIMB) vaccine, and compare it to M. bovis Bacille Calmette-Guerin (BCG) vaccine. Twenty-four goat kids were divided in 3 groups as following: HIMB vaccinated group (n = 8), BCG vaccinated group (n = 8) and unvaccinated group (n = 8). Afterwards, goats were experimentally challenged with Mycobacterium caprae by the endobronchial route. Antigen specific interferon-gamma release assays and serology were performed after vaccination and challenge. Pathological and bacteriological parameters were evaluated after necropsy at 9 weeks post-challenge (p.c.). HIMB vaccine showed similar levels of protection to BCG in terms of volume reduction of thoracic TB lesions, presence of extra-pulmonary lesions, as well as a slight reduction of bacterial load in pulmonary lymph nodes. Moreover, HIMB vaccine did not induce interferences on the interferon-gamma release assay based on reagents previously developed to differentiate infected from BCG vaccinated individuals. The results indicate that HIMB is a suitable vaccine candidate for further larger-scale trials under field conditions in goats.	[Arrieta-Villegas, Claudia; Peralvarez, Tania; Vidal, Enric; Domingo, Mariano; Perez de Val, Bernat] UAB, IRTA, Ctr Recerca Sanitat Anim CReSA, Campus UAB, Barcelona, Catalonia, Spain; [Puighibet, Zoe; Moll, Xavier; Espada, Yvonne] UAB, Dept Med & Cirurgia Anim, Barcelona, Catalonia, Spain; [Canturri, Albert; Domingo, Mariano] UAB, Dept Sanitat & Anat Anim, Barcelona, Catalonia, Spain; [Sevilla, Iker A.] NEIKER Tecnalia, Dept Sanidad Anim, Inst Vasco Invest & Desarrollo Agr, Bizkaia, Basque Country, Spain; [Juste, Ramon A.] SERIDA, Serv Reg Invest & Desarrollo Agroalimentario, Ctr Biotecnol Anim, Gijon, Asturias, Spain	Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; Autonomous University of Barcelona; Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA	de Val, BP (corresponding author), UAB, IRTA, Ctr Recerca Sanitat Anim CReSA, Campus UAB, Barcelona, Catalonia, Spain.	bernat.perez@irta.cat	Moll, Xavier/H-3203-2018; Vidal, Enric/P-2901-2019; DE VAL, BERNAT PÉREZ/G-6865-2012; Sevilla, Iker A/O-6060-2014; Vidal, Enric/I-1679-2014; Juste, Ramon A./C-3570-2008; Domingo, Mariano/A-1015-2009	Moll, Xavier/0000-0002-2992-9361; Vidal, Enric/0000-0002-4965-3286; DE VAL, BERNAT PÉREZ/0000-0003-3127-9182; Sevilla, Iker A/0000-0003-3968-3390; Vidal, Enric/0000-0002-4965-3286; Juste, Ramon A./0000-0001-6037-5873; Domingo, Mariano/0000-0002-9623-4826	Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) [RTA2015-0043-C02-01]; European Funds Regional Developement (FEDER); Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya; INIA (FPI-INIA) [CPD2016-0109]	Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); European Funds Regional Developement (FEDER); Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya; INIA (FPI-INIA)(Instituto de Investigacion Agropecuaria (INIA))	This research was partially supported by grant RTA2015-0043-C02-01 from Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA, WWW.inia.es), co-funded by European Funds Regional Developement (FEDER). Institut de Recerca i Tecnologia Agroalimentaries (IRTA) is supported by Centres de Recerca de Catalunya (CERCA) Programme/Generalitat de Catalunya (www.cerca.cat). Claudia Arrieta-Villegas holds a pre-doctoral scholarship from INIA (FPI-INIA, grant No. CPD2016-0109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balseiro A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180546; Beltran-Beck B, 2014, CLIN VACCINE IMMUNOL, V21, P12, DOI 10.1128/CVI.00488-13; Cardona PJ, 2017, INT J INFECT DIS, V56, P268, DOI 10.1016/j.ijid.2017.01.030; Chambers MA, 2014, VET REC, V175, P90, DOI 10.1136/vr.102581; Diez-Delgado I, 2017, TRANSBOUND EMERG DIS, V64, pE18, DOI 10.1111/tbed.12526; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; Jones GJ, 2016, VET IMMUNOL IMMUNOP, V182, P85, DOI 10.1016/j.vetimm.2016.10.010; Lesellier S, 2009, VACCINE, V27, P402, DOI 10.1016/j.vaccine.2008.10.068; Lyashchenko K, 2004, INFECT IMMUN, V72, P2462, DOI 10.1128/IAI.72.5.2462-2467.2004; Michel AL, 2010, VET MICROBIOL, V140, P371, DOI 10.1016/j.vetmic.2009.08.029; Napp S, 2013, VET REC, V172, DOI 10.1136/vr.101347; Palmer MV, 2009, ZOONOSES PUBLIC HLTH, V56, P243, DOI 10.1111/j.1863-2378.2008.01198.x; de Val BP, 2017, TRANSBOUND EMERG DIS, V64, P275, DOI 10.1111/tbed.12368; de Val BP, 2016, VACCINE, V34, P881, DOI 10.1016/j.vaccine.2016.01.004; de Val BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081317; de Val BP, 2012, CLIN VACCINE IMMUNOL, V19, P1339, DOI 10.1128/CVI.00275-12; de Val BP, 2011, CLIN VACCINE IMMUNOL, V18, P1872, DOI 10.1128/CVI.05323-11; Roy A, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00124; Thomas J, 2017, VET MICROBIOL, V208, P195, DOI 10.1016/j.vetmic.2017.08.007; van Duijn Esther, 2017, RCOM 200 18 TRIENNIA, P1, DOI [10.1371/journal.pone.0188448, DOI 10.1371/JOURNAL.PONE.0188448]; Vidal E, 2018, SMALL RUMINANT RES, V158, P22, DOI 10.1016/j.smallrumres.2017.11.010; Vidal E, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1182-5; Vordermeier HM, 2014, RES VET SCI, V97, pS53, DOI 10.1016/j.rvsc.2014.04.015; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; Wilton S, 1992, PCR Methods Appl, V1, P269	25	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196948	10.1371/journal.pone.0196948	http://dx.doi.org/10.1371/journal.pone.0196948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742150	Green Submitted, Green Published, gold			2022-12-26	WOS:000431757400049
J	Lee, M; Ban, JJ; Chung, JY; Im, W; Kim, M				Lee, Mijung; Ban, Jae-Jun; Chung, Jin-Young; Im, Wooseok; Kim, Manho			Amelioration of Huntington's disease phenotypes by Beta-Lapachone is associated with increases in Sirt1 expression, CREB phosphorylation and PGC-1 alpha deacetylation	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; MITOCHONDRIAL DYSFUNCTION; CANCER-CELLS; MUTANT HUNTINGTIN; ENERGY-METABOLISM; OXIDATIVE STRESS; REPEAT LENGTH; IN-VITRO; NEURODEGENERATION; SIRTUINS	Huntington's disease (HD) is one of the most devastating genetic neurodegenerative disorders with no effective medical therapy. beta-Lapachone (beta L) is a natural compound obtained from the bark of the Lapacho tree and has been reported to have beneficial effects on various diseases. Sirt1 is a deacetylase of the sirtuin family and deacetylates proteins including the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) which is associated with mitochondrial respiration and biogenesis. To examine the effectiveness of beta L on HD, beta L was orally applied to R6/2 HD mice and behavioral phenotypes associated with HD, such as impairment of rota-rod performance and increase of clasping behavior, as well as changes of Sirt1 expression, CREB phosphorylation and PGC-1 alpha deacetylation were examined. Western blot results showed that Sirt1 and p-CREB levels were significantly increased in the brains of beta L-treated R6/2 mice. An increase in deacetylation of PGC-1 alpha, which is thought to increase its activity, was observed by oral administration of beta L. In an in vitro HD model, beta L treatment resulted in an attenuation of MitoSOX red fluorescence intensity, indicating an amelioration of mitochondrial reactive oxygen species by beta L. Furthermore, improvements in the rota-rod performance and clasping score were observed in R6/2 HD mice after oral administration of beta L compared to that of vehicle control-treated mice. Taken together, our data show that beta L is a potential therapeutic candidate for the treatment of HD-associated phenotypes, and increases in Sirt1 level, CREB phosphorylation and PGC-103B1 deacetylation can be the possible underlying mechanism of the effects of beta L.	[Lee, Mijung; Ban, Jae-Jun; Im, Wooseok; Kim, Manho] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Chung, Jin-Young] Kangwon Natl Univ, Coll Vet Med, Dept Vet Internal Med & Geriatr, Gangwon, South Korea; [Im, Wooseok; Kim, Manho] Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea; [Kim, Manho] Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Kangwon National University; Seoul National University (SNU); Seoul National University (SNU)	Im, W; Kim, M (corresponding author), Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea.; Im, W; Kim, M (corresponding author), Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea.; Kim, M (corresponding author), Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul, South Korea.	imwooseok@gmail.com; kimmanho@snu.ac.kr			Korea Health 21 R&D Project by the Ministry of Health & Welfare, Republic of Korea [HI14C2348]; Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [800-20170122, 2016M3C7A1914002]; National Research Foundation of Korea [2015R1D1A1A01060056]; Seoul National University Hospital [26-2017-0030]; Korea Brain Research Institute [800-20170122]; SNUH research fund [26-2017-0030]	Korea Health 21 R&D Project by the Ministry of Health & Welfare, Republic of Korea; Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; National Research Foundation of Korea(National Research Foundation of Korea); Seoul National University Hospital; Korea Brain Research Institute; SNUH research fund	This work received support from the Korea Health 21 R&D Project (HI14C2348) by the Ministry of Health & Welfare, Republic of Korea, the Brain Research Program (800-20170122) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2016M3C7A1914002), National Research Foundation of Korea (2015R1D1A1A01060056), and Seoul National University Hospital (26-2017-0030). http.//www.nrf.re.kr/eng/main. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2016M3C7A1914002), Korea Brain Research Institute (800-20170122), and SNUH research fund (26-2017-0030).	Alves CJ, 2011, BRAIN RES, V1394, P90, DOI 10.1016/j.brainres.2011.02.060; Anastasiou D, 2006, PHYSIOLOGY, V21, P404, DOI 10.1152/physiol.00031.2006; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; CRUZ FS, 1978, ANTIMICROB AGENTS CH, V14, P630, DOI 10.1128/AAC.14.4.630; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; de Oliveira RM, 2010, CURR DRUG TARGETS, V11, P1270; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hayden MR, 1981, HUNTINGTONS CHOREA, Vxvii; Im W, 2015, SCI REP-UK, V5, DOI 10.1038/srep16887; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim JH, 2015, ARCH DERMATOL RES, V307, P229, DOI 10.1007/s00403-015-1543-5; Kung HN, 2008, AM J PHYSIOL-CELL PH, V295, pC931, DOI 10.1152/ajpcell.00266.2008; La Spada AR, 2012, NAT MED, V18, P24, DOI 10.1038/nm.2624; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Lee EJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0355-z; Lee JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047122; Lee M, 2016, EUR J NEUROSCI, V44, P2114, DOI 10.1111/ejn.13275; LI CJ, 1993, J BIOL CHEM, V268, P22463; Li YZ, 2003, P NATL ACAD SCI USA, V100, P2674, DOI 10.1073/pnas.0538044100; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Ma J, 2015, BIOORG MED CHEM LETT, V25, P4828, DOI 10.1016/j.bmcl.2015.06.073; Macedo L, 2013, PHYTOMEDICINE, V21, P25, DOI 10.1016/j.phymed.2013.08.010; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Moon DO, 2007, INT IMMUNOPHARMACOL, V7, P506, DOI 10.1016/j.intimp.2006.12.006; Moore Z, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.564; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Oliveira JMA, 2010, J NEUROCHEM, V114, P1, DOI 10.1111/j.1471-4159.2010.06741.x; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Park JS, 2016, FREE RADICAL BIO MED, V97, P168, DOI 10.1016/j.freeradbiomed.2016.05.024; Parka EJ, 2011, CHEM-BIOL INTERACT, V189, P37, DOI 10.1016/j.cbi.2010.10.013; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; SCHAFFNERSABBA K, 1984, J MED CHEM, V27, P990, DOI 10.1021/jm00374a010; Sharma S, 2015, PHARMACOL RES, V100, P157, DOI 10.1016/j.phrs.2015.08.002; Shin BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064953; Sitonio MM, 2013, INFLAMM RES, V62, P107, DOI 10.1007/s00011-012-0557-0; Smith BC, 2006, STRUCTURE, V14, P1207, DOI 10.1016/j.str.2006.07.004; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Strand AD, 2007, J NEUROSCI, V27, P11758, DOI 10.1523/JNEUROSCI.2461-07.2007; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Tsunemi T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003799; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004	62	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0195968	10.1371/journal.pone.0195968	http://dx.doi.org/10.1371/journal.pone.0195968			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742127	Green Published, Green Submitted, gold			2022-12-26	WOS:000431757400018
J	Asghar, MY; Kemppainen, K; Lassila, T; Tornquist, K				Asghar, Muhammad Yasir; Kemppainen, Kati; Lassila, Taru; Tornquist, Kid			Sphingosine 1-phosphate attenuates MMP2 and MMP9 in human anaplastic thyroid cancer C643 cells: Importance of S1P(2)	PLOS ONE			English	Article							MT1-MMP MEMBRANE TRANSLOCATION; SIGNALING PATHWAYS; G-PROTEINS; MIGRATION; INVASION; RECEPTOR; SPHINGOSINE-1-PHOSPHATE; CALPAIN; KINASE; INHIBITION	In anaplastic thyroid cancer C643 cells, sphingosine 1-phosphate (S1P) attenuates migration by activating the S1P2 receptor and the Rho-ROCK pathway. In the present study, we show that stimulating C643 cells with S1P decreases the expression, secretion and activity of matrix metalloproteinase-2 (MMP2), and to a lesser extent MMP9. Using receptor-specific antagonists, and S1P2 siRNA, we showed that the inhibition of expression of MMP2 is mediated through S1P2. Furthermore, S1P inhibited calpain activity, and inhibiting calpain pharmacologically, inhibited the effect of S1P on MMP2 expression and activity, and on MMP9 activity. S1P treatment increased Rho activity, and by incubating cells with the Rho inhibitor C3 transferase or the ROCK inhibitor Y27632, the S1P-induced inhibition of invasion and MMP2 expression and activity was abolished. We conclude that S1P attenuates the invasion of C643 cells by activating S1P2 and the Rho-ROCK pathway, by decreasing calpain activity, and by decreasing the expression, secretion and activity of MMP2 and, to a lesser extent, MMP9. Our results thus unveil a novel function for the S1P2 receptor in attenuating thyroid cancer cell invasion.	[Asghar, Muhammad Yasir; Kemppainen, Kati; Lassila, Taru; Tornquist, Kid] Abo Akad Univ, Fac Sci & Engn, Cell Biol, BioCity, Turku, Finland; [Asghar, Muhammad Yasir; Tornquist, Kid] Biomedicum Helsinki, Minerva Fdn Inst Med Res, Helsinki, Finland	Abo Akademi University; University of Helsinki	Tornquist, K (corresponding author), Abo Akad Univ, Fac Sci & Engn, Cell Biol, BioCity, Turku, Finland.; Tornquist, K (corresponding author), Biomedicum Helsinki, Minerva Fdn Inst Med Res, Helsinki, Finland.	ktornqvi@abo.fi	Asghar, Muhammad Yasir/AAX-4895-2020	Kemppainen, Kati/0000-0003-3785-2269; Asghar, Muhammad Yasir/0000-0002-1935-8462	Sigrid Juselius Foundation; Oskar Oflund Foundation; Ida Montin Foundation; Finnish-Norwegian Medical Foundation	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Oskar Oflund Foundation; Ida Montin Foundation; Finnish-Norwegian Medical Foundation	This work was supported by the Sigrid Juselius Foundation (http://sigridjuselius.fi/en/), the Oskar Oflund Foundation (http://oskaroflund.fi), the Ida Montin Foundation (http://www.idamontininsaatio.fi) and the Finnish-Norwegian Medical Foundation (http://www.foundationweb.net/finsknorska/).; This study was financially supported by the Sigrid Juselius Foundation, the Oskar Oflund Foundation, the Ida Montin Foundation and the Finnish-Norwegian Medical Foundation, which is gratefully acknowledged.	Asghar MY, 2012, ENDOCR-RELAT CANCER, V19, P667, DOI 10.1530/ERC-12-0092; Balthasar S, 2008, ENDOCR-RELAT CANCER, V15, P521, DOI 10.1677/ERC-07-0253; Balthasar S, 2006, BIOCHEM J, V398, P547, DOI 10.1042/BJ20060299; Bergelin N, 2010, ENDOCRINOLOGY, V151, P2994, DOI [10.1210/en.2009-1387, 10.1210//en.2009-1387]; Bi Y, 2014, AM J PATHOL, V184, P2791, DOI 10.1016/j.ajpath.2014.06.023; Devine KM, 2008, GYNECOL ONCOL, V110, P237, DOI 10.1016/j.ygyno.2008.04.013; Gonda K, 1999, BIOCHEM J, V337, P67, DOI 10.1042/0264-6021:3370067; Hashimoto M, 2008, AM J RESP CELL MOL, V39, P356, DOI 10.1165/rcmb.2006-0427OC; Hyder CL, 2015, J CELL SCI, V128, P2057, DOI 10.1242/jcs.160341; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Jaganathan BG, 2007, STEM CELLS, V25, P1966, DOI 10.1634/stemcells.2007-0167; Kalhori V, 2015, MOL CELL ENDOCRINOL, V404, P113, DOI 10.1016/j.mce.2015.01.037; Kang HJ, 2011, J BIOL CHEM, V286, P42017, DOI 10.1074/jbc.M111.290841; Kim ES, 2011, J CELL SCI, V124, P2220, DOI 10.1242/jcs.076794; Kwak HI, 2012, ANGIOGENESIS, V15, P287, DOI 10.1007/s10456-012-9262-4; Lepley D, 2005, CANCER RES, V65, P3788, DOI 10.1158/0008-5472.CAN-04-2311; Marei H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10664; Nabeshima K, 2002, PATHOL INT, V52, P255, DOI 10.1046/j.1440-1827.2002.01343.x; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; Patmanathan SN, 2016, SCI REP-UK, V6, DOI 10.1038/srep25650; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Rajoria S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015879; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Skoura A, 2009, CARDIOVASC RES, V82, P221, DOI 10.1093/cvr/cvp088; Spiegel S, 2002, TRENDS CELL BIOL, V12, P236, DOI 10.1016/S0962-8924(02)02277-8; Storr SJ, 2015, PATHOBIOLOGY, V82, P133, DOI 10.1159/000430464; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Takashima S, 2008, CARDIOVASC RES, V79, P689, DOI 10.1093/cvr/cvn118; Takuwa N, 2011, AM J CANCER RES, V1, P460; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Witt W, 2012, CARDIOVASC RES, V93, P490, DOI 10.1093/cvr/cvs002; Yang Q, 2013, J CLIN ENDOCR METAB, V98, pE1909, DOI 10.1210/jc.2013-2583; Zhang XG, 2012, EXP THER MED, V4, P1005, DOI 10.3892/etm.2012.729; Zhuge Y, 2001, J BIOL CHEM, V276, P16248, DOI 10.1074/jbc.M010190200	35	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196992	10.1371/journal.pone.0196992	http://dx.doi.org/10.1371/journal.pone.0196992			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734379	gold, Green Published, Green Submitted			2022-12-26	WOS:000431481700038
J	Filho, HA; Machicao, J; Bruno, OM				Filho, Humberto A.; Machicao, Jeaneth; Bruno, Odemir M.			A hierarchical model of metabolic machinery based on the kcore decomposition of plant metabolic networks	PLOS ONE			English	Article							PATHWAY DATABASE; ORGANIZATION; ARACYC; MODULARITY; SUBSTANCE; METACYC; PROTEIN	Modeling the basic structure of metabolic machinery is a challenge for modern biology. Some models based on complex networks have provided important information regarding this machinery. In this paper, we constructed metabolic networks of 17 plants covering unicellular organisms to more complex dicotyledonous plants. The metabolic networks were built based on the substrate-product model and a topological percolation was performed using the kcore decomposition. The distribution of metabolites across the percolation layers showed correlations between the metabolic integration hierarchy and the network topology. We show that metabolites concentrated in the internal network (maximum kcore) only comprise molecules of the primary basal metabolism. Moreover, we found a high proportion of a set of common metabolites, among the 17 plants, centered at the inner kcore layers. Meanwhile, the metabolites recognized as participants in the secondary metabolism of plants are concentrated in the outermost layers of the network. This data suggests that the metabolites in the central layer form a basic molecular module in which the whole plant metabolism is anchored. The elements from this central core participate in almost all plant metabolic reactions, which suggests that plant metabolic networks follows a centralized topology.	[Filho, Humberto A.; Machicao, Jeaneth; Bruno, Odemir M.] Univ Sao Paulo, Sao Carlos Inst Phys, POB 369, BR-13560970 Sao Carlos, SP, Brazil	Universidade de Sao Paulo	Bruno, OM (corresponding author), Univ Sao Paulo, Sao Carlos Inst Phys, POB 369, BR-13560970 Sao Carlos, SP, Brazil.	bruno@ifsc.usp.br	Justo, M. Jeaneth Machicao/AAW-2407-2020; Bruno, Odemir M/A-5279-2009; Bruno, Odemir/AAU-7209-2020; Machicao, Jeaneth/GYD-4168-2022	Justo, M. Jeaneth Machicao/0000-0002-1202-0194; Bruno, Odemir M/0000-0002-2945-1556; Bruno, Odemir/0000-0002-2945-1556; Machicao, Jeaneth/0000-0002-1202-0194; Antunes de Almeida Filho, Humberto/0000-0002-8497-777X	CNPq (National Council for Scientific and Technological Development, Brazil) [153137/2013-4]; CAPES (Coordination for the Improvement of Higher Education Personnel); CNPq [153137/2013-4, 405503/2017-2, 307797/2014-7]; FAPESP (Sao Paulo Research Foundation) [2014/08026-1]	CNPq (National Council for Scientific and Technological Development, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	H. A. F. gratefully acknowledges the financial support of CNPq (National Council for Scientific and Technological Development, Brazil) (grant #153137/2013-4). J.M. is grateful for the support of CAPES (Coordination for the Improvement of Higher Education Personnel) and CNPq grant #405503/2017-2. O.M.B. gratefully acknowledges the financial support of CNPq (grants #307797/2014-7, #405503/2017-2 and #153137/2013-4) and FAPESP (Sao Paulo Research Foundation) (grant #2014/08026-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Hamelin J.I., 2006, ADV NEURAL INFORM PR, P41; Bassham JA., 1960, CO2 ASSIMILATION ASS, P884; Batagelj Vladimir, 2002, CORR; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chae L, 2014, SCIENCE, V344, P510, DOI 10.1126/science.1252076; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Dorogovtsev SN, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.040601; Dreher Kate, 2014, Methods Mol Biol, V1083, P151, DOI 10.1007/978-1-62703-661-0_10; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Holme P, 2010, CHINESE SCI BULL, V55, P3161, DOI 10.1007/s11434-010-4086-3; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Kornberg H, 2000, NAT REV MOL CELL BIO, V1, P225, DOI 10.1038/35043073; Ma HW, 2003, BIOINFORMATICS, V19, P1423, DOI 10.1093/bioinformatics/btg177; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Mueller LA, 2003, PLANT PHYSIOL, V132, P453, DOI 10.1104/pp.102.017236; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; PlantCyc, 2015, PLANT MET NETW PMN; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rhee SY, 2006, BIOTECH AGR FOREST, V57, P141; Seigler D.S., 2012, PLANT SECONDARY META; Viant MR, 2017, CURR OPIN CHEM BIOL, V36, P64, DOI 10.1016/j.cbpa.2017.01.001; Wuchty S, 2005, PROTEOMICS, V5, P444, DOI 10.1002/pmic.200400962; Zhang PF, 2010, PLANT PHYSIOL, V153, P1479, DOI 10.1104/pp.110.157396; Zhang PF, 2005, PLANT PHYSIOL, V138, P27, DOI 10.1104/pp.105.060376; Zhang ZG, 2006, CHINESE SCI BULL, V51, P1729, DOI 10.1007/s11434-006-2047-7	27	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0195843	10.1371/journal.pone.0195843	http://dx.doi.org/10.1371/journal.pone.0195843			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734359	Green Published, gold, Green Submitted			2022-12-26	WOS:000431481700006
J	Germano, A; Saba, L; De Francia, S; Rapa, I; Perotti, P; Berruti, A; Volante, M; Terzolo, M				Germano, Antonina; Saba, Laura; De Francia, Silvia; Rapa, Ida; Perotti, Paola; Berruti, Alfredo; Volante, Marco; Terzolo, Massimo			CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells	PLOS ONE			English	Article							ADJUVANT MITOTANE; CUSHINGS-SYNDROME; GENE-EXPRESSION; ADRENAL CANCER; O,P'-DDD; STEROIDOGENESIS; BINDING; 3-METHYLSULFONYL-DDE; METYRAPONE; THERAPY	Mitotane is the reference drug for adrenocortical carcinoma (ACC) and the metabolic activation of the drug is considered as essential for its activity. The aim of this study was to assess the role of CYP11B1 on mitotane action and metabolism in H295R ACC cells to understand whether this enzyme may influence mitotane action. The simultaneous incubation with mitotane and metyrapone, an adrenolytic molecule targeting 11-beta-hydroxylase, did not influence mitotane-mediated cytotoxic effect and metabolism in H295R ACC cells. CYP11B1 silencing confirmed the lack of a significant metyrapone effect on mitotane action. The present findings do not support the view that CYP11B1 catalyzes a crucial step in the metabolic activation of mitotane and that CYP11B1 confers the adrenal specificity to mitotane.	[Germano, Antonina; Saba, Laura; De Francia, Silvia; Perotti, Paola; Terzolo, Massimo] Univ Turin, San Luigi Hosp, Dept Clin & Biol Sci, Internal Med, Turin, Italy; [Rapa, Ida; Volante, Marco] Univ Turin, San Luigi Hosp, Dept Oncol, Pathol, Turin, Italy; [Berruti, Alfredo] Univ Brescia, ASST Spedali Civili Brescia, Dept Surg Radiol & Publ Hlth, Oncol Unit, Brescia, Italy	University of Turin; University of Turin; Hospital Spedali Civili Brescia; University of Brescia	Terzolo, M (corresponding author), Univ Turin, San Luigi Hosp, Dept Clin & Biol Sci, Internal Med, Turin, Italy.	massimo.terzolo@unito.it	Saba, Laura/AAC-3536-2022; Perotti, Paola/AAC-4714-2022; Germano, Antonina/K-8490-2016; Berruti, Alfredo/AAC-2069-2019; Terzolo, Massimo/D-5051-2015	Germano, Antonina/0000-0002-6488-7814; SABA, Laura/0000-0001-9246-0511; Terzolo, Massimo/0000-0002-4171-2851; VOLANTE, Marco/0000-0003-0719-105X	Associazione Italiana per la Ricerca sul Cancro [17678]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a research grant from Associazione Italiana per la Ricerca sul Cancro to MT (AIRC grant number 17678); http://www.airc.it/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen A, 1999, THER DRUG MONIT, V21, P355, DOI 10.1097/00007691-199906000-00020; Breen M, 2011, TOXICOL SCI, V123, P80, DOI 10.1093/toxsci/kfr167; CAI W, 1995, J PHARM SCI, V84, P134, DOI 10.1002/jps.2600840203; Cai W, 1997, CANCER CHEMOTH PHARM, V39, P537, DOI 10.1007/s002800050610; CAI W, 1995, BIOCHEM PHARMACOL, V49, P1483, DOI 10.1016/0006-2952(95)00028-X; Claps M, 2017, ENDOCRINE; Daffara F, 2008, ENDOCR-RELAT CANCER, V15, P1043, DOI 10.1677/ERC-08-0103; Daniel E, 2015, EUR J ENDOCRINOL, V172, pR263, DOI 10.1530/EJE-14-1014; De Francia S, 2006, J CHROMATOGR B, V837, P69, DOI 10.1016/j.jchromb.2006.04.005; Fassnacht M, 2012, NEW ENGL J MED, V366, P2189, DOI 10.1056/NEJMoa1200966; Fassnacht M, 2011, NAT REV ENDOCRINOL, V7, P323, DOI 10.1038/nrendo.2010.235; Germano A, 2015, MOL CELL ENDOCRINOL, V401, P105, DOI 10.1016/j.mce.2014.11.027; Hermansson V, 2007, ARCH TOXICOL, V81, P793, DOI 10.1007/s00204-007-0206-5; Hermsen IG, 2011, J CLIN ENDOCR METAB, V96, P1844, DOI 10.1210/jc.2010-2676; Hescot S, 2014, HORM CANCER-US, V5, P312, DOI 10.1007/s12672-014-0189-7; Hescot S, 2013, ENDOCR-RELAT CANCER, V20, P371, DOI 10.1530/ERC-12-0368; Kamenicky P, 2011, J CLIN ENDOCR METAB, V96, P2796, DOI 10.1210/jc.2011-0536; Kroiss Matthias, 2011, Front Endocrinol (Lausanne), V2, P27, DOI 10.3389/fendo.2011.00027; Lehmann TP, 2013, MOL MED REP, V7, P893, DOI 10.3892/mmr.2012.1244; Lin CW, 2012, TOXICOLOGY, V298, P14, DOI 10.1016/j.tox.2012.04.007; Lindhe O, 2002, J CLIN ENDOCR METAB, V87, P1319, DOI 10.1210/jc.87.3.1319; LUND BO, 1995, J BIOL CHEM, V270, P20895, DOI 10.1074/jbc.270.36.20895; Owen LJ, 2010, ANN CLIN BIOCHEM, V47, P573, DOI 10.1258/acb.2010.010167; Sbiera S, 2015, ENDOCRINOLOGY, V156, P3895, DOI 10.1210/en.2015-1367; Schteingart DE, 2007, NEW ENGL J MED, V356, P2415, DOI 10.1056/NEJMe078087; Terzolo M, 2012, ENDOCRINE, V42, P521, DOI 10.1007/s12020-012-9719-7; Terzolo M, 2007, NEW ENGL J MED, V356, P2372, DOI 10.1056/NEJMoa063360; TOUITOU Y, 1978, J STEROID BIOCHEM, V9, P1217, DOI 10.1016/0022-4731(78)90015-8; Veytsman I, 2009, J CLIN ONCOL, V27, P4619, DOI 10.1200/JCO.2008.17.2775; Volante M, 2012, CLIN CANCER RES, V18, P3452, DOI 10.1158/1078-0432.CCR-11-2692; Waszut U, 2017, J PHYSIOL PHARMACOL, V68, P13; YOUNG RB, 1973, J STEROID BIOCHEM, V4, P585, DOI 10.1016/0022-4731(73)90033-2	32	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196931	10.1371/journal.pone.0196931	http://dx.doi.org/10.1371/journal.pone.0196931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734384	Green Published, gold, Green Submitted			2022-12-26	WOS:000431481700033
J	Komura, R; Aoki, W; Motone, K; Satomura, A; Ueda, M				Komura, Ryo; Aoki, Wataru; Motone, Keisuke; Satomura, Atsushi; Ueda, Mitsuyoshi			High-throughput evaluation of T7 promoter variants using biased randomization and DNA barcoding	PLOS ONE			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; CIS-REGULATORY ELEMENTS; IDENTIFICATION; RECOGNITION; EXPRESSION; INSIGHTS	Cis-regulatory elements (CREs) are one of the important factors in controlling gene expression and elucidation of their roles has been attracting great interest. We have developed an improved method for analyzing a large variety of mutant CRE sequences in a simple and high-throughput manner. In our approach, mutant CREs with unique barcode sequences were obtained by biased randomization in a single PCR amplification. The original T7 promoter sequence was randomized by biased randomization, and the target number of base substitutions was set to be within the range of 0 to 5. The DNA library and subsequent transcribed RNA library were sequenced by next generation sequencers (NGS) to quantify transcriptional activity of each mutant. We succeeded in producing a randomized T7 promoter library with high coverage rate at each target number of base substitutions. In a single NGS analysis, we quantified the transcriptional activity of 7847 T7 promoter variants. We confirmed that the bases from -9 to -7 play an important role in the transcriptional activity of the T7 promoter. This information coincides with the previous researches and demonstrated the validity of our methodology. Furthermore, using an in vitro transcription/translation system, we found that transcriptional activities of these T7 variants were well correlated with the resultant protein abundance. We demonstrate that our method enables simple and high-throughput analysis of the effects of various CRE mutations on transcriptional regulation.	[Komura, Ryo; Aoki, Wataru; Motone, Keisuke; Satomura, Atsushi; Ueda, Mitsuyoshi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto, Japan; [Motone, Keisuke; Satomura, Atsushi] Japan Soc Promot Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto, Japan	Kyoto University; Japan Society for the Promotion of Science	Ueda, M (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto, Japan.	miueda@kais.kyoto-u.ac.ip		Aoki, Wataru/0000-0002-3118-9390	Core Research for Evolutional Science and Technology [JPMJCR16G2]; JST, CREST [JPMJCR16G2]	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by the Core Research for Evolutional Science and Technology (JP (JPMJCR16G2) to Prof. Mitsuyoshi Ueda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by JST, CREST [grant number JPMJCR16G2].	Aoki W, 2014, SCI REP-UK, V4, DOI 10.1038/srep04722; CHAPMAN KA, 1988, NUCLEIC ACIDS RES, V16, P4511, DOI 10.1093/nar/16.10.4511; Chizzolini F, 2014, ACS SYNTH BIOL, V3, P363, DOI 10.1021/sb4000977; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Epstein Douglas J., 2009, Briefings in Functional Genomics & Proteomics, V8, P310, DOI 10.1093/bfgp/elp021; Gasperini M, 2016, NAT PROTOC, V11, P1782, DOI 10.1038/nprot.2016.135; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Ichihashi N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3494; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; Karzbrun E, 2014, SCIENCE, V345, P829, DOI 10.1126/science.1255550; Kinkhabwala A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002030; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kurihara K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9352; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Li J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090225, 10.1371/journal.pone.0105508]; Li T, 1996, BIOCHEMISTRY-US, V35, P3722, DOI 10.1021/bi9524373; Li YF, 2015, BIOSYSTEMS, V138, P6, DOI 10.1016/j.biosystems.2015.10.002; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mathelier A, 2015, TRENDS GENET, V31, P67, DOI 10.1016/j.tig.2014.12.003; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; RASKIN CA, 1992, J MOL BIOL, V228, P506, DOI 10.1016/0022-2836(92)90838-B; Rong MQ, 1998, P NATL ACAD SCI USA, V95, P515, DOI 10.1073/pnas.95.2.515; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sun ZZ, 2014, ACS SYNTH BIOL, V3, P387, DOI 10.1021/sb400131a; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Ujvari A, 1997, J MOL BIOL, V273, P775, DOI 10.1006/jmbi.1997.1350; van Nies P, 2015, METHOD ENZYMOL, V550, P187, DOI 10.1016/bs.mie.2014.10.048; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	35	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196905	10.1371/journal.pone.0196905	http://dx.doi.org/10.1371/journal.pone.0196905			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734387	Green Submitted, Green Published, gold			2022-12-26	WOS:000431481700031
J	Shintani, Y; Hayata-Takano, A; Moriguchi, K; Nakazawa, T; Ago, Y; Kasai, A; Seiriki, K; Shintani, N; Hashimoto, H				Shintani, Yusuke; Hayata-Takano, Atsuko; Moriguchi, Keita; Nakazawa, Takanobu; Ago, Yukio; Kasai, Atsushi; Seiriki, Kaoru; Shintani, Norihito; Hashimoto, Hitoshi			beta-Arrestin1 and 2 differentially regulate PACAP-induced PAC1 receptor signaling and trafficking	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; BETA-ARRESTIN ISOFORMS; PC12 CELLS; DEFICIENT MICE; INTERNALIZATION; SCHIZOPHRENIA; TRANSDUCTION; NEURON; ERK1/2; ROLES	A pituitary adenylate cyclase-activating polypeptide (PACAP)- specific receptor, PAC1R, is coupled with multiple signal transduction pathways including stimulation of adenylate cyclase, phospholipase C and extracellular- signal regulated kinase (ERK) 1/2. PAC1R has been shown to exert its long- lasting and potent signals via beta-arrestin1 and beta-arrestin2. However, the precise roles of the two beta-arrestin isoforms in PACAP- PAC1R signaling remain unclear. Here we examined the interaction between the two beta-arrestin isoforms and PAC1R, beta-arrestin-dependent PAC1R subcellular localization and ERK1/2 activation. Upon PACAP stimulation, although PAC1R similarly interacted with beta-arrestin1 and beta-arrestin2 in HEK293T cells, the complex of PAC1R and beta-arrestin2 was translocated from the cell surface into cytosol, but that of beta-arrestin1 remained in the cell surface regions in HeLa cells and mouse primary cultured neurons. Silencing of beta-arrestin2 blocked PACAP- induced PAC1R internalization and ERK1/2 phosphorylation, but silencing of beta-arrestin1 increased ERK1/2 phosphorylation. These results show that beta-arrestin1 and beta-arrestin2 exert differential actions on PAC1R internalization and PAC1R-dependent ERK1/ 2 activation, and suggest that the two beta-arrestin isoforms may be involved in fine and precise tuning of the PAC1R signaling pathways.	[Shintani, Yusuke; Hayata-Takano, Atsuko; Moriguchi, Keita; Nakazawa, Takanobu; Ago, Yukio; Kasai, Atsushi; Seiriki, Kaoru; Shintani, Norihito; Hashimoto, Hitoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka, Japan; [Hayata-Takano, Atsuko; Hashimoto, Hitoshi] Chiba Univ, Hamamatsu Univ Sch Med, Kanazawa Univ, Osaka Univ,Ctr Child Mental Dev,United Grad Sch C, Suita, Osaka, Japan; [Hayata-Takano, Atsuko; Hashimoto, Hitoshi] Univ Fukui, Suita, Osaka, Japan; [Nakazawa, Takanobu] Osaka Univ, Grad Sch Dent, Dept Pharmacol, Osaka, Japan; [Seiriki, Kaoru] Osaka Univ, Inst Acad Initiat, Interdisciplinary Program Biomed Sci, Suita, Osaka, Japan; [Hashimoto, Hitoshi] Osaka Univ, Inst Databil Sci, Div Biosci, Suita, Osaka, Japan	Osaka University; Chiba University; Kanazawa University; Osaka University; University of Fukui; Osaka University; Osaka University; Osaka University	Hayata-Takano, A; Hashimoto, H (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka, Japan.; Hayata-Takano, A; Hashimoto, H (corresponding author), Chiba Univ, Hamamatsu Univ Sch Med, Kanazawa Univ, Osaka Univ,Ctr Child Mental Dev,United Grad Sch C, Suita, Osaka, Japan.; Hayata-Takano, A; Hashimoto, H (corresponding author), Univ Fukui, Suita, Osaka, Japan.; Hashimoto, H (corresponding author), Osaka Univ, Inst Databil Sci, Div Biosci, Suita, Osaka, Japan.	a-hayata@phs.osaka-u.ac.jp; hasimoto@phs.osaka-u.ac.jp	Kasai, Atsushi/C-8073-2011; Ago, Yukio/H-9142-2019; Hashimoto, Hitoshi/D-1209-2010; Shintani, Norihito/N-1600-2019	Kasai, Atsushi/0000-0002-1612-3078; Ago, Yukio/0000-0001-7562-4000; Hashimoto, Hitoshi/0000-0001-6548-4016; Shintani, Norihito/0000-0002-7850-9064; NAKAZAWA, Takanobu/0000-0003-4863-1277	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP16K08269, JP26293020, JP17H03989, JP17K19488]; Japan Agency for Medical Research and Development (AMED) [JP17dm0107122h0002, JP17dm0207061h0001]; AMED [JP18am0101084]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); AMED	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI, Grant-in-Aid for Scientific Research (C), grant numbers JP16K08269 (Atsuko Hayata-Takano), Grant-in-Aid for Scientific Research (B), grant numbers JP26293020 (Hitoshi Hashimoto), grant numbers JP17H03989 (Hitoshi Hashimoto) and Grant-in-Aid for Exploratory Research, JP17K19488 (Hitoshi Hashitmoto), http://www.jsps.go.jp/index.html. These funders have the role of data collection and analysis, decision to publish and preparation of the manuscript. Japan Agency for Medical Research and Development (AMED) under Grant Number JP17dm0107122h0002 (Hitoshi Hashimoto) and JP17dm0207061h0001 (Hitoshi Hashimoto), https://www.amed.go.jp/. This research was also partially performed using GloMAX discover system by Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED under Grant Number JP18am0101084. These funders have the role of data collection and analysis, decision to publish and preparation of the manuscript.	Abrisqueta M, 2013, J CELL SCI, V126, P3724, DOI 10.1242/jcs.128322; Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Arimura A, 1998, JPN J PHYSIOL, V48, P301, DOI 10.2170/jjphysiol.48.301; Barrie AP, 1997, J BIOL CHEM, V272, P19666, DOI 10.1074/jbc.272.32.19666; Bologna Z, 2017, BIOMOL THER, V25, P12, DOI 10.4062/biomolther.2016.165; Broca C, 2009, J BIOL CHEM, V284, P4332, DOI 10.1074/jbc.M807595200; Clason TA, 2016, J MOL NEUROSCI, V59, P309, DOI 10.1007/s12031-016-0766-z; Corgiat BA, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00171; Dautzenberg FM, 2001, NEUROPHARMACOLOGY, V40, P394, DOI 10.1016/S0028-3908(00)00167-2; Freson K, 2004, J CLIN INVEST, V113, P905, DOI 10.1172/JCI200419252; Groer CE, 2011, J BIOL CHEM, V286, P31731, DOI 10.1074/jbc.M111.248310; Gupte RP, 2016, NEUROPHARMACOLOGY, V101, P291, DOI 10.1016/j.neuropharm.2015.10.006; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Hashimoto H., 2016, PITUITARY ADENYLATE, P757, DOI [10.1007/978-3-319- 35135-3_44, DOI 10.1007/978-3-319-35135-3_44]; Hashimoto H, 2009, J NEUROCHEM, V110, P595, DOI 10.1111/j.1471-4159.2009.06168.x; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; Hattori Satoko, 2012, Front Behav Neurosci, V6, P58, DOI 10.3389/fnbeh.2012.00058; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lyu RM, 2000, J BIOL CHEM, V275, P36134, DOI 10.1074/jbc.M004612200; Mabuchi T, 2004, J NEUROSCI, V24, P7283, DOI 10.1523/JNEUROSCI.0983-04.2004; May V, 2014, AM J PHYSIOL-CELL PH, V306, pC1068, DOI 10.1152/ajpcell.00001.2014; McCrink KA, 2017, HYPERTENSION, V70, P972, DOI 10.1161/HYPERTENSIONAHA.117.09817; Merriam LA, 2013, J NEUROSCI, V33, P4614, DOI 10.1523/JNEUROSCI.4999-12.2013; Nakamachi T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12034; Ogata K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120526; Ohtaki H, 2006, P NATL ACAD SCI USA, V103, P7488, DOI 10.1073/pnas.0600375103; Peterson YK, 2017, PHARMACOL REV, V69, P256, DOI 10.1124/pr.116.013367; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Reglodi D, 2012, J MOL NEUROSCI, V48, P482, DOI 10.1007/s12031-012-9762-0; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Sakai Y, 2004, MOL BRAIN RES, V123, P18, DOI 10.1016/j.molbrainres.2003.12.013; Sakai Y, 2002, REGUL PEPTIDES, V109, P149, DOI 10.1016/S0167-0115(02)00198-2; Schulze W, 2015, BIOCHEM BIOPH RES CO, V459, P81, DOI 10.1016/j.bbrc.2015.02.073; Srivastava A, 2015, TRENDS ENDOCRIN MET, V26, P628, DOI 10.1016/j.tem.2015.09.001; Tanaka K, 2006, J NEUROSCI, V26, P5091, DOI 10.1523/JNEUROSCI.4376-05.2006; Tian Xufan, 2014, Handb Exp Pharmacol, V219, P173, DOI 10.1007/978-3-642-41199-1_9; Urs NM, 2017, BIOL PSYCHIAT, V81, P78, DOI 10.1016/j.biopsych.2016.10.011; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Watari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068351; Zhang XH, 2017, BIOMOL THER, V25, P26, DOI 10.4062/biomolther.2016.186	43	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196946	10.1371/journal.pone.0196946	http://dx.doi.org/10.1371/journal.pone.0196946			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734363	Green Published, gold, Green Submitted			2022-12-26	WOS:000431481700035
J	Tsotetsi, TN; Collins, NE; Oosthuizen, MC; Sibeko-Matjila, KP				Tsotetsi, Teboho N.; Collins, Nicola E.; Oosthuizen, Marinda C.; Sibeko-Matjila, Kgomotso P.			Selection and evaluation of housekeeping genes as endogenous controls for quantification of mRNA transcripts in Theileria parva using quantitative real-time polymerase chain reaction (qPCR)	PLOS ONE			English	Article							RT-PCR; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; EXPRESSION; VALIDATION; ANNULATA; ASSAYS; TOOL; SEQ	The reliability of any quantitative real-time polymerase chain reaction (qPCR) experiment can be seriously compromised by variations between samples as well as between PCR runs. This usually result from errors in sample quantification, especially with samples that are obtained from different individuals and tissues and have been collected at various time intervals. Errors also arise from differences in qPCR efficiency between assays performed simultaneously to target multiple genes on the same plate. Consequently, the derived quantitative data for the target genes become distorted. To avoid this grievous error, an endogenous control, with relatively constant transcription levels in the target individual or tissue, is included in the qPCR assay to normalize target gene expression levels in the analysis. Several housekeeping genes (HKGs) have been used as endogenous controls in quantification studies of mRNA transcripts; however, there is no record in the literature of the evaluation of these genes for the tick-borne protozoan parasite, Theileria parva. Importantly, the expression of these genes should be invariable between different T. parva stocks, ideally under different experimental conditions, to gain extensive application in gene expression studies of this parasite. Thus, the expression of several widely used HKGs was evaluated in this study, including the genes encoding beta-actin, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 28S rRNA, cytochrome b and fructose-2.6-biphosphate aldolase (F6P) proteins. The qPCR analysis revealed that the expression of genes encoding cytochrome b, F6P and GAPDH varied considerably between the two T. parva stocks investigated, the cattle-derived T. parva Muguga and the buffalo-derived T. parva 7014. 28S rRNA and beta-actin gene expression was the most stable; thus, these genes were considered suitable candidates to be used as endogenous control genes for mRNA quantification studies in T. parva.	[Tsotetsi, Teboho N.; Collins, Nicola E.; Oosthuizen, Marinda C.; Sibeko-Matjila, Kgomotso P.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Vectors & Vector Borne Dis Res Programme, Onderstepoort, Gauteng Provinc, South Africa	University of Pretoria	Sibeko-Matjila, KP (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Vectors & Vector Borne Dis Res Programme, Onderstepoort, Gauteng Provinc, South Africa.	kgomolso.sibeko@up.ac.za	Collins, Nicola/O-6342-2014; Oosthuizen, Marinda C/N-8706-2014; Sibeko-Matjila, Kgomotso/O-3691-2019; Sibeko-Matjila, Kgomotso/X-6565-2019	Collins, Nicola/0000-0001-7296-3912; Oosthuizen, Marinda C/0000-0002-1893-0818; Sibeko-Matjila, Kgomotso/0000-0003-1139-7333	Genomics Research Institute of the University of Pretoria	Genomics Research Institute of the University of Pretoria	This work was funded by the Genomics Research Institute of the University of Pretoria, (http://www.up.ac.zaithe-genomics-research-institute/home) to KPS-M. The funder had no role in study design, data collection and analysis,	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2005, ENCY DIAGNOSIS GENOM, P1131; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Espinola SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102228; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Gachohi J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-194; Galeano Esteban, 2014, BMC Res Notes, V7, P464, DOI 10.1186/1756-0500-7-464; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Hakimi MA, 2007, CURR OPIN MICROBIOL, V10, P357, DOI 10.1016/j.mib.2007.07.005; Hoffmann B, 2009, J CLIN MICROBIOL, V47, P2992, DOI 10.1128/JCM.00599-09; Hostettler I, 2014, INT J PARASITOL-DRUG, V4, P201, DOI 10.1016/j.ijpddr.2014.09.003; Huggett J., 2005, STRATEG CONSID GENES, P1, DOI DOI 10.1038/SJ.GENE.6364142; Irish H, 2015, INT ANIM HLTH J, V2, P22; Ishitani R, 1996, J NEUROCHEM, V66, P928; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Janssens Nico, 2004, Mol Diagn, V8, P107, DOI 10.2165/00066982-200408020-00005; Jin L, 1997, J CLIN LAB ANAL, V11, P2, DOI 10.1002/(SICI)1098-2825(1997)11:1<2::AID-JCLA2>3.0.CO;2-F; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Love JL, 2006, J MICROBIOL METH, V67, P349, DOI 10.1016/j.mimet.2006.04.005; Ma Ying Jun, 1996, Methods (Orlando), V10, P273, DOI 10.1006/meth.1996.0102; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; NORVAL RAI, 1991, PARASITOLOGY, V102, P347, DOI 10.1017/S0031182000064295; Norval RAI, 1992, EPIDEMIOLOGY THEILER; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; PETERSEN BH, 1990, J CLIN ENDOCR METAB, V70, P1756, DOI 10.1210/jcem-70-6-1756; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, BIOTECHNOL LETT, V23, P275, DOI 10.1023/A:1005658330108; Putignani Lorenza, 2010, Interdiscip Perspect Infect Dis, V2010, DOI 10.1155/2010/753512; Sanders R, 2014, ANAL BIOANAL CHEM, V406, P6471, DOI 10.1007/s00216-014-7857-x; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schmuckli-Maurer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004839; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Spooner S, 2015, MAIL GUARDIAN A 0511; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Streit S, 2009, NAT PROTOC, V4, P37, DOI 10.1038/nprot.2008.216; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; Sultana R, 2017, ARCH VET SCI TECHNOL; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhao HX, 2016, KOREAN J PARASITOL, V54, P39, DOI 10.3347/kjp.2016.54.1.39	50	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2018	13	5							e0196715	10.1371/journal.pone.0196715	http://dx.doi.org/10.1371/journal.pone.0196715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE7ZR	29727459	gold, Green Published, Green Submitted			2022-12-26	WOS:000431452100008
J	Enshaeifar, S; Zoha, A; Markides, A; Skillman, S; Acton, ST; Elsaleh, T; Hassanpour, M; Ahrabian, A; Kenny, M; Klein, S; Rostill, H; Nilforooshan, R; Barnaghi, P				Enshaeifar, Shirin; Zoha, Ahmed; Markides, Andreas; Skillman, Severin; Acton, Sahr Thomas; Elsaleh, Tarek; Hassanpour, Masoud; Ahrabian, Alireza; Kenny, Mark; Klein, Stuart; Rostill, Helen; Nilforooshan, Ramin; Barnaghi, Payam			Health management and pattern analysis of daily living activities of people with dementia using in-home sensors and machine learning techniques	PLOS ONE			English	Article							OLDER-ADULTS; BEHAVIORAL-PATTERNS; ALZHEIMERS-DISEASE	The number of people diagnosed with dementia is expected to rise in the coming years. Given that there is currently no definite cure for dementia and the cost of care for this condition soars dramatically, slowing the decline and maintaining independent living are important goals for supporting people with dementia. This paper discusses a study that is called Technology Integrated Health Management (TIHM). TIHM is a technology assisted monitoring system that uses Internet of Things (loT) enabled solutions for continuous monitoring of people with dementia in their own homes. We have developed machine learning algorithms to analyse the correlation between environmental data collected by loT technologies in TIHM in order to monitor and facilitate the physical well-being of people with dementia. The algorithms are developed with different temporal granularity to process the data for longterm and short-term analysis. We extract higher-level activity patterns which are then used to detect any change in patients' routines. We have also developed a hierarchical information fusion approach for detecting agitation, irritability and aggression. We have conducted evaluations using sensory data collected from homes of people with dementia. The proposed techniques are able to recognise agitation and unusual patterns with an accuracy of up to 80%.	[Enshaeifar, Shirin; Zoha, Ahmed; Markides, Andreas; Skillman, Severin; Acton, Sahr Thomas; Elsaleh, Tarek; Hassanpour, Masoud; Ahrabian, Alireza; Barnaghi, Payam] Univ Surrey, Dept Elect & Elect Engn, Surrey, England; [Kenny, Mark; Klein, Stuart; Rostill, Helen; Nilforooshan, Ramin] Surrey & Borders Partnership NHS Fdn Trust, Leatherhead, Surrey, England	University of Surrey	Barnaghi, P (corresponding author), Univ Surrey, Dept Elect & Elect Engn, Surrey, England.	p.barnaghi@surrey.ac.uk	Enshaeifar, Shirin/M-7783-2016; Barnaghi, Payam/ABE-9236-2020; Zoha, Ahmed/ABB-8933-2020; Elsaleh, Tarek/X-1141-2019; Elsaleh, Tarek/AAK-5803-2021	Enshaeifar, Shirin/0000-0001-6216-0622; Barnaghi, Payam/0000-0001-8591-9638; Zoha, Ahmed/0000-0001-7497-9336; Elsaleh, Tarek/0000-0002-9134-0232	Office of Life Sciences at Department of Health UK [TS/N009894/1]	Office of Life Sciences at Department of Health UK	This project is supported by a grant from the Office of Life Sciences at Department of Health UK, grant number (TS/N009894/1) (PB). More information can be found here: (https://www.gov.uk/government/orgaresations/office-for-life-sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DEM INCL ALZH DIS; Arthur D., 2007, P ADV 18 ANN ACM SIA, V1027, P1035; Barger TS, 2005, IEEE T SYST MAN CY A, V35, P22, DOI 10.1109/TSMCA.2004.838474; Buchanan JA, 2011, BEHAV THER, V42, P9, DOI 10.1016/j.beth.2010.01.003; Charernboon Thammanard, 2014, Journal of the Medical Association of Thailand, V97, P560; Dawadi PN, 2013, TECHNOL HEALTH CARE, V21, P323, DOI 10.3233/THC-130734; Demiris G, 2008, Yearb Med Inform, P33; Devroye L, 2013, PROBABILISTIC THEORY, V31; Enshaeifar S, 2017, IEEE INTERN IN PRESS; Galambos Colleen, 2013, Gerontechnology, V11, P457, DOI 10.4017/gt.2013.11.3.004.00; Gu Y., 2005, P 5 ACM SIGCOMM C IN, P32; Han GY, 2006, IEEE T INFORM THEORY, V52, P5251, DOI 10.1109/TIT.2006.885481; HATTORI I, 1976, J INT ASS MATH GEOL, V8, P477, DOI 10.1007/BF01028983; Hubert M, 2008, COMPUT STAT DATA AN, V52, P5186, DOI 10.1016/j.csda.2007.11.008; Kaye JA, 2011, J GERONTOL B-PSYCHOL, V66, P180, DOI [10.1093/geronb/ghq095, 10.1093/geronb/gbq095]; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Lotfi A, 2012, J AMB INTEL HUM COMP, V3, P205, DOI 10.1007/s12652-010-0043-x; Lymberopoulos D, 2011, UNIVERSAL ACCESS INF, V10, P125, DOI 10.1007/s10209-010-0197-5; Morris S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007382; Ni Q, 2015, SENSORS-BASEL, V15, P11312, DOI 10.3390/s150511312; Norris J. R, 1998, MARKOV CHAINS 2; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rashidi P, 2013, IEEE J BIOMED HEALTH, V17, P579, DOI 10.1109/JBHI.2012.2234129; Skubic M, 2015, IEEE J TRANSL ENG HE, V3, DOI 10.1109/JTEHM.2015.2421499; Skubic Marjorie, 2009, Technol Health Care, V17, P183, DOI 10.3233/THC-2009-0551; Song XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051657; Tan XB, 2008, APPL MATH COMPUT, V205, P562, DOI 10.1016/j.amc.2008.05.028; Urwyler P, 2017, SCI REP-UK, V7, DOI 10.1038/srep42084; Virone G, 2008, IEEE T INF TECHNOL B, V12, P387, DOI 10.1109/TITB.2007.904157; Volicer L, 2001, AM J PSYCHIAT, V158, P704, DOI 10.1176/appi.ajp.158.5.704; Wang S, 2012, IEEE T INF TECHNOL B, V16, P607, DOI 10.1109/TITB.2012.2196439; Wang W, 2010, PROC CVPR IEEE, P2368, DOI 10.1109/CVPR.2010.5539927	32	41	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0195605	10.1371/journal.pone.0195605	http://dx.doi.org/10.1371/journal.pone.0195605			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723236	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000431305100007
J	Lamason, RL; Kafai, NM; Welch, MD				Lamason, Rebecca L.; Kafai, Natasha M.; Welch, Matthew D.			A streamlined method for transposon mutagenesis of Rickettsia parkeri yields numerous mutations that impact infection	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; INVASION; PROTEIN; CELLS; SECRETION; ADHERENCE; FAMILY; ROMPB	The rickettsiae are obligate intracellular alphaproteobacteria that exhibit a complex infectious life cycle in both arthropod and mammalian hosts. As obligate intracellular bacteria, rickettsiae are highly adapted to living inside a variety of host cells, including vascular endothelial cells during mammalian infection. Although it is assumed that the rickettsiae produce numerous virulence factors that usurp or disrupt various host cell pathways, they have been challenging to genetically manipulate to identify the key bacterial factors that contribute to infection. Motivated to overcome this challenge, we sought to expand the repertoire of available rickettsial loss-of-function mutants, using an improved mariner-based transposon mutagenesis scheme. Here, we present the isolation of over 100 transposon mutants in the spotted fever group species Rickettsia parkeri. Transposon insertions disrupted genes whose products are implicated in a variety of pathways, including bacterial replication and metabolism, the type IV secretion system, factors with previously established roles in host cell interactions and pathogenesis, or are of unknown function. Given the need to identify critical virulence factors, forward genetic screens such as this will provide an excellent platform to more directly investigate rickettsial biology and pathogenesis.	[Lamason, Rebecca L.; Kafai, Natasha M.; Welch, Matthew D.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Lamason, Rebecca L.] MIT, Dept Biol, Cambridge, MA USA; [Kafai, Natasha M.] Washington Univ, Sch Med, Med Scientist Training Program, St Louis, MO USA	University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Washington University (WUSTL)	Lamason, RL; Welch, MD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	rlamason@mit.edu; welch@berkeley.edu		Welch, Matthew/0000-0003-2537-6349	Helen Hay Whitney Foundation postdoctoral fellowship; National Institutes of Health [K99 GM115765, R01 AI109044]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM115765, R00GM115765] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation postdoctoral fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.L.L. was supported by a Helen Hay Whitney Foundation postdoctoral fellowship and National Institutes of Health grant K99 GM115765. This work in the lab of M.D.W. is supported by National Institutes of Health grant R01 AI109044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Banajee KH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135175; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Choe JE, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw099; CLARK TR, 2011, TRANSFORMATION FREQU, V193, P4993, DOI DOI 10.1128/JB.05279-11; Gillespie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002018; Gillespie JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004833; Gillespie JJ, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw058; Gillespie JJ, 2015, FEMS MICROBIOL REV, V39, P47, DOI 10.1111/1574-6976.12084; Grasperge BJ, 2012, INFECT IMMUN, V80, P1846, DOI 10.1128/IAI.00109-12; Grohmann E, 2018, MOL MICROBIOL, V107, P455, DOI 10.1111/mmi.13896; HEINZEN RA, 1993, INFECT IMMUN, V61, P1926, DOI 10.1128/IAI.61.5.1926-1935.1993; Hillman RD, 2013, CELL MICROBIOL, V15, P727, DOI 10.1111/cmi.12068; Kaur SJ, 2012, J BACTERIOL, V194, P4920, DOI 10.1128/JB.00793-12; Kleba B, 2010, INFECT IMMUN, V78, P2240, DOI 10.1128/IAI.00100-10; Lamason RL, 2017, CURR OPIN MICROBIOL, V35, P48, DOI 10.1016/j.mib.2016.11.007; Lamason RL, 2016, CELL, V167, P670, DOI 10.1016/j.cell.2016.09.023; Li H, 1998, MICROB PATHOGENESIS, V24, P289, DOI 10.1006/mpat.1997.0197; Liu ZM, 2007, APPL ENVIRON MICROB, V73, P6644, DOI 10.1128/AEM.01727-07; McClure EE, 2017, NAT REV MICROBIOL, V15, P544, DOI 10.1038/nrmicro.2017.59; Noriea NF, 2015, MBIO, V6, DOI 10.1128/mBio.00323-15; Paddock CD, 2004, CLIN INFECT DIS, V38, P805, DOI 10.1086/381894; Paddock CD, 2008, CLIN INFECT DIS, V47, P1188, DOI 10.1086/592254; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Qin AP, 2004, APPL ENVIRON MICROB, V70, P2816, DOI 10.1128/AEM.70.5.2816-2822.2004; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; Reed SCO, 2014, CURR BIOL, V24, P98, DOI 10.1016/j.cub.2013.11.025; Reed SCO, 2012, CELL MICROBIOL, V14, P529, DOI 10.1111/j.1462-5822.2011.01739.x; Serio AW, 2010, CELL HOST MICROBE, V7, P388, DOI 10.1016/j.chom.2010.04.008; Uchiyama T, 2003, ANN NY ACAD SCI, V990, P585, DOI 10.1111/j.1749-6632.2003.tb07431.x; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; Welch MD, 2012, INTERCELLULAR PATHOGENS II: RICKETTSIALES, P154, DOI 10.1128/9781555817336.ch5; Welch MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037310	33	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0197012	10.1371/journal.pone.0197012	http://dx.doi.org/10.1371/journal.pone.0197012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723287	Green Published, Green Submitted, gold			2022-12-26	WOS:000431305100100
J	Liu, N; Nan, HW				Liu, Ning; Nan, Hongwei			Carbon stocks of three secondary coniferous forests along an altitudinal gradient on Loess Plateau in inland China	PLOS ONE			English	Article							SOIL ORGANIC-CARBON; TEMPERATE FORESTS; DECOMPOSITION RATES; PICEA-MEYERI; BIOMASS; STORAGE; ALPINE; SEEDLINGS; CLIMATE; PRODUCTIVITY	Natural forests in inland China are generally distributed in montane area and secondary due to a semi-arid climate and past anthropogenic disturbances. However, quantification of carbon (C) stock in these forests and the role of altitude in determining C storage and its partition among ecosystem components are unclear. We sampled 54 stands of three secondary coniferous forests (Larix principis-rupprechtii (LP) forest, Picea meyerii (PM) forest and Pinus tabulaeformis (PT) forest) on Loess Plateau in an altitudinal range of 1200-2700m a. s.l. C stocks of tree layer, shrub layer, herb layer, coarse wood debris, forest floor and soil were estimated. We found these forests had relatively high total C stocks. Driven by both higher vegetation and soil C stocks, total C stocks of LP and PM forests in the high altitudinal range were 375.0 and 368.4 t C ha(-1) respectively, significantly higher than that of PT forest in the low altitudinal range (230.2 t C ha(-1)). In addition, understory shrubs accounted for about 20% of total biomass in PT forest. The proportions of vegetation to total C stock were similar among in the three forests (below 45%), so were the proportions of soil C stock (over 54%). Necromass C stocks were also similar among these forests, but their proportions to total C stock were significantly lower in LP and PM forests (1.4% and 1.6%) than in PT forest (3.0%). Across forest types, vegetation biomass and soil C stock simultaneously increased with increasing altitude, causing fairly unchanged C partitioning among ecosystem components along the altitudinal gradient. Soil C stock also increased with altitude in LP and PT forests. Forest floor necromass decreased with increasing altitude across the three forests. Our results suggest the important role of the altitudinal gradient in C sequestration and floor necromass of these three forests in terms of alleviated water conditions and in soil C storage of LP and PM forests in terms of temperature change.	[Liu, Ning; Nan, Hongwei] Shanxi Agr Univ, Sch Forestry, Taigu, Shanxi, Peoples R China	Shanxi Agricultural University	Liu, N (corresponding author), Shanxi Agr Univ, Sch Forestry, Taigu, Shanxi, Peoples R China.	dningliu@139.com			National Natural Science Foundation of China [31470630]; Shanxi Agricultural University [2013YJ17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanxi Agricultural University	This study was supported by National Natural Science Foundation of China [31470630, URL: www.nsfc.gov.cn], and Talent Recruiting Program of Shanxi Agricultural University [2013YJ17, URL: www.sxau.edu.cn].	[Anonymous], 2021, LANG ENV STAT COMP; Cai QF, 2013, DENDROCHRONOLOGIA, V31, P311, DOI 10.1016/j.dendro.2012.07.003; Chen Xia-lin, 2002, Forest Research, V15, P304; Conant RT, 2008, ECOLOGY, V89, P2384, DOI 10.1890/08-0137.1; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Ensslin A, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00492.1; Fang JY, 2007, SCI CHINA SER D, V50, P92, DOI 10.1007/s11430-007-2031-3; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fehse J, 2002, FOREST ECOL MANAG, V163, P9, DOI 10.1016/S0378-1127(01)00535-7; Gao Jie, 2016, Shengtaixue Zazhi, V35, P2707, DOI 10.13292/j.1000-4890.201610.032; Garkoti SC, 2008, ECOL RES, V23, P41, DOI 10.1007/s11284-007-0355-2; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Herrmann S, 2013, SCAND J FOREST RES, V28, P346, DOI 10.1080/02827581.2012.747622; Homeier J, 2010, BIOTROPICA, V42, P140, DOI 10.1111/j.1744-7429.2009.00547.x; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; Kharkwal Geeta, 2010, Journal of Forestry Research (Harbin), V21, P355, DOI 10.1007/s11676-010-0067-2; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Korner C., 2005, ECOSYSTEMS HUMAN WEL, P683; Lal R, 2002, LAND DEGRAD DEV, V13, P469, DOI 10.1002/ldr.531; Li KR, 2004, SCI CHINA SER D, V47, P49, DOI 10.1360/02yd0029; Liao CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010867; Liu B, 2018, FOREST ECOL MANAG, V419, P51, DOI 10.1016/j.foreco.2018.03.033; Liu CJ, 2004, GLOBAL ECOL BIOGEOGR, V13, P105, DOI 10.1111/j.1466-882X.2004.00072.x; Liu N, 2017, POL J ECOL, V65, P183, DOI [10.3161/15052249PJE2017.65.2.002, 10.3161/15052249pje2017.65.2.002]; Liu N, 2016, SCAND J FOREST RES, V31, P46, DOI 10.1080/02827581.2015.1055790; Ma QinYan, 2002, Journal of Beijing Forestry University, V24, P96; [孟蕾 Meng Lei], 2010, [水土保持通报, Bulletin of Soil and Water Conservation], V30, P133; Peng CH, 2009, GLOBAL PLANET CHANGE, V66, P179, DOI 10.1016/j.gloplacha.2008.12.001; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1754, DOI 10.1111/j.1365-2486.2005.001010.x; Reinhardt K, 2011, TREE PHYSIOL, V31, P615, DOI 10.1093/treephys/tpr055; Salamanca EF, 2003, APPL SOIL ECOL, V22, P271, DOI 10.1016/S0929-1393(02)00153-1; Sheikh M. A., 2009, Carbon Balance and Management, V4; Shi P, 2008, FUNCT ECOL, V22, P213, DOI 10.1111/j.1365-2435.2007.01370.x; Smith WK, 2009, BOT REV, V75, P163, DOI 10.1007/s12229-009-9030-3; State Forestry Administration, 2014, GUID CARB ACC MON FO, P55; [孙美美 Sun Meimei], 2017, [生态学报, Acta Ecologica Sinica], V37, P2665; Tang J. L., 1995, J BEIJING FORESTRY U, V17, P36; Thurner M, 2014, GLOBAL ECOL BIOGEOGR, V23, P297, DOI 10.1111/geb.12125; van Breugel M, 2011, FOREST ECOL MANAG, V262, P1648, DOI 10.1016/j.foreco.2011.07.018; Wang CK, 2006, FOREST ECOL MANAG, V222, P9, DOI 10.1016/j.foreco.2005.10.074; Wang N., 2014, THESIS; [王宁 Wang Ning], 2013, [土壤通报, Journal of Soil Science], V44, P858; [王宁 Wang Ning], 2013, [水土保持通报, Bulletin of Soil and Water Conservation], V33, P151; Wang YB, 2015, ENVIRON PROG SUSTAIN, V34, P333, DOI 10.1002/ep.11988; Wang YD, 2012, CAN J FOREST RES, V42, P657, DOI [10.1139/x2012-017, 10.1139/X2012-017]; Xiao Y, 1998, J SHANXI AGR U, V18, P5, DOI DOI 10.13842/J.CNKI.ISSN1671-8151.1998.01.002; Xie ZB, 2007, GLOBAL CHANGE BIOL, V13, P1989, DOI 10.1111/j.1365-2486.2007.01409.x; [杨晓梅 Yang Xiaomei], 2010, [水土保持学报, Journal of Soil and Water Conservation], V24, P123; Yang YH, 2007, BIOGEOCHEMISTRY, V84, P131, DOI 10.1007/s10533-007-9109-z; Yang YH, 2014, GLOBAL CHANGE BIOL, V20, P2687, DOI 10.1111/gcb.12536; Yuan ZY, 2012, FUNCT ECOL, V26, P991, DOI 10.1111/j.1365-2435.2012.02007.x; Zhang J, 1993, J SHANXI U NAT SCI, V15, P72, DOI [10.13451/j.cnki.shanxi.univ(nat.sci.;1992.01.016, DOI 10.13451/J.CNKI.SHANXI.UNIV(NAT.SCI.;1992.01.016]; [张金屯 Zhang Jintun], 2006, [山地学报, Journal of Mountain Science], V24, P1; Zhang L J, 2013, ENV MONITORING FOREW, V5, P10, DOI DOI 10.13448/J.CNKI.JALRE.2013.05.027; Zhang WT, 2012, FOREST ECOL MANAG, V265, P142, DOI 10.1016/j.foreco.2011.10.017; Zhang XP, 2009, PLANT ECOL, V201, P1, DOI 10.1007/s11258-008-9507-x; Zhang YD, 2013, FOREST ECOL MANAG, V300, P88, DOI 10.1016/j.foreco.2012.06.010; Zhao JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094966; [周晓红 Zhou Xiaohong], 2005, [干旱区研究, Arid Zone Research], V22, P116; Zhu BA, 2010, J PLANT RES, V123, P439, DOI 10.1007/s10265-009-0301-1	62	12	12	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196927	10.1371/journal.pone.0196927	http://dx.doi.org/10.1371/journal.pone.0196927			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723254	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100092
J	Plummer, IH; Johnson, CJ; Chesney, AR; Pedersen, JA; Samuel, MD				Plummer, Ian H.; Johnson, Chad J.; Chesney, Alexandra R.; Pedersen, Joel A.; Samuel, Michael D.			Mineral licks as environmental reservoirs of chronic wasting disease prions	PLOS ONE			English	Article							WHITE-TAILED DEER; MULE DEER; INFECTIOUS PRIONS; TRANSMISSION; SOIL; SCRAPIE; FATE; ELK; PROTEIN; RISK	Chronic wasting disease (CWD) is a fatal neurodegenerative disease of deer, elk, moose, and reindeer (cervids) caused by misfolded prion proteins. The disease has been reported across North America and recently discovered in northern Europe. Transmission of CWD in wild cervid populations can occur through environmental routes, but limited ability to detect prions in environmental samples has prevented the identification of potential transmission "hot spots". We establish widespread CWD prion contamination of mineral licks used by free-ranging cervids in an enzootic area in Wisconsin, USA. We show mineral licks can serve as reservoirs of CWD prions and thus facilitate disease transmission. Furthermore, mineral licks attract livestock and other wildlife that also obtain mineral nutrients via soil and water consumption. Exposure to CWD prions at mineral licks provides potential for cross-species transmission to wildlife, domestic animals, and humans. Managing deer use of mineral licks warrants further consideration to help control outbreaks of CWD.	[Plummer, Ian H.; Samuel, Michael D.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Johnson, Chad J.] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA; [Johnson, Chad J.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Johnson, Chad J.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA; [Chesney, Alexandra R.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI USA; [Pedersen, Joel A.] Univ Wisconsin, Dept Soil Sci, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA; [Pedersen, Joel A.] Univ Wisconsin, Dept Chem, Mol & Environm Toxicol Ctr, 1101 Univ Ave, Madison, WI 53706 USA; [Pedersen, Joel A.] Univ Wisconsin, Dept Civil & Environm Engn, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Samuel, MD (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.; Pedersen, JA (corresponding author), Univ Wisconsin, Dept Soil Sci, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA.; Pedersen, JA (corresponding author), Univ Wisconsin, Dept Chem, Mol & Environm Toxicol Ctr, 1101 Univ Ave, Madison, WI 53706 USA.; Pedersen, JA (corresponding author), Univ Wisconsin, Dept Civil & Environm Engn, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA.	joelpedersen@wisc.edu; mdsamuel@wisc.edu	Pedersen, Joel A./L-4007-2019	Pedersen, Joel A./0000-0002-3918-1860; Samuel, Michael/0000-0002-4267-2724	National Science Foundation [DEB-0914484, CBET-0547484]; Wisconsin Department of Natural Resources; US Geological Survey Contaminant Biology Program; William A. Rothermel-Bascom Professorship	National Science Foundation(National Science Foundation (NSF)); Wisconsin Department of Natural Resources; US Geological Survey Contaminant Biology Program; William A. Rothermel-Bascom Professorship	Funding for development of PMCA methods was provided by the National Science Foundation grants DEB-0914484 (M.D.S.) and CBET-0547484 (J.A.P.). Funding for laboratory equipment and environmental testing was provided respectively by the Wisconsin Department of Natural Resources and the US Geological Survey Contaminant Biology Program. The Department of Forest and Wildlife Ecology, University of Wisconsin Madison provided assistance with publication costs. J.A.P. gratefully acknowledges support from the William A. Rothermel-Bascom Professorship.	Bartz JC, 1998, VIROLOGY, V251, P297, DOI 10.1006/viro.1998.9427; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; Beringue V, 2008, VET RES, V39, DOI 10.1051/vetres:2008024; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Cheng YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166187; Collinge J, 2012, SCIENCE, V335, P411, DOI 10.1126/science.1218167; Cooke CM, 2007, ENVIRON SCI TECHNOL, V41, P811, DOI 10.1021/es0618189; Diringer H, 1998, J GEN VIROL, V79, P609, DOI 10.1099/0022-1317-79-3-609; Edmunds DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161127; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; Haley NJ, 2015, ANNU REV ANIM BIOSCI, V3, P305, DOI 10.1146/annurev-animal-022114-111001; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Henderson DM, 2015, J GEN VIROL, V96, P210, DOI 10.1099/vir.0.069906-0; Hoover CE, 2017, J VIROL, V91, DOI 10.1128/JVI.00077-17; Jacobson KH, 2010, J ENVIRON QUAL, V39, P1145, DOI 10.2134/jeq2009.0137; Jennelle CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091043; Jennelle CS, 2009, J WILDLIFE MANAGE, V73, P655, DOI 10.2193/2008-282; Johnson CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035383; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2011, J TOXICOL ENV HEAL A, V74, P161, DOI 10.1080/15287394.2011.529066; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Keane DP, 2008, J VET DIAGN INVEST, V20, P698, DOI 10.1177/104063870802000534; Kim TY, 2005, J VET MED SCI, V67, P753, DOI 10.1292/jvms.67.753; Klaus G., 1998, Mammalia, V62, P481; Lavelle MJ, 2014, ENVIRON GEOCHEM HLTH, V36, P1049, DOI 10.1007/s10653-014-9600-0; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Meyerett-Reid C, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00372-16; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Monello RJ, 2014, J WILDLIFE MANAGE, V78, P214, DOI 10.1002/jwmg.665; Moudjou M, 2014, MBIO, V5, DOI 10.1128/mBio.00829-13; Nichols TA, 2009, PRION, V3, P171, DOI 10.4161/pri.3.3.9819; Nichols TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062455; Pedersen J., 2012, DECONTAMINATION PRIO, P19; Plummer IH, 2017, J GEN VIROL, V98, P1932, DOI 10.1099/jgv.0.000845; Pritzkow S, 2015, CELL REP, V11, P1168, DOI 10.1016/j.celrep.2015.04.036; Pulford B, 2012, J WILDLIFE DIS, V48, P425, DOI 10.7589/0090-3558-48.2.425; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Saunders SE, 2008, PRION, V2, P162, DOI 10.4161/pri.2.4.7951; Schramm PT, 2006, REV MINERAL GEOCHEM, V64, P135, DOI 10.2138/rmg.2006.64.5; SCHULTZ SR, 1992, J RANGE MANAGE, V45, P546, DOI 10.2307/4002569; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Sigurdson CJ, 2008, VET RES, V39, DOI 10.1051/vetres:2008018; Smith CB, 2011, J ENVIRON QUAL, V40, P449, DOI 10.2134/jeq2010.0412; Srivastava S, 2017, J BIOL CHEM, V292, P2359, DOI 10.1074/jbc.M116.768010; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; Terry LA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-65; Thompson AK, 2008, J WILDLIFE MANAGE, V72, P416, DOI 10.2193/2006-543; VerCauteren KC, 2007, J WILDLIFE DIS, V43, P784, DOI 10.7589/0090-3558-43.4.784; Waddell L, 2017, TRANSBOUND EMERG DIS, P1; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Wyckoff AC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01885	54	26	26	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196745	10.1371/journal.pone.0196745	http://dx.doi.org/10.1371/journal.pone.0196745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29719000	gold, Green Published, Green Submitted			2022-12-26	WOS:000431281900077
J	Sahibzada, S; Hernandez-Jover, M; Jordan, D; Thomson, PC; Heller, J				Sahibzada, Shafi; Hernandez-Jover, Marta; Jordan, David; Thomson, Peter C.; Heller, Jane			Emergence of highly prevalent CA-MRSA ST93 as an occupational risk in people working on a pig farm in Australia	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; COMMUNITY-ASSOCIATED MRSA; LIVESTOCK-ASSOCIATED MRSA; ANTIMICROBIAL RESISTANCE; CARRIAGE; CONTACT	Background The occurrence of livestock-associated (LA) MRSA (ST398) in pig herds has emerged as a threat to occupational safety in many parts of the world. Recently, an outbreak of skin lesions due to MRSA occurred in workers at a pig farm in regional Australia and both the humans and pigs were shown to have a high prevalence of carriage of either the human-strain ST93 or porcine strain ST398. This study closely scrutinises this outbreak to determine factors associated with MRSA carriage amongst the workers. Methods Information on potential risk factors was collected from employees by means of a questionnaire. The carriage status of MRSA by workers was assessed by nasal swabs processed using standard laboratory techniques with confirmed isolates subjected to sequence typing. Associations between MRSA carriage in workers and their questionnaire responses were investigated using univariable and multivariable logistic regression. Results Nasal carriage of MRSA was identified in 60% (31/52) of participants. Workers having contact with pigs had 24 times the odds of MRSA carriage compared to workers with no direct contact (OR 23.6; CI 5.2-172.8). In addition, the probability of MRSA carriage in workers was significantly (P < 0.001) associated with the number of hours in contact with pigs and each hour of contact-time per day increased the risk of MRSA carriage by 1.44 times (CI 1.14-1.96). These associations were significant (P < 0.001) for both strains, ST398 and ST93, present on this farm. Using a multivariable logistic regression model that incorporated human exposure to five different pig age groups (dry sows, farrowing, weaner, grower, and finisher) as fixed effects, a significant (P = 0.027) increased odds of MRSA carriage was found for persons working with farrowing sows compared with those who did not (OR 6.39, CI 1.23-39.36). Conclusions This study shows that workers in close contact with pigs on a pig farm where MRSA is present had a higher risk of MRSA carriage as the number of hours of direct contact with pigs increased. Since we have detected a significant association for the human-derived CA-MRSA ST93, similar to the pig-adapted LA-MRSA ST398, we consider ST93 as a potential occupational risk for piggery workers. The risk of MRSA carriage is greatest when working with the farrowing group; therefore, an emphasis is required on personal protective equipment while working in the farrowing house. The study has ramifications for the conduct of surveillance for MRSA in people exposed to pigs.	[Sahibzada, Shafi; Hernandez-Jover, Marta; Heller, Jane] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia; [Sahibzada, Shafi; Hernandez-Jover, Marta; Thomson, Peter C.; Heller, Jane] Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; [Jordan, David] New South Wales Dept Primary Ind, Wollongbar, NSW, Australia; [Thomson, Peter C.] Univ Sydney, Sch Life & Environm Sci, Camden, NSW, Australia	Charles Sturt University; NSW Department of Primary Industries; University of Sydney	Sahibzada, S; Heller, J (corresponding author), Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia.; Sahibzada, S; Heller, J (corresponding author), Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia.	sshafiullah@csu.edu.au; jheller@csu.edu.au	Jordan, David/P-7281-2019; Heller, Jane/H-9596-2016; Hernandez-Jover, Marta/F-8688-2016; Thomson, Peter/V-7290-2019; Sahibzada, Shafi/K-1043-2019	Heller, Jane/0000-0003-3993-0160; Thomson, Peter/0000-0003-4428-444X; Sahibzada, Shafi/0000-0001-7362-8323; Hernandez-Jover, Marta/0000-0001-8803-9062	Australian Pork Limited [2015/013]	Australian Pork Limited(Australian Pork Limited)	This study was funded by Australian Pork Limited (Project number 2015/013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2001, ANTIMICROB AGENTS CH, V45, P2054, DOI 10.1128/AAC.45.7.2054-2059.2001; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bisdorff B, 2012, EPIDEMIOL INFECT, V140, P1800, DOI 10.1017/S0950268811002378; Brennan L, 2013, J HOSP INFECT, V83, P205, DOI 10.1016/j.jhin.2012.10.014; Butaye P, 2016, CURR CLIN MICROBIOL, V3, P19, DOI 10.1007/s40588-016-0031-9; Chuang YY, 2015, INT J ANTIMICROB AG, V45, P334, DOI 10.1016/j.ijantimicag.2014.12.007; CLSI, 2014, PERF STAND ANT SUSC; COOMBS GW, 2015, W AUSTR METHICILLIN; Crombe F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00057; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Dorado-Garcia A, 2015, EMERG INFECT DIS, V21, P950, DOI 10.3201/eid2106.140706; Funk JA, 2006, MICROB DRUG RESIST, V12, P210, DOI 10.1089/mdr.2006.12.210; Goerge T, 2017, VET MICROBIOL, V200, P6, DOI 10.1016/j.vetmic.2015.10.027; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Lindsay JA, 2013, INT J MED MICROBIOL, V303, P318, DOI 10.1016/j.ijmm.2013.02.005; Liu WD, 2015, AM J INFECT CONTROL, V43, P469, DOI 10.1016/j.ajic.2014.12.009; Munckhof WJ, 2009, CLIN MICROBIOL INFEC, V15, P149, DOI 10.1111/j.1469-0691.2008.02652.x; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Sahibzada S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04789-0; SARAVOLATZ LD, 1982, ANN INTERN MED, V96, P11, DOI 10.7326/0003-4819-96-1-11; UDO EE, 1993, J HOSP INFECT, V25, P97, DOI 10.1016/0195-6701(93)90100-E; van Cleef BAGL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127190; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Xia GQ, 2014, INFECT GENET EVOL, V21, P593, DOI 10.1016/j.meegid.2013.04.022; Ye XH, 2015, AM J INFECT CONTROL, V43, P676, DOI 10.1016/j.ajic.2015.03.026	30	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195510	10.1371/journal.pone.0195510	http://dx.doi.org/10.1371/journal.pone.0195510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718930	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900019
J	Zhang, J; Hartman, B; Siegel, J; Marchi, G; Clausen-Schaumann, H; Sudhop, S; Huber, HP				Zhang, Jun; Hartman, Bastian; Siegel, Julian; Marchi, Gabriele; Clausen-Schaumann, Hauke; Sudhop, Stefanie; Huber, Heinz P.			Sacrificial-layer free transfer of mammalian cells using near infrared femtosecond laser pulses	PLOS ONE			English	Article							MINIATURIZED BIOSENSORS PREPARATION; EXCIMER-LASER; LIQUIDS; MECHANISMS; DEPOSITION; EJECTION; TISSUES	Laser-induced cell transfer has been developed in recent years for the flexible and gentle printing of cells. Because of the high transfer rates and the superior cell survival rates, this technique has great potential for tissue engineering applications. However, the fact that material from an inorganic sacrificial layer, which is required for laser energy absorption, is usually transferred to the printed target structure, constitutes a major drawback of laser based cell printing. Therefore alternative approaches using deep UV laser sources and protein based acceptor films for energy absorption, have been introduced. Nevertheless, deep UV radiation can introduce DNA double strand breaks, thereby imposing the risk of carcinogenesis. Here we present a method for the laser-induced transfer of hydrogels and mammalian cells, which neither requires any sacrificial material for energy absorption, nor the use of UV lasers. Instead, we focus a near infrared femtosecond (fs) laser pulse (lambda = 1030 nm, 450 fs) directly underneath a thin cell layer, suspended on top of a hydrogel reservoir, to induce a rapidly expanding cavitation bubble in the gel, which generates a jet of material, transferring cells and hydrogel from the gel/cell reservoir to an acceptor stage. By controlling laser pulse energy, well-defined cell-laden droplets can be transferred with high spatial resolution. The transferred human (SCP1) and murine (B16F1) cells show high survival rates, and good cell viability. Time laps microscopy reveals unaffected cell behavior including normal cell proliferation.	[Zhang, Jun; Hartman, Bastian; Siegel, Julian; Huber, Heinz P.] Munich Univ Appl Sci, Laserctr, Lothstr, Munich, Germany; [Zhang, Jun; Hartman, Bastian; Siegel, Julian; Clausen-Schaumann, Hauke; Sudhop, Stefanie; Huber, Heinz P.] Munich Univ Appl Sci, Ctr Appl Tissue Engn & Regenerat Med CANTER, Lothstr, Munich, Germany; [Zhang, Jun; Clausen-Schaumann, Hauke; Sudhop, Stefanie] Univ Munich, Ctr NanoSci, Munich, Germany; [Zhang, Jun] Dept Trauma Surg, Expt Trauma Surg, Franz Josef Strauss Allee, Regensburg, Germany; [Marchi, Gabriele] Munich Univ Appl Sci, Photon Lab, Lothstr, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Huber, HP (corresponding author), Munich Univ Appl Sci, Laserctr, Lothstr, Munich, Germany.; Huber, HP (corresponding author), Munich Univ Appl Sci, Ctr Appl Tissue Engn & Regenerat Med CANTER, Lothstr, Munich, Germany.	heinz.huber@hm.edu	Sudhop, Stefanie/A-2134-2019; Clausen-Schaumann, Hauke/W-1830-2017; Hartmann, Bastian/ABF-1009-2021; Huber, Heinz Paul/AAC-4144-2020	Clausen-Schaumann, Hauke/0000-0002-9413-0310; Hartmann, Bastian/0000-0002-9928-0860; Huber, Heinz Paul/0000-0003-2444-9833; Sudhop, Stefanie/0000-0002-0838-9503	research Focus "Herstellung and biophysikalische Charakterisierung dreidimensionaler Gewebe - CANTER" of the Bavarian State Ministry for Science and Education; Research Focus "Herstellung and biophysikalische Charakterisierung dreidimensionaler Gewebe-CANTER" of the Bavarian State Ministry for Science and Education	research Focus "Herstellung and biophysikalische Charakterisierung dreidimensionaler Gewebe - CANTER" of the Bavarian State Ministry for Science and Education; Research Focus "Herstellung and biophysikalische Charakterisierung dreidimensionaler Gewebe-CANTER" of the Bavarian State Ministry for Science and Education	The authors acknowledge financial support through the research focus "Herstellung and biophysikalische Charakterisierung dreidimensionaler Gewebe CANTER" of the Bavarian State Ministry for Science and Education.; The authors acknowledge technical assistance by Conny Hasselberg-Christoph, and financial support through the Research Focus "Herstellung and biophysikalische Charakterisierung dreidimensionaler Gewebe-CANTER" of the Bavarian State Ministry for Science and Education. Jun Zhang would like to acknowledge the coworkers of the Lasercenter at Munich University of Applied Sciences for valuable discussion on laser technology. Further, the authors thank Matthias Domke for his valuable input at the early stage of our work.	BARNES PA, 1968, APPL PHYS LETT, V13, P282, DOI 10.1063/1.1652611; Barron JA, 2004, THIN SOLID FILMS, V453, P383, DOI 10.1016/j.tsf.2003.11.161; Barron JA, 2004, APPL PHYS A-MATER, V79, P1027, DOI 10.1007/s00339-004-2620-3; Bocker W, 2008, J CELL MOL MED, V12, P1347, DOI [10.1111/j.1582-4934.2008.00299.x, 10.1111/j.1582-4934.2008.0299.x]; BOHANDY J, 1986, J APPL PHYS, V60, P1538, DOI 10.1063/1.337287; Brown MS, 2012, J FLUID MECH, V709, P341, DOI 10.1017/jfm.2012.337; Brown MS, 2010, J APPL PHYS, V107, DOI 10.1063/1.3327432; Caracciolo E, 2016, OPT LETT, V41, P3395, DOI 10.1364/OL.41.003395; Chichkov B., 2014, BIONANOMATERIALS, V15, P71, DOI 10.1515/bnm-2014-0005; Colina M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2191569; Colina M, 2005, BIOSENS BIOELECTRON, V20, P1638, DOI 10.1016/j.bios.2004.08.047; Doraiswamy A, 2006, APPL SURF SCI, V252, P4743, DOI 10.1016/j.apsusc.2005.07.166; Duck F.A., 1990, MED PHYS, V18; Duocastella M, 2010, OPT EXPRESS, V18, P21815, DOI 10.1364/OE.18.021815; Duocastella M, 2010, SENSOR ACTUAT B-CHEM, V145, P596, DOI 10.1016/j.snb.2009.11.055; Duocastella M, 2008, J LASER MICRO NANOEN, V3, P1, DOI 10.2961/jlmn.2008.01.0001; FIDLER IJ, 1975, CANCER RES, V35, P218; Gerstman BS, 1996, LASER SURG MED, V18, P10, DOI 10.1002/(SICI)1096-9101(1996)18:1<10::AID-LSM2>3.0.CO;2-U; Gruene M, 2011, TISSUE ENG PART C-ME, V17, P973, DOI [10.1089/ten.tec.2011.0185, 10.1089/ten.TEC.2011.0185]; Gruene M, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-19; Gudapati H, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035022; Guillemot F, 2010, ACTA BIOMATER, V6, P2494, DOI 10.1016/j.actbio.2009.09.029; Ivanov DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103817; Juhasz T, 1996, LASER SURG MED, V19, P23, DOI 10.1002/(SICI)1096-9101(1996)19:1<23::AID-LSM4>3.3.CO;2-2; Koch L, 2010, TISSUE ENG PART C-ME, V16, P847, DOI [10.1089/ten.tec.2009.0397, 10.1089/ten.TEC.2009.0397]; Lin YF, 2009, J APPL PHYS, V106, DOI 10.1063/1.3202388; LIU JM, 1982, OPT LETT, V7, P196, DOI 10.1364/OL.7.000196; Patrascioiu A, 2014, MICROFLUID NANOFLUID, V16, P55, DOI 10.1007/s10404-013-1218-5; Patrascioiu A, 2011, APPL SURF SCI, V257, P5190, DOI 10.1016/j.apsusc.2010.11.093; Pique A, 1999, APPL PHYS A-MATER, V69, pS279, DOI 10.1007/s003390051400; Raof NA, 2011, BIOMATERIALS, V32, P1802, DOI 10.1016/j.biomaterials.2010.11.015; Rau KR, 2004, APPL PHYS LETT, V84, P2940, DOI 10.1063/1.1705728; Reuten R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13515; Ringeisen BR, 2004, TISSUE ENG, V10, P483, DOI 10.1089/107632704323061843; Schaffer CB, 2000, DYNAMICS FEMTOSECOND; Schiele NR, 2011, TISSUE ENG PART C-ME, V17, P289, DOI [10.1089/ten.tec.2010.0442, 10.1089/ten.TEC.2010.0442]; Schiele NR, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/032001; Serra P, 2004, APPL PHYS LETT, V85, P1639, DOI 10.1063/1.1787614; Serra P, 2006, J LASER MICRO NANOEN, V1, P236, DOI 10.2961/jlmn.2006.03.0017; Tinne N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114437; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; Vogel A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.038102; Wang W, 2009, MSEC 2008: PROCEEDINGS OF THE ASME INTERNATIONAL MANUFACTURING SCIENCE AND ENGINEERING CONFERENCE 2008, VOL 2, P505; Wang W, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2896118; Waynant R., 2002, LASERS MED; Xiong RT, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa74f2	47	10	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195479	10.1371/journal.pone.0195479	http://dx.doi.org/10.1371/journal.pone.0195479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718923	gold, Green Published, Green Submitted			2022-12-26	WOS:000431281900017
J	Hua, L; Zhuo, Y; Jiang, DD; Li, J; Huang, XH; Zhu, YG; Li, Z; Yan, LJ; Jin, C; Jiang, XM; Che, LQ; Fang, ZF; Lin, Y; Xu, SY; Li, J; Feng, B; Wu, D				Hua, Lun; Zhuo, Yong; Jiang, Dandan; Li, Jing; Huang, Xiaohua; Zhu, Yingguo; Li, Zhen; Yan, Lijun; Jin, Chao; Jiang, Xuemei; Che, Lianqiang; Fang, Zhengfeng; Lin, Yan; Xu, Shengyu; Li, Jian; Feng, Bin; Wu, De			Identification of hepatic fibroblast growth factor 21 as a mediator in 17-estradiol-induced white adipose tissue browning	FASEB JOURNAL			English	Article						FGF21; E2; ER; mTOR	ESTROGEN-RECEPTOR-ALPHA; DIETARY-PROTEIN DILUTION; SKELETAL-MUSCLE; INDUCED OBESITY; SEX-DIFFERENCES; FEMALE MICE; FGF21; LIVER; METABOLISM; ACTIVATION	Both ovarian E2 and hepatic fibroblast growth factor 21 (FGF21) are critical for energy homeostasis and white adipose tissue browning. Estrogen receptor (ER) is abundantly expressed in liver. However, whether FGF21 has a role in E2-induced white adipose tissue browning remains uncertain. In this study, we showed that hepatic Fgf21 expression and secretion during estrus cycle changed with the tetradian oscillatory secretion of circulation E2 in adult, female mice, with their peak expressions and secretions at the proestrus. In addition, exogenous E2 robustly stimulated liver Fgf21 expression and elevated serum FGF21 concentrations, which induced browning gene expression and reduced the tissue weight in subcutaneous white adipose in mice with ovariectomies. The inhibitor of mammalian target of rapamycin (mTOR) and of ER blocked the induction effect of E2 on the expression of Fgf21 in primary hepatocytes, which revealed that E2 might stimulate FGF21 expression via the ER-mTOR pathway. Furthermore, FGF21 liver-specific deficiency abolished E2-induced white adipose browning in mice with ovariectomies. This study indicates that ovarian E2 increased liver FGF21 expression directly, which in turn, functioned as an endocrine signal to influence inguinal white adipose tissue browning.Hua, L., Zhuo, Y., Jiang, D., Li, J., Huang, X., Zhu, Y., Li, Z., Yan, L., Jin, C., Jiang, X., Che, L., Fang, Z., Lin, Y., Xu, S., Li, J., Feng, B., Wu, D. Identification of hepatic fibroblast growth factor 21 as a mediator in 17-estradiol-induced white adipose tissue browning.	[Hua, Lun; Zhuo, Yong; Jiang, Dandan; Li, Jing; Huang, Xiaohua; Zhu, Yingguo; Li, Zhen; Yan, Lijun; Jin, Chao; Jiang, Xuemei; Che, Lianqiang; Fang, Zhengfeng; Lin, Yan; Xu, Shengyu; Li, Jian; Feng, Bin; Wu, De] Sichuan Agr Univ, Minist Educ China, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China; [Hua, Lun; Zhuo, Yong; Jiang, Dandan; Li, Jing; Huang, Xiaohua; Zhu, Yingguo; Li, Zhen; Yan, Lijun; Jin, Chao; Jiang, Xuemei; Che, Lianqiang; Fang, Zhengfeng; Lin, Yan; Li, Jian; Feng, Bin; Wu, De] Sichuan Agr Univ, Minist Educ China, Key Lab Anim Dis Resistant Nutr, Chengdu, Sichuan, Peoples R China	Ministry of Education, China; Sichuan Agricultural University; Ministry of Education, China; Sichuan Agricultural University	Feng, B; Wu, D (corresponding author), Sichuan Agr Univ, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China.	fengbin@sicau.edu.cn; wude@sicau.edu.cn	Feng, Bin/GLU-0109-2022; Xu, Shengyu/AFN-8288-2022; FENG, BIN/E-9505-2017	Xu, Shengyu/0000-0002-4415-8542; FENG, BIN/0000-0001-6258-2729; Huang, Xiaohua/0000-0003-4150-0477	National Natural Science Foundation of China [31772616]; 1000 Talent Program from the Sichuan Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 1000 Talent Program from the Sichuan Province	This work was supported by the National Natural Science Foundation of China (Grant 31772616) to D.W. B.F. was a recipient of the 1000 Talent Program from the Sichuan Province. The funders had no role in the design, analysis, or writing of this article. The authors declare no conflicts of interest.	BonDurant LD, 2017, CELL METAB, V25, P935, DOI 10.1016/j.cmet.2017.03.005; Chapnik N, 2017, J NUTR BIOCHEM, V40, P116, DOI 10.1016/j.jnutbio.2016.10.017; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Ciana P, 2003, NAT MED, V9, P82, DOI 10.1038/nm809; Cyphert HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094996; Della Torre S, 2017, CELL METAB, V25, P499, DOI 10.1016/j.cmet.2017.01.006; Della Torre S, 2016, CELL REP, V15, P360, DOI 10.1016/j.celrep.2016.03.019; Della Torre S, 2011, CELL METAB, V13, P205, DOI 10.1016/j.cmet.2011.01.002; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Feng B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081710; Feng B, 2014, DIABETES, V63, P2924, DOI 10.2337/db14-0066; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Fortress AM, 2013, LEARN MEMORY, V20, P147, DOI 10.1101/lm.026732.112; Frank AP, 2018, PHYSIOL BEHAV, V187, P24, DOI 10.1016/j.physbeh.2017.09.026; Guridi M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3715; Hart-Unger S, 2017, INT J OBESITY, V41, P945, DOI 10.1038/ijo.2017.50; Keipert S, 2015, MOL METAB, V4, P537, DOI 10.1016/j.molmet.2015.04.006; Kim JH, 2014, MOL METAB, V3, P177, DOI 10.1016/j.molmet.2013.12.009; Laeger T, 2016, CELL REP, V16, P707, DOI 10.1016/j.celrep.2016.06.044; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Larson KR, 2017, ENDOCRINOLOGY, V158, P3477, DOI 10.1210/en.2017-00331; Maida A, 2016, J CLIN INVEST, V126, P3263, DOI 10.1172/JCI85946; de Morentin PBM, 2014, CELL METAB, V20, P41, DOI 10.1016/j.cmet.2014.03.031; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; Mitra S, 2016, FRONT BEHAV NEUROSCI, V10, DOI [10.3389/fnbeh.2016.00244, 10.3389/fnbeh.2016.00215]; Olofsson LE, 2009, P NATL ACAD SCI USA, V106, P15932, DOI 10.1073/pnas.0904747106; Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012; Prossnitz ER, 2007, MOL CELL ENDOCRINOL, V265, P138, DOI 10.1016/j.mce.2006.12.010; Ribas V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3815; Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405; Shimizu N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7693; Singhal G, 2016, MOL METAB, V5, P690, DOI 10.1016/j.molmet.2016.05.010; Solon-Biet SM, 2016, CELL METAB, V24, P555, DOI 10.1016/j.cmet.2016.09.001; Song P., 2018, CELL METAB; Torres MJ, 2018, CELL METAB, V27, P167, DOI 10.1016/j.cmet.2017.10.003; Villa A, 2012, P NATL ACAD SCI USA, V109, P11806, DOI 10.1073/pnas.1205797109; Wanders D, 2017, DIABETES, V66, P858, DOI 10.2337/db16-1212; Weigt C, 2012, MOL CELL ENDOCRINOL, V351, P227, DOI 10.1016/j.mce.2011.12.013	41	19	19	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5602	5611		10.1096/fj.201800240R	http://dx.doi.org/10.1096/fj.201800240R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29718710				2022-12-26	WOS:000447972500033
J	Persson, A; Toledo, AG; Vorontsov, E; Nasir, W; Willen, D; Noborn, F; Ellervik, U; Mani, K; Nilsson, J; Larson, G				Persson, Andrea; Toledo, Alejandro Gomez; Vorontsov, Egor; Nasir, Waqas; Willen, Daniel; Noborn, Fredrik; Ellervik, Ulf; Mani, Katrin; Nilsson, Jonas; Larson, Goran			LC-MS/MS characterization of xyloside-primed glycosaminoglycans with cytotoxic properties reveals structural diversity and novel glycan modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; chondroitin sulfate; dermatan sulfate; glycosaminoglycan; mass spectrometry (MS); glycan structure; xyloside	PROTEIN LINKAGE REGION; HEPARAN-SULFATE OLIGOSACCHARIDES; ELECTROSPRAY MASS-SPECTROMETRY; BETA-D-XYLOSIDES; CHONDROITIN SULFATE; HNK-1 SULFOTRANSFERASE; COMPOSITIONAL ANALYSIS; LIQUID-CHROMATOGRAPHY; KERATAN SULFATE; CULTURED-CELLS	Structural characterization of glycosaminoglycans remains a challenge but is essential for determining structure-function relationships between glycosaminoglycans and the biomolecules with which they interact and for gaining insight into the biosynthesis of glycosaminoglycans. We have recently reported that xyloside-primed chondroitin/dermatan sulfate derived from a human breast carcinoma cell line, HCC70, has cytotoxic effects and shown that it differs in disaccharide composition from nontoxic chondroitin/dermatan sulfate derived from a human breast fibroblast cell line, CCD-1095Sk. To further investigate the structural requirements for the cytotoxic effect, we developed a novel LC-MS/MS approach based on reversed-phase dibutylamine ion-pairing chromatography and negative-mode higher-energy collision dissociation and used it in combination with cell growth studies and disaccharide fingerprinting. This strategy enabled detailed structural characterization of linkage regions, internal oligosaccharides, and nonreducing ends, revealing not only differences between xyloside-primed chondroitin/dermatan sulfate from HCC70 cells and CCD-1095Sk cells, but also sialylation of the linkage region and previously undescribed methylation and sulfation of the nonreducing ends. Although the xyloside-primed chondroitin/dermatan sulfate from HCC70 cells was less complex in terms of presence and distribution of iduronic acid than that from CCD-1095Sk cells, both glucuronic acid and iduronic acid appeared to be essential for the cytotoxic effect. Our data have moved us one step closer to understanding the structure of the cytotoxic chondroitin/dermatan sulfate from HCC70 cells primed on xylosides and demonstrate the suitability of the LC-MS/MS approach for structural characterization of glycosaminoglycans.	[Persson, Andrea; Mani, Katrin] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden; [Persson, Andrea; Toledo, Alejandro Gomez; Nasir, Waqas; Noborn, Fredrik; Nilsson, Jonas; Larson, Goran] Univ Gothenburg, Dept Clin Chem & Transfus Med, SE-41345 Gothenburg, Sweden; [Vorontsov, Egor] Univ Gothenburg, Sahlgrenska Acad, Prote Core Facil, SE-40530 Gothenburg, Sweden; [Willen, Daniel; Ellervik, Ulf] Lund Univ, Ctr Chem & Chem Engn, Ctr Anal & Synth, SE-22100 Lund, Sweden	Lund University; University of Gothenburg; University of Gothenburg; Lund University	Larson, G (corresponding author), Univ Gothenburg, Dept Clin Chem & Transfus Med, SE-41345 Gothenburg, Sweden.	goran.larson@clinchem.gu.se	Larson, Göran/AAF-3404-2019	Mani, Katrin/0000-0002-1821-0634	Fund of the Hedda and John Forssman Foundation, Lund University; Medical Faculty at Lund University; Swedish Cancer Society [17 0255]; Swedish Research Council [K2014-68X-08266-27-4, K2015-66X-22693-01-4]; Ahlen Foundation	Fund of the Hedda and John Forssman Foundation, Lund University; Medical Faculty at Lund University; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ahlen Foundation	This work was supported by Governmental grants to the Sahlgrenska University Hospital, Gothenburg, the Fund of the Hedda and John Forssman Foundation, Lund University, the Medical Faculty at Lund University, Swedish Cancer Society Grant 17 0255 (to K. M.), Swedish Research Council Grants K2014-68X-08266-27-4 (to G. L.) and K2015-66X-22693-01-4 (to K. M.), and the Ahlen Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chua JS, 2017, ACCOUNTS CHEM RES, V50, P2693, DOI 10.1021/acs.accounts.7b00289; COSTER L, 1991, BIOCHEM J, V276, P533, DOI 10.1042/bj2760533; Desaire H, 2000, J AM SOC MASS SPECTR, V11, P916, DOI 10.1016/S1044-0305(00)00168-9; DICKENSON JM, 1990, BIOCHEM J, V269, P55, DOI 10.1042/bj2690055; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; FREEZE HH, 1993, J BIOL CHEM, V268, P1618; FRITZ TA, 1994, J BIOL CHEM, V269, P300; Hashiguchi T, 2011, J BIOL CHEM, V286, P33003, DOI 10.1074/jbc.M111.279174; HOPWOOD JJ, 1974, BIOCHEM J, V141, P57, DOI 10.1042/bj1410057; Kamhi E, 2013, BIOL REV, V88, P928, DOI 10.1111/brv.12034; Kitagawa H, 2008, J BIOL CHEM, V283, P27438, DOI 10.1074/jbc.M803279200; Koike T, 2014, J BIOL CHEM, V289, P6695, DOI 10.1074/jbc.M113.520536; Kuberan B, 2002, J AM CHEM SOC, V124, P8707, DOI 10.1021/ja0178867; Laremore TN, 2010, BIOCHEM J, V431, P199, DOI 10.1042/BJ20100788; Lawrence R, 2004, GLYCOBIOLOGY, V14, P467, DOI 10.1093/glycob/cwh057; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Li GY, 2015, ACS CHEM BIOL, V10, P1303, DOI 10.1021/acschembio.5b00011; LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; Malmstrom A, 2012, J HISTOCHEM CYTOCHEM, V60, P916, DOI 10.1369/0022155412459857; Mani K, 1998, CANCER RES, V58, P1099; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Miller RL, 2017, ANAL CHEM, V89, P8942, DOI 10.1021/acs.analchem.7b01417; Miller RL, 2015, EUR J MASS SPECTROM, V21, P245, DOI 10.1255/ejms.1337; Nakagawa N, 2011, BIOCHEM BIOPH RES CO, V415, P109, DOI 10.1016/j.bbrc.2011.10.023; Nasir W, 2016, J PROTEOME RES, V15, P2826, DOI 10.1021/acs.jproteome.6b00417; Nilsson J, 2017, J AM SOC MASS SPECTR, V28, P229, DOI 10.1007/s13361-016-1539-1; Noborn F, 2015, MOL CELL PROTEOMICS, V14, P41, DOI 10.1074/mcp.M114.043703; OKAYAMA M, 1973, J BIOCHEM-TOKYO, V74, P1069; OTSU K, 1985, BIOCHEM J, V227, P37, DOI 10.1042/bj2270037; Otsuka Y, 2018, ANAL CHEM, V90, P5201, DOI 10.1021/acs.analchem.7b05438; Palaniappan KK, 2016, CHEM REV, V116, P14277, DOI 10.1021/acs.chemrev.6b00023; Persson A, 2016, J BIOL CHEM, V291, P14871, DOI 10.1074/jbc.M116.716829; Plaas AHK, 1997, J BIOL CHEM, V272, P20603, DOI 10.1074/jbc.272.33.20603; Prydz K, 2015, BIOMOLECULES, V5, P2003, DOI 10.3390/biom5032003; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; SALIMATH PV, 1995, J BIOL CHEM, V270, P9164, DOI 10.1074/jbc.270.16.9164; SCHWARTZ NB, 1974, P NATL ACAD SCI USA, V71, P4047, DOI 10.1073/pnas.71.10.4047; Skidmore MA, 2010, NAT PROTOC, V5, P1983, DOI 10.1038/nprot.2010.145; Stachtea XN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140279; SUGAHARA K, 1991, EUR J BIOCHEM, V202, P805, DOI 10.1111/j.1432-1033.1991.tb16436.x; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Thanawiroon C, 2004, J BIOL CHEM, V279, P2608, DOI 10.1074/jbc.M304772200; Toledo AG, 2015, MOL CELL PROTEOMICS, V14, P3118, DOI 10.1074/mcp.M115.051136; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Vassal-Stermann E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047933; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Volpi N, 2014, NAT PROTOC, V9, P541, DOI 10.1038/nprot.2014.026; Wen JZ, 2014, P NATL ACAD SCI USA, V111, P15723, DOI 10.1073/pnas.1417993111; WESTERGRENTHORSSON G, 1991, J CELL PHYSIOL, V147, P523, DOI 10.1002/jcp.1041470319; Wolff JJ, 2008, J AM SOC MASS SPECTR, V19, P294, DOI 10.1016/j.jasms.2007.10.007; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yu YL, 2017, J AM CHEM SOC, V139, P16986, DOI 10.1021/jacs.7b10164; Zaia J, 2001, ANAL CHEM, V73, P233, DOI 10.1021/ac000777a; Zaia J, 2003, ANAL CHEM, V75, P2445, DOI 10.1021/ac0263418; Zhao X, 2013, J BIOL CHEM, V288, P9226, DOI 10.1074/jbc.M112.437236	60	11	11	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10202	10219		10.1074/jbc.RA118.002971	http://dx.doi.org/10.1074/jbc.RA118.002971			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29739851	Green Published, hybrid			2022-12-26	WOS:000437096700021
J	Wu, CY; Satapati, S; Gui, WJ; Wynn, RM; Sharma, G; Lou, ML; Qi, XB; Burgess, SC; Malloy, C; Khemtong, C; Sherry, AD; Chuang, DT; Merritt, ME				Wu, Cheng-Yang; Satapati, Santhosh; Gui, Wenjun; Wynn, R. Max; Sharma, Gaurav; Lou, Mingliang; Qi, Xiangbing; Burgess, Shawn C.; Malloy, Craig; Khemtong, Chalermchai; Sherry, A. Dean; Chuang, David T.; Merritt, Matthew E.			A novel inhibitor of pyruvate dehydrogenase kinase stimulates myocardial carbohydrate oxidation in diet-induced obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pyruvate dehydrogenase complex (PDC); cardiomyopathy; nuclear magnetic resonance (NMR); diabetes; glucose metabolism; drug development; intermediary metabolism; fatty acid oxidation; mitochondria; hyperpolarization	CITRIC-ACID CYCLE; C-13 NMR-SPECTROSCOPY; DIABETIC CARDIOMYOPATHY; RAT-HEART; ISOTOPOMER ANALYSIS; MAGNETIC-RESONANCE; GLUCOSE-OXIDATION; CARBON FLUX; DICHLOROACETATE; METABOLISM	The pyruvate dehydrogenase complex (PDC) is a key control point of energy metabolism and is subject to regulation by multiple mechanisms, including posttranslational phosphorylation by pyruvate dehydrogenase kinase (PDK). Pharmacological modulation of PDC activity could provide a new treatment for diabetic cardiomyopathy, as dysregulated substrate selection is concomitant with decreased heart function. Dichloroacetate (DCA), a classic PDK inhibitor, has been used to treat diabetic cardiomyopathy, but the lack of specificity and side effects of DCA indicate a more specific inhibitor of PDK is needed. This study was designed to determine the effects of a novel and highly selective PDK inhibitor, 2((2,4-dihydroxyphenyl)sulfonyl) isoindoline-4,6-diol (designated PS10), on pyruvate oxidation in diet-induced obese (DIO) mouse hearts compared with DCA-treated hearts. Four groups of mice were studied: lean control, DIO, DIO + DCA, and DIO + PS10. Both DCA and PS10 improved glucose tolerance in the intact animal. Pyruvate metabolism was studied in perfused hearts supplied with physiological mixtures of long chain fatty acids, lactate, and pyruvate. Analysis was performed using conventional H-1 and C-13 isotopomer methods in combination with hyperpolarized [1-C-13]pyruvate in the same hearts. PS10 and DCA both stimulated flux through PDC as measured by the appearance of hyperpolarized [C-13]bicarbonate. DCA but not PS10 increased hyperpolarized [1-C-13]lactate production. Total carbohydrate oxidation was reduced in DIO mouse hearts but increased by DCA and PS10, the latter doing so without increasing lactate production. The present results suggest that PS10 is a more suitable PDK inhibitor for treatment of diabetic cardiomyopathy.	[Wu, Cheng-Yang; Gui, Wenjun; Wynn, R. Max; Chuang, David T.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wu, Cheng-Yang; Satapati, Santhosh; Sharma, Gaurav; Burgess, Shawn C.; Malloy, Craig; Khemtong, Chalermchai; Sherry, A. Dean] Univ Texas Southwestern Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Wynn, R. Max; Malloy, Craig; Chuang, David T.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Malloy, Craig; Khemtong, Chalermchai; Sherry, A. Dean] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Sherry, A. Dean] Univ Texas Dallas, Dept Chem, Richardson, TX 75080 USA; [Merritt, Matthew E.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Lou, Mingliang; Qi, Xiangbing] Natl Inst Biol Sci, Chem Ctr, Beijing 102206, Peoples R China; [Lou, Mingliang; Qi, Xiangbing] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; State University System of Florida; University of Florida; National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Chuang, DT (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Merritt, ME (corresponding author), 1200 Newell Dr,R3-266B, Gainesville, FL 32610 USA.	david.chuang@utsouthwestern.edu; matthewmerritt@ufl.edu	Sharma, Gaurav/L-3259-2018; qi, xiangbing/A-4043-2019; Sherry, Dean/P-2348-2018	Sharma, Gaurav/0000-0002-1754-7163; Wynn, Richard/0000-0002-1879-2136; qi, xiangbing/0000-0002-7139-5164; Sherry, Dean/0000-0001-7150-8301; Wu, Cheng-Yang/0000-0002-3582-083X; Merritt, Matthew/0000-0003-4617-9651; Malloy, Craig/0000-0001-5077-0642	National Institutes of Health [DK62306, R37-HL034557, P41-EB015908, R01s DK105346, HD087306, DK112865, P41122698, U24DK097209]; Welch Foundation [I-1286, I-1804]; NSF [DMR 1644779]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD087306] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097209, R01DK062306, R56DK062306, R01DK105346, R01DK078184, R01DK112865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM122698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK62306, R37-HL034557, and P41-EB015908 and by Welch Foundation Grants I-1286 and I-1804. This work was also supported by National Institutes of Health Grants R01s DK105346, HD087306, DK112865, P41122698, and U24DK097209 and by NSF DMR 1644779 (to M.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Bersin RM, 1997, AM HEART J, V134, P841, DOI 10.1016/S0002-8703(97)80007-5; Bull RJ, 2000, ENVIRON HEALTH PERSP, V108, P241, DOI 10.1289/ehp.00108s2241; Chatham JC, 1999, CARDIOVASC RES, V43, P96, DOI 10.1016/S0008-6363(99)00056-5; Cunningham CH, 2016, CIRC RES, V119, P1177, DOI 10.1161/CIRCRESAHA.116.309769; Du XL, 2006, J CLIN INVEST, V116, P1071, DOI 10.1172/JCI23354; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Fukushima A, 2016, BBA-MOL CELL BIOL L, V1861, P1525, DOI 10.1016/j.bbalip.2016.03.020; GARVEY WT, 1993, AM J PHYSIOL, V264, pH837, DOI 10.1152/ajpheart.1993.264.3.H837; Hall JL, 1996, AM J PHYSIOL-HEART C, V271, pH2320, DOI 10.1152/ajpheart.1996.271.6.H2320; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Jones HB, 2014, TOXICOL PATHOL, V42, P1250, DOI 10.1177/0192623314530195; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; KUO TH, 1985, DIABETES, V34, P1075, DOI 10.2337/diabetes.34.11.1075; LAPIDOT A, 1994, J BIOL CHEM, V269, P27198; Le Page LM, 2015, DIABETES, V64, P2735, DOI 10.2337/db14-1560; Lei B, 2004, J MOL CELL CARDIOL, V36, P567, DOI 10.1016/j.yjmcc.2004.02.004; Lopaschuk GD, 1997, CIRCULATION, V95, P313; MALLOY CR, 1990, AM J PHYSIOL, V259, pH987, DOI 10.1152/ajpheart.1990.259.3.H987; MALLOY CR, 1990, BIOCHEMISTRY-US, V29, P6756, DOI 10.1021/bi00481a002; Malloy CR, 1996, MAGN RESON MATER PHY, V4, P35, DOI 10.1007/BF01759778; MALLOY CR, 1987, FEBS LETT, V212, P58, DOI 10.1016/0014-5793(87)81556-9; MALLOY CR, 1988, J BIOL CHEM, V263, P6964; Mayers RM, 2003, BIOCHEM SOC T, V31, P1165; Merritt ME, 2007, P NATL ACAD SCI USA, V104, P19773, DOI 10.1073/pnas.0706235104; MJOS OD, 1971, J CLIN INVEST, V50, P1386, DOI 10.1172/JCI106621; Moreno KX, 2010, AM J PHYSIOL-HEART C, V298, pH1556, DOI 10.1152/ajpheart.00656.2009; Nakayama H, 2001, JPN CIRC J, V65, P783, DOI 10.1253/jcj.65.783; Purmal C, 2014, AM J PHYSIOL-HEART C, V307, pH1134, DOI 10.1152/ajpheart.00407.2014; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; REGAN TJ, 1977, J CLIN INVEST, V60, P885, DOI 10.1172/JCI108843; RIBES G, 1979, DIABETES, V28, P852, DOI 10.2337/diab.28.9.852; RUSSELL RR, 1991, AM J PHYSIOL, V261, pH1756, DOI 10.1152/ajpheart.1991.261.6.H1756; Schroeder MA, 2009, FASEB J, V23, P2529, DOI 10.1096/fj.09-129171; SHERRY AD, 1992, BIOCHEMISTRY-US, V31, P4833, DOI 10.1021/bi00135a014; STACPOOLE PW, 1990, FUND APPL TOXICOL, V14, P327, DOI 10.1016/0272-0590(90)90212-3; Standl E, 2016, CIRC RES, V118, P1830, DOI 10.1161/CIRCRESAHA.116.306924; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Sugden MC, 2000, J ENDOCRINOL, V167, P339, DOI 10.1677/joe.0.1670339; SUNDQVIST KE, 1989, BIOCHEM J, V257, P913, DOI 10.1042/bj2570913; Taegtmeyer H, 2013, AM J PHYSIOL-HEART C, V305, pH1693, DOI 10.1152/ajpheart.00854.2012; Tso SC, 2014, J BIOL CHEM, V289, P4432, DOI 10.1074/jbc.M113.533885; WELLS PG, 1980, DIABETOLOGIA, V19, P109, DOI 10.1007/BF00421855; WHITEHOUSE S, 1973, BIOCHEM J, V134, P651, DOI 10.1042/bj1340651; Wu CY, 2018, MOL METAB, V12, P12, DOI 10.1016/j.molmet.2018.03.014; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200; Yazaki Y, 1999, HEART, V81, P153, DOI 10.1136/hrt.81.2.153; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007	51	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9604	9613		10.1074/jbc.RA118.002838	http://dx.doi.org/10.1074/jbc.RA118.002838			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29739849	Green Published, hybrid			2022-12-26	WOS:000436102300005
J	Evanson, NK; Guilhaume-Correa, F; Herman, JP; Goodman, MD				Evanson, Nathan K.; Guilhaume-Correa, Fernanda; Herman, James P.; Goodman, Michael D.			Optic tract injury after closed head traumatic brain injury in mice: A model of indirect traumatic optic neuropathy	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; ENGINEERED ROTATIONAL ACCELERATION; AXONAL INJURY; MOUSE MODEL; NEURONAL DEGENERATION; IMPACT MODEL; FLUORO-JADE; NERVE; DEFICITS; MICROGLIA	Adult male C57BL/6J mice have previously been reported to have motor and memory deficits after experimental closed head traumatic brain injury (TBI), without associated gross pathologic damage or neuroimaging changes detectable by magnetic resonance imaging or diffusion tensor imaging protocols. The presence of neurologic deficits, however, suggests neural damage or dysfunction in these animals. Accordingly, we undertook a histologic analysis of mice after TBI. Gross pathology and histologic analysis using Nissl stain and NeuN immunohistochemistry demonstrated no obvious tissue damage or neuron loss. However, Luxol Fast Blue stain revealed myelin injury in the optic tract, while Fluoro Jade B and silver degeneration staining revealed evidence of axonal neurodegeneration in the optic tract as well as the lateral geniculate nucleus of the thalamus and superior colliculus (detectable at 7 days, but not 24 hours, after injury). Fluoro Jade B staining was not detectable in other white matter tracts, brain regions or in cell somata. In addition, there was increased GFAP staining in these optic tract, lateral geniculate, and superior colliculus 7 days post-injury, and morphologic changes in optic tract microglia that were detectable 24 hours after injury but were more prominent 7 days post-injury. Interestingly, there were no findings of degeneration or gliosis in the suprachiasmatic nucleus, which is also heavily innervated by the optic tract. Using micro-computed tomography imaging, we also found that the optic canal appears to decrease in diameter with a dorsal-ventral load on the skull, which suggests that the optic canal may be the site of injury. These results suggest that there is axonal degeneration in the optic tract and a subset of directly innervated areas, with associated neuroinflammation and astrocytosis, which develop within 7 days of injury, and also suggest that this weight drop injury may be a model for studying indirect traumatic optic neuropathy.	[Evanson, Nathan K.; Guilhaume-Correa, Fernanda] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, Cincinnati, OH 45229 USA; [Evanson, Nathan K.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45220 USA; [Herman, James P.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA; [Goodman, Michael D.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Evanson, NK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, Cincinnati, OH 45229 USA.; Evanson, NK (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati, OH 45220 USA.	nathan.evason@cchmc.org		Guilhaume Correa, Fernanda/0000-0002-3878-5283; Evanson, Nathan/0000-0003-2474-9764	National Institutes of Health - Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD001097]; Cincinnati Children's Hospital Medical Center Division of Pediatric Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001097] Funding Source: NIH RePORTER	National Institutes of Health - Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Cincinnati Children's Hospital Medical Center Division of Pediatric Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by National Institutes of Health - Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov), grant HD001097 (NE) and by the Cincinnati Children's Hospital Medical Center Division of Pediatric Rehabilitation Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Baron JC, 2014, J CEREBR BLOOD F MET, V34, P2, DOI 10.1038/jcbfm.2013.188; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; Cui Q, 2015, NEUROSCIENCE, V284, P845, DOI 10.1016/j.neuroscience.2014.11.002; Dennis EL, 2017, NEUROLOGY, V88, P1392, DOI 10.1212/WNL.0000000000003808; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Dharmarajan S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0855-0; Ellis MJ, 2016, CURR SPORT MED REP, V15, P27, DOI 10.1249/JSR.0000000000000223; Ellis MU, 2016, J NEUROTRAUM, V33, P990, DOI 10.1089/neu.2015.4023; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Erskine L, 2014, ASN NEURO, V6, DOI 10.1177/1759091414562107; Finkelstein E, 2006, INCIDENCE EC BURDEN, Vxiii; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Garman RH, 2011, TOXICOL PATHOL, V39, P22, DOI 10.1177/0192623310389621; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GROSS CE, 1981, J NEUROSURG, V55, P963, DOI 10.3171/jns.1981.55.6.0963; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LAWRENCE PM, 2014, J COMP NEUROL, V522, P3733, DOI DOI 10.1002/CNE.23635; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Martersteck EM, 2017, CELL REP, V18, P2058, DOI 10.1016/j.celrep.2017.01.075; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Ohlsson M, 2003, J NEUROTRAUM, V20, P895, DOI 10.1089/089771503322385827; Patel VC, 2017, EXP NEUROL, V289, P85, DOI 10.1016/j.expneurol.2016.12.012; Pilati N, 2008, J HISTOCHEM CYTOCHEM, V56, P539, DOI 10.1369/jhc.2008.950246; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Rizzo JR, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00227; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shin SS, 2017, BRAIN IMAGING BEHAV, V11, P591, DOI 10.1007/s11682-017-9684-0; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Singman EL, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0069-2; Steinsapir K D, 1999, Curr Opin Ophthalmol, V10, P340, DOI 10.1097/00055735-199910000-00011; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Tao WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12225-6; Tzekov R, 2016, BRAIN INJURY, V30, P1428, DOI 10.1080/02699052.2016.1219062; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Xu LY, 2015, EXP NEUROL, V273, P168, DOI 10.1016/j.expneurol.2015.08.014; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; You YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052061; Zhang SD, 2009, BRAIN RES, V1303, P131, DOI 10.1016/j.brainres.2009.09.029	64	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197346	10.1371/journal.pone.0197346	http://dx.doi.org/10.1371/journal.pone.0197346			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746557	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700105
J	Lomet, D; Piegu, B; Wood, SH; Dardente, H				Lomet, Didier; Piegu, Benoit; Wood, Shona H.; Dardente, Hugues			Anti-angiogenic VEGFAxxxb transcripts are not expressed in the medio-basal hypothalamus of the seasonal sheep	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; THYROID-HORMONE; VEGF; ISOFORMS; VEGF(165)B; BEVACIZUMAB; BIOLOGY	This study investigated Vegfa expression in the pars tuberalis (PT) of the pituitary and medio-basal hypothalamus (MBH) of sheep, across seasons and reproductive states. It has recently been proposed that season impacts alternative splicing of Vegfa mRNA in the PT, which shifts the balance between angiogenic VEGFAxxx and anti-angiogenic VEGFAxxxb isoforms (with xxx the number of amino acids of the mature VEGFA proteins) to modulate seasonal breeding. Here, we used various RT-PCR methodologies and analysis of RNAseq datasets to investigate seasonal variation in expression and splicing of the ovine Vegfa gene. Collectively, we identify 5 different transcripts for Vegfa within the ewe PT/MBH, which correspond to splicing events previously described in mouse and human. All identified transcripts encode angiogenic VEGFAxxx isoforms, with no evidence for alternative splicing within exon 8. These findings led us to investigate in detail how "Vegfaxxxb-like" PCR products could be generated by RT-PCR and misidentified as endogenous transcripts, in sheep and human HEK293 cells. In conclusion, our findings do not support the existence of antiangiogenic VEGFAxxxb isoforms in the ovine PT/MBH and shed new light on the interpretation of prior studies, which claimed to identify Vegfaxxxb isoforms by RT-PCR.	[Lomet, Didier; Piegu, Benoit; Dardente, Hugues] Univ Tours, PRC, INRA, CNRS,IFCE, Nouzilly, France; [Wood, Shona H.] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway	Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Tours; UiT The Arctic University of Tromso	Dardente, H (corresponding author), Univ Tours, PRC, INRA, CNRS,IFCE, Nouzilly, France.	hugues.dardente@inra.fr	DARDENTE, Hugues/ABI-5590-2020; Wood, Shona/I-4175-2017	DARDENTE, Hugues/0000-0001-7209-5940; Wood, Shona/0000-0002-8273-4045	Career Integration Grant from the FP7-Marie-Curie actions [320553]	Career Integration Grant from the FP7-Marie-Curie actions	This work was supported by a Career Integration Grant (No 320553) from the FP7-Marie-Curie actions.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Artac RA, 2009, BIOL REPROD, V81, P978, DOI 10.1095/biolreprod.109.078097; Barrett P, 2007, ENDOCRINOLOGY, V148, P3608, DOI 10.1210/en.2007-0316; Bates DO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068399; Bates DO, 2002, CANCER RES, V62, P4123; Bevan HS, 2008, NEPHRON PHYSIOL, V110, P57, DOI 10.1159/000177614; Bridgett S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00100-3; Castle-Miller J, 2017, P NATL ACAD SCI USA, V114, pE2514, DOI 10.1073/pnas.1618917114; Catena R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-320; Dardente H, 2015, CURR BIOL, V25, pR988, DOI 10.1016/j.cub.2015.09.002; Dardente H, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00019; Dardente H, 2010, CURR BIOL, V20, P2193, DOI 10.1016/j.cub.2010.10.048; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dokun AO, 2011, CIRC RES, V109, P246, DOI 10.1161/CIRCRESAHA.111.249953; Ergorul C, 2008, MOL VIS, V14, P1517; Eswarappa SM, 2014, CELL, V157, P1605, DOI 10.1016/j.cell.2014.04.033; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gustafsson T, 2005, J APPL PHYSIOL, V98, P2137, DOI 10.1152/japplphysiol.01402.2004; Guyot M, 2017, ONCOTARGET, V8, P9174, DOI 10.18632/oncotarget.13942; Guyot Melanie, 2015, Methods Mol Biol, V1332, P3, DOI 10.1007/978-1-4939-2917-7_1; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Harris S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035231; Ikegami K, 2014, CELL REP, V9, P801, DOI 10.1016/j.celrep.2014.10.006; Jabbour HN, 1997, MOL CELL ENDOCRINOL, V134, P91, DOI 10.1016/S0303-7207(97)00158-5; KARSCH FJ, 1984, RECENT PROG HORM RES, V40, P185; Lomet D, 2018, CELL MOL LIFE SCI, V75, P905, DOI 10.1007/s00018-017-2667-x; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Perrin RM, 2005, DIABETOLOGIA, V48, P2422, DOI 10.1007/s00125-005-1951-8; Qiu Y, 2009, BIOCHEM SOC T, V37, P1207, DOI 10.1042/BST0371207; Varey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Wood SH, 2015, CURR BIOL, V25, P2651, DOI 10.1016/j.cub.2015.09.014; Xin H, 2016, CELL, V167, P275, DOI 10.1016/j.cell.2016.08.054; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117; Zhao M, 2011, EXP EYE RES, V93, P921, DOI 10.1016/j.exer.2011.10.013	37	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197123	10.1371/journal.pone.0197123	http://dx.doi.org/10.1371/journal.pone.0197123			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746548	Green Submitted, Green Published, gold			2022-12-26	WOS:000431851700074
J	Riveros-Iregui, DA; Lorenzo, TM; Liang, LYL; Hu, J				Riveros-Iregui, Diego A.; Lorenzo, Theresa M.; Liang, Liyin L.; Hu, Jia			Summer dry-down modulates the isotopic composition of soil CO2 production in snow-dominated landscapes	PLOS ONE			English	Article							SHORT-TERM VARIATIONS; ECOSYSTEM RESPIRATION; CARBON-DIOXIDE; WATER-CONTENT; RESPIRED CO2; MOISTURE-CONTENT; CLIMATE-CHANGE; HIGH-ELEVATION; FOREST; TEMPERATURE	In mountainous landscapes, soil moisture is highly dynamic due to the effects of topography and the temporal variability imposed by seasonal precipitation, including rainfall and snow. Soil moisture is known to affect ecosystem carbon exchange both aboveground and belowground, as well as the stable isotopic composition of exchanged CO2. In this study we used an extensive suite of measurements to examine the effects of seasonal changes in soil moisture on the isotopic composition of soil CO2 production at the landscape level. We show that the seasonal decline in soil moisture (i.e., summer dry-down) appeared to impose a trend in the delta C-13 of soil CO2 production (delta(p)) with more negative delta(p) early in the growing season when soils were wet, and more positive delta(p) as the growing season progressed and soils dried out. This seemingly generalizable pattern for a snow-dominated watershed is likely to represent the variability of recently assimilated C, tracked through the plant-soil system and imprinted in the respired CO2. Thus, our observations suggest that, at least for mountainous environments, seasonal changes in delta(p) are largely mediated by soil moisture and their spatial variability is partially organized by topography.	[Riveros-Iregui, Diego A.] Univ North Carolina Chapel Hill, Dept Geog, Chapel Hill, NC 27599 USA; [Lorenzo, Theresa M.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Liang, Liyin L.] Univ Waikato, Sch Sci, Hamilton, New Zealand; [Liang, Liyin L.] Univ Waikato, Environm Res Inst, Hamilton, New Zealand; [Hu, Jia] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Arizona State University; Arizona State University-Tempe; University of Waikato; University of Waikato; University of Arizona	Riveros-Iregui, DA (corresponding author), Univ North Carolina Chapel Hill, Dept Geog, Chapel Hill, NC 27599 USA.	diegori@unc.edu	Liáng, Lìyǐn Lín/G-4503-2015	Liáng, Lìyǐn Lín/0000-0001-9831-4793	U.S. Department of Agriculture [2012-67019-19360]; Department of Geography at UNC-Chapel Hill	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Department of Geography at UNC-Chapel Hill	This work was supported by the U.S. Department of Agriculture (award No. 2012-67019-19360) and by the Department of Geography at UNC-Chapel Hill.	Adams HR, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00296.1; Alstad KP, 2007, TREE PHYSIOL, V27, P1361, DOI 10.1093/treephys/27.10.1361; Bowling DR, 2015, BIOGEOSCIENCES, V12, P5143, DOI 10.5194/bg-12-5143-2015; Bowling DR, 2008, NEW PHYTOL, V178, P24, DOI 10.1111/j.1469-8137.2007.02342.x; Bowling DR, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002394; Bowling DR, 2002, OECOLOGIA, V131, P113, DOI 10.1007/s00442-001-0851-y; Brandes E, 2006, GLOBAL CHANGE BIOL, V12, P1922, DOI 10.1111/j.1365-2486.2006.01205.x; Bruggemann N, 2011, BIOGEOSCIENCES, V8, P3457, DOI 10.5194/bg-8-3457-2011; Burton AJ, 2000, OECOLOGIA, V125, P389, DOI 10.1007/s004420000455; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; CERLING TE, 1991, GEOCHIM COSMOCHIM AC, V55, P3403, DOI 10.1016/0016-7037(91)90498-T; CERLING TE, 1984, EARTH PLANET SC LETT, V71, P229, DOI 10.1016/0012-821X(84)90089-X; Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Ehleringer JR, 2000, ECOL APPL, V10, P412, DOI 10.1890/1051-0761(2000)010[0412:CIRIBC]2.0.CO;2; Ehleringer JR, 2002, PLANT BIOLOGY, V4, P181, DOI 10.1055/s-2002-25733; Ekblad A, 2001, OECOLOGIA, V127, P305, DOI 10.1007/s004420100667; Famiglietti JS, 1998, J HYDROL, V210, P259, DOI 10.1016/S0022-1694(98)00187-5; Farnes PE, 1995, RJVAINT92734 USDA FO; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Fessenden JE, 2003, OECOLOGIA, V136, P129, DOI 10.1007/s00442-003-1260-1; Fierer N, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002644; GARTEN CT, 1992, OECOLOGIA, V90, P1, DOI 10.1007/BF00317801; Gessler A, 2007, FUNCT PLANT BIOL, V34, P692, DOI 10.1071/FP07064; Grayson RB, 1997, WATER RESOUR RES, V33, P2897, DOI 10.1029/97WR02174; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hashimoto S, 2006, J FOREST RES-JPN, V11, P41, DOI 10.1007/s10310-005-0185-4; Holdorf H., 1981, SOIL RESOURCE INVENT; Hu J, 2010, GLOBAL CHANGE BIOL, V16, P771, DOI 10.1111/j.1365-2486.2009.01967.x; Huang WJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01998-z; Jencso KG, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008818; KEELING CD, 1958, GEOCHIM COSMOCHIM AC, V13, P322, DOI 10.1016/0016-7037(58)90033-4; Knohl A, 2005, OECOLOGIA, V142, P70, DOI 10.1007/s00442-004-1702-4; KOWALENKO CG, 1978, SOIL BIOL BIOCHEM, V10, P417, DOI 10.1016/0038-0717(78)90068-8; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P425, DOI 10.1016/j.soilbio.2005.08.020; Lai CT, 2005, GLOBAL CHANGE BIOL, V11, P633, DOI 10.1111/j.1365-2486.2005.00931.x; Liang LYL, 2016, J GEOPHYS RES-BIOGEO, V121, P2328, DOI 10.1002/2015JG003193; Lin GH, 1997, PLANT PHYSIOL, V114, P391, DOI 10.1104/pp.114.1.391; Luce CH, 2018, ADV GLOB CHANGE RES, V63, P25, DOI 10.1007/978-3-319-56928-4_3; Martin J, 2017, NEW PHYTOL, V215, P1387, DOI 10.1111/nph.14668; McCaughey WW, 1996, EXPT FORESTS RANGES; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Monson RK, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002684; Mortazavi B, 2005, OECOLOGIA, V142, P57, DOI 10.1007/s00442-004-1692-2; Pacific VJ, 2011, HYDROL PROCESS, V25, P811, DOI 10.1002/hyp.7870; Pacific V, 2008, BIOGEOCHEMISTRY, V91, P51, DOI 10.1007/s10533-008-9258-8; Pataki DE, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003865; Payne JT, 2004, CLIMATIC CHANGE, V62, P233, DOI 10.1023/B:CLIM.0000013694.18154.d6; Raczka B, 2017, J GEOPHYS RES-BIOGEO; Risk D, 2012, SOIL BIOL BIOCHEM, V50, P26, DOI 10.1016/j.soilbio.2012.01.025; Riveros-Iregui DA, 2012, GLOBAL CHANGE BIOL, V18, P749, DOI 10.1111/j.1365-2486.2011.02556.x; Riveros-Iregui DA, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001556; Riveros-Iregui DA, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000885; Riveros-Iregui DA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030938; Schaeffer SM, 2008, AGR FOREST METEOROL, V148, P592, DOI 10.1016/j.agrformet.2007.11.003; SKOPP J, 1990, SOIL SCI SOC AM J, V54, P1619, DOI 10.2136/sssaj1990.03615995005400060018x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Swetnam TL, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1797; WELCH BL, 1951, BIOMETRIKA, V38, P330, DOI 10.2307/2332579; Western AW, 2002, ANNU REV EARTH PL SC, V30, P149, DOI 10.1146/annurev.earth.30.091201.140434; Williams CJ, 2009, HYDROL EARTH SYST SC, V13, P1325, DOI 10.5194/hess-13-1325-2009; Wingate L, 2010, NEW PHYTOL, V188, P576, DOI 10.1111/j.1469-8137.2010.03384.x; Wood AW, 2004, CLIMATIC CHANGE, V62, P189, DOI 10.1023/B:CLIM.0000013685.99609.9e	66	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197471	10.1371/journal.pone.0197471	http://dx.doi.org/10.1371/journal.pone.0197471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746589	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700116
J	Santillan, V; Quitian, M; Tinoco, BA; Zarate, E; Schleuning, M; Bohning-Gaese, K; Neuschulz, EL				Santillan, Vinicio; Quitian, Marta; Tinoco, Boris A.; Zarate, Edwin; Schleuning, Matthias; Boehning-Gaese, Katrin; Neuschulz, Eike Lena			Spatio-temporal variation in bird assemblages is associated with fluctuations in temperature and precipitation along a tropical elevational gradient	PLOS ONE			English	Article							SPECIES-RICHNESS; CLIMATE; FOREST; DIVERSITY; PATTERNS; SCALE; ABUNDANCE; ECUADOR; ENERGY; DISTRIBUTIONS	Understanding the spatial and temporal dynamics of species assemblages is a main challenge in ecology. The mechanisms that shape species assemblages and their temporal fluctuations along tropical elevational gradients are particularly poorly understood. Here, we examined the spatio-temporal dynamics of bird assemblages along an elevational gradient in Ecuador. We conducted bird point counts at three elevations (1000, 2000 and 3000 m) on 18 1-ha plots and repeated the sampling eight times over two years (216 hours in total). For each plot, we obtained data of monthly temperatures and precipitation and recorded the overall resource availability (i.e., the sum of flower, fruit, and invertebrate resources). As expected, bird richness decreased from low to high elevations. Moreover, we found a significant decrease in bird abundance and richness and an increase in evenness between the most and least humid season at each of the three elevations. Climatic factors were more closely related to these temporal fluctuations than local resource availability. While temperature had significant positive effects on the abundance of birds at mid and high elevations, precipitation negatively affected bird abundance at low and mid elevations. Our study highlights that bird assemblages along tropical elevational gradients can show pronounced seasonal fluctuations. In particular, low temperatures and high precipitation seem to impose important constraints on birds. We conclude that potential changes in climate, due to global warming, are likely to affect the spatio-temporal dynamics of bird assemblages along tropical elevational gradients.	[Santillan, Vinicio; Quitian, Marta; Schleuning, Matthias; Boehning-Gaese, Katrin; Neuschulz, Eike Lena] Senckenberg Biodivers & Climate Res Ctr Frankfurt, Frankfurt, Germany; [Santillan, Vinicio; Quitian, Marta; Boehning-Gaese, Katrin] Goethe Univ Frankfurt, Dept Biol Sci, Frankfurt, Germany; [Santillan, Vinicio; Tinoco, Boris A.; Zarate, Edwin] Univ Azuay, Escuela Biol Ecol & Gest, Cuenca, Ecuador	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Universidad del Azuay	Santillan, V (corresponding author), Senckenberg Biodivers & Climate Res Ctr Frankfurt, Frankfurt, Germany.; Santillan, V (corresponding author), Goethe Univ Frankfurt, Dept Biol Sci, Frankfurt, Germany.; Santillan, V (corresponding author), Univ Azuay, Escuela Biol Ecol & Gest, Cuenca, Ecuador.	vesantillanr@gmail.com	Schleuning, Matthias/H-2154-2015; Quitián, Marta/AAA-8775-2020	Schleuning, Matthias/0000-0001-9426-045X; 	German Research Foundation (DFG) [PAK 825/1, BO 1221/20-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The German Research Foundation (DFG, [http://www.dfg.de/) has supported KBG in the framework of the Research Unit 823-825 "Platform for Biodiversity and Ecosystem Monitoring and Research in South Ecuador" (PAK 825/1; BO 1221/20-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EP., 2011, CLIMATE CHANGE BIODI, P1, DOI DOI 10.13140/2.1.3718.4969; [Anonymous], 2006, LYONIA; Barry R.G., 1992, MOUNTAIN WEATHER CLI, V2nd edn; Bendix J, 2006, CLIMATE RES, V30, P133, DOI 10.3354/cr030133; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Blake JG, 2015, PEERJ, V3, DOI 10.7717/peerj.1177; Borghesio L, 2004, J TROP ECOL, V20, P145, DOI 10.1017/S0266467403001159; Boyle WA, 2011, OIKOS, V120, P1803, DOI 10.1111/j.1600-0706.2011.19432.x; Boyle WA, 2010, P ROY SOC B-BIOL SCI, V277, P2511, DOI 10.1098/rspb.2010.0344; Brown JH, 2014, J BIOGEOGR, V41, P8, DOI 10.1111/jbi.12228; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Dehling DM, 2014, ECOGRAPHY, V37, P1047, DOI 10.1111/ecog.00623; Dornelas Maria, 2013, Proceedings of the Royal Society Biological Sciences Series B, V280, P1; Emck P., 2007, THESIS FRIEDRICH ALE; FEINSINGER P, 1976, ECOL MONOGR, V46, P257, DOI 10.2307/1942255; Ferger SW, 2014, GLOBAL ECOL BIOGEOGR, V23, P541, DOI 10.1111/geb.12151; Fiedler K., 2008, V198, P167; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Fries A, 2009, ERDKUNDE, V63, P321, DOI 10.3112/erdkunde.2009.04.03; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Hau M, 2001, HORM BEHAV, V40, P281, DOI 10.1006/hbeh.2001.1673; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2003, ECOLOGY, V84, P1608, DOI 10.1890/0012-9658(2003)084[1608:PAHAPO]2.0.CO;2; Herzog SK, 2005, ECOGRAPHY, V28, P209, DOI 10.1111/j.0906-7590.2005.03935.x; Homeier J., 2008, V198, P87; Jetz W, 2005, GLOBAL ECOL BIOGEOGR, V14, P97, DOI 10.1111/j.1466-822X.2004.00129.x; Larsen T.H., 2011, CLIMATE CHANGE BIODI, P47, DOI DOI 10.13140/2.1.4009.3128; LOISELLE BA, 1991, ECOLOGY, V72, P180, DOI 10.2307/1938913; Louthan AM, 2015, TRENDS ECOL EVOL, V30, P780, DOI 10.1016/j.tree.2015.09.011; MCCAIN C. M., 2010, ENCY LIFE SCI, DOI [DOI 10.1002/9780470015902.A0022548, 10.1002/9780470015902.a0022548]; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; Merkord C. L., 2010, THESIS; Mulwa RK, 2013, OIKOS, V122, P524, DOI 10.1111/j.1600-0706.2012.20640.x; O'Brien EM, 1998, J BIOGEOGR, V25, P379, DOI 10.1046/j.1365-2699.1998.252166.x; Pigot AL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2013; POULIN B, 1992, ECOLOGY, V73, P2295, DOI 10.2307/1941476; R Development Core Team, 2016, R LANG ENV STAT COMP; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ridgely RS, 2001, THE BIRDS OF ECUADOR, VII; Rollenbeck R, 2011, ATMOS RES, V99, P277, DOI 10.1016/j.atmosres.2010.10.018; ROOT T, 1988, ECOLOGY, V69, P330, DOI 10.2307/1940431; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosenzweig ML, 1993, SPECIES DIVERSITY EC, P67; Ruggiero A, 2008, ECOGRAPHY, V31, P306, DOI 10.1111/j.0906-7590.2008.05333.x; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; TERBORGH J, 1985, ECOLOGY, V66, P1237, DOI 10.2307/1939177; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Williams M, 2016, J LARYNGOL OTOL, V130, P82, DOI 10.1017/S0022215115002881; Williams SE, 2008, DIVERS DISTRIB, V14, P69, DOI 10.1111/j.1472-4642.2007.00418.x; Wilman H, 2014, ECOLOGY, V95, P2027, DOI DOI 10.1890/13-1917.1; WINGFIELD JC, 1992, J EXP ZOOL, V261, P214, DOI 10.1002/jez.1402610212; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Zhang J, 2013, J BIOGEOGR, V40, P1131, DOI 10.1111/jbi.12063	57	22	24	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196179	10.1371/journal.pone.0196179	http://dx.doi.org/10.1371/journal.pone.0196179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746478	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700009
J	Batista, LFS; Utsunomiya, YT; Silva, TBF; Carneiro, MM; Paiva, JSF; Silva, RB; Tomokane, TY; Rossi, CN; Pacheco, AD; Torrecilha, RBP; Silveira, FT; Marcondes, M; Nunes, CM; Laurenti, MD				Batista, Luis F. S.; Utsunomiya, Yuri T.; Silva, Thais B. F.; Carneiro, Mariana M.; Paiva, Joyr S. F.; Silva, Rafaela B.; Tomokane, Thaise Y.; Rossi, Claudio N.; Pacheco, Acacio D.; Torrecilha, Rafaela B. P.; Silveira, Fernando T.; Marcondes, Mary; Nunes, Caris M.; Laurenti, Marcia D.			Canine leishmaniasis: Genome-wide analysis and antibody response to Lutzomyia longipalpis saliva	PLOS ONE			English	Article							SAND FLY SALIVA; B-CELLS; INHIBITION; DIAGNOSIS; BETA; AREA; DOGS	The anti-inflammatory properties of sand fly saliva favor the establishment of the Leishmania infantum infection. In contrast, an antibody response against Lutzomyia longipalpis saliva is often associated with a protective cell-mediated response against canine visceral leishmaniasis. Genetic studies may demonstrate to what extent the ability to secrete antisaliva antibodies depends on genetic or environmental factors. However, the genetic basis of canine antibody response against sand fly saliva has not been assessed. The aim of this study was to identify chromosomal regions associated with the anti-Lu. longipalpis salivary IgG response in 189 dogs resident in endemic areas in order to provide information for prophylactic strategies. Dogs were classified into five groups based on serological and parasitological diagnosis and clinical evaluation. Anti-salivary gland homogenate (SGH) IgG levels were assessed by Enzyme-Linked Immunosorbent Assay (ELISA). Genomic DNA was isolated from blood samples and genotyped using a SNP chip with 173,662 single nucleotide polymorphism (SNP) markers. The following linear regression model was fitted: IgG level = mean + origin + sex + age + use of a repellent collar, and the residuals were assumed as pseudo-phenotypes for the association test between phenotypes and genotypes (GWA). A component of variance model that takes into account polygenic and sample structure effects (EMMAX) was employed for GWA. Phenotypic findings indicated that anti-SGH IgG levels remained higher in exposed and subclinically infected dogs than in severely diseased dogs even in regression model residuals. Five associated markers were identified on chromosomes 2, 20 and 31. The mapped genes included CD180 (RP105) and MITF related to the rapid activation of B lymphocytes and differentiation into antibody-secreting plasma cells. The findings pointed to chromosomal segments useful for functional confirmation studies and a search for adjuvant molecules of the anti-saliva response.	[Batista, Luis F. S.] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Patol Vet, Sao Paulo, Brazil; [Batista, Luis F. S.; Carneiro, Mariana M.; Paiva, Joyr S. F.; Silva, Rafaela B.] Univ Salvador, Escola Saude, Salvador, Ba, Brazil; [Utsunomiya, Yuri T.; Torrecilha, Rafaela B. P.] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Med Vet Prevent & Reprod Anim, Jaboticabal, SP, Brazil; [Silva, Thais B. F.; Tomokane, Thaise Y.; Laurenti, Marcia D.] Univ Sao Paulo, Fac Med, Lab Patol Doencas Infecciosas, Sao Paulo, Brazil; [Rossi, Claudio N.] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Clin, Sao Paulo, Brazil; [Pacheco, Acacio D.; Marcondes, Mary] Univ Estadual Paulista, Fac Med Vet, Dept Clin Cirurgia & Reprod Anim, Aracatuba, SP, Brazil; [Silveira, Fernando T.] Inst Evandro Chagas, Dept Parasitol, Ananindeua, Para, Brazil; [Nunes, Caris M.] Univ Estadual Paulista, Fac Med Vet, Dept Saude Anim & Prod, Aracatuba, SP, Brazil	Universidade de Sao Paulo; Universidad de El Salvador; Universidade Salvador (UNIFACS); Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista; Instituto Evandro Chagas; Universidade Estadual Paulista	Batista, LFS (corresponding author), Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Patol Vet, Sao Paulo, Brazil.; Batista, LFS (corresponding author), Univ Salvador, Escola Saude, Salvador, Ba, Brazil.	luisfabiobatista@gmail.com	Utsunomiya, Yuri Tani T/K-5214-2013; Laurenti, Marcia Dalastra/C-4734-2012; Tomokane, Thaise Yumie/A-3864-2013; Nunes, Caris M/R-9337-2016; Silveira, Fernando Tobias/AAE-5767-2021; Duarte Pacheco, Acacio/B-9021-2017	Utsunomiya, Yuri Tani T/0000-0002-6526-8337; Tomokane, Thaise Yumie/0000-0002-1431-6829; Nunes, Caris M/0000-0002-5463-3845; Silveira, Fernando Tobias/0000-0002-0412-6060; Marcondes, Mary/0000-0001-6931-4479; Duarte Pacheco, Acacio/0000-0002-5080-7799	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP) [2012/50285-9, 2012/05847-9, 2014/01095-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil [476479/2012-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); Hospital das Clinicas-Faculdade de Medicina da Universidade de Sao Paulo (HC-FMUSP), Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Hospital das Clinicas-Faculdade de Medicina da Universidade de Sao Paulo (HC-FMUSP), Brazil	Financial support was provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP) grants no. 2012/50285-9 (M.D.L.), no. 2012/05847-9 (L.F.S.B.), and no. 2014/01095-8 (Y.T.U.); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil grant no. 476479/2012-6 (M.D.L.); and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) grant no. Scholarship Social Demand (L.F.S.B.); and Hospital das Clinicas-Faculdade de Medicina da Universidade de Sao Paulo (HC-FMUSP), Brazil (M.D.L.). M.D.L., M.M., and C.M.N. are senior researchers from CNPq; L.F. S.B. is a researcher from Universidade Salvador (UNIFACS).	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Andrade BB, 2007, SCAND J IMMUNOL, V66, P122, DOI 10.1111/j.1365-3083.2007.01964.x; Araujo-Santos T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000873; Aschar M, 2016, VET PARASITOL, V225, P108, DOI 10.1016/j.vetpar.2016.06.005; Batista LFS, 2016, INFECT IMMUN, V84, P12; Belo VS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002182; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Ceccarelli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088845; Chaplin JW, 2011, J IMMUNOL, V187, P4199, DOI 10.4049/jimmunol.1100198; Chen KJ, 2014, AM J PHYSIOL-GASTR L, V307, pG1044, DOI 10.1152/ajpgi.00241.2014; Collin N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000441; Abbehusen MMC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15651-8; Batista LFD, 2016, REV SOC BRAS MED TRO, V49, P361, DOI 10.1590/0037-8682-0360-2015; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fakiola M, 2013, NAT GENET, V45, P208, DOI 10.1038/ng.2518; Ferreira VP, 2016, SCI REP-UK, V6, DOI 10.1038/srep19300; Gary-Gouy H, 2006, BIOCHEM BIOPH RES CO, V344, P134, DOI 10.1016/j.bbrc.2006.03.121; Gomes RB, 2002, J INFECT DIS, V186, P1530, DOI 10.1086/344733; Kamhawi S, 2000, MICROBES INFECT, V2, P1765, DOI 10.1016/S1286-4579(00)01331-9; Kaneko JJ, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P1; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; KILLICKKENDRICK R, 1973, T ROY SOC TROP MED H, V67, P434, DOI 10.1016/0035-9203(73)90054-0; Laurenti MD, 2014, VET PARASITOL, V205, P444, DOI 10.1016/j.vetpar.2014.09.002; Lin L, 2004, J EXP MED, V200, P115, DOI 10.1084/jem.20040612; Miura Y, 1998, BLOOD, V92, P2815, DOI 10.1182/blood.V92.8.2815.420k09_2815_2822; Paltrinieri S, 2010, JAVMA-J AM VET MED A, V236, P1184, DOI 10.2460/javma.236.11.1184; Prates DB, 2011, J LEUKOCYTE BIOL, V90, P575, DOI 10.1189/jlb.0211105; Seva AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162854; Shen WJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9372; Solca MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep32619; Utsunomiya YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136749; Vlkova M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001344; Werneck GL, 2003, INFECTION, V31, P174, DOI 10.1007/s15010-003-3139-9; Yazawa N, 2003, BLOOD, V102, P1374, DOI 10.1182/blood-2002-11-3573	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0197215	10.1371/journal.pone.0197215	http://dx.doi.org/10.1371/journal.pone.0197215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742167	Green Published, Green Submitted, gold			2022-12-26	WOS:000431757400068
J	Cho, S; Hiott, LM; Barrett, JB; McMillan, EA; House, SL; Humayoun, SB; Adams, ES; Jackson, CR; Frye, JG				Cho, Sohyun; Hiott, Lari M.; Barrett, John B.; McMillan, Elizabeth A.; House, Sandra L.; Humayoun, Shaheen B.; Adams, Eric S.; Jackson, Charlene R.; Frye, Jonathan G.			Prevalence and characterization of Escherichia coli isolated from the Upper Oconee Watershed in Northeast Georgia	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE PROFILES; SURFACE-WATER; TETRACYCLINE ANTIBIOTICS; PHYLOGENETIC GROUP; E. COLI; VIRULENCE; RIVER; ENUMERATION; ENVIRONMENT; SALMONELLA	Surface waters are important sources of water for drinking, industrial, agricultural, and recreational uses; hence, contamination of water by fecal, pathogenic, or antimicrobial resistant (AR) bacteria is a major environmental and public health concern. However, very little data is available on prevalence of these bacteria in surface water throughout a watershed. This study aimed to characterize Escherichia coli present in the Upper Oconee Watershed, a mixed-use watershed in Athens, GA, USA for potential pathogenicity and AR. E. coli were enumerated by colony counts, cultured by enrichment and direct plating, and characterized by phylo-groups, diarrheagenic pathotypes, and antimicrobial susceptibility. From the analysis, 99.3% (455/458) of the total samples were positive for E. coli resulting in 496 isolates. E. coli counts were as high as 1.2x10(4) CFU/100 ml, which is above the United States Environmental Protection Agency (U.S. EPA) threshold for recreational water (235 CFU/100 ml based on a one-time measurement). Phylo-groups B2 (31.7%; 157/496) and B1 (30.8%; 153/496) were the most prevalent among the isolates. Enteropathogenic E. coli (EPEC) (19/496) and Shiga toxin-producing E. coli (STEC) (1/496) were the only diarrheagenic pathotypes detected. AR was observed in 6.9% (34/496) of the isolates, 15 of which were multidrug resistant (MDR; resistance to two or more classes of antimicrobials). Tetracycline resistance was most often detected (76.5%; 26/34), followed by ampicillin (32.4%; 11/34), streptomycin (23.5%; 8/34), sulfisoxazole (23.5%; 8/34), and nalidixic acid (14.7%; 5/34). Results from this study showed that E. coli is prevalent in high levels in the Upper Oconee Watershed, suggesting possible widespread fecal contamination. The presence of pathogenic, AR E. coli in the watershed indicates that environmental water can serve as a reservoir of resistant bacteria that may be transferred to humans through drinking and recreational activities.	[Cho, Sohyun; McMillan, Elizabeth A.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Hiott, Lari M.; Barrett, John B.; House, Sandra L.; Humayoun, Shaheen B.; Adams, Eric S.; Jackson, Charlene R.; Frye, Jonathan G.] ARS, Bacterial Epidemiol & Antimicrobial Resistance Re, USDA, Athens, GA 30605 USA	University System of Georgia; University of Georgia; United States Department of Agriculture (USDA)	Frye, JG (corresponding author), ARS, Bacterial Epidemiol & Antimicrobial Resistance Re, USDA, Athens, GA 30605 USA.	jonathan.frye@ars.usda.gov	Frye, Jonathan G./I-6382-2013; McMillan, Elizabeth A./AAR-5791-2020; Cho, Sohyun/AAY-4615-2021	Frye, Jonathan G./0000-0002-8500-3395; McMillan, Elizabeth A./0000-0002-7503-514X; Cho, Sohyun/0000-0002-1967-9397	United States Department of Agriculture, Agricultural Research Service Intramural funding Project [6040-32000-009-00]; Agricultural Research Service Sub-Project [6040-32000-009-08R]	United States Department of Agriculture, Agricultural Research Service Intramural funding Project; Agricultural Research Service Sub-Project	Funded by United States Department of Agriculture, Agricultural Research Service Intramural funding Project Number: 6040-32000-009-00 https://iapreview.ars.usda.gov/research/projects/projects.htm?ACCN_NO=430182. Centers for Disease Control and Prevention. Broad Agency Announcement to address antibiotic resistance, Agricultural Research Service Sub-Project Number: 6040-32000-009-08R https://www.cdc.gov/drugresistance/solutions-Initiative/innovations-to-slow-AR.html.	[Anonymous], 2000, Can Commun Dis Rep, V26, P170; Boyd EF, 1998, J BACTERIOL, V180, P1159, DOI 10.1128/JB.180.5.1159-1165.1998; CDC (Centers for Disease Control and Prevention), 2015, ANN REPORT; Centers for Disease Control and Prevention, 2014, ANN REPORT; Centers for Disease Control and Prevention (CDC), 2016, SURV FOODB DIS OUTBR; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; CLSI, 2016, PERFORMANCE STANDARD; Conners D. E., 2001, P 2001 GEORG WAT RES; Daghrir R, 2013, ENVIRON CHEM LETT, V11, P209, DOI 10.1007/s10311-013-0404-8; Davison J, 1999, PLASMID, V42, P73, DOI 10.1006/plas.1999.1421; Environmental Protection Division (EPD), 2016, DRAFT 2016 INT 305 B; Erin G, 2016, ATHENS OUTDATED SEWA; EUCAST, 2014, BREAKP TABL INT MICS; Fisher DS, 2000, FOREST ECOL MANAG, V128, P39, DOI 10.1016/S0378-1127(99)00270-4; Fisher DS, 2001, P 2001 GEORG WAT RES; Georgia Adopt-A-Stream, 2014, BACT MON; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Gu GY, 2013, CAN J MICROBIOL, V59, P175, DOI 10.1139/cjm-2012-0599; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Hamelin K, 2007, APPL ENVIRON MICROB, V73, P477, DOI 10.1128/AEM.01445-06; Higgins J, 2007, J MICROBIOL METH, V70, P227, DOI 10.1016/j.mimet.2007.04.009; HOBBS F, 2002, CENSUS 2000 SPECIAL; Ibekwe AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020819; ISAACSON M, 1993, LANCET, V341, P961, DOI 10.1016/0140-6736(93)91253-I; Jang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100585; Johnson TJ, 2010, MICROBIOL MOL BIOL R, V74, P477, DOI 10.1128/MMBR.00002-10; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; KEENE WE, 1994, NEW ENGL J MED, V331, P579, DOI 10.1056/NEJM199409013310904; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Lee B, 2015, OCONEE COUNTY REPORT; Li XD, 2014, ENVIRON MONIT ASSESS, V186, P1253, DOI 10.1007/s10661-013-3454-2; Little E., 2007, P GEORGIA WATER RESO; Maal-Bared R, 2013, SCI TOTAL ENVIRON, V443, P315, DOI 10.1016/j.scitotenv.2012.10.106; McCarthy TA, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e59; Meinersmann RJ, 2008, MICROB ECOL, V55, P444, DOI 10.1007/s00248-007-9290-6; Metropolitan North Georgia Water Planning District, 2016, EN0507151024SPB METR; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; National Agricultural Statistics Service (NASS), 2017, EXPL STAT; Nguyen TV, 2005, J CLIN MICROBIOL, V43, P755, DOI 10.1128/JCM.43.2.755-760.2005; Olaniran AO, 2009, WORLD J MICROB BIOT, V25, P1743, DOI 10.1007/s11274-009-0071-x; Parveen S, 1997, APPL ENVIRON MICROB, V63, P2607, DOI 10.1128/AEM.63.7.2607-2612.1997; Paton AW, 1998, J CLIN MICROBIOL, V36, P598, DOI 10.1128/JCM.36.2.598-602.1998; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Probert WS, 2017, EMERG INFECT DIS, V23, P1216, DOI 10.3201/eid2307.170226; ROSENBERG ML, 1977, ANN INTERN MED, V86, P714, DOI 10.7326/0003-4819-86-6-714; Schraft H, 2005, J MICROBIOL METH, V60, P335, DOI 10.1016/j.mimet.2004.10.008; Sidhu JPS, 2013, APPL ENVIRON MICROB, V79, P328, DOI 10.1128/AEM.02888-12; Sjolund-Karlsson M, 2011, ANTIMICROB AGENTS CH, V55, P3985, DOI 10.1128/AAC.00590-11; Titilawo Y, 2015, SCI TOTAL ENVIRON, V523, P82, DOI 10.1016/j.scitotenv.2015.03.095; Toma C, 2003, J CLIN MICROBIOL, V41, P2669, DOI 10.1128/JCM.41.6.2669-2671.2003; U. S. Environmental Protection Agency (EPA), 1986, EPAA440584002 OFF WA; Vail JH, 2003, J ENVIRON QUAL, V32, P368, DOI 10.2134/jeq2003.0368; Zhang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111026	55	28	29	9	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0197005	10.1371/journal.pone.0197005	http://dx.doi.org/10.1371/journal.pone.0197005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738574	gold, Green Published, Green Submitted			2022-12-26	WOS:000431724900042
J	Fodor, N; Foskolos, A; Topp, CFE; Moorby, JM; Pasztor, L; Foyer, CH				Fodor, Nandor; Foskolos, Andreas; Topp, Cairistiona F. E.; Moorby, Jon M.; Pasztor, Laszlo; Foyer, Christine H.			Spatially explicit estimation of heat stress-related impacts of climate change on the milk production of dairy cows in the United Kingdom	PLOS ONE			English	Article							PRODUCTION SYSTEMS; SHADE; TEMPERATURE; CATTLE; CHALLENGES; STRATEGIES; TOLERANCE; HUMIDITY; BEHAVIOR; PASTURE	Dairy farming is one the most important sectors of United Kingdom (UK) agriculture. It faces major challenges due to climate change, which will have direct impacts on dairy cows as a result of heat stress. In the absence of adaptations, this could potentially lead to considerable milk loss. Using an 11-member climate projection ensemble, as well as an ensemble of 18 milk loss estimation methods, temporal changes in milk production of UK dairy cows were estimated for the 21st century at a 25 km resolution in a spatially-explicit way. While increases in UK temperatures are projected to lead to relatively low average annual milk losses, even for southern UK regions (<180 kg/cow), the 'hottest' 25x25 km grid cell in the hottest year in the 2090s, showed an annual milk loss exceeding 1300 kg/cow. This figure represents approximately 17% of the potential milk production of today's average cow. Despite the potential considerable inter-annual variability of annual milk loss, as well as the large differences between the climate projections, the variety of calculation methods is likely to introduce even greater uncertainty into milk loss estimations. To address this issue, a novel, more biologically-appropriate mechanism of estimating milk loss is proposed that provides more realistic future projections. We conclude that South West England is the region most vulnerable to climate change economically, because it is characterised by a high dairy herd density and therefore potentially high heat stress-related milk loss. In the absence of mitigation measures, estimated heat stress-related annual income loss for this region by the end of this century may reach 13.4M pound in average years and 33.8M pound in extreme years.	[Fodor, Nandor; Foyer, Christine H.] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds, W Yorkshire, England; [Fodor, Nandor] Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Martonvasar, Hungary; [Foskolos, Andreas; Moorby, Jon M.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Topp, Cairistiona F. E.] Scotlands Rural Coll, Crop & Soil Syst, Edinburgh, Midlothian, Scotland; [Pasztor, Laszlo] Hungarian Acad Sci, Ctr Agr Res, Inst Soil Sci & Agr Chem, Budapest, Hungary	University of Leeds; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Scotland's Rural College; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Fodor, N (corresponding author), Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds, W Yorkshire, England.; Fodor, N (corresponding author), Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Martonvasar, Hungary.	fodor.nandor@agrar.mta.hu	Foyer, Christine/K-2143-2012; Pásztor, László/B-3270-2014; Moorby, Jon/L-4586-2018; Topp, Cairistiona/L-8439-2016; Foskolos, Andreas/J-9444-2019	Pásztor, László/0000-0002-1605-4412; Moorby, Jon/0000-0002-4449-8432; Topp, Cairistiona/0000-0002-7064-638X; Foskolos, Andreas/0000-0002-7339-1140; Fodor, Nandor/0000-0002-6460-1767; Foyer, Christine/0000-0001-5989-6989	BBSRC [BB/N004914/1]; Scottish Government RESAS Strategic Research Programme; Welsh Government; Higher Education Funding Council for Wales through the Ser Cymru National Research Network for Low Carbon, Energy and Environment; Szechenyi programme; European Regional Development Fund-"Investing in your future"; Hungarian Government [GINOP-2.3.2-15-2016-00028]; BBSRC [BB/N004973/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government RESAS Strategic Research Programme; Welsh Government; Higher Education Funding Council for Wales through the Ser Cymru National Research Network for Low Carbon, Energy and Environment; Szechenyi programme; European Regional Development Fund-"Investing in your future"; Hungarian Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The results were obtained within an international research project named "FACCE MACSUR Modelling European Agriculture with Climate Change for Food Security, a FACCE JPI knowledge hub" and acknowledge the respective national or regional funding organizations. NF and CF thank BBSRC for financial support (BB/N004914/1). Financial support was provided by the Scottish Government RESAS Strategic Research Programme, and the Welsh Government and Higher Education Funding Council for Wales through the Ser Cymru National Research Network for Low Carbon, Energy and Environment. Project: Consequential Life Cycle Assessment of Environmental and Economic Effects of Dairy and Beef Consolidation and Intensification Pathways 'Cleaner Cows'. The research was supported by the Szechenyi 2020 programme, the European Regional Development Fund-"Investing in your future" and the Hungarian Government (GINOP-2.3.2-15-2016-00028).	AHDB Dairy, 2015, AV HERD SIZ; AHDB Dairy, 2015, DAIR STAT INS GUID 2; AHDB Dairy, 2015, COW NUMB COUNT; [Anonymous], 2017, NUTS NOMENCLATURE TE; Asseng S, 2013, NAT CLIM CHANGE, V3, P827, DOI [10.1038/nclimate1916, 10.1038/NCLIMATE1916]; Bassu S, 2014, GLOBAL CHANGE BIOL, V20, P2301, DOI 10.1111/gcb.12520; Bernabucci U, 2014, J DAIRY SCI, V97, P471, DOI 10.3168/jds.2013-6611; Bishop-Williams KE, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0607-2; Bohmanova J, 2007, J DAIRY SCI, V90, P1947, DOI 10.3168/jds.2006-513; Boonkum W, 2011, J DAIRY SCI, V94, P487, DOI 10.3168/jds.2010-3421; Brown I., 2016, UK CLIMATE CHANGE RI; Brugemann K, 2012, ARCH TIERZUCHT, V55, P13, DOI 10.5194/aab-55-13-2012; Collier RJ, 2006, J DAIRY SCI, V89, P1244, DOI 10.3168/jds.S0022-0302(06)72193-2; Cross JA, 2006, GEOGR REV, V96, P1; Dunn RJH, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/6/064006; FAO, 2016, MILK MILK PROD; Fox DG, 1998, J DAIRY SCI, V81, P3085, DOI 10.3168/jds.S0022-0302(98)75873-4; Fox NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016126; Garner JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep34114; Gauly M, 2013, ANIMAL, V7, P843, DOI 10.1017/S1751731112002352; Hammami H, 2013, J DAIRY SCI, V96, P1844, DOI 10.3168/jds.2012-5947; Harrington LMB, 2010, GEOGR REV, V100, P538, DOI 10.1111/j.1931-0846.2010.00057.x; Henley J., 2014, GUARDIAN; Hill DL, 2015, ANIMAL, V9, P138, DOI 10.1017/S1751731114002456; IGERS, 2005, REV CALV PATT MAN DA; Kendall PE, 2006, LIVEST SCI, V103, P148, DOI 10.1016/j.livsci.2006.02.004; Kipling RP, 2016, AGR SYST, V147, P24, DOI 10.1016/j.agsy.2016.05.007; Lamp O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125264; March MD, 2014, J DAIRY SCI, V97, P7985, DOI 10.3168/jds.2014-8265; Martre P, 2015, GLOBAL CHANGE BIOL, V21, P911, DOI 10.1111/gcb.12768; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Mitchell TD, 2003, CLIMATIC CHANGE, V60, P217, DOI 10.1023/A:1026035305597; Murphy J.M, 2009, UK CLIMATE PROJECTIO; Nguyen TTT, 2017, J DAIRY SCI, V100, P7362, DOI 10.3168/jds.2017-12898; Nguyen TTT, 2016, J DAIRY SCI, V99, P2849, DOI 10.3168/jds.2015-9685; NRC, 1981, EFF ENV NUTR REQ DOM; NRC National Research Council, 1971, GUID ENV RES AN; Pinedo PJ, 2010, J DAIRY SCI, V93, P2250, DOI 10.3168/jds.2009-2572; Poisky L, 2017, J DAIRY SCI, V100, P8645, DOI 10.3168/jds.2017-12651; Pryce JE, 2018, J DAIRY SCI, V101, P3702, DOI 10.3168/jds.2017-13377; Ravagnolo O, 2000, J DAIRY SCI, V83, P2120, DOI 10.3168/jds.S0022-0302(00)75094-6; Renaudeau D, 2012, ANIMAL, V6, P707, DOI 10.1017/S1751731111002448; Rungruang S, 2014, J DAIRY SCI, V97, P5023, DOI 10.3168/jds.2013-6970; Schuller LK, 2013, J DAIRY SCI, V96, P7731, DOI 10.3168/jds.2013-6736; Schutz KE, 2014, J DAIRY SCI, V97, P3599, DOI 10.3168/jds.2013-7649; Schutz KE, 2011, J DAIRY SCI, V94, P273, DOI 10.3168/jds.2010-3608; Seedorf J, 1998, J AGR ENG RES, V70, P49, DOI 10.1006/jaer.1997.0284; Sexton DMH, 2010, UKCP09 SPATIALLY COH; Silanikove N, 2000, LIVEST PROD SCI, V67, P1, DOI 10.1016/S0301-6226(00)00162-7; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Styles D, 2018, GLOBAL CHANGE BIOL, V24, P681, DOI 10.1111/gcb.13868; Tank AMGK, 2003, J CLIMATE, V16, P3665, DOI [10.1175/1520-0442(2003)016<3665:TIIODT>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;3665:TIIODT&gt;2.0.CO;2]; Tucker CB, 2007, APPL ANIM BEHAV SCI, V105, P1, DOI [10.1016/j.applanim.2006.06.009, 10.1016/j.applanim.2007.03.015]; TUKEY JW, 1958, ANN MATH STAT, V29, P614; Van Laer E, 2015, ANIMAL, V9, P1547, DOI 10.1017/S1751731115000816; Vitali A, 2015, J DAIRY SCI, V98, P4572, DOI 10.3168/jds.2015-9331; West JW, 1999, J ANIM SCI, V77, P21; Yousef M. K., 1985, STRESS PHYSL LIVESTO; Zimbelman R.B., 2009, P SW NUTR MAN C TEMP, P113	59	24	25	15	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0197076	10.1371/journal.pone.0197076	http://dx.doi.org/10.1371/journal.pone.0197076			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738581	Green Published, Green Submitted, gold			2022-12-26	WOS:000431724900048
J	Foord, SH; Swanepoel, LH; Evans, SW; Schoeman, CS; Erasmus, BFN; Schoeman, MC; Keith, M; Smith, A; Mauda, EV; Maree, N; Nembudani, N; Dippenaar-Schoeman, AS; Munyai, TC; Taylor, PJ				Foord, Stefan Hendrik; Swanepoel, Lourens Hendrik; Evans, Steven William; Schoeman, Colin Stefan; Erasmus, Barend Frederik N.; Schoeman, M. Corrie; Keith, Mark; Smith, Alain; Mauda, Evans Vusani; Maree, Naudene; Nembudani, Nkhumeleni; Dippenaar-Schoeman, Anna Sophia; Munyai, Thinandavha Caswell; Taylor, Peter John			Animal taxa contrast in their scale-dependent responses to land use change in rural Africa	PLOS ONE			English	Article							BATS RHINOLOPHUS-HIPPOSIDEROS; SPECIES-DIVERSITY; SOUTH-AFRICA; SAVANNA RANGELANDS; ECOSYSTEM SERVICES; BETA-DIVERSITY; CONSERVATION; RODENT; BIODIVERSITY; LANDSCAPES	Human-dominated landscapes comprise the bulk of the world's terrestrial surface and Africa is predicted to experience the largest relative increase over the next century. A multi-scale approach is required to identify processes that maintain diversity in these landscapes. Here we identify scales at which animal diversity responds by partitioning regional diversity in a rural African agro-ecosystem between one temporal and four spatial scales. Human land use practices are the main driver of diversity in all seven animal assemblages considered, with medium sized mammals and birds most affected. Even the least affected taxa, bats and non-volant small mammals (rodents), responded with increased abundance in settlements and agricultural sites respectively. Regional turnover was important to invertebrate taxa and their response to human land use was intermediate between that of the vertebrate extremes. Local scale (< 300 m) heterogeneity was the next most important level for all taxa, highlighting the importance of fine scale processes for the maintenance of biodiversity. Identifying the triggers of these changes within the context of functional landscapes would provide the context for the long-term sustainability of these rapidly changing rapidly landscapes.	[Foord, Stefan Hendrik; Swanepoel, Lourens Hendrik; Schoeman, Colin Stefan; Mauda, Evans Vusani; Maree, Naudene; Dippenaar-Schoeman, Anna Sophia] Univ Venda, Dept Zool, Sch Math & Nat Sci, Thohoyandou, South Africa; [Foord, Stefan Hendrik; Swanepoel, Lourens Hendrik; Evans, Steven William; Schoeman, Colin Stefan; Mauda, Evans Vusani; Maree, Naudene; Nembudani, Nkhumeleni; Dippenaar-Schoeman, Anna Sophia; Taylor, Peter John] Univ Venda, Ctr Invas Biol, Sch Math & Nat Sci, Thohoyandou, South Africa; [Evans, Steven William; Nembudani, Nkhumeleni; Taylor, Peter John] Univ Venda, South African Res Chair Biodivers Value & Change, Sch Math & Nat Sci, Thohoyandou, South Africa; [Erasmus, Barend Frederik N.] Univ Witwatersrand, Global Change & Sustainabil Res Chair, Johannesburg, South Africa; [Schoeman, M. Corrie] Univ KwaZulu Natal, Coll Agr Engn & Sci, Sch Life Sci, Durban, South Africa; [Keith, Mark; Smith, Alain] Univ Pretoria, Ctr Wildlife Management, Pretoria, South Africa; [Munyai, Thinandavha Caswell] Univ KwaZulu Natal, Coll Agr Engn & Sci, Sch Life Sci, Pietermaritzburg, South Africa; [Taylor, Peter John] Univ KwaZulu Natal, Coll Agr Engn & Sci, Sch Life Sci, Westville, South Africa	University of Venda; University of Venda; University of Venda; University of Witwatersrand; University of Kwazulu Natal; University of Pretoria; University of Kwazulu Natal; University of Kwazulu Natal	Foord, SH (corresponding author), Univ Venda, Dept Zool, Sch Math & Nat Sci, Thohoyandou, South Africa.; Foord, SH (corresponding author), Univ Venda, Ctr Invas Biol, Sch Math & Nat Sci, Thohoyandou, South Africa.	stefan.foord@univen.ac.za	Keith, Mark/Q-1527-2018; Foord, Stefan Hendrik/F-3282-2018; Taylor, Peter John/N-3172-2019; Swanepoel, L H/O-3226-2019; Munyai, Caswell TC/F-9919-2013; Munyai, Caswell/AAD-3110-2020; Mauda, Evans Vusani V/G-6378-2018; Taylor, Peter/E-8655-2011; Erasmus, Barend/G-3411-2012; Mauda, Evans Vusani/M-2751-2019	Keith, Mark/0000-0001-7179-9989; Foord, Stefan Hendrik/0000-0002-9195-2562; Swanepoel, L H/0000-0002-9955-8076; Munyai, Caswell/0000-0002-1562-2385; Mauda, Evans Vusani V/0000-0001-9236-0473; Taylor, Peter/0000-0001-9048-7366; Erasmus, Barend/0000-0003-1869-8091; Mauda, Evans Vusani/0000-0001-9236-0473; Schoeman, Corrie/0000-0003-3736-0264	German Federal Government, BMBF (SPACES programme: Limpopo Living Landscapes project); National Research Foundation (NRF); Department of Science & Technology (DST) through the South African Research Chairs Initiative (SARChI) Chair on Biodiversity Value and Change in the Vhembe Biosphere Reserve, hosted; University of Venda; Sasol Agriculture Trust; Bundesministerium fur Bildung und Forschung; University of Venda [SMNS/17/Zoo/01]; International Foundation for Science [D/4984-2]; Centre for Invasion Biology	German Federal Government, BMBF (SPACES programme: Limpopo Living Landscapes project)(Federal Ministry of Education & Research (BMBF)); National Research Foundation (NRF); Department of Science & Technology (DST) through the South African Research Chairs Initiative (SARChI) Chair on Biodiversity Value and Change in the Vhembe Biosphere Reserve, hosted(Department of Science & Technology (India)); University of Venda; Sasol Agriculture Trust; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); University of Venda; International Foundation for Science(International Foundation for Science); Centre for Invasion Biology	Funded by German Federal Government, BMBF (SPACES programme: Limpopo Living Landscapes project); the National Research Foundation (NRF); the Department of Science & Technology (DST) through the South African Research Chairs Initiative (SARChI) Chair on Biodiversity Value and Change in the Vhembe Biosphere Reserve, hosted and supported by the University of Venda; the Sasol Agriculture Trust; Bundesministerium fur Bildung und Forschung; the University of Venda (SMNS/17/Zoo/01 to LHS); International Foundation for Science (D/4984-2 to LHS); and the Centre for Invasion Biology.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIS J, 1979, ZOOL ANZ, V202, P177; Arlettaz R, 2000, BIOL CONSERV, V93, P55, DOI 10.1016/S0006-3207(99)00112-3; BARCLAY RMR, 1985, CAN J ZOOL, V63, P2507, DOI 10.1139/z85-371; Barton BT, 2009, ECOL LETT, V12, P1317, DOI 10.1111/j.1461-0248.2009.01386.x; Barton PS, 2013, GLOBAL ECOL BIOGEOGR, V22, P639, DOI 10.1111/geb.12031; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Blaum N, 2007, AFR J ECOL, V45, P189, DOI 10.1111/j.1365-2028.2006.00696.x; Blaum N, 2009, BIODIVERS CONSERV, V18, P1187, DOI 10.1007/s10531-008-9498-x; Bontadina F, 2002, J ZOOL, V258, P281, DOI 10.1017/S0952836902001401; Borremans B, 2015, WILDLIFE RES, V42, P143, DOI 10.1071/WR14109; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Buckley LB, 2012, GLOBAL ECOL BIOGEOGR, V21, P873, DOI 10.1111/j.1466-8238.2011.00737.x; Cirovic D, 2016, BIOL CONSERV, V199, P51, DOI 10.1016/j.biocon.2016.04.027; COE MJ, 1976, OECOLOGIA, V22, P341, DOI 10.1007/BF00345312; Coetzee BW, 2016, ECOLOGY EVOLUTION; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Desmet PG, 2013, TECHNICAL REPORT; Dobson A, 2006, ECOLOGY, V87, P1915, DOI 10.1890/0012-9658(2006)87[1915:HLTCAT]2.0.CO;2; Farina A, 2000, BIOSCIENCE, V50, P313, DOI 10.1641/0006-3568(2000)050[0313:TCLAAM]2.3.CO;2; Fenton M.B., 1985, COMMUNICATION CHIROP; Fenton MB, 2001, J MAMMAL, V82, P721, DOI 10.1644/1545-1542(2001)082<0721:TEAZCP>2.0.CO;2; Fenton MB, 1998, CONSERV BIOL, V12, P399, DOI 10.1046/j.1523-1739.1998.96376.x; Fischer J, 2006, OIKOS, V112, P473, DOI 10.1111/j.0030-1299.2006.14148.x; Joseph GS, 2011, LANDSCAPE ECOL, V26, P439, DOI 10.1007/s10980-011-9572-8; Joseph GS, ECOSYSTEMS; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; KORN H, 1987, OECOLOGIA, V71, P597, DOI 10.1007/BF00379304; Lefcheck JS, 2015, ECOLOGY, V96, P2973, DOI 10.1890/14-1977.1; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Massawe AW, 2007, AFR J ECOL, V45, P293, DOI 10.1111/j.1365-2028.2006.00709.x; Mauda EV, 2018, BIODIVERS CONSERV, V27, P947, DOI 10.1007/s10531-017-1474-x; Meek P, 2016, ECOL EVOL, V6, P3216, DOI 10.1002/ece3.2111; Meek PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110832; Miller BW, 2001, ACTA CHIROPTEROL, V3, P93; Monadjem A., 2015, RODENTS SUBSAHARAN A; Monadjem A, 2009, MAMMALIA, V73, P353, DOI 10.1515/MAMM.2009.056; Muhly TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064311; Munyai TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122035; Nyffeler M, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1440-1; Oksanen J., 2007, R PACKAGE VERSION, V1, P15; Overson R, 2015, ZOOKEYS, P115, DOI 10.3897/zookeys.507.9303; QGIS Development Team, 2017, QGIS GEOGRAPHIC INFO; R Development Core Team, 2017, R LANG ENV STAT COMP; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Ribeiro DB, 2010, BIOTROPICA, V42, P710, DOI 10.1111/j.1744-7429.2010.00648.x; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; ROGERS LE, 1988, ANN ENTOMOL SOC AM, V81, P782, DOI 10.1093/aesa/81.5.782; Rouget M, 2003, BIOL CONSERV, V112, P217, DOI 10.1016/S0006-3207(02)00415-9; Schoeman Colin S., 2012, Transactions of the Royal Society of South Africa, V67, P1, DOI 10.1080/0035919X.2011.641690; Schoeman MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003715; Schuette P, 2013, BIOL CONSERV, V158, P301, DOI 10.1016/j.biocon.2012.08.008; Singleton GR, 2010, WILDLIFE RES, V37, P355, DOI 10.1071/WR10084; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Taylor PJ, 2015, J TROP ECOL, V31, P37, DOI 10.1017/S0266467414000613; Taylor PJ, 2013, AFR J ECOL, V51, P552, DOI 10.1111/aje.12066; Taylor PJ, 2013, S AFR J WILDL RES, V43, P12, DOI 10.3957/056.043.0117; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tibesigwa B, 2015, ENV DEV DISCUSSION P, P15; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Twine W, 2013, AFR J RANGE FOR SCI, V30, P39, DOI 10.2989/10220119.2013.768703; Vasconcelos HL, 2008, AUSTRAL ECOL, V33, P221, DOI 10.1111/j.1442-9993.2007.01811.x; Veech JA, 2010, ECOLOGY, V91, P1988, DOI 10.1890/09-1140.1; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013; Weier SM, 2016, MAMMALIA, V16, P27; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Wilson E.O., 1987, Conservation Biology, V1, P344, DOI 10.1111/j.1523-1739.1987.tb00055.x; Zhao ZH, 2013, METHODS ECOL EVOL, V4, P865, DOI 10.1111/2041-210X.12083	70	11	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0194336	10.1371/journal.pone.0194336	http://dx.doi.org/10.1371/journal.pone.0194336			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738559	gold, Green Published, Green Submitted			2022-12-26	WOS:000431724900002
J	Higaki, S; Muramatsu, M; Matsuda, A; Matsumoto, K; Satoh, J; Michikawa, M; Niida, S				Higaki, Sayuri; Muramatsu, Masashi; Matsuda, Akio; Matsumoto, Kenji; Satoh, Jun-ichi; Michikawa, Makoto; Niida, Shumpei			Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; MIR-200 FAMILY; MESENCHYMAL TRANSITION; SECRETED OLIGOMERS; INSULIN-RESISTANCE; NATURAL OLIGOMERS; COGNITIVE DECLINE; REPRESSORS ZEB1; IN-VIVO; PROTEIN	MiRNA molecules are important post-transcriptional regulators of gene expression in the brain function. Altered miRNA profiles could represent a defensive response against the pathogenesis of neurodegenerative disorders, such as Alzheimer's disease (AD). Endogenous miRNAs have lower toxic effects than other gene silencing methods, thus enhancing the expression of defensive miRNA could be an effective therapy. However, little is known about the potential of targeting miRNAs for the treatment of AD. Here, we examined the function of the miR-200 family (miR-200a, -141, -429, -200b, -200c), identified using miRNA microarray analysis of cortical tissue from Tg2576 transgenic mice. In murine primary neurons, we found that upregulation of miR-200b or -200c was induced by the addition of amyloid beta (A beta). Neurons transfected with miR-200b or -200c reduced secretion of A beta in conditioned medium. Moreover, mice infused with miR-200b/c into the brain were relieved of memory impairments induced by intracerebroventricular injection of oligomeric A beta, and demonstrated proper spatial learning in the Barnes maze. To gain further understanding of the relationship between miR-200b/c and A beta, we identified target mRNAs via an RNA-binding protein immunoprecipitation-microarray assay. Western blot analysis showed that expression of ribosomal protein S6 kinase B1 (S6K1), a candidate target, was inhibited by miR-200c. S6K1, a downstream effector of mammalian target of rapamycin (mTOR), serves as a negative feedback mediator that phosphorylates insulin receptor substrate 1 at serine residues (IRS-1pSer). S6K1-dependent IRS-1pSer suppresses insulin signaling leading to insulin resistance, which is frequently observed in AD brains. Notably, miR-200b/c transfection of SH-SY5Y cells reduced the levels of IRS-1pSer. This finding indicates that miR-200b/ c has the potential to alleviate insulin resistance via modulation of S6K1. Taken together, miR-200b/c may contribute to reduce A beta secretion and A beta-induced cognitive impairment by promoting insulin signaling.	[Higaki, Sayuri; Muramatsu, Masashi; Niida, Shumpei] Natl Ctr Geriatr & Gerontol, Med Genome Ctr, Obu, Aichi, Japan; [Muramatsu, Masashi] Kumamoto Univ, Inst Resource Dev & Anal, Div Phenotype Dis Anal, Kumamoto, Japan; [Matsuda, Akio; Matsumoto, Kenji] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Setagaya ku, Tokyo, Japan; [Satoh, Jun-ichi] Meiji Pharmaceut Univ, Dept Bioinformat & Mol Neuropathol, Kiyose, Tokyo, Japan; [Michikawa, Makoto] Nagoya City Univ, Dept Biochem, Grad Sch Med Sci, Nagoya, Aichi, Japan	National Center for Geriatrics & Gerontology; Kumamoto University; National Center for Child Health & Development - Japan; Meiji Pharmaceutical University; Nagoya City University	Higaki, S (corresponding author), Natl Ctr Geriatr & Gerontol, Med Genome Ctr, Obu, Aichi, Japan.	higaki@ncgg.go.jp			Advanced Research for Products Mining Program from the National Institute of Biomedical Innovation of Japan [10-43]; New Energy and Industrial Technology Development Organization (NEDO) [P14009]; Japan Agency for Medical Research and development (AMED) [P14009]	Advanced Research for Products Mining Program from the National Institute of Biomedical Innovation of Japan; New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Advanced Research for Products Mining Program [10-43] from the National Institute of Biomedical Innovation of Japan. This work was partially supported by the "Development of Diagnostic Technology for Detection of miRNA in Body Fluids" grant [P14009] from a project commissioned by the New Energy and Industrial Technology Development Organization (NEDO) and from Japan Agency for Medical Research and development (AMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Costa PM, 2015, J CONTROL RELEASE, V207, P31, DOI 10.1016/j.jconrel.2015.04.002; Cummings BJ, 1996, NEUROBIOL AGING, V17, P921, DOI 10.1016/S0197-4580(96)00170-4; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; Doi Y, 2009, AM J PATHOL, V175, P2121, DOI 10.2353/ajpath.2009.090418; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Haniu M, 2000, J BIOL CHEM, V275, P21099, DOI 10.1074/jbc.M002095200; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kishimoto Y, 2013, BRAIN RES, V1491, P117, DOI 10.1016/j.brainres.2012.10.066; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lourenco MV, 2013, CELL METAB, V18, P831, DOI 10.1016/j.cmet.2013.11.002; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Mouri A, 2012, J NEUROSCI, V32, P4562, DOI 10.1523/JNEUROSCI.6458-11.2012; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Parsons RB, 2007, BIOCHEM SOC T, V35, P974, DOI 10.1042/BST0350974; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Provost P, 2010, AGING-US, V2, P166, DOI 10.18632/aging.100131; Schonrock N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011070; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Sisodia S S, 1995, Neuroimaging Clin N Am, V5, P59; Son SM, 2012, DIABETES, V61, P3126, DOI 10.2337/db11-1735; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Uchino K, 2013, MOL THER, V21, P610, DOI 10.1038/mt.2012.269; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Zhang L, 2013, NEUROSCI LETT, V555, P112, DOI 10.1016/j.neulet.2013.09.030; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zhou ZD, 2011, CELL ADHES MIGR, V5, P280, DOI 10.4161/cam.5.4.16986; Zhu HC, 2012, BRAIN RES BULL, V88, P596, DOI 10.1016/j.brainresbull.2012.05.018	53	54	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196929	10.1371/journal.pone.0196929	http://dx.doi.org/10.1371/journal.pone.0196929			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738527	Green Submitted, gold, Green Published			2022-12-26	WOS:000431724900029
J	Zhang, T; Li, ZY; Liu, T; Li, SX; Gao, H; Wei, C; Shi, WY				Zhang, Ting; Li, Zhiyuan; Liu, Ting; Li, Suxia; Gao, Hua; Wei, Chao; Shi, Weiyun			Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment	PLOS ONE			English	Article							CORNEAL ALLOGRAFT-REJECTION; ANTERIOR-CHAMBER; T-CELLS; AQUEOUS-HUMOR; TRANSPLANTATION; PRIVILEGE; GRAFT; MICE; EYE; SURVIVAL	Cyclosporine A (CsA) is an essential medication used to prevent corneal allograft rejection. Our preliminary studies revealed that CsA drug-delivery system (DDS) was more effective in preventing high-risk corneal allograft rejection than topical CsA application. However, the impacts of CsA DDS on the intraocular immune microenvironment were not fully elucidated. In the present study, we investigated the effect of CsA DDS on the cornea allograft, aqueous humor, and iris-ciliary body using a rabbit model of high-risk penetrating keratoplasty. New Zealand white rabbits were divided into four groups: a normal control group, an untreated group, a CsA eye drop group and a CsA DDS group. Graft survival was monitored for 12 weeks, and the therapeutic effects of CsA DDS were evaluated at 3 and 12 weeks after high-risk keratoplasty. In the CsA DDS group, the mean graft survival time was significantly prolonged when compared with the untreated and CsA eye drop groups. At all time-points, Langerhans cell density, inflammatory cell density, and central corneal thickness in the CsA DDS group were much lower(all p < 0.01) than the untreated and CsA eye drop groups, in which their parameters were significantly higher than the normal control group (all p < 0.01). Compared with the untreated and CsA eye drop groups, an implanted CsA DDS markedly decreased the CD11b(+) and CD8(+) T cell infiltration in the corneal grafts. CsA DDS treatment also greatly reduced the CD4(+) T cell density and the expression of interferon-gamma, interleukin-2 (IL-2), IL-6, CD80, and CD86 mRNA both in the corneal graft and iris-ciliary body (all p < 0.01). Moreover, CsA DDS significantly reduced the IL-2 level in aqueous humor (p < 0.01). Taken together, our results suggest that CsA DDS implanted into the anterior chamber create a relative immunosuppressive microenvironment in the corneal graft, iris-ciliary body, and aqueous humor. Stabilizing the intraocular immune microenvironment could partially elucidate the mechanism of CsA DDS in suppressing corneal graft rejection.	[Zhang, Ting; Li, Zhiyuan; Liu, Ting; Wei, Chao; Shi, Weiyun] Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Qingdao, Peoples R China; [Zhang, Ting; Li, Suxia; Gao, Hua; Shi, Weiyun] Shandong Acad Med Sci, Shandong Eye Inst, Shandong Eye Inst, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Wei, C; Shi, WY (corresponding author), Shandong Acad Med Sci, Shandong Eye Inst, Shandong Prov Key Lab Ophthalmol, State Key Lab Cultivat Base, Qingdao, Peoples R China.; Shi, WY (corresponding author), Shandong Acad Med Sci, Shandong Eye Inst, Shandong Eye Inst, Jinan, Shandong, Peoples R China.	chaowei_82@163.com; weiyunshi@163.com		Wei, Chao/0000-0003-1581-8377	Innovation Project of Shandong Academy of Medical Sciences; Natural Science Foundation of Shandong Province [ZR2017PH064]; National Natural Science Foundation of China [81530027, 81500767, 81570821]	Innovation Project of Shandong Academy of Medical Sciences; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Innovation Project of Shandong Academy of Medical Sciences, Natural Science Foundation of Shandong Province (ZR2017PH064), and National Natural Science Foundation of China (81530027, 81500767 and 81570821). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AB, 2016, J IMMUNOL, V197, P2045, DOI 10.4049/jimmunol.1601135; Asai T, 2007, IMMUNOLOGY, V121, P349, DOI 10.1111/j.1365-2567.2007.02581.x; Beekhuis WH, 2003, DEV OPHTHALMOL, V36, P12; Brandt C, 2009, ALLERGY, V64, P1588, DOI 10.1111/j.1398-9995.2009.02054.x; Cai Q, 2000, J BIOMAT SCI-POLYM E, V11, P273, DOI 10.1163/156856200743698; Coenen JJA, 2007, BONE MARROW TRANSPL, V39, P537, DOI 10.1038/sj.bmt.1705628; Comer RM, 2002, INVEST OPHTH VIS SCI, V43, P1095; Dai ZX, 2016, MAT SCI ENG C-MATER, V66, P206, DOI 10.1016/j.msec.2016.04.077; Eperon S, 2013, INT J PHARMACEUT, V443, P254, DOI 10.1016/j.ijpharm.2012.12.033; Filantenkov A, 2002, TRANSPLANT P, V34, P2895, DOI 10.1016/S0041-1345(02)03551-0; Hamrah P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1132, DOI 10.1001/archopht.121.8.1132; Holt MP, 2017, J IMMUNOL, V198, P1503, DOI 10.4049/jimmunol.1601670; Hori J, 2010, OCUL IMMUNOL INFLAMM, V18, P325, DOI 10.3109/09273948.2010.512696; Kagaya F, 2002, EXP EYE RES, V74, P131, DOI 10.1006/exer.2001.1109; Koudouna E, 2017, INVEST OPHTH VIS SCI, V58, P242, DOI 10.1167/iovs.16-20019; Larkin DFP, 1997, CLIN EXP IMMUNOL, V107, P381, DOI 10.1111/j.1365-2249.1997.279-ce1171.x; Lass JH, 2017, JAMA OPHTHALMOL, V135, P1394, DOI 10.1001/jamaophthalmol.2017.4970; Liu YC, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14475; Liu Zhao-sheng, 2004, Zhonghua Yan Ke Za Zhi, V40, P108; Lu X, 2004, TRANSPL P, V36, P2429, DOI 10.1016/j.transproceed.2004.08.033; Maier P, 2011, MOL VIS, V17, P1016; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Marino J, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00582; Nicholls SM, 2006, EXP EYE RES, V83, P339, DOI 10.1016/j.exer.2005.12.018; Niederkorn JY, 2013, INT REV IMMUNOL, V32, P57, DOI 10.3109/08830185.2012.737877; Niederkorn JY, 2002, CRIT REV IMMUNOL, V22, P13; Panther F, 2011, TRANSPLANTATION, V91, P597, DOI 10.1097/TP.0b013e3182090f67; Qazi Y, 2013, J CLIN CELL IMMUNOL, V2013, DOI [10.4172/2155-9899.S9-006, DOI 10.4172/2155-9899.S9-006, 10.4172/2155-9899.s9-006]; Qazi Y, 2013, SEMIN OPHTHALMOL, V28, P287, DOI 10.3109/08820538.2013.825297; Reinhard T, 2002, ARCH OPHTHALMOL-CHIC, V120, P1630; Reinhard T, 2002, CORNEA, V21, P56, DOI 10.1097/00003226-200201000-00013; Shao H, 2002, CURR EYE RES, V25, P271, DOI 10.1076/ceyr.25.5.271.13491; Shi Wei-yun, 2004, Zhonghua Yan Ke Za Zhi, V40, P696; Shi WY, 2006, INVEST OPHTH VIS SCI, V47, P3339, DOI 10.1167/iovs.05-1425; Shi WY, 2013, OPHTHALMOLOGY, V120, P695, DOI 10.1016/j.ophtha.2012.09.035; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; Sugita S, 2009, ARCH IMMUNOL THER EX, V57, P263, DOI 10.1007/s00005-009-0030-0; Tan DTH, 2008, OPHTHALMOLOGY, V115, P975, DOI 10.1016/j.ophtha.2007.08.049; Taylor AW, 2009, EYE, V23, P1885, DOI 10.1038/eye.2008.382; Taylor AW, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00037; Tsuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031465; Verdier DD, 2013, CORNEA, V32, P729, DOI 10.1097/ICO.0b013e31827b14c7; Wang FH, 2012, INT J OPHTHALMOL-CHI, V5, P681, DOI 10.3980/j.issn.2222-3959.2012.06.06; Wang HJ, 2006, TRANSPLANTATION, V82, P1484, DOI 10.1097/01.tp.0000246312.89689.17; Xin M, 2012, J OCUL PHARMACOL TH, V28, P609, DOI 10.1089/jop.2012.0065; Yu AL, 2014, CORNEA, V33, P1149, DOI 10.1097/ICO.0000000000000225; Zhang HK, 2015, BIOL PHARM BULL, V38, P893, DOI 10.1248/bpb.b15-00111	47	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196571	10.1371/journal.pone.0196571	http://dx.doi.org/10.1371/journal.pone.0196571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734357	Green Published, gold, Green Submitted			2022-12-26	WOS:000431481700022
J	Farkas, IJ; Wang, SH				Farkas, Illes J.; Wang, Shuohong			Spatial flocking: Control by speed, distance, noise and delay	PLOS ONE			English	Article							COLLECTIVE MOTION; BACTERIAL COLONIES; PHASE-TRANSITION; MODEL; FLUCTUATIONS; DYNAMICS; BEHAVIOR; AGENTS; SYSTEM; BIRDS	Fish, birds, insects and robots frequently swim or fly in groups. During their three dimensional collective motion, these agents do not stop, they avoid collisions by strong short-range repulsion, and achieve group cohesion by weak long-range attraction. In a minimal model that is isotropic, and continuous in both space and time, we demonstrate that (i) adjusting speed to a preferred value, combined with (ii) radial repulsion and an (iii) effective long-range attraction are sufficient for the stable ordering of autonomously moving agents in space. Our results imply that beyond these three rules ordering in space requires no further rules, for example, explicit velocity alignment, anisotropy of the interactions or the frequent reversal of the direction of motion, friction, elastic interactions, sticky surfaces, a viscous medium, or vertical separation that prefers interactions within horizontal layers. Noise and delays are inherent to the communication and decisions of all moving agents. Thus, next we investigate their effects on ordering in the model. First, we find that the amount of noise necessary for preventing the ordering of agents is not sufficient for destroying order. In other words, for realistic noise amplitudes the transition between order and disorder is rapid. Second, we demonstrate that ordering is more sensitive to displacements caused by delayed interactions than to uncorrelated noise (random errors). Third, we find that with changing interaction delays the ordered state disappears at roughly the same rate, whereas it emerges with different rates. In summary, we find that the model discussed here is simple enough to allow a fair understanding of the modeled phenomena, yet sufficiently detailed for the description and management of large flocks with noisy and delayed interactions. Our code is available at http://github.com/fij/floc.	[Farkas, Illes J.] Huazhong Univ Sci & Technol, Dept Automat Control, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China; [Farkas, Illes J.] Hungarian Acad Sci, MTA ELTE Stat & Biol Phys Res Grp, Pazmany Peter Setany 1A, H-1117 Budapest, Hungary; [Wang, Shuohong] Fudan Univ, Sch Comp Sci, 825 Zhangheng Rd, Shanghai 201203, Peoples R China	Huazhong University of Science & Technology; Hungarian Academy of Sciences; Fudan University	Farkas, IJ (corresponding author), Huazhong Univ Sci & Technol, Dept Automat Control, 1037 Luoyu Rd, Wuhan 430074, Hubei, Peoples R China.; Farkas, IJ (corresponding author), Hungarian Acad Sci, MTA ELTE Stat & Biol Phys Res Grp, Pazmany Peter Setany 1A, H-1117 Budapest, Hungary.	fij@elte.hu			Hungarian Scientific Research Fund (OTKA) [NN 103114]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The authors gratefully acknowledge support from the Hungarian Scientific Research Fund (OTKA NN 103114), and advice received from T. Vicsek, M. Nagy, and H.-T. Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.095702; Bae HO, 2012, NONLINEARITY, V25, DOI 10.1088/0951-7715/25/4/1155; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Ballerini M, 2008, ANIM BEHAV, V76, P201, DOI 10.1016/j.anbehav.2008.02.004; Bialek W, 2014, P NATL ACAD SCI USA, V111, P7212, DOI 10.1073/pnas.1324045111; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Czirok A, 1996, PHYS REV E, V54, P1791, DOI 10.1103/PhysRevE.54.1791; Deseigne J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.098001; Erban R, 2016, SIAM J APPL MATH, V76, P1535, DOI 10.1137/15M1030467; Farkas IJ, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.012807; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Ginelli F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.184502; Grossman D, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/023036; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2000, PHYS REV LETT, V84, P1240, DOI 10.1103/PhysRevLett.84.1240; Hemelrijk CK, 2015, J STAT PHYS, V158, P563, DOI 10.1007/s10955-014-1154-0; Jadbabaie A, 2003, IEEE T AUTOMAT CONTR, V48, P988, DOI 10.1109/TAC.2003.812781; Kaiser A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.268307; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Lindley B, 2013, AM CONTR C ACC; Mendelson NH, 1999, J BACTERIOL, V181, P600, DOI 10.1128/JB.181.2.600-609.1999; Mier-y-Teran-Romero L, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.056202; Nagy M, 2007, PHYSICA A, V373, P445, DOI 10.1016/j.physa.2006.05.035; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Nguyen NHP, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011136; Olfati-Saber R, 2004, IEEE T AUTOMAT CONTR, V49, P1520, DOI 10.1109/TAC.2004.834113; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Romenskyy M, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-30821-1; Schweitzer F, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.021110; Ton TV, 2014, ANAL APPL, V12, P63, DOI 10.1142/S0219530513500255; TONER J, 1995, PHYS REV LETT, V75, P4326, DOI 10.1103/PhysRevLett.75.4326; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Wu YL, 2009, P NATL ACAD SCI USA, V106, P1222, DOI 10.1073/pnas.0811662106; Zhang HP, 2010, P NATL ACAD SCI USA, V107, P13626, DOI 10.1073/pnas.1001651107	36	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2018	13	5							e0191745	10.1371/journal.pone.0191745	http://dx.doi.org/10.1371/journal.pone.0191745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE7ZR	29727441	gold, Green Published, Green Submitted			2022-12-26	WOS:000431452100002
J	Jiang, ZL; Gao, S; Li, MJ				Jiang, Zilong; Gao, Shu; Li, Mingjiang			An improved advertising CTR prediction approach based on the fuzzy deep neural network	PLOS ONE			English	Article							CONFUSION-MATRIX	Combining a deep neural network with fuzzy theory, this paper proposes an advertising click-through rate (CTR) prediction approach based on a fuzzy deep neural network (FDNN). In this approach, fuzzy Gaussian-Bernoulli restricted Boltzmann machine (FGBRBM) is first applied to input raw data from advertising datasets. Next, fuzzy restricted Boltzmann machine (FRBM) is used to construct the fuzzy deep belief network (FDBN) with the unsupervised method layer by layer. Finally, fuzzy logistic regression (FLR) is utilized for modeling the CTR. The experimental results show that the proposed FDNN model outperforms several baseline models in terms of both data representation capability and robustness in advertising click log datasets with noise.	[Jiang, Zilong; Gao, Shu] Wuhan Univ Technol, Sch Comp Sci & Technol, Wuhan, Hubei, Peoples R China; [Jiang, Zilong; Li, Mingjiang] Qiannan Normal Univ Nationalities, Sch Comp & Informat, Duyun, Guizhou, Peoples R China	Wuhan University of Technology	Li, MJ (corresponding author), Qiannan Normal Univ Nationalities, Sch Comp & Informat, Duyun, Guizhou, Peoples R China.	mingjiangli1975@gmail.com			Natural Science Research Project of Education Department of Guizhou Province of China [KY12017350]; Project Funds of the Digital Engineering Research Center for Local National Culture of Universities in Guizhou [KY2013227]; Scientific Research Project of Qiannan Normal University for Nationalities [qnsy2017006]	Natural Science Research Project of Education Department of Guizhou Province of China; Project Funds of the Digital Engineering Research Center for Local National Culture of Universities in Guizhou; Scientific Research Project of Qiannan Normal University for Nationalities	This work is supported by the Natural Science Research Project of Education Department of Guizhou Province of China (No.KY12017350), the Project Funds of the Digital Engineering Research Center for Local National Culture of Universities in Guizhou (No.KY2013227) and the Scientific Research Project of Qiannan Normal University for Nationalities (No.qnsy2017006). The funder makes contributions on analysis, decision to publish.	Akimova T, 2016, METHODS MOL BIOL, V1371, P43, DOI 10.1007/978-1-4939-3139-2_4; Anh-Phuong TA, 2015, PROCEEDINGS 2015 IEEE INTERNATIONAL CONFERENCE ON BIG DATA, P2889, DOI 10.1109/BigData.2015.7364112; Asghari-Larimi M, 2012, INT MATH FORUM, P531; Baqapuri Afroze Ibrahim, 2014, 14126601 ARXIV; Chapelle O, 2014, ACM T INTEL SYST TEC, V5, P1, DOI [10.1145/2532128, DOI 10.1145/2532128]; Chen CLP, 2015, IEEE T FUZZY SYST, V23, P2163, DOI 10.1109/TFUZZ.2015.2406889; Chen C, 2016, IEICE T INF SYST, VE99D, P270, DOI 10.1587/transinf.2015EDL8116; Chen J., 2016, P ACM MULTIMEDIA ACM, P811; Dave Kushal, 2010, PREDICTING CLICK THR, P1; Deng XY, 2016, INFORM SCIENCES, V340, P250, DOI 10.1016/j.ins.2016.01.033; Dreyfus SE, 2012, J GUIDANCE CONTROL D, V13, P926; Dutta S, 2015, SOFT COMPUT, V19, P99, DOI 10.1007/s00500-014-1356-z; Gao W, 2016, SCI CHINA INFORM SCI, V59, DOI 10.1007/s11432-015-5470-z; Gelfand Alan E, 2000, J AM STAT ASSOC, V95, P1300, DOI [10.1080/01621459.2000.10474335, DOI 10.1080/01621459.2000.10474335]; Gustav Klimt, 2003, FUZZY PROBABILITIES, V20, P363; Hamrawi H, 2017, IEEE T FUZZY SYST, V25, P682, DOI 10.1109/TFUZZ.2016.2574914; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; HORIKAWA S, 1992, IEEE T NEURAL NETWOR, V3, P801, DOI 10.1109/72.159069; Jiang ZL, 2016, CONTROL ENG APPL INF, V18, P11; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Juan YC, 2016, PROCEEDINGS OF THE 10TH ACM CONFERENCE ON RECOMMENDER SYSTEMS (RECSYS'16), P43, DOI 10.1145/2959100.2959134; Kim HC, 2017, INT CONF ACOUST SPEE, P6150, DOI 10.1109/ICASSP.2017.7953338; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lei YG, 2016, IEEE T IND ELECTRON, V63, P3137, DOI 10.1109/TIE.2016.2519325; Mosca A, 2017, ADV INTELL SYST COMP, V513, P433, DOI 10.1007/978-3-319-46562-3_28; Najafi-Asadolahi S, 2014, M&SOM-MANUF SERV OP, V16, P482, DOI 10.1287/msom.2014.0491; Oentaryo RJ, 2014, WSDM'14: PROCEEDINGS OF THE 7TH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING, P123, DOI 10.1145/2556195.2556240; Ohsaki M, 2017, IEEE T KNOWL DATA EN, V29, P1806, DOI 10.1109/TKDE.2017.2682249; Pan Z, 2016, IEEE DATA MINING, P400, DOI [10.1109/ICDM.2016.53, 10.1109/ICDM.2016.0051]; Rendle S, 2012, ACM T INTEL SYST TEC, V3, DOI 10.1145/2168752.2168771; Runkler T.A., 1994, DECADE FAST CENTROID, P161; Shimin Yu, 2016, PREDICTION ADS CLICK, P12; Shrestha R, 2016, IEEE T BIOMED CIRC S, V10, P884, DOI 10.1109/TBCAS.2016.2546838; Taher Osman, 2016, INT J URBAN SCI, V58, P1; Talabani AJ, 2017, INT J COLORECTAL DIS, V32, P41, DOI 10.1007/s00384-016-2644-0; Triba MN, 2015, MOL BIOSYST, V11, P13, DOI 10.1039/c4mb00414k; Wang H, 2017, KNOWL-BASED SYST, V118, P15, DOI 10.1016/j.knosys.2016.11.008; [徐泽水 Xu Zeshui], 2002, [模糊系统与数学, Fuzzy Systems and Mathematics], V16, P47; Zhang YY, 2014, AAAI CONF ARTIF INTE, P1369; Zhong Li, 2016, 2016 IEEE International Conference on Automation, Quality and Testing, Robotics (AQTR). Proceedings, P1, DOI 10.1109/AQTR.2016.7501283	41	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2018	13	5							e0190831	10.1371/journal.pone.0190831	http://dx.doi.org/10.1371/journal.pone.0190831			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE7ZR	29727443	Green Published, gold, Green Submitted			2022-12-26	WOS:000431452100001
J	Poma, P; Labbozzetta, M; Notarbartolo, M; Bruno, M; Maggio, A; Rosselli, S; Sajeva, M; Zito, P				Poma, Paola; Labbozzetta, Manuela; Notarbartolo, Monica; Bruno, Maurizio; Maggio, Antonella; Rosselli, Sergio; Sajeva, Maurizio; Zito, Pietro			Chemical composition, in vitro antitumor and pro-oxidant activities of Glandora rosmarinifolia (Boraginaceae) essential oil	PLOS ONE			English	Article							BIOLOGICAL-PROPERTIES; ANTICANCER ACTIVITY; NAPHTHOQUINONES; LITHODORA; DERIVATIVES; DITERPENES; CURCUMIN; CANCER	The biological properties of essential oils have been demonstrated in the treatment of several diseases and to enhance the bioavailability of other drugs. In natural habitats the essential oils compounds may play important roles in the protection of the plants as antibacterials, antivirals, antifungals, insecticides and also against herbivores by reducing their appetite for such plants or by repelling undesirable others. We analyzed by gas-chromatography mass spectrometry the chemical composition of the essential oil of aerial parts of Glandora rosmarinifolia (Ten.) D.C. Thomas obtained by hydrodistillation and verified some biological activities on a panel of hepatocellular carcinoma cell lines (HA22T/VGH, HepG2, Hep3B) and triple negative breast cancer cell lines (SUM 149, MDA-MB-231). In the essential oil we detected 35 compounds. The results of the biological assays indicate that essential oil of G. rosmarinifolia induces cell growth inhibition at concentration-dependent way in all cell line models. This oil does not seem to possess antioxidant activity, while the cytotoxicity of G. rosmarinifolia essential oil appeared to involve, at least in part, a pro-oxidant mechanism. Our results show for the first time the antitumoral and pro-oxidant activities of G. rosmarinifolia essential oil and suggest that it may represent a resource of pharmacologically active compounds.	[Poma, Paola; Labbozzetta, Manuela; Notarbartolo, Monica] Univ Palermo, Dept Hlth Sci & Mother & Child Care G DAlessandro, Pharmacol Unit, Palermo, Italy; [Bruno, Maurizio; Maggio, Antonella; Rosselli, Sergio; Sajeva, Maurizio; Zito, Pietro] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, Palermo, Italy	University of Palermo; University of Palermo	Notarbartolo, M (corresponding author), Univ Palermo, Dept Hlth Sci & Mother & Child Care G DAlessandro, Pharmacol Unit, Palermo, Italy.; Bruno, M; Sajeva, M (corresponding author), Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, Palermo, Italy.	monica.notarbartolo@unipa.it; maurizio.bruno@unipa.it; maurizio.sajeva@unipa.it	Labbozzetta, Manuela/AAE-5418-2022; Zito, Pietro/N-7527-2014; Maggio, Antonella Maria/AAW-2804-2021; Notarbartolo di Villarosa, Monica/AAE-5324-2022; Poma, Paola/AAE-5325-2022; Sajeva, Maurizio/N-7544-2014	Zito, Pietro/0000-0002-6188-5434; Maggio, Antonella Maria/0000-0002-0861-626X; Sajeva, Maurizio/0000-0003-4731-7112; ROSSELLI, Sergio/0000-0002-2448-9192	MIUR-ITALY PRIN [2015MSCKCE_003]	MIUR-ITALY PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by a grant from MIUR-ITALY PRIN2015 "Top-down and Bottom-up approach in the development of new bioactive chemical entities inspired on natural products scaffolds" (Project N. 2015MSCKCE_003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant from MIUR-ITALY PRIN2015 "Top-down and Bottom -up approach in the development of new bioactive chemical entities inspired on natural products scaffolds" (Project N. 2015MSCKCE_003).	Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Adorjan B, 2010, FLAVOUR FRAG J, V25, P407, DOI 10.1002/ffj.2024; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Bass, 1990, HERBAL MED PRESENT R; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Castovejo S, 2012, FLORA IBERICA PLANTA, V11; Fernandes F, 2017, ARAB J CHEM, V10, P583, DOI 10.1016/j.arabjc.2015.01.012; Ferreres F, 2013, FOOD CHEM, V136, P1390, DOI 10.1016/j.foodchem.2012.09.089; Ferrero V, 2012, ANN BOT-LONDON, V109, P655, DOI 10.1093/aob/mcr222; Ferrero V, 2011, PLANT BIOLOGY, V13, P7, DOI 10.1111/j.1438-8677.2009.00307.x; Ferrero V, 2009, PERSPECT PLANT ECOL, V11, P111, DOI 10.1016/j.ppees.2009.01.004; Hassler M., 2018, SPECIES 2000 ITIS CA; Islam MT, 2017, PHYTOTHER RES, V31, P691, DOI 10.1002/ptr.5800; Khan IA, 2009, LEUNGS ENCY COMMON N; Kumagai Y, 2012, ANNU REV PHARMACOL, V52, P221, DOI 10.1146/annurev-pharmtox-010611-134517; Kumar BS, 2017, BIOORGAN MED CHEM, V25, P1364, DOI 10.1016/j.bmc.2016.12.043; Labbozzetta M, 2009, ANN NY ACAD SCI, V1155, P278, DOI 10.1111/j.1749-6632.2009.03699.x; LÓPEZ LÓPEZ Lluvia Itzel, 2014, Vitae, V21, P248; Murakami K, 2010, TOXICOL IN VITRO, V24, P905, DOI 10.1016/j.tiv.2009.11.018; Notarbartolo M, 2005, CANCER LETT, V224, P53, DOI 10.1016/j.canlet.2004.10.051; Poma P, 2017, OMICS, V21, P225, DOI 10.1089/omi.2017.0020; Ramos-Peralta L, 2015, NAPHTHOQUINONE BIOAC; Scotti L, 2014, NAT PROD COMMUN, V9, P911; Song Y., 2015, BIOCH ANAL BIOCH, V4, P211; Thomas DC, 2008, TAXON, V57, P79, DOI 10.2307/25065950; Zerbe P, 2015, TRENDS BIOTECHNOL, V33, P419, DOI 10.1016/j.tibtech.2015.04.006	27	22	22	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196947	10.1371/journal.pone.0196947	http://dx.doi.org/10.1371/journal.pone.0196947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723282	Green Published, Green Submitted, gold			2022-12-26	WOS:000431305100095
J	de Oliveira, D; Keeling, LJ				de Oliveira, Daiana; Keeling, Linda J.			Routine activities and emotion in the life of dairy cows: Integrating body language into an affective state framework	PLOS ONE			English	Article							AUTOMATIC MILKING SYSTEM; HEART-RATE; EAR POSTURES; VETERINARY PROCEDURE; POSITIVE EMOTIONS; TAIL-DOCKING; TELL US; WELFARE; BEHAVIOR; CATTLE	We assessed dairy cows' body postures while they were performing different stationary activities in a loose housing system and then used the variation within and between individuals to identify potential connections between specific postures and the valence and arousal dimensions of emotion. We observed 72 individuals within a single milking herd focusing on their ear, neck and tail positions while they were: feeding from individual roughage bins, being brushed by a mechanical rotating brush and queuing to enter a single automatic milking system. Cows showed different ear, neck and tail postures depending on the situation. When combined, their body posture during feeding was ears back up and neck down, with tail wags directed towards the body, during queuing their ears were mainly axial and forward, their neck below the horizontal and the tail hanging stationary, and during brushing their ears were backwards and asymmetric, the neck horizontal and the tail wagging vigorously. We then placed these findings about cow body posture during routine activities into an arousal/valence framework used in animal emotion research (dimensional model of core affect). In this way we generate a priori predictions of how the positions of the ears, neck and tail of cows may change in other situations, previously demonstrated to vary in valence and arousal. We propose that this new methodology, with its different steps of integration, could contribute to the identification and validation of behavioural (postural) indicators of how positively or negatively cows experience other activities, or situations, and how calm or aroused they are. Although developed here on dairy cattle, by focusing on relevant postures, this approach could be easily adapted to other species.	[de Oliveira, Daiana; Keeling, Linda J.] Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Uppsala, Sweden	Swedish University of Agricultural Sciences	Keeling, LJ (corresponding author), Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Uppsala, Sweden.	linda.keeling@slu.se	Keeling, Linda J/K-6542-2012; de Oliveira, Daiana/N-3038-2013	Keeling, Linda J/0000-0003-2629-0117; de Oliveira, Daiana/0000-0002-6787-2626	Swedish Research Council Formas [221-2013-330]; National Council for Scientific and Technological Development (CNPq)	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the Swedish Research Council Formas (http:www.formas.se/en/), grant number 221-2013-330 to LK and the National Council for Scientific and Technological Development (CNPq) to DO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkema HW, 2015, J DAIRY SCI, V98, P7426, DOI 10.3168/jds.2015-9377; Blokhuis HJ, 2010, ACTA AGR SCAND A-AN, V60, P129, DOI 10.1080/09064702.2010.523480; Boissy A, 2011, ANIM WELFARE, V20, P47; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Bokkers EAM, 2012, ANIM WELFARE, V21, P307, DOI 10.7120/09627286.21.3.307; Breuer K, 2003, APPL ANIM BEHAV SCI, V84, P3, DOI 10.1016/S0168-1591(03)00146-1; Briefer EF, 2015, ANIM BEHAV, V99, P131, DOI 10.1016/j.anbehav.2014.11.002; Ceballos A, 2002, APPL ANIM BEHAV SCI, V77, P249, DOI 10.1016/S0168-1591(02)00054-0; Chapagain D, 2014, APPL ANIM BEHAV SCI, V160, P64, DOI 10.1016/j.applanim.2014.08.004; Dalla Costa E, 2016, ANIM WELFARE, V25, P481, DOI 10.7120/09627286.25.4.481; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DAWKINS MS, 1990, BEHAV BRAIN SCI, V13, P1, DOI 10.1017/S0140525X00077104; de Vere AJ, 2016, WIRES COGN SCI, V7, P354, DOI 10.1002/wcs.1399; de Vries M, 2015, PREV VET MED, V118, P80, DOI 10.1016/j.prevetmed.2014.11.016; Duncan IJH, 1993, J AGR ENVIRON ETHIC, P9; Eicher SD, 2000, J DAIRY SCI, V83, P1456, DOI 10.3168/jds.S0022-0302(00)75017-X; Frondelius L, 2015, PHYSIOL BEHAV, V139, P437, DOI 10.1016/j.physbeh.2014.12.002; Gleerup KB, 2015, APPL ANIM BEHAV SCI, V171, P25, DOI 10.1016/j.applanim.2015.08.023; Guesgen MJ, 2017, ANIM WELFARE, V26, P383, DOI 10.7120/09627286.26.4.383; Guesgen MJ, 2016, ANIM WELFARE, V25, P171, DOI 10.7120/09627286.25.2.171; Halachmi I, 2009, BIOSYST ENG, V102, P453, DOI 10.1016/j.biosystemseng.2009.01.010; Hedlund L, 2015, J DAIRY SCI, V98, P5819, DOI 10.3168/jds.2014-8667; Lecorps B, 2015, BEHAV PROCESS, V120, P25, DOI 10.1016/j.beproc.2015.08.002; Leliveld LMC, 2013, APPL ANIM BEHAV SCI, V145, P1, DOI 10.1016/j.applanim.2013.02.002; Melin M, 2006, APPL ANIM BEHAV SCI, V96, P201, DOI 10.1016/j.applanim.2005.06.013; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Moe RO, 2009, APPL ANIM BEHAV SCI, V121, P171, DOI 10.1016/j.applanim.2009.10.002; Ocklenburg S, 2016, PHYSIOL BEHAV, V164, P321, DOI 10.1016/j.physbeh.2016.06.020; Oltenacu PA, 2010, ANIM WELFARE, V19, P39; Pacella D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187463; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Phillips CJC, 2015, J DAIRY SCI, V98, P2389, DOI 10.3168/jds.2014-8648; Prescott NB, 1998, APPL ANIM BEHAV SCI, V57, P23, DOI 10.1016/S0168-1591(97)00112-3; Proctor HS, 2015, PHYSIOL BEHAV, V147, P1, DOI 10.1016/j.physbeh.2015.04.011; Proctor HS, 2014, APPL ANIM BEHAV SCI, V161, P20, DOI 10.1016/j.applanim.2014.09.015; Quaranta A, 2007, CURR BIOL, V17, pR199, DOI 10.1016/j.cub.2007.02.008; Reefmann N, 2009, APPL ANIM BEHAV SCI, V118, P199, DOI 10.1016/j.applanim.2009.02.013; Reimert I, 2013, PHYSIOL BEHAV, V109, P42, DOI 10.1016/j.physbeh.2012.11.002; Rolls E. T., 2005, EMOTION EXPLAINED; Rolls ET, 2013, EMOT REV, V5, P241, DOI 10.1177/1754073913477514; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2009, COGNITION EMOTION, V23, P1259, DOI 10.1080/02699930902809375; Schmied C, 2008, APPL ANIM BEHAV SCI, V109, P25, DOI 10.1016/j.applanim.2007.01.013; Schmied C, 2010, INTERACT STUD, V11, P467, DOI 10.1075/is.11.3.08sch; Stull CL, 2002, J AM VET MED ASSOC, V220, P1298, DOI 10.2460/javma.2002.220.1298; Tuyttens FAM, 2014, ANIM BEHAV, V90, P273, DOI 10.1016/j.anbehav.2014.02.007; Uetake K, 1997, J ANIM SCI, V75, P954; Verbeek E, 2012, APPL ANIM BEHAV SCI, V142, P18, DOI 10.1016/j.applanim.2012.09.001; von Keyserlingk MAG, 2009, J DAIRY SCI, V92, P4101, DOI 10.3168/jds.2009-2326; Waiblinger S, 2004, APPL ANIM BEHAV SCI, V85, P31, DOI 10.1016/j.applanim.2003.07.002; Wemelsfelder F, 2001, ANIM BEHAV, V62, P209, DOI 10.1006/anbe.2001.1741; Westerath HS, 2014, APPL ANIM BEHAV SCI, V156, P12, DOI 10.1016/j.applanim.2014.04.003	52	24	24	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195674	10.1371/journal.pone.0195674	http://dx.doi.org/10.1371/journal.pone.0195674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5SH	29718937	Green Submitted, Green Published, gold			2022-12-26	WOS:000431281900028
J	Uhlich, GA; Andreozzi, E; Cottrell, BJ; Reichenberger, ER; Zhang, XM; Paoli, GC				Uhlich, Gaylen A.; Andreozzi, Elise; Cottrell, Bryan J.; Reichenberger, Erin R.; Zhang, Xinmin; Paoli, George C.			Sulfamethoxazole-Trimethoprim represses csgD but maintains virulence genes at 30 degrees C in a clinical Escherichia coli O157:H7 isolate	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ENTEROCYTE EFFACEMENT GENES; BIOFILM FORMATION; CONTROLS EXPRESSION; LOCUS; O157-H7; REGULATOR; PROMOTER; TRANSCRIPTION; ANTIBIOTICS	The high frequency of prophage insertions in the mlrA gene of clinical serotype O157: H7 isolates renders such strains deficient in csgD-dependent biofilm formation but prophage induction may restore certain mlrA properties. In this study we used transcriptomics to study the effect of high and low sulfamethoxazole-trimethoprim (SMX-TM) concentrations on prophage induction, biofilm regulation, and virulence gene expression in strain PA20 under environmental conditions following 5-hour and 12-hour exposures in broth or on agar. SMXTM at a sub-lethal concentration induced strong RecA expression resulting in concentrationand time-dependent major transcriptional shifts with emphasis on up-regulation of genes within horizontally-transferred chromosomal regions (HTR). Neither high or low levels of SMX-TM stimulated csgD expression at either time point, but both levels resulted in slight repression. Full expression of Ler-dependent genes paralleled expression of group 1 pch homologues in the presence of high glrA. Finally, stx(2) expression, which is strongly dependent on prophage induction, was enhanced at 12 hours but repressed at five hours, in spite of early SOS initiation by the high SMX-TM concentration. Our findings indicate that, similar to host conditions, exposure to environmental conditions increased the expression of virulence genes in a clinical isolate but genes involved in the protective biofilm response were repressed.	[Uhlich, Gaylen A.; Andreozzi, Elise; Cottrell, Bryan J.; Reichenberger, Erin R.; Paoli, George C.] ARS, USDA, Mol Characterizat Foodborne Pathogens Res Unit, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA; [Zhang, Xinmin] BioInfoRx Inc, Madison, WI USA	United States Department of Agriculture (USDA)	Uhlich, GA (corresponding author), ARS, USDA, Mol Characterizat Foodborne Pathogens Res Unit, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA.	gaylen.uhlich@ars.usda.gov			United States Department of Agriculture, Agricultural Research Service, National Program 108 Food Safety [8072-42000-076]; BioInfoRx Inc.	United States Department of Agriculture, Agricultural Research Service, National Program 108 Food Safety; BioInfoRx Inc.	This work was supported by United States Department of Agriculture, Agricultural Research Service, National Program 108 Food Safety [Project # 8072-42000-076] (GAU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Neither Dr. Xinmin Zhang or BioInfoRx Inc. provided financial support in any form. The specific roles of this author are detailed in the 'Author Contributions' section. Dr. Xinmin Zhang's affiliation with BioInfoRx, Inc.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Asadulghani M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000408; Barba J, 2005, J BACTERIOL, V187, P7918, DOI 10.1128/JB.187.23.7918-7930.2005; Bingle LEH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080160; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056/NEJM199508103330608; Boyd E Fidelma, 2012, Bacteriophage, V2, P139; Brown PK, 2001, MOL MICROBIOL, V41, P349, DOI 10.1046/j.1365-2958.2001.02529.x; Chen CJ, 2016, PHYS PLASMAS, V23, DOI 10.1063/1.4968841; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Ethelberg S, 2004, EMERG INFECT DIS, V10, P842, DOI 10.3201/eid1005.030576; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Freedman SB, 2016, CLIN INFECT DIS, V62, P1251, DOI 10.1093/cid/ciw099; Frye JG, 2005, J BACTERIOL, V187, P1485, DOI 10.1128/JB.187.4.1485-1492.2005; Garcia A, 2010, ILAR J, V51, P221, DOI 10.1093/ilar.51.3.221; Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Herold S, 2005, ANTIMICROB AGENTS CH, V49, P931, DOI 10.1128/AAC.49.3.931-944.2005; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Iyoda S, 2004, MICROBIOL-SGM, V150, P2357, DOI 10.1099/mic.0.27100-0; Jorgensen MG, 2012, MOL MICROBIOL, V84, P36, DOI 10.1111/j.1365-2958.2012.07976.x; Kimmitt PT, 2000, EMERG INFECT DIS, V6, P458, DOI 10.3201/eid0605.000503; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Landstorfer R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-353; Lara-Ochoa C, 2010, CURRENT RES TECHNOLO, V1, P635; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Mellies JL, 1999, MOL MICROBIOL, V33, P296, DOI 10.1046/j.1365-2958.1999.01473.x; Miyashita A, 2012, FEMS MICROBIOL LETT, V333, P59, DOI 10.1111/j.1574-6968.2012.02599.x; Ogasawara H, 2010, FEMS MICROBIOL LETT, V312, P160, DOI 10.1111/j.1574-6968.2010.02112.x; Ogasawara H, 2010, MICROBIOL-SGM, V156, P2470, DOI 10.1099/mic.0.039131-0; Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4; Porter ME, 2005, J BACTERIOL, V187, P458, DOI 10.1128/JB.187.2.458-472.2005; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Russell RM, 2007, J BACTERIOL, V189, P5387, DOI 10.1128/JB.00553-07; Sangurdekar DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-583; Scheiring J, 2008, PEDIATR NEPHROL, V23, P1749, DOI 10.1007/s00467-008-0935-6; Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003; Sharp FC, 2007, INFECT IMMUN, V75, P2432, DOI 10.1128/IAI.02003-06; Snedecor G.W., 1989, AMES IOWA STATE U PR; Sommerfeldt N, 2009, MICROBIOL-SGM, V155, P1318, DOI 10.1099/mic.0.024257-0; Sperandio V, 2000, MOL MICROBIOL, V38, P781, DOI 10.1046/j.1365-2958.2000.02168.x; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Thomason MK, 2010, ANNU REV GENET, V44, P167, DOI 10.1146/annurev-genet-102209-163523; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Tree JJ, 2009, TRENDS MICROBIOL, V17, P361, DOI 10.1016/j.tim.2009.06.001; Uhlich GA, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.01460-16; Uhlich GA, 2017, MICROBIOL-SGM, V163, P611, DOI 10.1099/mic.0.000448; Uhlich GA, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw123; Uhlich GA, 2013, MICROBIOL-SGM, V159, P1586, DOI 10.1099/mic.0.066118-0; Uhlich GA, 2012, PLASMID, V67, P259, DOI 10.1016/j.plasmid.2011.12.003; Uhlich GA, 2009, MICROBIOL-SGM, V155, P3589, DOI 10.1099/mic.0.031435-0; Wagner PL, 2001, J BACTERIOL, V183, P2081, DOI 10.1128/JB.183.6.2081-2085.2001; Wang GQ, 2010, FEBS LETT, V584, P194, DOI 10.1016/j.febslet.2009.11.067; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Williams AP, 2006, FEMS MICROBIOL ECOL, V58, P54, DOI 10.1111/j.1574-6941.2006.00142.x; Zhang LH, 2004, INFECT IMMUN, V72, P7282, DOI 10.1128/IAI.72.12.7282-7293.2004	64	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196271	10.1371/journal.pone.0196271	http://dx.doi.org/10.1371/journal.pone.0196271			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718957	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900049
J	Lee, J; Yi, S; Won, M; Song, YS; Yi, HS; Park, YJ; Park, KC; Kim, JT; Chang, JY; Lee, MJ; Sul, HJ; Choi, JE; Kim, KS; Kero, J; Kim, J; Shong, M				Lee, Junguee; Yi, Shinae; Won, Minho; Song, Young Shin; Yi, Hyon-Seung; Park, Young Joo; Park, Ki Cheol; Kim, Jung Tae; Chang, Joon Young; Lee, Min Joung; Sul, Hae Joung; Choi, Ji Eun; Kim, Koon Soon; Kero, Jukka; Kim, Joon; Shong, Minho			Loss-of-function of IFT88 determines metabolic phenotypes in thyroid cancer	ONCOGENE			English	Article							INTRAFLAGELLAR TRANSPORT PROTEINS; CYSTIC KIDNEY-DISEASE; BARDET-BIEDL-SYNDROME; PRIMARY CILIA; TUMOR SUPPRESSORS; GENE TG737; SENESCENCE; COMPLEX; AURORA; CELLS	Primary cilia are microtubule-based, dynamic organelles characterized by continuous assembly and disassembly. The intraflagellar transport (IFT) machinery, including IFT88 in cilia, is involved in the maintenance of bidirectional motility along the axonemes, which is required for ciliogenesis and functional competence. Cancer cells are frequently associated with loss of primary cilia and IFT functions. However, there is little information on the role of IFT88 or primary cilia in the metabolic remodeling of cancer cells. Therefore, we investigated the cellular and metabolic effects of the loss-of-function (LOF) mutations of IFT88/primary cilia in thyroid cancer cells. IFT88-deficient 8505C thyroid cancer cells were generated using the CRISPR/Cas9 system, and RNA-sequencing analysis was performed. LOF of the IFT88 gene resulted in a marked defect in ciliogenesis and mitochondrial oxidative function. Gene expression patterns in IFT88-deficient thyroid cancer cells favored glycolysis and lipid biosynthesis. However, LOF of IFT88/primary cilia did not promote thyroid cancer cell proliferation, migration, and invasion. The results suggest that IFT88/primary mary cilia play a role in metabolic reprogramming in thyroid cancer cells.	[Lee, Junguee; Sul, Hae Joung; Choi, Ji Eun] Catholic Univ Korea, Dept Pathol, Daejeon St Marys Hosp, Coll Med, 64 Daeheung Ro, Daejeon 34943, South Korea; [Yi, Shinae; Yi, Hyon-Seung; Kim, Jung Tae; Chang, Joon Young; Kim, Koon Soon; Shong, Minho] Chungnam Natl Univ, Sch Med, Res Ctr Endocrine & Metab Dis, Div Endocrinol,Dept Internal Med, 266 Munhwa Ro, Daejeon 35015, South Korea; [Won, Minho] Chungnam Natl Univ, Sch Med, Dept Pharmacol, 266 Munhwa Ro, Daejeon 35015, South Korea; [Song, Young Shin; Park, Young Joo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, 101 Daehak Ro, Seoul 03080, South Korea; [Park, Ki Cheol] Catholic Univ Korea, Clin Res Inst, Daejeon St Marys Hosp, Coll Med, 64 Daeheung Ro, Daejeon 34943, South Korea; [Lee, Min Joung] Chungnam Natl Univ, Sch Med, Dept Biochem, 266 Munhwa Ro, Daejeon 35015, South Korea; [Kero, Jukka] Univ Turku, Res Ctr Integrat Physiol & Pharmacol, Inst Biomed, Kiinamyllynkatu 10, FIN-20520 Turku, Finland; [Kim, Joon] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, 291 Daehak Ro, Daejeon 34040, South Korea	Catholic University of Korea; Chungnam National University; Chungnam National University; Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea; Chungnam National University; University of Turku; Korea Advanced Institute of Science & Technology (KAIST)	Shong, M (corresponding author), Chungnam Natl Univ, Sch Med, Res Ctr Endocrine & Metab Dis, Div Endocrinol,Dept Internal Med, 266 Munhwa Ro, Daejeon 35015, South Korea.	minhos@cnu.ac.kr	/H-7803-2012; kero, jukka/G-3448-2014; Yi, Hyon-Seung/ABA-2729-2022; Kim, Joon/C-1833-2011; Choi, Ji Eun/H-4890-2016; Park, Young Joo/J-4161-2012	kero, jukka/0000-0001-8767-7222; Choi, Ji Eun/0000-0001-9132-2029; Yi, Hyon-Seung/0000-0002-3767-1954; Won, Minho/0000-0002-5873-5216; Park, Young Joo/0000-0002-3671-6364; shong, minho/0000-0002-0247-7115	NRF/MISIT, Korea [NRF-2015R1C1A1A02037434]; Catholic Medical Center Research Foundation; Daejeon St. Mary's Hospital; NRF - Ministry of Science and ICT [NRF-2014M3A9D8034464]; NRF/MISIT of Korea [NRF-2015M3A9B3028218]	NRF/MISIT, Korea; Catholic Medical Center Research Foundation; Daejeon St. Mary's Hospital; NRF - Ministry of Science and ICT; NRF/MISIT of Korea	This work was supported by a grant (NRF-2015R1C1A1A02037434) from NRF/MISIT, Korea and a grant from the Catholic Medical Center Research Foundation made in the program year of 2016, and a grant from Daejeon St. Mary's Hospital. M. S. was supported by a grant from the NRF funded by the Ministry of Science and ICT (grant number: NRF-2014M3A9D8034464) and a grant from the NRF/MISIT of Korea (grant number: NRF-2015M3A9B3028218).	Ademowo OS, 2017, BIOGERONTOLOGY, V18, P859, DOI 10.1007/s10522-017-9710-z; Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Bishop CL, 2010, MOL CELL, V40, P533, DOI 10.1016/j.molcel.2010.10.027; Boehlke C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140378; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Bonura C, 1999, HEPATOLOGY, V30, P677, DOI 10.1002/hep.510300325; Boren J, 2012, CELL DEATH DIFFER, V19, P1561, DOI 10.1038/cdd.2012.34; Chevrollier A, 2011, BBA-BIOENERGETICS, V1807, P562, DOI 10.1016/j.bbabio.2010.10.008; CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Degnim AC, 2015, BREAST CANCER RES TR, V152, P687, DOI 10.1007/s10549-015-3513-1; Desvignes T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-256; Dupont PY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-482; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Haferkamp S, 2009, J INVEST DERMATOL, V129, P1983, DOI 10.1038/jid.2009.5; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Katoh Y, 2016, J BIOL CHEM, V291, P10962, DOI 10.1074/jbc.M116.713883; Kero J, 2007, J CLIN INVEST, V117, P2399, DOI 10.1172/JCI30380; Lai CK, 2011, MOL BIOL CELL, V22, P1104, DOI 10.1091/mbc.E10-07-0596; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lee J, 2016, ONCOTARGET, V7, P79103, DOI 10.18632/oncotarget.12997; Lee J, 2015, CARCINOGENESIS, V36, P1407, DOI 10.1093/carcin/bgv122; Lee SE, 2017, DIABETES, V66, P2774, DOI 10.2337/db17-0333; Llona-Minguez S, 2015, PROG LIPID RES, V58, P51, DOI 10.1016/j.plipres.2015.01.004; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Mignogna C, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0238-7; Oh EC, 2015, CELL METAB, V21, P21, DOI 10.1016/j.cmet.2014.11.019; Paraskevas KI, 2006, CLIN RHEUMATOL, V25, P687, DOI 10.1007/s10067-005-0122-0; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Plotnikova OV, 2012, MOL BIOL CELL, V23, P2658, DOI 10.1091/mbc.E11-12-1056; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Rahmouni K, 2008, J CLIN INVEST, V118, P1458, DOI 10.1172/JCI32357; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Rohrig F, 2016, NAT REV CANCER, V16, P732, DOI 10.1038/nrc.2016.89; Sanchez I, 2016, NAT CELL BIOL, V18, P711, DOI 10.1038/ncb3370; Schraml P, 2009, MODERN PATHOL, V22, P31, DOI 10.1038/modpathol.2008.132; Seeger-Nukpezah Tamina, 2013, Drug Discov Today Dis Mech, V10, pe135; Song Z, 2010, MOL BIOL REP, V37, P4091, DOI 10.1007/s11033-010-0069-3; Taschner M, 2016, EMBO J, V35, P773, DOI 10.15252/embj.201593164; TeSlaa T, 2014, METHOD ENZYMOL, V542, P91, DOI 10.1016/B978-0-12-416618-9.00005-4; van Diepen JA, 2013, ATHEROSCLEROSIS, V228, P306, DOI 10.1016/j.atherosclerosis.2013.02.028; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yan S, 2015, WORLD J GASTROENTERO, V21, P3492, DOI 10.3748/wjg.v21.i12.3492; Yaqoob P, 2003, CURR OPIN CLIN NUTR, V6, P133, DOI 10.1097/00075197-200303000-00002; Yuan K, 2010, J HISTOCHEM CYTOCHEM, V58, P857, DOI 10.1369/jhc.2010.955856	55	19	19	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 9	2018	37	32					4455	4474		10.1038/s41388-018-0211-6	http://dx.doi.org/10.1038/s41388-018-0211-6			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP8FA	29743590				2022-12-26	WOS:000441144300009
J	Park, IK; Yu, JS; Cho, ES; Kim, JH; Chung, JJ				Park, In Kyung; Yu, Jeong-Sik; Cho, Eun-Suk; Kim, Joo Hee; Chung, Jae-Joon			Apparent diffusion coefficient of hepatocellular carcinoma on diffusion- weighted imaging: Histopathologic tumor grade versus arterial vascularity during dynamic magnetic resonance imaging	PLOS ONE			English	Article							FOCAL LIVER-LESIONS; INTRAVOXEL INCOHERENT MOTION; HISTOLOGICAL GRADE; DIFFERENTIATION; TRANSPLANTATION; BENIGN; CANCER; MRI; ENHANCEMENT; SENSITIVITY	Objectives Apparent diffusion coefficient (ADC) has been suggested to reflect the tumor grades of hepatocellular carcinomas (HCCs); i.e., it can be used as a biomarker to predict the patients' prognosis. To verify its feasibility as a biomarker, the present study sought to determine how the ADC values of HCC are affected by a tumor's histopathologic grade and arterial vascularity. Materials and methods From 131 consecutive patients, 141 surgically resected HCCs (16 well-differentiated [wd-HCCs], 83 moderately-differentiated [md-HCCs], and 42 poorly-differentiated HCCs [pd-HCCs]) were subjected to a comparison of the tumors' arterial vascularity (non-, slightly-, or markedly-hypervascular) determined on dynamic magnetic resonance imaging (MRI) and the ADC was measured retrospectively. Results The pd-HCCs (1.05 +/- 0.16 x 10(-3) mm(2)/s) had a significantly lower ADC than md-HCCs (1.16 +/- 0.21 x 10(-3) mm(2)/s; p = 0.010), but there was no significant difference compared to wdHCCs (1.11 +/- 0.18 x 10(-3) mm(2)/s; p = 0.968). The mean ADC was significantly higher in markedly hypervascular lesions (1.20 +/- 0.20 x 10(-3) mm(2)/s) than in nonhypervascular lesions (0.95 +/- 0.14 x 10(-3) mm(2)/s; p<0.001) or slightly hypervascular lesions (1.04 +/- 0.15 x 10(-3) mm(2)/ s; p<0.001). The ADC values and arterial vascularity were significantly correlated in wd-HCCs (p = 0.005) and md-HCCs (p<0.001). The mean ADC of pd-HCCs was significantly lower than those of other lesions, even in the markedly hypervascular lesion subgroup (p = 0.020). Conclusion Although pd-HCC constantly shows low ADCs regardless of arterial vascularities, ADCs cannot stably stratify histopathologic tumor grades due to the variable features of wd-HCCs; and the ADC should be used with caution as a tumor biomarker of HCC.	[Park, In Kyung; Yu, Jeong-Sik; Cho, Eun-Suk; Kim, Joo Hee; Chung, Jae-Joon] Yonsei Univ, Gangnam Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System	Yu, JS (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea.	yjsrad97@yuhs.ac	Nam, Jae Do/F-2201-2013	KIM, JOO HEE/0000-0001-5383-3602; Chung, Jae-Joon/0000-0002-7447-1193; Yu, Jeong-Sik/0000-0002-8171-5838				Asayama Y, 2008, AM J ROENTGENOL, V190, pW28, DOI 10.2214/AJR.07.2117; Bruegel M, 2008, EUR RADIOL, V18, P477, DOI 10.1007/s00330-007-0785-9; Chang WC, 2014, ABDOM IMAGING, V39, P1202, DOI 10.1007/s00261-014-0168-z; Chen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117661; Cillo U, 2004, ANN SURG, V239, P150, DOI 10.1097/01.sla.0000109146.72827.76; Fitzmorris P, 2015, J CANCER RES CLIN, V141, P861, DOI 10.1007/s00432-014-1806-0; Gourtsoyianni S, 2008, EUR RADIOL, V18, P486, DOI 10.1007/s00330-007-0798-4; Granata V, 2016, ONCOTARGET, V7, P79343, DOI 10.18632/oncotarget.12689; Guo WH, 2015, INT J CLIN EXP MED, V8, P4164; HARATAKE J, 1993, CANCER, V72, P1178, DOI 10.1002/1097-0142(19930815)72:4<1178::AID-CNCR2820720408>3.0.CO;2-Q; Heo SH, 2010, KOREAN J RADIOL, V11, P295, DOI 10.3348/kjr.2010.11.3.295; Inchingolo R, 2015, EUR RADIOL, V25, P1087, DOI 10.1007/s00330-014-3500-7; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Kele PG, 2010, WORLD J GASTROENTERO, V16, P1567, DOI 10.3748/wjg.v16.i13.1567; Kenis C, 2012, EUR J RADIOL, V81, P1016, DOI 10.1016/j.ejrad.2011.02.019; Kim CK, 2005, RADIOLOGY, V237, P529, DOI 10.1148/radiol.2372041634; Kim HJ, 2015, RADIOLOGY, V274, P712, DOI 10.1148/radiol.14140390; Kim YK, 2011, CLIN RADIOL, V66, P489, DOI 10.1016/j.crad.2010.09.007; Kojiro M, 2007, HEPATOL RES, V37, pS121, DOI 10.1111/j.1872-034X.2007.00174.x; Lee MH, 2011, AM J ROENTGENOL, V197, pW868, DOI 10.2214/AJR.10.6237; Li XB, 2016, J MAGN RESON IMAGING, V44, P1442, DOI 10.1002/jmri.25323; Lowenthal D, 2011, EUR RADIOL, V21, P832, DOI 10.1007/s00330-010-1977-2; Muhi A, 2009, J MAGN RESON IMAGING, V30, P1005, DOI 10.1002/jmri.21931; Nasu K, 2006, RADIOLOGY, V239, P122, DOI 10.1148/radiol.2383041384; Nasu K, 2009, AM J ROENTGENOL, V193, P438, DOI 10.2214/AJR.08.1424; Nishie A, 2011, EUR J RADIOL, V80, pE29, DOI 10.1016/j.ejrad.2010.06.019; Parikh T, 2008, RADIOLOGY, V246, P812, DOI 10.1148/radiol.2463070432; Partridge SC, 2010, AM J ROENTGENOL, V194, P1664, DOI 10.2214/AJR.09.3534; Perez-Saborido B, 2007, TRANSPL P, V39, P2304, DOI 10.1016/j.transproceed.2007.06.059; Shan QG, 2017, ABDOM RADIOL, V42, P2079, DOI 10.1007/s00261-017-1107-6; Suh KS, 2007, DIGEST DIS, V25, P329, DOI 10.1159/000106913; Takeuchi M, 2009, RADIOLOGY, V251, P112, DOI 10.1148/radiol.2511080873; Tamai K, 2007, J MAGN RESON IMAGING, V26, P682, DOI 10.1002/jmri.20997; Tang YH, 2016, ABDOM RADIOL, V41, P1539, DOI 10.1007/s00261-016-0715-x; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; White NS, 2014, MAGN RESON MED, V72, P1435, DOI 10.1002/mrm.25039; Woo S, 2014, RADIOLOGY, V270, P758, DOI 10.1148/radiol.13130444; Xu J, 2009, MAGN RESON MED, V61, P828, DOI 10.1002/mrm.21793; Zimmerman MA, 2008, ARCH SURG-CHICAGO, V143, P182, DOI 10.1001/archsurg.2007.39	40	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0197070	10.1371/journal.pone.0197070	http://dx.doi.org/10.1371/journal.pone.0197070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750794	gold, Green Published			2022-12-26	WOS:000431856300014
J	Peters, MEM; Kockelkoren, R; de Brouwer, EJM; Koek, HL; Bleys, RLAW; Mali, WPTM; Hendrikse, J; Rozemuller, AM; de Jong, PA				Peters, Melissa E. M.; Kockelkoren, Remko; de Brouwer, Esther J. M.; Koek, Huiberdina L.; Bleys, Ronald L. A. W.; Mali, Willem P. Th M.; Hendrikse, Jeroen; Rozemuller, Annemieke M.; de Jong, Pim A.			Histological validation of calcifications in the human hippocampus as seen on computed tomography	PLOS ONE			English	Article							BASAL GANGLIA; DISEASE	Background Calcifications within the hippocampus were recently described for the first time on computed tomography (CT). These calcifications appeared in patients older than 50 years, the prevalence increases with age and they may be associated with cognitive decline. The aim of this study was to determine the histological basis (the presence, severity and location) of these CT-detected hippocampal calcifications of post-mortem brains. Methods CT scans of seven post-mortem brains were scored for the presence and severity (mild, moderate, severe) of hippocampal calcification. After this, samples from nine hippocampi (bilateral in two brains, unilateral in five brains) were stained with hematoxylin and eosin (HE) to indicate the cytoarchitecture, with Elastica van Gieson to analyse the elastic connective tissue of the vessel walls and with von Kossa for detection of calcium. Results In four brains (six hippocampi), calcifications were both found on CT and in corresponding histology. In three brains (three hippocampi), calcifications were absent on CT and corresponding histology. In histology, mild calcifications were located in the tail and severe calcifications involved the tail, body and sometimes the head of the hippocampus. The calcifications co-localised with precapillaries, capillaries and arteries of the molecular and granular layers of the dentate gyrus and the Cornu Ammonis 1. Conclusions In this study, calcifications of the hippocampus as seen on CT scans were histologically located in vascular structures of the tail, body and head of the hippocampus.	[Peters, Melissa E. M.; Kockelkoren, Remko; Mali, Willem P. Th M.; Hendrikse, Jeroen; de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [de Brouwer, Esther J. M.; Koek, Huiberdina L.] Univ Med Ctr Utrecht, Dept Geriatr, Utrecht, Netherlands; [Bleys, Ronald L. A. W.] Univ Med Ctr Utrecht, Dept Anat, Utrecht, Netherlands; [Rozemuller, Annemieke M.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	de Jong, PA (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	P.deJong-8@umcutrecht.nl			Netherlands Organization for Scientific Research Medical Sciences (NWO-MW) [904-65-095]; European Research Council under the European Union [637024, 66681]	Netherlands Organization for Scientific Research Medical Sciences (NWO-MW)(Netherlands Organization for Scientific Research (NWO)); European Research Council under the European Union(European Research Council (ERC))	JH was supported for the funding of this project. Funding for this paper was received as part of a grant from the Netherlands Organization for Scientific Research Medical Sciences (NWO-MW: project No. 904-65-095). This funding source had no role in the design, data collection, data analyses and data interpretation of the study or writing of the report. We also gratefully acknowledge the funding from the European Research Council under the European Union's Horizon 2020 Programme (H2020) / ERC grant agreement n637024 and n66681 (SVDs@target). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Chew APT, 2012, RADIOLOGY, V265, P504, DOI 10.1148/radiol.12110636; COHEN CR, 1980, RADIOLOGY, V134, P97, DOI 10.1148/radiology.134.1.7350641; DAVIES MJ, 1993, BRIT HEART J, V69, pS3; Deng H, 2015, AGEING RES REV, V22, P20, DOI 10.1016/j.arr.2015.04.004; Duvernoy H. M, 2005, HUMAN HIPPOCAMPUS FU; Gossner J, 2017, DIAGN INTERV IMAG, V98, P83, DOI 10.1016/j.diii.2016.07.006; Kockelkoren R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168360; Kockelkoren R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167444; KOLLER WC, 1979, NEUROLOGY, V29, P328, DOI 10.1212/WNL.29.3.328; MODIC MT, 1980, RADIOLOGY, V135, P369, DOI 10.1148/radiology.135.2.7367628; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Osborn AG., 1999, DIAGNOSTIC CEREBRAL, V2nd ed; Strange BA, 1999, P NATL ACAD SCI USA, V96, P4034, DOI 10.1073/pnas.96.7.4034; Suzuki A, 2009, AM J SURG PATHOL, V33, P1601, DOI 10.1097/PAS.0b013e3181ae29d6; Vos A, 2016, STROKE, V47, P221, DOI 10.1161/STROKEAHA.115.011196; Wegiel J, 2002, ACTA NEUROPATHOL, V103, P333, DOI 10.1007/s00401-001-0471-y; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8	18	10	10	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0197073	10.1371/journal.pone.0197073	http://dx.doi.org/10.1371/journal.pone.0197073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750809	Green Published, Green Submitted, gold			2022-12-26	WOS:000431856300015
J	Zhang, DY; Zhou, XG; Zhang, J; Lan, YB; Xu, C; Liang, D				Zhang, Dongyan; Zhou, Xingen; Zhang, Jian; Lan, Yubin; Xu, Chao; Liang, Dong			Detection of rice sheath blight using an unmanned aerial system with high-resolution color and multispectral imaging	PLOS ONE			English	Article								Detection and monitoring are the first essential step for effective management of sheath blight (ShB), a major disease in rice worldwide. Unmanned aerial systems have a high potential of being utilized to improve this detection process since they can reduce the time needed for scouting for the disease at a field scale, and are affordable and user-friendly in operation. In this study, a commercialized quadrotor unmanned aerial vehicle (UAV), equipped with digital and multispectral cameras, was used to capture imagery data of research plots with 67 rice cultivars and elite lines. Collected imagery data were then processed and analyzed to characterize the development of ShB and quantify different levels of the disease in the field. Through color features extraction and color space transformation of images, it was found that the color transformation could qualitatively detect the infected areas of ShB in the field plots. However, it was less effective to detect different levels of the disease. Five vegetation indices were then calculated from the multispectral images, and ground truths of disease severity and GreenSeeker measured NDVI (Normalized Difference Vegetation Index) were collected. The results of relationship analyses indicate that there was a strong correlation between ground-measured NDVIs and image-extracted NDVIs with the R-2 of 0.907 and the root mean square error (RMSE) of 0.0854, and a good correlation between image-extracted NDVIs and disease severity with the R-2 of 0.627 and the RMSE of 0.0852. Use of image-based NDVIs extracted from multispectral images could quantify different levels of ShB in the field plots with an accuracy of 63%. These results demonstrate that a customer-grade UAV integrated with digital and multispectral cameras can be an effective tool to detect the ShB disease at a field scale.	[Zhang, Dongyan; Xu, Chao; Liang, Dong] Anhui Univ, Anhui Engn Lab Agroecol Big Data, Hefei, Anhui, Peoples R China; [Zhou, Xingen; Lan, Yubin] Texas A&M Univ Syst, Texas A&M AgriLife Res Ctr, Beaumont, TX USA; [Zhang, Jian] Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Hubei, Peoples R China; [Lan, Yubin] South China Agr Univ, Coll Engn, Guangzhou, Guangdong, Peoples R China	Anhui University; Texas A&M University System; Huazhong Agricultural University; South China Agricultural University	Liang, D (corresponding author), Anhui Univ, Anhui Engn Lab Agroecol Big Data, Hefei, Anhui, Peoples R China.	dliang@ahu.edu.cn	Lan, Yubin/W-3695-2018		National Natural Science Foundation of China [41771463, 41771469]; Science and Technology Development Program of Anhui Province [1604A0702016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Program of Anhui Province	This research was financially supported by the National Natural Science Foundation of China (Grant No. 41771463, 41771469), and the Science and Technology Development Program of Anhui Province (1604A0702016).	Arora A, 2012, CLEF; Ballesteros R, 2014, PRECIS AGRIC, V15, P579, DOI 10.1007/s11119-014-9355-8; Bauriegel E, 2014, AGRICULTURE-BASEL, V4, P32, DOI 10.3390/agriculture4010032; Berni JAJ, 2009, IEEE T GEOSCI REMOTE, V47, P722, DOI 10.1109/TGRS.2008.2010457; Devadas R, 2009, PRECIS AGRIC, V10, P459, DOI 10.1007/s11119-008-9100-2; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; Granier C, 2014, CURR OPIN PLANT BIOL, V18, P96, DOI 10.1016/j.pbi.2014.02.009; Haboudane D, 2004, REMOTE SENS ENVIRON, V90, P337, DOI 10.1016/j.rse.2003.12.013; Hemming J, 2001, J AGR ENG RES, V78, P233, DOI 10.1006/jaer.2000.0639; Huang Y, 2010, BIOSYST ENG, V107, P212, DOI 10.1016/j.biosystemseng.2010.08.003; Kruse FA, 1984, P INT S REM SENS ENV, P755; Kuska M, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0073-7; Lan YB, 2010, COMPUT ELECTRON AGR, V74, P34, DOI 10.1016/j.compag.2010.07.001; Mahlein AK, 2016, PLANT DIS, P1; Pena JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077151; Mewes T, 2011, PRECIS AGRIC, V12, P795, DOI 10.1007/s11119-011-9222-9; Mulla DJ, 2013, BIOSYST ENG, V114, P358, DOI 10.1016/j.biosystemseng.2012.08.009; Nguy-Robertson A, 2012, AGRON J, V104, P1336, DOI 10.2134/agronj2012.0065; Qin ZH, 2005, INT J APPL EARTH OBS, V7, P115, DOI 10.1016/j.jag.2005.03.004; RPH, 2014, RIC PROD HDB; Wu W, 2012, FIELD CROP RES, V128, P101, DOI 10.1016/j.fcr.2012.01.002; Yang CM, 2010, PRECIS AGRIC, V11, P61, DOI 10.1007/s11119-009-9122-4; Yang WN, 2013, CURR OPIN PLANT BIOL, V16, P180, DOI 10.1016/j.pbi.2013.03.005; Yengoh G.T., 2015, USE NORMALIZED DIFFE; Zhang DY, 2015, ASABE INT M NEW ORL; Zhou X., 2010, PLOS ONE, V5, P1; Zhou XG, 2015, TEXAS AGRILIFE RES B, P44	28	49	49	9	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0187470	10.1371/journal.pone.0187470	http://dx.doi.org/10.1371/journal.pone.0187470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746473	gold, Green Submitted, Green Published			2022-12-26	WOS:000431851700001
J	Gisselgard, J; Lebedev, AV; Kurz, KD; Joa, I; Johannessen, JO; Bronnick, K				Gisselgard, Jens; Lebedev, Alexander, V; Kurz, Kathinka Daehli; Joa, Inge; Johannessen, Jan Olav; Bronnick, Kolbjorn			Structural and functional alterations in the brain during working memory in medication-naive patients at clinical high-risk for psychosis	PLOS ONE			English	Article							ULTRA-HIGH-RISK; SWITCHING SCHIZOPHRENIA-PATIENTS; SURFACE-BASED ANALYSIS; EFFECTIVE CONNECTIVITY; TYPICAL NEUROLEPTICS; LONGITUDINAL YOUTH; PRODROMAL SIGNS; MENTAL STATE; INDIVIDUALS; METAANALYSIS	Several previous studies suggest that clinical high risk for psychosis (CHR) is associated with prefrontal functional abnormalities and more widespread reduced grey matter in prefrontal, temporal and parietal areas. We investigated neural correlates to CHR in medication-naive patients. 41 CHR patients and 37 healthy controls were examined with 1.5 Tesla MRI, yielding functional scans while performing an N-back task and structural T1-weighted brain images. Functional and structural data underwent automated preprocessing steps in SPM and Freesurfer, correspondingly. The groups were compared employing mass-univariate strategy within the generalized linear modelling framework. CHR demonstrated reduced suppression of the medial temporal lobe (MTL) regions during n-back task. We also found that, consistent with previous findings, CHR subjects demonstrated thinning in prefrontal, cingulate, insular and inferior temporal areas, as well as reduced hippocampal volumes. The present findings add to the growing evidence of specific structural and functional abnormalities in the brain as potential neuroimaging markers of psychosis vulnerability.	[Gisselgard, Jens; Joa, Inge; Johannessen, Jan Olav; Bronnick, Kolbjorn] Stavanger Univ Hosp, TIPS Reg Ctr Clin Res Psychosis, Stavanger, Norway; [Lebedev, Alexander, V] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lebedev, Alexander, V] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Lebedev, Alexander, V] Stockholm Univ, Stockholm, Sweden; [Kurz, Kathinka Daehli] Stavanger Univ Hosp, Dept Radiol, Radiol Res Grp, Stavanger, Norway; [Kurz, Kathinka Daehli] Univ Stavanger, Dept Elect & Comp Engn, Stavanger, Norway; [Joa, Inge; Johannessen, Jan Olav; Bronnick, Kolbjorn] Univ Stavanger, Network Med Sci, Stavanger, Norway	Stavanger University Hospital; Karolinska Institutet; Karolinska Institutet; Stockholm University; Stavanger University Hospital; Universitetet i Stavanger; Universitetet i Stavanger	Gisselgard, J (corresponding author), Stavanger Univ Hosp, TIPS Reg Ctr Clin Res Psychosis, Stavanger, Norway.	jens@gisselgard.se		Lebedev, Alexander/0000-0002-0319-2357				Andrew AS, 2017, INT J MOL SCI, V18, DOI [10.3390/ijms18030535, 10.3390/ijms18030651]; Babor TF., 2001, AUDIT ALCOHOL USE DI; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Berman AH, 2002, DUDIT DRUG USE DISOR; Borgwardt S, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-46; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deserno L, 2012, J NEUROSCI, V32, P12, DOI 10.1523/JNEUROSCI.3405-11.2012; Dutt A, 2015, J PSYCHIATR RES, V61, P122, DOI 10.1016/j.jpsychires.2014.08.018; Feigenson KA, 2014, NEUROSCI BIOBEHAV R, V38, P72, DOI 10.1016/j.neubiorev.2013.11.006; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fryer Susanna L, 2013, Front Psychiatry, V4, P92, DOI 10.3389/fpsyt.2013.00092; Fusar-Poli P, 2013, NEUROSCI BIOBEHAV R, V37, P1680, DOI 10.1016/j.neubiorev.2013.06.001; Fusar-Poli P, 2011, J PSYCHIATR RES, V45, P190, DOI 10.1016/j.jpsychires.2010.05.012; Fusar-Poli P, 2010, SCHIZOPHR RES, V123, P45, DOI 10.1016/j.schres.2010.06.008; Fusar-Poli P, 2016, SCHIZOPHRENIA BULL, V42, P732, DOI 10.1093/schbul/sbv162; Fusar-Poli P, 2016, JAMA PSYCHIAT, V73, P211, DOI 10.1001/jamapsychiatry.2015.2313; Fusar-Poli P, 2016, JAMA PSYCHIAT, V73, P113, DOI 10.1001/jamapsychiatry.2015.2324; Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269; Fusar-Poli P, 2012, ARCH GEN PSYCHIAT, V69, P562, DOI 10.1001/archgenpsychiatry.2011.1592; Fusar-Poli P, 2012, J PSYCHIATR NEUROSCI, V37, P106, DOI 10.1503/jpn.110021; Fusar-Poli P, 2010, ARCH GEN PSYCHIAT, V67, P683, DOI 10.1001/archgenpsychiatry.2010.77; Gifford G, 2017, NEUROIMAGE, V145, P209, DOI 10.1016/j.neuroimage.2016.03.075; Giuliano AJ, 2012, CURR PHARM DESIGN, V18, P399; Haatveit B, 2016, NEUROIMAGE-CLIN, V12, P389, DOI 10.1016/j.nicl.2016.08.012; Ho NF, 2017, NEUROPSYCHOPHARMACOL, V42, P1361, DOI 10.1038/npp.2017.5; Howes OD, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.278; Joa I, 2008, SCHIZOPHRENIA BULL, V34, P466, DOI 10.1093/schbul/sbm095; Joa I, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0470-5; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Jung WH, 2011, SCHIZOPHRENIA BULL, V37, P839, DOI 10.1093/schbul/sbp151; Klauser P, 2015, SCHIZOPHRENIA BULL, V41, P1285, DOI 10.1093/schbul/sbv012; Koutsouleris N, 2010, SCHIZOPHR RES, V123, P175, DOI 10.1016/j.schres.2010.08.032; Koutsouleris N, 2009, ARCH GEN PSYCHIAT, V66, P700, DOI 10.1001/archgenpsychiatry.2009.62; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lee JH, 2005, J ABNORM PSYCHOL, V114, P599, DOI 10.1037/0021-843X.114.4.599; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; Melle I, 2004, ARCH GEN PSYCHIAT, V61, P143, DOI 10.1001/archpsyc.61.2.143; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040; Morey RA, 2005, ARCH GEN PSYCHIAT, V62, P254, DOI 10.1001/archpsyc.62.3.254; Nenadic I, 2015, SCHIZOPHR RES, V161, P169, DOI 10.1016/j.schres.2014.10.041; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P19, DOI 10.1093/schbul/sbn162; Radua J, 2012, NEUROSCI BIOBEHAV R, V36, P2325, DOI 10.1016/j.neubiorev.2012.07.012; Schlagenhauf F, 2008, EUR NEUROPSYCHOPHARM, V18, P589, DOI 10.1016/j.euroneuro.2008.04.013; Schlagenhauff F, 2010, SCHIZOPHR RES, V118, P189, DOI 10.1016/j.schres.2010.01.022; Schmidt A., 2013, J AUTOMATION MOBILE, V7, P11; Schmidt A, 2014, J PSYCHIATR NEUROSCI, V39, P239, DOI 10.1503/jpn.130102; Schultz CC, 2012, EUR ARCH PSY CLIN N, V262, pS97, DOI 10.1007/s00406-012-0360-5; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Seidman LJ, 2010, ARCH GEN PSYCHIAT, V67, P578, DOI 10.1001/archgenpsychiatry.2010.66; Siever LJ, 2004, AM J PSYCHIAT, V161, P398, DOI 10.1176/appi.ajp.161.3.398; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smieskova R, 2012, HUM BRAIN MAPP, V33, P2281, DOI 10.1002/hbm.21360; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Thermenos HW, 2016, SCHIZOPHR RES, V173, P1, DOI 10.1016/j.schres.2016.02.023; Trotman HD, 2013, HORM BEHAV, V64, P411, DOI 10.1016/j.yhbeh.2013.02.018; Valli I, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00052; Valli I, 2011, BIOL PSYCHIAT, V69, P97, DOI 10.1016/j.biopsych.2010.08.033; Van Snellenberg JX, 2006, NEUROPSYCHOLOGY, V20, P497, DOI 10.1037/0894-4105.20.5.497; Walker E, 2002, SCHIZOPHR RES, V54, P17, DOI 10.1016/S0920-9964(01)00347-4; Ward AM, 2014, HUM BRAIN MAPP, V35, P1061, DOI 10.1002/hbm.22234; Weibell MA, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-319; Wood SJ, 2011, BIOL PSYCHIAT, V70, P619, DOI 10.1016/j.biopsych.2011.05.034; Wood SJ, 2010, NEUROIMAGE, V52, P62, DOI 10.1016/j.neuroimage.2010.04.012; Yaakub SN, 2013, AM J PSYCHIAT, V170, P1297, DOI 10.1176/appi.ajp.2013.12081135; Zhou L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21657	71	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196289	10.1371/journal.pone.0196289	http://dx.doi.org/10.1371/journal.pone.0196289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF2GV	29742121	Green Published, Green Submitted, gold			2022-12-26	WOS:000431757400024
J	Raczkowski, F; Rissiek, A; Ricklefs, I; Heiss, K; Schumacher, V; Wundenberg, K; Haag, F; Koch-Nolte, F; Tolosa, E; Mittrucker, HW				Raczkowski, Friederike; Rissiek, Anne; Ricklefs, Isabell; Heiss, Kirsten; Schumacher, Valea; Wundenberg, Kira; Haag, Friedrich; Koch-Nolte, Friedrich; Tolosa, Eva; Mittruecker, Hans-Willi			CD39 is upregulated during activation of mouse and human T cells and attenuates the immune response to Listeria monocytogenes	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DENDRITIC CELLS; ADENOSINE GENERATION; ECTONUCLEOTIDASE CD39; CYTOKINE PRODUCTION; ATP RELEASE; EXPRESSION; CD73; DIFFERENTIATION; RECEPTORS	The ectoenzymes CD39 and CD73 degrade extracellular ATP to adenosine. ATP is released by stressed or damaged cells and provides pro-inflammatory signals to immune cells through P2 receptors. Adenosine, on the other hand, suppresses immune cells by stimulating P1 receptors. Thus, CD39 and CD73 can shape the quality of immune responses. Here we demonstrate that upregulation of CD39 is a consistent feature of activated conventional CD4(+) and CD8(+) T cells. Following stimulation in vitro, CD4(+) and CD8(+) T cells from human blood gained surface expression of CD39 but displayed only low levels of CD73. Activated human T cells from inflamed joints largely presented with a CD39(+)CD73(-) phenotype. In line, in spleens of mice with acute Listeria monocytogenes, listeria-specific CD4(+) and CD8(+) T cells acquired a CD39(+)CD73(-) phenotype. To test the function of CD39 in control of bacterial infection, CD39-deficient (CD39(-/-)) mice were infected with L. monocytogenes. CD39(-/-) mice showed better initial control of L. monocytogenes, which was associated with enhanced production of inflammatory cytokines. In the late stage of infection, CD39(-/-) mice accumulated more listeria-specific CD8(+) T cells in the spleen than wildtype animals suggesting that CD39 attenuates the CD8(+) T-cell response to infection. In conclusion, our results demonstrate that CD39 is upregulated on conventional CD4(+) and CD8(+) T cells at sites of acute infection and inflammation, and that CD39 dampens responses to bacterial infection.	[Raczkowski, Friederike; Rissiek, Anne; Ricklefs, Isabell; Heiss, Kirsten; Schumacher, Valea; Wundenberg, Kira; Haag, Friedrich; Koch-Nolte, Friedrich; Tolosa, Eva; Mittruecker, Hans-Willi] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany; [Ricklefs, Isabell] Univ Lubeck, Childrens & Adolescents Hosp, Dept Pediat Pulmonol & Allergy, Lubeck, Germany; [Heiss, Kirsten] Univ Hosp Heidelberg, Ctr Infect Dis, Parasitol, Heidelberg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Ruprecht Karls University Heidelberg	Mittrucker, HW (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany.	h.mittruecker@uke.de	Tolosa, Eva/S-3454-2016	Koch-Nolte, Friedrich/0000-0003-1730-6674; Mittrucker, Hans-Willi/0000-0001-6166-4191	Deutsche Forschungsgemeinschaft [Mi476/3-1, SFB841, RA 2893/2, RI 2952/1]; Landesforschungsforderung City of Hamburg, Readme	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landesforschungsforderung City of Hamburg, Readme	This work was supported by Deutsche Forschungsgemeinschaft (Mi476/3-1 to H-WM, SFB841 to H-WM, RA 2893/2 to FR, and RI 2952/1 to AR) and Landesforschungsforderung City of Hamburg, Readme (to H-WM, ET, FH, FK-N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04486; Alam MS, 2009, J INFECT DIS, V199, P494, DOI 10.1086/596205; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bai AP, 2014, J IMMUNOL, V193, P3366, DOI 10.4049/jimmunol.1400346; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Burnstock G, 2014, PURINERG SIGNAL, V10, P103, DOI 10.1007/s11302-013-9395-y; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Cohen HB, 2013, BLOOD, V122, P1935, DOI 10.1182/blood-2013-04-496216; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Csoka B, 2008, FASEB J, V22, P3491, DOI 10.1096/fj.08-107458; Csoka B, 2015, FASEB J, V29, P25, DOI 10.1096/fj.14-253567; Danquah W, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8463; de Salles EM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006595; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Doherty GA, 2012, EUR J IMMUNOL, V42, P3062, DOI 10.1002/eji.201242623; Dwyer KM, 2010, AM J TRANSPLANT, V10, P2410, DOI 10.1111/j.1600-6143.2010.03291.x; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Francois V, 2015, MUCOSAL IMMUNOL, V8, P773, DOI 10.1038/mi.2014.108; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Ghanem ENB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005126; Gordon-Smith SB, 2015, ARTHRITIS RHEUMATOL, V67, P545, DOI 10.1002/art.38959; Gupta PK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005177; Hasegawa T, 2008, CIRC RES, V103, P1410, DOI 10.1161/CIRCRESAHA.108.180059; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hoge J, 2013, J IMMUNOL, V190, P703, DOI 10.4049/jimmunol.1201044; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Karmakar M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10555; Kursar M, 2005, J EXP MED, V201, P1447, DOI 10.1084/jem.20041204; Levesque SA, 2010, EUR J IMMUNOL, V40, P1473, DOI 10.1002/eji.200939741; Li L, 2012, J CLIN INVEST, V122, P3931, DOI 10.1172/JCI63170; Linden J, 2012, ARTERIOSCL THROM VAS, V32, P2097, DOI 10.1161/ATVBAHA.111.226837; Longhi MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087956; Ma Y, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25964; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Mandapathil M, 2009, J IMMUNOL METHODS, V346, P55, DOI 10.1016/j.jim.2009.05.004; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Moncrieffe H, 2010, J IMMUNOL, V185, P134, DOI 10.4049/jimmunol.0803474; Moreno-Fernandez ME, 2011, BLOOD, V117, P5372, DOI 10.1182/blood-2010-12-323162; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Ohtsuka T, 2010, J IMMUNOL, V185, P1321, DOI 10.4049/jimmunol.0901847; Panther E, 2003, BLOOD, V101, P3985, DOI 10.1182/blood-2002-07-2113; Regateiro FS, 2011, EUR J IMMUNOL, V41, P2955, DOI 10.1002/eji.201141512; Rissiek A, 2015, J AUTOIMMUN, V58, P12, DOI 10.1016/j.jaut.2014.12.007; Rissiek B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00204; Bono MR, 2015, FEBS LETT, V589, P3454, DOI 10.1016/j.febslet.2015.07.027; Schenk U, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001270; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schnurr M, 2004, BLOOD, V103, P1391, DOI 10.1182/blood-2003-06-1959; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Sims S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114323; Toth I, 2013, J LEUKOCYTE BIOL, V94, P551, DOI 10.1189/jlb.0113018; Tsukamoto H, 2012, BLOOD, V119, P4554, DOI 10.1182/blood-2011-09-375899; Wilson JM, 2009, J IMMUNOL, V182, P4616, DOI 10.4049/jimmunol.0801279; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Yegutkin GG, 2010, J IMMUNOL, V184, P5112, DOI 10.4049/jimmunol.0902760; Zhou WL, 2009, AM J PHYSIOL-LUNG C, V296, pL780, DOI 10.1152/ajplung.90295.2008; Zhoua Q, 2009, AM J TRANSPLANT, V9, P2303, DOI 10.1111/j.1600-6143.2009.02777.x	62	31	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0197151	10.1371/journal.pone.0197151	http://dx.doi.org/10.1371/journal.pone.0197151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742141	Green Published, gold, Green Submitted			2022-12-26	WOS:000431757400065
J	Wedeking, R; Maucourt, M; Deborde, C; Moing, A; Gibon, Y; Goldbach, HE; Wimmer, MA				Wedeking, Rita; Maucourt, Mickael; Deborde, Catherine; Moing, Annick; Gibon, Yves; Goldbach, Heiner E.; Wimmer, Monika A.			H-1-NMR metabolomic profiling reveals a distinct metabolic recovery response in shoots and roots of temporarily drought-stressed sugar beets	PLOS ONE			English	Article							BETA-VULGARIS L.; CARBON-ISOTOPE DISCRIMINATION; WATER-STRESS; ABIOTIC STRESS; ACCUMULATION; PLANTS; ARABIDOPSIS; PHOTOSYNTHESIS; TOLERANCE; LEAVES	Yield formation in regions with intermittent drought periods depends on the plant's ability to recover after cessation of the stress. The present work assessed differences in metabolic recovery of leaves and roots of drought-stressed sugar beets with high temporal resolution. Plants were subjected to drought for 13 days, and rewatered for 12 days. At one to two-day intervals, plant material was harvested for untargeted H-1-NMR metabolomic profiling, targeted analyses of hexose-phosphates, starch, amino acids, nitrate and proteins, and physiological measurements including relative water content, osmotic potential, electrolyte leakage and malondialdehyde concentrations. Drought triggered changes in primary metabolism, especially increases in amino acids in both organs, but leaves and roots responded with different dynamics to rewatering. After a transient normalization of most metabolites within 8 days, a second accumulation of amino acids in leaves might indicate a stress imprint beneficial in upcoming drought events. Repair mechanisms seemed important during initial recovery and occurred at the expense of growth for at least 12 days. These results indicate that organ specific metabolic recovery responses might be related to distinct functions and concomitant disparate stress levels in above- and belowground organs. With respect to metabolism, recovery was not simply a reversal of the stress responses.	[Wedeking, Rita; Goldbach, Heiner E.; Wimmer, Monika A.] Univ Bonn, INRES, Dept Plant Nutr, Bonn, Germany; [Maucourt, Mickael; Deborde, Catherine; Moing, Annick; Gibon, Yves] Univ Bordeaux, INRA, Biol Fruit & Pathol UMR1332, Villenave Dornon, France; [Maucourt, Mickael; Deborde, Catherine; Moing, Annick] Ctr Genom Fonct IBVM, Plateforme Metabolome Bordeaux MetaboHUB, Villenave Dornon, France; [Wedeking, Rita] Bayer AG, Crop Sci Div, Environm Safety Metab, Monheim, Germany; [Wimmer, Monika A.] Univ Hohenheim, Qual Plant Prod 340e, Inst Crop Sci, Stuttgart, Germany	University of Bonn; INRAE; UDICE-French Research Universities; Universite de Bordeaux; Bayer AG; University Hohenheim	Wimmer, MA (corresponding author), Univ Bonn, INRES, Dept Plant Nutr, Bonn, Germany.; Wimmer, MA (corresponding author), Univ Hohenheim, Qual Plant Prod 340e, Inst Crop Sci, Stuttgart, Germany.	m.wimmer@uni-hohenheim.de	Deborde, Catherine/AAE-2776-2019; Moing, Annick/X-3694-2019; Deborde, Catherine/B-6902-2008; Deborde, Catherine/HCH-3128-2022; Deborde, Catherine/X-6991-2019	Deborde, Catherine/0000-0001-5687-9059; Moing, Annick/0000-0003-1144-3600; Deborde, Catherine/0000-0001-5687-9059; Deborde, Catherine/0000-0001-5687-9059; Gibon, Yves/0000-0001-8161-1089	Bayer AG; MetaboHUB project [ANR-11-INBS-0010]; PHENOME project [ANR-11-INBS-012]; German Federal Ministry of Education and Research [BMBF 0315529]; European Union for regional development [EFRE z1011bc001a]	Bayer AG(Bayer AG); MetaboHUB project; PHENOME project; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union for regional development	RW received a salary from Bayer AG. The specific role of this author is articluated in the 'author contributions' section. We thank MetaboHUB (ANR-11-INBS-0010 project) and PHENOME (ANR-11-INBS-012) projects for financing. This study was also financially supported by the German Federal Ministry of Education and Research (BMBF 0315529) and the European Union for regional development (EFRE z1011bc001a) and is part of CROPSENSe.net, the competence network for phenotyping research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo WL, 2011, TRENDS PLANT SCI, V16, P489, DOI 10.1016/j.tplants.2011.05.008; Benstein RM, 2013, PLANT CELL, V25, P5011, DOI 10.1105/tpc.113.118992; Bhargava S, 2013, PLANT BREEDING, V132, P21, DOI 10.1111/pbr.12004; Binder S., 2010, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0137; Bloch D, 2006, EUR J AGRON, V24, P218, DOI 10.1016/j.eja.2005.08.004; Bloch D, 2006, J AGRON CROP SCI, V192, P17, DOI 10.1111/j.1439-037X.2006.00185.x; Bohnert HJ, 1998, CURR OPIN PLANT BIOL, V1, P267, DOI 10.1016/S1369-5266(98)80115-5; Bowne JB, 2012, MOL PLANT, V5, P418, DOI 10.1093/mp/ssr114; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN KF, 1987, J AGR SCI, V109, P421, DOI 10.1017/S0021859600081636; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Chen THH, 2002, CURR OPIN PLANT BIOL, V5, P250, DOI 10.1016/S1369-5266(02)00255-8; Chen THH, 2011, PLANT CELL ENVIRON, V34, P1, DOI 10.1111/j.1365-3040.2010.02232.x; Choluj D, 2008, ACTA PHYSIOL PLANT, V30, P679, DOI 10.1007/s11738-008-0166-2; Crisp PA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501340; Cross JM, 2006, PLANT PHYSIOL, V142, P1574, DOI 10.1104/pp.106.086629; Deborde C., 2014, MERY B METABOLOMIC D, P3; Deborde C, 2017, PROG NUCL MAG RES SP, V102, P61, DOI 10.1016/j.pnmrs.2017.05.001; Ding G, 2012, PLANT J, V70, P562, DOI 10.1111/j.1365-313X.2011.04893.x; EEA, 2015, IND ASS DAT MAPS GLO; Enz M., 1997, COMPENDIUM GROWTH ST; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Ferry-Dumazet H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-104; Flexas J, 2009, J EXP BOT, V60, P2361, DOI 10.1093/jxb/erp069; FOX TC, 1986, PLANT PHYSIOL, V80, P239, DOI 10.1104/pp.80.1.239; Foyer CH, 1998, PLANT PHYSIOL, V117, P283, DOI 10.1104/pp.117.1.283; Galili G, 2016, ANNU REV PLANT BIOL, V67, P153, DOI 10.1146/annurev-arplant-043015-112213; Gargallo-Garriga A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06829; Geigenberger P, 1997, PLANTA, V201, P502, DOI 10.1007/s004250050095; Gibon Y, 2002, PLANT J, V30, P221, DOI 10.1046/j.1365-313X.2001.01278.x; Greenham K, 2015, NAT REV GENET, V16, P598, DOI 10.1038/nrg3976; HANSON AD, 1982, ANNU REV PLANT PHYS, V33, P163, DOI 10.1146/annurev.pp.33.060182.001115; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; HITZ WD, 1982, CROP SCI, V22, P47, DOI 10.2135/cropsci1982.0011183X002200010011x; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hoffmann CM, 2014, J AGRON CROP SCI, V200, P108, DOI 10.1111/jac.12051; Hoffmann CM, 2010, J AGRON CROP SCI, V196, P243, DOI 10.1111/j.1439-037X.2009.00415.x; Jones PD, 2003, CLIMATIC CHANGE, V58, P93, DOI 10.1023/A:1023420102432; Lyon D, 2016, MOL CELL PROTEOMICS, V15, P1921, DOI 10.1074/mcp.M115.049205; Meyer E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-527; Moing A, 2004, FUNCT PLANT BIOL, V31, P889, DOI 10.1071/FP04066; Monti A, 2006, J EXP BOT, V57, P1253, DOI 10.1093/jxb/erj091; Obata T, 2012, CELL MOL LIFE SCI, V69, P3225, DOI 10.1007/s00018-012-1091-5; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Pires MV, 2016, PLANT CELL ENVIRON, V39, P1304, DOI 10.1111/pce.12682; Robredo A, 2011, ENVIRON EXP BOT, V71, P399, DOI 10.1016/j.envexpbot.2011.02.011; Ruffel S, 2014, J EXP BOT, V65, P5509, DOI 10.1093/jxb/eru321; Semel Y, 2007, METABOLOMICS, V3, P289, DOI 10.1007/s11306-007-0055-5; Sims L, 2012, OECOLOGIA, V170, P65, DOI 10.1007/s00442-012-2296-x; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Usadel B, 2008, PLANT PHYSIOL, V146, P1834, DOI 10.1104/pp.107.115592; VANDERPOEL PW, 1998, SUGAR TECHNOLOGY BEE; Wedeking R, 2017, FUNCT PLANT BIOL, V44, P119, DOI 10.1071/FP16112; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Witt S, 2012, MOL PLANT, V5, P401, DOI 10.1093/mp/ssr102; Wu GQ, 2014, SOIL SCI PLANT NUTR, V60, P565, DOI 10.1080/00380768.2014.921579; ZRENNER R, 1991, PLANT CELL ENVIRON, V14, P939, DOI 10.1111/j.1365-3040.1991.tb00963.x	57	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196102	10.1371/journal.pone.0196102	http://dx.doi.org/10.1371/journal.pone.0196102			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738573	Green Published, Green Submitted, gold			2022-12-26	WOS:000431724900005
J	Espinosa, J; Domenech, B; Vazquez, C; Perez, J; Mas, D				Espinosa, Julian; Domenech, Begona; Vazquez, Carmen; Perez, Jorge; Mas, David			Blinking characterization from high speed video records. Application to biometric authentication	PLOS ONE			English	Article							EYELID MOVEMENTS; INCOMPLETE BLINKS; SEARCH COIL; SYSTEM; VERIFICATION; RECOGNITION; DYNAMICS; REFLEX; MOTION	The evaluation of eye blinking has been used for the diagnosis of neurological disorders and fatigue. Despite the extensive literature, no objective method has been found to analyze its kinematic and dynamic behavior. A non-contact technique based on the high-speed recording of the light reflected by the eyelid in the blinking process and the off-line processing of the sequence is presented. It allows for objectively determining the start and end of a blink, besides obtaining different physical magnitudes: position, speed, eyelid acceleration as well as the power, work and mechanical impulse developed by the muscles involved in the physiological process. The parameters derived from these magnitudes provide a unique set of features that can be used to biometric authentication. This possibility has been tested with a limited number of subjects with a correct identification rate of up to 99.7%, thus showing the potential application of the method.	[Espinosa, Julian; Domenech, Begona; Vazquez, Carmen; Perez, Jorge; Mas, David] Univ Alicante, Dept Opt Pharmacol & Anat, Alicante, Spain; [Espinosa, Julian; Domenech, Begona; Vazquez, Carmen; Perez, Jorge; Mas, David] Univ Alicante, Univ Inst Phys Appl Sci & Technol, Alicante, Spain	Universitat d'Alacant; Universitat d'Alacant	Espinosa, J (corresponding author), Univ Alicante, Dept Opt Pharmacol & Anat, Alicante, Spain.; Espinosa, J (corresponding author), Univ Alicante, Univ Inst Phys Appl Sci & Technol, Alicante, Spain.	julian.espinosa@ua.es	Pérez, Jorge/K-1666-2014; Mas, David/J-9842-2014; Vazquez, Carmen/GVT-8878-2022; Espinosa, Julián/K-1652-2014; Domenech, Begona/R-5781-2018; Espinosa, Julián/AGV-7288-2022	Pérez, Jorge/0000-0002-9380-2947; Mas, David/0000-0002-9206-4591; Espinosa, Julián/0000-0001-6817-3117; Domenech, Begona/0000-0002-9771-7336; Espinosa, Julián/0000-0001-6817-3117; Vazquez, Carmen/0000-0001-6909-5528				Abo-Zahhad M., 2016, Pattern Recognition Letters, V82, P216, DOI 10.1016/j.patrec.2015.07.034; Abo-Zahhad M, 2015, IEEE SIGNAL PROC LET, V22, P876, DOI 10.1109/LSP.2014.2374338; Argiles M, 2015, INVEST OPHTH VIS SCI, V56, P6679, DOI 10.1167/iovs.15-16967; Armstrong BC, 2015, NEUROCOMPUTING, V166, P59, DOI 10.1016/j.neucom.2015.04.025; Bacher LF, 2004, DEV PSYCHOBIOL, V44, P95, DOI 10.1002/dev.10162; Bentivoglio AR, 1997, MOVEMENT DISORD, V12, P1028, DOI 10.1002/mds.870120629; Bernard F, 2013, COMPUT METH PROG BIO, V112, P22, DOI 10.1016/j.cmpb.2013.06.003; Blount W., 1927, Q J EXP PHYSL, V18, P16, DOI [DOI 10.1113/EXPPHYSIOL.1927.SP000426, 10.1113/expphysiol.1927.sp000426]; Bour LJ, 2000, J NEUROPHYSIOL, V83, P166, DOI 10.1152/jn.2000.83.1.166; Breiman L., 1984, CLASSIFICATION REGRE; Caffier PP, 2003, EUR J APPL PHYSIOL, V89, P319, DOI 10.1007/s00421-003-0807-5; Casse G, 2007, GRAEF ARCH CLIN EXP, V245, P1789, DOI 10.1007/s00417-007-0611-8; Choi SH, 2003, MED BIOL ENG COMPUT, V41, P146, DOI 10.1007/BF02344882; Corthout E, 2011, EXP BRAIN RES, V210, P243, DOI 10.1007/s00221-011-2626-y; DENNEY D, 1984, BRIT J OPHTHALMOL, V68, P225, DOI 10.1136/bjo.68.4.225; DOANE MG, 1980, AM J OPHTHALMOL, V89, P507, DOI 10.1016/0002-9394(80)90058-6; DURKIN M, 1990, PSYCHOPHYSIOLOGY, V27, P599, DOI 10.1111/j.1469-8986.1990.tb01983.x; Esteban A, 1999, NEUROPHYSIOL CLIN, V29, P7, DOI 10.1016/S0987-7053(99)80039-2; EVINGER C, 1995, NEWS PHYSIOL SCI, V10, P147, DOI 10.1152/physiologyonline.1995.10.4.147; EVINGER C, 1991, INVEST OPHTH VIS SCI, V32, P387; Fang JS, 2007, OPT EXPRESS, V15, P3271, DOI 10.1364/OE.15.003271; Fisher R.A., 1936, USE MULTIPLE MEASURE; GITTINS J, 1995, PHYSIOL MEAS, V16, P303, DOI 10.1088/0967-3334/16/4/010; GUITTON D, 1991, INVEST OPHTH VIS SCI, V32, P3298; Hsieh CS, 2013, INSTRUM SCI TECHNOL, V41, P429, DOI 10.1080/10739149.2013.796560; Jiang XT, 2013, BEHAV RES METHODS, V45, P656, DOI 10.3758/s13428-012-0294-x; Johnston PR, 2013, CLIN OPHTHALMOL, V7, P253, DOI 10.2147/OPTH.S39104; Juhola M, 2013, COMPUT BIOL MED, V43, P42, DOI 10.1016/j.compbiomed.2012.10.005; KARSON CN, 1983, BRAIN, V106, P643, DOI 10.1093/brain/106.3.643; Kwon KA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0227; Larose D. T., 2005, DISCOVERING KNOWLEDG, P90, DOI [DOI 10.1002/0471687545.CH5, 10.1002/0471687545.ch5]; Lee WO, 2010, J NEUROSCI METH, V193, P356, DOI 10.1016/j.jneumeth.2010.08.034; Mak FHW, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.0932; Mas D, 2010, OPT LETT, V35, P1884, DOI 10.1364/OL.35.001884; Mitelman R, 2009, J NEUROSCI METH, V178, P350, DOI 10.1016/j.jneumeth.2008.12.007; Morcego B, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.2.025005; Narsky I., 2013, STAT ANAL TECHNIQUES, P221, DOI DOI 10.1002/9783527677320.CH11; NIIDA T, 1987, JPN J OPHTHALMOL, V31, P255; Ongerboer de Visser B W, 1974, J Neurol Neurosurg Psychiatry, V37, P1225; Perez J, 2011, J MOD OPTIC, V58, P1857, DOI 10.1080/09500340.2011.554898; Portello JK, 2013, OPTOMETRY VISION SCI, V90, P482, DOI 10.1097/OPX.0b013e31828f09a7; Roy RN, 2014, BIOMED SIGNAL PROCES, V14, P256, DOI 10.1016/j.bspc.2014.08.007; Schellini SA, 2005, ORBIT, V24, P239, DOI 10.1080/01676830590922057; SCHLAG J, 1983, VISION RES, V23, P1025, DOI 10.1016/0042-6989(83)90013-5; Schleicher R, 2008, ERGONOMICS, V51, P982, DOI 10.1080/00140130701817062; Sforza C, 2008, OPHTHAL PHYSL OPT, V28, P345, DOI 10.1111/j.1475-1313.2008.00577.x; Shultz S, 2011, P NATL ACAD SCI USA, V108, P21270, DOI 10.1073/pnas.1109304108; Somia NN, 2000, CLIN BIOMECH, V15, P766, DOI 10.1016/S0268-0033(00)00062-0; STAVA MW, 1994, INVEST OPHTH VIS SCI, V35, P3966; STERN JA, 1994, HUM FACTORS, V36, P285, DOI 10.1177/001872089403600209; Sugiyama K., 1996, JSAE REV, V17, P159; Sun WS, 1997, INVEST OPHTH VIS SCI, V38, P92; Tsubota K, 1998, PROG RETIN EYE RES, V17, P565, DOI 10.1016/S1350-9462(98)00004-4; Uzair M, 2015, OPT EXPRESS, V23, P15160, DOI 10.1364/OE.23.015160; VanderWerf F, 2003, J NEUROPHYSIOL, V89, P2784, DOI 10.1152/jn.00557.2002; ZAMETKIN AJ, 1979, ANN NEUROL, V5, P453, DOI 10.1002/ana.410050509; Zhang C, 2017, BIOMED SIGNAL PROCES, V33, P189, DOI 10.1016/j.bspc.2016.11.022	57	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196125	10.1371/journal.pone.0196125	http://dx.doi.org/10.1371/journal.pone.0196125			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE8KX	29734389	Green Published, Green Submitted, gold			2022-12-26	WOS:000431481700008
J	Luo, HS; He, CY; Han, LB				Luo, Hongsong; He, Chunyan; Han, Liebao			Heterologous expression of ZjOMT from Zoysia japonica in Escherichia coli confers aluminum resistance through melatonin production	PLOS ONE			English	Article							N-ACETYLSEROTONIN METHYLTRANSFERASE; ACID O-METHYLTRANSFERASE; EXOGENOUS MELATONIN; STRESS TOLERANCE; LEAF SENESCENCE; ANTIOXIDANT; PLANTS; SALINITY; DEFENSE	Melatonin is a molecule that can enhance the resistance of plants to abiotic stress. It can alleviate the damage of heavy metal ions, and other chemical substances, changes in temperature and humidity, oxidative stress in higher plants, and enhance resistance of plants to abiotic stress. The transformation of N-Acetyl-5-hydroxy tryptamin into melatonin requires the involvement of methyltransferase. In this study, a methyltransferase gene ZjOMT has been cloned from Zoysia japonica. The gene was induced by aluminum (Al) stress in the leaves and roots of Zoysia japonica, and was up-regulated by 20.86-and 31.18-folds, respectively. The expression of ZjOMT in Escherichia coli increased the content of melatonin by about 8-fold in the recombinant strain compared with that of the empty vector strain. Al resistance test showed that the resistance of recombinant strain BL21-pET32-ZjOMT to Al was significantly higher than that of the empty vector strain BL21-pET32. The survival rate of the recombinant strain expressing ZjOMT was about 100-fold higher than that of the empty vector strain when treated with 0.35 mM Al. These findings suggest that the heterologous expression of ZjOMT improved the resistance of E. coli to Al by increasing the content of melatonin.	[Luo, Hongsong; He, Chunyan; Han, Liebao] Beijing Forestry Univ, Turfgrass Res Inst, Coll Forestry, Beijing, Peoples R China	Beijing Forestry University	Han, LB (corresponding author), Beijing Forestry Univ, Turfgrass Res Inst, Coll Forestry, Beijing, Peoples R China.	liebaohan2017@163.com			National Natural Science Foundation of China [31601989, 31672477]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31601989 and No. 31672477). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124497; Back K, 2016, J PINEAL RES, V61, P426, DOI 10.1111/jpi.12364; Byeon Y, 2016, APPL MICROBIOL BIOT, V100, P6683, DOI 10.1007/s00253-016-7458-z; Byeon Y, 2015, J EXP BOT, V66, P6917, DOI 10.1093/jxb/erv396; Byeon Y, 2014, J PINEAL RES, V57, P219, DOI 10.1111/jpi.12160; Facchini PJ, 2000, PHYTOCHEMISTRY, V54, P121, DOI 10.1016/S0031-9422(00)00050-9; Janas KM, 2013, ACTA PHYSIOL PLANT, V35, P3285, DOI 10.1007/s11738-013-1372-0; Kang K, 2011, J PINEAL RES, V50, P304, DOI 10.1111/j.1600-079X.2010.00841.x; Kolar J, 2005, J PINEAL RES, V39, P333, DOI 10.1111/j.1600-079X.2005.00276.x; Lazar D, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23279; Li X, 2018, MOLECULES, V23, DOI 10.3390/molecules23010165; Liang CZ, 2015, J PINEAL RES, V59, P91, DOI 10.1111/jpi.12243; Nawaz MA, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01230; Posmyk MM, 2009, J PINEAL RES, V46, P214, DOI 10.1111/j.1600-079X.2008.00652.x; Reiter RJ, 2002, ANN NY ACAD SCI, V957, P341, DOI 10.1111/j.1749-6632.2002.tb02938.x; Shi HT, 2015, J PINEAL RES, V58, P335, DOI 10.1111/jpi.12219; Tal O, 2011, J EXP BOT, V62, P1903, DOI 10.1093/jxb/erq378; Tan DX, 2007, FASEB J, V21, P1724, DOI 10.1096/fj.06-7745com; Tan DX, 2012, J EXP BOT, V63, P577, DOI 10.1093/jxb/err256; Tan DX, 2007, PLANT SIGNAL BEHAV, V2, P514, DOI 10.4161/psb.2.6.4639; Tan DX, 2000, BIOL SIGNAL RECEPT, V9, P137; Van Tassel DL, 2001, J PINEAL RES, V31, P1, DOI 10.1034/j.1600-079X.2001.310101.x; von Gall C, 2002, CELL TISSUE RES, V309, P151, DOI 10.1007/s00441-002-0581-4; Wang P, 2013, J PINEAL RES, V54, P292, DOI [10.1111/j.1600-079X.2012.00999.x, 10.1111/jpi.12017]; Weeda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093462; Wei W, 2015, J EXP BOT, V66, P695, DOI 10.1093/jxb/eru392; Xuan JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075705; Zhang HJ, 2014, J PINEAL RES, V57, P269, DOI 10.1111/jpi.12167; Zhang JR, 2017, FUNCT PLANT BIOL, V44, P961, DOI 10.1071/FP17003; Zhang LJ, 2013, N HORTIC, P106; Zuo BX, 2014, J PINEAL RES, V57, P408, DOI 10.1111/jpi.12180	31	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196952	10.1371/journal.pone.0196952	http://dx.doi.org/10.1371/journal.pone.0196952			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734371	Green Published, gold, Green Submitted			2022-12-26	WOS:000431481700037
J	Gong, YP; Yang, J; Wu, WS; Liu, F; Su, AP; Li, ZH; Zhu, JQ; Wei, T				Gong, Yanping; Yang, Jing; Wu, Wenshuang; Liu, Feng; Su, Anping; Li, Zhihui; Zhu, Jingqiang; Wei, Tao			Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer	PLOS ONE			English	Article							CHANNEL BETA-1 SUBUNIT; GATED SODIUM-CHANNELS; BREAST-CANCER; TUMOR-SUPPRESSOR; CELLS; GENE; IDENTIFICATION; METASTASIS; CARCINOMA	Voltage-gated sodium channel beta subunits (encoded by SCN1B to SCN4B genes) have been demonstrated as important multifunctional signaling molecules modulating cellular processes such as cell adhesion and cell migration. In this study, we aimed to explore the expression profiles of SCN4B in papillary thyroid cancer (PTC) and its prognostic value in terms of recurrence-free survival (RFS) in classical PTC. In addition, we also examined the potential effect of DNA methylation on its expression. A retrospective study was performed by using data from available large databases, including the Gene Expression Omnibus (GEO) datasets and the Cancer Genome Atlas (TCGA)-Thyroid Cancer (THCA). Results showed that SCN4B is downregulated at both RNA and protein level in PTC compared with normal thyroid tissues. Preserved SCN4B expression was an independent indicator of favorable RFS in patients with classical PTC, no matter as categorical variables (HR: 0.243, 95%CI: 0.107-0.551, p = 0.001) or as a continuous variable (HR: 0.684, 95%CI: 0.520-0.899, p = 0.007). The methylation status of one CpG site (Chr11: 118,022,316-318) in SCN4B DNA had a moderately negative correlation with SCN4B expression in all PTC cases (Pearson's r = -0.48) and in classical PTC cases (Pearson's r = -0.41). In comparison, SCN4B DNA copy number alterations (CNAs) were not frequent and might not influence its mRNA expression. In addition, no somatic mutation was found in SCN4B DNA. Based on these findings, we infer that preserved SCN4B expression might independently predict favorable RFS in classical PTC. Its expression might be suppressed by DNA hypermethylation, but is less likely to be influenced by DNA CNAs/mutations.	[Gong, Yanping; Yang, Jing; Wu, Wenshuang; Liu, Feng; Su, Anping; Li, Zhihui; Zhu, Jingqiang; Wei, Tao] Sichuan Univ, West China Hosp, Thyroid & Parathyroid Surg Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University	Wei, T (corresponding author), Sichuan Univ, West China Hosp, Thyroid & Parathyroid Surg Ctr, Chengdu, Sichuan, Peoples R China.	surgeonwei@163.com			Sichuan Province Science and Technology Project of China [2017SZ0058, 2018SZ0215]	Sichuan Province Science and Technology Project of China	This study was supported by grants from Sichuan Province Science and Technology Project of China (grant no.2017SZ0058 to ZL and 2018SZ0215 to YG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2004, ONCOGENE, V23, P7791, DOI 10.1038/sj.onc.1208067; Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Black JA, 2013, NEURON, V80, P280, DOI 10.1016/j.neuron.2013.09.012; Bon E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13648; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Brassard M, 2011, J CLIN ENDOCR METAB, V96, P1352, DOI 10.1210/jc.2010-2708; Chioni AM, 2009, INT J BIOCHEM CELL B, V41, P1216, DOI 10.1016/j.biocel.2008.11.001; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Dando I, 2016, IUBMB LIFE, V68, P722, DOI 10.1002/iub.1534; de Melo TG, 2014, J ENDOCRINOL INVEST, V37, P1195, DOI 10.1007/s40618-014-0131-4; Diss JKJ, 2008, PROSTATE CANCER P D, V11, P325, DOI 10.1038/sj.pcan.4501012; Hernandez-Plata E, 2012, INT J CANCER, V130, P2013, DOI 10.1002/ijc.26210; Katzenmaier EM, 2017, IUBMB LIFE, V69, P962, DOI 10.1002/iub.1690; Khatami F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184892; Liu DX, 2013, JNCI-J NATL CANCER I, V105, P1617, DOI 10.1093/jnci/djt249; Nelson M, 2014, INT J CANCER, V135, P2338, DOI 10.1002/ijc.28890; O'Malley HA, 2015, ANNU REV PHYSIOL, V77, P481, DOI 10.1146/annurev-physiol-021014-071846; Qiang W, 2014, J CLIN ENDOCR METAB, V99, pE1163, DOI 10.1210/jc.2013-3729; Toniato A, 2008, ANN SURG ONCOL, V15, P1518, DOI 10.1245/s10434-008-9859-4; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Zhou SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187356	22	22	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0197007	10.1371/journal.pone.0197007	http://dx.doi.org/10.1371/journal.pone.0197007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723302	Green Submitted, Green Published, gold			2022-12-26	WOS:000431305100099
J	Miki, A; Ricordi, C; Sakuma, Y; Yamamoto, T; Misawa, R; Mita, A; Molano, RD; Vaziri, ND; Pileggi, A; Ichii, H				Miki, Atsushi; Ricordi, Camillo; Sakuma, Yasunaru; Yamamoto, Toshiyuki; Misawa, Ryosuke; Mita, Atsuyoshi; Molano, Ruth D.; Vaziri, Nosratola D.; Pileggi, Antonello; Ichii, Hirohito			Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation	PLOS ONE			English	Article							HUMAN PANCREATIC-ISLETS; LASER-SCANNING CYTOMETRY; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; ALLOGRAFT-REJECTION; RADICAL SCAVENGER; OXIDATIVE STRESS; NITRIC-OXIDE; DNA-DAMAGE; MASS	Background Type 1 and Type 2 diabetes mellitus (T1DM and T2DM) are caused by beta(beta)-cell loss and functional impairment. Identification of mechanisms of beta-cell death and therapeutic interventions to enhance beta-cell survival are essential for prevention and treatment of diabetes. Oxidative stress is a common feature of both T1DM and T2DM; elevated biomarkers of oxidative stress are detected in blood, urine and tissues including pancreas of patients with DM. Islet transplantation is a promising treatment for diabetes. However, exposure to stress (chemical and mechanical) and ischemia-reperfusion during isolation and transplantation causes islet loss by generation of reactive oxygen species (ROS). Human intracellular antioxidant enzymes and related molecules are essential defenses against ROS. Antioxidant enzyme levels including superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPX) have been shown to be low in islet cells. However, little is known about the expression and function of antioxidant enzymes within islet cell subsets. We evaluated the expression of the key antioxidant enzymes in beta- and alpha(alpha)-cell and accessed effects of oxidative stress, islet isolation and transplantation on beta/alpha-cell ratio and viability in human islets. Methods Human pancreata from T1DM, T2DM and non-diabetic deceased donors were obtained and analyzed by confocal microscopy. Isolated islets were (I) transplanted in the renal sub-capsular space of streptozotocin-induced diabetic nude mice (in vivo bioassay), or II) exposed to oxidative (H2O2) and nitrosative (NO donor) stress for 24 hrs in vitro. The ratio, % viability and death of beta- and alpha-cells, and DNA damage (8OHdG) were measured. Results and conclusions Catalase and GPX expression was much lower in beta- than alpha-cells. The beta/alpha-cell ratio fells significantly following islet isolation and transplantation. Exposure to oxidative stress caused a significantly lower survival and viability, with higher DNA damage in beta- than alpha-cells. These findings identified the weakness of beta-cell antioxidant capacity as a main cause of vulnerability to oxidative stress. Potential strategies to enhance beta-cell antioxidant capacity might be effective in prevention/treatment of diabetes.	[Miki, Atsushi; Ricordi, Camillo; Sakuma, Yasunaru; Yamamoto, Toshiyuki; Misawa, Ryosuke; Mita, Atsuyoshi; Molano, Ruth D.; Pileggi, Antonello; Ichii, Hirohito] Univ Miami, Cell Transplant Ctr, Diabet Res Inst, Miami, FL 33124 USA; [Vaziri, Nosratola D.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Ichii, Hirohito] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA; [Miki, Atsushi; Sakuma, Yasunaru] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi, Japan; [Yamamoto, Toshiyuki] Fujita Hlth Univ, Dept Surg, Toyoake, Aichi, Japan; [Misawa, Ryosuke; Mita, Atsuyoshi] Shinshu Univ, Dept Surg, Matsumoto, Nagano, Japan; [Ichii, Hirohito] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA	University of Miami; University of California System; University of California Irvine; University of California System; University of California Irvine; Jichi Medical University; Fujita Health University; Shinshu University; University of California System; University of California Irvine	Ichii, H (corresponding author), Univ Miami, Cell Transplant Ctr, Diabet Res Inst, Miami, FL 33124 USA.; Ichii, H (corresponding author), Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA.; Ichii, H (corresponding author), Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA.	hichii@uci.edu	RICORDI, CAMILLO/AAA-4740-2019; Ichii, Hirohito/AAV-8256-2021; Pileggi, Antonello/A-2394-2008	Pileggi, Antonello/0000-0001-7819-2813; Ichii, Hirohito/0000-0002-3635-5773	NIH-NCRR; GCRC [MO1RR16587]; NIDDK [R01-DK55347-IU42RR016603, 5R01DK25802]; ICR [5U42RR016603, UL1 TR000153, KL2 TR000147]; NIH-NCRR [UL1 TR000153, KL2 TR000147]; Juvenile Diabetes Research Foundation [4-200-946, 4-2004-361, 17-2011-609]; JSPS KAKENHI [JP 25870665]; MEDICAL UNIVERSITY YOUNG INVESTIGATOR AWARD; Diabetes Research Institute Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001416] Funding Source: NIH RePORTER	NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ICR; NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEDICAL UNIVERSITY YOUNG INVESTIGATOR AWARD; Diabetes Research Institute Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by NIH-NCRR, GCRC MO1RR16587, NIDDK R01-DK55347-IU42RR016603, 5R01DK25802, ICR 5U42RR016603, UL1 TR000153, KL2 TR000147, NIH-NCRR UL1 TR000153, KL2 TR000147; the Juvenile Diabetes Research Foundation International 4-200-946, 4-2004-361, and 17-2011-609, JSPS KAKENHI Grant Number JP 25870665, MEDICAL UNIVERSITY YOUNG INVESTIGATOR AWARD and the Diabetes Research Institute Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreozzi F, 2004, ENDOCRINOLOGY, V145, P2845, DOI 10.1210/en.2003-0939; Bassi R, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-158; Ben Nasr M, 2015, ACTA DIABETOL, V52, P917, DOI 10.1007/s00592-015-0735-y; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; Bottino R, 2002, DIABETES, V51, P2561, DOI 10.2337/diabetes.51.8.2561; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chen HN, 2001, DIABETES, V50, P2040, DOI 10.2337/diabetes.50.9.2040; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P8992, DOI 10.1073/pnas.90.19.8992; Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Engberding N, 2004, CIRCULATION, V110, P2175, DOI 10.1161/01.CIR.0000144303.24894.1C; Ferrannini E, 2004, DIABETOLOGIA, V47, P943, DOI 10.1007/s00125-004-1381-z; Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x; Folli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009923; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; Ichii H, 2006, AM J TRANSPLANT, V6, P2060, DOI 10.1111/j.1600-6143.2006.01452.x; Ichii H, 2005, AM J TRANSPLANT, V5, P1635, DOI 10.1111/j.1600-6143.2005.00913.x; Ichii H, 2005, AM J TRANSPLANT, V5, P21, DOI 10.1111/j.1600-6143.2005.00698.x; Ichii H, 2008, LAB INVEST, V88, P1167, DOI 10.1038/labinvest.2008.87; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Keymeulen B, 2006, P NATL ACAD SCI USA, V103, P17444, DOI 10.1073/pnas.0608141103; LATIF ZA, 1988, TRANSPLANTATION, V45, P827; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; MALAISSE WJ, 1982, P NATL ACAD SCI-BIOL, V79, P927, DOI 10.1073/pnas.79.3.927; Marchetti P, 2004, J CLIN ENDOCR METAB, V89, P5535, DOI 10.1210/jc.2004-0150; Miki A, 2008, AM J TRANSPLANT, V8, P433; Moriscot C, 2007, DIABETES METAB, V33, P44, DOI 10.1016/j.diabet.2006.09.004; Mysore TB, 2005, DIABETES, V54, P2109, DOI 10.2337/diabetes.54.7.2109; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Olcott AP, 2004, DIABETES, V53, P2574, DOI 10.2337/diabetes.53.10.2574; Patane G, 2002, DIABETES, V51, P2749, DOI 10.2337/diabetes.51.9.2749; Pisania A, 2010, LAB INVEST, V90, P1661, DOI 10.1038/labinvest.2010.124; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Ponte GM, 2007, CELL TRANSPLANT, V16, P595, DOI 10.3727/000000007783465082; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; RABINOVITCH A, 1992, DIABETOLOGIA, V35, P409, DOI 10.1007/BF02342435; Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Ricordi C, 2014, IN VITRO ASSESSMENT; Robertson RP, 2006, CURR OPIN PHARMACOL, V6, P615, DOI 10.1016/j.coph.2006.09.002; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Sakuraba H, 2002, DIABETOLOGIA, V45, P85, DOI 10.1007/s125-002-8248-z; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sjoholm A, 1998, CELL DEATH DIFFER, V5, P461, DOI 10.1038/sj.cdd.4400379; Takahashi H, 2008, AM J TRANSPLANT, V8, P474; Tang C, 2007, DIABETES, V56, P2722, DOI 10.2337/db07-0279; Thomas DA, 2007, J AM SOC NEPHROL, V18, P213, DOI 10.1681/ASN.2006080825; Todorov I, 2010, TRANSPLANTATION, V90, P836, DOI 10.1097/TP.0b013e3181f1db5d	53	50	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196570	10.1371/journal.pone.0196570	http://dx.doi.org/10.1371/journal.pone.0196570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723228	Green Published, gold			2022-12-26	WOS:000431305100040
J	Nasser, AB; Zamli, KZ; Alsewari, AA; Ahmed, BS				Nasser, Abdullah B.; Zamli, Kamal Z.; Alsewari, AbdulRahman A.; Ahmed, Bestoun S.			Hybrid flower pollination algorithm strategies for t-way test suite generation	PLOS ONE			English	Article							OPTIMIZATION; DESIGN	The application of meta-heuristic algorithms for t-way testing has recently become prevalent. Consequently, many useful meta-heuristic algorithms have been developed on the basis of the implementation of t-way strategies (where t indicates the interaction strength). Mixed results have been reported in the literature to highlight the fact that no single strategy appears to be superior compared with other configurations. The hybridization of two or more algorithms can enhance the overall search capabilities, that is, by compensating the limitation of one algorithm with the strength of others. Thus, hybrid variants of the flower pollination algorithm (FPA) are proposed in the current work. Four hybrid variants of FPA are considered by combining FPA with other algorithmic components. The experimental results demonstrate that FPA hybrids overcome the problems of slow convergence in the original FPA and offers statistically superior performance compared with existing t-way strategies in terms of test suite size.	[Nasser, Abdullah B.; Zamli, Kamal Z.; Alsewari, AbdulRahman A.] Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Kuantan, Pahang, Malaysia; [Ahmed, Bestoun S.] Czech Tech Univ, Fac Elect Engn, Dept Comp Sci, Prague 2, Czech Republic	Universiti Malaysia Pahang; Czech Technical University Prague	Zamli, KZ (corresponding author), Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Kuantan, Pahang, Malaysia.	kamalz@ump.edu.my	Nasser, Abdullah B./AAX-5352-2020; Ahmed, Bestoun S./B-4429-2010; Alsewari, AbdulRahman Ahmed/Q-3966-2019; Zamli, Kamal Z./F-6437-2010	Nasser, Abdullah B./0000-0002-5377-999X; Ahmed, Bestoun S./0000-0001-9051-7609; Alsewari, AbdulRahman Ahmed/0000-0002-7802-6628; Zamli, Kamal Z./0000-0003-4626-0513	Fundamental Research Grant: Reinforcement Learning Sine Cosine based Strategy for Combinatorial Test Suite Generation from the Ministry of Higher Education Malaysia [RDU170103]	Fundamental Research Grant: Reinforcement Learning Sine Cosine based Strategy for Combinatorial Test Suite Generation from the Ministry of Higher Education Malaysia	The work undertaken in this paper is supported by the Fundamental Research Grant: Reinforcement Learning Sine Cosine based Strategy for Combinatorial Test Suite Generation (grant no: RDU170103) from the Ministry of Higher Education Malaysia.; The work undertaken in this paper is supported by the Fundamental Research Grant: Reinforcement Learning Sine Cosine based Strategy for Combinatorial Test Suite Generation (grant no: RDU170103) from the Ministry of Higher Education Malaysia. Additionally, we also thanked Dr Nasser M. Tairan from King Khaled University, Saudi Arabia for his initial support of our work.	Abdel-Baset M., 2015, ADV ENG TECHNOLOGY A, P27; Abdel-Baset M, 2014, INT J ED MANAG ENG, V4, P1, DOI DOI 10.5815/IJEME.2014.02.01; Ahmed BS, 2015, INFORM SOFTWARE TECH, V66, P13, DOI 10.1016/j.infsof.2015.05.005; Ahmed BS, 2012, INT J INNOV COMPUT I, V8, P431; Ahmed BS, 2011, J SYST SOFTWARE, V84, P2171, DOI 10.1016/j.jss.2011.06.004; Alsewari ARA, 2012, INFORM SOFTWARE TECH, V54, P553, DOI 10.1016/j.infsof.2012.01.002; Alsewari ARA, 2014, ORCHESTRATED SURVEY, P255; [Anonymous], 2009, NABIC 2009 WORLD C 2, DOI [10.1109/NABIC.2009.5393690, DOI 10.1109/NABIC.2009.5393690]; Bell K. Z., 2006, THESIS; Bell KZ, 2005, ENABLING TECHNOLOGIES FOR THE NEW KNOWLEDGE SOCIETY, P221; Blum C, 2011, APPL SOFT COMPUT, V11, P4135, DOI 10.1016/j.asoc.2011.02.032; Blum C, 2008, STUD COMPUT INTELL, V114, P1; Burr K, 1998, COMBINATORIAL TEST T; Chakraborty D, 2014, DE FPA HYBRID DIFFER, P1; Cohen DM, 1997, IEEE T SOFTWARE ENG, V23, P437, DOI 10.1109/32.605761; Cohen DM, 1996, IEEE SOFTWARE, V13, P83, DOI 10.1109/52.536462; Cohen MB, 2004, THESIS; Dorigo M., 2008, ANT COLONY OPTIMIZAT; Dubey HM, 2015, RENEW ENERG, V83, P188, DOI 10.1016/j.renene.2015.04.034; Forbes M, 2008, J RES NATL INST STAN, V113, P287, DOI 10.6028/jres.113.022; Geem ZW, 2006, ENG OPTIMIZ, V38, P259, DOI 10.1080/03052150500467430; Glover F., 1999, TABU SEARCH; Grindal M, 2005, SOFTW TEST VERIF REL, V15, P167, DOI 10.1002/stvr.319; Gruter C, 2011, COMMUNICATIVE INTEGR, V4; Hartman A, 2004, DISCRETE MATH, V284, P149, DOI 10.1016/j.disc.2003.11.029; Hezam IM, 2015, INFORM SCI LETT, V5, P29; HOLLAND JH, 1992, SCI AM, V267, P66, DOI 10.1038/scientificamerican0792-66; Jenkins B, 2003, JENNY TOOL; Johal N. K., 2010, INT J COMPUTER APPL, V6; Kennedy J., 2010, ENCY MACHINE LEARNIN, P760, DOI DOI 10.1007/978-0-387-30164-8_630; KIRKPATRICK S, 1984, J STAT PHYS, V34, P975, DOI 10.1007/BF01009452; Kuhn D. R., 2010, NIST SPECIAL PUBLICA, V800-142; Lee KS, 2005, COMPUT METHOD APPL M, V194, P3902, DOI 10.1016/j.cma.2004.09.007; Lee KY, 2006, 2006 IEEE/PES POWER SYSTEMS CONFERENCE AND EXPOSITION. VOLS 1-5, P188, DOI 10.1109/PSCE.2006.296295; Lei Y, 1998, THIRD IEEE INTERNATIONAL HIGH-ASSURANCE SYSTEMS ENGINEERING SYMPOSIUM, PROCEEDINGS, P254, DOI 10.1109/HASE.1998.731623; Lei Y, 2008, SOFTW TEST VERIF REL, V18, P125, DOI 10.1002/stvr.381; Lei Y, 2007, ECBS 2007: 14TH ANNUAL IEEE INTERNATIONAL CONFERENCE AND WORKSHOPS ON THE ENGINEERING OF COMPUTER-BASED SYSTEMS, PROCEEDINGS, P549; Leins P., 2010, FLOWER FRUIT MORPHOL; Mirjalili S, 2016, KNOWL-BASED SYST, V96, P120, DOI 10.1016/j.knosys.2015.12.022; Nasser A.B., 2015, ARPN J ENG APPL SCI, V10, P8948; Pham D, 2011, BEES ALGORITHM NOVEL; Shiba T, 2004, USING ARTIFICIAL LIF, P72; Stardom J., 2001, METAHEURISTICS SEARC; Sthamer H.-H., 1995, AUTOMATIC GENERATION; Wang R. L., 2014, MATH PROBLEMS ENG, V2014; Wang R, 2016, INFORM PROCESS LETT, V116, P1, DOI 10.1016/j.ipl.2015.08.007; Wang R, 2015, BIO-MED MATER ENG, V26, pS1345, DOI 10.3233/BME-151432; Williams A, 1996, TCONFIG TOOL; Williams A. W., 2002, SOFTWARE COMPONENTS; Williams AW, 2000, INT FED INFO PROC, V48, P59; Xin-She Yang, 2012, Unconventional Computation and Natural Computation. Proceedings of the 11th International Conference, UCNC 2012, P240, DOI 10.1007/978-3-642-32894-7_27; Yang X., 2008, NATURE INSPIRED META, V2nd; Yang XS, 2014, ENG OPTIMIZ, V46, P1222, DOI 10.1080/0305215X.2013.832237; Yang XS, 2010, RESEARCH AND DEVELOPMENT IN INTELLIGENT SYSTEMS XXVI, P209, DOI 10.1007/978-1-84882-983-1_15; Yilmaz C, 2006, IEEE T SOFTWARE ENG, V32, P20, DOI 10.1109/TSE.2006.8; Zamli KZ, 2016, APPL SOFT COMPUT, V44, P57, DOI 10.1016/j.asoc.2016.03.021; Zhou YQ, 2016, INT J PATTERN RECOGN, V30, DOI 10.1142/S0218001416590102; Zhou YQ, 2016, NEUROCOMPUTING, V188, P294, DOI 10.1016/j.neucom.2015.01.110	61	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195187	10.1371/journal.pone.0195187	http://dx.doi.org/10.1371/journal.pone.0195187			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718918	Green Submitted, Green Published, gold			2022-12-26	WOS:000431281900014
J	Wermuth, PJ; Jimenez, SA				Wermuth, Peter J.; Jimenez, Sergio A.			Abrogation of transforming growth factor-beta-induced tissue fibrosis in TBRIca Col1a2Cre transgenic mice by the second generation tyrosine kinase inhibitor SKI-606 (Bosutinib)	PLOS ONE			English	Article							EXPERIMENTAL DERMAL FIBROSIS; FOCAL ADHESION KINASE; SYSTEMIC-SCLEROSIS; TGF-BETA; IMATINIB MESYLATE; SCLERODERMA FIBROBLASTS; MYOFIBROBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; PULMONARY-FIBROSIS; FACTOR-RECEPTOR	Transforming growth factor-beta (TGF-beta) plays a crucial role in the pathogenesis of Systemic Sclerosis (SSc) and other fibrotic disorders. TGF-beta-mediated c-Abl and Src kinase activation induces strong profibrotic cascade signaling. The purpose of this study was to test in vivo the antifibrotic activity of Bosutinib (SKI-606), a second generation c-Abl and Src kinase inhibitor, on TGF-beta induced cutaneous and pulmonary fibrosis. For this purpose, we employed the TBRIca Col1a2Cre transgenic mice expressing an inducible constitutively active TGF-beta receptor 1 constitutively activated by Col1a promoter-mediated Cre recombinase. The mice were treated parenterally with 2.5, 5.0 or 10.0 mg/kg/day of Bosutinib for 42 days. Skin and lungs from control and Bosutinib-treated mice (n = 6 per group) were assessed by histopathology, measurement of tissue hydroxyproline content, PCR analysis of tissue fibrosis associated gene expression, and evidence of myofibroblast activation. Mice with constitutive TGF-beta-1 signaling displayed severe cutaneous and pulmonary fibrosis. Bosutinib administration decreased collagen deposition and hydroxyproline content in the dermis and lungs in a dose-dependent manner. Bosutinib also reversed the marked increase in profibrotic and myofibroblast activation-associated gene expression. These results demonstrate that constitutive TGF-beta-1-signaling-induced cutaneous and pulmonary fibrosis were abrogated in a dose-related manner following parenteral administration of the c-Abl and Src tyrosine kinase inhibitor, Bosutinib. These results indicate that Bosutinib may be a potential therapeutic agent for tissue fibrosis in SSc and other fibroproliferative disorders.	[Jimenez, Sergio A.] Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Scleroderma Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Jimenez, SA (corresponding author), Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA.	sergio.jimenez@jefferson.edu		Jimenez, Sergio/0000-0001-5213-1203; Wermuth, Peter/0000-0002-0242-7265	Investigator Initiated Project Grant Pfizer Inc. [WI194340]	Investigator Initiated Project Grant Pfizer Inc.	This work was supported by an Investigator Initiated Project Grant (WI194340) from Pfizer Inc. (https.//www.pfizer.com/sciencei/collaboration/investigator-intated-research) to SAJ. Pfizer Inc. also provided Bosutinib free of charge. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmetshina A, 2008, FASEB J, V22, P2214, DOI 10.1096/fj.07-105627; Artlett CM, 2014, OPEN ACCESS RHEUMATO, V6, P65, DOI 10.2147/OARRR.S50009; Avouac J, 2014, METHODS MOL BIOL, V1142, P91, DOI 10.1007/978-1-4939-0404-4_11; Beyer C, 2015, ANN RHEUM DIS, V74, P1408, DOI 10.1136/annrheumdis-2013-204508; Bhattacharyya S, 2009, ONCOGENE, V28, P1285, DOI 10.1038/onc.2008.479; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Carthy JM, 2017, J CELL PHYSL, V429, P2373; Catarzi S, 2005, BBA-MOL CELL RES, V1745, P166, DOI 10.1016/j.bbamcr.2005.03.004; Dabiri G, 2008, J INVEST DERMATOL, V128, P280, DOI 10.1038/sj.jid.5700975; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Daniels CE, 2010, AM J RESP CRIT CARE, V181, P604, DOI 10.1164/rccm.200906-0964OC; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Denton CP, 2007, ARTHRITIS RHEUM-US, V56, P323, DOI 10.1002/art.22289; Denton CP, 2017, LANCET, V390, P1685, DOI 10.1016/S0140-6736(17)30933-9; Derrett-Smith EC, 2009, CURR OPIN RHEUMATOL, V21, P630, DOI 10.1097/BOR.0b013e32833130c1; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Distler JHW, 2008, RHEUMATOLOGY, V47, pV10, DOI 10.1093/rheumatology/ken276; Distler JHW, 2008, ARTHRITIS RHEUM, V58, P2538, DOI 10.1002/art.23694; Distler JHW, 2007, ARTHRITIS RHEUM-US, V56, P311, DOI 10.1002/art.22314; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; Falke LL, 2015, NAT REV NEPHROL, V11, P233, DOI 10.1038/nrneph.2014.246; Golas JM, 2003, CANCER RES, V63, P375; Gordon JK, 2010, CURR OPIN RHEUMATOL, V22, P690, DOI 10.1097/BOR.0b013e32833f1105; Grehn F, 2007, OPHTHALMOLOGY, V114, P1831, DOI 10.1016/j.ophtha.2007.06.028; Haak AJ, 2014, J PHARMACOL EXP THER, V349, P480, DOI 10.1124/jpet.114.213520; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Horton JA, 2013, INT J RADIAT BIOL, V89, P162, DOI 10.3109/09553002.2013.741281; Ihn H, 2001, ARTHRITIS RHEUM, V44, P474, DOI 10.1002/1529-0131(200102)44:2<474::AID-ANR67>3.3.CO;2-R; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Jimenez SA, 2010, CURR RHEUMATOL REV, V6, P283, DOI 10.2174/157339710793205611; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kantarjian HM, 2014, BLOOD, V123, P1309, DOI 10.1182/blood-2013-07-513937; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; Kawakami T, 1998, J INVEST DERMATOL, V110, P47, DOI 10.1046/j.1523-1747.1998.00073.x; Kay J, 2008, ARTHRITIS RHEUM, V58, P2543, DOI 10.1002/art.23696; Keller-von Amsberg G, 2012, EXPERT REV ANTICANC, V12, P1121, DOI [10.1586/ERA.12.84, 10.1586/era.12.84]; Lafyatis R, 2014, NAT REV RHEUMATOL, V10, P706, DOI 10.1038/nrrheum.2014.137; Lakos G, 2004, AM J PATHOL, V165, P203, DOI 10.1016/S0002-9440(10)63289-0; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Leask A, 2002, ARTHRITIS RHEUM-US, V46, P1857, DOI 10.1002/art.10333; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Manne J, 2013, BIOCHEM RES INT, V2013, DOI 10.1155/2013/436053; Markova MS, 2004, J INVEST DERMATOL, V123, P1052, DOI 10.1111/j.0022-202X.2004.23494.x; Mathew P, 2008, BRIT J CANCER, V99, P1426, DOI 10.1038/sj.bjc.6604706; Mathew P, 2007, CLIN CANCER RES, V13, P5816, DOI 10.1158/1078-0432.CCR-07-1269; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Mendoza FA, 2006, SEMIN ARTHRITIS RHEU, V35, P238, DOI 10.1016/j.semarthrit.2005.08.002; Mendoza FA, 2016, ARTHRITIS RHEUMATOL, V68, P210, DOI 10.1002/art.39421; Mendoza FA, 2011, ARTHRITIS RHEUM-US, V63, P3199, DOI 10.1002/art.30545; Mimura Y, 2005, J INVEST DERMATOL, V124, P886, DOI 10.1111/j.0022-202X.2005.23701.x; Mishra R, 2007, AM J PHYSIOL-CELL PH, V292, pC1361, DOI 10.1152/ajpcell.00370.2006; Mori Y, 2003, ARTHRITIS RHEUM-US, V48, P1964, DOI 10.1002/art.11157; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Piera-Velazquez S., 2016, J SCLERODERMA RELATE, V1, P48; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Rice LM, 2015, J CLIN INVEST, V125, P2795, DOI 10.1172/JCI77958; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Rosenbloom J, 2017, METHODS MOL BIOL, V1627, P1, DOI 10.1007/978-1-4939-7113-8_1; Rosenbloom J, 2013, BBA-MOL BASIS DIS, V1832, P1088, DOI 10.1016/j.bbadis.2012.12.007; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Sabnani I, 2009, RHEUMATOLOGY, V48, P49, DOI 10.1093/rheumatology/ken369; Sato M, 2002, J INVEST DERMATOL, V118, P704, DOI 10.1046/j.1523-1747.2002.01719.x; Sfikakis PP, 2008, RHEUMATOLOGY, V47, P735, DOI 10.1093/rheumatology/ken104; Skhirtladze C, 2008, ARTHRITIS RHEUM, V58, P1475, DOI 10.1002/art.23436; Sonnylal S, 2007, ARTHRITIS RHEUM-US, V56, P334, DOI 10.1002/art.22328; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Trojanowska M, 2008, RHEUMATOLOGY, V47, pV2, DOI 10.1093/rheumatology/ken265; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Varga John, 2009, Front Biosci (Schol Ed), V1, P226, DOI 10.2741/s22; Varney SD, 2016, J CELL SCI, V129, P774, DOI 10.1242/jcs.170589; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Wermuth PJ, 2009, ARTHRITIS RHEUM-US, V60, P1508, DOI 10.1002/art.24471; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xu SW, 2012, RHEUMATOLOGY, V51, P2146, DOI 10.1093/rheumatology/kes234; Xu SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126015; YAMASHITA H, 1994, J BIOL CHEM, V269, P20172; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440	87	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196559	10.1371/journal.pone.0196559	http://dx.doi.org/10.1371/journal.pone.0196559			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718973	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900060
J	Yang, SS; Liu, B; Ji, KY; Fan, RW; Dong, CS				Yang, Shanshan; Liu, Bo; Ji, Kaiyuan; Fan, Ruiwen; Dong, Changsheng			MicroRNA-5110 regulates pigmentation by cotargeting melanophilin and WNT family member 1	FASEB JOURNAL			English	Article						MLPH; WNT1; RAB27A; MYO5A	TRANSCRIPTION FACTOR; MELANOMA-CELLS; MYOSIN-VA; EXPRESSED MICRORNAS; DOWN-REGULATION; BINDING DOMAIN; COAT COLOR; MELANOCYTES; PROTEIN; MITF	Mammalian pigmentation requires the production of melanin by melanocytes and its transfer to neighboring keratinocytes. These complex processes are regulated by several molecular pathways. Melanophilin (MLPH) and WNT family member 1 (WNT1), known to be involved in melanin transfer and melanin production, respectively, were predicted to be targets of microRNA-5110 using bioinformatics. In the current study, we investigated the effects of microRNA-5110 on pigmentation in alpaca (Vicugna pacos) melanocytes. In situ hybridization identified high levels of microRNA-5110 in the cytoplasm of alpaca melanocytes. Luciferase activity assays confirmed that MLPH and WNT1 were targeted by microRNA-5110 in these cells. Overexpression and knockdown of microRNA-5110 in alpaca melanocytes downregulated and upregulated MLPH and WNT1 expression at the mRNA and protein levels, respectively. In addition, overexpression and knockdown of microRNA-5110 in alpaca melanocytes decreased and increased, respectively, the mRNA levels of the melanin transfer-related genes, rat sarcoma (RAS)-associated binding (RAB27a) and myosin 5a (MYO5a); the mRNA levels of microphthalmia-associated transcription factor (MITF), tyrosinase (TYR), and tyrosinase-related protein (TYRP)1; and the production of total alkali melanin and pheomelanin. In contrast, overexpression and knockdown of microRNA-5110 increased and decreased the mRNA levels of TYRP2, respectively. Overexpression of microRNA-5110 also increased eumelanin. These results indicate that microRNA-5110 regulates pigmentation in alpaca melanocytes by directly targeting MLPH and WNT1 to affect eumelanin production and transfer.Yang, S., Liu, B., Ji, K., Fan, R., Dong, C. MicroRNA-5110 regulates pigmentation by cotargeting melanophilin and WNT family member 1.	[Yang, Shanshan; Liu, Bo; Ji, Kaiyuan; Fan, Ruiwen; Dong, Changsheng] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 030801, Peoples R China	Shanxi Agricultural University	Fan, RW (corresponding author), Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 030801, Peoples R China.; Dong, CS (corresponding author), Shanxi Agr Univ, Coll Anim Sci & Vet Med, Taigu 080301, Peoples R China.	ruiwenfan@163.com; csdong18@163.com			Young Sanjin Scholars Distinguished Professor Program; Aid Program for Innovation Team at Shanxi Agricultural University [CXTD201202]; 863 Project [2013AA102506]	Young Sanjin Scholars Distinguished Professor Program; Aid Program for Innovation Team at Shanxi Agricultural University; 863 Project	This study was supported by the Young Sanjin Scholars Distinguished Professor Program (to R.F.), the Aid Program for Innovation Team at Shanxi Agricultural University (CXTD201202), and the 863 Project (2013AA102506). The authors declare no conflicts of interest.	Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Bai R, 2010, ASIAN AUSTRAL J ANIM, V23, P430, DOI 10.5713/ajas.2010.90465; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cecchi T, 2011, ITAL J ANIM SCI, V10, P159, DOI 10.4081/ijas.2011.e30; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dong CS, 2012, RNA, V18, P1679, DOI 10.1261/rna.033977.112; Dunn KJ, 2005, PIGM CELL RES, V18, P167, DOI 10.1111/j.1600-0749.2005.00226.x; Dynoodt P, 2013, INT J ONCOL, V42, P1443, DOI 10.3892/ijo.2013.1823; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V281, P1226, DOI 10.1006/bbrc.2001.4512; Goswami S, 2010, J BIOL CHEM, V285, P20532, DOI 10.1074/jbc.M110.109298; Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lim XH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008029; Liu JL, 2014, ARCH BIOCHEM BIOPHYS, V563, P13, DOI 10.1016/j.abb.2014.07.023; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Nagashima K, 2002, FEBS LETT, V517, P233, DOI 10.1016/S0014-5793(02)02634-0; ORLOW SJ, 1995, J INVEST DERMATOL, V105, P3, DOI 10.1111/1523-1747.ep12312291; Prasad R, 2014, ONCOTARGET, V5, P10636, DOI 10.18632/oncotarget.2527; Provance DW, 2002, TRAFFIC, V3, P124, DOI 10.1034/j.1600-0854.2002.030205.x; Schepsky A, 2006, MOL CELL BIOL, V26, P8914, DOI 10.1128/MCB.02299-05; Tachibana M, 2000, PIGM CELL RES, V13, P230, DOI 10.1034/j.1600-0749.2000.130404.x; Tian X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-555; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Yang S, 2015, J ANIM SCI, V93, P1622, DOI 10.2527/jas.2014-8404; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhang WG, 2007, OMICS, V11, P385, DOI 10.1089/omi.2006.0031; Zhou JD, 2014, INT J CLIN EXP PATHO, V7, P7182; Zhu Z, 2010, DOMEST ANIM ENDOCRIN, V38, P200, DOI 10.1016/j.domaniend.2009.10.004	37	10	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5405	5412		10.1096/fj.201800040R	http://dx.doi.org/10.1096/fj.201800040R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29733692	Green Published, hybrid			2022-12-26	WOS:000447972500017
J	Ahangar, MS; Furze, CM; Guy, CS; Cooper, C; Maskew, KS; Graham, B; Cameron, AD; Fullam, E				Ahangar, Mohd Syed; Furze, Christopher M.; Guy, Collette S.; Cooper, Charlotte; Maskew, Kathryn S.; Graham, Ben; Cameron, Alexander D.; Fullam, Elizabeth			Structural and functional determination of homologs of the Mycobacterium tuberculosis N-acetylglucosamine-6-phosphate deacetylase (NagA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate; crystal structure; tuberculosis; Mycobacterium tuberculosis; enzyme kinetics; X-ray crystallography; peptidoglycan; bacterial cell wall; N-acetylglucosamine-6-phosphate deactylase; TB	RESUSCITATION-PROMOTING FACTORS; ACETYL-D-GLUCOSAMINE; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; CELL-WALL; N-ACETYLGLUCOSAMINE-6-PHOSPHATE DEACETYLASE; N-ACETYLGLUCOSAMINE; N-ACETYL-D-GLUCOSAMINE-6-PHOSPHATE DEACETYLASE; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC PRODUCTION	The Mycobacterium tuberculosis (Mtb) pathogen encodes a GlcNAc-6-phosphate deacetylase enzyme, NagA (Rv3332), that belongs to the amidohydrolase superfamily. NagA enzymes catalyze the deacetylation of GlcNAc-6-phosphate (GlcNAc6P) to glucosamine-6-phosphate (GlcN6P). NagA is a potential antitubercular drug target because it represents the key enzymatic step in the generation of essential amino-sugar precursors required for Mtb cell wall biosynthesis and also influences recycling of cell wall peptidoglycan fragments. Here, we report the structural and functional characterization of NagA from Mycobacterium smegmatis (MSNagA) and Mycobacterium marinum (MMNagA), close relatives of Mtb. Using a combination of X-ray crystallography, site-directed mutagenesis, and biochemical and biophysical assays, we show that these mycobacterial NagA enzymes are selective for GlcNAc6P. Site-directed mutagenesis studies revealed crucial roles of conserved residues in the active site that underpin stereoselective recognition, binding, and catalysis of substrates. Moreover, we report the crystal structure of MSNagA in both ligand-free form and in complex with the GlcNAc6P substrate at 2.6 and 2.0 resolutions, respectively. The GlcNAc6P complex structure disclosed the precise mode of GlcNAc6P binding and the structural framework of the active site, including two divalent metals located in the / binuclear site. Furthermore, we observed a cysteine residue located on a flexible loop region that occludes the active site. This cysteine is unique to mycobacteria and may represent a unique subsite for targeting mycobacterial NagA enzymes. Our results provide critical insights into the structural and mechanistic properties of mycobacterial NagA enzymes having an essential role in amino-sugar and nucleotide metabolism in mycobacteria.	[Ahangar, Mohd Syed; Furze, Christopher M.; Guy, Collette S.; Cooper, Charlotte; Maskew, Kathryn S.; Cameron, Alexander D.; Fullam, Elizabeth] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Guy, Collette S.; Graham, Ben] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Fullam, E (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	e.fullam@warwick.ac.uk		Cooper, Charlotte/0000-0003-4855-4187; Furze, Christopher/0000-0002-2785-4618; Ahangar, Mohd Syed/0000-0003-2251-6107; Cameron, Alexander/0000-0001-8776-3518; Guy, Collette/0000-0002-5153-0613; Maskew, Kathryn/0000-0002-5933-9186	Sir Henry Dale Fellowship - Wellcome Trust [104193/Z/14/Z]; Sir Henry Dale Fellowship - Royal Society [104193/Z/14/Z]; Wellcome Warwick Quantitative Biomedicine Programme Institution Strategic Support Fund Seed Grant [105627/Z/14/Z]; Midlands Doctoral Training Partnership Studentship [BB/M01116X/1]; Warwick Integrative Synthetic Biology research technology platform [BB/M017982/1]; Wellcome Trust Grant [201442/Z/16/Z]; Royal Society Research Grant [RG120405]; BBSRC [1790828, BB/M017982/1] Funding Source: UKRI	Sir Henry Dale Fellowship - Wellcome Trust; Sir Henry Dale Fellowship - Royal Society; Wellcome Warwick Quantitative Biomedicine Programme Institution Strategic Support Fund Seed Grant; Midlands Doctoral Training Partnership Studentship; Warwick Integrative Synthetic Biology research technology platform; Wellcome Trust Grant(Wellcome Trust); Royal Society Research Grant(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Sir Henry Dale Fellowship (to E.F.) jointly funded by the Wellcome Trust and Royal Society Grant 104193/Z/14/Z, Wellcome Trust Grant 201442/Z/16/Z (to E.F.), Royal Society Research Grant RG120405 (to E.F.), and Wellcome Warwick Quantitative Biomedicine Programme Institution Strategic Support Fund Seed Grant 105627/Z/14/Z; a Midlands Doctoral Training Partnership Studentship BB/M01116X/1 (to C.C.); this work was also supported in part by Warwick Integrative Synthetic Biology research technology platform (Grant BB/M017982/1). The authors declare that they have no conflicts of interest with the contents of this article.	Abrahams KA, 2018, PARASITOLOGY, V145, P116, DOI 10.1017/S0031182016002377; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergfeld AK, 2012, J BIOL CHEM, V287, P28865, DOI 10.1074/jbc.M112.363549; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cole ST, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0430; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira FM, 2000, ACTA CRYSTALLOGR D, V56, P670, DOI 10.1107/S0907444900003668; Ferreira FM, 2006, J MOL BIOL, V359, P308, DOI 10.1016/j.jmb.2006.03.024; Fullam E, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160105; Hagel M, 2011, NAT CHEM BIOL, V7, P22, DOI 10.1038/NCHEMBIO.492; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7942, DOI 10.1021/bi700543x; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7953, DOI 10.1021/bi700544c; IMADA A, 1977, J GEN MICROBIOL, V100, P329, DOI 10.1099/00221287-100-2-329; Johnson JW, 2013, ANN NY ACAD SCI, V1277, P54, DOI 10.1111/j.1749-6632.2012.06813.x; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Komatsuzawa H, 2004, MOL MICROBIOL, V53, P1221, DOI 10.1111/j.1365-2958.2004.04200.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042769; Li YM, 2011, CARBOHYD RES, V346, P1714, DOI 10.1016/j.carres.2011.05.024; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCNEIL M, 1990, J BIOL CHEM, V265, P18200; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mikusova K, 1996, J BIOL CHEM, V271, P7820, DOI 10.1074/jbc.271.13.7820; MOBLEY HLT, 1982, J BACTERIOL, V150, P8, DOI 10.1128/JB.150.1.8-15.1982; Moraes GL, 2015, TUBERCULOSIS, V95, P95, DOI 10.1016/j.tube.2015.01.006; Mukamolova GV, 1998, P NATL ACAD SCI USA, V95, P8916, DOI 10.1073/pnas.95.15.8916; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; PLUMBRIDGE JA, 1990, J BACTERIOL, V172, P2728, DOI 10.1128/jb.172.5.2728-2735.1990; Prigozhin DM, 2013, J BIOL CHEM, V288, P31549, DOI 10.1074/jbc.M113.510792; Rosser A, 2017, CRIT REV MICROBIOL, V43, P621, DOI 10.1080/1040841X.2017.1283485; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Souza JM, 1997, ARCH BIOCHEM BIOPHYS, V340, P338, DOI 10.1006/abbi.1997.9780; Swiatek MA, 2012, BIOENGINEERED, V3, P280, DOI 10.4161/bioe.21371; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Uehara T, 2004, J BACTERIOL, V186, P7273, DOI 10.1128/JB.186.21.7273-7279.2004; Unsleber S, 2017, CARBOHYD RES, V445, P98, DOI 10.1016/j.carres.2017.04.005; Urem M, 2016, MOL MICROBIOL, V102, P183, DOI 10.1111/mmi.13464; Vincent F, 2004, J BIOL CHEM, V279, P2809, DOI 10.1074/jbc.M310165200; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang F, 2010, ANTIMICROB AGENTS CH, V54, P3776, DOI 10.1128/AAC.00453-10; WHO, 2017, GLOB TUB REP	53	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9770	9783		10.1074/jbc.RA118.002597	http://dx.doi.org/10.1074/jbc.RA118.002597			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29728457	hybrid, Green Published			2022-12-26	WOS:000436102300021
J	Merino, P; Diaz, A; Manrique, LG; Cheng, LH; Yepes, M				Merino, Paola; Diaz, Ariel; Manrique, Luis Guillermo; Cheng, Lihong; Yepes, Manuel			Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						urokinase receptor; plasmin; ezrin; cytoskeleton; synapse; stroke	ERM PROTEINS; CELL-ADHESION; CROSS-TALK; RECEPTOR; EXPRESSION; ACTIN; REVEALS; FAMILY; PHOSPHORYLATION; TRAFFICKING	Synaptic repair in the ischemic brain is a complex process that requires reorganization of the actin cytoskeleton. Ezrin, radixin, and moesin (ERM) are a group of evolutionarily conserved proteins that link the plasma membrane to the actin cytoskeleton and act as scaffolds for signaling transduction. Urokinase-type plasminogen activator (uPA) is a serine proteinase that upon binding to the urokinase-type plasminogen activator receptor (uPAR) catalyzes the conversion of plasminogen into plasmin on the cell surface and activates intracellular signaling pathways. Early studies indicate that uPA and uPAR expression increase during the recovery phase from an ischemic stroke and that uPA binding to uPAR promotes neurorepair in the ischemic brain. The in vitro and in vivo studies presented here show that either the release of neuronal uPA or treatment with recombinant uPA induces the local synthesis of ezrin in the synapse and the recruitment of 3-integrin to the postsynaptic density (PSD) of cerebral cortical neurons by a plasminogen-independent mechanism. We found that 3-integrin has a double effect on ezrin, inducing its recruitment to the PSD via the intercellular adhesion molecule-5 (ICAM-5) and its subsequent activation by phosphorylation at Thr-567. Finally, our data indicate that by triggering the reorganization of the actin cytoskeleton in the postsynaptic terminal, active ezrin induces the recovery of dendritic spines and synapses that have been damaged by an acute ischemic stroke. In summary, our data show that uPA-uPAR binding promotes synaptic repair in the ischemic brain via ezrin-mediated reorganization of the actin cytoskeleton in the postsynaptic terminal.	[Merino, Paola; Diaz, Ariel; Manrique, Luis Guillermo; Cheng, Lihong; Yepes, Manuel] Yerkes Natl Primate Res Ctr, Div Neuropharmacol & Neurol Dis, 954 Gatewood Rd NE, Atlanta, GA 30329 USA; [Merino, Paola; Diaz, Ariel; Manrique, Luis Guillermo; Cheng, Lihong; Yepes, Manuel] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Merino, Paola; Diaz, Ariel; Manrique, Luis Guillermo; Cheng, Lihong; Yepes, Manuel] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Yepes, Manuel] Vet Affairs Med Ctr, Dept Neurol, Atlanta, GA 30033 USA	Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Yepes, M (corresponding author), Yerkes Natl Primate Res Ctr, Div Neuropharmacol & Neurol Dis, 954 Gatewood Rd NE, Atlanta, GA 30329 USA.	myepes@emory.edu	Díaz, Ariel/ABF-7295-2020	Díaz, Ariel/0000-0001-5677-5751; Merino, Paola/0000-0002-5203-4507; Yepes, Manuel/0000-0002-5224-9663	National Institutes of Health [NS-091201, NS-079331]; Veterans Affairs Merit Award [IO1BX003441]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079331, R01NS091201] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants NS-091201 (to M. Y.) and NS-079331 (to M. Y.) and Veterans Affairs Merit Award IO1BX003441 (to M. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfano D, 2005, THROMB HAEMOSTASIS, V93, P205, DOI 10.1160/TH04-09-0592; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Antelmi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075113; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Clucas J, 2014, J CELL SCI, V127, P267, DOI 10.1242/jcs.133108; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Dammer EB, 2015, PROTEOMICS, V15, P508, DOI 10.1002/pmic.201400189; Degryse B, 2005, J BIOL CHEM, V280, P24792, DOI 10.1074/jbc.M413954200; Degryse B, 2017, INT J BIOCHEM CELL B, V88, P14, DOI 10.1016/j.biocel.2017.04.012; DENT MAR, 1993, EUR J NEUROSCI, V5, P633, DOI 10.1111/j.1460-9568.1993.tb00529.x; Diaz A, 2017, J NEUROSCI, V37, P10310, DOI 10.1523/JNEUROSCI.1630-17.2017; Echeverry R, 2010, J CLIN INVEST, V120, P2194, DOI 10.1172/JCI41722; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Furutani Y, 2012, J BIOL CHEM, V287, P39041, DOI 10.1074/jbc.M112.383851; Gahmberg Carl G, 2014, Adv Neurobiol, V8, P117; Ghasemi A, 2017, CELL SIGNAL, V32, P104, DOI 10.1016/j.cellsig.2017.01.020; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hofmeijer J, 2012, STROKE, V43, P607, DOI 10.1161/STROKEAHA.111.632943; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Lavialle M, 2011, P NATL ACAD SCI USA, V108, P12915, DOI 10.1073/pnas.1100957108; Lino N, 2014, DEV DYNAM, V243, P676, DOI 10.1002/dvdy.24114; Mao J, 2013, CELL BIOCHEM BIOPHYS, V67, P1507, DOI 10.1007/s12013-013-9653-1; Marsick BM, 2011, JOVE-J VIS EXP, DOI 10.3791/2409; Marsick BM, 2012, J NEUROSCI, V32, P282, DOI 10.1523/JNEUROSCI.4794-11.2012; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Matsumoto Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105435; Merino P, 2017, J BIOL CHEM, V292, P2741, DOI 10.1074/jbc.M116.761650; Milner R, 2002, J NEUROSCI RES, V69, P286, DOI 10.1002/jnr.10321; Ning L, 2013, J CELL SCI, V126, P77, DOI 10.1242/jcs.106674; OKA S, 1990, NEUROSCIENCE, V35, P93, DOI 10.1016/0306-4522(90)90124-M; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Ponuwei GA, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0246-3; RAO A, 1991, J NEUROSCI, V11, P2881; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; SUMI Y, 1992, DEVELOPMENT, V116, P625; Tian L, 2000, J CELL BIOL, V150, P243, DOI 10.1083/jcb.150.1.243; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Weingarten J, 2014, MOL CELL NEUROSCI, V59, P106, DOI 10.1016/j.mcn.2014.02.003; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Wu F, 2014, J NEUROSCI, V34, P14219, DOI 10.1523/JNEUROSCI.5309-13.2014; Wu F, 2012, J NEUROSCI, V32, P9848, DOI 10.1523/JNEUROSCI.1241-12.2012	49	17	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9234	9247		10.1074/jbc.RA118.002534	http://dx.doi.org/10.1074/jbc.RA118.002534			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29720403	hybrid, Green Published			2022-12-26	WOS:000435441400011
J	Wang, YF; Chang, CF; Tsai, HP; Chi, CY; Su, IJ; Wang, JR				Wang, Ya-Fang; Chang, Chuan-Fa; Tsai, Huey-Pin; Chi, Chia-Yu; Su, Ih-Jen; Wang, Jen-Ren			Glycan-binding preferences and genetic evolution of human seasonal influenza A (H3N2) viruses during 1999-2007 in Taiwan	PLOS ONE			English	Article							RECEPTOR-BINDING; ANTIGENIC VARIATION; HEMAGGLUTININ; SPECIFICITY; CELLS	It is generally agreed that human influenza virus preferentially binds to alpha-2,6-linked sialic acid-containing receptors, and mutations that change the binding preference may alter virus infectivity and host tropism. Limited information is available on the glycan-binding specificity of epidemic influenza viruses. In this study, we systemically investigated the glycan-binding preferences of human influenza A(H3N2) viruses isolated from 1999 to 2007 in Taiwan using a high-throughput carbohydrate array. The binding patterns of 37 H3N2 viruses were classified into three groups with significant binding-pattern variations. The results showed that the carbohydrate-binding patterns of H3N2 varied over time. A phylogenetic analysis of the hemagglutinin gene also revealed progressive drift year to year. Of note, the viruses that caused large outbreaks in 1999 and 2003 showed glycan-binding preferences to both alpha-2,3 and alpha-2,6 sialylated glycans. Twenty amino acid substitutions were identified primarily at antigenic sites that might contribute to H3N2 virus evolution and the change in the glycan-binding patterns. This study provides not only a systematic analysis of the receptor-binding specificity of influenza clinical isolates but also information that could help to monitor the outbreak potential and virus evolution of influenza viruses.	[Wang, Ya-Fang; Chi, Chia-Yu; Su, Ih-Jen; Wang, Jen-Ren] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan; [Wang, Ya-Fang; Chang, Chuan-Fa; Tsai, Huey-Pin; Wang, Jen-Ren] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Wang, Ya-Fang; Chang, Chuan-Fa; Wang, Jen-Ren] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan, Taiwan; [Tsai, Huey-Pin; Su, Ih-Jen; Wang, Jen-Ren] Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan, Taiwan; [Chi, Chia-Yu] Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Wang, JR (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan.; Wang, JR (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan.; Wang, JR (corresponding author), Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan, Taiwan.; Wang, JR (corresponding author), Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan, Taiwan.	jrwang@mail.ncku.edu.tw	Wang, Jen-Ren/F-5254-2011; Chang, Chuan-Fa/F-8660-2011	Chang, Chuan-Fa/0000-0003-2404-1248	National Health Research Institutes [99A1-IDPP13-014, 05A1-IVPP09-014]; Center of Infectious Diseases and Signal Research, National Cheng Kung University; Aim for the Top University Project, Ministry of Education; Ministry of Science and Technology (MOST) [MOST 104-2321-B006-002]	National Health Research Institutes(National Health Research Institutes, Japan); Center of Infectious Diseases and Signal Research, National Cheng Kung University; Aim for the Top University Project, Ministry of Education; Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China)	This study was financially supported by grants from the National Health Research Institutes (99A1-IDPP13-014, 05A1-IVPP09-014), Center of Infectious Diseases and Signal Research, National Cheng Kung University, Aim for the Top University Project, Ministry of Education, and Ministry of Science and Technology (MOST) (grant no. MOST 104-2321-B006-002).	Air GM, 2014, CURR OPIN VIROL, V7, P128, DOI 10.1016/j.coviro.2014.06.004; Akazawa M, 2003, VALUE HEALTH, V6, P107, DOI 10.1046/j.1524-4733.2003.00209.x; Asaoka N, 2006, MICROBES INFECT, V8, P511, DOI 10.1016/j.micinf.2005.08.006; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chang CF, 2011, GLYCOBIOLOGY, V21, P895, DOI 10.1093/glycob/cwr021; DESSELBERGER U, 1978, P NATL ACAD SCI USA, V75, P3341, DOI 10.1073/pnas.75.7.3341; GOLDSTEI.MA, 1970, APPL MICROBIOL, V19, P290, DOI 10.1128/AEM.19.2.290-294.1970; Gulati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066325; Gulati S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-22; Kobayashi Y, 2012, J VIROL, V86, P3446, DOI 10.1128/JVI.06147-11; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Medeiros R, 2001, VIROLOGY, V289, P74, DOI 10.1006/viro.2001.1121; Meisen I, 2012, GLYCOBIOLOGY, V22, P1055, DOI 10.1093/glycob/cws077; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; SCHILD GC, 1974, B WORLD HEALTH ORGAN, V51, P1; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Stevens J, 2010, J VIROL, V84, P8287, DOI 10.1128/JVI.00058-10; Stohr K, 2002, LANCET INFECT DIS, V2, P517, DOI 10.1016/S1473-3099(02)00366-3; Stray SJ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-91; Tsai HP, 2006, J CLIN MICROBIOL, V44, P2705, DOI 10.1128/JCM.02694-05; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Viswanathan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013768; Viswanathan K, 2010, GLYCOCONJUGATE J, V27, P561, DOI 10.1007/s10719-010-9303-4; Wang SF, 2009, J MED VIROL, V81, P1457, DOI 10.1002/jmv.21531; Wang YF, 2012, J MED VIROL, V84, P679, DOI 10.1002/jmv.23219; WEBSTER RG, 1969, B WORLD HEALTH ORGAN, V41, P483; Webster Robert G., 1997, Journal of Infectious Diseases, V176, pS14, DOI 10.1086/514168; Wilks S, 2012, VACCINE, V30, P4369, DOI 10.1016/j.vaccine.2012.02.076	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196727	10.1371/journal.pone.0196727	http://dx.doi.org/10.1371/journal.pone.0196727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746492	gold, Green Published, Green Submitted			2022-12-26	WOS:000431851700032
J	Martin, T; Arnal, PJ; Hoffman, MD; Millet, GY				Martin, Tristan; Arnal, Pierrick J.; Hoffman, Martin D.; Millet, Guillaume Y.			Sleep habits and strategies of ultramarathon runners	PLOS ONE			English	Article							ATHLETIC PERFORMANCE; DAYTIME SLEEPINESS; CIRCADIAN-RHYTHMS; INFLAMMATORY MARKERS; GENERAL-POPULATION; QUALITY INDEX; ELITE SOCCER; RISK-FACTORS; EXERCISE; DEPRIVATION	Among factors impacting performance during an ultramarathon, sleep is an underappreciated factor that has received little attention. The aims of this study were to characterize habitual sleep behaviors in ultramarathon runners and to examine strategies they use to manage sleep before and during ultramarathons. Responses from 636 participants to a questionnaire were considered. This population was found to sleep more on weekends and holidays (7-8 h to 8-9 h) than during weekdays (6-7 h to 7-8 h; p < 0.001). Work was a mediator of napping habits since 19-25% reported napping on work days and 37-56% on non-work days. There were 24.5% of the participants reporting sleep disorders, with more women (38.9%) reporting sleep problems than men (22.0%; p < 0.005). Mean (+/- SD) sleepiness score on the Epworth Sleepiness Scale was 8.9 +/- 4.3 with 37.6% of respondents scoring higher than 10, reflecting excessive daytime sleepiness. Most of the study participants (73.9%) had a strategy to manage sleep preceding an ultramarathon, with 54.7% trying to increase their opportunities for sleep. Only 21% of participants reported that they had a strategy to manage sleep during ultramarathons, with micronaps being the most common strategy specified. Sub-analyses from 221 responses indicated that sleep duration during an ultramarathon was correlated with finish time for races lasting 36-60 h (r = 0.48; p < 0.01) or > 60 h (r = 0.44; p < 0.001). We conclude that sleep duration among ultramarathon runners was comparable to the general population and other athletic populations, yet they reported a lower prevalence of sleep disorders. Daytime sleepiness was among the lowest rates encountered in athletic populations, which may be related to the high percentage of nappers in our population. Sleep extension, by increasing sleep time at night and daytime napping, was the main sleep strategy to prepare for ultramarathons.	[Martin, Tristan; Millet, Guillaume Y.] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada; [Arnal, Pierrick J.] Rhythm, San Francisco, CA USA; [Hoffman, Martin D.] Northern Calif Hlth Care Syst, Dept Vet Affairs, Dept Phys Med & Rehabil, Sacramento, CA USA; [Hoffman, Martin D.] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Hoffman, Martin D.] Ultra Sports Sci Fdn, Sacramento, CA USA	University of Calgary; University of California System; University of California Davis	Millet, GY (corresponding author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.	gmillet@ucalgary.ca	Millet, Guillaume/AAO-6520-2020	Millet, Guillaume/0000-0002-6395-0762; Martin, Tristan/0000-0001-7576-883X	Rythm Company	Rythm Company	This material is the result of work supported with resources and the use of facilities at the VA Northern California Health Care System. Rythm Company provided support in the form of salary for author PJA, but did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	[Anonymous], 2015, SLEEP HLTH, V1, pe12, DOI [10.1016/j.sleh.2015.04.012, DOI 10.1016/J.SLEH.2015.04.012]; Arnal PJ, 2016, MED SCI SPORT EXER, V48, P1595, DOI 10.1249/MSS.0000000000000925; Arnal PJ, 2015, SLEEP, V38, P1935, DOI 10.5665/sleep.5244; ATKINSON G, 1993, ERGONOMICS, V36, P273, DOI 10.1080/00140139308967882; Atkinson G, 2007, EUR J APPL PHYSIOL, V99, P331, DOI 10.1007/s00421-006-0361-z; Barger LK, 2004, AM J PHYSIOL-REG I, V286, pR1077, DOI 10.1152/ajpregu.00397.2003; Beaudreau SA, 2012, SLEEP MED, V13, P36, DOI 10.1016/j.sleep.2011.04.005; Beck F, 2009, M S-MED SCI, V25, P201, DOI 10.1051/medsci/2009252201; Bonnet MH, 2003, SLEEP MED REV, V7, P297, DOI 10.1053/smrv.2001.0245; BONNET MH, 1982, BIOL PSYCHOL, V14, P287, DOI 10.1016/0301-0511(82)90009-6; BONNET MH, 1995, SLEEP, V18, P97, DOI 10.1093/sleep/18.2.97; Borbely A A, 1982, Hum Neurobiol, V1, P195; Buman MP, 2014, SLEEP MED, V15, P755, DOI 10.1016/j.sleep.2014.01.008; Buxton OM, 2003, AM J PHYSIOL-REG I, V284, pR714, DOI 10.1152/ajpregu.00355.2002; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; Clark I, 2017, SLEEP MED REV, V31, P70, DOI 10.1016/j.smrv.2016.01.006; Dattilo M, 2011, MED HYPOTHESES, V77, P220, DOI 10.1016/j.mehy.2011.04.017; Didier S, 2017, RES SPORTS MED, V25, P244, DOI 10.1080/15438627.2017.1282356; Drake C, 2013, J CLIN SLEEP MED, V9, P1195, DOI 10.5664/jcsm.3170; Ferrara M, 2001, SLEEP MED REV, V5, P155, DOI 10.1053/smrv.2000.0138; Flausino NH, 2012, PSYCHOPHYSIOLOGY, V49, P186, DOI 10.1111/j.1469-8986.2011.01300.x; Fullagar HHK, 2015, SPORTS MED, V45, P161, DOI 10.1007/s40279-014-0260-0; Gander PH, 2005, SLEEP, V28, P249, DOI 10.1093/sleep/28.2.249; Goel N, 2013, PROG MOL BIOL TRANSL, V119, P155, DOI 10.1016/B978-0-12-396971-2.00007-5; Haack M, 2007, SLEEP, V30, P1145, DOI 10.1093/sleep/30.9.1145; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Hoffman MD, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0019-7; Hoffman MD, 2016, INT J SPORT PHYSIOL, V11, P831, DOI 10.1123/IJSPP.2016-0472; Hoffman MD, 2016, PHYS MED REH CLIN N, V27, P203, DOI 10.1016/j.pmr.2015.08.004; Hoffman MD, 2015, CLIN NEPHROL, V83, P235, DOI 10.5414/CN108233; Hoffman MD, 2014, SPORTS MED, V44, P1055, DOI 10.1007/s40279-014-0189-3; Hoffman MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083867; Hoffman MD, 2013, J STRENGTH COND RES, V27, P2939, DOI 10.1519/JSC.0b013e3182a1f261; HORNE JA, 1985, ELECTROEN CLIN NEURO, V60, P33, DOI 10.1016/0013-4694(85)90948-4; Hurtado-Alvarado G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/801341; Jaehne A, 2009, SLEEP MED REV, V13, P363, DOI 10.1016/j.smrv.2008.12.003; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Khodaee M, 2015, INT J SPORTS MED, V36, P867, DOI 10.1055/s-0035-1550045; Khodaee M, 2012, CURR SPORT MED REP, V11, P290, DOI 10.1249/JSR.0b013e318272c34b; Krauchi K, 2001, NEUROPSYCHOPHARMACOL, V25, pS92, DOI 10.1016/S0893-133X(01)00315-3; Kredlow MA, 2015, J BEHAV MED, V38, P427, DOI 10.1007/s10865-015-9617-6; Lastella M, 2016, J HUM KINET, V54, P219, DOI 10.1515/hukin-2016-0049; Lastella M, 2015, EUR J SPORT SCI, V15, P94, DOI 10.1080/17461391.2014.932016; Lastella M, 2015, J SPORT SCI, V33, P293, DOI 10.1080/02640414.2014.942690; Leeder J, 2012, J SPORT SCI, V30, P541, DOI 10.1080/02640414.2012.660188; Leger D, 2008, CURR MED RES OPIN, V24, P307, DOI 10.1185/030079907X253771; Leger D, 2000, J SLEEP RES, V9, P35, DOI 10.1046/j.1365-2869.2000.00178.x; Lentino Cynthia V, 2013, US Army Med Dep J, P98; Mah CD, 2011, SLEEP, V34, P943, DOI 10.5665/SLEEP.1132; Millet GY, 2011, SPORTS MED, V41, P489, DOI 10.2165/11588760-000000000-00000; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Monk TH, 2003, CHRONOBIOL INT, V20, P97, DOI 10.1081/CBI-120017812; Natale V, 2009, SLEEP, V32, P423, DOI 10.1093/sleep/32.3.423; Nedelec M, 2015, SPORTS MED, V45, P1547, DOI 10.1007/s40279-015-0377-9; Nedelec M, 2015, SPORTS MED, V45, P1387, DOI 10.1007/s40279-015-0358-z; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Oliver SJ, 2009, EUR J APPL PHYSIOL, V107, P155, DOI 10.1007/s00421-009-1103-9; Pallesen S, 2007, SLEEP, V30, P619, DOI 10.1093/sleep/30.5.619; Poussel M, 2015, RES SPORTS MED, V23, P330, DOI 10.1080/15438627.2015.1040916; Reilly T, 2009, EUR J APPL PHYSIOL, V106, P321, DOI 10.1007/s00421-009-1066-x; Roehrs T, 2001, SLEEP MED REV, V5, P287, DOI 10.1053/smrv.2001.0162; Roehrs T, 2008, SLEEP MED REV, V12, P153, DOI 10.1016/j.smrv.2007.07.004; Rupp TL, 2009, SLEEP, V32, P311, DOI 10.1093/sleep/32.3.311; Sander C, 2016, SLEEP BREATH, V20, P1337, DOI 10.1007/s11325-016-1363-7; Sanford SD, 2006, SLEEP MED, V7, P319, DOI 10.1016/j.sleep.2006.01.010; Sargent C, 2014, CHRONOBIOL INT, V31, P1160, DOI 10.3109/07420528.2014.957306; Schwartz J, 2015, PHYSIOL BEHAV, V151, P541, DOI 10.1016/j.physbeh.2015.08.035; Skein M, 2011, MED SCI SPORT EXER, V43, P1301, DOI 10.1249/MSS.0b013e31820abc5a; Slater G, 2012, J THORAC DIS, V4, P608, DOI 10.3978/j.issn.2072-1439.2012.10.07; Soehner AM, 2011, CHRONOBIOL INT, V28, P802, DOI 10.3109/07420528.2011.613137; Swinbourne R, 2016, EUR J SPORT SCI, V16, P850, DOI 10.1080/17461391.2015.1120781; Taylor L, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00083; Temesi J, 2013, MED SCI SPORT EXER, V45, P2243, DOI 10.1249/MSS.0b013e31829ce379; Thun E, 2015, SLEEP MED REV, V23, P1, DOI 10.1016/j.smrv.2014.11.003; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; VUORI I, 1988, ACTA PHYSIOL SCAND, V133, P3; Walsleben JA, 2004, SLEEP, V27, P293, DOI 10.1093/sleep/27.2.293; Wright KP, 2015, BRAIN BEHAV IMMUN, V47, P24, DOI 10.1016/j.bbi.2015.01.004; Youngstedt SD, 2005, CLIN SPORT MED, V24, P355, DOI 10.1016/j.csm.2004.12.003; Youngstedt SD, 1997, SLEEP, V20, P203, DOI 10.1093/sleep/20.3.203	81	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0194705	10.1371/journal.pone.0194705	http://dx.doi.org/10.1371/journal.pone.0194705			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF2GV	29742118	gold, Green Published, Green Submitted			2022-12-26	WOS:000431757400006
J	Molnar, T; Csuvar, A; Benedek, I; Molnar, M; Kabai, P				Molnar, Tamas; Csuvar, Adrienn; Benedek, Ildiko; Molnar, Marcell; Kabai, Peter			Domestication affects exploratory behaviour of pikeperch (Sander lucioperca L.) during the transition to pelleted food	PLOS ONE			English	Article							RAINBOW-TROUT; STOCKING DENSITY; CORTISOL RESPONSE; STRESS RESPONSIVENESS; GROWTH; PERSONALITY; SELECTION; HATCHERY; MAINTENANCE; AGGRESSION	Genetic selection for body size during domestication of animal species can inadvertently affect a number of physiological and behavioural traits. The pace-of-life syndrome (POLS) hypothesis predicts that domestication in an artificial environment lacking predators and providing abundant resources prefers proactive individuals with strong feeding motivation, high levels of aggression and risk taking, with low hypothalamus-pituitary-adrenal (HPA) axis responsiveness. In the present experiment we weaned fingerling pike-perch from live feed and habituated them to formulated feed. We recorded the number of weeks needed for the fish to accept pellets, their body length at the age of 100 days, their boldness in a novel object test and their HPI axis responsiveness. Individuals accepting the artificial feed within the first week grew larger than fish habituating later; therefore early weaners would be kept and bred in routine aquaculture procedures. Contrary to predictions of POLS hypothesis, fish weaning earlier and thus growing faster were less bold and had higher HPI axis responsiveness than fish accepting the pellets later or never. As live feed is preferred to artificial pellets, less competitive individuals may switch to pellets earlier. Inadvertent selection for stress sensitive fish may have an effect on production in aquaculture as well as on natural population after intensive restocking.	[Molnar, Tamas; Csuvar, Adrienn; Benedek, Ildiko; Molnar, Marcell; Kabai, Peter] Kaposvar Univ, Inst Environm Sci & Nat Protect, Kaposvar, Hungary	Hungarian University of Agriculture & Life Sciences; Kaposvar University	Molnar, T (corresponding author), Kaposvar Univ, Inst Environm Sci & Nat Protect, Kaposvar, Hungary.	molnart75@gmail.com	Kabai, Peter/C-9909-2010; Molnar, Tamas/H-7945-2019	Molnar, Tamas/0000-0003-1752-4268	National Research, Development and Innovation Office (Hungary) [OTKA K112070]; European Union [EFOP-3.6.1-16-2016-00007]	National Research, Development and Innovation Office (Hungary); European Union(European Commission)	The work was supported by the National Research, Development and Innovation Office (Hungary) (OTKA K112070), and by the EFOP-3.6.1-16-2016-00007 project of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CE, 2007, CAN J FISH AQUAT SCI, V64, P336, DOI 10.1139/F07-018; Adriaenssens B, 2011, APPL ANIM BEHAV SCI, V132, P90, DOI 10.1016/j.applanim.2011.03.005; Adriaenssens B, 2011, BEHAV ECOL, V22, P135, DOI 10.1093/beheco/arq185; Baras E, 1999, J FISH BIOL, V54, P106, DOI 10.1111/j.1095-8649.1999.tb00615.x; Blecha M, 2016, TURK J FISH AQUAT SC, V16, P15, DOI 10.4194/1303-2712-v16_1_02; Bodis M, 2007, AQUACULT INT, V15, P83, DOI 10.1007/s10499-006-9063-0; Brelin D, 2008, HORM BEHAV, V53, P546, DOI 10.1016/j.yhbeh.2007.12.011; Castanheira MF, 2017, REV AQUACULT, V9, P23, DOI 10.1111/raq.12100; Colchen T, 2017, APPL ANIM BEHAV SCI, V194, P127, DOI 10.1016/j.applanim.2017.05.012; Cook KV, 2012, COMP BIOCHEM PHYS A, V161, P337, DOI 10.1016/j.cbpa.2011.12.002; Culbert BM, 2016, PHYSIOL BEHAV, V164, P306, DOI 10.1016/j.physbeh.2016.06.012; Ruiz-Gomez MD, 2011, PHYSIOL BEHAV, V102, P317, DOI 10.1016/j.physbeh.2010.11.023; Ferno Anders, 1998, Nordic Journal of Freshwater Research, V0, P95; Ferrari S, 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P245, DOI 10.1016/S0003-3472(76)80034-6; Hutchings JA, 2008, MOL ECOL, V17, P294, DOI 10.1111/j.1365-294X.2007.03485.x; Jeffrey JD, 2014, GEN COMP ENDOCR, V196, P8, DOI 10.1016/j.ygcen.2013.11.010; Jeffrey JD, 2012, GEN COMP ENDOCR, V176, P201, DOI 10.1016/j.ygcen.2012.01.016; Jeney Z, TECHNIQUES FISH IMMU; Johnsson JI, 2001, CAN J FISH AQUAT SCI, V58, P788, DOI 10.1139/cjfas-58-4-788; Jones KA, 2010, P ROY SOC B-BIOL SCI, V277, P625, DOI 10.1098/rspb.2009.1607; KABAI P, 1978, ACTA BIOL ACAD SCI H, V29, P295; Kestemont P, 2007, AQUACULTURE, V264, P197, DOI 10.1016/j.aquaculture.2006.12.034; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Lepage O, 2000, BRAIN BEHAV EVOLUT, V56, P259, DOI 10.1159/000047209; Magnhagen C, 2015, BIOL CULTURE PERCID, P399; Mangel M, 2001, EVOL ECOL RES, V3, P583; Manley CB, 2014, AQUACULTURE, V420, P89, DOI 10.1016/j.aquaculture.2013.10.040; Millidine KJ, 2006, FUNCT ECOL, V20, P839, DOI 10.1111/j.1365-2435.2006.01166.x; Molnar T, 2004, AQUACULT INT, V12, P181, DOI 10.1023/B:AQUI.0000032079.62056.8c; Molnar T, 2004, J APPL ICHTHYOL, V20, P105, DOI 10.1046/j.1439-0426.2003.00529.x; Naumowicz K, 2017, REV FISH BIOL FISHER, V27, P193, DOI 10.1007/s11160-017-9465-2; Overli O, 2005, INTEGR COMP BIOL, V45, P463, DOI 10.1093/icb/45.3.463; Overli O, 2004, HORM BEHAV, V45, P324, DOI 10.1016/j.yhbeh.2004.01.001; Overli O, 2002, J EXP BIOL, V205, P391; Pottinger TG, 1999, GEN COMP ENDOCR, V116, P122, DOI 10.1006/gcen.1999.7355; Pottinger TG, 2001, HORM BEHAV, V40, P419, DOI 10.1006/hbeh.2001.1707; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Salonen A, 2006, ANIM BEHAV, V72, P819, DOI 10.1016/j.anbehav.2005.12.012; Schjolden J, 2005, HORM BEHAV, V48, P537, DOI 10.1016/j.yhbeh.2005.04.008; Sebastien F, 2016, APPL ANIM BEHAV SCI, V180, P147, DOI 10.1016/j.applanim.2016.04.017; Sundstrom LF, 2004, BEHAV ECOL, V15, P192, DOI 10.1093/beheco/arg089; Templeton CN, 2004, BEHAV ECOL, V15, P673, DOI 10.1093/beheco/arh065	44	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196118	10.1371/journal.pone.0196118	http://dx.doi.org/10.1371/journal.pone.0196118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742135	gold, Green Submitted, Green Published			2022-12-26	WOS:000431757400020
J	Bretz, CL; Frey, WD; Teruyama, R; Kim, J				Bretz, Corey L.; Frey, Wesley D.; Teruyama, Ryoichi; Kim, Joomyeong			Allele and dosage specificity of the Peg3 imprinted domain	PLOS ONE			English	Article							ANGELMAN SYNDROME; GENE; EXPRESSION; REGION	The biological impetus for gene dosage and allele specificity of mammalian imprinted genes is not fully understood. To address this, we generated and analyzed four sets of mice from a single breeding scheme with varying allelic expression and gene dosage of the Peg3 domain. The mutants with abrogation of the two paternally expressed genes, Peg3 and Usp29, showed a significant decrease in growth rates for both males and females, while the mutants with biallelic expression of Peg3 and Usp29 resulted in an increased growth rate of female mice only. The mutant cohort with biallelic expression of Peg3 and Usp29 tended to have greater numbers of pups compared to the other genotypes. The mutants with switched active alleles displayed overall similar phenotypes to the wild type, but did show some differences in gene expression, suggesting potential non-redundant roles contributed by the maternal and paternal alleles. Overall, this study demonstrates a novel in vivo approach to investigate the allele and dosage specificity of mammalian imprinted domains.	[Bretz, Corey L.; Frey, Wesley D.; Teruyama, Ryoichi; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Kim, Joomyeong/0000-0001-6577-5526; Frey, Wesley/0000-0003-0392-5714	NIH (National Institute of General Medical Sciences) [R01-GM066225, R01-GM097074]	NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the NIH (National Institute of General Medical Sciences; R01-GM066225 and R01-GM097074 to J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andergassen D, 2017, ELIFE, V6, DOI 10.7554/eLife.25125; Barlow DP, 2014, COLD SPRING HARB PER, V6; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Beaudet AL, 2012, NATURE, V481, P150, DOI 10.1038/nature10784; Bretz CL, 2017, EPIGENETICS-US, V12, P945, DOI 10.1080/15592294.2017.1377869; Caldwell HK, 2017, DEV NEUROBIOL, V77, P190, DOI 10.1002/dneu.22431; Caldwell HK, 2016, CURR TOP BEHAV NEURO, V27, P51, DOI 10.1007/7854_2015_390; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; Faisal M, 2014, GENE, V533, P434, DOI 10.1016/j.gene.2013.10.006; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Frey WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144459; He HZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38136; He Hongzhi, 2014, Genomics & Informatics, V12, P105, DOI 10.5808/GI.2014.12.3.105; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Ivanova E, 2011, J MOL ENDOCRINOL, V47, pR67, DOI 10.1530/JME-11-0065; Keverne EB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0327; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154216; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145531; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Meng LY, 2015, NATURE, V518, P409, DOI 10.1038/nature13975; Perera BPU, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164158; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Renfree MB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0151; Thiaville MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075417; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Ye A, 2016, EPIGENETICS-US, V11, P889, DOI 10.1080/15592294.2016.1255385	34	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0197069	10.1371/journal.pone.0197069	http://dx.doi.org/10.1371/journal.pone.0197069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734399	Green Published, gold, Green Submitted			2022-12-26	WOS:000431481700044
J	McGinity, MJ; Grandhi, R; Michalek, JE; Rodriguez, JS; Trevino, AM; McGinity, AC; Seifi, A				McGinity, Michael J.; Grandhi, Ramesh; Michalek, Joel E.; Rodriguez, Jesse S.; Trevino, Aron M.; McGinity, Ashley C.; Seifi, Ali			The impact of tackle football injuries on the American healthcare system with a neurological focus	PLOS ONE			English	Article							HIGH-SCHOOL FOOTBALL; CHRONIC TRAUMATIC ENCEPHALOPATHY; CONCUSSION; EPIDEMIOLOGY; PLAYERS	Background Recent interest in the study of concussion and other neurological injuries has heightened awareness of the medical implications of American tackle football injuries amongst the public. Objective Using the National Emergency Department Sample (NEDS) and the National Inpatient Sample (NIS), the largest publicly available all-payer emergency department and inpatient healthcare databases in the United States, we sought to describe the impact of tackle football injuries on the American healthcare system by delineating injuries, specifically neurological in nature, suffered as a consequence of tackle football between 2010 and 2013. Methods The NEDS and NIS databases were queried to collect data on all patients presented to the emergency department (ED) and/or were admitted to hospitals with an ICD code for injuries related to American tackle football between the years 2010 and 2013. Subsequently those with football-related neurological injuries were abstracted using ICD codes for concussion, skull/face injury, intracranial injury, spine injury, and spinal cord injury (SCI). Patient demographics, length of hospital stay (LOS), cost and charge data, neurosurgical interventions, hospital type, and disposition were collected and analyzed. Results A total of 819,000 patients presented to EDs for evaluation of injuries secondary to American tackle football between 2010 and 2013, with 1.13% having injuries requiring inpatient admission (average length of stay 2.4 days). 80.4% of the ED visits were from the pediatric population. Of note, a statistically significant increase in the number of pediatric concussions over time was demonstrated (OR = 1.1, 95% CI 1.1 to 1.2). Patients were more likely to be admitted to trauma centers, teaching hospitals, the south or west regions, or with private insurance. There were 471 spinal cord injuries and 1,908 total spine injuries. Ten patients died during the study time period. The combined ED and inpatient charges were $1.35 billion. Conclusion Injuries related to tackle football are a frequent cause of emergency room visits, specifically in the pediatric population, but severe acute trauma requiring inpatient admission or operative interventions are rare. Continued investigation in the long-term health impact of football related concussion and other repetitive lower impact trauma is warranted.	[McGinity, Michael J.; Grandhi, Ramesh; Rodriguez, Jesse S.; Seifi, Ali] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA; [Michalek, Joel E.; Trevino, Aron M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [McGinity, Ashley C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Seifi, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA.	Seifi@uthscsa.edu	Seifi, Ali/AAR-6163-2020	Seifi, Ali/0000-0002-5010-5041				[Anonymous], 2014, STUD ATHL PART 1981; [Anonymous], PROFOOTBALL IS STILL; [Anonymous], HIGH SCH ATHL PART S; Bentz JE, 2013, J LANC GEN HOSP, V8; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Collins CL, 2016, AM J SPORT MED, V44, P1382, DOI 10.1177/0363546516629626; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Dick R, 2007, J ATHL TRAINING, V42, P221; Domb BG, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114534824; Feeley BT, 2008, AM J SPORT MED, V36, P1597, DOI 10.1177/0363546508316021; Forbes JA, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12288; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; HCUP National Inpatient Sample (NIS), 2012, HEALTHC COST UT PROJ; HCUP Nationwide Emergency Department Sample (NEDS), 2008, HEALTHC COST UT PROJ; Houck Z, 2016, AM J SPORTS MED; Johnson LSM, 2012, J SCHOOL HEALTH, V82, P180, DOI 10.1111/j.1746-1561.2011.00684.x; Kerr Z. Y, 2016, JAMA PEDIAT; King H, 2015, J PHYS ACT HEALTH, V12, P1162, DOI 10.1123/jpah.2014-0356; Lawrence D, 2016, AUST NZ J PSYCHIAT, V50, P876, DOI 10.1177/0004867415617836; Lehman E.J., 2016, AM J SPORTS MED; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Nationwide Emergency Department Sample (NEDS), 2007, HEALTHC COST UT PROJ; Nationwide Emergency Department Sample (NEDS), 2009, HEALTHC COST UT PROJ; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rihn JA, 2009, SPORTS MED, V39, P697, DOI 10.2165/11315190-000000000-00000; SAAL JA, 1991, SPORTS MED, V12, P132, DOI 10.2165/00007256-199112020-00005; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; The Physical Activity Council's, 2016, PHYS ACT COUNC ANN S	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0195827	10.1371/journal.pone.0195827	http://dx.doi.org/10.1371/journal.pone.0195827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734348	Green Published, gold			2022-12-26	WOS:000431481700005
J	Pamboris, GM; Noorkoiv, M; Baltzopoulos, V; Gokalp, H; Marzilger, R; Mohagheghi, AA				Pamboris, George M.; Noorkoiv, Marika; Baltzopoulos, Vasilios; Gokalp, Hulya; Marzilger, Robert; Mohagheghi, Amir A.			Effects of an acute bout of dynamic stretching on biomechanical properties of the gastrocnemius muscle determined by shear wave elastography	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; PROFESSIONAL SOCCER PLAYERS; ANKLE JOINT STIFFNESS; IN-VIVO; TENDON UNIT; PASSIVE STIFFNESS; ULTRASOUND ELASTOGRAPHY; TRANSIENT ELASTOGRAPHY; SPORTS-MEDICINE; SKELETAL-MUSCLE	Aims The aim of this study was to examine the acute effects of dynamic stretching (DS) exercise on passive ankle range of motion (RoM), resting localized muscle stiffness, as measured by shear wave speed (SWS) of medial gastrocnemius muscle, fascicle strain, and thickness. Methods/Results Twenty-three participants performed a DS protocol. Before and after stretching, SWS was measured in the belly of the resting medial gastrocnemius muscle (MGM) using shear wave elastography. DS produced small improvements in maximum dorsiflexion (+1.5 degrees +/- 1.5; mean difference +/- 90% confidence limits) and maximum plantarflexion (+2.3 degrees +/- 1.8), a small decrease in fascicle strain (-2.6% +/- 4.4) and a small increase in SWS at neutral resting angle (+11.4% +/- 1.5). There was also a small increase in muscle thickness (+4.1mm +/- 2.0). Conclusions Through the use of elastography, this is the first study to suggest that DS increases muscle stiffness, decreases fascicle strain and increases muscle thickness as a result of improved RoM. These results can be beneficial to coaches, exercise and clinical scientists when choosing DS as a muscle conditioning or rehabilitation intervention.	[Pamboris, George M.; Noorkoiv, Marika; Gokalp, Hulya; Mohagheghi, Amir A.] Brunel Univ London, Ctr Human Performance Exercise & Rehabil, Uxbridge, Middx, England; [Noorkoiv, Marika; Mohagheghi, Amir A.] Brunel Univ London, Inst Environm Hlth & Soc, Uxbridge, Middx, England; [Baltzopoulos, Vasilios] Liverpool John Moores Univ, RISES, Liverpool, Merseyside, England; [Marzilger, Robert] Humboldt Univ, Dept Training & Movement Sci, Berlin, Germany; [Marzilger, Robert] Humboldt Univ, Berlin Sch Movement Sci, Berlin, Germany; [Mohagheghi, Amir A.] Univ Social Welf & Rehabil Sci, Tehran, Iran	Brunel University; Brunel University; Liverpool John Moores University; Humboldt University of Berlin; Humboldt University of Berlin	Pamboris, GM (corresponding author), Brunel Univ London, Ctr Human Performance Exercise & Rehabil, Uxbridge, Middx, England.	gpamboris@hotmail.com	Gokalp, Hulya/AAZ-5486-2020	Pamboris, George/0000-0002-1461-8210; Baltzopoulos, Vasilios/0000-0003-2050-9501				Agten CA, 2017, AM J ROENTGENOL, V208, P402, DOI 10.2214/AJR.16.16617; Akagi R, 2014, SCAND J MED SCI SPOR, V24, P950, DOI 10.1111/sms.12111; Akagi R, 2013, MED SCI SPORT EXER, V45, P1348, DOI 10.1249/MSS.0b013e3182850e17; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Avela J, 1999, J APPL PHYSIOL, V86, P1283, DOI 10.1152/jappl.1999.86.4.1283; Ayala F, 2013, J SPORT SCI, V31, P831, DOI 10.1080/02640414.2012.751119; Bandy WD, 1998, J ORTHOP SPORT PHYS, V27, P295, DOI 10.2519/jospt.1998.27.4.295; Basford JR, 2002, ARCH PHYS MED REHAB, V83, P1530, DOI 10.1053/apmr.2002.35472; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Behm DG, 2016, APPL PHYSIOL NUTR ME, V41, P1, DOI 10.1139/apnm-2015-0235; Behm DG, 2013, J ELECTROMYOGR KINES, V23, P1215, DOI 10.1016/j.jelekin.2013.05.002; Bensamoun SF, 2007, J MAGN RESON IMAGING, V26, P708, DOI 10.1002/jmri.21073; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Brandenburg JE, 2014, ARCH PHYS MED REHAB, V95, P2207, DOI 10.1016/j.apmr.2014.07.007; Catheline S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.064301; CAVAGNA GA, 1964, J APPL PHYSIOL, V19, P249, DOI 10.1152/jappl.1964.19.2.249; Chaouachi A, 2010, J STRENGTH COND RES, V24, P2001, DOI 10.1519/JSC.0b013e3181aeb181; Chernak LA, 2013, PHYSIOL MEAS, V34, P713, DOI 10.1088/0967-3334/34/6/713; Chino K, 2016, EUR J APPL PHYSIOL, V116, P823, DOI 10.1007/s00421-016-3339-5; Chino K, 2015, CLIN BIOMECH, V30, P1230, DOI 10.1016/j.clinbiomech.2015.07.014; Chleboun GS, 1998, MED SCI SPORT EXER, V30, P529, DOI 10.1097/00005768-199804000-00010; Cipriani DJ, 2012, J STRENGTH COND RES, V26, P2119, DOI 10.1519/JSC.0b013e31823b862a; Cohen J, 1977, STAT POWER ANAL BEHA, DOI [10.1016/c2013-0-10517-x, DOI 10.1016/C2013-0-10517-X]; Correas JM, 2014, EUR J RADIOL, V83, P442, DOI 10.1016/j.ejrad.2014.01.018; Cramer JT, 2007, J SPORT SCI, V25, P687, DOI 10.1080/02640410600818416; Cramer JT, 2007, J ORTHOP SPORT PHYS, V37, P130, DOI 10.2519/jospt.2007.2389; Dubois G, 2015, ULTRASOUND MED BIOL, V41, P2284, DOI 10.1016/j.ultrasmedbio.2015.04.020; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Fisher R, 1921, METRON, P3; Fletcher IM, 2010, J STRENGTH COND RES, V24, P2096, DOI 10.1519/JSC.0b013e3181e312db; Fletcher IM, 2004, J STRENGTH COND RES, V18, P885; Freitas SR, 2015, EUR J APPL PHYSIOL, V115, P1263, DOI 10.1007/s00421-015-3104-1; Gajdosik RL, 1999, PHYS THER, V79, P827, DOI 10.1093/ptj/79.9.827; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Gennisson JL, 2005, J BIOMECH, V38, P1543, DOI 10.1016/j.jbiomech.2004.07.013; Gennisson JL, 2003, J ACOUST SOC AM, V114, P536, DOI 10.1121/1.1579008; Guilhem G, 2016, ACTA PHYSIOL, V217, P152, DOI 10.1111/apha.12654; GUISSARD N, 1988, EUR J APPL PHYSIOL O, V58, P47; Halbertsma JPK, 1996, ARCH PHYS MED REHAB, V77, P688, DOI 10.1016/S0003-9993(96)90009-X; Herda TJ, 2013, J SPORT SCI, V31, P479, DOI 10.1080/02640414.2012.736632; Hirata K, 2016, EUR J APPL PHYSIOL, V116, P911, DOI 10.1007/s00421-016-3349-3; Hoang PD, 2005, J BIOMECH, V38, P1333, DOI 10.1016/j.jbiomech.2004.05.046; Hoge KM, 2010, J STRENGTH COND RES, V24, P2618, DOI 10.1519/JSC.0b013e3181e73974; Hopkins W.G., 2006, SPORTSCIENCE, V10, P46; Hopkins W.G., 2007, SPORTSCIENCE, V11, P16; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2002, SPORTSCIENCE; Hopkins WG., 2015, SPORTSCIENCE, V19, P36; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; HOWELL JN, 1993, J PHYSIOL-LONDON, V464, P183, DOI 10.1113/jphysiol.1993.sp019629; Kato E, 2010, EUR J SPORT SCI, V10, P111, DOI 10.1080/17461390903307834; Kay AD, 2015, MED SCI SPORT EXER, V47, P2181, DOI 10.1249/MSS.0000000000000632; Kay AD, 2009, J APPL PHYSIOL, V106, P1249, DOI 10.1152/japplphysiol.91476.2008; KER RF, 1988, J ZOOL, V216, P309, DOI 10.1111/j.1469-7998.1988.tb02432.x; Koo TK, 2014, CLIN BIOMECH, V29, P33, DOI 10.1016/j.clinbiomech.2013.11.009; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Kubo K, 2002, J PHYSIOL-LONDON, V538, P219, DOI 10.1113/jphysiol.2001.012703; Kubo K, 2009, INT J SPORTS MED, V30, P139, DOI 10.1055/s-0028-1104573; Kubo K, 2001, EUR J APPL PHYSIOL, V85, P226, DOI 10.1007/s004210100463; Kubo K, 2015, J BIOMECH, V48, P1937, DOI 10.1016/j.jbiomech.2015.04.012; Kumagai K, 2000, J APPL PHYSIOL, V88, P811, DOI 10.1152/jappl.2000.88.3.811; Lacourpaille L, 2014, ACTA PHYSIOL, V211, P135, DOI 10.1111/apha.12272; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee SSM, 2016, CLIN BIOMECH, V31, P20, DOI 10.1016/j.clinbiomech.2015.10.006; Lee S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/632902; Little T, 2006, J STRENGTH COND RES, V20, P203; Luomala T, 2014, J BODYW MOV THER, V18, P462, DOI 10.1016/j.jbmt.2013.11.020; Magnusson SP, 1996, ARCH PHYS MED REHAB, V77, P373, DOI 10.1016/S0003-9993(96)90087-8; Magnusson SP, 1996, AM J SPORT MED, V24, P622, DOI 10.1177/036354659602400510; Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009; Marshall PWM, 2011, J SCI MED SPORT, V14, P535, DOI 10.1016/j.jsams.2011.05.003; Marzilger R, 2018, EUR J APPL PHYSIOL, V118, P291, DOI 10.1007/s00421-017-3769-8; McHugh MP, 1999, AM J SPORT MED, V27, P594, DOI 10.1177/03635465990270050801; Miyamoto N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124311; Mizuno T, 2016, INT J SPORTS MED, V37, P1044, DOI 10.1055/s-0042-108807; Morse CI, 2008, J PHYSIOL-LONDON, V586, P97, DOI 10.1113/jphysiol.2007.140434; Nakamura M, 2017, MUSCULOSKEL SCI PRAC, V32, P98, DOI 10.1016/j.msksp.2017.09.006; Nakamura M, 2014, ULTRASOUND MED BIOL, V40, P1991, DOI 10.1016/j.ultrasmedbio.2014.03.024; Nakamura M, 2013, MANUAL THER, V18, P211, DOI 10.1016/j.math.2012.09.010; Nakamura M, 2011, J ORTHOP RES, V29, P1759, DOI 10.1002/jor.21445; Nordez A, 2008, J BIOMECH, V41, P2305, DOI 10.1016/j.jbiomech.2008.03.033; Nordez A, 2010, J BIOMECH, V43, P379, DOI 10.1016/j.jbiomech.2009.07.034; O'Sullivan K, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-37; Powers S.K., 2012, EXERCISE PHYSL THEOR, V8th; PURSLOW PP, 1989, J BIOMECH, V22, P21, DOI 10.1016/0021-9290(89)90181-4; Riemann BL, 2001, J ATHL TRAINING, V36, P369; Ringleb SI, 2007, J MAGN RESON IMAGING, V25, P301, DOI 10.1002/jmri.20817; Royer D, 2011, J ACOUST SOC AM, V129, P2757, DOI 10.1121/1.3559681; Samukawa M, 2011, MANUAL THER, V16, P618, DOI 10.1016/j.math.2011.07.003; Sarvazyan AP, 2013, ULTRASOUND MED BIOL, V39, P1133, DOI 10.1016/j.ultrasmedbio.2013.02.006; Semenick D., 1994, ESSENTIALS STRENGTH, V1st ed., P258; Smith TB, 2011, MED SCI SPORT EXER, V43, P2155, DOI 10.1249/MSS.0b013e31821d3f8e; Spudich JA, 2001, NAT REV MOL CELL BIO, V2, P387, DOI 10.1038/35073086; Taniguchi K, 2015, SCAND J MED SCI SPOR, V25, P32, DOI 10.1111/sms.12146; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Tew GA, 2011, MICROVASC RES, V81, P177, DOI 10.1016/j.mvr.2010.12.001; WILSON GJ, 1991, INT J SPORTS MED, V12, P403, DOI 10.1055/s-2007-1024702; WILSON GJ, 1992, MED SCI SPORT EXER, V24, P116; Witvrouw E, 2007, BRIT J SPORT MED, V41, P224, DOI 10.1136/bjsm.2006.034165; Witvrouw E, 2004, SPORTS MED, V34, P443, DOI 10.2165/00007256-200434070-00003; Witvrouw E, 2003, AM J SPORT MED, V31, P41, DOI 10.1177/03635465030310011801; Witvrouw E, 2000, AM J SPORT MED, V28, P480, DOI 10.1177/03635465000280040701; Wong D, 2011, J SPORT SCI MED, V10, P408; Yoshitake Y, 2016, ULTRASOUND MED BIOL, V42, P674, DOI 10.1016/j.ultrasmedbio.2015.11.022	106	7	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196724	10.1371/journal.pone.0196724	http://dx.doi.org/10.1371/journal.pone.0196724			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723229	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000431305100058
J	Zhang, TY; Xu, JL; Deng, SY; Zhou, FQ; Li, J; Zhang, LW; Li, L; Wang, QE; Li, FH				Zhang, Tianyu; Xu, Jielin; Deng, Siyuan; Zhou, Fengqi; Li, Jin; Zhang, Liwei; Li, Lang; Wang, Qi-En; Li, Fuhai			Core signaling pathways in ovarian cancer stem cell revealed by integrative analysis of multi-marker genomics data	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE; ANTITUMOR-ACTIVITY; HEDGEHOG PATHWAY; EXPRESSION; COMBINATION; METFORMIN; RESISTANCE; GROWTH; CD133; IDENTIFICATION	Tumor recurrence occurs in more than 70% of ovarian cancer patients, and the majority eventually becomes refractory to treatments. Ovarian Cancer Stem Cells (OCSCs) are believed to be responsible for the tumor relapse and drug resistance. Therefore, eliminating ovarian CSCs is important to improve the prognosis of ovarian cancer patients. However, there is a lack of effective drugs to eliminate OCSCs because the core signaling pathways regulating OCSCs remain unclear. Also it is often hard for biologists to identify a few testable targets and infer driver signaling pathways regulating CSCs from a large number of differentially expression genes in an unbiased manner. In this study, we propose a straightforward and integrative analysis to identify potential core signaling pathways of OCSCs by integrating transcriptome data of OCSCs isolated based on two distinctive markers, ALDH and side population, with regulatory network (Transcription Factor (TF) and Target Interactome) and signaling pathways. We first identify the common activated TFs in two OCSC populations integrating the gene expression and TF-target Interactome; and then uncover up-stream signaling cascades regulating the activated TFs. In specific, 22 activated TFs are identified. Through literature search validation, 15 of them have been reported in association with cancer stem cells. Additionally, 10 TFs are found in the KEGG signaling pathways, and their upstream signaling cascades are extracted, which also provide potential treatment targets. Moreover, 40 FDA approved drugs are identified to target on the up-stream signaling cascades, and 15 of them have been reported in literatures in cancer stem cell treatment. In conclusion, the proposed approach can uncover the activated up-stream signaling, activated TFs and up-regulated target genes that constitute the potential core signaling pathways of ovarian CSC. Also drugs and drug combinations targeting on the core signaling pathways might be able to eliminate OCSCs. The proposed approach can also be applied for identifying potential activated signaling pathways of other types of cancers.	[Zhang, Tianyu; Xu, Jielin; Deng, Siyuan; Zhou, Fengqi; Li, Jin; Li, Lang; Li, Fuhai] Ohio State Univ, Dept BioMed Informat BMI, Columbus, OH 43210 USA; [Zhang, Tianyu; Zhang, Liwei] Dalian Univ Technol, Sch Math Sci, Dalian, Peoples R China; [Wang, Qi-En] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Dalian University of Technology; University System of Ohio; Ohio State University	Li, FH (corresponding author), Ohio State Univ, Dept BioMed Informat BMI, Columbus, OH 43210 USA.	Fuhai.Li@osumc.edu		Li, Fuhai/0000-0002-3773-146X	Department of Biomedical Informatics, Translational Data Analytics, The Ohio State University; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA211175] Funding Source: NIH RePORTER	Department of Biomedical Informatics, Translational Data Analytics, The Ohio State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by the startup fund from Department of Biomedical Informatics, Translational Data Analytics, The Ohio State University to FL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Bonuccelli G, 2017, ONCOTARGET, V8, P9868, DOI 10.18632/oncotarget.14196; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Bugde P, 2017, EXPERT OPIN THER TAR, V21, P511, DOI 10.1080/14728222.2017.1310841; Chen HY, 2017, TUMOR BIOL, V39, P1, DOI 10.1177/1010428317705131; Coffman LG, 2016, ONCOTARGET, V7, P6916, DOI 10.18632/oncotarget.6870; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Das JK, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.AM2016-3312; De Angelis ML, 2016, STEM CELL TRANSL MED, V5, P511, DOI 10.5966/sctm.2015-0214; Della Corte CM, 2017, WORLD J GASTROENTERO, V23, P4330, DOI 10.3748/wjg.v23.i24.4330; Della Corte CM, 2016, ONCOTARGET, V7, P4265, DOI 10.18632/oncotarget.6559; Della Corte CM, 2015, CLIN CANCER RES, V21, P4686, DOI 10.1158/1078-0432.CCR-14-3319; Emadali A, 2016, BLOOD, V127, P3040, DOI 10.1182/blood-2015-09-671040; Fang L, 2016, CANCER RES, V76, P891, DOI 10.1158/0008-5472.CAN-15-1519; Fasano M, 2015, CLIN LUNG CANCER, V16, P57, DOI 10.1016/j.cllc.2014.06.010; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fitzgerald Timothy L., 2015, Advances in Biological Regulation, V59, P65, DOI 10.1016/j.jbior.2015.06.003; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Galardi S, 2016, EMBO REP, V17, P1872, DOI 10.15252/embr.201541489; Gao XC, 2014, TUMOR BIOL, V35, P11505, DOI 10.1007/s13277-014-2466-z; Gil J, 2008, J APPL GENET, V49, P193, DOI 10.1007/BF03195612; Han H, 2018, NUCLEIC ACIDS RES, V46, pD380, DOI 10.1093/nar/gkx1013; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardy K, 2016, NUCLEUS-PHILA, V7, P50, DOI 10.1080/19491034.2016.1150392; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Huang L, 2014, BIOINFORMATICS, V30, P228, DOI 10.1093/bioinformatics/btu278; Janzer A, 2014, P NATL ACAD SCI USA, V111, P10574, DOI 10.1073/pnas.1409844111; Julian LM, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00161; Karamboulas C, 2013, BBA-GEN SUBJECTS, V1830, P2481, DOI 10.1016/j.bbagen.2012.11.008; Kumazoe M, 2017, J BIOL CHEM, V292, P10813, DOI 10.1074/jbc.M116.772111; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Leao R, 2017, UROL INT, V99, P125, DOI 10.1159/000455160; Ledur PF, 2012, PURINERG SIGNAL, V8, P39, DOI 10.1007/s11302-011-9252-9; Lee CJ, 2016, ONCOTARGET, V7, P59845, DOI 10.18632/oncotarget.11337; Li F, 2016, 2016 IEEE EMBS INT C; Li F., 2017, MED RES ARCH, V5; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Macha MA, 2017, ONCOTARGET, V8, P20961, DOI 10.18632/oncotarget.15468; Marbach D, 2016, NAT METHODS, V13, P366, DOI [10.1038/NMETH.3799, 10.1038/nmeth.3799]; Martin-Castillo B, 2015, ONCOTARGET, V6, P32317, DOI 10.18632/oncotarget.6094; Mayer MJ, 2015, PROSTATE CANCER P D, V18, P303, DOI 10.1038/pcan.2015.35; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Morgillo F, 2017, ESMO OPEN, V2, DOI 10.1136/esmoopen-2016-000132; Osmanbeyoglu HU, 2014, GENOME RES, V24, P1869, DOI 10.1101/gr.173039.114; Papaccio F, 2017, STEM CELL TRANSL MED, V6, P2115, DOI 10.1002/sctm.17-0138; Parenti S, 2009, ALIMENT PHARM THER, V31, P108, DOI 10.1111/j.1365-2036.2009.04149.x; Regan Kelly E, 2017, AMIA Jt Summits Transl Sci Proc, V2017, P247; Ren F, 2013, WORLD J GASTROENTERO, V19, P2603, DOI 10.3748/wjg.v19.i17.2603; Ryu KJ, 2017, ONCOTARGET, V8, P2466, DOI 10.18632/oncotarget.13690; Salim Elsayed I, 2016, Asian Pac J Cancer Prev, V17, P1023; Seidman JD, 2004, INT J GYNECOL PATHOL, V23, P41, DOI 10.1097/01.pgp.0000101080.35393.16; Sette G, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.217; Shah MM, 2014, GYNECOL ONCOL, V132, P483, DOI 10.1016/j.ygyno.2013.12.001; Sharrow AC, 2016, GYNECOL ONCOL, V142, P341, DOI 10.1016/j.ygyno.2016.03.022; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tachi K, 2016, CANCER SCI, V107, P281, DOI 10.1111/cas.12870; Tanei T, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0662-4; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; Tomuleasa C, 2010, J BUON, V15, P758; Vathipadiekal V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029079; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wu HY, 2017, BMC SYST BIOL, V11, P5, DOI 10.1186/s12918-017-0462-9; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109575; Xiao ZJ, 2017, ELIFE, V6, DOI 10.7554/eLife.26733; Xu JL, 2018, BIOCOMPUT-PAC SYM, P92; Yevshin I, 2017, NUCLEIC ACIDS RES, V45, pD61, DOI 10.1093/nar/gkw951; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zhang M, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a027128; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhao YY, 2013, ONCOL REP, V30, P1782, DOI 10.3892/or.2013.2627	77	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196351	10.1371/journal.pone.0196351	http://dx.doi.org/10.1371/journal.pone.0196351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723215	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100023
J	Thompson, AM; Smith, JL; Monroe, LD; Kreutz, JE; Schneider, T; Fujimoto, BS; Chiu, DT; Radich, JP; Paguirigan, AL				Thompson, Alison M.; Smith, Jordan L.; Monroe, Luke D.; Kreutz, Jason E.; Schneider, Thomas; Fujimoto, Bryant S.; Chiu, Daniel T.; Radich, Jerald P.; Paguirigan, Amy L.			Self-digitization chip for single-cell genotyping of cancer-related mutations	PLOS ONE			English	Article							CLONAL DIVERSITY; EVOLUTION; HETEROGENEITY; PROGRESSION; METASTASIS; LEUKEMIA	Cancer is a heterogeneous disease, and patient-level genetic assessments can guide therapy choice and impact prognosis. However, little is known about the impact of genetic variability within a tumor, intratumoral heterogeneity (ITH), on disease progression or outcome. Current approaches using bulk tumor specimens can suggest the presence of ITH, but only single-cell genetic methods have the resolution to describe the underlying clonal structures themselves. Current techniques tend to be labor and resource intensive and challenging to characterize with respect to sources of biological and technical variability. We have developed a platform using a microfluidic self-digitization chip to partition cells in stationary volumes for cell imaging and allele-specific PCR. Genotyping data from only confirmed single-cell volumes is obtained and subject to a variety of relevant quality control assessments such as allele dropout, false positive, and false negative rates. We demonstrate single-cell genotyping of the NPM1 type A mutation, an important prognostic indicator in acute myeloid leukemia, on single cells of the cell line OCI-AML3, describing a more complex zygosity distribution than would be predicted via bulk analysis.	[Thompson, Alison M.; Smith, Jordan L.; Monroe, Luke D.; Radich, Jerald P.; Paguirigan, Amy L.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Thompson, Alison M.; Kreutz, Jason E.; Schneider, Thomas; Fujimoto, Bryant S.; Chiu, Daniel T.] Univ Washington, Dept Chem, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Paguirigan, AL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	apaguiri@fredhutch.org	Smith, Jordan/AAR-9126-2021; Smith, Jordan/GVU-3480-2022		National Institutes of Health [R01-CA175215, R01-EB021878, K01-ES02684, R21-EB018831]; NATIONAL CANCER INSTITUTE [R01CA175215, U10CA180861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB018831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K01ES026842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (www.nih.gov) R01-CA175215 for JPR, ALP, JLS, AMT, LDM, DTC; R01-EB021878 for JPR and DTC; K01-ES02684 for ALP; R21-EB018831 for DTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen DE, 2010, ANAL CHEM, V82, P5707, DOI 10.1021/ac100713u; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Gawad C, 2014, P NATL ACAD SCI USA, V111, P17947, DOI 10.1073/pnas.1420822111; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hughes AEO, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004462; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Leung ML, 2016, NAT PROTOC, V11, P214, DOI 10.1038/nprot.2016.005; McPherson JD, 2014, NAT METHODS, V11, P1003, DOI 10.1038/nmeth.3106; MERCIER B, 1990, NUCLEIC ACIDS RES, V18, P5908, DOI 10.1093/nar/18.19.5908; Merlo LMF, 2010, CANCER PREV RES, V3, P1388, DOI 10.1158/1940-6207.CAPR-10-0108; Meshinchi S, 2009, CLIN CANCER RES, V15, P4263, DOI 10.1158/1078-0432.CCR-08-1123; Navin NE, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0452-9; Paguirigan AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0763; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Potter NE, 2013, GENOME RES, V23, P2115, DOI 10.1101/gr.159913.113; Rau R, 2009, HEMATOL ONCOL, V27, P171, DOI 10.1002/hon.904; Schneider T, 2013, ANAL CHEM, V85, P10417, DOI 10.1021/ac402383n; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sloan CE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153016; Tao Y, 2011, P NATL ACAD SCI USA, V108, P12042, DOI 10.1073/pnas.1108715108; Thompson AM, 2014, ANAL CHEM, V86, P12308, DOI 10.1021/ac5035924; Wang Y, 2015, MOL CELL, V58, P598, DOI 10.1016/j.molcel.2015.05.005; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; You Y, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405	30	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196801	10.1371/journal.pone.0196801	http://dx.doi.org/10.1371/journal.pone.0196801			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718986	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900084
J	Zhang, YL; Fu, F				Zhang, Yanling; Fu, Feng			Strategy intervention for the evolution of fairness	PLOS ONE			English	Article							ULTIMATUM GAME; STRUCTURED POPULATIONS; RESPONDER BEHAVIOR; STRONG RECIPROCITY; COOPERATION; DYNAMICS; PUNISHMENT; MIGRATION; MOTIVES; OFFERS	The 'irrational' preference for fairness has attracted increasing attention. Although previous studies have focused on the effects of spitefulness on the evolution of fairness, they did not consider non-monotonic rejections shown in behavioral experiments. In this paper, we introduce a non-monotonic rejection in an evolutionary model of the Ultimatum Game. We propose strategy intervention to study the evolution of fairness in general structured populations. By sequentially adding five strategies into the competition between a fair strategy and a selfish strategy, we arrive at the following conclusions. First, the evolution of fairness is inhibited by altruism, but it is promoted by spitefulness. Second, the non-monotonic rejection helps fairness overcome selfishness. Particularly for group-structured populations, we analytically investigate how fairness, selfishness, altruism, and spitefulness are affected by population size, mutation, and migration in the competition among seven strategies. Our results may provide important insights into understanding the evolutionary origin of fairness.	[Zhang, Yanling] Univ Sci & Technol Beijing, Sch Automat & Elect Engn, Minist Educ, Key Lab Knowledge Automat Ind Proc, Beijing, Peoples R China; [Fu, Feng] Dartmouth Coll, Dept Math, Hanover, NH 03755 USA; [Fu, Feng] Dartmouth Coll, Geisel Sch Med, Dept Biomed Data Sci, Hanover, NH 03755 USA	University of Science & Technology Beijing; Dartmouth College; Dartmouth College	Fu, F (corresponding author), Dartmouth Coll, Dept Math, Hanover, NH 03755 USA.; Fu, F (corresponding author), Dartmouth Coll, Geisel Sch Med, Dept Biomed Data Sci, Hanover, NH 03755 USA.	fufeng@gmail.com	Fu, Feng/R-3686-2017	Fu, Feng/0000-0001-8252-1990	Fundamental Research Funds for the Central Universities [FRF-TP-15-116A1]; China Postdoctoral Science Foundation [2015M580989]; National Natural Science Foundation of China [61603036]; Dartmouth Faculty Startup Fund; Walter & Constance Burke Research Initiation Award; NIH [C16A12652]; DARPA [D17PC00002-002]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Dartmouth Faculty Startup Fund; Walter & Constance Burke Research Initiation Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	Y. Z. is grateful for support by the Fundamental Research Funds for the Central Universities (No. FRF-TP-15-116A1), the China Postdoctoral Science Foundation (No. 2015M580989), and the National Natural Science Foundation of China (No. 61603036). F. F. acknowledges generous support from the Dartmouth Faculty Startup Fund, Walter & Constance Burke Research Initiation Award, NIH (No. C16A12652), and DARPA (No. D17PC00002-002). The funders had no role in study design, data	Antal T, 2009, P NATL ACAD SCI USA, V106, P8597, DOI 10.1073/pnas.0902528106; Bahry DL, 2006, J ECON BEHAV ORGAN, V60, P37, DOI 10.1016/j.jebo.2004.07.005; Barcelo H, 2015, SCI REP-UK, V5, DOI 10.1038/srep07937; Bauch CT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11219; Bauch CT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002452; Beerenwinkel N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004717; Branas-Garza P, 2006, EXP ECON, V9, P253, DOI 10.1007/s10683-006-9126-0; Branas-Garza P, 2014, SCI REP-UK, V4, DOI 10.1038/srep06025; Capraro V, 2015, ARXIV150907599; Capraro V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072427; Chen XJ, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052823; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; Espin AM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00214; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Forber P, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2439; Fu F, 2013, J STAT PHYS, V151, P637, DOI 10.1007/s10955-012-0631-6; Guth W, 2014, J ECON BEHAV ORGAN, V108, P396, DOI 10.1016/j.jebo.2014.06.006; Hennig-Schmidt H, 2008, J ECON BEHAV ORGAN, V65, P373, DOI 10.1016/j.jebo.2005.10.003; Henrich J, 2006, SCIENCE, V312, P60, DOI 10.1126/science.1126398; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Huck S, 1999, J ECON PSYCHOL, V20, P183, DOI 10.1016/S0167-4870(99)00004-5; Ichinose G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05104; Iranzo J, 2011, J THEOR BIOL, V278, P1, DOI 10.1016/j.jtbi.2011.02.020; Killingback T, 2001, P ROY SOC B-BIOL SCI, V268, P1797, DOI 10.1098/rspb.2001.1697; Legros M, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0148; Leventhal GE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7101; Masuda N, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/3/033031; Masuda N, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033012; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Page KM, 2000, P ROY SOC B-BIOL SCI, V267, P2177, DOI 10.1098/rspb.2000.1266; Page KM, 2002, B MATH BIOL, V64, P1101, DOI 10.1006/bulm.2002.0321; Perc M, 2017, PHYS REP, V687, P1, DOI 10.1016/j.physrep.2017.05.004; Perc M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11027; Rand DG, 2013, P NATL ACAD SCI USA, V110, P2581, DOI 10.1073/pnas.1214167110; Rand DG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1442; Schuster S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05122-5; Staffiero G, 2013, ECON LETT, V121, P236, DOI 10.1016/j.econlet.2013.08.021; Suleiman R, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171709; Szolnoki A, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/28005; Szolnoki A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.078701; Tarnita CE, 2011, P NATL ACAD SCI USA, V108, P2334, DOI 10.1073/pnas.1016008108; Tarnita CE, 2009, P NATL ACAD SCI USA, V106, P8601, DOI 10.1073/pnas.0903019106; THALER RH, 1988, J ECON PERSPECT, V2, P195, DOI 10.1257/jep.2.4.195; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104; Wang Q, 2018, APPL MATH COMPUT, V328, P162, DOI 10.1016/j.amc.2018.01.045; Wang XF, 2015, J THEOR BIOL, V380, P103, DOI 10.1016/j.jtbi.2015.05.020; Wu T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01550; Yamagishi T, 2012, P NATL ACAD SCI USA, V109, P20364, DOI 10.1073/pnas.1212126109; Yang HX, 2018, APPL MATH COMPUT, V316, P460, DOI 10.1016/j.amc.2017.08.049; Zhang BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074540; Zhang YL, 2018, APPL MATH COMPUT, V321, P641, DOI 10.1016/j.amc.2017.11.013; Zhang YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35114	52	20	21	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196524	10.1371/journal.pone.0196524	http://dx.doi.org/10.1371/journal.pone.0196524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5SH	29718977	gold, Green Published, Green Submitted			2022-12-26	WOS:000431281900057
J	Gilbreth, RN; Oganesyan, VY; Amdouni, H; Novarra, S; Grinberg, L; Barnes, A; Baca, M				Gilbreth, Ryan N.; Oganesyan, Vaheh Y.; Amdouni, Hamza; Novarra, Shabazz; Grinberg, Luba; Barnes, Arnita; Baca, Manuel			Crystal structure of the human 4-1BB/4-1BBL complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structural biology; structure-function; T-cell biology; crystal structure; tumor necrosis factor (TNF); protein-protein interaction; protein structure	TNF; IMMUNOTHERAPY; 4-1BB; CANCER; LIGAND	4-1BBL is a member of the tumor necrosis factor (TNF) superfamily and is the ligand for the TNFR superfamily receptor, 4-1BB. 4-1BB plays an immunomodulatory role in T cells and NK cells, and agonists of this receptor have garnered strong attention as potential immunotherapy agents. Broadly speaking, the structural features of TNF superfamily members, their receptors, and ligand-receptor complexes are similar. However, a published crystal structure of human 4-1BBL suggests that it may be unique in this regard, exhibiting a three-bladed propeller-like trimer assembly that is distinctly different from that observed in other family members. This unusual structure also suggests that the human 4-1BB/4-1BBL complex may be structurally unique within the TNF/TNFR superfamily, but to date no structural data have been reported. Here we report the crystal structure of the human 4-1BB/4-1BBL complex at 2.4- resolution. In this structure, 4-1BBL does not adopt the unusual trimer assembly previously reported, but instead forms a canonical bell-shaped trimer typical of other TNF superfamily members. The structure of 4-1BB is also largely canonical as is the 4-1BB/4-1BBL complex. Mutational data support the 4-1BBL structure reported here as being biologically relevant, suggesting that the previously reported structure is not. Together, the data presented here offer insight into structure/function relationships in the 4-1BB/4-1BBL system and improve our structural understanding of the TNF/TNFR superfamily more broadly.	[Gilbreth, Ryan N.; Oganesyan, Vaheh Y.; Amdouni, Hamza; Novarra, Shabazz; Grinberg, Luba; Barnes, Arnita; Baca, Manuel] MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune	Gilbreth, RN (corresponding author), MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.; Baca, M (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	gilbrethr@medimmune.com; Manuel.Baca@gilead.com			United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, NIGMS (including Grant P41GM103393).	An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; Bartkowiak T, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00117; Bitra A, 2018, J BIOL CHEM, V293, P1317, DOI 10.1074/jbc.M117.814905; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Chattopadhyay K, 2007, P NATL ACAD SCI USA, V104, P19452, DOI 10.1073/pnas.0709264104; Chester C, 2018, BLOOD, V131, P49, DOI 10.1182/blood-2017-06-741041; Compaan DM, 2006, STRUCTURE, V14, P1321, DOI 10.1016/j.str.2006.06.015; Dimasi N, 2009, J MOL BIOL, V393, P672, DOI 10.1016/j.jmb.2009.08.032; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Jones T. A., 1990, CRYSTALLOGRAPHIC MOD; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leyland R, 2017, CLIN CANCER RES, V23, P3416, DOI 10.1158/1078-0432.CCR-16-2000; Li JX, 2013, ADV IMMUNOL, V119, P135, DOI 10.1016/B978-0-12-407707-2.00005-9; Liu WF, 2014, STRUCTURE, V22, P1252, DOI 10.1016/j.str.2014.06.013; Magis C, 2012, TRENDS BIOCHEM SCI, V37, P353, DOI 10.1016/j.tibs.2012.06.002; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Novarra S, 2016, MABS-AUSTIN, V8, P1118, DOI 10.1080/19420862.2016.1186321; Sanmamed MF, 2015, SEMIN ONCOL, V42, P640, DOI 10.1053/j.seminoncol.2015.05.014; Schaer DA, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-7; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vanamee E. S., 2018, SCI SIGNAL, V11, P4910, DOI [10.1016/scisignal.aao4910, DOI 10.1016/SCISIGNAL.AAO4910]; Vinay DS, 2012, MOL CANCER THER, V11, P1062, DOI 10.1158/1535-7163.MCT-11-0677; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Won EY, 2010, J BIOL CHEM, V285, P9202, DOI 10.1074/jbc.M109.084442; Yi L, 2017, IMMUNOL CELL BIOL, V95, P24, DOI 10.1038/icb.2016.64; Yi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086337	30	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9880	9891		10.1074/jbc.RA118.002803	http://dx.doi.org/10.1074/jbc.RA118.002803			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29720399	hybrid, Green Published			2022-12-26	WOS:000436102300029
J	Guimaraes, MA; de Oliveira, RN; de Almeida, RL; Mafud, AC; Sarkis, ALV; Ganassin, R; da Silva, MP; Roquini, DB; Veras, LM; Sawada, TCH; Ropke, CD; Muehlmann, LA; Joanitti, GA; Kuckelhaus, SAS; Allegretti, SM; Mascarenhas, YP; de Moraes, J; Leite, JRSA				Guimaraes, Maria A.; de Oliveira, Rosimeire N.; de Almeida, Rebeca L.; Mafud, Ana C.; Sarkis, Ana L., V; Ganassin, Rayane; da Silva, Marcos P.; Roquini, Daniel B.; Veras, Leiz M.; Sawada, Tania C. H.; Ropke, Cristina D.; Muehlmann, Luis A.; Joanitti, Graziella A.; Kuckelhaus, Selma A. S.; Allegretti, Silmara M.; Mascarenhas, Yvonne P.; de Moraes, Josue; Leite, Jose R. S. A.			Epiisopilosine alkaloid has activity against Schistosoma mansoni in mice without acute toxicity	PLOS ONE			English	Article							SUBCHRONIC TOXICITY; IN-VITRO; LEAVES; PRAZIQUANTEL; AGGREGATION; ACID; RATS	Schistosomiasis is a disease caused by parasites of the genus Schistosoma, currently affecting more than 200 million people. Among the various species of this parasite that infect humans, S. mansoni is the most common. Pharmacological treatment is limited to the use of a single drug, praziquantel (PZQ), despite reports of parasite resistance and low efficacy. It is therefore necessary to investigate new potential schistosomicidal compounds. In this study, we tested the efficacy of epiisopilosine (EPIIS) in a murine model of schistosomiasis. A single dose of EPIIS (100 or 400 mg/kg) administered orally to mice infected with adult S. mansoni resulted in reduced worm burden and egg production. The treatment with the lower dose of EPIIS (100 mg/kg) significantly reduced total worm burden by 60.61% (P < 0.001), as well as decreasing hepatosplenomegaly and egg excretion. Scanning electron microscopy revealed morphological changes in the worm tegument after treatment. Despite good activity of EPIIS in adult S. mansoni, oral treatment with single dose of EPIIS 100 mg/kg had only moderate effects in mice infected with juvenile S. mansoni. In addition, we performed cytotoxicity and toxicological studies with EPIIS and found no in vitro cytotoxicity (in HaCaT, and NIH-3T3 cells) at a concentration of 512 mu g/mL. We also performed in silico analysis of toxicological properties and showed that EPIIS had low predicted toxicity. To confirm this, we investigated systemic acute toxicity in vivo by orally administering a 2000 mg/kg dose to Swiss mice. Treated mice showed no significant changes in hematological, biochemical, or histological parameters compared to non-treated animals. Epiisopilosine showed potential as a schistosomicidal drug: it did not cause acute toxicity and it displayed an acceptable safety profile in the animal model.	[Guimaraes, Maria A.; de Almeida, Rebeca L.; Veras, Leiz M.] Univ Fed Piaui, BIOTEC, Nucleo Pesquisa Biodiversidade & Biotecnol, Parnaiba, Piaui, Brazil; [Guimaraes, Maria A.; Sawada, Tania C. H.] Phytobios Pesquisa Desenvolvimento & Inovacao LTD, Parnaiba, Piaui, Brazil; [Guimaraes, Maria A.; Ropke, Cristina D.; Leite, Jose R. S. A.] Ponto Focal Univ Fed Piaui, RENORBIO, Programa Posgrad Biotecnol, Teresina, Piaui, Brazil; [de Oliveira, Rosimeire N.; Allegretti, Silmara M.] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Campinas, SP, Brazil; [Mafud, Ana C.; Mascarenhas, Yvonne P.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Carlos, SP, Brazil; [Mafud, Ana C.] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Sarkis, Ana L., V; Kuckelhaus, Selma A. S.; Leite, Jose R. S. A.] Univ Brasilia, UNB, Fac Med, Campus Dacy Ribeiro, Brasilia, DF, Brazil; [Ganassin, Rayane; Muehlmann, Luis A.; Joanitti, Graziella A.] Univ Brasilia, UNB, Lab Nanobiotecnol, Inst Biol, Campus Dacy Ribeiro, Brasilia, DF, Brazil; [da Silva, Marcos P.; Roquini, Daniel B.; de Moraes, Josue] Univ Guarulhos, Nucleo Pesquisa Doencas Negligenciadas, Sao Paulo, Brazil; [Muehlmann, Luis A.; Joanitti, Graziella A.] Univ Brasilia, UNB, Fac Ceilandia, Brasilia, DF, Brazil; [de Oliveira, Rosimeire N.] Univ Estadual Ponta Grossa, Ponta Grossa, Parana, Brazil	Universidade Federal do Piaui; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; University of Basel; Swiss Tropical & Public Health Institute; Universidade de Brasilia; Universidade de Brasilia; Universidade Guarulhos; Universidade de Brasilia; Universidade Estadual de Ponta Grossa	Leite, JRSA (corresponding author), Ponto Focal Univ Fed Piaui, RENORBIO, Programa Posgrad Biotecnol, Teresina, Piaui, Brazil.; Leite, JRSA (corresponding author), Univ Brasilia, UNB, Fac Med, Campus Dacy Ribeiro, Brasilia, DF, Brazil.	jrsaleite@gmail.com	Mascarenhas, Yvonne P/L-6914-2015; Veras, Leiz M C/H-8873-2013; de Moraes, Josué/F-4762-2014; Oliveira, Rosimeire R.N/C-2247-2013; Allegretti, Silmara/C-2271-2013; Leite, Jose Roberto/H-9065-2013; Joanitti, Graziella/G-5853-2015	Mascarenhas, Yvonne P/0000-0003-1918-114X; de Moraes, Josué/0000-0003-1766-7031; Oliveira, Rosimeire R.N/0000-0003-1984-6543; Allegretti, Silmara/0000-0003-4975-3663; Leite, Jose Roberto/0000-0002-1096-3236; Joanitti, Graziella/0000-0002-6888-1284; Kuckelhaus, Selma/0000-0001-7677-772X; Muehlmann, Luis/0000-0003-4711-7583	Phytobios Pesquisa Desenvolvimento e Inovacao LTDA., company of the Centroflora Group; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (MCTI/Cnpq/MS-SCTIE DECIT) [404134/2012-2]; Foundation for Research Support of Sao Paulo State (FAPESP) [2014/02282-76, 2016/18023-5]; FAPESP [2016/22488-3]	Phytobios Pesquisa Desenvolvimento e Inovacao LTDA., company of the Centroflora Group; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (MCTI/Cnpq/MS-SCTIE DECIT); Foundation for Research Support of Sao Paulo State (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors are grateful to Phytobios Pesquisa Desenvolvimento e Inovacao LTDA., company of the Centroflora Group, for its support during the realization of this research. SMA is grateful to Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (MCTI/Cnpq/MS-SCTIE DECIT N. 404134/2012-2). ACM is grateful to Foundation for Research Support of Sao Paulo State (FAPESP) (Grants 2014/02282-76 and 2016/18023-5). JM is grateful to FAPESP (Grant 2016/22488-3). Phytobios company played a role in the study design, data analysis, decision to publish and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Habori M, 2002, J ETHNOPHARMACOL, V83, P209, DOI 10.1016/S0378-8741(02)00223-4; Arcanjo DDR, 2017, INT J PEPT RES THER, V23, P323, DOI 10.1007/s10989-016-9564-2; Avancini G, 2003, PHYTOCHEMISTRY, V63, P171, DOI 10.1016/S0031-9422(03)00102-X; Bento RRF, 2010, BRAZ J PHYS, V40, P217, DOI 10.1590/S0103-97332010000200016; Billaud EM, 2009, CLIN DRUG INVEST, V29, P481, DOI 10.2165/00044011-200929070-00006; Botros S, 2003, ANTIMICROB AGENTS CH, V47, P3853, DOI 10.1128/AAC.47.12.3853-3858.2003; Carrillo JC, 2014, REGUL TOXICOL PHARM, V70, P222, DOI 10.1016/j.yrtph.2014.07.007; Day TA, 1996, PARASITOLOGY, V113, P55, DOI 10.1017/S0031182000066270; de Moraes J, 2012, CURRENT TOPICS IN TROPICAL MEDICINE, P333; de Moraes J, 2015, FUTURE MED CHEM, V7, P801, DOI [10.4155/FMC.15.23, 10.4155/fmc.15.23]; de Moraes J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002617; DELGADO VS, 1992, PARASITOL RES, V78, P648, DOI 10.1007/BF00931515; DOENHOFF MJ, 1987, T ROY SOC TROP MED H, V81, P947, DOI 10.1016/0035-9203(87)90360-9; El Ridi R, 2012, INT J ANTIMICROB AG, V39, P232, DOI 10.1016/j.ijantimicag.2011.08.019; Frenkel YV, 2005, J MED CHEM, V48, P1974, DOI 10.1021/jm049439i; Guimaraes MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003656; Guimaraes MA, 2014, J NANOSCI NANOTECHNO, V14, P4519, DOI 10.1166/jnn.2014.8248; Hams E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00089; Hermeto Marco Victor, 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P99, DOI 10.1590/S0036-46651994000200001; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Kowalska-Pylka H, 2001, ATLA-ALTERN LAB ANIM, V29, P547, DOI 10.1177/026119290102900508; Li FJ, 2015, J ETHNOPHARMACOL, V175, P499, DOI 10.1016/j.jep.2015.10.002; Li HJ, 2012, PARASITOL RES, V110, P1727, DOI 10.1007/s00436-011-2692-x; Lucio E. M. R. A., 2000, REV BRAS FARMACOGN, V9, P23, DOI DOI 10.1590/S0102-695X2000000100003; Malone MH., 1977, NEW NATURAL PRODUCTS, P23; OECD, 2002, OECD SER TEST ASS, P39; Oecd E., 2010, OECD SER TEST ASSESS, V20, P1; OECD (Organisation for Economic Co-operation and Development), 2002, OECD SER TEST ASS; [OECD] Organisation for Economic Co-operation and Development, 2002, TEST 423 AC OR TOX A; OLIVIER L, 1952, J PARASITOL, V38, P19, DOI 10.2307/3274166; PELLEGRINO J., 1956, REV BRASIL MALARIOL E DOENCAS TROP, V8, P589; Pereira AC, 2015, ACTA TROP, V149, P195, DOI 10.1016/j.actatropica.2015.06.005; Pires DEV, 2015, J MED CHEM, V58, P4066, DOI 10.1021/acs.jmedchem.5b00104; Robinson RLM, 2011, MOL INFORM, V30, P443, DOI 10.1002/minf.201000159; Rocha JA, 2017, PHYTOTHER RES, V31, P624, DOI 10.1002/ptr.5771; Savjani KT, 2012, ISRN PHARM, V2012, DOI DOI 10.5402/2012/195727; Silva MP, 2017, INT J ANTIMICROB AG, V50, P467, DOI 10.1016/j.ijantimicag.2017.06.005; Skorupa Ladislau A., 2000, Acta Amazonica, V30, P59; Tsubone TM, 2014, J BRAZIL CHEM SOC, V25, P890, DOI 10.5935/0103-5053.20140058; Veras LM, 2012, CURR MED CHEM, V19, P2051; Veras LMC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066702; Vieira ALS, 2013, RES VET SCI, V94, P399, DOI 10.1016/j.rvsc.2012.10.028; Wang SC, 2012, MOL PHARMACEUT, V9, P996, DOI 10.1021/mp300023x; Xiao SH, 2000, ACTA TROP, V75, P341, DOI 10.1016/S0001-706X(00)00067-X	44	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0196667	10.1371/journal.pone.0196667	http://dx.doi.org/10.1371/journal.pone.0196667			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750792	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000431856300003
J	Kastor, A; Mohanty, SK				Kastor, Anshul; Mohanty, Sanjay K.			Disease-specific out-of-pocket and catastrophic health expenditure on hospitalization in India: Do Indian households face distress health financing?	PLOS ONE			English	Article							LOW-INCOME; CARE; PAYMENTS; POOR; COUNTRIES; ILLNESS; URBAN	Background Rising non-communicable diseases (NCDs) coupled with increasing injuries have resulted in a significant increase in health spending in India. While out-of-pocket expenditure remains the major source of health care financing in India (two-thirds of the total health spending), the financial burden varies enormously across diseases and by the economic well-being of the households. Though prior studies have examined the variation in disease pattern, little is known about the financial risk to the families by type of diseases in India. In this context, the present study examines disease-specific out-of-pocket expenditure (OOPE), catastrophic health expenditure (CHE) and distress health financing. Methods and materials Unit data from the 71(st) round of the National Sample Survey Organization (2014) was used for this study. OOPE is defined as health spending on hospitalization net of reimbursement, and CHE is defined as household health spending exceeding 10% of household consumption expenditure. Distress health financing is defined as a situation when a household has to borrow money or sell their property/assets or when it gets contributions from friends/relatives to meet its health care expenses. OOPE was estimated for 16 selected diseases and across three broad categories- communicable diseases, NCDs and injuries. Multivariate logistic regression was used to understand the determinants of distress financing and CHE. Results Mean DOPE on hospitalization was INR 19,210 and was the highest for cancer (INR 57,232) followed by heart diseases (INR 40,947). About 28% of the households incurred CHE and faced distress financing. Among all the diseases, cancer caused the highest CHE (79%) and distress financing (43%). More than one-third of the inpatients reported distressed financing for heart diseases, neurological disorders, genito urinary problems, musculoskeletal diseases, gastro-intestinal problems and injuries. The likelihood of incurring distress financing was 3.2 times higher for those hospitalized for cancer (OR 3.23; 95% CI: 2.62-3.99) and 2.6 times for tuberculosis patients (OR 2.61; 95% CI: 2.06-3.31). A large proportion of households who had reported distress financing also incurred CHE. Recommendations Free treatment for cancer and heart diseases is recommended for the vulnerable sections of the society. Risk-pooling and social security mechanisms based on contributions from both households as well as the central and state governments can reduce the financial burden of diseases and avert households from distress health financing.	[Kastor, Anshul; Mohanty, Sanjay K.] IIPS, Dept Fertil Studies, Bombay, Maharashtra, India	International Institute for Population Sciences	Kastor, A (corresponding author), IIPS, Dept Fertil Studies, Bombay, Maharashtra, India.	anshulkastor@gmail.com	Mohanty, Sanjay K/AAR-7658-2020	Mohanty, Sanjay K/0000-0001-9041-5952				Ajay Mahal, 2002, Economic and Political Weekly, V37, P559; Baird KE, 2016, SAGE OPEN MED, V4, DOI 10.1177/2050312115623792; Berki S E, 1986, Health Aff (Millwood), V5, P138, DOI 10.1377/hlthaff.5.4.138; Berman P, 2010, EC POLIT WKLY, VXLV, P65; Binnendijk E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-23; Bloom DE, 2014, EC NONCOMMUNICABLE D; Bonu S, 2009, HEALTH POLICY PLANN, V24, P445, DOI 10.1093/heapol/czp032; Central Bureau of Health Intelligence, 2015, NAT HLTH PROF 2015; Choi JW, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0675-1; Engelgau MM, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-9; Garg CC, 2009, HEALTH POLICY PLANN, V24, P116, DOI 10.1093/heapol/czn046; Goli S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156437; Gupt A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149824; Joe W, 2015, HEALTH POLICY PLANN, V30, P728, DOI 10.1093/heapol/czu050; Karan A, 2017, SOC SCI MED, V181, P83, DOI 10.1016/j.socscimed.2017.03.053; Nguyen KT, 2012, SOC SCI MED, V74, P724, DOI 10.1016/j.socscimed.2011.10.027; Kruk ME, 2009, HEALTH AFFAIR, V28, P1056, DOI 10.1377/hlthaff.28.4.1056; Kumar K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135051; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Ministry of Health and Family Welfare, 2012, REV NAT TUB CONTR PR; Ministry of Health and Family Welfare, RASHTR SWASTH BIM YO; Ministry of Health and Family Welfare Government of India, 2016, NAT HLTH ACC EST IND; Ministry of Health Family Welfare GoI, 2017, NAT HLTH POL 2017; Ministry of Home Affairs, 2009, RE CAUS DEATH IND 20; Mohanty SK, 2016, J PUBLIC HEALTH-HEID, V24, P215, DOI 10.1007/s10389-016-0712-0; Mohanty SK, 2014, SOC INDIC RES, V115, P1137, DOI 10.1007/s11205-013-0261-7; MOHFW G, 2009, NAT HLTH ACC IND 200; Moreno-Serra R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001087; Muniyandi M., 2005, Indian Journal of Tuberculosis, V52, P188; Nair Harish, 2011, J Glob Health, V1, P79; National Sample Survey Organization (NSSO), 2015, 71 NSSO MIN STAT PRO; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; Planning Commission, 2011, EV STUD NAT RUR HLTH; Prinja S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137315; Raban MZ, 2013, B WORLD HEALTH ORGAN, V91, P726, DOI 10.2471/BLT.12.113100; Ramachandran A, 2007, DIABETES CARE, V30, P252, DOI 10.2337/dc06-0144; Rao KD, 2011, INDIAN J MED RES, V133, P57; Rashad AS, 2015, AM J EC, V5, P526, DOI DOI 10.1093/HEAP0L/CZQ070; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Sauerborn R, 1996, SOC SCI MED, V43, P291, DOI 10.1016/0277-9536(95)00375-4; Soumitra Ghosh, 2011, Economic and Political Weekly, V46, P63; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21, DOI 10.2471/BLT.05.023739; Taylor DW, 2010, BURD NONCOMMUNICABLE; Tripathy JP, 2016, TROP MED INT HEALTH, V21, P1019, DOI 10.1111/tmi.12732; United Nations, 2015, 2030 AG SUST DEV; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Wang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116897; Weraphong J, 2013, SE ASIAN J TROP MED, V44, P124; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organisation, 2021, NONC DIS; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yesudian CAK, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0080-x	54	94	95	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196106	10.1371/journal.pone.0196106	http://dx.doi.org/10.1371/journal.pone.0196106			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF3JM	29746481	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700008
J	Kojima, K; Nakamura, T; Ohbu, M; Katoh, H; Ooizumi, Y; Igarashi, K; Ishii, S; Tanaka, T; Yokoi, K; Nishizawa, N; Yokota, K; Kosaka, Y; Sato, T; Watanabe, M; Yamashita, K				Kojima, Keita; Nakamura, Takatoshi; Ohbu, Makoto; Katoh, Hiroshi; Ooizumi, Yosuke; Igarashi, Kazuharu; Ishii, Satoru; Tanaka, Toshimichi; Yokoi, Keigo; Nishizawa, Nobuyuki; Yokota, Kazuko; Kosaka, Yoshimasa; Sato, Takeo; Watanabe, Masahiko; Yamashita, Keishi			Cysteine dioxygenase type1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer	PLOS ONE			English	Article							ABERRANT DNA METHYLATION; CYSTEINE DIOXYGENASE; BIOMARKER; SURVIVAL; COLON; PANEL; EPIGENOMICS; EVOLUTION; DIAGNOSIS; SERUM	Background Progression of colorectal cancer (CRC) has been explained by genomic abnormalities along with the adenoma-carcinoma sequence theory (ACS). The aim of our study is to elucidate whether the promoter DNA methylation of the cancer-specific methylation gene, cysteine dioxygenase 1 (CDO1), contributes to the carcinogenic process in CRC. Methods The study group comprised 107 patients with CRC who underwent surgical resection and 90 adenomas treated with endoscopic resection in the Kitasato University Hospital in 2000. We analyzed the extent of methylation in each tissue using quantitative TaqMan methylation-specific PCR for CDO1. Results The methylation level increased along with the ACS process (p < 0.0001), and statistically significant differences were found between normal-appearing mucosa (NAM) and low-grade adenoma (p < 0.0001), and between low-grade adenoma and high-grade adenoma (p = 0.01), but not between high-grade adenoma and cancer with no liver metastasis. Furthermore, primary CRC cancers with liver metastasis harbored significantly higher methylation of CDO1 than those without liver metastasis (p = 0.02). As a result, the area under the curve by CDO1 promoter methylation was 0.96, 0.80, and 0.67 to discriminate cancer from NAM, low-grade adenoma from NAM, and low-grade adenoma from high-grade adenoma, respectively. Conclusions CDO1 methylation accumulates during the ACS process, and consistently contributes to CRC progression.	[Kojima, Keita; Nakamura, Takatoshi; Katoh, Hiroshi; Ooizumi, Yosuke; Igarashi, Kazuharu; Ishii, Satoru; Tanaka, Toshimichi; Yokoi, Keigo; Nishizawa, Nobuyuki; Yokota, Kazuko; Kosaka, Yoshimasa; Sato, Takeo; Watanabe, Masahiko; Yamashita, Keishi] Kitasato Univ, Sch Med, Dept Surg, Minami Ku, Sagamihara, Kanagawa, Japan; [Ohbu, Makoto] Kitasato Univ, Dept Pathol, Sch Allied Hlth Sci, Minami Ku, Sagamihara, Kanagawa, Japan; [Yamashita, Keishi] Ctr New Med Frontiers, Dept Res & Dev, Div Adv Surg Oncol, Minami Ku, Sagamihara, Kanagawa, Japan	Kitasato University; Kitasato University	Watanabe, M (corresponding author), Kitasato Univ, Sch Med, Dept Surg, Minami Ku, Sagamihara, Kanagawa, Japan.	gekaw@med.kitasato-u.ac.jp			Parents' Association Grant of Kitasato University, School of Medicine	Parents' Association Grant of Kitasato University, School of Medicine	This work was supported by the Parents' Association Grant of Kitasato University, School of Medicine.	Ahmed D, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.21; Andresen K, 2015, HEPATOLOGY, V61, P1651, DOI 10.1002/hep.27707; Andresen K, 2012, EPIGENETICS-US, V7, P1249, DOI 10.4161/epi.22191; Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; Deckers IAG, 2015, CLIN CANCER RES, V21, P3492, DOI 10.1158/1078-0432.CCR-14-2049; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Huang RL, 2017, CLIN CANCER RES, V23, P263, DOI 10.1158/1078-0432.CCR-16-0863; Igarashi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188178; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; *JAP SOC CANC COL, 2006, GEN RUL CLIN PATH ST; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeschke J, 2013, CLIN CANCER RES, V19, P3201, DOI 10.1158/1078-0432.CCR-12-3751; Johnson DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098238; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Joseph CA, 2007, CHEM COMMUN, P3338, DOI 10.1039/b702158e; Kalmar A, 2015, PATHOL ONCOL RES, V21, P1149, DOI 10.1007/s12253-015-9945-4; Kojima K, 2017, Dis Esophagus, V30, P1, DOI 10.1093/dote/dow001; Kwon J, 2015, TUMOR BIOL, V36, P7449, DOI 10.1007/s13277-015-3443-x; Lee KH, 2011, LANGENBECK ARCH SURG, V396, P1017, DOI 10.1007/s00423-011-0812-9; Liu D, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070679; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Meller S, 2016, EPIGENETICS-US, V11, P871, DOI 10.1080/15592294.2016.1241931; Minatani N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144862; MORSON B, 1974, P ROY SOC MED, V67, P451, DOI 10.1177/00359157740676P115; MUTO T, 1975, CANCER, V36, P2251, DOI 10.1002/cncr.2820360944; Ooki A, 2017, CLIN CANCER RES, V23, P7141, DOI 10.1158/1078-0432.CCR-17-1222; Prabhu A, 2014, CANCER RES, V74, P787, DOI 10.1158/0008-5472.CAN-13-1423; Rectum JSfCotCa, 2013, JAP CLASS COL CARC; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; SPRATT JS, 1958, ANN SURG, V148, P682, DOI 10.1097/00000658-195810000-00014; Stipanuk MH, 2009, AMINO ACIDS, V37, P55, DOI 10.1007/s00726-008-0202-y; Ushijima T, 2010, CANCER SCI, V101, P300, DOI 10.1111/j.1349-7006.2009.01434.x; Ushiku H, 2017, GASTRIC CANCER, V20, P784, DOI 10.1007/s10120-017-0697-6; Ushiku Hideki, 2017, Dis Esophagus, V30, P1, DOI 10.1111/dote.12496; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Wrangle J, 2014, CLIN CANCER RES, V20, P1856, DOI 10.1158/1078-0432.CCR-13-2109; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yamashita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113546; Yang Y, 2014, TOHOKU J EXP MED, V232, P187, DOI 10.1620/tjem.232.187	44	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0194785	10.1371/journal.pone.0194785	http://dx.doi.org/10.1371/journal.pone.0194785			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746493	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700004
J	Williams, SK; Weiner, ZP; Gilmore, RD				Williams, Shanna K.; Weiner, Zachary P.; Gilmore, Robert D.			Human neuroglial cells internalize Borrelia burgdorferi by coiling phagocytosis mediated by Daam1	PLOS ONE			English	Article							PRIMARY HUMAN MACROPHAGES; LYME-DISEASE SPIROCHETE; INFECTIOUS STRAIN; GENE; EXPRESSION; INVASION; TRANSMISSION; SURVIVAL; FORMINS; PROTEIN	Borrelia burgdorferi, the agent of Lyme borreliosis, can elude hosts' innate and adaptive immunity as part of the course of infection. The ability of B. burgdorferi to invade or be internalized by host cells in vitro has been proposed as a mechanism for the pathogen to evade immune responses or antimicrobials. We have previously shown that B. burgdorferi can be internalized by human neuroglial cells. In this study we demonstrate that these cells take up B. burgdorferi via coiling phagocytosis mediated by the formin, Daam1, a process similarly described for human macrophages. Following coincubation with glial cells, B. burgdorferi was enwrapped by Daam1-enriched coiling pseudopods. Coiling of B. burgdorferi was significantly reduced when neuroglial cells were pretreated with anti-Daam1 antibody indicating the requirement for Daam1 for borrelial phagocytosis. Confocal microscopy showed Daam1 colocalizing to the B. burgdorferi surface suggesting interaction with borrelial membrane protein(s). Using the yeast 2-hybrid system for identifying protein-protein binding, we found that the B. burgdorferi surface lipoprotein, BBA66, bound the FH2 subunit domain of Daam1. Recombinant proteins were used to validate binding by ELISA, pull-down, and co-immunoprecipitation. Evidence for native Daam1 and BBA66 interaction was suggested by colocalization of the proteins in the course of borrelial capture by the Daam1-enriched pseudopodia. Additionally, we found a striking reduction in coiling for a BBA66-deficient mutant strain compared to BBA66-expressing strains. These results show that coiling phagocytosis is a mechanism for borrelial internalization by neuroglial cells mediated by Daam1.	[Williams, Shanna K.; Weiner, Zachary P.; Gilmore, Robert D.] Ctr Dis Control & Prevent, Bacterial Dis Branch, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO 80521 USA; [Weiner, Zachary P.] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Gilmore, RD (corresponding author), Ctr Dis Control & Prevent, Bacterial Dis Branch, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO 80521 USA.	rbg6@cdc.gov			Centers for Disease Control and Prevention US Govt as part of official duties	Centers for Disease Control and Prevention US Govt as part of official duties(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funded by Centers for Disease Control and Prevention US Govt as part of official duties.	BENACH JL, 1984, J INFECT DIS, V150, P497, DOI 10.1093/infdis/150.4.497; Brissette CA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00041; Bunikis I, 2011, J MICROBIOL METH, V86, P243, DOI 10.1016/j.mimet.2011.05.004; Caimano MJ, 2015, INFECT IMMUN, V83, P3043, DOI 10.1128/IAI.00315-15; Carrasco SE, 2015, INFECT IMMUN, V83, P4848, DOI 10.1128/IAI.01215-15; Carroll JA, 2000, INFECT IMMUN, V68, P6677, DOI 10.1128/IAI.68.12.6677-6684.2000; Cervantes JL, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00055; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Clifton DR, 2006, MOL MICROBIOL, V61, P243, DOI 10.1111/j.1365-2958.2006.05224.x; Coburn J, 2013, TRENDS MICROBIOL, V21, P372, DOI 10.1016/j.tim.2013.06.005; Elias AF, 2003, J MOL MICROB BIOTECH, V6, P29, DOI 10.1159/000073406; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Embers ME, 2004, MICROBES INFECT, V6, P312, DOI 10.1016/j.micinf.2003.11.014; Filgueira L, 1996, J IMMUNOL, V157, P2998; Gilmore RD, 2007, INFECT IMMUN, V75, P2753, DOI 10.1128/IAI.00037-07; Gilmore RD, 2008, MICROB PATHOGENESIS, V45, P355, DOI 10.1016/j.micpath.2008.08.006; Girschick HJ, 1996, RHEUMATOL INT, V16, P125, DOI 10.1007/BF01409985; Hoffmann AK, 2014, FASEB J, V28, P3075, DOI 10.1096/fj.13-247049; Hughes JL, 2008, INFECT IMMUN, V76, P2498, DOI 10.1128/IAI.01583-07; Hyde Jenny A, 2011, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c04s20; Kawabata H, 2004, INFECT IMMUN, V72, P7147, DOI 10.1128/IAI.72.12.7147-7154.2004; KLEMPNER MS, 1993, J INFECT DIS, V167, P1074, DOI 10.1093/infdis/167.5.1074; KURTTI TJ, 1993, J MED ENTOMOL, V30, P586, DOI 10.1093/jmedent/30.3.586; Linder S, 2001, INFECT IMMUN, V69, P1739, DOI 10.1128/IAI.69.3.1739-1746.2001; Livengood JA, 2006, MICROBES INFECT, V8, P2832, DOI 10.1016/j.micinf.2006.08.014; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; MA Y, 1991, INFECT IMMUN, V59, P671, DOI 10.1128/IAI.59.2.671-678.1991; MONTGOMERY RR, 1994, PARASITOL TODAY, V10, P154, DOI 10.1016/0169-4758(94)90268-2; Montgomery RR, 1996, INFECT IMMUN, V64, P2867, DOI 10.1128/IAI.64.7.2867-2872.1996; Montgomery RR, 2002, J INFECT DIS, V185, P1773, DOI 10.1086/340826; Naj X, 2017, CURR TOP MICROBIOL, V399, P133, DOI 10.1007/82_2016_26; Naj X, 2013, INFECT IMMUN, V81, P1683, DOI 10.1128/IAI.01411-12; Patton TG, 2013, INFECT IMMUN, V81, P2488, DOI 10.1128/IAI.00140-13; Petnicki-Ocwieja T, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00175; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; RITTIG MG, 1992, INFECT IMMUN, V60, P4205, DOI 10.1128/IAI.60.10.4205-4212.1992; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Stewart PE, 2001, MOL MICROBIOL, V39, P714, DOI 10.1046/j.1365-2958.2001.02256.x; Weiner ZP, 2015, CLIN VACCINE IMMUNOL, V22, P1176, DOI 10.1128/CVI.00399-15; Wu J, 2011, INFECT IMMUN, V79, P1338, DOI 10.1128/IAI.01188-10; Yamashita M, 2007, GENES CELLS, V12, P1255, DOI 10.1111/j.1365-2443.2007.01132.x	41	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197413	10.1371/journal.pone.0197413	http://dx.doi.org/10.1371/journal.pone.0197413			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746581	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700111
J	Knoops, PGM; Borghi, A; Ruggiero, F; Badiali, G; Bianchi, A; Marchetti, C; Rodriguez-Florez, N; Breakey, RWF; Jeelani, O; Dunaway, DJ; Schievano, S				Knoops, Paul G. M.; Borghi, Alessandro; Ruggiero, Federica; Badiali, Giovanni; Bianchi, Alberto; Marchetti, Claudio; Rodriguez-Florez, Naiara; Breakey, Richard W. F.; Jeelani, Owase; Dunaway, David J.; Schievano, Silvia			A novel soft tissue prediction methodology for orthognathic surgery based on probabilistic finite element modelling	PLOS ONE			English	Article							MAXILLOFACIAL SURGERY; SIMULATION; DEFORMATIONS; DISTRACTION; VALIDATION; DEFORMITY; CARTILAGE; ACCURACY; SYSTEM; SKIN	Repositioning of the maxilla in orthognathic surgery is carried out for functional and aesthetic purposes. Pre-surgical planning tools can predict 3D facial appearance by computing the response of the soft tissue to the changes to the underlying skeleton. The clinical use of commercial prediction software remains controversial, likely due to the deterministic nature of these computational predictions. A novel probabilistic finite element model (FEM) for the prediction of postoperative facial soft tissues is proposed in this paper. A probabilistic FEM was developed and validated on a cohort of eight patients who underwent maxillary repositioning and had pre- and postoperative cone beam computed tomography (CBCT) scans taken. Firstly, a variables correlation assessed various modelling parameters. Secondly, a design of experiments (DOE) provided a range of potential outcomes based on uniformly distributed input parameters, followed by an optimisation. Lastly, the second DOE iteration provided optimised predictions with a probability range. A range of 3D predictions was obtained using the probabilistic FEM and validated using reconstructed soft tissue surfaces from the postoperative CBCT data. The predictions in the nose and upper lip areas accurately include the true postoperative position, whereas the prediction under-estimates the position of the cheeks and lower lip. A probabilistic FEM has been developed and validated for the prediction of the facial appearance following orthognathic surgery. This method shows how inaccuracies in the modelling and uncertainties in executing surgical planning influence the soft tissue prediction and it provides a range of predictions including a minimum and maximum, which may be helpful for patients in understanding the impact of surgery on the face.	[Knoops, Paul G. M.; Borghi, Alessandro; Ruggiero, Federica; Rodriguez-Florez, Naiara; Breakey, Richard W. F.; Jeelani, Owase; Dunaway, David J.; Schievano, Silvia] UCL Great Ormond St Inst Child Hlth, London, England; [Knoops, Paul G. M.; Borghi, Alessandro; Ruggiero, Federica; Rodriguez-Florez, Naiara; Breakey, Richard W. F.; Jeelani, Owase; Dunaway, David J.; Schievano, Silvia] Great Ormond St Hosp Sick Children, Craniofacial Unit, London, England; [Ruggiero, Federica; Badiali, Giovanni; Bianchi, Alberto; Marchetti, Claudio] St Orsola Malpighi Univ Hosp, Oral & Maxillofacial Surg Unit, Bologna, Italy; [Rodriguez-Florez, Naiara] Mondragon Univ, Dept Biomed Engn, Arrasate Mondragon, Spain	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Mondragon Unibertsitatea	Knoops, PGM (corresponding author), UCL Great Ormond St Inst Child Hlth, London, England.; Knoops, PGM (corresponding author), Great Ormond St Hosp Sick Children, Craniofacial Unit, London, England.	paul.knoops.14@ucl.ac.uk	Marchetti, Claudio/K-7242-2016; Ruggiero, Federica/AFU-2719-2022; RODRIGUEZ-FLOREZ, NAIARA/AAB-2637-2019	Ruggiero, Federica/0000-0001-5184-5271; RODRIGUEZ-FLOREZ, NAIARA/0000-0002-5911-8113; Bianchi, Alberto/0000-0001-9374-2748; Schievano, Silvia/0000-0003-2037-5339; Jeelani, Noor ul Owase/0000-0002-3240-681X; RUGGIERO, Florence/0000-0003-2915-5359; Dunaway, David/0000-0001-5063-9943	Great Ormond Street Hospital Charity [508857]; Engineering and Physical Sciences Research Council [EP/N02124X/1]; United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centre; EPSRC [EP/N02124X/1] Funding Source: UKRI	Great Ormond Street Hospital Charity; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Great Ormond Street Hospital Charity http.//www.gosh.org/: grant FaceValue (no. 508857) to Silvia Schievano, David Dunaway, Owase Jeelani; Engineering and Physical Sciences Research Council https://www.epsm.ac.uk/: award no EP/N02124X/1 to Silvia Schievano and this work was undertaken at Great Ormond Street Hospital and University College London Institute of Child Health, who received a proportion of funding from the United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centre funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centenero SAH, 2012, J CRANIO MAXILL SURG, V40, P162, DOI 10.1016/j.jcms.2011.03.014; Barbarino GG, 2011, SKIN RES TECHNOL, V17, P434, DOI 10.1111/j.1600-0846.2011.00515.x; Berthaume MA, 2012, J THEOR BIOL, V300, P242, DOI 10.1016/j.jtbi.2012.01.031; Borghi A, 2016, INT J CARS, V11, pS93; Chabanas M, 2003, MED IMAGE ANAL, V7, P131, DOI 10.1016/S1361-8415(02)00108-1; FONSECA CM, 1993, PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P416; Gilardino MS, 2009, CRANIOMAX TRAUM REC, V2, P49, DOI 10.1055/s-0029-1202591; Gosain AK, 2002, PLAST RECONSTR SURG, V109, P1797, DOI 10.1097/00006534-200205000-00004; Greig AVH, 2013, PLAST RECONSTR SURG, V131, p219E, DOI 10.1097/PRS.0b013e3182778882; Grellmann W, 2006, J BIOMED MATER RES A, V78A, P168, DOI 10.1002/jbm.a.30625; Jakobsone G, 2011, AM J ORTHOD DENTOFAC, V139, P80, DOI 10.1016/j.ajodo.2009.03.050; Janakiraman N, 2015, AM J ORTHOD DENTOFAC, V148, P1054, DOI 10.1016/j.ajodo.2015.08.012; Kau CH, 2007, PLAST RECONSTR SURG, V119, P2192, DOI 10.1097/01.prs.0000260707.99001.79; Kim H, 2012, PATIENT SPECIFIC MOD, V9, P413; Koch R. M., 1996, Computer Graphics Proceedings. SIGGRAPH '96, P421, DOI 10.1145/237170.237281; Kretschmer WB, 2009, BRIT J ORAL MAX SURG, V47, P446, DOI 10.1016/j.bjoms.2009.06.004; Lee HJ, 2014, ANGLE ORTHOD, V84, P322, DOI 10.2319/050313-338.1; Lee SJ, 2010, LARYNGOSCOPE, V120, P1508, DOI 10.1002/lary.20976; Mangado N, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00085; Marchetti C, 2011, INT J ORAL MAX SURG, V40, P26, DOI 10.1016/j.ijom.2010.09.004; Mazza E, 2011, FACIAL PLAST SURG CL, V19, P623, DOI 10.1016/j.fsc.2011.07.006; Mazzoni S, 2015, J ORAL MAXIL SURG, V73, P701, DOI 10.1016/j.joms.2014.10.028; Mazzoni S, 2010, J CRANIOFAC SURG, V21, P1698, DOI 10.1097/SCS.0b013e3181f3c6a8; Meittinen K., 2008, MULTIOBJECTIVE OPTIM; Miettinen KM, 1999, NONLINEAR MULTIOBJEC; Mollemans W, 2007, MED IMAGE ANAL, V11, P282, DOI 10.1016/j.media.2007.02.003; Pan BB, 2016, COMPUT BIOL MED, V75, P1, DOI 10.1016/j.compbiomed.2016.04.020; Pataky TC, 2016, PEER J COMPUTER SCI, V2, pe96, DOI [10.1016/j.ijom.2016.10.016, DOI 10.1016/J.IJOM.2016.10.016]; Peterman RJ, 2016, PROG ORTHOD, V17, DOI 10.1186/s40510-016-0132-2; Reh S, 2006, STRUCT SAF, V28, P17, DOI 10.1016/j.strusafe.2005.03.010; Resnick CM, 2017, INT J ORAL MAX SURG, V46, P289, DOI 10.1016/j.ijom.2016.10.016; Richmon JD, 2006, AM J RHINOL, V20, P496, DOI 10.2500/ajr.2006.20.2932; Stefanou G, 2009, COMPUT METHOD APPL M, V198, P1031, DOI 10.1016/j.cma.2008.11.007; Suh HY, 2012, J ORAL MAXIL SURG, V70, pE553, DOI 10.1016/j.joms.2012.06.187; Swennen GRJ, 2009, J ORAL MAXIL SURG, V67, P2080, DOI 10.1016/j.joms.2009.06.007; Terzic A, 2014, AESTHET PLAST SURG, V38, P184, DOI 10.1007/s00266-013-0248-4; Wang JW, 2014, MED SCI MONITOR, V20, P1808, DOI 10.12659/MSM.892278; Westermark A, 2005, J CRANIOFAC SURG, V16, P100, DOI 10.1097/00001665-200501000-00019; Wu JZ, 2003, BIO-MED MATER ENG, V13, P373; Wu JZ, 2006, BIO-MED MATER ENG, V16, P53; Xia J, 2001, IEEE T INF TECHNOL B, V5, P97, DOI 10.1109/4233.924800; Xia JJ, 2007, J ORAL MAXIL SURG, V65, P248, DOI 10.1016/j.joms.2006.10.005; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Zhang XY, 2016, ANN BIOMED ENG, V44, P1656, DOI 10.1007/s10439-015-1480-7	44	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0197209	10.1371/journal.pone.0197209	http://dx.doi.org/10.1371/journal.pone.0197209			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742139	Green Published, Green Submitted, gold			2022-12-26	WOS:000431757400067
J	Cairney, J; Chirico, D; Li, YC; Bremer, E; Graham, JD				Cairney, John; Chirico, Daniele; Li, Yao-Chuen; Bremer, Emily; Graham, Jeffrey D.			Are Canadian-born Major League Baseball players more likely to bat left-handed? A partial test of the hockey-influence on batting hypothesis	PLOS ONE			English	Article							LATERALITY	It has been suggested that Canadian-born Major League Baseball (MLB) players are more likely to bat left-handed, possibly owing to the fact that they learn to play ice hockey before baseball, and that there is no clear hand-preference when shooting with a hockey stick; approximately half of all ice hockey players shoot left. We constructed a database on active (i.e., October, 2016) MLB players from four countries/regions based on place of birth (Canada, United States of America [USA], Dominican Republic and South Asia [i.e., Japan, Taiwan and South Korea]), including information on which hand they use to bat and throw. We also extracted information on all Canadian-born MLB players, dating back to 1917. Our results confirm that the proportion of left-handed batters born in Canada is higher when compared to the other countries selected; also, since 1917, the proportion of Canadian MLB players who bat left has been consistently higher than the league average. We also compared the proportion of left-handed batters in Canada with players born in states in the USA grouped into high, average and low based on hockey participation. The proportion of MLB players born in states with a high level of hockey participation were more likely to bat left, although the differences were significant at trend level only (p<.10). Lastly, we found that while Canadians were more likely to bat left-handed, this did not correspond with a greater left-hand dominance, as determined by throwing hand. In conclusion, the present study confirms that Canadian-born MLB players are more likely to bat left-handed when compared to American, Dominican Republic and South Asian-born MLB players, providing partial support for the hockey influence on batting hypothesis.	[Cairney, John] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Cairney, John; Chirico, Daniele; Li, Yao-Chuen; Bremer, Emily; Graham, Jeffrey D.] McMaster Univ, Infant & Child Hlth Lab, Dept Family Med, Hamilton, ON, Canada; [Chirico, Daniele] Univ Ottawa, Heart Inst, Div Prevent & Rehabil, Exercise Physiol & Cardiovasc Hlth Lab, Ottawa, ON, Canada; [Li, Yao-Chuen] Natl Hlth Res Inst, Child Hlth Res Ctr, Inst Populat Hlth Sci, Zhunan, Miaoli County, Taiwan; [Bremer, Emily] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	University of Toronto; McMaster University; University of Ottawa; University of Ottawa Heart Institute; National Health Research Institutes - Taiwan; McMaster University	Cairney, J (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.; Cairney, J (corresponding author), McMaster Univ, Infant & Child Hlth Lab, Dept Family Med, Hamilton, ON, Canada.	john.cairney@utoronto.ca	Cairney, John/AAQ-9703-2020; Li, Yao-Chuen/ABC-9743-2020; Bremer, Emily/AGB-5113-2022; Li, Yao-Chuen/I-7280-2017	Cairney, John/0000-0003-2856-3967; Bremer, Emily/0000-0003-1488-1032; Graham, Jeffrey/0000-0002-6728-2597; Li, Yao-Chuen/0000-0002-9156-4033	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We received no external or internal funding to collect the data for this study. Dr. Graham was supported by a post-doctoral fellowship from the Canadian Institutes of Health Research (CIHR) during the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala O, 2013, UNM ORTHOP RES J, V2, P19; [Anonymous], 2017, HANDEDNESS REPORT; [Anonymous], 2013, CBC NEWS; Brenner JS, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2148; Census TBot, 2017, ANN EST RES POP US R; Chu CYC, 2016, JING JI LUN WEN, V44, P171; Clark W., 2008, KIDS SPORTS CANADIAN, P85; Foxsports, 2016, HOCK HELP EUR NAT RI; Grodin S, 1994, STAPS, V15, P65; Grondin S, 1999, J EXP PSYCHOL HUMAN, V25, P747, DOI 10.1037/0096-1523.25.3.747; Hackfort D., 2006, ESSENTIAL PROCESSES, P10; Hockey Canada, 2014, 2014 OL WINT GAM MEN; Humber W., 1995, W DIAMONDS N CONCISE; Kidd B., 1996, STRUGGLE CANADIAN SP; Kim Hae-Young, 2017, Restor Dent Endod, V42, P152, DOI 10.5395/rde.2017.42.2.152; Leonard P, 2016, RIGHTY LEFTY WHAT YO; Loffing F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105800; Pellegrin C, 2008, LEFT HANDED BASEBALL; Puterman J, 2010, J SPORT SCI, V28, P1581, DOI 10.1080/02640414.2010.514281; Robidoux M, 2002, J AM FOLKLORE, V115, P209, DOI 10.2307/4129220; USA Hockey, MEMB STAT; Walsh J., 2007, THE HARDBALL TIMES; World Baseball Softball Confederation, 2017, BAS WORLD RANK	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195252	10.1371/journal.pone.0195252	http://dx.doi.org/10.1371/journal.pone.0195252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718915	gold, Green Published			2022-12-26	WOS:000431281900015
J	McQueeney, KE; Salamoun, JM; Ahn, JG; Pekic, P; Blanco, IK; Struckman, HL; Sharlow, ER; Wipf, P; Lazo, JS				McQueeney, Kelley E.; Salamoun, Joseph M.; Ahn, Jennifer G.; Pekic, Paula; Blanco, Isabella K.; Struckman, Heather L.; Sharlow, Elizabeth R.; Wipf, Peter; Lazo, John S.			A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion	FASEB JOURNAL			English	Article						phosphatase; inhibitor; migration; extracellular matrix; Emilin	EXTRACELLULAR-MATRIX; COLORECTAL-CANCER; PRL-3; PHOSPHATASE; GROWTH; PROLIFERATION; METASTASIS; EXPRESSION; MIGRATION; LIVER	Dysregulation of the tightly controlled protein phosphorylation networks that govern cellular behavior causes cancer. The membrane-associated, intracellular protein tyrosine phosphatase PTP4A3 is overexpressed in human colorectal cancer and contributes to cell migration and invasion. To interrogate further the role of PTP4A3 in colorectal cancer cell migration and invasion, we deleted the Ptp4a3 gene from murine colorectal tumor cells. The resulting PTP4A3(-/-) cells exhibited impaired colony formation, spheroid formation, migration, and adherence compared with the paired PTP4A3(fl/fl) cells. We replicated these phenotypic changes using the new small-molecule, allosteric PTP4A3 inhibitor JMS-053. A related structure, JMS-038, which lacked phosphatase inhibition, displayed no cellular activity. Reduction in cell viability and colony formation by JMS-053 occurred in both mouse and human colorectal cell lines and required PTP4A3 expression. Ptp4a3 deletion increased the expression of extracellular matrix (ECM) and adhesion genes, including the tumor suppressor Emilin 1. JMS-053 also increased Emilin 1 gene expression. Moreover, The Cancer Genome Atlas genomic database revealed human colorectal tumors with high Ptp4a3 expression had low Emilin 1 expression. These chemical and biologic reagents reveal a previously unknown communication between the intracellular PTP4A3 phosphatase and the ECM and support efforts to pharmacologically target PTP4A3.McQueeney, K. E., Salamoun, J. M., Ahn J. G., Pekic, P., Blanco, I. K., Struckman, H. L., Sharlow, E. R., Wipf, P., Lazo, J. S. A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion.	[McQueeney, Kelley E.; Ahn, Jennifer G.; Pekic, Paula; Blanco, Isabella K.; Struckman, Heather L.; Sharlow, Elizabeth R.; Lazo, John S.] Univ Virginia, Dept Pharmacol, Fiske Drug Discovery Lab, Charlottesville, VA 22908 USA; [Salamoun, Joseph M.; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lazo, JS (corresponding author), Univ Virginia, Dept Pharmacol, POB 800735, Charlottesville, VA 22908 USA.	lazo@virginia.edu	Wipf, Peter/AAG-1771-2021	Wipf, Peter/0000-0001-7693-5863; Struckman, Heather/0000-0002-1758-0780	National Institutes of Health (NIH) National Cancer Institute [R21CA191944, F31CA196062, P30 CA44579]; NIH National Institute of General Medical Sciences [T32GM007055]; NIH Office of the Director Grant [S10OD021723]; Farrow Fellowship; Fiske Drug Discovery Fund; Owens Foundation; Ivy Foundation; Boehringer-Ingelheim Pharmaceuticals (Ridgefield, CT, USA); NATIONAL CANCER INSTITUTE [P30CA044579, F31CA196062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007055] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021723] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Office of the Director Grant; Farrow Fellowship; Fiske Drug Discovery Fund; Owens Foundation; Ivy Foundation; Boehringer-Ingelheim Pharmaceuticals (Ridgefield, CT, USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Alex Cheung (University of Virginia) for assistance in spheroid assay development, Dr. Mark Zimmerman (University of Pittsburgh) for providing tumor tissue from the colorectal tumors of Ptp4a3<SUP>fl/fl</SUP> and Ptp4a3<SUP>-/-</SUP> mice, Sophie Lewandoski (Oberlin College, Oberlin, OH, USA) for help in characterizing the JMS-053 and JMS-038 compounds, and Yongde Bao (University of Virginia Genomic Analysis and Technology Core) for assistance with RNA sequencing. This research was supported by National Institutes of Health (NIH) National Cancer Institute Grants R21CA191944 (to J.S.L.), F31CA196062 (to K.E.M.), and P30 CA44579, NIH National Institute of General Medical Sciences Grant T32GM007055, and NIH Office of the Director Grant S10OD021723 (to J.S.L.); the Farrow Fellowship (to K.E.M.); the Fiske Drug Discovery Fund (to J.S.L.); the Owens Foundation (to J.S.L.); the Ivy Foundation (to J.S.L.); and by discretionary funding from Boehringer-Ingelheim Pharmaceuticals (Ridgefield, CT, USA) (to P.W.). The authors declare no conflicts of interest.	Al-aidaroos AQO, 2013, J CLIN INVEST, V123, P3459, DOI 10.1172/JCI66824; Bardelli A, 2003, CLIN CANCER RES, V9, P5607; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Connell LC, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0463-3; Cramer JM, 2014, STEM CELL RES, V13, P164, DOI 10.1016/j.scr.2014.05.004; Danussi C, 2012, CANCER PREV RES, V5, P1131, DOI 10.1158/1940-6207.CAPR-12-0076-T; Daouti S, 2008, CANCER RES, V68, P1162, DOI 10.1158/0008-5472.CAN-07-2349; De Donatis A, 2008, J BIOL CHEM, V283, P19948, DOI 10.1074/jbc.M709428200; den Hollander P, 2016, CANCER RES, V76, P1942, DOI 10.1158/0008-5472.CAN-14-0673; Fiordalisi JJ, 2006, CANCER RES, V66, P3153, DOI 10.1158/0008-5472.CAN-05-3116; Forte E, 2008, BBA-MOL CELL RES, V1783, P334, DOI 10.1016/j.bbamcr.2007.11.004; Foy M, 2017, EXP CELL RES, V353, P88, DOI 10.1016/j.yexcr.2017.03.012; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gari HH, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.50; Gari HH, 2016, CANCER LETT, V380, P505, DOI 10.1016/j.canlet.2016.07.017; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Hao RT, 2010, J CANCER RES CLIN, V136, P1349, DOI 10.1007/s00432-010-0786-y; Hoeger B, 2014, EUR J MED CHEM, V88, P89, DOI 10.1016/j.ejmech.2014.08.060; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jiang YJ, 2011, CANCER RES, V71, P234, DOI 10.1158/0008-5472.CAN-10-1487; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Kato H, 2004, CLIN CANCER RES, V10, P7318, DOI 10.1158/1078-0432.CCR-04-0485; Kostantin E, 2016, J BIOL CHEM, V291, P10716, DOI 10.1074/jbc.M115.705863; Lai W, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0566-z; Laurent C, 2011, CANCER RES, V71, P666, DOI 10.1158/0008-5472.CAN-10-0605; Liang FB, 2007, J BIOL CHEM, V282, P5413, DOI 10.1074/jbc.M608940200; Maltzman T, 1997, CARCINOGENESIS, V18, P2435, DOI 10.1093/carcin/18.12.2435; McParland V, 2011, BIOCHEMISTRY-US, V50, P7579, DOI 10.1021/bi201095z; McQueeney K. E., 2017, ONCOTARGET, V9, P8223; National Cancer Institute, 2016, SEER CANC STAT FACTS, V2017; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Ooki A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-122; Orgaz Jose L, 2014, Small GTPases, V5, pe29019, DOI 10.4161/sgtp.29019; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Polato F, 2005, CLIN CANCER RES, V11, P6835, DOI 10.1158/1078-0432.CCR-04-2357; Qian F, 2007, MOL MED, V13, P151, DOI 10.2119/2006-00076.Qian; Rabajdova M, 2016, J CANCER RES CLIN, V142, P2397, DOI 10.1007/s00432-016-2226-0; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; SAIGA T, 1987, IN VITRO CELL DEV B, V23, P850; Salamoun JM, 2016, ORG BIOMOL CHEM, V14, P6398, DOI 10.1039/c6ob00946h; Schwartz MA, 2001, J CELL SCI, V114, P2553; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Slordahl TS, 2016, ONCOTARGET, V7, P27295, DOI 10.18632/oncotarget.8422; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Walls CD, 2013, MOL CELL PROTEOMICS, V12, P3759, DOI 10.1074/mcp.M113.028886; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang Y, 2007, INT J COLORECTAL DIS, V22, P1179, DOI 10.1007/s00384-007-0303-1; Xing C, 2016, CANCER RES, V76, P83, DOI 10.1158/0008-5472.CAN-14-3595; Xing XF, 2009, HISTOPATHOLOGY, V54, P309, DOI 10.1111/j.1365-2559.2009.03226.x; Xu ZY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000663; Yang YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169665; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004; Zanoni M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19103; Zhou J, 2014, EXP HEMATOL, V42; Zimmerman MW, 2014, J BIOL CHEM, V289, P5904, DOI 10.1074/jbc.M113.480038; Zimmerman MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058300	59	11	11	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5661	5673		10.1096/fj.201701446R	http://dx.doi.org/10.1096/fj.201701446R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29746167	Green Published, Bronze			2022-12-26	WOS:000447972500038
J	Shi, SJ; Mutchler, SM; Blobner, BM; Kashlan, OB; Kleyman, TR				Shi, Shujie; Mutchler, Stephanie M.; Blobner, Brandon M.; Kashlan, Ossama B.; Kleyman, Thomas R.			Pore-lining residues of MEC-4 and MEC-10 channel subunits tune the Caenorhabditis elegans degenerin channel's response to shear stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); shear stress; gating; mechanotransduction; acid sensing ion channel (ASIC); degenerin; pore	EPITHELIAL NA+ CHANNEL; TRANSMEMBRANE DOMAIN; SELECTIVITY FILTER; MUTATIONS; TOUCH; GENE; MECHANOTRANSDUCTION; NEURODEGENERATION; PERMEABILITY; TRANSDUCTION	The Caenorhabditis elegans MEC-4/MEC-10 channel mediates the worm's response to gentle body touch and is activated by laminar shear stress (LSS) when expressed in Xenopus oocytes. Substitutions at multiple sites within the second transmembrane domain (TM2) of MEC-4 or MEC-10 abolish the gentle touch response in worms, but the roles of these residues in mechanosensing are unclear. The present study therefore examined the role of specific MEC-4 and MEC-10 TM2 residues in the channel's response to LSS. We found that introducing mutations within the TM2 of MEC-4 or MEC-10 not only altered channel activity, but also affected the channel's response to LSS. This response was enhanced by Cys substitutions at selected MEC-4 sites (Phe(715), Gly(716), Gln(718), and Leu(719)) between the degenerin and the putative amiloride-binding sites in this subunit. In contrast, the LSS response was largely blunted in MEC-10 variants bearing single Cys substitutions in the regions preceding and following the amiloride-binding site (Gly(677)-Leu(681)), as well as with four MEC-10 touch-deficient mutations that introduced charged residues into the TM2 domain. An enhanced response to LSS was observed with a MEC-10 mutation in the putative selectivity filter. Overall, MEC-4 or MEC-10 mutants that altered the channel's LSS response are primarily clustered between the degenerin site and the selectivity filter, a region that probably forms the narrowest portion of the channel pore. Our results suggest that pore-lining residues of MEC-4 and MEC-10 have important yet different roles in tuning the channel's response to mechanical forces.	[Shi, Shujie; Mutchler, Stephanie M.; Blobner, Brandon M.; Kashlan, Ossama B.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Mutchler, Stephanie M.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Kashlan, Ossama B.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, 3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu		Mutchler, Stephanie/0000-0002-4288-4452; , Thomas/0000-0002-2413-5415	National Institutes of Health [DK103834, DK098204, DK051391, DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098204, P30DK079307, R01DK051391, R37DK051391, K01DK103834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part by National Institutes of Health Grants DK103834 (to S. S.) DK098204 (to O. B. K), DK051391 (to T. R. K.), and DK079307 (to the Pittsburgh Center for Kidney Research). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abi-Antoun T, 2011, AM J PHYSIOL-RENAL, V300, pF1089, DOI 10.1152/ajprenal.00610.2010; Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Arnadottir J, 2011, J NEUROSCI, V31, P12695, DOI 10.1523/JNEUROSCI.4580-10.2011; Ashley Z, 2018, AM J PHYSIOL-HEART C, V314, pH1022, DOI 10.1152/ajpheart.00506.2017; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; Bianchi L, 2007, MOL NEUROBIOL, V36, P254, DOI 10.1007/s12035-007-8009-5; Brown AL, 2007, J GEN PHYSIOL, V129, P161, DOI 10.1085/jgp.200609672; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Champigny G, 1998, J BIOL CHEM, V273, P15418, DOI 10.1074/jbc.273.25.15418; Chatzigeorgiou M, 2010, J NEUROPHYSIOL, V104, P3334, DOI 10.1152/jn.00330.2010; Chen YS, 2016, MOL BIOL CELL, V27, P1272, DOI 10.1091/mbc.E15-08-0561; Chen YS, 2015, P NATL ACAD SCI USA, V112, P11690, DOI 10.1073/pnas.1515968112; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Drummond HA, 2008, PHYSIOLOGY, V23, P23, DOI 10.1152/physiol.00034.2007; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Hoger JH, 2002, P NATL ACAD SCI USA, V99, P7780, DOI 10.1073/pnas.102184999; Hong K, 2000, J NEUROSCI, V20, P2575; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028706; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kellenberger S, 2002, J PHYSIOL-LONDON, V543, P413, DOI 10.1113/jphysiol.2002.022020; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; Kusche-Vihrog K, 2010, STEROIDS, V75, P544, DOI 10.1016/j.steroids.2009.09.003; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Matthewman C, 2016, AM J PHYSIOL-CELL PH, V311, pC920, DOI 10.1152/ajpcell.00247.2016; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Ranade SS, 2015, NEURON, V87, P1162, DOI 10.1016/j.neuron.2015.08.032; Raouf R, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-21; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Shi SJ, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2224; Shi SJ, 2016, J BIOL CHEM, V291, P14012, DOI 10.1074/jbc.M116.718031; Shi SJ, 2013, AM J PHYSIOL-RENAL, V305, pF1585, DOI 10.1152/ajprenal.00337.2013; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781	40	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10757	10766		10.1074/jbc.RA118.002499	http://dx.doi.org/10.1074/jbc.RA118.002499			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29743244	hybrid, Green Published			2022-12-26	WOS:000437828400030
J	Paradis-Isler, N; Boehm, J				Paradis-Isler, Nicolas; Boehm, Jannic			NMDA receptor-dependent dephosphorylation of serine 387 in Argonaute 2 increases its degradation and affects dendritic spine density and maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Argonaute; neuron; protein turnover; protein phosphorylation; dendrite	UBIQUITIN-PROTEASOME SYSTEM; MESSENGER-RNA TRANSLATION; TERM-MEMORY FORMATION; SYNAPTIC PLASTICITY; NONCODING RNA; HIPPOCAMPAL-NEURONS; LOCAL TRANSLATION; EMERGING ROLES; MIRNA ACTIVITY; P-BODIES	Argonaute (AGO) proteins are essential components of the microRNA (miRNA) pathway. AGO proteins are loaded with miRNAs to target mRNAs and thereby regulate mRNA stability and protein translation. As such, AGO proteins are important actors in controlling local protein synthesis, for instance, at dendritic spines and synapses. Although miRNA-mediated regulation of dendritic mRNAs has become a focus of intense interest over the past years, the mechanisms regulating neuronal AGO proteins remain largely unknown. Here, using rat hippocampal neurons, we report that dendritic Ago2 is down-regulated by the proteasome upon NMDA receptor activation. We found that Ser-387 in Ago2 is dephosphorylated upon NMDA treatment and that this dephosphorylation precedes Ago2 degradation. Expressing Ser-387 phosphorylation-deficient or phosphomimetic Ago2 in neurons, we observed that this phosphorylation site is involved in modulating dendritic spine morphology and postsynaptic density protein 95 (PSD-95) expression in spines. Collectively, our results point toward a signaling pathway linking NMDA receptor-dependent Ago2 dephosphorylation and turnover to postsynaptic structural changes. They support a model in which NMDA receptor-mediated dephosphorylation of Ago2 and Ago2 turnover contributes to the de-repression of mRNAs involved in spine growth and maturation.	[Paradis-Isler, Nicolas; Boehm, Jannic] Univ Montreal, Dept Neurosci, Grp Rech Syst Nerveux Cent, Montreal, PQ H3T 1J4, Canada	Universite de Montreal	Boehm, J (corresponding author), Univ Montreal, Dept Neurosci, 2960 Chemin Tour, Montreal, PQ H3T 1J4, Canada.	jannic.boehm@umontreal.ca	Boehm, Jannic/AAK-8882-2020	Paradis-Isler, Nicolas/0000-0001-8832-0110	"Natural Sciences and Engineering Research Council of Canada" (NSERC) Discovery Grant [371858]; Natural Sciences and Engineering Research Council of Canada (NSERC) "Alexander Graham Bell" master student stipend; Quebec "Fonds de Recherche Nature et Technologies" (FQRNT); "Fonds de Recherche Sante Quebec" (FRQS)	"Natural Sciences and Engineering Research Council of Canada" (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada (NSERC) "Alexander Graham Bell" master student stipend; Quebec "Fonds de Recherche Nature et Technologies" (FQRNT); "Fonds de Recherche Sante Quebec" (FRQS)	This work was supported in part by an operating grant from the "Natural Sciences and Engineering Research Council of Canada" (NSERC) Discovery Grant 371858. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Natural Sciences and Engineering Research Council of Canada (NSERC) "Alexander Graham Bell" master student stipend and a Ph.D. stipend from the Quebec "Fonds de Recherche Nature et Technologies" (FQRNT).; Supported by a salary award from the "Fonds de Recherche Sante Quebec" (FRQS). To whom correspondence should be addressed: Dept. of Neurosciences, Universite de Montreal, 2960 Chemin de la Tour, Montreal, Quebec H3T 1J4, Canada; Tel.: 514 343 6370; E-mail: jannic.boehm@umontreal.ca.	Adams BD, 2009, ENDOCRINOLOGY, V150, P14, DOI 10.1210/en.2008-0984; Alvarez-Castelao B, 2015, J BIOL CHEM, V290, P28623, DOI 10.1074/jbc.R115.657130; Antoniou A, 2014, EMBO REP, V15, P548, DOI 10.1002/embr.201337631; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Cane M, 2014, J NEUROSCI, V34, P2075, DOI 10.1523/JNEUROSCI.3353-13.2014; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cohen LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063191; Cougot N, 2008, J NEUROSCI, V28, P13793, DOI 10.1523/JNEUROSCI.4155-08.2008; Darnell RB, 2013, ANNU REV NEUROSCI, V36, P243, DOI 10.1146/annurev-neuro-062912-114322; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Dong CH, 2014, NEUROSCI LETT, V583, P199, DOI 10.1016/j.neulet.2014.09.038; Dong CH, 2014, J NEUROSCI, V34, P3171, DOI 10.1523/JNEUROSCI.3291-13.2014; Eacker SM, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00136; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Filipowicz W, 2015, RNA, V21, P519, DOI 10.1261/rna.051219.115; Hamilton AM, 2012, NEURON, V74, P1023, DOI 10.1016/j.neuron.2012.04.031; Hanus C, 2013, NAT REV NEUROSCI, V14, P638, DOI 10.1038/nrn3546; Hauptmann J, 2013, DEV CELL, V25, P553, DOI 10.1016/j.devcel.2013.06.009; Ho VM, 2011, SCIENCE, V334, P623, DOI 10.1126/science.1209236; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Horman SR, 2013, MOL CELL, V50, P356, DOI 10.1016/j.molcel.2013.03.015; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Iwakawa HO, 2015, TRENDS CELL BIOL, V25, P651, DOI 10.1016/j.tcb.2015.07.011; Jarome TJ, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00061; Jarome TJ, 2013, NEUROBIOL LEARN MEM, V105, P107, DOI 10.1016/j.nlm.2013.03.009; Jee D, 2014, TRENDS CELL BIOL, V24, P546, DOI 10.1016/j.tcb.2014.04.008; Johnston M, 2010, MOL BIOL CELL, V21, P1462, DOI 10.1091/mbc.E09-10-0885; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Juvvuna PK, 2012, NUCLEIC ACIDS RES, V40, P6808, DOI 10.1093/nar/gks293; Kenny PJ, 2014, CELL REP, V9, P1729, DOI 10.1016/j.celrep.2014.10.054; Khoutorsky A, 2013, NEURON, V78, P298, DOI 10.1016/j.neuron.2013.02.025; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Leung AKL, 2015, TRENDS CELL BIOL, V25, P601, DOI 10.1016/j.tcb.2015.07.005; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Loohuis NFMO, 2012, CELL MOL LIFE SCI, V69, P89, DOI 10.1007/s00018-011-0788-1; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Muddashetty RS, 2011, MOL CELL, V42, P673, DOI 10.1016/j.molcel.2011.05.006; Nalavadi VC, 2012, J NEUROSCI, V32, P2582, DOI 10.1523/JNEUROSCI.5057-11.2012; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Pai B, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00285; Pasquinelli AE, 2015, RNA, V21, P709, DOI 10.1261/rna.049981.115; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Patranabis S, 2016, MOL CELL BIOL, V36, P1260, DOI 10.1128/MCB.00054-16; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Rosenberg T, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00086; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Sahin U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102957; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Siegel G, 2011, CURR OPIN GENET DEV, V21, P491, DOI 10.1016/j.gde.2011.04.008; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Smibert P, 2013, NAT STRUCT MOL BIOL, V20, P789, DOI 10.1038/nsmb.2606; Swanger SA, 2011, CURR OPIN GENET DEV, V21, P414, DOI 10.1016/j.gde.2011.04.002; Taft CE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0134; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Valdmanis PN, 2012, NUCLEIC ACIDS RES, V40, P3704, DOI 10.1093/nar/gkr1274; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Weiss K, 2015, EUR J CELL BIOL, V94, P363, DOI 10.1016/j.ejcb.2015.05.011; Yang M, 2014, MOL CELL, V55, P782, DOI 10.1016/j.molcel.2014.07.018; Ye YQ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4959523; Zeitelhofer M, 2008, J NEUROSCI, V28, P7555, DOI 10.1523/JNEUROSCI.0104-08.2008; Zeitelhofer M, 2008, RNA BIOL, V5, P244, DOI 10.4161/rna.6948; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599	80	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9311	9325		10.1074/jbc.RA117.001007	http://dx.doi.org/10.1074/jbc.RA117.001007			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29735530	Green Published, hybrid			2022-12-26	WOS:000435441400017
J	Ahmed, N; Saleem, M				Ahmed, Naveed; Saleem, M.			Studying heating effects on desi ghee obtained from buffalo milk using fluorescence spectroscopy	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; VIRGIN OLIVE OIL; VITAMIN-E; ANTIOXIDANT; DEFICIENCY	Characterisation and thermal deterioration of desi ghee obtained from buffalo milk is presented for the first time using the potential of Fluorescence spectroscopy. The emission bands in non-heated desi ghee centred at 375 nm is labelled for vitamin D, 390 nm for vitamin K, 440-460 nm for isomers of conjugated linoleic acid (CLA), 490 nm for vitamin A and the region 620-700 nm is assigned to chlorophyll contents. Fluorescence emission spectra from all the heated and non-heated ghee samples were recorded using excitation wavelengths at 280, and 410 nm which were found best for getting maximum spectral signatures. Heating of desi ghee affects its molecular composition, however, the temperature range from 140 to 170 degrees C may be defined safe for cooking /frying where it does not lose much of its molecular composition. Further, the rise in temperature induces prominent spectral variations which confirm the deterioration of valuable vitamins, isomers of CLA and chlorophyll contents. Fluorescence emission peak at 552 nm shows oxidation product and an increase in its intensity with the rise in temperature is observed. In order to classify heated samples at different temperatures, principal component analysis (PCA) has been applied on heated and non-heated ghee samples that further elucidated the temperature effects.	[Ahmed, Naveed; Saleem, M.] Natl Inst Lasers & Optron NILOP, Agri & Biophoton Div, Islamabad, Pakistan; [Ahmed, Naveed] Mirpur Univ Sci & Technol MUST Mirpur, Dept Phys, Azad Kashmir, Pakistan		Saleem, M (corresponding author), Natl Inst Lasers & Optron NILOP, Agri & Biophoton Div, Islamabad, Pakistan.	salim569mail@gmail.com	Saleem, Muhammad/M-8215-2016	Saleem, Muhammad/0000-0001-8376-0459				Ahmad S, 2013, J ANIM PLANT SCI, V23, P62; Ali H, 2016, J RAMAN SPECTROSC, V47, P706, DOI 10.1002/jrs.4891; Andrewes P, 2012, FOOD CHEM, V135, P921, DOI 10.1016/j.foodchem.2012.06.013; BernuyDel Carpio B, 2010, THESIS; Binkley N, 2009, J BONE MINER RES, V24, P983, DOI [10.1359/JBMR.081254, 10.1359/jbmr.081254]; BURTON GW, 1990, ANNU REV NUTR, V10, P357, DOI [10.1146/annurev.nu.10.070190.002041, 10.1146/annurev.nutr.10.1.357]; Cheikhousman R, 2005, ANAL BIOANAL CHEM, V382, P1438, DOI 10.1007/s00216-005-3286-1; Chinnadurai K, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-121; Chiou A, 2017, COMPR REV FOOD SCI F, V16, P632, DOI 10.1111/1541-4337.12268; Dufour E, 2001, INT DAIRY J, V11, P465, DOI 10.1016/S0958-6946(01)00086-3; GANGULI NC, 1973, J DAIRY SCI, V56, P19, DOI 10.3168/jds.S0022-0302(73)85109-4; Guimet Vila F, 2006, THESIS U ROVIRA VIRG; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Kongbonga Y. G. M., 2011, Food and Nutrition Sciences, V2, P692, DOI 10.4236/fns.2011.27095; Kyriakidis NB, 2000, J AOAC INT, V83, P1435; Liu XM, 2007, J DAIRY SCI, V90, P24, DOI 10.3168/jds.S0022-0302(07)72605-X; Mahood F, 2015, SPECTROCHIM ACTA A, V143, P298, DOI 10.1016/j.saa.2015.01.119; Mann M. E, 1990, TETRAHEDRON, V76, P1; McCrorie TA, 2011, NUTR RES REV, V24, P206, DOI 10.1017/S0954422411000114; Muik B, 2005, CHEM PHYS LIPIDS, V134, P173, DOI 10.1016/j.chemphyslip.2005.01.003; Nawaz H, 2017, J RAMAN SPECTROSC, V48, P697, DOI 10.1002/jrs.5108; Nikolova K., 2012, J FOOD SCI ENG, V2, P674; Poulli KI, 2009, J AGR FOOD CHEM, V57, P8194, DOI 10.1021/jf902758d; Rajakumar K, 2015, PEDIATRICS, P112; RICHARD C, 1990, CRIT CARE MED, V18, P4, DOI 10.1097/00003246-199001000-00002; Saleem M, 2017, LASER PHYS, V27, DOI 10.1088/1555-6611/aa8cd7; Schamberger GP, 2006, J FOOD SCI, V71, pC69, DOI 10.1111/j.1365-2621.2006.tb08884.x; Silveira MB, 2007, PUBLIC HEALTH NUTR, V10, P1181, DOI 10.1017/S1368980007000687; Skjervold PO, 2003, J FOOD SCI, V68, P1161, DOI 10.1111/j.1365-2621.2003.tb09618.x; Smith G. M., 2012, THESIS; Sserunjogi ML, 1998, INT DAIRY J, V8, P677, DOI 10.1016/S0958-6946(98)00106-X; Tena N, 2009, J AGR FOOD CHEM, V57, P10505, DOI 10.1021/jf902009b; Tome D, 2009, AM J CLIN NUTR, V90, p838S, DOI 10.3945/ajcn.2009.27462W; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; Ullah A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0161787; Valli E, 2010, J AGR FOOD CHEM, V58, P8158, DOI 10.1021/jf1009582; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; West Jr KP, 2002, J NUTR S, V132, pS2857S, DOI 10.1093/jn/132.9.2857S; West KP, 2008, NUTR HEALTH SER, P377, DOI 10.1007/978-1-59745-464-3_13; Whigham LD, 2000, PHARMACOL RES, V42, P503, DOI 10.1006/phrs.2000.0735; Zandomeneghi M, 2005, J AGR FOOD CHEM, V53, P759, DOI 10.1021/jf048742p	41	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0197340	10.1371/journal.pone.0197340	http://dx.doi.org/10.1371/journal.pone.0197340			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750812	Green Published, gold, Green Submitted			2022-12-26	WOS:000431856300029
J	Hunt, D; Figley, C; Manage, DP; Lauzon, J; Figley, R; Pilarski, LM; McMullen, LM; Pilarski, PM				Hunt, Darin; Figley, Curtis; Manage, Dammika P.; Lauzon, Jana; Figley, Rachel; Pilarski, Linda M.; McMullen, Lynn M.; Pilarski, Patrick M.			Monitoring food pathogens: Novel instrumentation for cassette PCR testing	PLOS ONE			English	Article							ESCHERICHIA-COLI; UNITED-STATES; OUTBREAKS; TECHNOLOGY; PLATFORM; DNA	In this manuscript, we report the design and development of a fast, reliable instrument to run gel-based cassette polymerase chain reactions (PCR). Here termed the GelCycler Mark II, our instrument is a miniaturized molecular testing system that is fast, low cost and sensitive. Cassette PCR utilizes capillary reaction units that carry all reagents needed for PCR, including primers and Taq polymerase, except the sample, which is loaded at the time of testing. Cassette PCR carries out real time quantitative PCR followed by melt curve analysis (MCA) to verify amplicon identity at the expected melt temperature (T-m). The cassette PCR technology is well developed, particularly for detecting pathogens, and has been rigorously validated for detecting pathogenic Escherichia coli in meat samples. However, the work has been hindered by the lack of a robust and stable instrument to carry out the PCR, which requires fast and accurate temperature regulation, improved light delivery and fluorescent recording, and faster PCR reactions that maintain a high sensitivity of detection. Here, we report design and testing of a new instrument to address these shortcomings and to enable standardized testing by cassette PCR and commercial manufacture of a robust and accurate instrument that can be mass produced to deliver consistent performance. As a corollary to our new instrument development, we also report the use of an improved design approach using a machined aluminum cassette to meet the new instrument standards, prevent any light bleed across different trenches in each cassette, and allow testing of a larger number of samples for more targets in a single run. The GelCycler Mark II can detect and report E. coli contamination in 41 minutes. Sample positives are defined in as having a melt curve comparable to the internal positive control, with peak height exceeding that of the internal negative control. In a fractional analysis, as little as 1 bacterium per capillary reaction unit is directly detectable, with no enrichment step, in 35 cycles of PCR/MCA, in a total time of 53 minutes, making this instrument and technology among the very best for speed and sensitivity in screening food for pathogenic contamination.	[Hunt, Darin; Figley, Curtis; Figley, Rachel] CBF Syst Inc, Coll Plaza, Edmonton, AB, Canada; [Manage, Dammika P.; Lauzon, Jana; Pilarski, Linda M.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Manage, Dammika P.; Lauzon, Jana; Pilarski, Linda M.] Cross Canc Inst, Edmonton, AB, Canada; [McMullen, Lynn M.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Pilarski, Patrick M.] Univ Alberta, Div Phys Med & Rehabil, Dept Med, Katz Grp Ctr Pharm & Hlth Res 5 005, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Pilarski, PM (corresponding author), Univ Alberta, Div Phys Med & Rehabil, Dept Med, Katz Grp Ctr Pharm & Hlth Res 5 005, Edmonton, AB, Canada.	pilarski@ualberta.ca	McMullen, Lynn/AAC-4579-2019	Manage, Dammika/0000-0002-9681-6674	Alberta Innovates - University of Alberta [B10-14-001]; Alberta Innovates - CBF Systems [B10-14-001]; Agriculture Funding Consortium; Alberta Innovates Bio Solutions; Alberta Innovates BioSolutions; Agriculture Funding Consortium (Alberta Innovates BioSolutions); Agriculture Funding Consortium (Alberta Meat and Livestock Association)	Alberta Innovates - University of Alberta; Alberta Innovates - CBF Systems; Agriculture Funding Consortium; Alberta Innovates Bio Solutions; Alberta Innovates BioSolutions; Agriculture Funding Consortium (Alberta Innovates BioSolutions); Agriculture Funding Consortium (Alberta Meat and Livestock Association)	The development of the instrument described here was funded by a peer-reviewed research grant B10-14-001 from Alberta Innovates, a provincial funding organization, awarded jointly to the University of Alberta and CBF Systems. CBF Systems is an engineering design and development company with no commercial products relating to this work. Company involvement was solely as a research partner; no financial support was provided by CBF Systems. An additional grant was obtained from the Agriculture Funding Consortium to the University of Alberta, to support extended testing of functionality. The grant funders did not provide any salary support for principal investigators in the university or in CBF Systems. The funders did not have any role in the study design, data collection, or analysis, decision to publish or preparation of the manuscript. Financial support was entirely provided by the independent granting agencies, Alberta Innovates Bio Solutions and the Agriculture Funding Consortium. All authors for this manuscript contributed to the research effort and to writing of the manuscript. Specific roles are articulated in the author contributions section.; We thank Alberta Innovates BioSolutions and the Agriculture Funding Consortium (Alberta Innovates BioSolutions and the Alberta Meat and Livestock Association) for generously funding the development of the GelCycler Mark II. We are especially grateful to Dr. Cornelia Kreplin for her constant support and encouragement.	[Anonymous], 2011, HLTH CANADA HLTH PRO; Arora HS, 2017, PEDIATR INFECT DIS J, V36, P685, DOI 10.1097/INF.0000000000001551; Atrazhev A, 2010, ANAL CHEM, V82, P8079, DOI 10.1021/ac1013157; Cloke J, 2016, J AOAC INT, V99, P1537, DOI 10.5740/jaoacint.16-0235; Deisingh AK, 2004, J APPL MICROBIOL, V96, P419, DOI 10.1111/j.1365-2672.2003.02170.x; Gould LH, 2017, EMERG INFECT DIS, V23, P525, DOI 10.3201/eid2303.161462; Heiman KE, 2015, EMERG INFECT DIS, V21, P1293, DOI 10.3201/eid2108.141364; Hirvonen JJ, 2012, J CLIN MICROBIOL, V50, P3586, DOI 10.1128/JCM.01754-12; Huszczynski G, 2013, J FOOD PROTECT, V76, P1689, DOI 10.4315/0362-028X.JFP-13-059; Kraft AL, 2017, LETT APPL MICROBIOL, V65, P213, DOI 10.1111/lam.12771; Manage DP, 2015, METHODS MOL BIOL, V1310, P175, DOI 10.1007/978-1-4939-2690-9_15; Manage DP, 2014, J MOL DIAGN, V16, P550, DOI 10.1016/j.jmoldx.2014.04.004; Manage DP, 2013, LAB CHIP, V13, P4011, DOI 10.1039/c3lc50755f; Manage DP, 2013, LAB CHIP, V13, P4087, DOI 10.1039/c3lc50655j; Manage DP, 2013, LAB CHIP, V13, P2576, DOI [10.1039/c31c41419a, 10.1039/c3lc41419a]; Manage DP, 2012, LAB CHIP, V12, P1664, DOI 10.1039/c2lc40061h; Priyanka B, 2016, INDIAN J MED RES, V144, P327, DOI 10.4103/0971-5916.198677; Wang JL, 2016, TOXINS, V8, DOI 10.3390/toxins8040092; Wasilenko JL, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00081; White A, 2016, FOODBORNE PATHOG DIS, V13, P527, DOI 10.1089/fpd.2016.2140	20	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197100	10.1371/journal.pone.0197100	http://dx.doi.org/10.1371/journal.pone.0197100			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746561	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700068
J	Nagel, S; Meyer, C; Kaufmann, M; Zaborski, M; MacLeod, RAF; Drexler, HG				Nagel, Stefan; Meyer, Corinna; Kaufmann, Maren; Zaborski, Margarete; MacLeod, Roderick A. F.; Drexler, Hans G.			Aberrant activity of NKL homeobox gene NKX3-2 in a T-ALL subset	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CELL LEUKEMIA; HOMEODOMAIN PROTEINS; MICRORNA EXPRESSION; TUMOR-SUPPRESSOR; STEM-CELL; ETP-ALL; ACTIVATION; PROSTATE; IDENTIFICATION	T-cell acute lymphoblastic leukemia (T-ALL) is a hematopoietic malignancy originating from T-cell progenitors in which differentiation is blocked at early stages. Physiological expression of specific NKL homeobox genes obeys a hematopoietic NKL-code implicated in the process of lymphopoiesis while in differentiated T-cells these genes are silenced. We propose that this developmental expression pattern underlies the observation that NKL homeobox genes are the most ubiquitous group of transcription factors deregulated in TALL, including TLX1, TLX3, NKX2-5 and NKX3-1. Here, we describe a novel member of the NKL homeobox gene subclass, NKX3-2 (BAPX1), which is aberrantly activated in 18% of pediatric T-ALL patients analyzed while being normally expressed in developing spleen. Identification of NKX3-2 expression in T-ALL cell line CCRF-CEM qualified these cells to model its deregulation and function in a leukemic context. Genomic and chromosomal analyses demonstrated normal configuration of the NKX3-2 locus at chromosome 4p15, thus excluding cytogenetic dysregulation. Comparative expression profiling analysis of NKX3-2 patient data revealed deregulated activity of BMP- and MAPK-signalling. These candidate pathways were experimentally confirmed to mediate aberrant NKX3-2 expression. We also show that homeobox gene SIX6, plus MIR17HG and GATA3 are downstream targets of NKX3-2 and plausibly contribute to the pathogenesis of this malignancy by suppressing T-cell differentiation. Finally, NKL homeobox gene NKX2-5 was activated by NKX3-2 in CCRF-CEM and by FOXG1 in PEER, representing mutually inhibitory activators of this translocated oncogene. Together, our findings reveal a novel oncogenic NKL homeobox gene subclass member which is aberrantly expressed in a large subset of T-ALL patients and participates in a deregulated gene network likely to arise in developing spleen.	[Nagel, Stefan; Meyer, Corinna; Kaufmann, Maren; Zaborski, Margarete; MacLeod, Roderick A. F.; Drexler, Hans G.] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Nagel, S (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	sna@dsmz.de						Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Addis RC, 2013, J MOL CELL CARDIOL, V60, P97, DOI 10.1016/j.yjmcc.2013.04.004; Anderson AM, 2012, DEVELOPMENT, V139, P991, DOI 10.1242/dev.077255; Brendolan A, 2005, DEVELOPMENT, V132, P3113, DOI 10.1242/dev.01884; BROWN L, 1990, EMBO J, V9, P3343, DOI 10.1002/j.1460-2075.1990.tb07535.x; Burglin TR, 2016, CHROMOSOMA, V125, P497, DOI 10.1007/s00412-015-0543-8; Cardoso BA, 2008, BRAZ J MED BIOL RES, V41, P344, DOI 10.1590/S0100-879X2008005000016; Chen H, 2002, CANCER RES, V62, P338; Corbeaux T, 2010, P NATL ACAD SCI USA, V107, P16613, DOI 10.1073/pnas.1004623107; Coskun E, 2013, LEUKEMIA RES, V37, P647, DOI 10.1016/j.leukres.2013.02.019; Dadi S, 2012, CANCER CELL, V21, P563, DOI 10.1016/j.ccr.2012.02.013; Dalton S, 2013, CURR OPIN CELL BIOL, V25, P241, DOI 10.1016/j.ceb.2012.09.005; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Della Gatta G, 2012, NAT MED, V18, P436, DOI 10.1038/nm.2610; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; Dutta A, 2016, SCIENCE, V352, P1576, DOI 10.1126/science.aad9512; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Fransecky L, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0324-8; Graux C, 2006, LEUKEMIA, V20, P1496, DOI 10.1038/sj.leu.2404302; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; Hidaka K, 2010, STEM CELLS DEV, V19, P1735, DOI 10.1089/scd.2009.0466; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Homminga I, 2012, LEUKEMIA, V26, P572, DOI 10.1038/leu.2011.330; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Ikawa T, 2014, CURR TOP MICROBIOL, V381, P1, DOI 10.1007/82_2014_370; Iqbal J, 2014, BLOOD, V123, P2915, DOI 10.1182/blood-2013-11-536359; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Kaye J, 2000, IMMUNOL RES, V21, P71, DOI 10.1385/IR:21:2-3:71; Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003; Kusy S, 2010, J EXP MED, V207, P2141, DOI 10.1084/jem.20100745; Ledford KL, 2017, DEV BIOL, V426, P418, DOI 10.1016/j.ydbio.2017.04.003; Lee B, 2012, DEV BIOL, V366, P393, DOI 10.1016/j.ydbio.2012.04.023; Li X, 2002, SCIENCE, V297, P1180; Lopez-Rios J, 2003, DEVELOPMENT, V130, P185, DOI 10.1242/dev.00185; MacLeod RAF, 2003, GENE CHROMOSOME CANC, V37, P84, DOI 10.1002/gcc.10194; MacLeod RAF, 2011, METHODS MOL BIOL, V731, P57, DOI 10.1007/978-1-61779-080-5_6; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Nagel S, 2008, LEUKEMIA, V22, P600, DOI 10.1038/sj.leu.2405067; Nagel S, 2003, CANCER RES, V63, P5329; Nagel S, 2007, CANCER RES, V67, P1461, DOI 10.1158/0008-5472.CAN-06-2615; Nagel S, 2017, ONCOTARGET, V8, P66815, DOI 10.18632/oncotarget.18609; Nagel S, 2017, LEUKEMIA LYMPHOMA, V58, P2196, DOI 10.1080/10428194.2017.1283029; Nagel S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171164; Nagel S, 2015, ONCOTARGET, V6, P40112, DOI 10.18632/oncotarget.5556; Nagel S, 2015, LEUKEMIA LYMPHOMA, V56, P480, DOI 10.3109/10428194.2014.924119; Nagel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040747; Nagel S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-371; Nagel S, 2009, LEUKEMIA LYMPHOMA, V50, P101, DOI 10.1080/10428190802626632; Park M, 2007, NAT CELL BIOL, V9, P287, DOI 10.1038/ncb1538; Patterson KD, 1999, DEV DYNAM, V214, P34, DOI 10.1002/(SICI)1097-0177(199901)214:1<34::AID-DVDY4>3.0.CO;2-R; Reecy JM, 1999, DEVELOPMENT, V126, P839; Riz I, 2009, BIOCHEM BIOPH RES CO, V380, P361, DOI 10.1016/j.bbrc.2009.01.099; Skowronska-Krawczyk D, 2015, MOL CELL, V59, P931, DOI 10.1016/j.molcel.2015.07.027; Soulier J, 2005, BLOOD, V106, P274, DOI 10.1182/blood-2004-10-3900; Talos F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14662; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Uhl E, 2011, GENE CHROMOSOME CANC, V50, P950, DOI 10.1002/gcc.20917; Varas A, 2003, TRENDS IMMUNOL, V24, P197, DOI 10.1016/S1471-4906(03)00033-4; Villarese P, 2017, IDENTIFY SUBGROUP NK; Wei QZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026795; Xiao LJ, 2016, ONCOTARGET, V7, P47891, DOI 10.18632/oncotarget.10294; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	64	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197194	10.1371/journal.pone.0197194	http://dx.doi.org/10.1371/journal.pone.0197194			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746601	Green Submitted, Green Published, gold			2022-12-26	WOS:000431851700083
J	Olatunde, AC; Abell, LP; Landuyt, AE; Schwartz, EH				Olatunde, Adesola C.; Abell, Laura P.; Landuyt, Ashley E.; Schwartz, Elizabeth Hiltbold			Development of endocytosis, degradative activity, and antigen processing capacity during GM-CSF driven differentiation of murine bone marrow	PLOS ONE			English	Article							DENDRITIC CELL-DEVELOPMENT; CROSS-PRESENTATION; STEADY-STATE; FLT3 LIGAND; MACROPHAGES; RECEPTOR; PHAGOCYTOSIS; PROGENITORS; MATURATION; INFECTION	Dendritic cells (DC) are sentinels of the immune system, alerting and enlisting T cells to clear pathogenic threats. As such, numerous studies have demonstrated their effective uptake and proteolytic activities coupled with antigen processing and presentation functions. Yet, less is known about how these cellular mechanisms change and develop as myeloid cells progress from progenitor cells to more differentiated cell types such as DC. Thus, our study comparatively examined these functions at different stages of myeloid cell development driven by the GM-CSF. To measure these activities at different stages of development, GM-CSF driven bone marrow cells were sorted based on expression of Ly6C, CD115, and CD11c. This strategy enables isolation of cells representing five distinct myeloid cell types: Common Myeloid Progenitor (CMP), Granulocyte/Macrophage Progenitor (GMP), monocytes, monocyte-derived Macrophage/monocyte-derived Dendritic cell Precursors (moMac/moDP), and monocyte-derived DC (moDC). We observed significant differences in the uptake capacity, proteolysis, and antigen processing and presentation functions between these myeloid cell populations. CMP showed minimal uptake capacity with no detectable antigen processing and presenting function. The GMP population showed higher uptake capacity, modest proteolytic activity, and little T cell stimulatory function. In the monocyte population, the uptake capacity reached its peak, yet this cell type had minimal antigen processing and presentation function. Finally, moMac/moDP and moDC had a modestly decreased uptake capacity, high degradative capacity and strong antigen processing and presentation functions. These insights into when antigen processing and presentation function develop in myeloid cells during GM-CSF driven differentiation are crucial to the development of vaccines, allowing targeting of the most qualified cells as an ideal vaccine vehicles.	[Olatunde, Adesola C.; Abell, Laura P.; Landuyt, Ashley E.; Schwartz, Elizabeth Hiltbold] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	Auburn University System; Auburn University	Schwartz, EH (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	ehs0009@auburn.edu			National Institutes of Health, National Institutes of Allergy and Infectious Diseases [R15 AI107773]	National Institutes of Health, National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported National Institutes of Health, National Institutes of Allergy and Infectious Diseases, Grant R15 AI107773. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alloatti A, 2015, IMMUNITY, V43, P1087, DOI 10.1016/j.immuni.2015.11.006; Amiel E, 2007, EXP CELL RES, V313, P1438, DOI 10.1016/j.yexcr.2007.02.011; Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Canton J, 2014, MOL BIOL CELL, V25, P3330, DOI 10.1091/mbc.E14-05-0967; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Eligini S, 2013, J CELL PHYSIOL, V228, P1464, DOI 10.1002/jcp.24301; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ip WKE, 2010, J IMMUNOL, V184, P7071, DOI 10.4049/jimmunol.1000110; Jozefowski S, 2012, INFLAMM RES, V61, P113, DOI 10.1007/s00011-011-0395-5; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Larson SR, 2016, CELL DEATH DIFFER, V23, P997, DOI 10.1038/cdd.2016.24; Lefevre L, 2013, IMMUNITY, V38, P1038, DOI 10.1016/j.immuni.2013.04.010; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Levin R, 2016, IMMUNOL REV, V273, P156, DOI 10.1111/imr.12439; Louis C, 2015, J IMMUNOL, V195, P134, DOI 10.4049/jimmunol.1500369; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Merad M, 2013, ANN REV IMMUNOLOGY, V31; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Na YR, 2016, MOL CELLS, V39, P734, DOI 10.14348/molcells.2016.0160; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Pu S, 2016, SCI REPORTS, V6; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Rogers PB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181985; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Savage NDL, 2008, J IMMUNOL, V181, P2220, DOI 10.4049/jimmunol.181.3.2220; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Savina A, 2009, IMMUNITY, V30, P544, DOI 10.1016/j.immuni.2009.01.013; Serbina NV, 2012, ADV IMMUNOL, V113, P119, DOI 10.1016/B978-0-12-394590-7.00003-8; Sharif O, 2013, J IMMUNOL, V190, P5640, DOI 10.4049/jimmunol.1202270; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; VANVOORHIS WC, 1982, J EXP MED, V155, P1172, DOI 10.1084/jem.155.4.1172; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Wattananit S, 2016, J NEUROSCI, V36, P4182, DOI 10.1523/JNEUROSCI.4317-15.2016; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Westcott MM, 2007, CELL MICROBIOL, V9, P1397, DOI 10.1111/j.1462-5822.2006.00880.x; Westcott MM, 2010, INFECT IMMUN, V78, P2956, DOI 10.1128/IAI.01027-09; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577	61	5	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196591	10.1371/journal.pone.0196591	http://dx.doi.org/10.1371/journal.pone.0196591			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746488	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700025
J	Rezic-Muzinic, N; Mastelic, A; Benzon, B; Markotic, A; Mudnic, I; Grkovic, I; Grga, M; Milat, AM; Kljucevic, N; Boban, M				Rezic-Muzinic, Nikolina; Mastelic, Angela; Benzon, Benjamin; Markotic, Anita; Mudnic, Ivana; Grkovic, Ivica; Grga, Mia; Milat, Ana Marija; Kljucevic, Nikola; Boban, Mladen			Expression of adhesion molecules on granulocytes and monocytes following myocardial infarction in rats drinking white wine	PLOS ONE			English	Article							RED WINE; INFLAMMATORY BIOMARKERS; WHOLE-BLOOD; HYALURONAN; CD44; RECEPTOR; MATRIX; INJURY; PROTECTION; MIGRATION	Neutrophils and monocytes through their CD15s, CD11b and CD44 adhesion molecules are implicated in the initiation and resolution of cardiac inflammation as well as in healing processes after the myocardial infarction (MI). The aim of this study was to determine the effect of white wine consumption on granulocyte and monocyte CD15s, CD11b, and CD44 expression 24h after the surgically inflicted MI. Granulocytes and monocytes were analyzed by flow cytometry, using whole blood of male Sprague-Dawley rats that consumed white wine for 4 weeks. This group was compared with water only drinking controls, sham animals (subject to surgery without myocardial infarction) and baseline group (intact animals that received no intervention prior to being sacrificed). Sham animals did not differ from baseline animals in CD11b+CD44+ percentage and CD44+ median fluorescence intensity. Wine drinking was associated with striking increase in CD44 expression on monocyte subpopulations. Its expression was three and fourfold increased on monocytes and large monocytes, respectively, relative to the water only drinking controls. Because of known role of CD44 on suppression of post-infarction inflammation, its upregulation on granulocytes and monocytes may significantly contribute to the microenvironment favourable for the cardiac regeneration.	[Rezic-Muzinic, Nikolina; Mastelic, Angela; Markotic, Anita] Univ Split, Dept Med Chem & Biochem, Sch Med, Split, Croatia; [Benzon, Benjamin; Grkovic, Ivica; Kljucevic, Nikola] Univ Split, Dept Anat Histol & Embryol, Sch Med, Split, Croatia; [Mudnic, Ivana; Grga, Mia; Milat, Ana Marija; Boban, Mladen] Univ Split, Sch Med, Dept Pharmacol, Split, Croatia	University of Split; University of Split; University of Split	Boban, M (corresponding author), Univ Split, Sch Med, Dept Pharmacol, Split, Croatia.	mladen.boban@mefst.hr	Mužinić, Nikolina Režić/D-6889-2017; Milat, Ana Marija/E-6609-2017; Boban, Mladen/E-2777-2017	Mužinić, Nikolina Režić/0000-0002-9628-1067; Milat, Ana Marija/0000-0001-7184-1227; Boban, Mladen/0000-0003-1570-9621	Croatian Science Foundation [8652]	Croatian Science Foundation	This study was performed under the framework of the research project "Biological effects of wine: the influence of vinification technology, dealcoholisation and aging of wine" (No. 8652, PI Mladen Boban) supported by the Croatian Science Foundation.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Bonafe F, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0100-4; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Cheng B, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0315-2; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Dutta P, 2015, ARTERIOSCL THROM VAS, V35, P1066, DOI 10.1161/ATVBAHA.114.304652; Elbim C, 1998, AM J PATHOL, V152, P1081; Forman Henry Jay U F, 2014, NUTR AGING, V2, P117, DOI DOI 10.3233/NUA-130033; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Guic MM, 2010, NEUROSCI LETT, V469, P314, DOI 10.1016/j.neulet.2009.12.016; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Henke C, 1996, AM J PATHOL, V149, P1639; Huebener P, 2008, J IMMUNOL, V180, P2625, DOI 10.4049/jimmunol.180.4.2625; Iyer RP, 2015, INT J CARDIOL, V185, P198, DOI 10.1016/j.ijcard.2015.03.054; Jung K, 2013, CIRC RES, V112, P891, DOI 10.1161/CIRCRESAHA.111.300484; Katalinic V, 2004, FOOD CHEM, V86, P593, DOI 10.1016/j.foodchem.2003.10.007; Kaya G, 1997, GENE DEV, V11, P996, DOI 10.1101/gad.11.8.996; Koller M, 1999, ANN RHEUM DIS, V58, P709, DOI 10.1136/ard.58.11.709; Krenz M, 2012, J MOL CELL CARDIOL, V52, P93, DOI 10.1016/j.yjmcc.2011.10.011; Lee S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2060; Li HG, 2012, CIRC RES, V111, P959, DOI 10.1161/CIRCRESAHA.112.278705; Liebetrau C, 2015, CIRC RES, V116, P867, DOI 10.1161/CIRCRESAHA.116.304653; Markoski MM, 2016, NUTR METAB INSIGHTS, V9, P51, DOI 10.4137/NMI.S32909; McDonald B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00068; Milat AM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8315803; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Opie LH, 2007, EUR HEART J, V28, P1683, DOI 10.1093/eurheartj/ehm149; PEAKMAN M, 1993, J IMMUNOL METHODS, V158, P87, DOI 10.1016/0022-1759(93)90261-5; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Quinones M, 2013, PHARMACOL RES, V68, P125, DOI 10.1016/j.phrs.2012.10.018; Rodriguez-Morato J, 2016, DRUG METAB REV, V48, P218, DOI 10.1080/03602532.2016.1179754; Sacanella E, 2007, AM J CLIN NUTR, V86, P1463, DOI 10.1093/ajcn/86.5.1463; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; Svee K, 1996, J CLIN INVEST, V98, P1713, DOI 10.1172/JCI118970; Thirunavukkarasu M, 2008, J AGR FOOD CHEM, V56, P6733, DOI 10.1021/jf801473v; WALDENSTROM A, 1991, J CLIN INVEST, V88, P1622, DOI 10.1172/JCI115475; Wibulswas A, 2000, AM J PATHOL, V157, P2037, DOI 10.1016/S0002-9440(10)64842-0; Yue TL, 2001, CIRCULATION, V104, P2588, DOI 10.1161/hc4601.099403	40	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196842	10.1371/journal.pone.0196842	http://dx.doi.org/10.1371/journal.pone.0196842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746525	Green Submitted, Green Published, gold			2022-12-26	WOS:000431851700042
J	Silva, SJ; Barbieri, LK; Thomer, AK				Silva, Sam J.; Barbieri, Lindsay K.; Thomer, Andrea K.			Observing vegetation phenology through social media	PLOS ONE			English	Article							MODIS	The widespread use of social media has created a valuable but underused source of data for the environmental sciences. We demonstrate the potential for images posted to the website Twitter to capture variability in vegetation phenology across United States National Parks. We process a subset of images posted to Twitter within eight U.S. National Parks, with the aim of understanding the amount of green vegetation in each image. Analysis of the relative greenness of the images show statistically significant seasonal cycles across most National Parks at the 95% confidence level, consistent with springtime green-up and fall senescence. Additionally, these social media-derived greenness indices correlate with monthly mean satellite NDVI (r = 0.62), reinforcing the potential value these data could provide in constraining models and observing regions with limited high quality scientific monitoring.	[Silva, Sam J.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Barbieri, Lindsay K.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT USA; [Barbieri, Lindsay K.] Univ Vermont, Gund Inst Environm, Burlington, VT USA; [Thomer, Andrea K.] Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA	Massachusetts Institute of Technology (MIT); University of Vermont; University of Vermont; University of Michigan System; University of Michigan	Silva, SJ (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	samsilva@mit.edu	Silva, Sam/GQB-1345-2022	Thomer, Andrea/0000-0001-6238-3498; /0000-0001-6343-8382	Earth Science Information Partners	Earth Science Information Partners	This work was supported by the Earth Science Information Partners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157734; [Anonymous], 2015, SOCIAL MEDIA USAGE 2; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Blumenfeld Josh, 2017, GETTING PETABYTES PE; Boyd D, 2012, INFORM COMMUN SOC, V15, P662, DOI 10.1080/1369118X.2012.678878; Carrie Sessions, 2016, J ENVIRON MANAGE, V183, P703, DOI [10.1016/j.jenvman.2016.09.018, DOI 10.1016/J.JENVMAN.2016.09.018]; Case NA, 2015, GEOPHYS RES LETT, V42, P3668, DOI 10.1002/2015GL063709; Cheng T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097807; Earle P, 2010, NAT GEOSCI, V3, P221, DOI 10.1038/ngeo832; Edwards Jim, 2016, LEAKED TWITTER API D; Ford B, 2017, ATMOS CHEM PHYS, V17, P7541, DOI 10.5194/acp-17-7541-2017; Hollstein A, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8080666; Keenan TF, 2014, ECOL APPL, V24, P1478, DOI 10.1890/13-0652.1; Littman Justin, 2017, IMPLICATIONS CHANGES; Liu Y, 2017, AGR FOREST METEOROL, V237, P311, DOI 10.1016/j.agrformet.2017.02.026; Lunetta RS, 2006, REMOTE SENS ENVIRON, V105, P142, DOI 10.1016/j.rse.2006.06.018; Morstatter F, 2013, P 7 INT C WEBL SOC M; Pearse WD, 2017, NAT ECOL EVOL, V1, P1876, DOI 10.1038/s41559-017-0350-0; Pickering C, 2018, J OUTDOOR REC TOUR, V21, P10, DOI 10.1016/j.jort.2017.11.002; Piper Andy, 2017, TWITTER DEV FOR 0522; Richardson A. D., 2017, PHENO CAM DATASET V1; Richardson AD, 2007, OECOLOGIA, V152, P323, DOI 10.1007/s00442-006-0657-z; Richardson Andrew D., 2013, AGR FOREST METEOROL, V169, P156, DOI [10.1016/j.agrformet.2012.09.012, DOI 10.1016/J.AGRFORMET.2012.09.012]; Sonter LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162372; Toomey M, 2015, ECOL APPL, V25, P99, DOI 10.1890/14-0005.1; Vagata P., 2014, SCALING FACEBOOK DAT; van Zanten BT, 2016, P NATL ACAD SCI USA, V113, P12974, DOI 10.1073/pnas.1614158113; Weil Kevin, 2010, MEASURING TWEE 0222; Westergaard-Nielsen A, 2013, ISPRS J PHOTOGRAMM, V86, P89, DOI 10.1016/j.isprsjprs.2013.09.006; Wood SA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02976; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9	31	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197325	10.1371/journal.pone.0197325	http://dx.doi.org/10.1371/journal.pone.0197325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746592	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700102
J	Kirkpatrick, NJ; Ravichandran, VJ; Perreault, EJ; Schaefer, SY; Honeycutt, CF				Kirkpatrick, Nathan J.; Ravichandran, Vengateswaran J.; Perreault, Eric J.; Schaefer, Sydney Y.; Honeycutt, Claire F.			Evidence for startle as a measurable behavioral indicator of motor learning	PLOS ONE			English	Article							REACTION-TIME; RETICULOSPINAL CONTRIBUTIONS; ACOUSTIC STIMULATION; PARKINSONS-DISEASE; HAND FUNCTION; LOBE LESIONS; FRONTAL-LOBE; MOVEMENTS; HEALTHY; REFLEX	The ability of the classic startle reflex to evoke voluntarily prepared movement involuntarily has captured the attention of neuroscientists for its wide-ranging functional utility and potential uses in patient populations. To date, there is only one documented task resistant to the startReact phenomenon-index finger abduction. Previous reports have suggested the lack of startReact is due to different neural mechanisms driving individuated finger movement and more proximal joint control (e.g. elbow, wrist movement). However, an alternative hypothesis exists. Though not particularly difficult to execute, isolated index finger abduction is rarely performed during activities of daily living and is not a natural correlate to common individuated finger tasks. We propose that startReact can be evoked during individuated finger movements but only during tasks that are highly trained or familiar. The objective of this study was to determine the impact of a 2-week training regimen on the ability to elicit startReact. We found evidence in support of our hypothesis that following training, individuated movements of the hands (specifically index finger abduction) become susceptible to startReact. This is significant not only because it indicates that individuated finger movements are in fact amenable to startReact, but also that startle has differential response characteristics in novel tasks compared to highly trained tasks suggesting that startle is a measurable behavioral indicator of motor learning.	[Kirkpatrick, Nathan J.; Ravichandran, Vengateswaran J.; Schaefer, Sydney Y.; Honeycutt, Claire F.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA; [Perreault, Eric J.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Perreault, Eric J.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Perreault, Eric J.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA	Arizona State University; Arizona State University-Tempe; Shirley Ryan AbilityLab; Northwestern University; Northwestern University	Honeycutt, CF (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA.	claire.honeycutt@asu.edu	Perreault, Eric/B-7632-2009	Perreault, Eric/0000-0002-9860-6427	National Institutes of Child Health and Human Development [K99/R00 HD073240]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD073240] Funding Source: NIH RePORTER	National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The following study was supported by National Institutes of Child Health and Human Development grant K99/R00 HD073240. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Xi Zong for his technical and scientific expertise. The following study was supported by National Institutes of Child Health and Human Development grant K99/R00 HD073240.	Alibiglou L, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2011.219592; Baker SN, 2017, J NEUROSCI, V37, P9778, DOI 10.1523/JNEUROSCI.3368-16.2017; Baker SN, 2011, J PHYSIOL-LONDON, V589, P5603, DOI 10.1113/jphysiol.2011.215160; Bretzner F, 2013, J NEUROSCI, V33, P14681, DOI 10.1523/JNEUROSCI.5231-12.2013; BROWN P, 1991, BRAIN, V114, P1891, DOI 10.1093/brain/114.4.1891; Brownstone RM, 2015, CURR OPIN NEUROBIOL, V33, P166, DOI 10.1016/j.conb.2015.04.007; Campbell AD, 2012, J NEUROPHYSIOL, V108, P2946, DOI 10.1152/jn.01157.2011; CANAVAN AGM, 1990, NEUROPSYCHOLOGIA, V28, P969, DOI 10.1016/0028-3932(90)90112-2; Carlsen AN, 2004, EXP BRAIN RES, V159, P301, DOI 10.1007/s00221-004-1924-z; Carlsen AN, 2004, J MOTOR BEHAV, V36, P253, DOI 10.3200/JMBR.36.3.253-264; Carlsen AN, 2012, CLIN NEUROPHYSIOL, V123, P21, DOI 10.1016/j.clinph.2011.04.028; Carlsen AN, 2011, NEUROSCI BIOBEHAV R, V35, P366, DOI 10.1016/j.neubiorev.2010.04.009; Carlsen AN, 2009, J NEUROPHYSIOL, V101, P306, DOI 10.1152/jn.00878.2007; Chen YT, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00396; Cressman EK, 2006, EXP BRAIN RES, V171, P278, DOI 10.1007/s00221-006-0459-x; DAVIS M, 1977, J COMP PHYSIOL PSYCH, V91, P549, DOI 10.1037/h0077345; DAVIS M, 1982, J NEUROSCI, V2, P791; Dean LR, 2017, J NEUROPHYSIOL, V117, P1713, DOI 10.1152/jn.01009.2015; Forgaard CJ, 2016, NEUROSCIENCE, V337, P163, DOI 10.1016/j.neuroscience.2016.09.010; GRAFTON ST, 1992, J NEUROSCI, V12, P2542; GROVES PM, 1974, BEHAV BIOL, V10, P391, DOI 10.1016/S0091-6773(74)91975-0; HAMMOND GR, 1973, PHYSIOL BEHAV, V10, P239, DOI 10.1016/0031-9384(73)90304-1; HEINDEL WC, 1989, J NEUROSCI, V9, P582; Honeycutt CF, 2015, CLIN NEUROPHYSIOL, V126, P160, DOI 10.1016/j.clinph.2014.05.025; Honeycutt CF, 2014, CLIN NEUROPHYSIOL, V125, P1682, DOI 10.1016/j.clinph.2013.12.102; Honeycutt CF, 2013, J NEUROPHYSIOL, V110, P1476, DOI 10.1152/jn.00866.2012; Honeycutt CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043097; Jankelowitz SK, 2004, NEUROLOGY, V62, P114, DOI 10.1212/01.WNL.0000101711.48946.35; Kawai R, 2015, NEURON, V86, P800, DOI 10.1016/j.neuron.2015.03.024; KOHFELD DL, 1969, J EXP PSYCHOL, V82, P88, DOI 10.1037/h0028033; KOHFELD DL, 1971, J EXP PSYCHOL, V88, P251, DOI 10.1037/h0030891; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Marinovic W, 2016, NEUROSCI LETT, V618, P134, DOI 10.1016/j.neulet.2016.03.009; Marinovic W, 2015, HUM MOVEMENT SCI, V42, P81, DOI 10.1016/j.humov.2015.05.003; Marinovic W, 2014, BEHAV NEUROSCI, V128, P548, DOI 10.1037/bne0000007; Marinovic W, 2014, J PHYSIOL-LONDON, V592, P153, DOI 10.1113/jphysiol.2013.254581; Maslovat D, 2011, BEHAV NEUROSCI, V125, P226, DOI 10.1037/a0022567; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Nonnekes J, 2014, J NEUROL, V261, P943, DOI 10.1007/s00415-014-7304-0; Nonnekes J, 2014, J NEUROSCI, V34, P275, DOI 10.1523/JNEUROSCI.2948-13.2014; Nonnekes J, 2013, J NEUROL, V260, P2387, DOI 10.1007/s00415-013-7002-3; Norton DW, 1952, EMPIRICAL INVESTIGAT; PETRIDES M, 1985, NEUROPSYCHOLOGIA, V23, P601, DOI 10.1016/0028-3932(85)90062-4; Ravichandran VJ, 2013, EXP BRAIN RES, V230, P59, DOI 10.1007/s00221-013-3630-1; Rothwell J C, 2006, Suppl Clin Neurophysiol, V58, P223; Rothwell JC, 2002, MOVEMENT DISORD, V17, pS27, DOI 10.1002/mds.10054; Seitz R J, 1990, Neuroreport, V1, P57, DOI 10.1097/00001756-199009000-00016; Siegmund GP, 2001, J PHYSIOL-LONDON, V535, P289, DOI 10.1111/j.1469-7793.2001.00289.x; Tazoe T, 2017, J PHYSIOL-LONDON, V595, P2715, DOI 10.1113/JP273679; Valls-Sole A J, 2004, ADV CLIN NEUROPHYSIO, P554, DOI [10.1016/s1567-424x(09), DOI 10.1016/S1567-424X(09)]; Valls-Sole J, 1999, J PHYSIOL-LONDON, V516, P931, DOI 10.1111/j.1469-7793.1999.0931u.x; WEINER MJ, 1983, NEUROLOGY, V33, P766, DOI 10.1212/WNL.33.6.766; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Zheng JZ, 2011, IEEE INT CONF ROBOT	54	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0195689	10.1371/journal.pone.0195689	http://dx.doi.org/10.1371/journal.pone.0195689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF2GV	29742130	Green Published, gold, Green Submitted			2022-12-26	WOS:000431757400011
J	Crawford, J; Milenkovic, T				Crawford, Joseph; Milenkovic, Tijana			ClueNet: Clustering a temporal network based on topological similarity rather than denseness	PLOS ONE			English	Article							NODE	Network clustering is a very popular topic in the network science field. Its goal is to divide (partition) the network into groups (clusters or communities) of "topologically related" nodes, where the resulting topology-based clusters are expected to "correlate" well with node label information, i.e., metadata, such as cellular functions of genes/proteins in biological networks, or age or gender of people in social networks. Even for static data, the problem of network clustering is complex. For dynamic data, the problem is even more complex, due to an additional dimension of the data-their temporal (evolving) nature. Since the problem is computationally intractable, heuristic approaches need to be sought. Existing approaches for dynamic network clustering (DNC) have drawbacks. First, they assume that nodes should be in the same cluster if they are densely interconnected within the network. We hypothesize that in some applications, it might be of interest to cluster nodes that are topologically similar to each other instead of or in addition to requiring the nodes to be densely interconnected. Second, they ignore temporal information in their early steps, and when they do consider this information later on, they do so implicitly. We hypothesize that capturing temporal information earlier in the clustering process and doing so explicitly will improve results. We test these two hypotheses via our new approach called ClueNet. We evaluate ClueNet against six existing DNC methods on both social networks capturing evolving interactions between individuals (such as interactions between students in a high school) and biological networks capturing interactions between biomolecules in the cell at different ages. We find that ClueNet is superior in over 83% of all evaluation tests. As more real-world dynamic data are becoming available, DNC and thus ClueNet will only continue to gain importance.	[Crawford, Joseph; Milenkovic, Tijana] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Crawford, Joseph; Milenkovic, Tijana] Univ Notre Dame, ECK Inst Global Hlth, Notre Dame, IN 46556 USA; [Crawford, Joseph; Milenkovic, Tijana] Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat iCeN, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Milenkovic, T (corresponding author), Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA.; Milenkovic, T (corresponding author), Univ Notre Dame, ECK Inst Global Hlth, Notre Dame, IN 46556 USA.; Milenkovic, T (corresponding author), Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat iCeN, Notre Dame, IN 46556 USA.	tmilenko@nd.edu			National Science Foundation CAREER [CCF-1452795]; Division of Computing and Communication Foundations [1452795] Funding Source: National Science Foundation	National Science Foundation CAREER(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work is supported by the National Science Foundation CAREER CCF-1452795 grant awarded to TM.	Ahmed NK, 2015, IEEE DATA MINING, P1, DOI 10.1109/ICDM.2015.141; Aynaud T, 2011, P 5 SOC NETW MIN WOR, P69; Barabasi AL, 2016, NETWORK SCIENCE, P1; Bayati M, 2009, IEEE DATA MINING, P705, DOI 10.1109/ICDM.2009.135; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Berger-Wolf TY, 2006, P 12 ACM SIGKDD INT, P523, DOI [10.1145/1150402.1150462, DOI 10.1145/1150402.1150462]; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Cantini L, 2015, SCI REP-UK, V5, DOI 10.1038/srep17386; Chi Y, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P153; Conte D, 2004, INT J PATTERN RECOGN, V18, P265, DOI 10.1142/S0218001404003228; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; Faisal Fazle E, 2015, EURASIP J Bioinform Syst Biol, V2015, P3, DOI 10.1186/s13637-015-0022-9; Faisal FE, 2014, BIOINFORMATICS, V30, P1721, DOI 10.1093/bioinformatics/btu089; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Greene D, 2010, 2010 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2010), P176, DOI 10.1109/ASONAM.2010.17; Hocevar T, 2014, BIOINFORMATICS, V30, P559, DOI 10.1093/bioinformatics/btt717; Hulovatyy Y, 2015, BIOINFORMATICS, V31, P171, DOI 10.1093/bioinformatics/btv227; Lancichinetti A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00336; Marcus D, 2012, COMPUT NETW, V56, P810, DOI 10.1016/j.comnet.2011.08.019; Mastrandrea R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136497; Milenkovic T, 2008, CANCER INFORM, V6, P257; Narayanan A, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P1825, DOI 10.1109/IJCNN.2011.6033446; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11863; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Peel L, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602548; Priebe C. Y., 2005, Computational & Mathematical Organization Theory, V11, P229, DOI 10.1007/s10588-005-5378-z; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018209; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Simpson JE, 2011, NEUROBIOL AGING, V32, P1795, DOI 10.1016/j.neurobiolaging.2011.04.013; Solava RW, 2012, BIOINFORMATICS, V28, pI480, DOI 10.1093/bioinformatics/bts376; Vanhems P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073970; Vijayan V, 2015, BIOINFORMATICS, V31, P2409, DOI 10.1093/bioinformatics/btv161; Vinh NX, 2010, J MACH LEARN RES, V11, P2837; Wiwie C, 2015, NAT METHODS, V12, P1033, DOI [10.1038/NMETH.3583, 10.1038/nmeth.3583]; Yang J, 2015, KNOWL INF SYST, V42, P181, DOI 10.1007/s10115-013-0693-z; Yang J, 2013, IEEE DATA MINING, P1151, DOI 10.1109/ICDM.2013.167; ZASLAVSKIY M, 2009, SYSTEMS MAN CYBERN A, V31, P2227, DOI DOI 10.1109/TPAMI.2008.245	41	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0195993	10.1371/journal.pone.0195993	http://dx.doi.org/10.1371/journal.pone.0195993			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738568	Green Submitted, gold, Green Published			2022-12-26	WOS:000431724900004
J	Zhao, RL; Zhao, R; Tu, YS; Zhang, XM; Deng, LP; Chen, XD				Zhao, Ruili; Zhao, Rui; Tu, Yishuai; Zhang, Xiaoming; Deng, Liping; Chen, Xiangdong			A novel alpha-galactosidase from the thermophilic probiotic Bacillus coagulans with remarkable protease-resistance and high hydrolytic activity	PLOS ONE			English	Article							RAFFINOSE FAMILY OLIGOSACCHARIDES; FLATULENCE-CAUSING FACTORS; STEAROTHERMOPHILUS NCIM-5146; TRANSGLYCOSYLATION ACTIVITY; HETEROLOGOUS EXPRESSION; SUBSTRATE-SPECIFICITY; PICHIA-PASTORIS; PURIFICATION; CLONING; REMOVAL	A novel alpha-galactosidase of glycoside hydrolase family 36 was cloned from Bacillus coagulans, overexpressed in Escherichia coli, and characterized. The purified enzyme Aga-BC7050 was 85 kDa according to SDS-PAGE and 168 kDa according to gel filtration, indicating that its native structure is a dimer. With p-nitrophenyl-alpha-D- galactopyranoside (pNPGal) as the substrate, optimal temperature and pH were 55 degrees C and 6.0, respectively. At 60 degrees C for 30 min, it retained > 50% of its activity. It was stable at pH 5.0-10.0, and showed remarkable resistance to proteinase K, subtilisin A, alpha-chymotrypsin, and trypsin. Its activity was not inhibited by glucose, sucrose, xylose, or fructose, but was slightly inhibited at galactose concentrations up to 100 mM. Aga-BC7050 was highly active toward pNPGal, melibiose, raffinose, and stachyose. It completely hydrolyzed melibiose, raffinose, and stachyose in < 30 min. These characteristics suggest that Aga-BC7050 could be used in feed and food industries and sugar processing.	[Zhao, Ruili; Zhao, Rui; Tu, Yishuai; Zhang, Xiaoming; Deng, Liping; Chen, Xiangdong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China; [Chen, Xiangdong] China Ctr Type Culture Collect, Wuhan, Hubei, Peoples R China	Wuhan University	Chen, XD (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hubei, Peoples R China.; Chen, XD (corresponding author), China Ctr Type Culture Collect, Wuhan, Hubei, Peoples R China.	xdchen@whu.edu.cn			National Natural Science Foundation of China [31270145]; National Fund for Fostering Talents of Basic Sciences [J1103513]; Research (Innovative) Fund of Laboratory of Wuhan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Fund for Fostering Talents of Basic Sciences; Research (Innovative) Fund of Laboratory of Wuhan University	This research was financially supported by grants from the National Natural Science Foundation of China (No. 31270145), the National Fund for Fostering Talents of Basic Sciences (J1103513), and Research (Innovative) Fund of Laboratory of Wuhan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademark P, 2001, EUR J BIOCHEM, V268, P2982, DOI 10.1046/j.1432-1327.2001.02188.x; Anisha GS, 2009, PROCESS BIOCHEM, V44, P327, DOI 10.1016/j.procbio.2008.11.009; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Cao YN, 2007, ENZYME MICROB TECH, V41, P835, DOI 10.1016/j.enzmictec.2007.07.005; Cao YN, 2010, ENZYME MICROB TECH, V47, P305, DOI 10.1016/j.enzmictec.2010.09.007; Cao YN, 2009, APPL MICROBIOL BIOT, V83, P875, DOI 10.1007/s00253-009-1939-2; Chen YS, 2000, PROTEIN EXPRES PURIF, V20, P472, DOI 10.1006/prep.2000.1325; Comfort DA, 2007, BIOCHEMISTRY-US, V46, P3319, DOI 10.1021/bi061521n; Cox T. M., 1996, TRENDS GENET, V12, P78; Du F, 2014, WORLD J MICROB BIOT, V30, P1261, DOI 10.1007/s11274-013-1549-0; Du F, 2013, PLANT PHYSIOL BIOCH, V69, P49, DOI 10.1016/j.plaphy.2013.04.017; Eneyskaya EV, 1999, APPL MICROBIOL BIOT, V52, P226, DOI 10.1007/s002530051513; Ferreira JG, 2011, APPL BIOCHEM BIOTECH, V164, P1111, DOI 10.1007/s12010-011-9198-y; Gao ZF, 1999, PLANT PHYSIOL, V119, P979, DOI 10.1104/pp.119.3.979; Ghazi S, 2003, BRIT POULTRY SCI, V44, P410, DOI 10.1080/00071660310001598283; Gote M, 2004, PROCESS BIOCHEM, V39, P1723, DOI 10.1016/j.procbio.2003.07.008; Gote MM, 2007, ENZYME MICROB TECH, V40, P1312, DOI 10.1016/j.enzmictec.2006.10.004; Gote MM, 2006, PROCESS BIOCHEM, V41, P1311, DOI 10.1016/j.procbio.2006.01.003; Goulas T, 2009, APPL MICROBIOL BIOT, V82, P471, DOI 10.1007/s00253-008-1750-5; Guerrero-Olazaran M, 2010, APPL ENVIRON MICROB, V76, P5601, DOI 10.1128/AEM.00762-10; Guo SY, 2009, BIOTECHNOL LETT, V31, P1769, DOI 10.1007/s10529-009-0078-2; Hu YZ, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/8972764; Hu YJ, 2017, INT J BIOL MACROMOL, V104, P576, DOI 10.1016/j.ijbiomac.2017.06.077; Hu YJ, 2017, INT J BIOL MACROMOL, V94, P122, DOI 10.1016/j.ijbiomac.2016.10.005; Huang Y, 2018, INT J BIOL MACROMOL, V108, P98, DOI 10.1016/j.ijbiomac.2017.11.154; Ishiguro M, 2001, APPL ENVIRON MICROB, V67, P1601, DOI 10.1128/AEM.67.4.1601-1616.2001; Jurenka JS, 2012, ALTERN MED REV, V17, P76; Katrolia P, 2012, BIORESOURCE TECHNOL, V110, P578, DOI 10.1016/j.biortech.2012.01.144; Kurakake M, 2015, FOOD CHEM, V172, P150, DOI 10.1016/j.foodchem.2014.09.038; Kurakake M, 2011, FOOD CHEM, V126, P177, DOI 10.1016/j.foodchem.2010.10.095; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Liu XD, 2009, WORLD J MICROB BIOT, V25, P1633, DOI 10.1007/s11274-009-0057-8; Merceron R, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394114; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nakai H, 2010, FEBS J, V277, P3538, DOI 10.1111/j.1742-4658.2010.07763.x; Patil AGG, 2010, J MICROBIOL BIOTECHN, V20, P1546, DOI 10.4014/jmb.0912.12012; Sampietro D, 2012, ANTON LEEUW INT J G, V102, P257, DOI 10.1007/s10482-012-9734-y; Sangeetha R, 2014, BRAZ J MICROBIOL, V45, P389, DOI 10.1590/S1517-83822014000200004; Shivam K, 2010, PROCESS BIOCHEM, V45, P1088, DOI 10.1016/j.procbio.2010.03.027; Singh N, 2012, J AGR FOOD CHEM, V60, P3253, DOI 10.1021/jf204538m; SUZUKI H, 1969, AGR BIOL CHEM TOKYO, V33, P506, DOI 10.1080/00021369.1969.10859355; Wang HM, 2014, BIORESOURCE TECHNOL, V153, P361, DOI 10.1016/j.biortech.2013.11.078; Weignerova L, 2009, BIOCATAL BIOTRANSFOR, V27, P79, DOI 10.1080/10242420802583416; Yanan C, 2009, J MICROBIOL BIOTECHN, V19, P1295, DOI 10.4014/jmb.0904.04003; Yang DX, 2015, APPL BIOCHEM BIOTECH, V176, P2157, DOI 10.1007/s12010-015-1705-0; Yang WX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129294; Zhao H, 2008, FEMS MICROBIOL LETT, V285, P278, DOI 10.1111/j.1574-6968.2008.01246.x; Zhou JP, 2016, FOOD CHEM, V194, P156, DOI 10.1016/j.foodchem.2015.08.015; Zhou JP, 2012, J MICROBIOL BIOTECHN, V22, P1532, DOI 10.4014/jmb.1112.12036; Zininga J, 2015, ANN INT C ADV BIOT, DOI [10.5176/2251-2489_BioTech15.68, DOI 10.5176/2251-2489_BIOTECH15.68]	50	20	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0197067	10.1371/journal.pone.0197067	http://dx.doi.org/10.1371/journal.pone.0197067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738566	Green Submitted, Green Published, gold			2022-12-26	WOS:000431724900047
J	Han, KJ; Lee, YH				Han, Kyu Jin; Lee, Young Hoon			Optical coherence tomography automated layer segmentation of macula after retinal detachment repair	PLOS ONE			English	Article							VISUAL RECOVERY; BUCKLE SURGERY; REATTACHMENT; VITRECTOMY; RESOLUTION; THICKNESS; MODEL	Purpose To investigate the thickness of retinal layers and association with final visual acuity using spectral-domain optical coherence tomography (SD-OCT) in macular area of macula-off rhegmatogenous retinal detachment (RRD) patients after a successful macular reattachment. Methods In retrospective study, a total 24 eyes with macula-off RRD were enrolled. All patients underwent vitrectomy to repair RRD. Outer plexiform layer (OPL), outer nuclear layer (ONL), photoreceptor layer (PR), retinal pigment epithelium (RPE) thicknesses were measured by the Spectralis (Heidelberg Engineering, Heidelberg, Germany) SD-OCT with automated segmentation software. The relationship between the thicknesses of each retinal layer and postoperative logarithm of the minimum angle of resolution scale (LogMAR) visual acuity was analyzed. Results OPL and RPE thicknesses were not significantly different between the retinal detachment eyes and fellow eyes (P = 0.839, 0.999, respectively). The ONL and photoreceptor thickness were significantly thinner in the retinal detachment eyes (P < 0.001 and 0.001, respectively). In the univariate regression analysis, preoperative best corrected visual acuity (BCVA), ONL thickness and photoreceptor thickness showed association with the postoperative BCVA (P = 0.003, <0.001 and 0.024, respectively). In final multiple linear regression model, ONL thickness was the only variable significantly associated with postoperative BCVA (P = 0.044). Conclusions Segmented ONL and photoreceptor thickness of retinal detachment eyes were significantly thinner than fellow eyes. Segmental analysis of the retinal layer in macular region may provide valuable information for evaluation RRD. And ONL thickness can be used as a potential biomarker to predict visual outcome after RRD repair.	[Han, Kyu Jin; Lee, Young Hoon] Konyang Univ, Dept Ophthalmol, Coll Med, 685 Gasuwondong, Daejeon, South Korea	Konyang University; Konyang University Hospital	Lee, YH (corresponding author), Konyang Univ, Dept Ophthalmol, Coll Med, 685 Gasuwondong, Daejeon, South Korea.	astrix001@gmail.com						Benson SE, 2007, OPHTHALMOLOGY, V114, P108, DOI 10.1016/j.ophtha.2006.07.022; Cunha-Vaz J G, 1979, Mod Probl Ophthalmol, V20, P89; Dooley I, 2015, CURR EYE RES, V40, P1073, DOI 10.3109/02713683.2014.971936; Frings A, 2016, BRIT J OPHTHALMOL, V100, P1466, DOI 10.1136/bjophthalmol-2015-308153; GUERIN CJ, 1993, INVEST OPHTH VIS SCI, V34, P175; Hagimura N, 2002, AM J OPHTHALMOL, V133, P516, DOI 10.1016/S0002-9394(01)01427-1; Han DP, 1998, AM J OPHTHALMOL, V126, P658, DOI 10.1016/S0002-9394(98)00181-0; Heussen N, 2011, GRAEF ARCH CLIN EXP, V249, P1129, DOI 10.1007/s00417-011-1619-7; Kajic V, 2010, OPT EXPRESS, V18, P14730, DOI 10.1364/OE.18.014730; Kim JH, 2012, INVEST OPHTH VIS SCI, V53, P7316, DOI 10.1167/iovs.12-10155; Kwak YK, 1996, J KOREAN OPHTHALMOL, V37, P1688; 박현준, 2010, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V51, P552; LIEM ATA, 1994, OPHTHALMOLOGY, V101, P1945; MACHEMER R, 1984, AM J OPHTHALMOL, V98, P681, DOI 10.1016/0002-9394(84)90682-2; MACHEMER R, 1968, AM J OPHTHALMOL, V66, P1075, DOI 10.1016/0002-9394(68)90816-7; Menke MN, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14412; Michels R, RETINAL DETACHMENT, P917; Mitry D, 2010, BRIT J OPHTHALMOL, V94, P678, DOI 10.1136/bjo.2009.157727; NORK TM, 1995, ARCH OPHTHALMOL-CHIC, V113, P1066, DOI 10.1001/archopht.1995.01100080118039; Park JL, 2002, J KOREAN OPHTHALMOL, V43, P1015; PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217; Salicone A, 2006, OPHTHALMOLOGY, V113, P1734, DOI 10.1016/j.ophtha.2006.03.064; TANI P, 1981, AM J OPHTHALMOL, V92, P611, DOI 10.1016/S0002-9394(14)74651-3; Terauchi G, 2015, BRIT J OPHTHALMOL, V99, P1323, DOI 10.1136/bjophthalmol-2014-306252; Wojtkowski M, 2005, OPHTHALMOLOGY, V112, P1734, DOI 10.1016/j.ophtha.2005.05.023; Wolfensberger TJ, 2004, OPHTHALMOLOGY, V111, P1340, DOI 10.1016/j.ophtha.2003.12.049; Wolfensberger TJ, 2002, GRAEF ARCH CLIN EXP, V240, P85, DOI 10.1007/s00417-001-0410-6; Xie Z, 2012, EYE, V26, P144, DOI 10.1038/eye.2011.254	28	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0197058	10.1371/journal.pone.0197058	http://dx.doi.org/10.1371/journal.pone.0197058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734400	Green Published, Green Submitted, gold			2022-12-26	WOS:000431481700043
J	Miao, YT; Deng, Y; Jia, HK; Liu, YD; Hou, ML				Miao, Yu-Tong; Deng, Yao; Jia, Hao-Kang; Liu, Yu-Di; Hou, Mao-Lin			Proteomic analysis of watery saliva secreted by white-backed planthopper, Sogatella furcifera	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; BROWN PLANTHOPPER; GENE-EXPRESSION; V-ATPASE; PROTEINS; CLONING; IDENTIFICATION; TRANSCRIPTOME; VIRULENCE; CALCIUM	The white-backed planthopper, Sogatella furcifera, is a phloem sap feeder that secretes watery and gelling saliva during feeding. In this study, we identified the major proteins in watery saliva of S. furcifera by shotgun LC-MS/MS analysis combined with transcriptomic analysis. A total of 161 proteins were identified, which were divided into 8 function categories, including enzymes, transporter, calcium ion binding protein, salivary sheath protein, cytoskeleton protein, DNA-, RNA-, and protein-binding or regulating proteins, other non-enzyme proteins and unknown proteins. Gene expression pattern of 11 secretory proteins were analyzed by real time quantitative-PCR. We detected the mucin-like protein, which had a unique expression level in salivary gland, most likely to be a candidate effector involved in regulation of plant defense. This study identified the watery saliva component of S. furcifera and it provided a list of proteins which may play a role in interaction between S. furcifera and rice.	[Miao, Yu-Tong; Deng, Yao; Jia, Hao-Kang; Liu, Yu-Di; Hou, Mao-Lin] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Miao, Yu-Tong; Deng, Yao; Jia, Hao-Kang; Liu, Yu-Di; Hou, Mao-Lin] Minist Agr, Sci Observing & Expt Stn Crop Pests Guilin, Guilin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Liu, YD (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.; Liu, YD (corresponding author), Minist Agr, Sci Observing & Expt Stn Crop Pests Guilin, Guilin, Peoples R China.	ydliu@ippcaas.cn			National Natural Science Foundation of China [31772538, 31370439]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Foundation of China (No. 31772538 and 31370439) to YL, http://www.nsfc.gov.cn/.	Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; An XK, 2016, J ECON ENTOMOL, V109, P879, DOI 10.1093/jee/tov333; Bekendam RH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12579; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Chaudhary R, 2015, J PROTEOME RES, V14, P1762, DOI 10.1021/pr501128k; Cooper WR, 2013, ANN ENTOMOL SOC AM, V106, P86, DOI 10.1603/AN12096; Corena MD, 2002, J EXP BIOL, V205, P591; Gupta L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015410; Hattori M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123671; Hu Li-Ming, 2011, Acta Entomologica Sinica, V54, P1452; Huang HJ, 2018, J PROTEOMICS, V172, P25, DOI 10.1016/j.jprot.2017.11.003; Huang HJ, 2017, J INSECT PHYSIOL, V98, P223, DOI 10.1016/j.jinsphys.2017.01.012; Huang HJ, 2016, J PROTEOME RES, V15, P1883, DOI 10.1021/acs.jproteome.6b00086; Jaouannet M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00663; LI ZW, 2016, PLOS GENET, V12, DOI DOI 10.1371/JOURNAL.PONE.0123671; Liu XQ, 2016, J INSECT PHYSIOL, V89, P60, DOI 10.1016/j.jinsphys.2016.04.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macours N, 2003, INSECT MOL BIOL, V12, P233, DOI 10.1046/j.1365-2583.2003.00406.x; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; Nelson TJ, 1996, P NATL ACAD SCI USA, V93, P13808, DOI 10.1073/pnas.93.24.13808; Nelson TJ, 2003, COMP BIOCHEM PHYS B, V135, P627, DOI 10.1016/S1096-4959(03)00144-1; Nicholson SJ, 2014, J PROTEOMICS, V105, P186, DOI 10.1016/j.jprot.2013.12.005; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Schewe B, 2008, J EXP BIOL, V211, P805, DOI 10.1242/jeb.002667; Shangguan XX, 2018, PLANT PHYSIOL, V176, P552, DOI 10.1104/pp.17.00755; Sharma A, 2014, B ENTOMOL RES, V104, P117, DOI 10.1017/S0007485313000618; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Thomas JE, 2005, BIOCHEM J, V386, P357, DOI 10.1042/BJ20041753; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Vandermoten S, 2014, INSECT MOL BIOL, V23, P67, DOI 10.1111/imb.12061; Villarroel CA, 2016, PLANT J, V86, P119, DOI 10.1111/tpj.13152; Wang L, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/giw004; Wei D, 2015, INSECT MOL BIOL, V24, P41, DOI 10.1111/imb.12134; Wessing A, 1997, J INSECT PHYSIOL, V43, P17, DOI 10.1016/S0022-1910(96)00078-9; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-553; ZABRISKIE TM, 1994, ARCH INSECT BIOCHEM, V26, P27, DOI 10.1002/arch.940260104	40	18	18	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2018	13	5							e0193831	10.1371/journal.pone.0193831	http://dx.doi.org/10.1371/journal.pone.0193831			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE7ZR	29727440	Green Submitted, Green Published, gold			2022-12-26	WOS:000431452100003
J	Ceccarelli, F; Perricone, C; Pirone, C; Massaro, L; Alessandri, C; Mina, C; Marianetti, M; Spinelli, FR; Valesini, G; Conti, F				Ceccarelli, Fulvia; Perricone, Carlo; Pirone, Carmelo; Massaro, Laura; Alessandri, Cristiano; Mina, Concetta; Marianetti, Massimo; Spinelli, Francesca Romana; Valesini, Guido; Conti, Fabrizio			Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study	PLOS ONE			English	Article							NEUROPSYCHIATRIC MANIFESTATIONS; IMPAIRMENT; ANTIBODIES; AUTOANTIBODIES; ASSOCIATION; DISEASE; PREVALENCE; DEPRESSION; DIAGNOSIS; SERUM	Objective Cognitive impairment (CI) has been described in 3-80% of Systemic lupus erythematosus (SLE) patients but only short-term studies evaluated its over-time changes, suggesting that CI is usually a stable finding. We aimed at evaluating the changes of SLE-related CI in a 10-years prospective single center cohort study. Methods We evaluated 43 patients (M/F 5/38; mean age = 45.7 +/- 10.1 years; mean disease duration = 230.8 +/- 74.3 months) at baseline (T0) and after 10 years (T1). A test battery designed to detect fronto-subcortical dysfunction across five domains (memory, attention, abstract reasoning, executive and visuospatial function) was administered. A global cognitive dysfunction score (GCD) was obtained and associated with clinical and laboratory features. Results Prevalence of CI was 20.9% at T0 and 13.9% at T1 (P = NS). This impairment was prevalently mild at T0 (55.5%) and mild or moderate at T1 (36.3% for both degrees). After 10 years, CI improved in 50% of patients, while 10% worsened. Impaired memory (P = 0.02), executive functions (P = 0.02) and abstract reasoning (P = 0.03) were associated with dyslipidemia at T0. Worsening of visuospatial functions was significantly associated with dyslipidemia and Lupus Anticoagulant (P = 0.04 for both parameters). Finally, GCD significantly correlated with chronic damage measured by SLICC/damage index at T0 (r = 0.3; P = 0.04) and T1 (r = 0.3; P = 0.03). Conclusions For the first time, we assessed CI changes over 10-years in SLE. CI improved in the majority of the patients. Furthermore, we observed an improvement of the overall cognitive functions. These results could suggest that an appropriate management of the disease during the follow-up could be able to control SLE-related CI.	[Ceccarelli, Fulvia; Perricone, Carlo; Pirone, Carmelo; Massaro, Laura; Alessandri, Cristiano; Spinelli, Francesca Romana; Valesini, Guido; Conti, Fabrizio] Sapienza Univ Rome, Lupus Clin, Dipartimento Med Interna & Specialita Med, Viale Policlin, Rome, Italy; [Mina, Concetta; Marianetti, Massimo] Sapienza Univ Roma, Dipartimento Neurol & ORL, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Conti, F (corresponding author), Sapienza Univ Rome, Lupus Clin, Dipartimento Med Interna & Specialita Med, Viale Policlin, Rome, Italy.	fabrizio.conti@uniroma1.it	Spinelli, Francesca Romana/AAM-7061-2020	Spinelli, Francesca Romana/0000-0003-1969-2097; Ceccarelli, Fulvia/0000-0001-5026-8783; Marianetti, Massimo/0000-0002-1402-3831; Perricone, Carlo/0000-0003-4771-6981; Pirone, Carmelo/0000-0002-3131-3523; Valesini, Guido/0000-0002-7757-8092				Afeltra A, 2003, NEUROLOGY, V61, P108, DOI 10.1212/01.WNL.0000058904.94330.A7; Appenzeller S, 2012, CURR RHEUMATOL REP, V14, P95, DOI 10.1007/s11926-011-0224-4; BUCHBINDER R, 1988, AUST NZ J MED, V18, P679, DOI 10.1111/j.1445-5994.1988.tb00150.x; CARBOTTE RM, 1986, J NERV MENT DIS, V174, P357, DOI 10.1097/00005053-198606000-00008; Carlomagno S, 2000, J NEUROL, V247, P273, DOI 10.1007/s004150050583; Cimaz R, 2006, LUPUS, V15, P191, DOI 10.1191/0961203306lu2272rr; Conti F, 2014, IMMUNOL RES, V60, P270, DOI 10.1007/s12026-014-8609-x; Conti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045934; Conti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033824; Delunardo F, 2016, ARTHRITIS RHEUMATOL, V68, P2708, DOI 10.1002/art.39750; Fabrizio C, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/328078; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gao Y, 2016, LUPUS, V25, P637, DOI 10.1177/0961203315624022; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2002, J RHEUMATOL, V29, P288; Govoni M, 2016, J AUTOIMMUN, V74, P41, DOI 10.1016/j.jaut.2016.06.013; Govoni M, 2012, RHEUMATOLOGY, V51, P157, DOI 10.1093/rheumatology/ker310; HAHN RC, 1988, CANCER, V61, P845, DOI 10.1002/1097-0142(19880215)61:4<845::AID-CNCR2820610434>3.0.CO;2-Q; Hanly JG, 1997, ARTHRITIS RHEUM, V40, P1542, DOI 10.1002/art.1780400825; HAY EM, 1992, ARTHRITIS RHEUM, V35, P411, DOI 10.1002/art.1780350409; Ho RC, 2016, AUTOIMMUN REV, V15, P124, DOI 10.1016/j.autrev.2015.10.003; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kozora E, 1996, ARTHRITIS RHEUM, V39, P2035, DOI 10.1002/art.1780391213; Lam D.W., 2015, ENDOTEXT; Lapteva L, 2006, ARTHRITIS RHEUM, V54, P2505, DOI 10.1002/art.22031; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Lukhanina EP, 2009, CLIN NEUROPHYSIOL, V120, P1852, DOI 10.1016/j.clinph.2009.07.040; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Mok CC, 2017, EXPERT REV CLIN IMMU; Nikpour M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1152, DOI 10.1002/art.24741; Perricone C, 2015, ISR MED ASSOC J, V17, P171; Sanna G, 2003, J RHEUMATOL, V30, P985; Shi ZR, 2015, LUPUS, V24, P588, DOI 10.1177/0961203314560003; Shimada H, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.05.017; Tay SH, 2017, AUTOIMMUN REV, V16, P114, DOI 10.1016/j.autrev.2016.12.002; Unterman A, 2011, SEMIN ARTHRITIS RHEU, V41, P1, DOI 10.1016/j.semarthrit.2010.08.001; UTSET TO, 1994, J RHEUMATOL, V21, P2039; Valesini G, 2006, ANN NY ACAD SCI, V1069, P118, DOI 10.1196/annals.1351.010; van Vollenhoven RF, 2014, ANN RHEUM DIS, V73, P958, DOI 10.1136/annrheumdis-2013-205139; Waterloo K, 2002, RHEUMATOLOGY, V41, P411, DOI 10.1093/rheumatology/41.4.411; Yaniv G, 2015, AUTOIMMUN REV, V14, P75, DOI 10.1016/j.autrev.2014.10.003; Zhou HQ, 2008, LUPUS, V17, P93, DOI 10.1177/0961203307085671	42	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196103	10.1371/journal.pone.0196103	http://dx.doi.org/10.1371/journal.pone.0196103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723209	gold, Green Published, Green Submitted			2022-12-26	WOS:000431305100013
J	Lukasova, K; Nucci, MP; Neto, RMD; Vieira, G; Sato, JR; Amaro, E				Lukasova, Katerina; Nucci, Mariana P.; de Azevedo Neto, Raymundo Machado; Vieira, Gilson; Sato, Joao R.; Amaro Jr, Edson			Predictive saccades in children and adults: A combined fMRI and eye tracking study	PLOS ONE			English	Article							INHIBITORY CONTROL; NEURAL ACTIVITY; TASK; PERFORMANCE; MOVEMENTS; TIME; NEUROANATOMY; EXPECTATION; ANTISACCADE; ACQUISITION	Saccades were assessed in 21 adults (age 24 years, SD = 4) and 15 children (age 11 years, SD = 1), using combined functional magnetic resonance imaging (fMRI) and eye-tracking. Subjects visually tracked a point on a horizontal line in four conditions: time and position predictable task (PRED), position predictable (pPRED), time predictable (tPRED) and visually guided saccades (SAC). Both groups in the PRED but not in pPRED, tPRED and SAC produced predictive saccades with latency below 80 ms. In task versus group comparisons, children's showed less efficient learning compared to adults for predictive saccades (adults = 48%, children = 34%, p = 0.05). In adults brain activation was found in the frontal and occipital regions in the PRED, in the intraparietal sulcus in pPRED and in the frontal eye field, posterior intraparietal sulcus and medial regions in the tPRED task. Group-task interaction was found in the supplementary eye field and visual cortex in the PRED task, and the frontal cortex including the right frontal eye field and left frontal pole, in the pPRED condition. These results indicate that, the basic visuomotor circuitry is present in both adults and children, but fine-tuning of the activation according to the task temporal and spatial demand mature late in child development.	[Lukasova, Katerina; Nucci, Mariana P.; de Azevedo Neto, Raymundo Machado; Vieira, Gilson; Amaro Jr, Edson] Univ Sao Paulo, Fac Med, NIF Neuroimagem Func, LIM 44, Sao Paulo, Brazil; [Lukasova, Katerina; Sato, Joao R.] Univ Fed ABC, Ctr Math Computat & Cognit, Sao Bernardo Do Campo, SP, Brazil; [Vieira, Gilson] Univ Sao Paulo, Interinst Grad Program Bioinformat, IME USP, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo	Lukasova, K (corresponding author), Univ Sao Paulo, Fac Med, NIF Neuroimagem Func, LIM 44, Sao Paulo, Brazil.; Lukasova, K (corresponding author), Univ Fed ABC, Ctr Math Computat & Cognit, Sao Bernardo Do Campo, SP, Brazil.	katerinaluka@gmail.com	Nucci, Mariana/AAC-4990-2020; Nucci, Mariana/AAM-6841-2021; amaro, edson/GLR-7735-2022; Lukasova, Katerina/ABH-7764-2020; Machado de Azevedo Neto, Raymundo/F-6654-2012	Nucci, Mariana/0000-0002-1502-9215; amaro, edson/0000-0002-5889-1382; Lukasova, Katerina/0000-0002-1137-7298; Machado de Azevedo Neto, Raymundo/0000-0003-2209-9112; Sato, Joao Ricardo/0000-0002-7503-9781	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) [A/11/7209]	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by a scholarship for the first author PhD study, number A/11/7209, from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior).	Bates D, 2015, J STAT SOFTWARE; Biscaldi M, 2000, PERCEPTION, V29, P509, DOI 10.1068/p2666a; Bucci MP, 2012, EXP BRAIN RES, V222, P21, DOI 10.1007/s00221-012-3192-7; Campos M, 2010, J NEUROPHYSIOL, V104, P2831, DOI 10.1152/jn.01124.2009; Campos M, 2009, J NEUROPHYSIOL, V101, P448, DOI 10.1152/jn.90704.2008; Canfield RL, 2001, INFANCY, V2, P197, DOI 10.1207/S15327078IN0202_5; Church JA, 2010, HUM BRAIN MAPP, V31, P852, DOI 10.1002/hbm.21036; Connolly JD, 2002, NAT NEUROSCI, V5, P1345, DOI 10.1038/nn969; Curtis CE, 2008, J NEUROPHYSIOL, V99, P133, DOI 10.1152/jn.00899.2007; Dore-Mazars K, 2011, INVEST OPHTH VIS SCI, V52, P4813, DOI 10.1167/iovs.10-6626; Eckstein MP, 2011, J VISION, V11, DOI 10.1167/11.5.14; Ego C, 2013, J NEUROPHYSIOL, V110, P358, DOI 10.1152/jn.00981.2012; Emerson RW, 2015, DEVELOPMENTAL SCI, V18, P314, DOI 10.1111/desc.12215; Fischer B, 1997, EXP BRAIN RES, V116, P191, DOI 10.1007/PL00005749; Fischer B, 1997, BRAIN RES, V754, P285, DOI 10.1016/S0006-8993(97)00094-2; Gagnon D, 2002, BRAIN, V125, P123, DOI 10.1093/brain/awf005; Goldberg MC, 2002, NEUROPSYCHOLOGIA, V40, P2039, DOI 10.1016/S0028-3932(02)00059-3; Gredeback G, 2006, EXP BRAIN RES, V173, P159, DOI 10.1007/s00221-006-0376-z; Hwang K, 2010, J NEUROSCI, V30, P15535, DOI 10.1523/JNEUROSCI.2825-10.2010; Irving EL, 2006, INVEST OPHTH VIS SCI, V47, P2478, DOI 10.1167/iovs.05-1311; Isotalo E, 2005, EXP BRAIN RES, V165, P461, DOI 10.1007/s00221-005-2317-7; Joiner WM, 2009, J COMPUT NEUROSCI, V26, P119, DOI 10.1007/s10827-008-0102-x; Klein C, 2003, PSYCHOPHYSIOLOGY, V40, P17, DOI 10.1111/1469-8986.00003; Klein C, 2001, PSYCHOPHYSIOLOGY, V38, P179; Kowler E, 2011, VISION RES, V51, P1457, DOI 10.1016/j.visres.2010.12.014; Liddle E, 2009, NEUROPSYCHOLOGIA, V47, P77, DOI 10.1016/j.neuropsychologia.2008.08.013; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; O'Reilly JX, 2008, J NEUROPHYSIOL, V99, P2731, DOI 10.1152/jn.01141.2007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ordaz S, 2010, ACTA PSYCHOL, V134, P253, DOI 10.1016/j.actpsy.2010.02.007; Ordaz SJ, 2013, J NEUROSCI, V33, P18109, DOI 10.1523/JNEUROSCI.1741-13.2013; Oswal A, 2007, J NEUROPHYSIOL, V97, P2722, DOI 10.1152/jn.01238.2006; Rose SA, 2002, CHILD DEV, V73, P47, DOI 10.1111/1467-8624.00391; ROSS SM, 1987, VISION RES, V27, P2177, DOI 10.1016/0042-6989(87)90131-3; Salman MS, 2006, VISION RES, V46, P1432, DOI 10.1016/j.visres.2005.06.011; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Shelhamer M, 2003, J NEUROPHYSIOL, V90, P2763, DOI 10.1152/jn.00478.2003; Simo LS, 2005, CEREB CORTEX, V15, P1982, DOI 10.1093/cercor/bhi073; Tark KJ, 2009, NAT NEUROSCI, V12, P1463, DOI 10.1038/nn.2406; Velanova K, 2008, CEREB CORTEX, V18, P2505, DOI 10.1093/cercor/bhn012; Velanova K, 2009, J NEUROSCI, V29, P12558, DOI 10.1523/JNEUROSCI.1579-09.2009; Wentworth N, 1998, DEV PSYCHOL, V34, P247, DOI 10.1037/0012-1649.34.2.247; Wong AL, 2014, J NEUROPHYSIOL, V111, P2084, DOI 10.1152/jn.00779.2013; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Yuan WH, 2009, HUM BRAIN MAPP, V30, P1481, DOI 10.1002/hbm.20616	47	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196000	10.1371/journal.pone.0196000	http://dx.doi.org/10.1371/journal.pone.0196000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718927	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900041
J	Ramirez-Santana, M; Farias-Gomez, C; Zuniga-Venegas, L; Sandoval, R; Roeleveld, N; van der Velden, K; Scheepers, PTJ; Pancetti, F				Ramirez-Santana, Muriel; Farias-Gomez, Cristian; Zuniga-Venegas, Liliana; Sandoval, Rodrigo; Roeleveld, Nel; van der Velden, Koos; Scheepers, Paul T. J.; Pancetti, Floria			Biomonitoring of blood cholinesterases and acylpeptide hydrolase activities in rural inhabitants exposed to pesticides in the Coquimbo Region of Chile	PLOS ONE			English	Article							OXIDIZED PROTEIN HYDROLASE; ORGANOPHOSPHATE PESTICIDES; AGRICULTURAL-WORKERS; PEPTIDE HYDROLASE; BIOMARKERS; BUTYRYLCHOLINESTERASE; IDENTIFICATION; ACETYLCHOLINESTERASE; EXPOSURES; CHLORPYRIFOS	In Chile, agriculture is a relevant economic activity and is concomitant with the use of pesticides to improve the yields. Acute intoxications of agricultural workers occur with some frequency and they must be reported to the surveillance system of the Ministry of Health. However the impacts of chronic and environmental pesticide exposure have been less studied. Among pesticides frequently used in Chile for insects control are organophosphates (OP) and carbamates (CB). They are inhibitors of acetylcholinesterase (AChE) and butyryl-cholinesterase (BChE). In this study we determined the pattern of both biomarkers activity in three populations with different type of chronic exposure to OP/CB: environmentally exposed (EE), occupationally exposed (OE) and a reference group (RG) without exposure. Besides this, we also measured the activity of acylpeptide hydrolase (APEH), an enzyme involved in relevant functions in the central synapses that is also expressed in erythrocytes and previously reported to be highly inhibited by some OP. A baseline measurement was done in both exposure groups and then a second measurement was done during the spraying season. The RG was measured only once at any time of the year. Our results indicate that people under chronic OP/CB exposure showed an adaptive response through an increase of basal BChE activity. During the spray season only BChE activity was decreased in the EE and OE groups (p<0.05 and p<0.01, respectively) and the higher magnitude of BChE inhibition was observed in the EE group. The analysis of the frequencies of inhibition above 30% (biological tolerance limit declared by Chilean legislation) indicated that BChE was most frequently inhibited in the EE group (53% of the individuals displayed inhibition) and AChE in the OE group (55% of the individuals displayed AChE inhibition). APEH activity showed the highest frequency of inhibition in the EE group independent of its magnitude (64%). Our results demonstrate that the rural population living nearby agricultural settings displays high levels of environmental exposure. APEH activity seems to be a sensitive biomarker for acute low-level exposure and its usefulness as a routine biomarker must to be explored in future studies. Systematic biomonitoring and health outcomes studies are necessary as well as obtaining the baseline for BChE and AChE activity levels with the aim to improve environmental and occupational health policies in Chile.	[Ramirez-Santana, Muriel] Univ Catolica Norte, Fac Med, Dept Publ Hlth, Coquimbo, Chile; [Ramirez-Santana, Muriel; van der Velden, Koos] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands; [Farias-Gomez, Cristian; Sandoval, Rodrigo; Pancetti, Floria] Univ Catolica Norte, Fac Med, Lab Environm Neurotoxicol, Coquimbo, Chile; [Zuniga-Venegas, Liliana] Univ Catolica Maule, Fac Med, Lab Biomed Res, Talca, Chile; [Roeleveld, Nel; Scheepers, Paul T. J.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Nijmegen, Netherlands	Universidad Catolica del Norte; Radboud University Nijmegen; Universidad Catolica del Norte; Universidad Catolica del Maule; Radboud University Nijmegen	Pancetti, F (corresponding author), Univ Catolica Norte, Fac Med, Lab Environm Neurotoxicol, Coquimbo, Chile.	pancetti@ucn.cl	van der Velden, J./H-8101-2014; Scheepers, Paul/L-4628-2015; Roeleveld, Nel/B-4242-2008; Scheepers, Paul/C-4209-2016; ramirez, muriel mrs/L-3644-2013	Scheepers, Paul/0000-0002-8546-2161; Roeleveld, Nel/0000-0002-3390-4466; ramirez, muriel mrs/0000-0002-3642-6965; Pancetti, Floria/0000-0002-6990-9832	Fondo de Fomento al Desarrollo Cientifico y Tecnologico [D09I1057]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [3120231]; FONDEF [D09I1057]; Fondecyt [3120231]; Department of Occupational Health of the Instituto de Salud Publica de Chile (ISP)	Fondo de Fomento al Desarrollo Cientifico y Tecnologico; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDEF; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Department of Occupational Health of the Instituto de Salud Publica de Chile (ISP)	This work was supported by the Fondo de Fomento al Desarrollo Cientifico y Tecnologico D09I1057 (MRS, RS and FP; www.conicyt.cl/fondef/) and Fondo Nacional de Desarrollo Cientifico y Tecnologico 3120231 (LZV; www.conicyt.cl/fondecyt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by FONDEF D09I1057 (M.R.S., R.S. and F.P.) and Fondecyt 3120231 (L.Z.V.). Authors are also indebted to Ian S.Acuna-Rodriguez for his support in preparing the map, Hans Groenewoud for his support with data analysis and with the Department of Occupational Health of the Instituto de Salud Publica de Chile (ISP) for supporting this research.	[Anonymous], 2008, INF YENT PLAG US AGR; Banks CN, 2012, NEUROTOXICOLOGY, V33, P575, DOI 10.1016/j.neuro.2012.02.002; Casida JE, 2017, J AGR FOOD CHEM, V65, P4553, DOI 10.1021/acs.jafc.7b01813; Chen WL, 1999, REGUL TOXICOL PHARM, V29, P15, DOI 10.1006/rtph.1998.1256; Corral SA, 2017, NEUROTOXICOL TERATOL, V62, P13, DOI 10.1016/j.ntt.2017.05.003; Costa LG, 2006, CLIN CHIM ACTA, V366, P1, DOI 10.1016/j.cca.2005.10.008; Division Proteccion pecuaria, 2008, PLAN CONT POL RAC VI; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Farahat FM, 2011, ENVIRON HEALTH PERSP, V119, P801, DOI 10.1289/ehp.1002873; Fujino T, 2000, J BIOCHEM, V127, P1087, DOI 10.1093/oxfordjournals.jbchem.a022702; Fujino T, 2000, BBA-PROTEIN STRUCT M, V1478, P102, DOI 10.1016/S0167-4838(00)00004-2; Fujino T, 1998, J BIOCHEM-TOKYO, V124, P1077, DOI 10.1093/oxfordjournals.jbchem.a022224; Galea KS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-856; Garcia-Garcia CR, 2016, LIFE SCI, V145, P274, DOI 10.1016/j.lfs.2015.10.013; Garcia-Rojo G, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00483; Giardina T, 1999, BIOCHIMIE, V81, P1049, DOI 10.1016/S0300-9084(99)00330-2; Gogliettino M, 2014, FEBS J, V281, P401, DOI 10.1111/febs.12610; How V, 2014, J AGROMEDICINE, V19, P35, DOI 10.1080/1059924X.2013.866917; Kamel F, 2004, ENVIRON HEALTH PERSP, V112, P950, DOI 10.1289/ehp.7135; Kapka-Skrzypczak L, 2011, ANN AGR ENV MED, V18, P294; Khan K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004177; Kim JH, 2010, ADV EXP MED BIOL, V660, P61, DOI 10.1007/978-1-60761-350-3_7; KRISHNA RG, 1992, PROTEIN SCI, V1, P582, DOI 10.1002/pro.5560010504; Lein PJ, 2012, NEUROTOXICOLOGY, V33, P660, DOI 10.1016/j.neuro.2011.12.017; Lionetto MG, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/321213; Lockridge O, 2016, CHEM RES TOXICOL, V29, P1381, DOI 10.1021/acs.chemrestox.6b00228; LONDON L, 1995, AM J IND MED, V27, P1, DOI 10.1002/ajim.4700270102; Lozano-Paniagua D, 2016, CHEM-BIOL INTERACT, V259, P160, DOI 10.1016/j.cbi.2016.04.008; Mangas I, 2017, TOXICOLOGY, V376, P30, DOI 10.1016/j.tox.2016.06.006; Maroni M, 2000, TOXICOLOGY, V143, P1; Marquez C, 2005, ENVIRON MOL MUTAGEN, V45, P1, DOI 10.1002/em.20085; MARRS TC, 1993, PHARMACOL THERAPEUT, V58, P51, DOI 10.1016/0163-7258(93)90066-M; Marsillach J, 2013, TOXICOLOGY, V307, P46, DOI 10.1016/j.tox.2012.12.007; Marsillach J, 2013, CHEM-BIOL INTERACT, V203, P85, DOI 10.1016/j.cbi.2012.10.019; MUTCH E, 1992, HUM EXP TOXICOL, V11, P109, DOI 10.1177/096032719201100209; Nigg HN, 2000, REV ENVIRON CONTAM T, V163, P29; Nolan RJ, 1984, INT J HEALTH GEOGR, V73, P8, DOI DOI 10.1016/0041-008X(84)90046-2; Olmos C, 2009, TOXICOL APPL PHARM, V238, P37, DOI 10.1016/j.taap.2009.04.011; Palmieri G, 2017, J ALZHEIMERS DIS, V60, P1097, DOI 10.3233/JAD-170389; Palmieri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025888; Prodecop Intihuasi, 1998, MAN PROD CITR; Ramirez-Santana M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1463-5; Richards PG, 2000, MOL PHARMACOL, V58, P577, DOI 10.1124/mol.58.3.577; Sandoval R, 2012, NEUROSCI LETT, V520, P98, DOI 10.1016/j.neulet.2012.05.041; Shimizu K, 2004, BIOCHEM BIOPH RES CO, V324, P140, DOI 10.1016/j.bbrc.2004.08.231; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stefanidou M, 2009, INTERN MED J, V39, P57, DOI 10.1111/j.1445-5994.2008.01779.x; Strelitz J, 2014, OCCUP ENVIRON MED, V71, P842, DOI 10.1136/oemed-2014-102315; Suratman S, 2015, REV ENVIRON HEALTH, V30, P65, DOI 10.1515/reveh-2014-0072; Munoz-Quezada MT, 2016, GAC SANIT, V30, P227, DOI 10.1016/j.gaceta.2016.01.006; Munoz-Quezada MT, 2014, GAC SANIT, V28, P190, DOI 10.1016/j.gaceta.2014.01.003; van Gemert M, 2001, REGUL TOXICOL PHARM, V33, P110, DOI 10.1006/rtph.2000.1447; Vankampen E, 1961, CLIN CHIM ACTA, V6, P538, DOI 10.1016/0009-8981(61)90145-0; WOOLLEN BH, 1993, ANN OCCUP HYG, V37, P525, DOI 10.1093/annhyg/37.5.525; Xiao X, 2017, FOOD CHEM TOXICOL, V105, P456, DOI 10.1016/j.fct.2017.05.003; Yusa V, 2015, CHEMOSPHERE, V139, P91, DOI 10.1016/j.chemosphere.2015.05.082; Zhao QY, 2006, REGUL TOXICOL PHARM, V44, P111, DOI 10.1016/j.yrtph.2005.10.003; ZuCuiga L., 2007, THEORIA-SPAIN, V16, P77; Zuniga-Venegas L, 2015, J TOXICOL ENV HEAL A, V78, P357, DOI 10.1080/15287394.2014.982843	59	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196084	10.1371/journal.pone.0196084	http://dx.doi.org/10.1371/journal.pone.0196084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718943	gold, Green Published, Green Submitted			2022-12-26	WOS:000431281900046
J	Ghavampour, S; Kleefeldt, F; Bommel, H; Volland, J; Paus, A; Horst, A; Pfeiffer, V; Hubner, S; Wagner, N; Rueckschloss, U; Ergun, S				Ghavampour, Sharang; Kleefeldt, Florian; Boemmel, Heike; Volland, Julian; Paus, Alexander; Horst, Andrea; Pfeiffer, Verena; Huebner, Stefan; Wagner, Nicole; Rueckschloss, Uwe; Erguen, Sueleyman			Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling	FASEB JOURNAL			English	Article						atherosclerosis; eNOS; adherence; endothelial dysfunction; vascular permeability	CELL-ADHESION MOLECULE-1; NITRIC-OXIDE SYNTHASE; TYROSINE PHOSPHORYLATION; TNF-ALPHA; IN-VITRO; CEACAM1; GLYCOCALYX; EXPRESSION; CADHERIN; CONTRIBUTES	Carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) is known to be crucial to vasculogenesis and angiogenesis. Recently, CEACAM1 deficiency was shown to result in the formation of aortic plaque-like lesions, indicating a role for CEACAM1 in adult vessels as well. The underlying mechanisms remained largely elusive. Therefore, we aimed to elucidate the role of CEACAM1 in endothelial homeostasis. Here, we show that CEACAM1 deficiency causes subcellular eNOS redistribution in endothelial cells (i.e., by eNOS depalmitoylation) and alters endothelial glycocalyx that confers antiadhesive properties to the endothelium (i.e., by repression of glycocalyx-degrading enzymes). Accordingly, our analysis revealed an increased leukocyte-endothelial interaction in CEACAM1-deficient endothelium. In addition, CEACAM1 age dependently modulated basal and TNF--mediated endothelial barrier (EB) leakiness. In younger mice, CEACAM1 was protective for EB, whereas in aged mice it promoted EB leakiness. EB function depends on interendothelial adherence junctions formed by -catenin/vascular endothelial-cadherin complexes. We show here that CEACAM1 influenced basal and TNF--mediated phosphorylation of -catenin and caveolin-1, which are essential players in EB modulation. Both increased adhesiveness to leukocytes and EB modulation due to CEACAM1 deficiency may facilitate inflammatory cell transmigration into the vascular wall and subsequent plaque formation. Collectively, these results identify a crucial role for CEACAM1 in endothelial homeostasis of adult blood vessels.Ghavampour, S., Kleefeldt, F., Bommel, H., Volland, J., Paus, A., Horst, A., Pfeiffer, V., Hubner, S., Wagner, N., Rueckschloss, U., Ergun, S. Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling.	[Ghavampour, Sharang; Kleefeldt, Florian; Boemmel, Heike; Volland, Julian; Pfeiffer, Verena; Huebner, Stefan; Wagner, Nicole; Rueckschloss, Uwe; Erguen, Sueleyman] Julius Maximilians Univ Wurzburg, Inst Anat & Cell Biol, Koellikerstr 6, D-97070 Wurzburg, Germany; [Paus, Alexander] Univ Hosp Essen, Inst Anat, Essen, Germany; [Horst, Andrea] Univ Hosp Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany	University of Wurzburg; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Ergun, S (corresponding author), Julius Maximilians Univ Wurzburg, Inst Anat & Cell Biol, Koellikerstr 6, D-97070 Wurzburg, Germany.	sueleyman.erguen@uni-wuerzburg.de			Deutsche Forschungsgemeinschaft (DFG)/Collaborative Research Center [SFB688 TP A19]	Deutsche Forschungsgemeinschaft (DFG)/Collaborative Research Center(German Research Foundation (DFG))	The authors are grateful to Nadja Hohn and Tanja Metzger (Institute of Anatomy and Cell Biology, Julius-Maximilians-University Wurzburg) for excellent technical assistance. The authors thank Sonja Najjar (Ohio University, Athens, OH, USA) and Nicole Beauchemin (McGill University, Montreal, QC, Canada) for providing the Cc1<SUP>-/-</SUP> mice. The authors are grateful to Kathrin Holmes (University of Colorado, Denver, CO, USA) for providing the mouse monoclonal anti-CEACAM1 antibody and to Ralf Benndorf [Martin Luther University Halle-Wittenberg, Halle (Saale), Germany] for providing the monocytic cell line THP-1. This study was supported by the Deutsche Forschungsgemeinschaft (DFG)/Collaborative Research Center (SFB688 TP A19). U.R. and S.E. are senior authors. The authors declare no conflicts of interest.	Adam AP, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/272858; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Biffl WL, 1996, J SURG RES, V63, P328, DOI 10.1006/jsre.1996.0270; Bommel H, 2017, HISTOCHEM CELL BIOL, V148, P117, DOI 10.1007/s00418-017-1562-8; Broman MT, 2006, CIRC RES, V98, P73, DOI 10.1161/01.RES.0000198387.44395.e9; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; BRUMMER J, 1995, ONCOGENE, V11, P1649; Chistiakov DA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00365; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Constantinescu AA, 2001, AM J PHYSIOL-HEART C, V280, pH1051, DOI 10.1152/ajpheart.2001.280.3.H1051; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; Csiszar A, 2003, FASEB J, V17, P1183, DOI 10.1096/fj.02-1049fje; Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; Fiori V, 2012, ANN I SUPER SANITA, V48, P161, DOI [10.4415/ANN_12_02.09, 10.4415/ANN_12_02_09]; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Golenhofen N, 2002, HISTOCHEM CELL BIOL, V117, P203, DOI 10.1007/s00418-001-0378-7; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Gu A, 2009, EXP CELL RES, V315, P1668, DOI 10.1016/j.yexcr.2009.02.026; Horst AK, 2006, J CLIN INVEST, V116, P1596, DOI 10.1172/JCI24340; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Jin L, 2008, EXP BIOL MED, V233, P849, DOI 10.3181/0712-RM-352; Khan BV, 1996, P NATL ACAD SCI USA, V93, P9114, DOI 10.1073/pnas.93.17.9114; Kilic N, 2007, BLOOD, V110, P4223, DOI 10.1182/blood-2007-06-097592; Kronstein R, 2012, CARDIOVASC RES, V93, P130, DOI 10.1093/cvr/cvr256; Leung N, 2006, ONCOGENE, V25, P5527, DOI 10.1038/sj.onc.1209541; Liu GQ, 2011, ARTERIOSCL THROM VAS, V31, P1342, DOI 10.1161/ATVBAHA.110.222208; Ludewig P, 2013, CIRC RES, V113, P1013, DOI 10.1161/CIRCRESAHA.113.301207; Marcos-Ramiro B, 2014, THROMB HAEMOSTASIS, V112, P1088, DOI 10.1160/TH14-04-0299; Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003; Muller MM, 2009, J CELL BIOL, V187, P569, DOI 10.1083/jcb.200904150; Najjar SM, 2013, AM J PHYSIOL-ENDOC M, V305, pE519, DOI 10.1152/ajpendo.00266.2013; Nouvion AL, 2010, J CELL SCI, V123, P4221, DOI 10.1242/jcs.073635; Paolisso G, 1998, AM J PHYSIOL-ENDOC M, V275, pE294, DOI 10.1152/ajpendo.1998.275.2.E294; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Quillard T, 2015, EUR HEART J, V36, P1394, DOI 10.1093/eurheartj/ehv044; Ramnath R, 2014, FASEB J, V28, P4686, DOI 10.1096/fj.14-252221; Sowa G, 1999, J BIOL CHEM, V274, P22524, DOI 10.1074/jbc.274.32.22524; Spaulding CC, 1997, MECH AGEING DEV, V93, P87, DOI 10.1016/S0047-6374(96)01824-6; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; van den Berg BM, 2009, PFLUG ARCH EUR J PHY, V457, P1199, DOI 10.1007/s00424-008-0590-6; Wang H, 2009, MOL ENDOCRINOL, V23, P1613, DOI 10.1210/me.2009-0115; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Yen WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117133; ZABORSZKY L, 1989, NEUROANATOMICAL TRAC, V2, P49; Zhang Q, 2006, ARTERIOSCL THROM VAS, V26, P1015, DOI 10.1161/01.ATV.0000216044.49494.c4; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	51	16	16	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5612	5625		10.1096/fj.201800331R	http://dx.doi.org/10.1096/fj.201800331R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29746166	Bronze			2022-12-26	WOS:000447972500034
J	Yue, JN; Lv, DC; Wang, CY; Li, L; Zhao, QN; Chen, HZ; Xu, L				Yue, Jinnan; Lv, Dacheng; Wang, Caiyun; Li, Ling; Zhao, Qingnan; Chen, Hongzhuan; Xu, Lu			Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin beta 3	ONCOGENE			English	Article							CELL LUNG-CANCER; CONVENTIONAL CARE REGIMENS; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; MICRORNA; EXPRESSION; ERLOTINIB; TKI; PROLIFERATION; DEREGULATION	All lung cancers patients with epidermal growth factor receptor (EGFR) mutation inevitably develop acquired resistance to EGFR tyrosine kinase inhibitors (TKI). In up to 30% of cases, the mechanism underlying acquired resistance remains unknown. MicroRNAs (miRNAs) is a group of small non-coding RNAs commonly dysregulated in human cancers and have been implicated in therapy resistance. The aim of this study was to understand the roles of novel miRNAs in acquired EGFR TKI resistance in EGFR-mutant non-small cell lung cancer (NSCLC). Here, we reported the evidence of miR-483-3p silencing and epithelial-to-mesenchymal transition (EMT) phenotype in both in vitro and in vivo EGFR-mutant NSCLC models with acquired resistance to gefitinib. In those tumor models, forced expression of miR-483-3p efficiently increased sensitivity of gefitinib-resistant lung cancer cells to gefitinib by inhibiting proliferation and promoting apoptosis. Moreover, miR-483-3p reversed EMT and inhibited migration, invasion, and metastasis of gefitinib-resistant lung cancer cells. Mechanistically, miR-483-3p directly targeted integrin beta 3, and thus repressed downstream FAK/Erk signaling pathway. Furthermore, the silencing of miR-483-3p in gefitinib-resistant lung cancer cells was due to hypermethylation of its own promoter. Taken together, our data identify miR-483-3p as a promising target for combination therapy to overcome acquired EGFR TKI resistance in EGFR-mutant NSCLC.	[Yue, Jinnan; Lv, Dacheng; Wang, Caiyun; Li, Ling; Zhao, Qingnan; Chen, Hongzhuan; Xu, Lu] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Chen, HZ; Xu, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, Shanghai, Peoples R China.	hongzhuan_chen@hotmail.com; luxuluxu@yahoo.com	xu, lu/AAI-6516-2020		National Natural Science Foundation of China [81372522, 81773747]; Science and Technology Commission of Shanghai Municipality [12ZR1416000, 12140901400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The work was supported by National Natural Science Foundation of China (81372522 and 81773747), Science and Technology Commission of Shanghai Municipality (12ZR1416000 and 12140901400).	Adams BD, 2014, CURR BIOL, V24, pR762, DOI 10.1016/j.cub.2014.06.043; Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bertero T, 2013, CELL CYCLE, V12, P2183, DOI 10.4161/cc.25330; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chung JH, 2011, LUNG CANCER, V73, P176, DOI 10.1016/j.lungcan.2010.11.011; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Dombret H, 2015, BLOOD, V126, P291, DOI 10.1182/blood-2015-01-621664; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Golubovskaya VM, 2014, FRONT BIOSCI-LANDMRK, V19, P687, DOI 10.2741/4236; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Hao J, 2011, FEBS LETT, V585, P207, DOI 10.1016/j.febslet.2010.11.039; Hayakawa H, 2013, CANCER SCI, V104, P1440, DOI 10.1111/cas.12284; Ju LX, 2010, J CELL BIOCHEM, V111, P1565, DOI 10.1002/jcb.22888; Kanda R, 2013, CANCER RES, V73, P6243, DOI 10.1158/0008-5472.CAN-12-4502; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kong D, 2012, ONCOGENE, V31, P3949, DOI 10.1038/onc.2011.558; La Monica S, 2016, J THORAC ONCOL, V11, P1051, DOI 10.1016/j.jtho.2016.03.006; Lee DH, 2017, PHARMACOL THERAPEUT, V174, P1, DOI 10.1016/j.pharmthera.2017.02.001; Li B, 2014, LUNG CANCER, V83, P146, DOI 10.1016/j.lungcan.2013.11.003; Li L, 2017, ONCOTARGET, V8, P92240, DOI 10.18632/oncotarget.21170; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mongroo Perry S, 2010, Cancer Biol Ther, V10, P219; Ozata DM, 2011, ENDOCR-RELAT CANCER, V18, P643, DOI 10.1530/ERC-11-0082; Rupaimoole R, 2016, CANCER DISCOV, V6, P235, DOI 10.1158/2159-8290.CD-15-0893; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103305; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Stahlhut C, 2015, CELL CYCLE, V14, P2171, DOI 10.1080/15384101.2014.1003008; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; Wang CP, 2015, TUMOR BIOL, V36, P9447, DOI 10.1007/s13277-015-3690-x; Wang W, 2012, WORLD J GASTROENTERO, V18, P5442, DOI 10.3748/wjg.v18.i38.5442; Wang W, 2012, CARCINOGENESIS, V33, P1113, DOI 10.1093/carcin/bgs113; Yamamoto C, 2010, CANCER RES, V70, P8715, DOI 10.1158/0008-5472.CAN-10-0043; Yi C, 2012, ONCOGENE, V31, P4421, DOI 10.1038/onc.2011.629; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhou JY, 2014, CANCER LETT, V351, P265, DOI 10.1016/j.canlet.2014.06.010	44	57	60	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 2	2018	37	31					4300	4312		10.1038/s41388-018-0276-2	http://dx.doi.org/10.1038/s41388-018-0276-2			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP1HN	29717264	Green Published, hybrid			2022-12-26	WOS:000440566100008
J	Yang, J; Huang, M; Zhou, L; He, X; Jiang, XG; Zhang, Y; Xu, GQ				Yang, Jing; Huang, Min; Zhou, Liang; He, Xian; Jiang, Xiaogang; Zhang, Yang; Xu, Guoqiang			Cereblon suppresses the lipopolysaccharide-induced inflammatory response by promoting the ubiquitination and degradation of c-Jun	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; AP1 transcription factor (AP-1); ubiquitylation (ubiquitination); c-Jun transcription factor; protein degradation; apoptosis; cereblon; inflammatory response	NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; ACTIVATOR PROTEIN-1; GLUTAMINE-SYNTHETASE; GENE-EXPRESSION; CELL-CULTURE; AMINO-ACIDS; AP-1; THALIDOMIDE; APOPTOSIS	Chronic inflammation is associated with multiple human disorders, such as rheumatoid arthritis, metabolic diseases, and neurodegenerative diseases. Therefore, alleviation of inflammation induced by environmental stimuli is important for disease prevention or treatment. Cereblon (CRBN) functions as a substrate receptor of the cullin-4 RING E3 ligase to mediate protein ubiquitination and degradation. Although it has been reported that CRBN reduces the inflammatory response through its nonenzymatic function, its role as a substrate receptor of the E3 ligase is not explored in mediating this process. Here we used a quantitative proteomics approach to find that the major component of the activator protein 1 (AP-1) complex, c-Jun, is significantly down-regulated upon CRBN expression. Biochemical approaches further discover that CRBN interacts and partially colocalizes with c-Jun and promotes the formation of Lys(48)-linked polyubiquitin chains on c-Jun, enhancing c-Jun degradation. We further reveal that CRBN attenuates the transcriptional activity of the AP-1 complex and reduces the mRNA expression and protein level of several pro-inflammatory cytokines. Moreover, flow cytometry analyses show that CRBN attenuates lipopolysaccharide-induced apoptosis in differentiated THP-1 cells. Through genetic manipulation and pharmacological inhibition, we uncover a new molecular mechanism by which CRBN regulates the inflammatory response and apoptosis induced by lipopolysaccharide. Our work and previous studies demonstrate that CRBN suppresses the inflammatory response by promoting or inhibiting the ubiquitination of two key molecules at different levels of the inflammatory cascade through its enzymatic function as a substrate receptor and its nonenzymatic function as a protein binding partner.	[Xu, Guoqiang] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China; Soochow Univ, Coll Pharmaceut Sci, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Xu, GQ (corresponding author), Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.	gux2002@suda.edu.cn		Xu, Guoqiang/0000-0002-4753-4769	National Natural Science Foundation of China [31670833, 81703535]; China Postdoctoral Science Foundation [2017M611895]; Natural Science Foundation of Jiangsu Higher Education Institutions of China [17KJD180005]; Jiangsu Postdoctoral Science Foundation [1701130C]; Jiangsu Key Laboratory of Neuropsychiatric Diseases [BM2013003]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Jiangsu Higher Education Institutions of China; Jiangsu Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Key Laboratory of Neuropsychiatric Diseases; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (31670833 and 81703535), the China Postdoctoral Science Foundation (2017M611895), the Natural Science Foundation of Jiangsu Higher Education Institutions of China (17KJD180005), the Jiangsu Postdoctoral Science Foundation (1701130C), the Jiangsu Key Laboratory of Neuropsychiatric Diseases (BM2013003), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare that they have no conflicts of interest with the contents of this article.	Adcock I M, 1997, Monaldi Arch Chest Dis, V52, P178; Afonina IS, 2017, NAT IMMUNOL, V18, P861, DOI 10.1038/ni.3772; AKIYAMA H, 1994, TOHOKU J EXP MED, V174, P295, DOI 10.1620/tjem.174.295; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; Chamberlain PP, 2014, NAT STRUCT MOL BIOL, V21, P803, DOI 10.1038/nsmb.2874; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Chen YA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10667; Del Prete D, 2016, J BIOL CHEM, V291, P17209, DOI 10.1074/jbc.M116.733626; Demoruelle MK, 2014, CURR OPIN RHEUMATOL, V26, P64, DOI 10.1097/BOR.0000000000000017; Eichner R, 2016, NAT MED, V22, P735, DOI 10.1038/nm.4128; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guo C, 2014, INFLAMMATION, V37, P621, DOI 10.1007/s10753-013-9778-9; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; Harrison LM, 2005, MICROB PATHOGENESIS, V38, P63, DOI 10.1016/j.micpath.2004.12.003; Hsu TC, 2000, FREE RADICAL BIO MED, V28, P1338, DOI 10.1016/S0891-5849(00)00220-3; Hull C, 2002, J IMMUNOL, V169, P2611, DOI 10.4049/jimmunol.169.5.2611; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kang JA, 2016, P NATL ACAD SCI USA, V113, P8771, DOI 10.1073/pnas.1502166113; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lee KM, 2014, J BIOL CHEM, V289, P23343, DOI 10.1074/jbc.M113.523423; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517; Manohar Murli, 2017, World J Gastrointest Pharmacol Ther, V8, P10, DOI 10.4292/wjgpt.v8.i1.10; Mao RF, 2011, CELL SIGNAL, V23, P222, DOI 10.1016/j.cellsig.2010.09.006; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meng QH, 2011, PROTEIN CELL, V2, P889, DOI 10.1007/s13238-011-1113-3; Min Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.226; Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; Ren HG, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-40; Sawamura N, 2015, BIOCHEM BIOPH RES CO, V464, P1054, DOI 10.1016/j.bbrc.2015.07.068; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; Nguyen TV, 2017, P NATL ACAD SCI USA, V114, P3565, DOI 10.1073/pnas.1700949114; Van Nguyen T, 2016, MOL CELL, V61, P809, DOI 10.1016/j.molcel.2016.02.032; Wu MY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102034; Xaus J, 2000, BLOOD, V95, P3823; Xu GQ, 2013, J BIOL CHEM, V288, P29573, DOI 10.1074/jbc.M113.472092; Xu QQ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2331-0; Ye N, 2014, J MED CHEM, V57, P6930, DOI 10.1021/jm5004733; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200; Zhang Y, 2018, BIOCHEM J, V475, P1507, DOI 10.1042/BCJ20180005; Zhou L, 2018, HUM MOL GENET, V27, P667, DOI 10.1093/hmg/ddx433; Zhou YQ, 2016, J PROTEOMICS, V148, P94, DOI 10.1016/j.jprot.2016.07.015	59	24	29	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10141	10157		10.1074/jbc.RA118.002246	http://dx.doi.org/10.1074/jbc.RA118.002246			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29748389	Green Published, hybrid			2022-12-26	WOS:000437096700017
J	Lokhandwala, S; McCague, N; Chahin, A; Escobar, B; Feng, ML; Ghassemi, MM; Stone, DJ; Celi, LA				Lokhandwala, Sharukh; McCague, Ned; Chahin, Abdullah; Escobar, Braiam; Feng, Mengling; Ghassemi, Mohammad M.; Stone, David J.; Celi, Leo Anthony			One-year mortality after recovery from critical illness: A retrospective cohort study	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; HOSPITAL MORTALITY; MODEL; PREDICTION	Rationale Factors associated with one-year mortality after recovery from critical illness are not well understood. Clinicians generally lack information regarding post-hospital discharge outcomes of patients from the intensive care unit, which may be important when counseling patients and families. Objective We sought to determine which factors among patients who survived for at least 30 days post-ICU admission are associated with one-year mortality. Methods Single-center, longitudinal retrospective cohort study of all ICU patients admitted to a tertiary-care academic medical center from 2001-2012 who survived >30 days from ICU admission. Cox's proportional hazards model was used to identify the variables that are associated with one-year mortality. The primary outcome was one-year mortality. Results 32,420 patients met the inclusion criteria and were included in the study. Among patients who survived to >30 days, 28,583 (88.2%) survived for greater than one year, whereas 3,837 (11.8%) did not. Variables associated with decreased one-year survival include: increased age, malignancy, number of hospital admissions within the prior year, duration of mechanical ventilation and vasoactive agent use, sepsis, history of congestive heart failure, end-stage renal disease, cirrhosis, chronic obstructive pulmonary disease, and the need for renal replacement therapy. Numerous effect modifications between these factors were found. Conclusion Among survivors of critical illness, a significant number survive less than one year. More research is needed to help clinicians accurately identify those patients who, despite surviving their acute illness, are likely to suffer one-year mortality, and thereby to improve the quality of the decisions and care that impact this outcome.	[Lokhandwala, Sharukh; McCague, Ned; Chahin, Abdullah; Escobar, Braiam; Feng, Mengling; Ghassemi, Mohammad M.; Celi, Leo Anthony] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lokhandwala, Sharukh] Univ Washington, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA; [McCague, Ned] Kyruus, Boston, MA USA; [Chahin, Abdullah] Mem Hosp Rhode Isl, Pawtucket, RI USA; [Escobar, Braiam] Escuela Ingn Antioquia, Envigado, Colombia; [Feng, Mengling] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Stone, David J.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Celi, Leo Anthony] Harvard Med Sch, Boston, MA USA; [Celi, Leo Anthony] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; National University of Singapore; University of Virginia; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Lokhandwala, S (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lokhandwala, S (corresponding author), Univ Washington, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA.	slokhand@uw.edu	Chahin, Abdullah/V-5179-2019	Lokhandwala, Sharukh/0000-0002-2573-388X	National Institutes of Health (NIH) through National Institute of Biomedical Imaging and Bioengineering [R01 EB017205-01A1]; Philips; A*STAR Graduate Scholarship; National Institutes of Health (NIH), National Heart, Lung, Blood Institute (NHLBI) [T32 HL007287-39]; Kyruus	National Institutes of Health (NIH) through National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philips; A*STAR Graduate Scholarship(Agency for Science Technology & Research (A*STAR)); National Institutes of Health (NIH), National Heart, Lung, Blood Institute (NHLBI); Kyruus	LAC is funded by the National Institutes of Health (NIH) through National Institute of Biomedical Imaging and Bioengineering grant R01 EB017205-01A1 (https://www.nibib.nih.gov/) and by Philips (https://www.usa.philips.com/healthcare). MF was supported by an A*STAR Graduate Scholarship (https://www.a-star.edu.sg/). SL was supported by grant T32 HL007287-39 from the National Institutes of Health (NIH), National Heart, Lung, Blood Institute (NHLBI) (https://www.nhlbi.nih.gov/). NM is funded by Kyruus. Kyruus provided support in the form of salary for author NM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Philips provided support in the form of research funding for author LAC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions' section."	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Badawi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048758; Carson SS, 2012, CRIT CARE MED, V40, P1171, DOI 10.1097/CCM.0b013e3182387d43; Cox CE, 2016, AM J RESP CRIT CARE, V193, P242, DOI 10.1164/rccm.201508-1628CP; Erickson SE, 2009, CRIT CARE MED, V37, P1574, DOI 10.1097/CCM.0b013e31819fefdf; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Garland A, 2014, INTENS CARE MED, V40, P1097, DOI 10.1007/s00134-014-3348-y; Gill TM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2361; Higgins TL, 2007, CRIT CARE MED, V35, P827, DOI 10.1097/01.CCM.0000257337.63529.9F; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Kahn JM, 2015, CRIT CARE MED, V43, P282, DOI 10.1097/CCM.0000000000000710; Kranidiotis G, 2010, CRIT CARE, V14, DOI 10.1186/cc9380; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Moitra VK, 2016, CRIT CARE MED, V44, P655, DOI 10.1097/CCM.0000000000001480; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Ouanes I, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.003; Paul E, 2013, J CRIT CARE, V28, P935, DOI 10.1016/j.jcrc.2013.07.058; Prescott HC, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2375; Prescott HC, 2014, AM J RESP CRIT CARE, V190, P62, DOI 10.1164/rccm.201403-0471OC; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Unroe M, 2010, ANN INTERN MED, V153, P167, DOI 10.7326/0003-4819-153-3-201008030-00007; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	25	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0197226	10.1371/journal.pone.0197226	http://dx.doi.org/10.1371/journal.pone.0197226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750814	Green Submitted, gold, Green Published			2022-12-26	WOS:000431856300024
J	Obia, A; Mulder, J; Hale, SE; Nurida, NL; Cornelissen, G				Obia, Alfred; Mulder, Jan; Hale, Sarah Elizabeth; Nurida, Neneng Laela; Cornelissen, Gerard			The potential of biochar in improving drainage, aeration and maize yields in heavy clay soils	PLOS ONE			English	Article							PHYSICAL-PROPERTIES; WATER-RETENTION; FARMYARD MANURE; VERTISOLS; QUALITY; PRODUCTIVITY; INDICATORS; MANAGEMENT; IMPACTS	Heavy clay soils are globally widespread but their poor drainage and poor aeration limit their use for agriculture. This study was designed to test the effect of the amendment of biochar (BC) from woody shrubs on drainage/saturated hydraulic conductivity (K-sat), soil aeration/air capacity, available water capacity and biomass and grain yields of maize. In a field experiment, BC from Gliricidia sepium was applied in planting basins or rip lines at 2.5% and 5% w/w in addition to a control without BC. The maize biomass and grain yields were higher in BC treated plots compared to control (p<0.05) during the 2012 and 2013 seasons. There was no significant difference in the yields between 2.5% and 5% BC treatments (e.g. grain yield were 6.6 and 8.1 t ha(-1) in 2012 and 9.3 and 10.3 t ha(-1) in 2013 compared to control with 4.2 and 6.7 t ha(-1) in 2012 and 2013, respectively). Soil from the same field site was also mixed with a similar woody shrub BC from Eupatorium adenophorum in the laboratory at rates of 2.5%, 5% and 10% BC w/w and a control without BC. The mixtures were then incubated and subjected to two wet-dry cycles for two weeks. Core samples were taken from the incubated soil and tested for bulk density, K-sat and pF measurements. Total porosity and moisture at field capacity and wilting point were 72.3%, 43.7% and 23.7%, respectively, and not affected by BC amendment (p>0.05). In contrast, bulk density decreased linearly by 0.011 +/- 0.002 g cm(-3) per percent BC added (p<0.001). K-sat and air capacity of the soil were 288 cm day(-1) and 30.9%, respectively falling within the generally accepted optimal range. Both K-sat and air capacity followed a significant quadratic relation (p<0.05) upon BC addition, decreasing at low BC doses, reaching a minimum at 3-5% BC and increasing at higher doses. Results allowed a partial attribution of the yield increases to changes in soil physical properties such as changes in bulk density and not clearly to K-sat and air capacity.	[Obia, Alfred; Hale, Sarah Elizabeth; Cornelissen, Gerard] NGI, Dept Environm Engn, Oslo, Norway; [Obia, Alfred; Mulder, Jan; Cornelissen, Gerard] Norwegian Univ Life Sci NMBU, Fac Environm Sci & Nat Resource Management MINA, As, Norway; [Nurida, Neneng Laela] ICALRRD, Bogor, Indonesia; [Obia, Alfred] Gulu Univ, Fac Agr & Environm, Dept Agron, Gulu, Uganda	Norwegian Geotechnical Institute, NGI; Norwegian University of Life Sciences	Obia, A (corresponding author), NGI, Dept Environm Engn, Oslo, Norway.; Obia, A (corresponding author), Norwegian Univ Life Sci NMBU, Fac Environm Sci & Nat Resource Management MINA, As, Norway.; Obia, A (corresponding author), Gulu Univ, Fac Agr & Environm, Dept Agron, Gulu, Uganda.	obialfrd@yahoo.com	Obia, Alfred/AAE-7257-2019	Obia, Alfred/0000-0003-0960-7020; Hale, Sarah E./0000-0002-7743-9199	Norwegian Research Council [203901, 217918]; Norwegian Geotechnical Institute; FriPro project	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Geotechnical Institute; FriPro project	Norwegian Research Council (https://www.forskningsradet.no/) provided funding to GC under projects NorGlobal No. 203901 and FriPro No. 217918, which was used for field research in Indonesia. Norwegian Geotechnical Institute (https://www.ngi.no/eng/) and FriPro project funded the Postdoctoral fellowship of AO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript other than the named authors.	Abiven S, 2015, PLANT SOIL, V395, P45, DOI 10.1007/s11104-015-2533-2; Ajayi AE, 2016, SOIL TILL RES, V164, P34, DOI 10.1016/j.still.2016.01.011; Asai H, 2009, FIELD CROP RES, V111, P81, DOI 10.1016/j.fcr.2008.10.008; Bandyopadhyay KK, 2010, SOIL TILL RES, V110, P115, DOI 10.1016/j.still.2010.07.007; Barnes RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108340; Carvalho MTM, 2016, GEODERMA, V276, P7, DOI 10.1016/j.geoderma.2016.04.013; Castellini M, 2015, SOIL TILL RES, V154, P1, DOI 10.1016/j.still.2015.06.016; Cornelissen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154617; Cornelissen G, 2013, AGRONOMY-BASEL, V3, P256, DOI 10.3390/agronomy3020256; Coulombe CE, 1996, ADV AGRON, V57, P289, DOI 10.1016/S0065-2113(08)60927-X; Carvalho MTD, 2014, SOLID EARTH, V5, P939, DOI 10.5194/se-5-939-2014; Easson DL, 1995, ANN APPL BIOL, V127, P363, DOI 10.1111/j.1744-7348.1995.tb06680.x; Hati KM, 2006, BIORESOURCE TECHNOL, V97, P2182, DOI 10.1016/j.biortech.2005.09.033; IUSS Working Group WRB, 2015, WORLD REF BAS SOIL R, V106, DOI 10.1017/S0014479706394902; Jeffery S, 2015, GEODERMA, V251, P47, DOI 10.1016/j.geoderma.2015.03.022; Kanwar JS, 1982, VERT RIC SOILS TROP; Laird DA, 2010, GEODERMA, V158, P443, DOI 10.1016/j.geoderma.2010.05.013; Lu SG, 2014, CATENA, V114, P37, DOI 10.1016/j.catena.2013.10.014; Madari BE, 2017, GEODERMA, V305, P100, DOI 10.1016/j.geoderma.2017.05.029; Mukherjee A, 2013, AGRONOMY-BASEL, V3, P313, DOI 10.3390/agronomy3020313; Obia A, 2017, SOIL TILL RES, V170, P114, DOI 10.1016/j.still.2017.03.009; Obia A, 2016, SOIL TILL RES, V155, P35, DOI 10.1016/j.still.2015.08.002; Obia A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138781; Ouyang L, 2013, J SOIL SCI PLANT NUT, V13, P991, DOI 10.4067/S0718-95162013005000078; Ouyang L., 2013, J SOIL SEDIMENT, V13, P1561, DOI DOI 10.1007/s11368-013-0738-7; Pandit NR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176378; R Core Team, 2016, R LANG ENV STAT COMP, P3503, DOI [10.1007/978-3-540-74686-7, DOI 10.1007/978-3-540-74686-7]; Reynolds WD, 2007, SOIL TILL RES, V96, P316, DOI 10.1016/j.still.2007.07.003; Reynolds WD, 2009, GEODERMA, V152, P252, DOI 10.1016/j.geoderma.2009.06.009; Reynolds WD, 2003, CAN J SOIL SCI, V83, P381, DOI 10.4141/S02-066; Reynolds WD, 2002, GEODERMA, V110, P131, DOI 10.1016/S0016-7061(02)00228-8; Sun FF, 2014, J PLANT NUTR SOIL SC, V177, P26, DOI 10.1002/jpln.201200639; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Wani SP, 2003, SOIL USE MANAGE, V19, P217, DOI 10.1111/j.1475-2743.2003.tb00307.x; Zong YT, 2014, J PLANT NUTR SOIL SC, V177, P920, DOI 10.1002/jpln.201300596; [No title captured]	36	33	33	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0196794	10.1371/journal.pone.0196794	http://dx.doi.org/10.1371/journal.pone.0196794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750796	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000431856300005
J	Moriguchi, M; Maeshige, N; Ueno, M; Yoshikawa, Y; Terashi, H; Fujino, H				Moriguchi, Maiki; Maeshige, Noriaki; Ueno, Mizuki; Yoshikawa, Yoshiyuki; Terashi, Hiroto; Fujino, Hidemi			Modulation of plantar pressure and gastrocnemius activity during gait using electrical stimulation of the tibialis anterior in healthy adults	PLOS ONE			English	Article							DIABETIC-NEUROPATHY; FOOT ULCERATION; MUSCLE-ACTIVITY; HIGH-RISK; WALKING; SUPPORT; PROGRESSION; PREVENTION; INSOLES; ULCERS	High plantar flexor moment during the stance phase is known to cause high plantar pressure under the forefoot; however, the effects on plantar pressure due to a change of gastrocnemius medialis (GM) activity during gait, have not been investigated to date. Reciprocal inhibition is one of the effects of electrical stimulation (ES), and is the automatic antagonist alpha motor neuron inhibition which is evoked by excitation of the agonist muscle. The aim of this study was to investigate the influences of ES of the tibialis anterior (TA) on plantar pressure and the GM activity during gait in healthy adults. ES was applied to the TAs of twenty healthy male adults for 30 minutes at the level of intensity that causes a full range of dorsiflexion in the ankle (frequency; 50 Hz, on-time; 10 sec, off-time; 10 sec). Subjects walked 10 meters before and after ES, and we measured the peak plantar pressure (PP), pressure time integral (PTI), and gait parameters by using an F-scan system. The percentage of integrated electromyogram (%IEMG), active time, onset time, peak time, and cessation time of TA and GM were calculated. PP and PTI under the forefoot, rear foot, and total plantar surface significantly decreased after the application of ES. Meanwhile, changes of gait parameters were not observed. %IEMG and the active time of both muscles did not change; however, onset time and peak time of GM became significantly delayed. ES application to the TA delayed the timing of onset and peak in the GM, and caused the decrease of plantar pressure during gait. The present results suggest that ES to the TA could become a new method for the control of plantar pressure via modulation of GM activity during gait.	[Moriguchi, Maiki; Maeshige, Noriaki; Ueno, Mizuki; Fujino, Hidemi] Kobe Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Suma Ku, Kobe, Hyogo, Japan; [Yoshikawa, Yoshiyuki] Miyabinosato Home Visit Nursing Care Stn, Patio Akashi 1F,Uozumicho, Akashi, Hyogo, Japan; [Terashi, Hiroto] Kobe Univ, Grad Sch Med, Dept Plast Surg, Chuo Ku, Kusunokicho, Kobe, Hyogo, Japan	Kobe University; Kobe University	Maeshige, N (corresponding author), Kobe Univ, Grad Sch Hlth Sci, Dept Rehabil Sci, Suma Ku, Kobe, Hyogo, Japan.	nmaeshige@pearl.kobe-u.ac.jp	Maeshige, Noriaki/GRY-4152-2022	yoshikawa, yoshiyuki/0000-0003-3318-1816; Maeshige, Noriaki/0000-0002-3573-347X				Allet L, 2011, GAIT POSTURE, V34, P300, DOI 10.1016/j.gaitpost.2011.05.013; Bacarin TA, 2009, CLINICS, V64, P113, DOI 10.1590/S1807-59322009000200008; Carlson Tammy, 2003, Int J Low Extrem Wounds, V2, P19, DOI 10.1177/1534734603002001004; Chalmers GR, 2000, J GERONTOL A-BIOL, V55, pB570, DOI 10.1093/gerona/55.12.B570; Fernando M, 2013, CLIN BIOMECH, V28, P831, DOI 10.1016/j.clinbiomech.2013.08.004; Fong DTP, 2008, J BIOMECH, V41, P2597, DOI 10.1016/j.jbiomech.2008.05.007; Francis CA, 2013, GAIT POSTURE, V38, P993, DOI 10.1016/j.gaitpost.2013.05.009; Gutierrez-Farewik EM, 2006, HUM MOVEMENT SCI, V25, P238, DOI 10.1016/j.humov.2005.11.001; Honeine JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052943; HUGHES J, 1991, CLIN BIOMECH, V6, P14, DOI 10.1016/0268-0033(91)90036-P; Kim S, 2001, J SOC BIOMECHANISMS, V25, P29; Kodesh E, 2012, GAIT POSTURE, V35, P66, DOI 10.1016/j.gaitpost.2011.08.008; Koyama S, 2014, SOMATOSENS MOT RES, V31, P221, DOI 10.3109/08990220.2014.931279; Kwon OY, 2003, GAIT POSTURE, V18, P105, DOI 10.1016/S0966-6362(02)00166-2; Landorf KB, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-243; Lipsky BA, 2004, CLIN INFECT DIS, V39, P885, DOI 10.1086/383271; Liu MQ, 2006, J BIOMECH, V39, P2623, DOI 10.1016/j.jbiomech.2005.08.017; Melai T, 2013, HUM MOVEMENT SCI, V32, P785, DOI 10.1016/j.humov.2013.05.001; Michelle HC, 2012, PHYS AGENTS REHABILI; Nagai K, 2011, J JPN PHYS THER ASS, V38, P84; Nakano S, 2016, J PHYS THER SCI, V28, P124, DOI 10.1589/jpts.28.1633; Neptune RR, 2001, J BIOMECH, V34, P1387, DOI 10.1016/S0021-9290(01)00105-1; Paton J, 2011, J DIABETES COMPLICAT, V25, P52, DOI 10.1016/j.jdiacomp.2009.09.002; Pham H, 2000, DIABETES CARE, V23, P606, DOI 10.2337/diacare.23.5.606; Powlson AS, 2010, J ANTIMICROB CHEMOTH, V65, piii3, DOI 10.1093/jac/dkq299; Robinson Caroline Cabral, 2013, J Diabetes Sci Technol, V7, P1113; Sartor CD, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-137; Segal A, 2004, FOOT ANKLE INT, V25, P926, DOI 10.1177/107110070402501215; Tang UH, 2015, DIABET FOOT ANKLE, V6, DOI 10.3402/dfa.v6.27593; UEHARA S, 2012, J BEHAV BRAIN SCI, V2, P343, DOI DOI 10.4236/JBBS.2012.23039; van Netten JJ, 2016, DIABETES-METAB RES, V32, P84, DOI 10.1002/dmrr.2701; Waaijman R, 2014, DIABETES CARE, V37, P1697, DOI 10.2337/dc13-2470; Waaijman R, 2013, DIABETES CARE, V36, P1613, DOI 10.2337/dc12-1330	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0195309	10.1371/journal.pone.0195309	http://dx.doi.org/10.1371/journal.pone.0195309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746498	Green Submitted, Green Published, gold			2022-12-26	WOS:000431851700005
J	Kim, SW; Haendiges, J; Keller, EN; Myers, R; Kim, A; Lombard, JE; Karns, JS; Van Kessel, JAS; Haley, BJ				Kim, Seon Woo; Haendiges, Julie; Keller, Eric N.; Myers, Robert; Kim, Alexander; Lombard, Jason E.; Karns, Jeffrey S.; Van Kessel, Jo Ann S.; Haley, Bradd J.			Genetic diversity and virulence profiles of Listeria monocytogenes recovered from bulk tank milk, milk filters, and milking equipment from dairies in the United States (2002 to 2014)	PLOS ONE			English	Article							RUMINANT RHOMBENCEPHALITIS; ANTIMICROBIAL RESISTANCE; US DAIRIES; PASTEURIZED MILK; RISK-FACTORS; PREVALENCE; STRAINS; FARM; CONTAMINATION; INFECTION	Unpasteurized dairy products are known to occasionally harbor Listeria monocytogenes and have been implicated in recent listeriosis outbreaks and numerous sporadic cases of listeriosis. However, the diversity and virulence profiles of L. monocytogenes isolates recovered from these products have not been fully described. Here we report a genomic analysis of 121 L. monocytogenes isolates recovered from milk, milk filters, and milking equipment collected from bovine dairy farms in 19 states over a 12-year period. In a multi-virulence-locus sequence typing (MVLST) analysis, 59 Virulence Types (VT) were identified, of which 25% were Epidemic Clones I, II, V, VI, VII, VIII, IX, or X, and 31 were novel VT. In a multi-locus sequence typing (MLST) analysis, 60 Sequence Types (ST) of 56 Clonal Complexes (CC) were identified. Within lineage I, CC5 and CC1 were among the most abundant, and within lineage II, CC7 and CC37 were the most abundant. Multiple CCs previously associated with central nervous system and maternal-neonatal infections were identified. A genomic analysis identified variable distribution of virulence markers, Listeria pathogenicity islands (LIPI) -1, -3, and -4, and stress survival island-1 (SSI-1). Of these, 14 virulence markers, including LIPI-3 and -4 were more frequently detected in one lineage (I or II) than the other. LIPI-3 and LIPI-4 were identified in 68% and 28% of lineage I CCs, respectively. Results of this analysis indicate that there is a high level of genetic diversity among the L. monocytogenes present in bulk tank milk in the United States with some strains being more frequently detected than others, and some being similar to those that have been isolated from previous non-dairy related outbreaks. Results of this study also demonstrate significant number of strains isolated from dairy farms encode virulence markers associated with severe human disease.	[Kim, Seon Woo; Karns, Jeffrey S.; Van Kessel, Jo Ann S.; Haley, Bradd J.] ARS, Environm Microbial & Food Safety Lab, Beltsville Agr Res Ctr, USDA, Beltsville, MD 20705 USA; [Haendiges, Julie; Keller, Eric N.; Myers, Robert; Kim, Alexander] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA; [Lombard, Jason E.] USDA Anim & Plant Hlth Inspect Serv, Ctr Epidemiol & Anim Hlth, Vet Serv, Ft Collins, CO USA	United States Department of Agriculture (USDA); Maryland Department of Health & Mental Hygiene; United States Department of Agriculture (USDA)	Haley, BJ (corresponding author), ARS, Environm Microbial & Food Safety Lab, Beltsville Agr Res Ctr, USDA, Beltsville, MD 20705 USA.	bradd.haley@ars.usda.gov	Haley, Bradd/AAB-9164-2020	Haley, Bradd/0000-0001-7996-1143	internal USDA/ARS research fund	internal USDA/ARS research fund	This project was supported by internal USDA/ARS research funding.	Bakardjiev AI, 2006, PLOS PATHOG, V2, P623, DOI 10.1371/journal.ppat.0020066; Balandyte L, 2011, APPL ENVIRON MICROB, V77, P8325, DOI 10.1128/AEM.06507-11; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borucki MK, 2005, APPL ENVIRON MICROB, V71, P5893, DOI 10.1128/AEM.71.10.5893-5899.2005; Borucki MK, 2003, APPL ENVIRON MICROB, V69, P7336, DOI 10.1128/AEM.69.12.7336-7342.2003; Center for Genomic Epidemiology, RESFINDER WEBT; Centers for Disease Control and Prevention, 2014, MULT OUTB LIST LINK, P4; Centers for Disease Control and Prevention, LIST LIST PEOPL RISK; Centers for Disease Control and Prevention, 2015, MMWR-MORBID MORTAL W, P10; Centers for Disease Control and Prevention, 2001, MORB MORTAL WKLY REP, V50; Centers for Disease Control and Prevention, 2016, MULT OUTBR LIST LINK, P12; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P1097; CHERUBIN CE, 1991, REV INFECT DIS, V13, P1108; Cotter PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000144; Del Collo LP, 2017, J DAIRY SCI, V100, P3470, DOI 10.3168/jds.2016-12084; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Dreyer M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36419; Esteban JI, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-2; Fedio WM, 1992, INT DAIRY J, V2, P197, DOI 10.1016/0958-6946(92)90016-F; Fenlon DR, 1996, J APPL BACTERIOL, V81, P641; FLEMING DW, 1985, NEW ENGL J MED, V312, P404, DOI 10.1056/NEJM198502143120704; Fox E, 2009, J FOOD PROTECT, V72, P1450, DOI 10.4315/0362-028X-72.7.1450; Garcia JA, 2016, J VET DIAGN INVEST, V28, P65, DOI 10.1177/1040638715616658; Glaser P, 2001, SCIENCE, V294, P849; Hain T, 2007, INT J MED MICROBIOL, V297, P541, DOI 10.1016/j.ijmm.2007.03.016; Haley BJ, 2015, FOODBORNE PATHOG DIS, V12, P844, DOI 10.1089/fpd.2014.1886; Hasegawa M, 2014, FOODBORNE PATHOG DIS, V11, P96, DOI 10.1089/fpd.2013.1616; Henri C, 2016, APPL ENVIRON MICROB, V82, P5720, DOI 10.1128/AEM.00583-16; Institut Pasteur, LIST SEQ TYP; Janakiraman Vanitha, 2008, Rev Obstet Gynecol, V1, P179; Jayarao BM, 2001, J DAIRY SCI, V84, P2157, DOI 10.3168/jds.S0022-0302(01)74661-9; Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Langer AJ, 2012, EMERG INFECT DIS, V18, P385, DOI 10.3201/eid1803.111370; Latorre AA, 2010, J DAIRY SCI, V93, P2792, DOI 10.3168/jds.2009-2717; Latorre AA, 2009, APPL ENVIRON MICROB, V75, P1315, DOI 10.1128/AEM.01826-08; Lee KS, 2007, PERSPECT BIOL MED, V50, P585, DOI 10.1353/pbm.2007.0051; Linke K, 2014, APPL ENVIRON MICROB, V80, P5583, DOI 10.1128/AEM.01018-14; Lomonaco S, 2009, INT J FOOD MICROBIOL, V128, P516, DOI 10.1016/j.ijfoodmicro.2008.10.009; Martin B, 2014, FOOD MICROBIOL, V44, P119, DOI 10.1016/j.fm.2014.05.014; Maury MM, 2016, NAT GENET, V48, P308, DOI 10.1038/ng.3501; Mungai EA, 2015, EMERG INFECT DIS, V21, P119, DOI 10.3201/eid2101.140447; Nightingale KK, 2008, APPL ENVIRON MICROB, V74, P6570, DOI 10.1128/AEM.00997-08; Nightingale KK, 2005, JAVMA-J AM VET MED A, V227, P1808, DOI 10.2460/javma.2005.227.1808; Quereda JJ, 2017, MBIO, V8, DOI 10.1128/mBio.00259-17; Rocha PRD, 2013, APPL ENVIRON MICROB, V79, P3059, DOI 10.1128/AEM.00219-13; SANAA M, 1993, J DAIRY SCI, V76, P2891, DOI 10.3168/jds.S0022-0302(93)77628-6; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; SCHWARZE R, 1989, INFECTION, V17, P131, DOI 10.1007/BF01644011; Siegman-Igra Y, 2002, EMERG INFECT DIS, V8, P305; Sonnier JL, 2018, J DAIRY SCI, V101, P1943, DOI 10.3168/jds.2017-13546; Southwick FS, 1996, NEW ENGL J MED, V334, P770, DOI 10.1056/NEJM199603213341206; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Van Kessel JAS, 2011, J FOOD PROTECT, V74, P759, DOI 10.4315/0362-028X.JFP-10-423; Van Kessel JS, 2004, J DAIRY SCI, V87, P2822, DOI 10.3168/jds.S0022-0302(04)73410-4; Wang GY, 2015, FOOD CONTROL, V50, P202, DOI 10.1016/j.foodcont.2014.07.057; Wang HQ, 2016, FOOD POLICY, V63, P44, DOI 10.1016/j.foodpol.2016.06.005; Wu S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00168; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang W, 2004, APPL ENVIRON MICROB, V70, P913, DOI 10.1128/AEM.70.2.913-920.2004	63	46	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0197053	10.1371/journal.pone.0197053	http://dx.doi.org/10.1371/journal.pone.0197053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742151	gold, Green Published, Green Submitted			2022-12-26	WOS:000431757400058
J	Salama, M; Shalash, A; Magdy, A; Makar, M; Roushdy, T; Elbalkimy, M; Elrassas, H; Elkafrawy, P; Mohamed, W; Abou Donia, MB				Salama, Mohamed; Shalash, Ali; Magdy, Alshimaa; Makar, Marianne; Roushdy, Tamer; Elbalkimy, Mahmoud; Elrassas, Hanan; Elkafrawy, Passent; Mohamed, Wael; Abou Donia, Mohamed B.			Tubulin and Tau: Possible targets for diagnosis of Parkinson's and Alzheimer's diseases	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALPHA-SYNUCLEIN; PLASMA TAU; BIOMARKERS; MUTATIONS; AUTOANTIBODIES; EPIDEMIOLOGY; MICROTUBULES; ANTIBODIES; NEUROPATHY	Neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD) are characterized by progressive neuronal loss and pathological accumulation of some proteins. Developing new biomarkers for both diseases is highly important for the early diagnosis and possible development of neuro-protective strategies. Serum antibodies (AIAs) against neuronal proteins are potential biomarkers for AD and PD that may be formed in response to their release into systemic circulation after brain damage. In the present study, two AIAs (tubulin and tau) were measured in sera of patients of PD and AD, compared to healthy controls. Results showed that both antibodies were elevated in patients with PD and AD compared to match controls. Curiously, the profile of elevation of antibodies was different in both diseases. In PD cases, tubulin and tau AIAs levels were similar. On the other hand, AD patients showed more elevation of tau AIAs compared to tubulin. Our current results suggested that AIAs panel could be able to identify cases with neuro-degeneration when compared with healthy subjects. More interestingly, it is possible to differentiate between PD and AD cases through identifying specific AIAs profile for each neurodegenerative states.	[Salama, Mohamed] Mansoura Univ, Fac Med, MERC, Mansoura, Egypt; [Salama, Mohamed] Mansoura Univ, Fac Med, Toxicol Dept, Mansoura, Egypt; [Shalash, Ali; Makar, Marianne; Roushdy, Tamer; Elbalkimy, Mahmoud] Ain Shams Univ, Fac Med, Dept Neurol, Cairo, Egypt; [Magdy, Alshimaa] Mansoura Univ, Fac Med, Biochem Dept, Mansoura, Egypt; [Elrassas, Hanan] Ain Shams Univ, Fac Med, Okasha Inst Psychiat, Cairo, Egypt; [Elkafrawy, Passent] Menoufia Univ, Fac Sci, Shebeen Elkoum, Egypt; [Mohamed, Wael] Menoufia Univ, Fac Med, Dept Pharmacol, Shebeen Elkoum, Egypt; [Mohamed, Wael] Int Islamic Univ Malaysia, Basic Med Sci Dept, Kulliyyah Med, Kuantan Pahang, Malaysia; [Abou Donia, Mohamed B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Menofia University; Egyptian Knowledge Bank (EKB); Menofia University; International Islamic University Malaysia; Duke University	Salama, M (corresponding author), Mansoura Univ, Fac Med, MERC, Mansoura, Egypt.; Salama, M (corresponding author), Mansoura Univ, Fac Med, Toxicol Dept, Mansoura, Egypt.	toxicsalama@hotmail.com	Elrassas, Hanan/AFQ-3281-2022; Mohamed, Wael/H-3195-2014; Elrassas, Hanan/ABA-2094-2020; Roushdy, Tamer Mahmoud/ABG-9151-2020	Mohamed, Wael/0000-0003-1317-0829; Roushdy, Tamer Mahmoud/0000-0002-3123-9204; ElKafrawy, Passent/0000-0002-8557-4286; Salama, Mohamed/0000-0003-1644-0273; Shalash, Ali/0000-0001-7012-5907	Egyptian Academy of Scientific Research and Technology (ASRT) through the program JESOR Development	Egyptian Academy of Scientific Research and Technology (ASRT) through the program JESOR Development	The present work was supported by a grant from Egyptian Academy of Scientific Research and Technology (ASRT) through the program JESOR Development (MS; MAB).	Abd El Rahman HA, 2018, NEUROTOX RES, V33, P316, DOI 10.1007/s12640-017-9793-y; Abou-Donia MB, 2017, NEUROTOXICOL TERATOL, V61, P36, DOI 10.1016/j.ntt.2017.03.002; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Ascherio A, 2016, LANCET NEUROL, V15, P1255, DOI 10.1016/S1474-4422(16)30230-7; Baas PW, 2001, TRENDS CELL BIOL, V11, P244, DOI 10.1016/S0962-8924(01)02005-0; Beach TG, 2017, NEUROL THER, V6, pS5, DOI 10.1007/s40120-017-0072-x; Cappelletti G, 2015, BIOCHEM SOC T, V43, P292, DOI 10.1042/BST20150007; Carletti E, 2011, CHEM RES TOXICOL, V24, P797, DOI 10.1021/tx100447k; Cartelli D, 2017, MOL NEUROBIOL, V54, P6762, DOI 10.1007/s12035-016-0188-5; Chiu MJ, 2014, HUM BRAIN MAPP, V35, P3132, DOI 10.1002/hbm.22390; de la Fuente-Fernandez R, 2011, ANN NEUROL, V69, P803, DOI 10.1002/ana.22284; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; DeMarshall C, 2015, INT REV NEUROBIOL, V122, P1, DOI 10.1016/bs.irn.2015.05.005; DeMarshall Cassandra A, 2016, Alzheimers Dement (Amst), V3, P51, DOI 10.1016/j.dadm.2016.03.002; Dumurgier J, 2017, J ALZHEIMERS DIS, V60, P1451, DOI [10.3233/JAD-170511, 10.3233/jad-170511]; El-Fawal H.A.N., 2011, ENCY ENV HLTH, VVolume 4, P87; El-Fawal HAN, 2008, NEUROTOXICOL TERATOL, V30, P161, DOI 10.1016/j.ntt.2008.01.005; El-Fawal HAN, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/340875; Esteves AR, 2014, BBA-MOL BASIS DIS, V1842, P7, DOI 10.1016/j.bbadis.2013.10.003; Gillingwater TH, 2003, J NEUROCYTOL, V32, P863, DOI 10.1023/B:NEUR.0000020629.51673.f5; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Inekci D, 2015, CURR ALZHEIMER RES, V12, P829, DOI 10.2174/1567205012666150710111211; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Kambe T, 2011, NEUROBIOL DIS, V42, P404, DOI 10.1016/j.nbd.2011.02.002; Kronimus Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164953; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; Ludolph AC, 2009, EUR J NEUROL, V16, P297, DOI 10.1111/j.1468-1331.2008.02513.x; Maetzler W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088604; Maetzler W, 2011, J ALZHEIMERS DIS, V26, P171, DOI 10.3233/JAD-2011-110221; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Monahan AJ, 2008, CELL TRANSPLANT, V17, P363; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Niwa S, 2013, EMBO J, V32, P1352, DOI 10.1038/emboj.2013.59; Nogales E, 2001, ANNU REV BIOPH BIOM, V30, P397, DOI 10.1146/annurev.biophys.30.1.397; Papuc E, 2017, J NEURAL TRANSM, V124, P209, DOI 10.1007/s00702-016-1632-4; Petersen RC, 2009, CURR ALZHEIMER RES, V6, P324, DOI 10.2174/156720509788929237; Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377; Rahman TTA, 2009, GERIATR GERONTOL INT, V9, P54, DOI 10.1111/j.1447-0594.2008.00509.x; Sengupta U, 2015, BIOL PSYCHIAT, V78, P672, DOI 10.1016/j.biopsych.2014.12.019; Shalash A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00720; Shekhar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159099; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Snyder HM, 2014, ALZHEIMERS DEMENT, V10, P109, DOI 10.1016/j.jalz.2013.10.007; SOLOMON F, 1981, J CELL BIOL, V89, P157, DOI 10.1083/jcb.89.1.157; Song Yuyu, 2014, Bioarchitecture, V4, P22, DOI 10.4161/bioa.28080; Stocchi F, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/2047-9158-4-4; Takenokuchi M, 2010, NEUROSCI LETT, V473, P182, DOI 10.1016/j.neulet.2010.02.032; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Toth C, 2010, ANN NEUROL, V68, P28, DOI 10.1002/ana.22021; Vekrellis K, 2012, EXPERT OPIN THER TAR, V16, P421, DOI 10.1517/14728222.2012.674111; Vickers JC, 2009, BRAIN RES BULL, V80, P217, DOI 10.1016/j.brainresbull.2009.08.004; Wootla B, 2015, JAMA NEUROL, V72, P1346, DOI 10.1001/jamaneurol.2015.2188	56	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196436	10.1371/journal.pone.0196436	http://dx.doi.org/10.1371/journal.pone.0196436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742117	Green Published, gold, Green Submitted			2022-12-26	WOS:000431757400028
J	Sahamishirazi, S; Moehring, J; Zikeli, S; Fleck, M; Claupein, W; Graeff-Hoenninger, S				Sahamishirazi, Samira; Moehring, Jens; Zikeli, Sabine; Fleck, Michael; Claupein, Wilhelm; Graeff-Hoenninger, Simone			Agronomic performance of new open pollinated experimental lines of broccoli (Brassica oleracea L. var. italica) evaluated under organic farming	PLOS ONE			English	Article							HOLLOW STEM; YIELD; TEMPERATURE; AGRICULTURE; STABILITY; MODELS; PLENCK	In order to develop new open pollinating cultivars of broccoli for organic farming, two experiments were conducted during fall 2015 and spring 2016. This study was aimed at comparing the agronomic performance of eleven new open pollinating breeding lines of broccoli to introduce new lines and to test their seasonal suitability for organic farming. Field experiments were carried out at the organic research station Kleinhohenheim of the University of Hohenheim (Stuttgart-Germany). Different agronomic traits total biomass fresh weight, head fresh weight, head diameter, hollow-stem, fresh weight harvest index and marketable yield were assessed together with commercial control cultivars. The data from both experiments were analyzed using a two-stage mixed model approach. In our study, genotype, growing season and their interaction had significant effects on most traits. Plants belonging to the fall growing season had bigger sizes in comparison to spring with significantly (p < 0.0001) higher biomass fresh weight. Some experimental lines had significant lower head fresh weight in spring in comparison to the fall season. The high temperature during the harvest period for the spring season affected the yield negatively through decreasing the firmness of broccoli heads. The low average minimum temperatures during the spring growing season lead to low biomass fresh weight but high fresh weight harvest index. Testing the seasonal suitability of all open pollinating lines showed that the considered fall season was better for broccoli production. However, the change in yield between the fall and the spring growing season was not significant for "Line 701" and "CHE-MIC". Considering the expression of different agronomic traits, "CHE-GRE-G", "Calinaro" and "CAN-SPB" performed the best in the fall growing season, and "CHE-GRE-G", "CHE-GRE-A", "CHE-BAL-A" and "CHE-MIC" and "Line 701" were best in the spring growing season, specifically due to the highest marketable yield and proportion of marketable heads.	[Sahamishirazi, Samira; Zikeli, Sabine; Claupein, Wilhelm; Graeff-Hoenninger, Simone] Univ Hohenheim, Inst Crop Sci, Dept Agron, Stuttgart, Baden Wuerttemb, Germany; [Moehring, Jens] Univ Hohenheim, Inst Crop Sci, Dept Biostat, Stuttgart, Baden Wuerttemb, Germany; [Fleck, Michael] Kultursaat eV Breeding Assoc, Echzell, Hesse, Germany	University Hohenheim; University Hohenheim	Sahamishirazi, S (corresponding author), Univ Hohenheim, Inst Crop Sci, Dept Agron, Stuttgart, Baden Wuerttemb, Germany.	samira.sahami@gmail.com			Bundesanstalt fur Landwirtschaft and Ernahrung [FKZ 28100E112]	Bundesanstalt fur Landwirtschaft and Ernahrung	This work was funded by "Bundesanstalt fur Landwirtschaft and Ernahrung" (www.ble.de) under the project's fund of FKZ 28100E112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER HC, 1988, PLANT BREEDING, V101, P1, DOI 10.1111/j.1439-0523.1988.tb00261.x; Ciancaleoni S, 2016, EUR J AGRON, V72, P1, DOI 10.1016/j.eja.2015.09.009; Craufurd PQ, 1999, CROP SCI, V39, P136, DOI 10.2135/cropsci1999.0011183X003900010022x; CUTCLIFFE JA, 1975, CAN J PLANT SCI, V55, P867, DOI 10.4141/cjps75-138; CUTCLIFFE JA, 1972, CAN J PLANT SCI, V52, P833, DOI 10.4141/cjps72-135; Damesa TM, 2017, AGRON J, V109, P845, DOI 10.2134/agronj2016.07.0395; Dufault RJ, 1996, J AM SOC HORTIC SCI, V121, P705, DOI 10.21273/JASHS.121.4.705; Elwan MWM, 2011, SCI HORTIC-AMSTERDAM, V127, P181, DOI 10.1016/j.scienta.2010.09.017; Farnham MW, 2011, HORTSCIENCE, V46, P858, DOI 10.21273/HORTSCI.46.6.858; Fess TL, 2011, SUSTAINABILITY-BASEL, V3, P1742, DOI 10.3390/su3101742; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; GRIFFITH M, 1991, CAN J PLANT SCI, V71, P579, DOI 10.4141/cjps91-087; Hebener M, 2013, VERSUCHSZENTRUM GART, P1; HIPP B W, 1974, Hortscience, V9, P68; *IFOAM, 2014, IFOAM NORMS ORG PROD; Kaluzewicz A., 2009, Vegetable Crops Research Bulletin, V71, P51, DOI 10.2478/v10032-009-0026-7; Khattree R, 1999, APPL MULTIVARIATE ST; Malik WA, 2018, CROP SCI, V58, P1061, DOI 10.2135/cropsci2017.12.0747; Mead R., 1988, DESIGN EXPT, P185; Hernandez-Hierro JM, 2012, J AGR FOOD CHEM, V60, P7352, DOI 10.1021/jf3018113; Mohring J, 2009, CROP SCI, V49, P1977, DOI 10.2135/cropsci2009.02.0083; Mourao ID, 2000, ACTA HORTIC, P47; Pek Z, 2012, HORTSCIENCE, V47, P1646, DOI 10.21273/HORTSCI.47.11.1646; Prohens J, 2008, VEGETABLES; Renaud ENC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095683; Sahamishirazi S, 2018, J AGRONOMY AGR ASPEC; Sharma SR., 2005, J NEW SEEDS, V6, P151, DOI [10.1300/J153v06n02_08, DOI 10.1300/J153V06N02_08]; Smith A, 2001, AUST NZ J STAT, V43, P129, DOI 10.1111/1467-842X.00163; Tan DKY, 1999, SCI HORTICULTURAE, V84, P227; Tan DKY, 2006, MODELLING BROCCOLI D, P1; Torricelli R, 2009, 1 IFOAM INT C ORG AN, P92; Torricelli R, 2014, EUPHYTICA, V199, P385, DOI 10.1007/s10681-014-1139-8; van Bueren ETL, 2011, NJAS-WAGEN J LIFE SC, V58, P193, DOI 10.1016/j.njas.2010.04.001; van Bueren ETL, 2003, CROP SCI, V43, P1922, DOI 10.2135/cropsci2003.1922; VANEEUWIJK FA, 1995, EUPHYTICA, V84, P1, DOI 10.1007/BF01677551; Wolfe MS, 2008, EUPHYTICA, V163, P323, DOI 10.1007/s10681-008-9690-9; Zink F., 1968, HOLLOW IN BROCCOLI, P8	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196775	10.1371/journal.pone.0196775	http://dx.doi.org/10.1371/journal.pone.0196775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738530	Green Submitted, Green Published, gold			2022-12-26	WOS:000431724900018
J	Nong, DH; Lepczyk, CA; Miura, T; Fox, JM				Nong, Duong H.; Lepczyk, Christopher A.; Miura, Tomoaki; Fox, Jefferson M.			Quantifying urban growth patterns in Hanoi using landscape expansion modes and time series spatial metrics	PLOS ONE			English	Article							LAND-USE CHANGE; SPATIOTEMPORAL DYNAMICS; SPRAWL; FRAGMENTATION; COALESCENCE; REGION; CHINA; AREA	Urbanization has been driven by various social, economic, and political factors around the world for centuries. Because urbanization continues unabated in many places, it is crucial to understand patterns of urbanization and their potential ecological and environmental impacts. Given this need, the objectives of our study were to quantify urban growth rates, growth modes, and resultant changes in the landscape pattern of urbanization in Hanoi, Vietnam from 1993 to 2010 and to evaluate the extent to which the process of urban growth in Hanoi conformed to the diffusion-coalescence theory. We analyzed the spatiotemporal patterns and dynamics of the built-up land in Hanoi using landscape expansion modes, spatial metrics, and a gradient approach. Urbanization was most pronounced in the periods of 2001 +/- 2006 and 2006 +/- 2010 at a distance of 10 to 35 km around the urban center. Over the 17 year period urban expansion in Hanoi was dominated by infilling and edge expansion growth modes. Our findings support the diffusion-coalescence theory of urbanization. The shift of the urban growth areas over time and the dynamic nature of the spatial metrics revealed important information about our understanding of the urban growth process and cycle. Furthermore, our findings can be used to evaluate urban planning policies and aid in urbanization issues in rapidly urbanizing countries.	[Nong, Duong H.] Vietnam Natl Univ Agr, Fac Environm, Hanoi, Vietnam; [Nong, Duong H.; Fox, Jefferson M.] East West Ctr, Honolulu, HI 96848 USA; [Lepczyk, Christopher A.] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA; [Miura, Tomoaki] Univ Hawaii Manoa, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA	Vietnam National University of Agriculture (VNUA); East West Center; Auburn University System; Auburn University; University of Hawaii System; University of Hawaii Manoa	Nong, DH (corresponding author), Vietnam Natl Univ Agr, Fac Environm, Hanoi, Vietnam.; Nong, DH (corresponding author), East West Ctr, Honolulu, HI 96848 USA.	nhduong@vnua.edu.vn	; Nong, Duong/O-8753-2017	Miura, Tomoaki/0000-0002-0882-3568; Nong, Duong/0000-0001-9867-5249	National Science Foundation [0909410]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (https://www.nsf.gov/awardsearch/showAward?AWD_ID=0909410), grant number: 0909410, to JMF.	Aguilera F, 2011, LANDSCAPE URBAN PLAN, V99, P226, DOI 10.1016/j.landurbplan.2010.10.004; Alberti M, 2005, INT REGIONAL SCI REV, V28, P168, DOI 10.1177/0160017605275160; Alberti M., 2000, INTEGRATED ASSESS, V1, P215, DOI [10.1023/A:1019140101212, DOI 10.1023/A:1019140101212]; An LQ, 1995, VIETN IRRI PARTN RIC, p45 ; BAKER WL, 1992, LANDSCAPE ECOL, V7, P291, DOI 10.1007/BF00131258; Bhatta B, 2010, ANAL URBAN GROWTH SP; Boyce R. R., 1966, BRIT COLUMBIA GEOGRA, V7, P31; Brenner N, 2014, INT J URBAN REGIONAL, V38, P731, DOI 10.1111/1468-2427.12115; Brown A, 2011, UGEC VIEWPOINTS, V6, P4; Christian DP, 1998, BIOMASS BIOENERG, V14, P395, DOI 10.1016/S0961-9534(97)10076-9; Danielle L., 2010, FACING URBAN TRANSIT; Deuskar C., 2014, E ASIAS CHANGING URB; Dietzel C, 2005, INT J GEOGR INF SCI, V19, P175, DOI 10.1080/13658810410001713407; Dietzel C, 2005, ENVIRON PLANN B, V32, P231, DOI 10.1068/b31148; Huynh DT, 2017, URBAN BOOK SERIES, P267, DOI 10.1007/978-3-319-43851-1_13; DUNCAN B, 1962, AM J SOCIOL, V67, P418, DOI 10.1086/223165; Francis R. A, 2013, URBAN ECOSYSTEMS UND; Frey H., 2003, DESIGNING CITY MORE; Harris CD, 1945, ANN AM ACAD POLIT SS, V242, P7, DOI 10.1177/000271624524200103; Hoyt H., 1939, STRUCTURE GROWTH RES; Hristov J, 2012, OUTLOOK AGR, V41, P109, DOI 10.5367/oa.2012.0081; HSO, 2009, HAN STAT YB 2008; Jenerette GD, 2010, LANDSCAPE ECOL, V25, P657, DOI 10.1007/s10980-010-9457-2; Kaji H., 2003, IS COMPACT CITY APPR; Khuong VM, 2004, COMPETITIVENESS VIET; Lepczyk CA, 2007, LANDSCAPE ECOL, V22, P939, DOI 10.1007/s10980-006-9066-2; Li C, 2013, LANDSCAPE ECOL, V28, P1875, DOI 10.1007/s10980-013-9933-6; Lindenmayer DB, 1999, BIOL CONSERV, V88, P387, DOI 10.1016/S0006-3207(98)00111-6; Liu XP, 2010, LANDSCAPE ECOL, V25, P671, DOI 10.1007/s10980-010-9454-5; Luan TD, 2000, SOCIOECONOMIC RENOVA, P65; Markussen T, 2013, INTER INTRA FARM LAN; Martellozzo F, 2011, ENVIRON PLANN B, V38, P1085, DOI 10.1068/b36090; McGarigal K., 2002, FRAGSTATS SPATIAL PA; McGarigal K, 1994, DOLORES CO, P1; Ng C, 2013, COMP SPATIAL TEMPORA, p565 ; Nong DH, 2015, LAND-BASEL, V4, P1213, DOI 10.3390/land4041213; Olsen AkselK., 2013, BERKELEY PLANNING J, V26; Park R. E., 1925, CITY SUGGESTIONS INV; Pham HM, 2011, INT J REMOTE SENS, V32, P1901, DOI 10.1080/01431161003639652; Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3; Quang NN, 2013, P E ASIA SOC TRANSPO; RIITTERS KH, 1995, LANDSCAPE ECOL, V10, P23, DOI 10.1007/BF00158551; Schneider A, 2005, ENVIRON PLANN B, V32, P323, DOI 10.1068/b31142; Seto KC, 2005, LANDSCAPE ECOL, V20, P871, DOI 10.1007/s10980-005-5238-8; Tischendorf L, 2001, LANDSCAPE ECOL, V16, P235, DOI 10.1023/A:1011112719782; Tuyen TQ, 2014, J ASIA PAC ECON, V19, P423, DOI 10.1080/13547860.2014.908539; Tratalos J, 2007, LANDSCAPE URBAN PLAN, V83, P308, DOI 10.1016/j.landurbplan.2007.05.003; Tsuboi Yoshiharu, 2007, 20 YEARS ADOPTION DO; Ulfarsson GF, 2006, ENVIRON PLANN B, V33, P767, DOI 10.1068/b30104; UN-Habitat, 2010, STAT WORLDS CIT 2010; Pham VC, 2015, J LAND USE SCI, V10, P224, DOI 10.1080/1747423X.2014.884643; Waibel M., 2004, ASIEN, V92, P30; WorldBank, 2011, 611 WORLD BANK; Wu JG, 2011, ECOL COMPLEX, V8, P1, DOI 10.1016/j.ecocom.2010.03.002; Xie YC, 2006, LANDSCAPE ECOL, V21, P1297, DOI 10.1007/s10980-006-0024-9; Xu C, 2007, LANDSCAPE ECOL, V22, P925, DOI 10.1007/s10980-007-9079-5; Yu XJ, 2007, LANDSCAPE URBAN PLAN, V79, P96, DOI 10.1016/j.landurbplan.2006.03.008; Zhu M, 2006, LANDSCAPE ECOL, V21, P723, DOI 10.1007/s10980-005-5323-z; [No title captured]	59	39	39	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196940	10.1371/journal.pone.0196940	http://dx.doi.org/10.1371/journal.pone.0196940			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE8KX	29734346	Green Submitted, Green Published, gold			2022-12-26	WOS:000431481700034
J	Clark, T; Hapiak, V; Oakes, M; Mills, H; Komuniecki, R				Clark, Tobias; Hapiak, Vera; Oakes, Mitchell; Mills, Holly; Komuniecki, Richard			Monoamines differentially modulate neuropeptide release from distinct sites within a single neuron pair	PLOS ONE			English	Article							DENSE CORE VESICLES; REGULATED SECRETORY PATHWAY; DEPRESSION-RELATED BEHAVIOR; CAENORHABDITIS-ELEGANS; LEFT/RIGHT ASYMMETRY; NERVOUS-SYSTEM; SEROTONIN; RECEPTOR; PROTEIN; EXPRESSION	Monoamines and neuropeptides often modulate the same behavior, but monoaminergic-peptidergic crosstalk remains poorly understood. In Caenorhabditis elegans, the adrenergic-like ligands, tyramine (TA) and octopamine (OA) require distinct subsets of neuropeptides in the two ASI sensory neurons to inhibit nociception. TA selectively increases the release of ASI neuropeptides encoded by nlp-14 or nlp-18 from either synaptic/perisynaptic regions of ASI axons or the ASI soma, respectively, and OA selectively increases the release of ASI neuropeptides encoded by nlp-9 asymmetrically, from only the synaptic/perisynaptic region of the right ASI axon. The predicted amino acid preprosequences of genes encoding either TA- or OA-dependent neuropeptides differed markedly. However, these distinct preprosequences were not sufficient to confer monoamine-specificity and additional N-terminal peptide-encoding sequence was required. Collectively, our results demonstrate that TA and OA specifically and differentially modulate the release of distinct subsets of neuropeptides from different subcellular sites within the ASIs, highlighting the complexity of monoaminergic/peptidergic modulation, even in animals with a relatively simple nervous system.	[Clark, Tobias; Hapiak, Vera; Oakes, Mitchell; Mills, Holly; Komuniecki, Richard] Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA	University of Toledo	Komuniecki, R (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	rkomuni@uoft02.utoledo.edu			National Institutes of Health [AI072644]; Joan L. and Julius H. Jacobson Biomedical Professorship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joan L. and Julius H. Jacobson Biomedical Professorship	This work was supported by National Institutes of Health Grant AI072644 awarded to RK, and funds from the Joan L. and Julius H. Jacobson Biomedical Professorship awarded to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee N, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006697; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bhattacharya R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004584; Birse RT, 2006, J NEUROBIOL, V66, P33, DOI 10.1002/neu.20189; Blanco EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059695; Brakch N, 2002, J NEUROCHEM, V81, P1166, DOI 10.1046/j.1471-4159.2002.00919.x; BRENNER S, 1974, GENETICS, V77, P71; Brunetti L, 2005, EUR J PHARMACOL, V519, P48, DOI 10.1016/j.ejphar.2005.07.008; Carnell L, 2005, J NEUROSCI, V25, P10671, DOI 10.1523/JNEUROSCI.3399-05.2005; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Charbogne P, 2014, NEUROPHARMACOLOGY, V76, P204, DOI 10.1016/j.neuropharm.2013.08.028; COOL DR, 1994, BIOCHIMIE, V76, P265, DOI 10.1016/0300-9084(94)90156-2; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Cunningham KA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004394; Donnelly JL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001529; El Meskini R, 2001, ENDOCRINOLOGY, V142, P864, DOI 10.1210/endo.142.2.7929; Emtage L, 2012, J NEUROSCI, V32, P16285, DOI 10.1523/JNEUROSCI.2667-12.2012; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Ezcurra M, 2016, J NEUROSCI, V36, P3157, DOI 10.1523/JNEUROSCI.1128-15.2016; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Fuenzalida LC, 2011, ENDOCRINOLOGY, V152, P4310, DOI 10.1210/en.2011-1416; Gallagher T, 2013, J NEUROSCI, V33, P9716, DOI 10.1523/JNEUROSCI.4493-12.2013; Gardella E, 2013, NEUROCHEM INT, V62, P360, DOI 10.1016/j.neuint.2013.02.003; Garrison JL, 2012, SCIENCE, V338, P540, DOI 10.1126/science.1226201; Graeff FG, 2017, NEUROSCI BIOBEHAV R, V76, P48, DOI 10.1016/j.neubiorev.2016.10.013; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Gurel G, 2012, GENETICS, V192, P1359, DOI 10.1534/genetics.112.142125; Guo M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6655; Hache G, 2012, NEUROREPORT, V23, P525, DOI 10.1097/WNR.0b013e328353d70a; Halford Jason C G, 2012, Handb Exp Pharmacol, P349, DOI 10.1007/978-3-642-24716-3_16; Hammarlund M, 2008, J CELL BIOL, V180, P483, DOI 10.1083/jcb.200708018; Hapiak V, 2013, J NEUROSCI, V33, P14107, DOI 10.1523/JNEUROSCI.1324-13.2013; Hapiak VM, 2009, GENETICS, V181, P153, DOI 10.1534/genetics.108.096891; Harris G, 2010, J NEUROSCI, V30, P7889, DOI 10.1523/JNEUROSCI.0497-10.2010; Harris GP, 2009, J NEUROSCI, V29, P1446, DOI 10.1523/JNEUROSCI.4585-08.2009; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Heisler LK, 2006, NEURON, V51, P239, DOI 10.1016/j.neuron.2006.06.004; Hendricks M, 2012, NATURE, V487, P99, DOI 10.1038/nature11081; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hobert O, 2014, GENESIS, V52, P528, DOI 10.1002/dvg.22747; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Hu ZT, 2011, NEURON, V71, P92, DOI 10.1016/j.neuron.2011.04.021; Huang YH, 2015, FEBS LETT, V589, P1607, DOI 10.1016/j.febslet.2015.05.007; Husson SJ, 2010, METHODS MOL BIOL, V615, P29, DOI 10.1007/978-1-60761-535-4_3; Isaac RE, 2009, GEN COMP ENDOCR, V162, P8, DOI 10.1016/j.ygcen.2008.12.011; Jin X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004184; Johard HAD, 2001, BRAIN RES, V919, P94, DOI 10.1016/S0006-8993(01)03004-9; Karhunen T, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0005.2001; Kohler S, 2016, J PSYCHOPHARMACOL, V30, P13, DOI 10.1177/0269881115609072; Koelle Michael R, 2018, WormBook, V2018, P1, DOI 10.1895/wormbook.1.75.2; Koren D, 2017, NEURON, V95, P914, DOI 10.1016/j.neuron.2017.07.020; Law WJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004794; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma GQ, 2008, TRAFFIC, V9, P2165, DOI 10.1111/j.1600-0854.2008.00836.x; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mills H, 2016, J NEUROSCI, V36, P5498, DOI 10.1523/JNEUROSCI.4520-15.2016; Mills H, 2012, EMBO J, V31, P667, DOI 10.1038/emboj.2011.422; Murrough JW, 2015, EXPERT OPIN EMERG DR, V20, P393, DOI 10.1517/14728214.2015.1049996; Nassel DR, 2009, INVERTEBR NEUROSCI, V9, P57, DOI 10.1007/s10158-009-0090-1; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Noble T, 2013, CELL METAB, V18, P672, DOI 10.1016/j.cmet.2013.09.007; Oakes MD, 2017, J NEUROSCI, V37, P2859, DOI 10.1523/JNEUROSCI.3151-16.2017; Ortiz CO, 2006, GENETICS, V173, P131, DOI 10.1534/genetics.106.055749; Painsipp E, 2008, GENES BRAIN BEHAV, V7, P532, DOI 10.1111/j.1601-183X.2008.00389.x; Painsipp E, 2010, J PSYCHOPHARMACOL, V24, P1541, DOI 10.1177/0269881109104851; Palamiuc L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14237; Perello M, 2008, J BIOL CHEM, V283, P19936, DOI 10.1074/jbc.M800732200; Portman Douglas S, 2006, WormBook, P1; Raiteri L, 2009, BRIT J PHARMACOL, V157, P474, DOI 10.1111/j.1476-5381.2009.00163.x; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; Salio C, 2006, CELL TISSUE RES, V326, P583, DOI 10.1007/s00441-006-0268-3; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Shakiryanova D, 2011, P NATL ACAD SCI USA, V108, P4477, DOI 10.1073/pnas.1017837108; Si W, 2010, J NEUROCHEM, V115, P475, DOI 10.1111/j.1471-4159.2010.06947.x; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Simon AC, 2013, J MOL CELL BIOL, V5, P250, DOI 10.1093/jmcb/mjt014; Smith ES, 2013, J BIOL CHEM, V288, P37071, DOI 10.1074/jbc.M113.517367; Sohn JW, 2011, NEURON, V71, P488, DOI 10.1016/j.neuron.2011.06.012; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Stigloher C, 2011, J NEUROSCI, V31, P4388, DOI 10.1523/JNEUROSCI.6164-10.2011; Stogner KA, 2000, EUR J PHARMACOL, V387, pR9, DOI 10.1016/S0014-2999(99)00800-6; Stojilkovic SS, 2005, TRENDS ENDOCRIN MET, V16, P81, DOI 10.1016/j.tem.2005.02.002; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Tasan RO, 2009, NEUROSCIENCE, V158, P1717, DOI 10.1016/j.neuroscience.2008.11.048; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Voigt JP, 2015, BEHAV BRAIN RES, V277, P14, DOI 10.1016/j.bbr.2014.08.065; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; Xia XF, 2009, J CELL SCI, V122, P75, DOI 10.1242/jcs.034603; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zang KE, 2017, ELIFE, V6, DOI 10.7554/eLife.22771; Zhang BJ, 2005, CELL MOL NEUROBIOL, V25, P581, DOI 10.1007/s10571-005-3970-x; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745; Zhou KM, 2007, NEURON, V56, P657, DOI 10.1016/j.neuron.2007.09.015	100	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196954	10.1371/journal.pone.0196954	http://dx.doi.org/10.1371/journal.pone.0196954			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723289	Green Submitted, Green Published, gold			2022-12-26	WOS:000431305100097
J	Hanaoka, H; Iida, H; Kiyokawa, T; Takakuwa, Y; Okazaki, T; Yamada, H; Ozaki, S; Kawahata, K				Hanaoka, Hironari; Iida, Harunobu; Kiyokawa, Tomofumi; Takakuwa, Yukiko; Okazaki, Takahiro; Yamada, Hidehiro; Ozaki, Shoichi; Kawahata, Kimito			Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome	PLOS ONE			English	Article							SYNDROME NEPHROPATHY; ERYTHEMATOSUS; DISEASE; CLASSIFICATION; ASSOCIATION; CRITERIA; DIAGNOSIS; CONSENSUS; OUTCOMES; UPDATE	Objective We sought to evaluate the effect of antiplatelet therapy in addition to conventional immunosuppressive therapy for lupus nephritis (LN) patients positive for antiphospholipid antibodies (aPL) without definite antiphospholipid syndrome (APS). Methods Patients with biopsy-proven LN class III or IV were retrospectively evaluated. We selected patients positive for anticardiolipin antibody (aCL) or lupus anticoagulant (LA) who did not meet the criteria for a diagnosis of APS. The patients were divided into two subgroups according to whether antiplatelet therapy was received. The cumulative complete renal response (CR) rate, relapse-free rate, and change in estimated glomerular filtration rate (eGFR) over 3 years after induction therapy were calculated. Results We identified 17 patients who received antiplatelet therapy and 21 who did not. Baseline clinicopathological characteristics and immunosuppressive therapy did not show a significant difference between the two groups except for a higher incidence of LN class IV in the treatment group (p = 0.03). There was no difference in cumulative CR rate, relapse-free rate, or eGFR change between these subgroups. However, when data on LA-positive patients were assessed, an improvement in eGFR was found (p = 0.04) in patients receiving antiplatelet treatment. Conclusion Addition of anti-platelet therapy was associated with an improvement of eGFR in LA-positive patients with LN class III or IV.	[Hanaoka, Hironari; Iida, Harunobu; Kiyokawa, Tomofumi; Takakuwa, Yukiko; Okazaki, Takahiro; Ozaki, Shoichi; Kawahata, Kimito] St Marianna Univ, Div Rheumatol & Allergol, Dept Internal Med, Sch Med, Kawasaki, Kanagawa, Japan; [Yamada, Hidehiro] Seirei Yokohama Hosp, Med Ctr Rheumat Dis, Yokohama, Kanagawa, Japan	Saint Marianna University	Hanaoka, H (corresponding author), St Marianna Univ, Div Rheumatol & Allergol, Dept Internal Med, Sch Med, Kawasaki, Kanagawa, Japan.	hhanaoka1208@yahoo.co.jp						AUSTIN HA, 1994, KIDNEY INT, V45, P544, DOI 10.1038/ki.1994.70; Bertsias GK, 2012, ANN RHEUM DIS, V71, P1771, DOI 10.1136/annrheumdis-2012-201940; Bhandari S, 1998, QJM-MON J ASSOC PHYS, V91, P401, DOI 10.1093/qjmed/91.6.401; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; Bazan EC, 2013, IMMUNOL RES, V56, P358, DOI 10.1007/s12026-013-8407-x; Daugas E, 2002, J AM SOC NEPHROL, V13, P42, DOI 10.1681/ASN.V13142; Erkan D, 2007, ARTHRITIS RHEUM-US, V56, P2382, DOI 10.1002/art.22663; Erre GL, 2014, RHEUMATOL INT, V34, P535, DOI 10.1007/s00296-013-2900-3; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Hanaoka H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175152; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Ikeuchi H, 2016, MOD RHEUMATOL, V26, P908, DOI 10.3109/14397595.2016.1158896; Khamashta MA, 2004, AUTOIMMUNITY, V37, P309, DOI 10.1080/08916930410001708706; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Moroni G, 2004, AM J KIDNEY DIS, V43, P28, DOI 10.1053/j.ajkd.2003.09.011; Moss KE, 2001, RHEUMATOLOGY, V40, P863, DOI 10.1093/rheumatology/40.8.863; Opatrny L, 2006, J RHEUMATOL, V33, P2214; Reber G, 2004, J THROMB HAEMOST, V2, P1860, DOI 10.1111/j.1538-7836.2004.00910.x; Stahl-Hallengren C, 2000, J RHEUMATOL, V27, P685; Tektonidou MG, 2014, LUPUS, V23, P1276, DOI 10.1177/0961203314538687; Tincani A, 2001, THROMB HAEMOSTASIS, V86, P575; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Uthman I, 2006, SEMIN ARTHRITIS RHEU, V35, P360, DOI 10.1016/j.semarthrit.2006.01.001; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Wisloff F, 2002, THROMB RES, V108, P263, DOI 10.1016/S0049-3848(02)00400-0	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196172	10.1371/journal.pone.0196172	http://dx.doi.org/10.1371/journal.pone.0196172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723256	Green Published, gold			2022-12-26	WOS:000431305100015
J	Moyano, E; Martinez-Rivas, FJ; Blanco-Portales, R; Molina-Hidalgo, FJ; Ric-Varas, P; Matas-Arroyo, AJ; Caballero, JL; Munoz-Blanco, J; Rodriguez-Franco, A				Moyano, Enriqueta; Martinez-Rivas, Felix J.; Blanco-Portales, Rosario; Javier Molina-Hidalgo, Francisco; Ric-Varas, Pablo; Matas-Arroyo, Antonio J.; Luis Caballero, Jose; Munoz-Blanco, Juan; Rodriguez-Franco, Antonio			Genome-wide analysis of the NAC transcription factor family and their expression during the development and ripening of the Fragaria x ananassa fruits	PLOS ONE			English	Article							STRAWBERRY FRUIT; ABSCISIC-ACID; CELL-WALL; ARABIDOPSIS-THALIANA; POSITIVE REGULATOR; PROTEIN HOMOLOGY; LEAF SENESCENCE; STRESS-RESPONSE; FACTOR GENES; SALT STRESS	NAC proteins are a family of transcription factors which have a variety of important regulatory roles in plants. They present a very well conserved group of NAC subdomains in the N-terminal region and a highly variable domain at the C-terminus. Currently, knowledge concerning NAC family in the strawberry plant remains very limited. In this work, we analyzed the NAC family of Fragaria vesca, and a total of 112 NAC proteins were identified after we curated the annotations from the version 4.0.a1 genome. They were placed into the ligation groups (pseudo-chromosomes) and described its physicochemical and genetic features. A microarray transcriptomic analysis showed six of them expressed during the development and ripening of the Fragaria x ananassa fruit. Their expression patterns were studied in fruit (receptacle and achenes) in different stages of development and in vegetative tissues. Also, the expression level under different hormonal treatments (auxins, ABA) and drought stress was investigated. In addition, they were clustered with other NAC transcription factor with known function related to growth and development, senescence, fruit ripening, stress response, and secondary cell wall and vascular development. Our results indicate that these six strawberry NAC proteins could play different important regulatory roles in the process of development and ripening of the fruit, providing the basis for further functional studies and the selection for NAC candidates suitable for biotechnological applications.	[Moyano, Enriqueta; Martinez-Rivas, Felix J.; Blanco-Portales, Rosario; Javier Molina-Hidalgo, Francisco; Luis Caballero, Jose; Munoz-Blanco, Juan; Rodriguez-Franco, Antonio] Univ Cordoba, Dept Bioquim & Biol Mol, Campus Rabanales,Edificio Severo Ochoa, Cordoba, Spain; [Ric-Varas, Pablo; Matas-Arroyo, Antonio J.] Univ Malaga, Dept Biol Vegetal, Inst Hortofruticultura Subtrop & Mediterranea May, Malaga, Spain	Universidad de Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM)	Rodriguez-Franco, A (corresponding author), Univ Cordoba, Dept Bioquim & Biol Mol, Campus Rabanales,Edificio Severo Ochoa, Cordoba, Spain.	arfranco@uco.es	Moyano, Enriqueta/K-8353-2017; Molina-Hidalgo, Francisco Javier/AAQ-1302-2021; Martinez Rivas, Felix Juan/GRS-9625-2022; Matas, Antonio J./A-9325-2008; Rodriguez Franco, Antonio/K-3804-2013; Martinez Rivas, Felix/AGD-4189-2022; Blanco-Portales, Rosario/K-8352-2017; Caballero, José L./L-2067-2014	Moyano, Enriqueta/0000-0001-8773-5971; Molina-Hidalgo, Francisco Javier/0000-0003-1184-6354; Martinez Rivas, Felix Juan/0000-0003-3808-9306; Matas, Antonio J./0000-0003-4348-3930; Rodriguez Franco, Antonio/0000-0002-0431-8273; Martinez Rivas, Felix/0000-0003-3808-9306; Blanco-Portales, Rosario/0000-0001-7540-6417; Caballero, José L./0000-0002-2678-4849; Ric Varas, Pablo Daniel/0000-0002-8307-1650	Spanish Ministerio de Ciencia e Innovacion [AGL2014-55784-C2]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by AGL2014-55784-C2 from the Spanish Ministerio de Ciencia e Innovacion.	Almeida JRM, 2007, ARCH BIOCHEM BIOPHYS, V465, P61, DOI 10.1016/j.abb.2007.04.040; Asif MH, 2000, PLANT MOL BIOL REP, V18, P109, DOI 10.1007/BF02824018; Aslam M, 2012, MOL BIOL REP, V39, P9629, DOI 10.1007/s11033-012-1828-0; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bombarely A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-503; Cao YX, 2017, PLANTA, V245, P31, DOI 10.1007/s00425-016-2589-0; Carvalho RF, 2016, CURR PLANT BIOL, V6, P19, DOI 10.1016/j.cpb.2016.09.002; Castellarin SD, 2007, PLANTA, V227, P101, DOI 10.1007/s00425-007-0598-8; Cherian S, 2014, J EXP BOT, V65, P4705, DOI 10.1093/jxb/eru280; CREELMAN RA, 1992, PLANT PHYSIOL, V99, P1258, DOI 10.1104/pp.99.3.1258; Cumplido-Laso G, 2012, J EXP BOT, V63, P4275, DOI 10.1093/jxb/ers120; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Estrada-Johnson E, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00889; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Giampieri F, 2012, NUTRITION, V28, P9, DOI 10.1016/j.nut.2011.08.009; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Gong W, 2004, PLANT PHYSIOL, V135, P773, DOI 10.1104/pp.104.042176; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hu W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136993; Hussey SG, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-173; Molina-Hidalgo FJ, 2017, J EXP BOT, V68, P4529, DOI 10.1093/jxb/erx257; Jia HF, 2016, PLANT BIOTECHNOL J, V14, P2045, DOI 10.1111/pbi.12563; Jia HF, 2013, NEW PHYTOL, V198, P453, DOI 10.1111/nph.12176; Jiang GX, 2017, PLANT CELL PHYSIOL, V58, P1075, DOI 10.1093/pcp/pcx054; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kim HJ, 2016, CURR OPIN PLANT BIOL, V33, P48, DOI 10.1016/j.pbi.2016.06.002; Kim SG, 2010, PLANT SCI, V178, P239, DOI 10.1016/j.plantsci.2009.12.007; KNEE M, 1977, J EXP BOT, V28, P377, DOI 10.1093/jxb/28.2.377; Liang MW, 2015, TRAFFIC, V16, P1062, DOI 10.1111/tra.12311; Ling L, 2017, PHYSIOL MOL BIOL PLA, V23, P343, DOI 10.1007/s12298-017-0421-3; Lira BS, 2017, PLANT PHYSIOL, V175, P77, DOI 10.1104/pp.17.00452; Ma NN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0351-y; Mao CZ, 2007, NEW PHYTOL, V176, P288, DOI 10.1111/j.1469-8137.2007.02177.x; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Medina-Puche L, 2016, FUNCT INTEGR GENOMIC, V16, P671, DOI 10.1007/s10142-016-0510-3; Medina-Puche L, 2015, PLANT PHYSIOL, V168, P598, DOI 10.1104/pp.114.252908; Medina-Puche L, 2014, J EXP BOT, V65, P401, DOI 10.1093/jxb/ert377; Meng C, 2016, J PLANT PHYSIOL, V193, P88, DOI 10.1016/j.jplph.2016.01.014; Molina-Hidalgo FJ, 2015, PLANT SCI, V238, P198, DOI 10.1016/j.plantsci.2015.06.013; Molina-Hidalgo FJ, 2013, J EXP BOT, V64, P1471, DOI 10.1093/jxb/ers386; Moyano-Canete E, 2013, PLANT CELL PHYSIOL, V54, P218, DOI 10.1093/pcp/pcs167; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Oda-Yamamizo C, 2016, SCI REP-UK, V6, DOI 10.1038/srep23609; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Pedersen S., 2001, BIORADIATIONS, V107, P10; Pei HX, 2013, PLANT PHYSIOL, V163, P775, DOI 10.1104/pp.113.223388; Pinheiro GL, 2009, GENE, V444, P10, DOI 10.1016/j.gene.2009.05.012; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Raab T, 2006, PLANT CELL, V18, P1023, DOI 10.1105/tpc.105.039784; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Shan W, 2012, J EXP BOT, V63, P5171, DOI 10.1093/jxb/ers178; Shao HB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00902; Shiriga K, 2014, META GENE, V2, P407, DOI 10.1016/j.mgene.2014.05.001; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Su HY, 2015, J PLANT BIOCHEM BIOT, V24, P176, DOI 10.1007/s13562-014-0255-9; Tranbarger TJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00603; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Vallarino JG, 2015, NEW PHYTOL, V208, P482, DOI 10.1111/nph.13463; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang XE, 2009, MOL PLANT MICROBE IN, V22, P1227, DOI 10.1094/MPMI-22-10-1227; Wang YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166727; Wei SW, 2016, PLANT CELL REP, V35, P1827, DOI 10.1007/s00299-016-1997-8; Wei W, 2016, PLANT PHYSIOL BIOCH, V105, P129, DOI 10.1016/j.plaphy.2016.04.014; Wu ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131890; Xu XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070959; Yamaguchi M, 2010, PLANT CELL, V22, P1249, DOI 10.1105/tpc.108.064048; You J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122027; Zheng X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157871; Zhou H, 2015, PLANT J, V82, P105, DOI 10.1111/tpj.12792; Zhu MK, 2014, PLANT CELL PHYSIOL, V55, P119, DOI 10.1093/pcp/pct162	74	30	34	11	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196953	10.1371/journal.pone.0196953	http://dx.doi.org/10.1371/journal.pone.0196953			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723301	gold, Green Published, Green Submitted			2022-12-26	WOS:000431305100096
J	Bhavsar, S; Dudhagara, P; Tank, S				Bhavsar, Sunil; Dudhagara, Pravin; Tank, Shantilal			R software package based statistical optimization of process components to simultaneously enhance the bacterial growth, laccase production and textile dye decolorization with cytotoxicity study	PLOS ONE			English	Article							SP. STRAIN BN6; AZO DYES; MICROBIAL DECOLORIZATION; BIOTRANSFORMATION ENZYMES; ANAEROBIC CONDITIONS; REDOX MEDIATORS; WASTE-WATER; BACILLUS SP; DEGRADATION; BIODEGRADATION	The thermophilic bacterium, Bacillus licheniformis U1 is used for the optimization of bacterial growth (R1), laccase production (R2) and synthetic disperse blue DBR textile dye decolorization (R3) in the present study. Preliminary optimization has been performed by one variable at time (OVAT) approach using four media components viz., dye concentration, copper sulphate concentration, pH, and inoculum size. Based on OVAT result further statistical optimization of R1, R2 and R3 performed by Box-Behnken design (BBD) using response surface methodology (RSM) in R software with R Commander package. The total 29 experimental runs conducted in the experimental design study towards the construction of a quadratic model. The model indicated that dye concentration 110 ppm, copper sulphate 0.2 mM, pH 7.5 and inoculum size 6% v/v were found to be optimum to maximize the laccase production and bacterial growth. Whereas, maximum dye decolorization achieved in media containing dye concentration 110 ppm, copper sulphate 0.6 mM, pH 6 and inoculum size 6% v/v. R package predicted R 2 of R1, R2 and R3 were 0.9917, 0.9831 and 0.9703 respectively; likened to Design-Expert (Stat-Ease) (DOE) predicted R 2 of R1, R2, and R3 were 0.9893, 0.9822 and 0.8442 respectively. The values obtained by R software were more precise, reliable and reproducible, compared to the DOE model. The laccase production was 1.80 fold increased, and 2.24 fold enhancement in dye decolorization was achieved using optimized medium than initial experiments. Moreover, the laccase-treated sample demonstrated the less cytotoxic effect on L132 and MCF-7 cell lines compared to untreated sample using MTT assay. Higher cell viability and lower cytotoxicity observed in a laccase-treated sample suggest the impending application of bacterial laccase in the reduction of toxicity of dye to design rapid biodegradation process.	[Bhavsar, Sunil; Dudhagara, Pravin; Tank, Shantilal] Veer Narmad South Gujarat Univ, Dept Biosci UGC SAP 2, Surat, Gujarat, India; [Dudhagara, Pravin; Tank, Shantilal] Veer Narmad South Gujarat Univ, Dept Biosci UGC SAP 2, Bioinformat & Supercomp Lab, Surat, Gujarat, India	Veer Narmad South Gujarat University; Veer Narmad South Gujarat University	Bhavsar, S (corresponding author), Veer Narmad South Gujarat Univ, Dept Biosci UGC SAP 2, Surat, Gujarat, India.	ssunil48@gmail.com	Bhavsar, Sunil/M-3050-2019	Bhavsar, Sunil/0000-0002-7525-0624	University Grant Commission (UGC), Govt. of India, New Delhi; BSR [F.7/327/2011]	University Grant Commission (UGC), Govt. of India, New Delhi; BSR	The authors gratefully acknowledge the University Grant Commission (UGC), Govt. of India, New Delhi that funded the work as part of SAP (Special Assistance Programme) and BSR support (F.7/327/2011) awarded to Department of Biosciences, Veer Narmad South Gujarat University, Surat, Gujarat, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the University Grant Commission (UGC), Govt. of India, New Delhi that funded the work as part of SAP (Special Assistance Programme) and BSR support (F.7/327/2011) awarded to Department of Biosciences, Veer Narmad South Gujarat University, Surat, Gujarat, India.	Alabdraba WMS, BIODEGRADATION AZO D; Ansari A.A., 2006, COLOURAGE, V2, P27; Asamudo NU, 2005, AFRICAN J BIOTECHNOL, V4; Ayed L, 2010, CHEM ENG J, V165, P200, DOI 10.1016/j.cej.2010.09.018; Ayed L, 2010, CHEM ENG J, V162, P495, DOI 10.1016/j.cej.2010.05.050; Babu BR, 2007, J COTTON SCI; Banat IM, 1996, BIORESOURCE TECHNOL, V58, P217, DOI 10.1016/S0960-8524(96)00113-7; Bhagat DD, 2016, J MICROB BIOTEC FOOD, V5, P396, DOI 10.15414/jmbfs.2016.5.5.396-406; Bhosale S, 2006, J BASIC MICROB, V46, P444, DOI 10.1002/jobm.200510117; Box G. E., 1960, TECHNOMETRICS, V2, P455, DOI [10.2307/1266454, DOI 10.2307/1266454, 10.1080/00401706.1960.10489912, DOI 10.1080/00401706.1960.10489912]; BROWN D, 1983, CHEMOSPHERE, V12, P405, DOI 10.1016/0045-6535(83)90115-7; BROWN D, 1987, CHEMOSPHERE, V16, P1539, DOI 10.1016/0045-6535(87)90094-4; BROWN D, 1983, CHEMOSPHERE, V12, P397, DOI 10.1016/0045-6535(83)90114-5; Casas N, 2013, ENVIRON TECHNOL, V34, P113, DOI 10.1080/09593330.2012.683820; CHUNG KT, 1992, MUTAT RES, V277, P201, DOI 10.1016/0165-1110(92)90044-A; CHUNG KT, 1993, ENVIRON TOXICOL CHEM, V12, P2121, DOI 10.1002/etc.5620121120; Cristovao RO, 2009, BIORESOURCE TECHNOL, V100, P1094, DOI 10.1016/j.biortech.2008.08.007; Dafale N, 2008, BIORESOURCE TECHNOL, V99, P2552, DOI 10.1016/j.biortech.2007.04.044; Delee W, 1998, J CHEM TECHNOL BIOT, V73, P323, DOI 10.1002/(SICI)1097-4660(199812)73:4<323::AID-JCTB976>3.3.CO;2-J; Dudhagara DR, 2016, CHEMOMETR INTELL LAB, V159, P155, DOI 10.1016/j.chemolab.2016.10.018; Duran N, 2000, APPL CATAL B-ENVIRON, V28, P83, DOI 10.1016/S0926-3373(00)00168-5; El-Fakharany EM, 2016, INT J AGRIC BIOL, V18, P939, DOI 10.17957/IJAB/15.0190; Fox J, 2012, RCMDR R COMMANDER R; Gallego Adriana, 2006, Actualidades Biologicas (Medellin), V28, P39; GINGELL R, 1971, Xenobiotica, V1, P231; Gromping U., 2011, TUTORIAL DESIGNING E; Hatvani N, 2001, PROCESS BIOCHEM, V37, P491, DOI 10.1016/S0032-9592(01)00236-9; Jin XC, 2007, APPL MICROBIOL BIOT, V74, P239, DOI 10.1007/s00253-006-0658-1; John AB, 1995, PROG IND M, V32, P157; Kaira GS, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-014-0092-1; Kalme S, 2009, ENZYME MICROB TECH, V44, P65, DOI 10.1016/j.enzmictec.2008.10.005; Kaushik G, 2014, BIOREMEDIAT J, V18, P28, DOI 10.1080/10889868.2013.834869; Keck A, 1997, APPL ENVIRON MICROB, V63, P3684, DOI 10.1128/AEM.63.9.3684-3690.1997; Khalid A, 2008, APPL MICROBIOL BIOT, V79, P1053, DOI 10.1007/s00253-008-1498-y; Kodam KM, 2005, WORLD J MICROB BIOT, V21, P367, DOI 10.1007/s11274-004-5957-z; Kudlich M, 1997, APPL ENVIRON MICROB, V63, P3691, DOI 10.1128/AEM.63.9.3691-3694.1997; LEVINE WG, 1991, DRUG METAB REV, V23, P253, DOI 10.3109/03602539109029761; Lin YH, 2008, BIOCHEM ENG J, V39, P457, DOI 10.1016/j.bej.2007.10.015; Malhotra K, 2004, BIOTECHNOL LETT, V26, P1047, DOI 10.1023/B:BILE.0000032959.10370.18; Marmion D.M., 1991, HDB US COLORANTS FOO; McMullan G, 2001, APPL MICROBIOL BIOT, V56, P81, DOI 10.1007/s002530000587; Mohamed F.A., 2014, J BIOREMED BIODEG, V5, P2; Montgomery DC, 2008, DESIGN ANAL EXPT; Myers RH., 2016, RESPONSE SURFACE MET; Nachiyar CV, 2005, ENZYME MICROB TECH, V36, P503, DOI 10.1016/j.enzmictec.2004.11.015; Niladevi KN, 2008, BIORESOURCE TECHNOL, V99, P4583, DOI 10.1016/j.biortech.2007.06.056; Ola IO, 2010, AFRICAN J BIOTECHNOL, V9; Ooi T, 2007, APPL MICROBIOL BIOT, V75, P377, DOI 10.1007/s00253-006-0836-1; Patel R., 2015, INT J APPL SCI BIOTE, V2, P137; Rahman SHA, 2007, BIORESOURCE TECHNOL, V98, P554, DOI 10.1016/j.biortech.2006.02.016; Rai HS, 2005, CRIT REV ENV SCI TEC, V35, P219, DOI 10.1080/10643380590917932; Rajeshkannan R, 2010, BIODEGRADATION, V21, P713, DOI 10.1007/s10532-010-9337-0; Rajeswari M, 2015, CHARACTERIZATION OPT; RazoFlores E, 1997, ENVIRON SCI TECHNOL, V31, P2098, DOI 10.1021/es960933o; Reinhammar B, 1981, BLUE COPPER CONTAINI, V3; RIDE JP, 1980, PHYSIOL PLANT PATHOL, V16, P187, DOI 10.1016/0048-4059(80)90033-8; Sabu A, 2005, BIORESOURCE TECHNOL, V96, P1223, DOI 10.1016/j.biortech.2004.11.002; Salokhe MD, 1999, WORLD J MICROB BIOT, V15, P259, DOI 10.1023/A:1008875404889; Saratale RG, 2009, BIORESOURCE TECHNOL, V100, P2493, DOI 10.1016/j.biortech.2008.12.013; Sarmiento F, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00148; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Singh K, 2011, CRIT REV ENV SCI TEC, V41, P807, DOI 10.1080/10643380903218376; Sondhi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096951; Stolz A, 2001, APPL MICROBIOL BIOT, V56, P69, DOI 10.1007/s002530100686; VAIDYA AA, 1982, COLOURAGE, V29, P3; Verma A., 2014, SCH ACAD J BIOSCI, V2, P479; WALKER R, 1970, FOOD COSMET TOXICOL, V8, P539, DOI 10.1016/S0015-6264(70)80455-2; Zhang FF, 2002, J ENVIRON SCI HEAL A, V37, P707, DOI 10.1081/ESE-120003248; Zhang XD, 1997, J FOOD SCI, V62, P97, DOI 10.1111/j.1365-2621.1997.tb04376.x	69	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195795	10.1371/journal.pone.0195795	http://dx.doi.org/10.1371/journal.pone.0195795			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718934	Green Submitted, gold, Green Published			2022-12-26	WOS:000431281900030
J	Hai, D; Min, DZ; Khang, NS; Tan, YH; Thoa, PTK; Bramley, GLC; de Kok, RPJ; Li, B				Do Van Hai; Min, Dao-Zhang; Nguyen Sinh Khang; Tan, Yun-Hong; Pham Thi Kim Thoa; Bramley, Gemma L. C.; de Kok, Rogier P. J.; Li, Bo			Premna vietnamensis (Lamiaceae, Premnoideae), a distinct new species from the Central Highlands of Vietnam	PLOS ONE			English	Article							FLORA-MALESIANA AREA; L. LAMIACEAE; PHYLOGENY; MODEL	Premna vietnamensis, a distinct new species which is endemic to Gia Lai Province in Central Highlands of Vietnam, is described and illustrated. It is characterized by its calyx tube bearing a semi-globose fleshy appendage, which has not been reported before from all known congeneric taxa, as well as from the Lamiaceae. A phylogenetic analysis of the whole Lamiaceae based on a sampling including representatives from all 12 currently recognized subfamilies confirmed the placement of this new species within Premna of the Premnoideae. Morphologically and geographically, P. vietnamensis is most similar to P. stenobotrys, but differs significantly in many aspects.	[Do Van Hai; Nguyen Sinh Khang] Vietnam Acad Sci & Technol, Inst Ecol & Biol Resources, Hanoi, Vietnam; [Min, Dao-Zhang; Li, Bo] Jiangxi Agr Univ, Coll Agron, Nanchang, Jiangxi, Peoples R China; [Tan, Yun-Hong] Chinese Acad Sci, Southeast Asia Biodivers Res Inst, Yezin, Nay Pyi Taw, Myanmar; [Tan, Yun-Hong] Chinese Acad Sci, Ctr Integrat Conservat, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Pham Thi Kim Thoa] Danang Univ Sci & Technol, Fac Environm, Danang, Vietnam; [Bramley, Gemma L. C.] Royal Bot Gardens Kew, Herbarium, Richmond, Surrey, England; [de Kok, Rogier P. J.] Natl Pk Board, Singapore Bot Gardens, Singapore, Singapore	Vietnam Academy of Science & Technology (VAST); Jiangxi Agricultural University; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; University of Danang; Royal Botanic Gardens, Kew	Li, B (corresponding author), Jiangxi Agr Univ, Coll Agron, Nanchang, Jiangxi, Peoples R China.	hanbolijx@163.com		Pham Thi, Kim Thoa/0000-0003-4988-7864	National Natural Science Foundation of China [31460044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China: granted to BL, grant no. 31460044, http://wm.nsfc.gov.cn/. The funder is fully responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	[Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Blume C. L., 2011, TREE FLORA SABAH SAR, V7, P42; Briquet J., 1897, NATURLICHEN PFLANZEN, P132; Charan L., 2009, NAT HIST J CHULALONG, V9, P113; Chen S.L., 1994, FLORA CHINA, V17, P16; Daniel P., 2002, INDIAN VERBENACEAE; de Kok R, 2013, KEW BULL, V68, P55, DOI 10.1007/s12225-013-9433-5; de Kok Rogier, 2011, Gardens' Bulletin (Singapore), V63, P495; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harley RM, 2004, FA GE VAS P, V7, P167; Ho P.H, 2003, CAY CO VIET NAM ILLU, V2; Kumar Konickal Mambetta Prabhu, 2013, Webbia, V68, P127, DOI 10.1080/00837792.2013.849937; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leeratiwong C, 2008, NAT HIST J CHULALONG, V8, P7; Li B, 2017, PHYTOTAXA, V313, P222, DOI 10.11646/phytotaxa.313.2.9; Li B, 2016, SCI REP-UK, V6, DOI 10.1038/srep34343; Mabberley D.J., 2004, FLORE NOUVELLE CALED, V25, P20; McNEILL J., 2012, INT CODE NOMENCLATUR; Moldenke H.N., 1983, REVISED HDB FLORA CE, V4, P196; MUNIR A A, 1984, Journal of the Adelaide Botanic Gardens, V7, P1; Paul TK., 2008, PLEIONE, V2, P239; Phuong VX, 2007, FLORA OF VIETNAM, V6, P147; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rajendran A., 1993, Journal of the Bombay Natural History Society, V90, P80; Rajendran A, 1997, B BOT SURVEY INDIA, V34, P174; Rajendran A, 1997, B BOT SURVEY INDIA, V34, P177; Refulio-Rodriguez NF, 2014, AM J BOT, V101, P287, DOI 10.3732/ajb.1300394; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schaferhoff B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-352; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tan YH, 2017, PHYTOKEYS, P93, DOI [10.3897/phytokeys.83.12869, 10.3897/phytokeys.85.19983]; Tan YH, 2014, PHYTOTAXA, V173, P207, DOI 10.11646/phytotaxa.173.3.3; VERDCOURT B, 1992, FLORA TROPICAL E AFR, P1; Young ND, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-6	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195811	10.1371/journal.pone.0195811	http://dx.doi.org/10.1371/journal.pone.0195811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718994	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900033
J	Teshome, DF; Demssie, AF; Zeleke, BM				Teshome, Destaw Fetene; Demssie, Amsalu Feleke; Zeleke, Berihun Megabiaw			Determinants of blood pressure control amongst hypertensive patients in Northwest Ethiopia	PLOS ONE			English	Article							CROSS-SECTIONAL SURVEY; UNCONTROLLED HYPERTENSION; SOUTHWEST ETHIOPIA; PREVALENCE; AWARENESS; INDIA	Background Controlling blood pressure (BP) leads to significant reduction in cardiovascular risks and associated deaths. In Ethiopia, data is scarce about the level and determinants of optimal BP control among hypertensive patients. This study aimed to assess the prevalence and associated factors of optimal BP control among hypertensive patients attending at a district hospital. Methods A hospital-based, cross-sectional study was conducted among 392 hypertensive patients who were on treatment and follow-up at a district hospital. A structured questionnaire adopted from WHO approach was prepared to collect the data. Medication adherence was measured by the four-item Morisky Green Levine Scale, with a score >= 3 defined as "good adherence" Blood pressure was measured, and optimal BP control was 0DEFined as systolic BP < 140 mmHg and diastolic BP<90 mmHg. Both binary and multivariable logistic regressions models were fitted to identify correlates of optimal BP control. All statistical tests were two-sided and a p values < 0.05 was considered for statistical significance. Results The mean age of the participants was 58 years (SD +/- 13 years). Over half (53.8%) were females. Three quarters (77.3%) of the participants were adherent to their medications. The overall proportion of participants with optimally controlled BP was 42.9%. Female sex (Adjusted Odd Ratio(AOR) = 1.94, 95% CI: 1.15, 3.26), age older than 60 years (AOR = 2.95, 95% CI: 1.18, 7.40), consumption of vegetables on most days of the week (AOR = 2.16, 95% CI: 1.25, 3.73), physical activity (AOR = 4.85, 95% CI: 2.39, 9.83), and taking less than three drugs per day (AOR = 3.04, 95% CI: 1.51, 6.14) were positively associated with optimally controlled BP. Poor adherence to medications (AOR = 0.18, 95% CI: 0.09, 0.35), having asthma comorbidity (AOR = 0.33, 95% CI: 0.12, 0.88) and use of top added salt on a plate (AOR = 0.20, 95% CI: 0.11, 0.36) were negatively associated with optimal BP control. Conclusion A higher proportion of hypertensive patients remain with un-controlled BP. Modifiable risk factors including poor adherence to medications, lack of physical exercise, adding salt into meals, being on multiple medications and comorbidities were significantly and independently associated with poor BP control. Evidence-based, adherence-enhancing and healthy life style interventions should be implemented.	[Teshome, Destaw Fetene; Zeleke, Berihun Megabiaw] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Demssie, Amsalu Feleke] Univ Gondar, Inst Publ Hlth, Dept Hlth Serv Management & Hlth Econ, Gondar, Ethiopia; [Zeleke, Berihun Megabiaw] Monash Univ, Sch Publ Hlth & Preventat Med, Dept Epidemiol & Preventat Med, Melbourne, Vic, Australia	University of Gondar; University of Gondar; Monash University	Teshome, DF (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia.	destaw.fetene@gmail.com		zeleke, BERIHUN/0000-0001-9369-3915				Akinyi H, 2013, PAN AFRICAN MED J, V16; Ambaw AD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-282; Awoke A, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-113; Babiker FA, 2013, CARDIOVASC J AFR, V24, P208, DOI 10.5830/CVJA-2013-035; Bonsa F, 2014, ETHIOP J HEALTH SCI, V24, P21, DOI 10.4314/ejhs.v24i1.3; Chow CK, 2015, JAMA-J AM MED ASSOC, V310, P959; Duncan P, 2014, S AFR FAM PRACT, V56, P297, DOI 10.1080/20786190.2014.975481; Dzudie A, 2012, BMJ; Ekwunife O. I., 2010, Health, V2, P731; Federal Ministry of Health, 2010, HLTH HLTH REL IND; Gudina EK, 2013, INTEGR BLOOD PRESS C, V6, P111, DOI 10.2147/IBPC.S47298; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; Kalavathy MC, 2000, NATL MED J INDIA, V13, P9; Ke L, 2015, AM J HYPERTENSION, V28; Lichisa G, 2014, INT J PHARM BIOL SCI, V2; Maimaris W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001490; Maryon-Davis A, 2005, EASING PRESSURE TACK; Mohan V, 2007, J Assoc Physicians India, V55, P326; National Heart Lung and Blood Institute., 2003, YOUR GUID LOW BLOOD; Okoro RN., 2012, INT J BIOMED SCI, V3, P47; Peterson ED, 2014, JNC 8 NEW GUIDELINES; Rahman MM, 2015, J HYPERTENS, V33, P465, DOI 10.1097/HJH.0000000000000421; Ramli Azuana, 2012, Patient Prefer Adherence, V6, P613, DOI 10.2147/PPA.S34704; Son PT, 2012, J HUM HYPERTENS, V26, P268, DOI 10.1038/jhh.2011.18; WHO, WHO STEP WIS APPR CH; Yang L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-903; Yip W, 2013, J HYPERTENS, V31, P1539, DOI 10.1097/HJH.0b013e328361d52b	27	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196535	10.1371/journal.pone.0196535	http://dx.doi.org/10.1371/journal.pone.0196535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718964	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900059
J	Samarani, M; Loberto, N; Solda, G; Straniero, L; Asselta, R; Duga, S; Lunghi, G; Zucca, FA; Mauri, L; Ciampa, MG; Schiumarini, D; Bassi, R; Giussani, P; Chiricozzi, E; Prinetti, A; Aureli, M; Sonnino, S				Samarani, Maura; Loberto, Nicoletta; Solda, Giulia; Straniero, Letizia; Asselta, Rosanna; Duga, Stefano; Lunghi, Giulia; Zucca, Fabio A.; Mauri, Laura; Ciampa, Maria Grazia; Schiumarini, Domitilla; Bassi, Rosaria; Giussani, Paola; Chiricozzi, Elena; Prinetti, Alessandro; Aureli, Massimo; Sonnino, Sandro			A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest	FASEB JOURNAL			English	Article						glycosphingolipids; glycohydrolases; cell proliferation; cell surface; catabolism	HUMAN FIBROBLASTS; SUCROSE MODEL; GANGLIOSIDE; CERAMIDE; PROTEIN; DIFFERENTIATION; IDENTIFICATION; BIOGENESIS; SURFACE; TFEB	Lysosomal accumulation of undegraded materials is a common feature of lysosomal storage diseases, neurodegenerative disorders, and the aging process. To better understand the role of lysosomal storage in the onset of cell damage, we used human fibroblasts loaded with sucrose as a model of lysosomal accumulation. Sucrose-loaded fibroblasts displayed increased lysosomal biogenesis followed by arrested cell proliferation. Notably, we found that reduced lysosomal catabolism and autophagy impairment led to an increase in sphingolipids (i.e., sphingomyelin, glucosylceramide, ceramide, and the gangliosides GM3 and GD3), at both intracellular and plasma membrane (PM) levels. In addition, we observed an increase in the lysosomal membrane protein Lamp-1 on the PM of sucrose-loaded fibroblasts and a greater release of the soluble lysosomal protein cathepsin D in their extracellular medium compared with controls. These results indicate increased fusion between lysosomes and the PM, as also suggested by the increased activity of lysosomal glycosphingolipid hydrolases on the PM of sucrose-loaded fibroblasts. The inhibition of -glucocerebrosidase and nonlysosomal glucosylceramidase, both involved in ceramide production resulting from glycosphingolipid catabolism on the PM, partially restored cell proliferation. Our findings indicate the existence of a new molecular mechanism underlying cell damage triggered by lysosomal impairment.Samarani, M., Loberto, N., Solda, G., Straniero, L., Asselta, R., Duga, S., Lunghi, G., Zucca, F. A., Mauri, L., Ciampa, M. G., Schiumarini, D., Bassi, R., Giussani, P., Chiricozzi, E., Prinetti, A., Aureli, M., Sonnino, S. A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest.	[Samarani, Maura; Loberto, Nicoletta; Lunghi, Giulia; Mauri, Laura; Ciampa, Maria Grazia; Schiumarini, Domitilla; Bassi, Rosaria; Giussani, Paola; Chiricozzi, Elena; Prinetti, Alessandro; Aureli, Massimo; Sonnino, Sandro] Univ Milan, Dept Med Biotechnol & Translat Med, Via Fratelli Cervi 93, I-20090 Milan, Italy; [Solda, Giulia; Straniero, Letizia; Asselta, Rosanna; Duga, Stefano] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Solda, Giulia; Straniero, Letizia; Asselta, Rosanna; Duga, Stefano] Humanitas Clin & Res Ctr, Milan, Italy; [Zucca, Fabio A.] Natl Res Council Italy, Inst Biomed Technol, Segrate, Italy	University of Milan; Humanitas University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Aureli, M; Sonnino, S (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, Via Fratelli Cervi 93, I-20090 Milan, Italy.	massimo.aureli@unimi.it; sandro.sonnino@unimi.it	mauri, laura/GPS-4868-2022; Solda', Giulia/A-4053-2011; Zucca, Fabio A./O-4368-2015; Soldà, Giulia/AAG-3589-2020; Chiricozzi, Elena/AAC-2018-2019; Straniero, Letizia/HHM-4707-2022; Lunghi, Giulia/GLU-1509-2022; Asselta, Rosanna/AAC-2367-2019; STRANIERO, LETIZIA/AAB-4869-2020; MAURI, LAURA/H-5076-2017; Duga, Stefano/F-8173-2014	Solda', Giulia/0000-0003-0972-610X; Zucca, Fabio A./0000-0003-1230-1129; Soldà, Giulia/0000-0003-0972-610X; Straniero, Letizia/0000-0002-1733-7561; Asselta, Rosanna/0000-0001-5351-0619; STRANIERO, LETIZIA/0000-0002-1733-7561; MAURI, LAURA/0000-0002-4194-4804; CHIRICOZZI, ELENA/0000-0001-7431-9207; Duga, Stefano/0000-0003-3457-1410; LUNGHI, GIULIA/0000-0002-3099-3395	Fondazione Cariplo Grant 2015-1017; Italian National Research Council's flagship "InterOmics" Project [PB.P05]; National Research Program (Italian Ministry of Education, Universities and Research); National Research Council (Italian Ministry of Education, Universities and Research); Medical University of South Carolina's Lipidomics Shared Resource [Hollings Cancer Center, Medical University of South Carolina (MUSC)] [P30 CA138313]; Lipidomics Shared Resource of the South Carolina Lipidomics and Pathobiology Centers of Biomedical Research Excellence (COBRE); MUSC Department of Biochemistry [P20 RR017677]; U.S. National Institutes of Health, National Center for Research Resources [C06 RR018823]; U.S. National Institutes of Health, Office of the Director [C06 RR018823]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER	Fondazione Cariplo Grant 2015-1017(Fondazione Cariplo); Italian National Research Council's flagship "InterOmics" Project; National Research Program (Italian Ministry of Education, Universities and Research); National Research Council (Italian Ministry of Education, Universities and Research); Medical University of South Carolina's Lipidomics Shared Resource [Hollings Cancer Center, Medical University of South Carolina (MUSC)]; Lipidomics Shared Resource of the South Carolina Lipidomics and Pathobiology Centers of Biomedical Research Excellence (COBRE); MUSC Department of Biochemistry; U.S. National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. National Institutes of Health, Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Maria Carla Panzeri (Advanced Light and Electron Microscopy BioImaging Center, San Raffaele Scientific Institute, Milan, Italy) for her expert assistance in electron microscopy imaging, and Prof. J. M. F. G. Aerts (Leiden University, Leiden, The Netherlands) for providing AMP-DNM. This work was supported by Fondazione Cariplo Grant 2015-1017 to M. A., and was partially supported by the Italian National Research Council's flagship "InterOmics" Project (PB.P05), part of the 2012-2014 program on aging sponsored by the National Research Program and the National Research Council (Italian Ministry of Education, Universities and Research). Lipidomic analyses were partially supported by the Medical University of South Carolina's Lipidomics Shared Resource [Hollings Cancer Center, Medical University of South Carolina (MUSC); Grant P30 CA138313]; the Lipidomics Shared Resource of the South Carolina Lipidomics and Pathobiology Centers of Biomedical Research Excellence (COBRE); MUSC Department of Biochemistry (Grant P20 RR017677); and the U.S. National Institutes of Health, National Center for Research Resources and Office of the Director (Grant C06 RR018823) for the occupancy of space for the Lipidomics Shared Resource, 505 Children's Research Institute (CRI) Analytical Unit. The authors declare no conflicts of interest.	ALTIN JG, 1995, ANAL BIOCHEM, V224, P382, DOI 10.1006/abio.1995.1054; APPELMANS F, 1955, BIOCHEM J, V59, P438, DOI 10.1042/bj0590438; Aureli M, 2014, MOL NEUROBIOL, V50, P76, DOI 10.1007/s12035-013-8592-6; Aureli M, 2012, J INHERIT METAB DIS, V35, P1081, DOI 10.1007/s10545-012-9478-x; Aureli M, 2012, GLYCOCONJUGATE J, V29, P585, DOI 10.1007/s10719-012-9385-2; Aureli M, 2012, NEUROCHEM RES, V37, P1344, DOI 10.1007/s11064-012-0719-z; Aureli M, 2011, J NEUROCHEM, V116, P891, DOI 10.1111/j.1471-4159.2010.07019.x; Aureli M, 2009, FEBS LETT, V583, P2469, DOI 10.1016/j.febslet.2009.06.048; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Carmona-Gutierrez D, 2016, AGEING RES REV, V32, P2, DOI 10.1016/j.arr.2016.04.009; Chigorno V, 1996, J BIOL CHEM, V271, P21738, DOI 10.1074/jbc.271.36.21738; Chigorno V, 1997, EUR J BIOCHEM, V250, P661, DOI 10.1111/j.1432-1033.1997.00661.x; Chigorno V, 1985, GLYCOCONJUGATE J, VV2, P279; COLE SR, 1987, MOL IMMUNOL, V24, P699, DOI 10.1016/0161-5890(87)90051-4; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; FOLCH J, 1957, J BIOL CHEM, V226, P497; GIGLIONI A, 1990, BIOCHEM INT, V22, P85; Hamer I, 2005, EXP CELL RES, V309, P284, DOI 10.1016/j.yexcr.2005.06.006; Helip-Wooley A, 2004, EXP CELL RES, V292, P89, DOI 10.1016/j.yexcr.2003.09.003; Higuchi T, 2015, J CELL BIOCHEM, V116, P609, DOI 10.1002/jcb.25012; HUG G, 1984, NEW ENGL J MED, V310, P1018, DOI 10.1056/NEJM198404193101604; Isaac EL, 2000, EXP CELL RES, V254, P204, DOI 10.1006/excr.1999.4755; JAHRAUS A, 1994, J CELL SCI, V107, P145; Karageorgos LE, 1997, EXP CELL RES, V234, P85, DOI 10.1006/excr.1997.3581; KATO T, 1984, MOL CELL BIOCHEM, V60, P83; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173771; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Mencarelli S, 2005, FEBS LETT, V579, P5501, DOI 10.1016/j.febslet.2005.08.081; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Perera RM, 2016, ANNU REV CELL DEV BI, V32, P223, DOI 10.1146/annurev-cellbio-111315-125125; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; Prinetti A, 2001, J NEUROCHEM, V78, P1162, DOI 10.1046/j.1471-4159.2001.00515.x; Prinetti A, 2011, NEUROCHEM RES, V36, P1654, DOI 10.1007/s11064-010-0380-3; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Santaguida S, 2015, AUTOPHAGY, V11, P2383, DOI 10.1080/15548627.2015.1110670; Santaguida S, 2015, GENE DEV, V29, P2010, DOI 10.1101/gad.269118.115; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schiumarini D, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/1730245; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Sciannamblo M, 2002, GLYCOCONJUGATE J, V19, P181, DOI 10.1023/A:1024249707516; Settembre C, 2015, METHOD CELL BIOL, V126, P45, DOI 10.1016/bs.mcb.2014.11.011; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Sonnino S, 2000, METHOD ENZYMOL, V311, P639; Sonnino S, 2006, CHEM REV, V106, P2111, DOI 10.1021/cr0100446; TOYOKUNI T, 1991, J LABELLED COMPD RAD, V29, P567, DOI 10.1002/jlcr.2580290508; Valaperta R, 2007, J NEUROCHEM, V100, P708, DOI 10.1111/j.1471-4159.2006.04279.x; Valaperta R, 2006, FASEB J, V20, P1227, DOI 10.1096/fj.05-5077fje; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VASKOVSKY VE, 1968, J LIPID RES, V9, P396; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014; Walkley SU, 2004, SEMIN CELL DEV BIOL, V15, P433, DOI 10.1016/j.semcdb.2004.03.002; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; WOLFF RA, 1994, J BIOL CHEM, V269, P19605; Zhang LS, 2009, ACTA BIOCH BIOPH SIN, V41, P437, DOI 10.1093/abbs/gmp031	68	25	25	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5685	5702		10.1096/fj.201701512RR	http://dx.doi.org/10.1096/fj.201701512RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29746165	Green Published, Bronze			2022-12-26	WOS:000447972500040
J	Peladeau, C; Adam, NJ; Jasmin, BJ				Peladeau, Christine; Adam, Nadine J.; Jasmin, Bernard J.			Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression	FASEB JOURNAL			English	Article						DMD; NSAID; p38 MAPK; Celebrex	DUCHENNE MUSCULAR-DYSTROPHY; ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; MESSENGER-RNA; GLYCOPROTEIN COMPLEX; MOUSE MUSCLE; FIBER-TYPE; P38 MAPK; BINDING; PATHOLOGY	Duchenne muscular dystrophy (DMD) is a genetic and progressive neuromuscular disorder caused by mutations and deletions in the dystrophin gene. Although there is currently no cure, one promising treatment for DMD is aimed at increasing endogenous levels of utrophin A to compensate functionally for the lack of dystrophin. Recent studies from our laboratory revealed that heparin treatment of mdx mice activates p38 MAPK, leading to an upregulation of utrophin A expression and improvements in the dystrophic phenotype. Based on these findings, we sought to determine the effects of other potent p38 activators, including the cyclooxygenase (COX)-2 inhibitor celecoxib. In this study, we treated 6-wk-old mdx mice for 4 wk with celecoxib. Immunofluorescence analysis of celecoxib-treated mdx muscles revealed a fiber type switch from a fast to a slower phenotype along with beneficial effects on muscle fiber integrity. In agreement, celecoxib-treated mdx mice showed improved muscle strength. Celecoxib treatment also induced increases in utrophin A expression ranging from approximate to 1.5- to 2-fold in tibialis anterior diaphragm and heart muscles. Overall, these results highlight that activation of p38 in muscles can indeed lead to an attenuation of the dystrophic phenotype and reveal the potential role of celecoxib as a novel therapeutic agent for the treatment of DMD.Peladeau, C., Adam, N. J., Jasmin, B. J. Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression.	[Peladeau, Christine; Adam, Nadine J.; Jasmin, Bernard J.] Univ Ottawa, Fac Med, Ctr Neuromuscular Dis, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Ottawa	Jasmin, BJ (corresponding author), Univ Ottawa, Fac Med, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	jasmin@uottawa.ca			Jesse's Journey; Association Francaise contre les Myopathies; Muscular Dystrophy Association; Canadian Institutes of Health Research; Centre for Neuromuscular Disease (CNMD) Scholarships in Translational Research	Jesse's Journey; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Muscular Dystrophy Association(Muscular Dystrophy Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Centre for Neuromuscular Disease (CNMD) Scholarships in Translational Research	The authors are grateful to John Lunde (University of Ottawa) for expert technical assistance. This work was supported by grants from Jesse's Journey, the Association Francaise contre les Myopathies, the Muscular Dystrophy Association and the Canadian Institutes of Health Research. C.P. benefited from Centre for Neuromuscular Disease (CNMD) Scholarships in Translational Research throughout this work. The authors declare no conflicts of interest.	Al-Rewashdy H, 2015, HUM MOL GENET, V24, P1243, DOI 10.1093/hmg/ddu535; Amenta AR, 2011, P NATL ACAD SCI USA, V108, P762, DOI 10.1073/pnas.1013067108; Amirouche A, 2013, HUM MOL GENET, V22, P3093, DOI 10.1093/hmg/ddt165; Baby SM, 2010, BRAIN PATHOL, V20, P323, DOI 10.1111/j.1750-3639.2009.00275.x; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Bogdanovich S, 2004, J MOL MED, V82, P102, DOI 10.1007/s00109-003-0484-1; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Brueggemann Lioubov I, 2010, Mol Cell Pharmacol, V2, P15; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Chakkalakal JV, 2005, FASEB J, V19, P880, DOI 10.1096/fj.04-1956rev; Chalkiadaki A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004490; CLERK A, 1993, HISTOCHEM J, V25, P554; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Courdier-Fruh I, 2002, NEUROMUSCULAR DISORD, V12, pS95, DOI 10.1016/S0960-8966(02)00089-5; Daham K, 2011, CLIN EXP ALLERGY, V41, P36, DOI 10.1111/j.1365-2222.2010.03617.x; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; DESILVA S, 1987, ARCH NEUROL-CHICAGO, V44, P818, DOI 10.1001/archneur.1987.00520200022012; Drmic D, 2017, WORLD J GASTROENTERO, V23, P5304, DOI 10.3748/wjg.v23.i29.5304; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Dudley RWR, 2006, AM J PATHOL, V168, P1276, DOI 10.2353/ajpath.2006.050683; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Durie D, 2011, ONCOGENE, V30, P1460, DOI 10.1038/onc.2010.527; Ehmsen J, 2002, J CELL SCI, V115, P2801; Ehrenborg E, 2009, PHARMACOL REV, V61, P373, DOI 10.1124/pr.109.001560; Farooq F, 2013, HUM MOL GENET, V22, P3415, DOI 10.1093/hmg/ddt191; Farooq F, 2009, HUM MOL GENET, V18, P4035, DOI 10.1093/hmg/ddp352; FENICHEL GM, 1991, NEUROLOGY, V41, P1874, DOI 10.1212/WNL.41.12.1874; Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615; Gayraud J, 2010, PEDIATR PULM, V45, P552, DOI 10.1002/ppul.21204; Ghosh T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134809; Giordano C, 2015, HUM MOL GENET, V24, P2147, DOI 10.1093/hmg/ddu735; Gong L, 2012, PHARMACOGENET GENOM, V22, P310, DOI 10.1097/FPC.0b013e32834f94cb; Gordon BS, 2013, CLIN NUTR, V32, P104, DOI 10.1016/j.clnu.2012.06.003; Goyenvalle A, 2011, HUM MOL GENET, V20, pR69, DOI 10.1093/hmg/ddr105; Gramolini AO, 2001, AM J PHYSIOL-CELL PH, V281, pC1300, DOI 10.1152/ajpcell.2001.281.4.C1300; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Gregorevic P, 2008, MOL THER, V16, P657, DOI 10.1038/mt.2008.28; Guiraud S, 2017, CURR OPIN PHARMACOL, V34, P36, DOI 10.1016/j.coph.2017.04.002; Guiraud S, 2015, HUM MOL GENET, V24, P4212, DOI 10.1093/hmg/ddv154; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Hsiao PW, 2007, TOXICOL APPL PHARM, V222, P97, DOI 10.1016/j.taap.2007.04.007; Hu F, 2005, MOL PSYCHIATR, V10, P426, DOI 10.1038/sj.mp.4001644; Irrcher I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003614; Irwin AN, 2017, PHARMACOTHERAPY, V37, pE109, DOI [10.1002/phar.1966, 10.1002/phar.1996]; Ishikawa-Sakurai M, 2004, HUM MOL GENET, V13, P693, DOI 10.1093/hmg/ddh087; Janghra N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150818; Johnson EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081521; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Ljubicic V, 2015, MUSCLE NERVE, V52, P139, DOI 10.1002/mus.24692; Ljubicic V, 2014, AM J PHYSIOL-CELL PH, V307, pC66, DOI 10.1152/ajpcell.00357.2013; Ljubicic V, 2011, HUM MOL GENET, V20, P3478, DOI 10.1093/hmg/ddr265; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; Lu QL, 2011, MOL THER, V19, P9, DOI 10.1038/mt.2010.219; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Miura P, 2010, HUM MOL GENET, V19, P1211, DOI 10.1093/hmg/ddp591; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; Miura P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002309; Miyatake S, 2016, DRUG DES DEV THER, V10, P2745, DOI 10.2147/DDDT.S110163; Mojumdar K, 2014, EMBO MOL MED, V6, P1476, DOI 10.15252/emmm.201403967; MOKRI B, 1975, NEUROLOGY, V25, P1111, DOI 10.1212/WNL.25.12.1111; Moorwood C, 2013, J BIOMOL SCREEN, V18, P400, DOI 10.1177/1087057112465648; Moorwood C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026169; Mosqueira M, 2013, MED RES REV, V33, P1174, DOI 10.1002/med.21279; Moxley RT, 2010, J CHILD NEUROL, V25, P1116, DOI 10.1177/0883073810371004; Mukthinuthalapati PK, 2018, J CLIN GASTROENTEROL, V52, P114, DOI 10.1097/MCG.0000000000000888; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nakamura A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/184393; Niks EH, 2017, EXPERT OPIN BIOL TH, V17, P225, DOI 10.1080/14712598.2017.1271872; Nitahara-Kasahara Y, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0019-0; Novak ML, 2009, AM J PHYSIOL-REG I, V296, pR1132, DOI 10.1152/ajpregu.90874.2008; Parks TEC, 2017, HUM MOL GENET, V26, P1821, DOI 10.1093/hmg/ddx085; PASQUINI F, 1995, NEUROMUSCULAR DISORD, V5, P105, DOI 10.1016/0960-8966(94)00042-8; Paulson SK, 2000, XENOBIOTICA, V30, P731, DOI 10.1080/00498250050078039; Paulson SK, 1999, BIOPHARM DRUG DISPOS, V20, P293, DOI 10.1002/(SICI)1099-081X(199909)20:6<293::AID-BDD188>3.0.CO;2-X; Peladeau C, 2016, HUM MOL GENET, V25, P24, DOI 10.1093/hmg/ddv444; Perkins KJ, 2002, NEUROMUSCULAR DISORD, V12, pS78, DOI 10.1016/S0960-8966(02)00087-1; Peters MF, 1998, J CELL BIOL, V142, P1269, DOI 10.1083/jcb.142.5.1269; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; Reyes NL, 2015, P NATL ACAD SCI USA, V112, P424, DOI 10.1073/pnas.1413021112; Riserus U, 2008, DIABETES, V57, P332, DOI 10.2337/db07-1318; Rodino-Klapac LR, 2013, HUM MOL GENET, V22, P4929, DOI 10.1093/hmg/ddt342; Ryan TD, 2014, ASAIO J, V60, P246, DOI 10.1097/MAT.0000000000000050; Serra F, 2012, MUSCLE NERVE, V46, P773, DOI 10.1002/mus.23432; Simon LS, 1998, ARTHRITIS RHEUM-US, V41, P1591, DOI 10.1002/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J; Slone S, 2016, CELL SIGNAL, V28, P1735, DOI 10.1016/j.cellsig.2016.08.005; Song B, 2017, ONCOL LETT, V14, P1775, DOI 10.3892/ol.2017.6316; Squire S, 2002, HUM MOL GENET, V11, P3333, DOI 10.1093/hmg/11.26.3333; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; St-Pierre SJG, 2004, FASEB J, V18, P1937, DOI 10.1096/fj.04-1859fje; Steffel J, 2006, BIOCHEM BIOPH RES CO, V349, P597, DOI 10.1016/j.bbrc.2006.08.075; Strakova J, 2014, J MOL CELL CARDIOL, V76, P106, DOI 10.1016/j.yjmcc.2014.08.013; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Tinsley J, 2015, J CLIN PHARMACOL, V55, P698, DOI 10.1002/jcph.468; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; TORRES LFB, 1987, BRAIN, V110, P269, DOI 10.1093/brain/110.2.269; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Weir AP, 2002, J BIOL CHEM, V277, P45285, DOI 10.1074/jbc.M205177200; WINDER SJ, 1995, J CELL SCI, V108, P63; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; YANG B, 1995, J BIOL CHEM, V270, P4975, DOI 10.1074/jbc.270.10.4975; Zbinden-Foncea H, 2012, MED SCI SPORT EXER, V44, P1463, DOI 10.1249/MSS.0b013e31824e0d5d	111	13	13	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5090	5103		10.1096/fj.201800081R	http://dx.doi.org/10.1096/fj.201800081R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29723037	Bronze			2022-12-26	WOS:000443817700038
J	Asano, S; Azuma, K; Shimizu, K; Yamamoto, R; Lee, J; Murata, H; Inoue, T; Asaoka, R; Obata, R				Asano, Shotaro; Azuma, Keiko; Shimizu, Kimiko; Yamamoto, Risako; Lee, Jinhee; Murata, Hiroshi; Inoue, Tatsuya; Asaoka, Ryo; Obata, Ryo			Choroidal structure as a biomarker for visual acuity in intravitreal aflibercept therapy for polypoidal choroidal vasculopathy	PLOS ONE			English	Article							MACULAR DEGENERATION; PHOTODYNAMIC THERAPY; HEALTHY EYES; RANIBIZUMAB; THICKNESS; OUTCOMES; HYPERPERMEABILITY; BINARIZATION; AMD	Purpose To investigate the relationship between choroidal structure and visual acuity after intravitreal aflibercept therapy for polypoidal choroidal vasculopathy (PCV). Methods We conducted a retrospective, single-centre and observational study including 18 eyes of 18 patients with PCV (73.8 +/- 10.2 years of age) who were treated with three monthly intravitreal aflibercept injections followed by additional treatments in a treat-and-extend protocol. The cross-sectional images of the macula were obtained with enhanced depth imaging optical coherence tomography at baseline, at 3 months, and at 12 months. The choroidal layer was divided into luminal or stromal segments by applying binarization processing to calculate these areas. The relationships between age, spherical equivalent, best-corrected visual acuity (BCVA), baseline value, or changes in the luminal or the stromal areas, and the BCVA change at 12 months were analysed using multiple regression analyses and model selection procedures. Results Both stromal and luminal areas were decreased at 3 and 12 months compared to baseline areas (5% and 9% at 3 months, 6% and 12% at 12 months, p < 0.0001, p < 0.0001, p < 0.0001 and p < 0.0001, respectively). Greater improvement of visual acuity (VA) at 12 months was significantly associated with younger age, greater spherical equivalent, worse baseline BCVA, greater baseline luminal area, and smaller baseline stromal area. Conclusions Choroidal structure might be useful as a new biomarker for potential Visual outcomes after intravitreal aflibercept therapy for PCV.	[Asano, Shotaro; Azuma, Keiko; Shimizu, Kimiko; Yamamoto, Risako; Murata, Hiroshi; Inoue, Tatsuya; Asaoka, Ryo; Obata, Ryo] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo, Japan; [Asano, Shotaro; Azuma, Keiko; Shimizu, Kimiko; Yamamoto, Risako; Murata, Hiroshi; Inoue, Tatsuya; Asaoka, Ryo; Obata, Ryo] Univ Tokyo, Fac Med, Tokyo, Japan; [Lee, Jinhee] Miyata Eye Hosp, Miyazaki, Japan	University of Tokyo; University of Tokyo	Obata, R (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo, Japan.; Obata, R (corresponding author), Univ Tokyo, Fac Med, Tokyo, Japan.	robata-tky@umin.ac.jp			JSPS KAKENHI [JP16K11260]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was done under JSPS KAKENHI Grant Number JP16K11260. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2016, SCI REP-UK, V6, DOI 10.1038/srep21090; Bakthavatsalam M, 2017, GRAEF ARCH CLIN EXP, V255, P935, DOI 10.1007/s00417-017-3591-3; Bhutto I, 2012, MOL ASPECTS MED, V33, P295, DOI 10.1016/j.mam.2012.04.005; Boyer DS, 2007, OPHTHALMOLOGY, V114, P246, DOI 10.1016/j.ophtha.2006.10.045; Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Campochiaro PA, 2015, PROG RETIN EYE RES, V49, P67, DOI 10.1016/j.preteyeres.2015.06.002; Chin-Yee D, 2016, BRIT J OPHTHALMOL, V100, P914, DOI 10.1136/bjophthalmol-2015-306987; Chong V, 2016, EYE, V30, P270, DOI 10.1038/eye.2015.217; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Daizumoto E, 2017, BRIT J OPHTHALMOL, V101, P56, DOI 10.1136/bjophthalmol-2016-309694; Delaey C, 2000, OPHTHALMIC RES, V32, P249, DOI 10.1159/000055622; Goodenough AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034338; Hikichi T, 2012, AM J OPHTHALMOL, V154, P117, DOI 10.1016/j.ajo.2011.12.019; Holz FG, 2015, BRIT J OPHTHALMOL, V99, P220, DOI 10.1136/bjophthalmol-2014-305327; Jirarattanasopa P, 2012, INVEST OPHTH VIS SCI, V53, P3663, DOI 10.1167/iovs.12-9619; Kikushima W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16476-1; Koizumi H, 2016, OPHTHALMOLOGY, V123, P617, DOI 10.1016/j.ophtha.2015.10.039; Koizumi H, 2015, AM J OPHTHALMOL, V159, P627, DOI 10.1016/j.ajo.2014.12.025; Kong M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184058; Kuroda Y, 2016, AM J OPHTHALMOL, V161, P94, DOI 10.1016/j.ajo.2015.09.032; Mallows CL, 2000, TECHNOMETRICS, V42, P87, DOI 10.2307/1271437; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Oishi A, 2015, AM J OPHTHALMOL, V159, P853, DOI 10.1016/j.ajo.2015.01.018; Patel PJ, 2017, CLIN OPHTHALMOL, V11, P1957, DOI 10.2147/OPTH.S145732; Saito M, 2016, JPN J OPHTHALMOL, V60, P35, DOI 10.1007/s10384-015-0411-3; Sakurada Y, 2017, RETINA-J RET VIT DIS, V37, P1866, DOI 10.1097/IAE.0000000000001427; Sasahara M, 2006, AM J OPHTHALMOL, V142, P601, DOI 10.1016/j.ajo.2006.05.051; Shin JY, 2015, ACTA OPHTHALMOL, V93, P524, DOI 10.1111/aos.12653; Sonoda S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157190; Sonoda S, 2015, AM J OPHTHALMOL, V159, P1123, DOI 10.1016/j.ajo.2015.03.005; Sonoda S, 2014, INVEST OPHTH VIS SCI, V55, P3893, DOI 10.1167/iovs.14-14447; Sonoda S, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-43; Tibshirani RJ, 2012, ANN STAT, V40, P1198, DOI 10.1214/12-AOS1003; Ting DSW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08276-4; Ting DSW, 2016, AM J OPHTHALMOL, V164, P128, DOI 10.1016/j.ajo.2015.12.024; TORNQUIST P, 1979, ACTA PHYSIOL SCAND, V106, P351, DOI 10.1111/j.1748-1716.1979.tb06409.x; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yamamoto A, 2017, OPHTHALMOLOGICA, V237, P139, DOI 10.1159/000458538; Yanagi Y, 2018, RETINA-J RET VIT DIS, V38, P1509, DOI 10.1097/IAE.0000000000001758; Ying GS, 2013, OPHTHALMOLOGY, V120, P122, DOI 10.1016/j.ophtha.2012.07.042; Zhang Z., 2016, ANN TRANSLATIONAL ME, V4	44	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197042	10.1371/journal.pone.0197042	http://dx.doi.org/10.1371/journal.pone.0197042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746511	Green Submitted, Green Published, gold			2022-12-26	WOS:000431851700059
J	Neubauer, PR; Widmann, C; Wibberg, D; Schroder, L; Frese, M; Kottke, T; Kalinowski, J; Niemann, HH; Sewald, N				Neubauer, Pia R.; Widmann, Christiane; Wibberg, Daniel; Schroeder, Lea; Frese, Marcel; Kottke, Tilman; Kalinowski, Joern; Niemann, Hartmut H.; Sewald, Norbert			A flavin-dependent halogenase from metagenomic analysis prefers bromination over chlorination	PLOS ONE			English	Article							TRYPTOPHAN 7-HALOGENASE PRNA; ENZYMATIC HALOGENATION; BIOSYNTHESIS; MECHANISM; PURIFICATION; ANTIBIOTICS; REFINEMENT; GENERATION; INSIGHTS; FEATURES	Flavin-dependent halogenases catalyse halogenation of aromatic compounds. In most cases, this reaction proceeds with high regioselectivity and requires only the presence of FADH(2), oxygen, and halide salts. Since marine habitats contain high concentrations of halides, organisms populating the oceans might be valuable sources of yet undiscovered halogenases. A new Hidden-Markov-Model (HMM) based on the PFAM tryptophan halogenase model was used for the analysis of marine metagenomes. Eleven metagenomes were screened leading to the identification of 254 complete or partial putative Flavin-dependent halogenase genes. One predicted halogenase gene (brvH) was selected, codon optimised for E. coli, and overexpressed. Substrate screening revealed that this enzyme represents an active flavin-dependent halogenase able to convert indole to 3-bromoindole. Remarkably, bromination prevails also in a large excess of chloride. The BrvH crystal structure is very similar to that of tryptophan halogenases but reveals a substrate binding site that is open to the solvent instead of being covered by a loop.	[Neubauer, Pia R.; Frese, Marcel; Sewald, Norbert] Bielefeld Univ, Organ & Bioorgan Chem OCIII, Bielefeld, Germany; [Widmann, Christiane; Niemann, Hartmut H.] Bielefeld Univ, Struct Biochem BCIV, Bielefeld, Germany; [Wibberg, Daniel; Kalinowski, Joern] Bielefeld Univ, Ctr Biotechnol CeBiTec, Bielefeld, Germany; [Schroeder, Lea; Kottke, Tilman] Bielefeld Univ, Phys Chem PCIII, Bielefeld, Germany	University of Bielefeld; University of Bielefeld; University of Bielefeld; University of Bielefeld	Sewald, N (corresponding author), Bielefeld Univ, Organ & Bioorgan Chem OCIII, Bielefeld, Germany.	norbert.sewald@uni-bielefeld.de	Niemann, Hartmut/F-7947-2011; Sewald, Norbert/A-2541-2012; Kottke, Tilman/B-7102-2011	Niemann, Hartmut/0000-0002-8582-0360; Sewald, Norbert/0000-0002-0309-2655; Kottke, Tilman/0000-0001-8080-9579; Frese, Marcel/0000-0002-2232-7755; Neubauer, Pia Rebecca/0000-0002-6773-7360	Deutsche Forschungsgemeinschaft; Open Access Publication Fund of Bielefeld University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of Bielefeld University	The authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2014, NAT CHEM BIOL, V10, P640, DOI 10.1038/nchembio.1564; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ausec L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025724; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bischoff D, 2001, ANGEW CHEM INT EDIT, V40, P1693, DOI 10.1002/1521-3773(20010504)40:9<1693::AID-ANIE16930>3.0.CO;2-8; Buedenbender S, 2009, J MOL BIOL, V385, P520, DOI 10.1016/j.jmb.2008.10.057; Castro P., 2013, MARINE BIOL; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Dorrestein PC, 2005, P NATL ACAD SCI USA, V102, P13843, DOI 10.1073/pnas.0506964102; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EHRLICH J, 1947, SCIENCE, V106, P417, DOI 10.1126/science.106.2757.417; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Flecks S, 2008, ANGEW CHEM INT EDIT, V47, P9533, DOI 10.1002/anie.200802466; Fraley AE, 2017, J AM CHEM SOC, V139, P12060, DOI 10.1021/jacs.7b06773; Frese M, 2016, CHEMCATCHEM, V8, P1799, DOI 10.1002/cctc.201600317; Frese M, 2015, ANGEW CHEM INT EDIT, V54, P298, DOI 10.1002/anie.201408561; Frese M, 2014, CHEMCATCHEM, V6, P1270, DOI 10.1002/cctc.201301090; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Keller S, 2000, ANGEW CHEM INT EDIT, V39, P2300, DOI 10.1002/1521-3773(20000703)39:13<2300::AID-ANIE2300>3.0.CO;2-I; Kirner S, 1998, J BACTERIOL, V180, P1939, DOI 10.1128/JB.180.7.1939-1943.1998; KOTAKI A, 1970, J BIOCHEM-TOKYO, V68, P287, DOI 10.1093/oxfordjournals.jbchem.a129358; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Magarvey NA, 2006, ACS CHEM BIOL, V1, P766, DOI 10.1021/cb6004307; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menon BRK, 2017, ANGEW CHEM INT EDIT, V56, P11841, DOI 10.1002/anie.201706342; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ortega MA, 2017, ACS CHEM BIOL, V12, P548, DOI 10.1021/acschembio.6b01031; Pereira ER, 1996, J MED CHEM, V39, P4471; Podzelinska K, 2010, J MOL BIOL, V397, P316, DOI 10.1016/j.jmb.2010.01.020; Puk O, 2002, CHEM BIOL, V9, P225, DOI 10.1016/S1074-5521(02)00101-1; Raffelberg S, 2013, BIOL CHEM, V394, P1517, DOI 10.1515/hsz-2013-0163; Sanchez C, 2002, CHEM BIOL, V9, P519, DOI 10.1016/S1074-5521(02)00126-6; Schnepel C, 2017, CHEM-EUR J, V23, P12064, DOI 10.1002/chem.201701209; Schnepel C, 2016, ANGEW CHEM INT EDIT, V55, P14159, DOI 10.1002/anie.201605635; Schrodinger L, 2010, PYMOL PYMOL MOL GRAP; Seibold C, 2006, BIOCATAL BIOTRANSFOR, V24, P401, DOI 10.1080/10242420601033738; Shepherd SA, 2016, CHEMBIOCHEM, V17, P821, DOI 10.1002/cbic.201600051; Smith DRM, 2017, ACS CHEM BIOL, V12, P1281, DOI 10.1021/acschembio.6b01115; Stoveken J, 2015, J BIOTECHNOL, V201, P60, DOI 10.1016/j.jbiotec.2014.09.010; Tasdemir D, 2002, J MED CHEM, V45, P529, DOI 10.1021/jm0102856; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; van Pee KH, 2000, BIOL CHEM, V381, P1; van Pee KH, 2001, ARCH MICROBIOL, V175, P250, DOI 10.1007/s002030100263; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Weichold V, 2016, ANGEW CHEM INT EDIT, V55, P6374, DOI 10.1002/anie.201509573; Weiss C, 2013, NAT PROD REP, V30, P924, DOI 10.1039/c3np70022d; WIERENGA RK, 1983, J MOL BIOL, V167, P725, DOI 10.1016/S0022-2836(83)80106-5; WIESNER W, 1988, J BIOL CHEM, V263, P13725; Williams DH, 1999, ANGEW CHEM INT EDIT, V38, P1173, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1172::AID-ANIE1172>3.0.CO;2-C; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213; Zehner S, 2005, CHEM BIOL, V12, P445, DOI 10.1016/j.chembiol.2005.02.005; Zeng J, 2010, CHEMBIOCHEM, V11, P2119, DOI 10.1002/cbic.201000439; Zhu XF, 2009, J MOL BIOL, V391, P74, DOI 10.1016/j.jmb.2009.06.008	59	43	45	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196797	10.1371/journal.pone.0196797	http://dx.doi.org/10.1371/journal.pone.0196797			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746521	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700039
J	Wang, KH; Wan, R; Chiu, LH; Tsai, YH; Fang, CL; Bowley, JF; Chen, KC; Shih, HN; Lai, WFT				Wang, Kuo-Hwa; Wan, Richard; Chiu, Li-Hsuan; Tsai, Yu-Hui; Fang, Chia-Lang; Bowley, John F.; Chen, Kuan-Chou; Shih, Hsin-Nung; Lai, Wen-Fu Thomas			Effects of collagen matrix and bioreactor cultivation on cartilage regeneration of a full-thickness critical-size knee joint cartilage defects with subchondral bone damage in a rabbit model	PLOS ONE			English	Article							AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; CHONDROGENIC PROGENITOR CELLS; HUMAN ARTICULAR CHONDROCYTES; MESENCHYMAL STEM-CELLS; ENGINEERED CARTILAGE; II COLLAGEN; IN-VITRO; GROWTH-FACTORS; REPAIR; DIFFERENTIATION	Cartilage has limited self-repair ability. The purpose of this study was to investigate the effects of different species of collagen-engineered neocartilage for the treatment of criticalsize defects in the articular joint in a rabbit model. Type II and I collagen obtained from rabbits and rats was mixed to form a scaffold. The type II/I collagen scaffold was then mixed with rabbit chondrocytes to biofabricate neocartilage constructs using a rotating cell culture system [three-dimensional (3D)-bioreactor]. The rabbit chondrocytes were mixed with rabbit collagen scaffold and rat collagen scaffold to form neoRBT (neo-rabbit cartilage) and neoRAT (neo-rat cartilage) constructs, respectively. The neocartilage matrix constructs were implanted into surgically created defects in rabbit knee chondyles, and histological examinations were performed after 2 and 3 months. Cartilage-like lacunae formation surrounding the chondrocytes was noted in the cell cultures. After 3 months, both the neoRBT and neoRAT groups showed cartilage-like repair tissue covering the 5-mm circular, 4-mm-deep defects that were created in the rabbit condyle and filled with neocartilage plugs. Reparative chondrocytes were aligned as apparent clusters in both the neoRAT and neoRBT groups. Both neoRBT and neoRAT cartilage repair demonstrated integration with healthy adjacent tissue; however, more integration was obtained using the neoRAT cartilage. Our data indicate that different species of type II/I collagen matrix and 3D bioreactor cultivation can facilitate cartilage engineering in vitro for the repair of critical-size defect.	[Wang, Kuo-Hwa; Wan, Richard; Chen, Kuan-Chou; Lai, Wen-Fu Thomas] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Wang, Kuo-Hwa] Cheng Ching Hosp, Dept Obstet & Gynecol, Chung Kang Branch, Taichung, Taiwan; [Chiu, Li-Hsuan; Tsai, Yu-Hui; Lai, Wen-Fu Thomas] Taipei Med Univ, Dept Res, Shaung Ho Hosp, Taipei, Taiwan; [Chiu, Li-Hsuan; Lai, Wen-Fu Thomas] Harvard Med Sch, McLean Imaging Ctr, McLean Hosp, Belmont, MA USA; [Fang, Chia-Lang] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan; [Bowley, John F.] Harvard Sch Dent Med, Restorat Dent & Biomat Sci, Boston, MA USA; [Shih, Hsin-Nung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Orthoped Surg, Linkou Taoyuan, Taiwan	Taipei Medical University; Taipei Medical University; Harvard University; McLean Hospital; Taipei Medical University; Harvard University; Harvard School of Dental Medicine; Chang Gung Memorial Hospital	Lai, WFT (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Lai, WFT (corresponding author), Taipei Med Univ, Dept Res, Shaung Ho Hosp, Taipei, Taiwan.; Lai, WFT (corresponding author), Harvard Med Sch, McLean Imaging Ctr, McLean Hosp, Belmont, MA USA.; Shih, HN (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Orthoped Surg, Linkou Taoyuan, Taiwan.	aronc0103@icloud.com; laitw@tmu.edu.tw			Ministry of Science and Technology, Taiwan [NSC-101-2120-M-038-001, MOST 104-2622-B-038 -006 -CC1, MOST 104-2917-I-564-006]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/) (grants NSC-101-2120-M-038-001 to Prof. Wen-Fu Thomas Lai, MOST 104-2622-B-038 -006 -CC1 to Prof. Wen-Fu Thomas Lai, and MOST 104-2917-I-564-006 to Dr. Li-Hsuan Chiu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkisson HD, 2010, AM J SPORT MED, V38, P1324, DOI 10.1177/0363546510361950; Barlic A, 2008, FOLIA BIOL-PRAGUE, V54, P177; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Bouwmeester PSJM, 2002, J ORTHOP RES, V20, P267, DOI 10.1016/S0736-0266(01)00099-7; Bozec L, 2007, BIOPHYS J, V92, P70, DOI 10.1529/biophysj.106.085704; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc; Caplan A, 1986, PROCESS MAT STIMULAT; Chaipinyo K, 2004, J ORTHOP RES, V22, P446, DOI 10.1016/j.orthres.2003.07.001; Chaipinyo K, 2002, J ORTHOPAED RES, V20, P1070, DOI 10.1016/S0736-0266(02)00025-6; Chen CW, 2005, J ORTHOP RES, V23, P446, DOI 10.1016/j.orthres.2004.09.002; Chiu LH, 2011, J CELL PHYSIOL, V226, P1981, DOI 10.1002/jcp.22530; Folch A, 2000, J BIOMED MATER RES, V52, P346, DOI 10.1002/1097-4636(200011)52:2<346::AID-JBM14>3.0.CO;2-H; FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808; Gille J, 2010, KNEE SURG SPORT TR A, V18, P1456, DOI 10.1007/s00167-010-1042-3; Gillogly SD, 1998, J ORTHOP SPORT PHYS, V28, P241, DOI 10.2519/jospt.1998.28.4.241; Hiraki Y, 2001, OSTEOARTHR CARTILAGE, V9, pS102, DOI 10.1016/S1063-4584(01)94436-X; HOIKKA VEJ, 1990, ACTA ORTHOP SCAND, V61, P36, DOI 10.3109/17453679008993062; Hong HJ, 2012, ARTIF ORGANS, V36, P998, DOI 10.1111/j.1525-1594.2012.01486.x; Hong Y, 2005, BIOMATERIALS, V26, P6305, DOI 10.1016/j.biomaterials.2005.03.038; Huang BJ, 2017, J TISSUE ENG REGEN M, V11, P2323, DOI 10.1002/term.2132; Hunt Stephen A, 2002, J Am Acad Orthop Surg, V10, P356; ITAY S, 1987, CLIN ORTHOP RELAT R, P284; Iyer K, 2016, J BURN CARE RES, V37, pE353, DOI 10.1097/BCR.0000000000000281; Jin CZ, 2010, J BIOMED MATER RES A, V92A, P1567, DOI 10.1002/jbm.a.32419; Kang SW, 2011, MACROMOL BIOSCI, V11, P267, DOI 10.1002/mabi.201000315; Kim IG, 2016, BIOMATERIALS, V85, P18, DOI 10.1016/j.biomaterials.2016.01.048; KIMURA T, 1984, CLIN ORTHOP RELAT R, P231; Komura M, 2013, LARYNGOSCOPE, V123, P1547, DOI 10.1002/lary.23269; Kon E, 2013, BONE JOINT RES, V2, P18, DOI 10.1302/2046-3758.22.2000092; Lai W., 1999, RECONSTITUTED COLLAG; Lai WF, 2003, FABRICATION CARTILAG; Lai WFT, 2005, INT J ORAL MAX SURG, V34, P311, DOI 10.1016/j.ijom.2004.05.003; Leu BW, 2001, THESIS; Lin CH, 2009, BIOMATERIALS, V30, P4117, DOI 10.1016/j.biomaterials.2009.04.028; Marlovits S, 2003, INT J ARTIF ORGANS, V26, P319, DOI 10.1177/039139880302600407; MESSNER K, 1993, J BIOMED MATER RES, V27, P949, DOI 10.1002/jbm.820270714; Minas T, 1997, ORTHOPEDICS, V20, P525; O'Sullivan ES, 2011, ENDOCR REV, V32, P827, DOI 10.1210/er.2010-0026; Park JS, 2010, J BIOMED MATER RES A, V92A, P988, DOI 10.1002/jbm.a.32341; Peterson L, 1996, Acta Orthop Belg, V62 Suppl 1, P196; Pulkkinen HJ, 2013, OSTEOARTHR CARTILAGE, V21, P481, DOI 10.1016/j.joca.2012.12.004; Punwar Shahid, 2011, Open Orthop J, V5 Suppl 2, P296, DOI 10.2174/1874325001105010296; Schinhan M, 2013, OSTEOARTHR CARTILAGE, V21, P217, DOI 10.1016/j.joca.2012.10.006; Seol D, 2012, ARTHRITIS RHEUM-US, V64, P3626, DOI 10.1002/art.34613; SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009; Toh WS, 2013, J ORTHOP RES, V31, P1136, DOI 10.1002/jor.22330; Toh WS, 2012, BIOMATERIALS, V33, P3835, DOI 10.1016/j.biomaterials.2012.01.065; Tsai YH, 2010, J BIOMED MATER RES A, V92A, P1115, DOI 10.1002/jbm.a.32465; Vazquez-Portalatin N, 2016, BIOMACROMOLECULES, V17, P3145, DOI 10.1021/acs.biomac.6b00684; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013; Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953; Whitney GA, 2012, BIORESEARCH OPEN ACC, V1, P157, DOI 10.1089/biores.2012.0231; Wong CC, 2010, J BIOMATER APPL, V25, P75, DOI 10.1177/0885328209343611; Yu Y, 2015, ARTHRITIS RHEUMATOL, V67, P1274, DOI 10.1002/art.39049	55	10	12	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196779	10.1371/journal.pone.0196779	http://dx.doi.org/10.1371/journal.pone.0196779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746554	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700038
J	Guo, L; Mei, YJ; Guan, JJ; Tan, XL; Xu, YK; Chen, WF; Feng, QJ; Feng, YQ				Guo, Li; Mei, Yingjie; Guan, Jijing; Tan, Xiangliang; Xu, Yikai; Chen, Wufan; Feng, Qianjin; Feng, Yanqiu			Morphology-adaptive total variation for the reconstruction of quantitative susceptibility map from the magnetic resonance imaging phase	PLOS ONE			English	Article							FIELD; COSMOS; ROBUST	Quantitative susceptibility mapping (QSM) is a magnetic resonance imaging technique that quantifies the magnetic susceptibility distribution within biological tissues. QSM calculates the underlying magnetic susceptibility by deconvolving the tissue magnetic field map with a unit dipole kernel. However, this deconvolution problem is ill-posed. The morphology enabled dipole inversion (MEDI) introduces total variation (TV) to regularize the susceptibility reconstruction. However, MEDI results still contain artifacts near tissue boundaries because MEDI only imposes TV constraint on voxels inside smooth regions. We introduce a Morphology-Adaptive TV (MATV) for improving TV-regularized QSM. The MATV method first classifies imaging target into smooth and nonsmooth regions by thresholding magnitude gradients. In the dipole inversion for QSM, the TV regularization weights are a monotonically decreasing function of magnitude gradients. Thus, voxels inside smooth regions are assigned with larger weights than those in nonsmooth regions. Using phantom and in vivo datasets, we compared the performance of MATV with that of MEDI. MATV results had better visual quality than MEDI results, especially near tissue boundaries. Preliminary brain imaging results illustrated that MATV has potential to improve the reconstruction of regions near tissue boundaries.	[Guo, Li; Mei, Yingjie; Guan, Jijing; Chen, Wufan; Feng, Qianjin; Feng, Yanqiu] Southern Med Univ, Guangdong Prov Key Lab Med Image Proc, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Mei, Yingjie] Philips Healthcare, Guangzhou, Guangdong, Peoples R China; [Tan, Xiangliang; Xu, Yikai] Southern Med Univ, Dept Med Imaging Ctr, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Philips; Philips Healthcare; Southern Medical University - China	Chen, WF; Feng, YQ (corresponding author), Southern Med Univ, Guangdong Prov Key Lab Med Image Proc, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China.	chenwf@smu.edu.cn; foree@163.com	feng, qianjin/GNM-7856-2022; Feng, Qianjin/Y-5438-2019	feng, qianjin/0000-0002-3830-5120; 	National Natural Science Funds of China [61671228, 61728107]; Guangdong Provincial Science & Technology Program [20176090912006]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science & Technology Program	This research was funded by the National Natural Science Funds of China [61671228 and 61728107, http://www.nsfc.gov.cn/] and the Guangdong Provincial Science & Technology Program [20176090912006, http://pro.gdstc.gov.cn/egrantweb/] to YF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao LJ, 2016, IEEE T MED IMAGING, V35, P2040, DOI 10.1109/TMI.2016.2544958; Bilgic B, 2015, PROC SPIE, V9597, DOI 10.1117/12.2188535; Bilgic B, 2016, NEUROIMAGE, V125, P1131, DOI 10.1016/j.neuroimage.2015.08.015; Bilgic B, 2014, MAGN RESON MED, V72, P1444, DOI 10.1002/mrm.25029; Bilgic B, 2014, J MAGN RESON IMAGING, V40, P181, DOI 10.1002/jmri.24365; Bilgic B, 2012, NEUROIMAGE, V59, P2625, DOI 10.1016/j.neuroimage.2011.08.077; Cai CB, 2016, COMPUT BIOL MED, V79, P59, DOI 10.1016/j.compbiomed.2016.10.002; de Rochefort L, 2008, MAGN RESON MED, V60, P1003, DOI 10.1002/mrm.21710; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; Deistung A, 2016, NMR BIOMEDICINE; GOLUB GH, 1979, TECHNOMETRICS, V21, P215, DOI 10.1080/00401706.1979.10489751; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P663, DOI 10.1002/jmri.22276; Hansen P.C., 2001, COMPUTATIONAL INVERS; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kee Y, 2017, MAGN RESON MED, V78, P2416, DOI 10.1002/mrm.26627; Langkammer C, 2017, MAGNETIC RESONANCE M; Li L, 2004, MAGN RESON MED, V51, P1077, DOI 10.1002/mrm.20054; Li L, 2001, MAGNET RESON MED, V46, P907, DOI 10.1002/mrm.1276; Liu CL, 2015, TOMOGRAPHY, V1, P3, DOI 10.18383/j.tom.2015.00136; Liu CL, 2010, MAGN RESON MED, V63, P1471, DOI 10.1002/mrm.22482; Liu JY, 2011, MATER ENG, V8, P82, DOI DOI 10.1016/J.NEUR0IMAGE.2011.08.082; Liu T, 2013, MAGN RESON MED, V69, P467, DOI 10.1002/mrm.24272; Liu T, 2012, IEEE T MED IMAGING, V31, P816, DOI 10.1109/TMI.2011.2182523; Liu T, 2011, MAGN RESON MED, V66, P777, DOI 10.1002/mrm.22816; Liu T, 2011, NMR BIOMED, V24, P1129, DOI 10.1002/nbm.1670; Liu T, 2009, MAGN RESON MED, V61, P196, DOI 10.1002/mrm.21828; Morgan J, 2007, P INT SOC MAG RESON, V15, P35; Ravishankar S, 2011, IEEE T MED IMAGING, V30, P1028, DOI 10.1109/TMI.2010.2090538; Schofield MA, 2003, OPT LETT, V28, P1194, DOI 10.1364/OL.28.001194; Schweser F, 2013, MAGN RESON MED, V69, P1581, DOI 10.1002/mrm.24405; Schweser F, 2012, NEUROIMAGE, V62, P2083, DOI 10.1016/j.neuroimage.2012.05.067; Schweser F, 2010, MED PHYS, V37, P5165, DOI 10.1118/1.3481505; Shmueli K, 2009, MAGN RESON MED, V62, P1510, DOI 10.1002/mrm.22135; Tang J, 2013, MAGN RESON MED, V69, P1396, DOI 10.1002/mrm.24384; Wang S, 2013, IEEE T BIO-MED ENG, V60, P3441, DOI 10.1109/TBME.2013.2266795; Wang Y, 2015, MAGN RESON MED, V73, P82, DOI 10.1002/mrm.25358; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wei HJ, 2015, NMR BIOMED, V28, P1294, DOI 10.1002/nbm.3383; Weller DS, 2014, MAGN RESON MED, V71, P1760, DOI 10.1002/mrm.24840; Wen Y, 2016, MAGN RESON MED, V75, P823, DOI 10.1002/mrm.25652; Wharton S, 2010, MAGN RESON MED, V63, P1292, DOI 10.1002/mrm.22334; Wu B, 2012, MAGN RESON MED, V67, P137, DOI 10.1002/mrm.23000; Zhou D, 2014, NMR BIOMED, V27, P312, DOI 10.1002/nbm.3064	43	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196922	10.1371/journal.pone.0196922	http://dx.doi.org/10.1371/journal.pone.0196922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738526	gold, Green Submitted, Green Published			2022-12-26	WOS:000431724900028
J	Lopez-Rodriguez, R; Perez-Pampin, E; Marquez, A; Blanco, FJ; Joven, B; Carreira, P; Ferrer, MA; Caliz, R; Valor, L; Narvaez, J; Canete, JD; Ordonez, MD; Manrique-Arija, S; Vasilopoulos, Y; Balsa, A; Pascual-Salcedo, D; Moreno-Ramos, MJ; Alegre-Sancho, JJ; Navarro-Sarabia, F; Moreira, V; Garcia-Portales, R; Raya, E; Magro-Checa, C; Martin, J; Gomez-Reino, JJ; Gonzalez, A				Lopez-Rodriguez, Rosario; Perez-Pampin, Eva; Marquez, Ana; Blanco, Francisco J.; Joven, Beatriz; Carreira, Patricia; Ferrer, Miguel Angel; Caliz, Rafael; Valor, Lara; Narvaez, Javier; Canete, Juan D.; Ordonez, Maria del Carmen; Manrique-Arija, Sara; Vasilopoulos, Yiannis; Balsa, Alejandro; Pascual-Salcedo, Dora; Moreno-Ramos, Manuel J.; Alegre-Sancho, Juan Jose; Navarro-Sarabia, Federico; Moreira, Virginia; Garcia-Portales, Rosa; Raya, Enrique; Magro-Checa, Cesar; Martin, Javier; Gomez-Reino, Juan J.; Gonzalez, Antonio			Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; REPLICATION; THERAPY; PDE3A-SLCO1C1; VARIANTS; CRITERIA; COUNTS; COHORT; RA	Genetic biomarkers are sought to personalize treatment of patients with rheumatoid arthritis (RA), given their variable response to TNF inhibitors (TNFi). However, no genetic biomaker is yet sufficiently validated. Here, we report a validation study of 18 previously reported genetic biomarkers, including 11 from GWAS of response to TNFi. The validation was attempted in 581 patients with RA that had not been treated with biologic antirheumatic drugs previously. Their response to TNFi was evaluated at 3, 6 and 12 months in two ways: change in the DAS28 measure of disease activity, and according to the EULAR criteria for response to antirheumatic drugs. Association of these parameters with the genotypes, obtained by PCR amplification followed by single-base extension, was tested with regression analysis. These analyses were adjusted for baseline DAS28, sex, and the specific TNFi. However, none of the proposed biomarkers was validated, as none showed association with response to TNFi in our study, even at the time of assessment and with the outcome that showed the most significant result in previous studies. These negative results are notable because this was the first independent validation study for 12 of the biomarkers, and because they indicate that prudence is needed in the interpretation of the proposed biomarkers of response to TNFi even when they are supported by very low p values. The results also emphasize the requirement of independent replication for validation, and the need to search protocols that could increase reproducibility of the biomarkers of response to TNFi.	[Lopez-Rodriguez, Rosario; Perez-Pampin, Eva; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ de Santiago, Inst Invest Sanitaria, Expt & Observat Rheumatol & Rheumatol Unit, Santiago De Compostela, Spain; [Marquez, Ana; Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Blanco, Francisco J.] Complejo Hosp Univ A Coruna, Inst Invest Biomed, Rheumatol Dept, Coruna, Spain; [Joven, Beatriz; Carreira, Patricia] Reumatol Dept, Madrid, Spain; [Ferrer, Miguel Angel; Valor, Lara] Hosp Univ Virgen Nieves, Rheumatol Unit, Granada, Spain; [Valor, Lara] Hosp Gen Univ Gregorio Maranon, Rheumatol Unit, Madrid, Spain; [Narvaez, Javier] Hosp Univ Bellvitge, Dept Rheumatol, Barcelona, Spain; [Canete, Juan D.] Hosp Clin & IDIBAPS, Rheumatol Dpt, Arthrit Unit, Barcelona, Spain; [Ordonez, Maria del Carmen; Manrique-Arija, Sara] Univ Malaga, Inst Invest Biorned Malaga IBIMA, HRU Carlos Haya, Serv Reumatol, Malaga, Spain; [Vasilopoulos, Yiannis] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Balsa, Alejandro] Hosp Univ La Paz, Inst Invest Sanitaria Hosp Univ La Paz IdiPAZ, Rheumatol Unit, Madrid, Spain; [Pascual-Salcedo, Dora] Inst Invest Sanitaria Hosp Univ La Paz IdiPAZ, Dept Immunol, Madrid, Spain; [Moreno-Ramos, Manuel J.] Hosp Virgen Arrixaca, Dept Rheumatol, Murcia, Spain; [Alegre-Sancho, Juan Jose] Hosp Doctor Peset, Dept Rheumatol, Valencia, Spain; [Navarro-Sarabia, Federico] Hosp Univ Virgen Macarena, Rheumatol Unit, Seville, Spain; [Garcia-Portales, Rosa] Hosp Virgen Victoria, Dept Rheumatol, Malaga, Spain; [Raya, Enrique] Hosp Clin San Cecilio, Dept Rheumatol, Granada, Spain; [Magro-Checa, Cesar] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Gomez-Reino, Juan J.] Fdn Ramon Dominguez, Santiago De Compostela, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Hospital Universitario Virgen de las Nieves; General University Gregorio Maranon Hospital; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Carlos Haya; Universidad de Malaga; University of Thessaly; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Universitario Virgen Macarena; Hospital Virgen de la Victoria; Hospital Universitario San Cecilio; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Gonzalez, A (corresponding author), Hosp Clin Univ de Santiago, Inst Invest Sanitaria, Expt & Observat Rheumatol & Rheumatol Unit, Santiago De Compostela, Spain.	agmartinezp@ser.es	Gonzalez, Antonio/C-4444-2008; Martin, Javier/B-8141-2008; Perez-Pampin, Eva/ABF-7200-2020; Blanco, Francisco J./C-3192-2014; Lopez-Rodriguez, Rosario/M-3381-2014; Ferrer, Miguel A A/L-3863-2013; Ferrer, Miguel/AFU-8286-2022; Cañete, Juan D/AAV-8910-2021; Narvaez, Javier/AAD-7434-2020; Martín, Javier/AAV-5209-2021; Martín, María/HDL-9512-2022; López-Rodríguez, Rosario/AAB-2290-2022; Balsa, Alejandro/ABF-6456-2020; Rosa, Garcia/W-3638-2019; Gomez-Reino, Juan/ABI-2853-2020; Narvaez, Javier/AAD-7456-2020; Carreira, Patricia E/D-4429-2018	Gonzalez, Antonio/0000-0002-2624-0606; Martin, Javier/0000-0002-2202-0622; Blanco, Francisco J./0000-0001-9821-7635; Lopez-Rodriguez, Rosario/0000-0002-4713-0633; Ferrer, Miguel A A/0000-0002-2924-1225; Cañete, Juan D/0000-0003-2606-0573; López-Rodríguez, Rosario/0000-0002-4713-0633; Narvaez, Javier/0000-0002-1614-8064; Perez-Pampin, Eva/0000-0003-0319-4456; Vasilopoulos, Yiannis/0000-0002-3167-7642; Carreira, Patricia E/0000-0001-8279-3806; Gomez-Reino, Juan/0000-0001-5229-6294; Marquez, Ana/0000-0001-9913-7688; Valor-Mendez, Larissa/0000-0002-4872-3502; Alegre Sancho, Juan Jose/0000-0003-1641-0875	Instituto de Salud Carlos III (Spain) [PI14/01651, RD16/0012/0014, PI12/01909]; European Regional Development Fund of the EU (FEDER); Instituto de Salud Carlos III (Spain) through a Postdoctoral Contract "Sara Borrell" [CD14/00186]	Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); European Regional Development Fund of the EU (FEDER); Instituto de Salud Carlos III (Spain) through a Postdoctoral Contract "Sara Borrell"	This work was supported by the Instituto de Salud Carlos III (Spain) through grants [PI14/01651 and RD16/0012/0014 to AG; and PI12/01909 to JJG-R]. These grants are partially financed by the European Regional Development Fund of the EU (FEDER). R. L.-R. was supported by Instituto de Salud Carlos III (Spain) through a Postdoctoral Contract "Sara Borrell" [CD14/00186]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Colman I, 2013, PHARMACOGENOMICS, V14, P727, DOI [10.2217/PGS.13.60, 10.2217/pgs.13.60]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bek S, 2017, PHARMACOGENOMICS J, V17, P403, DOI 10.1038/tpj.2017.26; Burmester GR, 2017, LANCET, V389, P2338, DOI 10.1016/S0140-6736(17)31491-5; Cui J, 2017, ARTHRITIS RHEUMATOL, V69, P735, DOI 10.1002/art.39966; Cui J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003394; Cui J, 2010, ARTHRITIS RHEUM-US, V62, P1849, DOI 10.1002/art.27457; Cuppen BVJ, 2016, RHEUMATOLOGY, V55, P826, DOI 10.1093/rheumatology/kev421; Ferreiro-Iglesias A, 2015, PHARMACOGENOMICS J; Frisell T, 2016, ANN RHEUM DIS, V75, P1120, DOI 10.1136/annrheumdis-2015-207670; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Gorlov IP, 2014, HUM GENET, V133, P1477, DOI 10.1007/s00439-014-1493-6; Honne K, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0920-6; Jiang X, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1174-z; Julia A, 2016, PHARMACOGENOMICS J, V16, P147, DOI 10.1038/tpj.2015.31; Karsdal MA, 2014, ARTHRIT CARE RES, V66, P1273, DOI 10.1002/acr.22289; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Krintel SB, 2012, PHARMACOGENET GENOM, V22, P577, DOI 10.1097/FPC.0b013e3283544043; Mathews RJ, 2014, ANN RHEUM DIS, V73, P1202, DOI 10.1136/annrheumdis-2013-203276; Mirkov MU, 2015, ANN RHEUM DIS, V74, P2183, DOI 10.1136/annrheumdis-2014-205541; Mirkov MU, 2013, ANN RHEUM DIS, V72, P1375, DOI 10.1136/annrheumdis-2012-202405; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Oliver J, 2015, BIOMARK MED, V9, P499, DOI 10.2217/bmm.15.18; Plant D, 2016, ARTHRITIS RHEUMATOL, V68, P1353, DOI 10.1002/art.39590; Plant D, 2012, ARTHRITIS RHEUM-US, V64, P665, DOI 10.1002/art.33381; Plant D, 2011, ARTHRITIS RHEUM-US, V63, P645, DOI 10.1002/art.30130; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Sieberts SK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12460; Smith SL, 2016, PHARMACOGENOMICS, V17, P715, DOI 10.2217/pgs.16.16; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Sode J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139781; Standish KA, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1299-8; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B	33	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196793	10.1371/journal.pone.0196793	http://dx.doi.org/10.1371/journal.pone.0196793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734345	Green Published, gold, Green Submitted			2022-12-26	WOS:000431481700027
J	Jiao, AR; Diao, H; Yu, B; He, J; Yu, J; Zheng, P; Huang, ZQ; Luo, YH; Luo, JQ; Mao, XB; Chen, DW				Jiao, A. R.; Diao, H.; Yu, B.; He, J.; Yu, J.; Zheng, P.; Huang, Z. Q.; Luo, Y. H.; Luo, J. Q.; Mao, X. B.; Chen, D. W.			Oral administration of short chain fatty acids could attenuate fat deposition of pigs	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; GENE-EXPRESSION; DIETARY FIBER; BODY-WEIGHT; OBESITY; BUTYRATE; CHOLESTEROL; IMPROVEMENT; METABOLISM; MECHANISMS	Short chain fatty acids (SCFAs) are the main products of indigestible carbohydrates that are fermented by microbiota in the hindgut. This study was designed to investigate the effects of oral SCFAs administration on the lipid metabolism of weaned pigs. A total of 21 barrows were randomly allocated into three groups, including control group (orally infused with 200 mL physiological saline per day), low dose SCFAs group (orally infused with 200 mL SCFAs containing acetic acid 20.04 mM, propionic acid 7.71 mM and butyric acid 4.89 mM per day), and high dose SCFAs group (orally infused with 200 mL SCFAs containing acetic acid 40.08 mM, propionic acid 15.42 mM and butyric acid 9.78 mM per day). The results showed that the average daily feed intake of SCFAs groups were lower than that of control group (P<0.05). Oral administration of SCFAs decreased the concentrations of triglyceride (TG), total cholesterol (TC), high density lipoprotein-cholesterol and insulin (P<0.05), and increased the leptin concentration in serum (P<0.05). The total fat, as well as TC and TG levels in liver, was decreased by oral SCFAs administration (P<0.05). In addition, SCFAs down-regulated the mRNA expressions of fatty acid synthase (FAS) and sterol regulatory element binding protein 1c (P<0.05), and enhanced the mRNA expression of carnitine palmitoyltransferase-1 alpha (CPT-1 alpha) in liver (P<0.05). SCFAs also decreased FAS, acetyl-CoA carboxylase (ACC) and peroxisome proliferator activated receptor sigma mRNA expressions in longissimus dorsi (P<0.05). And in abdominal fat, SCFAs reduced FAS and ACC mRNA expressions (P<0.05), and increased CPT-1 alpha mRNA expression (P<0.05). These results suggested that oral administration of SCFAs could attenuate fat deposition in weaned pigs via reducing lipogenesis and enhancing lipolysis of different tissues.	[Jiao, A. R.; Diao, H.; Yu, B.; He, J.; Yu, J.; Zheng, P.; Huang, Z. Q.; Luo, Y. H.; Luo, J. Q.; Mao, X. B.; Chen, D. W.] Sichuan Agr Univ, China Minist Educ, Key Lab Anim Dis Resistance Nutr, Inst Anim Nutr, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University	Mao, XB; Chen, DW (corresponding author), Sichuan Agr Univ, China Minist Educ, Key Lab Anim Dis Resistance Nutr, Inst Anim Nutr, Yaan, Sichuan, Peoples R China.	acatmxb2003@163.com; dwchen@sicau.edu.an			National Natural Science Foundation of China [31672436]; earmarked fund for the China Agricultural Research System [CARS-35]; Sichuan Province Science and Technology Support Project [2012NZ0001]; National Basic Research Program of China [2013CB531406]; National High Technology Research and Development Program of China [2014AA022209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the China Agricultural Research System; Sichuan Province Science and Technology Support Project; National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This study was financially funded by the National Natural Science Foundation of China (31672436), the earmarked fund for the China Agricultural Research System (CARS-35), Sichuan Province Science and Technology Support Project (2012NZ0001), the National Basic Research Program of China (2013CB531406), and the National High Technology Research and Development Program of China (2014AA022209) to DWC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially funded by the National Natural Science Foundation of China (31672436), the earmarked fund for the China Agricultural Research System (CARS-35), Sichuan Province Science and Technology Support Project (2012NZ0001), the National Basic Research Program of China (2013CB531406), and the National High Technology Research and Development Program of China (2014AA022209).	Angulo P, 2007, J GASTROENTEROLO SS1, V65, pS57; Baskin DG, 1999, DIABETES, V48, P828, DOI 10.2337/diabetes.48.4.828; Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Chambers ES, 2015, P NUTR SOC, V74, P328, DOI 10.1017/S0029665114001657; Couillard C, 1998, DIABETES, V47, P953, DOI 10.2337/diabetes.47.6.953; Den BG, 2015, DIABETES, V64, P2398, DOI [10.2337/44641213, DOI 10.2337/44641213]; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Du HD, 2010, AM J CLIN NUTR, V91, P329, DOI 10.3945/ajcn.2009.28191; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hara H, 1999, J NUTR, V129, P942, DOI 10.1093/jn/129.5.942; Horton JD, 1999, CURR OPIN LIPIDOL, V10, P143, DOI 10.1097/00041433-199904000-00008; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; KISSEBAH AH, 1994, PHYSIOL REV, V74, P761, DOI 10.1152/physrev.1994.74.4.761; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Liu SM, 2003, AM J CLIN NUTR, V78, P920, DOI 10.1093/ajcn/78.5.920; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malecha S, 2012, INT J ENDOCRINOL, V2012; Mao XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146312; Parnell JA, 2009, AM J CLIN NUTR, V89, P1751, DOI 10.3945/ajcn.2009.27465; Puddu A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/162021; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; Rumberger JM, 2014, PEERJ, V2, DOI 10.7717/peerj.611; Sanz Y, 2010, P NUTR SOC, V69, P434, DOI 10.1017/S0029665110001813; Shimano H, 2002, VITAM HORM, V65, P167, DOI 10.1016/S0083-6729(02)65064-2; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; So PW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001309; SUKHIJA PS, 1988, J AGR FOOD CHEM, V36, P1202, DOI 10.1021/jf00084a019; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Vernarelli JA, 2015, EUR J NUTR, V54, P59, DOI 10.1007/s00394-014-0685-0; Wan J, 2017, RSC ADV, V7, P9669, DOI 10.1039/c7ra00142h; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; Yamashita H, 2007, BIOSCI BIOTECH BIOCH, V71, P1236, DOI 10.1271/bbb.60668; Yan H, 2017, EUROPEAN J NUTR, V56, P1; Yu S, 2017, LIVEST SCI, V195, P80, DOI 10.1016/j.livsci.2016.11.013; Zaibi MS, 2010, FEBS LETT, V584, P2381, DOI 10.1016/j.febslet.2010.04.027; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	43	22	26	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196867	10.1371/journal.pone.0196867	http://dx.doi.org/10.1371/journal.pone.0196867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723298	Green Published, Green Submitted, gold			2022-12-26	WOS:000431305100081
J	Louvigne, M; Rouleau, S; Caldagues, E; Souto, I; Montcho, Y; Bouvagnet, AM; Baud, O; Carel, JC; Gascoin, G; Coutant, R				Louvigne, Mathilde; Rouleau, Stephanie; Caldagues, Emmanuelle; Souto, Isabelle; Montcho, Yanis; Bouvagnet, Audrey Migraine; Baud, Olivier; Carel, Jean Claude; Gascoin, Geraldine; Coutant, Regis			Association of maternal nutrition with transient neonatal hyperinsulinism	PLOS ONE			English	Article							WEIGHT-GAIN; GLUCOSE-METABOLISM; ENERGY-EXPENDITURE; BISPHENOL-A; LIFE-STYLE; PREGNANCY; HYPOGLYCEMIA; INFANTS; MANAGEMENT; QUESTIONNAIRE	Objective The objective was to determine whether maternal nutritional factors are associated with transient neonatal hyperinsulinism (HI). Design and setting Case control study in 4 French tertiary Obstetrics and Neonatology Departments between 2008 and 2015. Methods Sixty-seven mothers of neonates diagnosed with transient hyperinsulinism and 113 mothers of controls were included. The screening for hyperinsulinemic hypoglycemia in neonates was performed because of clinical symptoms suggestive of hypoglycemia or in the presence of conventional risk factors (small-for-gestational-age, prematurity, anoxo-ischemia, hypothermia, macrosomia, gestational diabetes). Hyperinsulinemic hypoglycemia was confirmed in the HI neonates and ruled out in the controls. This allowed for comparing maternal nutrition in cases and controls in a context of similar risk factors. One to 2 mothers of control neonates were included per case, and a food frequency questionnaire was addressed to the mothers between day 5 and day 10 after the birth of their newborn. Results Crude odds ratio showed that maternal weight gain, abnormal fetal rate, C-section, gender, consumption of fresh cooked vegetables, fresh fruits and fruit juices, low fat diary products, light fat products, and daily bread were significantly associated with hyperinsulinism. Maternal body mass index, hypertension, gestational diabetes, birth weight percentile, gestational age and 5-minute Apgar score were not related to HI. In a multiple backward logistic regression model, consumption of fresh cooked vegetable >= 1/day (OR = 0.33 [0.14-0.77]) and light-fat products >= 1/week (OR = 0.24 [0.08-0.71]) was protective against hyperinsulinism, whereas gestational weight gain >20 kg (OR = 9.5 [2.0-45.5]) and between 15-20 kg (OR = 4.0 [1.2-14.0]), abnormal fetal heart rate (OR = 4.4 [1.6-12.0]), and C-section (OR = 3.4 [1.3-8.9]) were risk factors. Conclusions A diet rich in fresh cooked vegetable and reduced in fat, together with the avoidance of a high gestational weight gain may be protective against transient neonatal hyperinsulinism.	[Louvigne, Mathilde; Rouleau, Stephanie; Coutant, Regis] CHU Angers, Serv Diabetol & Endocrinol Pediat, Dept Pediat, Angers, France; [Louvigne, Mathilde; Rouleau, Stephanie; Coutant, Regis] CHU Angers, Ctr Reference Malad Endocriniennes Rares Thyrdide, Angers, France; [Louvigne, Mathilde; Souto, Isabelle] Ctr Hosp Mans, Serv Pediat, Le Mans, France; [Rouleau, Stephanie] CHU Angers, Serv Reanimat & Med Neonatale, Angers, France; [Caldagues, Emmanuelle] CHU Nantes, Serv Pediat, Serv Diabetol & Endocrinol Pediat, Nantes, France; [Montcho, Yanis] Ctr Hosp Mans, Serv Reanimat & Med Neonatale, Le Mans, France; [Bouvagnet, Audrey Migraine] CHU Nantes, Serv Neonatol, Nantes, France; [Baud, Olivier] Hop Univ Robert Debre, Serv Reanimat & Pediat Neonatale, Paris, France; [Carel, Jean Claude; Gascoin, Geraldine] Univ Paris Diderot, Serv Endocrinol Diabetol Pediat, Hop Univ Robert Debre, AP HP,Sorbonne Paris Cite, Paris, France; [Carel, Jean Claude; Gascoin, Geraldine] Univ Paris Diderot, Ctr Reference Malad Endocriniennes Rares Croissan, Hop Univ Robert Debre, AP HP,Sorbonne Paris Cite, Paris, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre Hospitalier Le Mans; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Nantes Universite; CHU de Nantes; Centre Hospitalier Le Mans; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Coutant, R (corresponding author), CHU Angers, Serv Diabetol & Endocrinol Pediat, Dept Pediat, Angers, France.; Coutant, R (corresponding author), CHU Angers, Ctr Reference Malad Endocriniennes Rares Thyrdide, Angers, France.	regis.coutant@univ-angers.fr	Carel, Jean-Claude/AAZ-7691-2020; Co, Re/Z-5330-2019; Gascoin, Geraldine/ABE-4950-2020	Carel, Jean-Claude/0000-0002-0424-6767; 				Adamkin DH, 2011, PEDIATRICS, V127, P575, DOI 10.1542/peds.2010-3851; American College of Obstetricians and Gynecologists, 2017, PRACT B, V130, pe17, DOI [10.1097/AOG.0000000000002159, DOI 10.1097/AOG.0000000000002159]; [Anonymous], 2010, J GYNECOL OBST BIO R; Arnoux JB, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-63; Arnoux JB, 2010, EARLY HUM DEV, V86, P287, DOI 10.1016/j.earlhumdev.2010.05.003; Avatapalle HB, 2013, FRONT ENDOCRINOL, V4, P60, DOI [10.3389/fendo.2013.00060, DOI 10.3389/FENDO.2013.00060, DOI 10.3389/FEND0.2013.00060]; Balazard F, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3690-9; Bo S, 2001, DIABETOLOGIA, V44, P972, DOI 10.1007/s001250100590; Cade JE, 2004, NUTR RES REV, V17, P5, DOI 10.1079/NRR200370; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; Cole M D, 1994, J Perinatol, V14, P118; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; Garcia-Arevalo M, 2016, ENDOCRINOLOGY, V157, P4158, DOI 10.1210/en.2016-1390; Gilmore LA, 2016, OBSTET GYNECOL, V127, P884, DOI 10.1097/AOG.0000000000001372; Giovannelli J, 2014, J ACAD NUTR DIET, V114, P552, DOI 10.1016/j.jand.2013.07.002; GOLDBERG GR, 1993, AM J CLIN NUTR, V57, P494, DOI 10.1093/ajcn/57.4.494; Hedderson MM, 2006, OBSTET GYNECOL, V108, P1153, DOI 10.1097/01.AOG.0000242568.75785.68; Hillman Noah H, 2012, Clin Perinatol, V39, P769, DOI 10.1016/j.clp.2012.09.009; Hoe FM, 2006, J PEDIATR-US, V148, P207, DOI 10.1016/j.jpeds.2005.10.002; Hoirisch-Clapauch S, 2016, MED HYPOTHESES, V87, P80, DOI 10.1016/j.mehy.2015.11.017; Julia E, 2016, SALAIRES SECTEUR PRI; Kaiser JR, 2015, JAMA PEDIATR, V169, P913, DOI 10.1001/jamapediatrics.2015.1631; Knight-Agarwal CR, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010667; Kojima I, 2014, ENDOCRINOL METAB, V29, P12, DOI 10.3803/EnM.2014.29.1.12; Ley SH, 2011, AM J CLIN NUTR, V94, P1232, DOI 10.3945/ajcn.111.018861; Lindley KJ, 2005, EARLY HUM DEV, V81, P61, DOI 10.1016/j.earlhumdev.2004.10.007; McKinlay CJD, 2017, JAMA PEDIATR, V171, P972, DOI 10.1001/jamapediatrics.2017.1579; Menni F, 2001, PEDIATRICS, V107, P476, DOI 10.1542/peds.107.3.476; Rasmussen KM, 2009, WEIGHT GAIN PREGNANC; Sausenthaler S, 2007, AM J CLIN NUTR, V85, P530; Siemelink M, 2002, DIABETOLOGIA, V45, P1397, DOI 10.1007/s00125-002-0918-2; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Stanley CA, 2015, J PEDIATR-US, V166, P1520, DOI 10.1016/j.jpeds.2015.02.045; Stotland NE, 2006, OBSTET GYNECOL, V108, P635, DOI 10.1097/01.AOG.0000228960.16678.bd; Streuling I, 2011, J PERINAT MED, V39, P123, DOI [10.1515/JPM.2010.127, 10.1515/jpm.2010.127]; Thornton PS, 2015, J PEDIATR-US, V167, P238, DOI 10.1016/j.jpeds.2015.03.057; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Yorifuji Tohru, 2014, Ann Pediatr Endocrinol Metab, V19, P57, DOI 10.6065/apem.2014.19.2.57	38	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0195383	10.1371/journal.pone.0195383	http://dx.doi.org/10.1371/journal.pone.0195383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723237	Green Published, Green Submitted, gold			2022-12-26	WOS:000431305100006
J	Veronese, P; Hachul, DT; Scanavacca, MI; Hajjar, LA; Wu, TC; Sacilotto, L; Veronese, C; Darrieux, FCD				Veronese, Pedro; Hachul, Denise Tessariol; Scanavacca, Mauricio Ibrahim; Hajjar, Ludhmila Abrahao; Wu, Tan Chen; Sacilotto, Luciana; Veronese, Carolina; da Costa Darrieux, Francisco Carlos			Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer	PLOS ONE			English	Article							CARDIO-ONCOLOGY; LATE POTENTIALS; TROPONIN-I; DISPERSION; CARDIOTOXICITY; EPIRUBICIN; LYMPHOMA; THERAPY; LONG	Aim Acute and subacute cardiotoxicity are characterized by prolongation of the corrected QT interval (QTc) and other measures derived from the QTc interval, such as QTc dispersion (QTdc) and transmural dispersion of repolarization (DTpTe). Although anthracyclines prolong the QTc interval, it is unclear whether breast cancer patients who undergo the ACT chemotherapy regimen of anthracycline (doxorubicin: A), cyclophosphamide (C) and taxane (T) may present with QTc, QTdc and DTpTe prolongation. Methods Twenty-three consecutive patients with breast cancer were followed prospectively during ACT chemotherapy and were analyzed according to their QT measurements. QTc, QTdc and DTpTe measurements were determined by a 12-lead electrocardiogram (EKG) prior to chemotherapy (baseline), immediately after the first phase of anthracycline and cyclophosphamide (AC) treatment, and immediately after T treatment. Serum troponin and B-type natriuretic peptide (BNP) levels were also measured. Results Compared to baseline values, the QTc interval was significantly prolonged after the AC phase (439.7 +/- 33.2 ms vs. 472.5 +/- 36.3 ms, p = 0.001) and after T treatment (439.7 +/- 33.2 ms vs. 467.9 +/- 42.6 ms, p < 0.001). Troponin levels were elevated after the AC phase (23.0 pg/mL [min-max: 6.0-85.0] vs. 6.0 pg/mL [min-max: 6.0-22.0], p < 0.001) and after T treatment (25.0 pg/mL [min-max: 6.0-80.0] vs. 6.0 pg/mL [min-max: 6.0-22.0], p < 0.001) compared to baseline values. Conclusion In this prospective study of patients with non-metastatic breast cancer who underwent ACT chemotherapy, significant QTc prolongation and an elevation in serum troponin levels were observed.	[Veronese, Pedro; Hachul, Denise Tessariol; Scanavacca, Mauricio Ibrahim; Hajjar, Ludhmila Abrahao; Wu, Tan Chen; Sacilotto, Luciana; da Costa Darrieux, Francisco Carlos] Univ Sao Paulo, Inst Coracao InCor, Hosp Clin HCFMUSP, Clin Unit Arrhythmia & Pacing,Fac Med, Sao Paulo, SP, Brazil; [Hajjar, Ludhmila Abrahao] Univ Sao Paulo, Canc Inst ICESP, Hosp Clin HCFMUSP, Oncol Dept,Fac Med, Sao Paulo, SP, Brazil; [Veronese, Carolina] Univ North Carolina Chapel Hill, Clin Dept, Chapel Hill, NC USA	Universidade de Sao Paulo; Universidade de Sao Paulo; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Veronese, P (corresponding author), Univ Sao Paulo, Inst Coracao InCor, Hosp Clin HCFMUSP, Clin Unit Arrhythmia & Pacing,Fac Med, Sao Paulo, SP, Brazil.	veronesepedro@hotmail.com	Sacilotto, Luciana/H-8134-2012; DARRIEUX, FRANCISCO C/D-4970-2013; Scanavacca, Mauricio/F-7693-2012	Sacilotto, Luciana/0000-0002-3679-5349; DARRIEUX, FRANCISCO C/0000-0001-5818-5958; Abrahao Hajjar, Ludhmila/0000-0001-5645-2055; Veronese, Pedro/0000-0003-1559-684X; Tessariol Hachul, Denise/0000-0001-5338-3242; Scanavacca, Mauricio/0000-0001-7327-2275				Al-Khatib SM, 2003, JAMA-J AM MED ASSOC, V289, P2120, DOI 10.1001/jama.289.16.2120; Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Arbel Y, 2007, ANTI-CANCER DRUG, V18, P493, DOI 10.1097/CAD.0b013e328012d023; BUJA G, 1994, PACE, V17, P1833, DOI 10.1111/j.1540-8159.1994.tb03755.x; Cardinale D, 2004, CIRCULATION, V109, P2749, DOI 10.1161/01.CIR.0000130926.51766.CC; Cardinale D, 2002, ANN ONCOL, V13, P710, DOI 10.1093/annonc/mdf170; Florescu Maria, 2013, Maedica (Bucur), V8, P59; Fradley Michael G, 2015, Card Electrophysiol Clin, V7, P341, DOI 10.1016/j.ccep.2015.03.013; Galetta F, 2005, BIOMED PHARMACOTHER, V59, P541, DOI 10.1016/j.biopha.2004.12.003; Guglin M, 2009, EUROPACE, V11, P1579, DOI 10.1093/europace/eup300; Horacek JM, 2014, BIOMED PAP, V158, P511, DOI 10.5507/bp.2014.004; Johnson JN, 2009, BRIT J SPORT MED, V43, P657, DOI 10.1136/bjsm.2008.054734; Kalil R, 2011, ARQ BRAS CARDIOL, V96, P1, DOI 10.1590/S0066-782X2011000700001; Kitagawa K, 2012, ANN ONCOL, V23, P743, DOI 10.1093/annonc/mdr296; Kuittinen T, 2010, CLIN PHYSIOL FUNCT I, V30, P175, DOI 10.1111/j.1475-097X.2009.00920.x; Malik M, 2000, J AM COLL CARDIOL, V36, P1749, DOI 10.1016/S0735-1097(00)00962-1; Markman TM, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26556; Mavinkurve-Groothuis AMC, 2008, PEDIATR HEMAT ONCOL, V25, P655, DOI 10.1080/08880010802244001; Nousiainen T, 1999, J INTERN MED, V245, P359, DOI 10.1046/j.1365-2796.1999.00480.x; Schimmel KJM, 2004, CANCER TREAT REV, V30, P181, DOI 10.1016/j.ctrv.2003.07.003; Tanriverdi O, 2012, MED ONCOL, V29, P3265, DOI 10.1007/s12032-012-0291-z; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Zamorano JL, 2016, EUR HEART J, V37, P2768, DOI 10.1093/eurheartj/ehw211	23	20	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196763	10.1371/journal.pone.0196763	http://dx.doi.org/10.1371/journal.pone.0196763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723224	Green Submitted, Green Published, gold			2022-12-26	WOS:000431305100060
J	Bergman, L; Zetterberg, H; Kaihola, H; Hagberg, H; Blennow, K; Akerud, H				Bergman, Lina; Zetterberg, Henrik; Kaihola, Helena; Hagberg, Henrik; Blennow, Kaj; Akerud, Helena			Blood-based cerebral biomarkers in preeclampsia: Plasma concentrations of NfL, tau, S100B and NSE during pregnancy in women who later develop preeclampsia - A nested case control study	PLOS ONE			English	Article							NEUROFILAMENT LIGHT-CHAIN; CEREBROSPINAL-FLUID; BRAIN-INJURY; PROTEINS; DISEASE; ENCEPHALOPATHY; PREDICTORS; DIAGNOSIS; ECLAMPSIA; ELISA	Objective To evaluate if concentrations of the neuronal proteins neurofilament light chain and tau are changed in women developing preeclampsia and to evaluate the ability of a combination of neurofilament light chain, tau, S100B and neuron specific enolase in identifying neurologic impairment before diagnosis of preeclampsia. Methods A nested case-control study within a longitudinal study cohort was performed. 469 healthy pregnant women were enrolled between 2004-2007 and plasma samples were collected at gestational weeks 10, 25, 28, 33 and 37. Plasma concentrations of tau and neurofilament light chain were analyzed in 16 women who eventually developed preeclampsia and 36 controls throughout pregnancy with single molecule array (Simoa) method and compared within and between groups. S100B and NSE had been analyzed previously in the same study population. A statistical model with receiving characteristic operation curve was constructed with the four biomarkers combined. Results Plasma concentrations of neurofilament light chain were significantly increased in women who developed preeclampsia in gestational week 33 (11.85 ng/L, IQR 7.48-39.93 vs 6.80 ng/L, IQR 5.65-11.40) and 37 (22.15 ng/L, IQR 10.93-35.30 vs 8.40 ng/L, IQR 6.40-14.30) and for tau in gestational week 37 (4.33 ng/L, IQR 3.97-12.83 vs 3.77 ng/L, IQR 1.91-5.25) in contrast to healthy controls. A combined model for preeclampsia with tau, neurofilament light chain, S100B and neuron specific enolase in gestational week 25 displayed an area under the curve of 0.77, in week 28 it was 0.75, in week 33 it was 0.89 and in week 37 it was 0.83. Median week for diagnosis of preeclampsia was at 38 weeks of gestation. Conclusion Concentrations of both tau and neurofilament light chain are increased in the end of pregnancy in women developing preeclampsia in contrast to healthy pregnancies. Cerebral biomarkers might reflect cerebral involvement before onset of disease.	[Bergman, Lina] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Bergman, Lina] Ctr Clin Res, Falun, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Queen Sq, London, England; [Zetterberg, Henrik] UK Dementia Res Inst, London, England; [Kaihola, Helena; Akerud, Helena] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Hagberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Perinatal Ctr, Dept Obstet & Gynecol, Gothenburg, Sweden; [Hagberg, Henrik] Kings Coll London, Ctr Developing Brain, London, England	Uppsala University; University of Gothenburg; Sahlgrenska University Hospital; University of London; University College London; Uppsala University; University of Gothenburg; University of London; King's College London	Bergman, L (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.; Bergman, L (corresponding author), Ctr Clin Res, Falun, Sweden.	lina.bergman@kbh.uu.se	Bergman, Lina/ABF-7954-2021	Bergman, Lina/0000-0001-5202-9428; Hagberg, Henrik/0000-0003-3962-1448	European Research Council; Swedish State Support for Clinical Research (ALFGBG); Torsten Soderberg Foundation; Knut and Alice Wallenberg Foundation; Swedish Research Council [D 2013-2546, D0277902, D0277901]; Center for clinical research, Falun, Sweden	European Research Council(European Research Council (ERC)European Commission); Swedish State Support for Clinical Research (ALFGBG); Torsten Soderberg Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Center for clinical research, Falun, Sweden	This study was financed by the European Research Council, Swedish State Support for Clinical Research (ALFGBG), the Torsten Soderberg Foundation, the Knut and Alice Wallenberg Foundation, The Swedish Research Council D 2013-2546, D0277902 and D0277901 and Center for clinical research, Falun, Sweden.	Akkermans J, 2014, EUR J OBSTET GYN R B, V179, P58, DOI 10.1016/j.ejogrb.2014.05.021; Anderson UD, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0584-7; Bergman L, 2016, REPROD SCI, V23, P395, DOI 10.1177/1933719115604732; Bergman L, 2014, AM J HYPERTENS, V27, P1105, DOI 10.1093/ajh/hpu020; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Hammer ES, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0575-8; Johnson AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113670; Junewar V, 2014, AM J NEURORADIOL, V35, P1728, DOI 10.3174/ajnr.A3923; Kalm MS, 2017, BRIAN RES; Koel-Simmelink MJA, 2014, J IMMUNOL METHODS, V402, P43, DOI 10.1016/j.jim.2013.11.008; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Lederer W, 2016, PREGNANCY HYPERTENS, V6, P384, DOI 10.1016/j.preghy.2016.08.243; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/S1474-4422(16)00070-3, 10.1016/s1474-4422(16)00070-3]; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Saraf S, 2014, OBSTET GYNECOL, V123, p169S, DOI 10.1097/01.AOG.0000447177.91016.48; Schoonenboom NSM, 2005, CLIN CHEM, V51, P189, DOI 10.1373/clinchem.2004.039735; Shahim P, 2013, PEDIATR NEUROL, V49, P31, DOI 10.1016/j.pediatrneurol.2013.02.015; Sibai BM, 2005, OBSTET GYNECOL, V105, P402, DOI 10.1097/01.AOG.0000152351.13671.99; Sibai BM, 2004, AM J OBSTET GYNECOL, V190, P1520, DOI 10.1016/j.ajog.2003.12.057; Sovio U, 2017, HYPERTENSION, V69, P731, DOI 10.1161/HYPERTENSIONAHA.116.08620; Thangaratinam S, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0827-3; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Wikstrom AK, 2012, PREGNANCY HYPERTENS, V2, P398, DOI 10.1016/j.preghy.2012.03.001; Zetterberg H, 2017, NEUROPATH APPL NEURO, V43, P194, DOI 10.1111/nan.12378	28	22	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196025	10.1371/journal.pone.0196025	http://dx.doi.org/10.1371/journal.pone.0196025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29719006	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900042
J	Hughes, M; Peng, CI; Lin, CW; Rubite, RR; Blanc, P; Chung, KF				Hughes, Mark; Peng, Ching-, I; Lin, Che-Wei; Rubite, Rosario Rivera; Blanc, Patrick; Chung, Kuo-Fang			Chloroplast and nuclear DNA exchanges among Begonia sect. Baryandra species (Begoniaceae) from Palawan Island, Philippines, and descriptions of five new species	PLOS ONE			English	Article							GENUS BEGONIA; ASIAN BEGONIA; DISPERSAL; ARCHIPELAGO; PHYLOGENY; EVOLUTION; AFRICA; DIVERSIFICATION; HYBRIDIZATION; DIPLOCLINIUM	The Philippine island of Palawan is highly biodiverse. During fieldwork there in 2011 & 2014 we found five unknown species in the large genus Begonia. The species are similar in their rhizomatous stems, four-tepaled flowers, inferior two-or three-locular ovaries with bilamel-late placentas, and are assignable to Begonia sect. Baryandra. Our observations support the recognition of these as five new species endemic to Palawan: B. elnidoensis, B. gironellae, B. quinquealata, B. tabonensis and B. tenuibracteata which are described here. The five new species were added to phylogenies based Bayesian analysis of nrDNA (ITS) and chloroplast DNA (ndhA, ndhF-rpl32, rpl32-trnL, trnC-trnD), along with 45 other allied ingroup species. A majority of the species show incongruent positions in the two phylogenies, with evidence of prevalent chloroplast capture. Models show chloroplast capture is more likely in plant populations with high levels of inbreeding following a reduction in selfing rate after hybridisation; we suggest that this is a possible explanation for the massive amount of chloroplast exchange seen in our phylogeny, as Begonia species often exist as small isolated populations and may be prone to inbreeding depression. Our data also indicate a level of nuclear genetic exchange between species. The high prevalence of hybrid events in Begonia is potentially an important factor in driving genomic change and species evolution in this mega-diverse genus.	[Hughes, Mark] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Peng, Ching-, I; Chung, Kuo-Fang] Acad Sinica, Biodivers Res Ctr, Res Museum & Herbarium HAST, Taipei, Taiwan; [Lin, Che-Wei] Taiwan Forestry Res Inst, Herbarium Taiwan Forestry Res Inst TAIF, Taipei, Taiwan; [Rubite, Rosario Rivera] Univ Philippines Manila, Dept Biol, Manila, Philippines; [Blanc, Patrick] CNRS, 3 Rue Michel Ange, Paris, France	Academia Sinica - Taiwan; University of the Philippines System; University of the Philippines Manila; Centre National de la Recherche Scientifique (CNRS)	Chung, KF (corresponding author), Acad Sinica, Biodivers Res Ctr, Res Museum & Herbarium HAST, Taipei, Taiwan.	bochung@gate.sinica.edu.tw		Chung, Kuo-Fang/0000-0003-3628-2567; Hughes, Mark/0000-0002-2168-0514	Ministry of Science and Technology, Taiwan [MOST 101-2621-6-001-003]; Academia Sinica [MOST 101-2621-6-001-003]; University of the Philippines Enhanced Creative Work and Research Grant [ECWRG-2015-2-035]; Sibbald Trust; Royal Society of Edinburgh Bilateral Programme; Scottish Government's Rural and Environment Science and Analytical Services Division	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); University of the Philippines Enhanced Creative Work and Research Grant; Sibbald Trust; Royal Society of Edinburgh Bilateral Programme; Scottish Government's Rural and Environment Science and Analytical Services Division	This study was supported in part by grants from Ministry of Science and Technology, Taiwan and Academia Sinica to Ching-I Pen g and Kuo-Fang Chung (MOST 101-2621-6-001-003) as well as the University of the Philippines Enhanced Creative Work and Research Grant (ECWRG-2015-2-035) to Rosario R. Rubite. Mark Hughes is grateful to the Sibbald Trust and The Royal Society of Edinburgh Bilateral Programme for funding research visits to Academia Sinica. The Royal Botanic Garden Edinburgh is supported by the Scottish Government's Rural and Environment Science and Analytical Services Division. During 2017 we are also grateful for the support of players of People's Postcode Lottery towards our scientific research.	[Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Atkins H, 2001, BIOL J LINN SOC, V72, P143, DOI 10.1111/j.1095-8312.2001.tb01306.x; Brown RM, 2016, MOL PHYLOGENET EVOL, V94, P531, DOI 10.1016/j.ympev.2015.10.010; Chiang TY, 2001, J PLANT RES, V114, P343, DOI 10.1007/PL00013996; Chung KF, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-1; Clement WL, 2004, AM J BOT, V91, P905, DOI 10.3732/ajb.91.6.905; Critical Ecosystem Partnership Fund (CEPF), 2001, PHIL HOTSP; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Wilde JJFE, 2011, TAXON, V60, P1685, DOI 10.1002/tax.606013; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Forrest LL, 2005, SYST BOT, V30, P671, DOI 10.1600/0363644054782297; Forrest LL, 2003, PLANT SYST EVOL, V241, P193, DOI 10.1007/s00606-002-0033-y; Goodall-Copestake WP, 2010, BIOL J LINN SOC, V101, P243, DOI 10.1111/j.1095-8312.2010.01489.x; Goodall-Copestake WP, 2009, BOT J LINN SOC, V159, P363, DOI 10.1111/j.1095-8339.2009.00948.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hughes M, 2008, MOL ECOL, V17, P2643, DOI 10.1111/j.1365-294X.2008.03788.x; Hughes M., 2010, Edinburgh Journal of Botany, V67, P123, DOI 10.1017/S0960428609990266; Hughes M., 2009, Edinburgh Journal of Botany, V66, P205, DOI 10.1017/S0960428609005307; Hughes M, 2015, AM J BOT, V102, P695, DOI 10.3732/ajb.1400428; Hughes M, 2011, BOT STUD, V52, P203; Matolweni LO, 2000, AM J BOT, V87, P431, DOI 10.2307/2656639; Mcneill J., 2012, INT COD NOM ALG FUNG; Moonlight PW, 2015, J BIOGEOGR, V42, P1137, DOI 10.1111/jbi.12496; Muir G, 2001, MOL BIOL EVOL, V18, P112, DOI 10.1093/oxfordjournals.molbev.a003785; Naciri Y, 2015, TAXON, V64, P3, DOI 10.12705/641.24; Neale S., 2006, Floriculture, ornamental and plant biotechnology, P606; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peng CI, 2009, BOT STUD, V50, P241; Peng CI, 2000, ANN MO BOT GARD, V87, P273, DOI 10.2307/2666164; Plana V, 2004, MOL PHYLOGENET EVOL, V31, P449, DOI 10.1016/j.ympev.2003.08.023; Rajbhandary S., 2011, Gardens' Bulletin (Singapore), V63, P277; RIESEBERG LH, 1991, EVOL TREND PLANT, V5, P65; Roa F, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-225; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rubite R, 2015, BOT STUD, V56, P1, DOI 10.1186/s40529-015-0099-1; Rubite RR, 2013, BOT STUD, V54, DOI 10.1186/1999-3110-54-38; Salichos L, 2014, MOL BIOL EVOL, V31, P1261, DOI 10.1093/molbev/msu061; Santos C., 2016, PALAWAN NEWS    1101; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Tebbitt MC, 2006, SYST BOT, V31, P327, DOI 10.1600/036364406777585784; Thomas DC, 2012, J BIOGEOGR, V39, P98, DOI 10.1111/j.1365-2699.2011.02596.x; Thomas DC, 2011, MOL PHYLOGENET EVOL, V60, P428, DOI 10.1016/j.ympev.2011.05.006; Tsitrone A, 2003, EVOLUTION, V57, P1776, DOI 10.1111/j.0014-3820.2003.tb00585.x; Twyford AD, 2014, HEREDITY, V112, P382, DOI 10.1038/hdy.2013.116; Twyford AD, 2013, BOT J LINN SOC, V171, P260, DOI 10.1111/j.1095-8339.2012.01265.x	46	17	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0194877	10.1371/journal.pone.0194877	http://dx.doi.org/10.1371/journal.pone.0194877			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718922	Green Submitted, Green Published, gold			2022-12-26	WOS:000431281900011
J	Mitchell, EA; Stewart, AW; Braithwaite, I; Murphy, R; Hancox, RJ; Wall, C; Beasley, R				Mitchell, Edwin A.; Stewart, Alistair W.; Braithwaite, Irene; Murphy, Rinki; Hancox, Robert J.; Wall, Clare; Beasley, Richard		ISAAC Phase Three Study Grp	Factors associated with body mass index in children and adolescents: An international cross-sectional study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MATERNAL SMOKING; OFFSPRING OBESITY; CHILDHOOD OBESITY; RISK-FACTORS; PREGNANCY; TELEVISION; OVERWEIGHT; ADIPOSITY; ALLERGIES	Background The increasing prevalence of overweight and obesity in childhood has implications for their future health. There are many potential contributors to overweight and obesity in childhood. The aim was to investigate the association b etween postulated risk factors and body mass index (BMI) in children and adolescents. Methods Secondary analysis of data from a multi-centre, multi-country, cross-sectional study (ISAAC Phase Three). Parents/guardians of children aged 6-7 years completed a questionnaire about their child's current height and weight, and the postulated risk factors. Adolescents aged 13-14 years reported their own height and weight and answered questions about the postulated risk factors. A general linear mixed model was used to determine the association between BMI and the postulated risk factors. Imputation was used if there were missing responses for 3 or fewer explanatory variables. Results 65,721 children (27 centres, 15 countries) and 189,282 adolescents (70 centres, 35 countries) were included in the final analyses. Many statistically significant associations were identified, although for most variables the effect sizes were small. In children birth weight (for each kg increase in birth weight the BMI increased by +0.43 kg/m(2), p<0.001), television viewing (5+ hours/day + 0.33 kg/m(2) vs. < 1 hour/day, p<0.001), fast food(>= 3 times/week + 0.16 kg/m(2) vs. never, p<0.001) vigorous physical activity (3+ hours/week 0.071 kg/m(2) vs. never, p = 0.023) and maternal smoking in the first year of life (+ 0.13 kg/m(2), p<0.001) were associated with a higher BMI in the adjusted model. Nut consumption (>= 3 times/week -0.11 kg/m(2) vs. never, p = 0.002) was associated with a lower BMI. Early life exposures (antibiotics, paracetamol and breast feeding) were also associated with BMI. For adolescents statistically significant associations with BMI and were seen with maternal smoking (+0.25 kg/m(2), p<0.001), television viewing (5+ hours/day + 0.23 kg/m(2) vs. < 1 hour/day, p<0.001), fast food (>= 3 times/week -0.19 kg/m(2) vs. never, p<0.001), vigorous physical activity (3+hours/week 0.047 kg/m(2) vs. never, p<0.001) and nuts (>= 3 times/week -0.22 kg/m(2) vs. never, p<0.001). Conclusions Although several early life exposures were associated with small differences in BMI, most effect sizes were small. Larger effect sizes were seen with current maternal smoking, television viewing (both with higher BMI) and frequent nut consumption (lower BMI) in both children and adolescents, suggesting that current behaviours are more important than early exposures. Although many variables may influence BMI in childhood, the putative factors studied are not of sufficient magnitude to support major public health interventions.	[Mitchell, Edwin A.] Univ Auckland, Fac Med & Hlth Sci, Dept Paediat Child & Youth Hlth, Auckland, New Zealand; [Stewart, Alistair W.] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Auckland, New Zealand; [Braithwaite, Irene; Beasley, Richard] Med Res Inst New Zealand, Wellington, New Zealand; [Murphy, Rinki] Univ Auckland, Fac Med & Hlth Sci, Dept Med, Auckland, New Zealand; [Hancox, Robert J.] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand; [Wall, Clare] Univ Auckland, Fac Med & Hlth Sci, Discipline Nutr & Dietet, Auckland, New Zealand	University of Auckland; University of Auckland; Medical Research Institute Of New Zealand; University of Auckland; University of Otago; University of Auckland	Mitchell, EA (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Paediat Child & Youth Hlth, Auckland, New Zealand.	e.mitchell@auckland.ac.nz	Braithwaite, Irene/L-2811-2019; Braithwaite, Irene/G-2045-2014	Braithwaite, Irene/0000-0001-5327-3027; Braithwaite, Irene/0000-0001-5327-3027; Mitchell, Edwin/0000-0001-6187-7648	Cure Kids (NZ)	Cure Kids (NZ)	Ed Mitchell was funded by Cure Kids (NZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mamun A, 2006, AM J EPIDEMIOL, V164, P317, DOI 10.1093/aje/kwj209; [Anonymous], 2010, WHITE HOUSE TASK FOR; Bhat VN., 2016, J SOCIAL SCI, V12, P129, DOI [10.3844/jssp.2016.129.135, DOI 10.3844/JSSP.2016.129.135]; Braithwaite I, 2015, BMC PEDIATR, V15, P200; Braithwaite I, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005813; Braithwaite I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074263; Braithwaite IE, 2017, ACTA PAEDIATR, V106, P1323, DOI 10.1111/apa.13903; Casazza K, 2013, NEW ENGL J MED, V368, P446, DOI 10.1056/NEJMsa1208051; Ellwood P, 2005, INT J TUBERC LUNG D, V9, P10; Ellwood P, 2010, INT J TUBERC LUNG D, V14, P1059; Field AE, 2003, INT J OBESITY, V27, P821, DOI 10.1038/sj.ijo.0802297; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; Florath I, 2014, PEDIATR OBES, V9, P121, DOI 10.1111/j.2047-6310.2012.00146.x; Flores-Mateo G, 2013, AM J CLIN NUTR, V97, P1346, DOI 10.3945/ajcn.111.031484; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Hancox RJ, 2015, PEDIATR OBES, V10, P283, DOI 10.1111/ijpo.266; Hancox RJ, 2006, INT J OBESITY, V30, P171, DOI 10.1038/sj.ijo.0803071; Ibarrola-Jurado N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057367; Ino T, 2010, PEDIATR INT, V52, P94, DOI 10.1111/j.1442-200X.2009.02883.x; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Mitchell EA, 2017, PEDIATR OBES, V12, P280, DOI 10.1111/ijpo.12138; Murphy R, 2014, INT J OBESITY, V38, P1115, DOI 10.1038/ijo.2013.218; Murphy R, 2015, OBESITY, V23, P1030, DOI 10.1002/oby.21045; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Ros E, 2006, BRIT J NUTR, V96, pS29, DOI 10.1017/BJN20061861; Sahota P, 2001, BMJ-BRIT MED J, V323, P1029, DOI 10.1136/bmj.323.7320.1029; Wall CR, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030316; World Health Organization, GLOBAL STATUS REPORT	33	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196221	10.1371/journal.pone.0196221	http://dx.doi.org/10.1371/journal.pone.0196221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718950	Green Submitted, Green Published, gold			2022-12-26	WOS:000431281900048
J	Peng, XM; Gao, S; Deng, HT; Cai, HX; Zhou, ZA; Xiang, R; Zhang, QZ; Li, LY				Peng, Xue-Mei; Gao, Shan; Deng, Hui-Ting; Cai, Hong-Xing; Zhou, Zhuan; Xiang, Rong; Zhang, Qiang-Zhe; Li, Lu-Yuan			Perturbation of epithelial apicobasal polarity by rhomboid family-1 gene overexpression	FASEB JOURNAL			English	Article						acinus; Par6; RHBDF1; protein complex	CELL-POLARITY; COMMON TARGETS; CANCER-CELLS; EXPRESSION; PROTEINS; PAR3; MORPHOGENESIS; APOPTOSIS; GTPASES	The human rhomboid family (RHBDF)1 gene is highly expressed in breast cancer under clinical conditions but not in normal mammary gland tissues. Silencing the RHBDF1 gene in breast cancer xenograft tumors leads to inhibition of tumor growth. We show in this study that artificially raising RHBDF1 protein levels in the mammary epithelial cells MCF-10A results in severe perturbations of the ability of the cells to form lumen-containing acini, either in 3-dimensional cell cultures or implanted in mouse mammary fat pads. Knocking down RHBDF1 with short hairpin (sh)RNA leads to restoration of acinus formation. Consistently, RHBDF1 overexpression gives rise to disordered distribution of polarity markers GM130 and laminin-5, which otherwise are located in apical and basal positions, respectively, in the acini. Further investigations reveal that RHBDF1 directly binds to Par6a, a component of a protein complex consisting of partitioning-defective scaffold protein (Par)6, Par3, renin-angiotensin system-related C3 botulinum toxin substrate (Rac)1, and cell-division cycle (Cdc)42, which is structurally critical to the formation of apicobasal polarity. RHBDF1 binding to Par6a results in collapse of the protein complex and thus disruption of polarity formation. Since early stages of breast cancer are characterized by the loss of mammary gland epithelial cell polarity, our findings indicate that perturbations of apicobasal polarity by high levels of RHBDF1 is a significant attribute in the development of breast neoplasia.Peng, X.-M., Gao, S., Deng, H.-T., Cai, H.-X., Zhou, Z., Xiang, R., Zhang, Q.-Z., Li, L.-Y. Perturbation of epithelial apicobasal polarity by rhomboid family-1 gene overexpression.	[Peng, Xue-Mei; Gao, Shan; Deng, Hui-Ting; Cai, Hong-Xing; Zhou, Zhuan; Xiang, Rong; Zhang, Qiang-Zhe; Li, Lu-Yuan] Nankai Univ, Tianjin Key Lab Mol Drug Res, Coll Pharm, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Peng, Xue-Mei; Gao, Shan; Deng, Hui-Ting; Cai, Hong-Xing; Zhou, Zhuan; Xiang, Rong; Zhang, Qiang-Zhe; Li, Lu-Yuan] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Tianjin, Peoples R China; [Peng, Xue-Mei; Gao, Shan; Deng, Hui-Ting; Cai, Hong-Xing; Zhou, Zhuan; Xiang, Rong; Zhang, Qiang-Zhe; Li, Lu-Yuan] Nankai Univ, Sch Med, Tianjin, Peoples R China; [Peng, Xue-Mei] Shanxi Datong Univ, Sch Med, Dept Immunol, Datong, Peoples R China	Nankai University; Nankai University; Nankai University; Shanxi Datong University	Zhang, QZ; Li, LY (corresponding author), Nankai Univ, State Key Lab Med Chem Biol 203, 94 Weijin Rd, Tianjin 300071, Peoples R China.	zhangqiangzhe@nankai.edu.cn; liluyuan@nankai.edu.cn			National Natural Science Foundation of China (NSFC) [81672747, 31560323, 81272356, 81330029]; Tianjin Municipality Science and Technology Commission [10ZCKFSH00100, 15JCYBJC50100]; Programs for Changjiang Scholars and Innovative Teams at Nankai University [IRT13023]; Ministry of Education Science and Technology Development Center [20130031120040]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin Municipality Science and Technology Commission; Programs for Changjiang Scholars and Innovative Teams at Nankai University; Ministry of Education Science and Technology Development Center	This work is supported, in part, by the National Natural Science Foundation of China (NSFC) Grants 81672747 and 31560323 (to Q.-Z.Z.), and 81272356 and 81330029 (to L.-Y.L.); Tianjin Municipality Science and Technology Commission Grants 10ZCKFSH00100 (to L.-Y.L.) and 15JCYBJC50100 (to Q.-Z.Z.); Programs for Changjiang Scholars and Innovative Teams at Nankai University (IRT13023); and Ministry of Education Science and Technology Development Center Grant 20130031120040 (to Q.-Z.Z.). The authors declare no conflicts of interest.	Archibald A, 2015, ONCOGENE, V34, P3199, DOI 10.1038/onc.2014.242; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Freeman M, 2016, BIOCHEM SOC T, V44, P945, DOI 10.1042/BST20160035; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Herr R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-17; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Javier RT, 2008, ONCOGENE, V27, P7031, DOI 10.1038/onc.2008.352; Javier RT, 2011, J VIROL, V85, P11544, DOI 10.1128/JVI.05410-11; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Khursheed M, 2014, J BIOSCIENCES, V39, P145, DOI 10.1007/s12038-013-9410-z; Kinch LN, 2013, BBA-BIOMEMBRANES, V1828, P2937, DOI 10.1016/j.bbamem.2013.06.031; Kitaichi T, 2017, HUM PATHOL, V62, P134, DOI 10.1016/j.humpath.2017.01.009; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Lee W, 2015, SCI REP-UK, V5, DOI 10.1038/srep09701; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lin CC, 2014, J INFORM OPTIM SCI, V35, P1, DOI 10.1080/02522667.2013.867734; Lof-Ohlin ZM, 2017, NAT CELL BIOL, V19, P1313, DOI 10.1038/ncb3628; Mack Natalie Ann, 2014, Small GTPases, V5, P10, DOI 10.4161/21541248.2014.973768; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; McCaffrey LM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001370; Nakagawa T, 2005, DEV DYNAM, V233, P1315, DOI 10.1002/dvdy.20450; Nolan ME, 2008, CANCER RES, V68, P8201, DOI 10.1158/0008-5472.CAN-07-6567; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Sequeira SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000615; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Ward JD, 2015, CANCER LETT, V356, P382, DOI 10.1016/j.canlet.2014.09.030; Yan ZW, 2008, MOL CANCER THER, V7, P1355, DOI 10.1158/1535-7163.MCT-08-0104; Yang GL, 2017, FASEB J, V31, P2001, DOI 10.1096/fj.201600800R; Zen K, 2009, ONCOGENE, V28, P2910, DOI 10.1038/onc.2009.148; Zhou Z, 2014, CANCER RES, V74, P2719, DOI 10.1158/0008-5472.CAN-13-1027; Zou HF, 2009, FASEB J, V23, P425, DOI 10.1096/fj.08-112771	36	4	5	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5577	5586		10.1096/fj.201800016R	http://dx.doi.org/10.1096/fj.201800016R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29727209				2022-12-26	WOS:000447972500031
J	Bitra, A; Doukov, T; Croft, M; Zajonc, DM				Bitra, Aruna; Doukov, Tzanko; Croft, Michael; Zajonc, Dirk M.			Crystal structures of the human 4-1BB receptor bound to its ligand 4-1BBL reveal covalent receptor dimerization as a potential signaling amplifier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor necrosis factor (TNF); protein-protein interaction; recombinant protein expression; cell surface receptor; protein structure; X-ray crystallography	T-CELL FUNCTION; TNF SUPERFAMILY; CANCER-IMMUNOTHERAPY; MONOCLONAL-ANTIBODY; DECOY RECEPTOR; COMPLEX; ANTIGEN; GALECTIN-9; UNIQUE; OSTEOPROTEGERIN	Human (h)4-1BB (TNFRSF9 or CD137) is an inducible tumor necrosis factor receptor (TNFR) superfamily member that interacts with its cognate ligand h4-1BBL to promote T lymphocyte activation and proliferation. h4-1BB is currently being targeted with agonists in cancer immunotherapy. Here, we determined the crystal structures of unbound h4-1BBL and both WT h4-1BB and a dimerization-deficient h4-1BB mutant (C121S) in complex with h4-1BBL at resolutions between 2.7 and 3.2 angstrom. We observed that the structural arrangement of 4-1BBL, both unbound and in the complex, represents the canonical bell shape as seen in other similar TNF proteins and differs from the previously reported three-bladed propeller structure of 4-1BBL. We also found that the binding site for the receptor is at the crevice formed between two protomers of h4-1BBL, but that h4-1BB interacts predominantly with only one ligand protomer. Moreover, h4-1BBL lacked the conserved tyrosine residue in the DE loop that forms canonical interactions between other TNFR family molecules and their ligands, suggesting h4-1BBL engages h4-1BB through a distinct mechanism. Of note, we discovered that h4-1BB forms a disulfide-linked dimer because of the presence of an additional cysteine residue found in its cysteine-rich domain 4 (CRD4). As a result, h4-1BB dimerization, in addition to trimerization via h4-1BBL binding, could result in cross-linking of individual ligand-receptor complexes to form a 2D network that stimulates strong h4-1BB signaling. This work provides critical insights into the structural and functional properties of both h4-1BB and h4-1BBL and reveals that covalent receptor dimerization amplifies h4-1BB signaling.	[Bitra, Aruna; Croft, Michael; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol LJI, Div Immune Regulat, La Jolla, CA 92037 USA; [Doukov, Tzanko] SLAC, Stanford Synchrotron Radiat Light Source, Menlo Pk, CA 94025 USA; [Croft, Michael] Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California San Diego; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol, Div Immune Regulat, 9420 Athena Cir, La Jolla, CA 92037 USA.	dzajonc@lji.org		Zajonc, Dirk/0000-0001-7215-1981; Doukov, Tzanko/0000-0001-8625-2572	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI110929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Stanford Synchrotron Lightsource (SSRL) for access to remote data collection and the SSRL beamline scientists for support. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and National Institutes of Health, NIGMS (including Grant P41GM103393).	An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bitra A, 2018, J BIOL CHEM, V293, P1317, DOI 10.1074/jbc.M117.814905; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Cha SS, 2000, J BIOL CHEM, V275, P31171, DOI 10.1074/jbc.M004414200; Chan FKM, 2007, CYTOKINE, V37, P101, DOI 10.1016/j.cyto.2007.03.005; Chattopadhyay K, 2008, P NATL ACAD SCI USA, V105, P635, DOI 10.1073/pnas.0710529105; Chattopadhyay K, 2007, P NATL ACAD SCI USA, V104, P19452, DOI 10.1073/pnas.0709264104; Chattopadhyay K, 2009, IMMUNOL REV, V229, P356, DOI 10.1111/j.1600-065X.2009.00778.x; Compaan DM, 2006, STRUCTURE, V14, P1321, DOI 10.1016/j.str.2006.06.015; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fisher TS, 2012, CANCER IMMUNOL IMMUN, V61, P1721, DOI 10.1007/s00262-012-1237-1; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lee SW, 2009, ADV EXP MED BIOL, V647, P120, DOI 10.1007/978-0-387-89520-8_8; Liu CZ, 2010, J IMMUNOL, V184, P6910, DOI 10.4049/jimmunol.0904033; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Luan XD, 2012, J IMMUNOL, V189, P245, DOI 10.4049/jimmunol.1103387; Madireddi S, 2014, J EXP MED, V211, P1425, DOI 10.1084/jem.20132687; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; POLLOK KE, 1994, EUR J IMMUNOL, V24, P367, DOI 10.1002/eji.1830240215; POLLOK KE, 1993, J IMMUNOL, V150, P771; Sanchez-Paulete AR, 2016, EUR J IMMUNOL, V46, P513, DOI 10.1002/eji.201445388; Snell LM, 2011, IMMUNOL REV, V244, P197, DOI 10.1111/j.1600-065X.2011.01063.x; So T, 2008, CYTOKINE GROWTH F R, V19, P253, DOI 10.1016/j.cytogfr.2008.04.003; Sznol M, 2008, J CLIN ONCOL, V26; VANLIER RAW, 1987, J IMMUNOL, V139, P1589; Vinay DS, 2006, J MOL MED, V84, P726, DOI 10.1007/s00109-006-0072-2; Vinay DS, 1998, SEMIN IMMUNOL, V10, P481, DOI 10.1006/smim.1998.0157; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Won EY, 2010, J BIOL CHEM, V285, P9202, DOI 10.1074/jbc.M109.084442; Wyzgol A, 2009, J IMMUNOL, V183, P1851, DOI 10.4049/jimmunol.0802597; Yi L, 2017, IMMUNOL CELL BIOL, V95, P24, DOI 10.1038/icb.2016.64; Zhan CY, 2011, STRUCTURE, V19, P162, DOI 10.1016/j.str.2010.12.004	45	19	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					9958	9969		10.1074/jbc.RA118.003176	http://dx.doi.org/10.1074/jbc.RA118.003176			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29720398	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000437096700003
J	Garrido-Bigotes, A; Figueroa, NE; Figueroa, PM; Figueroa, CR				Garrido-Bigotes, Adrian; Figueroa, Nicolas E.; Figueroa, Pablo M.; Figueroa, Carlos R.			Jasmonate signalling pathway in strawberry: Genome-wide identification, molecular characterization and expression of JAZs and MYCs during fruit development and ripening	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ANTHOCYANIN ACCUMULATION; ARABIDOPSIS; REPRESSION; GENE; ACTIVATION; RESPONSES; PROTEINS; FAMILY; VISUALIZATION	Jasmonates (JAs) are signalling molecules involved in stress responses, development and secondary metabolism biosynthesis, although their roles in fleshy-fruit development and ripening processes are not well known. In strawberry fruit, it has been proposed that JAs could regulate the early development through the activation of the JAs biosynthesis. Moreover, it has been reported that JA treatment increases anthocyanin content in strawberry fruit involving the bioactive jasmonate biosynthesis. Nevertheless, JA signalling pathway, of which main components are the COI1-JAZ co-receptor and the MYC transcription factors (TFs), has not been characterized in strawberry until now. Here we identified and characterized the woodland strawberry (Fragaria vesca) JAZ and MYC genes as well as studied their expression during development and ripening stages in commercial strawberry (Fragaria x ananassa) fruit. We described twelve putative JAZ proteins and two MYC TFs, which showed high conservation with respect to their orthologs in Arabidopsis thaliana and in other fleshy-fruit species such as Malus x domestica, Vitis vinifera and Solanum lycopersicum as revealed by gene synteny and phylogenetic analyses. Noteworthy, their expression levels exhibited a significant decrease from fruit development to ripening stages in F. x ananassa, along with others of the JA signalling-related genes such as FaNINJA and FaJAMs, encoding for negative regulators of JA responses. Moreover, we found that main JA signalling-related genes such as FaMYC2, and FaJAZ1 are promptly induced by JA treatment at early times in F. x ananassa fruit. These results suggest the conservation of the canonical JA signalling pathway in strawberry and a possible role of this pathway in early strawberry fruit development, which also correlates negatively with the beginning of the ripening process.	[Garrido-Bigotes, Adrian; Figueroa, Nicolas E.; Figueroa, Pablo M.; Figueroa, Carlos R.] Univ Talca, Phytohormone Res Lab, Inst Biol Sci, Talca, Chile; [Garrido-Bigotes, Adrian] Univ Concepcion, Fac Forest Sci, Doctorate Program Forest Sci, Concepcion, Chile; [Figueroa, Nicolas E.] Tech Univ Munich, Biotechnol Nat Prod, Freising Weihenstephan, Germany	Universidad de Talca; Universidad de Concepcion; Technical University of Munich	Figueroa, CR (corresponding author), Univ Talca, Phytohormone Res Lab, Inst Biol Sci, Talca, Chile.	cfigueroa@utalca.cl	Garrido, Adrian/Y-8091-2019; Figueroa, Carlos R./I-1727-2019; Figueroa, Pablo/K-1275-2015	Garrido, Adrian/0000-0001-6123-9523; Figueroa, Carlos R./0000-0002-1372-8207; Figueroa, Pablo/0000-0002-1918-5493; Figueroa Fuentealba, Nicolas E./0000-0001-7808-314X	National Commission for Scientific and Technological Research (CONICYT, Chile) [1140663]; CONICYT through 'Beca Doctorado Nacional [21151411]	National Commission for Scientific and Technological Research (CONICYT, Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); CONICYT through 'Beca Doctorado Nacional	This research was funded by the National Commission for Scientific and Technological Research (CONICYT, Chile, http://www.conicyt.cl/), grant CONICYT, FONDECYT/Regular 1140663 to C.R.F. A.G.-B. acknowledges the support by CONICYT through 'Beca Doctorado Nacional 2015 No. 21151411.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00813; An JP, 2016, PLANT PHYSIOL BIOCH, V108, P24, DOI 10.1016/j.plaphy.2016.06.032; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Bai YH, 2011, GENOMICS, V98, P128, DOI 10.1016/j.ygeno.2011.05.002; Bottcher C, 2015, J INTEGR PLANT BIOL, V57, P618, DOI 10.1111/jipb.12321; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chen R, 2012, PLANT CELL, V24, P2898, DOI 10.1105/tpc.112.098277; Cherian S, 2014, J EXP BOT, V65, P4705, DOI 10.1093/jxb/eru280; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177381; Chini A, 2016, CURR OPIN PLANT BIOL, V33, P147, DOI 10.1016/j.pbi.2016.07.005; Chini A, 2009, PLANT J, V59, P77, DOI 10.1111/j.1365-313X.2009.03852.x; Chorev Michal, 2012, Frontiers in Genetics, V3, P55, DOI 10.3389/fgene.2012.00055; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Concha CM, 2013, PLANT PHYSIOL BIOCH, V70, P433, DOI 10.1016/j.plaphy.2013.06.008; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Geyter N, 2012, TRENDS PLANT SCI, V17, P349, DOI 10.1016/j.tplants.2012.03.001; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Figueroa P, 2015, PLANT J, V81, P849, DOI 10.1111/tpj.12776; Figueroa P, 2012, PLANT CELL PHYSIOL, V53, P330, DOI 10.1093/pcp/pcr178; Fonseca S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086182; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; Gansser D, 1997, J AGR FOOD CHEM, V45, P2477, DOI 10.1021/jf9608940; Garrido-Bigotes A, 2018, J PLANT GROWTH REGUL, V37, P101, DOI 10.1007/s00344-017-9710-x; Gasic K., 2004, Plant Molecular Biology Reporter, V22, P437, DOI 10.1007/BF02772687; Giusti M. M., 2001, CURR PROTOC FOOD ANA, V00, DOI DOI 10.1002/0471142913.FAF0102S00; Grunewald W, 2009, EMBO REP, V10, P923, DOI 10.1038/embor.2009.103; Gupta N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-38; Hao YW, 2014, J EXP BOT, V65, P1013, DOI 10.1093/jxb/ert440; He ZL, 2016, NUCLEIC ACIDS RES, V44, pW236, DOI 10.1093/nar/gkw370; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huang Z, 2016, PEERJ, V4, DOI 10.7717/peerj.2620; Jung S, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0931-5; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Li T, 2017, PLANT CELL, V29, P1316, DOI 10.1105/tpc.17.00349; Li XQ, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0808-z; Liu B, 2016, GENOME, V59, P79, DOI 10.1139/gen-2015-0116; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Nakata M, 2013, PLANT CELL, V25, P1641, DOI 10.1105/tpc.113.111112; Niu YJ, 2011, J EXP BOT, V62, P2143, DOI 10.1093/jxb/erq408; Oswald A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-107; Paolacci AR, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1069-4; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Perez AC, 2013, PLANT CELL ENVIRON, V36, P2071, DOI 10.1111/pce.12121; Preuss A, 2014, J PLANT PHYSIOL, V171, P1315, DOI 10.1016/j.jplph.2014.06.004; Prior RL, 2010, J SCI FOOD AGR, V90, P1473, DOI 10.1002/jsfa.3966; Qi TC, 2011, PLANT CELL, V23, P1795, DOI 10.1105/tpc.111.083261; Sanchez-Sevilla JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14239-6; Sasaki-Sekimoto Y, 2013, PLANT PHYSIOL, V163, P291, DOI 10.1104/pp.113.220129; Shan XY, 2009, J EXP BOT, V60, P3849, DOI 10.1093/jxb/erp223; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Shyu C, 2012, PLANT CELL, V24, P536, DOI 10.1105/tpc.111.093005; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Thatcher LF, 2016, J EXP BOT, V67, P2367, DOI 10.1093/jxb/erw040; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thireault C, 2015, PLANT J, V82, P669, DOI 10.1111/tpj.12841; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Wang QH, 2017, SCI REP-UK, V7, DOI 10.1038/srep41477; Wang YK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3582-0; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wasternack C, 2018, ANNU REV PLANT BIOL, V69, P363, DOI 10.1146/annurev-arplant-042817-040440; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; White DWR, 2006, P NATL ACAD SCI USA, V103, P13238, DOI 10.1073/pnas.0604349103; Woldemariam MG, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-73; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Zhang F, 2015, NATURE, V525, P269, DOI 10.1038/nature14661; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]; Zhou YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22852	76	24	25	9	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197118	10.1371/journal.pone.0197118	http://dx.doi.org/10.1371/journal.pone.0197118			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746533	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700073
J	Giosa, E; Mammides, C; Zotos, S				Giosa, Efthymia; Mammides, Christos; Zotos, Savvas			The importance of artificial wetlands for birds: A case study from Cyprus	PLOS ONE			English	Article							AGRICULTURAL LANDSCAPES; CONSTRUCTED WETLANDS; HUNTING DISTURBANCE; ECOSYSTEM SERVICES; SPECIES RICHNESS; BETA DIVERSITY; SOUTHERN SPAIN; HABITAT; WATERBIRDS; BIODIVERSITY	The degradation of natural wetlands has significant effects on the ecosystem services they provide and the biodiversity they sustain. Under certain conditions, these negative effects can be mitigated by the presence of artificial wetlands. However, the conservation value of artificial wetlands needs to be explored further. In addition, it is unclear how certain anthropogenic variables, such as road networks and hunting reserves (i.e., areas where hunting of birds is prohibited) affect biodiversity in both artificial and natural wetlands. Here, we use data from thirteen artificial and six natural wetlands in Cyprus, to assess their similarities in bird species diversity and composition, and to quantify the relationship between species diversity and the density of road networks, hunting reserves, wetland size, and wetland depth. We found that while on average natural wetlands have more species and support higher abundances, certain artificial wetlands have the potential to support similarly diverse communities. Overall, regardless of the type, larger wetlands, with shallower waters tend to be more biodiverse. The same is true for wetlands surrounded by a higher percentage of hunting reserves and a lower density of road networks, albeit the effect of road networks was weaker. We conclude, from our results, that although the conservation value of natural wetlands is higher, artificial wetlands have the potential to play a complimentary role in the conservation of bird communities, assuming those wetlands have the right characteristics (e.g., in terms of size and depth) and assuming that the disturbances resulting from highimpact human-activities (e.g., hunting) are minimized.	[Giosa, Efthymia] Univ Ioannina, Dept Biol Applicat & Technol, Ioannina, Greece; [Giosa, Efthymia; Zotos, Savvas] Frederick Univ, Nat Conservat Unit, Nicosia, Cyprus; [Mammides, Christos] Guangxi Univ, Coll Forestry, Guangxi Key Lab Forest Ecol & Conservat, Nanning, Peoples R China; [Zotos, Savvas] Open Univ Cyprus, Sch Pure & Appl Sci, Nicosia, Cyprus; [Zotos, Savvas] Terra Cypria, Limassol, Cyprus	University of Ioannina; Guangxi University; Open University of Cyprus	Mammides, C (corresponding author), Guangxi Univ, Coll Forestry, Guangxi Key Lab Forest Ecol & Conservat, Nanning, Peoples R China.	cmammides@outlook.com	Mammides, Christos/H-4194-2019	Mammides, Christos/0000-0003-1747-175X; Zotos, Savvas/0000-0002-9767-396X				[Anonymous], 2015, MUMIN MULTIMODEL INF; Balcombe CK, 2005, ECOL ENG, V25, P85, DOI 10.1016/j.ecoleng.2005.03.003; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bellakhal M, 2017, ARTIFICIAL WETLANDS; Bellakhal M, 2014, ECOL ENG, V63, P114, DOI 10.1016/j.ecoleng.2013.12.029; Bellio MG, 2009, BIOL CONSERV, V142, P3076, DOI 10.1016/j.biocon.2009.08.007; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bregnballe T, 2004, BIOL CONSERV, V119, P93, DOI 10.1016/j.biocon.2003.10.025; Brehm G, 2003, ECOGRAPHY, V26, P456, DOI 10.1034/j.1600-0587.2003.03498.x; Brochet AL, 2009, BIODIVERS CONSERV, V18, P1879, DOI 10.1007/s10531-008-9562-6; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cardoso TAL, 2017, ORNITOL NEOTROP, V28, P89; Casas F, 2009, ANIM CONSERV, V12, P346, DOI 10.1111/j.1469-1795.2009.00259.x; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; Czech HA, 2002, WATERBIRDS, V25, P56; FAHRIG L, 2009, ECOL SOC, V14; Findlay CS, 1997, CONSERV BIOL, V11, P1000, DOI 10.1046/j.1523-1739.1997.96144.x; Fisher IJ, 2006, BIOL CONSERV, V131, P421, DOI 10.1016/j.biocon.2006.02.018; Fisher RA, 1943, J ANIMAL ECOLOGY, P42; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Fox J., 2019, R COMPANION APPL REG, V.; Giosa E, 2017, DATASET IMPORTANCE A, DOI [10.6084/m9.figshare.5526757.v5, DOI 10.6084/M9.FIGSHARE.5526757.V5]; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Guadagnin DL, 2007, BIODIVERS CONSERV, V16, P1231, DOI 10.1007/s10531-006-9127-5; Guareschi S, 2015, ECOL INDIC, V49, P204, DOI 10.1016/j.ecolind.2014.10.012; Gucel S, 2012, PAK J BOT, V44, P213; Hazell D, 2004, BIOL CONSERV, V119, P61, DOI 10.1016/j.biocon.2003.10.022; Hellicar M. A., 2014, IMPORTANT BIRD AREAS; Hsu CB, 2011, ECOL ENG, V37, P1533, DOI 10.1016/j.ecoleng.2011.06.002; Ibrahim I, 2012, PROCD SOC BEHV, V42, P242, DOI 10.1016/j.sbspro.2012.04.187; Iezekiel S, 2004, IMPORTANT BIRD AREAS; Karakas R, 2017, PADDY WATER ENVIRON, V15, P919, DOI 10.1007/s10333-017-0602-2; Kloskowski J, 2009, AQUAT CONSERV, V19, P815, DOI 10.1002/aqc.1027; Lawler SP, 2001, ISR J ZOOL, V47, P513, DOI 10.1560/X7K3-9JG8-MH2J-XGX1; Li DL, 2013, BIRD CONSERV INT, V23, P184, DOI 10.1017/S0959270913000099; Ma ZJ, 2010, WETLANDS, V30, P15, DOI 10.1007/s13157-009-0001-6; Madsen J, 1998, J APPL ECOL, V35, P386, DOI 10.1046/j.1365-2664.1998.00314.x; Madsen J, 1995, WILDLIFE BIOL, V1, P193, DOI 10.2981/wlb.1995.0025; Mammides C, 2016, ACTA OECOL, V71, P14, DOI 10.1016/j.actao.2016.01.004; Mammides C, 2015, LANDSCAPE ECOL, V30, P67, DOI 10.1007/s10980-014-0100-5; Marquez-Ferrando R, 2014, BIOL CONSERV, V171, P127, DOI 10.1016/j.biocon.2014.01.022; Mateo R, 2007, ECOTOX ENVIRON SAFE, V66, P119, DOI 10.1016/j.ecoenv.2005.12.010; Morelli F, 2013, ECOL INDIC, V34, P372, DOI 10.1016/j.ecolind.2013.05.021; Navedo JG, 2012, BIRD CONSERV INT, V22, P316, DOI 10.1017/S0959270911000311; Oksanen J., 2016, VEGAN COMMUNITY ECOL, P4, DOI DOI 10.4135/9781412971874.N145; Paillisson JM, 2002, BIOL CONSERV, V106, P115, DOI 10.1016/S0006-3207(01)00239-7; Paracuellos M, 2004, WATERBIRDS, V27, P446, DOI 10.1675/1524-4695(2004)027[0446:FATDOA]2.0.CO;2; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; R Core Team, 2013, R LANG ENV STAT COMP; Rajpar MN, 2013, WATERBIRDS, V36, P482, DOI 10.1675/063.036.0405; Ramachandran R, 2017, AMBIO, V46, P613, DOI 10.1007/s13280-017-0907-9; Ramirez F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192702; Robledano F, 2010, ECOL INDIC, V10, P274, DOI 10.1016/j.ecolind.2009.05.006; Sebastian-Gonzalez E, 2016, ECOGRAPHY, V39, P1176, DOI 10.1111/ecog.01736; Sebastian-Gonzalez E, 2014, RESTOR ECOL, V22, P311, DOI 10.1111/rec.12078; Sebastian-Gonzalez E, 2010, EUR J WILDLIFE RES, V56, P11, DOI 10.1007/s10344-009-0288-x; Sirami C, 2013, BIOL CONSERV, V164, P30, DOI 10.1016/j.biocon.2013.04.017; Stahlschmidt P, 2012, BASIC APPL ECOL, V13, P196, DOI 10.1016/j.baae.2012.02.001; Thiere G, 2009, BIOL CONSERV, V142, P964, DOI 10.1016/j.biocon.2009.01.006; Tiega A., 2011, Journal of International Wildlife Law & Policy, V14, P173; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Walton MEM, 2015, AQUACULTURE, V448, P382, DOI 10.1016/j.aquaculture.2015.06.017; Warnock N, 2002, WATERBIRDS, V25, P79; Webb EB, 2010, J WILDLIFE MANAGE, V74, P109, DOI 10.2193/2008-577; Whited D, 2000, LANDSCAPE URBAN PLAN, V49, P49, DOI 10.1016/S0169-2046(00)00046-3; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; Xia S, 2016, IDENTIFYING PRIORITY, DOI [1016/j.biocon.2016.2007.2025, DOI 10.1016/J.BIOCON.2016.2007.2025]; Yang W, 2008, ECOL ECON, V68, P116, DOI 10.1016/j.ecolecon.2008.02.008; Yuan YJ, 2014, ECOL ENG, V67, P67, DOI 10.1016/j.ecoleng.2014.03.012; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zomeni M., 2014, J LANDSC ECOL REPUB, V7, P75, DOI [10.2478/jlecol-2014-0010, DOI 10.2478/JLECOL-2014-0010]	74	19	20	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197286	10.1371/journal.pone.0197286	http://dx.doi.org/10.1371/journal.pone.0197286			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746545	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700096
J	Wang, XL; Zhao, W; Li, L; You, J; Ni, BA; Chen, X				Wang, Xiaolong; Zhao, Wei; Li, Lin; You, Jian; Ni, Biao; Chen, Xia			Clonal plasticity and diversity facilitates the adaptation of Rhododendron aureum Georgi to alpine environment	PLOS ONE			English	Article							GENETIC DIVERSITY; MORPHOLOGICAL PLASTICITY; DYNAMICS; PLANTS; AFLP; DNA; POPULATIONS; ERICACEAE; SHRUB	Four small oval populations and five large intensive populations of Rhododendron aureum growing at the alpine in Changbai Mountain (China) were studied in two types of habitat (in the tundra and in Betula ermaniiforest). Identification and delimitation of genets were inferred from excavation in small populations and from amplified fragment length polymorphism (AFLP) markers by the standardized sampling design in large populations. Clonal architecture and clonal diversity were then estimated. For the four small populations, they were monoclonal, the spacer length (18.6 +/- 5.6 in tundra, 29.7 +/- 9.7 in Betula ermanii forest, P < 0.05) was shorter and branching intensity (136.7 +/- 32.9 in tundra, 43.4 +/- 12.3 in Betula ermanii forest, P < 0.05) was higher in the tundra than that in Betula ermanii forest. For the five large populations, they were composed of multiple genets with high level of clonal diversity (Simpson's index D = 0.84, clonal richness R = 0.25, Fager's evenness E = 0.85); the spatial distribution of genets showed that the clonal growth strategy of R. aureum exhibits both guerilla and phalanx. Our results indicate that the clonal plasticity of R. aureum could enhance exploitation of resource heterogeneity and in turn greatly contribute to maintenance or improvement of fitness and the high clonal diversity of R. aureum increase the evolutionary rates to adapt the harsh alpine environment in Changbai Mountain.	[Wang, Xiaolong; Zhao, Wei; Li, Lin; You, Jian; Ni, Biao; Chen, Xia] Jilin Univ, Sch Life Sci, Natl & Local United Engn Lab Chinese Herbal Med, Changchun, Jilin, Peoples R China; [Wang, Xiaolong; Li, Lin] Qiqihar Med Univ, Dept Biochem, Qiqihar, Heilongjiang, Peoples R China	Jilin University; Qiqihar Medical University	Chen, X (corresponding author), Jilin Univ, Sch Life Sci, Natl & Local United Engn Lab Chinese Herbal Med, Changchun, Jilin, Peoples R China.	chenxiajlu@163.com	chen, xia/GXM-5435-2022					[Anonymous], 1997, MOL BIOL BIOTECHNOLO; ANTONOVICS J, 1984, EVOLUTION, V38, P103, DOI 10.1111/j.1558-5646.1984.tb00263.x; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bell AD, 1984, DYNAMIC MORPHOLOGY C; BILLINGS WD, 1968, BIOL REV, V43, P481, DOI 10.1111/j.1469-185X.1968.tb00968.x; Billings WDMH, 1968, BOT J LINN SOC, V80, P125; Blears MJ, 1998, J IND MICROBIOL BIOT, V21, P99, DOI 10.1038/sj.jim.2900537; Bliss L. C., 1971, ANNU REV ECOL SYST, V2, P405, DOI [10.1146/annurev.es.02.110171.002201, DOI 10.1146/ANNUREV.ES.02.110171.002201]; COOK RE, 1983, AM SCI, V71, P244; de Witte LC, 2012, MOL ECOL, V21, P1081, DOI 10.1111/j.1365-294X.2011.05326.x; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; Diggle PK, 1998, INT J PLANT SCI, V159, P606, DOI 10.1086/297579; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; DOUST LL, 1981, NEW PHYTOL, V89, P495, DOI 10.1111/j.1469-8137.1981.tb02330.x; E Douglas, 1995, ANNU REV ECOL SYST, V26, P423; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; ELLSTRAND NC, 1987, AM J BOT, V74, P123, DOI 10.2307/2444338; ERIKSSON O, 1993, TRENDS ECOL EVOL, V8, P313, DOI 10.1016/0169-5347(93)90237-J; ERIKSSON O, 1993, J ECOL, V81, P533, DOI 10.2307/2261531; ERIKSSON O, 1989, OIKOS, V55, P231, DOI 10.2307/3565427; Escaravage N, 1998, MOL ECOL, V7, P975, DOI 10.1046/j.1365-294x.1998.00415.x; FAGER EW, 1972, AM NAT, V106, P293, DOI 10.1086/282772; Falk EEK Donald A, 2001, INTRO RESTORATION GE; FLACH M, 1966, NATURE, V209, P1369, DOI 10.1038/2091369b0; Gabrielsen TM, 1998, MOL ECOL, V7, P1701, DOI 10.1046/j.1365-294x.1998.00503.x; Gill D.E., 1986, PLANT ECOLOGY, P321; Gomez S, 2008, NEW PHYTOL, V179, P1142, DOI 10.1111/j.1469-8137.2008.02542.x; Groenendael JV, 1990, CLONAL GROWTH PLANTS; Grover A, 2016, CRIT REV BIOTECHNOL, V36, P290, DOI 10.3109/07388551.2014.959891; Hirao AS, 2006, MOL ECOL, V15, P1165, DOI 10.1111/j.1365-294X.2006.02853.x; Holderegger R, 2002, MOL ECOL, V11, P1409, DOI 10.1046/j.1365-294X.2002.01548.x; Hu LZFM, 1994, FLORA CHINA; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Jackson JBC, 1987, Q REV BIOL, V115, P62; Jianjun L, 2007, 3 GLOB BOT GARD C WU, P160; Jimenez-Mejias P, 2015, J BIOGEOGR, V42, P1455, DOI 10.1111/jbi.12507; Jonathan P, 1995, PLANT ECOL, V76, P1147; Jonsdottir I.S., 1997, ECOLOGY EVOLUTION CL, P109; Jonsson BO, 1996, J ECOL, V84, P449, DOI 10.2307/2261206; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; Korner C, 1995, ALPINE PLANT DIVERSI; Kroon HD, 1997, ECOLOGY EVOLUTION CL; KUDO G, 1992, CAN J BOT, V70, P1684, DOI 10.1139/b92-207; KUDO G, 1993, AM J BOT, V80, P1300, DOI 10.2307/2445714; L RC, 1972, EVOL BIOL, V6, P388; Lechuga-Lago Y, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plw023; Liu YF, 2012, PLANT SYST EVOL, V298, P921, DOI 10.1007/s00606-012-0601-0; Mezo-Kricsfalusy G, 1977, POPULATION BIOL PLAN, P67; Ming D, 1996, ACTA BOT SIN, V38, P828; NEI M, 1978, GENETICS, V89, P583; Norman C, 1987, AM J BOT, V74, P123; PARKER KC, 1992, AM J BOT, V79, P86, DOI 10.2307/2445201; Peck JR, 1998, NATURE, V391, P889, DOI 10.1038/36099; PIELOU E C, 1969, P286; Pornon A, 2000, MOL ECOL, V9, P1099, DOI 10.1046/j.1365-294x.2000.00976.x; Richards AJ, 1997, PLANT BREEDING SYSTE, V39, P142; Rohlf FJ, 1997, NTSYS PC VERSION 2 0; Roiloa S. R., 2015, Ecosistemas, V24, P76, DOI 10.7818/ECOS.2015.24-1.12; Silvertown J., 1997, PLANT LIFE HIST ECOL; Steinger T, 1996, OECOLOGIA, V105, P94, DOI 10.1007/BF00328796; Stocklin J, 2009, BOT HELV, V119, P125, DOI 10.1007/s00035-009-0065-1; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Thiel-Egenter C, 2009, GLOBAL ECOL BIOGEOGR, V18, P78, DOI 10.1111/j.1466-8238.2008.00421.x; Tong Wang XL, 2016, J PLANT ECOLOGY; Vonlanthen B, 2010, AM J BOT, V97, P234, DOI 10.3732/ajb.0800329; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Widen B, 1994, FOLIA GEOBOT, V29, P245; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Yang X., 1998, J FORESTRY RES, V9, P217, DOI DOI 10.1007/BF02910074; 董鸣, 1996, 植物生态学报, V20, P543	73	10	11	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197089	10.1371/journal.pone.0197089	http://dx.doi.org/10.1371/journal.pone.0197089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746526	Green Submitted, gold, Green Published			2022-12-26	WOS:000431851700064
J	He, Y; Huang, YY; Xi, LY; Gelfand, JA; Hamblin, MR				He, Ya; Huang, Ying-Ying; Xi, Liyan; Gelfand, Jeffrey A.; Hamblin, Michael R.			Tetracyclines function as dual-action light-activated antibiotics	PLOS ONE			English	Article							ANTIMICROBIAL PHOTODYNAMIC INACTIVATION; IN-VITRO; PHOTOTOXICITY; RIBOSOME; HISTORY	Antimicrobial photodynamic inactivation (aPDI) employs photosensitizing dyes activated by visible light to produce reactive oxygen species. aPDI is independent of the antibiotic resistance status of the target cells, and is thought unlikely to produce resistance itself. Among many PS that have been investigated, tetracyclines occupy a unique niche. They are potentially dual-action compounds that can both kill bacteria under illumination, and prevent bacterial regrowth by inhibiting ribosomes. Tetracycline antibiotics are regarded as bacteriostatic rather than bactericidal. Doxycycline (DOTC) is excited best by UVA light (365 nm) while demeclocycline (DMCT) can be efficiently activated by blue light (415 nm) as well as UVA. Both compounds were able to eradicate Gram-positive (methicillin-resistant Staphylococcus aureus) and Gram-negative (Escherichia coli) bacteria (>6 log(10) steps of killing) at concentrations (10-50 mu M) and fluences (10-20J/cm(2)). In contrast to methylene blue, MB plus red light, tetracyclines photoinactivated bacteria in rich growth medium. When similar to 3 logs of bacteria were killed with DMCT/DOTC+light and the surviving cells were added to growth medium, further bacterial killing was observed, while the same experiment with MB allowed complete regrowth. MIC studies were carried out either in the dark or exposed to 0.5mW/cm(2) blue light. Up to three extra steps (8-fold) increased antibiotic activity was found with light compared to dark, with MRSA and tetracycline-resistant strains of E. coli. Tetracyclines can accumulate in bacterial ribosomes, where they could be photoactivated with blue/UVA light producing microbial killing via ROS generation.	[He, Ya; Xi, Liyan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou, Guangdong, Peoples R China; [He, Ya; Huang, Ying-Ying; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Huang, Ying-Ying; Hamblin, Michael R.] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA; [Xi, Liyan] Southern Med Univ, Dermatol Hosp, Guangzhou, Guangdong, Peoples R China; [Gelfand, Jeffrey A.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Hamblin, Michael R.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Sun Yat Sen University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Southern Medical University - China; Harvard University; Massachusetts General Hospital; Harvard University	Hamblin, MR (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.; Hamblin, MR (corresponding author), Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA.; Gelfand, JA (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Hamblin, MR (corresponding author), Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	jglfand@partners.org; Hamblin@helix.mgh.harvard.edu	Hamblin, Michael R/H-2758-2019; Hamblin, Mike/AAB-2511-2022; Gelfand, Jeffrey A/G-1885-2018; Huang, Yingying/G-3153-2011	Hamblin, Michael R/0000-0001-6431-4605; Gelfand, Jeffrey A/0000-0002-4118-5676; Huang, Yingying/0000-0003-3066-6981	US NIH [R01AI050875, R21AI121700]	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by US NIH grants R01AI050875 and R21AI121700.	Abrahamse H, 2016, BIOCHEM J, V473, P347, DOI 10.1042/BJ20150942; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; [Anonymous], 2015, PERF STAND ANT SUSC; Branco TM, 2018, PHOTODIAGN PHOTODYN, V21, P285, DOI 10.1016/j.pdpdt.2018.01.001; Budkevich TV, 2008, NUCLEIC ACIDS RES, V36, P4736, DOI 10.1093/nar/gkn424; Choi S, 2015, J PHOTOCH PHOTOBIO B, V153, P7, DOI 10.1016/j.jphotobiol.2015.09.003; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; DASCHNER F, 1977, ZBL BAKT-INT J MED M, V239, P527; Di Poto A, 2009, BIOMATERIALS, V30, P3158, DOI 10.1016/j.biomaterials.2009.02.038; DUGGAR BM, 1948, ANN NY ACAD SCI, V51, P177, DOI 10.1111/j.1749-6632.1948.tb27262.x; Franklin TJ, 1966, BIOCH STUDIES ANTIMI, P192; Goetze S, 2017, SKIN PHARMACOL PHYS, V30, P76, DOI 10.1159/000458761; GOLDMAN RA, 1983, BIOCHEMISTRY-US, V22, P359, DOI 10.1021/bi00271a020; Hamblin MR, 2016, CURR OPIN MICROBIOL, V33, P67, DOI 10.1016/j.mib.2016.06.008; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; HASAN T, 1986, P NATL ACAD SCI USA, V83, P4604, DOI 10.1073/pnas.83.13.4604; HASAN T, 1985, BIOCHEM PHARMACOL, V34, P1065, DOI 10.1016/0006-2952(85)90610-0; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; Malik Z, 1995, INVENTORSSYNERGISTIC; MARTIN JP, 1987, J BACTERIOL, V169, P2516, DOI 10.1128/jb.169.6.2516-2522.1987; Minnock A, 2000, ANTIMICROB AGENTS CH, V44, P522, DOI 10.1128/AAC.44.3.522-527.2000; Moan J, 2003, ANTICANCER RES, V23, P3591; Nelson ML, 2011, ANN NY ACAD SCI, V1241, P17, DOI 10.1111/j.1749-6632.2011.06354.x; Niu JF, 2013, CHEMOSPHERE, V92, P1423, DOI 10.1016/j.chemosphere.2013.03.049; NOVO E, 1979, J GEN VIROL, V45, P323, DOI 10.1099/0022-1317-45-2-323; O'Neill J., 2015, REV ANTIMICROBIOL RE; Sperandio Felipe F, 2013, Recent Pat Antiinfect Drug Discov, V8, P108; STRATIGOS JD, 1968, BRIT J DERMATOL, V80, P391, DOI 10.1111/j.1365-2133.1968.tb12326.x; Viens AM, 2015, PUBLIC HEALTH ETH-UK, V8, P255, DOI 10.1093/phe/phv015; Wainwright M, 2017, LANCET INFECT DIS, V17, pE49, DOI 10.1016/S1473-3099(16)30268-7; Xing BG, 2011, CHEM COMMUN, V47, P1601, DOI 10.1039/c0cc04434b; Zhang YS, 2015, NANOMEDICINE-UK, V10, P603, DOI 10.2217/nnm.14.131	32	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196485	10.1371/journal.pone.0196485	http://dx.doi.org/10.1371/journal.pone.0196485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742128	Green Published, Green Submitted, gold			2022-12-26	WOS:000431757400030
J	Oladele, RO; Toriello, C; Ogunsola, FT; Ayanlowo, OO; Foden, P; Fayemiwo, AS; Osaigbovo, II; Iwuafor, AA; Shettima, S; Ekundayo, HA; Richardson, MD; Denning, DW				Oladele, Rita O.; Toriello, Conchita; Ogunsola, Folasade T.; Ayanlowo, Olusola O.; Foden, Philip; Fayemiwo, Adetona S.; Osaigbovo, Iriagbonse I.; Iwuafor, Anthony A.; Shettima, Shuwaram; Ekundayo, Halimat A.; Richardson, Malcolm D.; Denning, David W.			Prior subclinical histoplasmosis revealed in Nigeria using histoplasmin skin testing	PLOS ONE			English	Article							SENSITIVITY; CAPSULATUM	Objectives Disseminated histoplasmosis is an AIDS-defining illness. Histoplasmosis is commonly misdiagnosed as tuberculosis. Nigeria has the second highest number of people living with HIV/AIDS in Africa. The present study was carried out to investigate the prevalence of skin sensitivity amongst Nigerians to histoplasmin. Design A cross-sectional study was conducted in six centres across five geopolitical zones of Nigeria. Methods We recruited both healthy non-HIV and HIV-positive adults with CD4 count >= 350 cells/mm(3) regardless of their ART status from March to May 2017. Skin tests were performed intradermally; induration >= 5 mm were considered to be histoplasmin positive. Results 750 participants were recruited from Lagos (n = 52), Yola (n = 156), Ilorin (n = 125), Calabar (n = 120), Ibadan (n = 202) and Benin (n = 95). 467 (62.3%) were HIV negative, 247 (32.9%) were HIV positive and 36 (4.8%) did not know their HIV status. A total of 32/735 (4.4%) participants had a positive skin test. Study centre (p<0.001), education (p = 0.002) and age (p = 0.005) appeared to be significantly associated with positive skin reactivity at the 0.5% significance level, while sex (p = 0.031) and occupation (p = 0.031) would have been significant at the 5% significance level. Males had a higher rate of reactivity than females (p = 0.031, 7% vs 3%). The highest positive rates were recorded from Benin City (13/86 (15%)) and Calabar (7/120 (6%)) and no positives were recorded in Lagos (p<0.001). HIV status was not statistically significant (p = 0.70). Conclusion Histoplasmosis diagnostics should be included in the Nigerian HIV guidelines. Epidemiological vigilance of progressive disseminated histoplasmosis should be considered by local health authorities.	[Oladele, Rita O.; Ogunsola, Folasade T.] Univ Lagos, Coll Med, Dept Med Microbiol & Parasitol, Lagos, Nigeria; [Oladele, Rita O.; Richardson, Malcolm D.; Denning, David W.] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Oladele, Rita O.; Richardson, Malcolm D.; Denning, David W.] Global Act Fund Fungal Infect, Geneva, Switzerland; [Toriello, Conchita] Univ Nacl Autonoma Mexico, Fac Med, Mexico City, DF, Mexico; [Ayanlowo, Olusola O.] Univ Lagos, Coll Med, Dept Med, Lagos, Nigeria; [Foden, Philip] Univ Hosp South Manchester, Med Stat Dept, Manchester, Lancs, England; [Fayemiwo, Adetona S.] Univ Ibadan, Coll Med, Dept Med Microbiol & Parasitol, Ibadan, Nigeria; [Osaigbovo, Iriagbonse I.] Univ Benin Teaching Hosp, Dept Med Microbiol, Benin, Nigeria; [Iwuafor, Anthony A.] Univ Calabar, Coll Med Sci, Dept Med Microbiol & Parasitol, Calabar, Nigeria; [Shettima, Shuwaram] Fed Med Ctr Yola, Dept Med Microbiol, Yola, Nigeria; [Ekundayo, Halimat A.] Gen Hosp Ilorin, Dept Med Microbiol, Ilorin, Nigeria; [Richardson, Malcolm D.] Univ Hosp South Manchester, Mycol Reference Ctr Manchester, Manchester, Lancs, England; [Denning, David W.] Univ Hosp South Manchester, Natl Aspergillosis Ctr, Manchester, Lancs, England	University of Lagos; University of Manchester; Universidad Nacional Autonoma de Mexico; University of Lagos; Wythenshawe Hospital NHS Foundation Trust; University of Ibadan; University of Benin; University of Calabar; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital NHS Foundation Trust	Oladele, RO (corresponding author), Univ Lagos, Coll Med, Dept Med Microbiol & Parasitol, Lagos, Nigeria.; Oladele, RO (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England.; Oladele, RO (corresponding author), Global Act Fund Fungal Infect, Geneva, Switzerland.	rita.oladele@postgrad.manchester.ac.uk	Denning, David/AAC-6931-2019	Denning, David/0000-0001-5626-2251; AYANLOWO, OLUSOLA/0000-0002-1134-3813	University Hospital South Manchester Charity	University Hospital South Manchester Charity	University Hospital South Manchester Charity supported with some funds for participants recruitment.	Adenis A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003100; Adenis A, 2014, AM J TROP MED HYG, V90, P216, DOI 10.4269/ajtmh.13-0084; [Anonymous], 2015, J POLLUT EFF CONTROL, V4; Armstrong-James D, 2014, TRENDS MICROBIOL, V22, P120, DOI 10.1016/j.tim.2014.01.001; Awofala AA, 2016, SAUDI J BIOL SCI; Bahr Nathan C, 2015, Curr Trop Med Rep, V2, P70; BALL JD, 1954, BRIT MED J, V2, P848, DOI 10.1136/bmj.2.4892.848; BEZJAK V, 1971, TROP GEOGR MED, V23, P71; Centers for Disease Control (CDC), 1985, MMWR Morb Mortal Wkly Rep, V34, P373; Diakite S, 1969, AM J TROP MED HYG, V18, P264, DOI DOI 10.4269/AJTRAG.1969.18264; EDWARDS PQ, 1956, AM J TROP MED HYG, V5, P224, DOI 10.4269/ajtmh.1956.5.224; Gugnani Harish C., 1997, Revista Iberoamericana de Micologia, V14, P155; GUGNANI HC, 1991, J TROP MED HYG, V94, P24; Homei A, 2013, FUNGAL DIS BRITAIN U; LURIE H. I., 1949, S AFRICAN MED JOUR, V23, P180; MAHVI TA, 1970, MYCOPATH MYCOL APPL, V41, P167, DOI 10.1007/BF02051492; MOCHI A, 1952, Bull World Health Organ, V5, P259; Muotoe-okafor FA, 1996, NATURAL FOCUS HISTOP, P71; MuotoeOkafor FA, 1996, MYCOPATHOLOGIA, V134, P71, DOI 10.1007/BF00436867; Njoku-Obi A N, 1968, West Afr Med J Niger Pract, V17, P37; Oladele Rita O, 2017, PLOS NEGL TROP DIS; Queiroz-Telles F, 2017, LANCET INFECT DIS; Sipsas NV, 2008, INFECTION, V36, P515, DOI 10.1007/s15010-008-8129-5; STOTT H, 1954, BRIT MED J, V1, P22, DOI 10.1136/bmj.1.4852.22; TORIELLO C, 1993, MYCOPATHOLOGIA, V122, P7, DOI 10.1007/BF01103703; TORIELLO C, 1991, MYCOSES, V34, P133, DOI 10.1111/j.1439-0507.1991.tb00634.x; Umar H. Y., 2011, Journal of Human Ecology, V33, P53; World Health Organization, 2016, GLOB TUB REP 2016, P214	28	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196224	10.1371/journal.pone.0196224	http://dx.doi.org/10.1371/journal.pone.0196224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742119	Green Published, Green Submitted, gold			2022-12-26	WOS:000431757400023
J	Rausch, RL; Libby, RT; Kiernan, AE				Rausch, Rebecca L.; Libby, Richard T.; Kiernan, Amy E.			Ciliary margin-derived BMP4 does not have a major role in ocular development	PLOS ONE			English	Article							ANTERIOR SEGMENT DYSGENESIS; AQUEOUS OUTFLOW PATHWAY; RETINAL GANGLION-CELLS; EARLY EYE DEVELOPMENT; OPTIC VESICLE; MOLECULAR-MECHANISMS; HETEROZYGOUS MICE; HUMAN-DISEASES; AXONAL INJURY; EXPRESSION	Heterozygous Bmp4 mutations in humans and mice cause severe ocular anterior segment dysgenesis (ASD). Abnormalities include pupil displacement, corneal opacity, iridocorneal adhesions, and variable intraocular pressure, as well as some retinal and vascular defects. It is presently not known what source of BMP4 is responsible for these defects, as BMP4 is expressed in several developing ocular and surrounding tissues. In particular, BMP4 is expressed in the ciliary margins of the optic cup which give rise to anterior segment structures such as the ciliary body and iris, making it a good candidate for the required source of BMP4 for anterior segment development. Here, we test whether ciliary margin-derived BMP4 is required for ocular development using two different conditional knockout approaches. In addition, we compared the conditional deletion phenotypes with Bmp4 heterozygous null mice. Morphological, molecular, and functional assays were performed on adult mutant mice, including histology, immunohistochemistry, in vivo imaging, and intraocular pressure measurements. Surprisingly, in contrast to Bmp4 heterozygous mutants, our analyses revealed that the anterior and posterior segments of Bmp4 conditional knockouts developed normally. These results indicate that ciliary margin-derived BMP4 does not have a major role in ocular development, although subtle alterations could not be ruled out. Furthermore, we demonstrated that the anterior and posterior phenotypes observed in Bmp4 heterozygous animals showed a strong propensity to co-occur, suggesting a common, non-cell autonomous source for these defects.	[Rausch, Rebecca L.] Univ Rochester, Med Ctr, Neurosci Grad Program, Rochester, NY 14642 USA; [Rausch, Rebecca L.; Libby, Richard T.; Kiernan, Amy E.] Univ Rochester, Med Ctr, Dept Ophthalmol, Rochester, NY 14642 USA; [Rausch, Rebecca L.; Libby, Richard T.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; [Libby, Richard T.; Kiernan, Amy E.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Rausch, Rebecca L.] EyeCRO, Ann Arbor, MI USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Kiernan, AE (corresponding author), Univ Rochester, Med Ctr, Dept Ophthalmol, Rochester, NY 14642 USA.; Kiernan, AE (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA.	amy_kiernan@urmc.rochester.edu		Libby, Richard/0000-0003-2844-7632	Flaum Eye Institute [F31 EY026301, T32 EY007125]; Research to Prevent Blindness (Career Development Grant); NATIONAL EYE INSTITUTE [F31EY026301, T32EY007125] Funding Source: NIH RePORTER	Flaum Eye Institute; Research to Prevent Blindness (Career Development Grant); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by F31 EY026301 and T32 EY007125 (RLR), the Flaum Eye Institute, and from the Research to Prevent Blindness (Career Development Grant to AEK and an unrestricted grant to the University of Rochester's Department of Ophthalmology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R, 2007, DEV BIOL, V305, P1, DOI 10.1016/j.ydbio.2007.01.045; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bakrania P, 2008, AM J HUM GENET, V82, P304, DOI 10.1016/j.ajhg.2007.09.023; Behesti H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-62; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; Cai ZG, 2010, J NEUROSCI, V30, P4110, DOI 10.1523/JNEUROSCI.4364-09.2010; Chang B, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-18; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Cvekl A, 2004, BIOESSAYS, V26, P374, DOI 10.1002/bies.20009; Cvekl A, 2014, DEVELOPMENT, V141, P4432, DOI 10.1242/dev.107953; DEKATER AW, 1992, INVEST OPHTH VIS SCI, V33, P424; Du Y, 2010, INVEST OPHTH VIS SCI, V51, P3764, DOI 10.1167/iovs.09-4906; Dudley AT, 1997, DEV DYNAM, V208, P349; Fernandes KA, 2014, NEUROBIOL DIS, V69, P108, DOI 10.1016/j.nbd.2014.05.015; Fernandes KA, 2013, EXP EYE RES, V112, P106, DOI 10.1016/j.exer.2013.04.021; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; Gueta K, 2016, DEVELOPMENT, V143, P4182, DOI 10.1242/dev.129734; Harder JM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00530; Hayashi S, 2008, AM J MED GENET A, V146A, P2905, DOI 10.1002/ajmg.a.32519; Huang J, 2015, DEV BIOL, V407, P256, DOI 10.1016/j.ydbio.2015.09.009; Huang J, 2015, DEV BIOL, V402, P119, DOI 10.1016/j.ydbio.2015.03.006; Hung FC, 2002, VISION RES, V42, P427, DOI 10.1016/S0042-6989(01)00242-5; Hussein KA, 2014, EXP EYE RES, V125, P79, DOI 10.1016/j.exer.2014.05.012; Ito YA, 2014, CLIN EXP OPHTHALMOL, V42, P13, DOI 10.1111/ceo.12152; Jia SH, 2013, DEVELOPMENT, V140, P423, DOI 10.1242/dev.081927; Keller Kate E, 2013, J Ocul Biol, V1, P3; Kiernan AE, 2007, GENETICS, V177, P307, DOI 10.1534/genetics.107.075960; Klimova L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063029; Ko F, 2015, PROG BRAIN RES, V221, P177, DOI 10.1016/bs.pbr.2015.06.005; Ko MK, 2013, MOL VIS, V19, P2561; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mao M, 2015, INVEST OPHTH VIS SCI, V56, P6823, DOI 10.1167/iovs.15-17527; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mathura JR, 2000, INVEST OPHTH VIS SCI, V41, P592; Matsushima D, 2011, DEVELOPMENT, V138, P443, DOI 10.1242/dev.055178; Moreno-Miralles I, 2011, ARTERIOSCL THROM VAS, V31, P2216, DOI 10.1161/ATVBAHA.111.230235; Napier HRL, 2007, EXP EYE RES, V84, P615, DOI 10.1016/j.exer.2006.07.012; Reis LM, 2011, CURR OPIN OPHTHALMOL, V22, P314, DOI 10.1097/ICU.0b013e328349412b; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Uchimura T, 2009, GENESIS, V47, P374, DOI 10.1002/dvg.20511; van der Merwe EL, 2016, EXP EYE RES, V146, P293, DOI 10.1016/j.exer.2016.04.003; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Yoshiki A, 2006, ILAR J, V47, P94, DOI 10.1093/ilar.47.2.94; Zhao SL, 2002, DEVELOPMENT, V129, P4435; Zhou Y, 2013, P NATL ACAD SCI USA, V110, P8966, DOI 10.1073/pnas.1218145110	51	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0197048	10.1371/journal.pone.0197048	http://dx.doi.org/10.1371/journal.pone.0197048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738572	Green Submitted, gold, Green Published			2022-12-26	WOS:000431724900045
J	Bumgardner, SA; Zhang, L; LaVoy, AS; Andre, B; Frank, CB; Kajikawa, A; Klaenhammer, TR; Dean, GA				Bumgardner, Sara A.; Zhang, Lin; LaVoy, Alora S.; Andre, Barbara; Frank, Chad B.; Kajikawa, Akinobu; Klaenhammer, Todd R.; Dean, Gregg A.			Nod2 is required for antigen-specific humoral responses against antigens orally delivered using a recombinant Lactobacillus vaccine platform	PLOS ONE			English	Article							LIPOTEICHOIC ACID; ACIDOPHILUS NCFM; PROBIOTIC LACTOBACILLI; COLONIC INFLAMMATION; MUCOSAL VACCINES; DENDRITIC CELLS; IMMUNE-SYSTEM; MICE; ACTIVATION; DEFICIENT	Safe and efficacious orally-delivered mucosal vaccine platforms are desperately needed to combat the plethora of mucosally transmitted pathogens. Lactobacillus spp. have emerged as attractive candidates to meet this need and are known to activate the host innate immune response in a species-and strain-specific manner. For selected bacterial isolates and mutants, we investigated the role of key innate immune pathways required for induction of innate and subsequent adaptive immune responses. Co-culture of murine macrophages with L. gasseri (strain NCK1785), L. acidophilus (strain NCFM), or NCFM-derived mutants D NCK2025 and NCK2031-elicited an M2b-like phenotype associated with TH2 skewing and immune regulatory function. For NCFM, this M2b phenotype was dependent on expression of lipoteichoic acid and S layer proteins. Through the use of macrophage genetic knockouts, we identified Toll-like receptor 2 (TLR2), the cytosolic nucleotide-binding oligomerization domain containing 2 (NOD2) receptor, and the inflammasome-associated caspase-1 as contributors to macrophage activation, with NOD2 cooperating with caspase-1 to induce inflammasome derived interleukin (IL)-1 beta in a pyroptosis-independent fashion. Finally, utilizing an NCFM-based mucosal vaccine platform with surface expression of human immunodeficiency virus type 1 (HIV-1) Gag or membrane proximal external region (MPER), we demonstrated that NOD2 signaling is required for antigen-specific mucosal and systemic humoral responses. We show that lactobacilli differentially utilize innate immune pathways and highlight NOD2 as a key mediator of macrophage function and antigen-specific humoral responses to a Lactobacillus acidophilus mucosal vaccine platform.	[Bumgardner, Sara A.] North Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC USA; [Zhang, Lin; LaVoy, Alora S.; Andre, Barbara; Frank, Chad B.; Dean, Gregg A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Kajikawa, Akinobu] Tokyo Univ Agr, Dept Appl Biol & Chem, Setagaya Ku, Tokyo, Japan; [Klaenhammer, Todd R.] North Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC USA; [Bumgardner, Sara A.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA	University of North Carolina; North Carolina State University; Colorado State University; Tokyo University of Agriculture; University of North Carolina; North Carolina State University; University System of Georgia; University of Georgia	Dean, GA (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	gregg.dean@colostate.edu	Dean, Gregg A/A-5623-2012	Dean, Gregg A/0000-0001-7025-9550; Graham, Barbara/0000-0002-4221-1979; LaVoy, Alora/0000-0003-3376-0842	National Institutes of Health [R01 DE019069, R21 AI112486]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Institutes of Health (https://www.nih.gov/), R01 DE019069 and R21 AI112486, GAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; Azegami T, 2014, INT IMMUNOL, V26, P517, DOI 10.1093/intimm/dxu063; BAREFOOT SF, 1983, APPL ENVIRON MICROB, V45, P1808, DOI 10.1128/AEM.45.6.1808-1815.1983; Barreau F, 2010, GUT, V59, P207, DOI 10.1136/gut.2008.171546; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bron PA, 2013, CURR OPIN MICROBIOL, V16, P262, DOI 10.1016/j.mib.2013.06.001; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Dinarello CA, 2013, SEMIN IMMUNOL, V25, P389, DOI 10.1016/j.smim.2013.10.001; Duong T, 2011, MICROB BIOTECHNOL, V4, P357, DOI 10.1111/j.1751-7915.2010.00200.x; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Goh YJ, 2009, APPL ENVIRON MICROB, V75, P3093, DOI 10.1128/AEM.02502-08; Goverse G, 2015, EUR J IMMUNOL, V45, P89, DOI 10.1002/eji.201343340; Gutzeit C, 2014, IMMUNOL REV, V260, P76, DOI 10.1111/imr.12189; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Kaji R, 2010, J IMMUNOL, V184, P3505, DOI 10.4049/jimmunol.0901569; Kajikawa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141713; Kajikawa A, 2012, CLIN VACCINE IMMUNOL, V19, P1374, DOI 10.1128/CVI.00049-12; Kajikawa A, 2011, APPL ENVIRON MICROB, V77, P6587, DOI 10.1128/AEM.05153-11; Kamdar K, 2013, VIRULENCE, V4, P207, DOI 10.4161/viru.23354; Kemgang TS, 2014, J APPL MICROBIOL, V117, P303, DOI 10.1111/jam.12521; Khazaie K, 2012, P NATL ACAD SCI USA, V109, P10462, DOI 10.1073/pnas.1207230109; Kim D, 2016, NAT MED, V22, P524, DOI 10.1038/nm.4075; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Konieczna P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120261; Konstantinov SR, 2008, P NATL ACAD SCI USA, V105, P19474, DOI 10.1073/pnas.0810305105; Lapaquette P, 2012, CELL MICROBIOL, V14, P791, DOI 10.1111/j.1462-5822.2012.01768.x; Lee JS, 2006, J VIROL, V80, P4079, DOI 10.1128/JVI.80.8.4079-4087.2006; Li JJ, 2011, DEV COMP IMMUNOL, V35, P872, DOI 10.1016/j.dci.2011.03.021; Li R, 2015, VET MICROBIOL, V179, P250, DOI 10.1016/j.vetmic.2015.07.020; Lindner C, 2015, NAT IMMUNOL, V16, P880, DOI 10.1038/ni.3213; Magalhaes JG, 2011, P NATL ACAD SCI USA, V108, P14896, DOI 10.1073/pnas.1015063108; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Miettinen M, 2012, GUT MICROBES, V3, P510, DOI 10.4161/gmic.21736; Mohamadzadeh M, 2011, P NATL ACAD SCI USA, V108, P4623, DOI 10.1073/pnas.1005066107; Mohamadzadeh M, 2010, FUTURE MICROBIOL, V5, P1289, DOI 10.2217/FMB.10.78; Moran JP, 2009, INFLAMM BOWEL DIS, V15, P1022, DOI 10.1002/ibd.20900; Morcock DR, 2005, J VIROL, V79, P1533, DOI 10.1128/JVI.79.3.1533-1542.2005; Murray RZ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00538; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Pavot V, 2014, J IMMUNOL, V193, P5781, DOI 10.4049/jimmunol.1402184; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Petterson T, 2011, J LEUKOCYTE BIOL, V89, P177, DOI 10.1189/jlb.0210061; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Rosenzweig HL, 2008, INVEST OPHTH VIS SCI, V49, P1518, DOI 10.1167/iovs.07-1174; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Russell WM, 2001, APPL ENVIRON MICROB, V67, P4361, DOI 10.1128/AEM.67.9.4361-4364.2001; Salle B, 2010, J INFECT DIS, V202, P337, DOI 10.1086/653619; Seegers JFML, 2002, TRENDS BIOTECHNOL, V20, P508, DOI 10.1016/S0167-7799(02)02075-9; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shafique M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061287; Shida K, 2006, J DAIRY SCI, V89, P3306, DOI 10.3168/jds.S0022-0302(06)72367-0; Shida K, 2009, IMMUNOLOGY, V128, pe858, DOI 10.1111/j.1365-2567.2009.03095.x; Stoeker L, 2011, CLIN VACCINE IMMUNOL, V18, P1834, DOI 10.1128/CVI.05277-11; Suschak JJ, 2015, J IMMUNOL, V194, P630, DOI 10.4049/jimmunol.1402530; Tunis MC, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/606383; Velez MP, 2007, APPL ENVIRON MICROB, V73, P3595, DOI 10.1128/AEM.02083-06; Weiss G, 2010, IMMUNOLOGY, V131, P268, DOI 10.1111/j.1365-2567.2010.03301.x; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Zadeh M, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-7; Zeuthen LH, 2008, IMMUNOLOGY, V124, P489, DOI 10.1111/j.1365-2567.2007.02800.x; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	68	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196950	10.1371/journal.pone.0196950	http://dx.doi.org/10.1371/journal.pone.0196950			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734365	Green Published, Green Submitted, gold			2022-12-26	WOS:000431481700036
J	San Emeterio, MC; Fernandez-Ortiz, R; Arteaga-Ortiz, J; Dorta-Gonzalez, P				Clavel San Emeterio, Monica; Fernandez-Ortiz, Ruben; Arteaga-Ortiz, Jesus; Dorta-Gonzalez, Pablo			Measuring the gradualist approach to internationalization: Empirical evidence from the wine sector	PLOS ONE			English	Article							PSYCHIC DISTANCE; CULTURAL DISTANCE; FOREIGN OWNERSHIP; BUSINESS RESEARCH; FRICTION; EXPERIENCE; ENTRY; FIRMS; PERCEPTIONS; PERSPECTIVE	The objective of this paper is to fill a gap in the literature on internationalization, in relation to the absence of objective and measurable performance indicators for the process of how firms sequentially enter external markets. To that end, this research develops a quantitative tool for use as a performance indicator of gradualness for firms entering external markets at a sectoral level. The performance indicator is based on firms' export volumes, number of years operating in the export market, geographic areas targeted for export and when exports began to each area. The indicator is tested empirically in the wine sector. The main contribution of this study is the creation of a reliable international priority index, which can serve more widely as a valuable tool because of its potential use in other industry sectors and geographic areas, and which would allow the analysis of how geographically differentiated internationalization strategies develop.	[Clavel San Emeterio, Monica; Fernandez-Ortiz, Ruben] Univ La Rioja, Econ & Business Dept, Logrono, Spain; [Arteaga-Ortiz, Jesus; Dorta-Gonzalez, Pablo] Univ Las Palmas Gran Canaria, Business & Management Dept, Las Palmas Gran Canaria, Spain	Universidad de La Rioja; Universidad de Las Palmas de Gran Canaria	San Emeterio, MC (corresponding author), Univ La Rioja, Econ & Business Dept, Logrono, Spain.	monica.clavel-san@unirioja.es	Fernández, Rubén/AAA-4521-2019; Dorta-González, Pablo/C-6425-2009; SAN EMETERIO, MONICA CLAVEL/AAA-4518-2019	Dorta-González, Pablo/0000-0003-0494-2903; SAN EMETERIO, MONICA CLAVEL/0000-0003-2478-0198; /0000-0002-6908-0657				Ambos B, 2014, J INT MANAG, V20, P1, DOI 10.1016/j.intman.2013.10.003; ANDERSEN O, 1993, J INT BUS STUD, V24, P209, DOI 10.1057/palgrave.jibs.8490230; [Anonymous], 2017, STAT REP WORLD VIT; ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783; Bae JH, 2010, ADV INTL MANAGEMENT, V23, P327, DOI 10.1108/S1571-5027(2010)00000230020; Barkema HG, 1996, STRATEGIC MANAGE J, V17, P151, DOI 10.1002/(SICI)1097-0266(199602)17:2<151::AID-SMJ799>3.0.CO;2-Z; BECKERMAN W, 1956, REV ECON STAT, V38, P31, DOI 10.2307/1925556; BENITO GRG, 1992, J INT BUS STUD, V23, P461, DOI 10.1057/palgrave.jibs.8490275; Berry H, 2010, J INT BUS STUD, V41, P1460, DOI 10.1057/jibs.2010.28; Brewer PA, 2007, J INT MARKETING, V15, P44, DOI 10.1509/jimk.15.1.044; Carneiro Jorge, 2008, BAR, Braz. Adm. Rev., V5, P85; Cerrato D, 2012, J MANAG GOV, V16, P617, DOI 10.1007/s10997-010-9166-x; Chikhouni A, 2017, J INT MANAG, V23, P32, DOI 10.1016/j.intman.2016.07.003; Cho KR, 2005, INT BUS REV, V14, P307, DOI 10.1016/j.ibusrev.2005.01.001; CLARK T, 2001, INT BUSINESS REV, V10, P285, DOI DOI 10.1016/S0969-5931(01)00017-8; DAVIDSON WH, 1980, J INT BUS STUD, V11, P9, DOI 10.1057/palgrave.jibs.8490602; Dikova D, 2009, INT BUS REV, V18, P38, DOI 10.1016/j.ibusrev.2008.11.001; Dow D, 2006, J INT BUS STUD, V37, P578, DOI 10.1057/palgrave.jibs.8400221; Drogendijk R, 2010, ADV INTL MANAGEMENT, V23, P189, DOI 10.1108/S1571-5027(2010)00000230015; Evans J, 2002, J INT BUS STUD, V33, P515, DOI 10.1057/palgrave.jibs.8491029; Forsgren M, 2001, CONCEPT LEARNING UPP; Fuentes-Lombardo G, 2011, INTANGIBLE CAPITAL, V7; Galvan I., 2003, THESIS; George G, 2005, J MANAGE, V31, P210, DOI 10.1177/0149206304271760; Ghemawat P, 2001, HARVARD BUS REV, V79, P137; Hadley RD., 2003, INT BUS REV, V12, P697, DOI [DOI 10.1016/J.IBUSREV.2003.01.001, 10.1016/j.ibusrev.2003.01.001]; Hakanson L, 2016, J WORLD BUS, V51, P308, DOI 10.1016/j.jwb.2015.11.005; Hakansson H., 2006, SCAND J MANAG, V22, P256, DOI [10.1016/0956-5221(89)90026-2, 10.1016/j. scaman.2006.10.005, 10.1016/j.scaman.2006.10.005]; Hofstede G., 1980, CULTURES CONSEQUENCE; Hollensen S., 2010, ESTRATEGIAS MARKETIN; Hosseini H., 2008, J SOCIO-ECON, V37, P939; ICEX Espana Exportacion e Inversiones, 2017, EST COM EXT; JOHANSON J, 1977, J INT BUS STUD, V8, P23, DOI 10.1057/palgrave.jibs.8490676; JOHANSON J, 1975, J MANAGE STUD, V12, P305, DOI 10.1111/j.1467-6486.1975.tb00514.x; Johanson J., 1990, INT MARKET REV, V7, P11, DOI DOI 10.1108/02651339010137414; Joliet R, 2003, J FINANCIAL QUANTITA, V16, P113; Klein S., 1990, INT MARKET REV, V7, P27, DOI DOI 10.1108/EUM0000000001533; Knight GA, 1996, ADV INT MAR, V8, P11; KOGUT B, 1988, J INT BUS STUD, V19, P411, DOI 10.1057/palgrave.jibs.8490394; Kostova T, 1999, ACAD MANAGE REV, V24, P308, DOI 10.2307/259084; Langhoff T., 1997, NATURE INT FIRM, P135; Leonidou LC, 1996, J INT BUS STUD, V27, P517, DOI 10.1057/palgrave.jibs.8490846; Lopez AV, 2007, COMEDIA ROMANA, P23; Luo YD, 2011, MANAGE INT REV, V51, P433, DOI 10.1007/s11575-011-0087-y; Martin OM, 2014, J SMALL BUS MANAGE, V52, P102, DOI 10.1111/jsbm.12035; MCDOUGALL PP, 1994, J BUS VENTURING, V9, P469; Nebus J, 2014, J INT MANAG, V20, P8, DOI 10.1016/j.intman.2013.01.001; Nordman ER, 2014, INT BUS REV, V23, P30, DOI 10.1016/j.ibusrev.2013.08.010; Nordstrom K, 1994, INT TRADE REGIONAL G; Nordstrom KA, 1991, INT PROCESS FIRM SEA; OGrady S, 1996, J INT BUS STUD, V27, P309, DOI 10.1057/palgrave.jibs.8490137; Oviatt BM, 1999, RES GLOB ST, V7, P23; Padmanabhan P, 1999, J INT BUS STUD, V30, P25, DOI 10.1057/palgrave.jibs.8490059; Pangarkar N, 2008, J WORLD BUS, V43, P475, DOI 10.1016/j.jwb.2007.11.009; Pla Barber J., 2001, ICADE REV FACULTADES, V52, P155; Pla J., 2004, PAPELES EC ESPANOLA, P193; Prime N, 2009, INT BUS REV, V18, P184, DOI 10.1016/j.ibusrev.2009.02.011; Reid SD, 1984, INT MARKETING MANAGE; RONEN S, 1985, ACAD MANAGE REV, V10, P435, DOI 10.2307/258126; Rugman AM, 2004, J INT BUS STUD, V35, P3, DOI 10.1057/palgrave.jibs.8400073; Sahaym A, 2013, INT BUS REV, V22, P421, DOI 10.1016/j.ibusrev.2012.06.002; Shenkar O, 2001, J INT BUS STUD, V32, P519, DOI 10.1057/palgrave.jibs.8490982; Shenkar O, 2008, ACAD MANAGE REV, V33, P905; Shenkar O, 2012, J INT BUS STUD, V43, P12, DOI 10.1057/jibs.2011.42; Smith B, 2010, ADV INTL MANAGEMENT, V23, P213, DOI 10.1108/S1571-5027(2010)00000230016; Sousa CMP, 2011, INT MARKET REV, V28, P201, DOI 10.1108/02651331111122678; Sousa CMP, 2006, J INT MARKETING, V14, P49, DOI 10.1509/jimk.14.1.49; Spanish Wine Federation, 2017, MEM ACT; Stottinger B, 2000, INT MARKET REV, V17, P169, DOI 10.1108/02651330010322723; Tung RL, 2010, J INT BUS STUD, V41, P1259, DOI 10.1057/jibs.2010.41; Vaaler PA, 2004, ORGAN SCI, V15, P687, DOI 10.1287/orsc.1040.0089; Whitelock J, 2002, INT MARKET REV, V19, P342, DOI 10.1108/02651330210435654; Yildiz HE, 2016, J INT BUS STUD, V47, P830, DOI 10.1057/jibs.2016.27; Zaheer S, 2012, J INT BUS STUD, V43, P18, DOI 10.1057/jibs.2011.43	74	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2018	13	5							e0196804	10.1371/journal.pone.0196804	http://dx.doi.org/10.1371/journal.pone.0196804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE7ZR	29727461	Green Published, gold, Green Submitted			2022-12-26	WOS:000431452100010
J	Gupalova, T; Leontieva, G; Kramskaya, T; Grabovskaya, K; Bormotova, E; Korjevski, D; Suvorov, A				Gupalova, T.; Leontieva, G.; Kramskaya, T.; Grabovskaya, K.; Bormotova, E.; Korjevski, D.; Suvorov, A.			Development of experimental GBS vaccine for mucosal immunization	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; BETA-ANTIGEN; AGALACTIAE; PROTEIN; GENE; IMMUNOGENICITY; IDENTIFICATION; MICROSPHERES; COLONIZATION; PILI	Streptococcus agalactiae, or group B streptococcus (GBS), is an important pathogen as it is the leading cause of neonatal deaths due to sepsis, meningitis or bacterial pneumonia. Although the development of an effective and safe GBS vaccine is on the agenda of many research labs, there is no GBS vaccine on the market yet. In the present study we attempted to engineer a live vaccine strain based on Bac, a surface protein of GBS, incorporated into a surface fimbrial protein of probiotic Enterococcus. The resulting strain induced specific systemic and local immune responses in mice and provided protection against GBS when administered via the intranasal, oral or intravaginal immunization routes.	[Gupalova, T.; Leontieva, G.; Kramskaya, T.; Grabovskaya, K.; Bormotova, E.; Korjevski, D.; Suvorov, A.] Inst Expt Med, St Petersburg, Russia; [Suvorov, A.] St Petersburg State Univ, St Petersburg, Russia	Institute of Experimental Medicine; Saint Petersburg State University	Leontieva, G (corresponding author), Inst Expt Med, St Petersburg, Russia.	galeonte@yandex.ru	Kramskaya, Tatiana/AAH-2447-2021; Leontieva, Galina/AAH-1660-2019; Gupalova, Tatyana/E-1290-2014; Bormotova, Elena/ABI-6322-2020; Korzhevskii, Dmitrii/C-2206-2012	Leontieva, Galina/0000-0002-9876-6594; Gupalova, Tatyana/0000-0002-4824-3621; Korzhevskii, Dmitrii/0000-0002-2456-8165	Ministry of Education and Science, Russian Federation [14.613.21.0023]	Ministry of Education and Science, Russian Federation(Ministry of Education and Science, Russian FederationRussian Federation)	This work was supported by the budget of Federal State Budgetary Scientific Institution "Institute of Experimental Medicine", Saint Petersburg, Russian Federation. The work was supported by grant No 14.613.21.0023 of the Ministry of Education and Science, Russian Federation.	Bahey-El-Din M, 2010, CURR GENE THER, V10, P34, DOI 10.2174/156652310790945557; BAKER CJ, 1976, INFECT IMMUN, V13, P284, DOI 10.1128/IAI.13.1.284-288.1976; Baker JA, 2017, VACCINE, V35, P1273, DOI 10.1016/j.vaccine.2017.01.029; Bermudez-Humaran LG, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S4; Danne C, 2012, RES MICROBIOL, V163, P645, DOI 10.1016/j.resmic.2012.10.012; Desheva YA, VIROLOGY RES TREATME, V8, P1; Desheva Yulia A, 2016, Open Microbiol J, V10, P168; Ermolenko Elena, 2013, Biosci Microbiota Food Health, V32, P41, DOI 10.12938/bmfh.32.41; FERRETTI JJ, 1980, INFECT IMMUN, V30, P69, DOI 10.1128/IAI.30.1.69-73.1980; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Hunter SK, 2001, AM J OBSTET GYNECOL, V185, P1174, DOI 10.1067/mob.2001.117658; Jarva H, 2003, MOL IMMUNOL, V40, P95, DOI 10.1016/S0161-5890(03)00108-1; Jerlstrom PG, 1996, INFECT IMMUN, V64, P2787; Kannika K, 2017, J APPL MICROBIOL, V122, P1497, DOI 10.1111/jam.13447; Karlskas IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091125; Koroleva IV, 2002, J BACTERIOL, V184, P6384, DOI 10.1128/JB.184.22.6384-6386.2002; Lazzarin M, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1057-8; Liu G, 2017, VACCINE, V35, P1246, DOI 10.1016/j.vaccine.2017.01.041; Madhi SA, 2016, LANCET INFECT DIS, V16, P923, DOI 10.1016/S1473-3099(16)00152-3; MICHON C, 2016, MICROB CELL FACT, V15; Santillan DA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.024; Stockmann C, 2016, CLIN INFECT DIS, V63, P619, DOI 10.1093/cid/ciw357; Suvorov A, 2004, INDIAN J MED RES, V119, P228; Suvorov Alexander, 2013, Biosci Microbiota Food Health, V32, P81, DOI 10.12938/bmfh.32.81; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ustinovitch I, 1999, FOLIA MICROBIOL, V44, P726, DOI 10.1007/BF02825670; Vintini EO, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-46; Vorobieva EI, 2005, FOLIA MICROBIOL, V50, P172, DOI 10.1007/BF02931468	28	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2018	13	5							e0196564	10.1371/journal.pone.0196564	http://dx.doi.org/10.1371/journal.pone.0196564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE7ZR	29727446	Green Published, gold, Green Submitted			2022-12-26	WOS:000431452100006
J	Barrera, J; Subramanian, S; Chiba-Falek, O				Barrera, Julio; Subramanian, Shobana; Chiba-Falek, Ornit			Probing the role of PPAR gamma in the regulation of late-onset Alzheimer's disease-associated genes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; IDENTIFIES VARIANTS; COMMON VARIANTS; EXPRESSION; REVEALS; CANCER; CD2AP; EPHA1; RISK	Peroxisome proliferator-activated receptor-gamma (PPAR gamma), is a transcription factor that governs pathways, such as lipid metabolism and immune response, that have been implicated in the etiology of LOAD. Previously, we established HepG2-derived cell-lines with stable knockdown of PPAR gamma gene, and showed an increase in mRNA levels of genes mapped in the APOE linkage disequilibrium (LD) region on chromosome 19q13.32, with the greatest effect observed for APOE-mRNA. Here, we extended the analysis using our PPAR gamma knockdown model system and investigated the broader effect on expression changes of genes implicated in LOAD via genome wide association studies (GWAS). We applied the nCounter gene expression assay (NanoString) using a panel of twenty-four LOAD-associated genes inferred by proximity to the top significantly associated SNPs. Two independent PPAR gamma knockdown cell-lines showed changes in mRNA levels of a total of seven genes compared to a control HepG2 cell-line; six of which, ABCA7, APOE, CASS4, CELF1, PTK2B, and ZCWPW1, were upregulated and one, DSG2, was downregulated upon PPAR gamma knockdown. Our results propose that PPAR gamma may act as a master regulator of the transcription of several genes involved in LOAD pathogenesis. Our study provided the premise for further analyses including a larger set of genes positioned within a wider range of linkage disequilibrium (LD) regions tagged by all LOAD significantly associated SNPs.	[Barrera, Julio; Subramanian, Shobana; Chiba-Falek, Ornit] Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27708 USA; [Barrera, Julio; Chiba-Falek, Ornit] Duke Univ, Med Ctr, Ctr Genom & Computat Biol, Durham, NC 27708 USA	Duke University; Duke University	Chiba-Falek, O (corresponding author), Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27708 USA.; Chiba-Falek, O (corresponding author), Duke Univ, Med Ctr, Ctr Genom & Computat Biol, Durham, NC 27708 USA.	o.chibafalek@duke.edu		Subramanian, Shobana/0000-0003-0722-5651; Chiba-Falek, Ornit/0000-0002-2529-8785	National Institute on Aging (NIA) [R01AG040370, R01AG057522]; NATIONAL INSTITUTE ON AGING [R01AG057522] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Institute on Aging (NIA) [R01AG040370 and R01AG057522 to O.C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; This work was funded by the National Institute on Aging (NIA) [R01AG040370 and R01AG057522 to O.C.].	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; Allen M, 2012, NEUROLOGY, V79, P221, DOI 10.1212/WNL.0b013e3182605801; Beck Tim N, 2014, Oncoscience, V1, P486; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Cai W, 2018, PROG NEUROBIOL, V163, P27, DOI 10.1016/j.pneurobio.2017.10.002; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Chen YC, 2012, MOL NEUROBIOL, V46, P114, DOI 10.1007/s12035-012-8259-8; Cifdaloz M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02353-y; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Elsnerova K, 2017, J CANCER, V8, P3598, DOI 10.7150/jca.20766; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; He WM, 2009, PPAR RES, V2009, DOI 10.1155/2009/849538; Heinzen EL, 2010, J ALZHEIMERS DIS, V19, P69, DOI 10.3233/JAD-2010-1212; Heneka MT, 2011, CURR NEUROPHARMACOL, V9, P643, DOI 10.2174/157015911798376325; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015; Johnson W, 2008, NEUROSCI LETT, V434, P50, DOI 10.1016/j.neulet.2008.01.027; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Jones L, 2010, BBA-MOL CELL BIOL L, V1801, P754, DOI 10.1016/j.bbalip.2010.04.005; Kamboh MI, 2012, MOL PSYCHIATR, V17, P1340, DOI 10.1038/mp.2011.135; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lewis K, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00128-17; Linnertz C, 2014, ALZHEIMERS DEMENT, V10, P541, DOI 10.1016/j.jalz.2013.08.280; Matsui T, 2007, BRAIN RES, V1161, P116, DOI 10.1016/j.brainres.2007.05.050; Musicco M, 2013, NEUROLOGY, V81, P322, DOI 10.1212/WNL.0b013e31829c5ec1; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Ott J, 2000, P NATL ACAD SCI USA, V97, P2, DOI 10.1073/pnas.97.1.2; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Rosenthal Samantha L, 2014, Curr Genet Med Rep, V2, P85; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Singleton A, 2004, HUM MOL GENET, V13, pR123, DOI 10.1093/hmg/ddh093; Su Y, 2018, MOL CELL ENDOCRINOL, V471, P97, DOI 10.1016/j.mce.2017.07.037; Subramanian S, 2017, BBA-MOL BASIS DIS, V1863, P810, DOI 10.1016/j.bbadis.2017.01.004; Villapol S, 2018, CELL MOL NEUROBIOL, V38, P121, DOI 10.1007/s10571-017-0554-5; Yarchoan M, 2017, J ALZHEIMERS DIS, V56, P699, DOI 10.3233/JAD-160977; Zarow C, 1998, EXP NEUROL, V149, P79, DOI 10.1006/exnr.1997.6709; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	43	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196943	10.1371/journal.pone.0196943	http://dx.doi.org/10.1371/journal.pone.0196943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723294	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100094
J	Chu, FI; Marin-Franch, I; Ramezani, K; Racette, L				Chu, Fang-I; Marin-Franch, Ivan; Ramezani, Koosha; Racette, Lyne			Associations between structure and function are different in healthy and glaucomatous eyes	PLOS ONE			English	Article							RETINAL NERVE-FIBER; OPTICAL COHERENCE TOMOGRAPHY; SCANNING LASER POLARIMETRY; VISUAL-FIELD DEFECTS; OPEN-ANGLE GLAUCOMA; LAYER THICKNESS; OCULAR HYPERTENSION; AUTOMATED PERIMETRY; STATISTICAL-METHOD; AFRICAN DESCENT	Purpose To assess if there are differences in the structure-function associations between healthy and glaucomatous eyes. Methods Structure-function associations were assessed in healthy and glaucomatous eyes in three datasets, globally and in the six sectors of the optic nerve head. Structural parameters included rim area (RA) and retinal nerve fiber layer thickness (RNFLT). Functional parameters included unweighted mean of sensitivity thresholds (MS) and unweighted mean of total deviation values (MD), assessed with standard automated perimetry, short-wavelength automated perimetry, frequency-doubling technology perimetry, or contrast sensitivity perimetry. All structural and functional parameters were expressed as percent of mean normal. SF associations were assessed with correlation analyses (Pearson, Spearman and Kendall). We also assessed the SF associations with linear regression analyses: the generalized estimating equation (GEE) was used to adjust for inter-eye correlations and ordinary least squares (OLS) linear models were used when these adjustments were not necessary. We applied Bonferroni corrections to adjust for the impact of multiple comparisons. Results Overall, none of the Pearson correlations tested in healthy eyes were significant (correlations ranged from -0.17 to 0.37), whereas 77% of the correlations tested in glaucomatous eyes were significant (correlations ranged from 0.01 to 0.79). Similarly, none of the slopes obtained with GEE and OLS were significant in healthy eyes (slopes ranged from -0.30 to 0.87), whereas 82% of the slopes obtained in glaucomatous eyes were significant (slopes ranged from 0.02 to 1.38). Conclusions Significant associations between structure and function were consistently observed in glaucomatous eyes, but not in healthy eyes. These differences in association should be considered in the design of structure-function models for progression.	[Chu, Fang-I; Ramezani, Koosha; Racette, Lyne] Indiana Univ, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46204 USA; [Marin-Franch, Ivan; Ramezani, Koosha; Racette, Lyne] Univ Alabama Birmingham, Sch Med, Dept Ophthalmol & Visual Sci, Birmingham, AL 35294 USA	Indiana University System; Indiana University-Purdue University Indianapolis; University of Alabama System; University of Alabama Birmingham	Racette, L (corresponding author), Indiana Univ, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46204 USA.; Racette, L (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Ophthalmol & Visual Sci, Birmingham, AL 35294 USA.	lracette@uabmc.edu	Marín-Franch, Iván/AAF-4195-2021; Racette, Lyne/AAX-3088-2020	Racette, Lyne/0000-0003-4550-124X; Marin-Franch, Ivan/0000-0001-7079-6874	BrightFocus Foundation [G2014096]; National Institutes of Health (National Eye Institute) [EY025756]; Indiana University - Purdue University Indianapolis DRIVE award; EyeSight Foundation of Alabama, Birmingham, AL; Research to Prevent Blindness; NIH [P30EY022589, EY021818, EY11008, U10EY14267, EY019869]; Eyesight Foundation of Alabama; Edith C. Blum Research Fund of the New York Glaucoma Research Institute, New York, NY; Research to Prevent Blindness, New York, New York; National Institutes of Health [R01EY007716, 5P30EY019008]; Department of Healths NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology; National Eye Institute [R01-EY-09076, R01-EY-02115]; Iowa City Veteran Administration (VA) Center for the Prevention and Treatment of Visual Loss VA RR&D Division grant from the Veterans Administration (Rehabilitation Division) [C9251-C, C1821-R]; VA Merit Review Grant; Iowa City Veteran Administration (VA) Center for the Prevention and Treatment of Visual Loss VA RR&D Division grant from the Veterans Administration (Merit Review) [C9251-C, C1821-R]; NATIONAL EYE INSTITUTE [P30EY022589, U10EY014267, R01EY019869, R01EY025756] Funding Source: NIH RePORTER	BrightFocus Foundation(BrightFocus Foundation); National Institutes of Health (National Eye Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Indiana University - Purdue University Indianapolis DRIVE award; EyeSight Foundation of Alabama, Birmingham, AL; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eyesight Foundation of Alabama; Edith C. Blum Research Fund of the New York Glaucoma Research Institute, New York, NY; Research to Prevent Blindness, New York, New York(Research to Prevent Blindness (RPB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Healths NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Iowa City Veteran Administration (VA) Center for the Prevention and Treatment of Visual Loss VA RR&D Division grant from the Veterans Administration (Rehabilitation Division); VA Merit Review Grant(US Department of Veterans Affairs); Iowa City Veteran Administration (VA) Center for the Prevention and Treatment of Visual Loss VA RR&D Division grant from the Veterans Administration (Merit Review); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors acknowledge the donors of the National Glaucoma Research, a program of BrightFocus Foundation, for support of this research (G2014096) (LR) (https://urldefense.proofpoint.com/v2/url?u=https-3A_www.brightfocus.org_research_national-2Dglaucoma-2Dresearch-2Dprogram & National Institutes of Health (National Eye Institute) grant EY025756 (LR) EY025756 (https://nei.nih.gov); Indiana University - Purdue University Indianapolis DRIVE award (LR); an unrestricted grant from the EyeSight Foundation of Alabama, Birmingham, AL; and an unrestricted grant from Research to Prevent Blindness. The DIGS and ADAGES studies were supported by NIH grants P30EY022589, EY021818, EY11008, U10EY14267, EY019869; Eyesight Foundation of Alabama; Edith C. Blum Research Fund of the New York Glaucoma Research Institute, New York, NY; unrestricted grant from Research to Prevent Blindness, New York, New York. The SUNY-IU dataset was supported by National Institutes of Health Grants R01EY007716 (William H. Swanson) and 5P30EY019008 (Indiana University School of Optometry) and partial funding (Rizwan Malik) from the Department of Healths NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The IOWA datasets were supported by National Eye Institute Grants R01-EY-09076 and R01-EY-02115, Iowa City Veteran Administration (VA) Center for the Prevention and Treatment of Visual Loss VA RR&D Division grant C9251-C (Randy H. Kardon and Michael Wall), grant C1821-R (Michael Wall) from the Veterans Administration (Rehabilitation Division and Merit Review), an unrestricted grant from Research to Prevent Blindness, New York, New York, a VA Merit Review Grant and by an unrestricted grant to the Department of Ophthalmology, University of Iowa College of Medicine from Research to Prevent Blindness, New York, New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Acknowledgment is made to the donors of the National Glaucoma Research, a program of BrightFocus Foundation, for support of this research. This work was also supported in part by NIH grant EY025756, by an Indiana University-Purdue University Indianapolis DRIVE award, by an unrestricted grant from the EyeSight Foundation of Alabama, Birmingham, AL, and by an unrestricted grant from Research to Prevent Blindness.; We thank Linda M. Zangwill, Jeffrey M. Liebmann, Christopher A. Girkin and Felipe A. Medeiros (DIGS-ADAGES dataset), William H. Swanson and Mitchell W. Dul (SUNY-IU dataset), and Michael Wall and Randy H. Kardon (IOWA dataset) for providing the datasets used in this study. The DIGS and ADAGES studies were supported by NIH grants P30EY022589, EY021818, EY11008, U10EY14267, EY019869; Eyesight Foundation of Alabama; Edith C. Blum Research Fund of the New York Glaucoma Research Institute, New York, NY; unrestricted grant from Research to Prevent Blindness, New York, New York.; The SUNY-IU dataset was supported by National Institutes of Health Grants R01EY007716 (William H. Swanson) and 5P30EY019008 (Indiana University School of Optometry) and partial funding (Rizwan Malik) from the Department of Health's NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. David F. Garway-Heath served as member of the executive committee that defined the diagnostic criteria.; The IOWA datasets were supported by National Eye Institute Grants R01-EY-09076 and R01-EY-02115, Iowa City Veteran Administration (VA) Center for the Prevention and Treatment of Visual Loss VA RR&D Division grant C9251-C (Randy H. Kardon and Michael Wall), grant C1821-R (Michael Wall) from the Veterans Administration (Rehabilitation Division and Merit Review), an unrestricted grant from Research to Prevent Blindness, New York, New York, a VA Merit Review Grant and by an unrestricted grant to the Department of Ophthalmology, University of Iowa College of Medicine from Research to Prevent Blindness, New York, New York.	Alamouti B, 2003, BRIT J OPHTHALMOL, V87, P899, DOI 10.1136/bjo.87.7.899; [Anonymous], 2010, R LANG ENV STAT COMP; Aptel F, 2010, AM J OPHTHALMOL, V150, P825, DOI 10.1016/j.ajo.2010.06.011; BALAZSI AG, 1984, AM J OPHTHALMOL, V97, P760, DOI 10.1016/0002-9394(84)90509-9; Blanks JC, 1996, NEUROBIOL AGING, V17, P377, DOI 10.1016/0197-4580(96)00010-3; Centofanti M, 2005, OPHTHALMOLOGY, V112, P366, DOI 10.1016/j.ophtha.2004.11.030; Garway-Heath David F, 2017, Trans Am Ophthalmol Soc, V115, pT4; Garway-Heath DF, 2000, INVEST OPHTH VIS SCI, V41, P1774; Garway-Heath DF, 2002, INVEST OPHTH VIS SCI, V43, P2213; Harwerth RS, 2008, INVEST OPHTH VIS SCI, V49, P4437, DOI 10.1167/iovs.08-1753; Harwerth RS, 2004, INVEST OPHTH VIS SCI, V45, P3152, DOI 10.1167/iovs.04-0227; Harwerth RS, 1999, INVEST OPHTH VIS SCI, V40, P2242; Harwerth RS, 2002, PROG RETIN EYE RES, V21, P91, DOI 10.1016/S1350-9462(01)00022-2; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P4254, DOI 10.1167/iovs.08-2697; Kanamori A, 2013, ACTA OPHTHALMOL, V91, pE196, DOI 10.1111/aos.12028; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P829; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Leung CKS, 2005, INVEST OPHTH VIS SCI, V46, P3214, DOI 10.1167/iovs.05-0294; Malik R, 2012, CLIN EXP OPHTHALMOL, V40, P369, DOI 10.1111/j.1442-9071.2012.02770.x; Marin-Franch I, 2013, INVEST OPHTH VIS SCI, V54, P4189, DOI 10.1167/iovs.12-10377; Moore GPM, 2010, INTRO PRACTICE STAT; Mukaka MM, 2012, MALAWI MED J, V24, P69; Patel NB, 2014, INVEST OPHTH VIS SCI, V55, P5134, DOI 10.1167/iovs.14-14303; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453, DOI 10.1016/0002-9394(89)90488-1; Racette L, 2007, J GLAUCOMA, V16, P676, DOI 10.1097/IJG.0b013e31804d23c2; Racette L, 2010, ARCH OPHTHALMOL-CHIC, V128, P551, DOI 10.1001/archophthalmol.2010.58; Rao HL, 2011, ARCH OPHTHALMOL-CHIC, V129, P864, DOI 10.1001/archophthalmol.2011.145; Redmond T, 2013, INVEST OPHTH VIS SCI, V54, P2153, DOI 10.1167/iovs.12-10342; Reus NJ, 2005, INVEST OPHTH VIS SCI, V46, P4182, DOI 10.1167/iovs.04-1029; Russell RA, 2012, INVEST OPHTH VIS SCI, V53, P2760, DOI 10.1167/iovs.11-7976; Sample PA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1136, DOI 10.1001/archophthalmol.2009.187; Schlottmann PG, 2004, INVEST OPHTH VIS SCI, V45, P1823, DOI 10.1167/iovs.03-0692; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; Swanson WH, 2014, OPTOMETRY VISION SCI, V91, P1302, DOI 10.1097/OPX.0000000000000395; Taskinen S, 2013, J THEOR BIOL, V333, P38, DOI 10.1016/j.jtbi.2013.05.010; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wollstein G, 2012, BRIT J OPHTHALMOL, V96, P47, DOI 10.1136/bjo.2010.196907	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196814	10.1371/journal.pone.0196814	http://dx.doi.org/10.1371/journal.pone.0196814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723304	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100069
J	Oshima, T; Miyashita, H; Ishimura, Y; Ito, Y; Tanaka, Y; Hori, A; Kokubo, T; Kurokawa, T				Oshima, Tsutomu; Miyashita, Hideaki; Ishimura, Yoshimasa; Ito, Yuki; Tanaka, Yoko; Hori, Akira; Kokubo, Toshio; Kurokawa, Tomofumi			Fc engineering of anti-Nectin-2 antibody improved thrombocytopenic adverse event in monkey	PLOS ONE			English	Article							CELLULAR IMMUNE-MECHANISMS; IMMUNOGLOBULIN-LIKE LOOP; GAMMA-RI; ADHESION MOLECULE; TIGHT JUNCTIONS; BINDING-SITE; PVR CD155; HUMAN-IGG; V-DOMAIN; NECTIN	Nectin-2 is a transmembrane glycoprotein which is involved in the process of Ca2+-independent cell-cell adhesion. In our previous study, we have demonstrated that Nectin-2 is over-expressed in breast and ovarian cancer tissues by using gene expression analysis and immunohistochemistry. Furthermore, we discovered multiple anti-Nectin-2 fully human monoclonal antibodies which inhibited tumor growth in in vivo subcutaneous xenograft models with antibody-dependent cellular cytotoxicity (ADCC) as the principal mechanism of action. In this report, we assessed the toxicity of Y-443, a fully human IgG(1)/kappa anti-Nectin-2 monoclonal antibody exhibiting strong in vitro ADCC and in vivo anti-tumor activity in cynomolgus monkeys (Macaca fascicularis (Cynos)). Unexpectedly, upon administration, Y-443 induced strong thrombocytopenia through Nectin-2 expressed on Cyno platelets, presumably followed by phagocytosis in the mononuclear phagocytic system. To mitigate the adverse safety profile, we mutated the Fc region of Y-443 to reduce the Fc binding activity to Fc. receptor I, which is the primary receptor for phagocytosis on macrophages. Moreover, we further engineered the Fc through defucosylation to maintain ADCC activity. The resultant Fc engineered antibody, termed Y-634, demonstrated diminished thrombocytopenia in Cyno toxicological studies and maintained anti-tumor activity in a mouse xenograft model. These findings suggest that Y-634 may have a therapeutic potential for the treatment of Nectin-2 positive cancers, and moreover, Fc engineering is a potential mitigation strategy to ameliorate safety liabilities in antibody induced thrombocytopenia while maintaining antibody potency.	[Oshima, Tsutomu] Takeda Calif Inc, Immunobiol, San Diego, CA 92121 USA; [Miyashita, Hideaki; Tanaka, Yoko] Takeda Pharmaceut Co Ltd, Pharmaceut Sci, Hikari, Yamaguchi, Japan; [Ishimura, Yoshimasa; Ito, Yuki; Hori, Akira; Kokubo, Toshio; Kurokawa, Tomofumi] Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, Fujisawa, Kanagawa, Japan; [Ishimura, Yoshimasa] SCOHIA PHARMA Inc, Biol Lab, Fujisawa, Kanagawa, Japan; [Kokubo, Toshio] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan; [Kurokawa, Tomofumi] Taisho Pharmaceut Co Ltd, Pharmacol Labs, Saitama, Saitama, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals USA Inc. (TPUSA); Takeda California Inc; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; University of Tsukuba; Taisho Pharmaceutical Holdings Co Ltd	Oshima, T (corresponding author), Takeda Calif Inc, Immunobiol, San Diego, CA 92121 USA.	tsutomu.oshima@takeda.com			Takeda Pharmaceutical Company Limited in Fujisawa; Takeda Pharmaceutical Company in Yamaguchi; Takeda California Inc.	Takeda Pharmaceutical Company Limited in Fujisawa; Takeda Pharmaceutical Company in Yamaguchi; Takeda California Inc.	This study was funded by Takeda Pharmaceutical Company Limited in Fujisawa, Takeda Pharmaceutical Company in Yamaguchi and Takeda California Inc. All authors are/were employees of Takeda Pharmaceutical Company Limited and were paid as such. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Bouchard MJ, 2000, MOL CELL BIOL, V20, P2865, DOI 10.1128/MCB.20.8.2865-2873.2000; Bussel JB, 2000, SEMIN HEMATOL, V37, P261, DOI 10.1053/shem.2000.8957; Chan CJ, 2012, CURR OPIN IMMUNOL, V24, P246, DOI 10.1016/j.coi.2012.01.009; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; Cines DB, 2002, NEW ENGL J MED, V346, P995, DOI 10.1056/NEJMra010501; Coopamah MD, 2003, TRANSFUS MED REV, V17, P69, DOI 10.1053/tmrv.2003.50004; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; Desjarlais RJ, WO Patent, Patent No. [WO2007041635 A2, 2007041635]; DUNCAN AR, 1988, NATURE, V332, P563, DOI 10.1038/332563a0; Everds N, 2013, TOXICOL PATHOL, V41, P951, DOI 10.1177/0192623312474727; Fabre S, 2002, J BIOL CHEM, V277, P27006, DOI 10.1074/jbc.M203228200; Fukuhara A, 2003, J BIOL CHEM, V278, P51885, DOI 10.1074/jbc.M308015200; Fukuhara A, 2002, ONCOGENE, V21, P7642, DOI 10.1038/sj.onc.1205875; Fukuhara A, 2002, GENES CELLS, V7, P1059, DOI 10.1046/j.1365-2443.2002.00578.x; Go RS, 2007, HAEMATOLOGICA, V92, P283, DOI 10.3324/haematol.10667; Inagaki M, 2003, J COMP NEUROL, V460, P514, DOI 10.1002/cne.10653; JEFFERIS R, 1990, MOL IMMUNOL, V27, P1237, DOI 10.1016/0161-5890(90)90027-W; Kanda Y, 2006, BIOTECHNOL BIOENG, V94, P680, DOI 10.1002/bit.20880; Kiyoshi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7866; Kurokawa T, 2002, EUR J BIOCHEM, V269, P5459, DOI 10.1046/j.1432-1033.2002.03244.x; Lopez M, 1998, BLOOD, V92, P4602, DOI 10.1182/blood.V92.12.4602.424k21_4602_4611; LUND J, 1991, J IMMUNOL, V147, P2657; MCMILLAN R, 1987, BLOOD, V70, P1040; Miyahara M, 2000, J BIOL CHEM, V275, P613, DOI 10.1074/jbc.275.1.613; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Momose Y, 2002, BIOCHEM BIOPH RES CO, V293, P45, DOI 10.1016/S0006-291X(02)00183-3; MORGAN A, 1995, IMMUNOLOGY, V86, P319; Morita H, 2010, DEVELOPMENT, V137, P1315, DOI 10.1242/dev.043190; Oshima T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-60; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Rogers KA, 2006, J IMMUNOL, V177, P3848, DOI 10.4049/jimmunol.177.6.3848; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; SEMPLE JW, 1995, TRANSFUS MED REV, V9, P327, DOI 10.1016/S0887-7963(05)80080-X; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Wallace PK, 1997, CANCER IMMUNOL IMMUN, V45, P137, DOI 10.1007/s002620050416; Warncke M, 2012, J IMMUNOL, V188, P4405, DOI 10.4049/jimmunol.1200090; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Webster ML, 2006, BLOOD, V108, P943, DOI 10.1182/blood-2005-06-009761; Yasumi M, 2003, BIOCHEM BIOPH RES CO, V302, P61, DOI 10.1016/S0006-291X(03)00106-2	43	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196422	10.1371/journal.pone.0196422	http://dx.doi.org/10.1371/journal.pone.0196422			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723247	gold, Green Submitted, Green Published			2022-12-26	WOS:000431305100029
J	Tamura, R; Doi, S; Nakashima, A; Sasaki, K; Maeda, K; Ueno, T; Masaki, T				Tamura, Ryo; Doi, Shigehiro; Nakashima, Ayumu; Sasaki, Kensuke; Maeda, Kazuya; Ueno, Toshinori; Masaki, Takao			Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis	PLOS ONE			English	Article							MESOTHELIAL CELLS; TGF-BETA; MESENCHYMAL TRANSITION; HISTONE MODIFICATIONS; DIALYSIS PATIENTS; GENE-EXPRESSION; RENAL FIBROSIS; IN-VITRO; METHYLGLYOXAL; MEMBRANE	Transforming growth factor-beta 1 (TGF-beta 1) is a major mediator of peritoneal fibrosis and reportedly affects expression of the H3K4 methyltransferase, SET7/9. SET7/9-induced H3K4 mono-methylation (H3K4me1) critically activates transcription of fibrosis-related genes. In this study, we examined the effect of SET7/9 inhibition on peritoneal fibrosis in mice and in human peritoneal mesothelial cells (HPMCs). We also examined SET7/9 expression in nonadherent cells isolated from the effluent of peritoneal dialysis (PD) patients. Murine peritoneal fibrosis was induced by intraperitoneal injection of methylglyoxal (MGO) into male C57/BL6 mice over 21 days. Sinefungin, a SET7/9 inhibitor, was administered subcutaneously just before MGO injection (10 mg/kg). SET7/9 expression was elevated in both MGO-injected mice and nonadherent cells isolated from the effluent of PD patients. SET7/9 expression was positively correlated with dialysate/plasma ratio of creatinine in PD patients. Sinefungin was shown immunohistochemically to suppress expression of mesenchymal cells and collagen deposition, accompanied by decreased H3K4me1 levels. Peritoneal equilibration tests showed that sinefungin attenuated the urea nitrogen transport rate from plasma and the glucose absorption rate from the dialysate. In vitro, sinefungin suppressed TGF-beta 1-induced expression of fibrotic markers and inhibited H3K4me1. These findings suggest that inhibiting the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis.	[Tamura, Ryo; Doi, Shigehiro; Nakashima, Ayumu; Sasaki, Kensuke; Maeda, Kazuya; Ueno, Toshinori; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan	Hiroshima University	Doi, S (corresponding author), Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan.	sdoi@hiroshima-u.ac.jp	Nakashima, Ayumu/N-9158-2017; Nakashima, Ayumu/CAF-0274-2022; Doi, Shigehiro/AAQ-2655-2020	Nakashima, Ayumu/0000-0002-7838-1494; Nakashima, Ayumu/0000-0002-7838-1494; Doi, Shigehiro/0000-0001-9420-4124; SASAKI, KENSUKE/0000-0001-5899-0885	Hiroshima University; Ryokufukai	Hiroshima University; Ryokufukai	This work was supported by Hiroshima University Grant-in-Aid for Exploratory Research and the grant from Ryokufukai.; This work was supported by the Hiroshima University Grant-in-Aid for Exploratory Research and the grant from Ryokufukai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera Abelardo, 2005, Curr Opin Investig Drugs, V6, P262; Border WA, 1997, KIDNEY INT, V51, P1388, DOI 10.1038/ki.1997.190; De Vriese AS, 2003, J AM SOC NEPHROL, V14, P2109, DOI 10.1681/ASN.V1482109; Devuyst O, 2010, J AM SOC NEPHROL, V21, P1077, DOI 10.1681/ASN.2009070694; Dhanak D, 2014, BIOCHEM BIOPH RES CO, V455, P58, DOI 10.1016/j.bbrc.2014.07.006; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Hirahara I, 2006, PERITON DIALYSIS INT, V26, P380; Hirahara I, 2009, NEPHROL DIAL TRANSPL, V24, P437, DOI 10.1093/ndt/gfn495; Hung Kuan-Yu, 2005, J Chin Med Assoc, V68, P401; Io K, 2015, PERITON DIALYSIS INT, V35, P246, DOI 10.3747/pdi.2013.00089; Irifuku T, 2016, KIDNEY INT, V89, P147, DOI 10.1038/ki.2015.291; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kiribayashi I, 2005, KIDNEY INT, V67, P1126, DOI 10.1111/j.1523-1755.2005.00179.x; Lapolla A, 2005, ANN NY ACAD SCI, V1043, P217, DOI 10.1196/annals.1333.027; Loureiro J, 2011, J AM SOC NEPHROL, V22, P1682, DOI 10.1681/ASN.2010111197; Maeda K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173706; Margetts PJ, 2002, J AM SOC NEPHROL, V13, P2787, DOI 10.1681/ASN.V13112787; Mendelssohn DC, 2003, BLOOD PURIFICAT, V21, P24, DOI 10.1159/000067853; Meng FW, 2015, J MED CHEM, V58, P8166, DOI 10.1021/acs.jmedchem.5b01154; Nagai T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160993; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Nakayama M, 2003, AM J NEPHROL, V23, P390, DOI 10.1159/000074065; Onishi A, 2014, AM J NEPHROL, V40, P381, DOI 10.1159/000368424; Ramasamy R, 2006, CELL, V124, P258, DOI 10.1016/j.cell.2006.01.002; Rossetto D, 2012, EPIGENETICS-US, V7, P1098, DOI 10.4161/epi.21975; Sasaki K, 2016, J AM SOC NEPHROL, V27, P203, DOI 10.1681/ASN.2014090850; Schilte MN, 2009, PERITON DIALYSIS INT, V29, P605; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; STYLIANOU E, 1990, KIDNEY INT, V37, P1563, DOI 10.1038/ki.1990.150; Sun GD, 2010, J AM SOC NEPHROL, V21, P2069, DOI 10.1681/ASN.2010060633; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; THORNALLEY PJ, 1988, BIOCHEM J, V254, P751, DOI 10.1042/bj2540751; Ueno T, 2013, KIDNEY INT, V84, P297, DOI 10.1038/ki.2013.81; Wakabayashi Y, 2011, J BIOL CHEM, V286, P35456, DOI 10.1074/jbc.M111.236794; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Weissmann F, 2003, BIOESSAYS, V25, P792, DOI 10.1002/bies.10314; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Witowski J, 2001, J AM SOC NEPHROL, V12, P2434, DOI 10.1681/ASN.V12112434; Wolffe AP, 1996, CELL, V84, P817, DOI 10.1016/S0092-8674(00)81059-4; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang AH, 2003, KIDNEY INT, V63, P1530, DOI 10.1046/j.1523-1755.2003.00861.x; Yang YY, 2015, INT J CLIN EXP PATHO, V8, P2746; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Yoshizawa H, 2015, GENE THER, V22, P333, DOI 10.1038/gt.2014.116; Zhou Q, 2016, KIDNEY INT, V90, P515, DOI 10.1016/j.kint.2016.03.040; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zofall M, 2007, J BIOL CHEM, V282, P14065, DOI 10.1074/jbc.M700292200	50	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196844	10.1371/journal.pone.0196844	http://dx.doi.org/10.1371/journal.pone.0196844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723250	Green Published, Green Submitted, gold			2022-12-26	WOS:000431305100074
J	Cheng, CW; Putaporntip, C; Jongwutiwes, S				Cheng, Chew Weng; Putaporntip, Chaturong; Jongwutiwes, Somchai			Polymorphism in merozoite surface protein-7E of Plasmodium vivax in Thailand: Natural selection related to protein secondary structure	PLOS ONE			English	Article							MALARIA PARASITE; GENETIC DIVERSITY; FALCIPARUM; INVASION; BINDING; FAMILY; POPULATION; EVOLUTION	Merozoite surface protein 7 (MSP-7) is a multigene family expressed during malaria blood-stage infection. MSP-7 forms complex with MSP-1 prior to merozoite egress from erythrocytes, and could affect merozoite invasion of erythrocytes. To characterize sequence variation in the orthologue in P. vivax (PvMSP-7), a gene member encoding PvMSP-7E was analyzed among 92 Thai isolates collected from 3 major endemic areas of Thailand (Northwest: Tak, North-east: Ubon Ratchathani, and South: Yala and Narathiwat provinces). In total, 52 distinct haplotypes were found to circulate in these areas. Although population structure based on this locus was observed between each endemic area, no genetic differentiation occurred between populations collected from different periods in the same endemic area, suggesting spatial but not temporal genetic variation. Sequence microhetero-geneity in both N- and C-terminal regions was predicted to display 4 and 6 alpha-helical domains, respectively. Signals of purifying selection were observed in alpha-helices II-X, suggesting structural or functional constraint in these domains. By contrast, alpha-helix-I spanning the putative signal peptide was under positive selection, in which amino acid substitutions could alter predicted CD4+ T helper cell epitopes. The central region of PvMSP-7E comprised the 5'-trimorphic and the 3'-dimorphic subregions. Positive selection was identified in the 3' dimorphic subregion of the central domain. A consensus of intrinsically unstructured or disordered protein was predicted to encompass the entire central domain that contained a number of putative B cell epitopes and putative protein binding regions. Evidences of intra-genic recombination were more common in the central region than the remainders of the gene. These results suggest that the extent of sequence variation, recombination events and selective pressures in the PvMSP-7E locus seem to be differentially affected by protein secondary structure.	[Cheng, Chew Weng; Putaporntip, Chaturong; Jongwutiwes, Somchai] Chulalongkorn Univ, Fac Med, Dept Parasitol, Mol Biol Malaria & Opportunist Parasites Res Unit, Bangkok, Thailand	Chulalongkorn University	Jongwutiwes, S (corresponding author), Chulalongkorn Univ, Fac Med, Dept Parasitol, Mol Biol Malaria & Opportunist Parasites Res Unit, Bangkok, Thailand.	jongwutiwes@gmail.com		Cheng, Chew Weng/0000-0002-2873-0828	Thai Government Research Budgets [GRB-APS-12593011, GBA-600093004]; Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University [RA60/011]; 100th Anniversary Chulalongkorn University Fund; 90th Anniversary Chulalongkorn University Fund (Ratchadapiseksompotch Endowment Fund)	Thai Government Research Budgets; Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University(Chulalongkorn University); 100th Anniversary Chulalongkorn University Fund; 90th Anniversary Chulalongkorn University Fund (Ratchadapiseksompotch Endowment Fund)	The Thai Government Research Budgets (GRB-APS-12593011 and GBA-600093004) to SJ and CP. Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University (grant no. RA60/011) to SJ, CP and CW. The 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship and the 90th Anniversary Chulalongkorn University Fund (Ratchadapiseksompotch Endowment Fund) to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird JK, 2013, CLIN MICROBIOL REV, V26, P36, DOI 10.1128/CMR.00074-12; Beeson JG, 2016, FEMS MICROBIOL REV, V40, P343, DOI 10.1093/femsre/fuw001; Benson G., 1999, NUCL ACIDS RES; Castillo AI, 2017, INFECT GENET EVOL, V50, P7, DOI 10.1016/j.meegid.2017.01.024; Cowman AF, 2017, CELL HOST MICROBE, V22, P232, DOI 10.1016/j.chom.2017.07.003; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; de Monerri NCS, 2011, INFECT IMMUN, V79, P1086, DOI 10.1128/IAI.00902-10; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forman-Kay JD, 2013, STRUCTURE, V21, P1492, DOI 10.1016/j.str.2013.08.001; Garzon-Ospina D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-495; Garzon-Ospina D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045962; Garzon-Ospina D, 2011, INFECT GENET EVOL, V11, P528, DOI 10.1016/j.meegid.2010.12.002; Garzon-Ospina D, 2010, MOL PHYLOGENET EVOL, V55, P399, DOI 10.1016/j.ympev.2010.02.017; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Hughes AL, 2008, ANN NY ACAD SCI, V1133, P162, DOI 10.1196/annals.1438.001; HUGHES MK, 1995, MOL BIOCHEM PARASIT, V71, P99, DOI 10.1016/0166-6851(95)00037-2; Jongwutiwes S, 2010, VACCINE, V28, P3112, DOI 10.1016/j.vaccine.2010.02.062; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kadekoppala M, 2010, INT J PARASITOL, V40, P1155, DOI 10.1016/j.ijpara.2010.04.008; Kadekoppala M, 2008, EUKARYOT CELL, V7, P2123, DOI 10.1128/EC.00274-08; Kauth CW, 2006, J BIOL CHEM, V281, P31517, DOI 10.1074/jbc.M604641200; Kosuwin R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110463; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin CS, 2016, J BIOL CHEM, V291, P7703, DOI 10.1074/jbc.M115.698282; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; Mello K, 2004, INFECT IMMUN, V72, P1010, DOI 10.1128/IAI.72.2.1010-1018.2004; NEI M, 1986, MOL BIOL EVOL, V3, P418; Oyarzn P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-52; Pachebat JA, 2007, MOL BIOCHEM PARASIT, V151, P59, DOI 10.1016/j.molbiopara.2006.10.006; Perrin AJ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0750-z; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Price RN, 2014, LANCET INFECT DIS, V14, P982, DOI 10.1016/S1473-3099(14)70855-2; Putaporntip C, 2002, P NATL ACAD SCI USA, V99, P16348, DOI 10.1073/pnas.252348999; Putaporntip C, 2010, GENE, V456, P24, DOI 10.1016/j.gene.2010.02.007; Putaporntip C, 2009, INFECT GENET EVOL, V9, P1295, DOI 10.1016/j.meegid.2009.07.005; Putaporntip C, 2009, J INFECT DIS, V199, P1143, DOI 10.1086/597414; Romphruk AV, 1999, EUR J IMMUNOGENET, V26, P129, DOI 10.1046/j.1365-2370.1999.00133.x; Stafford WHL, 1996, MOL BIOCHEM PARASIT, V80, P159, DOI 10.1016/0166-6851(96)02696-5; STENBERG PE, 1985, J CELL BIOL, V101, P880, DOI 10.1083/jcb.101.3.880; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tewari R, 2005, BLOOD, V105, P394, DOI 10.1182/blood-2004-06-2106; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Trucco C, 2001, MOL BIOCHEM PARASIT, V112, P91, DOI 10.1016/S0166-6851(00)00350-9; Wang S, 2016, NUCLEIC ACIDS RES, V44, pW430, DOI 10.1093/nar/gkw306; WHO, 2016, WORLD MAL REP 2016; Woehlbier U, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-77; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Yang YD, 2018, BRIEF BIOINFORM, V19, P482, DOI 10.1093/bib/bbw129	53	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196765	10.1371/journal.pone.0196765	http://dx.doi.org/10.1371/journal.pone.0196765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718980	Green Submitted, Green Published, gold			2022-12-26	WOS:000431281900080
J	Wang, QQ; Wang, K; Solorzano-Vargas, RS; Lin, PY; Walthers, CM; Thomas, AL; Martin, MG; Dunn, JCY				Wang, Qianqian; Wang, Ke; Solorzano-Vargas, R. Sergio; Lin, Po-Yu; Walthers, Christopher M.; Thomas, Anne-Laure; Martin, Martin G.; Dunn, James C. Y.			Bioengineered intestinal muscularis complexes with long-term spontaneous and periodic contractions	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; SMOOTH-MUSCLE-CELL; IN-VITRO; INTERSTITIAL-CELLS; STEM-CELLS; MECHANISMS; EXPRESSION; RABBIT; RHYTHMICITY; ACTIVATION	Although critical for studies of gut motility and intestinal regeneration, the in vitro culture of intestinal muscularis with peristaltic function remains a significant challenge. Periodic contractions of intestinal muscularis result from the coordinated activity of smooth muscle cells (SMC), the enteric nervous system (ENS), and interstitial cells of Cajal (ICC). Reproducing this activity requires the preservation of all these cells in one system. Here we report the first serum-free culture methodology that consistently maintains spontaneous and periodic contractions of murine and human intestinal muscularis cells for months. In this system, SMC expressed the mature marker myosin heavy chain, and multipolar/dipolar ICC, uniaxonal/multipolar neurons and glial cells were present. Furthermore, drugs affecting neural signals, ICC or SMC altered the contractions. Combining this method with scaffolds, contracting cell sheets were formed with organized architecture. With the addition of intestinal epithelial cells, this platform enabled up to 11 types of cells from mucosa, muscularis and serosa to coexist and epithelial cells were stretched by the contracting muscularis cells. The method constitutes a powerful tool for mechanistic studies of gut motility disorders and the functional regeneration of the engineered intestine.	[Wang, Qianqian; Lin, Po-Yu; Walthers, Christopher M.; Dunn, James C. Y.] Univ Calif Los Angeles, Dept Bioengn, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA 90095 USA; [Wang, Qianqian; Lin, Po-Yu; Thomas, Anne-Laure; Dunn, James C. Y.] Stanford Univ, Sch Med, Dept Surg, Div Pediat Surg, Stanford, CA 94305 USA; [Wang, Ke] Univ North Carolina Chapel Hill, Dept Comp Sci, Chapel Hill, NC USA; [Solorzano-Vargas, R. Sergio; Martin, Martin G.] Univ Calif Los Angeles, Dept Pediat, Div Gastroenterol & Nutr, Mattel Childrens Hosp, Los Angeles, CA 90024 USA; [Solorzano-Vargas, R. Sergio; Martin, Martin G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Dunn, James C. Y.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford University	Dunn, JCY (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA 90095 USA.; Dunn, JCY (corresponding author), Stanford Univ, Sch Med, Dept Surg, Div Pediat Surg, Stanford, CA 94305 USA.; Dunn, JCY (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	jdunn2@stanford.edu	Martín, María/HDL-9512-2022	Dunn, James/0000-0002-6826-7065; Thomas, Anne-Laure/0000-0003-0904-0941	National Institutes of Health (NIH) [R01 DK083119]; China Scholarship Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085535, R21DK111216, P30DK041301] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) grant R01 DK083119 (https://www.nih.gov/) (JCYD) and the China Scholarship Council (http://en.csc.edu.cn/) (QW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma YT, 2016, N-S ARCH PHARMACOL, V389, P63, DOI 10.1007/s00210-015-1177-3; Benabdallah H, 2008, PHARMACOL RES, V57, P132, DOI 10.1016/j.phrs.2008.01.002; Bercik P, 2000, GASTROENTEROLOGY, V119, P386; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Bitar KN, 2014, GASTROENTEROLOGY, V146, P1614, DOI 10.1053/j.gastro.2014.03.044; Blair PJ, 2014, J NEUROGASTROENTEROL, V20, P294, DOI 10.5056/jnm14060; Boesmans W, 2015, GLIA, V63, P229, DOI 10.1002/glia.22746; BOLTON TB, 1972, J PHYSIOL-LONDON, V220, P647, DOI 10.1113/jphysiol.1972.sp009728; Brittingham J, 1998, GASTROENTEROLOGY, V115, P605, DOI 10.1016/S0016-5085(98)70140-4; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; Chen S, 2014, NEUROPATH APPL NEURO, V40, P759, DOI 10.1111/nan.12103; Chen Y, 2013, SCI WORLD J, DOI 10.1155/2013/624342; Collins J, 2014, NEUROGASTROENT MOTIL, V26, P98, DOI 10.1111/nmo.12236; Cordero-Erausquin M, 2000, TRENDS PHARMACOL SCI, V21, P211, DOI 10.1016/S0165-6147(00)01489-9; Dunn JCY, 2008, NAT CLIN PRACT GASTR, V5, P366, DOI 10.1038/ncpgasthep1151; Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951; Frei E, 2009, AM J PHYSIOL-GASTR L, V297, pG834, DOI 10.1152/ajpgi.00095.2009; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; Gibbons SJ, 2003, NEUROGASTROENT MOTIL, V15, P643, DOI 10.1046/j.1350-1925.2003.00448.x; Gulbransen BD, 2009, GASTROENTEROLOGY, V136, P1349, DOI 10.1053/j.gastro.2008.12.058; Hao MM, 2009, J CELL MOL MED, V13, P1193, DOI 10.1111/j.1582-4934.2009.00813.x; HARA Y, 1986, J PHYSIOL-LONDON, V372, P501, DOI 10.1113/jphysiol.1986.sp016022; Hibberd TJ, 2018, AM J PHYSIOL-GASTR L, V314, pG53, DOI 10.1152/ajpgi.00234.2017; Huber A, 2012, J TISSUE ENG REGEN M, V6, P505, DOI 10.1002/term.451; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; JESSEN KR, 1983, BRAIN RES, V262, P17, DOI 10.1016/0006-8993(83)90466-3; JESSEN KR, 1980, NATURE, V286, P736, DOI 10.1038/286736a0; Khademhosseini A, 2016, NAT PROTOC, V11, P1775, DOI 10.1038/nprot.2016.123; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kobayashi M, 2015, BIOMATERIALS, V61, P75, DOI 10.1016/j.biomaterials.2015.05.023; Komuro T., 2012, ATLAS INTERSTITIAL C, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Kuwahara M, 2004, NEUROGASTROENT MOTIL, V16, P14, DOI 10.1111/j.1743-3150.2004.00468.x; Lahar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026898; Lei NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084651; MCGRATH JC, 1990, BRIT J PHARMACOL, V99, P77, DOI 10.1111/j.1476-5381.1990.tb14657.x; Moore-Olufemi SD, 2015, DIGEST DIS SCI, V60, P1206, DOI 10.1007/s10620-014-3439-1; Nakayama S, 2002, JPN J PHYSIOL, V52, P217, DOI 10.2170/jjphysiol.52.217; Nakayama S, 2007, J CELL MOL MED, V11, P958, DOI 10.1111/j.1582-4934.2007.00107.x; Orlando G, 2013, GUT, V62, P774, DOI 10.1136/gutjnl-2011-301111; Revaud J, 2015, CVPR IEEE C COMP VIS, DOI [10.1063/1.4905777, DOI 10.1063/1.4905777]; Rich A, 2003, AM J PHYSIOL-GASTR L, V284, pG313, DOI 10.1152/ajpgi.00093.2002; Rodriguez LV, 2006, P NATL ACAD SCI USA, V103, P12167, DOI 10.1073/pnas.0604850103; SANDERS KM, 1992, AM J PHYSIOL, V262, pG379, DOI 10.1152/ajpgi.1992.262.3.G379; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scirocco A, 2016, J CELL PHYSIOL, V231, P295, DOI 10.1002/jcp.25105; Shieh SJ, 2005, SURGERY, V137, P1, DOI 10.1016/j.surg.2004.04.002; Shyer AE, 2013, SCIENCE, V342, P212, DOI 10.1126/science.1238842; Sobue K, 1999, MOL CELL BIOCHEM, V190, P105, DOI 10.1023/A:1006941621170; Tsai JC, 1996, J BIOL CHEM, V271, P3667; Tsvilovskyy VV, 2009, GASTROENTEROLOGY, V137, P1415, DOI 10.1053/j.gastro.2009.06.046; Ueno T, 2004, J GASTROINTEST SURG, V8, P831, DOI 10.1016/j.gassur.2004.06.004; Walthers CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114850; Wieck MM, 2016, TISSUE ENG PT A, V22, P53, DOI [10.1089/ten.tea.2015.0120, 10.1089/ten.TEA.2015.0120]; Workman MJ, 2017, NAT MED, V23, P49, DOI 10.1038/nm.4233; Yanagida H, 2004, GASTROENTEROLOGY, V127, P1748, DOI 10.1053/j.gastro.2004.09.053; Yoshida A, 2012, J PEDIATR SURG, V47, P329, DOI 10.1016/j.jpedsurg.2011.11.027; Zakhem E, 2014, BIOMATERIALS, V35, P1882, DOI 10.1016/j.biomaterials.2013.11.049; Zhang QY, 2013, MOL BIOL REP, V40, P2969, DOI 10.1007/s11033-012-2368-3	58	7	7	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195315	10.1371/journal.pone.0195315	http://dx.doi.org/10.1371/journal.pone.0195315			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718926	gold, Green Published, Green Submitted			2022-12-26	WOS:000431281900016
J	Baker, A; Wyatt, D; Bocchetta, M; Li, J; Filipovic, A; Green, A; Peiffer, DS; Fuqua, S; Miele, L; Albain, KS; Osipo, C				Baker, Andrew; Wyatt, Debra; Bocchetta, Maurizio; Li, Jun; Filipovic, Aleksandra; Green, Andrew; Peiffer, Daniel S.; Fuqua, Suzanne; Miele, Lucio; Albain, Kathy S.; Osipo, Clodia			Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+breast cancer cell proliferation and stem cell survival	ONCOGENE			English	Article							BREAST-CANCER; TRASTUZUMAB RESISTANCE; TENSIN HOMOLOG; CHROMOSOME-10 PTEN; GENE-EXPRESSION; PI3K PATHWAY; CYCLIN D1; NOTCH; ACTIVATION; RECEPTOR	Trastuzumab targets the HER2 receptor on breast cancer cells to attenuate HER2-driven tumor growth. However, resistance to trastuzumab-based therapy remains a major clinical problem for women with HER2+ breast cancer. Breast cancer stem cells (BCSCs) are suggested to be responsible for drug resistance and tumor recurrence. Notch signaling has been shown to promote BCSC survival and self-renewal. Trastuzumab-resistant cells have increased Notch-1 expression. Notch signaling drives cell proliferation in vitro and is required for tumor recurrence in vivo. We demonstrate herein a mechanism by which Notch-1 is required for trastuzumab resistance by repressing PTEN expression to contribute to activation of ERK1/2 signaling. Furthermore, Notch-1-mediated inhibition of PTEN is necessary for BCSC survival in vitro and in vivo. Inhibition of MEK1/2-ERK1/2 signaling in trastuzumab-resistant breast cancer cells mimics effects of Notch-1 knockdown on bulk cell proliferation and BCSC survival. These findings suggest that Notch-1 contributes to trastuzumab resistance by repressing PTEN and this may lead to hyperactivation of ERK1/2 signaling. Furthermore, high Notch-1 and low PTEN mRNA expression may predict poorer overall survival in women with breast cancer. Notch-1 protein expression predicts poorer survival in women with HER2+ breast cancer. These results support a potential future clinical trial combining anti-Notch-1 and anti-MEK/ERK therapy for trastuzumab-resistant breast cancer.	[Baker, Andrew; Peiffer, Daniel S.] Loyola Univ Chicago, Stritch Sch Med, Integrated Cell Biol Program, Maywood, IL 60153 USA; [Wyatt, Debra; Bocchetta, Maurizio; Osipo, Clodia] Loyola Univ Chicago, Stritch Sch Med, Oncol Res Inst, Maywood, IL 60153 USA; [Bocchetta, Maurizio] Loyola Univ Chicago, Stritch Sch Med, Dept Pathol, Maywood, IL 60153 USA; [Li, Jun] Univ Notre Dame, Dept Appl & Computat Math & Stat, Notre Dame, IN 46556 USA; [Filipovic, Aleksandra] Imperial Coll London, London, England; [Green, Andrew] Univ Nottingham, Nottingham, England; [Peiffer, Daniel S.] Loyola Univ Chicago, Stritch Sch Med, MD PhD Program, Maywood, IL 60153 USA; [Fuqua, Suzanne] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA; [Miele, Lucio] Louisiana State Univ, Dept Genet, New Orleans, LA 70112 USA; [Miele, Lucio] Louisiana State Univ, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Albain, Kathy S.] Loyola Univ Chicago, Stritch Sch Med, Dept Med, Div Hematol Oncol, Maywood, IL 60153 USA; [Osipo, Clodia] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; University of Notre Dame; Imperial College London; University of Nottingham; Loyola University Chicago; Baylor College of Medicine; Louisiana State University System; Louisiana State University System; Loyola University Chicago; Loyola University Chicago	Osipo, C (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Oncol Res Inst, Maywood, IL 60153 USA.; Osipo, C (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA.	cosipo@luc.edu	Li, Jun/C-3269-2015; Green, Andrew/AAF-1991-2020	Li, Jun/0000-0003-4353-5761; Green, Andrew/0000-0002-0488-5913; Miele, Lucio/0000-0002-5853-7287; Osipo, Clodia/0000-0003-1979-8465	American Cancer Society; Breast Cancer Research Foundation	American Cancer Society(American Cancer Society); Breast Cancer Research Foundation	This work was supported by the American Cancer Society (RSG-11-181-01-TBE) awarded to Dr. Clodia Osipo, the Arthur J. Schmitt Fellowship to Dr. Andrew Baker, and in part by the Breast Cancer Research Foundation to Drs. Kathy Albain and Clodia Osipo. We thank Ianina Bognini for assistance during animal studies.	Adachi R, 2011, BIOCHEM BIOPH RES CO, V411, P804, DOI 10.1016/j.bbrc.2011.07.033; Baker AT, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00360; Baldacchino S, 2014, EPMA J, V5, DOI 10.1186/1878-5085-5-3; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bonnefoi Herve, 2007, Lancet Oncol, V8, P1071, DOI 10.1016/S1470-2045(07)70345-5; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Buzdar AU, 2005, J CLIN ONCOL, V23, P3676, DOI 10.1200/JCO.2005.07.032; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao YW, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0097-2; Chetram MA, 2012, J RECEPT SIG TRANSD, V32, P190, DOI 10.3109/10799893.2012.695798; Chu D, 2011, ANN ONCOL, V22, P2440, DOI 10.1093/annonc/mdq776; Chung JH, 2005, CANCER RES, V65, P8096, DOI 10.1158/0008-5472.CAN-05-1888; Chung JH, 2005, CANCER RES, V65, P4108, DOI 10.1158/0008-5472.CAN-05-0124; Chung JH, 2006, HUM MOL GENET, V15, P2553, DOI 10.1093/hmg/ddl177; Cohen B, 2010, BREAST CANCER RES TR, V123, P113, DOI 10.1007/s10549-009-0621-9; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; D'Angelo RC, 2015, MOL CANCER THER, V14, P779, DOI 10.1158/1535-7163.MCT-14-0228; Das S, 2015, J BIOL CHEM, V290, P21705, DOI 10.1074/jbc.M115.655563; Dave B, 2011, J CLIN ONCOL, V29, P166, DOI 10.1200/JCO.2009.27.7814; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Dittrich A, 2014, J MAMMARY GLAND BIOL, V19, P253, DOI 10.1007/s10911-014-9329-5; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Du C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-869; Ebbesen SH, 2016, P NATL ACAD SCI USA, V113, P3030, DOI 10.1073/pnas.1523693113; Ellis MJ, 2013, CANCER DISCOV, V3, P27, DOI 10.1158/2159-8290.CD-12-0462; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Feilotter HE, 1999, BRIT J CANCER, V79, P718, DOI 10.1038/sj.bjc.6690115; Gong C, 2011, J BIOL CHEM, V286, P19127, DOI 10.1074/jbc.M110.216887; Graziani I, 2008, CANCER RES, V68, P9678, DOI 10.1158/0008-5472.CAN-08-0969; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Katoh M, 2007, INT J ONCOL, V31, P461; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Kopan R., 2012, COLD SPRING HARB PER, V4, P1; Loibl S, 2016, CLIN CANCER RES, V22, P2675, DOI 10.1158/1078-0432.CCR-15-0965; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Mao J, 2013, INT J BIOCHEM CELL B, V45, P1064, DOI 10.1016/j.biocel.2013.02.022; McDermott MSJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-157; Meurette O, 2009, CANCER RES, V69, P5015, DOI 10.1158/0008-5472.CAN-08-3478; Mittal S, 2014, MOL CANCER THER, V13, P3198, DOI 10.1158/1535-7163.MCT-14-0280; Mittal S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-128; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nunes J, 2016, ONCOTARGET, V7, P27599, DOI 10.18632/oncotarget.8504; O'Regan RM, 1998, JNCI-J NATL CANCER I, V90, P1552, DOI 10.1093/jnci/90.20.1552; Osipo C, 2008, ONCOGENE, V27, P5019, DOI 10.1038/onc.2008.149; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pandya K, 2011, BRIT J CANCER, V105, P796, DOI 10.1038/bjc.2011.321; Pandya K, 2016, CLIN CANCER RES, V22, P175, DOI 10.1158/1078-0432.CCR-15-0179; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Persson LM, 2010, J VIROL, V84, P1334, DOI 10.1128/JVI.01301-09; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stern HM, 2015, CLIN CANCER RES, V21, P2065, DOI 10.1158/1078-0432.CCR-14-2993; Thery JC, 2014, EUR J CANCER, V50, P892, DOI 10.1016/j.ejca.2014.01.003; Untch M, 2011, J CLIN ONCOL, V29, P3351, DOI 10.1200/JCO.2010.31.4930; Valabrega G, 2007, ANN ONCOL, V18, P977, DOI 10.1093/annonc/mdl475; WACHSMAN W, 1987, SCIENCE, V235, P674, DOI 10.1126/science.3027894; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Yakes FM, 2002, CANCER RES, V62, P4132; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Yun J, 2015, J CELL PHYSIOL, V230, P3115, DOI 10.1002/jcp.25052	73	60	66	0	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 16	2018	37	33					4489	4504		10.1038/s41388-018-0251-y	http://dx.doi.org/10.1038/s41388-018-0251-y			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GQ5OV	29743588	Green Submitted, Green Accepted			2022-12-26	WOS:000441736700001
J	Guo, H; Zhao, LM; Shi, BH; Bao, JY; Zheng, DX; Zhou, BG; Shi, J				Guo, Hui; Zhao, Lianmei; Shi, Bianhua; Bao, Jiayu; Zheng, Dexian; Zhou, Baoguo; Shi, Juan			GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90	ONCOGENE			English	Article							LONG NONCODING RNAS; 3' UNTRANSLATED REGIONS; HEAT-SHOCK PROTEINS; B-KINASE IKK; HISTONE METHYLTRANSFERASE; TRANSLATIONAL CONTROL; EXPRESSION; CELLS; HEAT-SHOCK-PROTEIN-90; PROLIFERATION	Recently, long noncoding RNAs (lncRNAs) have been reported to play a pivotal role in the occurrence and progression of cancer because of their unique characteristics and have therefore become an active area of cancer research. The object of this study was to screen lncRNAs that are dysregulated in gastric cancer and to investigate their potential functions. Global expression of lncRNAs in gastric cancer and adjacent normal tissues of patients was profiled using a microarray assay. We identified an lncRNA (GALNT5 uaRNA, UTR-associated RNA) that is derived from the 3'-UTR of GALNT5. This lncRNA was transcribed independently of the coding region of GALNT5 and was determined to be markedly upregulated in human gastric carcinoma relative to their corresponding normal gastric tissues by quantitative RT-PCR (qRT-PCR) analysis of tissues from 122 gastric carcinoma patients. The expression of GALNT5 uaRNA was significantly correlated with the TNM stage and with lymph node metastasis. Further results demonstrated that GALNT5 uaRNA facilitated the proliferation and migration of gastric cancer cells in vitro and promoted tumor growth in a mouse model of human gastric cancer. Our results also indicated that GALNT5 uaRNA might function in gastric cancer by binding with HSP90. Further studies indicated that the 5'-end stem-loop motifs of GALNT5 uaRNA promoted the binding of HSP90 and its client proteins, and thus inhibited ubiquitination of the clients. These results expanded our understanding of GALNT5 uaRNA as a new avenue for therapeutic intervention against gastric cancer progression.	[Guo, Hui; Zhao, Lianmei; Shi, Bianhua; Bao, Jiayu; Zheng, Dexian; Shi, Juan] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China; [Guo, Hui; Zhao, Lianmei; Shi, Bianhua; Bao, Jiayu; Zheng, Dexian; Shi, Juan] Peking Union Med Coll, Beijing 100005, Peoples R China; [Zhao, Lianmei] Hebei Med Univ, Hosp 4, Res Ctr, Shijiazhuang 050011, Hebei, Peoples R China; [Zhou, Baoguo] Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Harbin 150001, Heilongjiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Hebei Medical University; Harbin Medical University	Shi, J (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China.; Shi, J (corresponding author), Peking Union Med Coll, Beijing 100005, Peoples R China.; Zhou, BG (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Harbin 150001, Heilongjiang, Peoples R China.	zhoubaoguo@msn.com; shijuantt@163.com		Zheng, Dexian/0000-0003-3966-1212; bao, jiayu/0000-0001-9476-3225; Guo, Hui/0000-0003-3901-6336	Natural Science Foundation of China [81572755, 81372200]; CAMS Initiative for Innovative Medicine (CAMS-I2M) [2016-I2M-1-001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Initiative for Innovative Medicine (CAMS-I2M)	This work was partially supported by the Natural Science Foundation of China (Grant No. 81572755, 81372200 to J. Shi), CAMS Initiative for Innovative Medicine (CAMS-I2M Grant No. 2016-I2M-1-001to J. Shi).	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bishop SC, 2007, CURR CANCER DRUG TAR, V7, P369, DOI 10.2174/156800907780809778; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Cao JN, 2014, BIOL PROCED ONLINE, V16, DOI 10.1186/1480-9222-16-11; Cao WJ, 2013, WORLD J GASTROENTERO, V19, P3658, DOI 10.3748/wjg.v19.i23.3658; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Frith MC, 2005, EUR J HUM GENET, V13, P894, DOI 10.1038/sj.ejhg.5201459; Furuno M, 2006, PLOS GENET, V2, P537, DOI 10.1371/journal.pgen.0020037; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hamm CA, 2015, PHARMACOL THERAPEUT, V151, P72, DOI 10.1016/j.pharmthera.2015.03.003; He H, 2014, BRIT J CANCER, V110, P2021, DOI 10.1038/bjc.2014.93; Khurana N, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00100; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Li H, 2014, ONCOTARGET, V5, P2318, DOI 10.18632/oncotarget.1913; Lianos GD, 2015, CANCER LETT, V360, P114, DOI 10.1016/j.canlet.2015.02.026; Liu XF, 2012, EMBO J, V31, P4415, DOI 10.1038/emboj.2012.292; Matoulkova E, 2012, RNA BIOL, V9, P563, DOI 10.4161/rna.20231; Mayer MP, 2015, MOL CELL, V58, P8, DOI 10.1016/j.molcel.2015.02.022; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Mercer TR, 2010, GENOME RES, V20, P1639, DOI 10.1101/gr.112128.110; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Rodrigues TC, 2014, FUTURE ONCOL, V10, P2449, DOI 10.2217/fon.14.149; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stowell SR, 2015, ANNU REV PATHOL-MECH, V10, P473, DOI 10.1146/annurev-pathol-012414-040438; Sun M, 2016, CANCER RES, V76, P6299, DOI 10.1158/0008-5472.CAN-16-0356; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Vahid S, 2017, RECENT PAT ANTI-CANC, V12, P35, DOI 10.2174/1574892811666161102125252; Zhao L, 2016, ONCOGENE, V35, P5770, DOI 10.1038/onc.2016.110; Zhou CC, 2016, HEPATOLOGY, V63, P850, DOI 10.1002/hep.28393	40	25	25	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 16	2018	37	33					4505	4517		10.1038/s41388-018-0266-4	http://dx.doi.org/10.1038/s41388-018-0266-4			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GQ5OV	29743591				2022-12-26	WOS:000441736700002
J	Ahirwar, DK; Nasser, MW; Ouseph, MM; Elbaz, M; Cuitino, MC; Kladney, RD; Varikuti, S; Kaul, K; Satoskar, AR; Ramaswamy, B; Zhang, XL; Ostrowski, MC; Leone, G; Ganju, RK				Ahirwar, Dinesh K.; Nasser, Mohd W.; Ouseph, Madhu M.; Elbaz, Mohamad; Cuitino, Maria C.; Kladney, Raleigh D.; Varikuti, Sanjay; Kaul, Kirti; Satoskar, Abhay R.; Ramaswamy, Bhuvaneswari; Zhang, Xiaoli; Ostrowski, Michael C.; Leone, Gustavo; Ganju, Ramesh K.			Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation	ONCOGENE			English	Article							ENDOTHELIAL PROGENITOR CELLS; TIGHT JUNCTIONS; UP-REGULATION; ANGIOGENESIS; GROWTH; EXPRESSION; ADHERENS	The chemokine CXCL12 has been shown to regulate breast tumor growth, however, its mechanism in initiating distant metastasis is not well understood. Here, we generated a novel conditional allele of Cxcl12 in mice and used a fibroblast-specific Cre transgene along with various mammary tumor models to evaluate CXCL12 function in the breast cancer metastasis. Ablation of CXCL12 in stromal fibroblasts of mice significantly delayed the time to tumor onset and inhibited distant metastasis in different mouse models. Elucidation of mechanisms using in vitro and in vivo model systems revealed that CXCL12 enhances tumor cell intravasation by increasing vascular permeability and expansion of a leaky tumor vasculature. Furthermore, our studies revealed CXCL12 enhances permeability by recruiting endothelial precursor cells and decreasing endothelial tight junction and adherence junction proteins. High expression of stromal CXCL12 in large cohort of breast cancer patients was directly correlated to blood vessel density and inversely correlated to recurrence and overall patient survival. In addition, our analysis revealed that stromal CXCL12 levels in combination with number of CD31+ blood vessels confers poorer patient survival compared to individual protein level. However, no correlation was observed between epithelial CXCL12 and patient survival or blood vessel density. Our findings describe the novel interactions between fibroblasts-derived CXCL12 and endothelial cells in facilitating tumor cell intrvasation, leading to distant metastasis. Overall, our studies indicate that cross-talk between fibroblast-derived CXCL12 and endothelial cells could be used as novel biomarker and strategy for developing tumor microenvironment based therapies against aggressive and metastatic breast cancer.	[Ahirwar, Dinesh K.; Nasser, Mohd W.; Elbaz, Mohamad; Varikuti, Sanjay; Kaul, Kirti; Satoskar, Abhay R.; Ganju, Ramesh K.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Ouseph, Madhu M.; Cuitino, Maria C.; Kladney, Raleigh D.; Ostrowski, Michael C.; Leone, Gustavo] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Kladney, Raleigh D.; Ramaswamy, Bhuvaneswari; Ostrowski, Michael C.; Leone, Gustavo; Ganju, Ramesh K.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Ramaswamy, Bhuvaneswari] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Zhang, Xiaoli] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ganju, RK (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.; Leone, G (corresponding author), Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA.; Leone, G; Ganju, RK (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA.	gustavo.leone@osumc.edu; ramesh.ganju@osumc.edu	Nasser, Mohd/Y-3355-2019; Satoskar, Abhay/AAB-7748-2019; Ahirwar, Dinesh Kumar/CAG-3809-2022; Ostrowski, Michael C/H-3108-2011; Ouseph, Madhu/B-8940-2009	Ouseph, Madhu/0000-0002-3422-1675; Ahirwar, Dinesh/0000-0002-0518-7156	Pelotonia Idea award; Department of Defense level II breakthrough awards; NIH R01 grants [CA109527, CA153490]; Pelotonia Postdoctoral award; NATIONAL CANCER INSTITUTE [R01CA153490, R01CA109527, P01CA097189] Funding Source: NIH RePORTER	Pelotonia Idea award; Department of Defense level II breakthrough awards; NIH R01 grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pelotonia Postdoctoral award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are thankful to Reham S. Shehab, Sanjit Roy, Chan Fu, Mohamed Adel, and Nitika Agarwal for technical assistance. This work is supported in part by Pelotonia Idea award, Department of Defense level II breakthrough awards, and NIH R01 grants (CA109527 and CA153490) to RKG. DKA was recipient of Pelotonia Postdoctoral award.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Egeblad M, 2008, DIS MODEL MECH, V1, P155, DOI 10.1242/dmm.000596; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hillmer RE, 2015, INT J DEV BIOL, V59, P205, DOI 10.1387/ijdb.140348mj; Ivins S, 2015, DEV CELL, V33, P455, DOI 10.1016/j.devcel.2015.03.026; Li BY, 2015, J INTERF CYTOK RES, V35, P23, DOI 10.1089/jir.2014.0004; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Martins-Green M, 2008, METHOD ENZYMOL, V443, P137, DOI 10.1016/S0076-6879(08)02008-9; McLean AC, 2012, JOVE-J VIS EXP, DOI 10.3791/4389; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nasser MW, 2015, CANCER RES, V75, P974, DOI 10.1158/0008-5472.CAN-14-2161; Nasser MW, 2012, CANCER RES, V72, P604, DOI 10.1158/0008-5472.CAN-11-0669; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Punglia RS, 2007, NEW ENGL J MED, V356, P2399, DOI 10.1056/NEJMra065241; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Smolkova B, 2016, TRANSL ONCOL, V9, P184, DOI 10.1016/j.tranon.2016.03.004; SOULE HD, 1986, IN VITRO CELL DEV B, V22, P6, DOI 10.1007/BF02623435; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tan J, 2014, ONCOGENE, V33, P4050, DOI 10.1038/onc.2013.434; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Xu X, 2013, CELLS TISSUES ORGANS, V197, P103, DOI 10.1159/000342921; Yu PF, 2017, ONCOGENE, V36, P840, DOI 10.1038/onc.2016.252	36	68	76	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 9	2018	37	32					4428	4442		10.1038/s41388-018-0263-7	http://dx.doi.org/10.1038/s41388-018-0263-7			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP8FA	29720724	Green Accepted			2022-12-26	WOS:000441144300007
J	Tang, QY; Chakraborty, S; Xu, GZ				Tang, Qingyu; Chakraborty, Sayan; Xu, Guozhou			Mechanism of vaccinia viral protein B14-mediated inhibition of IB kinase beta activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular docking; autophosphorylation; protein kinase; virus; inhibition mechanism; B14; IKK; protein kinase; trans autophosphorylation; vaccinia virus	NF-KAPPA-B; IKK-BETA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DOCKING; TRANSCRIPTION; SERVER; CLUSPRO; COMPLEX; FRODOCK	Activation of IB kinase (IKK) is a central event in the NF-B-mediated canonical pro-inflammatory pathway. Numerous studies have reported that oligomerization-mediated trans autophosphorylation of IKK is indispensable for its phosphorylation, leading to its activation and IKK-mediated phosphorylation of substrates such as IB proteins. Moreover, IKK's interaction with the NF-B essential modifier (NEMO) is necessary for IKK activation. Interestingly, some viruses encode virulence factors that target IKK to inhibit NF-B-mediated antiviral immune responses. One of these factors is the vaccinia viral protein B14, which directly interacts with and inhibits IKK. Here we mapped the interaction interface on the B14 and IKK proteins. We observed that B14 binds to the junction of the kinase domain (KD) and scaffold and dimerization domain (SDD) of IKK. Molecular docking analyses identified key interface residues in both IKK and B14 that were further confirmed by mutational studies to promote binding of the two proteins. During trans autophosphorylation of protein kinases in the IKK complex, the activation segments of neighboring kinases need to transiently interact with each other's active sites, and we found that the B14-IKK interaction sterically hinders direct contact between the kinase domains of IKK in the IKK complex, containing IKK, IKK, and NEMO in human cells. We conclude that binding of B14 to IKK prevents IKK trans autophosphorylation and activation, thereby inhibiting NF-B signaling. Our study provides critical structural and mechanistic information for the design of potential therapeutic agents to target IKK activation for the management of inflammatory disorders.	[Tang, Qingyu; Chakraborty, Sayan; Xu, Guozhou] North Carolina State Univ, Coll Agr & Life Sci, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Xu, GZ (corresponding author), North Carolina State Univ, Coll Agr & Life Sci, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.	gxu3@ncsu.edu	Chakraborty, Sayan/AAC-4933-2021; Tang, Qingyu/W-4530-2018	Tang, Qingyu/0000-0002-5554-6540; Chakraborty, Sayan/0000-0002-2580-5097	National Institutes of Health [5R01AI118769]; North Carolina State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant 5R01AI118769 and new faculty startup funds from North Carolina State University (to G. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; Hauenstein AV, 2017, J MOL BIOL, V429, P3793, DOI 10.1016/j.jmb.2017.10.026; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hinz M, 2012, IMMUNOL REV, V246, P59, DOI 10.1111/j.1600-065X.2012.01102.x; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Huxford T, 2011, CURR TOP MICROBIOL, V349, P1, DOI 10.1007/82_2010_99; Garzon JI, 2009, BIOINFORMATICS, V25, P2544, DOI 10.1093/bioinformatics/btp447; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Li XH, 2001, J BIOL CHEM, V276, P4494, DOI 10.1074/jbc.M008353200; Liu SP, 2013, J BIOL CHEM, V288, P22758, DOI 10.1074/jbc.M113.482596; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Miller BS, 2001, J BIOL CHEM, V276, P36320, DOI 10.1074/jbc.M104051200; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Polley S, 2016, CELL REP, V17, P1907, DOI 10.1016/j.celrep.2016.10.067; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Ramirez-Aportela E, 2016, BIOINFORMATICS, V32, P2386, DOI 10.1093/bioinformatics/btw141; Rudolph D, 2000, GENE DEV, V14, P854; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Tang ED, 2003, J BIOL CHEM, V278, P38566, DOI 10.1074/jbc.M304374200; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhang JZ, 2014, BIOCHEM J, V461, P531, DOI 10.1042/BJ20140444	34	12	15	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10344	10352		10.1074/jbc.RA118.002817	http://dx.doi.org/10.1074/jbc.RA118.002817			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29748387	Green Published, hybrid			2022-12-26	WOS:000437096700032
J	Jiang, B; Zhao, WT; Shi, MG; Zhang, J; Chen, A; Ma, HH; Suleman, M; Lin, FR; Zhou, L; Wang, JY; Zhang, Y; Liu, MJ; Wen, SX; Ouyang, C; Wang, HH; Huang, XM; Zhou, HM; Li, QX				Jiang, Bin; Zhao, Wentao; Shi, Minggang; Zhang, Jia; Chen, Ai; Ma, Huanhuan; Suleman, Muhammad; Lin, Furong; Zhou, Lin; Wang, Jinyang; Zhang, Yan; Liu, Mengjue; Wen, Shixiong; Ouyang, Cong; Wang, Huihui; Huang, Xiumin; Zhou, Huamin; Li, Qinxi			IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p53; hypoxia-inducible factor (HIF); brain tumor; microRNA (miRNA); cell metabolism; IDH1 mutant	ONCOMETABOLITE 2-HYDROXYGLUTARATE; MUTATIONS; LEUKEMIA; ASTROCYTOMAS; RESTORATION; SUFFICIENT; INHIBITOR; MICRORNAS; SURVIVAL; PATHWAY	Resistance to apoptosis and uncontrolled proliferation are two hallmarks of cancer cells. p53 is crucial for apoptosis triggered by a broad range of stresses and a well-known gatekeeper for neoplastic transformation. Here we show that oncogenic IDH1 R132H/R132Q mutants robustly inhibit p53 expression and such an effect is attributed to 2-HG production. Mechanistically, 2-hydroxyglutarate (2-HG) stabilizes hypoxia-inducible factor-2, which in turn activates the expression of miR-380-5p, a characterized microRNA against p53 expression. Rescue expression of p53 can inhibit the proliferation rate and impair the resistance of apoptosis induced by doxorubicin in IDH1 R132Q mouse embryonic fibroblast cells. Furthermore, p53 protein levels correlates negatively with IDH1 R132H levels in human glioma samples. Our results thus shed a new light on how p53 is down-regulated by 2-HG and suggests that impairment of p53-mediated apoptosis contributes to the tumorigenesis driven by IDH1 mutants.	[Jiang, Bin; Zhao, Wentao; Zhang, Jia; Chen, Ai; Ma, Huanhuan; Suleman, Muhammad; Lin, Furong; Zhou, Lin; Wang, Jinyang; Zhang, Yan; Liu, Mengjue; Wen, Shixiong; Ouyang, Cong; Wang, Huihui; Zhou, Huamin; Li, Qinxi] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China; [Shi, Minggang] Huanhu Hosp, Dept Neurosurg, 6 Jizhao Rd, Tianjin 30050, Peoples R China; [Huang, Xiumin] Xiamen Univ, Zhongshan Hosp, Dept Gynecol & Obstet, Xiamen 361004, Peoples R China	Xiamen University; Xiamen University	Zhou, HM; Li, QX (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China.; Huang, XM (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Gynecol & Obstet, Xiamen 361004, Peoples R China.	huangxmxm@163.com; huaminzhou@xmu.edu.cn; liqinxi@xmu.edu.cn	wang, huimin/HDM-8421-2022; Suleman, Muhammad/AAD-6761-2022; wang, hui/GRS-4730-2022; Ma, Huan-Huan/G-8768-2017	Zhao, Wentao/0000-0003-4787-5245; Ma, Huan-Huan/0000-0001-8029-6814; Chen, Ai/0000-0003-3481-999X; Suleman, Muhammad/0000-0003-2914-1862; Zhou, Lin/0000-0002-1958-5286	National Natural Science Foundation of China [81372702, 81402285, 31701252]; National Science Foundation of China [J1310027]; State Key Laboratory of Cellular Stress Biology, Xiamen University [SKLCSB2018KF007]; Postdoctoral Science Foundation of China [2017M622071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Cellular Stress Biology, Xiamen University; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China Grants 81372702, 81402285, and 31701252, National Science Foundation of China for Fostering Talents in Basic Research Grant J1310027, the Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University Grant SKLCSB2018KF007, and Postdoctoral Science Foundation of China Grant 2017M622071. The authors declare that they have no conflicts of interest with the contents of this article.	Abbas S, 2010, BLOOD, V116, P2122, DOI 10.1182/blood-2009-11-250878; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; De Carli E, 2009, NEW ENGL J MED, V360, P2248, DOI 10.1056/NEJMc090593; Dubbink HJ, 2009, NEUROLOGY, V73, P1792, DOI 10.1212/WNL.0b013e3181c34ace; Ducray F, 2009, NEW ENGL J MED, V360, P2248; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gaal J, 2010, J CLIN ENDOCR METAB, V95, P1274, DOI 10.1210/jc.2009-2170; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Inoue S, 2016, CANCER CELL, V30, P337, DOI 10.1016/j.ccell.2016.05.018; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Li CA, 1997, NUCLEIC ACIDS RES, V25, P4165, DOI 10.1093/nar/25.20.4165; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Swarbrick A, 2010, NAT MED, V16, P1134, DOI 10.1038/nm.2227; Tian S, 2010, BIOCHEM BIOPH RES CO, V396, P435, DOI 10.1016/j.bbrc.2010.04.112; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	46	17	18	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9747	9758		10.1074/jbc.RA117.001385	http://dx.doi.org/10.1074/jbc.RA117.001385			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29743236	Green Published, hybrid			2022-12-26	WOS:000436102300019
J	Turcato, AM; Godi, M; Giardini, M; Arcolin, I; Nardone, A; Giordano, A; Schieppati, M				Turcato, Anna Maria; Godi, Marco; Giardini, Marica; Arcolin, Ilaria; Nardone, Antonio; Giordano, Andrea; Schieppati, Marco			Abnormal gait pattern emerges during curved trajectories in high-functioning Parkinsonian patients walking in line at normal speed	PLOS ONE			English	Article							DISEASE RATING-SCALE; TEST-RETEST RELIABILITY; GROUND REACTION FORCES; OLDER-ADULTS; STRIDE LENGTH; POSTURAL INSTABILITY; CADENCE RELATIONSHIP; HUNTINGTONS-DISEASE; TEMPORAL STABILITY; CONTROL MECHANISMS	Background Several patients with Parkinson's disease (PD) can walk normally along straight trajectories, and impairment in their stride length and cadence may not be easily discernible. Do obvious abnormalities occur in these high-functioning patients when more challenging trajectories are travelled, such as circular paths, which normally implicate a graded modulation in the duration of the interlimb gait cycle phases? Methods We compared a cohort of well-treated mildly to moderately affected PD patients to a group of age-matched healthy subjects (HS), by deliberately including HS spontaneously walking at the same speed of the patients with PD. All participants performed, in random order: linear and circular walking (clockwise and counter-clockwise) at self-selected speed. By means of pressure-sensitive insoles, we recorded walking speed, cadence, duration of single support, double support, swing phase, and stride time. Stride length-cadence relationships were built for linear and curved walking. Stride-to-stride variability of temporal gait parameters was also estimated. Results Walking speed, cadence or stride length were not different between PD and HS during linear walking. Speed, cadence and stride length diminished during curved walking in both groups, stride length more in PD than HS. In PD compared to HS, the stride length-cadence relationship was altered during curved walking. Duration of the double-support phase was also increased during curved walking, as was variability of the single support, swing phase and double support phase. Conclusion The spatio-temporal gait pattern and variability are significantly modified in well-treated, high-functioning patients with PD walking along circular trajectories, even when they exhibit no changes in speed in straight-line walking. The increased variability of the gait phases during curved walking is an identifying characteristic of PD. We discuss our findings in term of interplay between control of balance and of locomotor progression: the former is challenged by curved trajectories even in high-functioning patients, while the latter may not be critically affected.	[Turcato, Anna Maria; Godi, Marco; Giardini, Marica; Arcolin, Ilaria] IRCCS, Inst Veruno, ICS Maugeri SPA SB, Div Phys Med & Rehabil, Novara, Italy; [Nardone, Antonio] IRCCS, Inst Pavia, Ctr Studi Att Motorie, ICS Maugeri SPA SB, Pavia, Italy; [Nardone, Antonio] IRCCS, ICS Maugeri SPA SB, Inst Pavia, Neurorehabil Unit, Pavia, Italy; [Nardone, Antonio] IRCCS, ICS Maugeri SPA SB, Inst Pavia, Spinal Unit, Pavia, Italy; [Nardone, Antonio] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy; [Giordano, Andrea] IRCCS, Unit Bioengn, Inst Veruno, ICS Maugeri SPA SB, Novara, Italy; [Schieppati, Marco] LUNEX Univ, Int Univ Hlth Exercise & Sports, Dept Exercise & Sports Sci, Differdange, Luxembourg	Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS	Godi, M (corresponding author), IRCCS, Inst Veruno, ICS Maugeri SPA SB, Div Phys Med & Rehabil, Novara, Italy.	marco.godi@icsmaugeri.it	Nardone, Antonio/J-8733-2016; Godi, Marco/J-8148-2016; Giordano, Andrea/E-8442-2019; Giardini, Marica/E-8412-2019; Arcolin, Ilaria/AAB-9447-2020; Godi, Marco/K-9776-2019; Schieppati, Marco/K-5171-2016; Nardone, Antonio/ABH-1196-2020; Schieppati, Marco/O-2138-2019; Giardini, Marica/U-5695-2019	Nardone, Antonio/0000-0002-9547-1774; Godi, Marco/0000-0002-8501-6524; Giordano, Andrea/0000-0002-6051-0067; Giardini, Marica/0000-0002-8910-2649; Arcolin, Ilaria/0000-0001-5948-2428; Godi, Marco/0000-0002-8501-6524; Schieppati, Marco/0000-0002-0630-0819; Nardone, Antonio/0000-0002-9547-1774; Schieppati, Marco/0000-0002-0630-0819; Giardini, Marica/0000-0002-8910-2649; Turcato, Anna Maria/0000-0003-3371-3245	Italian Ministry of University and Research [2009 JMMYFZ, 2010R277FT]; Italian Ministry of Health [GR-2009-1471033]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy)	The study design, data collection and analysis of this work was supported by: "PRIN" grants (2009 JMMYFZ and 2010R277FT) from the Italian Ministry of University and Research (http://www.miur.gov.it/); and "Giovani Ricercatori" grant (GR-2009-1471033) from the Italian Ministry of Health (https://moh-it.pure.elsevier.com/en/).	Akram S, 2013, CAN J NEUROL SCI, V40, P520, DOI 10.1017/S0317167100014608; Almeida QJ, 2007, MOVEMENT DISORD, V22, P1735, DOI 10.1002/mds.21603; Ambati VNP, 2016, EXP BRAIN RES, V234, P2957, DOI 10.1007/s00221-016-4698-1; Arnadottir SA, 2000, PHYS THER, V80, P17, DOI 10.1093/ptj/80.1.17; Baltadjieva R, 2006, EUR J NEUROSCI, V24, P1815, DOI 10.1111/j.1460-9568.2006.05033.x; Banerjee Amitav, 2009, Ind Psychiatry J, V18, P127, DOI 10.4103/0972-6748.62274; Barrett MJ, 2011, J NEUROL NEUROSUR PS, V82, P1122, DOI 10.1136/jnnp.2010.209783; Bayle N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152469; Bejarano NC, 2017, ANN BIOMED ENG, V45, P1204, DOI 10.1007/s10439-017-1802-z; Bengevoord A, 2016, GAIT POSTURE, V43, P54, DOI 10.1016/j.gaitpost.2015.10.021; BLIN O, 1990, J NEUROL SCI, V98, P91, DOI 10.1016/0022-510X(90)90184-O; Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; Brach Jennifer S, 2005, J Neuroeng Rehabil, V2, P21, DOI 10.1186/1743-0003-2-21; BRENIERE Y, 1986, J BIOMECH, V19, P1035, DOI 10.1016/0021-9290(86)90120-X; Bryant MS, 2016, ACTA NEUROL SCAND, V134, P83, DOI 10.1111/ane.12505; Carpinella I, 2007, IEEE T NEUR SYS REH, V15, P543, DOI 10.1109/TNSRE.2007.908933; Chastan N, 2009, BRAIN, V132, P172, DOI 10.1093/brain/awn294; Chastan N, 2009, MOVEMENT DISORD, V24, P188, DOI 10.1002/mds.22269; Cheng FY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093572; Cheung R., 2016, THESIS; Chou PY, 2013, TZU CHI MED J, V25, P200, DOI 10.1016/j.tcmj.2013.06.003; Christofoletti G, 2016, HUM MOVEMENT SCI, V49, P308, DOI 10.1016/j.humov.2016.08.007; Cole MH, 2010, MOVEMENT DISORD, V25, P2369, DOI 10.1002/mds.23292; Courtine G, 2006, EXP BRAIN RES, V170, P320, DOI 10.1007/s00221-005-0215-7; Courtine G, 2004, J NEUROPHYSIOL, V91, P1524, DOI 10.1152/jn.00817.2003; Courtine G, 2003, EUR J NEUROSCI, V18, P191, DOI 10.1046/j.1460-9568.2003.02737.x; Courtine G, 2003, EUR J NEUROSCI, V18, P177, DOI 10.1046/j.1460-9568.2003.02736.x; Crenna P, 2007, GAIT POSTURE, V26, P172, DOI 10.1016/j.gaitpost.2007.04.010; Danoudis M, 2016, GAIT POSTURE, V48, P47, DOI 10.1016/j.gaitpost.2016.04.026; Danoudis M, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0161-8; Fortaleza ACD, 2017, GAIT POSTURE, V56, P76, DOI 10.1016/j.gaitpost.2017.05.006; Di Giulio I, 2016, J NEUROPHYSIOL, V116, P493, DOI 10.1152/jn.00996.2015; Dibilio V, 2016, J NEURAL TRANSM, V123, P495, DOI 10.1007/s00702-016-1516-7; Dillmann U, 2014, GAIT POSTURE, V39, P882, DOI 10.1016/j.gaitpost.2013.11.021; Duchesne C, 2016, NEUROIMAGE-CLIN, V12, P559, DOI 10.1016/j.nicl.2016.09.011; Duval K, 2011, J NEUROPHYSIOL, V106, P280, DOI 10.1152/jn.00657.2010; Earhart GM, 2013, MOVEMENT DISORD, V28, P1501, DOI 10.1002/mds.25592; Egerton T, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-116; Egerton T, 2011, GAIT POSTURE, V34, P178, DOI 10.1016/j.gaitpost.2011.04.006; Eggenberger P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182180; El-Gohary M, 2014, SENSORS-BASEL, V14, P356, DOI 10.3390/s140100356; Fahn S., 1987, RECENT DEV PARKINSON, P153; FERRANDEZ AM, 1990, EXP AGING RES, V16, P79, DOI 10.1080/07340669008251531; FERRANDEZ AM, 1991, BEHAV BRAIN RES, V45, P177, DOI 10.1016/S0166-4328(05)80083-X; Ferrandez AM, 1993, MODULATIONS GAIT NOR, P209; Fietzek UM, 2017, CLIN NEUROPHYSIOL, V128, P1954, DOI 10.1016/j.clinph.2017.07.399; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Fling BW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100291; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GABELL A, 1984, J GERONTOL, V39, P662, DOI 10.1093/geronj/39.6.662; Galna B, 2013, GAIT POSTURE, V37, P580, DOI 10.1016/j.gaitpost.2012.09.025; Giardini M, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5614242; Gilat M, 2017, NEUROIMAGE, V152, P207, DOI 10.1016/j.neuroimage.2017.02.073; Godi M, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-95; Godi M, 2010, J REHABIL MED, V42, P858, DOI [10.2340/16501977-0594, 10.2340/16501977.0594]; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Grasso R, 2000, J NEUROPHYSIOL, V83, P288, DOI 10.1152/jn.2000.83.1.288; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Guglielmetti S, 2009, MOVEMENT DISORD, V24, P598, DOI 10.1002/mds.22424; Han TR, 1999, GAIT POSTURE, V10, P248, DOI 10.1016/S0966-6362(99)00040-5; Hass CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042337; Hass CJ, 2005, ARCH PHYS MED REHAB, V86, P2172, DOI 10.1016/j.apmr.2005.05.013; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2001, J APPL PHYSIOL, V90, P2117, DOI 10.1152/jappl.2001.90.6.2117; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Hebenstreit F, 2015, HUM MOVEMENT SCI, V43, P118, DOI 10.1016/j.humov.2015.07.009; Honeine JL, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.229; Honeine JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052943; Hong M, 2009, NEUROREHAB NEURAL RE, V23, P166, DOI 10.1177/1545968308320639; Horak FB, 2016, PHYS THER, V96, P1364, DOI 10.2522/ptj.20150580; Hoskovcova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139849; Hulsdunker T, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00695; Hulbert S, 2015, DISABIL REHABIL, V37, P1382, DOI 10.3109/09638288.2014.961661; Huxham F, 2008, MOVEMENT DISORD, V23, P1391, DOI 10.1002/mds.21943; Huxham F, 2008, MOVEMENT DISORD, V23, P817, DOI 10.1002/mds.21932; Kincses P, 2017, PARKINSONS DIS-US, V2017, DOI 10.1155/2017/6434689; LORD M, 1994, J REHABIL RES DEV, V31, P214; Lord S, 2011, J NEUROL, V258, P566, DOI 10.1007/s00415-010-5789-8; Lowry KA, 2012, ARCH PHYS MED REHAB, V93, P802, DOI 10.1016/j.apmr.2011.12.007; Mancini M, 2008, CLIN BIOMECH, V23, P450, DOI 10.1016/j.clinbiomech.2007.11.007; Mancini M, 2016, GAIT POSTURE, V43, P125, DOI 10.1016/j.gaitpost.2015.08.015; Marinelli L, 2017, CLIN NEUROPHYSIOL, V128, P1127, DOI 10.1016/j.clinph.2017.03.042; Mellone S, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0147-4; Menant JC, 2009, GAIT POSTURE, V29, P392, DOI 10.1016/j.gaitpost.2008.10.057; Middleton A, 2016, J AGING PHYS ACTIV, V24, P214, DOI 10.1123/japa.2015-0104; Mirelman A, 2016, MOVEMENT DISORD, V31, P1527, DOI 10.1002/mds.26720; Moore ST, 2007, GAIT POSTURE, V26, P200, DOI 10.1016/j.gaitpost.2006.09.011; Morlino P, 2017, GAIT POSTURE, V58, P352, DOI 10.1016/j.gaitpost.2017.08.020; Morris M, 2005, MOVEMENT DISORD, V20, P40, DOI 10.1002/mds.20278; Morris M, 2000, GAIT POSTURE, V12, P205, DOI 10.1016/S0966-6362(00)00076-X; Morris M, 1998, MOVEMENT DISORD, V13, P61, DOI 10.1002/mds.870130115; Morris ME, 1996, PHYS THER, V76, P763, DOI 10.1093/ptj/76.7.763; MORRIS ME, 1994, J NEUROL NEUROSUR PS, V57, P1532, DOI 10.1136/jnnp.57.12.1532; Morris ME, 1996, PHYS THER, V76, P779, DOI 10.1093/ptj/76.7.779; Morton SM, 2003, J NEUROPHYSIOL, V89, P1844, DOI 10.1152/jn.00787.2002; Nanhoe-Mahabier W, 2011, NEUROSCIENCE, V182, P217, DOI 10.1016/j.neuroscience.2011.02.061; Nardone A, 2010, ARCH PHYS MED REHAB, V91, P1869, DOI 10.1016/j.apmr.2010.09.011; Nardone A, 2009, GAIT POSTURE, V30, P5, DOI 10.1016/j.gaitpost.2009.02.006; Nieuwboer A, 2009, NEUROREHAB NEURAL RE, V23, P831, DOI 10.1177/1545968309337136; NYSKA M, 1995, ACTA ORTHOP SCAND, V66, P53, DOI 10.3109/17453679508994640; O'Sullivan JD, 1998, MOVEMENT DISORD, V13, P900, DOI 10.1002/mds.870130607; Ota L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112952; Owings TM, 2003, J BIOMECH, V36, P1215, DOI 10.1016/S0021-9290(03)00108-8; Pal G, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0205-y; Paquette C, 2011, NEUROSCIENCE, V190, P177, DOI 10.1016/j.neuroscience.2011.06.020; Patla AE, 1991, ADAPTABILITY HUMAN G; Peyer KE, 2017, J BIOMECH, V60, P65, DOI 10.1016/j.jbiomech.2017.06.025; Post B, 2005, MOVEMENT DISORD, V20, P1577, DOI 10.1002/mds.20640; Randolph AL, 2000, ARCH PHYS MED REHAB, V81, P573, DOI 10.1053/mr.2000.3804; Riederer P, 2018, CELL TISSUE RES, V373, P297, DOI 10.1007/s00441-018-2832-z; Rochester L, 2004, ARCH PHYS MED REHAB, V85, P1578, DOI 10.1016/j.apmr.2004.01.025; Roemmich RT, 2013, CLIN BIOMECH, V28, P93, DOI 10.1016/j.clinbiomech.2012.09.005; Rosner B., 2011, HYPOTHESIS TESTING 2, P269; Rota V, 2011, INT J REHABIL RES, V34, P265, DOI 10.1097/MRR.0b013e328347be02; Salarian A, 2009, C P IEEE ENG MED BIO, V2009, P224, DOI [10.1109/IEMBS.2009.5333970, DOI 10.1109/IEMBS.2009.5333970]; SCHIEPPATI M, 1991, BRAIN, V114, P1227, DOI 10.1093/brain/114.3.1227; SCHIEPPATI M, 1994, ELECTROEN CLIN NEURO, V93, P286, DOI 10.1016/0168-5597(94)90031-0; Schlachetzki JCM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183989; Schmid M, 2004, GAIT POSTURE S1, V20, pS116; Segal AD, 2008, J BIOMECH, V41, P1486, DOI 10.1016/j.jbiomech.2008.02.012; Siderowf A, 2002, MOVEMENT DISORD, V17, P758, DOI 10.1002/mds.10011; Smith AJJ, 2018, GAIT POSTURE, V61, P125, DOI 10.1016/j.gaitpost.2018.01.003; Snijders AH, 2016, ANN NEUROL, V80, P644, DOI 10.1002/ana.24778; SNOW RE, 1994, ARCH PHYS MED REHAB, V75, P568; Sofuwa O, 2005, ARCH PHYS MED REHAB, V86, P1007, DOI 10.1016/j.apmr.2004.08.012; Spildooren J, 2017, J NEUROL PHYS THER, V41, P129, DOI 10.1097/NPT.0000000000000178; Spildooren J, 2010, MOVEMENT DISORD, V25, P2563, DOI 10.1002/mds.23327; Stack EL, 2006, PARKINSONISM RELAT D, V12, P87, DOI 10.1016/j.parkreldis.2005.08.008; Steffen T, 2008, PHYS THER, V88, P733, DOI 10.2522/ptj.20070214; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Stevenson AJT, 2013, J PHYSIOL-LONDON, V591, P4921, DOI 10.1113/jphysiol.2013.257949; Stuart S, 2017, EUR J NEUROSCI, V46, P1703, DOI 10.1111/ejn.13589; Svoboda Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171997; Turcato AM, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/1743-0003-12-4; Uitti RJ, 2005, NEUROLOGY, V64, P1925, DOI 10.1212/01.WNL.0000163993.82388.C8; Urquhart DM, 1999, ARCH PHYS MED REHAB, V80, P696, DOI 10.1016/S0003-9993(99)90175-2; van Hedel HJA, 2006, GAIT POSTURE, V24, P35, DOI 10.1016/j.gaitpost.2005.06.015; Vaugoyeau M, 2003, GAIT POSTURE, V18, P150, DOI 10.1016/S0966-6362(03)00034-1; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Vervoort G, 2016, NEUROSCIENCE, V317, P36, DOI 10.1016/j.neuroscience.2015.12.056; Wagner J, 2008, EXP BRAIN RES, V191, P247, DOI 10.1007/s00221-008-1520-8; Williams AJ, 2013, GAIT POSTURE, V38, P340, DOI 10.1016/j.gaitpost.2012.12.009; Wu T, 2015, NEUROBIOL DIS, V82, P226, DOI 10.1016/j.nbd.2015.06.014; Xu R, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0325-z; Yang WC, 2016, GAIT POSTURE, V44, P83, DOI 10.1016/j.gaitpost.2015.10.023; Zijlstra W, 1998, GAIT POSTURE, V7, P53, DOI 10.1016/S0966-6362(97)00037-4	146	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0197264	10.1371/journal.pone.0197264	http://dx.doi.org/10.1371/journal.pone.0197264			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF3LC	29750815	gold, Green Submitted, Green Published			2022-12-26	WOS:000431856300026
J	Axley, P; Mudumbi, S; Sarker, S; Kuo, YF; Singal, A				Axley, Page; Mudumbi, Sandhya; Sarker, Shabnam; Kuo, Yong-Fang; Singal, Ashwani			Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; AUTOIMMUNE HEPATITIS; PROGNOSTIC VALUE; SCORING SYSTEMS; FOLLOW-UP; MORTALITY; FEATURES; OUTCOMES; DEATH	Background and aims Advanced liver fibrosis is an important predictor of liver disease progression and mortality, and current guidelines recommend screening for complications of cirrhosis once patients develop F3 fibrosis. Our study compared liver disease progression and survival in patients with stage 3 (F3) and stage 4 (F4) fibrosis on liver biopsy. Methods Retrospective study of patients with F3 or F4 on liver biopsy followed for development of liver disease complications (variceal bleeding, ascites, and hepatic encephalopathy); hepatocellular carcinoma, and survival (overall and transplant free survival). Results Of 2488 patients receiving liver biopsy between 01/02 and 12/12, a total of 294 (171 F3) were analyzed. Over a median follow up period of 3 years, patients with F4 (mean age 53 years, 63% male) compared to F3 (mean age 49 years, 43% male) had higher five year cumulative probability of any decompensation (38% vs. 14%, p<0.0001), including variceal bleed (10% vs. 4%, p = 0.014), ascites (21% vs. 9%, p = 0.0014), and hepatic encephalopathy (14% vs. 5%, p = 0.003). F4 patients also had lower overall 5-year survival (80% vs. 93%, p = 0.003) and transplant free survival (80% vs. 93%, p = 0.002). Probability of hepatocellular carcinoma in 5 years after biopsy was similar between F3 and F4 (1.2% vs. 2%, p = 0.54). Conclusions Compared to F4 stage, patients with F3 fibrosis have decreased risk for development of liver disease complications and better survival. Prospective well designed studies are suggested with large sample size and overcoming the limitations identified in this study, to confirm and validate these findings, as basis for modifying guidelines and recommendations on follow up of patients with advanced fibrosis and stage 3 liver fibrosis.	[Axley, Page; Mudumbi, Sandhya; Sarker, Shabnam] Univ Alabama Birmingham, Dept Internal Med, Birmingham, AL USA; [Kuo, Yong-Fang] Univ Texas Med Branch, Dept Biostat, Galveston, TX 77555 USA; [Singal, Ashwani] Univ Alabama Birmingham, Div Gastroenterol & Hepatol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Medical Branch Galveston; University of Alabama System; University of Alabama Birmingham	Singal, A (corresponding author), Univ Alabama Birmingham, Div Gastroenterol & Hepatol, Birmingham, AL 35294 USA.	ashwanisingal.com@gmail.com	Singal, Ashwani/H-6181-2019	Singal, Ashwani/0000-0003-1207-3998	American College of Gastroenterology	American College of Gastroenterology(General Electric)	A Faculty Development Grant from the American College of Gastroenterology supported our work.	Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BEDOSSA P, 1993, ANN PATHOL, V13, P260; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bruden DJT, 2017, HEPATOLOGY, V66, P37, DOI 10.1002/hep.29115; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Czaja AJ, 2014, ALIMENT PHARM THER, V39, P385, DOI 10.1111/apt.12592; de Vries EMG, 2015, J HEPATOL, V63, P1212, DOI 10.1016/j.jhep.2015.06.008; Dhaliwal HK, 2015, AM J GASTROENTEROL, V110, P993, DOI 10.1038/ajg.2015.139; Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Everhart JE, 2010, HEPATOLOGY, V51, P585, DOI 10.1002/hep.23315; Haflidadottir S, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-166; Hagstrom H, 2017, J HEPATOL, V67, P1265, DOI 10.1016/j.jhep.2017.07.027; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Huang Y, 2015, INTERN MED J, V45, P48, DOI 10.1111/imj.12626; Lackner C, 2017, J HEPATOL, V66, P610, DOI 10.1016/j.jhep.2016.11.011; Lee R., 1994, HEPATOLOGY, P517; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Rozario R, 2003, J HEPATOL, V38, P223, DOI 10.1016/S0168-8278(02)00357-4; Xu FJ, 2016, CLIN INFECT DIS, V62, P289, DOI 10.1093/cid/civ860	21	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197117	10.1371/journal.pone.0197117	http://dx.doi.org/10.1371/journal.pone.0197117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746540	Green Submitted, gold, Green Published			2022-12-26	WOS:000431851700072
J	Yuan, LT; Chuah, SK; Yang, SC; Liang, CM; Wu, CK; Tai, WC; Hung, TH; Nguang, SH; Wang, JW; Tseng, KL; Ku, MK; Hsu, PI; Wu, DC; Hsu, CN				Yuan, Lan-Ting; Chuah, Seng-Kee; Yang, Shih-Cheng; Liang, Chih-Ming; Wu, Cheng-Kun; Tai, Wei-Chen; Hung, Tsung-Hsing; Nguang, Seng-Howe; Wang, Jiunn-Wei; Tseng, Kuo-Lun; Ku, Ming-Kun; Hsu, Pin-, I; Wu, Deng-Chyang; Hsu, Chien-Ning			Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis	PLOS ONE			English	Article							MORTALITY; BURDEN; PROPHYLAXIS; DYSFUNCTION; MANAGEMENT; THERAPY; HEALTH	Objective Patients with liver cirrhosis (LC) are at increased risk for bacterial infections. It is not fully understood how exposure to infections induces further development of hepatic encephalopathy (HE). This study estimated risks of infection associated with HE among patients with LC. Methods A nested case-control study of 14,428 adult patients with LC was performed using the population-based Longitudinal Health Insurance Database 2000 in Taiwan. Cases were cirrhotic patients who developed HE during follow-up. Controls were matched to each case by age at LC diagnosis (+/- 2 years), sex, Charlson Comorbid index score, year of LC, and follow-up time with a 1:1 ratio. A multivariate logistic regression model was used to determine and compare the odds of developing HE based on exposure to various risk factors, including site of infection, cirrhosis-related complications, Helicobacter pylori eradication therapy, and peptic ulcer bleeding. Patient survival was evaluated using the time-dependent Cox regression model. Results Cirrhotic patients with HE (n = 714) and without HE (n = 714) were matched to compare risks. Infections and more frequent yearly infections were significantly associated with increased risk of HE. Independent predictors of HE included spontaneous bacterial peritonitis (aOR, 5.13; 95% CI, 3.03-8.69), sepsis (aOR, 2.54; 95% CI, 1.82--3.53), and biliary tract infection (aOR, 2.03; 95% CI, 1.2-3.46), controlling for confounders. Conclusion Frequent infections are associated with increased risk of HE in cirrhotic patients. More frequent exposure to infection increases the risk of HE and mortality rates. Appropriate prevention of infection and the use of antibiotics for cirrhotic patients at risk for HE are needed.	[Yuan, Lan-Ting] Yuan Gen Hosp, Div Gastroenterol, Kaohsiung, Taiwan; [Chuah, Seng-Kee; Yang, Shih-Cheng; Liang, Chih-Ming; Wu, Cheng-Kun; Tai, Wei-Chen] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Chuah, Seng-Kee; Tai, Wei-Chen] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Hung, Tsung-Hsing] Buddist Tzu Chi Gen Hosp, Dept Internal Med, Div Hepatogastroenterol, Dalin Branch, Chiayi, Taiwan; [Nguang, Seng-Howe] Pin Tung Christian Hosp, Div Gastroenterol, Pingtung, Taiwan; [Wang, Jiunn-Wei; Tseng, Kuo-Lun; Wu, Deng-Chyang] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan; [Wang, Jiunn-Wei; Tseng, Kuo-Lun; Wu, Deng-Chyang] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Wang, Jiunn-Wei; Wu, Deng-Chyang] Kaohsiung Municipal TaTung Hosp, Div Gastroenterol, Kaohsiung, Taiwan; [Tseng, Kuo-Lun] Cishan Hosp, Div Gastroenterol, Kaohsiung, Taiwan; [Ku, Ming-Kun] FooYin Univ Hosp, Div Gastroenterol, Pingtung, Taiwan; [Hsu, Pin-, I] Natl Yang Ming Univ, Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan; [Hsu, Chien-Ning] Kaohsiung Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan; [Hsu, Chien-Ning] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Buddhist Tzu Chi General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Kaohsiung Medical University	Hsu, CN (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan.; Hsu, CN (corresponding author), Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan.	chien_ning_hsu@hotmail.com	Hsu, Chien-Ning/GLS-4014-2022	Hsu, Chien-Ning/0000-0001-7470-528X; Wang, Jiunn-Wei/0000-0003-2534-438X				Albrecht J, 2005, ROLE GLIA NEUROTOXIC, P329; Arroyo V, 2000, J HEPATOL, V32, P157, DOI 10.1016/S0168-8278(00)80423-7; Assy N, 1999, GASTROINTEST ENDOSC, V49, P690, DOI 10.1016/S0016-5107(99)70283-X; Bajaj JS, 2017, HEPATOLOGY, V66, P1727, DOI 10.1002/hep.29306; Bajaj JS, 2011, AM J GASTROENTEROL, V106, P1646, DOI 10.1038/ajg.2011.157; Chey WD, 2017, AM J GASTROENTEROL, V112, P212, DOI 10.1038/ajg.2016.563; Cordoba J, 2014, J HEPATOL, V60, P275, DOI 10.1016/j.jhep.2013.10.004; Dalal R, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008716.pub3; Dasani BM, 1998, AM J GASTROENTEROL, V93, P726, DOI 10.1111/j.1572-0241.1998.214_a.x; Dionigi E, 2017, AM J GASTROENTEROL, V112, P588, DOI 10.1038/ajg.2017.19; Fernandez J, 2006, GASTROENTEROLOGY, V131, P1049, DOI 10.1053/j.gastro.2006.07.010; Fernandez J, 2012, J HEPATOL, V56, pS1, DOI 10.1016/S0168-8278(12)60002-6; Gustot T, 2009, HEPATOLOGY, V50, P2022, DOI 10.1002/hep.23264; Hsu PI, 2005, AM J GASTROENTEROL, V100, P2387, DOI 10.1111/j.1572-0241.2005.00264.x; Hung TH, 2013, EPIDEMIOL INFECT, V141, P2671, DOI 10.1017/S0950268813000186; ITO S, 1994, EUR J GASTROEN HEPAT, V6, P167, DOI 10.1097/00042737-199402000-00013; Kelly CR, 2017, GASTROENTEROLOGY, V152, P681, DOI 10.1053/j.gastro.2017.01.028; Li YY, 2004, WORLD J GASTROENTERO, V10, P2397; Lo Re V, 2015, PHARMACOEPIDEM DR S, V24, P676, DOI 10.1002/pds.3774; Merli M, 2010, CLIN GASTROENTEROL H, V8, P979, DOI 10.1016/j.cgh.2010.06.024; Michitaka K, 2008, HEPATOL RES, V38, P1069, DOI 10.1111/j.1872-034X.2008.00374.x; Mokuolu AO, 1997, AM J GASTROENTEROL, V92, P644; Muto Y, 2005, CLIN GASTROENTEROL H, V3, P705, DOI 10.1016/S1542-3565(05)00017-0; NEITHERCUT WD, 1993, J CLIN PATHOL, V46, P544, DOI 10.1136/jcp.46.6.544; Piotrowski D, 2017, ADV MED SCI-POLAND, V62, P345, DOI 10.1016/j.advms.2016.11.009; Poordad FF, 2007, ALIMENT PHARM THERAP, V25, P3, DOI 10.1111/j.1746-6342.2006.03215.x; Prakash R, 2010, NAT REV GASTRO HEPAT, V7, P515, DOI 10.1038/nrgastro.2010.116; Schulz C, 2014, J CLIN GASTROENTEROL, V48, P491, DOI 10.1097/MCG.0000000000000108; Sheu BS, 2017, HELICOBACTER, V22, DOI 10.1111/hel.12368; Stepanova M, 2012, CLIN GASTROENTEROL H, V10, P1034, DOI 10.1016/j.cgh.2012.05.016; Vaquero J, 2003, GASTROENTEROLOGY, V125, P755, DOI 10.1016/S0016-5085(03)01051-5; Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210; Wang JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164824; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wong F, 2013, GASTROENTEROLOGY, V145, P1280, DOI 10.1053/j.gastro.2013.08.051; 2014, J HEPATOL, V61, P642, DOI DOI 10.1016/J.JHEP.2014.05.042	36	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197127	10.1371/journal.pone.0197127	http://dx.doi.org/10.1371/journal.pone.0197127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746564	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700075
J	Ilie, DE; Kusza, S; Sauer, M; Gavojdian, D				Ilie, Daniela Elena; Kusza, Szilvia; Sauer, Maria; Gavojdian, Dinu			Genetic characterization of indigenous goat breeds in Romania and Hungary with a special focus on genetic resistance to mastitis and gastrointestinal parasitism based on 40 SNPs	PLOS ONE			English	Article							EPITHELIAL-CELLS; INCREASED RISK; DIVERSITY; POLYMORPHISMS; EXPRESSION; RUMINANTS; ALLELE; ALPHA	Goat breeding has become an important sector in Eastern Europe, with Romania and Hungary being among the major producer countries. Given the limited number of research done up-to-date concerning genetic studies of indigenous goat breeds reared in Romania and Hungary, the current preliminary study aimed to analyze the variability of genes related to mastitis and gastrointestinal parasitism by using Kompetitive Allele Specific PCR (KASP (TM)). We studied 52 single nucleotide polymorphisms (SNPs) belonging to 19 genes in indigenous breeds from both countries, namely Banat's White (n = 36), Carpatina (n = 35) from Romania and Hungarian Milking (n = 79) and identified 16 polymorphic SNPs among 10 genes (PTX3, IL6, CLEC4E, IL8, IL1RN, IL15RA, TNFSF13, SOCS3, TNF and TLR3) in 150 animals. Furthermore, the diversity of the studied breeds was investigated. The PIC values ranged from 0.042 to 0.691. The mean values of observed and expected heterozygosity were 0.235 and 0.246 respectively. The highest observed heterozygosity was obtained for IL15RA g.10343904C>T in Banat's White (0.464), IL15RA g.10354813C>T in Carpatina (0.577) and SOCS3 g.52626440T>G in Hungarian Milking (0.588). Pairwise F-ST values between the Romanian breeds and Romanian and Hungarian breeds were small (0.009 and 0.015), indicating the close relationship among the studied goat populations. From all the polymorphic SNPs identified, the Hungarian Milking breed showed the highest proportion of polymorphisms (100%), whereas the Carpatina breed had the lowest percentage (87.5%). The highest value of MAF was obtained for SOCS3 g.52626440T>G (0.46), IL15RA g.10343904C>T (0.47), IL15RA g.10344025C>T (0.45), and IL15RA g.10354813C>T (0.42). The 16 polymorphic SNPs identified in a panel of 150 unrelated individuals belonging to three Romanian and Hungarian indigenous goat breeds could be used in future genomic based breeding schemes as markers for genetic resistance to mastitis and gastrointestinal parasitism in goat breeds found in Eastern and Central Europe.	[Ilie, Daniela Elena; Kusza, Szilvia; Sauer, Maria; Gavojdian, Dinu] Acad Agr & Forestry Sci, Dept Res, Res & Dev Stn Sheep & Goats Caransebes, Caransebes, Romania; [Ilie, Daniela Elena] Acad Agr & Forestry Sci, Dept Res, Res & Dev Stn Bovine Arad, Arad, Romania; [Kusza, Szilvia] Univ Debrecen, Inst Anim Sci Biotechnol & Nat Conservat, Anim Genet Lab, Debrecen, Hungary	University of Debrecen	Ilie, DE (corresponding author), Acad Agr & Forestry Sci, Dept Res, Res & Dev Stn Sheep & Goats Caransebes, Caransebes, Romania.; Ilie, DE (corresponding author), Acad Agr & Forestry Sci, Dept Res, Res & Dev Stn Bovine Arad, Arad, Romania.	danailie@animalsci-tm.ro	Gavojdian, Dinu/AAD-2019-2020; Ilie, Daniela Elena/D-7257-2015	Ilie, Daniela Elena/0000-0002-0464-3199; Gavojdian, Dinu/0000-0001-9603-881X	Romanian National Authority for Scientific Research and Innovation, CNCS - UEFISCDI [PN-II-RU-TE-2014-4-0005]	Romanian National Authority for Scientific Research and Innovation, CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was supported by a grant of the Romanian National Authority for Scientific Research and Innovation, CNCS - UEFISCDI, project number PN-II-RU-TE-2014-4-0005, grant awarded to Dinu Gavojdian. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, POPGENE VERSION 1 3; Arce I, 2004, EUR J IMMUNOL, V34, P210, DOI 10.1002/eji.200324230; Badaso T., 2015, GLOB VET, V15, P315, DOI DOI 10.5829/ID0STGV.2015.15.03.96108; Benavides MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122797; Bergonier D, 2003, LIVEST PROD SCI, V79, P1, DOI 10.1016/S0301-6226(02)00145-8; Bhuiyan AA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040751; Bishop S. C., 2010, Breeding for disease resistance in farm animals, DOI 10.1079/9781845935559.0000; Bishop SC, 2012, ANIMAL, V6, P741, DOI 10.1017/S1751731111000681; Blum JW, 2000, DOMEST ANIM ENDOCRIN, V19, P223, DOI 10.1016/S0739-7240(00)00079-5; Brenaut P, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-16; Cappuccio I, 2006, MOL ECOL NOTES, V6, P992, DOI 10.1111/j.1471-8286.2006.01425.x; Cotton JA, 2016, INT J INTERFERON CYT, V8, P13, DOI DOI 10.2147/IJICMR.S63682; Cremonesi P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-540; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Eurostat, 2017, GOATS POP ANN DAT; FAO/IAEA Agriculture Biotechnology Laboratory, 2004, FAO IAEA AGR BIOT LA, P18; Filipe J., 2015, P VET ANIMAL SCI DAY; Fumagalli M, 2009, J EXP MED, V206, P1395, DOI 10.1084/jem.20082779; Gentile DA, 2003, HUM IMMUNOL, V64, P338, DOI 10.1016/S0198-8859(02)00827-3; Ginja C, 2017, ANIM GENET, V48, P315, DOI 10.1111/age.12529; Graves H, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01271; Griesbeck-Zilch B, 2009, J DAIRY SCI, V92, P4621, DOI 10.3168/jds.2008-1954; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; Hedges JC, 2000, AM J RESP CELL MOL, V23, P86, DOI 10.1165/ajrcmb.23.1.4014; Hungarian Sheep and Goat Breeding Association, 2017, MAG JUH KECSK SZOV; Jiang ZD, 2003, J INFECT DIS, V188, P506, DOI 10.1086/377102; Kim KS, 2002, ASIAN AUSTRAL J ANIM, V15, P461, DOI 10.5713/ajas.2002.461; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Kukovics S., 2006, MAGYAR MEZOGAZDASAG, V15, P7; Kukovics S., 2001, MAGYAR JUHASZAT, V10, P4; Nemeth T, 2005, MAGYAR MEZOGAZDASAG, V14, P10; Notebaert S, 2008, COMP IMMUNOL MICROB, V31, P551, DOI 10.1016/j.cimid.2007.10.004; Pariset Lorraine, 2009, BMC Ecology, V9, P20, DOI 10.1186/1472-6785-9-20; Pascal C., 2011, Lucrari Stiintifice - Universitatea de Stiinte Agricole si Medicina Veterinara, Seria Zootehnie, V55, P328; Perrier S, 2006, FEBS LETT, V580, P6289, DOI 10.1016/j.febslet.2006.10.061; Piras Gianpiera, 2011, Agriculturae Conspectus Scientificus, V76, P175; Raven LA, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-29; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Redecsi A., 1984, NAGYUZEMI KECSKETENY; Russo RC, 2014, EXPERT REV CLIN IMMU, V10, P593, DOI 10.1586/1744666X.2014.894886; Salvatori G, 2012, MED MYCOL, V50, P225, DOI 10.3109/13693786.2011.648215; Sauer M, 2015, LANDBAUFORSCHUNG-GER, V65, P59, DOI 10.3220/LBF1439881037000; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Shafer ABA, 2012, J HERED, V103, P371, DOI 10.1093/jhered/esr138; Strillacci MG, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0106-7; Tackey E, 2004, LUPUS, V13, P339, DOI 10.1191/0961203304lu1023oa; vanHoutert MFJ, 1996, INT J PARASITOL, V26, P1151, DOI 10.1016/S0020-7519(96)00120-8; Voia S., 2010, Lucrari Stiintifice - Zootehnie si Biotehnologii, Universitatea de Stiinte Agricole si Medicina Veterinara a Banatului Timisoara, V43, P324; Wang HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128688; Ye BD, 2009, J CLIN GASTROENTEROL, V43, P233, DOI 10.1097/MCG.0b013e3181646701; Zsolnai A, 1999, ELECTROPHORESIS, V20, P1462, DOI 10.1002/(SICI)1522-2683(19990601)20:7<1462::AID-ELPS1462>3.0.CO;2-0	51	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0197051	10.1371/journal.pone.0197051	http://dx.doi.org/10.1371/journal.pone.0197051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742137	Green Published, gold, Green Submitted			2022-12-26	WOS:000431757400057
J	Leon-Palmero, E; Joglar, V; Alvarez, PA; Martin-Platero, A; Llamas, I; Reche, I				Leon-Palmero, Elizabeth; Joglar, Vanessa; Alvarez, Pedro A.; Martin-Platero, Antonio; Llamas, Inmaculada; Reche, Isabel			Diversity and antimicrobial potential in sea anemone and holothurian microbiomes	PLOS ONE			English	Article							MARINE NATURAL-PRODUCTS; RIBOSOMAL-RNA GENE; TRITERPENE GLYCOSIDES; ANTIBACTERIAL ACTIVITY; DEEP-SEA; COMMUNITIES; BACTERIA; MICROORGANISMS; DNA; INVERTEBRATES	Marine invertebrates, as holobionts, contain symbiotic bacteria that coevolve and develop antimicrobial substances. These symbiotic bacteria are an underexplored source of new bioactive molecules to face the emerging antibiotic resistance in pathogens. Here, we explored the antimicrobial activity of bacteria retrieved from the microbiota of two sea anemones (Anemonia sulcata, Actinia equina) and two holothurians (Holothuria tubulosa, Holothuria forskali). We tested the antimicrobial activity of the isolated bacteria against pathogens with interest for human health, agriculture and aquaculture. We isolated 27 strains with antibacterial activity and 12 of these isolates also showed antifungal activity. We taxonomically identified these strains being Bacillus and Vibrio species the most representative producers of antimicrobial substances. Microbiome species composition of the two sea anemones was similar between them but differed substantially of seawater bacteria. In contrast, microbiome species composition of the two holothurian species was different between them and in comparison with the bacteria in holothurian feces and seawater. In all the holobiont microbiomes Bacteroidetes was the predominant phylum. For each microbiome, we determined diversity and the rank-abundance dominance using five fitted models (null, preemption, log-Normal, Zipf and Zipf-Mandelbrot). The models with less evenness (i.e. Zipf and Zipf-Mandelblot) showed the best fits in all the microbiomes. Finally, we tracked (using the V4 hypervariable region of 16S rRNA gene) the relative abundance of these 27 isolates with antibacterial activity in the total pool of sequences obtained for the microbiome of each holobiont. Coincidences, although with extremely low frequencies, were detected only in the microbiome of H. forskali. This fact suggests that these isolated bacteria belong to the long tail of rare symbiotic bacteria. Therefore, more and more sophisticated culture techniques are necessary to explore this apparently vast pool of rare symbiontic bacteria and to determine their biotechnological potentiality.	[Leon-Palmero, Elizabeth; Joglar, Vanessa; Reche, Isabel] Univ Granada, Dept Ecol, Granada, Spain; [Leon-Palmero, Elizabeth; Joglar, Vanessa; Reche, Isabel] Univ Granada, Inst Agua, Granada, Spain; [Alvarez, Pedro A.] iMare Nat SL, Granada, Spain; [Martin-Platero, Antonio; Llamas, Inmaculada] Univ Granada, Dept Microbiol, Granada, Spain; [Llamas, Inmaculada] Univ Granada, Ctr Invest Biomed CIBM, Inst Biotecnol, Granada, Spain; [Joglar, Vanessa] Univ Vigo, Dept Ecol & Biol Anim, Vigo, Spain	University of Granada; University of Granada; University of Granada; University of Granada; Universidade de Vigo	Leon-Palmero, E (corresponding author), Univ Granada, Dept Ecol, Granada, Spain.; Leon-Palmero, E (corresponding author), Univ Granada, Inst Agua, Granada, Spain.; Llamas, I (corresponding author), Univ Granada, Dept Microbiol, Granada, Spain.; Llamas, I (corresponding author), Univ Granada, Ctr Invest Biomed CIBM, Inst Biotecnol, Granada, Spain.	eleonpalmero@ugr.es; illamas@ugr.es; ireche@ugr.es	Reche, Isabel/K-7120-2014; Llamas, Inmaculada/I-2410-2015; Martin-Platero, Antonio M/H-3201-2018; Llamas, Inmaculada/AAE-8460-2020; León-Palmero, Elizabeth/AFS-0701-2022; León-Palmero, Elizabeth/AAV-2887-2021	Reche, Isabel/0000-0003-2908-1724; Llamas, Inmaculada/0000-0001-6333-5033; Martin-Platero, Antonio M/0000-0003-2822-4885; Llamas, Inmaculada/0000-0001-6333-5033; León-Palmero, Elizabeth/0000-0001-8220-1188; León-Palmero, Elizabeth/0000-0001-8220-1188	Campus de Excelencia Internacional BIOTIC (CEI Biotic) Universidad de Granada [PBS46]; iMare Natural S.L.	Campus de Excelencia Internacional BIOTIC (CEI Biotic) Universidad de Granada; iMare Natural S.L.	This work was supported by Campus de Excelencia Internacional BIOTIC (CEI Biotic) Universidad de Granada, littp://biotic.ugr.es, Grant PBS46. iMare Natural S.L. provided support in the form of salaries for author PM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Barbosa J, 2015, J NAT PROD, V78, P2850, DOI 10.1021/np500424y; Beauregard KA, 2001, ADV EXP MED BIOL, V484, P55; BERGMANN W, 1950, J AM CHEM SOC, V72, P2809, DOI 10.1021/ja01162a543; BERGMANN W, 1951, J ORG CHEM, V16, P981, DOI 10.1021/jo01146a023; Bhatnagar I, 2010, MAR DRUGS, V8, P2673, DOI 10.3390/md8102673; Blunt JW, 2015, NAT PROD REP, V32, P116, DOI 10.1039/c4np00144c; Bordenstein SR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002226; Bostock J, 2010, PHILOS T R SOC B, V365, P2897, DOI 10.1098/rstb.2010.0170; Brana AF, 2015, MICROB ECOL, V69, P512, DOI 10.1007/s00248-014-0508-0; BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Careaga VP, 2011, CHEM BIODIVERS, V8, P467, DOI 10.1002/cbdv.201000044; Chaston J, 2010, FEMS MICROBIOL REV, V34, P41, DOI 10.1111/j.1574-6976.2009.00193.x; Chludil HD, 2002, J NAT PROD, V65, P860, DOI 10.1021/np0106236; Defoirdt T, 2011, CURR OPIN MICROBIOL, V14, P251, DOI 10.1016/j.mib.2011.03.004; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Donia M, 2003, LANCET INFECT DIS, V3, P338, DOI 10.1016/S1473-3099(03)00655-8; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; ElAhwany AMD, 2015, J BASIC MICROB, V55, P2, DOI 10.1002/jobm.201300195; Enomoto M, 2012, MICROBES ENVIRON, V27, P300, DOI 10.1264/jsme2.ME12020; FAROUK AE, 2007, AM J BIOCH BIOTECHNO, V3, P60, DOI DOI 10.3844/AJBBSP.2007.60.65; FENICAL W, 1993, CHEM REV, V93, P1673, DOI 10.1021/cr00021a001; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Frontier S., 1987, NATO ASI Series Series G Ecological Sciences, V14, P335; Frontier S, 1985, OCEANOGR MAR BIOL AN; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Gao CH, 2010, J ANTIBIOT, V63, P191, DOI 10.1038/ja.2010.7; Gao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100092; Gowda NM, 2008, J INVERTEBR PATHOL, V99, P141, DOI 10.1016/j.jip.2008.04.003; Hansson HG., 2001, COLLECTION PATRIMOIN, V50, P336; Haug T, 2002, J INVERTEBR PATHOL, V81, P94, DOI 10.1016/S0022-2011(02)00153-2; Kang HK, 2015, MAR DRUGS, V13, P618, DOI 10.3390/md13010618; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kumar R, 2007, BIOORG MED CHEM LETT, V17, P4387, DOI 10.1016/j.bmcl.2006.12.052; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Lok C, 2015, NATURE, V522, P270, DOI 10.1038/522270a; Martens EC, 2009, J BIOL CHEM, V284, P18445, DOI 10.1074/jbc.M109.008094; Martin-Platero AM, 2007, ANAL BIOCHEM, V366, P102, DOI 10.1016/j.ab.2007.03.010; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McFall-Ngai M, 2008, ADV EXP MED BIOL, V635, P102, DOI 10.1007/978-0-387-09550-9_9; Meron D, 2013, MICROB ECOL, V65, P269, DOI 10.1007/s00248-012-0127-6; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Montesinos E, 2003, INT MICROBIOL, V6, P245, DOI 10.1007/s10123-003-0144-x; Moore BS, 1999, NAT PROD REP, V16, P653, DOI 10.1039/a805873c; Natrah FMI, 2011, MAR BIOTECHNOL, V13, P109, DOI 10.1007/s10126-010-9346-3; Omran NEE, 2013, TOXICOL IND HEALTH, V29, P944, DOI 10.1177/0748233712448116; Paul VJ, 2011, NAT PROD REP, V28, P345, DOI 10.1039/c0np00040j; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Pedros-Alio C, 2012, ANNU REV MAR SCI, V4, P449, DOI 10.1146/annurev-marine-120710-100948; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; R-Core-Team, 2015, LANG ENV STAT COMP; Radjasa O, 2013, J COAST DEV, V7, p[65, 65]; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Roux FL, 2015, FRONT MICROBIOL, V6; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Sanchez-Tocino L, 2000, GUIA SUBMARINA INVER; Sansinenea E, 2011, BIOTECHNOL LETT, V33, P1523, DOI 10.1007/s10529-011-0617-5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Silchenko AS, 2005, J NAT PROD, V68, P564, DOI 10.1021/np049631n; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Subasinghe R.P., 2001, TECHN P C AQ 3 MILL, V167, P191; Sun W, 2014, MICROB ECOL, V67, P942, DOI 10.1007/s00248-014-0395-4; TAGG JR, 1971, APPL MICROBIOL, V21, P943, DOI 10.1128/AEM.21.5.943-943.1971; Tareq FS, 2015, BIOORG MED CHEM LETT, V25, P3325, DOI 10.1016/j.bmcl.2015.05.070; Theis KR, 2016, BIORXIV; Valliappan K, 2014, APPL MICROBIOL BIOT, V98, P7365, DOI 10.1007/s00253-014-5954-6; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WardRainey N, 1996, J EXP MAR BIOL ECOL, V203, P11, DOI 10.1016/0022-0981(96)02566-X; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; WILSON JB, 1991, J VEG SCI, V2, P35, DOI 10.2307/3235896; Wliffels RH, 2008, TRENDS BIOTECHNOL, V26, P26, DOI 10.1016/j.tibtech.2007.10.002; Zhang SY, 2006, J NAT PROD, V69, P1492, DOI 10.1021/np060106t; Zhang X, 2012, FEMS MICROBIOL LETT, V336, P122, DOI 10.1111/j.1574-6968.2012.02662.x	81	22	22	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196178	10.1371/journal.pone.0196178	http://dx.doi.org/10.1371/journal.pone.0196178			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742123	Green Published, gold, Green Submitted			2022-12-26	WOS:000431757400022
J	Kosovac, A; Johannesen, J; Krstic, O; Mitrovic, M; Cvrkovic, T; Tosevski, I; Jovic, J				Kosovac, Andrea; Johannesen, Jes; Krstic, Oliver; Mitrovic, Milana; Cvrkovic, Tatjana; Tosevski, Ivo; Jovic, Jelena			Widespread plant specialization in the polyphagous planthopper Hyalesthes obsoletus (Cixiidae), a major vector of stolbur phytoplasma: Evidence of cryptic speciation	PLOS ONE			English	Article							HYALESTHES-OBSOLETUS AUCHENORRHYNCHA; WHITEFLY BEMISIA-TABACI; MITOCHONDRIAL-DNA; HOST RACES; BOIS NOIR; GENETIC DIFFERENTIATION; MOLECULAR PHYLOGENETICS; GRAPEVINE; HEMIPTERA; CIXIIDAE	The stolbur phytoplasma vector Hyalesthes obsoletus is generally considered as a polyphagous species associated with numerous wild and cultivated plants. However, recent research in southeastern Europe, the distribution centre of H. obsoletus and the area of most stolbur-inflicted crop diseases, points toward specific host-plant associations of the vector, indicating specific vector-based transmission routes. Here, we study the specificity of populations associated with four host-plants using mitochondrial and nuclear genetic markers, and we evaluate the evolution of host-shifts in H. obsoletus. Host-plant use was confirmed for Convolvulus arvensis, Urtica dioica, Vitex agnus-castus and Crepis foetida. Mitochondrial genetic analysis showed sympatric occurrence of three phylogenetic lineages that were ecologically delineated by host-plant preference, but were morphologically inseparable. Nuclear data supported the existence of three genetic groups (Evanno's Delta K(3) = 803.72) with average genetic membership probabilities > 90%. While populations associated with C. arvensis and U. dioica form a homogenous group, populations affiliated with V. agnus-castus and C. foetida constitute two independent plant-associated lineages. The geographical signal permeating the surveyed populations indicated complex diversification processes associated with host-plant selection and likely derived from post-glacial refugia in the eastern Mediterranean. This study provides evidence for cryptic species diversification within H. obsoletus sensu lato: i) consistent mitochondrial differentiation (1.1-1.5%) among host-associated populations in syntopy and in geographically distant areas, ii) nuclear genetic variance supporting mitochondrial data, and iii) average mitochondrial genetic distances among host-associated meta-populations are comparable to the most closely related, morphologically distinguishable species, i.e., Hyalesthes thracicus (2.1-3.3%).	[Kosovac, Andrea; Krstic, Oliver; Mitrovic, Milana; Cvrkovic, Tatjana; Tosevski, Ivo; Jovic, Jelena] Inst Plant Protect & Environm, Dept Plant Pests, Zemun, Serbia; [Johannesen, Jes] Mainz Univ, Inst Organism & Mol Evolut, Mainz, Germany; [Tosevski, Ivo] CABI, Delemont, Switzerland; [Johannesen, Jes] DLR Westerwald Osteifel, Ctr Bees & Apiculture, Mayen, Germany	Johannes Gutenberg University of Mainz	Jovic, J (corresponding author), Inst Plant Protect & Environm, Dept Plant Pests, Zemun, Serbia.	jovic_biolab@yahoo.com	Mitrovic, Milana/A-6300-2018; Jovic, Jelena/H-4982-2019; Kosovac, Andrea/AAK-1649-2020; Cvrkovic, Tatjana/G-2595-2019; Tosevski, Ivo/A-1016-2010; Krstic, Oliver/S-9030-2019	Mitrovic, Milana/0000-0001-5034-6307; Jovic, Jelena/0000-0002-7623-0553; Kosovac, Andrea/0000-0002-4770-9362; Cvrkovic, Tatjana/0000-0001-5108-2323; Tosevski, Ivo/0000-0002-3666-3151; Krstic, Oliver/0000-0003-3688-2132	Ministry of Education, Science and Technological Development of the Republic of Serbia [III43001]; Stiftung Rheinland-Pfalz fur Innovation [15202-386261/861]; SCOPES program of the Swiss National Science Foundation [IZ73Z0_152414]	Ministry of Education, Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); Stiftung Rheinland-Pfalz fur Innovation; SCOPES program of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF))	This study was funded by Ministry of Education, Science and Technological Development of the Republic of Serbia (III43001), Stiftung Rheinland-Pfalz fur Innovation (15202-386261/861), and partly by the SCOPES program of the Swiss National Science Foundation (IZ73Z0_152414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksie Z, 1967, ZAST BILJA, V93-95, P67; Aryan A, 2014, EUR J PLANT PATHOL, V140, P213, DOI 10.1007/s10658-014-0455-0; Atanasova B, 2015, EUR J PLANT PATHOL, V142, P759, DOI 10.1007/s10658-015-0649-0; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Bernays EA, 2007, HOST PLANT SELECTION, V2; Bertin S, 2010, ANN APPL BIOL, V157, P435, DOI 10.1111/j.1744-7348.2010.00434.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Brown JM, 1996, EVOLUTION, V50, P777, DOI 10.1111/j.1558-5646.1996.tb03887.x; Brunner PC, 2004, HEREDITY, V93, P364, DOI 10.1038/sj.hdy.6800512; Calvignac S, 2011, MITOCHONDRION, V11, P246, DOI 10.1016/j.mito.2010.10.004; Cargnus E, 2012, B ENTOMOL RES, V102, P504, DOI 10.1017/S000748531200003X; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chuche J, 2016, ANN APPL BIOL, V169, P214, DOI 10.1111/aab.12291; Chuche J, 2018, J PEST SCI, V91, P145, DOI 10.1007/s10340-017-0885-5; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Ctuaglino F, 2013, INT J SYST EVOL MICR, V63, P2879, DOI 10.1099/ijs.0.044750-0; Cvrkovic T, 2014, PLANT PATHOL, V63, P42, DOI 10.1111/ppa.12080; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Barro P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025579; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Diegisser T, 2009, GENETICA, V137, P87, DOI 10.1007/s10709-009-9353-3; Dlabola J., 1994, ACTA MUS NAT PRAGA B, V49B, P1; Dlabola J, 1994, ACTA MUS NAT PRAGA B, V49, P41; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Duric Z, 2017, MITT KLOSTERNEUBURG, V67, P177; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EMELYANOV AF, 1995, ZOOL ZH, V74, P73; Endersby NM, 2006, MOL ECOL, V15, P107, DOI 10.1111/j.1365-294X.2005.02789.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fieber FX, 1872, VERH ZOOL BOT GES WI, V22, P27; Fu YX, 1997, GENETICS, V147, P915; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guclu S., 1988, Turkiye Bitki Koruma Dergisi, V12, P103; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedin MC, 1997, MOL BIOL EVOL, V14, P309, DOI 10.1093/oxfordjournals.molbev.a025766; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hoch H., 1985, Marburger Entomologische Publikationen, V2, P1; Hoch H., 1986, Marburger Entomologische Publikationen, V2, P87; Hoch H, 1986, P 2 INT C RHYNCH FAU, P31; Horowitz AR, 2014, PEST MANAG SCI, V70, P1568, DOI 10.1002/ps.3752; Horvath G, 1891, GLASNIK HRVATSKOG NA, VVI, P29; HUDSON RR, 1992, GENETICS, V132, P583; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunter MD, 2002, AGR FOREST ENTOMOL, V4, P159, DOI 10.1046/j.1461-9563.2002.00152.x; Imo M, 2013, MOL ECOL, V22, P2188, DOI 10.1111/mec.12237; Imo M, 2011, EUR J ENTOMOL, V108, P161, DOI 10.14411/eje.2011.019; Johannesen J, 2008, ENTOMOL EXP APPL, V126, P217, DOI 10.1111/j.1570-7458.2007.00655.x; Johannesen J, 2014, ANN APPL BIOL, V165, P488, DOI 10.1111/aab.12158; Johannesen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051809; KABIR M, 1988, PLANT BREEDING, V100, P54, DOI 10.1111/j.1439-0523.1988.tb00216.x; Kessler S, 2011, ENTOMOL EXP APPL, V139, P60, DOI 10.1111/j.1570-7458.2011.01107.x; Kosovac A, 2016, PLANT PATHOL, V65, P285, DOI 10.1111/ppa.12409; Kosovac A, 2013, P 3 EUR BOIS NOIR WO, P18; Kosovac A, 2016, MITT KLOSTERNEUBURG, V66, P24; Kosovac A, 2016, MITT KLOSTERNEUBURG, V66, P9; Landi L, 2015, J ECON ENTOMOL, V108, P1506, DOI 10.1093/jee/tov103; Langer M, 2004, VITIS, V43, P191; Loxdale HD, 2011, BIOL J LINN SOC, V103, P1, DOI 10.1111/j.1095-8312.2011.01627.x; Mahuku GS, 2004, PLANT MOL BIOL REP, V22, P71, DOI 10.1007/BF02773351; Maixner M., 2006, IOBC-WPRS Bulletin, V29, P161; MAIXNER M, 1994, VITIS, V33, P103; Maixner M, 2014, ECOL EVOL, V4, P3082, DOI 10.1002/ece3.1158; Maniyar B, 2013, J APPL ENTOMOL, V137, P589, DOI 10.1111/jen.12034; McPheron Bruce A., 2000, P483; Mitrovic M, 2016, EUR J PLANT PATHOL, V144, P619, DOI 10.1007/s10658-015-0800-y; Mullen SP, 2014, ANNU REV ENTOMOL, V59, P339, DOI 10.1146/annurev-ento-120710-100621; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Orenstein S, 2003, ANN APPL BIOL, V142, P341, DOI 10.1111/j.1744-7348.2003.tb00259.x; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rees DJ, 2001, MOL ECOL, V10, P427, DOI 10.1046/j.1365-294x.2001.01227.x; Remane R., 1986, Marburger Entomologische Publikationen, V2, P123; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saez AG, 2005, NATURE, V433, P111, DOI 10.1038/433111a; Scheffer SJ, 2000, MOL PHYLOGENET EVOL, V17, P244, DOI 10.1006/mpev.2000.0830; Sforza R, 1998, J PHYTOPATHOL, V146, P549, DOI 10.1111/j.1439-0434.1998.tb04753.x; Sharon R, 2005, J CHEM ECOL, V31, P1051, DOI 10.1007/s10886-005-4247-z; Signoret V, 1865, ANN SOC ENTOMOLOGIQU, P115; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Suhov KS, 1949, STOLBUR SOLANACEOUS, P7; Suhov KS, 1955, BIOL VIRUSES VIRUS D, P143; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Szpiech ZA, 2011, THEOR POPUL BIOL, V80, P100, DOI 10.1016/j.tpb.2011.03.006; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tosevski I, 2015, SYST ENTOMOL, V40, P268, DOI 10.1111/syen.12109; Tosevski I, 2011, SYST ENTOMOL, V36, P741, DOI 10.1111/j.1365-3113.2011.00593.x; Tsagkarakou A, 2007, B ENTOMOL RES, V97, P29, DOI 10.1017/S000748530700466X; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VIA S, 1990, ANNU REV ENTOMOL, V35, P421, DOI 10.1146/annurev.en.35.010190.002225; Vigna Taglianti Augusto, 1999, Biogeographia, V20, P31; Wang G, 2017, MITOCHONDRIAL DNA A, V28, P769, DOI 10.1080/24701394.2016.1186665; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002; Zeng E, 2012, LECT NOTES POPULATIO, P239	107	9	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196969	10.1371/journal.pone.0196969	http://dx.doi.org/10.1371/journal.pone.0196969			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738577	Green Published, gold, Green Submitted			2022-12-26	WOS:000431724900036
J	Solbach, P; Chhatwal, P; Woltemate, S; Tacconelli, E; Buhl, M; Gerhard, M; Thoeringer, CK; Vehreschild, MJGT; Jazmati, N; Rupp, J; Manns, MP; Bachmann, O; Suerbaum, S				Solbach, Philipp; Chhatwal, Patrick; Woltemate, Sabrina; Tacconelli, Evelina; Buhl, Michael; Gerhard, Markus; Thoeringer, Christoph K.; Vehreschild, Maria J. G. T.; Jazmati, Nathalie; Rupp, Jan; Manns, Michael P.; Bachmann, Oliver; Suerbaum, Sebastian			BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection	PLOS ONE			English	Article							REAL-TIME PCR; FECAL MICROBIOTA TRANSPLANTATION; BILE-SALT BIOTRANSFORMATIONS; GUT MICROBIOTA; INTESTINAL MICROBIOTA; MULTICENTER EVALUATION; ASYMPTOMATIC CARRIAGE; SPORE GERMINATION; SP NOV.; ACID	Background Clostridium difficile infection (CDI) is a major cause of hospital-acquired diarrhea. Secondary bile acids were shown to confer resistance to colonization by C. difficile. 7 alpha-dehydroxylation is a key step in transformation of primary to secondary bile acids and required genes have been located in a single bile acid-inducible (bai) operon in C. scindens as well as in C. hiranonis, two Clostridium sp. recently reported to protect against C. difficile colonization. Aim To analyze baiCD gene abundance in C. difficile positive and negative fecal samples. Material & methods A species-specific qPCR for detecting baiCD genes was established. Fecal samples of patients with CDI, asymptomatic toxigenic C. difficile colonization (TCD), non-toxigenic C. difficile colonization (NTCD), of C. difficile negative (NC) patients, and of two patients before and after fecal microbiota transplantation (FMT) for recurrent CDI (rCDI) were tested for the presence of the baiCD genes. Results The prevalence of the baiCD gene cluster was significantly higher in C. difficile negative fecal samples than in samples of patients diagnosed with CDI (72.5% (100/138) vs. 35.9% (23/64; p<0.0001). No differences in baiCD gene cluster prevalence were seen between NC and NTCD or NC and TCD samples. Both rCDI patients were baiCD-negative at baseline, but one of the two patients turned positive after successful FMT from a baiCD-positive donor. Conclusion Fecal samples of CDI patients are less frequently baiCD-positive than samples from asymptomatic carriers or C. difficile-negative individuals. Furthermore, we present a case of baiCD positivity observed after successful FMT for rCDI.	[Solbach, Philipp; Chhatwal, Patrick; Woltemate, Sabrina; Suerbaum, Sebastian] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, Hannover, Germany; [Solbach, Philipp; Manns, Michael P.; Bachmann, Oliver] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Solbach, Philipp; Chhatwal, Patrick; Woltemate, Sabrina; Bachmann, Oliver; Suerbaum, Sebastian] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany; [Tacconelli, Evelina] Tubingen Univ Hosp, Div Infect Dis, Dept Internal Med 1, Tubingen, Germany; [Tacconelli, Evelina; Buhl, Michael] German Ctr Infect Res DZIF, Partner Site Tubingen, Tubingen, Germany; [Buhl, Michael] Tubingen Univ Hosp, Inst Med Microbiol & Hyg, Tubingen, Germany; [Gerhard, Markus] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Gerhard, Markus; Thoeringer, Christoph K.; Suerbaum, Sebastian] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany; [Thoeringer, Christoph K.] Tech Univ Munich, Dept Internal Med 2, Klinikum Rechts Isar, Munich, Germany; [Vehreschild, Maria J. G. T.] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Vehreschild, Maria J. G. T.; Jazmati, Nathalie] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Bonn, Germany; [Jazmati, Nathalie] Univ Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany; [Rupp, Jan] Univ Hosp Schleswig Holstein, Dept Infect Dis & Microbiol, Lubeck, Germany; [Rupp, Jan] German Ctr Infect Res DZIF, Partner Site Hamburg Borstel Lubeck, Hamburg Borstel Lubeck, Germany; [Suerbaum, Sebastian] Ludwig Maximilians Univ Munchen, Max von Pettenkofer Inst, Munich, Germany	Hannover Medical School; Hannover Medical School; German Center for Infection Research; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; German Center for Infection Research; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Technical University of Munich; German Center for Infection Research; Technical University of Munich; University of Cologne; German Center for Infection Research; University of Cologne; University of Kiel; Schleswig Holstein University Hospital; German Center for Infection Research; University of Munich	Suerbaum, S (corresponding author), Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, Hannover, Germany.; Bachmann, O (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.; Bachmann, O; Suerbaum, S (corresponding author), German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany.; Suerbaum, S (corresponding author), German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany.; Suerbaum, S (corresponding author), Ludwig Maximilians Univ Munchen, Max von Pettenkofer Inst, Munich, Germany.	bachmann.oliver@mh-hannover.de; suerbaum@mvp.uni-muenchen.de	Gerhard, Markus/N-3387-2014; Bachmann, Oliver/AAV-4258-2021; Tacconelli, Evelina/AAC-8200-2019; Vehreschild, Maria/HGB-6948-2022; Gerhard, Markus/P-8996-2019	Gerhard, Markus/0000-0001-9110-3950; Bachmann, Oliver/0000-0002-6830-2975; Gerhard, Markus/0000-0001-9110-3950; Solbach, Philipp/0000-0003-2708-3611; Rupp, Jan/0000-0001-8722-1233	German Center for Infection Research (DZIF); DZIF; State of Lower Saxony in the framework of the consortium "CDiff: Epidemiology and systems biology of the bacterial pathogen Clostridium difficile" [VW NZ 2889]	German Center for Infection Research (DZIF); DZIF; State of Lower Saxony in the framework of the consortium "CDiff: Epidemiology and systems biology of the bacterial pathogen Clostridium difficile"	This project was supported by grants from the German Center for Infection Research (DZIF). Work in the laboratory of Sebastian Suerbaum was funded by DZIF and by a grant from the State of Lower Saxony in the framework of the consortium "CDiff: Epidemiology and systems biology of the bacterial pathogen Clostridium difficile" (VW NZ 2889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LCM, 2011, ANTIMICROB AGENTS CH, V55, P1494, DOI 10.1128/AAC.01664-10; Baron SF H P, 1996, GASTROINTESTINAL MIC; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Berr F, 1996, GASTROENTEROLOGY, V111, P1611, DOI 10.1016/S0016-5085(96)70024-0; Berry N, 2014, J HOSP INFECT, V87, P109, DOI 10.1016/j.jhin.2014.03.005; Britton RA, 2014, GASTROENTEROLOGY, V146, P1547, DOI 10.1053/j.gastro.2014.01.059; Britton RA, 2012, TRENDS MICROBIOL, V20, P313, DOI 10.1016/j.tim.2012.04.001; Buckwalter SP, 2014, J CLIN MICROBIOL, V52, P2139, DOI 10.1128/JCM.03389-13; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Cammarota G, 2017, GUT, V66, P569, DOI 10.1136/gutjnl-2016-313017; Cammarota G, 2014, J CLIN GASTROENTEROL, V48, P693, DOI 10.1097/MCG.0000000000000046; Carman RJ, 2005, REGUL TOXICOL PHARM, V43, P168, DOI 10.1016/j.yrtph.2005.06.005; Carroll IM, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-19; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Doerner KC, 1997, APPL ENVIRON MICROB, V63, P1185, DOI 10.1128/AEM.63.3.1185-1188.1997; FERRARI A, 1977, FEBS LETT, V75, P163, DOI 10.1016/0014-5793(77)80076-8; Francis MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003356; Gerding DN, 2015, JAMA-J AM MED ASSOC, V313, P1719, DOI 10.1001/jama.2015.3725; Giel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008740; Guerrero DM, 2013, J HOSP INFECT, V85, P155, DOI 10.1016/j.jhin.2013.07.002; Hartman LJ, 2005, MOL CELL PROBE, V19, P51, DOI 10.1016/j.mcp.2004.07.006; Hashimoto S, 1996, LIPIDS, V31, P601, DOI 10.1007/BF02523830; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HILL MJ, 1975, LANCET, V1, P535; Houser BA, 2010, FOODBORNE PATHOG DIS, V7, P719, DOI 10.1089/fpd.2009.0483; Jensen MBF, 2015, EUR J CLIN MICROBIOL, V34, P727, DOI 10.1007/s10096-014-2284-7; Kang DJ, 2008, BBA-MOL CELL BIOL L, V1781, P16, DOI 10.1016/j.bbalip.2007.10.008; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Kitahara M, 2001, MICROBIOL IMMUNOL, V45, P263, DOI 10.1111/j.1348-0421.2001.tb02616.x; Kitahara M, 2000, INT J SYST EVOL MICR, V50, P971, DOI 10.1099/00207713-50-3-971; Kitahara M, 2001, INT J SYST EVOL MICR, V51, P39, DOI 10.1099/00207713-51-1-39; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; MALLONEE DH, 1990, J BACTERIOL, V172, P7011, DOI 10.1128/jb.172.12.7011-7019.1990; MAY T, 1994, SCAND J GASTROENTERO, V29, P916, DOI 10.3109/00365529409094863; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Mills JP, 2018, CURR OPIN GASTROEN, V34, P3, DOI 10.1097/MOG.0000000000000410; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; NAGENGAST FM, 1995, EUR J CANCER, V31A, P1067, DOI 10.1016/0959-8049(95)00216-6; Nissle K, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0358-3; Ott SJ, 2016, GASTROENTEROLOGY; Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689; Paramsothy S, 2015, INFLAMM BOWEL DIS, V21, P1600, DOI 10.1097/MIB.0000000000000405; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Pop M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2777-0; QIAGEN UsM, 2016, QIAAMP DNA MIN BLOOD; Ridlon JM, 2016, GUT MICROBES, V7, P22, DOI 10.1080/19490976.2015.1127483; Ridlon JM, 2013, GUT MICROBES, V4, P382, DOI 10.4161/gmic.25723; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; ROLFE RD, 1984, INFECT IMMUN, V45, P185, DOI 10.1128/IAI.45.1.185-191.1984; Rosenstraus M, 1998, J CLIN MICROBIOL, V36, P191, DOI 10.1128/JCM.36.1.191-197.1998; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Snell H, 2004, J CLIN MICROBIOL, V42, P4863, DOI 10.1128/JCM.42.10.4863-4865.2004; Soh YS, 2014, ANN CLIN LAB SCI, V44, P27; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; STELLWAG EJ, 1978, AM J CLIN NUTR, V31, pS243, DOI 10.1093/ajcn/31.10.S243; Studer N, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00191; Tabak YP, 2013, INFECT CONT HOSP EP, V34, P588, DOI 10.1086/670621; Thanissery R, 2017, ANAEROBE, V45, P86, DOI 10.1016/j.anaerobe.2017.03.004; Theriot CM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00045-15; Tigchelaar EF, 2016, GUT, V65, P540, DOI 10.1136/gutjnl-2015-310328; Toda T, 2009, YAKUGAKU ZASSHI, V129, P601, DOI 10.1248/yakushi.129.601; van den Berg RJ, 2005, J CLIN MICROBIOL, V43, P5338, DOI 10.1128/JCM.43.10.5338-5340.2005; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Weingarden A, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0070-0; Weingarden AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147210; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; Wells JE, 2000, APPL ENVIRON MICROB, V66, P1107, DOI 10.1128/AEM.66.3.1107-1113.2000; Wells JE, 2000, J HEPATOL, V32, P4, DOI 10.1016/S0168-8278(00)80183-X; Wiegand PN, 2012, J HOSP INFECT, V81, P1, DOI 10.1016/j.jhin.2012.02.004; Yurist-Doutsch S, 2014, ANNU REV GENET, V48, P361, DOI 10.1146/annurev-genet-120213-092421; Zheng L, 2004, J CLIN MICROBIOL, V42, P3837, DOI 10.1128/JCM.42.8.3837-3840.2004	78	23	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196977	10.1371/journal.pone.0196977	http://dx.doi.org/10.1371/journal.pone.0196977			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738579	Green Published, Green Submitted, gold			2022-12-26	WOS:000431724900037
J	Unlu, AH; Tajeri, S; Bilgic, HB; Eren, H; Karagenc, T; Langsley, G				Unlu, Ahmet Hakan; Tajeri, Shahin; Bilgic, Huseyin Bilgin; Eren, Hasan; Karagenc, Tulin; Langsley, Gordon			The secreted Theileria annulata Ta9 protein contributes to activation of the AP-1 transcription factor	PLOS ONE			English	Article							CELLS; PARVA; PARASITE; JUN; LEUKOCYTES; INFECTION	Theileria annulata is an obligate intracellular protozoan parasite of the phylum Apicomplexa. Theileria sporozoites invade bovine leukocytes and develop into a multinucleate syncytial macroschizont that causes uncontrolled proliferation and dissemination of infected and transformed leukocytes. Activator protein 1 (AP-1) is a transcription factor driving expression of genes involved in proliferation and dissemination and is therefore a key player in Theileria-induced leukocytes transformation. Ta9 possesses a signal peptide allowing it to be secreted into the infected leukocyte cytosol and be presented to CD8 T cells in the context of MHC class I. First, we confirmed that Ta9 is secreted into the infected leukocyte cytosol, and then we generated truncated versions of GFP-tagged Ta9 and tested their ability to activate AP-1 in non-infected HEK293T human kidney embryo cells. The ability to activate AP-1-driven transcription was found to reside in the C-terminal 100 amino acids of Ta9 distant to the N-terminally located epitopes recognised by CD8+ T cells. Secreted Ta9 has therefore, not only the ability to stimulate CD8+ T cells, but also the potential to activate AP-1-driven transcription and contribute to T. annulata-induced leukocyte transformation.	[Unlu, Ahmet Hakan] Van Yuzuncu Yil Univ, Vocat Sch Gevas, Van, Turkey; [Tajeri, Shahin; Langsley, Gordon] Univ Paris 05, Fac Med, Lab Biol Cellulaire Comparat Apicomplexes, Sorbonne Paris Cite, Paris, France; [Tajeri, Shahin; Langsley, Gordon] Inserm, U1016, Cnrs UMR8104, Cochin Inst, Paris, France; [Tajeri, Shahin] Ferdowsi Univ Mashhad, Fac Vet Med, Dept Pathobiol, Mashhad, Iran; [Bilgic, Huseyin Bilgin; Eren, Hasan; Karagenc, Tulin] Adnan Menderes Univ, Fac Vet Med, Dept Parasitol, Aydin, Turkey	Yuzuncu Yil University; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Ferdowsi University Mashhad; Adnan Menderes University	Unlu, AH (corresponding author), Van Yuzuncu Yil Univ, Vocat Sch Gevas, Van, Turkey.	ahakanunlu@yyu.edu.tr	Bilgic, Huseyin Bilgin/AAH-4568-2019	langsley, gordon/0000-0001-6600-6286; Tajeri, Shahin/0000-0002-0482-1194	Wellcome Trust [075820/A/04/Z]; University of Adnan Menderes, Institute of Health Sciences [SAE-09004]; post-doctoral fellowship ParaFrap; ParaFrap [ANR-11-LABX-0024]; INSERM; CNRS	Wellcome Trust(Wellcome Trust); University of Adnan Menderes, Institute of Health Sciences(Adnan Menderes University); post-doctoral fellowship ParaFrap; ParaFrap; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS))	We acknowledge support from the Wellcome Trust (Ref 075820/A/04/Z) and funds from the University of Adnan Menderes, Institute of Health Sciences (Project No. SAE-09004). ST received post-doctoral fellowship ParaFrap. GL acknowledges support from ParaFrap (ANR-11-LABX-0024) and core funding from INSERM and the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson R, 2000, MOL BIOCHEM PARASIT, V106, P51, DOI 10.1016/S0166-6851(99)00213-3; BAYLIS HA, 1995, MOL BIOCHEM PARASIT, V69, P211, DOI 10.1016/0166-6851(94)00216-A; BERBERICH I, 1994, J IMMUNOL, V153, P4357; Bilgic HB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156645; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Brown C.G.D., 1987, P230; Brown CGD, 1997, TROP ANIM HEALTH PRO, V29, p1S, DOI 10.1007/BF02632905; Chaussepied M, 1998, MOL BIOCHEM PARASIT, V94, P215, DOI 10.1016/S0166-6851(98)00070-X; Dessauge G, 2005, ONCOGENE, V24, P1075, DOI 10.1038/sj.onc.1208314; Dobbelaere DAE, 2004, CURR OPIN IMMUNOL, V16, P524, DOI 10.1016/j.coi.2004.05.009; Dolan T.T., 1989, Revue Scientifique et Technique Office International des Epizooties, V8, P11; GLASS EJ, 1989, VET IMMUNOL IMMUNOP, V22, P355, DOI 10.1016/0165-2427(89)90171-2; Haidar M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006942; Haidar M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15688; Hayashida K, 2012, MBIO, V3, DOI 10.1128/mBio.00204-12; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Heussler V, 2006, PARASITOLOGY, V132, pS49, DOI 10.1017/S0031182006000850; Heussler VT, 2002, THEILERIA, P111; Ilhan T, 1999, THESIS; MacHugh ND, 2011, INFECT IMMUN, V79, P2059, DOI 10.1128/IAI.01285-10; Marsolier J, 2015, NATURE, V520, P378, DOI 10.1038/nature14044; Marsolier J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003222; Moreau MF, 1999, INFECT IMMUN, V67, P6678; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Plattner F, 2008, ANNU REV MICROBIOL, V62, P471, DOI 10.1146/annurev.micro.62.081307.162802; RINTELEN M, 1990, TROP MED PARASITOL, V41, P203; Shiels B, 2006, INT J PARASITOL, V36, P9, DOI 10.1016/j.ijpara.2005.09.002; SPOONER RL, 1989, IMMUNOLOGY, V66, P284; TREIER M, 1995, CELL, V83, P753, DOI 10.1016/0092-8674(95)90188-4	29	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196875	10.1371/journal.pone.0196875	http://dx.doi.org/10.1371/journal.pone.0196875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738531	Green Submitted, Green Published, gold			2022-12-26	WOS:000431724900025
J	Huang, JY; Butler, LM; Midttun, O; Ulvik, A; Wang, RW; Jin, AZ; Gao, YT; Ueland, PM; Koh, WP; Yuan, JM				Huang, Joyce Y.; Butler, Lesley M.; Midttun, Oivind; Ulvik, Arve; Wang, Renwei; Jin, Aizhen; Gao, Yu-Tang; Ueland, Per M.; Koh, Woon-Puay; Yuan, Jian-Min			A prospective evaluation of serum kynurenine metabolites and risk of pancreatic cancer	PLOS ONE			English	Article							SINGAPORE CHINESE HEALTH; ONE-CARBON METABOLISM; CIGARETTE-SMOKING; PLASMA FOLATE; LUNG-CANCER; BIOMARKERS; TRYPTOPHAN; VITAMIN-B-6; PATHWAY; METABOLOMICS	Background Serum pyridoxal 5'-phosphate (PLP), the active form of vitamin B-6, is associated with reduced risk of pancreatic cancer. Data on functional measures of vitamin B-6 status and risk of pancreatic cancer is lacking. Methods A nested case-control study involving 187 incident cases of pancreatic cancer and 362 individually matched controls were conducted within two prospective cohorts to evaluate the associations between kynurenine metabolites in pre-diagnostic serum samples and risk of pancreatic cancer. Results Higher serum concentrations of 3-hydroxyanthranilic acid (HAA) and the HAA:3-hydroxyky-nurenine (HK) ratio (a measure for in vivo functional status of PLP) were significantly associated with reduced risk of pancreatic cancer. Compared with the lowest tertile, odds ratios (95% confidence intervals) of pancreatic cancer for the highest tertile was 0.62 (0.39, 1.01) for HAA, and 0.59 (0.35-0.98) for the HAA: HK ratio, after adjustment for potential confounders and serum PLP (both Ps for trend<0.05). The kynurenine: tryptophan ratio or neopterin was not significantly associated with pancreatic cancer risk. Conclusions The inverse association between HAA or the HAA: HK ratio and risk of pancreatic cancer supports the notion that functional status of PLP may be a more important measure than circulating PLP alone for the development of pancreatic cancer.	[Huang, Joyce Y.; Butler, Lesley M.; Wang, Renwei; Yuan, Jian-Min] Univ Pittsburgh, UPMC Hillman Canc Ctr, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA; [Huang, Joyce Y.; Butler, Lesley M.; Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Midttun, Oivind] Bevital AS, Bergen, Norway; [Ulvik, Arve] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Jin, Aizhen] Hlth Promot Board, Natl Registry Dis Off, Singapore, Singapore; [Gao, Yu-Tang] Shanghai Jiao Tong Univ, Dept Epidemiol, Shanghai Canc Inst, Shanghai, Peoples R China; [Ueland, Per M.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Ueland, Per M.] Haukeland Hosp, Lab Clin Biochem, Bergen, Norway; [Koh, Woon-Puay] Duke NUS Grad Med Sch Singapore, Singapore, Singapore; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Bergen; Shanghai Jiao Tong University; University of Bergen; University of Bergen; Haukeland University Hospital; National University of Singapore; National University of Singapore	Yuan, JM (corresponding author), Univ Pittsburgh, UPMC Hillman Canc Ctr, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA.; Yuan, JM (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA.	yuanj@upmc.edu	Gao, Yu/HGE-1937-2022; Ueland, Per M/C-7340-2013; Gao, Y./GWZ-3665-2022; gao, yi/HCI-8298-2022	Yuan, Jian-Min/0000-0002-4620-3108; Ueland, Per Magne/0000-0002-1903-0571	National Cancer Institute [R01 CA144034, UM1 CA182876]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, Grant #R01 CA144034 and UM1 CA182876 to J-MY. The funder provided support in the form of salaries for JYH, RW, LMB, and JMY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aleksandrova K, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv010; Blackford A, 2009, CANCER RES, V69, P3681, DOI 10.1158/0008-5472.CAN-09-0015; Bostanci EI, 2017, INT J GYNECOL CANCER, V27, P754, DOI 10.1097/IGC.0000000000000952; Breslow N, 1980, IARC SCI PUB, V32; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; Choi Sang Woon, 2012, Subcell Biochem, V56, P247, DOI 10.1007/978-94-007-2199-9_13; Chuang SC, 2014, CANCER EPIDEM BIOMAR, V23, P461, DOI 10.1158/1055-9965.EPI-13-0770; Chuang SC, 2011, EUR J CANCER, V47, P1808, DOI 10.1016/j.ejca.2011.02.007; da Silva VR, 2013, J NUTR, V143, P1719, DOI 10.3945/jn.113.180588; Desvignes L, 2009, IMMUNITY, V31, P974, DOI 10.1016/j.immuni.2009.10.007; Hirata Y, 2017, CLIN CHIM ACTA, V468, P98, DOI 10.1016/j.cca.2017.02.011; Howlader N., 2016, SEER CANC STAT REV 1; Huang JY, 2016, CANCER CAUSE CONTROL, V27, P1447, DOI 10.1007/s10552-016-0822-6; Huang JY, 2016, CANCER EPIDEM BIOMAR, V25, P417, DOI 10.1158/1055-9965.EPI-15-0594; Kobayashi T, 2013, CANCER EPIDEM BIOMAR, V22, P571, DOI 10.1158/1055-9965.EPI-12-1033; Koliopanos A, 2002, ONCOGENE, V21, P6059, DOI 10.1038/sj.onc.1205633; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lowe MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087877; Mayers JR, 2014, NAT MED, V20, P1193, DOI 10.1038/nm.3686; McAllister F, 2014, CANCER CELL, V25, P621, DOI 10.1016/j.ccr.2014.03.014; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; OGASAWARA N, 1962, J BIOCHEM-TOKYO, V52, P162, DOI 10.1093/oxfordjournals.jbchem.a127591; Parkin DM, 2002, CANC INCIDENCE 5 CON, VVII; Pichler R, 2017, CANCER SCI, V108, P663, DOI 10.1111/cas.13171; Pingle Shubhangi K, 2008, Indian J Occup Environ Med, V12, P107, DOI 10.4103/0019-5278.44690; ROSS RK, 1992, LANCET, V339, P943, DOI 10.1016/0140-6736(92)91528-G; Schernhammer E, 2007, CANCER RES, V67, P5553, DOI 10.1158/0008-5472.CAN-06-4463; Stolzenberg-Solomon RZ, 2013, AM J CLIN NUTR, V98, P1057, DOI 10.3945/ajcn.113.058123; Stolzenberg-Solomon RZ, 1999, JNCI-J NATL CANCER I, V91, P535, DOI 10.1093/jnci/91.6.535; Ueland PM, 2017, MOL ASPECTS MED, V53, P10, DOI 10.1016/j.mam.2016.08.001; Ulvik A, 2013, AM J CLIN NUTR, V98, P934, DOI 10.3945/ajcn.113.064998; Yuan JM, 2003, CANCER EPIDEM BIOMAR, V12, P890; Yuan JM, 1996, JAMA-J AM MED ASSOC, V275, P1646, DOI 10.1001/jama.275.21.1646; Zhang G, 2013, CLIN CANCER RES, V19, P4983, DOI 10.1158/1078-0432.CCR-13-0209; Zuo H, 2016, AM J EPIDEMIOL, V183, P249, DOI 10.1093/aje/kwv242; Zuo H, 2014, CANCER-AM CANCER SOC, V120, P3370, DOI 10.1002/cncr.28869	36	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196465	10.1371/journal.pone.0196465	http://dx.doi.org/10.1371/journal.pone.0196465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734388	Green Submitted, gold, Green Published			2022-12-26	WOS:000431481700015
J	Huang, LH; Yuan, MQ; Ao, XJ; Ren, AY; Zhang, HB; Yang, MZ				Huang, Li-Hua; Yuan, Ming-Quan; Ao, Xiu-Jin; Ren, An-Yun; Zhang, Han Bo; Yang, Ming-Zhi			Endophytic fungi specifically introduce novel metabolites into grape flesh cells in vitro	PLOS ONE			English	Article							DUAL CULTURES; BERRIES; STRESS; HOST; ACID	Since endophytes can affect metabolism of host plants, they are expected to be used to improve crop quality, especially for crops with organoleptic sensitive products such as wine grape. However, details of metabolic interactions between endophytes and host plants were less understood. In this work, we used high pressure liquid chromatography (HPLC) to analyze the metabolites of fruit flesh cells of grape treated with dual culture of different endophytic fungal strains (EFS). We observed that the dual-culture with different fungal strains show different metabolites composition in grape cells. In response to different EFS, quantities of detected metabolites in grape cells varied from 6 to 17 in this assay, and 1 to 11 novel metabolites were introduced into metabolome of grape cells. Dual-culture with fungal strains CS2, RH16 and RH5 introduced the highest quantities (10 or 11) of novel metabolites in grape cells. More importantly, the modification of metabolic profiles in grape cells via fungal endophytes appeared to be fungal strain/genus-specificity. Overall, this work revealed that introduction of specific metabolites in host plants may be one consequence during the process of endophytes-host metabolic interactions, which raise the possibility to shape grape qualities and characteristics using tool of fungal endophytes.	[Huang, Li-Hua; Ao, Xiu-Jin; Ren, An-Yun; Zhang, Han Bo; Yang, Ming-Zhi] Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China; [Yuan, Ming-Quan] Yunnan Univ, Sch Chem & Chem Engn, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan University	Yang, MZ (corresponding author), Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China.	mzh-yang@163.com			National Natural Science Foundation of China [NSFC 31560538, 31160070]; Yunnan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan University	Our research was financially supported totally by the National Natural Science Foundation of China (NSFC 31560538 and 31160070) and Yunnan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berli FJ, 2013, J BERRY RES, V3, P1, DOI 10.3233/JBR-130047; Casassa LF, 2015, MOLECULES, V20, P7820, DOI 10.3390/molecules20057820; Chandra S, 2012, APPL MICROBIOL BIOT, V95, P47, DOI 10.1007/s00253-012-4128-7; Deluc LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-212; Huang LH, 2017, VITIS, V56, P71, DOI 10.5073/vitis.2017.56.71-77; Hubbard M, 2012, BOTANY, V90, P137, DOI [10.1139/b11-091, 10.1139/B11-091]; Kaul S, 2012, PHYTOCHEM REV, V11, P487, DOI 10.1007/s11101-012-9260-6; Ludwig-Muller J, 2015, BIOTECHNOL LETT, V37, P1325, DOI 10.1007/s10529-015-1814-4; Martin R. C., 2015, American Journal of Plant Sciences, V6, P3216, DOI 10.4236/ajps.2015.619313; Martinez-Luscher J, 2014, PHYTOCHEMISTRY, V102, P106, DOI 10.1016/j.phytochem.2014.03.014; Nisa H, 2015, MICROB PATHOGENESIS, V82, P50, DOI 10.1016/j.micpath.2015.04.001; Owen Noel L., 2004, Science Progress, V87, P79, DOI 10.3184/003685004783238553; Peters S, 1998, MYCOLOGIA, V90, P360, DOI 10.2307/3761393; SIRRENBERG A, 1995, NEW PHYTOL, V130, P149, DOI 10.1111/j.1469-8137.1995.tb01825.x; Soliman SSM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-93; Soubeyrand E, 2014, PHYTOCHEMISTRY, V103, P38, DOI 10.1016/j.phytochem.2014.03.024; Torres MS, 2012, FUNGAL ECOL, V5, P322, DOI 10.1016/j.funeco.2011.05.006; Unterseher M, 2013, BIODIVERS CONSERV, V22, P999, DOI 10.1007/s10531-013-0464-x; Venugopalan A, 2015, BIOTECHNOL ADV, V33, P873, DOI 10.1016/j.biotechadv.2015.07.004; Waqas M, 2012, MOLECULES, V17, P10754, DOI 10.3390/molecules170910754; Yang MZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163186; Zhao J, 2010, CURRENT RES TECHNOLO, P567, DOI DOI 10.1016/J.PHYTOCHEM.2012.07.021; Zoecklein BW, 1995, FOOD QUAL PREFER, V9, pVII	23	19	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196996	10.1371/journal.pone.0196996	http://dx.doi.org/10.1371/journal.pone.0196996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734364	Green Published, Green Submitted, gold			2022-12-26	WOS:000431481700039
J	Grundy, M; Jones, T; Elmi, L; Hall, M; Graham, A; Russell, N; Pallis, M				Grundy, Martin; Jones, Thomas; Elmi, Liban; Hall, Michael; Graham, Adam; Russell, Nigel; Pallis, Monica			Early changes in rpS6 phosphorylation and BH3 profiling predict response to chemotherapy in AML cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; S6 RIBOSOMAL-PROTEIN; DOUBLE-STRAND BREAKS; INDUCED APOPTOSIS; MAMMALIAN TARGET; KINASE INHIBITOR; STAT5 ACTIVATION; DNA-DAMAGE; BCL-2; RESISTANCE	Blasts from different patients with acute myeloid leukemia (AML) vary in the agent(s) to which they are most responsive. With a myriad of novel agents to evaluate, there is a lack of predictive biomarkers to precisely assign targeted therapies to individual patients. Primary AML cells often survive poorly in vitro, thus confounding conventional cytotoxicity assays. The purpose of this work was to assess the potential of two same-day functional predictive assays in AML cell lines to predict long-term response to chemotherapy. (i) Ribosomal protein S6 (rpS6) is a downstream substrate of PI3K/akt/mTOR/ kinase and MAPK kinase pathways and its dephosphorylation is also triggered by DNA double strand breaks. PhosphorpS6 is reliably measurable by flow cytometry and thus has the potential to function as a biomarker of responsiveness to several therapeutic agents. (ii) A cell's propensity for apoptosis can be interrogated via a functional assay termed "Dynamic BH3 Profiling" in which mitochondria) outer membrane permeabilization in drug-treated cells can be driven by pro-apoptotic BH3 domain peptides such as PUMA-BH3. The extent to which a particular cell is primed for apoptosis by the drug can be determined by measuring the amount of cytochrome C released on addition of BH3 peptide. We demonstrate that phospho-rpS6 expression and PUMA-BH3 peptide-induced cytochrome C release after 4 hours both predict long term chemoresponsiveness to tyrosine kinase inhibitors and DNA double strand break inducers in AML cell lines. We also describe changes in expression levels of the prosurvival BCL-2 family member Mcl-1 and the pro-apoptotic protein BIM after short term drug culture.	[Grundy, Martin; Russell, Nigel; Pallis, Monica] Univ Nottingham Hosp, Clin Haematol, Nottingham, England; [Jones, Thomas; Elmi, Liban; Hall, Michael; Graham, Adam; Russell, Nigel] Univ Nottingham, Div Canc & Stem Cells, Dept Haematol, Nottingham, England; [Jones, Thomas] Univ Sheffield, Acad Unit Mol Oncol, Dept Oncol & Metab, Sheffield, S Yorkshire, England	University of Nottingham; University of Nottingham; University of Sheffield	Grundy, M (corresponding author), Univ Nottingham Hosp, Clin Haematol, Nottingham, England.	m.grundy@nottingham.ac.uk		Jones, Thomas/0000-0002-7702-927X	Nottinghamshire Leukaemia Appeal; Nottingham University Hospitals Charity Pump priming grant	Nottinghamshire Leukaemia Appeal; Nottingham University Hospitals Charity Pump priming grant	This work was supported by the Nottinghamshire Leukaemia Appeal, Chairperson Mrs Sylvia Bishton (nla-appeal.org) project grant to MG and the Nottingham University Hospitals Charity (nottinghamhospitalscharity.org.uk) Pump priming grant to MP. The funders had no role in the study design, data collection, decision to publish or preparation of the manuscript.	Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; BANDI HR, 1993, J BIOL CHEM, V268, P4530; Bruner JK, 2017, CANCER RES, V77, P5554, DOI 10.1158/0008-5472.CAN-16-2593; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Burstein HJ, 2011, J CLIN ONCOL, V29, P3328, DOI 10.1200/JCO.2011.36.0354; Cam M, 2014, J BIOL CHEM, V289, P4083, DOI 10.1074/jbc.M113.530303; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chow S, 2006, EXP HEMATOL, V34, P1183, DOI 10.1016/j.exphem.2006.05.002; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Dieterlen MT, 2012, CYTOM PART B-CLIN CY, V82B, P151, DOI 10.1002/cyto.b.21005; Estey E, 2016, AM J HEMATOL, V91, P824, DOI 10.1002/ajh.24439; Fransecky Lars, 2015, Mol Cell Ther, V3, P2, DOI 10.1186/s40591-015-0040-8; Friedman AA, 2015, NAT REV CANCER, V15, P747, DOI 10.1038/nrc4015; Grundy M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-254; Grundy M, 2010, MOL CANCER THER, V9, P661, DOI 10.1158/1535-7163.MCT-09-1144; Gunawardane RN, 2013, MOL CANCER THER, V12, P438, DOI 10.1158/1535-7163.MCT-12-0305; Hawtin RE, 2010, ONCOTARGET, V1, P606; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Kapoor S, 2018, CLIN CANCER RES, V24, P234, DOI 10.1158/1078-0432.CCR-17-1629; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Kim TS, 2006, MOL BIOL CELL, V17, P824, DOI 10.1091/mbc.E05-08-0713; Kitada S, 1993, Antisense Res Dev, V3, P157; Levis M, 2001, BLOOD, V98, P885, DOI 10.1182/blood.V98.3.885; Li Y, 2012, BIOSCI BIOTECH BIOCH, V76, P486, DOI 10.1271/bbb.110774; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Lyons JF, 2001, ENDOCR-RELAT CANCER, V8, P219, DOI 10.1677/erc.0.0080219; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Montero J, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1040144; Montero J, 2015, CELL, V160, P977, DOI 10.1016/j.cell.2015.01.042; Nakajima W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.6; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Nogami A, 2015, ONCOTARGET, V6, P9189, DOI 10.18632/oncotarget.3279; Oaks J, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00388; Pallis M, 2003, BRIT J HAEMATOL, V120, P1009, DOI 10.1046/j.1365-2141.2003.04210.x; Pallis M, 2017, ONCOTARGET, V8, P16220, DOI 10.18632/oncotarget.8742; Pallis M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151480; Pan RQ, 2014, CANCER DISCOV, V4, P362, DOI 10.1158/2159-8290.CD-13-0609; Perl AE, 2012, CLIN CANCER RES, V18, P1716, DOI 10.1158/1078-0432.CCR-11-2346; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Rooswinkel RW, 2014, BLOOD, V123, P2806, DOI 10.1182/blood-2013-08-519470; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Ryan J, 2013, METHODS, V61, P156, DOI 10.1016/j.ymeth.2013.04.006; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Shrestha L, 2016, CURR TOP MED CHEM, V16, P2753, DOI 10.2174/1568026616666160413141911; Spiekermann K, 2003, CLIN CANCER RES, V9, P2140; Tepper AD, 1999, J CLIN INVEST, V103, P971, DOI 10.1172/JCI5457; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vock EH, 1998, MUTAT RES-GEN TOX EN, V413, P83, DOI 10.1016/S1383-5718(98)00019-9; Yaffe MB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003881; Yamauchi T, 2012, CANCER SCI, V103, P1722, DOI 10.1111/j.1349-7006.2012.02343.x; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034; ZWEIG MH, 1993, CLIN CHEM, V39, P561	55	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196805	10.1371/journal.pone.0196805	http://dx.doi.org/10.1371/journal.pone.0196805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723246	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000431305100066
J	Husser, D; Ueberham, L; Jacob, J; Heuer, D; Riedel-Heller, S; Walker, J; Hindricks, G; Bollmann, A				Husser, Daniela; Ueberham, Laura; Jacob, Josephine; Heuer, Denise; Riedel-Heller, Steffi; Walker, Jochen; Hindricks, Gerhard; Bollmann, Andreas			Prevalence of clinically apparent hypertrophic cardiomyopathy in Germany-An analysis of over 5 million patients	PLOS ONE			English	Article							ECHOCARDIOGRAPHIC ANALYSIS; POPULATION; ADULTS	Background Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease. Reported prevalence rates vary substantially between 1:500 (0.2%) and 1:3,000 (0.03%), which may be attributed to different study designs and population characteristics. Prevalence data for Germany is not available. Consequently, this study aimed (1) to quantify age- and gender-specific clinically diagnosed HCM prevalence in Germany based on the analysis of health care claims data of > 5 million insurants in 2015, and (2) to analyze temporal prevalence trends from 2011 to 2015. Methods Data were extracted from the InGef (Insitute for Applied Health Research) database, which is an anonymized healthcare claims database with longitudinal data from patients insured in one of approximately 70 German social health insurances (SHIs). Patients were classified as HCM prevalent, if they had at least one verified ambulatory or one hospital main- or secondary discharge diagnosis of HCM (142.1 or 142.2). Results In 2015, HCM was prevalent in 4,000 out of 5,490,810 patients (0.07%; 1:1,372). HCM prevalence increased gradually with age from 7.4/100,000 persons (95% CI 5.2-10.1) in 0-9 years old to 298.7/100,000 persons (95% CI 276.4-322.4) in patients > 80 years. In all age categories, men had a numerically higher prevalence than women with significant differences in patients > 30 years. There was a gradual annual prevalence increase from 75.8 (95% CI 75.2-76.4) in 2011 to 84.2 (95% CI 83.5-84.8) in 2015 per 100,000 persons. Conclusions Overall, prevalence of clinically diagnosed HCM in Germany is lower than in systematic population studies based on echocardiographic diagnosis. Prevalence increased with advancing age and showed a constant yearly rise. Those observations may improve our understanding of the burden of this genetic heart disease on the health care system in Germany, increase the diagnostic awareness among clinicians and shape future screening and management strategies.	[Husser, Daniela; Ueberham, Laura; Hindricks, Gerhard; Bollmann, Andreas] Heart Ctr Leipzig, Dept Electrophysiol, Leipzig, Germany; [Husser, Daniela; Ueberham, Laura; Hindricks, Gerhard; Bollmann, Andreas] Leipzig Heart Inst, Leipzig, Germany; [Jacob, Josephine; Heuer, Denise; Walker, Jochen] Inst Appl Hlth Res InGef, Berlin, Germany; [Riedel-Heller, Steffi] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, Leipzig, Germany	Heart Center Leipzig GMBH; Heart Center Leipzig GMBH; Leipzig University	Husser, D (corresponding author), Heart Ctr Leipzig, Dept Electrophysiol, Leipzig, Germany.; Husser, D (corresponding author), Leipzig Heart Inst, Leipzig, Germany.	dani11@gmx.net	Riedel-Heller, Steffi/ABG-1537-2021		Volkswagen Foundation Germany through the Lichtenberg professorship program [84901]	Volkswagen Foundation Germany through the Lichtenberg professorship program	This study was supported by the Volkswagen Foundation Germany through the Lichtenberg professorship program to DH (#84901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersohn F, 2016, PHARMACOEPIDEM DR S, V25, P106, DOI 10.1002/pds.3895; Claes GRF, 2016, EUR HEART J, V37, P1815, DOI 10.1093/eurheartj/ehv522; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; HADA Y, 1987, AM J CARDIOL, V59, P183, DOI 10.1016/S0002-9149(87)80107-8; Lind JM, 2008, J MOL CELL CARDIOL, V45, P217, DOI 10.1016/j.yjmcc.2008.05.016; Magnusson P, 2017, CLIN EPIDEMIOL, V9, P403, DOI 10.2147/CLEP.S139300; Maron BJ, 2004, AM J CARDIOL, V93, P1510, DOI 10.1016/j.amjcard.2004.03.007; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron MS, 2016, AM J CARDIOL, V117, P1651, DOI 10.1016/j.amjcard.2016.02.044; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Perez-Sanchez I, 2017, REV ESP CARDIOL; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019; Sundboll J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012832; Zou YB, 2004, AM J MED, V116, P14, DOI 10.1016/j.amjmed.2003.05.009	16	28	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196612	10.1371/journal.pone.0196612	http://dx.doi.org/10.1371/journal.pone.0196612			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723226	gold, Green Published, Green Submitted			2022-12-26	WOS:000431305100045
J	Jaafaru, MS; Nordin, N; Shaari, K; Rosli, R; Razis, AFA				Jaafaru, Mohammed Sani; Nordin, Norshariza; Shaari, Khozirah; Rosli, Rozita; Razis, Ahmad Faizal Abdull			Isothiocyanate from Moringa oleifera seeds mitigates hydrogen peroxide-induced cytotoxicity and preserved morphological features of human neuronal cells	PLOS ONE			English	Article							GLUCOMORINGIN ISOTHIOCYANATE; MITOCHONDRIAL DYSFUNCTION; MODEL; PATHWAY; DISEASE	Reactive oxygen species are well known for induction of oxidative stress conditions through oxidation of vital biomarkers leading to cellular death via apoptosis and other process, thereby causing devastative effects on the host organs. This effect is believed to be linked with pathological alterations seen in several neurodegenerative disease conditions. Many phytochemical compounds proved to have robust antioxidant activities that deterred cells against cytotoxic stress environment, thus protect apoptotic cell death. In view of that we studied the potential of glucomoringin-isothiocyanate (GMG-ITC) or moringin to mitigate the process that lead to neurodegeneration in various ways. Neuroprotective effect of GMG-ITC was performed on retinoic acid (RA) induced differentiated neuroblastoma cells (SHSY5Y) via cell viability assay, flow cytometry analysis and fluorescence microscopy by means of acridine orange and propidium iodide double staining, to evaluate the anti-apoptotic activity and morphology conservation ability of the compound. Additionally, neurite surface integrity and ultrastructural analysis were carried out by means of scanning and transmission electron microscopy to assess the orientation of surface and internal features of the treated neuronal cells. GMG-ITC pre-treated neuron cells showed significant resistance to H2O2-induced apoptotic cell death, revealing high level of protection by the compound. Increase of intracellular oxidative stress induced by H2O2 was mitigated by GMG-ITC. Thus, pre-treatment with the compound conferred significant protection to cytoskeleton and cytoplasmic inclusion coupled with conservation of surface morphological features and general integrity of neuronal cells. Therefore, the collective findings in the presence study indicated the potentials of GMG-ITC to protect the integrity of neuron cells against induced oxidative-stress related cytotoxic processes, the hallmark of neurodegenerative diseases.	[Jaafaru, Mohammed Sani; Rosli, Rozita] Univ Putra Malaysia, Inst Biosci, UPM MAKNA Canc Res Lab, Upm Serdang, Selangor, Malaysia; [Jaafaru, Mohammed Sani] Kaduna State Univ, Dept Biochem, Main Campus, Kaduna, Nigeria; [Nordin, Norshariza; Rosli, Rozita] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Upm Serdang, Selangor, Malaysia; [Shaari, Khozirah] Univ Putra Malaysia, Lab Nat Prod, Inst Biosci, Upm Serdang, Selangor, Malaysia; [Shaari, Khozirah] Univ Putra Malaysia, Fac Sci, Dept Chem, Upm Serdang, Selangor, Malaysia; [Razis, Ahmad Faizal Abdull] Univ Putra Malaysia, Inst Biosci, Lab Mol Biomed, Upm Serdang, Selangor, Malaysia; [Razis, Ahmad Faizal Abdull] Univ Putra Malaysia, Inst Trop Agr & Food Secur, Upm Serdang, Selangor, Malaysia; [Razis, Ahmad Faizal Abdull] Univ Putra Malaysia, Fac Food Sci & Technol, Dept Food Sci, Upm Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Razis, AFA (corresponding author), Univ Putra Malaysia, Inst Biosci, Lab Mol Biomed, Upm Serdang, Selangor, Malaysia.; Razis, AFA (corresponding author), Univ Putra Malaysia, Inst Trop Agr & Food Secur, Upm Serdang, Selangor, Malaysia.; Razis, AFA (corresponding author), Univ Putra Malaysia, Fac Food Sci & Technol, Dept Food Sci, Upm Serdang, Selangor, Malaysia.	madfaizal@upm.edu.my	MOHAMMED, JAAFARU SANI/Q-8642-2017; MOHAMMED, JAAFARU SANI/GPK-1389-2022; Abdull Razis, Ahmad Faizal/F-8079-2014	MOHAMMED, JAAFARU SANI/0000-0002-6635-4931; MOHAMMED, JAAFARU SANI/0000-0002-6635-4931; Nordin, Norshariza/0000-0003-1019-0496; Abdull Razis, Ahmad Faizal/0000-0001-9205-3764	Universiti Putra Malaysia through GP-IPS [9537300]; GP [9628600]	Universiti Putra Malaysia through GP-IPS; GP	The work was funded by Universiti Putra Malaysia through GP-IPS (Vot no. 9537300) and GP (Vot no.9628600) to Ahmad Faizal Abdull Razis (AFAR); http://www.rmc.upm.edu.my/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was funded by Universiti Putra Malaysia through GP-IPS (Vot no. 9537300) and GP (Vot no. 9628600). We thank MitoMasa Sdn. Bhd., Malaysia, a leading producer and exporter of M. oleifera products for providing us with dried M. oleifera seeds sample. Our special gratitude also goes to Dr Leon Sze Wei for the vital role he played in the isolation part of this study. Also, a big thank you to Mrs Enas Mohamad Eliaser and Miss Nurul Ashikin Abd Karim for their technical assistance throughout the experimental period.	Al-Asmari AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135814; Azmi NH, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-177; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; Dzotam JK, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-0990-7; Evans M, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-475; Ferguson R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159051; Franko E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071354; Galuppo M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/259417; Galuppo M, 2014, FITOTERAPIA, V95, P160, DOI 10.1016/j.fitote.2014.03.018; Galuppo M, 2013, MOLECULES, V18, P14340, DOI 10.3390/molecules181114340; Giacoppo S, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0929-4; Giacoppo S, 2015, BIOORGAN MED CHEM, V23, P80, DOI 10.1016/j.bmc.2014.11.022; Guo SX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124897; Holland D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047739; Holland D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042325; Huang HC, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-208; Im AR, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-370; Isachenko V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129108; Ismail Norsharina, 2014, BMC Complement Altern Med, V14, P467, DOI 10.1186/1472-6882-14-467; Jaja-Chimedza A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182658; Jin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015142; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069030; Kim Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184709; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Kumar ADN, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1354-z; Kumari A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178800; Kumssa DB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175503; Liu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058883; Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102; Mangieri LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093257; Mastrantonio R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149802; Mateen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152925; Michl C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157430; Nastruzzi C, 2000, J AGR FOOD CHEM, V48, P3572, DOI 10.1021/jf000191p; Olson ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159782; Rajan TS, 2016, FITOTERAPIA, V110, P1, DOI 10.1016/j.fitote.2016.02.007; Razis AFA, 2014, ASIAN PAC J CANCER P, V15, P8571, DOI 10.7314/APJCP.2014.15.20.8571; Sheng CX, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0894-y; Sun Z, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1177-y; Thurber MD, 2009, ECOL FOOD NUTR, V48, P212, DOI 10.1080/03670240902794598; Tobwala S, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-271; Wang ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075044; Waziri PM, 2016, J ETHNOPHARMACOL, V194, P549, DOI 10.1016/j.jep.2016.10.030; Weir HJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048225; Xu PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142719; Yun HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129250; Zarmouh NO, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-016-1525-y; Zhang LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149663; Zolezzi JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064019	49	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196403	10.1371/journal.pone.0196403	http://dx.doi.org/10.1371/journal.pone.0196403			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723199	Green Submitted, Green Published, gold			2022-12-26	WOS:000431305100028
J	Jung, Y; Cho, Y; Kim, N; Oh, IY; Kang, SW; Choi, EK; Hwang, GS				Jung, Youngae; Cho, Youngjin; Kim, Nami; Oh, Ii-Young; Kang, Sang Won; Choi, Eue-Keun; Hwang, Geum-Sook			Lipidomic profiling reveals free fatty acid alterations in plasma from patients with atrial fibrillation	PLOS ONE			English	Article							OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; CARDIOVERSION; INFLAMMATION; RISK; METABOLISM; EXPRESSION	Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its incidence is increasing worldwide. One method used to restore sinus rhythm is direct current cardioversion (DCCV). Despite the high success rate of DCCV, AF typically recurs within the first 2 weeks. However, our understanding of the pathophysiology of AF recurrence, incidence, and progression are highly limited. Lipidomic profiling was applied to identify altered lipids in plasma from patients with AF using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry coupled with multivariate statistical analysis. Partial least-squares discriminant analysis revealed a clear separation between AF patients and healthy controls. The levels of several lipid species, including fatty acids and phospholipids, were different between AF patients and healthy controls, indicating that oxidative stress and inflammation are associated with the pathogenesis of AF. Similar patterns were also detected between recurrent and non-recurrent AF patients. These results suggest that the elevated saturated fatty acid and reduced polyunsaturated fatty acid levels in AF patients may be associated with enhanced inflammation and that free fatty acid levels may play a crucial role in the development and progression of AF.	[Jung, Youngae; Kim, Nami; Hwang, Geum-Sook] Korea Basic Sci Inst, Western Seoul Ctr, Integrated Metabol Res Grp, Seoul, South Korea; [Jung, Youngae; Kang, Sang Won] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Cho, Youngjin; Oh, Ii-Young] Seoul Natl Univ, Div Cardiol, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; [Choi, Eue-Keun] Seoul Natl Univ Hosp, Div Cardiol, Dept Internal Med, Seoul, South Korea; [Hwang, Geum-Sook] Ewha Womans Univ, Dept Chem & Nanosci, Seoul, South Korea	Korea Basic Science Institute (KBSI); Ewha Womans University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Ewha Womans University	Hwang, GS (corresponding author), Korea Basic Sci Inst, Western Seoul Ctr, Integrated Metabol Res Grp, Seoul, South Korea.; Choi, EK (corresponding author), Seoul Natl Univ Hosp, Div Cardiol, Dept Internal Med, Seoul, South Korea.; Hwang, GS (corresponding author), Ewha Womans Univ, Dept Chem & Nanosci, Seoul, South Korea.	choiek17@snu.ac.kr; gshwang@kbsi.re.kr	Choi, Eue-Keun/J-5968-2014; Choi, Eue-Keun/K-3752-2019	Choi, Eue-Keun/0000-0002-0411-6372; 	National Research Foundation (NRF) of Korea [2013M3A9B6046418, 2017M3A9D5A01052449]; National Research Council of Science and Technology [DRC-14-3-KBSI, CAP-2012-2-KBSI]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); National Research Council of Science and Technology	This study was supported by the National Research Foundation (NRF) of Korea (no. 2013M3A9B6046418 and 2017M3A9D5A01052449), and the National Research Council of Science and Technology (DRC-14-3-KBSI and CAP-2012-2-KBSI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam-Ndoul B, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0241-4; Alonso A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142610; Assies J, 2014, ACTA PSYCHIAT SCAND, V130, P163, DOI 10.1111/acps.12265; BRODSKY MA, 1989, AM J CARDIOL, V63, P1065, DOI 10.1016/0002-9149(89)90079-9; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Cao H, 2014, INT J CARDIOL, V170, P287; Curtis CL, 2000, J BIOL CHEM, V275, P721, DOI 10.1074/jbc.275.2.721; De Souza AI, 2010, J MOL CELL CARDIOL, V49, P851, DOI 10.1016/j.yjmcc.2010.07.008; DITTRICH HC, 1989, AM J CARDIOL, V63, P193, DOI 10.1016/0002-9149(89)90284-1; Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063; Hadi HAR, 2010, J INFLAMM RES, V3, P75, DOI 10.2147/JIR.S10095; Hosseinzadeh Asghar, 2016, J Gastrointest Cancer, V47, P287, DOI 10.1007/s12029-016-9826-4; Hu YF, 2015, NAT REV CARDIOL, V12, P230, DOI 10.1038/nrcardio.2015.2; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Khawaja O, 2012, AM J CARDIOL, V110, P212, DOI 10.1016/j.amjcard.2012.03.010; Kim KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30111; Kim SM, 2014, CLIN BIOCHEM, V47, P869, DOI 10.1016/j.clinbiochem.2013.10.026; Koroglu S, 2012, TURK KARDIYOL DERN A, V40, P499, DOI 10.5543/tkda.2012.64160; Kumar KV, 2000, CLIN CHIM ACTA, V298, P111, DOI 10.1016/S0009-8981(00)00264-3; Li J, 2010, HEART RHYTHM, V7, P438, DOI 10.1016/j.hrthm.2009.12.009; Mayr M, 2008, J AM COLL CARDIOL, V51, P585, DOI 10.1016/j.jacc.2007.09.055; Nam M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16984; Neuman RB, 2007, CLIN CHEM, V53, P1652, DOI 10.1373/clinchem.2006.083923; Norby FL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151932; Okada A, 2016, HEART VESSELS, V31, P80, DOI 10.1007/s00380-014-0582-8; Oliver MF, 2006, QJM-INT J MED, V99, P701, DOI 10.1093/qjmed/hcl084; Oral H, 1999, NEW ENGL J MED, V340, P1849, DOI 10.1056/NEJM199906173402401; Oresic M, 2008, TRENDS BIOTECHNOL, V26, P647, DOI 10.1016/j.tibtech.2008.09.001; Park JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135228; Pilz S, 2008, CLIN CHEM LAB MED, V46, P429, DOI 10.1515/CCLM.2008.118; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rival T, 2013, BIOCHIMIE, V95, P2177, DOI 10.1016/j.biochi.2013.08.006; Siscovick DS, 2017, CIRCULATION, V135, pe867, DOI 10.1161/CIR.0000000000000482; Sterling M, 2014, IEEE ENG MED BIO, P5498, DOI 10.1109/EMBC.2014.6944871; Tang RB, 2006, MED HYPOTHESES, V67, P462, DOI 10.1016/j.mehy.2006.03.017; Tieleman RG, 1998, J AM COLL CARDIOL, V31, P167, DOI 10.1016/S0735-1097(97)00455-5; Volpe CMO, 2013, RECENT PATENTS ENDOC, V7, P189, DOI 10.2174/18715303113139990041; Watanabe H, 2011, CIRC J, V75, P2767, DOI 10.1253/circj.CJ-11-0780; Weaver KL, 2009, J BIOL CHEM, V284, P15400, DOI 10.1074/jbc.M109.004861; Wei W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093817; Zhao YY, 2015, CHEM-BIOL INTERACT, V240, P220, DOI 10.1016/j.cbi.2015.09.005; Zografos T, 2014, PACE, V37, P1530, DOI 10.1111/pace.12477	42	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196709	10.1371/journal.pone.0196709	http://dx.doi.org/10.1371/journal.pone.0196709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723222	Green Submitted, gold, Green Published			2022-12-26	WOS:000431305100056
J	Feinberg, T; Jones, DL; Lilly, C; Umer, A; Innes, K				Feinberg, Termeh; Jones, Dina L.; Lilly, Christa; Umer, Amna; Innes, Kim			The Complementary Health Approaches for Pain Survey (CHAPS): Validity testing and characteristics of a rural population with pain	PLOS ONE			English	Article							ALTERNATIVE MEDICINE USE; SELF-CARE COMPLEMENTARY; UNITED-STATES; TRANSTHEORETICAL MODEL; CAM-USE; PREVALENCE; COMMUNICATION; THERAPIES; BEHAVIOR; QUESTIONNAIRE	Objectives Little is known about patterns and correlates of Complementary Health Approaches (CHAs) in chronic pain populations, particularly in rural, underserved communities. This article details the development and implementation of a new survey instrument designed to address this gap, the Complementary Health Approaches for Pain Survey (CHAPS). Design Following pilot-testing using pre-specified criteria to assess quality and comprehension in our target population, and after feedback regarding face-validity from content experts and stakeholders, the final cross-sectional self-report survey required 10 +/- 12 minutes to complete. It contained 69 demographic, lifestyle and health-related factors, and utilized a Transtheoretical Model (TTM) underpinning to assess short-and long-term use of 12 CHAs for pain management. Twenty additional items on pain severity, feelings, clinical outcomes, and activities were assessed using the Short-Form Global Pain Scale (SF-GPS); Internal reliability was assessed using Cronbach's alpha. Settings/location Investigators conducted consecutive sampling in four West Virginia pain management and rheumatology practices. Participants 301 Appalachian adult patients seeking conventional care for pain management. Results Response rates were high (88% +/- 4.1%). High quality and comprehension deemed the CHAPS an appropriate measurement tool in a rural population with pain. Missing data were unrelated to patient characteristics. Participants predominantly experienced chronic pain (93%), had five or more health conditions (56%, Mean = 5.4 +/- 3.1), were white (92%), female (57%), and middle-aged (Mean = 55.6 (SD = 13.6) years). Over 40% were disabled (43%) and/or obese (44%, Mean BMI = 33.4 +/- 31.5). Additionally, 44% used opioids, 31% used other prescription medications, and 66% used at least one CHA for pain, with 48% using CHAs for greater than 6 months. There was high internal reliability of the SF-GPS (alpha =.93) and satisfactory internal reliability for each of the five TTM stages across (all) twelve CHAs: precontemplation (0.89), contemplation (0.72), preparation (0.75), action (0.70), and maintenance (0.70). Conclusions The CHAPS is the first comprehensive measurement tool to assess CHA use specifically for pain management. Ease of administration in a population with pain support further use in population-and clinic-based studies in similar populations.	[Feinberg, Termeh] Univ Maryland, Sch Med, Dept Family & Community Med, Ctr Integrat Med, Baltimore, MD 21201 USA; [Feinberg, Termeh; Umer, Amna; Innes, Kim] West Virginia Univ, Dept Epidemiol, Sch Publ Hlth, Morgantown, WV 26506 USA; [Jones, Dina L.] West Virginia Univ, Dept Orthopaed, Sch Med, Morgantown, WV USA; [Jones, Dina L.] West Virginia Univ, Div Phys Therapy, Sch Med, Morgantown, WV USA; [Jones, Dina L.] West Virginia Univ, Injury Control Res Ctr, Sch Publ Hlth, Morgantown, WV USA; [Lilly, Christa] West Virginia Univ, Dept Biostat, Sch Publ Hlth, Morgantown, WV USA; [Umer, Amna] West Virginia Univ, Dept Pediat, Sch Med, Morgantown, WV USA; [Innes, Kim] Univ Virginia Hlth Syst, Ctr Study Complementary & Alternat Therapies, Charlottesville, VA USA	University System of Maryland; University of Maryland Baltimore; West Virginia University; West Virginia University; West Virginia University; West Virginia University; West Virginia University; West Virginia University; University of Virginia	Feinberg, T (corresponding author), Univ Maryland, Sch Med, Dept Family & Community Med, Ctr Integrat Med, Baltimore, MD 21201 USA.; Feinberg, T (corresponding author), West Virginia Univ, Dept Epidemiol, Sch Publ Hlth, Morgantown, WV 26506 USA.	TFeinberg@som.umaryland.edu	Lilly, Christa L/R-6644-2017	Lilly, Christa L/0000-0002-0009-0638; Feinberg, Termeh/0000-0003-2567-1567	University of Maryland School of Medicine Department of Family and Community Medicines Center for Integrative Medicine; National Institutes of Health National Institute of General Medical Sciences [T32 GM081741]; NIH NIGMS grant [T32 GM081741]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	University of Maryland School of Medicine Department of Family and Community Medicines Center for Integrative Medicine; National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NIGMS grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was partially funded internally by the University of Maryland School of Medicine Department of Family and Community Medicines Center for Integrative Medicine, and by the National Institutes of Health National Institute of General Medical Sciences (https://www.nigms.nih.gov/Pages/default.aspx) grant T32 GM081741, which provided training and time for TF to conduct fieldwork as part of a predoctoral fellowship through the West Virginia University Behavioral and Biomedical Sciences training program. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Drs. Alfgeir Kristjansson and Peter Giacobbi for initial feedback on the CHAPS measurement tool, in addition to all clinicians, administrators, and patients who helped facilitate data collection. This research was partially funded by NIH NIGMS grant T32 GM081741. Author Disclosure Statement: TF, DJ, CL, AU, and KI declare no competing financial interests nor potential conflicts of interest regarding the publication of this paper.	[Anonymous], 2005, ABC NEWS         APR; [Anonymous], 2011, REL PAIN AM BLUEPR T; Ayers SL, 2010, HEALTH-LONDON, V14, P234, DOI 10.1177/1363459309347491; Berry SH, 2005, CONSUMERS HLTH CARE; Bhargava V, 2012, FAM CONSUM SCI RES J, V41, P18, DOI 10.1111/j.1552-3934.2012.02126.x; Bolyard J.L., 1981, MED PLANTS HOME REME; Brim OG, 2003, NATL SURVEY MIDLIFE; Brown C M, 1998, J Am Pharm Assoc (Wash), V38, P603; Bryden GM, 2016, COMPLEMENT THER MED, V27, P82, DOI 10.1016/j.ctim.2016.05.007; CDC, 2015, DRUG OV DEATHS STAT; CDC, 2016, CHRON DIS IND DAT 20; Centers for Disease Control and Prevention, 2016, NAT HLTH NUTR EX EX; Centers for Disease Control and Prevention (CDC), 2014, DRUG POIS DEATHS INV; Centers for Disease Control and Prevention U. S. Department of Health and Human Services, 2003, 2002 NAT HLTH INT SU; [Centers for Disease Control and Prevention U. S. Department of Health and Human Services National Center for Health Statistics], 2008, 2007 NAT HLTH INT SU; Centers for Disease Control and Prevention US Department of Health and Human Services, 2013, 2012 NAT HLTH INT SU; Chao MT, 2008, J NATL MED ASSOC, V100, P1341, DOI 10.1016/S0027-9684(15)31514-5; Cho MH, 2006, J ALTERN COMPLEM MED, V12, P475, DOI 10.1089/acm.2006.12.475; Choi JH, 2013, PSYCHO-ONCOLOGY, V22, P2253, DOI 10.1002/pon.3278; Clarke Tainya C, 2016, Natl Health Stat Report, P1; Clarke Tainya C, 2015, Natl Health Stat Report, P1; Clarke TC NR, 2012, NATL HLTH STAT REPOR, V98; Couper M. P., 2009, ICPSR25983 V1; Crellin JK, 1990, HERBAL MED PRESENT; Davis EL, 2012, ONCOLOGIST, V17, P1475, DOI 10.1634/theoncologist.2012-0223; Davis MA, 2011, HEALTH SERV RES, V46, P1402, DOI 10.1111/j.1475-6773.2011.01270.x; Delgado R, 2014, PAIN MED, V15, pS9, DOI 10.1111/pme.12412; Di Noia J, 2010, AM J HEALTH BEHAV, V34, P618; Dossett ML, 2014, AM J GASTROENTEROL, V109, P1705, DOI 10.1038/ajg.2014.108; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr6501e1, 10.1001/jama.2016.1464, 10.15585/mmwr.rr7103a1]; Druss BG, 1999, JAMA-J AM MED ASSOC, V282, P651, DOI 10.1001/jama.282.7.651; Edwards RR, 2016, PAIN, V157, P1851, DOI 10.1097/j.pain.0000000000000602; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Enders C. K., 2010, APPL MISSING DATA AN; Faith J, 2015, ALTERN THER HEALTH M, V21, P30; Farooqui Maryam, 2016, J Tradit Complement Med, V6, P321; Ferreira-Valente MA, 2011, PAIN, V152, P2399, DOI 10.1016/j.pain.2011.07.005; Gamus Dorit, 2015, Harefuah, V154, P9; Gentile DA, 2011, PAIN PHYSICIAN, V14, P61; Glanz K, 2008, HLTH BEHAV HLTH ED T, V4th; Harris KM, 2017, NATL LONGITUDINAL ST; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Henchoz Y, 2013, SCAND J RHEUMATOL, V42, P136, DOI 10.3109/03009742.2012.724707; Henson JB, 2017, J CLIN GASTROENTEROL, V51, P564, DOI 10.1097/MCG.0000000000000617; Herman PM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001046; Izzo AA, 2009, DRUGS, V69, P1777, DOI 10.2165/11317010-000000000-00000; Jackson JS, 2010, NATL SURVEY AM LIFE; Jezewski MA, 2009, RES NURS HEALTH, V32, P606, DOI 10.1002/nur.20352; Johnson P, 2013, BODY IMAGE, V10, P163, DOI 10.1016/j.bodyim.2012.12.002; Jones SMW, 2016, J ALTERN COMPLEM MED, V22, P936, DOI 10.1089/acm.2016.0242; Kessler R., NATL COMORBIDITY SUR; Knapik JJ, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-143; Kristoffersen AE, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/318781; Kristoffersen AE, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-463; Krochmal A, 1971, GUIDE MED PLANTS APP; Lachance LL, 2009, J ALTERN COMPLEM MED, V15, P489, DOI 10.1089/acm.2008.0430; Lanza FL, 2009, AM J GASTROENTEROL, V104, P728, DOI 10.1038/ajg.2009.115; Little R. J. A., 2002, STAT ANAL MISSING DA; Markides KS, 2009, HISPANIC ESTABLISHED; Marletta Giuseppe, 2015, Acta Biomed, V86 Suppl 2, P127; Mbada CE, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0695-3; Merskey H BN, 1994, DESCR CHRON PAIN SYN; Nahin Richard L, 2016, Natl Health Stat Report, P1; Nahin RL, 2016, MAYO CLIN PROC, V91, P1292, DOI 10.1016/j.mayocp.2016.06.007; Nahin RL, 2015, J PAIN, V16, P1147, DOI 10.1016/j.jpain.2015.07.013; Nahin RL, 2015, J PAIN, V16, P769, DOI 10.1016/j.jpain.2015.05.002; NIH, 2015, COMPL ALT INT HLTH W; O'Neil Michael, 2010, W V Med J, V106, P64; Oh Byeongsang, 2010, J Soc Integr Oncol, V8, P56; Ojukwu M, 2015, INTEGR CANCER THER, V14, P503, DOI 10.1177/1534735415589347; Omogbadegun Z, 2013, IJACSA INT J ADV COM, VXXX; Ottenbacher K, 2015, HISPANIC ESTABLISHED; Painter JT, 2013, JCR-J CLIN RHEUMATOL, V19, P72, DOI 10.1097/RHU.0b013e3182863447; Perrin KM., 2016, ESSENTIALS PLANNING; Plotnikoff GA, 2003, MAYO CLIN PROC, V78, P1463, DOI 10.4065/78.12.1463; Plotnikoff RC, 2009, APPETITE, V53, P345, DOI 10.1016/j.appet.2009.07.016; Prochaska JO, 2008, MED DECIS MAKING, V28, P845, DOI 10.1177/0272989X08327068; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Prochaska JO, 1994, CHANGING GOOD REVOLU; Purohit MP, 2013, PM&R, V5, P24, DOI 10.1016/j.pmrj.2012.06.012; Quandt SA, 2009, J ALTERN COMPLEM MED, V15, P331, DOI 10.1089/acm.2008.0521; Quandt SA, 2012, EUR J INTEGR MED, V4, pE205, DOI 10.1016/j.eujim.2011.12.009; Quartey NK, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/656812; Rao JK, 1999, ANN INTERN MED, V131, P409, DOI 10.7326/0003-4819-131-6-199909210-00003; Rheumatology ACo, RHEUM DIS AM PROBL; Roberts CS, 2005, J PSYCHOSOC ONCOL, V23, P35, DOI 10.1300/J077v23n04_03; Rosenberg EI, 2008, PAIN MED, V9, P1065, DOI 10.1111/j.1526-4637.2008.00477.x; Santaguida P, 2009, EVIDENCE BASED PRACT; Scanlon D., 2016, ALIGNING FORCES QUAL; Scher AI, 2017, NEUROLOGY, V89, P461, DOI 10.1212/WNL.0000000000004177; Scott B, 2015, READABILITY FORMULAS; Shelley BM, 2009, ANN FAM MED, V7, P139, DOI 10.1370/afm.947; Shelton F., 1965, PIONEER COMFORTS KIT; Smith K, 2008, INT J MED INFORM, V77, P576, DOI 10.1016/j.ijmedinf.2007.11.005; Su DJ, 2011, J HEALTH CARE POOR U, V22, P296, DOI 10.1353/hpu.2011.0002; Sutton-Tyrrell K, STUDY WOMEN NATION S; Waite L., 2017, NATL SOCIAL LIFE HLT; Weinstein M, 1998, BIODEMOGRAPHIC MODEL; Weinstein ND, 1998, HEALTH PSYCHOL, V17, P290, DOI 10.1037/0278-6133.17.3.290; World Health Organization, 2013, WHO TRAD MED STRAT 2; Wurzbach ME, 2002, COMMUNITY HLTH ED PR; Yeo Y, 2016, COMPLEMENT THER MED, V26, P108, DOI 10.1016/j.ctim.2016.03.008; Yuan Y, 2011, J STAT SOFTW, V45, P1; Zelinski E, 2011, LONG BEACH LONGITUDI	104	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196390	10.1371/journal.pone.0196390	http://dx.doi.org/10.1371/journal.pone.0196390			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5SH	29718951	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900051
J	Nakamura, BN; Glazier, A; Kattah, MG; Duong, B; Jia, YX; Campo, D; Shao, L				Nakamura, Brooke N.; Glazier, Alison; Kattah, Michael G.; Duong, Bao; Jia, Yanxia; Campo, Daniel; Shao, Ling			A20 regulates canonical wnt-signaling through an interaction with RIPK4	PLOS ONE			English	Article							NF-KAPPA-B; ZINC-FINGER PROTEIN; UBIQUITIN-EDITING ENZYME; RESTRICTS UBIQUITINATION; LINEAR POLYUBIQUITIN; COLORECTAL-CANCER; DENDRITIC CELLS; ACTIVATION; RECEPTOR; BINDING	A20 is a ubiquitin-editing enzyme that is known to regulate inflammatory signaling and cell death. However, A20 mutations are also frequently found in multiple malignancies suggesting a potential role as a tumor suppressor as well. We recently described a novel role for A20 in regulating the wnt-beta-catenin signaling pathway and suppressing colonic tumor development in mice. The underlying mechanisms for this phenomenon are unclear. To study this, we first generated A20 knockout cell lines by genome-editing techniques. Using these cells, we show that loss of A20 causes dysregulation of wnt-dependent gene expression by RNAseq. Mechanistically, A20 interacts with a proximal signaling component of the wnt-signaling pathway, receptor interacting protein kinase 4 (RIPK4), and regulation of wnt-signaling by A20 occurs through RIPK4. Finally, similar to the mechanism by which A20 regulates other members of the receptor interacting protein kinase family, A20 modifies ubiquitin chains on RIPK4 suggesting a possible molecular mechanism for A20's control over the wnt-signaling pathway.	[Nakamura, Brooke N.; Glazier, Alison; Jia, Yanxia; Shao, Ling] Univ Southern Calif, Keck Sch Med, Dept Med, Div Gastroenterol & Liver Dis, Los Angeles, CA 90007 USA; [Kattah, Michael G.; Duong, Bao] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA USA; [Campo, Daniel] Univ Southern Calif, Dept Biol Sci, Los Angeles, CA USA	University of Southern California; University of California System; University of California San Francisco; University of Southern California	Shao, L (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Med, Div Gastroenterol & Liver Dis, Los Angeles, CA 90007 USA.	lingshao@usc.edu		Nakamura, Brooke/0000-0002-3381-9958; Kattah, Michael/0000-0002-6067-6585	National Institute of Diabetes and Digestive and Kidney Diseases: K-08 award [DK100462-01]; Robert E. and May R. Wright Foundation Research Awards; Margaret E. Early Foundation Medical Research Trust; K-08 award [DK100462]; Wright Foundation; Margaret E. Early Foundation; NIH [P30 DK048522, S10 RR022508]; National Cancer Institute [P30CA014089]; USC Office of Research and Norris Medical Library; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK100462, P30DK048522] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases: K-08 award; Robert E. and May R. Wright Foundation Research Awards; Margaret E. Early Foundation Medical Research Trust; K-08 award; Wright Foundation; Margaret E. Early Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); USC Office of Research and Norris Medical Library; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (https://www.niddk.nih.gov/): K-08 award DK100462-01 (L.S); Robert E. and May R. Wright Foundation Research Awards (L.S.); Margaret E. Early Foundation Medical Research Trust (L.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a K-08 award (DK100462), the Wright Foundation (L.S.) and the Margaret E. Early Foundation (to L.S.). Microscopy services were provided by the Cell and Tissue Imaging Core of the USC Research Center for Liver Diseases, NIH grants No. P30 DK048522 and S10 RR022508. Additional core facility support was provided in part by award number P30CA014089 from the National Cancer Institute. We thank the USC Libraries Bioinformatics Service for assisting with data analysis. The bioinformatics software and computing resources used in the analysis are funded by the USC Office of Research and Norris Medical Library.	Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2017, R LANG ENV STAT COMP; Bahrami A, 2018, J CELL PHYSIOL, V233, P2058, DOI 10.1002/jcp.25890; Baker JM, 2014, JOVE-J VIS EXP, DOI 10.3791/50282; Bavi P, 2011, CLIN EPIGENETICS, V2, P417, DOI 10.1007/s13148-011-0049-z; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Callahan JA, 2013, J IMMUNOL, V191, P535, DOI 10.4049/jimmunol.1203335; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; De A, 2014, EMBO REP, V15, P775, DOI 10.15252/embr.201338305; De Groote P, 2015, CELL DEATH DIFFER, V22, P1012, DOI 10.1038/cdd.2014.191; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Draber P, 2015, CELL REP, V13, P2258, DOI 10.1016/j.celrep.2015.11.009; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Heyninck K, 1999, FEBS LETT, V442, P147, DOI 10.1016/S0014-5793(98)01645-7; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Huang XD, 2013, SCIENCE, V339, P1441, DOI 10.1126/science.1232253; Kalay E, 2012, AM J HUM GENET, V90, P76, DOI 10.1016/j.ajhg.2011.11.014; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Malynn BA, 2009, J EXP MED, V206, P977, DOI 10.1084/jem.20090765; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; Mitchell K, 2012, AM J HUM GENET, V90, P69, DOI 10.1016/j.ajhg.2011.11.013; O'Reilly SM, 2003, BIOCHEM BIOPH RES CO, V303, P586, DOI 10.1016/S0006-291X(03)00389-9; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Shao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062223; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Tokunaga F, 2012, EMBO J, V31, P3856, DOI 10.1038/emboj.2012.241; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Ungerback J, 2012, CARCINOGENESIS, V33, P2126, DOI 10.1093/carcin/bgs256; Urwyler-Rosselet C, 2018, J INVEST DERMATOL, V138, P1268, DOI 10.1016/j.jid.2017.12.031; Vereecke L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6103; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2015, NATURE, V528, P370, DOI 10.1038/nature16165; Zhang DW, 2010, CELL MOL IMMUNOL, V7, P243, DOI 10.1038/cmi.2010.10; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459	46	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195893	10.1371/journal.pone.0195893	http://dx.doi.org/10.1371/journal.pone.0195893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718933	gold, Green Published, Green Submitted			2022-12-26	WOS:000431281900038
J	Paredes, S; Angulo-Ibanez, M; Tasselli, L; Carlson, SM; Zheng, W; Li, TM; Chua, KF				Paredes, Silvana; Angulo-Ibanez, Maria; Tasselli, Luisa; Carlson, Scott M.; Zheng, Wei; Li, Tie-Mei; Chua, Katrin F.			The epigenetic regulator SIRT7 guards against mammalian cellular senescence induced by ribosomal DNA instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-I; DOUBLE-STRAND BREAKS; HUMAN RDNA UNITS; HETEROCHROMATIN FORMATION; HOT-SPOTS; CELLS; CHROMATIN; STRESS; GENES; DISEASE	In the yeast Saccharomyces cerevisiae, genomic instability in rDNA repeat sequences is an underlying cause of cell aging and is suppressed by the chromatin-silencing factor Sir2. In humans, rDNA instability is observed in cancers and premature aging syndromes, but its underlying mechanisms and functional consequences remain unclear. Here, we uncovered a pivotal role of sirtuin 7 (SIRT7), a mammalian Sir2 homolog, in guarding against rDNA instability and show that this function of SIRT7 protects against senescence in primary human cells. We found that, mechanistically, SIRT7 is required for association of SNF2H (also called SMARCA5, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin, subfamily A, member 5), a component of the nucleolar heterochromatin-silencing complex NoRC, with rDNA sequences. Defective rDNA-heterochromatin silencing in SIRT7-deficient cells unleashed rDNA instability, with excision and loss of rDNA gene copies, which in turn induced acute senescence. Mounting evidence indicates that accumulation of senescent cells significantly contributes to tissue dysfunction in aging-related pathologies. Our findings identify rDNA instability as a driver of mammalian cellular senescence and implicate SIRT7-dependent heterochromatin silencing in protecting against this process.	[Paredes, Silvana; Angulo-Ibanez, Maria; Tasselli, Luisa; Zheng, Wei; Li, Tie-Mei; Chua, Katrin F.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Paredes, Silvana; Angulo-Ibanez, Maria; Tasselli, Luisa; Zheng, Wei; Li, Tie-Mei; Chua, Katrin F.] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA 94304 USA; [Carlson, Scott M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Chua, KF (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	kfchua@stanford.edu	Tasselli, Luisa/AAM-6781-2020; Zheng, Wei/GQQ-8951-2022	Tasselli, Luisa/0000-0003-3349-1371; 	NIA, National Institutes of Health; Department of Veterans Affairs merit award; Paul F. Glenn Laboratories; NATIONAL CANCER INSTITUTE [K99CA190803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG050997] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000286] Funding Source: NIH RePORTER	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Veterans Affairs merit award(US Department of Veterans Affairs); Paul F. Glenn Laboratories; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by a grant from the NIA, National Institutes of Health; a Department of Veterans Affairs merit award; and the Paul F. Glenn Laboratories (to K. F. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Caburet S, 2005, GENOME RES, V15, P1079, DOI 10.1101/gr.3970105; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chamousset D, 2010, PROTEOMICS, V10, P3045, DOI 10.1002/pmic.201000162; Chen SF, 2013, MOL CELL, V52, P303, DOI 10.1016/j.molcel.2013.10.010; Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; de Magalhaes JP, 2018, MECH AGEING DEV, V170, P2, DOI 10.1016/j.mad.2017.07.001; Espada J, 2007, NUCLEIC ACIDS RES, V35, P2191, DOI 10.1093/nar/gkm118; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Ganley ARD, 2014, FEMS YEAST RES, V14, P49, DOI 10.1111/1567-1364.12133; Guetg C, 2010, EMBO J, V29, P2135, DOI 10.1038/emboj.2010.17; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Ianni A, 2017, BIOCHEM BIOPH RES CO, V492, P434, DOI 10.1016/j.bbrc.2017.08.081; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Killen MW, 2009, HUM MOL GENET, V18, P3417, DOI 10.1093/hmg/ddp282; Kobayashi T, 2004, CELL, V117, P441, DOI 10.1016/S0092-8674(04)00414-3; Kobayashi T, 2014, P JPN ACAD B-PHYS, V90, P119, DOI 10.2183/pjab.90.119; Lee N, 2014, PROTEOMICS, V14, P1610, DOI 10.1002/pmic.201400001; Li L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12235; Li Z, 2017, ONCOGENE, V36, P1887, DOI 10.1038/onc.2016.359; MacLeod RAF, 2000, LEUKEMIA, V14, P1803, DOI 10.1038/sj.leu.2401894; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Paredes S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001376; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Paredes S, 2009, GENETICS, V181, P1661, DOI 10.1534/genetics.108.099093; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Pietrzak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022585; Rieker C, 2011, J NEUROSCI, V31, P453, DOI 10.1523/JNEUROSCI.0590-10.2011; Ryu D, 2014, CELL METAB, V20, P856, DOI 10.1016/j.cmet.2014.08.001; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Santoro R, 2014, METHODS MOL BIOL, V1094, P319, DOI 10.1007/978-1-62703-706-8_25; Shin JY, 2013, CELL REP, V5, P654, DOI 10.1016/j.celrep.2013.10.007; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Stults DM, 2009, CANCER RES, V69, P9096, DOI 10.1158/0008-5472.CAN-09-2680; Tasselli L, 2016, NAT STRUCT MOL BIOL, V23, P434, DOI 10.1038/nsmb.3202; Tchurikov NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25866; Tchurikov NA, 2015, J MOL CELL BIOL, V7, P366, DOI 10.1093/jmcb/mju038; Toiber Debra, 2011, Handb Exp Pharmacol, V206, P189, DOI 10.1007/978-3-642-21631-2_9; Tsai YC, 2012, MOL CELL PROTEOMICS, V11, P60, DOI 10.1074/mcp.A111.015156; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Vazquez BN, 2016, EMBO J, V35, P1488, DOI 10.15252/embj.201593499; Wronska A, 2016, GERONTOLOGY, V62, P304, DOI 10.1159/000441603; Yu J, 2017, CELL REP, V18, P1229, DOI 10.1016/j.celrep.2017.01.009; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344	54	37	38	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11242	11250		10.1074/jbc.AC118.003325	http://dx.doi.org/10.1074/jbc.AC118.003325			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29728458	hybrid, Green Published			2022-12-26	WOS:000438882800035
J	Farmer, J; Jacobs, D				Farmer, Jenny; Jacobs, Donald			High throughput nonparametric probability density estimation	PLOS ONE			English	Article							DATA SCIENCE; STATISTICS; CONVERGENCE; DISTRIBUTIONS; DEVIATION; RISK	In high throughput applications, such as those found in bioinformatics and finance, it is important to determine accurate probability distribution functions despite only minimal information about data characteristics, and without using human subjectivity. Such an automated process for univariate data is implemented to achieve this goal by merging the maximum entropy method with single order statistics and maximum likelihood. The only required properties of the random variables are that they are continuous and that they are, or can be approximated as, independent and identically distributed. A quasi-log-likelihood function based on single order statistics for sampled uniform random data is used to empirically construct a sample size invariant universal scoring function. Then a probability density estimate is determined by iteratively improving trial cumulative distribution functions, where better estimates are quantified by the scoring function that identifies atypical fluctuations. This criterion resists under and over fitting data as an alternative to employing the Bayesian or Akaike information criterion. Multiple estimates for the probability density reflect uncertainties due to statistical fluctuations in random samples. Scaled quantile residual plots are also introduced as an effective diagnostic to visualize the quality of the estimated probability densities. Benchmark tests show that estimates for the probability density function (PDF) converge to the true PDF as sample size increases on particularly difficult test probability densities that include cases with discontinuities, multi-resolution scales, heavy tails, and singularities. These results indicate the method has general applicability for high throughput statistical inference.	[Farmer, Jenny; Jacobs, Donald] Univ North Carolina Charlotte, Dept Phys & Opt Sci, Charlotte, NC 28223 USA; [Farmer, Jenny] Univ North Carolina Charlotte, Dept Bioinformat & Genom, Charlotte, NC USA; [Jacobs, Donald] Univ North Carolina Charlotte, Ctr Biomed Engn & Sci, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte	Jacobs, D (corresponding author), Univ North Carolina Charlotte, Dept Phys & Opt Sci, Charlotte, NC 28223 USA.; Jacobs, D (corresponding author), Univ North Carolina Charlotte, Ctr Biomed Engn & Sci, Charlotte, NC 28223 USA.	djacobs1@uncc.edu		Jacobs, Donald/0000-0001-7711-1639	NIH [GM101570]; Center for Biomedical Engineering and Science, University of North Carolina at Charlotte; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM101570] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Biomedical Engineering and Science, University of North Carolina at Charlotte; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this study was provided by the NIH grant GM101570 and Center for Biomedical Engineering and Science, University of North Carolina at Charlotte to Dr. Donald Jacobs. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 2012, HDB MATH FUNCTIONS F; Alemany R, 2013, INSUR MATH ECON, V52, P255, DOI 10.1016/j.insmatheco.2012.12.008; ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; Bernacchia A, 2011, J R STAT SOC B, V73, P407, DOI 10.1111/j.1467-9868.2011.00772.x; Brito M, 2006, INSUR MATH ECON, V38, P571, DOI 10.1016/j.insmatheco.2005.12.002; BUTLER RW, 1982, ANN STAT, V10, P197, DOI 10.1214/aos/1176345702; Cavuoti S, 2017, MON NOT R ASTRON SOC, V465, P1959, DOI 10.1093/mnras/stw2930; Chaudhuri P, 2000, ANN STAT, V28, P408, DOI 10.1214/aos/1016218224; Dawson R, 2011, J STAT EDUC, V19, DOI 10.1080/10691898.2011.11889610; Desforges MJ, 1998, P I MECH ENG C-J MEC, V212, P687, DOI 10.1243/0954406981521448; Diggle PJ, 2015, J R STAT SOC A STAT, V178, P793, DOI 10.1111/rssa.12132; Evans DL, 2008, COMMUN STAT-SIMUL C, V37, P1396, DOI 10.1080/03610910801983160; Ewens W, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b137845; Fahoome G., 2002, J MODERN APPL STAT M, V1, P248, DOI DOI 10.22237/JMASM/1036110540; Farmer J, 2016, ARXIVORG160608861; Farmer J, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19120646; Fiorio CV, 2004, STATA J, V4, P168, DOI 10.1177/1536867X0400400207; Girolami M, 2003, IEEE T PATTERN ANAL, V25, P1253, DOI 10.1109/TPAMI.2003.1233899; Golan A., 1996, MAXIMUM ENTROPY ECON; Gu C, 2008, INVERSE PROBL, V24, DOI 10.1088/0266-5611/24/3/034002; Hajihosseini P, 2014, ISA T, V53, P230, DOI 10.1016/j.isatra.2013.11.007; Hannachi A, 2006, CLIM DYNAM, V27, P301, DOI 10.1007/s00382-006-0132-x; Hardle W, 1990, SMOOTHING TECHNIQUES; HARTER HL, 1968, OPER RES, V16, P783, DOI 10.1287/opre.16.4.783; Hartmann P, 2010, J EMPIR FINANC, V17, P241, DOI 10.1016/j.jempfin.2009.09.004; Hazelton M, 2014, KERNEL SMOOTHING; Hollands KGT, 2013, SOL ENERGY, V96, P103, DOI 10.1016/j.solener.2013.07.007; Houle P., RNGPACK HIGH QUALITY; Jacobs DJ, 2009, ENTROPY-SWITZ, V11, P1001, DOI 10.3390/e11041001; Kang E, 2016, AM J ROENTGENOL, V207, P126, DOI 10.2214/AJR.15.15469; Kapur J.N., 1989, MAXIMUM ENTROPY MODE; Knapp B, 2011, J COMPUT BIOL, V18, P997, DOI 10.1089/cmb.2010.0237; KULLBACK S, 1987, AM STAT, V41, P340; Kullback S, 1951, INFORM SUFFICIENCY, P79, DOI [10.1214/aoms/1177729694, DOI 10.1214/AOMS/1177729694]; Li XB, 2009, STRUCT SAF, V31, P335, DOI 10.1016/j.strusafe.2008.05.001; Lu N., 2011, IFAC P VOLUMES, P4296, DOI [10.3182/20110828-6-IT-1002.00385, DOI 10.3182/20110828-6-IT-1002.00385]; Malec P, 2014, COMPUT STAT DATA AN, V72, P57, DOI 10.1016/j.csda.2013.10.023; Munkhammar J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174573; Nobel A, 1996, ANN STAT, V24, P1084; Pasanen L, 2013, STAT, V2, P273, DOI 10.1002/sta4.35; Provost F, 2013, BIG DATA, V1, P51, DOI 10.1089/big.2013.1508; Rau MM, 2015, MON NOT R ASTRON SOC, V452, P3710, DOI 10.1093/mnras/stv1567; Rosado-Mendez IM, 2016, IEEE T ULTRASON FERR, V63, P1306, DOI 10.1109/TUFFC.2016.2547341; ROSENBLATT M, 1956, ANN MATH STAT, V27, P832, DOI 10.1214/aoms/1177728190; Sakov A, 2010, ANN APPL STAT, V4, P743, DOI 10.1214/09-AOAS304; Sawle L, 2016, J CHEM THEORY COMPUT, V12, P861, DOI 10.1021/acs.jctc.5b00999; Shankar PM, 2004, PHYS MED BIOL, V49, P1007, DOI 10.1088/0031-9155/49/6/011; Sheather SJ, 2004, STAT SCI, V19, P588, DOI 10.1214/088342304000000297; Silverman B.W, 1986, DENSITY ESTIM STAT D, V26, P1, DOI DOI 10.2307/2347507; Simonoff J.S., 1998, SMOOTHING METHODS ST, V2nd ed; Van Keilegom I, 2012, STAT INFERENCE, DOI [10.1007/978-3-7908-2349-3, DOI 10.1007/978-3-7908-2349-3]; Vio R, 1994, PROBABILITY DENSITY, P640; Wand MP., 1994, KERNEL SMOOTHING; WILKS SS, 1948, B AM MATH SOC, V54, P6, DOI 10.1090/S0002-9904-1948-08936-4; Woodbury AD, 2004, COMPUT GEOSCI-UK, V30, P131, DOI 10.1016/j.cageo.2003.09.001; Wu N., 1997, MAXIMUM ENTROPY METH; Wu XM, 2010, J ECONOMETRICS, V156, P354, DOI 10.1016/j.jeconom.2009.11.005; Wu XM, 2003, J ECONOMETRICS, V115, P347, DOI 10.1016/S0304-4076(03)00114-3; Xu SF, 2011, FILOMAT, V25, P197, DOI 10.2298/FIL1102197X; Xu S, 2016, IND ENG CHEM RES, V55, P1623, DOI 10.1021/acs.iecr.5b03068; Zhang J, 2009, STAT NEERL, V63, P13, DOI 10.1111/j.1467-9574.2008.00392.x	62	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0196937	10.1371/journal.pone.0196937	http://dx.doi.org/10.1371/journal.pone.0196937			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF3LC	29750803	Green Submitted, Green Published, gold			2022-12-26	WOS:000431856300009
J	Carter, S; Miard, S; Boivin, L; Salle-Lefort, S; Picard, F				Carter, Sophie; Miard, Stephanie; Boivin, Louise; Salle-Lefort, Sandrine; Picard, Frederic			Loss of Malat1 does not modify age- or diet-induced adipose tissue accretion and insulin resistance in mice	PLOS ONE			English	Article							NONCODING RNA MALAT1; COMPETING ENDOGENOUS RNA; GENE-EXPRESSION PROFILE; CALORIC RESTRICTION; BINDING PROTEIN; LNCRNA MALAT1; METABOLISM; CELLS; LIVER; METASTASIS	Several studies have suggested that signals emerging from white adipose tissue can contribute to the control of longevity. In turn, aging is associated with perturbed regulation and partitioning of fat depots and insulin resistance. However, the exact mechanisms involved in these relationships remain undetermined. Using RAP-PCR on adipose tissue of young and old male mice coupled with qPCR validation, we have uncovered the long non-coding RNA Malat1 as a gene robustly downregulated in visceral white adipose tissue (vWAT) during normal aging in male mice and men. Reductions in Malat1 expression in subcutaneous WAT (scWAT) were also observed in genetic (ob and db) as well as diet-induced models of obesity. Based on these findings, Malat1+/+ and Malat1-/- mouse littermates were thus probed to detect whether loss of Malat1 would impact age or diet-induced gain in fat mass and development of glucose intolerance. Contrary to this hypothesis, male and female Malat1-deficient mice gained as much weight, and developed insulin resistance to a similar extent as their Malat1+/+ littermates when studied up to eight months old on regular chow or a high-fat, high-sucrose diet. Moreover, we observed no marked difference in oxygen consumption, food intake, or lipid profiles between Malat1+/+ and Malat1-/- mice. Therefore, we conclude that the overall metabolic impact of the absence of Malat1 on adipose tissue accretion and glucose intolerance is either physiologically not relevant upon aging and obesity, or that it is masked by as yet unknown compensatory mechanisms.	[Carter, Sophie; Miard, Stephanie; Boivin, Louise; Salle-Lefort, Sandrine; Picard, Frederic] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Carter, Sophie; Salle-Lefort, Sandrine; Picard, Frederic] Laval Univ, Fac Pharm, Quebec City, PQ, Canada	Laval University; Laval University	Picard, F (corresponding author), Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada.; Picard, F (corresponding author), Laval Univ, Fac Pharm, Quebec City, PQ, Canada.	frederic.picard@criucpq.ulaval.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-06080]; PhD studentship award from the Fonds de Recherche du Quebec-Sante (FRQS); PhD studentship award from the IUCPQ Research Center; FRQS Senior Scholarship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); PhD studentship award from the Fonds de Recherche du Quebec-Sante (FRQS); PhD studentship award from the IUCPQ Research Center; FRQS Senior Scholarship	This study was supported by a grant from the Natural Sciences and Engineering Research Council of Canada to FP (RGPIN-2017-06080). SC was the recipient of a PhD studentship award from the Fonds de Recherche du Quebec-Sante (FRQS). SLL was the recipient of a PhD studentship award from the IUCPQ Research Center. FP had a FRQS Senior Scholarship.	Baar EL, 2016, AGING CELL, V15, P155, DOI 10.1111/acel.12425; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Brown JA, 2012, P NATL ACAD SCI USA, V109, P19202, DOI 10.1073/pnas.1217338109; Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598; Carter S, 2013, CLIN INTERV AGING, V8, P829, DOI 10.2147/CIA.S36367; Chen JS, 2018, BIOCHEM PHARMACOL, V152, P94, DOI 10.1016/j.bcp.2018.03.019; Chin CH, 2004, GENE DEV, V18, P1970, DOI 10.1101/gad.1213104; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dong YQ, 2015, TUMOR BIOL, V36, P1477, DOI 10.1007/s13277-014-2631-4; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Han XR, 2015, FASEB J, V29, P3054, DOI 10.1096/fj.14-259952; Higami Y, 2006, J NUTR, V136, P343, DOI 10.1093/jn/136.2.343; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jura M, 2016, AGE, V38, DOI 10.1007/s11357-016-9884-3; Karagiannides I, 2006, J BIOL CHEM, V281, P23025, DOI 10.1074/jbc.M513187200; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lelli A, 2015, HYPOXIA, V3, P45, DOI 10.2147/HP.S90555; Li Z, 2010, HORM METAB RES, V42, P787, DOI 10.1055/s-0030-1262854; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Meseure D, 2016, BRIT J CANCER, V114, P1395, DOI 10.1038/bjc.2016.123; Miard S, 2008, INT J OBESITY, V32, P1873, DOI 10.1038/ijo.2008.214; Miard S, 2017, ONCOL REP, V37, P2153, DOI 10.3892/or.2017.5468; Miard S, 2009, AGING CELL, V8, P449, DOI 10.1111/j.1474-9726.2009.00490.x; Muzumdar R, 2008, AGING CELL, V7, P438, DOI 10.1111/j.1474-9726.2008.00391.x; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Palmer AK, 2016, EXP GERONTOL, V86, P97, DOI 10.1016/j.exger.2016.02.013; RODBELL M, 1967, J BIOL CHEM, V242, P5751; Salle-Lefort S, 2016, INT J ONCOL, V49, P1731, DOI 10.3892/ijo.2016.3630; Schwarzer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046600; Toth MJ, 2000, EUR J CLIN NUTR, V54, pS121, DOI 10.1038/sj.ejcn.1601033; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; Wang SH, 2016, J CELL MOL MED, V20, P2299, DOI 10.1111/jcmm.12920; Wang SH, 2016, ONCOTARGET, V7, P37857, DOI [10.18632/oncotarget.9350, 10.18632/oncotarget.9347]; WELSH J, 1992, NUCLEIC ACIDS RES, V20, P4965, DOI 10.1093/nar/20.19.4965; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112; Yan CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep22640; Yu FJ, 2015, CELL CYCLE, V14, P3885, DOI 10.1080/15384101.2015.1120917; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhang L, 2011, AM J PHYSIOL-ENDOC M, V301, pE599, DOI 10.1152/ajpendo.00059.2011	50	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196603	10.1371/journal.pone.0196603	http://dx.doi.org/10.1371/journal.pone.0196603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746487	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700027
J	Patten, C; Levine, J; Pavlidis, I; Balls-Berry, J; Shah, A; Hughes, C; Brockman, T; Soto, MV; Witt, D; Koepp, G; Sinicrope, P; Richard, J				Patten, Christi; Levine, James; Pavlidis, Ioannis; Balls-Berry, Joyce; Shah, Arya; Hughes, Christine; Brockman, Tabetha; Soto, Miguel Valdez; Witt, Daniel; Koepp, Gabriel; Sinicrope, Pamela; Richard, Jamie			Survey of potential receptivity to robotic-assisted exercise coaching in a diverse sample of smokers and nonsmokers	PLOS ONE			English	Article							SMOKING-CESSATION; CIGARETTE-SMOKING; RANDOMIZED-TRIAL; INTERVENTION; TECHNOLOGY; WOMEN; PARTICIPATION; ACCEPTANCE; EFFICACY; ADULTS	A prior project found that an intensive (12 weeks, thrice weekly sessions) in-person, supervised, exercise coaching intervention was effective for smoking cessation among depressed women smokers. However, the sample was 90% White and of high socioeconomic status, and the intensity of the intervention limits its reach. One approach to intervention scalability is to deliver the supervised exercise coaching using a robotic human exercise trainer. This is done in real time via an iPad tablet placed on a mobile robotic wheel base and controlled remotely by an iOS device or computer. As an initial step, this preliminary study surveyed potential receptivity to a robotic-assisted exercise coaching intervention among 100 adults recruited in two community settings, and explored the association of technology acceptance scores with smoking status and other demographics. Participants watched a brief demonstration of the robot-delivered exercise coaching and completed a 19-item survey assessing socio-demographics and technology receptivity measured by the 8-item Technology Acceptance Scale (TAS). Open-ended written feedback was obtained, and content analysis was used to derive themes from these data. Respondents were: 40% female, 56% unemployed, 41% racial minority, 38% current smoker, and 58% depression history. Mean total TAS score was 34.0 (SD = 5.5) of possible 40, indicating overall very good receptivity to the robotic-assisted exercise intervention concept. Racial minorities and unemployed participants reported greater technology acceptance than White (p = 0.015) and employed (p<0.001) respondents. No association was detected between the TAS score and smoking status, depression, gender or age groups. Qualitative feedback indicated the robot was perceived as a novel, motivating, way to increase intervention reach and accessibility, and the wave of the future. Robotic technology has potential applicability for exercise coaching in a broad range of populations, including depressed smokers. Our next step will be to conduct a pilot trial to assess acceptability and potential efficacy of the robotic assisted exercise coaching intervention for smoking cessation.	[Patten, Christi; Hughes, Christine; Sinicrope, Pamela] Mayo Clin, Dept Psychol & Psychiat, Rochester, MN 55905 USA; [Levine, James; Koepp, Gabriel] Mayo Clin, Dept Obes Solut, Scottsdale, AZ USA; [Levine, James] Arizona State Univ, Obes Solut, Tempe, AZ USA; [Pavlidis, Ioannis] Univ Houston, Dept Comp Sci, Houston, TX 77204 USA; [Balls-Berry, Joyce] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Balls-Berry, Joyce; Brockman, Tabetha; Soto, Miguel Valdez] Mayo Clin, Off Community Engagement Res, Ctr Clin & Translat Sci, Rochester, MN USA; [Shah, Arya; Witt, Daniel] Mayo Clin, Sch Med, Rochester, MN USA; [Richard, Jamie] Rochester Area Family YMCA, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Arizona State University; Arizona State University-Tempe; University of Houston System; University of Houston; Mayo Clinic; Mayo Clinic; Mayo Clinic	Patten, C (corresponding author), Mayo Clin, Dept Psychol & Psychiat, Rochester, MN 55905 USA.	patten.christi@mayo.edu	Pavlidis, Ioannis/AAH-3817-2019	Witt, Daniel/0000-0002-9770-8042; Pavlidis, Ioannis/0000-0001-8025-2600; Patten, Christi/0000-0002-7194-8160	CTSA Grant from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1 TR000135]	CTSA Grant from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by CTSA Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and the funders had no role in the work of this manuscript.	American College of Sports Medicine, 2010, ACSMS GUIDELINES EXE; Anderson M., 2016, PEW RES CTR; Andrade AO, 2014, BIOMED SIGNAL PROCES, V10, P65, DOI 10.1016/j.bspc.2013.12.009; Barbash GI, 2010, NEW ENGL J MED, V363, P701, DOI 10.1056/NEJMp1006602; Bartlett Yvonne Kiera, 2017, J Med Internet Res, V19, pe124, DOI 10.2196/jmir.6616; Bernard P, 2015, J DUAL DIAGN, V11, P205, DOI 10.1080/15504263.2015.1113842; Bize R, 2010, TOB CONTROL, V19, P488, DOI 10.1136/tc.2009.030288; Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a; Brown RA, 2014, NICOTINE TOB RES, V16, P197, DOI 10.1093/ntr/ntt134; Chuttur M, 2009, WORK PAPERS INF SYST, P9, DOI DOI 10.1097/00001756-199612200-00068; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Evins AE, 2008, J CLIN PSYCHOPHARM, V28, P660, DOI 10.1097/JCP.0b013e31818ad7d6; French SA, 1998, J AM DIET ASSOC, V98, P198, DOI 10.1016/S0002-8223(98)00050-9; Giuseffi DL, 2011, STRESS HEALTH, V27, pE269, DOI 10.1002/smi.1389; Hall SM, 2006, AM J PUBLIC HEALTH, V96, P1808, DOI 10.2105/AJPH.2005.080382; Hulley S.B., 2013, DESIGNING CLIN RES E, V4th ed., P73; Jamal A, 2016, MMWR-MORBID MORTAL W, V65, P1205, DOI 10.15585/mmwr.mm6544a2; King WR, 2006, INFORM MANAGE-AMSTER, V43, P740, DOI 10.1016/j.im.2006.05.003; Krippendorff KH, 2013, CONTENT ANAL INTRO I, P42; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Levine JA, 2011, DIABETES, V60, P2667, DOI 10.2337/db11-1118; MacPherson L, 2010, J CONSULT CLIN PSYCH, V78, P55, DOI 10.1037/a0017939; Maddison R, 2014, ANN BEHAV MED, V48, P194, DOI 10.1007/s12160-014-9588-9; Marcus BH, 1999, ARCH INTERN MED, V159, P1229, DOI 10.1001/archinte.159.11.1229; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Passey M, 2014, ADDICTION, V109, P1049, DOI 10.1111/add.12548; Patten CA, 2017, NICOTINE TOB RES, V19, P77, DOI 10.1093/ntr/ntw208; Pew Research Center, 2022, MOB FACT SHEET; Provoost S, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6553; Ramsey A, 2016, J BEHAV HEALTH SER R, V43, P54, DOI 10.1007/s11414-014-9436-5; Skoogh J, 2010, ANN ONCOL, V21, P1905, DOI 10.1093/annonc/mdq058; Sorbi MJ, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.5.e38; Studts JL, 2006, CANCER EPIDEM BIOMAR, V15, P1825, DOI 10.1158/1055-9965.EPI-06-0393; Ussher MH, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002295.pub5; Vickers KS, 2009, NICOTINE TOB RES, V11, P985, DOI 10.1093/ntr/ntp101; Whiteley JA, 2012, AM J PREV MED, V43, P256, DOI 10.1016/j.amepre.2012.05.025; Wilcox S, 2011, CONTEMP CLIN TRIALS, V32, P931, DOI 10.1016/j.cct.2011.08.003; Williams JM, 2013, AM J PUBLIC HEALTH, V103, P1549, DOI 10.2105/AJPH.2013.301232	38	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197090	10.1371/journal.pone.0197090	http://dx.doi.org/10.1371/journal.pone.0197090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF3JM	29746530	Green Published, gold			2022-12-26	WOS:000431851700065
J	Kim, HS; Vargas, A; Eom, YS; Li, J; Yamamoto, KL; Craft, CM; Lee, EJ				Kim, Hwa Sun; Vargas, Andrew; Eom, Yun Sung; Li, Justin; Yamamoto, Kyra L.; Craft, Cheryl Mae; Lee, Eun-Jin			Tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina	PLOS ONE			English	Article							BREAST EPITHELIAL-CELLS; INHERITED PHOTORECEPTOR DEGENERATION; RAT MODEL; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; RD/RD MOUSE; GLUTAMATE RECEPTORS; 2ND-ORDER NEURONS; CONE DEGENERATION; MESANGIAL CELLS	Retinitis pigmentosa (RP), an inherited retinal degenerative disease, is characterized by a progressive loss of rod photoreceptors followed by loss of cone photoreceptors. Previously, when tissue inhibitor of metalloproteinase 1 (TIMP1), a key extracellular matrix (ECM) regulator that binds to and inhibits activation of Matrix metallopeptidase 9 (MMP9) was intravitreal injected into eyes of a transgenic rhodopsin rat model of RP, S334ter-line3, we discovered cone outer segments are partially protected. In parallel, we reported that a specific MMP9 and MMP2 inhibitor, SB-3CT, interferes with mechanisms leading to rod photoreceptor cell death in an MMP9 dependent manner. Here, we extend our initial rat studies to examine the potential of TIMP1 as a treatment in retinal degeneration by investigating neuroprotective effects in a classic mouse retinal degeneration model, rd(Pde6b-/-) (rd1). The results clearly demonstrate that intravitreal injections of TIMP1 produce extended protection to delay rod photoreceptor cell death. The mean total number of rods in whole-mount retinas was significantly greater in TIMP-treated rd1 retinas (postnatal (P) 30, P35 (P<0.0001) and P45 (P<0.05) than in saline-treated rd1 retinas. In contrast, SB-3CT did not delay rod cell death, leading us to further investigate alternative pathways that do not involve MMPs. In addition to inducing phosphorylated ERK1/2, TIMP1 significantly reduces BAX activity and delays attenuation of the outer nuclear layer (ONL). Physiological responses using scotopic electroretinograms (ERG) reveal b-wave amplitudes from TIMP1-treated retinas are significantly greater than from saline-treated rd1 retinas (P<0.05). In later degenerative stages of rd1 retinas, photopic b-wave amplitudes from TIMP1-treated rd1 retinas are significantly larger than from saline-treated rd1 retinas (P<0.05). Our findings demonstrate that TIMP1 delays photoreceptor cell death. Furthermore, this study provides new insights into how TIMP1 works in the mouse animal model of RP.	[Kim, Hwa Sun; Vargas, Andrew; Eom, Yun Sung; Li, Justin; Yamamoto, Kyra L.; Craft, Cheryl Mae; Lee, Eun-Jin] Univ Southern Calif, USC Roski Eye Inst, Dept Ophthalmol, MDA Vis Res,Keck Sch Med, Los Angeles, CA 90007 USA; [Craft, Cheryl Mae] Univ Southern Calif, Dept Integrat Anat Sci, Keck Sch Med, Los Angeles, CA USA; [Lee, Eun-Jin] Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA 90007 USA	University of Southern California; University of Southern California; University of Southern California	Lee, EJ (corresponding author), Univ Southern Calif, USC Roski Eye Inst, Dept Ophthalmol, MDA Vis Res,Keck Sch Med, Los Angeles, CA 90007 USA.; Lee, EJ (corresponding author), Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Los Angeles, CA 90007 USA.	eunjinl@usc.edu			VSoE Research Innovation Fund; USC; Research to Prevent Blindness; MDA Vision research foundation; William Hansen Sandberg Memorial Foundation	VSoE Research Innovation Fund; USC; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); MDA Vision research foundation; William Hansen Sandberg Memorial Foundation	This study was supported by the VSoE Research Innovation Fund (data collection and analysis); USC (data collection and analysis); Research to Prevent Blindness (data collection and analysis); MDA Vision research foundation (data collection and analysis); Dorie Miller, and the William Hansen Sandberg Memorial Foundation (preparation of the manuscript).	Ahuja S, 2008, INVEST OPHTH VIS SCI, V49, P1089, DOI 10.1167/iovs.07-0549; Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023; Akahane T, 2004, EXP CELL RES, V301, P158, DOI 10.1016/j.yexcr.2004.08.002; Al-Ubaidi MR, 2013, INVEST OPHTH VIS SCI, V54, P8119, DOI 10.1167/iovs.13-13536; Alexander CM, 1996, J CELL BIOL, V135, P1669, DOI 10.1083/jcb.135.6.1669; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Arango-Gonzalez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112142; Ashutosh, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.54; Baker AH, 1998, J CLIN INVEST, V101, P1478, DOI 10.1172/JCI1584; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Buch PK, 2006, MOL THER, V14, P700, DOI 10.1016/j.ymthe.2006.05.019; Buonfiglio DC, 2014, MOL VIS, V20, P742; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chao C, 2009, AM J INFECT DIS, V5, P307, DOI 10.3844/ajidsp.2009.307.313; Chin JR, 1997, DEVELOPMENT, V124, P1519; Chintala SK, 2002, J BIOL CHEM, V277, P47461, DOI 10.1074/jbc.M204824200; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Chua J, 2009, J COMP NEUROL, V514, P473, DOI 10.1002/cne.22029; Comitato A, 2014, INVEST OPHTH VIS SCI, V55, P3555, DOI 10.1167/iovs.14-13917; Concepcion F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010904; CORNELIUS LA, 1995, J INVEST DERMATOL, V105, P170, DOI 10.1111/1523-1747.ep12317080; Cuenca N, 2004, NEUROSCIENCE, V127, P301, DOI 10.1016/j.neuroscience.2004.04.042; Dalkara D, 2011, MOL THER, V19, P1602, DOI 10.1038/mt.2011.62; De Groef L, 2014, INVEST OPHTH VIS SCI, V55, P1953, DOI 10.1167/iovs.13-13630; DeMar J, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00059; Dong CJ, 2007, INVEST OPHTH VIS SCI, V48, P1410, DOI 10.1167/iovs.06-0890; Dunn FA, 2015, J NEUROSCI, V35, P2423, DOI 10.1523/JNEUROSCI.4284-14.2015; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; Fariss RN, 1998, BRIT J OPHTHALMOL, V82, P1329, DOI 10.1136/bjo.82.11.1329; Frasson M, 1999, INVEST OPHTH VIS SCI, V40, P2724; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; GARCIAFERNANDEZ JM, 1995, NEUROSCI LETT, V187, P33; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; German OL, 2008, J NEUROSCI RES, V86, P3503, DOI 10.1002/jnr.21813; Gibson R, 2013, J COMP NEUROL, V521, P1251, DOI 10.1002/cne.23284; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Gregory-Evans K, 2009, MOL VIS, V15, P962; Guedez L, 2001, AM J PATHOL, V158, P1207, DOI 10.1016/S0002-9440(10)64070-9; Guedez L, 1998, BLOOD, V92, P1342, DOI 10.1182/blood.V92.4.1342.416k22_1342_1349; Guo LJ, 2006, CALCIFIED TISSUE INT, V78, P285, DOI 10.1007/s00223-005-0092-x; Hansson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016185; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Hehr CL, 2005, DEVELOPMENT, V132, P3371, DOI 10.1242/dev.01908; Henriet P, 1999, APMIS, V107, P111, DOI 10.1111/j.1699-0463.1999.tb01533.x; HUANG PC, 1993, P NATL ACAD SCI USA, V90, P8484, DOI 10.1073/pnas.90.18.8484; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Ji Y, 2015, INVEST OPHTH VIS SCI, V56, P352, DOI 10.1167/iovs.14-15398; Ji Y, 2012, J COMP NEUROL, V520, P874, DOI 10.1002/cne.22800; Jimenez AJ, 1996, CELL TISSUE RES, V284, P193, DOI 10.1007/s004410050579; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; JOMARY C, 1995, J NEUROCHEM, V64, P2370; Jones BW, 2016, EXP EYE RES, V150, P149, DOI 10.1016/j.exer.2016.03.018; Jourquin J, 2005, EUR J NEUROSCI, V22, P2569, DOI 10.1111/j.1460-9568.2005.04426.x; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Jung YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038773; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kedzierski W, 1998, J NEUROSCI, V18, P4076; Kim B, 2014, INVEST OPHTH VIS SCI, V55, P2031, DOI 10.1167/iovs.13-13374; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Kong YX, 2009, INVEST OPHTH VIS SCI, V50, P5732, DOI 10.1167/iovs.09-3814; Kooragayala K, 2015, INVEST OPHTH VIS SCI, V56, P8428, DOI 10.1167/iovs.15-17901; Kucharska J, 2014, J NEUROCHEM, V130, P227, DOI 10.1111/jnc.12704; LaVail MM, 1997, EXP EYE RES, V65, P45, DOI 10.1006/exer.1997.0308; Li CH, 1999, J BIOL CHEM, V274, P25273, DOI 10.1074/jbc.274.36.25273; Li GY, 1999, CANCER RES, V59, P6267; Limb GA, 2002, AM J PATHOL, V160, P1847, DOI 10.1016/S0002-9440(10)61131-5; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; Lin HL, 2002, KIDNEY INT, V62, P60, DOI 10.1046/j.1523-1755.2002.00403.x; Lipinski DM, 2011, INVEST OPHTH VIS SCI, V52, P6617, DOI 10.1167/iovs.11-7932; Liu XW, 2005, CANCER RES, V65, P898; Liu XW, 2003, J BIOL CHEM, V278, P40364, DOI 10.1074/jbc.M302999200; LOLLEY RN, 1994, INVEST OPHTH VIS SCI, V35, P358; Magnoni S, 2007, GENE THER, V14, P621, DOI 10.1038/sj.gt.3302894; Manabe S, 2005, INVEST OPHTH VIS SCI, V46, P4747, DOI 10.1167/iovs.05-0128; Martin J, 2001, J AM SOC NEPHROL, V12, P88, DOI 10.1681/ASN.V12188; Matsuo T, 1998, JPN J OPHTHALMOL, V42, P377, DOI 10.1016/S0021-5155(98)00038-0; McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7; Miyata Y, 2012, CURR EYE RES, V37, P842, DOI 10.3109/02713683.2012.682635; MOLDAY RS, 1987, J CELL BIOL, V105, P2589, DOI 10.1083/jcb.105.6.2589; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; Nagase H, 1999, ANN NY ACAD SCI, V878, P1, DOI 10.1111/j.1749-6632.1999.tb07670.x; Nalluri S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137673; NIR I, 1990, EXP EYE RES, V51, P257, DOI 10.1016/0014-4835(90)90022-M; Nishiguchi KM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7006; Otani A, 2004, J CLIN INVEST, V114, P765, DOI 10.1172/JCI200421686; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Pierce EA, 2001, BIOESSAYS, V23, P605, DOI 10.1002/bies.1086; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Price BA, 2011, INVEST OPHTH VIS SCI, V52, P9728, DOI 10.1167/iovs.11-8654; Punzo C, 2007, INVEST OPHTH VIS SCI, V48, P849, DOI 10.1167/iovs.05-1555; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Puthussery T, 2009, EUR J NEUROSCI, V29, P1533, DOI 10.1111/j.1460-9568.2009.06728.x; Ray A, 2010, CELL TISSUE RES, V339, P481, DOI 10.1007/s00441-009-0916-5; Renault TT, 2013, METHODS, V61, P146, DOI 10.1016/j.ymeth.2013.03.030; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Sanftner LHM, 2001, MOL THER, V4, P622, DOI 10.1006/mthe.2001.0498; Schmid H, 2014, INVEST OPHTH VIS SCI, V55, P2777, DOI 10.1167/iovs.13-13372; Seiler MJ, 2017, INVEST OPHTH VIS SCI, V58, P614, DOI 10.1167/iovs.15-19028; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Shin JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167102; Shin JA, 2015, EXP EYE RES, V140, P41, DOI 10.1016/j.exer.2015.08.005; Strettoi E, 2003, VISION RES, V43, P867, DOI 10.1016/S0042-6989(02)00594-1; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Tan HK, 2003, MOL CELL NEUROSCI, V22, P98, DOI 10.1016/S1044-7431(02)00024-6; Touchard E, 2012, MOL THER, V20, P1559, DOI 10.1038/mt.2011.304; Tsagaraki I, 2010, CELL TISSUE RES, V342, P87, DOI 10.1007/s00441-010-1025-1; Vargas A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182389; Veleri S, 2015, DIS MODEL MECH, V8, P109, DOI 10.1242/dmm.017913; Vlachantoni D, 2011, HUM MOL GENET, V20, P322, DOI 10.1093/hmg/ddq467; WATANABE T, 1992, DEVELOPMENT, V114, P899; Xie XJ, 2014, DEVELOPMENT, V141, P3072, DOI 10.1242/dev.101972; Yamada E, 2001, HISTOL HISTOPATHOL, V16, P87, DOI 10.14670/HH-16.87; Yang L, 2004, INVEST OPHTH VIS SCI, V45, P648, DOI 10.1167/iovs.03-0827; Yu DY, 2000, INVEST OPHTH VIS SCI, V41, P3999; Yu DY, 2004, INVEST OPHTH VIS SCI, V45, P2013, DOI 10.1167/iovs.03-0845; Zeiss CJ, 1998, GENE, V225, P67, DOI 10.1016/S0378-1119(98)00521-6; Zencak D, 2013, P NATL ACAD SCI USA, V110, pE593, DOI 10.1073/pnas.1108297110; Zhang X, 2004, INVEST OPHTH VIS SCI, V45, P2374, DOI 10.1167/iovs.03-1239; Zhao L, 2015, EMBO MOL MED, V7, P1179, DOI 10.15252/emmm.201505298; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	127	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0197322	10.1371/journal.pone.0197322	http://dx.doi.org/10.1371/journal.pone.0197322			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742163	Green Published, Green Submitted, gold			2022-12-26	WOS:000431757400069
J	Lee, S; Zimmerman, ME; Narkhede, A; Nasrabady, SE; Tosto, G; Meier, IB; Benzinger, TLS; Marcus, DS; Fagan, AM; Fox, NC; Cairns, NJ; Holtzman, DM; Buckles, V; Ghetti, B; McDade, E; Martins, RN; Saykin, AJ; Masters, CL; Ringman, JM; Forster, S; Schofield, PR; Sperling, RA; Johnson, KA; Chhatwal, JP; Salloway, S; Correia, S; Jack, CR; Weiner, M; Bateman, RJ; Morris, JC; Mayeux, R; Brickman, AM				Lee, Seonjoo; Zimmerman, Molly E.; Narkhede, Atul; Nasrabady, Sara E.; Tosto, Giuseppe; Meier, Irene B.; Benzinger, Tammie L. S.; Marcus, Daniel S.; Fagan, Anne M.; Fox, Nick C.; Cairns, Nigel J.; Holtzman, David M.; Buckles, Virginia; Ghetti, Bernardino; McDade, Eric; Martins, Ralph N.; Saykin, Andrew J.; Masters, Colin L.; Ringman, John M.; Foerster, Stefan; Schofield, Peter R.; Sperling, Reisa A.; Johnson, Keith A.; Chhatwal, Jasmeer P.; Salloway, Stephen; Correia, Stephen; Jack, Clifford R., Jr.; Weiner, Michael; Bateman, Randall J.; Morris, John C.; Mayeux, Richard; Brickman, Adam M.		Dominantly Inherited Alzheimer Net	White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease	PLOS ONE			English	Article							ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; RECOMMENDATIONS; DEMENTIA; MICROBLEEDS	Introduction White matter hyperintensity (WMH) volume on MRI is increased among presymptomatic individuals with autosomal dominant mutations for Alzheimer' disease (AD). One potential explanation is that WMH, conventionally considered a marker of cerebrovascular disease, are a reflection of cerebral amyloid angiopathy (CAA) and that increased WMH in this population is a manifestation of this vascular form of primary AD pathology. We examined whether the presence of cerebral microbleeds, a marker of CAA, mediates the relationship between WMH and estimated symptom onset in individuals with and without autosomal dominant mutations for AD. Participants and methods Participants (n = 175, mean age = 41.1 years) included 112 with an AD mutation and 63 first-degree non-carrier controls. We calculated the estimated years from expected symptom onset (EYO) and analyzed baseline MRI data for WMH volume and presence of cerebral microbleeds. Mixed effects regression and tests of mediation were used to examine microbleed and WMH differences between carriers and non-carriers and to test the whether the association between WMH and mutation status is dependent on the presence of microbleeds. Results Mutation carriers were more likely to have microbleeds than non-carriers (p<0.05) and individuals with microbleeds had higher WMH volume than those without (p<0.05). Total WMH volume was increased in mutation carriers compared with non-carriers, up to 20 years prior to EYO, after controlling for microbleed status, as we demonstrated previously. Formal testing of mediation demonstrated that 21% of the association between mutation status and WMH was mediated by presence of microbleeds (p = 0.03) but a significant direct effect of WMH remained (p = 0.02) after controlling for presence of microbleeds. Discussion Although there is some co-dependency between WMH and microbleeds, the observed increases in WMH among mutation carriers does not appear to be fully mediated by this marker of CAA. The findings highlight the possibility that WMH represent a core feature of AD independent of vascular forms of beta amyloid.	[Lee, Seonjoo; Nasrabady, Sara E.; Mayeux, Richard] Res Fdn Mental Hyg Inc, New York, NY USA; [Lee, Seonjoo] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Zimmerman, Molly E.] Fordham Univ, Dept Psychol, Bronx, NY 10458 USA; [Zimmerman, Molly E.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Narkhede, Atul; Nasrabady, Sara E.; Tosto, Giuseppe; Meier, Irene B.; Mayeux, Richard; Brickman, Adam M.] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Tosto, Giuseppe; Mayeux, Richard; Brickman, Adam M.] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10027 USA; [Benzinger, Tammie L. S.; Marcus, Daniel S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Fagan, Anne M.; Holtzman, David M.; Buckles, Virginia; McDade, Eric; Bateman, Randall J.; Morris, John C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Fox, Nick C.] UCL Inst Neurol, Dementia Res Ctr, Dept Neurodegenerat Dis, London, England; [Cairns, Nigel J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Martins, Ralph N.] Edith Cowan Univ, Ctr Excellence Alzheimers Dis Res & Care, Sch Exercise Biomed & Hlth Sci, Perth, WA, Australia; [Saykin, Andrew J.] Indiana Univ Sch Med, Indiana Alzheimer Dis Ctr, Indianapolis, IN 46202 USA; [Saykin, Andrew J.] Indiana Univ Sch Med, Ctr Neuroimaging, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Masters, Colin L.] Univ Melbourne, Florey Inst, Parkville, Vic, Australia; [Ringman, John M.] Univ Southern Calif, Memory & Aging Ctr, Keck Sch Med, Los Angeles, CA USA; [Foerster, Stefan] TUM, German Ctr Neurodegenerat Dis DZNE Munchen & Tubi, Munich, Germany; [Foerster, Stefan] TUM, Dept Nucl Med, Munich, Germany; [Schofield, Peter R.] Neurosci Res Australia, Sydney, NSW, Australia; [Schofield, Peter R.] Univ New South Wales, Sydney, NSW, Australia; [Sperling, Reisa A.; Johnson, Keith A.; Chhatwal, Jasmeer P.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Sperling, Reisa A.; Johnson, Keith A.; Chhatwal, Jasmeer P.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Salloway, Stephen] Brown Univ, Alpert Med Sch, Butler Hosp, Providence, RI 02912 USA; [Salloway, Stephen] Brown Univ, Alpert Med Sch, Dept Neurol, Providence, RI 02912 USA; [Correia, Stephen] Brown Univ, Alpert Med Sch, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Jack, Clifford R., Jr.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Weiner, Michael] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Dept Radiol & Biomed Imaging, Ctr Imaging Neurodegenerat Dis, San Francisco, CA 94143 USA; [Weiner, Michael] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Weiner, Michael] Univ Calif San Francisco, Dept Radiol, 505 Parnassus Ave, San Francisco, CA USA; [Weiner, Michael] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Weiner, Michael] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Mayeux, Richard; Brickman, Adam M.] Columbia Univ, Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY 10027 USA	Columbia University; Fordham University; Yeshiva University; Albert Einstein College of Medicine; Columbia University; Columbia University; Washington University (WUSTL); Washington University (WUSTL); University of London; University College London; Washington University (WUSTL); Indiana University System; Indiana University Bloomington; Edith Cowan University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Southern California; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; Technical University of Munich; University of Munich; Neuroscience Research Australia; University of New South Wales Sydney; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Brown University; Butler Hospital Rhode Island; Brown University; Brown University; Mayo Clinic; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University	Brickman, AM (corresponding author), Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.; Brickman, AM (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10027 USA.; Brickman, AM (corresponding author), Columbia Univ, Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY 10027 USA.	amb2139@columbia.edu	Lee, Seonjoo/U-3494-2019; lee, seonjoo/ABB-9717-2020; Fox, Nick C/B-1319-2009; Benzinger, Tammie/L-6104-2013; Cairns, Nigel/AAB-9713-2020; Jack, Clifford R/F-2508-2010; Fox, Nick C/AAE-1849-2021; Schofield, Peter/C-9669-2011	lee, seonjoo/0000-0003-3177-6357; Fox, Nick C/0000-0002-6660-657X; Benzinger, Tammie/0000-0002-8114-0552; Cairns, Nigel/0000-0001-9858-3344; Jack, Clifford R/0000-0001-7916-622X; Fox, Nick C/0000-0002-6660-657X; Bateman, Randall/0000-0002-7729-1702; Masters, Colin/0000-0003-3072-7940; Morris, John/0000-0001-9820-5618; Martins, Ralph/0000-0002-4828-9363; Schofield, Peter/0000-0003-2967-9662	NIH/NIA [U19 AG032438, AG051348]; German Center for Neurodegenerative Diseases (DZNE); Raul Carrea Institute for Neurological Research (FLENI); Japan Agency for Medical Research and Development, AMED; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Dominantly Inherited Alzheimer's Network (DIAN) - National Institute on Aging (NIA) [UF1AG032438]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, TL1TR000449, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [UF1AG032438, P50AG005142, K01AG051348, U01AG032438, U19AG032438] Funding Source: NIH RePORTER; MRC [G0601846, G0801306, G116/143, G0401247, MR/M009106/1, UKDRI-1001] Funding Source: UKRI	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); German Center for Neurodegenerative Diseases (DZNE)(Helmholtz Association); Raul Carrea Institute for Neurological Research (FLENI); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Dominantly Inherited Alzheimer's Network (DIAN) - National Institute on Aging (NIA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by NIH/NIA U19 AG032438. SL is supported by NIH/NIA AG051348. This work was supported by the German Center for Neurodegenerative Diseases (DZNE), Raul Carrea Institute for Neurological Research (FLENI), with partial support by the Research and Development Grants for Dementia from Japan Agency for Medical Research and Development, AMED, and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; S.L. is supported by NIH/NIA AG051348. Data collection and sharing for this project was supported by The Dominantly Inherited Alzheimer's Network (DIAN, UF1AG032438) funded by the National Institute on Aging (NIA), the German Center for Neurodegenerative Diseases (DZNE), Raul Carrea Institute for Neurological Research (FLENI), Partial support by the Research and Development Grants for Dementia from Japan Agency for Medical Research and Development, AMED, and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI). This manuscript has been reviewed by DIAN Study investigators for scientific content and consistency of data interpretation with previous DIAN Study publications. We acknowledge the altruism of the participants and their families and contributions of the DIAN research and support staff at each of the participating sites for their contributions to this study.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Boulouis G, 2016, SEMIN NEUROL, V36, P233, DOI 10.1055/s-0036-1581993; Brickman AM, 2015, NEUROBIOL AGING, V36, P27, DOI 10.1016/j.neurobiolaging.2014.07.019; Cordonnier C, 2011, BRAIN, V134, P335, DOI 10.1093/brain/awq321; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Kantarci Kejal, 2013, Alzheimers Dement, V9, pS116, DOI 10.1016/j.jalz.2012.10.011; Kapasi A, 2017, ACTA NEUROPATHOL, V134, P171, DOI 10.1007/s00401-017-1717-7; Le Couteur David G, 2016, BMJ, V355, pi6771, DOI 10.1136/bmj.i6771; Lee S, 2016, ANN NEUROL, V79, P929, DOI 10.1002/ana.24647; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris John C, 2012, Clin Investig (Lond), V2, P975; Pearl J, 2014, PSYCHOL METHODS, V19, P459, DOI 10.1037/a0036434; Provenzano FA, 2013, JAMA NEUROL, V70, P455, DOI 10.1001/jamaneurol.2013.1321; Revesz T, 2009, ACTA NEUROPATHOL, V118, P115, DOI 10.1007/s00401-009-0501-8; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Ryan NS, 2015, NEUROBIOL AGING, V36, P3140, DOI 10.1016/j.neurobiolaging.2015.08.026; Ryan NS, 2012, BRAIN, V135, DOI 10.1093/brain/awr126; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Thanprasertsuk Sekh, 2014, Neurology, V83, P794, DOI 10.1212/WNL.0000000000000732; VanderWeele TJ, 2009, STAT INTERFACE, V2, P457; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8	24	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0195838	10.1371/journal.pone.0195838	http://dx.doi.org/10.1371/journal.pone.0195838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742105	Green Published, Green Submitted, gold			2022-12-26	WOS:000431757400015
J	Akeda, K; Yamaguchi, S; Matsushita, T; Kokubo, T; Murata, K; Takegami, N; Matsumine, A; Sudo, A				Akeda, Koji; Yamaguchi, Seiji; Matsushita, Tomiharu; Kokubo, Tadashi; Murata, Koichiro; Takegami, Norihiko; Matsumine, Akihiko; Sudo, Akihiro			Bioactive pedicle screws prepared by chemical and heat treatments improved biocompatibility and bone-bonding ability in canine lumbar spines	PLOS ONE			English	Article							IN-VIVO; TITANIUM IMPLANTS; SURFACE; FIXATION; TI; METAL; STABILIZATION; INTERFACE; COATINGS	Background Titanium (Ti)-6Al-4V alloy, which is widely used in spinal instrumentation with a pedicle screw (PS) system. However, significant clinical problems, including loosening and back out of PSs, persist. During the last decade, a novel technology that produces bioactive Ti from chemical and heat treatments has been reported that induces the spontaneous formation of a hydroxyapatite (HA) layer on the surface of Ti materials. The purpose of this study was to study the effect of bioactivation of Ti-6Al-4V PSs on the ability of HA formation in vitro and its biocompatibility and bone-bonding ability in vivo. Methods Ti-6V-4Al alloy PSs were prepared and bioactivated by NaOH-CaCl2-heat-water treatments. The HA-forming ability of bioactive PSs in simulated body fluid (SBF) was evaluated by field emission scanning electron microscopy (FE-SEM) and energy dispersive X-ray analysis (EDX). Six 11-month-old female beagle dogs were used for the in vivo study. Bioactive and control (without bioactivation) PSs were left and right randomly placed from L1 to L6. One and three months after surgery, lumbar spines were removed for biomechanical and histological analyses. Results In vitro: The surface analysis of bioactive PSs by FE-SEM and EDX showed substantial HA deposits over the entire surface. In vivo: The mean extraction torque was significantly higher for bioactive PSs compared to controls PSs (P<0.01); there was no significant difference in pull-out strength between control and bioactive PSs. Histologically, the contact area between bone tissue and screw surface showed no significant trend to be greater in bioactive PSs compared to control PSs (P = 0.06). Conclusions Bioactive PSs prepared by chemical and heat treatments formed layers of HA on the surface of screws in vitro that improved biocompatibility and bonding ability with bone in vivo. Bioactive PSs may reduce screw loosening to overcome the obstacles confronted in spinal instrumentation surgery.	[Akeda, Koji; Murata, Koichiro; Takegami, Norihiko; Sudo, Akihiro] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie, Japan; [Yamaguchi, Seiji; Matsushita, Tomiharu; Kokubo, Tadashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi, Japan; [Matsumine, Akihiko] Univ Fukui, Fac Med Sci, Dept Orthoped & Rehabil Med, Eiheiji, Japan	Mie University; Chubu University; University of Fukui	Akeda, K (corresponding author), Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie, Japan.	k_akeda@clin.medic.mie-u.ac.jp	Matsushita, Tomiharu/AAG-2432-2021; Souza, Lais/AAO-3018-2020	Akeda, Koji/0000-0001-9468-9387	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP16K45678]; Century Medical, Inc.	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Century Medical, Inc.	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI, grant-in-Aid for Scientific Research (C): Grant Number JP16K45678. This work was partially supported by the research grant form Century Medical, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksakal B, 2010, J APPL BIOMATER BIOM, V8, P33; Aldini NN, 2002, J ORTHOP RES, V20, P1217; BLOEBAUM RD, 1994, CLIN ORTHOP RELAT R, P19; Boos N, 1997, Eur Spine J, V6, P2, DOI 10.1007/BF01676569; Chen G, 2012, EUR SPINE J, V21, P1151, DOI 10.1007/s00586-011-2065-2; DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203; Fini M, 2003, J BIOMED MATER RES A, V66A, P176, DOI 10.1002/jbm.a.10605; Forster Yvonne, 2012, Biomatter, V2, P149, DOI 10.4161/biom.21563; Fujibayashi S, 2011, EUR SPINE J, V20, P1486, DOI 10.1007/s00586-011-1728-3; Fukuda A, 2011, ACTA BIOMATER, V7, P1379, DOI 10.1016/j.actbio.2010.09.026; Hacking SA, 2002, CLIN ORTHOP RELAT R, P24, DOI 10.1097/01.blo.0000038469.05771.3d; Hasegawa Toru, 2005, Spine J, V5, P239, DOI 10.1016/j.spinee.2004.11.010; JARCHO M, 1977, J BIOENG, V1, P79; Kawai T, 2015, J BIOMED MATER RES B, V103, P1069, DOI 10.1002/jbm.b.33281; Kawai T, 2013, J MATER SCI-MATER M, V24, P1707, DOI 10.1007/s10856-013-4919-0; Kawanabe K, 2009, J BIOMED MATER RES B, V90B, P476, DOI 10.1002/jbm.b.31309; Kim HM, 2003, J BIOMED MATER RES A, V67A, P1305, DOI 10.1002/jbm.a.20039; Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B; Kim HM, 2000, J MATER SCI-MATER M, V11, P555, DOI 10.1023/A:1008924102096; Kizuki T, 2010, ACTA BIOMATER, V6, P2836, DOI 10.1016/j.actbio.2010.01.007; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x; Lin TY, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-443; Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4; OHLIN A, 1994, SPINE, V19, P2774, DOI 10.1097/00007632-199412150-00007; Park HY, 2015, J KOREAN NEUROSURG S, V57, P100, DOI 10.3340/jkns.2015.57.2.100; Sanden B, 2004, J BONE JOINT SURG BR, V86B, P457, DOI 10.1302/0301-620X.86B3.14323; Sanden B, 2001, SPINE, V26, P2673, DOI 10.1097/00007632-200112150-00008; Sanden B, 2002, J BONE JOINT SURG BR, V84B, P387, DOI 10.1302/0301-620X.84B3.12388; Sanden B, 2001, EUR SPINE J, V10, P334, DOI 10.1007/s005860100291; Sengupta DK, 2012, ADV ORTHOP, V2012, DOI 10.1155/2012/424268; Shea TM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/748393; Shepperd JAN, 2005, J BONE JOINT SURG BR, V87B, P1046, DOI 10.1302/0301-620X.87B8.16692; SPIVAK JM, 1994, SPINE, V19, P955, DOI 10.1097/00007632-199404150-00015; Takemoto M, 2006, BIOMATERIALS, V27, P2682, DOI 10.1016/j.biomaterials.2005.12.014; Tian Y, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5612-2; Tokuhashi Y, 2008, SPINE, V33, P903, DOI 10.1097/BRS.0b013e31816b1eff; Upasani VV, 2009, SPINE, V34, P335, DOI 10.1097/BRS.0b013e318194878d; VILLANUEVA AR, 1974, STAIN TECHNOL, V49, P1, DOI 10.3109/10520297409116928; Wan SY, 2010, EUR SPINE J, V19, P2122, DOI 10.1007/s00586-010-1489-4; Wu JC, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.7.FOCUS11125; Yamaguchi S, 2011, J BIOMED MATER RES A, V97A, P135, DOI 10.1002/jbm.a.33036; Yamaguchi S, 2010, J MATER SCI-MATER M, V21, P439, DOI 10.1007/s10856-009-3904-0; Yan WQ, 1997, J BIOMED MATER RES, V37, P267, DOI 10.1002/(SICI)1097-4636(199711)37:2<267::AID-JBM17>3.0.CO;2-B	44	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196766	10.1371/journal.pone.0196766	http://dx.doi.org/10.1371/journal.pone.0196766			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734349	Green Submitted, gold, Green Published			2022-12-26	WOS:000431481700025
J	Guerfali, MM; Djobbi, W; Charaabi, K; Hamden, H; Fadhl, S; Marzouki, W; Dhaouedi, F; Chevrier, C				Guerfali, Meriem Msaad; Djobbi, Wafa; Charaabi, Kamel; Hamden, Heithem; Fadhl, Salma; Marzouki, Wafa; Dhaouedi, Ferjani; Chevrier, Claude			Evaluation of Providencia rettgeri pathogenicity against laboratory Mediterranean fruit fly strain (Ceratitis capitata)	PLOS ONE			English	Article							FEMALE DROSOPHILA-MELANOGASTER; STERILE INSECT TECHNIQUE; DIPTERA TEPHRITIDAE; SERRATIA-MARCESCENS; MASS-PRODUCTION; BACTERIA; RESISTANCE; FLIES; IDENTIFICATION; INFECTION	The Mediterranean fruit fly (medfly) Ceratitis capitata (Wiedemann) (Diptera: Tephritidae), is often referred to as the most severe agricultural pest. Its biological control is mainly through the Sterile Insect Technique (SIT). Colonization, mass-rearing conditions and the irradiation process impact the competitiveness of sterile males and disrupt symbiotic associations by favoring some bacterial species and suppressing others. Levels of Providencia species have been shown to fluctuate considerably in the gut of the medfly laboratory strain Vienna 8 under irradiation, increasing by up to 22%. This study aimed to determine the pathogenicity of Providencia rettgeri isolated from the gut of laboratory Vienna 8 medfly strains by examining the effects of 1) two different treatment doses on egg-hatching and development and 2) two infection methodologies (ingestion and injection) of male and female adults according to their mating status. Treatment of eggs with P. rettgeri (2%) significantly decreased the mean egg to pupae recovery rate. Our data showed significant high mortality in flies with both injection and ingestion after 24 hours without any effect of sex. Microbial counts demonstrated that the bacteria could proliferate and replicate in adult flies. There was a significant sex-dependent effect after infection, with mortality decreasing significantly for males more than females. Providencia rettgeri can be considered as a potential pathogen of C. capitata. Mating protected males and females against infection by P. rettgeri by triggering an immune response leading to double the levels of Cecropin being secreted compared to infected virgin adults, thus reducing the virulence of the bacteria.	[Guerfali, Meriem Msaad; Djobbi, Wafa; Charaabi, Kamel; Hamden, Heithem; Fadhl, Salma; Marzouki, Wafa; Dhaouedi, Ferjani] Natl Ctr Nucl Sci & Technol, LR16CNSTN01, Lab Biotechnol & Nucl Technol, Technopole Sidi Thabet, Tunis, Tunisia; [Chevrier, Claude] IRBI, Fac Sci & Technol, UMRCNRS, Tours, France	Centre National des Sciences Technologies Nucleaires; Institut National de Recherche d'Analyse Physico-Chimique	Guerfali, MM (corresponding author), Natl Ctr Nucl Sci & Technol, LR16CNSTN01, Lab Biotechnol & Nucl Technol, Technopole Sidi Thabet, Tunis, Tunisia.	msaad_tn@yahoo.fr	Charaabi, Kamel/P-1267-2017; Guerfali, Meriem Msaad/AAK-1475-2020; Msaad Guerfali, Meriem/U-1827-2017	Charaabi, Kamel/0000-0002-5402-1312; Msaad Guerfali, Meriem/0000-0001-9662-1116				Augustinos AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136459; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Behar A, 2008, J INSECT PHYSIOL, V54, P1377, DOI 10.1016/j.jinsphys.2008.07.011; Behar A, 2008, MOL ECOL, V17, P1375, DOI 10.1111/j.1365-294X.2008.03674.x; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; Behar Adi, 2009, P251; Ben Ami E, 2010, ISME J, V4, P28, DOI 10.1038/ismej.2009.82; Ben-Yosef M, 2008, PHYSIOL ENTOMOL, V33, P145, DOI 10.1111/j.1365-3032.2008.00617.x; BOMAN HG, 1972, NATURE, V237, P232, DOI 10.1038/237232a0; BRACKEN GK, 1967, J INVERTEBR PATHOL, V9, P130, DOI 10.1016/0022-2011(67)90054-7; Briceno RD, 1999, J KANSAS ENTOMOL SOC, V72, P17; CALKINS CO, 1984, J ECON ENTOMOL, V77, P198, DOI 10.1093/jee/77.1.198; Cayol JP, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P843; Chambers MC, 2014, INFECT IMMUN, V82, P4380, DOI 10.1128/IAI.02415-14; Daffonchio D, 1998, INT J SYST BACTERIOL, V48, P107, DOI 10.1099/00207713-48-1-107; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; DESOUZA HML, 1988, ENTOMOL EXP APPL, V49, P195; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dyck V.A., 2006, STERILE INSECT TECHN; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Fedorka KM, 2007, P ROY SOC B-BIOL SCI, V274, P1211, DOI 10.1098/rspb.2006.0394; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Galac MR, 2011, MICROBES INFECT, V13, P673, DOI 10.1016/j.micinf.2011.02.005; Gavriel S, 2011, J APPL ENTOMOL, V135, P564, DOI 10.1111/j.1439-0418.2010.01605.x; Giammanco GM, 2011, INT J SYST EVOL MICR, V61, P1638, DOI 10.1099/ijs.0.021964-0; Gomulski LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030857; Guerfali M. M'Saad, 2007, P535, DOI 10.1007/978-1-4020-6059-5_50; Guerfali MM, 2011, FLA ENTOMOL, V94, P1042, DOI 10.1653/024.094.0443; Hamden H, 2013, J ECON ENTOMOL, V106, P641, DOI 10.1603/EC12362; Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2; Innocenti P, 2009, J EVOLUTION BIOL, V22, P964, DOI 10.1111/j.1420-9101.2009.01708.x; Juneja P, 2010, MOL BIOL EVOL, V27, P2284, DOI 10.1093/molbev/msq114; Kaneshiro KY, 1998, ETHOL ECOL EVOL, V10, P369; Kaya, 1993, INSECT PATHOLOGY; Klassen W., 2005, STERILE INSECT TECHN, P40; Knipling EF, 1995, J ECON ENTOMOL, V48, P902; Kounatidis I, 2009, APPL ENVIRON MICROB, V75, P3281, DOI 10.1128/AEM.02933-08; Krieg A., 1987, P323; Kuzina LV, 2001, CURR MICROBIOL, V42, P290, DOI 10.1007/s002840010219; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; Lance DR, 2000, ANN ENTOMOL SOC AM, V93, P1179, DOI 10.1603/0013-8746(2000)093[1179:CASAWC]2.0.CO;2; Lauzon CR, 2009, ANN ENTOMOL SOC AM, V102, P85, DOI 10.1603/008.102.0109; Lauzon CR, 2003, CONT T ENT, P115; Lazzaro BP, 2006, GENETICS, V174, P1539, DOI 10.1534/genetics.105.054593; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Liquido N.J., 2013, MEDHOST ENCY BIBLIO; LIQUIDO NJ, 1990, J ECON ENTOMOL, V83, P1863, DOI 10.1093/jee/83.5.1863; Lux SA, 2002, FLA ENTOMOL, V85, P102, DOI 10.1653/0015-4040(2002)085[0102:EOIOTC]2.0.CO;2; LYSENKO O, 1985, ANNU REV MICROBIOL, V39, P673; Ma Q, 2012, ISME J, V6, P1356, DOI 10.1038/ismej.2011.210; Mack PD, 2006, P NATL ACAD SCI USA, V103, P10358, DOI 10.1073/pnas.0604046103; Magana C, 2007, J ECON ENTOMOL, V100, P1836, DOI 10.1603/0022-0493(2007)100[1836:RTMIFP]2.0.CO;2; Marchini D, 1997, BIOCHEM BIOPH RES CO, V240, P657, DOI 10.1006/bbrc.1997.7694; McInnis DO, 1996, ANN ENTOMOL SOC AM, V89, P739, DOI 10.1093/aesa/89.5.739; Mramba F, 2006, J FOOD PROTECT, V69, P671, DOI 10.4315/0362-028X-69.3.671; Msaad Guerfali M, 2001, J ECON ENTOMOL, V104, P188; O'Hara CM, 2000, CLIN MICROBIOL REV, V13, P534, DOI 10.1128/CMR.13.4.534-546.2000; Ohkusu K, 2000, J CLIN MICROBIOL, V38, P4586, DOI 10.1128/JCM.38.12.4586-4592.2000; Onstad D, 2006, ABRIDGED GLOSSARY TE; Payne M, 2015, EUR J CLIN MICROBIOL, V34, P303, DOI 10.1007/s10096-014-2235-3; PODGWAITE JD, 1976, J INVERTEBR PATHOL, V27, P199, DOI 10.1016/0022-2011(76)90146-4; Rolff J, 2002, P NATL ACAD SCI USA, V99, P9916, DOI 10.1073/pnas.152271999; ROSETTO M, 1993, GENE, V134, P241, DOI 10.1016/0378-1119(93)90100-H; Rosetto M, 1997, INSECT BIOCHEM MOLEC, V27, P1039, DOI 10.1016/S0965-1748(97)00090-8; Roth O, 2011, J EVOLUTION BIOL, V24, P1410, DOI 10.1111/j.1420-9101.2011.02273.x; SCHWARZ AJ, 1985, FLA ENTOMOL, V68, P467, DOI 10.2307/3495135; SEO ST, 1990, J ECON ENTOMOL, V83, P1948, DOI 10.1093/jee/83.5.1949; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Short SM, 2012, J INSECT PHYSIOL, V58, P1192, DOI 10.1016/j.jinsphys.2012.06.002; Short SM, 2010, P ROY SOC B-BIOL SCI, V277, P3649, DOI 10.1098/rspb.2010.0937; TANAKA N, 1969, J ECON ENTOMOL, V62, P967, DOI 10.1093/jee/62.4.967; Taylor PW, 2001, PHYTOPARASITICA, V29, P7, DOI 10.1007/BF02981808; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargas R., 1989, WORLD CROP PESTS FRU, V3, P141; Wigby S, 2008, J INSECT PHYSIOL, V54, P414, DOI 10.1016/j.jinsphys.2007.10.010; ZUK M, 1990, PARASITOL TODAY, V6, P231, DOI 10.1016/0169-4758(90)90202-F	77	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196343	10.1371/journal.pone.0196343	http://dx.doi.org/10.1371/journal.pone.0196343			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734397	Green Published, Green Submitted, gold			2022-12-26	WOS:000431481700012
J	Fricke, IB; De Souza, R; Ayub, LC; Francia, G; Kerbel, R; Jaffray, DA; Zheng, JZ				Fricke, Inga B.; De Souza, Raquel; Ayub, Lais Costa; Francia, Giulio; Kerbel, Robert; Jaffray, David A.; Zheng, Jinzi			Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2(+) and triple negative metastatic breast cancer xenograft models in mice	PLOS ONE			English	Article							CYCLOPHOSPHAMIDE; TRASTUZUMAB; RESISTANCE; BEHAVIOR; THERAPY; PET/CT	Background Preclinical breast cancer models recapitulating the clinical course of metastatic disease are crucial for drug development. Highly metastatic cell lines forming spontaneous metastasis following orthotopic implantation were previously developed and characterized regarding their biological and histological characteristics. This study aimed to non-invasively and longitudinally characterize the spatiotemporal pattern of metastasis formation and progression in the MDA-MB-231-derived triple negative LM2-4 and HER2(+) LM2-4H2N cell lines, using bioluminescence imaging (BLI), contrast enhanced computed tomography (CT), fluorescence imaging, and 2-deoxy-2-[fluorine-18]fluoro-D-glucose positron emission tomography ([F-18]FDG-PET). Material and methods LM2-4, LM2-4H2N, and MDA-MB-231 tumors were established in the right inguinal mammary fat pad (MFP) of female SCID mice and resected 14-16 days later. Metastasis formation was monitored using BLI. Metabolic activity of primary and metastatic lesions in mice bearing LM2-4 or LM2-4H2N was assessed by [F-18]FDG-PET. Metastatic burden at study endpoint was assessed by CT and fluorescence imaging following intravenous dual-modality liposome agent administration. Results Comparable temporal metastasis patterns were observed using BLI for the highly metastatic cell lines LM2-4 and LM2-4H2N, while metastasis formed about 10 days later for MDA-MB- 231. 21 days post primary tumor resection, metastases were detected in 86% of LM2-4, 69% of LM2-4H2N, and 60% of MDA-MB-231 inoculated mice, predominantly in the axillary region, contralateral MFP, and liver/lung. LM2-4 and LM2-4H2N tumors displayed high metabolism based on [F-18]FDG-PET uptake. Lung metastases were detected as the [F-18] FDG-PET uptake increased significantly between pre- and post-metastasis scan. Using a liposomal dual-modality agent, CT and fluorescence confirmed BLI detected lesions and identified additional metastatic nodules in the intraperitoneal cavity and lung. Conclusions The combination of complementary anatomical and functional imaging techniques can provide high sensitivity characterization of metastatic disease spread, progression and overall disease burden. The described models and imaging toolset can be implemented as an effective means for quantitative treatment response evaluation in metastatic breast cancer.	[Fricke, Inga B.; De Souza, Raquel; Jaffray, David A.; Zheng, Jinzi] Univ Hlth Network, TECHNA Inst Adv Technol Hlth, Toronto, ON, Canada; [Fricke, Inga B.; Jaffray, David A.; Zheng, Jinzi] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [De Souza, Raquel; Ayub, Lais Costa] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Francia, Giulio; Kerbel, Robert] Univ Toronto, Dept Med Biophys, Sunnybrook Res Inst, Biol Sci Platform, Toronto, ON, Canada; [Jaffray, David A.] Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada; [Francia, Giulio] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Texas System; University of Texas El Paso	Fricke, IB (corresponding author), Univ Hlth Network, TECHNA Inst Adv Technol Hlth, Toronto, ON, Canada.; Fricke, IB (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	inga.Fricke@rmp.uhn.ca		Jaffray, David/0000-0001-7378-7543; Fricke, Inga/0000-0002-8386-3375	Fidani Chair in Radiation Physics; Dr. Jinzi Zheng's TECHNA Faculty Start-up Fund; MITACS Accelerate Post-doctoral Fellowship	Fidani Chair in Radiation Physics; Dr. Jinzi Zheng's TECHNA Faculty Start-up Fund; MITACS Accelerate Post-doctoral Fellowship	This work was supported in-part by the Fidani Chair in Radiation Physics, Dr. Jinzi Zheng's TECHNA Faculty Start-up Fund, and a MITACS Accelerate Post-doctoral Fellowship awarded to Dr. Inga Fricke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiseshaiah Pavan P, 2014, Int J Mol Imaging, V2014, P102702, DOI 10.1155/2014/102702; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Bernards N, 2017, LIPOSOME IRINO UNPUB; Bridgeman VL, 2017, J PATHOL, V241, P362, DOI 10.1002/path.4845; Cruz-Munoz W, 2008, CANCER RES, V68, P4500, DOI 10.1158/0008-5472.CAN-08-0041; Deroose CM, 2007, J NUCL MED, V48, P295; du Manoir JM, 2006, CLIN CANCER RES, V12, P904, DOI 10.1158/1078-0432.CCR-05-1109; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Francia G, 2009, CLIN CANCER RES, V15, P6358, DOI 10.1158/1078-0432.CCR-09-0931; Goldstein RH, 2010, J BONE MINER RES, V25, P431, DOI 10.1002/jbmr.68; Groheux D, 2016, J NUCL MED, V57, p17S, DOI 10.2967/jnumed.115.157859; Guerin E, 2013, CANCER RES, V73, P2743, DOI 10.1158/0008-5472.CAN-12-4183; Harbeck N, 2017, LANCET, V389, P1134, DOI [10.1016/s0140-6736(16)31891-8, 10.1016/S0140-6736(16)31891-8]; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kerbel RS, 2015, CANCER J, V21, P274, DOI 10.1097/PPO.0000000000000134; Kitajima K, 2016, JPN J RADIOL, V34, P167, DOI 10.1007/s11604-015-0516-0; Leone JP, 2015, EXP HEMATOL ONCOL, V4, DOI 10.1186/s40164-015-0028-8; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lin NU, 2008, CANCER-AM CANCER SOC, V113, P2638, DOI 10.1002/cncr.23930; Lin NU, 2007, CLIN CANCER RES, V13, P1648, DOI 10.1158/1078-0432.CCR-06-2478; Man S, 2007, CANCER METAST REV, V26, P737, DOI 10.1007/s10555-007-9087-6; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Milsom CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071270; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Reddy S, 2012, ONCOLOGIST, V17, P1014, DOI 10.1634/theoncologist.2012-0043; Savci-Heijink CD, 2015, BREAST CANCER RES TR, V150, P547, DOI 10.1007/s10549-015-3352-0; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; SOM P, 1980, J NUCL MED, V21, P670; Soni A, 2015, AM J CLIN PATHOL, V143, P471, DOI 10.1309/AJCPYO5FSV3UPEXS; Wang H, 2016, ONCOTARGET, V8, p26368 ; Zheng JZ, 2015, BIOMATERIALS, V67, P160, DOI 10.1016/j.biomaterials.2015.07.010	31	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196892	10.1371/journal.pone.0196892	http://dx.doi.org/10.1371/journal.pone.0196892			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723251	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100086
J	Grinstein, A; Kodra, E; Chen, S; Sheldon, S; Zik, O				Grinstein, Amir; Kodra, Evan; Chen, Stone; Sheldon, Seth; Zik, Ory			Carbon innumeracy	PLOS ONE			English	Article							CLIMATE-CHANGE; CALORIE ESTIMATION; FOOD; CONSUMPTION; PERCEPTIONS; PERSPECTIVE; EMISSIONS; POLICIES; WEIGHT	Individuals must have a quantitative understanding of the carbon footprint tied to their everyday decisions to make efficient sustainable decisions. We report research of the innumeracy of individuals as it relates to their carbon footprint. In three studies that varied in terms of scale and sample, respondents estimate the quantity of CO2 released when combusting a gallon of gasoline in comparison to several well-known metrics including food calories and travel distance. Consistently, respondents estimated the quantity of CO2 from gasoline compared to other metrics with significantly less accuracy while exhibiting a tendency to underestimate CO2. Such relative absence of carbon numeracy of even a basic consumption habit may limit the effectiveness of environmental policies and campaigns aimed at changing individual behavior. We discuss several caveats as well as opportunities for policy design that could aid the improvement of people's quantitative understanding of their carbon footprint.	[Grinstein, Amir] Northeastern Univ, Mkt, DAmore McKim Sch Business, Boston, MA 02115 USA; [Grinstein, Amir] Vrije Univ Amsterdam, Sch Econ & Business Adm, Mkt, Amsterdam, Netherlands; [Kodra, Evan; Chen, Stone] RisQ Inc, Cambridge, MA USA; [Sheldon, Seth] Sheldon Data, Athens, OH USA; [Zik, Ory] Oryzik Com, Brookline, MA 02446 USA	Northeastern University; Vrije Universiteit Amsterdam	Grinstein, A (corresponding author), Northeastern Univ, Mkt, DAmore McKim Sch Business, Boston, MA 02115 USA.; Grinstein, A (corresponding author), Vrije Univ Amsterdam, Sch Econ & Business Adm, Mkt, Amsterdam, Netherlands.; Zik, O (corresponding author), Oryzik Com, Brookline, MA 02446 USA.	a.grinstei@neu.edu; zikory@gmail.com			Northeastern University; risQ Inc.; Sheldon Data	Northeastern University; risQ Inc.; Sheldon Data	This study was supported in part by a research budget provided by Northeastern University to AG. Additionally, risQ Inc. and Sheldon Data provided support in the form of salaries for authors EK, SC, and SS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; Allen M., 2014, IPCC 5 ASSESSMENT SY; Ariely D, 2008, NY TIMES; Attari SZ, 2010, P NATL ACAD SCI USA, V107, P16054, DOI 10.1073/pnas.1001509107; Brown RE, 2016, MED SCI SPORT EXER, V48, P521, DOI 10.1249/MSS.0000000000000796; Carels RA, 2007, APPETITE, V49, P450, DOI 10.1016/j.appet.2007.02.009; Caverni J. P., 1990, COGNITIVE BIASES, V68; Chandon P, 2007, J CONSUM RES, V34, P301, DOI 10.1086/519499; Cohen MA, 2012, ENERG ECON, V34, pS53, DOI 10.1016/j.eneco.2012.08.032; Deloitte CIO Journal Editor, 2014, WALL STREET J; Diamantopoulos A, 2003, J BUS RES, V56, P465, DOI 10.1016/S0148-2963(01)00241-7; Dickerson CA, 2003, J APPL SOC PSYCHOL, V22, P841; Dietz T, 2010, P NATL ACAD SCI USA, V107, P16007, DOI 10.1073/pnas.1010651107; Gadema Z, 2011, FOOD POLICY, V36, P815, DOI 10.1016/j.foodpol.2011.08.001; Gardner GT, 2008, ENVIRONMENT, V50, P12, DOI 10.3200/ENVT.50.5.12-25; Grant D, 2014, NAT CLIM CHANGE, V4, P977, DOI 10.1038/NCLIMATE2385; Guenther M, 2012, CARBON MANAG, V3, P445, DOI 10.4155/CMT.12.50; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kahneman D., 2011, THINKING FAST SLOW; Khachatryan H, 2013, J ENVIRON PSYCHOL, V34, P97, DOI 10.1016/j.jenvp.2013.01.001; Kidwell B, 2013, J CONSUM RES, V40, P350, DOI 10.1086/670610; Kiszko KM, 2014, J COMMUN HEALTH, V39, P1248, DOI 10.1007/s10900-014-9876-0; Kodra E, 2015, ENVIRON SCI TECHNOL, V49, P13692, DOI 10.1021/acs.est.5b03015; Krizan Z, 2007, PSYCHOL BULL, V133, P95, DOI 10.1037/0033-2909.133.1.95; MITTAL B, 1995, PSYCHOL MARKET, V12, P663, DOI 10.1002/mar.4220120708; Nail PR, 2009, J EXP SOC PSYCHOL, V45, P901, DOI 10.1016/j.jesp.2009.04.013; Pandey D, 2011, ENVIRON MONIT ASSESS, V178, P135, DOI 10.1007/s10661-010-1678-y; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Shen JY, 2008, J ENVIRON PSYCHOL, V28, P42, DOI 10.1016/j.jenvp.2007.10.003; Sterman JD, 2007, CLIMATIC CHANGE, V80, P213, DOI 10.1007/s10584-006-9107-5; Stern PC, 2000, J SOC ISSUES, V56, P407, DOI 10.1111/0022-4537.00175; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Tukker A, 2010, J IND ECOL, V14, P13, DOI 10.1111/j.1530-9290.2009.00208.x; Tversky A, 1975, UTILITY PROBABILITY, P141, DOI DOI 10.1007/978-94-010-1834-0_8; Whitmarsh L, 2011, GLOBAL ENVIRON CHANG, V21, P56, DOI 10.1016/j.gloenvcha.2010.07.011; Williams JH, 2012, SCIENCE, V335, P53, DOI 10.1126/science.1208365; Zik O, 2013, SUSTAIN SCI, V8, P295, DOI 10.1007/s11625-012-0177-1	38	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196282	10.1371/journal.pone.0196282	http://dx.doi.org/10.1371/journal.pone.0196282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE6AF	29723206	gold, Green Published, Green Submitted			2022-12-26	WOS:000431305100020
J	Mirrasekhian, E; Nilsson, JLA; Shionoya, K; Blomgren, A; Zygmunt, PM; Engblom, D; Hogestatt, ED; Blomqvist, A				Mirrasekhian, Elahe; Nilsson, Johan L. A.; Shionoya, Kiseko; Blomgren, Anders; Zygmunt, Peter M.; Engblom, David; Hoegestaett, Edward D.; Blomqvist, Anders			The antipyretic effect of paracetamol occurs independent of transient receptor potential ankyrin 1-mediated hypothermia and is associated with prostaglandin inhibition in the brain	FASEB JOURNAL			English	Article						fever; TRPA1; N-acetyl cysteine; NAPQI; acetaminophen	ACETAMINOPHEN-INDUCED HYPOTHERMIA; LIPOPOLYSACCHARIDE-INDUCED FEVER; GENE-DERIVED PROTEIN; ENDOTHELIAL-CELLS; E SYNTHASE-1; N-ACETYLCYSTEINE; MICE; TRPA1; RESPONSES; AM404	The mode of action of paracetamol (acetaminophen), which is widely used for treating pain and fever, has remained obscure, but may involve several distinct mechanisms, including cyclooxygenase inhibition and transient receptor potential ankyrin 1 (TRPA1) channel activation, the latter being recently associated with paracetamol's propensity to elicit hypothermia at higher doses. Here, we examined whether the antipyretic effect of paracetamol was due to TRPA1 activation or cyclooxygenase inhibition. Treatment of wild-type and TRPA1 knockout mice rendered febrile by immune challenge with LPS with a dose of paracetamol that did not produce hypothermia (150 mg/kg) but is known to be analgetic, abolished fever in both genotypes. Paracetamol completely suppressed the LPS-induced elevation of prostaglandin E-2 in the brain and also reduced the levels of several other prostanoids. The hypothermia induced by paracetamol was abolished in mice treated with the electrophile-scavenger N-acetyl cysteine. We conclude that paracetamol's antipyretic effect in mice is dependent on inhibition of cyclooxygenase activity, including the formation of pyrogenic prostaglandin E-2, whereas paracetamol-induced hypothermia likely is mediated by the activation of TRPA1 by electrophilic metabolites of paracetamol, similar to its analgesic effect in some experimental paradigms.Mirrasekhian, E., Nilsson, J. L. angstrom., Shionoya, K., Blomgren, A., Zygmunt, P. M., Engblom, D., Hogestatt, E. D., Blomqvist, A. The antipyretic effect of paracetamol occurs independent of transient receptor potential ankyrin 1-mediated hypothermia and is associated with prostaglandin inhibition in the brain.	[Mirrasekhian, Elahe; Shionoya, Kiseko; Engblom, David; Blomqvist, Anders] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Nilsson, Johan L. A.; Blomgren, Anders; Zygmunt, Peter M.; Hoegestaett, Edward D.] Lund Univ, Dept Lab Med, Div Clin Chem & Pharmacol, S-22185 Lund, Sweden	Linkoping University; Lund University	Zygmunt, PM (corresponding author), Lund Univ, Dept Lab Med, Div Clin Chem & Pharmacol, S-22185 Lund, Sweden.; Blomqvist, A (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Neurobiol, S-58185 Linkoping, Sweden.	peter.zygmunt@med.lu.se; anders.blomqvist@liu.se		Zygmunt, Peter/0000-0002-5102-8199; Blomqvist, Anders/0000-0002-6928-4473	Swedish Medical Research Council [20725, 07879, 2014-3801]; European Research Council (ERC) Starting Grant; Knut and Alice Wallenberg Foundation; Swedish Brain Foundation; Swedish Cancer Foundation [16/0572]; County Council of Ostergotland; Medical Faculty of Lund University (ALF); AFA Insurance	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); European Research Council (ERC) Starting Grant(European Research Council (ERC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Brain Foundation; Swedish Cancer Foundation; County Council of Ostergotland; Medical Faculty of Lund University (ALF); AFA Insurance	The authors thank Anna Eskilsson (Linkoping University, Linkoping, Sweden) for help with the illustrations. This study was supported by the Swedish Medical Research Council (20725 to D.E., 07879 to A.B., and 2014-3801 to P.M.Z. and E.D.H.), the European Research Council (ERC) Starting Grant (to D.E.), the Knut and Alice Wallenberg Foundation (to D.E.), the Swedish Brain Foundation (to D.E. and A.B.), the Swedish Cancer Foundation (16/0572 to A.B.), the County Council of Ostergotland (to D.E. and A.B.),the Medical Faculty of Lund University (ALF; to E.D.H. and P.M.Z.) and AFA Insurance (to E.D.H. and P.M.Z.). The authors declare no conflicts of interest.	Anderson BJ, 2008, PEDIATR ANESTH, V18, P915, DOI 10.1111/j.1460-9592.2008.02764.x; Andersson DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046917; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; Ayoub SS, 2006, EUR J PHARMACOL, V538, P57, DOI 10.1016/j.ejphar.2006.03.061; Ayoub SS, 2004, P NATL ACAD SCI USA, V101, P11165, DOI 10.1073/pnas.0404185101; Bar-Or D, 2015, REDOX BIOL, V4, P340, DOI 10.1016/j.redox.2015.01.006; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Boutaud O, 2002, P NATL ACAD SCI USA, V99, P7130, DOI 10.1073/pnas.102588199; DOHERTY NS, 1990, BRIT J PHARMACOL, V101, P869, DOI 10.1111/j.1476-5381.1990.tb14173.x; Eberhardt M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5381; Engblom D, 2003, NAT NEUROSCI, V6, P1137, DOI 10.1038/nn1137; Engstrom L, 2012, ENDOCRINOLOGY, V153, P4849, DOI 10.1210/en.2012-1375; Eskilsson A, 2014, J NEUROSCI, V34, P15957, DOI 10.1523/JNEUROSCI.3520-14.2014; FELDBERG W, 1973, J PHYSIOL-LONDON, V228, P41, DOI 10.1113/jphysiol.1973.sp010071; FLOWER R, 1972, NATURE-NEW BIOL, V238, P104, DOI 10.1038/newbio238104a0; FLOWER RJ, 1972, NATURE, V240, P410, DOI 10.1038/240410a0; Gentry C, 2015, SCI REP-UK, V5, DOI 10.1038/srep12771; Hogestatt ED, 2005, J BIOL CHEM, V280, P31405, DOI 10.1074/jbc.M501489200; Li SX, 2008, PROSTAG OTH LIPID M, V85, P89, DOI 10.1016/j.prostaglandins.2007.10.007; Mallet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012748; Meseguer V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4125; Moparthi L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28763; Nilsberth C, 2009, J NEUROENDOCRINOL, V21, P715, DOI 10.1111/j.1365-2826.2009.01888.x; Ouellet M, 2001, ARCH BIOCHEM BIOPHYS, V387, P273, DOI 10.1006/abbi.2000.2232; Raskovic A, 2014, MOLECULES, V19, P3869, DOI 10.3390/molecules19043869; Rudaya AY, 2005, AM J PHYSIOL-REG I, V289, pR1244, DOI 10.1152/ajpregu.00370.2005; Ruud LE, 2013, NEUROPHARMACOLOGY, V71, P124, DOI 10.1016/j.neuropharm.2013.03.012; Saha S, 2005, AM J PHYSIOL-REG I, V288, pR1100, DOI 10.1152/ajpregu.00872.2004; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Steiner AA, 2006, BLOOD, V107, P4000, DOI 10.1182/blood-2005-11-4743; Streng T, 2008, EUR UROL, V53, P391, DOI 10.1016/j.eururo.2007.10.024; Tateishi T, 1998, ACTA ANAESTH SCAND, V42, P1028, DOI 10.1111/j.1399-6576.1998.tb05371.x; WALKER RM, 1981, TOXICOL APPL PHARM, V59, P500, DOI 10.1016/0041-008X(81)90303-3; Wilhelms DB, 2014, J NEUROSCI, V34, P11684, DOI 10.1523/JNEUROSCI.1838-14.2014; Zygmunt PM, 2014, HANDB EXP PHARMACOL, V222, P583, DOI 10.1007/978-3-642-54215-2_23; Zygmunt PM, 2000, EUR J PHARMACOL, V396, P39, DOI 10.1016/S0014-2999(00)00207-7	37	18	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5751	5759		10.1096/fj.201800272R	http://dx.doi.org/10.1096/fj.201800272R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29738273	Bronze, Green Submitted			2022-12-26	WOS:000447972500045
J	Zhong, XC; Lee, HN; Kim, SH; Park, SA; Kim, W; Cha, YN; Surh, YJ				Zhong, Xiancai; Lee, Ha-Na; Kim, Seung Hyeon; Park, Sin-Aye; Kim, Wonki; Cha, Young-Nam; Surh, Young-Joon			Myc-nick promotes efferocytosis through M2 macrophage polarization during resolution of inflammation	FASEB JOURNAL			English	Article						c-Myc; phagocytosis; peritonitis; tubulin acetylation	APOPTOTIC CELLS; TUBULIN ACETYLATION; C-MYC; ENGULFMENT; RECEPTOR; CLEARANCE; PHAGOCYTOSIS; MECHANISMS; ALPHA; MICROTUBULES	A key event required for effective resolution of inflammation is efferocytosis, which is defined as phagocytic removal of apoptotic cells mostly by macrophages acquiring an alternatively activated phenotype (M2). c-Myc has been reported to play a role in alternative activation of human macrophages and is proposed as one of the M2 macrophage markers. We found that M2-like peritoneal macrophages from zymosan A-treated mice exhibited a marked accumulation of Myc-nick, a truncated protein generated by a Calpain-mediated proteolytic cleavage of full-length c-Myc. Further, ectopic expression of Myc-nick in murine bone marrow-derived macrophages promoted the M2 polarization and, consequently, enhanced their efferocytic capability. Notably, Myc-nick-induced efferocytosis was found to be tightly associated with -tubulin acetylation by K acetyltransferase 2a (Kat2a/Gcn5) activity. These findings suggest Myc-nick as a novel proresolving mediator that has a fundamental function in maintaining homeostasis under inflammatory conditions.Zhong, X., Lee, H.-N., Kim, S. H., Park, S.-A., Kim, W., Cha, Y.-N., Surh, Y.-J. Myc-nick promotes efferocytosis through M2 macrophage polarization during resolution of inflammation.	[Zhong, Xiancai; Lee, Ha-Na; Kim, Seung Hyeon; Park, Sin-Aye; Kim, Wonki; Surh, Young-Joon] Seoul Natl Univ, Tumor Microenvironm Global Core Res Ctr, Seoul, South Korea; [Zhong, Xiancai; Lee, Ha-Na; Kim, Seung Hyeon; Park, Sin-Aye; Kim, Wonki; Surh, Young-Joon] Seoul Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Seoul, South Korea; [Kim, Seung Hyeon; Surh, Young-Joon] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Surh, Young-Joon] Seoul Natl Univ, Grad Sch Convergence Sci, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Cha, Young-Nam] Inha Univ, Coll Med, Dept Pharmacol & Toxicol, Incheon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Inha University	Surh, YJ (corresponding author), Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro, Seoul 08826, South Korea.	surh@snu.ac.kr	Zhong, Xiancai/AAV-2761-2020; Zhong, Xiancai/AAM-3069-2020; Park, Sin-Aye/E-2303-2019	Zhong, Xiancai/0000-0001-8312-4057; Zhong, Xiancai/0000-0001-8312-4057; Park, Sin-Aye/0000-0003-2456-3572; Kim, Seung Hyeon/0000-0001-9197-5978	Global Core Research Center from the National Research Foundation of Korea [2011-0030001]	Global Core Research Center from the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Global Core Research Center Grant 2011-0030001 from the National Research Foundation of Korea. The authors declare no conflicts of interest.	Alessandri AL, 2013, PHARMACOL THERAPEUT, V139, P189, DOI 10.1016/j.pharmthera.2013.04.006; Anderson S, 2016, P NATL ACAD SCI USA, V113, pE5481, DOI 10.1073/pnas.1610994113; Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Conacci-Sorrell M, 2014, GENE DEV, V28, P689, DOI 10.1101/gad.231894.113; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Dayam RM, 2015, TRAFFIC, V16, P1010, DOI 10.1111/tra.12303; Donaldson JG., 2015, CURRENT PROTOCOLS, V69, p4.3.1; Etienne-Manneville S, 2013, ANNU REV CELL DEV BI, V29, P471, DOI 10.1146/annurev-cellbio-101011-155711; Flannagan RS, 2014, MOL BIOL CELL, V25, P1511, DOI 10.1091/mbc.E13-04-0212; Gilberti RM, 2015, MOL BIOL CELL, V26, P518, DOI 10.1091/mbc.E14-08-1301; Ginhoux F, 2017, TRENDS IMMUNOL, V38, P693, DOI 10.1016/j.it.2017.05.009; Grabiec AM, 2012, ANN RHEUM DIS, V71, P424, DOI 10.1136/ard.2011.154211; Grimaldi A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.73; Gronski MA, 2009, CELL DEATH DIFFER, V16, P1323, DOI 10.1038/cdd.2009.55; Hanayama R, 2004, J IMMUNOL, V172, P3876, DOI 10.4049/jimmunol.172.6.3876; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Harvey SR, 2012, J AM CHEM SOC, V134, P19384, DOI 10.1021/ja306519h; Hermetet F, 2016, BIOL CELL, V108, P189, DOI 10.1111/boc.201500090; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Holmes K, 2001, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0503s44; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Johnson DE, 2016, J CELL BIOL, V212, P677, DOI 10.1083/jcb.201507112; Khalil M, 2016, MUCOSAL IMMUNOL, V9, P1500, DOI 10.1038/mi.2016.16; Lavin B, 2014, ARTERIOSCL THROM VAS, V34, P1739, DOI 10.1161/ATVBAHA.114.303866; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Nishi C, 2014, MOL CELL BIOL, V34, P1512, DOI 10.1128/MCB.01394-13; Ono Y, 2016, NAT REV DRUG DISCOV, V15, P854, DOI 10.1038/nrd.2016.212; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park D, 2009, CURR BIOL, V19, P346, DOI 10.1016/j.cub.2009.01.042; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Pello OM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045399; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Portran D, 2017, NAT CELL BIOL, V19, P391, DOI 10.1038/ncb3481; Rai A, 2016, CELL, V164, P722, DOI 10.1016/j.cell.2015.12.054; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Tan HY, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2795090; Wang B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4479; Wang JD, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0226-x; Weavers H, 2016, CELL, V165, P1658, DOI 10.1016/j.cell.2016.04.049; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; Yan B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110718; Ying W., 2013, JOVE-J VIS EXP, V76	56	27	27	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5312	5325		10.1096/fj.201800223R	http://dx.doi.org/10.1096/fj.201800223R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29718706	Bronze			2022-12-26	WOS:000447972500010
J	Maurizi, G; Verma, N; Gadi, A; Mansukhani, A; Basilico, C				Maurizi, Giulia; Verma, Narendra; Gadi, Abhilash; Mansukhani, Alka; Basilico, Claudio			Sox2 is required for tumor development and cancer cell proliferation in osteosarcoma	ONCOGENE			English	Article							HIPPO PATHWAY; SELF-RENEWAL; MAINTAIN STEMNESS; ADULT; YAP; P53; RB	The stem cell transcription factor Sox2 is highly expressed in many cancers where it is thought to mark cancer stem cells (CSCs). In osteosarcomas, the most common bone malignancy, high Sox2 expression marks and maintains a fraction of tumor-initiating cells that show all the properties of CSC. Knockdown of Sox2 expression abolishes tumorigenicity and suppresses the CSC phenotype. Here we show that, in a mouse model of osteosarcoma, osteoblast-specific Sox2 conditional knockout (CKO) causes a drastic reduction in the frequency and onset of tumors. The rare tumors detected in the Sox2 CKO animals were all Sox2 positive, indicating that they arose from cells that had escaped Sox2 deletion. Furthermore, Sox2 inactivation in cultured osteosarcoma cells by CRISPR/CAS technology leads to a loss of viability and proliferation of the entire cell population. Inactivation of the YAP gene, a major Hippo pathway effector which is a direct Sox2 target, causes similar results and YAP overexpression rescues cells from the lethality caused by Sox2 inactivation. These effects were osteosarcoma-specific, suggesting a mechanism of cell "addiction" to Sox2-initiated pathways. The requirement of Sox2 for osteosarcoma formation as well as for the survival of the tumor cells suggests that disruption of Sox2-initiated pathways could be an effective strategy for the treatment of osteosarcoma.	[Maurizi, Giulia; Verma, Narendra; Gadi, Abhilash; Mansukhani, Alka; Basilico, Claudio] NYU Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University	Mansukhani, A; Basilico, C (corresponding author), NYU Sch Med, Dept Microbiol, New York, NY 10016 USA.	Alka.Mansukhani@med.nyu.edu; Claudio.Basilico@med.nyu.edu		Mansukhani, Alka/0000-0003-1020-3242; Maurizi, Giulia/0000-0003-0373-1370	NYSTEM [CO29560];  [NIH/NCI-R21CA186031]; NATIONAL CANCER INSTITUTE [R21CA186031] Funding Source: NIH RePORTER	NYSTEM; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported by NYSTEM contract CO29560 and NIH/NCI-R21CA186031. We thank Dr. Stuart Orkin for providing us with the Tp53, Rb mutant mice; Matthew Murtha for his contribution to some of the initial experiments; and Upal BasuRoy for helpful discussions. We also wish to acknowledge the Histopathology core services at NYU Langone Medical Center.	Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BASILICO C, 1969, J VIROL, V3, P140, DOI 10.1128/JVI.3.2.140-145.1969; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Basu-Roy U, 2010, CELL DEATH DIFFER, V17, P1345, DOI 10.1038/cdd.2010.57; Basu-Roy U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7411; Basu-Roy U, 2013, CANCER LETT, V338, P158, DOI 10.1016/j.canlet.2012.05.028; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Driessens G, 2011, CELL STEM CELL, V9, P283, DOI 10.1016/j.stem.2011.09.007; Ferone G, 2016, CANCER CELL, V30, P519, DOI 10.1016/j.ccell.2016.09.001; Guernet A, 2017, METHODS, V121, P130, DOI 10.1016/j.ymeth.2017.03.007; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liao SR, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv675; Mansouri Sheila, 2016, CNS Oncol, V5, P159, DOI 10.2217/cns-2016-0001; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Palumbo P, 2017, ONCOTARGET, V8, P25582, DOI 10.18632/oncotarget.16106; Rainusso N, 2013, CURR ONCOL REP, V15, P296, DOI 10.1007/s11912-013-0321-9; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Seo E, 2013, CELL REP, V3, P2075, DOI 10.1016/j.celrep.2013.05.029; Shahriyari L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076195; Siegle JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5511; Song WS, 2016, J CHIN MED ASSOC, V79, P538, DOI 10.1016/j.jcma.2016.03.010; Tafani M, 2014, CURR MED CHEM, V21, P1146, DOI 10.2174/0929867321666131129125624; Tan YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5619; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Weina K, 2016, PIGM CELL MELANOMA R, V29, P453, DOI 10.1111/pcmr.12483; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112	31	53	56	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 16	2018	37	33					4626	4632		10.1038/s41388-018-0292-2	http://dx.doi.org/10.1038/s41388-018-0292-2			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GQ5OV	29743593	Green Accepted			2022-12-26	WOS:000441736700010
J	Gluck, AA; Orlando, E; Leiser, D; Poliakova, M; Nisa, L; Quintin, A; Gavini, J; Stroka, DM; Berezowska, S; Bubendorf, L; Blaukat, A; Aebersold, DM; Medova, M; Zimmer, Y				Glueck, Astrid A.; Orlando, Eleonora; Leiser, Dominic; Poliakova, Michaela; Nisa, Lluis; Quintin, Aurelie; Gavini, Jacopo; Stroka, Deborah M.; Berezowska, Sabina; Bubendorf, Lukas; Blaukat, Andree; Aebersold, Daniel M.; Medova, Michaela; Zimmer, Yitzhak			Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1 alpha levels under hypoxia	ONCOGENE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; INDUCIBLE FACTOR-I; TYROSINE KINASE; MESSENGER-RNA; CANCER-CELLS; C-MET; TRANSCRIPTIONAL ACTIVATION; INVASIVE GROWTH; DNA-DAMAGE; EXPRESSION	Poor oxygenation is a common hallmark of solid cancers that strongly associates with aggressive tumor progression and treatment resistance. While a hypoxia-inducible factor 1 alpha (HIF-1 alpha)-associated transcriptional overexpression of the hepatocyte growth factor (HGF) receptor tyrosine kinase (RTK) MET has been previously documented, any regulation of the HIF-1a system through MET downstream signaling in hypoxic tumors has not been yet described. By using MET-driven in vitro as well as ex vivo tumor organotypic fresh tissue models we report that MET targeting results in depletion of HIF-1 alpha and its various downstream targets. Mechanistically, we provide evidence that MET regulates HIF-1 alpha levels through a protein translation mechanism that relies on phosphorylation modulation of the eukaryotic initiation factor 4G1 (eIF4G1) on serine 1232 (Ser-1232). Targeted phosphoproteomics data demonstrate a significant drop in eIF4G1 Ser-1232 phosphorylation following MET targeting, which is linked to an increased affinity between eIF4G1 and eIF4E. Since phosphorylation of eIF4G1 on Ser-1232 is largely mediated through mitogen-activated protein kinase (MAPK), we show that expression of a constitutively active K-RAS variant is sufficient to abrogate the inhibitory effect of MET targeting on the HIF-1 alpha pathway with subsequent resistance of tumor cells to MET targeting under hypoxic conditions. Analysis of The Cancer Genome Atlas data demonstrates frequent co-expression of MET, HIF-1 alpha and eIF4G1 in various solid tumors and its impact on disease-free survival of non-small cell lung cancer patients. Clinical relevance of the MET-eIF4G1-HIF-1 alpha pathway is further supported by a co-occurrence of their expression in common tumor regions of individual lung cancer patients.	[Glueck, Astrid A.; Orlando, Eleonora; Leiser, Dominic; Poliakova, Michaela; Nisa, Lluis; Quintin, Aurelie; Aebersold, Daniel M.; Medova, Michaela; Zimmer, Yitzhak] Bern Univ Hosp, Inselspital, Dept Radiat Oncol, CH-3010 Bern, Switzerland; [Glueck, Astrid A.; Orlando, Eleonora; Leiser, Dominic; Poliakova, Michaela; Nisa, Lluis; Quintin, Aurelie; Aebersold, Daniel M.; Medova, Michaela; Zimmer, Yitzhak] Univ Bern, CH-3010 Bern, Switzerland; [Glueck, Astrid A.; Orlando, Eleonora; Poliakova, Michaela; Nisa, Lluis; Quintin, Aurelie; Aebersold, Daniel M.; Medova, Michaela; Zimmer, Yitzhak] Bern Univ Hosp, Radiat Oncol, Inselspital, Dept BioMed Res, CH-3008 Bern, Switzerland; [Glueck, Astrid A.; Orlando, Eleonora; Poliakova, Michaela; Nisa, Lluis; Quintin, Aurelie; Gavini, Jacopo; Stroka, Deborah M.; Aebersold, Daniel M.; Medova, Michaela; Zimmer, Yitzhak] Univ Bern, CH-3008 Bern, Switzerland; [Gavini, Jacopo; Stroka, Deborah M.] Bern Univ Hosp, Inselspital, Dept BioMed Res Visceral & Transplantat Surg, CH-3008 Bern, Switzerland; [Berezowska, Sabina] Univ Bern, Inst Pathol, CH-3008 Bern, Switzerland; [Bubendorf, Lukas] Basel Univ Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Blaukat, Andree] Merck KGaA, Global Res & Dev, D-64293 Darmstadt, Germany	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Basel; Merck KGaA	Zimmer, Y (corresponding author), Bern Univ Hosp, Inselspital, Dept Radiat Oncol, CH-3010 Bern, Switzerland.; Zimmer, Y (corresponding author), Univ Bern, CH-3010 Bern, Switzerland.; Zimmer, Y (corresponding author), Bern Univ Hosp, Radiat Oncol, Inselspital, Dept BioMed Res, CH-3008 Bern, Switzerland.; Zimmer, Y (corresponding author), Univ Bern, CH-3008 Bern, Switzerland.	yitzhak.zimmer@insel.ch	Berezowska, Sabina/AAJ-4557-2021; Aebersold, Daniel Matthias/C-2946-2013; Bubendorf, Lukas/G-5299-2015	Berezowska, Sabina/0000-0001-5442-9791; Aebersold, Daniel Matthias/0000-0002-9493-3834; Bubendorf, Lukas/0000-0001-5970-1803; Medova, Michaela/0000-0003-0649-469X; Stroka, Deborah/0000-0002-3517-3871	Stiftung fur klinischexperimentelle Tumorforschung; Stiftung zur Krebsbekampfung [374/2016]	Stiftung fur klinischexperimentelle Tumorforschung; Stiftung zur Krebsbekampfung	This work has been supported by Stiftung fur klinischexperimentelle Tumorforschung (grant to YZ) and by Stiftung zur Krebsbekampfung (grant Nr. 374/2016 to MM). YZ received a drug donation from Merck / EMD Serono. Merck / EMD Serono has reviewed the publication, and the views and opinions described in the publication do not necessarily reflect those of Merck.	Badura M, 2012, P NATL ACAD SCI USA, V109, P18767, DOI 10.1073/pnas.1203853109; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezowska S, 2017, VIRCHOWS ARCH, V470, P323, DOI 10.1007/s00428-016-2057-z; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Boeckx Carolien, 2015, BMC Res Notes, V8, P203, DOI 10.1186/s13104-015-1197-6; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Cheng JC, 2013, CANCER LETT, V329, P197, DOI 10.1016/j.canlet.2012.10.029; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Clara CA, 2014, NEUROPATHOLOGY, V34, P343, DOI 10.1111/neup.12111; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Cosse JP, 2008, ANTI-CANCER AGENT ME, V8, P790, DOI 10.2174/187152008785914798; Dobrikov MI, 2013, MOL CELL BIOL, V33, P937, DOI 10.1128/MCB.01441-12; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Francica P, 2016, CLIN CANCER RES, V22, P5322, DOI 10.1158/1078-0432.CCR-15-2987; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Gariboldi MB, 2010, BIOCHEM PHARMACOL, V80, P455, DOI 10.1016/j.bcp.2010.05.011; Gluck AA, 2015, INT J BIOCHEM CELL B, V62, P101, DOI 10.1016/j.biocel.2015.02.018; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ide T, 2006, INT J CANCER, V119, P2750, DOI 10.1002/ijc.22178; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Leiser D, 2015, MOL ONCOL, V9, P1434, DOI 10.1016/j.molonc.2015.04.001; Liu XD, 2008, EXPERT OPIN INV DRUG, V17, P997, DOI [10.1517/13543784.17.7.997, 10.1517/13543784.17.7.997 ]; Medova M, 2013, MOL CANCER THER, V12, P2415, DOI 10.1158/1535-7163.MCT-13-0151; Michieli P, 2009, CELL CYCLE, V8, P3291, DOI 10.4161/cc.8.20.9741; Minchenko O, 2004, FEBS LETT, V576, P14, DOI 10.1016/j.febslet.2004.08.053; Minchenko OH, 2014, WORLD J GASTROENTERO, V20, P13705, DOI 10.3748/wjg.v20.i38.13705; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Okuda K, 2008, CANCER SCI, V99, P2280, DOI 10.1111/j.1349-7006.2008.00916.x; Paatero I, 2014, J BIOL CHEM, V289, P22459, DOI 10.1074/jbc.M113.533497; Paatero I, 2012, J BIOL CHEM, V287, P9659, DOI 10.1074/jbc.M111.299537; Pelletier J, 2015, CANCER RES, V75, P250, DOI 10.1158/0008-5472.CAN-14-2789; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pore N, 2006, CANCER RES, V66, P3197, DOI 10.1158/0008-5472.CAN-05-3090; Seiwert TY, 2009, CANCER RES, V69, P3021, DOI 10.1158/0008-5472.CAN-08-2881; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Skuli N, 2006, CANCER RES, V66, P482, DOI 10.1158/0008-5472.CAN-05-2299; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Takacova M, 2014, AM J PATHOL, V184, P953, DOI 10.1016/j.ajpath.2014.01.002; Tarun SZ, 1997, MOL CELL BIOL, V17, P6876, DOI 10.1128/MCB.17.12.6876; Thangasamy A, 2009, J BIOL CHEM, V284, P14001, DOI 10.1074/jbc.M809320200; Villa N, 2013, J BIOL CHEM, V288, P32932, DOI 10.1074/jbc.M113.517011; Vordermark D, 2016, CANCER RES, V198, P123; Zeng ZS, 2008, CANCER LETT, V265, P258, DOI 10.1016/j.canlet.2008.02.049	50	12	12	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 26	2018	37	30					4181	4196		10.1038/s41388-018-0256-6	http://dx.doi.org/10.1038/s41388-018-0256-6			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GO2YI	29717265				2022-12-26	WOS:000439847000010
J	Ippolito, E; Fiore, M; Di Donato, A; Silipigni, S; Rinaldi, C; Cornacchione, P; Infusino, E; Di Venanzio, C; Greco, C; Trodella, L; Ramella, S; D'Angelillo, RM				Ippolito, Edy; Fiore, Michele; Di Donato, Alessia; Silipigni, Sonia; Rinaldi, Carla; Cornacchione, Patrizia; Infusino, Erminia; Di Venanzio, Cristina; Greco, Carlo; Trodella, Lucio; Ramella, Sara; D'Angelillo, Rolando Maria			Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system	PLOS ONE			English	Article							ADAPTED RADIOTHERAPY; RADIATION; CANCER; REDUCTION	Background Voluntary deep inspiration breath hold technique (vDIBH) is considered as the key to achieving the widest cardiac sparing in whole breast irradiation. Several techniques have been implemented to achieve a reproducible, fast and friendly treatment. The aim of the present study is to implement vDIBH using the ExacTrac (BrainLAB AG, Germany) monitoring system. Methods Women with left-sided breast cancer, younger than 50 years or with cardiac disease, underwent whole breast RT with vDIBH using the ExacTrac (BrainLAB AG, Germany) monitoring system. Simulations were performed with patients positioned supine on a breast board with both arms raised above the head. Five optical markers were placed on the skin around the border of the left breast gland and their position was referenced with ink marking. Each patient received a training session to find the individual deep inspiration level. Finally, a vDIBH CT was taken. All patients were also studied in free breathing (FB) in order to compare the dose distribution for PTV, heart and left anterior descending coronary artery (LAD). Pre-treatment verification was carried out through the ExacTrac (BrainLAB AG, Germany) system and verified with electronic portal imaging (EPI). Moreover, daily real time EPIs in during modality (captured during the beam delivery) were taken in order to check the reproducibility. Results 34 patients have been evaluated and 30 were eligible for vDIBH. Most patients showed small setup errors during the treatment course of below 5 mm in 94.9% of the recorded fields. Mean Displacement was less in cranio-caudal direction. Mean intra-fraction displacement was below 3 mm in all directions. vDIBH plans provided better cardiac dosimetry. Conclusions vDIBH technique using ExacTrac (BrainLAB AG, Germany) monitoring system was applied with good reproducibility.	[Ippolito, Edy; Fiore, Michele; Di Donato, Alessia; Silipigni, Sonia; Rinaldi, Carla; Cornacchione, Patrizia; Infusino, Erminia; Di Venanzio, Cristina; Greco, Carlo; Trodella, Lucio; Ramella, Sara; D'Angelillo, Rolando Maria] Univ Campus Biomed, Radiat Oncol, Rome, Italy	University Campus Bio-Medico - Rome Italy	Ramella, S (corresponding author), Univ Campus Biomed, Radiat Oncol, Rome, Italy.	s.ramella@unicampus.it	RAMELLA, SARA/AAC-6523-2022; Cornacchione, Patrizia/AAA-3420-2022; Michele, Fiore/AAC-6070-2022	RAMELLA, SARA/0000-0002-5782-7717; Cornacchione, Patrizia/0000-0002-5573-6352; ippolito, edy/0000-0003-1775-2009; Fiore, Michele/0000-0003-1889-4578				Abe O, 2005, LANCET, V366, P2087; [Anonymous], BREAST CANC ATL RAD; Barlett FR, 2013, RADIOTHER ONCOL, V108, P242, DOI [10.1016/j.radonc.2013.04.021, DOI 10.1016/J.RADONC.2013.04.021]; Boero IJ, 2016, INT J RADIAT ONCOL, V94, P700, DOI 10.1016/j.ijrobp.2015.12.018; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Feng M, 2011, INT J RADIAT ONCOL, V79, P10, DOI 10.1016/j.ijrobp.2009.10.058; Hjelstuen MHB, 2012, ACTA ONCOL, V51, P333, DOI 10.3109/0284186X.2011.618510; Korreman SS, 2006, INT J RADIAT ONCOL, V65, P1375, DOI 10.1016/j.ijrobp.2006.03.046; Lee MS, 2013, AM J CARDIOL, V112, P1688, DOI 10.1016/j.amjcard.2013.07.031; Lutz CM, 2016, ACTA ONCOL, V55, P193, DOI 10.3109/0284186X.2015.1045625; McIntosh A, 2011, INT J RADIAT ONCOL, V81, pE569, DOI 10.1016/j.ijrobp.2011.01.044; Nielsen MH, 2013, ACTA ONCOL, V52, P703, DOI 10.3109/0284186X.2013.765064; Nissen HD, 2013, RADIOTHER ONCOL, V106, P28, DOI 10.1016/j.radonc.2012.10.016; Pedersen AN, 2004, RADIOTHER ONCOL, V72, P53, DOI 10.1016/j.radonc.2004.03.012; Schonecker S, 2016, RADIAT ONCOL, V11, DOI 10.1186/s13014-016-0716-5; Shah C, 2014, RADIOTHER ONCOL, V112, P9, DOI 10.1016/j.radonc.2014.04.009; Skytta ET, 2016, ACTA ONCOL STOCKH SW, V12, P1; Wong JW, 1999, INT J RADIAT ONCOL, V44, P911, DOI 10.1016/S0360-3016(99)00056-5; Yan D, 1997, INT J RADIAT ONCOL, V38, P197, DOI 10.1016/S0360-3016(97)00229-0; Yeboa DN, 2016, SEMIN RADIAT ONCOL, V26, P71, DOI 10.1016/j.semradonc.2015.09.003	21	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0195506	10.1371/journal.pone.0195506	http://dx.doi.org/10.1371/journal.pone.0195506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746482	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700006
J	Marenzoni, ML; Santoni, L; Felici, A; Maresca, C; Stefanetti, V; Storna, M; Franciosini, MP; Proietti, PC; Origgi, FC				Marenzoni, Maria Luisa; Santoni, Lorenzo; Felici, Andrea; Maresca, Carmen; Stefanetti, Valentina; Storna, Monica; Franciosini, Maria Pia; Proietti, Patrizia Casagrande; Origgi, Francesco Carlo			Clinical, virological and epidemiological characterization of an outbreak of Testudinid Herpesvirus 3 in a chelonian captive breeding facility: Lessons learned and first evidence of TeHV3 vertical transmission	PLOS ONE			English	Article							TURTLE MAUREMYS-CASPICA; LEUKOCYTE FUNCTIONS; TORTOISES; GRAECA	Testudinid herpesviruses (TeHVs) have a worldwide distribution among tortoises. However, information such as risk factors promoting the occurrence or the recrudescence of the associated disease and the mid-term sequelae of an outbreak comprising the extent and dynamic of the viral shedding have been only minimally investigated. Critical management information is also lacking or anecdotal. Furthermore, major aspects of the viral pathogenesis including the likelihood of vertical transmission of the virus are virtually unknown. The present study describes the occurrence and the management of an outbreak of Testudinid herpesvirus genotype 3 (TeHV3) in a large, private collection of chelonians. Clinical, pathological, molecular and serological characterization of the outbreak were carried out. Seventy-five percent of the infected tortoises died. Complementation of molecular and serological testing was a critical point for successful management implementations. A case-control study was performed to analyze possible risk factors associated with the infection. Furthermore, a subgroup of six asymptomatic infected tortoises was monitored for two consecutive seasons after the outbreak: all the infected tortoises were determined to be intermittent shedders, except one, which was a persistent shedder. Post-hibernation was associated with the highest number of shedders. Finally, evidence of the most likely vertical transmission of the virus was obtained for the first time.	[Marenzoni, Maria Luisa; Stefanetti, Valentina; Storna, Monica; Franciosini, Maria Pia; Proietti, Patrizia Casagrande] Univ Perugia, Dept Vet Med, Perugia, Italy; [Santoni, Lorenzo] Tartoombria, Perugia, Italy; [Felici, Andrea; Maresca, Carmen] Ist Zooprofilatt Sperimentale Umbria & Marche, Perugia, Italy; [Origgi, Francesco Carlo] Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth, Inst Vet Bacteriol, Bern, Switzerland	University of Perugia; IZS Umbria e Marche; University of Bern	Marenzoni, ML (corresponding author), Univ Perugia, Dept Vet Med, Perugia, Italy.	marialuisa.marenzoni@unipg.it	Marenzoni, Maria Luisa/AAR-8782-2020; Stefanetti, Valentina/AAL-8148-2020	Maresca, Carmen/0000-0002-0778-8190; Felici, Andrea/0000-0002-1306-6629; Marenzoni, Maria Luisa/0000-0002-4270-4263; FRANCIOSINI, Maria Pia/0000-0003-3395-265X; Reis, AlessanRSS/0000-0001-8486-7469	"Fondo per la Ricerca di Base"; University of Perugia	"Fondo per la Ricerca di Base"; University of Perugia	The research was partially funded by the "Fondo per la Ricerca di Base" and by the "Teaching grant 2014/2015" of the University of Perugia.	AMBROSIUS H, 1966, Z IMMUNITATSFORSCH, V130, P41; Cheylan M., 1981, THESIS; Gandar F, 2015, J VIROL, V89, P11438, DOI 10.1128/JVI.01794-15; Gaskell RM, 2012, INFECT DIS DOG CAT, p151 ; Greene CE., 2012, INFECT DIS DOG CAT, P48; Heldstab A., 1989, Herpetopathologia, V1, P5; Huot-Daubremont C., 1996, Amphibia-Reptilia, V17, P91, DOI 10.1163/156853896X00135; Kolesnik E, 2016, TIERAERZTL PRAX K H, V44, P283, DOI 10.15654/TPK-150843; Marschang RE, 2006, VET MICROBIOL, V117, P258, DOI 10.1016/j.vetmic.2006.06.009; Marschang RE, 2011, VIRUSES-BASEL, V3, P2087, DOI 10.3390/v3112087; Marschang RE, 2009, J ZOO WILDLIFE MED, V40, P211, DOI 10.1638/2008-0045.1; Marschang RE, 1997, J VET MED B, V44, P385, DOI 10.1111/j.1439-0450.1997.tb00989.x; Martel A, 2009, J WILDLIFE DIS, V45, P218, DOI 10.7589/0090-3558-45.1.218; McArthur S M, 2002, J HERPETOL MED SURG, p14 ; Munoz FJ, 2000, VET IMMUNOL IMMUNOP, V77, P27, DOI 10.1016/S0165-2427(00)00228-2; Munoz FJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P660, DOI 10.1086/323033; Origgi FC, 2004, VET PATHOL, V41, P50, DOI 10.1354/vp.41-1-50; Origgi FC, 2001, J CLIN MICROBIOL, V39, P3156, DOI 10.1128/JCM.39.9.3156-3163.2001; Origgi FC, 2003, P ARAV, p21 ; Origgi FC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134897; Origgi Francesco C., 2012, Journal of Herpetological Medicine and Surgery, V22, P42, DOI 10.5818/1529-9651-22.1-2.42; Pusterla N, 2014, VET CLIN N AM-EQUINE, V30, P489, DOI 10.1016/j.cveq.2014.08.006; Teifke JP, 2000, VET PATHOL, V37, P377, DOI 10.1354/vp.37-5-377; Thrusfield M., 2005, VET EPIDEMIOLOGY, P46; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996	25	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197169	10.1371/journal.pone.0197169	http://dx.doi.org/10.1371/journal.pone.0197169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746560	Green Submitted, Green Published, gold			2022-12-26	WOS:000431851700080
J	Pfeiffer, C; Andersen, LM; Lundqvist, D; Hamalainen, M; Schneiderman, JF; Oostenveld, R				Pfeiffer, Christoph; Andersen, Lau M.; Lundqvist, Daniel; Hamalainen, Matti; Schneiderman, Justin F.; Oostenveld, Robert			Localizing on-scalp MEG sensors using an array of magnetic dipole coils	PLOS ONE			English	Article							NEW-GENERATION; MAGNETOENCEPHALOGRAPHY; MAGNETOMETER	Accurate estimation of the neural activity underlying magnetoencephalography (MEG) signals requires co-registration i.e., determination of the position and orientation of the sensors with respect to the head. In modern MEG systems, an array of hundreds of low- T c SQUID sensors is used to localize a set of small, magnetic dipole-like (head-position indicator, HPI) coils that are attached to the subject's head. With accurate prior knowledge of the positions and orientations of the sensors with respect to one another, the HPI coils can be localized with high precision, and thereby the positions of the sensors in relation to the head. With advances in magnetic field sensing technologies, e.g., high-T-c SQUIDs and optically pumped magnetometers (OPM), that require less extreme operating temperatures than low- T-c SQUID sensors, on-scalp MEG is on the horizon. To utilize the full potential of on-scalp MEG, flexible sensor arrays are preferable. Conventional co-registration is impractical for such systems as the relative positions and orientations of the sensors to each other are subject-specific and hence not known a priori. Herein, we present a method for co-registration of on-scalp MEG sensors. We propose to invert the conventional co-registration approach and localize the sensors relative to an array of HPI coils on the subject's head. We show that given accurate prior knowledge of the positions of the HPI coils with respect to one another, the sensors can be localized with high precision. We simulated our method with realistic parameters and layouts for sensor and coil arrays. Results indicate co-registration is possible with sub-millimeter accuracy, but the performance strongly depends upon a number of factors. Accurate calibration of the coils and precise determination of the positions and orientations of the coils with respect to one another are crucial. Finally, we propose methods to tackle practical challenges to further improve the method.	[Pfeiffer, Christoph] Chalmers Univ Technol, Dept Microtechnol & Nanosci, Gothenburg, Sweden; [Andersen, Lau M.; Lundqvist, Daniel; Hamalainen, Matti; Oostenveld, Robert] Karolinska Inst, Dept Clin Neurosci, NatMEG, Stockholm, Sweden; [Hamalainen, Matti] Aalto Univ, Dept Neurosci & Biomed Engn, Espoo, Finland; [Hamalainen, Matti] Harvard Med Sch, Dept Radiol, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Hamalainen, Matti] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA; [Schneiderman, Justin F.] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Schneiderman, Justin F.] MedTech West, Gothenburg, Sweden; [Oostenveld, Robert] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	Chalmers University of Technology; Karolinska Institutet; Aalto University; Harvard University; Massachusetts General Hospital; Harvard University; University of Gothenburg; Radboud University Nijmegen	Pfeiffer, C (corresponding author), Chalmers Univ Technol, Dept Microtechnol & Nanosci, Gothenburg, Sweden.	christoph.pfeiffer@chalmers.se	Oostenveld, Robert/D-3259-2009; Andersen, Lau/ABF-8709-2021; Andersen, Lau Møller/ABA-3629-2020; Pfeiffer, Christoph/AAF-8989-2019; Hamalainen, Matti S/C-8507-2013; Schneiderman, Justin F/D-4508-2013; Lundqvist, Daniel/L-1670-2014	Oostenveld, Robert/0000-0002-1974-1293; Andersen, Lau Møller/0000-0001-7323-0614; Pfeiffer, Christoph/0000-0002-7388-4578; Schneiderman, Justin F/0000-0002-4441-2360; Lundqvist, Daniel/0000-0003-1593-2559; Hamalainen, Matti/0000-0001-6841-112X	Knut and Alice Wallenberg foundation; Swedish Research Council; Knut and Alice Wallenberg foundation [KAW2014.0102]; Swedish Research Council [621-2012-3673]; Karolinska Institutet Strategic Neuroscience Program - StratNeuro; Swedish Childhood Cancer Foundation [MT2014-0007]; National Institute of Biomedical Imaging and Bioengineering [P41EB015896, 5R01EB009048]; Innovative Training Network, ChildBrain - Marie Curie Actions of the European Commission	Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet Strategic Neuroscience Program - StratNeuro; Swedish Childhood Cancer Foundation(European Commission); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Innovative Training Network, ChildBrain - Marie Curie Actions of the European Commission	The NatMEG facility was supported by the Knut and Alice Wallenberg foundation and the Swedish Research Council. This work has further been supported by the Knut and Alice Wallenberg foundation (KAW2014.0102), the Swedish Research Council (621-2012-3673), the Karolinska Institutet Strategic Neuroscience Program - StratNeuro, the Swedish Childhood Cancer Foundation (MT2014-0007), the National Institute of Biomedical Imaging and Bioengineering (P41EB015896; 5R01EB009048), and the Innovative Training Network, ChildBrain, funded by the Marie Curie Actions of the European Commission (H2020-MSCA-ITN-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjamian P, 2004, CLIN NEUROPHYSIOL, V115, P691, DOI 10.1016/j.clinph.2003.10.023; Andersen LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178602; Bardouille T, 2012, IEEE T BIO-MED ENG, V59, P3491, DOI 10.1109/TBME.2012.2220356; Boto E, 2017, NEUROIMAGE, V149, P404, DOI 10.1016/j.neuroimage.2017.01.034; Boto E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157655; Chella F, 2012, PHYS MED BIOL, V57, P4855, DOI 10.1088/0031-9155/57/15/4855; Colombo AP, 2016, OPT EXPRESS, V24, P15403, DOI 10.1364/OE.24.015403; Dammers J, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880097; Engels L, 2010, NEUROPHYSIOL CLIN, V40, P19, DOI 10.1016/j.neucli.2010.01.002; ENGELS L, 2010, CLIN NEUROPHYSIOL, V40, P19, DOI DOI 10.1016/J.NEUCLI.2010.01.002; Faley MI, 2006, J PHYS CONF SER, V43, P1199, DOI 10.1088/1742-6596/43/1/292; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Iivanainen J, 2016, BIORXIV, DOI [10.1101/073585, DOI 10.1101/073585]; Kakisaka Y, 2012, EPILEPSY RES, V101, P191, DOI 10.1016/j.eplepsyres.2012.03.014; KNUUTILA J, 1987, REV SCI INSTRUM, V58, P2145, DOI 10.1063/1.1139478; Kominis IK, 2003, NATURE, V422, P596, DOI 10.1038/nature01484; Meyer SS, 2017, J NEUROSCI METH, V276, P38, DOI 10.1016/j.jneumeth.2016.11.009; Murthy SVK, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00326; Oisjoen F, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3698152; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Sander TH, 2012, BIOMED OPT EXPRESS, V3, P981, DOI 10.1364/BOE.3.000981; Schneiderman JF, 2014, J NEUROSCI METH, V222, P42, DOI 10.1016/j.jneumeth.2013.10.007; Strom JH, 2017, APPL PHYS LETT, V110; Supek S., 2019, MAGNETOENCEPHALOGRAP, V2nd Edn, DOI [10.1007/978-3-030-00087-5, DOI 10.1007/978-3-030-00087-5]; Troebinger L, 2014, NEUROIMAGE, V86, P583, DOI 10.1016/j.neuroimage.2013.07.065; Urban E, 2012, IEEE T BIO-MED ENG, V59, P255, DOI 10.1109/TBME.2011.2171960; Uutela K, 2001, NEUROIMAGE, V14, P1424, DOI 10.1006/nimg.2001.0915; Xie M, 2015, IEEE T APPL SUPERCON, V25, DOI 10.1109/TASC.2014.2366420	28	14	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0191111	10.1371/journal.pone.0191111	http://dx.doi.org/10.1371/journal.pone.0191111			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746486	Green Published, gold			2022-12-26	WOS:000431851700003
J	Leufflen, L; Francois, A; Salleron, J; Barlier, C; Dolivet, G; Marchal, F; Bezdetnaya, L				Leufflen, Lea; Francois, Aurelie; Salleron, Julia; Barlier, Catherine; Dolivet, Gilles; Marchal, Frederic; Bezdetnaya, Lina			Photodynamic diagnosis with methyl-5-aminolevulinate in squamous intraepithelial lesions of the vulva: Experimental research	PLOS ONE			English	Article							PROTOPORPHYRIN-IX ACCUMULATION; BASAL-CELL CARCINOMA; 5-AMINOLEVULINIC ACID; AMINOLEVULINIC-ACID; TOPICAL APPLICATION; CO2-LASER VAPORIZATION; IN-VITRO; FLUORESCENCE; THERAPY; SKIN	The incidence of the High-grade Squamous Intraepithelial Lesion of the vulva, formerly vulvar intra-epithelial neoplasia is progressively increasing. Today, an early detection and a precise localization of vulvar lesions are still problematic issues, due to the lack of accuracy of the available diagnostic tool. A new approach is the photodynamic diagnosis based on the fluorescence detection of protoporphyrin IX (PpIX) in cancer cells after topical application of a cream of methyl amino-levulinic acid. This study aimed to evaluate the effectiveness of photodiagnosis in order to discriminate the intensity of PpIX fluorescence between vulvar tumor and healthy skin. After topical application of the cream, the fluorescence on xenografted A431 tumor and adjacent skin was non-invasively measured with optical fiber. The tumor to skin fluorescence ratios were 1.38 and 1.41 at respectively 3h and 6h after application, which were significantly higher compared to those observed before application. PpIX accumulation at different depths of the tumor was investigated by spectrofluorimetry after PpIX chemical extraction from tumor sections at 3h and 6h post-application. It was noticed at both application times that the concentration of PpIX within the tumor progressively decreased. However PpIX fluorescence was always detectable up to 2.5 mm, a depth equivalent to more than three quarters of the tumor. The tumor to exposed skin ratios of PpIX fluorescence showed a good selectivity up to 1 mm depth at 3h post-application and up to 1.5mm at 6h post-m-ALA. Thus, the photodynamic diagnosis using in vivo topical methyl amino-levulinic acid appears to be a promising way to detect the intraepithelial lesions of the vulva. Our results open the possibility for implementation of topical methyl amino-levulinic acid in clinical settings for recognition of vulvar high-grade squamous intraepithelial lesions.	[Leufflen, Lea; Francois, Aurelie; Salleron, Julia; Barlier, Catherine; Dolivet, Gilles] Inst Cancerol Lorraine, Nancy, France; [Leufflen, Lea; Francois, Aurelie; Dolivet, Gilles; Marchal, Frederic; Bezdetnaya, Lina] Univ Lorraine, CNRS, CRAN, Nancy, France; [Marchal, Frederic; Bezdetnaya, Lina] Univ Lorraine, CHRU Nancy, Inst Cancerol Lorraine, Nancy, France	UNICANCER; Institut de cancerologie de Lorraine (ICL); Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; CHU de Nancy; Universite de Lorraine	Bezdetnaya, L (corresponding author), Univ Lorraine, CNRS, CRAN, Nancy, France.; Bezdetnaya, L (corresponding author), Univ Lorraine, CHRU Nancy, Inst Cancerol Lorraine, Nancy, France.	l.bolotine@nancy.unicancer.fr			French "Ligue Nationale contre le Cancer (CCIR-GE)"; Institut de Cancerologie de Lorraine (Nancy, France)	French "Ligue Nationale contre le Cancer (CCIR-GE)"; Institut de Cancerologie de Lorraine (Nancy, France)	This work was supported by the French "Ligue Nationale contre le Cancer (CCIR-GE)" and the Institut de Cancerologie de Lorraine (Nancy, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison RR, 2016, PHOTODIAGN PHOTODYN, V13, P73, DOI 10.1016/j.pdpdt.2015.11.008; Anand S, 2009, CLIN CANCER RES, V15, P3333, DOI 10.1158/1078-0432.CCR-08-3054; Angell-Petersen E, 2006, J INVEST DERMATOL, V126, P265, DOI 10.1038/sj.jid.5700048; Bornstein J, 2016, J LOW GENIT TRACT DI, V20, P11, DOI 10.1097/LGT.0000000000000169; Braathen LR, 2007, J AM ACAD DERMATOL, V56, P125, DOI 10.1016/j.jaad.2006.06.006; Colditz MJ, 2012, J CLIN NEUROSCI, V19, P1471, DOI 10.1016/j.jocn.2012.03.009; Cornelius JF, 2017, PHOTODIAGN PHOTODYN, V17, P147, DOI 10.1016/j.pdpdt.2016.12.007; Cosserat-Gerardin I, 2000, J PHOTOCH PHOTOBIO B, V59, P72, DOI 10.1016/S1011-1344(00)00142-1; Donnelly RF, 2006, PHOTOCHEM PHOTOBIOL, V82, P670, DOI 10.1562/2005-08-08-RA-641; Donnelly RF, 2006, PHOTODIAGN PHOTODYN, V3, P190, DOI 10.1016/j.pdpdt.2006.03.007; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Fung AS, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1091-6; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hambek M, 2001, CANCER RES, V61, P1045; HIETANEN S, 1995, BRIT J CANCER, V72, P134, DOI 10.1038/bjc.1995.289; Hillemanns P, 2006, GYNECOL ONCOL, V100, P271, DOI 10.1016/j.ygyno.2005.08.012; Jia Y, 2013, AM J MED SCI, V346, P303, DOI 10.1097/MAJ.0b013e318272087a; Krammer B, 2008, PHOTOCH PHOTOBIO SCI, V7, P283, DOI 10.1039/b712847a; Lee PK, 2013, J DRUGS DERMATOL, V12, P925; Leufflen L, 2013, J LOW GENIT TRACT DI, V17, P446, DOI 10.1097/LGT.0b013e318284c1ed; Ma LW, 2006, PHOTOCH PHOTOBIO SCI, V5, P755, DOI 10.1039/b603828j; MALIK Z, 1995, J PHOTOCH PHOTOBIO B, V28, P213, DOI 10.1016/1011-1344(95)07117-K; Mazdziarz A, 2013, PHOTODIAGN PHOTODYN, V10, P422, DOI 10.1016/j.pdpdt.2013.03.012; Moan J, 2003, INT J CANCER, V103, P132, DOI 10.1002/ijc.10802; Moch M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149106; Nowakowski Z, 2005, EUR J GYNAECOL ONCOL, V26, P315; Peng Q, 2001, J PHOTOCH PHOTOBIO B, V62, P140, DOI 10.1016/S1011-1344(01)00173-7; Peng Q, 1996, J PHOTOCH PHOTOBIO B, V34, P95, DOI 10.1016/1011-1344(95)07268-3; Preti M, 2014, BEST PRACT RES CL OB, V28, P1051, DOI 10.1016/j.bpobgyn.2014.07.010; Schulten R, 2012, N-S ARCH PHARMACOL, V385, P969, DOI 10.1007/s00210-012-0777-4; van de Nieuwenhof HP, 2008, CRIT REV ONCOL HEMAT, V68, P131, DOI 10.1016/j.critrevonc.2008.02.012; Witjes JA, 2007, NAT CLIN PRACT UROL, V4, P542, DOI 10.1038/ncpuro0917	32	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196753	10.1371/journal.pone.0196753	http://dx.doi.org/10.1371/journal.pone.0196753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742173	gold, Green Published, Green Submitted			2022-12-26	WOS:000431757400040
J	Sarabi, MT; Aoki, R; Tsumura, K; Keerativittayayut, R; Jimura, K; Nakahara, K				Sarabi, Mitra Taghizadeh; Aoki, Ryuta; Tsumura, Kaho; Keerativittayayut, Ruedeerat; Jimura, Koji; Nakahara, Kiyoshi			Visual perceptual training reconfigures post-task resting-state functional connectivity with a feature-representation region	PLOS ONE			English	Article							DECISION-MAKING; HUMAN BRAIN; TIME-COURSE; LONG-TERM; AREA MT; MOTION; MEMORY; SLEEP; FMRI; NETWORKS	The neural mechanisms underlying visual perceptual learning (VPL) have typically been studied by examining changes in task-related brain activation after training. However, the relationship between post-task "offline" processes and VPL remains unclear. The present study examined this question by obtaining resting-state functional magnetic resonance imaging (fMRI) scans of human brains before and after a task-fMRI session involving visual perceptual training. During the task-fMRI session, participants performed a motion coherence discrimination task in which they judged the direction of moving dots with a coherence level that varied between trials (20, 40, and 80%). We found that stimulus-induced activation increased with motion coherence in the middle temporal cortex (MT+), a feature-specific region representing visual motion. On the other hand, stimulus-induced activation decreased with motion coherence in the dorsal anterior cingulate cortex (dACC) and bilateral insula, regions involved in decision making under perceptual ambiguity. Moreover, by comparing pre-task and post-task rest periods, we revealed that resting-state functional connectivity (rs-FC) with the MT+ was significantly increased after training in widespread cortical regions including the bilateral sensorimotor and temporal cortices. In contrast, rs-FC with the MT+ was significantly decreased in subcortical regions including the thalamus and putamen. Importantly, the training-induced change in rs-FC was observed only with the MT+, but not with the dACC or insula. Thus, our findings suggest that perceptual training induces plastic changes in offline functional connectivity specifically in brain regions representing the trained visual feature, emphasising the distinct roles of feature-representation regions and decision-related regions in VPL.	[Sarabi, Mitra Taghizadeh; Keerativittayayut, Ruedeerat; Nakahara, Kiyoshi] Kochi Univ Technol, Sch Informat, Kami City, Kochi, Japan; [Aoki, Ryuta; Jimura, Koji; Nakahara, Kiyoshi] Kochi Univ Technol, Res Ctr Brain Commun, Kami City, Kochi, Japan; [Tsumura, Kaho; Jimura, Koji] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa, Japan; [Aoki, Ryuta] Kochi Univ Technol, Res Inst Future Design, Kochi, Kochi, Japan	Kochi University Technology; Kochi University Technology; Keio University; Kochi University Technology	Nakahara, K (corresponding author), Kochi Univ Technol, Sch Informat, Kami City, Kochi, Japan.; Nakahara, K (corresponding author), Kochi Univ Technol, Res Ctr Brain Commun, Kami City, Kochi, Japan.	nakahara.kiyoshi@kochi-tech.ac.jp		Nakahara, Kiyoshi/0000-0001-6701-6216	Japan Society for the Promotion of Science KAKENHI [24800023, 26350986, 17H00891, 17H06268]; Grants-in-Aid for Scientific Research [15K12777] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI (https //www.jsps.go.jp/english/index.html) grants no. 24800023 and 26350986 to KJ.; 17H00891 and 17H06268 to KN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NB, 2009, CURR BIOL, V19, P1023, DOI 10.1016/j.cub.2009.04.028; Amano K, 2009, J NEUROPHYSIOL, V102, P2704, DOI 10.1152/jn.00102.2009; Bassett DS, 2015, NAT NEUROSCI, V18, P744, DOI 10.1038/nn.3993; Beauchamp MS, 1997, J NEUROPHYSIOL, V78, P516, DOI 10.1152/jn.1997.78.1.516; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Censor N, 2012, NAT REV NEUROSCI, V13, P658, DOI 10.1038/nrn3315; Chen MY, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00063; Chen NH, 2015, NEUROIMAGE, V115, P17, DOI 10.1016/j.neuroimage.2015.04.041; Erickson DT, 2013, NEUROIMAGE, V79, P340, DOI 10.1016/j.neuroimage.2013.04.085; Eryilmaz H, 2011, NEUROIMAGE, V54, P2481, DOI 10.1016/j.neuroimage.2010.10.021; Gregory MD, 2014, NEUROIMAGE, V102, P666, DOI 10.1016/j.neuroimage.2014.08.044; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guerra-Carrillo B, 2014, NEUROSCIENTIST, V20, P522, DOI 10.1177/1073858414524442; Harmelech T, 2013, J NEUROSCI, V33, P9488, DOI 10.1523/JNEUROSCI.5911-12.2013; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Kahn AE, 2017, CEREB CORTEX, V27, P173, DOI 10.1093/cercor/bhw335; Kahnt T, 2011, NEURON, V70, P549, DOI 10.1016/j.neuron.2011.02.054; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kayser AS, 2010, J NEUROPHYSIOL, V103, P1179, DOI 10.1152/jn.00364.2009; Kelly C, 2014, NEUROPSYCHOL REV, V24, P63, DOI 10.1007/s11065-014-9252-y; Keuken MC, 2017, FRONT HUM NEUROSCI, V11, p1 , DOI [10.3389/fnhum.2017.00001, DOI 10.3389/FNHUM.2017.00001]; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Lamichhane B, 2016, NEUROSCIENCE, V327, P79, DOI 10.1016/j.neuroscience.2016.04.016; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Murty VP, 2017, J NEUROSCI, V37, P537, DOI [10.1523/JNEUROSCI.4032-15.2016, 10.1523/JNEUROSCI.4032-15.2017]; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Sami S, 2014, J NEUROSCI, V34, P3982, DOI 10.1523/JNEUROSCI.4341-13.2014; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shibata K, 2017, NAT NEUROSCI, V20, P470, DOI 10.1038/nn.4490; Shibata K, 2016, CEREB CORTEX, V26, P3681, DOI 10.1093/cercor/bhw176; Shibata K, 2014, ANN NY ACAD SCI, V1316, P18, DOI 10.1111/nyas.12419; Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Stevens WD, 2010, CEREB CORTEX, V20, P1997, DOI 10.1093/cercor/bhp270; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Urner M, 2013, NEUROIMAGE, V77, P148, DOI 10.1016/j.neuroimage.2013.03.050; Vahdat S, 2011, J NEUROSCI, V31, P16907, DOI 10.1523/JNEUROSCI.2737-11.2011; Vilsten JS, 2014, BRAIN COGNITION, V85, P170, DOI 10.1016/j.bandc.2013.12.005; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Walker MP, 2005, CEREB CORTEX, V15, P1666, DOI 10.1093/cercor/bhi043; Watanabe T, 2015, ANNU REV PSYCHOL, V66, P197, DOI 10.1146/annurev-psych-010814-015214; Webster MA, 2011, J VISION, V11, DOI 10.1167/11.5.3; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034; Yotsumoto Y, 2009, CURR BIOL, V19, P1278, DOI 10.1016/j.cub.2009.06.011	58	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196866	10.1371/journal.pone.0196866	http://dx.doi.org/10.1371/journal.pone.0196866			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF2GV	29742133	gold, Green Published, Green Submitted			2022-12-26	WOS:000431757400048
J	Chou, HY; Lun, CM; Smith, LC				Chou, Hung-Yen; Lun, Cheng Man; Smith, L. Courtney			SpTransformer proteins from the purple sea urchin opsonize bacteria, augment phagocytosis, and retard bacterial growth	PLOS ONE			English	Article							FIBRINOGEN-RELATED PROTEINS; IMMUNE-RESPONSE PROTEINS; CHITIN-BINDING PROTEINS; STRONGYLOCENTROTUS-PURPURATUS; GENE FAMILY; ANTIMICROBIAL PEPTIDES; COMPLEMENT COMPONENT; PHOSPHATIDIC-ACID; SP185/333 PROTEIN; DIVERSITY	The purple sea urchin, Strongylocentrotus purpuratus, has a complex and robust immune system that is mediated by a number of multi-gene families including the SpTransformer (SpTrf) gene family (formerly Sp185/333). In response to immune challenge from bacteria and various pathogen-associated molecular patterns, the SpTrf genes are up-regulated in sea urchin phagocytes and express a diverse array of SpTrf proteins. We show here that SpTrf proteins from coelomocytes and isolated by nickel affinity (cNi-SpTrf) bind to Gram-positive and Gram-negative bacteria and to Baker's yeast, Saccharomyces cerevisiae, with saturable kinetics and specificity. cNi-SpTrf opsonization of the marine bacteria, Vibrio diazotrophicus, augments phagocytosis, however, opsonization by the recombinant protein, rSpTrf-E1, does not. Binding by cNi-SpTrf proteins retards growth rates significantly for several species of bacteria. SpTrf proteins, previously thought to be strictly membrane-associated, are secreted from phagocytes in short term cultures and bind V. diazotrophicus that are located both outside of and within phagocytes. Our results demonstrate anti-microbial activities of native SpTrf proteins and suggest variable functions among different SpTrf isoforms. Multiple isoforms may act synergistically to detect a wide array of pathogens and provide flexible and efficient host immunity.	[Chou, Hung-Yen; Lun, Cheng Man; Smith, L. Courtney] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Chou, Hung-Yen] George Washington Univ, Inst Biomed Sci, Dept Microbiol & Immunol, Washington, DC USA; [Lun, Cheng Man] NCI, Virus Cell Interact Sect, HIV Dynam & Replicat Program, Ctr Canc Res, Frederick, MD 21701 USA	George Washington University; George Washington University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Smith, LC (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	csmith@gwu.edu	Chou, Hung-Yen/AAM-3725-2021	Chou, Hung-Yen/0000-0002-4368-5738; Smith, L Courtney/0000-0001-7099-7852	Research Scholarship Awards from the Wilbur V. Harlan Trust; Cosmos Club Foundation of Washington DC; Columbian College of Arts and Sciences at GWU; National Science Foundation [MCB-0744999, IOS-1146124]	Research Scholarship Awards from the Wilbur V. Harlan Trust; Cosmos Club Foundation of Washington DC; Columbian College of Arts and Sciences at GWU; National Science Foundation(National Science Foundation (NSF))	This research was supported by Research Scholarship Awards from the Wilbur V. Harlan Trust to HYC and CML, an award from the Cosmos Club Foundation of Washington DC and two Summer Dissertation Fellowships from the Columbian College of Arts and Sciences at GWU to CML, and funding from the National Science Foundation (MCB-0744999, IOS-1146124) to LCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for laboratory assistance from Lauren Sherman. This research was supported by Research Scholarship Awards from the Wilbur V. Harlan Trust to HYC and CML, an award from the Cosmos Club Foundation of Washington DC and two Summer Dissertation Fellowships from the Columbian College of Arts and Sciences at GWU to CML, and funding from the National Science Foundation (MCB-0744999, IOS-1146124) to LCS.	Adema CM, 1997, P NATL ACAD SCI USA, V94, P8691, DOI 10.1073/pnas.94.16.8691; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Boehm T, 2018, ANNU REV IMMUNOL, V36, P19, DOI 10.1146/annurev-immunol-042617-053028; Brockton V, 2008, J CELL SCI, V121, P339, DOI 10.1242/jcs.012096; Buckley KM, 2008, J MOL BIOL, V379, P912, DOI 10.1016/j.jmb.2008.04.037; Buckley KM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-68; Buckley KM, 2017, ELIFE, V6, DOI 10.7554/eLife.23481; Buckley KM, 2015, DEV COMP IMMUNOL, V49, P179, DOI 10.1016/j.dci.2014.10.013; Buckley KM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00136; Buckley KM, 2008, J IMMUNOL, V181, P8585, DOI 10.4049/jimmunol.181.12.8585; CANICATTI C, 1989, EXPERIENTIA, V45, P756, DOI 10.1007/BF01974579; Clow LA, 2000, IMMUNOGENETICS, V51, P1021, DOI 10.1007/s002510000233; Clow LA, 2004, J EXP BIOL, V207, P2147, DOI 10.1242/jeb.01001; Cross PS, 1999, DEV COMP IMMUNOL, V23, P429, DOI 10.1016/S0145-305X(99)00022-1; Dheilly NM, 2011, IMMUNOL CELL BIOL, V89, P861, DOI 10.1038/icb.2011.3; Dheilly NM, 2009, J IMMUNOL, V182, P2203, DOI 10.4049/jimmunol.07012766; Dishaw LJ, 2011, P NATL ACAD SCI USA, V108, P16747, DOI 10.1073/pnas.1109687108; Dishaw LJ, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-78; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; EBERT TA, 1967, SCIENCE, V157, P557, DOI 10.1126/science.157.3788.557; Gerdol M, 2015, DEV COMP IMMUNOL, V49, P59, DOI 10.1016/j.dci.2014.11.007; Gross PS, 2000, IMMUNOGENETICS, V51, P1034, DOI 10.1007/s002510000234; GUERINOT ML, 1981, CAN J MICROBIOL, V27, P311, DOI 10.1139/m81-048; Henson JH, 1999, MOL BIOL CELL, V10, P4075, DOI 10.1091/mbc.10.12.4075; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Ho ECH, 2016, IMMUNOL CELL BIOL, V94, P861, DOI 10.1038/icb.2016.51; Jacob F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00297; Jiang SA, 2015, FISH SHELLFISH IMMUN, V45, P583, DOI 10.1016/j.fsi.2015.05.021; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Kumanovics A, 2003, ANNU REV IMMUNOL, V21, P629, DOI 10.1146/annurev.immunol.21.090501.080116; Li C, 2015, DEV COMP IMMUNOL, V49, P190, DOI 10.1016/j.dci.2014.11.002; Li C, 2014, DEV COMP IMMUNOL, V43, P106, DOI 10.1016/j.dci.2013.10.013; Lun CM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00481; Lun CM, 2017, J IMMUNOL, V198, P2957, DOI 10.4049/jimmunol.1601795; Lun CM, 2016, IMMUNOBIOLOGY, V221, P889, DOI 10.1016/j.imbio.2016.03.006; Majeske AJ, 2014, J IMMUNOL, V193, P5678, DOI 10.4049/jimmunol.1401681; Majeske AJ, 2013, INNATE IMMUN-LONDON, V19, P569, DOI 10.1177/1753425912473850; Majeske AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061419; McDowell JM, 2008, DEV COMP IMMUNOL, V32, P736, DOI 10.1016/j.dci.2007.11.005; Miller CA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-575; Mone Y, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000813; Nair SV, 2005, PHYSIOL GENOMICS, V22, P33, DOI 10.1152/physiolgenomics.00052.2005; Ng TH, 2014, DEV COMP IMMUNOL, V46, P129, DOI 10.1016/j.dci.2014.04.002; Oren M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3241-x; Pancer Z, 1999, IMMUNOGENETICS, V49, P773, DOI 10.1007/s002510050551; Pancer Z, 2001, ADV EXP MED BIOL, V484, P31; Ramirez-Gomez F, 2010, INVERTEBRATE SURVIVA; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Roth MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0062079; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; Schrankel CS, 2009, THESIS; Shah M, 2003, DEV COMP IMMUNOL, V27, P529, DOI 10.1016/S0145-305X(03)00030-2; Sherman LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138892; Smith LC, 2016, ISJ-INVERT SURVIV J, V13, P355; Smith LC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00725; Smith LC, 2010, ADV EXP MED BIOL, V708, P260; SMITH LC, 1995, DEV COMP IMMUNOL, V19, P217, DOI 10.1016/0145-305X(95)00009-I; Smith LC, 1999, IMMUNOPHARMACOLOGY, V42, P107, DOI 10.1016/S0162-3109(99)00009-0; Smith LC, 2002, DEV COMP IMMUNOL, V26, P603; Smith LC, 2001, IMMUNOL REV, V180, P16, DOI 10.1034/j.1600-065X.2001.1800102.x; Smith LC, 2001, ADV EXP MED BIOL, V484, P363; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Taketa DA, 2015, DEV COMP IMMUNOL, V48, P254, DOI 10.1016/j.dci.2014.03.014; Terwilliger DP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-16; Terwilliger DP, 2006, PHYSIOL GENOMICS, V26, P134, DOI 10.1152/physiolgenomics.00011.2006; Tu Q, 2012, GENOME RES, V22, P2079, DOI 10.1101/gr.139170.112; van Kan EJM, 2002, BIOCHEMISTRY-US, V41, P7529, DOI 10.1021/bi012162t; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543; Zhang SM, 2008, INNATE IMMUN-LONDON, V14, P175, DOI 10.1177/1753425908093800	73	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196890	10.1371/journal.pone.0196890	http://dx.doi.org/10.1371/journal.pone.0196890			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738524	Green Published, gold			2022-12-26	WOS:000431724900026
J	Jerkovic, I; Marijanovic, Z; Roje, M; Kus, PM; Jokic, S; Coz-Rakovac, R				Jerkovic, Igor; Marijanovic, Zvonimir; Roje, Marin; Kus, Piotr M.; Jokic, Stela; Coz-Rakovac, Rozelinda			Phytochemical study of the headspace volatile organic compounds of fresh algae and seagrass from the Adriatic Sea (single point collection)	PLOS ONE			English	Article							OCEANIC PHYTOPLANKTON; POSIDONIA-OCEANICA; FLAVOR COMPOUNDS; SULFUR CYCLE; MARINE-ALGAE; BROWN-ALGAE; BIOSYNTHESIS; MACROALGAE; COMPONENTS; EXTRACTS	Performed phytochemical study contributes to the knowledge of volatile organic compounds (VOCs) of Halopteris filicina (Grateloup) Kutzing, Dictyota dichotoma (Hudson) J. V. Lamouroux, Posidonia oceanica (L.) Delile and Flabellia petiolata (Turra) Nizamuddin from the Adriatic Sea (single point collection). VOCs were investigated by headspace solid-phase microextraction (HS-SPME) and analysed by gas chromatography and mass spectrometry (GC-MS/FID). H. filicina headspace contained dimethyl sulfide (DMS; 12.8%), C-8-compounds (e.g. fucoserratene (I; 9.5%)), benzaldehyde (II; 8.7%), alkane C-17, dictyopterene D and C (III, IV), tribromomethane (V), 1-iodopentane, others. F. petiolata headspace was characterized by DMS (22.2%), 6-methylhept-5-en-2-one (9.5%), C-17 (9.1%), II (6.5%), compounds I-V. DMS (59.3%), C-15 (14.5%), C-17 (7.2%) and C-19 (6.3%) dominated in P. oceanica headspace. Sesquiterpenes were found in D. dichotoma, predominantly germacrene D (28.3%) followed by other cadinenyl (abundant), muurolenyl and amorphenyl structures. Determined VOCs may be significant for chemosystematics and chemical communications in marine ecosystem.	[Jerkovic, Igor] Univ Split, Fac Chem & Technol, Dept Organ Chem, Hr Split, Croatia; [Marijanovic, Zvonimir] Univ Split, Fac Chem & Technol, Dept Food Technol & Biotechnol, Hr Split, Croatia; [Roje, Marin] Rudjer Boskovic Inst, Div Organ Chem & Biochem, Hr Zagreb, Croatia; [Kus, Piotr M.] Wroclaw Med Univ, Dept Pharmacognosy, Wroclaw, Poland; [Jokic, Stela] Josip Juraj Strossmayer Univ Osijek, Fac Food Technol, Dept Proc Engn, Hr Osijek, Croatia; [Coz-Rakovac, Rozelinda] Rudjer Boskovic Inst, Lab Aquaculture Biotechnol, Hr Zagreb, Croatia	University of Split; University of Split; Rudjer Boskovic Institute; Wroclaw Medical University; Rudjer Boskovic Institute	Jerkovic, I (corresponding author), Univ Split, Fac Chem & Technol, Dept Organ Chem, Hr Split, Croatia.	igor@ktf-split.hr	Kuś, Piotr/AAE-1402-2020; Marijanovic, Zvonimir/AAI-2337-2021; Kuś, Piotr/AAZ-2950-2021	Kuś, Piotr/0000-0002-7368-1076; Kuś, Piotr/0000-0002-7368-1076	Croatian Science Foundation [HRZZ-IP-11-2013-8547]; Croatian Government; European Union through the European Regional Development Fund - the Competitiveness and Cohesion Operational Programme [KK.01.1.1.01]	Croatian Science Foundation; Croatian Government; European Union through the European Regional Development Fund - the Competitiveness and Cohesion Operational Programme	This research was supported by the Croatian Science Foundation under the project HRZZ-IP-11-2013-8547 (Research of Natural Products and Flavours: Chemical Fingerprinting and Unlocking the Potential) to Igor Jerkovic and by the Croatian Government and the European Union through the European Regional Development Fund - the Competitiveness and Cohesion Operational Programme (KK.01.1.1.01) - The Scientific Centre of Excellence for Marine Bioprospecting-BioProCro to Rozelinda Coz Rakovac.	Achyuthan KE, 2017, METABOLITES, V7, DOI 10.3390/metabo7030039; Akakabe Y, 2003, BIOORGAN MED CHEM, V11, P3607, DOI 10.1016/S0968-0896(03)00364-X; Alcolombri U, 2015, SCIENCE, V348, P1466, DOI 10.1126/science.aab1586; Alghazeer R., 2013, NATURAL SCI, V5, P7, DOI [10.4236/ns.2013.51002, DOI 10.4236/NS.2013.51002]; Amico V., 1976, BIOCH SYST ECOL, V4, P143, DOI DOI 10.1016/0305-1978(76)90028-4; Andrade PB, 2013, FOOD CHEM, V138, P1819, DOI 10.1016/j.foodchem.2012.11.081; BALLESTEROS E, 1992, BOT MAR, V35, P481, DOI 10.1515/botm.1992.35.6.481; BATES TS, 1985, J GEOPHYS RES-OCEANS, V90, P9168, DOI 10.1029/JC090iC05p09168; Bilgin F, 2002, TURK J BOT, V26, P87; Boatright J, 2004, PLANT PHYSIOL, V135, P1993, DOI 10.1104/pp.104.045468; BOLAND W, 1995, P NATL ACAD SCI USA, V92, P37, DOI 10.1073/pnas.92.1.37; Boonprab K, 2006, J APPL PHYCOL, V18, P409, DOI 10.1007/s10811-006-9038-6; Borges AV, 2015, AQUAT BOT, V125, P72, DOI 10.1016/j.aquabot.2015.05.008; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; DEROSA S, 1994, PHYTOCHEMISTRY, V37, P1327, DOI 10.1016/S0031-9422(00)90407-2; Enoiu M, 2000, ANALUSIS, V28, P285, DOI 10.1051/analusis:2000280285; Fink P, 2007, MAR FRESHW BEHAV PHY, V40, P155, DOI 10.1080/10236240701602218; FRANSSEN MCR, 1994, BIOCATALYSIS, V10, P87, DOI 10.3109/10242429409065220; GALLARDO T, 1993, BOT MAR, V36, P399, DOI 10.1515/botm.1993.36.5.399; Gally A., 1993, Journal of Essential Oil Research, V5, P27; Gnavi G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175941; Hammami S, 2013, NAT PROD RES, V27, P1265, DOI 10.1080/14786419.2012.725401; HATANAKA A, 1993, PHYTOCHEMISTRY, V34, P1201, DOI 10.1016/0031-9422(91)80003-J; Haznedaroglu MZ, 2007, PHARM BIOL, V45, P745, DOI 10.1080/13880200701585717; Holger S, 2006, J BIOL CHEM, V281, P9845, DOI 10.1074/jbc.M511668200; Hombeck M, 1998, TETRAHEDRON, V54, P11033, DOI 10.1016/S0040-4020(98)00660-7; HOURIET R, 1976, HELV CHIM ACTA, V59, P119, DOI 10.1002/hlca.19760590111; Itoh N, 1997, PHYTOCHEMISTRY, V45, P67, DOI 10.1016/S0031-9422(96)00786-8; Jerkovic I, 2016, MOLECULES, V21, DOI 10.3390/molecules21030377; KAJIWARA T, 1988, J FOOD SCI, V53, P960, DOI 10.1111/j.1365-2621.1988.tb08995.x; Kamenarska Z, 2002, BOT MAR, V45, P339, DOI 10.1515/BOT.2002.034; Le Bideau F, 2017, CHEM REV, V117, P6110, DOI 10.1021/acs.chemrev.6b00502; Le Pape MA, 2004, J AGR FOOD CHEM, V52, P550, DOI 10.1021/jf030478x; Milkova T, 1997, PHYTOCHEMISTRY, V45, P93, DOI 10.1016/S0031-9422(96)00588-2; Miller DJ, 2012, NAT PROD REP, V29, P60, DOI 10.1039/c1np00060h; MIRONOV OG, 1981, MAR ECOL PROG SER, V5, P303, DOI 10.3354/meps005303; Moore, 2016, VOLATILE ORGANIC COM, P1; MOORE RE, 1977, ACCOUNTS CHEM RES, V10, P40, DOI 10.1021/ar50110a002; MULLER DG, 1985, J PLANT PHYSIOL, V118, P401, DOI 10.1016/S0176-1617(85)80200-5; NEWMAN KA, 1987, LIMNOL OCEANOGR, V32, P702, DOI 10.4319/lo.1987.32.3.0702; NIZAMUDDIN M, 1987, NOVA HEDWIGIA, V44, P175; Ohshiro T, 1999, PHYTOCHEMISTRY, V52, P1211, DOI 10.1016/S0031-9422(99)00404-5; Paul C, 2011, NAT PROD REP, V28, P186, DOI 10.1039/c0np00043d; Personnic S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098994; Pohnert G, 2002, NAT PROD REP, V19, P108, DOI 10.1039/a806888g; Quinn PK, 2011, NATURE, V480, P51, DOI 10.1038/nature10580; REED RH, 1983, MAR BIOL LETT, V4, P173; Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x; Seymour JR, 2010, SCIENCE, V329, P342, DOI 10.1126/science.1188418; Siamopoulou P, 2004, PHYTOCHEMISTRY, V65, P2025, DOI 10.1016/j.phytochem.2004.06.018; Silva G, 2013, REV BRAS FARMACOGN, V23, P608, DOI 10.1590/S0102-695X2013005000048; SUGISAWA H, 1990, Food Reviews International, V6, P573; Sun SM, 2012, J APPL PHYCOL, V24, P1003, DOI 10.1007/s10811-011-9724-x; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; TANCHOTIKUL U, 1989, J FOOD SCI, V54, P1515, DOI 10.1111/j.1365-2621.1989.tb05149.x; WHITE RH, 1982, J MAR RES, V40, P529; Winterhalter P, 2001, ACS SYM SER, P1; Yamamoto M, 2014, SCI WORLD J, DOI 10.1155/2014/289780; Zhou L, 2017, J SCI FOOD AGR, V97, P761, DOI 10.1002/jsfa.7794	59	31	31	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196462	10.1371/journal.pone.0196462	http://dx.doi.org/10.1371/journal.pone.0196462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738535	Green Published, Green Submitted, gold			2022-12-26	WOS:000431724900009
J	Rao, SR; Liew, TS; Yow, YY; Ratnayeke, S				Rao, Suganiya Rama; Liew, Thor-Seng; Yow, Yoon-Yen; Ratnayeke, Shyamala			Cryptic diversity: Two morphologically similar species of invasive apple snail in Peninsular Malaysia	PLOS ONE			English	Article							POMACEA-CANALICULATA LAMARCK; GASTROPODA AMPULLARIIDAE; MOLECULAR METHOD; CAENOGASTROPODA; IMPACT; POPULATIONS; STRATEGIES; NORTHERN; BIOLOGY	Invasive snails in the genus Pomacea have spread across Southeast Asia including Peninsular Malaysia. Their effects on natural and agricultural wetlands are appreciable, but species-specific effects are less clear because of morphological similarity among the species. Our objective was to establish diagnostic characteristics of Pomacea species in Malaysia using genetic and morphological criteria. The mitochondrial COI gene of 52 adult snails from eight localities in Peninsular Malaysia was amplified, sequenced, and analysed to verify species and phylogenetic relationships. Shells were compared using geometric morphometric and covariance analyses. Two monophyletic taxa, P. canaliculata and P. maculata, occurred in our samples. The mean ratio of shell height: aperture height (P = 0.042) and shell height: shell width (P = 0.007) was smaller in P. maculata. P. maculata co-occurred with P. canaliculata in five localities, but samples from three localities contained only P. canaliculata. This study is the first to confirm the presence of two of the most invasive species of Pomacea in Peninsular Malaysia using a molecular technique. P. canaliculata appears to be the more widespread species. Despite statistical differences, both quantitative and qualitative morphological characteristics demonstrated much interspecific overlap and intraspecific variability; thus, shell morphology alone cannot reliably verify species identity. Molecular techniques for distinguishing between these two highly invasive Pomacea species are needed to understand their specific ecological niches and to develop effective protocols for their management.	[Rao, Suganiya Rama; Yow, Yoon-Yen; Ratnayeke, Shyamala] Sunway Univ, Dept Biol Sci, Sch Sci & Technol, Selangor, Malaysia; [Liew, Thor-Seng] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu, Sabah, Malaysia	Sunway University; Universiti Malaysia Sabah	Ratnayeke, S (corresponding author), Sunway Univ, Dept Biol Sci, Sch Sci & Technol, Selangor, Malaysia.	12047114@imail.sunway.edu.my	Yow, Yoon Yen/E-1248-2016; Ratnayeke, Shyamala/AAB-9412-2019; Yow, Yoon Yen/AES-9633-2022; Liew, Thor-Seng/AHC-0363-2022	Yow, Yoon Yen/0000-0002-3859-2094; Yow, Yoon Yen/0000-0002-3859-2094; Liew, Thor-Seng/0000-0002-9437-5924	Sunway University [INT-FST-BIOS-0115-02]; Wildlife Research Singapore [EXT-SST-DBS-WRS-2017-01]	Sunway University; Wildlife Research Singapore	This research was supported by a Sunway University internal grant (INT-FST-BIOS-0115-02) to Shyamala Ratnayeke and a Wildlife Research Singapore grant (EXT-SST-DBS-WRS-2017-01) awarded to the first author.	Arfan A. G., 2016, Pertanika Journal of Tropical Agricultural Science, V39, P343; Arfan A. G., 2014, Annual Research & Review in Biology, V4, P4123, DOI 10.9734/ARRB/2014/11398; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Carlsson NOL, 2004, ECOLOGY, V85, P1575, DOI 10.1890/03-3146; Cheng E. Y., 1989, Monograph - British Crop Protection Council, P69; Cooke GM, 2012, CONSERV GENET RESOUR, V4, P591, DOI 10.1007/s12686-011-9599-9; Cowie R., 2005, REPORT PLANT HLTH AU; Cowie R. H., 2002, Molluscs as crop pests, P145, DOI 10.1079/9780851993201.0145; Darrigran G, 2011, BRAZ J BIOL, V71, P9, DOI 10.1590/S1519-69842011000100004; Didham RK, 2005, TRENDS ECOL EVOL, V20, P470, DOI 10.1016/j.tree.2005.07.006; Estebenet AL, 2003, J MOLLUS STUD, V69, P301, DOI 10.1093/mollus/69.4.301; Estebenet AL, 2006, BIOCELL, V30, P329; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fry BG, 2003, J TOXICOL-TOXIN REV, V22, P23, DOI 10.1081/TXR-120019018; Glass NH, 2009, AQUAT ECOL, V43, P1085, DOI 10.1007/s10452-008-9226-3; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; Hayes KA, 2015, MALACOLOGIA, V58, P245, DOI 10.4002/040.058.0209; Hayes KA, 2012, ZOOL J LINN SOC-LOND, V166, P723, DOI 10.1111/j.1096-3642.2012.00867.x; Horgan FG, 2014, ACTA OECOL, V54, P90, DOI 10.1016/j.actao.2012.10.002; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Isnaningsih NR, 2011, BERITA BIOL, V10, P441; Joshi R. C., 2006, GLOBAL ADV; Lowe S., 2000, ALIENS INVASIVE SPEC, V12, P12; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mahilum Jhun Joules M., 2014, Journal of Entomology and Zoology Studies, V2, P139; Marwoto Ristiyanti M., 2011, Biotropia, V18, P123; Matsukura K, 2008, APPL ENTOMOL ZOOL, V43, P535, DOI 10.1303/aez.2008.535; Matsukura K, 2013, BIOL INVASIONS, V15, P2039, DOI 10.1007/s10530-013-0431-1; Miller M.A., 2010, P GAT COMP ENV WORKS; Mitrovski-Bogdanovic A, 2013, ANN ENTOMOL SOC AM, V106, P170, DOI 10.1603/AN12100; MOCHIDA O, 1991, MICRONESICA-SERIES, P51; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Naylor R, 1996, AMBIO, V25, P443; NG PKL, 1993, BIOL CONSERV, V64, P19, DOI 10.1016/0006-3207(93)90379-F; Nghiem LTP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071255; Phoong MJC, 2018, J TROPICAL IN PRESS; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Rawlings TA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-97; Salleh NHM, 2012, APCBEE PROC, V2, P129, DOI 10.1016/j.apcbee.2012.06.024; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sin TS, 2003, INT J PEST MANAGE, V49, P49, DOI 10.1080/713867835; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Team RC, 2014, R LANG ENV STAT COMP; Teo S., 1999, 5 INT C PLANT PROT T; Teo SS, 2001, CROP PROT, V20, P599, DOI 10.1016/S0261-2194(01)00029-1; Thaewnon-ngiw B, 2004, J BIOCHEM MOL BIOL, V37, P493; THOMPSON JD, 1991, BIOSCIENCE, V41, P393, DOI 10.2307/1311746; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thymer JM, 1996, ANNU REV ECOL SYST, V27, P83; Watermilfoil E, 2005, AQUATIC INVASIVE SPE; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Yahaya H., 2006, Global advances in ecology and management of golden apple snails, P215; Yang QQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19000-7; Yoshida K, 2014, J MOLLUS STUD, V80, P62, DOI 10.1093/mollus/eyt042; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	62	13	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196582	10.1371/journal.pone.0196582	http://dx.doi.org/10.1371/journal.pone.0196582			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734361	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000431481700024
J	Carter, GG; Forss, S; Page, RA; Ratcliffe, JM				Carter, Gerald G.; Forss, Sofia; Page, Rachel A.; Ratcliffe, John M.			Younger vampire bats (Desmodus rotundus) are more likely than adults to explore novel objects	PLOS ONE			English	Article							VERVET MONKEYS; SOCIAL-ORGANIZATION; FORAGING SUCCESS; LABORATORY RATS; AGE-DIFFERENCES; WILD; NEOPHOBIA; RESPONSIVENESS; BEHAVIOR; MICE	The effects of age on neophobia and exploration are best described in birds and primates, and broader comparisons require reports from other taxa. Here we present data showing age-dependent exploration in a long-lived social species, the common vampire bat (Desmodus rotundus). A previous study found that vampire bats regurgitated food to partners trapped in a cage. Interestingly, while only a few adult bats visited the trapped bat, in every trial all or most of the eight young males in the colony would visit the trapped bat without feeding it. To test whether this behavioral difference resulted from age class differences in exploration, we compared responses of the bats to a trapped conspecific versus an inanimate novel object. Some adults and young showed interest in trapped conspecifics, but only the young males explored the novel objects. Additional novel object tests in a second captive colony showed that higher rates of novel object exploration were shown by young of both sexes. Our results corroborate past findings from other mammals and birds that age predicts exploration. If age-dependent exploration is indeed adaptive, then the role of age as a predictor of exploration tendency should depend on species-specific life history traits. Finally, because younger vampire bats also appear to have higher exposure to pathogens such as rabies virus, there may be implications for pathogen transmission if younger and more exploratory vampire bats are more likely to feed on novel hosts.	[Carter, Gerald G.] Max Planck Inst Ornithol, Dept Collect Behav, Constance, Germany; [Carter, Gerald G.] Univ Konstanz, Dept Biol, Constance, Germany; [Forss, Sofia] Univ Tubingen, Grp Prehist & Archaeol Sci, Tubingen, Germany; [Page, Rachel A.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Ratcliffe, John M.] Univ Toronto, Dept Biol, Mississauga, ON, Canada	Max Planck Society; University of Konstanz; Eberhard Karls University of Tubingen; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Toronto; University Toronto Mississauga	Carter, GG (corresponding author), Max Planck Inst Ornithol, Dept Collect Behav, Constance, Germany.; Carter, GG (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	gcarter@orn.mpg.de	Page, Rachel A/GQQ-2818-2022; Page, Rachel/AAE-4816-2021	Page, Rachel A/0000-0001-7072-0669; Carter, Gerald/0000-0001-6933-5501; Forss, Sofia/0000-0002-6551-1907	Smithsonian Postdoctoral Fellowship; Smithsonian Institution Scholarly Studies Grant: "Tracking and manipulating cooperative relationships in vampire bats"; NSERC Discovery Grant	Smithsonian Postdoctoral Fellowship(Smithsonian Institution); Smithsonian Institution Scholarly Studies Grant: "Tracking and manipulating cooperative relationships in vampire bats"; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	GGC was supported by a Smithsonian Postdoctoral Fellowship. Work by GGC and RAP is supported by Smithsonian Institution Scholarly Studies Grant: "Tracking and manipulating cooperative relationships in vampire bats". Work by JMR is supported by a NSERC Discovery Grant.	[Anonymous], 1956, LEARNING INSTINCT AN; BARNETT SA, 1958, BRIT J PSYCHOL, V49, P195, DOI 10.1111/j.2044-8295.1958.tb00657.x; Benson-Amram S, 2013, ANIM BEHAV, V85, P349, DOI 10.1016/j.anbehav.2012.11.003; Benson-Amram S, 2012, P ROY SOC B-BIOL SCI, V279, P4087, DOI 10.1098/rspb.2012.1450; Bergman TJ, 2009, ANIM COGN, V12, P63, DOI 10.1007/s10071-008-0171-2; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; Blaszczyk MB, 2017, ANIM BEHAV, V123, P91, DOI 10.1016/j.anbehav.2016.10.017; Bobrowiec PED, 2015, J MAMMAL, V96, P54, DOI 10.1093/jmammal/gyu002; Canty A., 2015, BOOT BOOTSTRAP R S P; Carter GG, 2017, BEHAV ECOL, V28, P565, DOI 10.1093/beheco/arx006; Carter GG, 2016, ANIM BEHAV, V116, P45, DOI 10.1016/j.anbehav.2016.03.005; Carter GG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2524; Carter GG, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2573; Chaverri G, 2006, BIOTROPICA, V38, P77, DOI 10.1111/j.1744-7429.2005.00107.x; Crichton E. G., 2000, REPROD BIOL BATS; Delpietro HA, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160959; Delpietro VA, 2002, MAMM BIOL, V67, P65, DOI 10.1078/1616-5047-00011; DESROCHERS A, 1992, ANIM BEHAV, V43, P885, DOI 10.1016/0003-3472(92)90002-Q; FAIRBANKS LA, 1993, AM J PRIMATOL, V30, P119, DOI 10.1002/ajp.1350300204; FAIRBANKS LA, 1993, BEHAVIOUR, V124, P57, DOI 10.1163/156853993X00506; Forss SIF, 2017, INT J PRIMATOL, V38, P799, DOI 10.1007/s10764-017-9984-7; Forss SIF, 2015, AM J PRIMATOL, V77, P1109, DOI 10.1002/ajp.22445; GOCHFELD M, 1984, BEHAVIOUR, V88, P227, DOI 10.1163/156853984X00335; GOODRICK CL, 1967, PSYCHOL REP, V20, P159, DOI 10.2466/pr0.1967.20.1.159; Greenberg R, 2001, CURR ORNITHOL, V16, P119; Greenberg R, 2006, AM PUBLIC SERVICE RA, P175; GREENHALL A M, 1983, Mammalian Species, P1, DOI 10.2307/3503895; Greenhall A.M., 1988, P111; GREENHALL A M, 1971, Biotropica, V3, P136, DOI 10.2307/2989817; Greggor AL, 2015, CURR OPIN BEHAV SCI, V6, P82, DOI 10.1016/j.cobeha.2015.10.007; GREIG SA, 1983, ANIM BEHAV, V31, P1237, DOI 10.1016/S0003-3472(83)80030-X; Hamilton IM, 1998, J ANIM ECOL, V67, P930, DOI 10.1046/j.1365-2656.1998.6760930.x; Harlow HJ, 1997, COMP BIOCHEM PHYS A, V118, P665, DOI 10.1016/S0300-9629(96)00464-1; Heyser CJ, 2012, BEHAV PROCESS, V89, P232, DOI 10.1016/j.beproc.2011.12.004; Jenness R, 1976, SPECIAL PUBLICATIONS; Kendal RL, 2005, AM J PRIMATOL, V66, P167, DOI 10.1002/ajp.20136; Kim D, 2005, GENES BRAIN BEHAV, V4, P302, DOI 10.1111/j.1601-183X.2005.00133.x; KRONENBERGER JP, 1985, BEHAV PROCESS, V11, P53, DOI 10.1016/0376-6357(85)90102-0; KUNZ TH, 1995, J MAMMAL, V76, P769, DOI 10.2307/1382746; Kwiecinski GG, 2003, J MAMMAL, V84, P926, DOI 10.1644/BWG-029; Lopez-Forment W, 1969, ANALES I BIOL UNAM Z; Biondi LM, 2013, ETHOLOGY, V119, P221, DOI 10.1111/eth.12056; Biondi LM, 2010, ANIM COGN, V13, P701, DOI 10.1007/s10071-010-0319-8; Mayeaux DJ, 1998, PRIMATES, V39, P419, DOI 10.1007/BF02557566; MCGUIRE MT, 1994, AM J PRIMATOL, V33, P1, DOI 10.1002/ajp.1350330102; Mendoza MLZ, 2018, NATURE ECOL EVOL, V1; MENZEL EW, 1966, BEHAVIOUR, V26, P130, DOI 10.1163/156853966X00065; Mettke-Hofmann C, 2002, ETHOLOGY, V108, P249, DOI 10.1046/j.1439-0310.2002.00773.x; MITCHELL D, 1976, J COMP PHYSIOL PSYCH, V90, P190, DOI 10.1037/h0077196; Morand-Ferron J, 2011, BEHAV ECOL, V22, P1241, DOI 10.1093/beheco/arr120; MURPHEY RM, 1981, DEV PSYCHOBIOL, V14, P118, DOI 10.1002/dev.420140205; Nilsson ALK, 2010, NATURWISSENSCHAFTEN, V97, P981, DOI 10.1007/s00114-010-0714-7; PARK S-R, 1990, Journal of the Mammalogical Society of Japan, V15, P25; PELLIS SM, 1981, BIRD BEHAV, V3, P37, DOI 10.3727/015613881791560900; Puth MT, 2015, J ANIM ECOL, V84, P892, DOI 10.1111/1365-2656.12382; Ratcliffe JM, 2003, ANIM BEHAV, V65, P385, DOI 10.1006/anbe.2003.2059; Schmidt C., 1988, NATURAL HIST VAMPIRE, P246; Schuppli C, 2012, J HUM EVOL, V63, P843, DOI 10.1016/j.jhevol.2012.08.009; Sherratt TN, 2018, ANIM BEHAV, V138, P59, DOI 10.1016/j.anbehav.2018.01.025; Siwak CT, 2001, LEARN MEMORY, V8, P317, DOI 10.1101/lm.41701; Stowe M, 2006, ETHOLOGY, V112, P1079, DOI 10.1111/j.1439-0310.2006.01273.x; Streicker DG, 2012, P ROY SOC B-BIOL SCI, V279, P3384, DOI 10.1098/rspb.2012.0538; Tanas L, 2011, BEHAV PROCESS, V86, P279, DOI 10.1016/j.beproc.2010.12.018; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; VISALBERGHI E, 1988, AM J PRIMATOL, V15, P349, DOI 10.1002/ajp.1350150408; Volokhov DV, 2017, EPIDEMIOL INFECT, V145, P3154, DOI [10.1017/S095026881700231X, 10.1017/s095026881700231x]; Welker W., 1961, FUNCT VARIED EXPER, P175; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P111; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P123; Wilkinson GS, 1988, NATURAL HIST VAMPIRE	71	5	5	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196889	10.1371/journal.pone.0196889	http://dx.doi.org/10.1371/journal.pone.0196889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE6AF	29723260	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100084
J	Moyer, BD; Murray, JK; Ligutti, J; Andrews, K; Favreau, P; Jordan, JB; Lee, JH; Liu, D; Long, J; Sham, K; Shi, LC; Stocklin, R; Wu, B; Yin, RY; Yu, V; Zou, AR; Biswas, K; Miranda, LP				Moyer, Bryan D.; Murray, Justin K.; Ligutti, Joseph; Andrews, Kristin; Favreau, Philippe; Jordan, John B.; Lee, Josie H.; Liu, Dong; Long, Jason; Sham, Kelvin; Shi, Licheng; Stocklin, Reto; Wu, Bin; Yin, Ruoyuan; Yu, Violeta; Zou, Anruo; Biswas, Kaustav; Miranda, Les P.			Pharmacological characterization of potent and selective Na(v)1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V	PLOS ONE			English	Article							GATED SODIUM-CHANNELS; II VOLTAGE SENSOR; PROTX-II; TOXINS; PAIN; ANTAGONIST; MUTATIONS; TARGET; SCN9A; GENE	Identification of voltage-gated sodium channel Na(v)1.7 inhibitors for chronic pain therapeutic development is an area of vigorous pursuit. In an effort to identify more potent leads compared to our previously reported GpTx-1 peptide series, electrophysiology screening of fractionated tarantula venom discovered the Na v 1.7 inhibitory peptide JzTx-V from the Chinese earth tiger tarantula Chilobrachys jingzhao. The parent peptide displayed nominal selectivity over the skeletal muscle Na(v)1.4 channel. Attribute-based positional scan analoging identified a key Ile28Glu mutation that improved Na(v)1.4 selectivity over 100-fold, and further optimization yielded the potent and selective peptide leads AM-8145 and AM-0422. NMR analyses revealed that the Ile28Glu substitution changed peptide conformation, pointing to a structural rationale for the selectivity gains. AM-8145 and AM-0422 as well as GpTx-1 and HwTx-IV competed for ProTx-II binding in HEK293 cells expressing human Na(v)1.7, suggesting that these Na(v)1.7 inhibitory peptides interact with a similar binding site. AM-8145 potently blocked native tetrodotoxin-sensitive (TTX-S) channels in mouse dorsal root ganglia (DRG) neurons, exhibited 30- to 120-fold selectivity over other human TTX-S channels and exhibited over 1,000-fold selectivity over other human tetrodotoxin-resistant (TTX-R) channels. Leveraging Na(v)1.7-Na(v)1.5 chimeras containing various voltage-sensor and pore regions, AM-8145 mapped to the second voltage-sensor domain of Na(v)1.7. AM-0422, but not the inactive peptide analog AM-8374, dose-dependently blocked capsaicin-induced DRG neuron action potential firing using a multi-electrode array readout and mechanically-induced C-fiber spiking in a saphenous skin-nerve preparation. Collectively, AM-8145 and AM-0422 represent potent, new engineered Na(v)1.7 inhibitory peptides derived from the JzTx-V scaffold with improved Nav selectivity and biological activity in blocking action potential firing in both DRG neurons and C-fibers.	[Moyer, Bryan D.; Ligutti, Joseph; Liu, Dong; Shi, Licheng; Yin, Ruoyuan; Zou, Anruo] Amgen Discovery Res, Neurosci, Thousand Oaks, CA 91320 USA; [Murray, Justin K.; Long, Jason; Sham, Kelvin; Wu, Bin; Biswas, Kaustav; Miranda, Les P.] Amgen Discovery Res, Therapeut Discovery, Thousand Oaks, CA USA; [Andrews, Kristin] Amgen Discovery Res, Mol Engn, Cambridge, MA USA; [Favreau, Philippe; Stocklin, Reto] CH Bernex, Atheris Labs, Geneva, Switzerland; [Jordan, John B.] Amgen Discovery Res, Discovery Attribute Sci, Thousand Oaks, CA USA; [Lee, Josie H.; Yu, Violeta] Amgen Discovery Res, Neurosci, Cambridge, MA USA		Moyer, BD (corresponding author), Amgen Discovery Res, Neurosci, Thousand Oaks, CA 91320 USA.	bmoyer@amgen.corn		Moyer, Bryan/0000-0002-5548-3148	Amgen, Inc.	Amgen, Inc.(Amgen)	The authors were all Amgen, Inc. or Atheris Laboratories employees at the time the work was performed. No specific funding was received for this work. This work was fully supported by Amgen, Inc. Amgen, Inc. provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of the authors are listed in the 'Author contributions' section.	Alexandrou AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152405; Biswas K, 2017, ACS CHEM BIOL, V12, P2427, DOI 10.1021/acschembio.7b00542; Cardoso FC, 2018, BRIT J PHARMACOL, V175, P2138, DOI 10.1111/bph.13962; Cardoso FC, 2017, BRIT J PHARMACOL, V174, P2528, DOI 10.1111/bph.13865; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Deuis JR, 2017, NEUROPHARMACOLOGY, V127, P87, DOI 10.1016/j.neuropharm.2017.04.014; Deuis JR, 2017, SCI REP-UK, V7, DOI 10.1038/srep40883; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Emery EC, 2016, EXPERT OPIN THER TAR, V20, P975, DOI 10.1517/14728222.2016.1162295; Escoubas P, 2006, TOXICON, V47, P650, DOI 10.1016/j.toxicon.2006.01.018; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Flinspach M, 2017, SCI REP-UK, V7, DOI 10.1038/srep39662; Fukuoka T, 2008, J COMP NEUROL, V510, P188, DOI 10.1002/cne.21786; Fukuoka T, 2011, NEUROSCI RES, V70, P164, DOI 10.1016/j.neures.2011.01.020; Gilchrist John, 2014, Handb Exp Pharmacol, V221, P203, DOI 10.1007/978-3-642-41588-3_10; Gingras J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105895; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; HANSEN PE, 1991, BIOCHEMISTRY-US, V30, P10457, DOI 10.1021/bi00107a014; Ho C, 2011, MOL CELL NEUROSCI, V46, P159, DOI 10.1016/j.mcn.2010.08.017; Jordan JB, 2009, J BIOL CHEM, V284, P24155, DOI 10.1074/jbc.M109.017764; Kalia J, 2015, J MOL BIOL, V427, P158, DOI 10.1016/j.jmb.2014.07.027; KARPLUS M, 1959, J CHEM PHYS, V30, P11, DOI 10.1063/1.1729860; Klint JK, 2015, BRIT J PHARMACOL, V172, P2445, DOI 10.1111/bph.13081; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; Kornecook TJ, 2017, J PHARMACOL EXP THER, V362, P146, DOI 10.1124/jpet.116.239590; Liu ZH, 2013, J BIOL CHEM, V288, P20392, DOI 10.1074/jbc.M112.426627; Luo J, 2014, TOXINS, V6, P2177, DOI 10.3390/toxins6072177; Minassian NA, 2013, J BIOL CHEM, V288, P22707, DOI 10.1074/jbc.M113.461392; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Murray JK, 2016, J MED CHEM, V59, P2704, DOI 10.1021/acs.jmedchem.5b01947; Murray JK, 2015, BIOORG MED CHEM LETT, V25, P4866, DOI 10.1016/j.bmcl.2015.06.033; Murray JK, 2015, J MED CHEM, V58, P6784, DOI 10.1021/acs.jmedchem.5b00495; Murray JK, 2015, J MED CHEM, V58, P2299, DOI 10.1021/jm501765v; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Pinto V, 2008, J NEUROPHYSIOL, V99, P617, DOI 10.1152/jn.00944.2007; Ruiz MD, 2015, J MED CHEM, V58, P7093, DOI 10.1021/jm501981g; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Shcherbatko A, 2016, J BIOL CHEM, V291, P13974, DOI 10.1074/jbc.M116.725978; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Theriault O, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00285; Vetter I, 2017, PHARMACOL THERAPEUT, V172, P73, DOI 10.1016/j.pharmthera.2016.11.015; Wingerd JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01129-0; Wu Y, 2018, ACS CHEM NEUROSCI, V9, P187, DOI 10.1021/acschemneuro.7b00406; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2010, MOL PHARMACOL, V78, P1124, DOI 10.1124/mol.110.066332; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Yuan CH, 2007, BIOCHEM BIOPH RES CO, V352, P799, DOI 10.1016/j.bbrc.2006.11.086; Zeng XZ, 2007, TOXICON, V49, P388, DOI 10.1016/j.toxicon.2006.10.012; Zeng XZ, 2018, TOXINS, V10, DOI 10.3390/toxins10020064	52	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196791	10.1371/journal.pone.0196791	http://dx.doi.org/10.1371/journal.pone.0196791			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723257	Green Submitted, gold, Green Published			2022-12-26	WOS:000431305100063
J	Farhadinia, MS; Johnson, PJ; Macdonald, DW; Hunter, LTB				Farhadinia, Mohammad S.; Johnson, Paul J.; Macdonald, David W.; Hunter, Luke T. B.			Anchoring and adjusting amidst humans: Ranging behavior of Persian leopards along the Iran-Turkmenistan borderland	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; PANTHERA-PARDUS-SAXICOLOR; KERNEL DENSITY ESTIMATOR; HOME-RANGE; CLIMATE-CHANGE; SPACE USE; CARNIVORE CONSERVATION; SPATIAL-ORGANIZATION; AFRICAN LIONS; NATIONAL-PARK	Understanding the space use and movement ecology of apex predators, particularly in mosaic landscapes encompassing different land-uses, is fundamental for formulating effective conservation policy. The top extant big cat in the Middle East and the Caucasus, the Persian leopard Panthera pardus saxicolor, has disappeared from most of its historic range. Its spatial ecology in the areas where it remains is almost unknown. Between September 2014 and May 2017, we collared and monitored six adult leopards (5 males and 1 female) using GPS-satellite Iridium transmitters in Tandoureh National Park (355 km(2)) along the Iran-Turkmenistan borderland. Using auto-correlated Kernel density estimation based on a continuous-time stochastic process for relocation data, we estimated a mean home range of 103.4 +/- SE 51.8 km(2) for resident males which is larger than has been observed in other studies of Asian leopards. Most predation events occurred in core areas, averaging 32.4 +/- SE 12.7 km(2). Although neighboring leopards showed high spatiotemporal overlap, their hunting areas were largely exclusive. Five out of six of leopards spent some time outside the national park, among human communities. Our study suggests that a national park can play an 'anchoring' role for individuals of an apex predator that spend some time in the surrounding human-dominated landscapes. Therefore, we envisage that instead of emphasizing either land sharing or land sparing, a combined approach can secure the viability of resilient large carnivores that are able to coexist with humans in the rugged montane landscapes of west and central Asia.	[Farhadinia, Mohammad S.; Johnson, Paul J.; Macdonald, David W.] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney House, Oxford, Oxon, England; [Farhadinia, Mohammad S.] Future4Leopards Fdn, Tehran, Iran; [Hunter, Luke T. B.] Panthera, New York, NY USA; [Hunter, Luke T. B.] Univ KwaZulu Natal, Sch Life Sci, Westville Campus, Durban, South Africa	University of Oxford; University of Kwazulu Natal	Farhadinia, MS (corresponding author), Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney House, Oxford, Oxon, England.; Farhadinia, MS (corresponding author), Future4Leopards Fdn, Tehran, Iran.	mohammad.farhadinia@zoo.ox.ac.uk	Hunter, Luke T.B./H-3324-2019	Hunter, Luke T.B./0000-0001-9653-6544; Farhadinia, Mohammad/0000-0002-5385-6254	Panthera's Kaplan Graduate Award; People's Trust for Endangered Species; Zoologische Gesellschaft fur Arten- und Populationsschutr; Iranian Cheetah Society; Quagga Conservation Fund; IdeaWild; Association Francaise des Pares Zoologiques	Panthera's Kaplan Graduate Award; People's Trust for Endangered Species; Zoologische Gesellschaft fur Arten- und Populationsschutr; Iranian Cheetah Society; Quagga Conservation Fund; IdeaWild; Association Francaise des Pares Zoologiques	This study was supported by Panthera's Kaplan Graduate Award (www.panthera.org), the People's Trust for Endangered Species (www.ptes.org), Zoologische Gesellschaft fur Arten- und Populationsschutr (www.zgap.de), Iranian Cheetah Society (www.wildlife.ir), Quagga Conservation Fund, IdeaWild (www.ideawild.org) and Association Francaise des Pares Zoologiques (www.AFdPZ.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134815; Allen AM, 2016, ECOSPHERE, V7; Bailey, 1993, AFRICAN LEOPARD ECOL; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Baskin L., 2003, ECOLOGY UNGULATES HD; Benson JF, 2006, ANIM BEHAV, V71, P685, DOI 10.1016/j.anbehav.2005.08.005; Bjorneraas K, 2010, J WILDLIFE MANAGE, V74, P1361, DOI 10.2193/2009-405; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Cain JW, 2005, WILDLIFE SOC B, V33, P926, DOI 10.2193/0091-7648(2005)33[926:IOTAGF]2.0.CO;2; Calabrese JM, 2016, METHODS ECOL EVOL, V7, P1124, DOI 10.1111/2041-210X.12559; de Azevedo FCC, 2007, BIOL CONSERV, V137, P391, DOI 10.1016/j.biocon.2007.02.022; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Di Minin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep23814; Durant SM, 2015, J APPL ECOL, V52, P544, DOI 10.1111/1365-2664.12415; Ebrahimi A, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-017-7040-8; Farhadinia Mohammad S., 2017, Cat News, V65, P28; Farhadinia MS, 2015, BIOL CONSERV, V191, P770, DOI 10.1016/j.biocon.2015.08.027; Farhadinia MS, 2014, ZOOL MIDDLE EAST, V60, P195, DOI 10.1080/09397140.2014.939813; Fattebert J, 2016, J ZOOL, V299, P153, DOI 10.1111/jzo.12344; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Fleming CH, 2015, ECOLOGY, V96, P1182, DOI 10.1890/14-2010.1; Fleming CH, 2017, METHODS ECOL EVOL, V8, P571, DOI 10.1111/2041-210X.12673; Forrest JL, 2012, BIOL CONSERV, V150, P129, DOI 10.1016/j.biocon.2012.03.001; Frank L, 2003, WILDLIFE SOC B, V31, P309; Gavashelishvili A, 2008, J APPL ECOL, V45, P579, DOI 10.1111/j.1365-2664.2007.01432.x; Gompper ME, 2015, SCIENCE, V347, P381, DOI 10.1126/science.347.6220.382-b; Goodrich JM, 2010, J MAMMAL, V91, P737, DOI 10.1644/09-MAMM-A-293.1; Grassman Lon I., 1999, Natural History Bulletin of the Siam Society, V47, P77; Hamidi Amirhossein Kh., 2014, Cat News, V60, P12; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hunter L, 2011, CARNIVORES WORLD; Jacobson AP, 2016, PEERJ, V4, DOI 10.7717/peerj.1974; Jiang GS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15475; Johansson O, 2016, BIOL CONSERV, V203, P1, DOI 10.1016/j.biocon.2016.08.034; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 2000, J ZOOL, V250, P255; Kelt DA, 2001, AM NAT, V157, P637, DOI 10.1086/320621; Knopff KH, 2009, J WILDLIFE MANAGE, V73, P586, DOI 10.2193/2008-294; Kochanny CO, 2009, J WILDLIFE MANAGE, V73, P779, DOI 10.2193/2008-394; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Li J, 2016, BIOL CONSERV, V203, P188, DOI 10.1016/j.biocon.2016.09.026; Loveridge AJ, 2009, ECOGRAPHY, V32, P953, DOI 10.1111/j.1600-0587.2009.05745.x; Luo ZH, 2015, ECOL APPL, V25, P24, DOI 10.1890/13-1499.1; Mallon DP, 2009, J APPL ECOL, V46, P516, DOI 10.1111/j.1365-2664.2009.01654.x; Marino J, 2011, DIVERS DISTRIB, V17, P311, DOI 10.1111/j.1472-4642.2011.00744.x; Marker LL, 2005, S AFR J WILDL RES, V35, P105; McCarthy T., 2017, PANTHERA UNCIA IUCN; Mizutani F, 1998, J ZOOL, V244, P269, DOI 10.1111/j.1469-7998.1998.tb00031.x; Nilsen EB, 2005, ECOSCIENCE, V12, P68, DOI 10.2980/i1195-6860-12-1-68.1; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Odden M, 2005, WILDLIFE BIOL, V11, P145, DOI 10.2981/0909-6396(2005)11[145:SAAPOL]2.0.CO;2; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pierce BM, 2000, ECOLOGY, V81, P1533; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rostro-Garcia S, 2016, BIOL CONSERV, V201, P293, DOI 10.1016/j.biocon.2016.07.001; Rozhnov VV, 2015, BIOL BULL+, V42, P821, DOI 10.1134/S1062359015090095; Simcharoen S, 2008, BIOL CONSERV, V141, P2242, DOI 10.1016/j.biocon.2008.06.015; Stander PE, 1997, AFR J ECOL, V35, P156, DOI 10.1111/j.1365-2028.1997.068-89068.x; Stanovich KE, 2013, THINK REASONING, V19, P1, DOI 10.1080/13546783.2012.713178; Stein Andrew B., 2013, Mammalian Species, P30, DOI 10.1644/900.1; Steyn V, 2006, S AFR J WILDL RES, V36, P189; Swanepoel LH, 2015, ORYX, V49, P595, DOI 10.1017/S0030605313001282; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Vander Wal E, 2012, ECOL MODEL, V224, P48, DOI 10.1016/j.ecolmodel.2011.10.006; Williams ST, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.161090; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	71	31	32	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196602	10.1371/journal.pone.0196602	http://dx.doi.org/10.1371/journal.pone.0196602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29719005	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900064
J	Lonati, C; Bassani, GA; Brambilla, D; Leonardi, P; Carlin, A; Faversani, A; Gatti, S; Valenza, F				Lonati, Caterina; Bassani, Giulia A.; Brambilla, Daniela; Leonardi, Patrizia; Carlin, Andrea; Faversani, Alice; Gatti, Stefano; Valenza, Franco			Influence of ex vivo perfusion on the biomolecular profile of rat lungs	FASEB JOURNAL			English	Article						lung gene expression; hyaluronan; rat model; ischemic preconditioning; DCD	INJURY SALVAGE KINASE; REPERFUSION INJURY; DONOR LUNGS; TRANSPLANTATION; HYALURONAN; FRAGMENTATION; ISCHEMIA; IMPROVES; OUTCOMES; REMOVAL	Despite increasing clinical adoption, biologic influences of ex vivo lung perfusion (EVLP) remain insufficiently elucidated. The aim of the current study was to investigate biomolecular changes induced by EVLP in rat lungs. EVLP was maintained for 180 min. Hyaluronan, mediators, and cells were assessed in the perfusate. Gene expression, signaling pathways, and ATP content were investigated in lung tissue. EVLP induced the release of medium-high molecular weight hyaluronan and transcription of hyaluronan synthases (P < 0.001). Increasing concentrations of inflammatory mediators were detected in the perfusate (P < 0.001). Perfused lungs exhibited a distinctive transcriptional signature compared with organs examined before or after surgery/procurement (P = 0.003). Up-regulated genes were involved in inflammation and its regulation, apoptosis/survival, heat shock, and oxidative stress response (q = 0). Down-regulated genes were related to lymphocyte function (q = 0). The NF-B, signal transducer and activator of transcription 3, ERK1/2, p38, Akt, and stress-activated protein kinase/JNK signaling pathways were modulated by EVLP (P < 0.05). Most of these biomolecular changes were examined and confirmed in additional experiments that were performed in lungs procured from donation after cardiocirculatory death after 180 min of warm ischemia. The current study demonstrates that EVLP broadly affects the lung biomolecular phenotype. These findings improve our comprehension of the effects exerted by the procedure and encourage additional research in preclinical models to implement therapeutic interventions.Lonati, C., Bassani, G. A., Brambilla, D., Leonardi, P., Carlin, A., Faversani, A., Gatti, S., Valenza, F. Influence of ex vivo perfusion on the biomolecular profile of rat lungs.	[Lonati, Caterina; Bassani, Giulia A.; Brambilla, Daniela; Gatti, Stefano] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Ca Gr, Ctr Surg Res, Milan, Italy; [Lonati, Caterina; Bassani, Giulia A.; Leonardi, Patrizia; Carlin, Andrea] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Ca Gr, Ctr Preclin Invest, Dipartimento Anestesia Rianimaz Emergenza Urgenza, Milan, Italy; [Faversani, Alice] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Ca Gr, Div Pathol, Milan, Italy; [Leonardi, Patrizia; Carlin, Andrea] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Faversani, Alice] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, Italy	University of Milan; University of Milan	Lonati, C (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr Surg Res, 9 Pace St, I-20122 Milan, Italy.	caterina.lonati@gmail.com	Gatti, Stefano/AAE-3281-2022; lonati, caterina/GVT-5843-2022; lonati, caterina/ABI-1503-2020; Bassani, Giulia A./AAC-3634-2022; lonati, caterina/M-3748-2015	Gatti, Stefano/0000-0003-2209-4338; Bassani, Giulia A./0000-0001-9196-6975; lonati, caterina/0000-0001-7855-7851; Brambilla, Daniela/0000-0002-9669-278X	Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Grant 5x1000-2014; Centro Nazionale Trapianti (Rome, Italy); Milano Liver Transplant Association (MILTA); Lega Italiana Fibrosi Cistica Onlus (Lombardia, Italy)	Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Grant 5x1000-2014; Centro Nazionale Trapianti (Rome, Italy); Milano Liver Transplant Association (MILTA); Lega Italiana Fibrosi Cistica Onlus (Lombardia, Italy)	The authors acknowledge their colleagues at Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico; Dr. Maurizio Marchini (Referral Center for Systemic Autoimmune Diseases, University of Milan) for facilitating the logistics for the Luminex platform utilization; Dr. Emanuela Pappalardo (Department of Pathophysiology and Transplantation, University of Milan) for providing the Nanodrop spectrophotometer; and Drs. Mauro Pomati and Manuela Zappa (Laboratorio Oncoematologia Diagnostica, Milan, Italy) for allowing access to the 7900HT platform. The authors also thank Dr. Vincenzo Carbonelli (Referral Center for Systemic Autoimmune Diseases, University of Milan) for technical assistance in leukocyte characterization. This work was supported by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Grant 5x1000-2014 "Ottimizzazione della procedura di perfusione di organi isolati a scopo di trapianto mediante modulazione del liquido di perfusione (Improvement of the procedure to perfuse isolated organs before transplantation through perfusion fluid optimization)," Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico 5x1000-2014 "Il benessere animale nella ricerca preclinica: strategie di implememntazione (strategies for improvement of animal healthcare in preclinical research)", by Centro Nazionale Trapianti (Rome, Italy), by Milano Liver Transplant Association (MILTA), and by Lega Italiana Fibrosi Cistica Onlus (Lombardia, Italy). The authors declare no conflicts of interest.	Bassani GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167898; Boffini M, 2014, EUR J CARDIO-THORAC, V46, P789, DOI 10.1093/ejcts/ezu239; Cypel M, 2012, J THORAC CARDIOV SUR, V144, P1200, DOI 10.1016/j.jtcvs.2012.08.009; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; Eldridge L, 2011, AM J PHYSIOL-LUNG C, V301, pL782, DOI 10.1152/ajplung.00079.2011; Fildes JE, 2015, TRANSPLANTATION, V99, P1078, DOI 10.1097/TP.0000000000000462; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Harada M, 2015, GEN THORAC CARDIOVAS, V63, P645, DOI 10.1007/s11748-015-0585-0; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Hausenloy DJ, 2011, ANTIOXID REDOX SIGN, V14, P893, DOI 10.1089/ars.2010.3360; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Inokawa H, 2006, ANN THORAC SURG, V82, P1219, DOI 10.1016/j.athoracsur.2006.05.004; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kakishita T, 2010, ANN THORAC SURG, V89, P1773, DOI 10.1016/j.athoracsur.2010.02.077; Kariko K, 2004, J CEREBR BLOOD F MET, V24, P1288, DOI 10.1097/01.WCB.0000145666.68576.71; Koike T, 2011, J HEART LUNG TRANSPL, V30, P1312, DOI 10.1016/j.healun.2011.07.014; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lecour S, 2009, J MOL CELL CARDIOL, V47, P32, DOI 10.1016/j.yjmcc.2009.03.019; Liang JR, 2016, ADV DRUG DELIVER REV, V97, P186, DOI 10.1016/j.addr.2015.10.017; Lindstedt S, 2011, INTERACT CARDIOV TH, V12, P162, DOI 10.1510/icvts.2010.244830; Machuca TN, 2015, ANN SURG, V261, P591, DOI 10.1097/SLA.0000000000000974; Mehaffey JH, 2017, ANN THORAC SURG, V103, P1723, DOI 10.1016/j.athoracsur.2017.01.018; Moriondo A, 2007, J APPL PHYSIOL, V103, P747, DOI 10.1152/japplphysiol.00056.2007; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Noda K, 2014, TRANSPLANTATION, V98, P499, DOI 10.1097/TP.0000000000000254; Reeb J, 2016, CLIN TRANSPLANT, V30, P183, DOI 10.1111/ctr.12680; Sadaria MR, 2011, ANN THORAC SURG, V92, P478, DOI 10.1016/j.athoracsur.2011.04.027; Sanchez PG, 2016, CURR OPIN ORGAN TRAN, V21, P258, DOI 10.1097/MOT.0000000000000310; Selzner N, 2012, TRANSPLANT REV-ORLAN, V26, P115, DOI 10.1016/j.trre.2011.07.003; Slama A, 2017, J HEART LUNG TRANSPL, V36, P744, DOI 10.1016/j.healun.2017.02.011; Steen S, 2001, LANCET, V357, P825, DOI 10.1016/S0140-6736(00)04195-7; Steen S, 2007, ANN THORAC SURG, V83, P2191, DOI 10.1016/j.athoracsur.2007.01.033; Stone JP, 2016, AM J TRANSPLANT, V16, P33, DOI 10.1111/ajt.13446; Stone JP, 2014, J HEART LUNG TRANSPL, V33, P864, DOI 10.1016/j.healun.2014.03.005; Tanaka Y, 2015, AM J TRANSPLANT, V15, P1219, DOI 10.1111/ajt.13109; Todd JL, 2014, AM J RESP CRIT CARE, V189, P556, DOI 10.1164/rccm.201308-1481OC; Valenza F, 2014, TRANSPL INT, V27, P553, DOI 10.1111/tri.12295; Vogel T, 2012, TRANSPLANT REV-ORLAN, V26, P156, DOI 10.1016/j.trre.2011.02.004; Wagner FM, 2016, J THORAC CARDIOV SUR, V151, P547, DOI 10.1016/j.jtcvs.2015.10.052; Wallinder A, 2016, J HEART LUNG TRANSPL, V35, P1303, DOI 10.1016/j.healun.2016.05.021; Yeung JC, 2018, AM J TRANSPLANT, V18, P1518, DOI 10.1111/ajt.14700; Yuan H, 2015, ANAL BIOCHEM, V474, P78, DOI 10.1016/j.ab.2014.12.020; Zych B, 2012, J HEART LUNG TRANSPL, V31, P274, DOI 10.1016/j.healun.2011.10.008	44	21	21	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5532	5549		10.1096/fj.201701255R	http://dx.doi.org/10.1096/fj.201701255R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29718705	Bronze			2022-12-26	WOS:000447972500028
J	Freedman, H; Winter, P; Tuszynski, J; Tyrrell, DL; Houghton, M				Freedman, Holly; Winter, Philip; Tuszynski, Jack; Tyrrell, D. Lorne; Houghton, Michael			A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						computer modeling; computation; mitochondria; RNA polymerase; molecular dynamics; nucleoside; nucleotide analogue; nucleotide; molecular modeling; antiviral agent; mitochondrial RNA polymerase	EMPIRICAL FORCE-FIELD; MOLECULAR-DYNAMICS; FREE-ENERGY; NUCLEIC-ACIDS; DNA; TRANSCRIPTION; SIMULATIONS; INHIBITORS; INITIATION; FIDELITY	In the development of antiviral drugs that target viral RNA-dependent RNA polymerases, off-target toxicity caused by the inhibition of the human mitochondrial RNA polymerase (POLRMT) is a major liability. Therefore, it is essential that all new ribonucleoside analogue drugs be accurately screened for POLRMT inhibition. A computational tool that can accurately predict NTP binding to POLRMT could assist in evaluating any potential toxicity and in designing possible salvaging strategies. Using the available crystal structure of POLRMT bound to an RNA transcript, here we created a model of POLRMT with an NTP molecule bound in the active site. Furthermore, we implemented a computational screening procedure that determines the relative binding free energy of an NTP analogue to POLRMT by free energy perturbation (FEP), i.e. a simulation in which the natural NTP molecule is slowly transformed into the analogue and back. In each direction, the transformation was performed over 40 ns of simulation on our IBM Blue Gene Q supercomputer. This procedure was validated across a panel of drugs for which experimental dissociation constants were available, showing that NTP relative binding free energies could be predicted to within 0.97 kcal/mol of the experimental values on average. These results demonstrate for the first time that free-energy simulation can be a useful tool for predicting binding affinities of NTP analogues to a polymerase. We expect that our model, together with similar models of viral polymerases, will be very useful in the screening and future design of NTP inhibitors of viral polymerases that have no mitochondrial toxicity.	[Freedman, Holly; Tyrrell, D. Lorne; Houghton, Michael] Univ Alberta, Li Ka Shing Appl Virol Inst, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada; [Tuszynski, Jack] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada; [Winter, Philip; Tuszynski, Jack] Univ Alberta, Dept Oncol, Edmonton, AB T6G 2R7, Canada	University of Alberta; University of Alberta; University of Alberta	Freedman, H; Houghton, M (corresponding author), Univ Alberta, Li Ka Shing Appl Virol Inst, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada.	hfreedma@ualberta.ca; mhoughto@ualberta.ca	Tuszynski, Jack/AAA-2073-2020	Tuszynski, Jack/0000-0001-9976-0429; Houghton, Michael/0000-0003-3762-6771	Alberta Innovates; Canadian Excellence Research Chair grant	Alberta Innovates; Canadian Excellence Research Chair grant	This work was supported by computing resources provided by the Southern Ontario Smart Computing Innovation Platform, Scinet, Compute Canada, and WestGrid. This work was also supported by funds from Alberta Innovates to the Li Ka Shing Applied Virology Institute and by a Canadian Excellence Research Chair grant (to M.H.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2008, AMBER 10; [Anonymous], 2013, MOL OP ENV MOE; Arnold JJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003030; Arnold JJ, 2012, BBA-GENE REGUL MECH, V1819, P948, DOI 10.1016/j.bbagrm.2012.04.002; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1145/1188455.1188544; Bren U, 2006, J PHYS CHEM B, V110, P10557, DOI 10.1021/jp060292b; Brown SP, 2009, DRUG DISCOV TODAY, V14, P420, DOI 10.1016/j.drudis.2009.01.012; Cameron CE, 2009, CURR OPIN STRUC BIOL, V19, P768, DOI 10.1016/j.sbi.2009.10.012; Case DA, 2012, AMBER 12; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Cermakian N, 1997, J MOL EVOL, V45, P671, DOI 10.1007/PL00006271; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Choi KH, 2012, ADV EXP MED BIOL, V726, P267, DOI 10.1007/978-1-4614-0980-9_12; Cihlar T, 2010, ANTIVIR RES, V85, P39, DOI 10.1016/j.antiviral.2009.09.014; Deng YQ, 2009, J PHYS CHEM B, V113, P2234, DOI 10.1021/jp807701h; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Feng JY, 2017, TOXICOL SCI, V155, P2, DOI 10.1093/toxsci/kfw224; Feng JY, 2016, ANTIMICROB AGENTS CH, V60, P806, DOI 10.1128/AAC.01922-15; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Gilson MK, 1997, BIOPHYS J, V72, P1047, DOI 10.1016/S0006-3495(97)78756-3; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jin ZN, 2017, ANTIVIR RES, V143, P151, DOI 10.1016/j.antiviral.2017.04.005; KARPLUS M, 1980, BIOPHYS J, V32, P603, DOI 10.1016/S0006-3495(80)84993-9; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Nelms MD, 2015, CHEM RES TOXICOL, V28, P1891, DOI 10.1021/acs.chemrestox.5b00275; Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saenger W., 1984, PRINCIPLES NUCL ACID, P19; Santo-Domingo J, 2012, J GEN PHYSIOL, V139, P415, DOI 10.1085/jgp.201110767; Schwinghammer K, 2013, NAT STRUCT MOL BIOL, V20, P1298, DOI 10.1038/nsmb.2683; Shen HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002851; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Smidansky ED, 2011, BIOCHEMISTRY-US, V50, P5016, DOI 10.1021/bi200350d; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Swails JM, 2014, J CHEM THEORY COMPUT, V10, P1341, DOI 10.1021/ct401042b; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vanquelef E, 2011, NUCLEIC ACIDS RES, V39, pW511, DOI 10.1093/nar/gkr288; Velazquez G, 2015, RNA BIOL, V12, P514, DOI 10.1080/15476286.2015.1014283; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang L, 2015, J AM CHEM SOC, V137, P2695, DOI 10.1021/ja512751q; Yesselman JD, 2012, J COMPUT CHEM, V33, P189, DOI 10.1002/jcc.21963; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409	55	7	7	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9696	9705		10.1074/jbc.RA118.002588	http://dx.doi.org/10.1074/jbc.RA118.002588			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29739852	Green Published, hybrid			2022-12-26	WOS:000436102300014
J	Wang, L; Fang, B; Fujiwara, T; Krager, K; Gorantla, A; Li, CY; Feng, JQ; Jennings, ML; Zhou, J; Aykin-Burns, N; Zhao, HB				Wang, Lei; Fang, Bin; Fujiwara, Toshifumi; Krager, Kimberly; Gorantla, Akshita; Li, Chaoyuan; Feng, Jian Q.; Jennings, Michael L.; Zhou, Jian; Aykin-Burns, Nukhet; Zhao, Haibo			Deletion of ferroportin in murine myeloid cells increases iron accumulation and stimulates osteoclastogenesis in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						osteoclast; iron metabolism; bone; mitochondrial metabolism; mitochondria; osteoporosis; bone remodeling; ferroportin; iron metabolism; iron overload; osteoclast; hemochromatosis; thalassemia; Slc40a1	AUTOSOMAL-DOMINANT HEMOCHROMATOSIS; ESTROGEN RESPONSE ELEMENT; BONE-MINERAL DENSITY; REGULATES OSTEOCLASTOGENESIS; HEREDITARY HEMOCHROMATOSIS; GENETIC HEMOCHROMATOSIS; OXIDATIVE STRESS; SERUM FERRITIN; CRUCIAL ROLE; DIFFERENTIATION	Osteoporosis, osteopenia, and pathological bone fractures are frequent complications of iron-overload conditions such as hereditary hemochromatosis, thalassemia, and sickle cell disease. Moreover, animal models of iron overload have revealed increased bone resorption and decreased bone formation. Although systemic iron overload affects multiple organs and tissues, leading to significant changes on bone modeling and remodeling, the cell autonomous effects of excessive iron on bone cells remain unknown. Here, to elucidate the role of cellular iron homeostasis in osteoclasts, we generated two mouse strains in which solute carrier family 40 member 1 (Slc40a1), a gene encoding ferroportin (FPN), the sole iron exporter in mammalian cells, was specifically deleted in myeloid osteoclast precursors or mature cells. The FPN deletion mildly increased iron levels in both precursor and mature osteoclasts, and its loss in precursors, but not in mature cells, increased osteoclastogenesis and decreased bone mass in vivo. Of note, these phenotypes were more pronounced in female than in male mice. In vitro studies revealed that the elevated intracellular iron promoted macrophage proliferation and amplified expression of nuclear factor of activated T cells 1 (Nfatc1) and PPARG coactivator 1 (Pgc-1), two transcription factors critical for osteoclast differentiation. However, the iron excess did not affect osteoclast survival. While increased iron stimulated global mitochondrial metabolism in osteoclast precursors, it had little influence on mitochondrial mass and reactive oxygen species production. These results indicate that FPN-regulated intracellular iron levels are critical for mitochondrial metabolism, osteoclastogenesis, and skeletal homeostasis in mice.	[Wang, Lei; Zhou, Jian] Anhui Med Univ, Affiliated Hosp 1, Dept Orthoped, Hefei 230022, Anhui, Peoples R China; [Wang, Lei; Fang, Bin; Fujiwara, Toshifumi; Zhao, Haibo] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Div Endocrinol & Metab, Dept Internal Med, Little Rock, AR 72205 USA; [Krager, Kimberly; Gorantla, Akshita; Aykin-Burns, Nukhet] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA; [Jennings, Michael L.; Zhao, Haibo] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Fang, Bin] Huazhong Univ Sci & Technol, Union Hosp, Dept Hematol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China; [Li, Chaoyuan; Feng, Jian Q.] Texas A&M Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA; [Zhao, Haibo] Vet Affairs Long Beach Healthcare Syst, Res Dept, Tibor Rubin Vet Affairs Med Ctr, Long Beach, CA 90822 USA; [Zhao, Haibo] Univ Calif Irvine, Div Endocrinol, Dept Med, Irvine, CA 92697 USA	Anhui Medical University; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Huazhong University of Science & Technology; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine	Zhou, J (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Orthoped, Hefei 230022, Anhui, Peoples R China.; Zhao, HB (corresponding author), Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Div Endocrinol & Metab, Dept Internal Med, Little Rock, AR 72205 USA.; Aykin-Burns, N (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Little Rock, AR 72205 USA.; Zhao, HB (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.; Zhao, HB (corresponding author), Vet Affairs Long Beach Healthcare Syst, Res Dept, Tibor Rubin Vet Affairs Med Ctr, Long Beach, CA 90822 USA.; Zhao, HB (corresponding author), Univ Calif Irvine, Div Endocrinol, Dept Med, Irvine, CA 92697 USA.	zhoujian831207@163.com; NAykinburns@uams.edu; hzhao@uams.edu		Aykin-Burns, Nukhet/0000-0001-8574-4102; ZHAO, HAIBO/0000-0003-0836-7555; Li, Chaoyuan/0000-0002-2826-8725	Chinese Natural Science Fund [81501843]; National Institutes of Health from NIAMS [AR062012, AR068509]; University of Arkansas for Medical Sciences (UAMS) Bridge Fund; UAMS Medical Research Endowment Award; National Institutes of Health [R01 DE025659]; National Institutes of Health from NIGMS [GM109005]; NIEHS [ES022781]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062012, R21AR068509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES022781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109005] Funding Source: NIH RePORTER	Chinese Natural Science Fund(National Natural Science Foundation of China (NSFC)); National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Arkansas for Medical Sciences (UAMS) Bridge Fund; UAMS Medical Research Endowment Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Chinese Natural Science Fund Grant 81501843 (to J. Z.), National Institutes of Health Grants AR062012 and AR068509 from NIAMS (to H. Z.), University of Arkansas for Medical Sciences (UAMS) Bridge Fund, UAMS Medical Research Endowment Award (to H. Z.), and by National Institutes of Health Grant R01 DE025659 (to J. Q. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant GM109005 from NIGMS and Grant ES022781 from NIEHS.	Almeida A, 2005, BRIT J HAEMATOL, V129, P482, DOI 10.1111/j.1365-2141.2005.05476.x; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Bartell SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4773; Beaumont C, 2009, SEMIN HEMATOL, V46, P328, DOI 10.1053/j.seminhematol.2009.06.004; Boyce BF, 2013, J DENT RES, V92, P860, DOI 10.1177/0022034513500306; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chang H., 1931, ANAT REC, V49, P30; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032; Crownover BK, 2013, AM FAM PHYSICIAN, V87, P183; Dede AD, 2016, OSTEOPOROSIS INT, V27, P3409, DOI 10.1007/s00198-016-3719-z; Dhindsa S, 2016, CLIN ENDOCRINOL, V85, P772, DOI 10.1111/cen.13130; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Ellen BF, 2008, BONE, V43, P162, DOI 10.1016/j.bone.2008.03.003; Fernandes A, 2009, BLOOD, V114, P437, DOI 10.1182/blood-2008-03-146134; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Fujiwara T, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.213; Fujiwara T, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86330; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; GARRICK LM, 1991, J CELL PHYSIOL, V146, P460, DOI 10.1002/jcp.1041460317; Goettsch C, 2013, J CLIN INVEST, V123, P4731, DOI 10.1172/JCI67603; Gu ZM, 2015, CANCER RES, V75, P2211, DOI 10.1158/0008-5472.CAN-14-3804; Guggenbuhl P, 2005, OSTEOPOROSIS INT, V16, P1809, DOI 10.1007/s00198-005-1934-0; Guggenbuhl P, 2011, OSTEOPOROSIS INT, V22, P2313, DOI 10.1007/s00198-010-1456-2; Guggenbuhl P, 2011, BEST PRACT RES CL RH, V25, P649, DOI 10.1016/j.berh.2011.10.014; Guo JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139395; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexcr.2004.07.035; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; HOLTROP ME, 1977, CLIN ORTHOP RELAT R, P177; Hou YL, 2012, GENE, V511, P398, DOI 10.1016/j.gene.2012.09.060; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Ito Y, 2010, J CLIN INVEST, V120, P1981, DOI 10.1172/JCI39650; Jeney V, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00077; Jia P, 2012, J ORTHOP RES, V30, P1843, DOI 10.1002/jor.22133; Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011; Kang IS, 2016, SCI REP-UK, V6, DOI 10.1038/srep38014; Kanzaki H, 2013, J BIOL CHEM, V288, P23009, DOI 10.1074/jbc.M113.478545; Kim BJ, 2013, OSTEOPOROSIS INT, V24, P2627, DOI 10.1007/s00198-013-2363-0; Kim BJ, 2012, J BONE MINER RES, V27, P2279, DOI 10.1002/jbmr.1692; Kim H, 2017, J BONE MINER RES, V32, P397, DOI 10.1002/jbmr.2974; Kim H, 2013, CELL METAB, V17, P249, DOI 10.1016/j.cmet.2013.01.002; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Lawen A, 2013, ANTIOXID REDOX SIGN, V18, P2473, DOI 10.1089/ars.2011.4271; Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Lee JM, 2012, J IMMUNOL, V189, P5284, DOI 10.4049/jimmunol.1003738; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Mahachoklertwattana P, 2003, J CLIN ENDOCR METAB, V88, P3966, DOI 10.1210/jc.2002-021548; MILMAN N, 1992, ANN HEMATOL, V65, P96, DOI 10.1007/BF01698138; Montosi G, 2001, J CLIN INVEST, V108, P619, DOI 10.1172/JCI200113468; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Qian Y, 2015, CELL SIGNAL, V27, P934, DOI 10.1016/j.cellsig.2015.01.017; Rissanen JP, 2008, CALCIFIED TISSUE INT, V82, P108, DOI 10.1007/s00223-007-9091-4; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; SCOTT BL, 1956, ANAT REC, V126, P465, DOI 10.1002/ar.1091260405; Srinivasan S, 2010, ANN NY ACAD SCI, V1192, P245, DOI 10.1111/j.1749-6632.2009.05377.x; Sun L, 2014, GENE, V543, P161, DOI 10.1016/j.gene.2014.02.023; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; Thongchote K, 2015, AM J PHYSIOL-ENDOC M, V309, pE936, DOI 10.1152/ajpendo.00329.2015; Tsay J, 2010, BLOOD, V116, P2582, DOI 10.1182/blood-2009-12-260083; Vogiatzi MG, 2009, J BONE MINER RES, V24, P543, DOI [10.1359/jbmr.080505, 10.1359/JBMR.080505]; Vogiatzi MG, 2006, BONE, V38, P571, DOI 10.1016/j.bone.2005.10.001; Voskaridou E, 2001, BRIT J HAEMATOL, V112, P36, DOI 10.1046/j.1365-2141.2001.02549.x; Wang X, 2015, J ENDOCRINOL, V226, P121, DOI 10.1530/JOE-14-0657; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Xie WJ, 2016, CALCIFIED TISSUE INT, V98, P275, DOI 10.1007/s00223-015-0087-1; Xu WJ, 2013, CELL METAB, V17, P319, DOI 10.1016/j.cmet.2013.02.004; Yang Q, 2012, ENDOCRINOLOGY, V153, P3170, DOI 10.1210/en.2011-2045; Ye SQ, 2016, INT J BIOL SCI, V12, P1488, DOI 10.7150/ijbs.15583; Ye SQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027285; Zacharski LR, 2000, AM HEART J, V140, P98, DOI 10.1067/mhj.2000.106646; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhang Lin-Lin, 2013, Zhonghua Wai Ke Za Zhi, V51, P518; Zhang ZZ, 2011, BLOOD, V118, P1912, DOI 10.1182/blood-2011-01-330324; Zhao GY, 2015, INFLAMMATION, V38, P718, DOI 10.1007/s10753-014-9982-2; Zhao HB, 2006, J BONE MINER RES, V21, P456, DOI 10.1359/JBMR.051204; Zhou J, 2013, J BIOL CHEM, V288, P30064, DOI 10.1074/jbc.M113.478750; Zhou P, 2006, J IMMUNOL, V177, P8777, DOI 10.4049/jimmunol.177.12.8777; Zwerina J, 2005, FASEB J, V19, P2011, DOI 10.1096/fj.05-4278fje	90	25	29	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9248	9264		10.1074/jbc.RA117.000834	http://dx.doi.org/10.1074/jbc.RA117.000834			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29724825	hybrid, Green Published			2022-12-26	WOS:000435441400012
J	Garcia-Miguel, M; Riquelme, JA; Norambuena-Soto, I; Morales, PE; Sanhueza-Olivares, F; Nunez-Soto, C; Mondaca-Ruff, D; Cancino-Arenas, N; San Martin, A; Chiong, M				Garcia-Miguel, Marina; Riquelme, Jaime A.; Norambuena-Soto, Ignacio; Morales, Pablo E.; Sanhueza-Olivares, Fernanda; Nunez-Soto, Constanza; Mondaca-Ruff, David; Cancino-Arenas, Nicole; San Martin, Alejandra; Chiong, Mario			Autophagy mediates tumor necrosis factor-alpha-induced phenotype switching in vascular smooth muscle A7r5 cell line	PLOS ONE			English	Article							I-KAPPA-B; PROLIFERATION; ATHEROSCLEROSIS; METABOLISM; MECHANISMS; INHIBITORS; SECRETION; PATHWAY; GROWTH	Vascular smooth muscle cells (VSMC) dedifferentiation from a contractile to a synthetic phenotype contributes to atherosclerosis. Atherosclerotic tissue has a chronic inflammatory component with high levels of tumor necrosis factor-alpha (TNF-alpha). VSMC of atheromatous plaques have increased autophagy, a mechanism responsible for protein and intracellular organelle degradation. The aim of this study was to evaluate whether TNF-alpha induces phenotype switching of VSMCs and whether this effect depends on autophagy. Rat aortic Vascular smooth A7r5 cell line was used as a model to examine the phenotype switching and autophagy. These cells were stimulated with TNF-alpha 100 ng/mL. Autophagy was determined by measuring LC3-II and p62 protein levels. Autophagy was inhibited using chloroquine and siRNA Beclin1. Cell dedifferentiation was evaluated by measuring the expression of contractile proteins alpha-SMA and SM22, extracellular matrix protein osteopontin and type I collagen levels. Cell proliferation was measured by [H-3]-thymidine incorporation and MTT assay, and migration was evaluated by wound healing and transwell assays. Expression of IL-1 beta, IL-6 and IL-10 was assessed by ELISA. TNF-alpha induced autophagy as determined by increased LC3-II (1.91 +/- 0.21, p<0.001) and decreased p62 (0.86 +/- 0.02, p<0.05) when compared to control. Additionally, TNF-alpha decreased alpha-SMA (0.74 +/- 0.12, p<0.05) and SM22 (0.54 +/- 0.01, p<0.01) protein levels. Consequently, TNF-alpha induced migration (1.25 +/- 0.05, p<0.05), proliferation (2.33 +/- 0.24, p<0.05), and the secretion of IL-6 (258 +/- 53, p<0.01), type I collagen (3.09 +/- 0.85, p<0.01) and osteopontin (2.32 +/- 0.46, p<0.01). Inhibition of autophagy prevented all the TNF-alpha-induced phenotypic changes. TNF-alpha induces phenotype switching in A7r5 cell line by a mechanism that required autophagy. Therefore, autophagy may be a potential therapeutic target for the treatment of atherosclerosis.	[Garcia-Miguel, Marina; Riquelme, Jaime A.; Norambuena-Soto, Ignacio; Morales, Pablo E.; Sanhueza-Olivares, Fernanda; Nunez-Soto, Constanza; Mondaca-Ruff, David; Cancino-Arenas, Nicole; Chiong, Mario] Univ Chile, Fac Ciencias Quim & Farmaceut, Ctr Studies Exercise Metab & Canc CEMC, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [San Martin, Alejandra] Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA	Universidad de Chile; Emory University	Chiong, M (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Ctr Studies Exercise Metab & Canc CEMC, Adv Ctr Chron Dis ACCDiS, Santiago, Chile.	mchiong@uchile.cl	Riquelme, Jaime A/ABG-7889-2020; San Martin, Alejandra/HDN-0012-2022; Chiong, M./ABH-5784-2020; Chiong, Mario/I-1043-2013	Riquelme, Jaime A/0000-0003-0517-5697; Chiong, M./0000-0002-5174-6545; Chiong, Mario/0000-0002-5174-6545; Norambuena, Ignacio/0000-0002-2676-2674	Comision Nacional de Ciencia y Tecnologia (CONICYT), Chile [FONDECYT 1140329, 1180157, FONDECYT 3160298, FONDAP 15130011]; National Institute of Health [HL113167, HL095070]; CONICYT; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113167, P01HL095070] Funding Source: NIH RePORTER	Comision Nacional de Ciencia y Tecnologia (CONICYT), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded in part by Comision Nacional de Ciencia y Tecnologia (CONICYT), Chile (FONDECYT 1140329 and 1180157 to M.C.; FONDECYT 3160298 to J.A.R.; FONDAP 15130011 to M.C.). HL113167 and HL095070 from the National Institute of Health (to ASM). P.M. and DM-R hold CONICYT PhD fellowships.	Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Chiong M, 2013, VASA, V42, P8, DOI 10.1024/0301-1526/a000243; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Csiszar A, 2012, J GERONTOL A-BIOL, V67, P811, DOI 10.1093/gerona/glr228; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Gatica D, 2015, CIRC RES, V116, P456, DOI 10.1161/CIRCRESAHA.114.303788; GEER JC, 1961, AM J PATHOL, V38, P263; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Grootaert MOJ, 2015, AUTOPHAGY, V11, P2014, DOI 10.1080/15548627.2015.1096485; Hoshi S, 2000, J BIOL CHEM, V275, P883, DOI 10.1074/jbc.275.2.883; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Li HJ, 2012, AM J PHYSIOL-HEART C, V303, pH1319, DOI 10.1152/ajpheart.00160.2012; Long L, 2013, CIRC RES, V112, P1159, DOI 10.1161/CIRCRESAHA.111.300483; Loppnow H, 1998, BLOOD, V91, P134, DOI 10.1182/blood.V91.1.134.134_134_141; Madej A, 1998, INT J CLIN PHARM TH, V36, P345; Mendoza-Torres Evelyn, 2015, Ther Adv Cardiovasc Dis, V9, P217, DOI 10.1177/1753944715597623; Morales PE, 2014, BIOCHEM BIOPH RES CO, V446, P410, DOI 10.1016/j.bbrc.2014.03.004; Ohman T, 2014, J IMMUNOL, V192, P5952, DOI 10.4049/jimmunol.1303213; Pasquier B, 2016, CELL MOL LIFE SCI, V73, P985, DOI 10.1007/s00018-015-2104-y; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Salabei JK, 2013, BIOCHEM J, V451, P375, DOI 10.1042/BJ20121344; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Seidelmann SB, 2014, CELL MOL LIFE SCI, V71, P1977, DOI 10.1007/s00018-013-1478-y; Sharifi MN, 2016, CELL REP, V15, P1660, DOI 10.1016/j.celrep.2016.04.065; Tai S, 2016, INT J CARDIOL, V211, P1, DOI 10.1016/j.ijcard.2016.02.128; Torres G, 2016, BIOCHEM PHARMACOL, V104, P52, DOI 10.1016/j.bcp.2016.01.013; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang LJ, 2014, J BIOL CHEM, V289, P29322, DOI 10.1074/jbc.M114.559153; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]	35	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0197210	10.1371/journal.pone.0197210	http://dx.doi.org/10.1371/journal.pone.0197210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750813	gold, Green Submitted, Green Published			2022-12-26	WOS:000431856300023
J	Louet, M; Labbe, CM; Fagnen, C; Aono, CM; Homem-de-Mello, P; Villoutreix, BO; Miteva, MA				Louet, Maxime; Labbe, Celine M.; Fagnen, Charline; Aono, Cassiano M.; Homem-de-Mello, Paula; Villoutreix, Bruno O.; Miteva, Maria A.			Insights into molecular mechanisms of drug metabolism dysfunction of human CYP2C9*30	PLOS ONE			English	Article							HUMAN CYTOCHROME P4502C9; GENERAL FORCE-FIELD; DYNAMICS SIMULATIONS; COMPOUND-I; CYP2C9; 2C9; POLYMORPHISMS; DISCOVERY; VARIANTS; JAPANESE	Cytochrome P450 2C9 (CYP2C9) metabolizes about 15% of clinically administrated drugs. The allelic variant CYP2C9* 30 (A477T) is associated to diminished response to the antihypertensive effects of the prodrug losartan and affected metabolism of other drugs. Here, we investigated molecular mechanisms involved in the functional consequences of this amino-acid substitution. Molecular dynamics (MD) simulations performed for the active species of the enzyme (heme in the Compound I state), in the apo or substrate-bound state, and binding energy analyses gave insights into altered protein structure and dynamics involved in the defective drug metabolism of human CYP2C9.30. Our data revealed an increased rigidity of the key Substrate Recognition Sites SRS1 and SRS5 and shifting of the beta turn 4 of SRS6 toward the helix F in CYP2C9.30. Channel and binding substrate dynamics analyses showed altered substrate channel access and active site accommodation. These conformational and dynamic changes are believed to be involved in the governing mechanism of the reduced catalytic activity. An ensemble of representative conformations of the WT and A477T mutant properly accommodating drug substrates were identified, those structures can be used for prediction of new CYP2C9 and CYP2C9.30 substrates and drug-drug interactions.	[Louet, Maxime; Labbe, Celine M.; Fagnen, Charline; Villoutreix, Bruno O.; Miteva, Maria A.] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, UMR S 973,Mol Therapeut In Silico, Paris, France; [Louet, Maxime; Labbe, Celine M.; Fagnen, Charline; Villoutreix, Bruno O.; Miteva, Maria A.] INSERM, U973, Paris, France; [Fagnen, Charline] Univ Paris 06, Sorbonne Univ, UMR 7590, Inst Mineral Phys Mat & Cosmochim, Paris, France; [Aono, Cassiano M.; Homem-de-Mello, Paula] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, Brazil	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Universidade Federal do ABC (UFABC)	Miteva, MA (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, INSERM, UMR S 973,Mol Therapeut In Silico, Paris, France.; Miteva, MA (corresponding author), INSERM, U973, Paris, France.	maria.mitev@inserm.fr	Miteva, Maria M/N-2419-2018; Fagnen, Charline/GWZ-3317-2022; Homem-de-Mello, Paula/B-6618-2011; Villoutreix, Bruno/I-4565-2015	Miteva, Maria M/0000-0001-6895-1214; Fagnen, Charline/0000-0002-3308-631X; Homem-de-Mello, Paula/0000-0002-7049-4689; Villoutreix, Bruno/0000-0002-6456-7730	Inserm; University Paris Diderot; ANR ToxME; FAPESP; CNPq; French National Research Institute Inserm; ANR (ToxME)	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris Diderot; ANR ToxME(French National Research Agency (ANR)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); French National Research Institute Inserm; ANR (ToxME)(French National Research Agency (ANR))	This work was supported by Inserm, the University Paris Diderot, ANR ToxME (MAM), FAPESP (CMA), CNPq (PHM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supports from the French National Research Institute Inserm, the University Paris Diderot and ANR (ToxME) are greatly appreciated. PHM and CMA thank Brazilian agencies FAPESP and CNPq. We thank Pr. O. Taboureau for helpful discussions.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bathelt CM, 2005, J AM CHEM SOC, V127, P12900, DOI 10.1021/ja0520924; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Branden G, 2014, DRUG DISCOV TODAY, V19, P905, DOI 10.1016/j.drudis.2014.03.012; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; Dai D, 2001, PHARMACOGENETICS, V11, P597, DOI 10.1097/00008571-200110000-00006; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Dodani SC, 2016, NAT CHEM, V8, P419, DOI [10.1038/nchem.2474, 10.1038/NCHEM.2474]; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frappier V, 2015, NUCLEIC ACIDS RES, V43, pW395, DOI 10.1093/nar/gkv343; Fujikura K, 2015, PHARMACOGENET GENOM, V25, P584, DOI 10.1097/FPC.0000000000000172; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Hiratsuka M, 2012, DRUG METAB PHARMACOK, V27, P68, DOI 10.2133/dmpk.DMPK-11-RV-090; Hirota T, 2013, DRUG METAB PHARMACOK, V28, P28, DOI 10.2133/dmpk.DMPK-12-RV-085; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isvoran A, 2017, DRUG DISCOV TODAY, V22, P366, DOI 10.1016/j.drudis.2016.09.015; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lee MY, 2014, PHARMACOGENOMICS J, V14, P343, DOI 10.1038/tpj.2013.41; Maekawa K, 2006, PHARMACOGENET GENOM, V16, P497, DOI 10.1097/01.fpc.0000215069.14095.c6; Maekawa K, 2017, BIOCHEMISTRY-US, V56, P5476, DOI 10.1021/acs.biochem.7b00795; Maekawa K, 2009, DRUG METAB DISPOS, V37, P1895, DOI 10.1124/dmd.109.027003; Martiny VY, 2015, BIOINFORMATICS, V31, P3930, DOI 10.1093/bioinformatics/btv486; Martiny VY, 2013, J MOL BIOL, V425, P3978, DOI 10.1016/j.jmb.2013.07.010; Melet A, 2003, ARCH BIOCHEM BIOPHYS, V409, P80, DOI 10.1016/S0003-9861(02)00548-9; Miteva MA, 2005, NUCLEIC ACIDS RES, V33, pW372, DOI 10.1093/nar/gki365; Moroy G, 2015, FUTURE MED CHEM, V7, P2317, DOI 10.4155/fmc.15.150; Moroy G, 2012, DRUG DISCOV TODAY, V17, P44, DOI 10.1016/j.drudis.2011.10.023; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Roberts AG, 2010, BIOCHEMISTRY-US, V49, P8700, DOI 10.1021/bi100911q; Sano E, 2010, J COMPUT CHEM, V31, P2746, DOI 10.1002/jcc.21568; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wang BJ, 2015, J AM CHEM SOC, V137, P7379, DOI 10.1021/jacs.5b02800; Wang B, 2009, CURR DRUG METAB, V10, P781, DOI 10.2174/138920009789895480; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862; Yin T, 2008, HYPERTENS RES, V31, P1549, DOI 10.1291/hypres.31.1549	46	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197249	10.1371/journal.pone.0197249	http://dx.doi.org/10.1371/journal.pone.0197249			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746595	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700090
J	Nuismer, SL; May, R; Basinski, A; Remien, CH				Nuismer, Scott L.; May, Ryan; Basinski, Andrew; Remien, Christopher H.			Controlling epidemics with transmissible vaccines	PLOS ONE			English	Article							PANDEMIC INFLUENZA VACCINES; CHALLENGES; EVOLUTION; DISEASE	As the density of human and domestic animal populations increases, the threat of localized epidemics and global pandemics grows. Although effective vaccines have been developed for a number of threatening pathogens, manufacturing and disseminating vaccines in the face of a rapidly spreading epidemic or pandemic remains a formidable challenge. One potentially powerful solution to this problem is the use of transmissible vaccines. Transmissible vaccines are capable of spreading from one individual to another and are currently being developed for a range of infectious diseases. Here we develop and analyze mathematical models that allow us to quantify the benefits of vaccine transmission in the face of an imminent or ongoing epidemic. Our results demonstrate that even a small amount of vaccine transmission can greatly increase the rate at which a naive host population can be protected against an anticipated epidemic and substantially reduce the size of unanticipated epidemics if vaccination is initiated shortly after pathogen detection. In addition, our results identify key biological properties and implementation practices that maximize the impact of vaccine transmission on infectious disease.	[Nuismer, Scott L.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [May, Ryan; Basinski, Andrew; Remien, Christopher H.] Univ Idaho, Dept Math, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho	Nuismer, SL (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	snuismer@uidaho.edu			National Institute of General Medical Sciences (NIGMS) [R01GM122079]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122079] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institute of General Medical Sciences (NIGMS) R01GM122079 to SLN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo E, 2007, WILDLIFE RES, V34, P567, DOI 10.1071/WR06160; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Basinski A, 2017, VACCINE; Bull JJ, 2018, TRENDS MICROBIOL, V26, P6, DOI 10.1016/j.tim.2017.09.007; Burns CC, 2014, J INFECT DIS, V210, pS283, DOI 10.1093/infdis/jiu295; Butler D, 2017, NATURE, V541; Fauci AS, 2006, EMERG INFECT DIS, V12, P73; Feng ZL, 2011, AAPS J, V13, P427, DOI 10.1208/s12248-011-9284-7; Gandon S, 2003, P ROY SOC B-BIOL SCI, V270, P1129, DOI 10.1098/rspb.2003.2370; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Haaheim LR, 2009, VIRUSES-BASEL, V1, P1089, DOI 10.3390/v1031089; Hessel L, 2009, INFLUENZA OTHER RESP, V3, P165, DOI 10.1111/j.1750-2659.2009.00085.x; Kew O, 2012, CURR OPIN VIROL, V2, P188, DOI 10.1016/j.coviro.2012.02.006; Kieny MP, 2008, VACCINE, V26, pD3, DOI 10.1016/j.vaccine.2008.07.046; Kieny MP, 2006, VACCINE, V24, P6367, DOI 10.1016/j.vaccine.2006.07.021; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Magpantay FMG, 2014, SIAM J APPL MATH, V74, P1810, DOI 10.1137/140956695; Murphy AA, 2016, EXPERT REV VACCINES, V15, P31, DOI 10.1586/14760584.2016.1106942; Notton T, 2014, TRENDS BIOTECHNOL, V32, P401, DOI 10.1016/j.tibtech.2014.06.006; Nuismer SL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1903; Oshitani H, 2008, EMERG INFECT DIS, V14, P875, DOI 10.3201/eid1406.070839; Read AF, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002198; Smith KF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0950; Yakovenko ML, 2009, J VIROL, V83, P3402, DOI 10.1128/JVI.02122-08	24	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196978	10.1371/journal.pone.0196978	http://dx.doi.org/10.1371/journal.pone.0196978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746504	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700050
J	Qi, ZP; Xia, P; Pan, S; Zheng, S; Fu, C; Chang, YX; Ma, Y; Wang, JC; Yang, XY				Qi, Zhiping; Xia, Peng; Pan, Su; Zheng, Shuang; Fu, Chuan; Chang, Yuxin; Ma, Yue; Wang, Jincheng; Yang, Xiaoyu			Combined treatment with electrical stimulation and insulin-like growth factor-1 promotes bone regeneration in vitro	PLOS ONE			English	Article							MARROW STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; OSTEOBLAST PROLIFERATION; TRANSGENIC MICE; STEM-CELLS; IGF-I; SCAFFOLDS; METAANALYSIS; KNOCKOUT; DELIVERY	Electrical stimulation (ES) and insulin-like growth factor-1 (IGF-1) are widely used in bone regeneration because of their osteogenic activity. However, the combined effects of ES and supplemental IGF-1 on the whole bone formation process remain unclear. In this study, fluorescence staining and an MTT assay were first utilized to observe the influence of ES and IGF-1 on MC3T3-E1 cell proliferation and adhesion in vitro. Subsequently, osteogenic differentiation was evaluated by the alkaline phosphatase activity (ALP) and the expression of osteogenic marker genes. In addition, cell mineralization was determined by alizarin red staining and scanning electron microscopy (SEM). We demonstrated that the MC3T3-E1 cell proliferation was significantly higher for treatments combining IGF-1 and ES than for treatments with IGF-1 alone. The combination of IGF-1 and ES increased the MC3T3-E1 cell ALP activity, the expression of osteogenesis-related genes and the calcium deposition with a clear dose-dependent effect. Our data show the synergistic effect of IGF-1 and ES in promoting the proliferation, differentiation and mineralization of MC3T3-E1 cells, which suggests that it would be more effective to combine the proper dose of IGF-1 with ES to promote local bone damage repair and regeneration.	[Qi, Zhiping; Xia, Peng; Pan, Su; Zheng, Shuang; Fu, Chuan; Chang, Yuxin; Wang, Jincheng; Yang, Xiaoyu] Jilin Univ, Dept Orthoped Surg, Hosp 2, Changchun, Jilin, Peoples R China; [Ma, Yue] Jilin Univ, Dept Gynecol Oncol, Hosp 1, Changchun, Jilin, Peoples R China	Jilin University; Jilin University	Wang, JC; Yang, XY (corresponding author), Jilin Univ, Dept Orthoped Surg, Hosp 2, Changchun, Jilin, Peoples R China.	jinchengwang@hotmail.com; yangxiaoyu88@sina.com		Wang, Jincheng/0000-0002-1217-5962	National Natural Science Foundation of China [81672263, 31572217]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81672263 to XY, and No. 31572217).; This study was supported by the by the National Natural Science Foundation of China, No.81672263, No.31572217.	Aleem IS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31724; Azimi O, 2011, MOLECULES, V16, P9792, DOI 10.3390/molecules16129792; Blanquer A, 2018, J BIOMED MATER RES B, V106, P834, DOI 10.1002/jbm.b.33892; Bodamyali T, 1998, BIOCHEM BIOPH RES CO, V250, P458, DOI 10.1006/bbrc.1998.9243; Chen FM, 2009, BIOMATERIALS, V30, P5215, DOI 10.1016/j.biomaterials.2009.06.009; Chen L, 2016, BMB REP, V49, P122, DOI 10.5483/BMBRep.2016.49.2.228; Chisalita SI, 2017, ORTHOP SURG, V9, P380, DOI 10.1111/os.12358; Choi GH, 2014, MACROMOL BIOSCI, V14, P496, DOI 10.1002/mabi.201300368; Ciombor Deborah McK, 2005, Foot Ankle Clin, V10, P579, DOI 10.1016/j.fcl.2005.06.006; Cook JJ, 2015, CLIN PODIATR MED SUR, V32, P45, DOI 10.1016/j.cpm.2014.09.003; Di Luca A, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201700072; Doorn J, 2013, TISSUE ENG PT A, V19, P1817, DOI [10.1089/ten.tea.2012.0522, 10.1089/ten.TEA.2012.0522]; Duruel T, 2017, INT J BIOL MACROMOL, V104, P232, DOI 10.1016/j.ijbiomac.2017.06.029; Ebrahim S, 2014, CAN J SURG, V57, pE105, DOI 10.1503/cjs.010113; Eriksen EF, 1996, EUR J CLIN INVEST, V26, P525, DOI 10.1046/j.1365-2362.1996.00292.x; Feng XM, 2014, DEV GROWTH DIFFER, V56, P615, DOI 10.1111/dgd.12179; Goldstein C, 2010, J ORTHOP TRAUMA, V24, pS62, DOI 10.1097/BOT.0b013e3181cdde1b; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Guerra-Menendez L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-271; Haddad JB, 2007, J ALTERN COMPLEM MED, V13, P485, DOI 10.1089/acm.2007.5270; Jeong WK, 2008, J BIOMED MATER RES A, V86A, P1137, DOI 10.1002/jbm.a.32068; Jiang J, 2006, BONE, V39, P494, DOI 10.1016/j.bone.2006.02.068; Kim S, 2012, ACTA BIOMATER, V8, P1768, DOI 10.1016/j.actbio.2012.01.009; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6; Levin M, 2009, SEMIN CELL DEV BIOL, V20, P543, DOI 10.1016/j.semcdb.2009.04.013; Mobini S, 2017, PEERJ, V5, DOI 10.7717/peerj.2821; Naskar D, 2017, BIOMATERIALS, V136, P67, DOI 10.1016/j.biomaterials.2017.05.014; Park HR, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/421205; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Ren Q, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20176520, 10.1590/1414-431x20176520]; Rico-Llanos GA, 2017, J BIOMED MATER RES A, V105, P1867, DOI 10.1002/jbm.a.36051; Shu XL, 2017, J BIOMATER APPL, V32, P547, DOI 10.1177/0885328217737654; Sugumar A, 2004, INT J CANCER, V111, P293, DOI 10.1002/ijc.20253; Tahimic Candice G T, 2013, Front Endocrinol (Lausanne), V4, P6, DOI 10.3389/fendo.2013.00006; Thomas T, 1999, ENDOCRINOLOGY, V140, P5036, DOI 10.1210/en.140.11.5036; Valenti MT, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010041; Walsh S, 2003, BONE, V33, P80, DOI 10.1016/S8756-3282(03)00165-0; Wang SN, 2012, STEM CELL RES, V8, P346, DOI 10.1016/j.scr.2011.12.005; Wang YP, 2016, PLOS GENET, V12, DOI [10.1371/journal.pgen.1005803, 10.1371/journal.pgen.1006390]; Wennberg C, 2000, J BONE MINER RES, V15, P1879, DOI 10.1359/jbmr.2000.15.10.1879; Wiesmann HP, 2001, BBA-MOL CELL RES, V1538, P28, DOI 10.1016/S0167-4889(00)00135-X; Yao WG, 2008, GROWTH HORM IGF RES, V18, P517, DOI 10.1016/j.ghir.2008.04.006; Yu M, 2017, J PERIODONTOL, V88, pE159, DOI 10.1902/jop.2017.170016; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhang W, 2012, CELL BIOCHEM FUNCT, V30, P297, DOI 10.1002/cbf.2801; Zhao G, 2000, ENDOCRINOLOGY, V141, P2674, DOI 10.1210/en.141.7.2674	47	23	24	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197006	10.1371/journal.pone.0197006	http://dx.doi.org/10.1371/journal.pone.0197006			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746517	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700054
J	Lettieri-Barbato, D; Cannata, SM; Casagrande, V; Ciriolo, MR; Aquilano, K				Lettieri-Barbato, Daniele; Cannata, Stefano Maria; Casagrande, Viviana; Ciriolo, Maria Rosa; Aquilano, Katia			Time-controlled fasting prevents aging-like mitochondrial changes induced by persistent dietary fat overload in skeletal muscle	PLOS ONE			English	Article							CATABOLISM; LONGEVITY; HEALTH	A large body of evidence suggests that persistent dietary fat overload causes mitochondrial dysfunction and systemic metabolic gridlock. Mitochondrial and lipid metabolism in skeletal muscle (SkM) are severely affected upon persistent high fat diet (HFD) leading to premature tissue aging. Here, we designed weekly cycles of fasting (called as time-controlled fasting, TCF) and showed that they were effective in limiting mitochondrial damage and metabolic disturbances induced by HFD. Specifically, TCF was able to prevent the decline of adipose triglyceride lipase (Atgl), maintain efficient mitochondrial respiration in SkM as well as improve blood glucose and lipid profile. Atgl was found to be the mediator of such preventive effects as its down regulation or up-regulation in C2C12 myotubes triggers mitochondrial alteration or protects against the deleterious effects of high fat levels respectively. In conclusion, TCF could represent an effective strategy to limit mitochondrial impairment and metabolic inflexibility that are typically induced by modern western diets or during aging.	[Lettieri-Barbato, Daniele; Cannata, Stefano Maria; Ciriolo, Maria Rosa; Aquilano, Katia] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Casagrande, Viviana] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Ciriolo, Maria Rosa] IRCCS San Raffaele La Pisana, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; IRCCS San Raffaele Pisana	Lettieri-Barbato, D; Aquilano, K (corresponding author), Univ Roma Tor Vergata, Dept Biol, Rome, Italy.	d.lettieribarbato@hotmail.it; katia.aquilano@uniroma2.it	AQUILANO, KATIA/K-8888-2016; Lettieri Barbato, Daniele/K-8759-2016; Casagrande, Viviana/K-5398-2018	AQUILANO, KATIA/0000-0002-5905-9870; Ciriolo, Maria Rosa/0000-0002-7863-9029; Lettieri Barbato, Daniele/0000-0002-1172-814X; Casagrande, Viviana/0000-0003-3554-0181	Ministero della Salute [GR-2011-02348047]	Ministero della Salute(Ministry of Health, Italy)	This work was supported by Grants from Ministero della Salute GR-2011-02348047.	Aquilano K, 2016, ONCOTARGET, V7, P23019, DOI 10.18632/oncotarget.8552; Barbato DL, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.404; Barbato DL, 2016, AGEING RES REV, V28, P85, DOI 10.1016/j.arr.2016.05.007; Barbato DL, 2014, BBA-MOL CELL BIOL L, V1841, P1555, DOI 10.1016/j.bbalip.2014.08.004; Biswas D, 2016, FASEB J, V30, P3822, DOI 10.1096/fj.201600571RR; Chausse B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120413; Eshima H, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13250; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Gao XS, 2009, J BIOL CHEM, V284, P4767, DOI 10.1074/jbc.M806235200; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Hepple RT, 2016, FREE RADICAL BIO MED, V98, P177, DOI 10.1016/j.freeradbiomed.2016.03.017; Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Konopka AR, 2013, MOL CELL ENDOCRINOL, V379, P19, DOI 10.1016/j.mce.2013.05.008; Krizova E, 1996, PHYSIOL RES, V45, P379; Langone F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114018; Lettieri-Barbato D, 2017, ONCOTARGET, V8, P83407, DOI 10.18632/oncotarget.19948; Lightfoot AP, 2014, CURR OPIN PHARMACOL, V16, P116, DOI 10.1016/j.coph.2014.05.005; Mattson MP, 2017, AGEING RES REV, V39, P46, DOI 10.1016/j.arr.2016.10.005; Muoio DM, 2014, CELL, V159, P1253, DOI 10.1016/j.cell.2014.11.034; Nilwik R, 2013, EXP GERONTOL, V48, P492, DOI 10.1016/j.exger.2013.02.012; Pagel-Langenickel I, 2010, ENDOCR REV, V31, P25, DOI 10.1210/er.2009-0003; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Petersen KF, 2015, P NATL ACAD SCI USA, V112, P11330, DOI 10.1073/pnas.1514844112; Peterson Courtney M, 2012, J Aging Res, V2012, P194821, DOI 10.1155/2012/194821; Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; Sharples AP, 2016, AGING CELL, V15, P603, DOI 10.1111/acel.12486; Tatulli G, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00004; Traba J, 2017, J BIOL CHEM, V292, P12153, DOI 10.1074/jbc.M117.791715; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200	34	24	24	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0195912	10.1371/journal.pone.0195912	http://dx.doi.org/10.1371/journal.pone.0195912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742122	Green Published, Green Submitted, gold			2022-12-26	WOS:000431757400017
J	Dignam, BEA; O'Callaghan, M; Condron, LM; Kowalchuk, GA; Van Nostrand, JD; Zhou, JZ; Wakelin, SA				Dignam, Bryony E. A.; O'Callaghan, Maureen; Condron, Leo M.; Kowalchuk, George A.; Van Nostrand, Joy D.; Zhou, Jizhong; Wakelin, Steven A.			Effect of land use and soil organic matter quality on the structure and function of microbial communities in pastoral soils: Implications for disease suppression	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; RHIZOSPHERE BACTERIA; TRANSGENIC POTATOES; BIOLOGICAL-CONTROL; DIVERSITY; MANAGEMENT; GENES; FERTILIZATION; BIOGEOGRAPHY; PATHOGENS	Cropping soils vary in extent of natural suppression of soil-borne plant diseases. However, it is unknown whether similar variation occurs across pastoral agricultural systems. We examined soil microbial community properties known to be associated with disease suppression across 50 pastoral fields varying in management intensity. The composition and abundance of the disease-suppressive community were assessed from both taxonomic and functional perspectives. Pseudomonas bacteria were selected as a general taxonomic indicator of disease suppressive potential, while genes associated with the biosynthesis of a suite of secondary metabolites provided functional markers (GeoChip 5.0 microarray analysis). The composition of both the Pseudomonas communities and disease suppressive functional genes were responsive to land use. Underlying soil properties explained 37% of the variation in Pseudomonas community structure and up to 61% of the variation in the abundance of disease suppressive functional genes. Notably, measures of soil organic matter quality, C:P ratio, and aromaticity of the dissolved organic matter content (carbon recalcitrance), influenced both the taxonomic and functional disease suppressive potential of the pasture soils. Our results suggest that key components of the soil microbial community may be managed on-farm to enhance disease suppression and plant productivity.	[Dignam, Bryony E. A.; O'Callaghan, Maureen; Condron, Leo M.; Wakelin, Steven A.] Lincoln Univ, Bioprotect Res Ctr, Christchurch, New Zealand; [Dignam, Bryony E. A.; O'Callaghan, Maureen; Wakelin, Steven A.] AgResearch Ltd, Soil Biol Farm Syst & Environm, Christchurch, New Zealand; [Kowalchuk, George A.] Univ Utrecht, Inst Environm Biol, Ecol & Biodivers, Utrecht, Netherlands; [Van Nostrand, Joy D.; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [Zhou, Jizhong] Lawrence Berkeley Natl Lab, Earth Sci Div, Berkeley, CA USA; [Zhou, Jizhong] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing, Peoples R China; [Wakelin, Steven A.] Scion Res Ltd, Christchurch, New Zealand	Lincoln University - New Zealand; AgResearch - New Zealand; Utrecht University; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Tsinghua University	Dignam, BEA (corresponding author), Lincoln Univ, Bioprotect Res Ctr, Christchurch, New Zealand.; Dignam, BEA (corresponding author), AgResearch Ltd, Soil Biol Farm Syst & Environm, Christchurch, New Zealand.	bryony.dignam@agresearch.co.nz	吴, 昊/AAB-1620-2020; Wakelin, Steve/C-3170-2011	Wakelin, Steve/0000-0002-1167-8699; Kowalchuk, George/0000-0003-3866-0832	Bio-protection Research Centre	Bio-protection Research Centre	This work was funded by a Bio-protection Research Centre Phd scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; ALABOUVETTE C, 1993, PESTIC SCI, V37, P365, DOI 10.1002/ps.2780370409; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baligar VC, 2001, COMMUN SOIL SCI PLAN, V32, P921, DOI 10.1081/CSS-100104098; Bergmark L, 2012, FEMS MICROBIOL LETT, V333, P77, DOI 10.1111/j.1574-6968.2012.02601.x; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Cha JY, 2016, ISME J, V10, P119, DOI 10.1038/ismej.2015.95; Chapelle E, 2016, ISME J, V10, P265, DOI 10.1038/ismej.2015.82; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 2015, PRIMER V7 USER MANUA; Cleary DFR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029380; Cong J, 2015, SCI REPORTS, P5; Couillerot O, 2009, LETT APPL MICROBIOL, V48, P505, DOI 10.1111/j.1472-765X.2009.02566.x; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Dignam BEA, 2016, SOIL BIOL BIOCHEM, V95, P100, DOI 10.1016/j.soilbio.2015.12.006; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Garbeva P, 2004, FEMS MICROBIOL ECOL, V47, P51, DOI 10.1016/S0168-6496(03)00234-4; Ghani A, 2003, SOIL BIOL BIOCHEM, V35, P1231, DOI 10.1016/S0038-0717(03)00186-X; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Heuer H., 1997, Modern soil microbiology., P353; Hewitt AE., 1998, NZ SOIL CLASSIFICATI; Hjort K, 2010, FEMS MICROBIOL ECOL, V71, P197, DOI 10.1111/j.1574-6941.2009.00801.x; Kobayashi DY, 2002, APPL ENVIRON MICROB, V68, P1047, DOI 10.1128/AEM.68.3.1047-1054.2002; Kyselkova M, 2009, ISME J, V3, P1127, DOI 10.1038/ismej.2009.61; Latz E, 2012, J ECOL, V100, P597, DOI 10.1111/j.1365-2745.2011.01940.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LEMANCEAU P, 1992, APPL ENVIRON MICROB, V58, P2978, DOI 10.1128/AEM.58.9.2978-2982.1992; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Mazzola M, 2004, ANNU REV PHYTOPATHOL, V42, P35, DOI 10.1146/annurev.phyto.42.040803.140408; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Milling A, 2004, PLANT SOIL, V266, P23; MPI, 2012, PAST INP TRENDS NZ S, P34; Penton CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093893; Raaijmakers JM, 2016, SCIENCE, V352, P1392, DOI 10.1126/science.aaf3252; Raaijmakers JM, 2012, ANNU REV PHYTOPATHOL, V50, P403, DOI 10.1146/annurev-phyto-081211-172908; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Rasche F, 2006, FEMS MICROBIOL ECOL, V56, P219, DOI 10.1111/j.1574-6941.2005.00027.x; Reeve JR, 2010, ISME J, V4, P1099, DOI 10.1038/ismej.2010.42; Riber L, 2014, FEMS MICROBIOL ECOL, V90, P206, DOI 10.1111/1574-6941.12403; van Bruggen AHC, 2000, APPL SOIL ECOL, V15, P13, DOI 10.1016/S0929-1393(00)00068-8; van Dorst J, 2014, FEMS MICROBIOL ECOL, V89, P316, DOI 10.1111/1574-6941.12308; Overbeek LS, 2012, CAN J PLANT PATHOL, V34, P268, DOI 10.1080/07060661.2012.679622; Volk C, 2002, J ENVIRON MONITOR, V4, P43, DOI 10.1039/b107768f; Wakelin S, 2016, NZ J AGR RES, P1; Wakelin SA, 2008, SOIL BIOL BIOCHEM, V40, P803, DOI 10.1016/j.soilbio.2007.10.015; Wakelin SA, 2016, AUSTRALAS PLANT PATH, V45, P289, DOI 10.1007/s13313-016-0411-x; Wakelin SA, 2013, NEW ZEAL J AGR RES, V56, P248, DOI 10.1080/00288233.2013.822003; Wakelin S, 2012, APPL SOIL ECOL, V61, P40, DOI 10.1016/j.apsoil.2012.06.002; Wakelin SA, 2009, PEDOBIOLOGIA, V52, P237, DOI 10.1016/j.pedobi.2008.10.001; Wang XF, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-18, 10.1186/1471-2105-13-113]; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; White R.P., 2000, GRASSLAND ECOSYSTEMS; Yan Q, 2015, SCI REPORTS, P5; Yang YF, 2013, GLOBAL CHANGE BIOL, V19, P637, DOI 10.1111/gcb.12065; Zhou JZ, 2010, MBIO, V1, DOI 10.1128/mBio.00169-10	62	22	22	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196581	10.1371/journal.pone.0196581	http://dx.doi.org/10.1371/journal.pone.0196581			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734390	Green Published, Green Submitted, gold			2022-12-26	WOS:000431481700023
J	Amador, A; Campbell, S; Kazantzis, M; Lan, G; Burris, TP; Solt, LA				Amador, Ariadna; Campbell, Sean; Kazantzis, Melissa; Lan, Gary; Burris, Thomas P.; Solt, Laura A.			Distinct roles for REV-ERB alpha and REV-ERB beta in oxidative capacity and mitochondrial biogenesis in skeletal muscle	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTORS; CIRCADIAN BEHAVIOR; HORMONE-RECEPTORS; METABOLIC DISEASE; LIPID HOMEOSTASIS; CROSS-TALK; EXPRESSION; CLOCK; GENES; CELLS	The nuclear receptors REV-ERB alpha and REV-ERB beta have been demonstrated to be core members of the circadian clock and participate in the regulation of a diverse set of metabolic functions. Due to their overlapping tissue expression patterns and gene expression profiles, REV-ERB beta is thought to be redundant to REV-ERB alpha. Recent work has highlighted REV-ERB alpha's role in the regulation of skeletal muscle oxidative capacity and mitochondrial biogenesis. Considering the similarity between the REV-ERBs and the hypothesized overlap in function, we sought to determine whether REV-ERB beta-deficiency presented with a similar skeletal muscle phenotype as REV-ERB alpha-deficiency. Ectopic overexpression in C2C12 cells demonstrated that REV-ERB beta drives mitochondrial biogenesis and the expression of genes involved in fatty acid oxidation. Intriguingly, knock down of REV-ERB beta in C2C12 cultures also resulted in mitochondrial biogenesis and increased expression of genes involved in fatty acid beta-oxidation. To determine whether these effects occurred in vivo, we examined REV-ERB beta-deficient mice and observed a similar increase in expression of genes involved in mitochondrial biogenesis and fatty acid beta-oxidation. Consistent with these results, REV-ERB beta-deficient mice exhibited an altered metabolic phenotype compared to wild-type littermate controls when measured by indirect calorimetry. This likely compensated for the increased food consumption that occurred, possibly aiding in the maintenance of their weight over time. Since feeding behaviors are a direct circadian output, this study suggests that REV-ERB beta may have more subtle effects on circadian behaviors than originally identified. Furthermore, these data implicate REV-ERB beta in the control of skeletal muscle metabolism and energy expenditure and suggest that development of REV-ERB alpha versus REV-ERB beta selective ligands may have therapeutic utility in the treatment of metabolic syndrome.	[Amador, Ariadna] Scripps Res Inst, Kellogg Sch Sci & Technol, Jupiter, FL USA; [Campbell, Sean; Lan, Gary; Solt, Laura A.] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA; [Kazantzis, Melissa] Scripps Res Inst, Metab Core, Jupiter, FL USA; [Burris, Thomas P.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol, St Louis, MO USA; [Solt, Laura A.] Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA; [Amador, Ariadna] Columbia Univ, Med Ctr, Inst Genom Med, New York, NY USA; [Burris, Thomas P.] Washington Univ, Sch Med, Ctr Clin Pharmacol, St Louis, MO USA; [Burris, Thomas P.] St Louis Coll Pharm, St Louis, MO USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Saint Louis University; Scripps Research Institute; Columbia University; Washington University (WUSTL)	Solt, LA (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA.; Solt, LA (corresponding author), Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA.	lsolt@scripps.edu	Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	National Institute of Allergy and Infectious Diseases [R01AI116885]; National Institute of Mental Health [R01MH093429]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institute of Allergy and Infectious Diseases (R01AI116885, L.A.S) and the National Institute of Mental Health (R01MH093429, T.P.B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Banerjee S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6759; BONNELYE E, 1994, CELL GROWTH DIFFER, V5, P1357; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chomez P, 2000, DEVELOPMENT, V127, P1489; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; De Mei C, 2015, ONCOGENE, V34, P2597, DOI 10.1038/onc.2014.203; Delezie J, 2012, FASEB J, V26, P3321, DOI 10.1096/fj.12-208751; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; DUMAS B, 1994, MOL ENDOCRINOL, V8, P996, DOI 10.1210/me.8.8.996; FORMAN BM, 1994, MOL ENDOCRINOL, V8, P1253, DOI 10.1210/me.8.9.1253; Glatz JFC, 2017, BIOCHIMIE, V136, P21, DOI 10.1016/j.biochi.2016.12.007; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Holst D, 2003, BBA-MOL CELL BIOL L, V1633, P43, DOI 10.1016/S1388-1981(03)00071-4; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Lau P, 2004, J BIOL CHEM, V279, P36828, DOI 10.1074/jbc.M404927200; Marcheva Biliana, 2013, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-25950-0_6; Marcheva B, 2009, J APPL PHYSIOL, V107, P1638, DOI 10.1152/japplphysiol.00698.2009; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ramakrishnan SN, 2005, J BIOL CHEM, V280, P8651, DOI 10.1074/jbc.M413949200; Raspe E, 2002, J BIOL CHEM, V277, P49275, DOI 10.1074/jbc.M206215200; Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Simons SS, 2014, MOL ENDOCRINOL, V28, P173, DOI 10.1210/me.2013-1334; Smith AG, 2006, AM J PHYSIOL-CELL PH, V291, pC203, DOI 10.1152/ajpcell.00476.2005; Smith AG, 2005, INT J BIOCHEM CELL B, V37, P2047, DOI 10.1016/j.biocel.2005.03.002; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Solt LA, 2011, FUTURE MED CHEM, V3, P623, DOI [10.4155/FMC.11.9, 10.4155/fmc.11.9]; Stucchi P, 2012, ENDOCRINOLOGY, V153, P690, DOI 10.1210/en.2011-1023; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Wang JD, 2008, BBA-MOL CELL RES, V1783, P224, DOI 10.1016/j.bbamcr.2007.09.004; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213	42	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196787	10.1371/journal.pone.0196787	http://dx.doi.org/10.1371/journal.pone.0196787			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723273	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100062
J	Sempere-Rubio, N; Lopez-Pascual, J; Aguilar-Rodriguez, M; Cortes-Amador, S; Espi-Lopez, G; Villarrasa-Sapina, I; Serra-Ano, P				Sempere-Rubio, Nuria; Lopez-Pascual, Juan; Aguilar-Rodriguez, Marta; Cortes-Amador, Sara; Espi-Lopez, Gemma; Villarrasa-Sapina, Israel; Serra-Ano, Pilar			Characterization of postural control impairment in women with fibromyalgia	PLOS ONE			English	Article							BALANCE CONTROL; SAMPLE ENTROPY; SWAY; ANXIETY; MUSCLE; PAIN; VARIABILITY; RELIABILITY; COMPLEXITY; STABILITY	The main goal of this cross-sectional study was to detect whether women with fibromyalgia syndrome (FMS) have altered postural control and to study the sensory contribution to postural control. We also explored the possibility that self-induced anxiety and lower limb strength may be related to postural control. For this purpose, 129 women within an age range of 40 to 70 years were enrolled. Eighty of the enrolled women had FMS. Postural control variables, such as Ellipse, Root mean square (RMS) and Sample entropy (SampEn), in both directions (i.e. mediolateral and anteroposterior), were calculated under five different conditions. A force plate was used to register the center of pressure shifts. Furthermore, isometric lower limb strength was recorded with a portable dynamometer and normalized by lean body mass. The results showed that women with FMS have impaired postural control compared with healthy people, as they presented a significant increase in Ellipse and RMS values (p<0.05) and a significant decrease in SampEn in both directions (p<0.05). Postural control also worsens with the gradual alteration of sensory inputs in this population (p<0.05). Performing a stressor dual task only impacts Ellipse in women with FMS (p>0.05). There were no significant correlations between postural control and lower limb strength (p>0.05). Therefore, women with FMS have impaired postural control that is worse when sensory inputs are altered but is not correlated with their lower limb strength.	[Sempere-Rubio, Nuria; Aguilar-Rodriguez, Marta; Cortes-Amador, Sara; Espi-Lopez, Gemma; Serra-Ano, Pilar] Univ Valencia, Dept Physiotherapy, Valencia, Spain; [Lopez-Pascual, Juan] Univ Politecn Valencia, Biomech Inst Valencia, Valencia, Spain; [Villarrasa-Sapina, Israel] Univ Valencia, Dept Phys Educ & Sports, Valencia, Spain	University of Valencia; Instituto de Biomecanica de Valencia (IBV); Universitat Politecnica de Valencia; University of Valencia	Serra-Ano, P (corresponding author), Univ Valencia, Dept Physiotherapy, Valencia, Spain.	pilar.serra@uv.es	Serra-Añó, Pilar/L-6085-2014; Villarrasa-Sapiña, Israel/P-9427-2019; Espi Lopez, Gemma V./J-9002-2017	Serra-Añó, Pilar/0000-0002-0743-3445; Villarrasa-Sapiña, Israel/0000-0002-2831-1033; Espi Lopez, Gemma V./0000-0003-0042-8034; Lopez Pascual, Juan/0000-0002-6641-0200	Conselleria d'Educacio, Glenda i Esports [Valencian Regional Department of Education, Science and Sports], Valencia, Spain [GV2016/140]; Conselleria d'Educacio, Ciencia i Esports [Valencian Regional Department of Education, Science and Sports], Valencia, Spain [GV2016/140]	Conselleria d'Educacio, Glenda i Esports [Valencian Regional Department of Education, Science and Sports], Valencia, Spain; Conselleria d'Educacio, Ciencia i Esports [Valencian Regional Department of Education, Science and Sports], Valencia, Spain	This research was supported by Conselleria d'Educacio, Ciencia i Esports [Valencian Regional Department of Education, Science and Sports], Valencia, Spain [Grant GV2016/140]. PSA, NSR, MAR, SCA, GEL, http://www.ceice.gva.es/va/inicio:jsessionid=CB78D8F7BA7A76F84A8827307D23AC5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkaya N, 2013, CLIN RHEUMATOL, V32, P325, DOI 10.1007/s10067-012-2117-y; Azhim A., 2009, 11th International Congress of the IUPESM. World Congress on Medical Physics and Biomedical Engineering. Image Processing, Biosignal Processing, Modelling and Simulation, Biomechanics, P1075, DOI 10.1007/978-3-642-03882-2_286; Balaban CD, 2002, PHYSIOL BEHAV, V77, P469, DOI 10.1016/S0031-9384(02)00935-6; Balaban CD., 2000, SOC NEUR ABSTR, P1493; Bayazit YA, 2002, J NEUROL SCI, V196, P77, DOI 10.1016/S0022-510X(02)00032-1; Bennett RM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-27; Birznieks I, 2008, J PHYSIOL-LONDON, V586, P2713, DOI 10.1113/jphysiol.2008.151746; Bolmont B, 2002, NEUROSCI LETT, V329, P96, DOI 10.1016/S0304-3940(02)00578-5; Borg FG, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-38; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; Carpenter MG, 2001, GAIT POSTURE, V13, P35, DOI 10.1016/S0966-6362(00)00093-X; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Cohen H, 2002, ARTHRITIS RHEUM, V46, P845, DOI 10.1002/art.10103; Dusing SC, 2010, PHYS THER, V90, P1838, DOI 10.2522/ptj.2010033; Goes SM, 2016, J STRENGTH COND RES; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Govindan RB, 2007, PHYSICA A, V376, P158, DOI 10.1016/j.physa.2006.10.077; Hirschmuller A, 2011, INJURY, V42, P1135, DOI 10.1016/j.injury.2010.09.040; Huisinga JM, 2012, NEUROSCI LETT, V524, P124, DOI 10.1016/j.neulet.2012.07.020; Jones KD, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3432; Jones KD, 2009, JCR-J CLIN RHEUMATOL, V15, P16, DOI 10.1097/RHU.0b013e318190f991; King GW, 2016, ONCOTARGET, V7, P13297, DOI 10.18632/oncotarget.7758; Ko Y-H, 2015, ADV AGING RES, V4, P58; Lima TRL, 2014, PHYSIOTHER THEOR PR, V30, P79, DOI 10.3109/09593985.2013.820246; Lund E, 2003, SCAND J RHEUMATOL, V32, P138, DOI 10.1080/03009740310002461; Mehlhorn AT, 2016, GAIT POSTURE; Mergner T, 1998, BRAIN RES REV, V28, P118, DOI 10.1016/S0165-0173(98)00032-0; Muto L, 2014, EUR J PHYS REHABIL M; Muto LHA, 2012, ANN RHEUM DIS, P748, DOI [10.1136/annrheumdis-2012-201745, DOI 10.1136/ANNRHEUMDIS-2012-201745]; da Costa CSN, 2013, RES DEV DISABIL, V34, P2810, DOI 10.1016/j.ridd.2013.05.031; Niam S, 1999, ARCH PHYS MED REHAB, V80, P1227, DOI 10.1016/S0003-9993(99)90020-5; Paillard T, 2010, NEUROSCI RES, V68, P301, DOI 10.1016/j.neures.2010.08.004; Panton LB, 2006, PHYS THER, V86, P1479, DOI 10.2522/ptj.20050320; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Rasyada AR, 2016, HLTH SCI J; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Rigoldi C, 2013, RES DEV DISABIL, V34, P840, DOI 10.1016/j.ridd.2012.11.007; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Russek Leslie N., 2009, Physiotherapy Theory and Practice, V25, P555, DOI 10.3109/09593980802668050; Russell IJ, 2008, CNS SPECTRUMS, V13, P27, DOI 10.1017/S109285290002681X; Salavati M, 2016, J BODYW MOV THER, V20, P441, DOI 10.1016/j.jbmt.2015.10.003; Samuel AJ., 2015, PHYSIOTHERAPY OCCUPA, V8, P71, DOI [10.21088/potj.0974.5777.8215.4, DOI 10.21088/POTJ.0974.5777.8215.4]; Schniepp R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00115; Schuerger RJ, 1999, BRAIN RES REV, V30, P189, DOI 10.1016/S0165-0173(99)00015-6; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Speers RA, 2002, GAIT POSTURE, V16, P20, DOI 10.1016/S0966-6362(02)00003-6; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Talotta R, 2017, CLIN EXP RHEUMATOL, V35, pS6; Teggi R, 2009, HEADACHE, V49, P435, DOI 10.1111/j.1526-4610.2009.01338.x; Thieme K, 2004, PSYCHOSOM MED, V66, P837, DOI 10.1097/01.psy.0000146329.63158.40; Trevisan DC, 2017, CLIN BIOMECH, V44, P83, DOI 10.1016/j.clinbiomech.2017.03.011; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Valkeinen H, 2006, ARTHRITIS RHEUM, V54, P1334, DOI 10.1002/art.21751; Villarrasa-Sapina I, 2016, GAIT POSTURE, V49, P1, DOI 10.1016/j.gaitpost.2016.06.012; Wikstrom EA, 2012, J ATHL TRAINING, V47, P306, DOI 10.4085/1062-6050-47.3.16; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Zhou JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03422-4	62	13	13	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196575	10.1371/journal.pone.0196575	http://dx.doi.org/10.1371/journal.pone.0196575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE6AF	29723223	Green Published, gold			2022-12-26	WOS:000431305100041
J	Bautista-Arredondo, S; Colchero, MA; Amanze, OO; La Hera-Fuentes, G; Silverman-Retana, O; Contreras-Loya, D; Ashefor, GA; Ogungbemi, KM				Bautista-Arredondo, Sergio; Arantxa Colchero, M.; Amanze, Ogbonna O.; La Hera-Fuentes, Gina; Silverman-Retana, Omar; Contreras-Loya, David; Ashefor, Gregory A.; Ogungbemi, Kayode M.			Explaining the heterogeneity in average costs per HIV/AIDS patient in Nigeria: The role of supply-side and service delivery characteristics	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INCOME COUNTRIES; QUALITY; HIV; VIGNETTES; CARE; COMPETENCE	Objective We estimated the average annual cost per patient of ART per facility (unit cost) in Nigeria, described the variation in costs across facilities, and identified factors associated with this variation. Methods We used facility-level data of 80 facilities in Nigeria, collected between December 2014 and May 2015. We estimated unit costs at each facility as the ratio of total costs (the sum of costs of staff, recurrent inputs and services, capital, training, laboratory tests, and antiretro-viral and TB treatment drugs) divided by the annual number of patients. We applied linear regressions to estimate factors associated with ART cost per patient. Results The unit ART cost in Nigeria was $157 USD nationally and the facility-level mean was $231 USD. The study found a wide variability in unit costs across facilities. Variations in costs were explained by number of patients, level of care, task shifting (shifting tasks from doctors to less specialized staff, mainly nurses, to provide ART) and provider's competence. The study illuminated the potentially important role that management practices can play in improving the efficiency of ART services. Conclusions Our study identifies characteristics of services associated with the most efficient implementation of ART services in Nigeria. These results will help design efficient program scale-up to deliver comprehensive HIV services in Nigeria by distinguishing features linked to lower unit costs.	[Bautista-Arredondo, Sergio; Arantxa Colchero, M.; La Hera-Fuentes, Gina; Silverman-Retana, Omar; Contreras-Loya, David] Inst Nacl Salud PUbl, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Bautista-Arredondo, Sergio; Contreras-Loya, David] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA USA; [Amanze, Ogbonna O.; Ashefor, Gregory A.; Ogungbemi, Kayode M.] Natl Agcy Control AIDS, Abuja, Nigeria; [Silverman-Retana, Omar] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark	Instituto Nacional de Salud Publica; University of California System; University of California Berkeley; Aarhus University	Colchero, MA (corresponding author), Inst Nacl Salud PUbl, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico.	acolchero@insp.mx	Bautista-Arredondo, Sergio/N-7305-2016	Bautista-Arredondo, Sergio/0000-0001-8910-3011; La Hera Fuentes, Gina/0000-0002-6235-5582; Silverman-Retana, Omar/0000-0002-2744-9698	Bill & Melinda Gates Foundation; US President's Emergency Program for AIDS Relief (PEPFAR) through the US Agency for International Development office in Nigeria	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); US President's Emergency Program for AIDS Relief (PEPFAR) through the US Agency for International Development office in Nigeria(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was funded by the Bill & Melinda Gates Foundation as part of its E2 initiative to Sergio Bautista-Arredondo and by the US President's Emergency Program for AIDS Relief (PEPFAR) through the US Agency for International Development office in Nigeria.	Aliyu HB, 2012, JAIDS-J ACQ IMM DEF, V61, P221, DOI 10.1097/QAI.0b013e3182683b04; Apanga S, 2012, PAN AFR MED J, V12; Babigumira JB, 2009, PHARMACOECONOMICS, V27, P963, DOI 10.2165/11318230-000000000-00000; Babigumira JB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-192; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Bautista-Arredondo S, 2016, AIDS, V30, P2495, DOI 10.1097/QAD.0000000000001208; Bautista-Arredondo S, 2015, SALUD PUBLICA MEXICO, V57, pS153; Bikilla AD, 2009, COST EFF RESOUR ALLO, V7, P6, DOI DOI 10.1186/1478-7547-7-6; Bloom N, 2013, DOES MANAGEMENT MATT; Bloom N, 2007, Q J ECON, V122, P1351, DOI 10.1162/qjec.2007.122.4.1351; Bushnell JB, 2009, INT DIFFERENCES BUSI, P79; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Dalhatu I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165528; Das J, 2005, J DEV ECON, V78, P348, DOI 10.1016/j.jdeveco.2004.11.004; Das J, 2007, HEALTH AFFAIR, V26, pW338, DOI 10.1377/hlthaff.26.3.w338; Das J, 2007, HEALTH AFFAIR, V26, pW296, DOI 10.1377/hlthaff.26.3.w296; Federal Ministry of Health, 2010, NAT GUID HIV AIDS TR; Harling G, 2007, JAIDS-J ACQ IMM DEF, V45, P348; Harling G, 2007, SAMJ S AFR MED J, V97, P593; Kombe G, 2004, SCALING ANTIRETROVIR; Long L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001055; Marseille E, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-108; Marseille E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051993; Marseille Elliot A, 2011, Cost Eff Resour Alloc, V9, P18, DOI 10.1186/1478-7547-9-18; Menzies NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048726; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Naikoba S, 2017, JAIDS-J ACQ IMM DEF, V75, pE120, DOI 10.1097/qai.0000000000001378; National Agency for the Control of AIDS (NACA), 2014, GLOB AIDS RESP COUNT; Parand A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005055; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Peabody JW, 2004, ANN INTERN MED, V141, P771, DOI 10.7326/0003-4819-141-10-200411160-00008; Seidman G, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0200-9; Tagar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108304; World Health Organisation, 2008, TASK SHIFT GLOB REC	34	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0194305	10.1371/journal.pone.0194305	http://dx.doi.org/10.1371/journal.pone.0194305			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5SH	29718906	gold, Green Submitted, Green Published			2022-12-26	WOS:000431281900006
J	Lv, CD; Li, Q; Kong, LF				Lv, Changda; Li, Qi; Kong, Lingfeng			Comparative analyses of the complete mitochondrial genomes of Dosinia clams and their phylogenetic position within Veneridae	PLOS ONE			English	Article							COMPARATIVE MITOGENOMIC ANALYSES; PROTEIN-CODING GENES; TRANSFER-RNA GENES; BIVALVIA VENERIDAE; TANDEM REPEATS; COMPLETE MTDNA; DNA-SEQUENCE; EVOLUTION; MOLLUSCA; HETEROPLASMY	Mitochondrial genomes have proved to be a powerful tool in resolving phylogenetic relationship. In order to understand the mitogenome characteristics and phylogenetic position of the genus Dosinia, we sequenced the complete mitochondrial genomes of Dosinia altior and Dosinia troscheli (Bivalvia: Veneridae), compared them with that of Dosinia japonica and established a phylogenetic tree for Veneridae. The mitogenomes of D. altior (17,536 bp) and D. troscheli (17,229 bp) are the two smallest in Veneridae, which include 13 protein-coding genes, 2 ribosomal RNA genes, 22 tRNA genes, and non-coding regions. The mitogenomes of the Dosinia species are similar in size, gene content, AT content, AT-and GCskews, and gene arrangement. The phylogenetic relationships of family Veneridae were established based on 12 concatenated protein-coding genes using maximum likelihood and Bayesian analyses, which supported that Dosininae and Meretricinae have a closer relationship, with Tapetinae being the sister taxon. The information obtained in this study will contribute to further understanding of the molecular features of bivalve mitogenomes and the evolutionary history of the genus Dosinia.	[Lv, Changda; Li, Qi; Kong, Lingfeng] Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao, Peoples R China; [Li, Qi] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Li, Q (corresponding author), Ocean Univ China, Key Lab Mariculture, Minist Educ, Qingdao, Peoples R China.; Li, Q (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China.	qili66@ouc.edu.cn	Kong, Lingfeng/AAJ-3402-2021; Kong, Lingfeng/AAG-2473-2019	Kong, Lingfeng/0000-0001-5263-1697	Fundamental Research Funds for the Central Universities [201762014]; National Natural Science Foundation of China [31772414]; Industrial Development Project of Qingdao City [17-3-3-64-nsh]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Industrial Development Project of Qingdao City	This study was supported by research grants from Fundamental Research Funds for the Central Universities (201762014), National Natural Science Foundation of China (31772414), and Industrial Development Project of Qingdao City (17-3-3-64-nsh) to Qi Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by research grants from Fundamental Research Funds for the Central Universities (201762014), National Natural Science Foundation of China (31772414), and Industrial Development Project of Qingdao City (17-3-3-64-nsh).	Akasaki T, 2006, MOL PHYLOGENET EVOL, V38, P648, DOI 10.1016/j.ympev.2005.10.018; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; BOORE JL, 1994, GENETICS, V138, P423; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Canapa A, 2003, MAR BIOL, V142, P1125, DOI 10.1007/s00227-003-1048-1; CANTATORE P, 1987, NATURE, V329, P853, DOI 10.1038/329853a0; Chen J, 2011, ZOOL SCR, V40, P260, DOI 10.1111/j.1463-6409.2011.00471.x; Cunha RL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-210; Dreyer H, 2004, MOL PHYLOGENET EVOL, V31, P605, DOI 10.1016/j.ympev.2003.08.007; Fernandez-Perez J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184464; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Garcia-Souto D, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0150-7; Ghiselli F, 2017, PEERJ, V5, DOI 10.7717/peerj.3692; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hwang JY, 2015, MAR GENOM, V24, P329, DOI 10.1016/j.margen.2015.08.004; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Li Q, 2002, J SHELLFISH RES, V21, P811; Liu Ze-hao, 2010, Marine Sciences (Beijing), V34, P30; Lunt DH, 1998, MOL ECOL, V7, P1441, DOI 10.1046/j.1365-294x.1998.00495.x; Lv CD, 2018, CONSERV GENET RESOUR, V10, P375, DOI 10.1007/s12686-017-0828-8; MADDISON W, 1989, CLADISTICS, V5, P365, DOI 10.1111/j.1096-0031.1989.tb00569.x; Masuda K., 1963, Transactions of the Palaeontological Society of Japan, V49, P29; Milbury CA, 2005, MAR BIOTECHNOL, V7, P697, DOI 10.1007/s10126-005-0004-0; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Mundy NI, 1996, J HERED, V87, P21, DOI 10.1093/oxfordjournals.jhered.a022948; Ozawa G, 2017, MAR GENOM, V31, P43, DOI 10.1016/j.margen.2016.09.003; Perez-Garcia C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/754012; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Plazzi F, 2016, GENOME BIOL EVOL, V8, P2544, DOI 10.1093/gbe/evw187; RAND DM, 1993, J MOL EVOL, V37, P281, DOI 10.1007/BF00175505; Rawlings TA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-440; Ren JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-394; Ren JF, 2009, MITOCHONDR DNA, V20, P78, DOI 10.1080/19401730902964425; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russo CAM, 1996, MOL BIOL EVOL, V13, P525, DOI 10.1093/oxfordjournals.molbev.a025613; Salvi D, 2012, MOL PHYLOGENET EVOL, V65, P792, DOI 10.1016/j.ympev.2012.07.017; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shao RF, 2006, J MOL EVOL, V63, P251, DOI 10.1007/s00239-005-0196-y; Shen X, 2014, COMP BIOCHEM PHYS D, V12, P1, DOI 10.1016/j.cbd.2014.08.002; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SMITH MJ, 1993, J MOL EVOL, V36, P545, DOI 10.1007/BF00556359; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Sun SE, 2015, GENE, V557, P61, DOI 10.1016/j.gene.2014.12.011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang HX, 2011, MAR GENOM, V4, P263, DOI 10.1016/j.margen.2011.06.006; Wang HX, 2010, COMP BIOCHEM PHYS D, V5, P256, DOI 10.1016/j.cbd.2010.07.003; Wilkinson GS, 1997, GENETICS, V146, P1035; Wilson JJ, 2016, MITOCHONDRIAL DNA A, V27, P3553, DOI 10.3109/19401736.2015.1074214; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wu XY, 2014, GENE, V533, P439, DOI 10.1016/j.gene.2013.09.077; Wu XY, 2012, GENE, V507, P112, DOI 10.1016/j.gene.2012.07.032; Xu F, 2008, ILLUSTRATED BIVALVE; Xu XD, 2012, GENE, V494, P17, DOI 10.1016/j.gene.2011.12.002; Xu XD, 2010, GENOME, V53, P1041, DOI 10.1139/G10-096; Yokobori S, 2004, MOL BIOL EVOL, V21, P2034, DOI 10.1093/molbev/msh227; Yuan YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037557; Zardoya R, 1996, MOL BIOL EVOL, V13, P933, DOI 10.1093/oxfordjournals.molbev.a025661	62	18	18	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196466	10.1371/journal.pone.0196466	http://dx.doi.org/10.1371/journal.pone.0196466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718949	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900054
J	Rogers, S; McCloy, RA; Parker, BL; Gallego-Ortega, D; Law, AMK; Chin, VT; Conway, JRW; Fey, D; Millar, EKA; O'Toole, S; Deng, NT; Swarbrick, A; Chastain, PD; Cesare, AJ; Timpson, P; Caldon, CE; Croucher, DR; James, DE; Watkins, DN; Burgess, A				Rogers, Samuel; McCloy, Rachael A.; Parker, Benjamin L.; Gallego-Ortega, David; Law, Andrew M. K.; Chin, Venessa T.; Conway, James R. W.; Fey, Dirk; Millar, Ewan K. A.; O'Toole, Sandra; Deng, Niantao; Swarbrick, Alexander; Chastain, Paul D.; Cesare, Anthony J.; Timpson, Paul; Caldon, C. Elizabeth; Croucher, David R.; James, David E.; Watkins, D. Neil; Burgess, Andrew			MASTL overexpression promotes chromosome instability and metastasis in breast cancer	ONCOGENE			English	Article							PROTEIN PHOSPHATASE 2A; MITOTIC EXIT; GREATWALL KINASE; HUMAN-CELLS; DNA-DAMAGE; EPITHELIAL-CELLS; DEPHOSPHORYLATION; PHOSPHORYLATION; PHENOTYPE; SUBSTRATE	MASTL kinase is essential for correct progression through mitosis, with loss of MASTL causing chromosome segregation errors, mitotic collapse and failure of cytokinesis. However, in cancer MASTL is most commonly amplified and overexpressed. This correlates with increased chromosome instability in breast cancer and poor patient survival in breast, ovarian and lung cancer. Global phosphoproteomic analysis of immortalised breast MCF10A cells engineered to overexpressed MASTL revealed disruption to desmosomes, actin cytoskeleton, PI3K/AKT/mTOR and p38 stress kinase signalling pathways. Notably, these pathways were also disrupted in patient samples that overexpress MASTL. In MCF10A cells, these alterations corresponded with a loss of contact inhibition and partial epithelial-mesenchymal transition, which disrupted migration and allowed cells to proliferate uncontrollably in 3D culture. Furthermore, MASTL overexpression increased aberrant mitotic divisions resulting in increased micronuclei formation. Mathematical modelling indicated that this delay was due to continued inhibition of PP2A-B55, which delayed timely mitotic exit. This corresponded with an increase in DNA damage and delayed transit through interphase. There were no significant alterations to replication kinetics upon MASTL overexpression, however, inhibition of p38 kinase rescued the interphase delay, suggesting the delay was a G2 DNA damage checkpoint response. Importantly, knockdown of MASTL, reduced cell proliferation, prevented invasion and metastasis of MDA-MB-231 breast cancer cells both in vitro and in vivo, indicating the potential of future therapies that target MASTL. Taken together, these results suggest that MASTL overexpression contributes to chromosome instability and metastasis, thereby decreasing breast cancer patient survival.	[Rogers, Samuel; McCloy, Rachael A.; Gallego-Ortega, David; Law, Andrew M. K.; Chin, Venessa T.; Conway, James R. W.; Deng, Niantao; Swarbrick, Alexander; Timpson, Paul; Caldon, C. Elizabeth; Croucher, David R.; Watkins, D. Neil] Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW 2010, Australia; [Rogers, Samuel; Cesare, Anthony J.] Univ Sydney, Childrens Med Res Inst, Westmead, NSW, Australia; [Parker, Benjamin L.; James, David E.] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Gallego-Ortega, David; Fey, Dirk] Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland; [Millar, Ewan K. A.] St George Hosp, Dept Anat Pathol, NSW Hlth Pathol, Sydney, NSW 2217, Australia; [Millar, Ewan K. A.] UNSW Sydney, Sch Med Sci, Kensington, NSW 2033, Australia; [Millar, Ewan K. A.] Sydney Western Univ, Sch Med & Hlth Sci, Campbelltown, NSW 2560, Australia; [O'Toole, Sandra] Univ Sydney, Sydney Med Sch, Fisher Rd, Camperdown, NSW 2006, Australia; [O'Toole, Sandra] Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, Missenden Rd, Camperdown, NSW 2050, Australia; [Deng, Niantao; Swarbrick, Alexander; Caldon, C. Elizabeth; Croucher, David R.; Watkins, D. Neil] UNSW, St Vincents Clin Sch, Fac Med, Darlinghurst, NSW, Australia; [Chastain, Paul D.] Univ Illinois, Coll Med Rockford, Dept Hlth Sci Educ, Rockford, IL 61107 USA; [Croucher, David R.] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [James, David E.] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia; [Watkins, D. Neil] St Vincents Hosp, Dept Thorac Med, Darlinghurst, NSW 2010, Australia; [Burgess, Andrew] Univ Sydney, ANZAC Res Inst, Sydney, NSW 2139, Australia	Garvan Institute of Medical Research; Children's Medical Research Institute - Australia; University of Sydney; University of Sydney; University College Dublin; St George Hospital; University of New South Wales Sydney; University of Sydney; University of Sydney; University of New South Wales Sydney; University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; University College Dublin; University of Sydney; St Vincents Hospital Sydney; University of Sydney; ANZAC Research Institute	Burgess, A (corresponding author), Univ Sydney, ANZAC Res Inst, Sydney, NSW 2139, Australia.	andrew.burgess@anzac.edu.au	Cesare, Anthony J/F-4691-2010; Gallego-Ortega, David/AAK-9067-2020; Timpson, Paul/A-9429-2016; Swarbrick, Alexander/E-6107-2010; Research Institute, ANZAC/CAE-9030-2022; Burgess, Andrew/H-3339-2019; Cesare, Anthony/N-7415-2019; Chastain, Paul/AAN-2692-2020; Millar, Ewan/ABE-9127-2020	Cesare, Anthony J/0000-0002-0864-1254; Gallego-Ortega, David/0000-0002-2347-7835; Swarbrick, Alexander/0000-0002-3051-5676; Burgess, Andrew/0000-0003-4536-9226; Cesare, Anthony/0000-0002-0864-1254; Chastain, Paul/0000-0001-6782-6788; Millar, Ewan/0000-0002-9778-3253; James, David/0000-0001-5946-5257; McCloy, Rachael/0000-0001-7791-4044; Timpson, Paul/0000-0002-5514-7080; Fey, Dirk/0000-0002-5558-0167; Watkins, Neil/0000-0001-8218-4920; Chin, Venessa/0000-0002-4630-4451; Conway, James/0000-0003-3787-277X; Rogers, Samuel/0000-0002-5345-5741; Deng, Niantao/0000-0001-9717-2236; Croucher, David/0000-0003-4965-8674	NBCF [IIRS-18-103]; CINSW FRL [10/FRL/3-02]; Patricia Helen Guest Fellowship	NBCF; CINSW FRL; Patricia Helen Guest Fellowship	We thank Marcos Malumbres for his insightful comments, Medina Krcic for her assistance, A. Cippioni and C. Ormandy for their generous gifts of the AKT/mTOR MagPix and SILAC reagents. This work was supported by NBCF (IIRS-18-103), CINSW FRL (ID#10/FRL/3-02) and a Patricia Helen Guest Fellowship.	Alvarez-Fernandez, 2017, CELL DEATH DIFFER, P1; Alvarez-Fernandez M, 2013, P NATL ACAD SCI USA, V110, P17374, DOI 10.1073/pnas.1310745110; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Burgess A, 2017, CELL, V169, DOI 10.1016/j.cell.2017.06.003; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Charrasse S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00339-4; Chin VT, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8504; Cundell MJ, 2016, J CELL BIOL, V214, P539, DOI 10.1083/jcb.201606033; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Diril MK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006310; Duffy S, 2016, P NATL ACAD SCI USA, V113, P9967, DOI 10.1073/pnas.1611839113; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Herrmann D, 2014, CARCINOGENESIS, V35, P1671, DOI 10.1093/carcin/bgu108; Hinchcliffe EH, 2016, NAT CELL BIOL, V18, P668, DOI 10.1038/ncb3348; Kim ES, 2004, INT J ONCOL, V25, P1375; Kim MS, 2003, CANCER RES, V63, P5454; Lemaire M, 2006, CELL CYCLE, V5, P1649, DOI 10.4161/cc.5.15.3006; Lindqvist A, 2004, J CELL SCI, V117, P4979, DOI 10.1242/jcs.01395; Llopis A, 2012, CELL CYCLE, V11, P3627, DOI 10.4161/cc.21917; Lopez-Knowles E, 2010, INT J CANCER, V126, P1121, DOI 10.1002/ijc.24831; McCloy RA, 2015, MOL CELL PROTEOMICS, V14, P2194, DOI 10.1074/mcp.M114.046938; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Nagel R, 2015, MOL CANCER THER, V14, P1434, DOI 10.1158/1535-7163.MCT-14-0846; Ocasio CA, 2016, ONCOTARGET, V7, P71182, DOI 10.18632/oncotarget.11511; Peng AM, 2010, CELL CYCLE, V9, P4364, DOI 10.4161/cc.9.21.13632; Pereira B, 2016, NAT COMMUN, V7, P1; Piscitello D, 2017, ONCOGENE, V15, P356; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rogers S, 2016, J CELL SCI, V129, P1340, DOI 10.1242/jcs.179754; Sansregret L, 2018, NAT REV CLIN ONCOL, V85, P14; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Sflomos G, 2016, CANCER CELL, V29, P407, DOI 10.1016/j.ccell.2016.02.002; Tian JJ, 2017, BIOMED PHARMACOTHER, V92, P919, DOI 10.1016/j.biopha.2017.05.118; Vera J, 2015, ELIFE, V4, DOI 10.7554/eLife.10115; Vigneron S, 2009, EMBO J, V28, P2786, DOI 10.1038/emboj.2009.228; Voets E, 2010, CELL CYCLE, V9, P3591, DOI 10.4161/cc.9.17.12832; Wang L, 2014, ONCOTARGET, V5, P11479, DOI 10.18632/oncotarget.2565; Williams BC, 2014, ELIFE, V3, DOI 10.7554/eLife.01695; Wong PY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22230; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Young AIJ, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0781-6; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493; Zhuge BZ, 2017, EUR REV MED PHARMACO, V21, P2413	46	30	31	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 16	2018	37	33					4518	4533		10.1038/s41388-018-0295-z	http://dx.doi.org/10.1038/s41388-018-0295-z			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GQ5OV	29743597	Green Published, hybrid			2022-12-26	WOS:000441736700003
J	Gonzalez-Segura, L; Mujica-Jimenez, C; Juarez-Diaz, JA; Guemez-Toro, R; Martinez-Castilla, LP; Munoz-Clares, RA				Gonzalez-Segura, Lilian; Mujica-Jimenez, Carlos; Andres Juarez-Diaz, Javier; Guemez-Toro, Rodrigo; Martinez-Castilla, Leon P.; Munoz-Clares, Rosario A.			Identification of the allosteric site for neutral amino acids in the maize C-4 isozyme of phosphoenolpyruvate carboxylase: The critical role of Ser-100	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; protein structure; enzyme kinetics; crystal structure; site-directed mutagenesis; amino acid residue conservation; monocot and eudicot PEPC-C-4 isozymes; Zea mays L	ZEA-MAYS; BINDING-SITE; LEAVES; GLUCOSE-6-PHOSPHATE; ACTIVATION; PHOTOSYNTHESIS; GLYCINE; ENZYME; KRANZ; DESENSITIZATION	The isozymes of photosynthetic phosphoenolpyruvate carboxylase from C-4 plants (PEPC-C-4) play a critical role in their atmospheric CO2 assimilation and productivity. They are allosterically activated by phosphorylated trioses or hexoses, such as d-glucose 6-phosphate, and inhibited by l-malate or l-aspartate. Additionally, PEPC-C-4 isozymes from grasses are activated by glycine, serine, or alanine, but the allosteric site for these compounds remains unknown. Here, we report a new crystal structure of the isozyme from Zea mays (ZmPEPC-C-4) with glycine bound at the monomer-monomer interfaces of the two dimers of the tetramer, making interactions with residues of both monomers. This binding site is close to, but different from, the one proposed to bind glucose 6-phosphate. Docking experiments indicated that d/l-serine or d/l-alanine could also bind to this site, which does not exist in the PEPC-C-4 isozyme from the eudicot plant Flaveria, mainly because of a lysyl residue at the equivalent position of Ser-100 in ZmPEPC-C-4. Accordingly, the ZmPEPC-C-4 S100K mutant is not activated by glycine, serine, or alanine. Amino acid sequence alignments showed that PEPC-C-4 isozymes from the monocot family Poaceae have either serine or glycine at this position, whereas those from Cyperaceae and eudicot families have lysine. The size and charge of the residue equivalent to Ser-100 are not only crucial for the activation of PEPC-C-4 isozymes by neutral amino acids but also affect their affinity for the substrate phosphoenolpyruvate and their allosteric regulation by glucose 6-phosphate and malate, accounting for the reported kinetic differences between PEPC-C-4 isozymes from monocot and eudicot plants.	[Gonzalez-Segura, Lilian; Mujica-Jimenez, Carlos; Guemez-Toro, Rodrigo; Martinez-Castilla, Leon P.; Munoz-Clares, Rosario A.] Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico; [Andres Juarez-Diaz, Javier] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Biol Comparada, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Munoz-Clares, RA (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico.	clares@unam.mx	Juárez-Díaz, Javier Andrés/AAD-6398-2021	Juarez-Diaz, Javier Andres/0000-0001-9238-8564; Gonzalez-Segura, Lilian/0000-0001-7736-5065; Munoz-Clares, Rosario A./0000-0002-0115-3565	Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica PAPIIT [IN216911]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [252123]	Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica PAPIIT; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part by Direccion General de Asuntos del Personal Academico-Universidad Nacional Autonoma de Mexico Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica PAPIIT, Grant IN216911 and Consejo Nacional de Ciencia y Tecnologia (CONACYT) Grant 252123 (to R.A.M.-C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDREO CS, 1987, FEBS LETT, V213, P1, DOI 10.1016/0014-5793(87)81454-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANDARIAN V, 1992, PLANT PHYSIOL, V100, P1411, DOI 10.1104/pp.100.3.1411; Blasing OE, 2000, J BIOL CHEM, V275, P27917; Bowes G, 2002, FUNCT PLANT BIOL, V29, P379, DOI 10.1071/PP01219; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Christin PA, 2007, CURR BIOL, V17, P1241, DOI 10.1016/j.cub.2007.06.036; Christin PA, 2014, J EXP BOT, V65, P3609, DOI 10.1093/jxb/eru087; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DONCASTER HD, 1987, PLANT PHYSIOL, V84, P82, DOI 10.1104/pp.84.1.82; Edwards GE, 2004, ANNU REV PLANT BIOL, V55, P173, DOI 10.1146/annurev.arplant.55.031903.141725; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao Y, 1996, AUST J PLANT PHYSIOL, V23, P25, DOI 10.1071/PP9960025; GARSON L, 1991, BIOCHEM INT, V23, P299; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GILLINTA J, 1995, PHOTOSYNTH RES, V45, P121, DOI 10.1007/BF00032583; GONZALEZ DH, 1984, J PLANT PHYSIOL, V116, P425, DOI 10.1016/S0176-1617(84)80134-0; Gonzalez L., 2007, FASEB J, V21; Guemez-Toro R, 2012, J MEX CHEM SOC, V56, P58; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; HEINEKE D, 1991, PLANT PHYSIOL, V95, P1131, DOI 10.1104/pp.95.4.1131; HUDSPETH RL, 1989, PLANT MOL BIOL, V12, P579, DOI 10.1007/BF00036971; Izui K, 2004, ANNU REV PLANT BIOL, V55, P69, DOI 10.1146/annurev.arplant.55.031903.141619; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kai Y, 1999, P NATL ACAD SCI USA, V96, P823, DOI 10.1073/pnas.96.3.823; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEEGOOD RC, 1985, PLANTA, V164, P163, DOI 10.1007/BF00396078; Matsumura H, 2002, STRUCTURE, V10, P1721, DOI 10.1016/S0969-2126(02)00913-9; Matsumura H, 1999, FEBS LETT, V458, P93, DOI 10.1016/S0014-5793(99)01103-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mujica-Jimenez C, 1998, BBA-PROTEIN STRUCT M, V1386, P132, DOI 10.1016/S0167-4838(98)00093-4; NISHIKIDO T, 1973, BIOCHEM BIOPH RES CO, V53, P126, DOI 10.1016/0006-291X(73)91410-1; Paulus JK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2504; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rao SK, 2008, PLANT SCI, V174, P475, DOI 10.1016/j.plantsci.2008.01.010; RODRIGUEZSOTRES R, 1990, ARCH BIOCHEM BIOPHYS, V276, P180, DOI 10.1016/0003-9861(90)90025-T; Rosnow JJ, 2015, J EXP BOT, V66, P7347, DOI 10.1093/jxb/erv431; Rosnow JJ, 2014, J EXP BOT, V65, P3595, DOI 10.1093/jxb/eru053; Sanchez R, 2003, PLANT PHYSIOL, V132, P949, DOI 10.1104/pp.102.019653; Schlieper D, 2014, MOL PLANT, V7, P437, DOI 10.1093/mp/sst130; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; STIBOROVA M, 1985, PHOTOSYNTHETICA, V19, P177; STITT M, 1985, BIOCHIM BIOPHYS ACTA, V808, P400, DOI 10.1016/0005-2728(85)90148-3; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Takahashi-Terada A, 2005, J BIOL CHEM, V280, P11798, DOI 10.1074/jbc.M408768200; Tovar-Mendez A, 1998, BIOCHEM J, V332, P633, DOI 10.1042/bj3320633; Tovar-Mendez A, 2000, PLANT PHYSIOL, V123, P149, DOI 10.1104/pp.123.1.149; TovarMendez A, 1997, BBA-PROTEIN STRUCT M, V1337, P207, DOI 10.1016/S0167-4838(96)00166-5; UEDAN K, 1976, PLANT PHYSIOL, V57, P906, DOI 10.1104/pp.57.6.906; WONG KF, 1973, BIOCHEM J, V131, P451, DOI 10.1042/bj1310451; Yuan JP, 2006, PHOTOSYNTH RES, V88, P73, DOI 10.1007/s11120-005-9032-x	52	8	9	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					9945	9957		10.1074/jbc.RA118.002884	http://dx.doi.org/10.1074/jbc.RA118.002884			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29743237	Green Published, hybrid			2022-12-26	WOS:000437096700002
J	Emerenziani, GP; Ferrari, D; Vaccaro, MG; Gallotta, MC; Migliaccio, S; Lenzi, A; Baldari, C; Guidetti, L				Emerenziani, Gian Pietro; Ferrari, Dafne; Vaccaro, Maria Grazia; Gallotta, Maria Chiara; Migliaccio, Silvia; Lenzi, Andrea; Baldari, Carlo; Guidetti, Laura			Prediction equation to estimate heart rate at individual ventilatory threshold in female and male obese adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BODY-COMPOSITION; ANAEROBIC THRESHOLD; EXERCISE INTENSITY; PERCEIVED EXERTION; REFERENCE VALUES; WALKING TEST; ENDURANCE; CAPACITY; WOMEN	Objective Prescribing individualized moderate exercise intensity is a useful method to reach positive effects on health status in obese adults. This study aimed to establish a practical reference equation to estimate the heart rate (HR) at individual ventilatory threshold (IVT) (HRIVT). Methods One hundred sixty-one obese subjects were clinically evaluated and characterized by anthropometric and body composition. Participants performed the six-minute walking test (6-MWT) and the cardiopulmonary exercise test to assess IVT. Multiple regression analysis for HRIVT, including 6-MWT, anthropometric, and body composition parameters, as independent variables, was performed for both gender separately. A cross-validation study was also performed to determine the accuracy of the prediction equation. Results Whereas HRIVT was not significantly different between males (121.5 +/- 18.3 bpm) and females (117.6 +/- 17.1 bpm), it differently correlated with physical and performance parameters. Therefore, two sex-specific equations were developed including 6-MWTHR and HRrest (R-2 = 0.69 and 0.65 and root mean square errors of 8.8 and 10.1 bpm for females and males, respectively). Conclusion In conclusion, in female and male obese adults, the 6-MWT might be used to predict HR at IVT. These outcomes are useful to prescribe optimal physical activity intensity when gold standard methods (e.g. gas exchange analysis) are unavailable.	[Emerenziani, Gian Pietro] Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Catanzaro, Italy; [Ferrari, Dafne; Gallotta, Maria Chiara; Migliaccio, Silvia; Baldari, Carlo; Guidetti, Laura] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Sect Hlth Sci, Rome, Italy; [Vaccaro, Maria Grazia] Univ Catanzaro Magna Graecia, Inst Neurol, Dept Med Sci, Catanzaro, Italy; [Lenzi, Andrea] Sapienza Univ, Sect Med Pathophysiol Food Sci & Endocrinol, Dept Expt Med, Rome, Italy	Magna Graecia University of Catanzaro; Foro Italico University of Rome; Magna Graecia University of Catanzaro; Sapienza University Rome	Baldari, C (corresponding author), Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Sect Hlth Sci, Rome, Italy.	carlo.baldari@uniroma4.it	Gallotta, Maria Chiara/L-4982-2019; VACCARO, MARIA GRAZIA/AAN-7393-2020; VACCARO, Maria Grazia/ABD-9308-2020; Emerenziani, Gian Pietro/ABF-1876-2020; Baldari, Carlo/N-6756-2014	Gallotta, Maria Chiara/0000-0001-5532-6380; VACCARO, Maria Grazia/0000-0001-8666-0461; Emerenziani, Gian Pietro/0000-0002-5426-5317; Guidetti, Laura/0000-0002-1419-4550; Ferrari, Dafne/0000-0002-3675-0917; Migliaccio, Silvia/0000-0002-4563-6630; Baldari, Carlo/0000-0001-6227-3571	Ministry of Education, Universities and Research. Projects of Relevant National Interest (PRIM) [2011 052013, 2015- 2015TC3Y9B_004, 2015-2015JSWLTN_004]	Ministry of Education, Universities and Research. Projects of Relevant National Interest (PRIM)	Research was funded by Ministry of Education, Universities and Research. Projects of Relevant National Interest (PRIM): 2011 052013 to S. Migliaccio, 2015- 2015TC3Y9B_004 to L. Guidetti, 2015-2015JSWLTN_004 to C. Baldari.	Aiello M, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-96; Alexander DLJ, 2015, J CHEM INF MODEL, V55, P1316, DOI 10.1021/acs.jcim.5b00206; Aoike Danilo Takashi, 2012, Braz. J. Nephrol., V34, P139; Arena R, 2016, AM HEART J, V173, P49, DOI 10.1016/j.ahj.2015.12.006; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Beriault K, 2009, INT J SPORTS MED, V30, P725, DOI 10.1055/s-0029-1231043; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Capodaglio P, 2013, DISABIL REHABIL, V35, P1199, DOI 10.3109/09638288.2012.726313; Carter R, 2003, ARCH PHYS MED REHAB, V84, P1158, DOI 10.1016/S0003-9993(03)00047-9; Chetta A, 2006, RESP MED, V100, P1573, DOI 10.1016/j.rmed.2006.01.001; DaSilva SG, 2009, PERCEPT MOTOR SKILL, V109, P41, DOI 10.2466/PMS.109.1.41-60; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Ekkekakis P, 2006, INT J OBESITY, V30, P652, DOI 10.1038/sj.ijo.0803052; Emerenziani GP, 2018, J ENDOCRINOL INVEST, V41, P465, DOI 10.1007/s40618-017-0771-2; Emerenziani GP, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/6739150; Emerenziani GP, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/695297; Franckowiak SC, 2011, J STRENGTH COND RES, V25, P1407, DOI 10.1519/JSC.0b013e3181d682d2; Guidetti L, 2011, J AGING PHYS ACTIV, V19, P214, DOI 10.1123/japa.19.3.214; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Houghton AR, 2002, EUR J HEART FAIL, V4, P289, DOI 10.1016/S1388-9842(01)00236-7; Hulens M, 2001, SCAND J MED SCI SPOR, V11, P305, DOI 10.1034/j.1600-0838.2001.110509.x; KINDERMANN W, 1979, EUR J APPL PHYSIOL O, V42, P25, DOI 10.1007/BF00421101; Lavie CJ, 2010, MAYO CLIN PROC, V85, P605, DOI 10.4065/mcp.2010.0333; Lind E, 2008, J HEALTH PSYCHOL, V13, P464, DOI 10.1177/1359105308088517; Lord SR, 2002, ARCH PHYS MED REHAB, V83, P907, DOI 10.1053/apmr.2002.33227; Makni E, 2012, INT J OBESITY, V36, P908, DOI 10.1038/ijo.2011.257; Meyer T, 2005, INT J SPORTS MED, V26, pS38, DOI 10.1055/s-2004-830514; Nieman DC, 2013, RES SPORTS MED, V21, P136, DOI 10.1080/15438627.2012.757227; Pinet BM, 2008, OBESITY, V16, P2088, DOI 10.1038/oby.2008.272; Ranavolo A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/142323; Ross RM, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-31; Salvadego D, 2010, AM J PHYSIOL-REG I, V299, pR1298, DOI 10.1152/ajpregu.00038.2010; Skrypnik D, 2015, OBESITY FACTS, V8, P175, DOI 10.1159/000431002; Szulinska M, 2016, BIOMED ENVIRON SCI, V29, P706, DOI 10.3967/bes2016.095; Utter AC, 2004, MED SCI SPORT EXER, V36, P1776, DOI 10.1249/01.MSS.0000142310.97274.94; Wannamethee SG, 1998, LANCET, V351, P1603, DOI 10.1016/S0140-6736(97)12355-8; WASSERMAN K, 1987, CIRCULATION, V76, P29	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0197255	10.1371/journal.pone.0197255	http://dx.doi.org/10.1371/journal.pone.0197255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750822	Green Published, Green Submitted, gold			2022-12-26	WOS:000431856300025
J	Neubauer, P; Thorson, JT; Melnychuk, MC; Methot, R; Blackhart, K				Neubauer, Philipp; Thorson, James T.; Melnychuk, Michael C.; Methot, Richard; Blackhart, Kristan			Drivers and rates of stock assessments in the United States	PLOS ONE			English	Article							SETTING CATCH LIMITS; FISHERIES MANAGEMENT; FISH STOCKS; PERFORMANCE; DEPLETION	Fisheries management is most effective when based on scientific estimates of sustainable fishing rates. While some simple approaches allow estimation of harvest limits, more data-intensive stock assessments are generally required to evaluate the stock's biomass and fishing rates relative to sustainable levels. Here we evaluate how stock characteristics relate to the rate of new assessments in the United States. Using a statistical model based on time-to-event analysis and 569 coastal marine fish and invertebrate stocks landed in commercial fisheries, we quantify the impact of region, habitat, life-history, and economic factors on the annual probability of being assessed. Although the majority of landings come from assessed stocks in all regions, less than half of the regionally-landed species currently have been assessed. As expected, our time-to-event model identified landed tonnage and exvessel price as the dominant factors determining increased rates of new assessments. However, we also found that after controlling for landings and price, there has been a consistent bias towards assessing larger-bodied species. A number of vulnerable groups such as rockfishes (Scorpaeniformes) and groundsharks (Carcharhiniformes) have a relatively high annual probability of being assessed after controlling for their relatively small tonnage and low price. Due to relatively low landed tonnage and price of species that are currently unassessed, our model suggests that the number of assessed stocks will increase more slowly in future decades.	[Neubauer, Philipp] Dragonfly Data Sci, Wellington, New Zealand; [Thorson, James T.; Methot, Richard] NOAA, Norhwest Fisheries Sci Ctr, Seattle, WA USA; [Melnychuk, Michael C.] Univ Washington, Sch Aquat & Fisheries Sci, Seattle, WA 98195 USA; [Blackhart, Kristan] ECS Fed INC, Fairfax, VA USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle	Neubauer, P (corresponding author), Dragonfly Data Sci, Wellington, New Zealand.	philipp@dragonfly.co.nz	Thorson, James T/H-8771-2019; Thorson, James T/O-7937-2014; Melnychuk, Michael Colin/A-4680-2013	Thorson, James T/0000-0001-7415-1010; Thorson, James T/0000-0001-7415-1010; Neubauer, Philipp/0000-0002-4150-848X; Melnychuk, Michael Colin/0000-0002-6088-7657	Department of Commerce; Walton Family Foundation; NSERC Banting Fellowship; Dragonfly Data Science; ECS Federal Inc.	Department of Commerce; Walton Family Foundation; NSERC Banting Fellowship; Dragonfly Data Science; ECS Federal Inc.	PECASE (Presidential Early Career Award in Science and Engineering) grant to JTT from the Department of Commerce. M.C.M. was supported in this work by the Walton Family Foundation and by a NSERC Banting Fellowship. Commercial employers Dragonfly Data Science and ECS Federal Inc. provided support in the form of salaries of P.N. and K.B., respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 1993, P INT S MAN STRAT EX; Berkson J, 2015, ICES J MAR SCI, V72, P237, DOI 10.1093/icesjms/fsu085; Boettiger C, 2012, J FISH BIOL, V81, P2030, DOI 10.1111/j.1095-8649.2012.03464.x; Carruthers TR, 2014, FISH RES, V153, P48, DOI 10.1016/j.fishres.2013.12.014; Conway F, 2008, FISHERIES, V33, P269, DOI 10.1577/1548-8446-33.6.269; Cook RM, 2018, FISH FISH, V19, P455, DOI 10.1111/faf.12265; CORTES E, 2002, SFD0102152 SE FISH S; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Dichmont CM, 2016, FISH RES, V183, P447, DOI 10.1016/j.fishres.2016.07.001; Dick EJ, 2011, FISH RES, V110, P331, DOI 10.1016/j.fishres.2011.05.007; Doubleday ZA, 2016, CURR BIOL, V26, pR406, DOI 10.1016/j.cub.2016.04.002; Dowling NA, 2013, MAR POLICY, V40, P41, DOI 10.1016/j.marpol.2012.12.009; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Helser TE, 2006, PACIFIC FISHERY MANA, V7700, P97220; Hilborn R, 2012, CONSERV BIOL, V26, DOI 10.1111/j.1523-1739.2011.01800.x; Hutchings JA, 2010, CAN J FISH AQUAT SCI, V67, P1205, DOI 10.1139/F10-081; Jensen OP, 2012, THEOR ECOL-NETH, V5, P3, DOI 10.1007/s12080-011-0146-9; Kokkalis A, 2017, ICES J MAR SCI, V74, P69, DOI 10.1093/icesjms/fsw145; MacCall AD, 2009, ICES J MAR SCI, V66, P2267, DOI 10.1093/icesjms/fsp209; Melnychuk MC, 2017, P NATL ACAD SCI USA, V114, P178, DOI 10.1073/pnas.1609915114; Melnychuk MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056684; Melnychuk MC, 2012, FISH FISH, V13, P267, DOI 10.1111/j.1467-2979.2011.00429.x; Methot RD, 2014, ICES J MAR SCI, V71, P183, DOI 10.1093/icesjms/fst119; Methot RD, 2015, PRIORITIZING FISH ST; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; Newman D, 2015, FISH RES, V164, P86, DOI 10.1016/j.fishres.2014.10.018; NOAA Fisheries Statistics Division, 2015, FISH US; NOAA Fisheries Statistics Division, 2016, ANN COMM LAND STAT; Palomares M., 2010, SEALIFEBASE; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sethi SA, 2010, P NATL ACAD SCI USA, V107, P12163, DOI 10.1073/pnas.1003236107; Smith Tim., 2007, SCALING FISHERIES SC; Thorson JT, 2015, ICES J MAR SCI, V72, P428, DOI 10.1093/icesjms/fsu127; Thorson JT, 2015, FISH FISH, V16, P342, DOI 10.1111/faf.12061; Wetzel CR, 2011, MAR FRESHWATER RES, V62, P927, DOI 10.1071/MF11006; Wetzel CR, 2011, FISH RES, V110, P342, DOI 10.1016/j.fishres.2011.04.024; Wiedenmann J, 2013, N AM J FISH MANAGE, V33, P845, DOI 10.1080/02755947.2013.811128; Worm B, REBUILDING GLOBAL FI, V325, P578	39	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0196483	10.1371/journal.pone.0196483	http://dx.doi.org/10.1371/journal.pone.0196483			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750789	gold, Green Published			2022-12-26	WOS:000431856300002
J	Irwin, C; Van Reenen, M; Mason, S; Mienie, LJ; Wevers, RA; Westerhuis, JA; Reinecke, CJ				Irwin, Cindy; Van Reenen, Mari; Mason, Shayne; Mienie, Lodewyk J.; Wevers, Ron A.; Westerhuis, Johan A.; Reinecke, Carolus J.			The H-1-NMR-based metabolite profile of acute alcohol consumption: A metabolomics intervention study	PLOS ONE			English	Article							ETHANOL-INDUCED HYPERURICEMIA; ADENINE-NUCLEOTIDE TURNOVER; LIVER-DISEASE; MASS-SPECTROMETRY; SWIFT INCREASE; MOUSE MODEL; BRAIN; CIRRHOSIS; SERUM; H-1	Metabolomics studies of disease conditions related to chronic alcohol consumption provide compelling evidence of several perturbed metabolic pathways underlying the pathophysiology of alcoholism. The objective of the present study was to utilize proton nuclear magnetic resonance (H-1-NMR) spectroscopy metabolomics to study the holistic metabolic consequences of acute alcohol consumption in humans. The experimental design was a cross-over intervention study which included a number of substances to be consumed-alcohol, a nicotinamide adenine dinucleotide (NAD) supplement, and a benzoic acid-containing flavoured water vehicle. The experimental subjects-24 healthy, moderate-drinking young men-each provided six hourly-collected urine samples for analysis. Complete data sets were obtained from 20 of the subjects and used for data generation, analysis and interpretation. The results from the NMR approach produced complex spectral data, which could be resolved sufficiently through the application of a combination of univariate and multivariate methods of statistical analysis. The metabolite profiles resulting from acute alcohol consumption indicated that alcohol-induced NAD(+ )depletion, and the production of an excessive amount of reducing equivalents, greatly perturbed the hepatocyte redox homeostasis, resulting in essentially three major metabolic disturbances-up-regulated lactic acid metabolism, down-regulated purine catabolism and osmoregulation. Of these, the urinary excretion of the osmolyte sorbitol proved to be novel, and suggests hepatocyte swelling due to ethanol influx following acute alcohol consumption. Time-dependent metabolomics investigations, using designed interventions, provide a way of interpreting the variation induced by the different factors of a designed experiment, thereby also giving methodological significance to this study. The outcomes of this approach have the potential to significantly advance our understanding of the serious impact of the pathophysiological perturbations which arise from the consumption of a single, large dose of alcohol-a simulation of a widespread, and mostly naive, social practice.	[Irwin, Cindy; Van Reenen, Mari; Mason, Shayne; Mienie, Lodewyk J.; Reinecke, Carolus J.] North West Univ, Ctr Human Metabol, Fac Nat Sci & Agr, Potchefstroom Campus, Potchefstroom, South Africa; [Van Reenen, Mari; Westerhuis, Johan A.] North West Univ, Fac Nat Sci & Agr, Dept Stat, Potchefstroom Campus, Potchefstroom, South Africa; [Wevers, Ron A.] Radboud Univ Nijmegen, Dept Lab Med, Med Ctr, Nijmegen, Netherlands; [Westerhuis, Johan A.] Univ Amsterdam, Swammerdam Inst Life Sci, Biosyst Data Anal, Amsterdam, Netherlands	North West University - South Africa; North West University - South Africa; Radboud University Nijmegen; University of Amsterdam	Reinecke, CJ (corresponding author), North West Univ, Ctr Human Metabol, Fac Nat Sci & Agr, Potchefstroom Campus, Potchefstroom, South Africa.	carools.reinecke@nwu.ac.za	Wevers, Ron A./H-8116-2014	Wevers, Ron A./0000-0003-2278-9746; Mason, Shayne/0000-0002-2945-5768; Mienie, Japie/0000-0003-0860-5285; van Wyk, Mari/0000-0002-5856-3258	Technological Innovation Agency (TIA) of the Department of Science and Technology of South Africa	Technological Innovation Agency (TIA) of the Department of Science and Technology of South Africa	Research funding for the analytical and computational aspects of the project was provided by the Technological Innovation Agency (TIA) of the Department of Science and Technology of South Africa. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amathieu R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089230; Antti H, 2002, J CHEMOMETR, V16, P461, DOI 10.1002/cem.733; Bala S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096864; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Bradford BU, 2008, TOXICOL APPL PHARM, V232, P236, DOI 10.1016/j.taap.2008.06.022; Bradford BU, 2005, ALCOHOL, V35, P13, DOI 10.1016/j.alcohol.2004.12.001; Collins MA, 1998, FASEB J, V12, P221, DOI 10.1096/fasebj.12.2.221; DAY CP, 1991, HEPATOLOGY, V14, P798, DOI 10.1002/hep.1840140509; Diamond I, 1997, PHYSIOL REV, V77, P1, DOI 10.1152/physrev.1997.77.1.1; FALLER J, 1982, NEW ENGL J MED, V307, P1598, DOI 10.1056/NEJM198212233072602; Fernando H, 2010, ALCOHOL CLIN EXP RES, V34, P1937, DOI 10.1111/j.1530-0277.2010.01283.x; Gao XF, 2011, METABOLOMICS, V7, P363, DOI 10.1007/s11306-010-0252-5; Gibney MJ, 2005, AM J CLIN NUTR, V82, P497, DOI 10.1093/ajcn/82.3.497; Gika HG, 2012, J CHROMATOGR A, V1259, P128, DOI 10.1016/j.chroma.2012.02.053; Gika HG, 2016, MOL ASPECTS ALCOHOL, P213; HAWKINS RD, 1972, PHARMACOL REV, V24, P67; Irwin C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167309; Kim DH, 2015, INT J MOL SCI, V16, P18664, DOI 10.3390/ijms160818664; Kirpich IA, 2016, AM J PATHOL, V186, P765, DOI 10.1016/j.ajpath.2015.11.017; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lian JS, 2011, CHINESE MED J-PEKING, V124, P1367, DOI 10.3760/cma.j.issn.0366-6999.2011.09.018; Lieber CS, 1997, CLIN CHIM ACTA, V257, P59, DOI 10.1016/S0009-8981(96)06434-0; LIEBER CS, 1994, GASTROENTEROLOGY, V106, P1085, DOI 10.1016/0016-5085(94)90772-2; Loftus N, 2011, J PROTEOME RES, V10, P705, DOI 10.1021/pr100885w; Manna SK, 2011, J PROTEOME RES, V10, P4120, DOI 10.1021/pr200310s; Masuo Y, 2009, ELECTROPHORESIS, V30, P1259, DOI 10.1002/elps.200900045; Moon KH, 2014, ALCOHOL CLIN EXP RES, V38, P161, DOI 10.1111/acer.12221; Nahon P, 2012, CLIN CANCER RES, V18, P6714, DOI 10.1158/1078-0432.CCR-12-1099; Nicholas PC, 2008, CHEM RES TOXICOL, V21, P408, DOI 10.1021/tx700324t; NISHIMURA T, 1994, METABOLISM, V43, P745, DOI 10.1016/0026-0495(94)90125-2; Numminen H, 2000, STROKE, V31, P1269, DOI 10.1161/01.STR.31.6.1269; PUIG JG, 1984, J CLIN INVEST, V74, P936, DOI 10.1172/JCI111512; Rachakonda V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113860; Smilde AK, 2005, BIOINFORMATICS, V21, P3043, DOI 10.1093/bioinformatics/bti476; Strange K, 2004, ADV PHYSIOL EDUC, V28, P155, DOI 10.1152/advan.00034.2004; Tang WH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00087; Vazquez-Fresno R, 2012, ELECTROPHORESIS, V33, P2345, DOI 10.1002/elps.201100646; Viant MR, 2009, ENVIRON SCI TECHNOL, V43, P219, DOI 10.1021/es802198z; Westerhuis JA, 2010, METABOLOMICS, V6, P119, DOI 10.1007/s11306-009-0185-z; WHO, 2014, GLOB STAT REP ALC HL; Wishart DS, 2008, TRENDS FOOD SCI TECH, V19, P482, DOI 10.1016/j.tifs.2008.03.003; Wurtz P, 2016, INT J EPIDEMIOL, V45, P1493, DOI 10.1093/ije/dyw175; Yamamoto T, 2005, CLIN CHIM ACTA, V356, P35, DOI 10.1016/j.cccn.2005.01.024; Yoseph BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062792; YU TF, 1957, P SOC EXP BIOL MED, V96, P809; YUKI T, 1980, BIOCHEM J, V186, P119, DOI 10.1042/bj1860119; Zakhari S, 2007, HEPATOLOGY, V46, P2032, DOI 10.1002/hep.22010	47	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196850	10.1371/journal.pone.0196850	http://dx.doi.org/10.1371/journal.pone.0196850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746531	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700043
J	Park, SB; Park, JM; Moon, SH; Cho, YS; Sun, JM; Kim, BT; Lee, KH				Park, Soo Bin; Park, Jung Mi; Moon, Seung Hwan; Cho, Young Seok; Sun, Jong-Mu; Kim, Byung-Tae; Lee, Kyung-Han			Role of F-18-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis	PLOS ONE			English	Article							BONE METASTASES; 1ST MANIFESTATION; MULTIPLE-MYELOMA; MANAGEMENT; DIAGNOSIS; BENIGN; TUMORS	Background When subjects without a known malignancy present with suspicious skeletal lesions, differential diagnosis and primary cancer identification is important. Here, we investigated the role of FDG PET/CT in this clinical situation. Methods We enrolled 103 patients with no known malignancies who were referred for FDG PET/CT because of bone lesions that were suspicious for cancer metastasis. Each extra-skeletal FDG lesion was categorized as consistent with primary cancer or with metastasis based on the distribution and pattern of all abnormal lesions in the individual. Results Final diagnosis revealed that bone lesions represented cancer metastasis in 75 patients (72.8%). In the remaining 28 patients (27.2%), they were from other causes including multiple myeloma or lymphoma, malignant primary bone tumor, and benign bone disease. PET/CT indicated a primary cancer in 70 patients (68.0%). This was the correct primary site in 46 cases and the incorrect site in 13 cases (including 6 cases with cancer of unknown primary, CUP). In the remaining 11 cases, the bone lesions were due to other causes. PET/CT did not indicate a primary cancer in 33 patients (32.0%). Of these cases, 17 did not have a primary cancer, 8 had CUP, and 8 had primary cancers that were missed. Thus, PET/CT had a sensitivity of 61.3% and specificity of 60.7% for primary cancer identification in the entire population. Excluding patients with CUP, PET/CT sensitivity was 75.4%. PET/CT also provided information useful for recognizing multiple myeloma and benign bone disease as the cause of the skeletal lesions. Conclusions In patients without known malignancies with suspected skeletal cancer metastasis, FDG PET/CT can help identify the primary cancer and provide useful information for differential diagnosis.	[Park, Soo Bin] Soonchunhyang Univ, Dept Radiol, Seoul Hosp, Seoul, South Korea; [Park, Jung Mi] Soonchunhyang Univ, Bucheon Hosp, Dept Nucl Med, Gyeonggi, South Korea; [Moon, Seung Hwan; Cho, Young Seok; Kim, Byung-Tae; Lee, Kyung-Han] Sungkyunkwan Univ, Sch Med, Dept Nucl Med, Samsung Med Ctr, Seoul, South Korea; [Sun, Jong-Mu] Sungkyunkwan Univ, Div Hematol Oncol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea	Soonchunhyang University; Soonchunhyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, KH (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Nucl Med, Samsung Med Ctr, Seoul, South Korea.	khnm.lee@samsung.com	sun, jm/O-5938-2014	Lee, Kyung-Han/0000-0003-3565-5536	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2015R1A2A2A01006419]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning(National Research Foundation of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2015R1A2A2A01006419) to Kyung-Han Lee.	BARON MG, 1991, INT ORTHOP, V15, P373, DOI 10.1007/BF00186882; Beiderwellen K, 2014, EUR RADIOL, V24, P2023, DOI 10.1007/s00330-014-3229-3; Ben-Haim S, 2009, J NUCL MED, V50, P88, DOI 10.2967/jnumed.108.054205; Buckwalter JA, 1997, AM FAM PHYSICIAN, V55, P1761; Burglin SA, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006713; Cavo M, 2017, LANCET ONCOL, V18, pE206, DOI 10.1016/S1470-2045(17)30189-4; Choi YY, 2014, SEMIN MUSCULOSKEL R, V18, P133, DOI 10.1055/s-0034-1371016; Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G; Farwell MD, 2014, CANCER-AM CANCER SOC, V120, P3433, DOI 10.1002/cncr.28860; Kagohashi K, 2003, INT J CLIN PRACT, V57, P184; Katagiri H, 1999, CANCER, V86, P533, DOI 10.1002/(SICI)1097-0142(19990801)86:3<533::AID-CNCR24>3.0.CO;2-1; LOTE K, 1986, Acta Radiologica Oncology, V25, P227; Mihailovic J, 2015, SEMIN NUCL MED, V45, P16, DOI 10.1053/j.semnuclmed.2014.08.002; Resnick D, 2004, BONE JOINT IMAGING, P1121; Shimada H, 2014, MOL CLIN ONCOL, V2, P875, DOI 10.3892/mco.2014.326; Strobel K, 2008, EUR J NUCL MED MOL I, V35, P2000, DOI 10.1007/s00259-008-0876-0; Taira AV, 2007, RADIOLOGY, V243, P204, DOI 10.1148/radiol.2431052104; Vandecandelaere M, 2004, JOINT BONE SPINE, V71, P224, DOI 10.1016/S1297-319X(03)00123-4; Yanagawa T, 2010, J BONE JOINT SURG BR, V92B, P419, DOI 10.1302/0301-620X.92B3.23131	19	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196808	10.1371/journal.pone.0196808	http://dx.doi.org/10.1371/journal.pone.0196808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746513	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700040
J	Yang, XH; Xia, XZ; Zeng, Y; Nong, BX; Zhang, ZQ; Wu, YY; Xiong, FQ; Zhang, YX; Liang, HF; Deng, GF; Li, DT				Yang, Xinghai; Xia, Xiuzhong; Zeng, Yu; Nong, Baoxuan; Zhang, Zongqiong; Wu, Yanyan; Xiong, Faqian; Zhang, Yuexiong; Liang, Haifu; Deng, Guofu; Li, Danting			Identification of candidate genes for gelatinization temperature, gel consistency and pericarp color by GWAS in rice based on SLAF-sequencing	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GRAIN QUALITY TRAITS; ORYZA-SATIVA L.; NATURAL VARIATION; EATING QUALITY; AGRONOMIC TRAITS; ENCODES; QTL; SYNTHASE; COOKING	Rice is an important cereal in the world. The study of the genetic basis of important agronomic traits in rice landraces and identification of genes will facilitate the breed improvement. Gelatinization temperature (GT), gel consistency (GC) and pericarp color (PC) are important indices of rice cooking and eating quality evaluation and potential nutritional importance, which attract wide attentions in the application of genetic and breeding. To dissect the genetic basis of GT, GC and PC, a total of 419 rice landraces core germplasm collections consisting of 330 indica lines, 78 japonica lines and 11 uncertain varieties were planted, collected, then GT, GC, PC were measured for two years, and sequenced using specific-locus amplified fragment sequencing (SLAF-seq) technology. In this study, 261,385,070 clean reads and 56,768 polymorphic SLAF tags were obtained, which a total of 211,818 single nucleotide polymorphisms (SNPs) were discovered. With 208,993 SNPs meeting the criterion of minor allele frequency (MAF) > 0.05 and integrity> 0.5, the phylogenetic tree and population structure analysis were performed for all 419 rice landraces, and the whole panel mainly separated into six subpopulations based on population structure analysis. Genome-wide association study (GWAS) was carried out for the whole panel, indica subpanel and japonica subpanel with subset SNPs respectively. One quantitative trait locus (QTL) on chromosome 6 for GT was detected in the whole panel and indica subpanel, and one QTL associated with GC was located on chromosome 6 in the whole panel and indica subpanel. For the PC trait, 8 QTLs were detected in the whole panel on chromosome 1, 3, 4, 7, 8, 10 and 11, and 7 QTLs in the indica subpanel on chromosome 3, 4, 7, 8, 10 and 11. For the three traits, no QTL was detected in japonica subpanel, probably because of the polymorphism repartition between the subpanel, or small population size of japonica subpanel. This paper provides new gene resources and insights into the molecular mechanisms of important agricultural trait of rice phenotypic variation and genetic improvement of rice quality variety breeding.	[Yang, Xinghai; Xia, Xiuzhong; Zeng, Yu; Nong, Baoxuan; Zhang, Zongqiong; Zhang, Yuexiong; Liang, Haifu; Deng, Guofu; Li, Danting] Guangxi Acad Agr Sci, Rice Res Inst, Nanning, Guangxi, Peoples R China; [Wu, Yanyan] Guangxi Acad Agr Sci, Biotechnol Res Inst, Nanning, Guangxi, Peoples R China; [Xiong, Faqian] Guangxi Acad Agr Sci, Cash Crops Res Inst, Nanning, Guangxi, Peoples R China	Guangxi Academy of Agricultural Sciences; Guangxi Academy of Agricultural Sciences; Guangxi Academy of Agricultural Sciences	Li, DT (corresponding author), Guangxi Acad Agr Sci, Rice Res Inst, Nanning, Guangxi, Peoples R China.	ricegl@163.com	Ynag, Xinghai/G-4232-2018	Ynag, Xinghai/0000-0002-3476-2578	National key R D projects [2016YFD0100101-03]; Guangxi's Ministry of Science and Technology [AB16380117]; Guangxi Natural Science Foundation of China [2015GXNSFAA139054]; Guangxi Academy of Agricultural Sciences [2015YT15, 2016JM09]	National key R D projects; Guangxi's Ministry of Science and Technology; Guangxi Natural Science Foundation of China; Guangxi Academy of Agricultural Sciences	This study was financially supported by National key R & D projects (2016YFD0100101-03), Guangxi's Ministry of Science and Technology (AB16380117), Guangxi Natural Science Foundation of China (2015GXNSFAA139054) and Guangxi Academy of Agricultural Sciences (2015YT15; 2016JM09).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bao JS, 2000, THEOR APPL GENET, V100, P280, DOI 10.1007/s001220050037; Bao JS, 2002, THEOR APPL GENET, V104, P408, DOI 10.1007/s001220100688; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; CAGAMPANG GB, 1973, J SCI FOOD AGR, V24, P1589, DOI 10.1002/jsfa.2740241214; Chen LH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122722; Chen W, 2014, NAT GENET, V46, P714, DOI 10.1038/ng.3007; Chin HS, 2016, RICE, V9, DOI 10.1186/s12284-016-0080-y; Dias ALD, 2017, CURR OPIN CLIN NUTR, V20, P470, DOI 10.1097/MCO.0000000000000417; Druka A, 2003, GENE, V302, P171, DOI 10.1016/S0378-1119(02)01105-8; Fan CC, 2005, THEOR APPL GENET, V110, P1445, DOI 10.1007/s00122-005-1975-y; Furukawa T, 2007, PLANT J, V49, P91, DOI 10.1111/j.1365-313X.2006.02958.x; Gao ZY, 2011, J INTEGR PLANT BIOL, V53, P756, DOI 10.1111/j.1744-7909.2011.01065.x; Gao ZY, 2003, SCI CHINA SER C, V46, P661, DOI 10.1360/03yc0099; Han LZ, 2006, DESCRIPTORS DATA STA, V4, P70; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ji H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34376; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim JH, 2008, MOL CELLS, V25, P312; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li JM, 2004, GENOME, V47, P697, DOI [10.1139/g04-029, 10.1139/G04-029]; Li WT, 2017, CELL, V170, P114, DOI 10.1016/j.cell.2017.06.008; Li YB, 2014, NAT GENET, V46, P398, DOI 10.1038/ng.2923; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; LITTLE RR, 1958, CEREAL CHEM, V35, P111; Maeda H, 2014, BREEDING SCI, V64, P134, DOI 10.1270/jsbbs.64.134; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer RS, 2016, NAT GENET, V48, P1083, DOI 10.1038/ng.3633; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nakamura Y, 2005, PLANT MOL BIOL, V58, P213, DOI 10.1007/s11103-005-6507-2; Phung NTP, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0747-y; Oikawa T, 2015, PLANT CELL, V27, P2401, DOI 10.1105/tpc.15.00310; Pasaniuc B, 2012, NAT GENET, V44, P631, DOI 10.1038/ng.2283; Platt A, 2010, GENETICS, V186, P1045, DOI 10.1534/genetics.110.121665; Reddy AR, 1996, PLANT MOL BIOL, V32, P735, DOI 10.1007/BF00020214; Sakamoto T, 2008, CURR OPIN PLANT BIOL, V11, P209, DOI 10.1016/j.pbi.2008.01.009; Sakamoto W, 2001, PLANT CELL PHYSIOL, V42, P982, DOI 10.1093/pcp/pce128; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1433, DOI 10.1007/s00122-003-1376-z; Shih CH, 2008, PLANTA, V228, P1043, DOI 10.1007/s00425-008-0806-1; Si LZ, 2016, NAT GENET, V48, P447, DOI 10.1038/ng.3518; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Su Y, 2011, THEOR APPL GENET, V123, P859, DOI 10.1007/s00122-011-1632-6; Sun X, 2018, J EXP BOT; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Swamy BPM, 2012, J HERED, V103, P442, DOI 10.1093/jhered/esr145; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan YF, 1999, THEOR APPL GENET, V99, P642, DOI 10.1007/s001220051279; Tian R, 2005, MOL BREEDING, V15, P117, DOI 10.1007/s11032-004-3270-z; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Tran NA, 2011, THEOR APPL GENET, V123, P519, DOI 10.1007/s00122-011-1604-x; Umemoto T, 2004, FUNCT PLANT BIOL, V31, P671, DOI 10.1071/FP04009; Wang HR, 2016, MOL PLANT, V9, P975, DOI 10.1016/j.molp.2016.04.018; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang XQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17347-5; Wang YH, 2010, PLANT J, V64, P812, DOI 10.1111/j.1365-313X.2010.04370.x; Wang ZX, 1999, PLANT J, V19, P55, DOI 10.1046/j.1365-313X.1999.00498.x; Xu WJ, 2014, NEW PHYTOL, V202, P132, DOI 10.1111/nph.12620; Yang F, 2014, MOL BREEDING, V34, P1747, DOI 10.1007/s11032-014-0135-y; Yano K, 2016, NAT GENET, V48, P927, DOI 10.1038/ng.3596	74	13	17	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196690	10.1371/journal.pone.0196690	http://dx.doi.org/10.1371/journal.pone.0196690			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746484	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700030
J	Denis, GV; Sebastiani, P; Bertrand, KA; Strissel, KJ; Tran, AH; Slama, J; Medina, ND; Andrieu, G; Palmer, JR				Denis, Gerald, V; Sebastiani, Paola; Bertrand, Kimberly A.; Strissel, Katherine J.; Tran, Anna H.; Slama, Jaromir; Medina, Nilton D.; Andrieu, Guillaume; Palmer, Julie R.			Inflammatory signatures distinguish metabolic health in African American women with obesity	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; ADIPOSE-TISSUE; BREAST-CANCER; CARDIOVASCULAR-DISEASE; ADIPOCYTE DEATH; UNITED-STATES; RISK; ADULTS; ASSOCIATION	Obesity-driven Type 2 diabetes (T2D) is a systemic inflammatory condition associated with cardiovascular disease. However, plasma cytokines and tissue inflammation that discriminate T2D risk in African American women with obese phenotypes are not well understood. We analyzed 64 circulating cytokines and chemokines in plasma of 120 African American women enrolled in the Black Women's Health Study. We used regression analysis to identify cytokines and chemokines associated with obesity, co-morbid T2D and hypertension, and compared results to obese women without these co-morbidities, as well as to lean women without the co-morbidities. We then used hierarchical clustering to generate inflammation signatures by combining the effects of identified cytokines and chemokines and summarized the signatures using an inflammation score. The analyses revealed six distinct signatures of sixteen cytokines/chemokines (P = 0.05) that differed significantly by prevalence of T2D (P = 0.004), obesity (P = 0.0231) and overall inflammation score (P < E-12). Signatures were validated in two independent cohorts of African American women with obesity: thirty nine subjects with no metabolic complications or with T2D and hypertension; and thirteen breast reduction surgical patients. The signatures in the validation cohorts closely resembled the distributions in the discovery cohort. We find that blood-based cytokine profiles usefully associate inflammation with T2D risks in vulnerable subjects, and should be combined with metabolism and obesity counselling for personalized risk assessment. Obesity-driven Type 2 diabetes (T2D) is a systemic inflammatory condition associated with cardiovascular disease. However, plasma cytokines and tissue inflammation that discriminate T2D risk in African American women with obese phenotypes are not well understood. We analyzed 64 circulating cytokines and chemokines in plasma of 120 African American women enrolled in the Black Women's Health Study. We used regression analysis to identify cytokines and chemokines associated with obesity, co-morbid T2D and hypertension, and compared results to obese women without these co-morbidities, as well as to lean women without the co-morbidities. We then used hierarchical clustering to generate inflammation signatures by combining the effects of identified cytokines and chemokines and summarized the signatures using an inflammation score. The analyses revealed six distinct signatures of sixteen cytokines/chemokines (P = 0.05) that differed significantly by prevalence of T2D (P = 0.004), obesity (P = 0.0231) and overall inflammation score (P < E-12). Signatures were validated in two independent cohorts of African American women with obesity: thirty nine subjects with no metabolic complications or with T2D and hypertension; and thirteen breast reduction surgical patients. The signatures in the validation cohorts closely resembled the distributions in the discovery cohort. We find that blood-based cytokine profiles usefully associate inflammation with T2D risks in vulnerable subjects, and should be combined with metabolism and obesity counselling for personalized risk assessment.	[Denis, Gerald, V; Strissel, Katherine J.; Tran, Anna H.; Andrieu, Guillaume] Boston Univ, Sch Med, Canc Ctr, Boston, MA 02118 USA; [Denis, Gerald, V] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Sebastiani, Paola] Boston Univ, Dept Biostat, Boston, MA 02215 USA; [Bertrand, Kimberly A.; Palmer, Julie R.] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Slama, Jaromir; Medina, Nilton D.] Boston Univ, Sch Med, Div Plast & Reconstruct Surg, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University; Boston University	Denis, GV (corresponding author), Boston Univ, Sch Med, Canc Ctr, Boston, MA 02118 USA.; Denis, GV (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.	gdenis@bu.edu		Denis, Gerald/0000-0001-9886-0401; Andrieu, Guillaume/0000-0003-0289-4952; Bertrand, Kimberly/0000-0002-4565-7618; sebastiani, paola/0000-0001-6419-1545	National Institutes of Health from the National Cancer Institute [U01 CA182898, R01 CA058420]; National Institutes of Health from the National Heart Lung and Blood Institute [R21HL128871]; Dahod Breast Cancer Research Program at Boston University School of Medicine; NATIONAL CANCER INSTITUTE [U01CA164974] Funding Source: NIH RePORTER	National Institutes of Health from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health from the National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Dahod Breast Cancer Research Program at Boston University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health: U01 CA182898 (GVD, JRP) and R01 CA058420 (JRP) from the National Cancer Institute (https://www.cancer.gov/) and R21HL128871 (PS) from the National Heart Lung and Blood Institute (https://www.nhibi.nih.gov/). KAB was supported in part by the Dahod Breast Cancer Research Program at Boston University School of Medicine (https://www.bumc.bu.edu/busm/giving/explore-our-research/cancer/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724; Akinyemiju T, 2018, OBESITY, V26, P193, DOI 10.1002/oby.22067; Andrieu G, 2016, CANCER RES, V76, P6555, DOI 10.1158/0008-5472.CAN-16-0559; Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bastien M, 2014, PROG CARDIOVASC DIS, V56, P369, DOI 10.1016/j.pcad.2013.10.016; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Bigornia SJ, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.3; Bonora E, 1998, DIABETES CARE, V21, P221, DOI 10.2337/diacare.21.2.221; Browning LM, 2008, OBESITY FACTS, V1, P259, DOI 10.1159/000169832; Cherqaoui R, 2012, J CLIN HYPERTENS, V14, P92, DOI 10.1111/j.1751-7176.2011.00565.x; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Denis GV, 2017, OBESITY, V25, P1916, DOI 10.1002/oby.21943; Denis GV, 2017, CANCER PREV RES, V10, P267, DOI 10.1158/1940-6207.CAPR-17-0083; Despres JP, 2012, J CLIN ENDOCR METAB, V97, P2283, DOI 10.1210/jc.2012-2081; Franssens BT, 2015, DIABETES CARE, V38, P1945, DOI 10.2337/dc15-0684; Frasca D, 2017, CLIN EXP IMMUNOL, V187, P64, DOI 10.1111/cei.12824; Frasca D, 2017, MECH AGEING DEV, V162, P91, DOI 10.1016/j.mad.2017.01.004; Frasca D, 2016, OBESITY, V24, P615, DOI 10.1002/oby.21383; Iyengar NM, 2017, CANCER PREV RES, V10, P235, DOI 10.1158/1940-6207.CAPR-16-0314; Johnson JA, 2001, AM J PHYSIOL-ENDOC M, V280, pE40, DOI 10.1152/ajpendo.2001.280.1.E40; Kahn SE, 2006, DIABETES, V55, P2357, DOI 10.2337/db06-0116; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Kones RRU, 1995, HOSP PRACT, V42, P92; Kranendonk MEG, 2015, ATHEROSCLEROSIS, V239, P419, DOI 10.1016/j.atherosclerosis.2015.01.035; Krishnan S, 2007, OBESITY, V15, P1860, DOI 10.1038/oby.2007.220; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Lamas O, 2002, EUR J CLIN NUTR, V56, pS42, DOI 10.1038/sj.ejcn.1601484; Marini MA, 2007, DIABETES CARE, V30, P2145, DOI 10.2337/dc07-0419; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Metcalf TU, 2015, AGING CELL, V14, P421, DOI 10.1111/acel.12320; Moore LL, 2014, CANCER EPIDEM BIOMAR, V23, P2057, DOI 10.1158/1055-9965.EPI-14-0240; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Palmer JR, 2017, CANCER RES, V77, P6462, DOI 10.1158/0008-5472.CAN-17-1903; Park YMM, 2017, INT J CANCER, V140, P2657, DOI 10.1002/ijc.30684; Perreault M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088539; Phillips CM, 2013, J CLIN ENDOCR METAB, V98, pE1610, DOI 10.1210/jc.2013-2038; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; Romano M, 2003, J CLIN ENDOCR METAB, V88, P5321, DOI 10.1210/jc.2003-030508; Rosenberg L, 1995, J Am Med Womens Assoc (1972), V50, P56; Sebastiani P, 2017, AGING CELL, V16, P329, DOI 10.1111/acel.12557; Sebastiani P, 2016, FRONT GENET, V7, DOI [10.3389/fgene.2016.00144, 10.3389/fgene.7016.00144]; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Strissel KJ, 2016, CLIN MED INSIGHTS-WO, V9, P57, DOI 10.4137/CMWH.S34698; Vasudevan AR, 2006, J CLIN ENDOCR METAB, V91, P256, DOI 10.1210/jc.2005-1280; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	51	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196755	10.1371/journal.pone.0196755	http://dx.doi.org/10.1371/journal.pone.0196755			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738558	Green Published, gold, Green Submitted			2022-12-26	WOS:000431724900015
J	Meconi, A; Wortman, RC; Wright, DK; Neale, KJ; Clarkson, M; Shultz, SR; Christie, BR				Meconi, Alicia; Wortman, Ryan C.; Wright, David K.; Neale, Katie J.; Clarkson, Melissa; Shultz, Sandy R.; Christie, Brian R.			Repeated mild traumatic brain injury can cause acute neurologic impairment without overt structural damage in juvenile rats	PLOS ONE			English	Article							SPORT-RELATED CONCUSSION; COLLEGIATE FOOTBALL PLAYERS; CLOSED-HEAD-INJURY; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; HYPERPHOSPHORYLATED TAU; POSTCONCUSSION SYNDROME; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; OXIDATIVE STRESS	Repeated concussion is becoming increasingly recognized as a serious public health concern around the world. Moreover, there is a greater awareness amongst health professionals of the potential for repeated pediatric concussions to detrimentally alter the structure and function of the developing brain. To better study this issue, we developed an awake closed head injury (ACHI) model that enabled repeated concussions to be performed reliably and reproducibly in juvenile rats. A neurological assessment protocol (NAP) score was generated immediately after each ACHI to help quantify the cumulative effects of repeated injury on level of consciousness, and basic motor and reflexive capacity. Here we show that we can produce a repeated ACHI (4 impacts in two days) in both male and female juvenile rats without significant mortality or pain. We show that both single and repeated injuries produce acute neurological deficits resembling clinical concussion symptoms that can be quantified using the NAP score. Behavioural analyses indicate repeated ACHI acutely impaired spatial memory in the Barnes maze, and an interesting sex effect was revealed as memory impairment correlated moderately with poorer NAP score performance in a subset of females. These cognitive impairments occurred in the absence of motor impairments on the Rotarod, or emotional changes in the open field and elevated plus mazes. Cresyl violet histology and structural magnetic resonance imaging (MRI) indicated that repeated ACHI did not produce significant structural damage. MRI also confirmed there was no volumetric loss in the cortex, hippocampus, or corpus callosum of animals at 1 or 7 days post-ACHI. Together these data indicate that the ACHI model can provide a reliable, high throughput means to study the effects of concussions in juvenile rats.	[Meconi, Alicia; Wortman, Ryan C.; Neale, Katie J.; Clarkson, Melissa; Shultz, Sandy R.; Christie, Brian R.] Univ Victoria, Div Med Sci, Victoria, BC, Canada; [Wright, David K.; Shultz, Sandy R.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Wright, David K.; Shultz, Sandy R.] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia; [Shultz, Sandy R.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Christie, Brian R.] Univ British Columbia, Ctr Brain Hlth, Vancouver, BC, Canada; [Christie, Brian R.] Univ British Columbia, Program Neurosci, Vancouver, BC, Canada; [Christie, Brian R.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC, Canada	University of Victoria; Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne; University of British Columbia; University of British Columbia; University of British Columbia	Christie, BR (corresponding author), Univ Victoria, Div Med Sci, Victoria, BC, Canada.; Christie, BR (corresponding author), Univ British Columbia, Ctr Brain Hlth, Vancouver, BC, Canada.; Christie, BR (corresponding author), Univ British Columbia, Program Neurosci, Vancouver, BC, Canada.; Christie, BR (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC, Canada.	brain64@uvic.ca	Christie, Brian Ross/AAF-3766-2019	Christie, Brian Ross/0000-0002-6830-0160	NSERC; CFI; Australian NHMRC; CIHR/NSERC graduate fellowships	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CFI(Canada Foundation for Innovation); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CIHR/NSERC graduate fellowships	This development of this model was supported by funding from NSERC and CFI to BRC. MRI investigations by SS were supported by the Australian NHMRC. AM, RCW, and MC were supported by CIHR/NSERC graduate fellowships.	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Brocardo PS, 2012, NEUROPHARMACOLOGY, V62, P1607, DOI 10.1016/j.neuropharm.2011.10.006; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Clough M, 2018, J NEUROTRAUM, V35, P730, DOI 10.1089/neu.2017.5204; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Ding JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063850; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Erlanger DM, 2015, BRAIN INJURY, V29, P171, DOI 10.3109/02699052.2014.965211; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Flower O, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/637171; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Gilliland J, EPIDEMIOLOGIC PROFIL, DOI [10.1097/TA.0b013e3182aafdf5, DOI 10.1097/TA.0B013E3182AAFDF5]; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hawley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030222; Hendrich KS, 2001, MAGNET RESON MED, V46, P202, DOI 10.1002/mrm.1178; Hsieh TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178186; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Jones NC, 2008, EXP NEUROL, V209, P254, DOI 10.1016/j.expneurol.2007.09.026; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Luo YW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11458-9; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2017, BRIT J SPORT MED, V47; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ricciardi MC, 2017, J NEUROTRAUM, V34, P23, DOI 10.1089/neu.2015.4338; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Rosenfeld CS, 2014, JOVE-J VIS EXP, DOI 10.3791/51194; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; TEASDALE G, 1974, LANCET, V2, P81; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; White ER, 2017, J NEUROTRAUM, V34, P1111, DOI 10.1089/neu.2016.4638; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Wright AD, 2017, BRIT J SPORT MED, V51, DOI [10.1136/bjsports-2016-097270.96, DOI 10.1136/BJSPORTS-2016-097270.96]; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Xiong Y, 2013, ANIMAL MODELS TRAUMA, V18, P1199; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	92	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0197187	10.1371/journal.pone.0197187	http://dx.doi.org/10.1371/journal.pone.0197187			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738554	gold, Green Published			2022-12-26	WOS:000431724900053
J	Yang, LH; Hu, XW; Fang, L				Yang, Longhai; Hu, Xiaowei; Fang, Lin			Carbon emissions tax policy of urban road traffic and its application in Panjin, China	PLOS ONE			English	Article							BUILT ENVIRONMENT; DIOXIDE EMISSIONS; AIR-POLLUTION; TRANSPORT; DISTANCE; IMPACTS; FUTURE; MODEL; TIME	How to effectively solve traffic congestion and transportation pollution in urban development is a main research emphasis for transportation management agencies. A carbon emissions tax can affect travelers' generalized costs and will lead to changes in passenger demand, mode choice and traffic flow equilibrium in road networks, which are of significance in green travel and low-carbon transportation management. This paper first established a mesoscopic model to calculate the carbon emissions tax and determined the value of this charge in China, which was based on road traffic flow, vehicle speed, and carbon emissions. Referring to existing research results to calibrate the value of time, this paper modified the traveler's generalized cost function, including the carbon emissions tax, fuel surcharge and travel time cost, which can be used in the travel impedance model with the consideration of the carbon emissions tax. Then, a method for analyzing urban road network traffic flow distribution was put forward, and a joint traffic distribution model was established, which considered the relationship between private cars and taxis. Finally, this paper took the city of Panjin as an example to analyze the road traffic carbon emissions tax's impact. The results illustrated that the carbon emissions tax has a positive effect on road network flow equilibrium and carbon emission reduction. This paper will have good reference value and practical significance for the calculation and implementation of urban traffic carbon emissions taxes in China.	[Yang, Longhai; Hu, Xiaowei] Harbin Inst Technol, Sch Transportat Sci & Engn, Harbin, Heilongjiang, Peoples R China; [Fang, Lin] Shanghai Municipal Planning Design Res Inst, Shanghai, Peoples R China	Harbin Institute of Technology	Hu, XW (corresponding author), Harbin Inst Technol, Sch Transportat Sci & Engn, Harbin, Heilongjiang, Peoples R China.	xiaowei_hu@hit.edu.cn		Hu, Xiaowei/0000-0002-6633-7672	National Natural Science Foundation of China [71603063]; China Postdoctoral Science Foundation [2013M540299]; Natural Science Foundation of Heilongjiang [E2016032]; Fundamental Research Funds for the Central Universities [HIT.NSRIF.2015075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Heilongjiang(Natural Science Foundation of Heilongjiang Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (Project No. 71603063), China Postdoctoral Science Foundation funded project (No. 2013M540299), Natural Science Foundation of Heilongjiang (Project No. E2016032), and the Fundamental Research Funds for the Central Universities (No. HIT.NSRIF.2015075).	Ahn KG, 2008, TRANSPORT RES D-TR E, V13, P151, DOI 10.1016/j.trd.2008.01.005; Anthonissen J, 2015, J CLEAN PROD, V102, P96, DOI 10.1016/j.jclepro.2015.04.020; Aziz HMA, 2014, TRANSPORT RES D-TR E, V32, P334, DOI 10.1016/j.trd.2014.07.016; Baranzini A, 2000, ECOL ECON, V32, P395, DOI 10.1016/S0921-8009(99)00122-6; Barnett AG, 2014, ENVIRON INT, V66, P88, DOI 10.1016/j.envint.2014.01.029; Brand C, 2012, ENERG POLICY, V41, P107, DOI 10.1016/j.enpol.2010.08.019; Bureau B, 2011, ENERG ECON, V33, P121, DOI 10.1016/j.eneco.2010.07.011; Burns LD, 2013, NATURE, V497, P181, DOI 10.1038/497181a; Chen S. F., 2004, THESIS; Ding C, 2017, CITIES, V68, P25, DOI 10.1016/j.cities.2017.05.005; Ding C, 2017, TRANSPORT RES A-POL, V100, P65, DOI 10.1016/j.tra.2017.04.008; Ding C, 2017, TRANSPORT RES D-TR E, V51, P314, DOI 10.1016/j.trd.2017.02.002; Fang Li Jiu, 2013, THESIS; Gao HO, 2008, TRANSPORT RES A-POL, V42, P1064, DOI 10.1016/j.tra.2008.03.002; Gao S., 2012, THESIS; Grote M, 2016, TRANSPORT RES D-TR E, V43, P95, DOI 10.1016/j.trd.2015.12.010; [黄晓峰 Huang Xiaofeng], 2011, [计算机仿真, Computer Simulation], V28, P339; Kan HD, 2004, ATMOS ENVIRON, V38, P95, DOI 10.1016/j.atmosenv.2003.09.038; Lam SH, 2006, TRANSPORTATION, V33, P171, DOI 10.1007/s11116-005-3049-z; Lefevre B, 2009, ENERG POLICY, V37, P940, DOI 10.1016/j.enpol.2008.10.036; Ma XL, 2013, TRANSPORT RES C-EMER, V36, P1, DOI 10.1016/j.trc.2013.07.010; Rilett L. R., 1994, TRANSPORT RES REC, V1443, P176; Roess R.P., 2004, TRAFFIC ENG; Ryu BY, 2015, TRANSPORT RES D-TR E, V34, P245, DOI 10.1016/j.trd.2014.10.012; Tseng YY, 2013, TRANSPORT RES C-EMER, V30, P196, DOI 10.1016/j.trc.2011.11.006; Wang J, 2014, SUSTAINABILITY-BASEL, V6, P676, DOI 10.3390/su6020676; Zhang B.L., 2012, THESIS	27	4	4	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196762	10.1371/journal.pone.0196762	http://dx.doi.org/10.1371/journal.pone.0196762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF1VY	29738580	Green Published, gold, Green Submitted			2022-12-26	WOS:000431724900016
J	Bai, J; Bai, F; Zhu, HB; Xue, D				Bai, Jie; Bai, Fei; Zhu, Hongbo; Xue, Di			The perceived and objectively measured effects of clinical pathways' implementation on medical care in China	PLOS ONE			English	Article							OUTCOMES; IMPACT; GUIDELINES; MANAGEMENT; SURGERY; PATIENT	Introduction Substantial resources have been expended on clinical pathways (CPs), but the reported effects of CPs on medical care vary considerably. This study sought to determine the effects of CPs on medical care in Chinese hospitals, including the perceived effects of CPs on medical care and the objectively measured patient outcomes. Methods Study data were obtained from 54 public hospitals in three provinces of China in 2015. Hospital questionnaires, employee surveys, and chart reviews were used to collect data related to hospital characteristics, the implementation of CPs and compliance status, perceived effects of CPs, and objectively measured patient outcomes. Logistic regression models and linear regression models were adopted in this study. Results The effects of CPs were not highly perceived by the hospitals or by the managers and physicians in China. The relatively low involvement in the implementation of and adherence to CPs resulted in CPs having no significant effects on hospital medical care as a whole. However, a chart review of 5 conditions in Chinese hospitals demonstrated that compliance with national CPs reduced the length of stay (LOS) and inpatient medical costs. Conclusions CPs should be implemented widely and followed closely to improve hospital medical care as a whole, and further studies should be conducted to identify the key elements of the effects of CPs on patient clinical outcomes.	[Bai, Jie; Xue, Di] Fudan Univ, Natl Hlth Commiss, Key Lab Hlth Technol Assessment, Dept Hosp Management,Sch Publ Hlth, Shanghai, Peoples R China; [Bai, Fei] Natl Hlth Commiss China, Ctr Med Serv Adm, Beijing, Peoples R China; [Zhu, Hongbo] Hlth & Family Planning Commiss Hubei Prov, Med Adm & Management, Wuhan, Hubei, Peoples R China	Fudan University	Xue, D (corresponding author), Fudan Univ, Natl Hlth Commiss, Key Lab Hlth Technol Assessment, Dept Hosp Management,Sch Publ Hlth, Shanghai, Peoples R China.	xuedi@shmu.edu.cn			National Natural Science Foundation of China [71473047]; China Medical Board-Collaborating Program in Health Technology Assessment [13-153]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Medical Board-Collaborating Program in Health Technology Assessment	This work was supported by National Natural Science Foundation of China, DX, grant number 71473047, http://www.nsfc.gov.cn/; and China Medical Board-Collaborating Program in Health Technology Assessment, DX, grant number 13-153, https://www.chinamedicalboard.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjurling-Sjoberg P, 2015, J EVAL CLIN PRACT, V21, P255, DOI 10.1111/jep.12301; [陈永聪 Chen Yongcong], 2017, [中华医院管理杂志, Chinese Journal of Hospital Administration], V33, P21; De Allegri M, 2011, BMJ QUAL SAF, V20, P203, DOI 10.1136/bmjqs.2010.042465; Duncan CM, 2013, REGION ANESTH PAIN M, V38, P533, DOI 10.1097/AAP.0000000000000014; El Baz N, 2007, J EVAL CLIN PRACT, V13, P920, DOI 10.1111/j.1365-2753.2006.00774.x; Hassaballa H, 1998, Qual Manag Health Care, V7, P13; He XY, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1121-8; Lemmens L, 2008, J EVAL CLIN PRACT, V14, P880, DOI 10.1111/j.1365-2753.2008.01079.x; Lin DX, 2011, CELL BIOCHEM BIOPHYS, V61, P413, DOI 10.1007/s12013-011-9203-7; Little A B, 1996, J Nurs Care Qual, V11, P54; Lodewijckx C, 2011, INT J NURS STUD, V48, P1445, DOI 10.1016/j.ijnurstu.2011.06.006; Mamolen NL, 2000, J BURN CARE REHABIL, V21, P440, DOI 10.1097/00004630-200021050-00010; McCallum GB, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006595.pub3; McConnell T, 2013, WORLDV EVID-BASED NU, V10, P218, DOI 10.1111/wvn.12003; Ng BJH, 2011, INTERN MED J, V41, P251, DOI 10.1111/j.1445-5994.2009.02134.x; Passot G, 2017, ANN SURG, V265, P806, DOI 10.1097/SLA.0000000000001723; Petrakis M, 2011, J EVAL CLIN PRACT, V17, P722, DOI 10.1111/j.1365-2753.2010.01548.x; Ranasinghe I, 2014, CIRC-CARDIOVASC QUAL, V7, P209, DOI 10.1161/CIRCOUTCOMES.113.000527; Ransom SB, 2003, OBSTET GYNECOL, V101, P751, DOI 10.1016/S0029-7844(02)03129-0; Richter-Ehrenstein C, 2012, ARCH GYNECOL OBSTET, V285, P515, DOI 10.1007/s00404-011-1994-7; Ronellenfitsch U, 2008, LANGENBECK ARCH SURG, V393, P449, DOI 10.1007/s00423-008-0303-9; Rotter T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006632.pub2; Saint S, 2003, AM J MANAG CARE, V9, P758; Xia JL, 2017, CHINESE HOSP MANAGEM, P37; Zhang M, 2014, HEPATOB PANCREAT DIS, V13, P348, DOI 10.1016/S1499-3872(14)60279-4; Zheng XF, 2014, J EVAL CLIN PRACT, V20, P288, DOI 10.1111/jep.12127; Zuckermann J, 2008, ANN HEMATOL, V87, P139, DOI 10.1007/s00277-007-0390-7	27	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0196776	10.1371/journal.pone.0196776	http://dx.doi.org/10.1371/journal.pone.0196776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734350	gold, Green Published, Green Submitted			2022-12-26	WOS:000431481700026
J	Goto, I; Okamoto, R; Hashizume, R; Suzuki, N; Ito, R; Yamanaka, K; Saito, H; Kiyonari, H; Tawara, I; Kageyama, Y; Ogiharal, Y; Ali, Y; Yamada, N; Katayama, N; Ito, M				Goto, Itaru; Okamoto, Ryuji; Hashizume, Ryotaro; Suzuki, Noboru; Ito, Rie; Yamanaka, Keiichi; Saito, Hiromitsu; Kiyonari, Hiroshi; Tawara, Isao; Kageyama, Yuki; Ogiharal, Yoshito; Ali, Yusuf; Yamada, Norikazu; Katayama, Naoyuki; Ito, Masaaki			Renal papillary tip extract stimulates BNP production and excretion from cardiomyocytes	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; CARDIAC-HYPERTROPHY; INTERSTITIAL-CELLS; HEART DEVELOPMENT; HYPERTENSION; ACTIVATION; DISEASE; GENE; FAILURE; SYSTEM	Background Brain natriuretic peptide (BNP) is an important biomarker for patients with cardiovascular diseases, including heart failure, hypertension and cardiac hypertrophy. It is also known that BNP levels are relatively higher in patients with chronic kidney disease and no heart disease; however, the mechanism remains unclear. Methods and results We developed a BNP reporter mouse and occasionally found that this promoter was activated specifically in the papillary tip of the kidneys, and its activation was not accompanied by BNP mRNA expression. No evidence was found to support the existence of BNP isoforms or other nucleotide expression apart from BNP and tdTomato. The pBNP-tdTomato-positive cells were interstitial cells and were not proliferative. Unexpectedly, both the expression and secretion of BNP increased in primary cultured neonatal cardiomyocytes after their treatment with an extract of the renal papillary tip. Intraperitoneal injection of the extract of the papillary tips reduced blood pressure from 210 mmHg to 165 mmHg, the decrease being accompanied by an increase in serum BNP and urinary cGMP production in stroke-prone spontaneously hypertensive (SHR-SP) rats. Furthermore the induction of BNP by the papillary extract from rats with heart failure due to myocardial infarction was increased in cardiomyocytes. Conclusions These results suggested that the papillary tip express a substance that can stimulate BNP production and secretion from cardiomyocytes.	[Goto, Itaru; Okamoto, Ryuji; Ito, Rie; Ogiharal, Yoshito; Ali, Yusuf; Yamada, Norikazu; Ito, Masaaki] Mie Univ, Dept Cardiol & Nephrol, Grad Sch Med, Tsu, Mie, Japan; [Hashizume, Ryotaro] Mie Univ, Grad Sch Med, Dept Pathol & Matrix Biol, Tsu, Mie, Japan; [Suzuki, Noboru; Saito, Hiromitsu] Mie Univ, Funct Genom Inst, Dept Anim Genom, Life Sci Res Ctr, Tsu, Mie, Japan; [Yamanaka, Keiichi] Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie, Japan; [Kiyonari, Hiroshi] RIKEN Ctr Life Sci Technol, Anim Resource Dev Unit, Kobe, Hyogo, Japan; [Kiyonari, Hiroshi] RIKEN Ctr Life Sci Technol, Genet Engn Team, Kobe, Hyogo, Japan; [Tawara, Isao; Kageyama, Yuki; Katayama, Naoyuki] Mie Univ, Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie, Japan	Mie University; Mie University; Mie University; Mie University; RIKEN; RIKEN; Mie University	Okamoto, R (corresponding author), Mie Univ, Dept Cardiol & Nephrol, Grad Sch Med, Tsu, Mie, Japan.	ryuji@clin.medic.mie-u.ac.jp	Kageyama, Yuki/AAD-1098-2020	Kageyama, Yuki/0000-0002-0564-2227; Hashizume, Ryotaro/0000-0002-9237-029X; Ali, Yusuf/0000-0003-0753-3590	Ministry of Education, Culture, Sports, Science and Technology, Japan [24591113]; Japan Vascular Disease Research Foundation; Mie Medical Foundation; Okasan-Kato Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Vascular Disease Research Foundation(Japan Vascular Disease Research Foundation); Mie Medical Foundation; Okasan-Kato Foundation	This work is supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 24591113 to R.O.), the Japan Vascular Disease Research Foundation, the Mie Medical Foundation and the Okasan-Kato Foundation (to R.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belluardo P, 2006, AM J PHYSIOL-HEART C, V291, pH1529, DOI 10.1152/ajpheart.00107.2006; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; Glodny B, 2006, ACTA PHYSIOL, V187, P419, DOI 10.1111/j.1748-1716.2006.01578.x; He Q, 2002, AM J PHYSIOL-ENDOC M, V283, pE50, DOI 10.1152/ajpendo.00274.2001; KOHNO M, 1995, AM J MED, V98, P257, DOI 10.1016/S0002-9343(99)80372-6; Koivisto E, 2011, CAN J PHYSIOL PHARM, V89, P539, DOI [10.1139/Y11-049, 10.1139/y11-049]; Koivisto E, 2011, MOL CELL ENDOCRINOL, V338, P18, DOI 10.1016/j.mce.2011.02.015; LaPointe MC, 2005, PEPTIDES, V26, P944, DOI 10.1016/j.peptides.2004.08.028; Macheret F, 2012, J AM COLL CARDIOL, V60, P1558, DOI 10.1016/j.jacc.2012.05.049; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Minami H, 2017, J IMMUNOL, V199, P2343, DOI 10.4049/jimmunol.1700054; Mizutani H, 2010, CIRC J, V74, P120, DOI 10.1253/circj.CJ-09-0462; MUIRHEAD EE, 1993, J HYPERTENS, V11, pS53; Nelson DM, 2014, BIOMACROMOLECULES, V15, P1, DOI 10.1021/bm4010639; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Nishikimi T, 2011, J CARDIOL, V57, P131, DOI 10.1016/j.jjcc.2011.01.002; Okamoto R, 2013, FASEB J, V27, P1439, DOI 10.1096/fj.12-217018; Peter Libby ROB, 2007, BRAUNWALDS HEART DIS; PITCOCK JA, 1981, HYPERTENSION, V3, P75, DOI 10.1161/01.HYP.3.6_Pt_2.II-75; RITTER D, 1995, KIDNEY INT, V48, P1758, DOI 10.1038/ki.1995.474; Schuttert JB, 2002, KIDNEY INT, V61, P1407, DOI 10.1046/j.1523-1755.2002.00285.x; Sergeeva IA, 2014, CARDIOVASC RES, V101, P78, DOI 10.1093/cvr/cvt228; Sergeeva IA, 2013, BBA-MOL BASIS DIS, V1832, P2403, DOI 10.1016/j.bbadis.2013.07.003; Taniguchi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141130; Thomas CJ, 1996, CLIN EXP PHARMACOL P, V23, P777, DOI 10.1111/j.1440-1681.1996.tb01179.x; Zakeri R, 2015, CLIN CHIM ACTA, V443, P108, DOI 10.1016/j.cca.2014.12.009	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0197078	10.1371/journal.pone.0197078	http://dx.doi.org/10.1371/journal.pone.0197078			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734386	Green Published, gold, Green Submitted			2022-12-26	WOS:000431481700045
J	Yang, HY; Tian, SH; Flamand-Roze, C; Gao, L; Zhang, W; Li, Y; Wang, JJ; Sun, Z; Su, Y; Zhao, LB; Liang, ZH				Yang, Hongyan; Tian, Shenghua; Flamand-Roze, Constance; Gao, Ling; Zhang, Wei; Li, Yan; Wang, Jiajia; Sun, Zhou; Su, Ying; Zhao, Libin; Liang, Zhihou			A Chinese version of the Language Screening Test (CLAST) for early-stage stroke patients	PLOS ONE			English	Article							APHASIA; VALIDATION; REHABILITATION; BATTERY; TOOL	There is a severe lack of aphasia screening tools for bedside use in Chinese. A number of aphasia assessment tools have recently been developed abroad, but some of these scales were not suitable for patients with acute stroke. The Language Screening Test (which includes two parallel versions [a/b]) in French has been proven to be an effective and time-saving aphasia screening scale for early-stage stroke patients. Therefore, we worked out a Chinese version of the LAST taking into consideration Chinese language and culture. Two preliminary parallel versions (a/b) were tested on 154 patients with stroke at acute phase and 107 patients with stroke at non-acute phase, with the Western Aphasia Battery serving as a gold standard. The equivalence between the two parallel versions and the reliability/validity of each version were assessed. The median time to complete one preliminary Chinese version (each had some item redundancy) was 98 seconds. Two final parallel versions were established after adjustment/elimination of the redundant items and were found to be equivalent (intra-class correlation coefficient: 0.991). Internal consistency is(Cronbach a for each version [a/b] was 0.956 and 0.965, respectively) good. Internal validity was fine: (a) no floor or ceiling effect/item redundancy; (b) construct validity revealed a 1-dimension structure, just like the French version. The higher educated subjects scored higher than their lower educated counterparts (p<0.01). The external validity: at the optimum cut-off point where the score of version a/b <14 in higher educated group(<13 in lower): the specificity of each version was 0.878/0.902(1/1 in lower) and sensitivity was 0.972/0.944(0.944/0.944 in lower). Inter-rater equivalence (intraclass correlation coefficient) was 1. The Chinese version of the Language Screening Test was proved to be an efficient and time-saving bedside aphasia screening tool for stroke patients at acute phase and can be used by an average medical physician.	[Yang, Hongyan; Gao, Ling; Sun, Zhou; Su, Ying; Liang, Zhihou] Huazhong Sci & Technol Univ, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan, Hubei, Peoples R China; [Tian, Shenghua] Huazhong Sci Technol Univ, Union Hosp, Tongji Med Coll, Dept Endocrinol, Wuhan, Hubei, Peoples R China; [Flamand-Roze, Constance] Ctr Hosp Sud Francilien, Dept Neurol, Corbeil Essonnes, France; [Zhang, Wei] Shanxi Med Univ, Affiliated Hosp 1, Dept Neurol, Taiyuan, Shanxi, Peoples R China; [Li, Yan] Zhengzhou Univ, Luoyang Cent Hosp, Dept Neurol, Luoyang, Henan, Peoples R China; [Wang, Jiajia] Binzhou Peoples Hosp, Dept Neurol, Binzhou, Shandong, Peoples R China; [Zhao, Libin] Maternal & Child Hlth Hosp Baoan Dist, Dept Anesthesia, Shenzhen, Guangdong, Peoples R China; [Yang, Hongyan] Shenzhen Peoples Hosp, Dept Neurol, Longhua Branch, Shenzhen, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Centre Hospitalier Sud Francilien; Shanxi Medical University; Zhengzhou University; Jinan University	Liang, ZH (corresponding author), Huazhong Sci & Technol Univ, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan, Hubei, Peoples R China.	zhihouliang@msn.com						AlKhawaja I, 1996, J NEUROL, V243, P201, DOI 10.1007/BF02444015; Azuar C, 2013, J NEUROL, V260, P2110, DOI 10.1007/s00415-013-6943-x; Bishara AJ, 2012, PSYCHOL METHODS, V17, P399, DOI 10.1037/a0028087; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; CRARY MA, 1989, J SPEECH HEAR DISORD, V54, P163, DOI 10.1044/jshd.5402.163; de Winter JCF, 2009, MULTIVAR BEHAV RES, V44, P147, DOI 10.1080/00273170902794206; Enderby P M, 1987, Int Rehabil Med, V8, P166; Flamand-Roze C, 2011, STROKE, V42, P1224, DOI 10.1161/STROKEAHA.110.609503; Flowers HL, 2013, J COMMUN DISORD, V46, P238, DOI 10.1016/j.jcomdis.2013.04.001; Godecke E, 2012, INT J STROKE, V7, P635, DOI 10.1111/j.1747-4949.2011.00631.x; Godecke E, 2014, INT J LANG COMM DIS, V49, P149, DOI 10.1111/1460-6984.12074; Godecke E, 2013, SEMIN SPEECH LANG, V34, P129, DOI 10.1055/s-0033-1358369; Goodglass H, 1972, ASSESSMENT APHASIA R, Vvii; Goodglass H, 1983, ASSESSMENT APHASIA R, Vvii; Ionan AC, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-121; Kang H, 2013, J KOREAN ACAD NURS, V43, P587, DOI 10.4040/jkan.2013.43.5.587; Kim H, 2011, EUR NEUROL, V65, P113, DOI 10.1159/000324036; Koenig-Bruhin M, 2016, CEREBROVASC DIS EXTR, V6, P27, DOI 10.1159/000445778; Kostalova M, 2008, BRAIN INJURY, V22, P793, DOI 10.1080/02699050802372190; Nakase-Thompson R, 2005, BRAIN INJURY, V19, P685, DOI 10.1080/02699050400025331; Robin F, 2006, CAN J EXP PSYCHOL, V60, P221, DOI 10.1037/cjep2006021; Romero M, 2012, NEUROLOGIA, V27, P216, DOI 10.1016/j.nrl.2011.06.006; Sabe L, 2008, REV NEUROLOGIA, V46, P454, DOI 10.33588/rn.4608.2007509; Salter K, 2006, BRAIN INJURY, V20, P559, DOI 10.1080/02699050600744087; SHEWAN CM, 1980, J SPEECH HEAR DISORD, V45, P308, DOI 10.1044/jshd.4503.308; Sinanovic O, 2011, ACTA CLIN CROAT, V50, P79; Thommessen B, 1999, DISABIL REHABIL, V21, P110, DOI 10.1080/096382899297846; ZWEIG MH, 1993, CLIN CHEM, V39, P561	28	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2018	13	5							e0196646	10.1371/journal.pone.0196646	http://dx.doi.org/10.1371/journal.pone.0196646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE7ZR	29727462	Green Published, gold, Green Submitted			2022-12-26	WOS:000431452100007
J	Dai, JY; Chen, D; Wu, SQ; Wu, XF; Gao, G; Tang, XM; Shao, KQ; Lv, XY; Xue, WY; Yang, QQ; Zhu, SL				Dai, Jiangyu; Chen, Dan; Wu, Shiqiang; Wu, Xiufeng; Gao, Guang; Tang, Xiangming; Shao, Keqiang; Lv, Xueyan; Xue, Wanyun; Yang, Qianqian; Zhu, Senlin			Dynamics of phosphorus and bacterial phoX genes during the decomposition of Microcystis blooms in a mesocosm	PLOS ONE			English	Article							BACTERIOPLANKTON COMMUNITY COMPOSITION; EUTROPHIC LAKE TAIHU; FRESH-WATER LAKES; PHOSPHATASE; SHALLOW; PROGRAM; INPUTS; TAXA	Cyanobacterial blooms are a worldwide environmental problem and frequently occur in eutrophic lakes. Organophosphorus mineralization regulated by microbial alkaline phosphatase provides available nutrients for bloom regeneration. To uncover the dynamics of bacterial alkaline phosphatase activity and microbial backgrounds in relation to organophosphorus mineralization during the decomposition process of cyanobacterial blooms, the response of alkaline phosphatase PhoX-producing bacteria were explored using a 23-day mesocosm experiment with three varying densities of Microcystis biomass from eutrophic Lake Taihu. Our study found large amounts of soluble reactive phosphorus and dissolved organophosphorus were released into the lake water during the decomposition process. Bacterial alkaline phosphatase activity showed the peak values during days 5-7 in groups with different chlorophyll-a densities, and then all decreased dramatically to their initial experimental levels during the last stage of decomposition. Bacterial phoXabundances in the three experimental groups increased significantly along with the decomposition process, positively related to the dissolved organic carbon and organophosphorus released by the Microcystis blooms. The genotypes similar to the phoXgenes of Alphaproteobacteria were dominant in all groups, whereas the genotypes most similar to the phoXgenes of Betaproteobacteria and Cyanobacteria were also abundant in the low density (similar to 15 pg L-1 chlorophyll -a) group. At the end of the decomposition process, the number of genotypes most similar to the phoX of Betaproteobacteria and Cyanobacteria increased in the medium (similar to 150 pg L-1 chlorophyll-a) and high (1500 pg L-1 chlorophyll-a) density groups. The released organophosphorus and increased bacterial phoX abundance after decomposition of Microcystis aggregates could potentially provide sufficient nutrients and biological conditions for algal proliferation and are probably related to the regeneration of Microcystis blooms in eutrophic lakes.	[Dai, Jiangyu; Wu, Shiqiang; Wu, Xiufeng; Xue, Wanyun; Yang, Qianqian; Zhu, Senlin] Nanjing Hydraul Res Inst, State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China; [Chen, Dan] Nanjing Guohuan Sci & Technol Co Ltd, Nanjing Inst Environm Sci, MEP, Nanjing, Jiangsu, Peoples R China; [Gao, Guang; Tang, Xiangming; Shao, Keqiang] Chinese Acad Sci, Nanjing Inst Limnol & Geog, Nanjing, Jiangsu, Peoples R China; [Lv, Xueyan] Jiangsu Environm Monitoring Ctr, Nanjing, Jiangsu, Peoples R China	Nanjing Hydraulic Research Institute; Chinese Academy of Sciences	Dai, JY (corresponding author), Nanjing Hydraul Res Inst, State Key Lab Hydrol Water Resources & Hydraul En, Nanjing, Jiangsu, Peoples R China.	jydai@nhri.cn	Tang, Xiangming/ABG-7095-2021	Tang, Xiangming/0000-0002-2816-1004; xue, wanyun/0000-0001-5724-0951	National Key R&D Program of China [2016YFC0401506]; Program of International S&T Cooperation of China [2015DFA01000]; Projects of National Natural Science Foundation of China [51679146, 51479120, 51479121]; Special Research Fund of Nanjing Hydraulic Research Institute [Y117009]	National Key R&D Program of China; Program of International S&T Cooperation of China; Projects of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Research Fund of Nanjing Hydraulic Research Institute	This work was jointly funded by the National Key R&D Program of China (2016YFC0401506), the Program of International S&T Cooperation of China (2015DFA01000), the Projects of National Natural Science Foundation of China (51679146; 51479120; 51479121), and the Special Research Fund of Nanjing Hydraulic Research Institute (Y117009).; This work was jointly funded by the National Key R&D Program of China (2016YFC0401506), the Program of International S&T Cooperation of China (2015DFA01000), the Projects of National Natural Science Foundation of China (51679146; 51479120; 51479121), and the Special Research Fund of Nanjing Hydraulic Research Institute (Y117009). Finally, we are grateful to the anonymous reviewers for their constructive comments and helpful suggestions.	Braak TC, 2002, CANOCO WINDOWS 4 5 B; Callieri C, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw154; Callieri Cristiana, 2002, Journal of Limnology, V61, P1; Chuai XM, 2011, ECOL ENG, V37, P842, DOI 10.1016/j.ecoleng.2011.01.001; Dai JY, 2015, CAN J MICROBIOL, V61, P227, DOI 10.1139/cjm-2014-0446; Dai JY, 2014, CAN J MICROBIOL, V60, P167, DOI 10.1139/cjm-2013-0755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Gagala I, 2014, MICROB ECOL, V67, P465, DOI 10.1007/s00248-013-0303-3; Gao G, 2006, SCI CHINA SER D, V49, P176, DOI 10.1007/s11430-006-8117-5; Gorley C.K., 2006, GETTING STARTED PRIM; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hutalle-Schmelzer KML, 2010, MICROB ECOL, V60, P462, DOI 10.1007/s00248-010-9639-0; Ji NN, 2017, SCI TOTAL ENVIRON, V601, P1544, DOI 10.1016/j.scitotenv.2017.05.265; Jin X., 1990, STANDARD METHODS OBS; Kathuria S, 2011, ENVIRON MICROBIOL, V13, P74, DOI 10.1111/j.1462-2920.2010.02310.x; Khodse VB, 2011, AQUAT MICROB ECOL, V64, P299, DOI 10.3354/ame01529; Li HB, 2012, FEMS MICROBIOL ECOL, V79, P773, DOI 10.1111/j.1574-6941.2011.01262.x; Li HB, 2011, WATER RES, V45, P1702, DOI 10.1016/j.watres.2010.11.011; Liu YQ, 2013, GEOMICROBIOL J, V30, P17, DOI 10.1080/01490451.2011.638700; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu R.K., 1999, ANAL METHODS SOIL AG, P85; Luo HW, 2009, P NATL ACAD SCI USA, V106, P21219, DOI 10.1073/pnas.0907586106; Mahmoudi N, 2017, ENVIRON MICROBIOL, V19, P2629, DOI 10.1111/1462-2920.13745; McMahon KD, 2013, ANNU REV MICROBIOL, V67, P199, DOI 10.1146/annurev-micro-092412-155713; Muylaert K, 2002, APPL ENVIRON MICROB, V68, P4740, DOI 10.1128/AEM.68.10.4740-4750.2002; Paerl HW, 2013, MICROB ECOL, V65, P995, DOI 10.1007/s00248-012-0159-y; Paerl HW, 2011, WATER RES, V45, P1973, DOI 10.1016/j.watres.2010.09.018; Pinhassi J, 2004, APPL ENVIRON MICROB, V70, P6753, DOI 10.1128/AEM.70.11.6753-6766.2004; Qin BQ, 2015, J HAZARD MATER, V287, P356, DOI 10.1016/j.jhazmat.2015.01.047; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; Ragot SA, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fiw212; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sebastian M, 2009, ISME J, V3, P563, DOI 10.1038/ismej.2009.10; Shao KQ, 2014, SCI TOTAL ENVIRON, V488, P236, DOI [10.1016/j.scitotenv2014.04.101, 10.1016/j.scitotenv.2014.04.101]; Shao KQ, 2013, J BASIC MICROB, V53, P549, DOI 10.1002/jobm.201100532; Shi K, 2015, ENVIRON SCI TECHNOL, V49, P6448, DOI 10.1021/es505901a; Song CL, 2006, SCI CHINA SER D, V49, P102, DOI 10.1007/s11430-006-8110-z; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tang XM, 2009, MICROB ECOL, V58, P307, DOI 10.1007/s00248-008-9482-8; Valdespino-Castillo PM, 2014, FEMS MICROBIOL ECOL, V90, P504, DOI 10.1111/1574-6941.12411; Van der Gucht K, 2005, FEMS MICROBIOL ECOL, V53, P205, DOI 10.1016/j.femsec.2004.12.006; VINCENT WF, 2000, MICROBIAL BIOSYSTEMS; White AE, 2009, P NATL ACAD SCI USA, V106, P21013, DOI 10.1073/pnas.0912475107; Wu QL, 2007, ENVIRON MICROBIOL, V9, P2765, DOI 10.1111/j.1462-2920.2007.01388.x; Xing P, 2011, ISME J, V5, P792, DOI 10.1038/ismej.2010.176; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; Yuanyuan W, 2008, J ENVIRON SCI-CHINA, V20, P891, DOI 10.1016/S1001-0742(08)62143-9; Zeng J, 2012, APPL ENVIRON MICROB, V78, P177, DOI 10.1128/AEM.05117-11; Zhang XJ, 2011, APPL MICROBIOL BIOT, V91, P425, DOI 10.1007/s00253-011-3296-1; Zhou J, 2016, HARMFUL ALGAE, V55, P213, DOI 10.1016/j.hal.2016.03.016; Zhou Q., 2013, STUDY CHARACTERISTIC; Zhou YL, 2015, J HAZARD MATER, V287, P7, DOI 10.1016/j.jhazmat.2015.01.036; Zwart G, 2005, ENVIRON MICROBIOL, V7, P365, DOI 10.1111/j.1462-2920.2005.00715.x	55	8	10	9	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0195205	10.1371/journal.pone.0195205	http://dx.doi.org/10.1371/journal.pone.0195205			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723219	gold, Green Published, Green Submitted			2022-12-26	WOS:000431305100003
J	Stretch, C; Aubin, JM; Mickiewicz, B; Leugner, D; Almanasra, T; Tobola, E; Salazar, S; Sutherland, FR; Ball, CG; Dixon, E; Vogel, HJ; Damaraju, S; Baracos, VE; Bathe, OF				Stretch, Cynthia; Aubin, Jean-Michel; Mickiewicz, Beata; Leugner, Derek; Almanasra, Tariq; Tobola, Elizabeth; Salazar, Santiago; Sutherland, Francis R.; Ball, Chad G.; Dixon, Elijah; Vogel, Hans J.; Damaraju, Sambasivario; Baracos, Vickie E.; Bathe, Oliver F.			Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas	PLOS ONE			English	Article							MUSCLE RADIATION ATTENUATION; SKELETAL-MUSCLE; CANCER-PATIENTS; HEPATOCELLULAR-CARCINOMA; INSULIN-RESISTANCE; FRAILTY INDEX; IMPACT; RESECTION; OUTCOMES; SURVIVAL	Introduction Pancreatic and periampullary adenocarcinomas are associated with abnormal body composition visible on CT scans, including low muscle mass (sarcopenia) and low muscle radio-density due to fat infiltration in muscle (myosteatosis). The biological and clinical correlates to these features are poorly understood. Methods Clinical characteristics and outcomes were studied in 123 patients who underwent pancreaticoduodenectomy for pancreatic or non-pancreatic periampullary adenocarcinoma and who had available preoperative CT scans. In a subgroup of patients with pancreatic cancer (n = 29), rectus abdominus muscle mRNA expression was determined by cDNA microarray and in another subgroup (n = 29) H-1-NMR spectroscopy and gas chromatography-mass spectrometry were used to characterize the serum metabolome. Results Muscle mass and radiodensity were not significantly correlated. Distinct groups were identified: sarcopenia (40.7%), myosteatosis (25.2%), both (11.4%). Fat distribution differed in these groups; sarcopenia associated with lower subcutaneous adipose tissue (P<0.0001) and myosteatosis associated with greater visceral adipose tissue (P<0.0001). Sarcopenia, myosteatosis and their combined presence associated with shorter survival, Log Rank P = 0.005, P = 0.06, and P = 0.002, respectively. In muscle, transcriptomic analysis suggested increased inflammation and decreased growth in sarcopenia and disrupted oxidative phosphorylation and lipid accumulation in myosteatosis. In the circulating metabolome, metabolites consistent with muscle catabolism associated with sarcopenia. Metabolites consistent with disordered carbohydrate metabolism were identified in both sarcopenia and myosteatosis. Discussion Muscle phenotypes differ clinically and biologically. Because these muscle phenotypes are linked to poor survival, it will be imperative to delineate their pathophysiologic mechanisms, including whether they are driven by variable tumor biology or host response.	[Stretch, Cynthia; Bathe, Oliver F.] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Aubin, Jean-Michel; Leugner, Derek; Tobola, Elizabeth; Salazar, Santiago; Sutherland, Francis R.; Ball, Chad G.; Dixon, Elijah; Bathe, Oliver F.] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Mickiewicz, Beata; Almanasra, Tariq; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada; [Damaraju, Sambasivario] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Damaraju, Sambasivario; Baracos, Vickie E.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Alberta; University of Alberta	Bathe, OF (corresponding author), Univ Calgary, Dept Oncol, Calgary, AB, Canada.; Bathe, OF (corresponding author), Univ Calgary, Dept Surg, Calgary, AB, Canada.	bathe@ucalgary.ca		Stretch, Cynthia/0000-0002-5152-2728	Alberta Innovates; Canadian Institutes of Health Research; Alberta Cancer Foundation; Alberta Innovates [201610142] Funding Source: researchfish	Alberta Innovates; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; Alberta Innovates	Funded by Alberta Innovates (CS), Canadian Institutes of Health Research (VEB), Alberta Cancer Foundation (VEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini N, 2015, J GASTROINTEST SURG, V19, P1593, DOI 10.1007/s11605-015-2835-y; Antoun S, 2013, CANCER-AM CANCER SOC, V119, P3377, DOI 10.1002/cncr.28218; Aubrey J, 2014, ACTA PHYSIOL, V210, P489, DOI 10.1111/apha.12224; Buettner S, 2016, J AM COLL SURGEONS, V222, P397, DOI 10.1016/j.jamcollsurg.2015.12.020; Carrara G, 2017, CLIN NUTR, V36, P1649, DOI 10.1016/j.clnu.2016.10.014; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Honors MA, 2012, J CACHEXIA SARCOPENI, V3, P5, DOI 10.1007/s13539-011-0051-5; Incio J, 2016, CANCER DISCOV, V6, P852, DOI 10.1158/2159-8290.CD-15-1177; Joglekar S, 2015, J SURG ONCOL, V111, P771, DOI 10.1002/jso.23862; Kaibori M, 2015, J GASTROINTEST SURG, V19, P1315, DOI 10.1007/s11605-015-2838-8; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; Kawamura Y, 2008, J GASTROEN HEPATOL, V23, P1739, DOI 10.1111/j.1440-1746.2008.05436.x; Komura T, 2007, AM J GASTROENTEROL, V102, P1939, DOI 10.1111/j.1572-0241.2007.01354.x; Kumar A, 2016, GYNECOL ONCOL, V142, P311, DOI 10.1016/j.ygyno.2016.05.027; McConnell YJ, 2017, METABOLITES, V7, DOI 10.3390/metabo7010003; Miljkovic I, 2013, OBESITY, V21, P2118, DOI 10.1002/oby.20346; Miljkovic I, 2010, CURR OPIN CLIN NUTR, V13, P260, DOI 10.1097/MCO.0b013e328337d826; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Ninomiya G, 2017, INT J SURG, V39, P45, DOI 10.1016/j.ijsu.2017.01.075; Nishida Y, 2016, J GASTROINTEST SURG, V20, P1586, DOI 10.1007/s11605-016-3146-7; NOY A, 1994, J CLIN ENDOCR METAB, V79, P1223, DOI 10.1210/jc.79.5.1223; Okumura S, 2016, SURGERY, V159, P821, DOI 10.1016/j.surg.2015.08.047; Okumura S, 2015, SURGERY, V157, P1088, DOI 10.1016/j.surg.2015.02.002; Pecorelli N, 2016, BRIT J SURG, V103, P434, DOI 10.1002/bjs.10063; Peng P, 2012, J GASTROINTEST SURG, V16, P1478, DOI 10.1007/s11605-012-1923-5; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Rollins KE, 2016, CLIN NUTR, V35, P1103, DOI 10.1016/j.clnu.2015.08.005; Sabel MS, 2011, ANN SURG ONCOL, V18, P3579, DOI 10.1245/s10434-011-1976-9; Sandini M, 2016, NUTRITION, V32, P1231, DOI 10.1016/j.nut.2016.04.002; Scarborough JE, 2015, ANN SURG, V261, P432, DOI 10.1097/SLA.0000000000000767; Sepehri A, 2014, J THORAC CARDIOV SUR, V148, P3110, DOI 10.1016/j.jtcvs.2014.07.087; Stephens NA, 2011, J CACHEXIA SARCOPENI, V2, P111, DOI 10.1007/s13539-011-0030-x; Stretch C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065380; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Uppal S, 2015, GYNECOL ONCOL, V137, P98, DOI 10.1016/j.ygyno.2015.01.532; van Dijk DPJ, 2017, J CACHEXIA SARCOPENI, V8, P317, DOI 10.1002/jcsm.12155; van Vugt JLA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186547; Wesseltoft-Rao N, 2015, NUTR CANCER, V67, P472, DOI 10.1080/01635581.2015.1004728; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011	41	67	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196235	10.1371/journal.pone.0196235	http://dx.doi.org/10.1371/journal.pone.0196235			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723245	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100019
J	Calasans, TAS; Souza, GTR; Melo, CM; Madi, RR; Jeraldo, VDS				Soledade Calasans, Taissa Alice; Rangel Souza, Geza Thais; Melo, Claudia Moura; Madi, Rubens Riscala; Sierpe Jeraldo, Veronica de Lourdes			Socioenvironmental factors associated with Schistosoma mansoni infection and intermediate hosts in an urban area of northeastern Brazil	PLOS ONE			English	Article							BIOMPHALARIA-GLABRATA; PERNAMBUCO; TRANSMISSION; STATE; POPULATION	Schistosomiasis, which is caused by trematodes of the genus Schistosoma and by the species Schistosoma mansoni in Brazil, is transmitted primarily by Biomphalaria glabrata mollusks. Infections occur in humans and mollusks in freshwater environments contaminated with feces from infected humans. This study aimed to evaluate potential foci of schistosomiasis based on the identification of infection sites for the snails, factors that increased the human infection probability of S. mansoni infection, and the relationship of the disease with abiotic, biotic, and sociocultural factors. The study was conducted in an urban area on the northeast coast of Brazil; this location was chosen based on the following factors: the presence of B. glabrata, nearby freshwater, and the absence of sewer treatment. A parasitological analysis was performed to evaluate infections of the mollusks and residents inside the perimeter defined by the collection points. Questionnaires were applied to obtain demographic data and to identify behaviors that led to human infection. To verify the contamination of freshwater by human feces, a microbiological analysis of the water was performed at the mollusk collection points to determine the rate of contamination with fecal coliforms. A total of 10,270 B. glabrata mollusks were collected between August 2013 and August 2014, of which 8.8% were positive for S. mansoni; the prevalence ranged from 0 to 34.5% over the study period. A total of 232 coprological samples from the residents were analyzed. The S. mansoni infection prevalence rate was 16.4%, and the S. mansoni parasitic load in the infected residents was 54.9 eggs per gram of feces on average. Males were more affected by the parasite, especially in the 8-17-year-old age range. Thermotolerant coliforms were observed at the mollusk collection sites, which indicated that freshwater and sewage were in continuous contact. This contamination indicated poor sanitary conditions, as was previously observed, which could be combined with detrimental behavior due to the residents' habits. These conditions cause a predisposition for both intermediate and definitive infections of the hosts by creating a socioenvironmental scenario that is conducive to the formation and maintenance of potential schistosomiasis foci. This and similar areas deserve special attention from the government with an aim of improving sanitation services and local resident knowledge to prevent future contamination.	[Soledade Calasans, Taissa Alice; Melo, Claudia Moura; Sierpe Jeraldo, Veronica de Lourdes] Inst Technol & Res, Lab Infect & Parasit Dis, Aracaju, Sergipe, Brazil; [Soledade Calasans, Taissa Alice; Melo, Claudia Moura; Madi, Rubens Riscala; Sierpe Jeraldo, Veronica de Lourdes] Univ Tiradentes, Grad Program Hlth & Environm, Aracaju, Sergipe, Brazil; [Rangel Souza, Geza Thais; Madi, Rubens Riscala] Inst Technol & Res, Trop Biol Lab, Aracaju, Sergipe, Brazil; [Rangel Souza, Geza Thais] Fed Inst Sao Paulo, Avare, SP, Brazil	Universidade Tiradentes; Instituto Federal de Sao Paulo (IFSP)	Calasans, TAS (corresponding author), Inst Technol & Res, Lab Infect & Parasit Dis, Aracaju, Sergipe, Brazil.; Calasans, TAS (corresponding author), Univ Tiradentes, Grad Program Hlth & Environm, Aracaju, Sergipe, Brazil.	taissa.asc@gmail.com	Jeraldo, Verónica VL/M-7033-2017; Madi, Rubens Riscala/I-7692-2014; de Melo, Cláudia Moura/I-7764-2014	Jeraldo, Verónica VL/0000-0001-9813-7969; Madi, Rubens Riscala/0000-0002-1526-0687; de Melo, Cláudia Moura/0000-0001-9331-003X	Fundacao de Apoio a Pesquisa e Inovacao Tecnologica-Fapitec	Fundacao de Apoio a Pesquisa e Inovacao Tecnologica-Fapitec	We thank the Fundacao de Apoio a Pesquisa e Inovacao Tecnologica-Fapitec for the grant award.	Adad SJ, 2008, REV SOC BRAS MED TRO, V41, P293, DOI 10.1590/S0037-86822008000300013; Almeida NR, 2013, REV INTE, V6, P62; Balaban AE, 2013, COMP PARASITOL, V80, P118, DOI 10.1654/4591.1; Barbosa, 1998, Cad Saude Publica, V14, P129, DOI 10.1590/S0102-311X1998000100020; Barbosa CS, 2000, REV SAUDE PUBL, V34, P337, DOI 10.1590/S0034-89102000000400004; Carmo E H, 1994, Cad Saude Publica, V10, P425, DOI 10.1590/S0102-311X1994000400002; Tibirica SHC, 2011, CIENC SAUDE COLETIVA, V16, P1375, DOI 10.1590/S1413-81232011000700072; Chaves A, 1979, REV SAUDE PUBL, V3, P348; da Silva PB, 2006, QUIM NOVA, V29, P901, DOI 10.1590/S0100-40422006000500003; Dawaki S, 2016, REV INST MED TROP, V58, P11; Gomes ECD, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-51; Frezza T. F., 2007, Revista de Ciencias Farmaceuticas Basica e Aplicada, V28, P209; Gazzinelli A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001603; Gomes Elainne Christine de Souza, 2016, Rev. bras. epidemiol., V19, P822, DOI 10.1590/1980-5497201600040012; Guimaraes ICS, 2006, REV SOC BRAS MED TRO, V39, P451, DOI 10.1590/S0037-86822006000500006; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2010, AGL SUBN PRIM RES, P1; Leal Neto Onicio Batista, 2013, Cad. Saúde Pública, V29, P357, DOI 10.1590/S0102-311X2013000200022; Magalhaes RJS, 2011, ADV PARASIT, V74, P267, DOI 10.1016/B978-0-12-385897-9.00005-7; Mazigo HD, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-274; McManus DP, 2010, CLIN MICROBIOL REV, V23, P442, DOI 10.1128/CMR.00044-09; Melo A.G.S., 2011, CIENC CUID SAUDE, V10, P506, DOI DOI 10.4025/CIENCCUIDSAUDE.V10I3.12479; Ministerio da Saude Vigilancia e Controle de Moluscos de Importancia Epidemiologica-Diretrizes Tecnicas: Programa de Controle da Esquistossomose (PCE). Brasolia, 2008, ED MS A, V2; Moraes CN, 2014, HYGIEA, V10, P21; Neresb RCB, 2011, REV BAI SAUD PUBL, V35, P28; Nunes FC, 2005, CAD SAUDE COLET RIO, V13, P605; Oliveira DS, 2013, REV SOC BRAS MED TRO, V46, P654, DOI 10.1590/0037-8682-1486-2013; Pinto HA, 2013, REV SOC BRAS MED TRO, V46, P478, DOI 10.1590/0037-8682-0099-2013; Rocha T.J.M., 2016, REV PAN-AMAZ SAUDE, V2, P1, DOI DOI 10.5123/S2176-62232016000200003; Ruganuza DM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0997-9; Sanches Magda, 2016, Neotropical Helminthology, V10, P73; Santos AD, 2011, REV SOC BRAS MED TRO, V44; Sanya RE, 2015, TROP MED INT HEALTH, V20, P1201, DOI 10.1111/tmi.12545; Sarvel AK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000990; Scholte RGC, 2014, ACTA TROP, V132, P57, DOI 10.1016/j.actatropica.2013.12.007; Souza MAA, 2010, IHERINGIA SER ZOOL, V100, P19, DOI 10.1590/S0073-47212010000100003; Teles HMS, 2005, REV SOC BRAS MED TRO, V38, P426, DOI 10.1590/S0037-86822005000500013; Terra E, 2008, ESP GEOG, V11, P17; Vidal Licia Marques, 2011, Revista de Patologia Tropical, V40, P367; Rollemberg CVV, 2011, REV SOC BRAS MED TRO, V44; WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; Zar JH., 2010, BIOSTAT ANAL, V5th	41	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195519	10.1371/journal.pone.0195519	http://dx.doi.org/10.1371/journal.pone.0195519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718924	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900020
J	Zhang, Y; Qu, PX; Ma, XN; Qiao, F; Ma, YF; Qing, SZ; Zhang, Y; Wang, YS; Cui, W				Zhang, Ying; Qu, Pengxiang; Ma, Xiaonan; Qiao, Fang; Ma, Yefei; Qing, Suzhu; Zhang, Yong; Wang, Yongsheng; Cui, Wei			Tauroursodeoxycholic acid (TUDCA) alleviates endoplasmic reticulum stress of nuclear donor cells under serum starvation	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; BUFFALO BUBALUS-BUBALIS; ER-STRESS; CYCLE SYNCHRONIZATION; SOMATIC-CELLS; IN-VITRO; FETAL FIBROBLASTS; TRANSFER EMBRYOS; CLONED EMBRYOS; APOPTOSIS	Serum starvation is a routine protocol for synchronizing nuclear donor cells to G0/G1 phase during somatic cell nuclear transfer (SCNT). However, abrupt serum deprivation can cause serious stress to the cells cultured in vitro, which might result in endoplasmic reticulum (ER) stress, chromosome damage, and finally reduce the success rate of SCNT. In the present study, the effects of tauroursodeoxycholic acid (TUDCA), an effective ER stress-relieving drug, on the nuclear donor cells under serum deprivation condition as well as following SCNT procedures were first assessed in the bovine. The results showed that TUDCA significantly reduced ER stress and cell apoptosis in those nuclear donor cells. Moreover, it significantly decreased the expression of Hdac1 and Dnmt1, and increased the level of H3K9 acetylation in nuclear donor cells compared with control group. SCNT reconstructed embryos cloned from TUDCA-treated donor cells showed significantly higher fusion, cleavage, blastocyst formation rate, total cell number in day 7 blastocysts, and lower apoptotic index than that from control group. In addition, the expression of Hdac1, Dnmt1 and Bax was significantly lower in blastocysts derived from TUDCA-treated donor cells than that from control group. In conclusion, TUDCA significantly reduced the ER stress of nuclear donor cells under serum starvation condition, and significantly improved the developmental competence of following SCNT reconstructed embryos when these TUDCA-treated cells were used as the nuclear donors.	[Zhang, Ying; Qu, Pengxiang; Ma, Xiaonan; Qiao, Fang; Qing, Suzhu; Zhang, Yong; Wang, Yongsheng] Northwest A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China; [Zhang, Ying; Qu, Pengxiang; Ma, Xiaonan; Qiao, Fang; Qing, Suzhu; Zhang, Yong; Wang, Yongsheng] Engn Ctr Anim Embryo Technol, Yangling, Shaanxi, Peoples R China; [Zhang, Ying; Qu, Pengxiang; Ma, Xiaonan; Qiao, Fang; Qing, Suzhu; Zhang, Yong; Wang, Yongsheng] Northwest A&F Univ, Lab Embryo Technol Livestock, Yangling, Shaanxi, Peoples R China; [Ma, Yefei] Fourth Mil Med Univ, Tangdu Hosp, Dept Gynecol & Obstet, Xian, Shaanxi, Peoples R China; [Cui, Wei] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Cui, Wei] Univ Massachusetts, IALS, Anim Models Core Facil, Amherst, MA 01003 USA	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China; Air Force Military Medical University; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Zhang, Y; Wang, YS (corresponding author), Northwest A&F Univ, Coll Vet Med, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China.; Zhang, Y; Wang, YS (corresponding author), Engn Ctr Anim Embryo Technol, Yangling, Shaanxi, Peoples R China.; Zhang, Y; Wang, YS (corresponding author), Northwest A&F Univ, Lab Embryo Technol Livestock, Yangling, Shaanxi, Peoples R China.; Cui, W (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.; Cui, W (corresponding author), Univ Massachusetts, IALS, Anim Models Core Facil, Amherst, MA 01003 USA.	Zhangyong1956110@163.com; wangyongsheng01@nwsuaf.edu.cn; wcui@umass.edu	Cui, Wei/F-2192-2016	Cui, Wei/0000-0001-7281-3471	National Natural Science Foundation of China [31472094]; Lalor Foundation postdoctoral fellowship	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Lalor Foundation postdoctoral fellowship	This work was carried out with support from National Natural Science Foundation of China http://www.nsfc.gov.cn (no. 31472094) to YW, as well as Lalor Foundation postdoctoral fellowship http://Malorfound.org and faculty start-up fund to WC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Brocks D, 2017, NAT GENET, V49, P1052, DOI 10.1038/ng.3889; Chavatte-Palmer P, 2002, BIOL REPROD, V66, P1596, DOI 10.1095/biolreprod66.6.1596; Chevet E, 2015, CANCER DISCOV, V5, P586, DOI 10.1158/2159-8290.CD-14-1490; Choi SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep31925; Cibelli JB, 2014, CELL STEM CELL, V14, P699, DOI 10.1016/j.stem.2014.05.013; Clark A, 2013, MOL REPROD DEV, V80, DOI 10.1002/mrd.22260; Cui W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032044; Dalman A, 2010, REPROD DOMEST ANIM, V45, pE46, DOI 10.1111/j.1439-0531.2009.01520.x; de Barros FRO, 2010, REPROD DOMEST ANIM, V45, P38, DOI 10.1111/j.1439-0531.2008.01201.x; Diao YF, 2013, ANIM REPROD SCI, V141, P164, DOI 10.1016/j.anireprosci.2013.08.008; Dicks N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187717; Erbel S, 2010, EXP CLIN ENDOCR DIAB, V118, P81, DOI 10.1055/s-0029-1238318; Giraldo AA, 2008, BIOL REPROD, V78, P832, DOI 10.1095/biolreprod.107.066662; Hampton RY, 2000, CURR BIOL, V10, pR518, DOI 10.1016/S0960-9822(00)00583-2; Hayes O, 2005, ANIM REPROD SCI, V87, P181, DOI 10.1016/j.anireprosci.2004.11.011; Heyman Y, 2002, BIOL REPROD, V66, P6, DOI 10.1095/biolreprod66.1.6; Iwamoto D, 2012, CELL REPROGRAM, V14, P20, DOI 10.1089/cell.2011.0035; Jiao GZ, 2016, CELL REPROGRAM, V18, P17, DOI 10.1089/cell.2015.0055; Kahali S, 2012, FASEB J, V26, P2437, DOI 10.1096/fj.11-193706; Kasinathan P, 2001, NAT BIOTECHNOL, V19, P1176, DOI 10.1038/nbt1201-1176; Khammanit R, 2008, THERIOGENOLOGY, V70, P27, DOI 10.1016/j.theriogenology.2008.02.015; Kim JS, 2012, REPROD DOMEST ANIM, V47, P791, DOI 10.1111/j.1439-0531.2011.01969.x; Kostyuk SV, 2013, MUTAT RES-FUND MOL M, V747, P6, DOI 10.1016/j.mrfmmm.2013.04.007; Lin T, 2016, REPROD BIOL, V16, P269, DOI 10.1016/j.repbio.2016.10.003; Luo C, 2013, THERIOGENOLOGY, V80, P878, DOI 10.1016/j.theriogenology.2013.07.013; Ma LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135344; Mohlin C, 2014, BRAIN RES, V1585, P167, DOI 10.1016/j.brainres.2014.08.055; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Nakanishi K, 2007, FASEB J, V21, P2994, DOI 10.1096/fj.06-6408com; No JG, 2018, REPROD BIOL, V18, P18, DOI 10.1016/j.repbio.2017.11.001; Pang YW, 2013, J PINEAL RES, V54, P389, DOI 10.1111/jpi.12024; Park ES, 2004, MOL REPROD DEV, V68, P65, DOI 10.1002/mrd.20046; Park HJ, 2013, BIOCHEM BIOPH RES CO, V441, P344, DOI 10.1016/j.bbrc.2013.10.056; Qu PX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174535; Selokar NL, 2012, THERIOGENOLOGY, V78, P930, DOI 10.1016/j.theriogenology.2012.03.018; Selokar NL, 2013, CELL REPROGRAM, V15, P531, DOI 10.1089/cell.2013.0018; Shufaro Y, 2011, METHODS MOL BIOL, V761, P239, DOI 10.1007/978-1-61779-182-6_16; Smith LC, 2012, REPROD DOMEST ANIM, V47, P107, DOI 10.1111/j.1439-0531.2012.02063.x; Su JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018106; Tay KH, 2014, CELL SIGNAL, V26, P287, DOI 10.1016/j.cellsig.2013.11.008; Wang XJ, 2017, ONCOTARGETS THER, V10, P1865, DOI 10.2147/OTT.S130022; Wang YS, 2011, THERIOGENOLOGY, V75, P819, DOI 10.1016/j.theriogenology.2010.10.022; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilmut I, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0366; Xu WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064705; Yao XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059680; Yoon SB, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113480; Yoon YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep39838; Zhang JY, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095059; Zhang Kezhong, 2014, Front Genet, V5, P460, DOI 10.3389/fgene.2014.00460	52	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196785	10.1371/journal.pone.0196785	http://dx.doi.org/10.1371/journal.pone.0196785			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718981	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900083
J	Kim, G; Kim, JY; Lim, SC; Lee, KY; Kim, O; Choi, HS				Kim, Garam; Kim, Jin-Young; Lim, Sung-Chul; Lee, Kwang Youl; Kim, Okyun; Choi, Hong Seok			SUV39H1/DNMT3A-dependent methylation of the RB1 promoter stimulates PIN1 expression and melanoma development	FASEB JOURNAL			English	Article						prolyl isomerase; E2F1; CpG methylation; histone methylation	CELL-CYCLE PROGRESSION; PROLYL ISOMERASE PIN1; DNA METHYLATION; HISTONE H3; MALIGNANT-TRANSFORMATION; EPIDERMAL-CELLS; BREAST-CANCER; METHYLTRANSFERASE; MUTATIONS; GENE	Melanoma is among the most aggressive and treatment-resistant human cancers. Aberrant histone H3 methylation at Lys 9 (H3K9) correlates with carcinogenic gene silencing, but the significance of suppressor of variegation 3-9 homolog 1 (SUV39H1), an H3K9-specific methyltransferase, in melanoma initiation and progression remains unclear. Here, we show that SUV39H1-mediated H3K9 trimethylation facilitates retinoblastoma (RB)1 promoter CpG island methylation by interacting with DNA methyltransferase 3A and decreasing RB mRNA and protein in melanoma cells. Reduced RB abundance, in turn, impairs E2F1 transcriptional inhibition, leading to increased peptidyl-prolyl cis-trans isomerase never-in-mitosis A (NIMA)-interacting 1 (PIN1) levels, human keratinocyte neoplastic cell transformation, and melanoma tumorigenesis via enhanced rapidly accelerated fibrosarcoma 1(RAF1)-MEK-ERK signaling pathway activation. In a synergistic model with B16-F1 murine melanoma cells, SUV39H1 and PIN1 overexpression increased melanoma growth, which was abrogated by their inhibition in SUV39H1-overexpressing B16-F1 mice. SUV39H1 also positively correlated with PIN1 expression in human melanoma. Our studies establish SUV39H1 as an oncogene in melanoma and underscore the role of chromatin factors in regulating tumorigenesis.Kim, G., Kim, J.-Y., Lim, S.-C., Lee, K. Y., Kim, O., Choi, H. S. SUV39H1/DNMT3A-dependent methylation of the RB1 promoter stimulates PIN1 expression and melanoma development.	[Kim, Garam; Kim, Jin-Young; Kim, Okyun; Choi, Hong Seok] Chosun Univ, Coll Pharm, Room 1101,Bldg 2,309 Philmundaero, Gwangju 61452, South Korea; [Lim, Sung-Chul] Chosun Univ, Sch Med, Dept Pathol, Gwangju, South Korea; [Lee, Kwang Youl] Chonnam Natl Univ, Coll Pharm, Gwangju, South Korea	Chosun University; Chosun University; Chonnam National University	Choi, HS (corresponding author), Chosun Univ, Coll Pharm, Room 1101,Bldg 2,309 Philmundaero, Gwangju 61452, South Korea.	chs@chosun.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2016R1A2B4010536]; Ministry of Science, Information and Communications Technology (ICT), and Future Planning [NRF-2015R1A5A2009070]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Ministry of Science, Information and Communications Technology (ICT), and Future Planning	This work was supported by the National Research Foundation of Korea (NRF), funded by the Korean government (MSIP; NRF-2016R1A2B4010536) and the Ministry of Science, Information and Communications Technology (ICT), and Future Planning (NRF-2015R1A5A2009070). The authors declare no conflicts of interest.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bird AP, 1996, CANCER SURV, V28, P87; Brose MS, 2002, CANCER RES, V62, P6997; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chedin F, 2011, PROG MOL BIOL TRANSL, V101, P255, DOI 10.1016/B978-0-12-387685-0.00007-X; Chen BF, 2014, EPIGENETICS-US, V9, P669, DOI 10.4161/epi.28324; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Cherblanc F, 2012, FUTURE MED CHEM, V4, P425, DOI [10.4155/fmc.12.7, 10.4155/FMC.12.7]; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Cho YS, 2012, MOL CELL BIOCHEM, V367, P85, DOI 10.1007/s11010-012-1322-y; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deng T, 2009, BIOCHEM BIOPH RES CO, V387, P611, DOI 10.1016/j.bbrc.2009.07.093; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; DUNN JM, 1988, SCIENCE, V241, P1797, DOI 10.1126/science.3175621; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Han CY, 2011, BIOCHEM BIOPH RES CO, V410, P68, DOI 10.1016/j.bbrc.2011.05.106; He YY, 2008, CANCER RES, V68, P3752, DOI 10.1158/0008-5472.CAN-07-6138; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hunter T, 1998, CELL, V92, P141, DOI 10.1016/S0092-8674(00)80906-X; Ikegami K, 2007, GENES CELLS, V12, P1, DOI 10.1111/j.1365-2443.2006.01029.x; Indra AK, 2007, J INVEST DERMATOL, V127, P1250, DOI 10.1038/sj.jid.5700672; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Khanal P, 2013, FASEB J, V27, P4606, DOI 10.1096/fj.13-236851; Khanal P, 2010, MOL CANCER THER, V9, P606, DOI 10.1158/1535-7163.MCT-09-0560; Kruiswijk F, 2016, ONCOGENE, V35, P2166, DOI 10.1038/onc.2015.282; Li W, 2013, J HUAZHONG U SCI-MED, V33, P798, DOI 10.1007/s11596-013-1201-0; Liu HP, 2004, CURR OPIN GENET DEV, V14, P55, DOI 10.1016/j.gde.2003.11.005; Lo JA, 2014, SCIENCE, V346, P945, DOI 10.1126/science.1253735; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Radpour R, 2010, MODERN PATHOL, V23, P763, DOI 10.1038/modpathol.2009.195; Rastetter M, 2007, HISTOL HISTOPATHOL, V22, P1005, DOI 10.14670/HH-22.1005; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Riverso M, 2017, ONCOGENE, V36, P3322, DOI 10.1038/onc.2016.481; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Yang Y, 2015, ONCOGENE, V34, P104, DOI 10.1038/onc.2013.522; Zhang JC, 2014, TUMOR BIOL, V35, P2795, DOI 10.1007/s13277-013-1372-0	51	16	16	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5647	5660		10.1096/fj.201700645RRRRR	http://dx.doi.org/10.1096/fj.201700645RRRRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29750576	Bronze			2022-12-26	WOS:000447972500037
J	Teixeira, RD; Guzzo, CR; Arevalo, SJ; Andrade, MO; Abrahao, J; de Souza, RF; Farah, CS				Teixeira, Raphael D.; Guzzo, Cristiane R.; Arevalo, Santiago Justo; Andrade, Maxuel O.; Abrahao, Josielle; de Souza, Robson F.; Farah, Chuck S.			A bipartite periplasmic receptor-diguanylate cyclase pair (XAC2383-XAC2382) in the bacterium Xanthomonas citri	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic di-GMP (c-di-GMP); bacterial signal transduction; structural biology; receptor; cell motility; phytopathogen; plant pathogen; Xanthomonas	CYCLIC-DI-GMP; ABC-TRANSPORTER; BINDING-PROTEIN; EXOPOLYSACCHARIDE PRODUCTION; MYCOBACTERIUM-SMEGMATIS; CATALYTIC MECHANISM; RESPONSE REGULATOR; ALLOSTERIC CONTROL; SWARMING MOTILITY; CRYSTAL-STRUCTURE	The second messenger cyclic diguanylate monophosphate (c-di-GMP) is a central regulator of bacterial lifestyle, controlling several behaviors, including the switch between sessile and motile states. The c-di-GMP levels are controlled by the interplay between diguanylate cyclases (DGCs) and phosphodiesterases, which synthesize and hydrolyze this second messenger, respectively. These enzymes often contain additional domains that regulate activity via binding of small molecules, covalent modification, or protein-protein interactions. A major challenge remains to understand how DGC activity is regulated by these additional domains or interaction partners in specific signaling pathways. Here, we identified a pair of co-transcribed genes (xac2382 and xac2383) in the phytopathogenic, Gram-negative bacterium Xanthomonas citri subsp. citri (Xac), whose mutations resulted in opposing motility phenotypes. We show that the periplasmic cache domain of XAC2382, a membrane-associated DGC, interacts with XAC2383, a periplasmic binding protein, and we provide evidence that this interaction regulates XAC2382 DGC activity. Moreover, we solved the crystal structure of XAC2383 with different ligands, indicating a preference for negatively charged phosphate-containing compounds. We propose that XAC2383 acts as a periplasmic sensor that, upon binding its ligand, inhibits the DGC activity of XAC2382. Of note, we also found that this previously uncharacterized signal transduction system is present in several other bacterial phyla, including Gram-positive bacteria. Phylogenetic analysis of homologs of the XAC2382-XAC2383 pair supports several independent origins that created new combinations of XAC2382 homologs with a conserved periplasmic cache domain with different cytoplasmic output module architectures.	[Teixeira, Raphael D.; Arevalo, Santiago Justo; Andrade, Maxuel O.; Farah, Chuck S.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508000 Sao Paulo, Brazil; [Guzzo, Cristiane R.; de Souza, Robson F.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508000 Sao Paulo, Brazil; [Abrahao, Josielle] Univ Estadual Campinas, Inst Quim, Dept Quim Organ, BR-13083970 Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	Farah, CS (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508000 Sao Paulo, Brazil.	chsfarah@iq.usp.br	Andrade, Maxuel/J-8426-2013; Arevalo, Santiago Justo/AAQ-2506-2021; de Souza, RF/G-9716-2011; de Oliveira Andrade, Maxuel/O-9924-2019; Carvalho, Cristiane R. G/K-2855-2016; Farah, Chuck Shaker/G-5565-2012	Andrade, Maxuel/0000-0002-4162-4341; Arevalo, Santiago Justo/0000-0001-8833-4395; de Souza, RF/0000-0002-5284-4630; de Oliveira Andrade, Maxuel/0000-0002-4162-4341; Carvalho, Cristiane R. G/0000-0002-5664-8055; Farah, Chuck Shaker/0000-0003-3110-6302; Dias Teixeira, Raphael/0000-0001-9642-7508	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/07777-5]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) graduate scholarship (to R. D. T.) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Research Grant 2011/07777-5 (to C. S. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Airola MV, 2013, J MOL BIOL, V425, P886, DOI 10.1016/j.jmb.2012.12.011; Alicea I, 2011, J MOL BIOL, V414, P356, DOI 10.1016/j.jmb.2011.09.047; Alkhateeb RS, 2016, J BIOTECHNOL, V225, P18, DOI 10.1016/j.jbiotec.2016.03.020; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade MO, 2006, MOL MICROBIOL, V62, P537, DOI 10.1111/j.1365-2958.2006.05386.x; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Beyhan S, 2008, J BACTERIOL, V190, P7392, DOI 10.1128/JB.00564-08; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; Borrok MJ, 2007, PROTEIN SCI, V16, P1032, DOI 10.1110/ps.062707807; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carugo O, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/s12900-014-0019-8; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chatterjee D, 2014, ELIFE, V3, DOI 10.7554/eLife.03650; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheung J, 2009, PROTEINS, V77, P235, DOI 10.1002/prot.22485; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Cuneo MJ, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-50; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Di Virgilio F, 2007, PURINERG SIGNAL, V3, P1, DOI 10.1007/s11302-006-9048-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feirer N, 2015, MBIO, V6, DOI 10.1128/mBio.00156-15; Felder CB, 1999, AAPS PHARMSCI, V1; Ferreira RBR, 2012, J BACTERIOL, V194, P914, DOI 10.1128/JB.05807-11; Ferris HU, 2011, STRUCTURE, V19, P378, DOI 10.1016/j.str.2011.01.006; Gebhard S, 2008, J BACTERIOL, V190, P1335, DOI 10.1128/JB.01764-07; Gebhard S, 2006, MICROBIOL-SGM, V152, P3453, DOI 10.1099/mic.0.29201-0; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Giardina G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081324; Guzzo CR, 2013, J MOL BIOL, V425, P2174, DOI 10.1016/j.jmb.2013.03.021; Guzzo CR, 2009, J MOL BIOL, V393, P848, DOI 10.1016/j.jmb.2009.07.065; Hironaka I, 2013, APPL ENVIRON MICROB, V79, P2328, DOI 10.1128/AEM.03871-12; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Malone JG, 2007, MICROBIOL-SGM, V153, P980, DOI 10.1099/mic.0.2006/002824-0; Malone JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000804; Mccarthy Y, 2008, MOL PLANT PATHOL, V9, P819, DOI [10.1111/j.1364-3703.2008.00495.x, 10.1111/J.1364-3703.2008.00495.X]; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mempin R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-301; Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07; Minasov G, 2009, J BIOL CHEM, V284, P13174, DOI 10.1074/jbc.M808221200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Nicastro GG, 2014, ENVIRON MICROBIOL, V16, P1321, DOI 10.1111/1462-2920.12422; Nolan LM, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0392-x; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oliveira MC, 2015, J MOL BIOL, V427, P415, DOI 10.1016/j.jmb.2014.11.012; Oloo EO, 2004, J BIOL CHEM, V279, P45013, DOI 10.1074/jbc.M405084200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Raterman EL, 2013, INFECT IMMUN, V81, P3089, DOI 10.1128/IAI.01396-12; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Roy Ankita Basu, 2013, Bio Protoc, V3; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schirmer T, 2016, J MOL BIOL, V428, P3683, DOI 10.1016/j.jmb.2016.07.023; Seshasayee ASN, 2010, NUCLEIC ACIDS RES, V38, P5970, DOI 10.1093/nar/gkq382; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Souza DP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7453; Sundriyal A, 2014, J BIOL CHEM, V289, P6978, DOI 10.1074/jbc.M113.516195; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Trimble MJ, 2011, P NATL ACAD SCI USA, V108, P18079, DOI 10.1073/pnas.1113790108; Upadhyay AA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004862; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Whitney JC, 2012, J BIOL CHEM, V287, P23582, DOI 10.1074/jbc.M112.375378; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	77	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10767	10781		10.1074/jbc.RA118.003475	http://dx.doi.org/10.1074/jbc.RA118.003475			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29728456	Green Published, hybrid			2022-12-26	WOS:000437828400031
J	Diabate, S; Chamberland, A; Geraldo, N; Tremblay, C; Alary, M				Diabate, Souleymane; Chamberland, Annie; Geraldo, Nassirou; Tremblay, Cecile; Alary, Michel			Gonorrhea, Chlamydia and HIV incidence among female sex workers in Cotonou, Benin: A longitudinal study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; CONDOM USE; ANTIRETROVIRAL THERAPY; TRACHOMATIS INFECTION; WEST-AFRICA; HIGH-RISK; COHORT; PROGRAM; WOMEN; INTERVENTIONS	Female sex workers (FSWs) continue to carry a heavy burden of sexually transmitted infections (STI). For prevention purposes, there is a need to identify most-at-risk subgroups among them. The objective of this longitudinal cohort study conducted at Dispensaire IST, Cotonou, Benin, was to assess Neisseria gonorrhoeae (NG) / Chlamydia trachomatis (CT) incidence and determinants; and HIV incidence among FSWs in presence of STI/HIV risk reduction activities. Overall, 319 adult FSWs were followed quarterly from September 2008 to March 2012. NG/CT were detected from endocervical swabs by Amplified DNA Assays employing Strand displacement amplification technology. HIV testing was done on capillary blood using two consecutive rapid diagnostic tests. Anderson-Gill proportional hazard models (HR) were used to determine factors independently associated with NG/CT incidence. The majority of FSWs were HIV-negative (188, 58.9%). There were 6 HIV seroconversions among these 188 HIV-negative women. HIV incidence (95% Confidence interval, CI) was 1.41 (0.28-2.54) seroconversions per 100 person-years at risk (PYAR): 6 events / 425.1 PYAR. Sixty-two out of 319 women experienced 83 new episodes of NG/CT for an overall incidence rate (95% CI) of 10.8 (8.17-13.88) events / 100 PYAR. From month-24 onwards, HIV-positive women (treated: HR (95%CI): 4.2 (1.60-10.77); untreated: HR (95%CI): 4.2 (1.59-11.49) were more likely to acquire NG/CT compared to HIV-negative FSWs. Longer duration in sex work (>2 years: HR; 95%Cl: 0.4 (0.22-0.72)) was protective against NG/CT. Refusal by clients (55.8%) was the main reason for non-condom use. Enrolling women from one clinic (Dispensaire IST) may have impaired generalizability of the findings. New NG/CT/ HIV infections were observed among FSWs notwithstanding ongoing prevention interventions. To eliminate HIV transmission among FSWs, STI/HIV control programs need to promote women's empowerment and address vulnerability to infection of HIV-positive FSWs.	[Diabate, Souleymane; Alary, Michel] Univ Laval, CHU Quebec, Ctr Rech, Axe Sante Populat & Prat Optimales Sante, Quebec City, PQ, Canada; [Diabate, Souleymane; Alary, Michel] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Diabate, Souleymane] Univ Alassane Ouattara, Dept Infectiol & Sante Publ, Bouake, Cote Ivoire; [Chamberland, Annie; Tremblay, Cecile] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Geraldo, Nassirou] Ctr Sante Cotonou I, Dispensaire IST, Cotonou, Benin; [Alary, Michel] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada	Laval University; Laval University; Universite de Montreal; Institut national de sante publique du Quebec (INSPQ)	Diabate, S (corresponding author), Univ Laval, CHU Quebec, Ctr Rech, Axe Sante Populat & Prat Optimales Sante, Quebec City, PQ, Canada.; Diabate, S (corresponding author), Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada.; Diabate, S (corresponding author), Univ Alassane Ouattara, Dept Infectiol & Sante Publ, Bouake, Cote Ivoire.	dsouleym@hotmail.com		Alary, Michel/0000-0002-0246-4429	Canadian Institutes of Health Research (CIHR) [HPR-85528, ROH-115205]; CIHR [188974]; Fonds de la recherche en sante du Quebec [8722]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR; http://www.cihr-irsc.gc.ca) [grants # HPR-85528 and ROH-115205]. SD was a postdoctoral fellow of the CIHR [grant # 188974]. MA was a national researcher of the Fonds de la recherche en sante du Quebec [grant #8722]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Oppong A, 2007, AIDS EDUC PREV, V19, P160, DOI 10.1521/aeap.2007.19.2.160; Alary M, 2014, SEX TRANSM DIS, V41, P380, DOI 10.1097/OLQ.0000000000000138; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Behanzin L, 2013, JAIDS-J ACQ IMM DEF, V63, P126, DOI 10.1097/QAI.0b013e318286b9d4; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Braunstein SL, 2011, SEX TRANSM DIS, V38, P385, DOI 10.1097/OLQ.0b013e31820b8eba; Das A, 2013, SEX TRANSM INFECT, V89, P5, DOI 10.1136/sextrans-2012-050472; Elmes J, 2014, J INFECT DIS, V210, pS569, DOI 10.1093/infdis/jiu493; Francis SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101221; Hargreaves JR, 2016, JAIDS-J ACQ IMM DEF, V72, pE1, DOI 10.1097/QAI.0000000000000920; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; KARIM QA, 1995, AM J PUBLIC HEALTH, V85, P1521, DOI 10.2105/AJPH.85.11.1521; Low AJ, 2014, SEX TRANSM INFECT, V90, P100, DOI 10.1136/sextrans-2013-051233; Lowndes CM, 2007, SEX TRANSM INFECT, V83, P577, DOI 10.1136/sti.2007.027441; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; Masese L, 2013, SEX TRANSM DIS, V40, P221, DOI 10.1097/OLQ.0b013e318272fe45; Mukenge-Tshibaka L, 2002, SEX TRANSM DIS, V29, P324, DOI 10.1097/00007435-200206000-00003; Musyoki H, 2015, AIDS BEHAV, V19, pS46, DOI 10.1007/s10461-014-0919-4; Ndziessi G, 2013, AIDS CARE, V25, P347, DOI 10.1080/09540121.2012.701717; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; Sopheab H, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-167; Tounkara FK, 2014, SEX TRANSM DIS, V41, P312, DOI 10.1097/OLQ.0000000000000114; Traore IT, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20088; UNAIDS, 2016, UNAIDS AIDS CHANG EV; UNAIDS, 2014, GLOG REP UNAIDS REP; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Vandepitte J, 2013, JAIDS-J ACQ IMM DEF, V62, P119, DOI 10.1097/QAI.0b013e3182777167; Vuylsteke B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032627; Wirtz AL, 2015, JAIDS-J ACQ IMM DEF, V68, pS171, DOI 10.1097/QAI.0000000000000451; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2006, ANT THER HIV INF AD	33	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197251	10.1371/journal.pone.0197251	http://dx.doi.org/10.1371/journal.pone.0197251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF3JM	29746535	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700091
J	Fischer, L; Rappsilber, J				Fischer, Lutz; Rappsilber, Juri			False discovery rate estimation and heterobifunctional cross-linkers	PLOS ONE			English	Article							MASS-SPECTROMETRY; LINKING/MASS SPECTROMETRY; MOLECULAR ARCHITECTURE; PEPTIDES	False discovery rate (FDR) estimation is a cornerstone of proteomics that has recently been adapted to cross-linking/mass spectrometry. Here we demonstrate that heterobifunctional cross-linkers, while theoretically different from homobifunctional cross-linkers, need not be considered separately in practice. We develop and then evaluate the impact of applying a correct FDR formula for use of heterobifunctional cross-linkers and conclude that there are minimal practical advantages. Hence a single formula can be applied to data generated from the many different non-cleavable cross-linkers.	[Fischer, Lutz; Rappsilber, Juri] Univ Edinburgh, Wellcome Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Rappsilber, Juri] Tech Univ Berlin, Inst Biotechnol, Bioanalyt, Berlin, Germany	University of Edinburgh; Technical University of Berlin	Rappsilber, J (corresponding author), Univ Edinburgh, Wellcome Ctr Cell Biol, Edinburgh, Midlothian, Scotland.; Rappsilber, J (corresponding author), Tech Univ Berlin, Inst Biotechnol, Bioanalyt, Berlin, Germany.	juri.rappsilber@ed.ac.uk	Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015	Rappsilber, Juri/0000-0001-5999-1310; Fischer, Lutz/0000-0003-4978-0864	Wellcome Trust [103139, 203149]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust (https://wellcome.ac.uk) grant numbers 103139 to Juri Rappsilber and 203149. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3964; Belsom A, 2017, ANAL CHEM, V89, P5319, DOI 10.1021/acs.analchem.6b04938; Belsom A, 2016, MOL CELL PROTEOMICS, V15, P1105, DOI 10.1074/mcp.M115.048504; Brodie NI, 2015, J PROTEOMICS, V118, P12, DOI 10.1016/j.jprot.2014.08.012; Cretu C, 2016, MOL CELL, V64, P307, DOI 10.1016/j.molcel.2016.08.036; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Erzberger JP, 2014, CELL, V158, P1123, DOI 10.1016/j.cell.2014.07.044; Fischer L, 2017, ANAL CHEM, V89, P3829, DOI 10.1021/acs.analchem.6b03745; Giese SH, 2016, ANAL CHEM, V88, P8239, DOI 10.1021/acs.analchem.6b02082; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Herbst S, 2013, ANAL BIOANAL CHEM, V405, P9333, DOI 10.1007/s00216-013-7358-3; Holding AN, 2015, METHODS, V89, P54, DOI 10.1016/j.ymeth.2015.06.010; Kao AH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002212; Legal T, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150237; Leitner A, 2016, TRENDS BIOCHEM SCI, V41, P20, DOI 10.1016/j.tibs.2015.10.008; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Moore RE, 2002, J AM SOC MASS SPECTR, V13, P378, DOI 10.1016/S1044-0305(02)00352-5; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Sanowar S, 2010, MBIO, V1, DOI 10.1128/mBio.00158-10; Singh P, 2013, J MOL BIOL, V425, P3378, DOI 10.1016/j.jmb.2013.06.026; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Wu X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13414; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099	27	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196672	10.1371/journal.pone.0196672	http://dx.doi.org/10.1371/journal.pone.0196672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746514	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700029
J	Kim, YH; Han, K; Vu, D; Cho, KH; Lee, SH				Kim, Yang Hyun; Han, Kyungdo; Vu, David; Cho, Kyung-Hwan; Lee, Sang Hwa			Number of remaining teeth and its association with socioeconomic status in South Korean adults: Data from the Korean National Health and Nutrition Examination Survey 2012-2013	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; QUALITY-OF-LIFE; TOOTH LOSS; ORAL-HEALTH; METABOLIC SYNDROME; OLDER-PEOPLE; BEHAVIORS; RISK; POPULATION; HYGIENE	Background Socioeconomic status (SES) is associated with systemic disease and influences oral and general health. Several studies have found inequalities associated with oral health and SES. We examined the relationship between tooth loss and SES in Korean adults using data from the 2012-2013 Korean National Health and Nutrition Examination Survey. Methods: A total of 7,005 participants were included in this study. Subjects were divided into two groups depending on their total number of natural teeth: <20 and >= 20. Next, participants were divided into quartiles depending on household income and educational level. Multivariate logistic regression was used to obtain odds ratios (OR) for remaining teeth according to income and education levels. Results As income and education levels increased, subjects were more likely to have >= 20 remaining teeth (p-value and p-value for trend <0.001), brush their teeth more than three times per day, use extra oral products, and have regular oral-health checkups (all p<0.001). The odds of having >20 remaining teeth increased with increases in income and education, after adjusting for all covariates (OR = 1.493 for income Q3, OR = 1.571 for income Q4; OR = 1.763 for 10-12 years education, OR = 2.189 for >= 13 years education). Conclusion Subjects with higher SES had more remaining teeth than subjects with lower SES. Preserving remaining teeth should be encouraged in subjects with low SES by promoting good oral-health behavior and encouraging more oral-health checkups.	[Kim, Yang Hyun; Cho, Kyung-Hwan] Korea Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Han, Kyungdo] Catholic Univ, Coll Med, Dept Med Stat, Seoul, South Korea; [Vu, David] Wing Dent Ctr, Peace River, AB, Canada; [Lee, Sang Hwa] Catholic Univ Korea, Dept Dent, St Pauls Hosp, Coll Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea; Catholic University of Korea	Lee, SH (corresponding author), Catholic Univ Korea, Dept Dent, St Pauls Hosp, Coll Med, Seoul, South Korea.	justina@catholic.ac.kr		Kim, Yang-Hyun/0000-0003-3548-8758; Lee, Sang Hwa/0000-0002-2254-2105	Institute of Clinical Medicine Research at Yeouido St. Mary's Hospital the Catholic University of Korea [YSI 2015-30]	Institute of Clinical Medicine Research at Yeouido St. Mary's Hospital the Catholic University of Korea	This study was funded by a research grant from the Institute of Clinical Medicine Research at Yeouido St. Mary's Hospital the Catholic University of Korea (YSI 2015-30). The funder only provided support in research materials [to SHL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The specific roles of these authors are articulated in the 'author contributions' section.	Appleton Allison A, 2016, Curr Environ Health Rep, V3, P287, DOI 10.1007/s40572-016-0099-7; Arora M, 2010, J AM DENT ASSOC, V141, P1242, DOI 10.14219/jada.archive.2010.0052; Astrom AN, 2015, EUR J ORAL SCI, V123, P30, DOI 10.1111/eos.12160; BAKDASH B, 1994, J PERIODONTOL, V65, P539, DOI 10.1902/jop.1994.65.5s.539; Bernabe E, 2009, EUR J ORAL SCI, V117, P413, DOI 10.1111/j.1600-0722.2009.00655.x; Celeste RK, 2009, SOC SCI MED, V69, P1468, DOI 10.1016/j.socscimed.2009.08.005; Chatrchaiwiwatana S, 2007, PUBLIC HEALTH, V121, P106, DOI 10.1016/j.puhe.2006.06.010; Christensen Lisa Boge, 2003, Community Dent Health, V20, P229; Copeland LB, 2004, J PUBLIC HEALTH DENT, V64, P31, DOI 10.1111/j.1752-7325.2004.tb02723.x; de Oliveira C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2451; Elias AC, 1998, J ORAL REHABIL, V25, P649, DOI 10.1046/j.1365-2842.1998.00313.x; Esan Temitope Ayodeji, 2004, BMC Oral Health, V4, P3, DOI 10.1186/1472-6831-4-3; Garcez J, 2009, ORAL SURG ORAL MED O, V107, P224, DOI 10.1016/j.tripleo.2008.09.018; Gilbert GH, 2003, HEALTH SERV RES, V38, P1843, DOI 10.1111/j.1475-6773.2003.00205.x; Greenblatt AP, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2016-000211; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Haugejorden O, 2003, COMMUNITY DENT ORAL, V31, P261, DOI 10.1034/j.1600-0528.2003.00004.x; Haugejorden O, 2008, COMMUNITY DENT ORAL, V36, P269, DOI 10.1111/j.1600-0528.2007.00367.x; Hobdell M, 2003, INT DENT J, V53, P285, DOI 10.1111/j.1875-595X.2003.tb00761.x; Huang DL, 2015, J PUBLIC HEALTH DENT, V75, P85, DOI 10.1111/jphd.12072; Jimenez M, 2009, COMMUNITY DENT ORAL, V37, P267, DOI 10.1111/j.1600-0528.2009.00466.x; Jung SH, 2011, J ORAL REHABIL, V38, P517, DOI 10.1111/j.1365-2842.2010.02178.x; Khosravi R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/728987; Kim YH, 2014, CLIN ORAL INVEST, V18, P1517, DOI 10.1007/s00784-013-1112-2; Klein BEK, 2004, J PUBLIC HEALTH DENT, V64, P145, DOI 10.1111/j.1752-7325.2004.tb02744.x; Kobayashi Y, 2012, J DENT RES, V91, P479, DOI 10.1177/0022034512440707; Labouesse MA, 2014, BONE, V64, P138, DOI 10.1016/j.bone.2014.03.047; Laguzzi PN, 2016, J PUBLIC HEALTH DENT, V76, P143, DOI 10.1111/jphd.12123; Lerner UH, 2006, J DENT RES, V85, P596, DOI 10.1177/154405910608500704; Liljestrand JM, 2015, J DENT RES, V94, P1055, DOI 10.1177/0022034515586352; Lindberg L, 2016, PEDIATR OBES, V11, P313, DOI 10.1111/ijpo.12049; Liu ZW, 2016, CANCER EPIDEM BIOMAR, V25, P1201, DOI 10.1158/1055-9965.EPI-16-0149; Mbawalla HS, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-87; Montebugnoli L, 2004, J CLIN PERIODONTOL, V31, P25, DOI 10.1111/j.0303-6979.2004.00432.x; Moreira RD, 2010, ACTA ODONTOL SCAND, V68, P269, DOI 10.3109/00016357.2010.494617; Mundt T, 2011, COMMUNITY DENT ORAL, V39, P398, DOI 10.1111/j.1600-0528.2010.00607.x; Nascimento GG, 2016, OBES REV, V17, P587, DOI 10.1111/obr.12418; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Payne BJ, 1996, J PUBLIC HEALTH DENT, V56, P198, DOI 10.1111/j.1752-7325.1996.tb02436.x; Rawshani A, 2016, JAMA INTERN MED, V176, P1146, DOI 10.1001/jamainternmed.2016.2940; Recent advances in oral health, 1992, REP WHO EXP COMM, V826, P1; Ryan H, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/918368; Sanders AE, 2008, J DENT RES, V87, P969, DOI 10.1177/154405910808701006; Schroder SL, 2016, INT J CARDIOL, V219, P70, DOI 10.1016/j.ijcard.2016.05.066; Shen TQ, 2016, INT J GERIATR PSYCH, V31, P953, DOI 10.1002/gps.4396; Susin C, 2006, J PUBLIC HEALTH DENT, V66, P110, DOI 10.1111/j.1752-7325.2006.tb02565.x; Susin C, 2005, ACTA ODONTOL SCAND, V63, P85, DOI 10.1080/00016350510019694; Tada A, 2003, J PUBLIC HEALTH DENT, V63, P250, DOI 10.1111/j.1752-7325.2003.tb03508.x; The Korea Center for Disease Control and Prevention, 2008, STAND NAT HLTH SURV; Vedin O, 2016, EUR J PREV CARDIOL, V23, P839, DOI 10.1177/2047487315621978; Vysniauskaite Sonata, 2005, Gerodontology, V22, P44, DOI 10.1111/j.1741-2358.2004.00040.x; Wang TF, 2014, ARCH GERONTOL GERIAT, V58, P446, DOI 10.1016/j.archger.2014.01.002; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th edn, p., P19	55	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196594	10.1371/journal.pone.0196594	http://dx.doi.org/10.1371/journal.pone.0196594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF3JM	29746489	Green Submitted, gold, Green Published			2022-12-26	WOS:000431851700026
J	Tan, HY; Trier, S; Rahbek, UL; Dufva, M; Kutter, JP; Andresen, TL				Tan, Hsih-Yin; Trier, Sofie; Rahbek, Ulrik L.; Dufva, Martin; Kutter, Jorg P.; Andresen, Thomas L.			A multi-chamber microfluidic intestinal barrier model using Caco-2 cells for drug transport studies	PLOS ONE			English	Article							EPITHELIAL ELECTRICAL-RESISTANCE; IN-VITRO MODEL; PROTEIN EXPRESSION; INDUCED INCREASES; LINE CACO-2; ABSORPTION; PERMEABILITY; MEMBRANE; SYSTEM; PREDICTION	This paper presents the design and fabrication of a multi-layer and multi-chamber microchip system using thiol-ene 'click chemistry' aimed for drug transport studies across tissue barrier models. The fabrication process enables rapid prototyping of multi-layer microfluidic chips using different thiol-ene polymer mixtures, where porous Teflon membranes for cell monolayer growth were incorporated by masked sandwiching thiol-ene-based fluid layers. Electrodes for trans-epithelial electrical resistance (TEER) measurements were incorporated using low-melting soldering wires in combination with platinum wires, enabling parallel real-time monitoring of barrier integrity for the eight chambers. Additionally, the translucent porous Teflon membrane enabled optical monitoring of cell monolayers. The device was developed and tested with the Caco-2 intestinal model, and compared to the conventional Transwell system. Cell monolayer differentiation was assessed via in situ immunocytochemistry of tight junction and mucus proteins, P-glycoprotein 1 (P-gp) mediated efflux of Rhodamine 123, and brush border aminopeptidase activity. Monolayer tightness and relevance for drug delivery research was evaluated through permeability studies of mannitol, dextran and insulin, alone or in combination with the absorption enhancer tetradecylmaltoside (TDM). The thiol-ene-based microchip material and electrodes were highly compatible with cell growth. In fact, Caco-2 cells cultured in the device displayed differentiation, mucus production, directional transport and aminopeptidase activity within 9-10 days of cell culture, indicating robust barrier formation at a faster rate than in conventional Transwell models. The cell monolayer displayed high TEER and tightness towards hydrophilic compounds, whereas co-administration of an absorption enhancer elicited TEER-decrease and increased permeability similar to the Transwell cultures. The presented cell barrier microdevice constitutes a relevant tissue barrier model, enabling transport studies of drugs and chemicals under real-time optical and functional monitoring in eight parallel chambers, thereby increasing the throughput compared to previously reported microdevices.	[Tan, Hsih-Yin; Dufva, Martin; Andresen, Thomas L.] Tech Univ Denmark, Dept Micro & Nanotechnol, Orsteds Plads, Lyngby, Denmark; [Tan, Hsih-Yin; Andresen, Thomas L.] Tech Univ Denmark, Ctr Nanomed & Theranost, Orsteds Plads, Lyngby, Denmark; [Tan, Hsih-Yin] Natl Univ Singapore, Biomed Inst Global Hlth Res & Technol BIGHEART, Singapore, Singapore; [Trier, Sofie; Rahbek, Ulrik L.] Novo Nordisk AS, Global Res, Malov, Denmark; [Kutter, Jorg P.] Univ Copenhagen, Dept Pharm, Univ Pk 2, Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; National University of Singapore; Novo Nordisk; University of Copenhagen	Dufva, M (corresponding author), Tech Univ Denmark, Dept Micro & Nanotechnol, Orsteds Plads, Lyngby, Denmark.	martin.dufva@nanotech.dtu.dk	Dufva, Martin/V-9469-2019; Tan, Hsih-Yin/C-2739-2018; Dufva, Martin/D-1873-2012; Kutter, Jorg/E-3256-2010	Tan, Hsih-Yin/0000-0002-3328-0489; Dufva, Martin/0000-0001-5449-0189; Andresen, Thomas Lars/0000-0002-1048-127X; Kutter, Jorg/0000-0003-1065-1985	Danish Council for Independent Research (FTP); Lundbeck Foundation	Danish Council for Independent Research (FTP)(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	This work is supported by The Danish Council for Independent Research (FTP) and the Lundbeck Foundation; https://www.lundbeckfonden.com, https://dff.dk/en/front-page?set_language=en. None of the fund givers had any influence on the research.	Achyuta AKH, 2013, LAB CHIP, V13, P542, DOI 10.1039/c2lc41033h; ANDERSON JM, 1989, J CELL BIOL, V109, P1047, DOI 10.1083/jcb.109.3.1047; Antia M, 2007, PLOS PATHOG, V3, P939, DOI 10.1371/journal.ppat.0030099; Arnold JJ, 2004, J PHARM SCI-US, V93, P2205, DOI 10.1002/jps.20123; Artursson P, 1997, PHARMACEUT RES, V14, P1655, DOI 10.1023/A:1012155124489; ARTURSSON P, 1990, J PHARM SCI-US, V79, P476, DOI 10.1002/jps.2600790604; Basson MD, 1996, EXP CELL RES, V225, P301, DOI 10.1006/excr.1996.0180; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Borchard G, 2009, ORAL DELIVERY OF MACROMOLECULAR DRUGS: BARRIERS, STRATEGIES AND FUTURE TRENDS, P49, DOI 10.1007/978-1-4419-0200-9_3; Brayden DJ, 2015, EUR J PHARM BIOPHARM, V94, P194, DOI 10.1016/j.ejpb.2015.05.013; BriskeAnderson MJ, 1997, P SOC EXP BIOL MED, V214, P248; Bullen TF, 2006, LAB INVEST, V86, P1052, DOI 10.1038/labinvest.3700464; Carino GP, 1999, ADV DRUG DELIVER REV, V35, P249, DOI 10.1016/S0169-409X(98)00075-1; Carlborg CF, 2014, J POLYM SCI POL CHEM, V52, P2604, DOI 10.1002/pola.27276; Carlborg CF, 2011, LAB CHIP, V11, P3136, DOI 10.1039/c1lc20388f; Chi MY, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9966-5; Chumbimuni-Torres KY, 2011, RSC ADV, V1, P706, DOI 10.1039/c1ra00198a; DEBRUINE AP, 1993, DIFFERENTIATION, V53, P51, DOI 10.1111/j.1432-0436.1993.tb00645.x; Fonte Pedro, 2013, J Diabetes Sci Technol, V7, P520; FORSTNER G, 1995, ANNU REV PHYSIOL, V57, P585, DOI 10.1146/annurev.ph.57.030195.003101; Gao D, 2013, LAB CHIP, V13, P978, DOI 10.1039/c2lc41215b; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Guo P, 2000, AM J PHYSIOL-RENAL, V279, pF698, DOI 10.1152/ajprenal.2000.279.4.F698; Hansson Jonas, 2014, 2014 IEEE 27th International Conference on Micro Electro Mechanical Systems (MEMS), P987, DOI 10.1109/MEMSYS.2014.6765809; Henry OYF, 2017, LAB CHIP, V17, P2264, DOI 10.1039/c7lc00155j; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; HILGERS AR, 1990, PHARMACEUT RES, V7, P902, DOI 10.1023/A:1015937605100; Holmes AM, 2010, TOXICOLOGY, V267, P14, DOI 10.1016/j.tox.2009.11.006; HOWELL S, 1992, BIOCHEM J, V284, P595, DOI 10.1042/bj2840595; Hoyle CE, 2004, J POLYM SCI POL CHEM, V42, P5301, DOI 10.1002/pola.20366; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Huh D, 2013, NAT PROTOC, V8, P2135, DOI 10.1038/nprot.2013.137; Hung LH, 2008, LAB CHIP, V8, P983, DOI 10.1039/b717710k; Imura Y, 2009, ANAL SCI, V25, P1403, DOI 10.2116/analsci.25.1403; Ishikawa T, 2011, J THEOR BIOL, V279, P63, DOI 10.1016/j.jtbi.2011.03.026; Jia JX, 2008, J PHARM PHARM SCI, V11, P45, DOI 10.18433/J33S3Z; Jokhadar SZ, 2007, CELL BIOL INT, V31, P1097, DOI 10.1016/j.cellbi.2007.03.019; Jokhadar SZ, 2009, CELL COMMUN ADHES, V16, P1, DOI 10.1080/15419060902957296; Kim HJ, 2013, INTEGR BIOL-UK, V5, P1130, DOI 10.1039/c3ib40126j; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kimura H, 2008, LAB CHIP, V8, P741, DOI 10.1039/b717091b; Kongsuphol P, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0117-4; Kuschel C, 2006, BIOTECHNIQUES, V40, P523, DOI 10.2144/000112134; Lafleur JP, 2013, ANALYST, V138, P845, DOI 10.1039/c2an36424g; Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712; Lee WG, 2008, CURR APPL PHYS, V8, P696, DOI 10.1016/j.cap.2007.04.046; Lozoya-Agullo I, 2015, J PHARM SCI-US, V104, P3136, DOI 10.1002/jps.24447; Marx U, 2016, ALTEX-ALTERN ANIM EX, V33, P272, DOI 10.14573/altex.1603161; Natali M, 2008, LAB CHIP, V8, P492, DOI 10.1039/b716594c; Odijk M, 2015, LAB CHIP, V15, P745, DOI 10.1039/c4lc01219d; Petersen SB, 2013, EUR J PHARM SCI, V48, P726, DOI 10.1016/j.ejps.2013.01.009; Petersen SB, 2012, EUR J PHARM SCI, V47, P701, DOI 10.1016/j.ejps.2012.08.010; PINTO M, 1983, BIOL CELL, V47, P323; RAMADAN Q, 2016, ROYAL SOC CHEM, V16, P1899, DOI DOI 10.1039/C6LC00229C; Sabourin D, 2013, JALA-J LAB AUTOM, V18, P212, DOI 10.1177/2211068212461445; Sachs-Barrable K, 2007, J PHARM PHARM SCI, V10, P319; Sajay BNG, 2017, J MICROMECH MICROENG, V27, DOI 10.1088/1361-6439/aa96bd; Schreider C, 2002, J CELL SCI, V115, P543; Senkbeil S, 2016, J MICROMECH MICROENG, V26, DOI 10.1088/0960-1317/26/7/075014; Shah P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11535; Sikanen TM, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/3/037002; Spratt P, 2005, FOOD BIOPROD PROCESS, V83, P147, DOI 10.1205/fbp.04396; Stenberg P, 2001, J MED CHEM, V44, P1927, DOI 10.1021/jm001101a; STEWART BH, 1995, PHARMACEUT RES, V12, P693, DOI 10.1023/A:1016207525186; Sticker D, 2015, LAB CHIP, V15, P4542, DOI 10.1039/c5lc01028d; Sun T, 2010, LAB CHIP, V10, P1611, DOI 10.1039/c000699h; Svensson USH, 1999, DRUG METAB DISPOS, V27, P227; Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c; Trietsch SJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00259-3; Troutman MD, 2003, PHARMACEUT RES, V20, P1192, DOI 10.1023/A:1025096930604; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Uchiyama T, 1999, J PHARM PHARMACOL, V51, P1241, DOI 10.1211/0022357991776976; Vogel PA, 2011, ANAL CHEM, V83, P4296, DOI 10.1021/ac2004746; Wang JD, 2012, ANN BIOMED ENG, V40, P1862, DOI 10.1007/s10439-012-0562-z; Yang TZ, 2005, J DRUG TARGET, V13, P29, DOI 10.1080/10611860400020191; Zakeri-Milani P, 2007, J PHARM PHARM SCI, V10, P368	76	50	51	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197101	10.1371/journal.pone.0197101	http://dx.doi.org/10.1371/journal.pone.0197101			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746551	gold, Green Submitted, Green Published			2022-12-26	WOS:000431851700069
J	Hedd, A; Pollet, IL; Mauck, RA; Burke, CM; Mallory, ML; Tranquilla, LAM; Montevecchi, WA; Robertson, GJ; Ronconi, RA; Shutler, D; Wilhelm, SI; Burgess, NM				Hedd, April; Pollet, Ingrid L.; Mauck, Robert A.; Burke, Chantelle M.; Mallory, Mark L.; Tranquilla, Laura A. McFariane; Montevecchi, William A.; Robertson, Gregory J.; Ronconi, Robert A.; Shutler, Dave; Wilhelm, Sabina I.; Burgess, Neil M.			Foraging areas, offshore habitat use, and colony overlap by incubating Leach's storm-petrels Oceanodroma leucorhoa in the Northwest Atlantic	PLOS ONE			English	Article							MERCURY CONCENTRATIONS; SPATIAL SEGREGATION; GAS PLATFORMS; URIA-LOMVIA; SEABIRDS; OIL; CANADA; POPULATIONS; LABRADOR; WINTER	Despite their importance in marine food webs, much has yet to be learned about the spatial ecology of small seabirds. This includes the Leach's storm-petrel Oceanodroma leucorhoa, a species that is declining throughout its Northwest Atlantic breeding range. In 2013 and 2014, we used global location sensors to track foraging movements of incubating storm-petrels from 7 eastern Canadian breeding colonies. We determined and compared the foraging trip and at-sea habitat characteristics, analysed spatial overlap among colonies, and determined whether colony foraging ranges intersected with offshore oil and gas operations. Individuals tracked during the incubation period made 4.0 +/- 1.4 day foraging trips, travelling to highly pelagic waters over and beyond continental slopes which ranged, on average, 400 to 830 km from colonies. Cumulative travel distances ranged from similar to 900 to 2,100 km among colonies. While colony size did not influence foraging trip characteristics or the size of areas used at sea, foraging distances tended to be shorter for individuals breeding at the southern end of the range. Core areas did not overlap considerably among colonies, and individuals from all sites except Kent Island in the Bay of Fundy foraged over waters with median depths > 1,950 m and average chlorophyll a concentrations <= 0.6 mg/m(3). Sea surface temperatures within colony core areas varied considerably (11-23 degrees C), coincident with the birds' use of cold waters of the Labrador Current or warmer waters of the Gulf Stream Current. Offshore oil and gas operations intersected with the foraging ranges of 5 of 7 colonies. Three of these, including Baccalieu Island, Newfoundland, which supports the species' largest population, have experienced substantial declines in the last few decades. Future work should prioritize modelling efforts to incorporate information on relative predation risk at colonies, spatially explicit risks at-sea on the breeding and wintering grounds, effects of climate and marine ecosystem change, as well as lethal and sub-lethal effects of environmental contaminants, to better understand drivers of Leach's storm-petrel populations trends in Atlantic Canada.	[Hedd, April; Burke, Chantelle M.; Tranquilla, Laura A. McFariane; Montevecchi, William A.] Mem Univ, Psychol Dept, St John, NF, Canada; [Pollet, Ingrid L.; Mallory, Mark L.; Ronconi, Robert A.; Shutler, Dave] Acad Univ, Dept Biol, Wolfville, NS, Canada; [Mauck, Robert A.] Kenyon Coll, Biol Dept, Gambier, OH 43022 USA; [Hedd, April; Robertson, Gregory J.] Environm & Climate Change Canada, Wildlife Res Div, Mt Pearl, NF, Canada; [Wilhelm, Sabina I.] Environm & Climate Change Canada, Canadian Wildlife Serv, Mt Pearl, NF, Canada; [Burgess, Neil M.] Environm & Climate Change Canada, Ecotoxicol & Wildlife Hlth Div, Mt Pearl, NF, Canada; [Pollet, Ingrid L.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Tranquilla, Laura A. McFariane] Bird Studies Canada, Sackville, NB, Canada; [Ronconi, Robert A.] Environm & Climate Change Canada, Canadian Wildlife Serv, Dartmouth, NS, Canada	Memorial University Newfoundland; Acadia University; Kenyon College; Environment & Climate Change Canada; Canadian Wildlife Service; Wildlife Research Division - Environment Canada; Environment & Climate Change Canada; Canadian Wildlife Service; Environment & Climate Change Canada; Dalhousie University; Environment & Climate Change Canada; Canadian Wildlife Service	Hedd, A (corresponding author), Mem Univ, Psychol Dept, St John, NF, Canada.; Hedd, A (corresponding author), Environm & Climate Change Canada, Wildlife Res Div, Mt Pearl, NF, Canada.	april.hedd@canada.ca	Pollet, Ingrid Louise/O-5031-2019; Robertson, Greg/AAI-5849-2020	Pollet, Ingrid Louise/0000-0001-7207-8294; Robertson, Greg/0000-0001-8452-5506; Mauck, Robert/0000-0003-0534-4411; Hedd, April/0000-0003-2222-2627; Wilhelm, Sabina/0000-0002-7842-7317	Environment Canada; Natural Sciences and Engineering Research Council of Canada Discovery; Collaborative Research and Development grants; Environmental Damages Research Fund; Encana Corporation through Encana's Research and Development Fund; Nova Scotia Habitat Conservation Fund; Bird Studies Canada	Environment Canada(CGIAR); Natural Sciences and Engineering Research Council of Canada Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Collaborative Research and Development grants; Environmental Damages Research Fund; Encana Corporation through Encana's Research and Development Fund; Nova Scotia Habitat Conservation Fund; Bird Studies Canada	This research was supported by Environment Canada, Natural Sciences and Engineering Research Council of Canada Discovery (WAM, MLM) and Collaborative Research and Development grants (RAR), the Environmental Damages Research Fund (WAM), Encana Corporation through Encana's Research and Development Fund (RAR), Nova Scotia Habitat Conservation Fund (contributions from hunters and trappers), and also had support from Bird Studies Canada (LAMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINLEY D.G., 1975, LIVING BIRD, V13, P295; BIRDLIFE INTERNATIONAL, 2016, IUCN RED LIST THREAT, V2016, DOI [10.2305/IUCN.UK.2016-3.RLTS.T22698511A86230533.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22698511A86230533.EN]; Bond AL, 2009, SCI TOTAL ENVIRON, V407, P4340, DOI 10.1016/j.scitotenv.2009.04.018; Buren AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087589; Burgess NM, 2014, 35 ANN M SOC ENV TOX; Burke CM, 2012, J ENVIRON MANAGE, V104, P121, DOI 10.1016/j.jenvman.2012.02.012; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Catry P, 2013, PROG OCEANOGR, V110, P1, DOI 10.1016/j.pocean.2013.01.005; Catul V, 2011, REV FISH BIOL FISHER, V21, P339, DOI 10.1007/s11160-010-9176-4; CNLOPB (Canada Newfoundland and Labrador Offshore Petroleum Board), 2015, ANN REP 2014 2015; Corman AM, 2016, ECOL EVOL, V6, P974, DOI 10.1002/ece3.1884; Cyr F, 2015, ATMOS OCEAN, V53, P212, DOI 10.1080/07055900.2014.986710; Dias MP, 2015, J ORNITHOL, V156, P955, DOI 10.1007/s10336-015-1210-9; ELLIOTT JE, 1992, ARCH ENVIRON CON TOX, V22, P63, DOI 10.1007/BF00213303; Ellis JI, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00589-080204; Fort J, 2015, SCI TOTAL ENVIRON, V527, P448, DOI 10.1016/j.scitotenv.2015.05.018; Fraser GS, 2016, MAR POLLUT BULL, V107, P36, DOI 10.1016/j.marpolbul.2016.04.026; Fraser Gail S., 2006, Marine Ornithology, V34, P147; Fraser GS, 2014, PEAK OIL EC GROWTH W, P191, DOI 10.1007/978-1-4939-1954-3; Frederiksen M, 2016, BIOL CONSERV, V200, P26, DOI 10.1016/j.biocon.2016.05.011; Goodale MW, 2008, ECOHEALTH, V5, P409, DOI 10.1007/s10393-009-0211-7; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Hedd A, 2009, CAN J ZOOL, V87, P787, DOI 10.1139/Z09-060; Hedd A, 1999, THESIS; Hedd A, 2006, MAR ECOL PROG SER, V322, P291, DOI 10.3354/meps322291; Hedd A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085572; Huin N, 2002, AQUAT CONSERV, V12, P89, DOI 10.1002/aqc.479; Huntington CE, 1996, BIRDS N AM, DOI [10.2173/bna.233, DOI 10.2173/BNA.233]; Lea MA, 2002, POLAR BIOL, V25, P843, DOI 10.1007/s00300-002-0428-1; Linton A., 1978, THESIS; Lormee H, 2012, WILSON J ORNITHOL, V124, P245; Monteiro LR, 1996, MAR ECOL PROG SER, V141, P21, DOI 10.3354/meps141021; Montevecchi WA, 2006, ECOLOGICAL CONSEQUEN, P93; Nafpaktitis B. G, 1977, Memoirs Sears Fdn mem. Res., V1, P13; Navarro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062897; Oxley JR., 1999, THESIS; Paiva VH, 2018, ZOOLOGY, V126, P29, DOI 10.1016/j.zool.2017.12.006; Pepin P, 2013, DEEP-SEA RES PT I, V75, P119, DOI 10.1016/j.dsr.2013.01.012; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Podrazhanskaya S.G., 1993, Northwest Atlantic Fisheries Organization Scientific Council Studies, V19, P79; Pollet IL, 2017, ECOTOXICOLOGY, V26, P97, DOI 10.1007/s10646-016-1745-4; Pollet IL, 2014, J FIELD ORNITHOL, V85, P321, DOI 10.1111/jofo.12071; Pollet IL, 2014, J AVIAN BIOL, V45, P305, DOI 10.1111/jav.00361; Quillfeldt P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125007; Quillfeldt P, 2013, J BIOGEOGR, V40, P430, DOI 10.1111/jbi.12008; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Ratcliffe N, 2014, J BIOGEOGR, V41, P1183, DOI 10.1111/jbi.12279; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Robertson Gregory J., 2006, Atlantic Seabirds, V8, P41; Ronconi RA, 2015, J ENVIRON MANAGE, V147, P34, DOI 10.1016/j.jenvman.2014.07.031; SKLEPKOVYCH B O, 1989, American Birds, V43, P38; Stenhouse Ian J., 2000, Atlantic Seabirds, V2, P35; Stenhouse IJ, 1999, MAR ECOL PROG SER, V184, P303, DOI 10.3354/meps184303; Tranquilla LM, 2015, CAN J ZOOL, V93, P447, DOI 10.1139/cjz-2014-0315; Tranquilla LAM, 2013, MAR ECOL PROG SER, V472, P287, DOI 10.3354/meps10053; Trathan PN, 2006, MAR ECOL PROG SER, V323, P239, DOI 10.3354/meps323239; Vander Wal E, 2012, ECOL MODEL, V224, P48, DOI 10.1016/j.ecolmodel.2011.10.006; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; Wiese FK, 2001, MAR POLLUT BULL, V42, P1285, DOI 10.1016/S0025-326X(01)00096-0; Wilhelm S. I., 2017, OBIS CANADA DIGITAL; Wilhelm Sabina I., 2015, Marine Ornithology, V43, P211	61	39	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0194389	10.1371/journal.pone.0194389	http://dx.doi.org/10.1371/journal.pone.0194389			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742124	gold, Green Published, Green Submitted			2022-12-26	WOS:000431757400005
J	Kittiskulnam, P; Thokanit, NI; Katavetin, P; Susanthitaphong, P; Srisawat, N; Praditpornsilpa, K; Tungsanga, K; Eiam-Ong, S				Kittiskulnam, Piyawan; Thokanit, Nintita Sripaiboonkij; Katavetin, Pisut; Susanthitaphong, Paweena; Srisawat, Nattachai; Praditpornsilpa, Kearkiat; Tungsanga, Kriang; Eiam-Ong, Somchai			The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study	PLOS ONE			English	Article							BODY-MASS INDEX; GLOMERULAR-FILTRATION-RATE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; RISK; PREVALENCE; HEALTH; ADULTS	Background Although the prevalence of obesity and metabolic syndrome (MetS) among dialysis patients has been exceeding than general population, little is known regarding obesity and MetS in non-dialysis chronic kidney disease (CKD). We aimed to find the magnitude of obesity and MetS and their associations with impaired renal function among type 2 diabetes mellitus (T2DM) patients. Methods A national survey of T2DM patients was collected in the Thai National Health Security Office database during 2014-5. The sampling frame was designated as distinct geographic regions throughout the country. A stratified two-stage cluster sampling was used to select the study population. Anthropometry and 12-hour fasting blood samples were obtained by trained personnel. BMI of >= 25 kg/m(2) was classified as obesity. MetS was defined as having elevated waist circumference (>90 and >80 cm in men and women, respectively) plus any two of the followings: triglyceride >= 150 mg/dL, HDL-C <40 in men or <50 mg/dL in women, blood pressure >= 130/85 mmHg, and fasting blood sugar >= 100 mg/dL. CKD was defined as an impaired renal function (eGFR <60 mL/min/1.73m(2) according to the CKD-EPI equation). Logistic regression analysis was performed to examine the relationship between obesity and MetS with the presence of CKD. Results A total of 32,616 diabetic patients were finally recruited from 997 hospitals. The mean age was 61.5 +/- 10.9 years with 67.5% women. Of the participants, 35.4% were CKD patients. The prevalence of obesity was 46.5% in CKD and 54.1% in non-CKD patients with T2DM (p<0.001). In contrast, the prevalence of MetS in CKD patients was higher than their non-CKD counterparts (71.3 vs 68.8%, p<0.001). Moreover, there was an association between the prevalence of MetS with CKD stage from 3a to 5 (70.1, 72.3, 73.4, and 72.7%, respectively, p trend = 0.02). MetS, but not obesity, had a significant association with CKD in T2DM patients after adjusting for age, sex, and comorbidities [OR 1.14; 95% CI 1.06-1.22, p<0.001]. When stratified by each component of MetS, only high serum triglyceride and low HDL-C levels were increased in patients with CKD stage 4 and 5 compared with CKD stage 3 (p<0.001) and had a significant relationship with impaired renal function. Conclusion There were relatively high prevalences of both obesity and MetS in T2DM patients. A higher prevalence of MetS, but lower prevalence of obesity, was observed among diabetic CKD group compared with their non-CKD counterparts. MetS, as a surrogate of insulin resistance, appeared to be more important than obesity in the development of impaired renal function in diabetic population.	[Kittiskulnam, Piyawan] Chulalongkorn Univ, Fac Med, Dept Med, Div Internal Med Nephrol, Bangkok, Thailand; [Kittiskulnam, Piyawan] Thai Red Cross Soc, King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Kittiskulnam, Piyawan; Praditpornsilpa, Kearkiat; Eiam-Ong, Somchai] Chulalongkorn Univ, Special Task Force Activating Res Renal Nutr, Renal Nutr Res Grp, Off Res Affairs, Bangkok, Thailand; [Kittiskulnam, Piyawan; Katavetin, Pisut; Susanthitaphong, Paweena; Srisawat, Nattachai; Praditpornsilpa, Kearkiat; Tungsanga, Kriang; Eiam-Ong, Somchai] Chulalongkorn Univ, Fac Med, Div Nephrol, Dept Med, Bangkok, Thailand; [Thokanit, Nintita Sripaiboonkij] Mahidol Univ, Ramathibodi Hosp, Ramathibodi Comprehens Canc Ctr, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; Chulalongkorn University; Mahidol University	Eiam-Ong, S (corresponding author), Chulalongkorn Univ, Special Task Force Activating Res Renal Nutr, Renal Nutr Res Grp, Off Res Affairs, Bangkok, Thailand.; Eiam-Ong, S (corresponding author), Chulalongkorn Univ, Fac Med, Div Nephrol, Dept Med, Bangkok, Thailand.	somchai80754@yahoo.com	Praditpronsilpa, Kearkiat/AFT-5058-2022; Katavetin, Pisut/Q-4199-2019; Srisawat, Nattachai/I-3122-2019	Katavetin, Pisut/0000-0001-8779-500X; 	Special Task Force for Activating Research (STAR) in Renal Nutrition, Chulalongkorn University; National Health Security Office (NHSO) of Thailand	Special Task Force for Activating Research (STAR) in Renal Nutrition, Chulalongkorn University; National Health Security Office (NHSO) of Thailand	This work has been made possible in part by a Special Task Force for Activating Research (STAR) in Renal Nutrition, Chulalongkorn University funded grant to Dr. Kittiskulnam. This work was supported through the National Health Security Office (NHSO) of Thailand The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2010, HYPERTENSION, V56, P893, DOI 10.1161/HYPERTENSIONAHA.110.160747; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Arinsoy T, 2016, J RENAL NUTR, V26, P373, DOI 10.1053/j.jrn.2016.08.004; Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; Carrero JJ, 2015, SEMIN DIALYSIS, V28, P48, DOI 10.1111/sdi.12287; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Franca AKTD, 2014, INT J NEPHROL, V2014, DOI 10.1155/2014/574267; De Cosmo S, 2006, DIABETES CARE, V29, P432, DOI 10.2337/diacare.29.02.06.dc05-1841; De Cosmo S, 2013, NEPHROL DIAL TRANSPL, V28, P29, DOI 10.1093/ndt/gfs290; De Cosmo S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004007; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; Fujita T, 2008, J MOL MED, V86, P729, DOI 10.1007/s00109-008-0343-1; Gansevoort RT, 2005, KIDNEY INT, V67, pS28, DOI 10.1111/j.1523-1755.2005.09408.x; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; Hashimoto Y, 2015, CLIN J AM SOC NEPHRO, V10, P578, DOI 10.2215/CJN.08980914; Isomaa B, 2001, DIABETOLOGIA, V44, P1148, DOI 10.1007/s001250100615; Kanazawa M, 2005, WORLD REV NUTR DIET, V94, P1, DOI 10.1159/000088200; Kobayashi S, 2005, AM J KIDNEY DIS, V45, P275, DOI 10.1053/j.ajkd.2004.09.034; Kramer HJ, 2006, J AM SOC NEPHROL, V17, P1453, DOI 10.1681/ASN.2005111241; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Lamacchia O, 2008, AM J NEPHROL, V28, P54, DOI 10.1159/000109239; Lerman LO, 2011, REV ESP CARDIOL, V64, P358, DOI 10.1016/j.recesp.2011.01.005; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Luk AOY, 2008, DIABETES CARE, V31, P2357, DOI 10.2337/dc08-0971; Mathew H, 2016, METABOLISM, V65, P73, DOI 10.1016/j.metabol.2015.10.019; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Obermayr RP, 2008, NEPHROL DIAL TRANSPL, V23, P1265, DOI 10.1093/ndt/gfm790; Penno G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125512; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; The Nephrology Society of Thailand, ANN REP THAIL REN RE; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; United States Renal Data System (USRDS), ANN DAT REP 2016; Viazzi F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176058; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586; World Health Organization, WHO TECHN REP SER, V894; Young Daniel O, 2007, Hemodial Int, V11, P86; Zhang J, 2017, ONCOTARGET, V8, P35619, DOI 10.18632/oncotarget.10915; Zhang X, 2017, TRANSL RES, V183, P14, DOI 10.1016/j.trsl.2016.12.004; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zoccali C, 2011, J INTERN MED, V269, P407, DOI 10.1111/j.1365-2796.2010.02342.x	43	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196332	10.1371/journal.pone.0196332	http://dx.doi.org/10.1371/journal.pone.0196332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742114	Green Published, Green Submitted, gold			2022-12-26	WOS:000431757400025
J	Lai, J; Woodward, R; Alexandrov, Y; Munnee, QA; Lees, CC; Vaidyanathan, R; Nowlan, NC				Lai, Jonathan; Woodward, Richard; Alexandrov, Yuriy; Munnee, Qurratul Ain; Lees, Christoph C.; Vaidyanathan, Ravi; Nowlan, Niamh C.			Performance of a wearable acoustic system for fetal movement discrimination	PLOS ONE			English	Article							HEALTH; WOMEN; CARE	Fetal movements (FM) are a key factor in clinical management of high-risk pregnancies such as fetal growth restriction. While maternal perception of reduced FM can trigger self-referral to obstetric services, maternal sensation is highly subjective. Objective, reliable monitoring of fetal movement patterns outside clinical environs is not currently possible. A wearable and non-transmitting system capable of sensing fetal movements over extended periods of time would be extremely valuable, not only for monitoring individual fetal health, but also for establishing normal levels of movement in the population at large. Wearable monitors based on accelerometers have previously been proposed as a means of tracking FM, but such systems have difficulty separating maternal and fetal activity and have not matured to the level of clinical use. We introduce a new wearable system based on a novel combination of accelerometers and bespoke acoustic sensors as well as an advanced signal processing architecture to identify and discriminate between types of fetal movements. We validate the system with concurrent ultrasound tests on a cohort of 44 pregnant women and demonstrate that the garment is capable of both detecting and discriminating the vigorous, whole-body 'startle' movements of a fetus. These results demonstrate the promise of multimodal sensing for the development of a low-cost, non-transmitting wearable monitor for fetal movements.	[Lai, Jonathan; Lees, Christoph C.] Imperial Coll London, Queen Charlottes & Chelsea Hosp, Imperial Coll Healthcare Natl Hlth Serv Trust, Ctr Fetal Care, London, England; [Woodward, Richard; Alexandrov, Yuriy; Munnee, Qurratul Ain; Vaidyanathan, Ravi] Imperial Coll London, Dept Mech Engn, London, England; [Woodward, Richard; Alexandrov, Yuriy; Munnee, Qurratul Ain; Nowlan, Niamh C.] Imperial Coll London, Dept Bioengn, London, England; [Lees, Christoph C.] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium	Imperial College London; Imperial College London; Imperial College London; KU Leuven	Nowlan, NC (corresponding author), Imperial Coll London, Dept Bioengn, London, England.	n.nowlan@imperial.ac.uk		Woodward, Richard/0000-0002-3060-5225; Vaidyanathan, Ravi/0000-0002-9625-4544; Nowlan, Niamh/0000-0002-9083-6279	UK Medical Research Council (MRC)/Imperial College Confidence in Concept Scheme; European Research Council under the European Union's Seventh Framework Programme (ERC) [336306]; UK National Institute for Health Research Biomedical Research Centre based at Imperial College Healthcare National Health Service Trust; Imperial College London; Dyson Foundation; UK Medical Research Council/ Imperial College Confidence in Concept Scheme; UK Medical Research Council/ Imperial College Proof of Concept Scheme; MRC [MC_PC_13064] Funding Source: UKRI	UK Medical Research Council (MRC)/Imperial College Confidence in Concept Scheme; European Research Council under the European Union's Seventh Framework Programme (ERC)(European Research Council (ERC)); UK National Institute for Health Research Biomedical Research Centre based at Imperial College Healthcare National Health Service Trust; Imperial College London(General Electric); Dyson Foundation; UK Medical Research Council/ Imperial College Confidence in Concept Scheme; UK Medical Research Council/ Imperial College Proof of Concept Scheme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the UK Medical Research Council (MRC)/Imperial College Confidence in Concept Scheme to NCN and RV. Funding to NCN from the European Research Council under the European Union's Seventh Framework Programme (ERC Grant agreement n8 [336306]) is acknowledged. CCL is supported by the UK National Institute for Health Research Biomedical Research Centre based at Imperial College Healthcare National Health Service Trust and Imperial College London. RV and RW were partially supported by the Dyson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andonotopo W, 2006, J PERINAT MED, V34, P471, DOI 10.1515/JPM.2006.092; de Vries JIP, 2006, ULTRASOUND OBST GYN, V27, P701, DOI 10.1002/uog.2740; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Dutton PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039784; Efkarpidis S, 2004, MEDSCAPE GEN MED, V6; Friedman J, 2001, SPRINGER SERIES STAT, V10; Froen JF, 2008, SEMIN PERINATOL, V32, P243, DOI 10.1053/j.semperi.2008.04.004; Froen JF, 2004, J PERINAT MED, V32, P13, DOI 10.1515/JPM.2004.003; Froen JF, 2008, SEMIN PERINATOL; Girier T, 2010, 10 INT C INF SCI SIG; GRANT A, 1989, LANCET, V2, P345; Hayat TTA, 2011, AM J NEURORADIOL, V32, P331, DOI 10.3174/ajnr.A2295; HERTOGS K, 1979, BRIT MED J, V2, P1183, DOI 10.1136/bmj.2.6199.1183; Hu YT, 2014, ANN BIOMED ENG, V42, P2264, DOI 10.1007/s10439-014-1111-8; Jimenez-Gonzalez A, 2010, IEEE T BIO-MED ENG, V57, P2322, DOI 10.1109/TBME.2010.2051226; Lai J, 2016, ACTA OBSTET GYN SCAN, V95, P968, DOI 10.1111/aogs.12944; Mesbah M, 2011, ENG MED BIOL SOC EMB; Nishihara K, 2008, EARLY HUM DEV, V84, P595, DOI 10.1016/j.earlhumdev.2008.03.001; O'Sullivan O, 2009, J OBSTET GYNAECOL, V29, P705, DOI 10.3109/01443610903229598; Ryo E, 2012, MED ENG PHYS, V34, P566, DOI 10.1016/j.medengphy.2011.09.001; Vaidyanathan R, 2014, United States patent application, Patent No. [US 15/034,165, 15034165]; Whitworth M, 2011, REDUCED FETAL MOVEME; Woodward RB, 2017, IEEE-ASME T MECH, V22, P2022, DOI 10.1109/TMECH.2017.2715163	23	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0195728	10.1371/journal.pone.0195728	http://dx.doi.org/10.1371/journal.pone.0195728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734344	Green Published, gold			2022-12-26	WOS:000431481700004
J	Abdul, S; Peeters, M; Brouwers, E; Malfliet, JJMC; Leebeek, FWG; Declerck, PJ; Rijken, DC; de Willige, SU				Abdul, Shiraazkhan; Peeters, Miet; Brouwers, Els; Malfliet, Joyce J. M. C.; Leebeek, Frank W. G.; Declerck, Paul J.; Rijken, Dingeman C.; de Willige, Shirley Uitte			Generation and characterization of monoclonal antibodies against the N-terminus of alpha-2-antiplasmin	PLOS ONE			English	Article							HUMAN-PLASMA; ALPHA-2-PLASMIN INHIBITOR; ALPHA2-PLASMIN INHIBITOR; FIBRINOLYSIS INHIBITOR; ALPHA(2)-ANTIPLASMIN; PLASMINOGEN; FORMS; ACTIVATION; BINDING; GENE	Around 70% of circulating alpha-2-antiplasmin (alpha 2AP), the main natural plasmin inhibitor, is N-terminally cleaved between residues Pro12 and Asn13 by antiplasmin-cleaving enzyme. This converts native Met-alpha 2AP into the more potent fibrinolysis inhibitor Asn-alpha 2AP. The Arg6Trp (R6W) polymorphism affects the N-terminal cleavage rate of Met-alpha 2AP in a purified system, with similar to 8-fold faster conversion of Met(R6)-alpha 2AP than Met(W6)-alpha 2AP. To date, assays to determine N-terminally intact Met-alpha 2AP in plasma have been limited to an ELISA that only measures Met(R6)-alpha 2AP. The aim of this study was to generate and characterize monoclonal antibodies (mAbs) against Met(R6)-alpha 2AP, Met(W6)-alpha 2AP and all alpha 2AP forms (total-alpha 2AP) in order to develop specific Met(R6)-alpha 2AP and Met(W6)-alpha 2AP ELISAs. Recombinant Met(R6)-alpha 2AP, Met(W6)-alpha 2AP and Asn-alpha 2AP were expressed in Drosophila S2 cells. Using hybridoma technology, a panel of 25 mAbs was generated against a mixture of recombinant Met(R6)-alpha 2AP and Met(W6)-alpha 2AP. All mAbs were evaluated for their specific reactivity using the three recombinant alpha 2APs in one-site non-competitive ELISAs. Three mAbs were selected to develop sandwich-type ELISAs. MA-AP37E2 and MAAP34C4 were selected for their specific reactivity against Met(R6)-alpha 2AP and Met(W6)-alpha 2AP, respectively, and used for coating. MA-AP15D7 was selected for its reactivity against total-alpha 2AP and used for detection. With the novel ELISAs we determined Met(R6)-alpha 2AP and Met(W6)-alpha 2AP levels in plasma samples and we showed that Met(R6)-alpha 2AP was converted faster into Asn-alpha 2AP than Met(W6)-alpha 2AP in a plasma milieu. In conclusion, we developed two specific ELISAs for Met(R6)-alpha 2AP and Met(W6)-alpha 2AP, respectively, in plasma. This will enable us to determine N-terminal heterogeneity of alpha 2AP in plasma samples.	[Abdul, Shiraazkhan; Malfliet, Joyce J. M. C.; Leebeek, Frank W. G.; Rijken, Dingeman C.; de Willige, Shirley Uitte] Erasmus Univ, Med Ctr Rotterdam, Dept Hematol, Rotterdam, Netherlands; [Peeters, Miet; Brouwers, Els; Declerck, Paul J.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Therapeut & Diagnost Antibodies, Leuven, Belgium	Erasmus University Rotterdam; Erasmus MC; KU Leuven	de Willige, SU (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Dept Hematol, Rotterdam, Netherlands.	s.uittedewillige@erasmusmc.nl	Declerck, Paul J/A-2330-2017; Peeters, Marc/C-5525-2013	Declerck, Paul J/0000-0003-1259-9105; Peeters, Marc/0000-0003-4969-2303	EHA-ISTH Joint Fellowship; International Society for Fibrinolysis and Proteolysis (ISFP)	EHA-ISTH Joint Fellowship; International Society for Fibrinolysis and Proteolysis (ISFP)	This work was supported by the EHA-ISTH Joint Fellowship 2013 (https://www.isth.org/news/149624/Dr.-Shirley-Uitte-de-Willige-Awarded-2013-ISTH-EHA-Joint-Fellowship.htm) and the International Society for Fibrinolysis and Proteolysis (ISFP) travel grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; S. Uitte de Willige was funded by the EHA-ISTH Joint Fellowship 2013. S. Abdul received a travel grant from the International Society for Fibrinolysis and Proteolysis (ISFP) to visit the laboratory of Prof. Dr. PJ Declerck for the generation of the monoclonal antibodies.	Abdul S, 2016, BLOOD, V127, P538, DOI 10.1182/blood-2015-09-670117; BANGERT K, 1993, BIOCHEM J, V291, P623, DOI 10.1042/bj2910623; CHRISTENSEN U, 1978, BIOCHEM J, V175, P635, DOI 10.1042/bj1750635; Christiansen VJ, 2007, BLOOD, V109, P5286, DOI 10.1182/blood-2007-01-065185; CLEMMENSEN I, 1981, EUR J BIOCHEM, V120, P105, DOI 10.1111/j.1432-1033.1981.tb05675.x; COLLEN D, 1976, EUR J BIOCHEM, V69, P209, DOI 10.1111/j.1432-1033.1976.tb10875.x; de Bruijne ELE, 2009, J THROMB HAEMOST, V7, P919, DOI 10.1111/j.1538-7836.2009.03350.x; De Willige SU, 2013, J THROMB HAEMOST, V11, P2029, DOI 10.1111/jth.12396; de Willige SU, 2011, BLOOD, V117, P6694, DOI 10.1182/blood-2010-11-320325; Galfre G, 1981, Methods Enzymol, V73, P3; HATTEY E, 1987, THROMB RES, V45, P485, DOI 10.1016/0049-3848(87)90311-2; HIROSAWA S, 1988, P NATL ACAD SCI USA, V85, P6836, DOI 10.1073/pnas.85.18.6836; KLUFT C, 1981, THROMB RES, V21, P65, DOI 10.1016/0049-3848(84)90033-1; Law RHP, 2008, BLOOD, V111, P2049, DOI 10.1182/blood-2007-09-114215; Lee KN, 2007, J THROMB HAEMOST, V5, P2095, DOI 10.1111/j.1538-7836.2007.02707.x; Lee KN, 2006, BLOOD, V107, P1397, DOI 10.1182/blood-2005-08-3452; Lee KN, 2004, BLOOD, V103, P3783, DOI 10.1182/blood-2003-12-4240; LIJNEN HR, 1987, EUR J BIOCHEM, V166, P565, DOI 10.1111/j.1432-1033.1987.tb13551.x; Lind B, 1999, BRIT J HAEMATOL, V107, P317, DOI 10.1046/j.1365-2141.1999.01708.x; MIMURO J, 1987, BLOOD, V69, P446; MOROI M, 1976, J BIOL CHEM, V251, P5956; MULLERTZ S, 1976, BIOCHEM J, V159, P545; NAKANE PK, 1974, J HISTOCHEM CYTOCHEM, V22, P1084, DOI 10.1177/22.12.1084; Reed GL, 1997, HYBRIDOMA, V16, P281, DOI 10.1089/hyb.1997.16.281; Rijken DC, 2016, J THROMB HAEMOST, V14, P1453, DOI 10.1111/jth.13354; SAKATA Y, 1982, J CLIN INVEST, V69, P536, DOI 10.1172/JCI110479; Singh S, 2017, CIRCULATION, V135, P1011, DOI 10.1161/CIRCULATIONAHA.116.024421; Vandevenne E, 2009, J IMMUNOL METHODS, V349, P18, DOI 10.1016/j.jim.2009.08.004; WIMAN B, 1982, THROMB RES, V28, P193, DOI 10.1016/0049-3848(82)90261-4	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196911	10.1371/journal.pone.0196911	http://dx.doi.org/10.1371/journal.pone.0196911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723259	Green Published, Green Submitted, gold			2022-12-26	WOS:000431305100090
J	Corsello, A; Di Filippo, L; Massironi, S; Sileo, F; Capuzzo, AD; Gemma, M; Carlucci, C; Cusini, C; Colombo, B; Dallatomasina, A; Franchi, GM; Corti, A; Manzoni, MF				Corsello, Andrea; Di Filippo, Luigi; Massironi, Sara; Sileo, Federica; Capuzzo, Anna Dolcetta; Gemma, Marco; Carlucci, Claudia; Cusini, Claudio; Colombo, Barbara; Dallatomasina, Alice; Franchi, Giulia Maria; Corti, Angelo; Manzoni, Marco Federico			Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms	PLOS ONE			English	Article							HUMAN CHROMOGRANIN-A; ENDOTHELIAL-CELLS; CARCINOID-TUMORS; CLINICAL UTILITY; HEART-FAILURE; DISEASE; PEPTIDE; FRAGMENT; PLASMA; PANCREASTATIN	Background Chromogranin A (CgA) is a plasma biomarker widely used in the follow-up of patients with neuroendocrine neoplasms (NENs). However, its accuracy as a tumor biomarker is relatively low because plasma CgA can increase also in patients with other diseases or in subjects treated with proton-pump inhibitors (PPIs), a class of widely-used drugs. Methods In the attempt to identify a more reliable biomarker for NENs, we investigated, by ELISA, the circulating levels of full-length CgA (CgA(1-439)) and of various CgA-derived fragments in 17 patients with ileal or pancreatic NENs, 10 healthy controls, and 21 healthy volunteers before and after treatment with PPIs. Results Patients with ileal or pancreatic NENs showed increased plasma levels of total-CgA and CgA(1-76) fragment (vasostatin-1, VS-1) compared to controls [median (25th -75th -percentiles); total-CgA: 1.85 nM (1.01-4.28) vs 0.75 nM (0.52-0.89), p = 0.004; VS-1: 2.76 nM (1.097.10) vs 0.29 nM (0.26-0.32), p<0.001, respectively], but not of CgA(1)(-439) or CgA(1)(-373) fragment. VS-1 positively correlated with total-CgA (r = 0.65, p<0.001). The Receiver Operating Characteristic area under the curve was 0.9935 for VS-1 and 0.8824 for total-CgA (p = 0.067). Treatment of patients with somatostatin analogues decreased both total-CgA and VS-1. In contrast, administration of PPIs increased the plasma levels of total-CgA, but not of VS-1. Conclusion These findings suggest that plasma VS-1 is a novel biomarker for ileal and pancreatic NENs. Considering that VS-1 is a well-defined fragment not induced by proton-pump inhibitors, this polypeptide might represent a biomarker for NENs diagnosis and follow-up more accurate and easier to standardize than CgA.	[Corsello, Andrea; Di Filippo, Luigi; Sileo, Federica; Capuzzo, Anna Dolcetta; Cusini, Claudio; Franchi, Giulia Maria; Manzoni, Marco Federico] Ist Sci San Raffaele, Dept Gen Med, Milan, Italy; [Corsello, Andrea; Di Filippo, Luigi; Sileo, Federica; Capuzzo, Anna Dolcetta; Cusini, Claudio; Franchi, Giulia Maria; Manzoni, Marco Federico] Ist Sci San Raffaele, Endocrine Tumor Unit, Milan, Italy; [Massironi, Sara] Fdn IRCCS Ca Grande Osped Maggiore Policlin, Dept Gastroenterol, Milan, Italy; [Massironi, Sara] Fdn IRCCS Ca Grande Osped Maggiore Policlin, Endoscopy Unit, Milan, Italy; [Gemma, Marco] Ist Sci San Raffaele, Dept Neurointens Care, Milan, Italy; [Carlucci, Claudia] Haematol Project Fdn, Clin Study & Data Management Unit, Vicenza, Italy; [Colombo, Barbara; Dallatomasina, Alice; Corti, Angelo] Ist Sci San Raffaele, Div Expt Oncol, Milan, Italy; [Corti, Angelo; Manzoni, Marco Federico] San Raffaele Vita Salute Univ, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Manzoni, MF (corresponding author), Ist Sci San Raffaele, Dept Gen Med, Milan, Italy.; Manzoni, MF (corresponding author), Ist Sci San Raffaele, Endocrine Tumor Unit, Milan, Italy.; Corti, A (corresponding author), Ist Sci San Raffaele, Div Expt Oncol, Milan, Italy.; Corti, A; Manzoni, MF (corresponding author), San Raffaele Vita Salute Univ, Milan, Italy.	corti.angelo@hsr.it; manzoni.marca@hsr.it	Massironi, Sara/X-4138-2019; Colombo, Barbara/AAN-5045-2020; Corti, Angelo/F-7046-2012; Manzoni, Marco Federico/AAB-1738-2021; Massironi, Sara/X-2547-2019	Colombo, Barbara/0000-0002-5887-5868; Corti, Angelo/0000-0002-0893-6191; Massironi, Sara/0000-0003-3214-8192; Sileo, Federica/0000-0001-5732-2228; carlucci, claudia/0000-0001-9642-0242; Corsello, Andrea/0000-0001-8167-4338	Associazione Italiana per la Ricerca sul Cancro (AIRC, Special Program Molecular Clinical Oncology) [5x1000-9965, AIRC: IG-14338, IG-9965, IG-19220]; Italfarmaco SpA; Associazione Italiana Ricerca sul Cancro [AIRC: IG-14338, IG-9965]	Associazione Italiana per la Ricerca sul Cancro (AIRC, Special Program Molecular Clinical Oncology)(Fondazione AIRC per la ricerca sul cancro); Italfarmaco SpA; Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC, Special Program Molecular Clinical Oncology 5x1000-9965, AIRC: IG-14338, IG-9965, and IG-19220) and from Italfarmaco SpA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Associazione Italiana Ricerca sul Cancro (Grant No. AIRC: IG-14338 and IG-9965 to A.C.) and from Italfarmaco SpA.	AARDAL S, 1992, REGUL PEPTIDES, V41, P9, DOI 10.1016/0167-0115(92)90509-S; Bianco M, 2016, CANCER RES, V76, P1781, DOI 10.1158/0008-5472.CAN-15-1637; Blois A, 2006, REGUL PEPTIDES, V135, P78, DOI 10.1016/j.regpep.2006.04.007; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Ceconi C, 2002, EUR HEART J, V23, P967, DOI 10.1053/euhj.2001.2977; Colombo B, 2002, J BIOL CHEM, V277, P45911, DOI 10.1074/jbc.M202637200; Corti A, 1996, EUR J BIOCHEM, V235, P275, DOI 10.1111/j.1432-1033.1996.00275.x; Corti A, 1996, BRIT J CANCER, V73, P924, DOI 10.1038/bjc.1996.183; Corti A, 2000, ADV EXP MED BIOL, V482, P351; Corti A, 2018, PFLUG ARCH EUR J PHY, V470, P199, DOI 10.1007/s00424-017-2030-y; Corti A, 2010, CELL MOL NEUROBIOL, V30, P1163, DOI 10.1007/s10571-010-9587-8; Crippa L, 2013, BLOOD, V121, P392, DOI 10.1182/blood-2012-05-430314; Cunningham RT, 1999, J PATHOL, V187, P321; Gadroy P, 1998, J BIOL CHEM, V273, P34087, DOI 10.1074/jbc.273.51.34087; Giovinazzo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081111; Giusti M, 2004, EUR J ENDOCRINOL, V150, P299, DOI 10.1530/eje.0.1500299; Gregorc V, 2007, CANCER-AM CANCER SOC, V110, P845, DOI 10.1002/cncr.22856; Gut P, 2016, ARCH MED SCI, V12, P1, DOI 10.5114/aoms.2016.57577; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; Koshimizu H, 2011, MOL ENDOCRINOL, V25, P732, DOI 10.1210/me.2010-0124; Loh YP, 2012, J MOL NEUROSCI, V48, P347, DOI 10.1007/s12031-012-9728-2; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; Marotta V, 2018, ENDOCR-RELAT CANCER, V25, pR11, DOI 10.1530/ERC-17-0269; Massironi S, 2009, DIGEST LIVER DIS, V41, P31, DOI 10.1016/j.dld.2008.05.002; Modlin IM, 2010, ANN SURG ONCOL, V17, P2427, DOI 10.1245/s10434-010-1006-3; Oberg K, 1997, YALE J BIOL MED, V70, P501; OCONNOR DT, 1986, NEW ENGL J MED, V314, P1145, DOI 10.1056/NEJM198605013141803; Portela-Gomes GM, 2010, CELL MOL NEUROBIOL, V30, P1147, DOI 10.1007/s10571-010-9585-x; Pregun I, 2011, DIGESTION, V84, P22, DOI 10.1159/000321535; Ratti S, 2000, J BIOL CHEM, V275, P29257, DOI 10.1074/jbc.M003796200; Schneider F, 2012, INTENS CARE MED, V38, P1514, DOI 10.1007/s00134-012-2611-3; Sciolo V, 2009, INFLAMM BOWEL DIS, V15, P867, DOI 10.1002/ibd.20851; Stridsberg M, 2004, REGUL PEPTIDES, V117, P219, DOI 10.1016/j.regpep.2003.10.023; STRIDSBERG M, 1995, J ENDOCRINOL, V144, P49, DOI 10.1677/joe.0.1440049; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Theurl M, 2010, CIRC RES, V107, P1326, DOI 10.1161/CIRCRESAHA.110.219493; Tomassetti P, 2001, EUR J GASTROEN HEPAT, V13, P55, DOI 10.1097/00042737-200101000-00010; Tombetti E, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1082-2; Veschini L, 2011, FASEB J, V25, P3906, DOI 10.1096/fj.11-182410; ZIEGLER MG, 1990, KIDNEY INT, V37, P1357, DOI 10.1038/ki.1990.122	41	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196858	10.1371/journal.pone.0196858	http://dx.doi.org/10.1371/journal.pone.0196858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723285	Green Submitted, Green Published, gold			2022-12-26	WOS:000431305100078
J	Divan, A; Casselli, T; Narayanan, SA; Mukherjee, S; Zawieja, DC; Watt, JA; Brissette, CA; Newell-Rogers, MK				Divan, Ali; Casselli, Timothy; Narayanan, S. Anand; Mukherjee, Sanjib; Zawieja, David C.; Watt, John A.; Brissette, Catherine A.; Newell-Rogers, M. Karen			Borrelia burgdorferi adhere to blood vessels in the dura mater and are associated with increased meningeal T cells during murine disseminated borreliosis	PLOS ONE			English	Article							NONHUMAN PRIMATE MODEL; LYME NEUROBORRELIOSIS; NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; ANTIBODY-PRODUCTION; BINDING PROTEIN; MOUSE MODEL; LOCALIZATION; RESPONSES; DISEASE	Borrelia burgdorferi, the causative agent of Lyme disease, is a vector-borne bacterial infection that is transmitted through the bite of an infected tick. If not treated with antibiotics during the early stages of infection, disseminated infection can spread to the central nervous system (CNS). In non-human primates (NHPs) it has been demonstrated that the leptomeninges are among the tissues colonized by B. burgdorferi spirochetes. Although the NHP model parallels aspects of human borreliosis, a small rodent model would be ideal to study the trafficking of spirochetes and immune cells into the CNS. Here we show that during early and late disseminated infection, B. burgdorferi infects the meninges of intradermally infected mice, and is associated with concurrent increases in meningeal T cells. We found that the dura mater was consistently culture positive for spirochetes in transcardially perfused mice, independent of the strain of B. burgdorferi used. Within the dura mater, spirochetes were preferentially located in vascular regions, but were also present in perivascular, and extravascular regions, as late as 75 days post-infection. At the same end-point, we observed significant increases in the number of CD3+ T cells within the pia and dura mater, as compared to controls. Flow cytometric analysis of leukocytes isolated from the dura mater revealed that CD3+ cell populations were comprised of both CD4 and CD8 T cells. Overall, our data demonstrate that similarly to infection in peripheral tissues, spirochetes adhere to the dura mater during disseminated infection, and are associated with increases in the number of meningeal T cells. Collectively, our results demonstrate that there are aspects of B. burgdorferi meningeal infection that can be modelled in laboratory mice, suggesting that mice may be useful for elucidating mechanisms of meningeal pathogenesis by B. burgdorferi.	[Divan, Ali; Casselli, Timothy; Watt, John A.; Brissette, Catherine A.] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58202 USA; [Narayanan, S. Anand; Mukherjee, Sanjib; Zawieja, David C.] Texas A&M Hlth Sci Ctr, Dept Med Physiol, College Stn, TX USA; [Newell-Rogers, M. Karen] Univ Colorado, Trauma Hlth & Hazards Ctr, Colorado Springs, CO 80907 USA	University of North Dakota Grand Forks; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Colorado System; University of Colorado at Colorado Springs	Brissette, CA (corresponding author), Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58202 USA.	Catherine.brissette@med.und.edu		Casselli, Timothy/0000-0003-1954-2443; Brissette, Catherine/0000-0003-0792-1403; Divan, Ali/0000-0002-2569-5086	Global Lyme Alliance; NIH [U01HL123420, P20GM11312301, 1R21A1125775-01, 1R21A126883-01, 5P30GM103329, 5P20GM113123]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL123420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113123] Funding Source: NIH RePORTER	Global Lyme Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Newell-Rogers laboratory was financially supported by The Global Lyme Alliance; The Zawieja laboratory was financially supported by NIH (U01HL123420). Funding for the Brissette laboratory was provided by NIH (P20GM11312301, 1R21A1125775-01, 1R21A126883-01) and the Global Lyme Alliance. The Edward C. Carlson imaging and image analysis core facility was supported by NIH (5P30GM103329 and 5P20GM113123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonara S, 2011, ADV EXP MED BIOL, V715, P35, DOI 10.1007/978-94-007-0940-9_3; Bai YH, 2004, LAB INVEST, V84, P160, DOI 10.1038/labinvest.3700024; BARTHOLD SW, 1991, AM J PATHOL, V139, P263; BARTHOLD SW, 1993, AM J PATHOL, V143, P959; Bockenstedt LK, 2012, J CLIN INVEST, V122, P2652, DOI 10.1172/JCI58813; Bunikis I, 2011, J MICROBIOL METH, V86, P243, DOI 10.1016/j.mimet.2011.05.004; Cadavid D, 2001, INFECT IMMUN, V69, P3389, DOI 10.1128/IAI.69.5.3389-3397.2001; Cadavid D, 2000, LAB INVEST, V80, P1043, DOI 10.1038/labinvest.3780109; Caine JA, 2015, INFECT IMMUN, V83, P3184, DOI 10.1128/IAI.00349-15; DESOUZA MS, 1993, INFECT IMMUN, V61, P4493, DOI 10.1128/IAI.61.10.4493-4497.1993; Divan A, 2015, J LEUKOCYTE BIOL, V97, P653, DOI 10.1189/jlb.2RU0714-343RR; Elsner RA, 2015, INFECT IMMUN, V83, P48, DOI 10.1128/IAI.02471-14; Garcia-Monco JC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003288; GarciaMonco JC, 1997, J INFECT DIS, V175, P1243, DOI 10.1086/593681; GUO BP, 1995, INFECT IMMUN, V63, P3467, DOI 10.1128/IAI.63.9.3467-3472.1995; Gyllemark P, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0789-6; Hagman KE, 1998, INFECT IMMUN, V66, P2674, DOI 10.1128/IAI.66.6.2674-2683.1998; Halperin JJ, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-014-0445-6; Hastey CJ, 2012, J IMMUNOL, V188, P5612, DOI 10.4049/jimmunol.1103735; Henningsson AJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-36; Holub M, 2002, ACTA NEUROL SCAND, V106, P302, DOI 10.1034/j.1600-0404.2002.01314.x; Hove PR, 2014, INFECT IMMUN, V82, P43, DOI 10.1128/IAI.01061-13; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Imai DM, 2013, LAB INVEST, V93, P900, DOI 10.1038/labinvest.2013.81; Kazragis RJ, 1996, ANTIMICROB AGENTS CH, V40, P2632, DOI 10.1128/AAC.40.11.2632; Lemichez E, 2010, NAT REV MICROBIOL, V8, P93, DOI 10.1038/nrmicro2269; Li LB, 2006, J NEUROIMMUNOL, V173, P56, DOI 10.1016/j.jneuroim.2005.11.019; Liang FT, 2004, AM J PATHOL, V165, P977, DOI 10.1016/S0002-9440(10)63359-7; Liu Li, 2008, J Vis Exp, DOI 10.3791/960; Louveau A, 2015, DISSECTION IMMUNOSTA; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lunemann JD, 2007, INFECT IMMUN, V75, P243, DOI 10.1128/IAI.01110-06; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Moriarty TJ, 2012, MOL MICROBIOL, V86, P1116, DOI 10.1111/mmi.12045; Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090; Norman MU, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000169; Pachner AR, 2001, IMMUNOL REV, V183, P186, DOI 10.1034/j.1600-065x.2001.1830115.x; PACHNER AR, 1990, NEUROLOGY, V40, P1535, DOI 10.1212/WNL.40.10.1535; PACHNER AR, 1995, NEUROLOGY, V45, P165, DOI 10.1212/WNL.45.1.165; PERSING DH, 1994, INFECT IMMUN, V62, P3521, DOI 10.1128/IAI.62.8.3521-3527.1994; Roberts ED, 1998, J INFECT DIS, V178, P722, DOI 10.1086/515357; SCHOLZEN T, 1994, J BIOL CHEM, V269, P28270; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; Tracy KE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00116; Wadhwa S, 2007, BONE, V40, P861, DOI 10.1016/j.bone.2006.11.003; Whiteside SK, 2018, J IMMUNOL, V200, P1457, DOI 10.4049/jimmunol.1701248; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	48	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196893	10.1371/journal.pone.0196893	http://dx.doi.org/10.1371/journal.pone.0196893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723263	gold, Green Published, Green Submitted			2022-12-26	WOS:000431305100087
J	Lin, TK; Chou, P; Lin, CH; Hung, YJ; Jong, GP				Lin, Tsung-Kun; Chou, Pesus; Lin, Ching-Heng; Hung, Yi-Jen; Jong, Gwo-Ping			Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study	PLOS ONE			English	Article							COA REDUCTASE INHIBITORS; BONE-MINERAL DENSITY; SCANDINAVIAN SIMVASTATIN SURVIVAL; OSTEOBLAST DIFFERENTIATION; FRACTURE RISK; IN-VITRO; METAANALYSIS; PATHWAY; TRIAL; EXPRESSION	Background Several observational cohort and meta-analytical studies in humans have shown that statin users have a lower risk of fractures or greater bone mineral densities (BMD) than nonusers. However, some studies including randomized clinical trials have the opposite results, particularly in Asian populations. Objective This study investigates the impacts of statins on new-onset osteoporosis in Taiwan. Methods In a nationwide retrospective population-based cohort study, 45,342 subjects aged between 50-90 years having received statin therapy (statin-users) since January 1 2001, and observed through December 31 2013 were selected from the National Health Insurance Research Database of Taiwan. Likewise, 115,594 patients had no statin therapy (statin-non-users) were included as controls in this study. Multivariable Cox proportional hazards analysis for drug exposures was employed to evaluate the association between statin treatment and new-onset of osteoporosis risk. We also used the long-rank test to evaluate the difference of probability of osteoporosis-free survival. Results During the 13-year follow-up period, 16,146 of all enrolled subjects (10.03%) developed osteoporosis, including 3097 statin-users (6.83%) and 13,049 statin-non-users (11.29%). Overall, statin therapy reduced the risk of new-onset osteoporosis by 48% (adjusted hazard ratio [HR] 0.52; 95% CI 0.50 to 0.54). A dose-response relationship between statin treatment and the risk of new-onset osteoporosis was observed. The adjusted hazard ratios for new-onset osteoporosis were 0.84 (95% CI, 0.78 to 0.90), 0.56 (95% CI, 0.52 to 0.60) and 0.23 (95% CI, 0.21 to 0.25) when cumulative defined daily doses (cDDDs) ranged from 28 to 90, 91 to 365, and more than 365, respectively, relative to nonusers. Otherwise, high-potency statins (rosuvastatin and atorvastatin) and moderate-potency statin (simvastatin) seemed to have a potential protective effect for osteoporosis. Conclusions In this population-based cohort study, we found that statin use is associated with a decreased risk of osteoporosis in both genders. The osteoprotective effect of statins seemed to be more prominent with a dependency on the cumulative dosage and statin intensity.	[Lin, Tsung-Kun] Taoyuan Armed Forces Gen Hosp, Taoyuan, Taiwan; [Lin, Tsung-Kun; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Lin, Tsung-Kun; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan; [Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Hung, Yi-Jen] Natl Def Med Ctr, Triserv Gen Hosp, Div Endocrinol & Metab, Dept Internal Med,Sch Med, Taipei, Taiwan; [Jong, Gwo-Ping] Chung Shan Med Univ Hosp, Div Internal Cardiol, Taichung, Taiwan; [Jong, Gwo-Ping] Chung Shan Med Univ, Taichung, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Defense Medical Center; Tri-Service General Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Jong, GP (corresponding author), Chung Shan Med Univ Hosp, Div Internal Cardiol, Taichung, Taiwan.; Jong, GP (corresponding author), Chung Shan Med Univ, Taichung, Taiwan.	cgp8009@yahoo.com.tw		Jong, Gwo-Ping/0000-0002-7786-5497	Taichung Veterans General Hospital, Taiwan [TCVGH-NHR110603, TCVGH-1067310C, TCVGH-FCU1068205, TCVGH-YM1060201, TCVGH-VTA106PREM1]	Taichung Veterans General Hospital, Taiwan	This study was supported in part by grants from Taichung Veterans General Hospital, Taiwan (TCVGH-NHR110603, TCVGH-1067310C, TCVGH-FCU1068205, TCVGH-YM1060201, TCVGH-VTA106PREM1). The authors would like to thank the Healthcare Service Research Center (HSRC) of Taichung Veterans General Hospital for statistical support. There was no additional external funding received for this study.	Ahn KS, 2008, INT J CANCER, V123, P1733, DOI 10.1002/ijc.23745; An T, 2017, OSTEOPOROSIS INT, V28, P47, DOI 10.1007/s00198-016-3844-8; Bjarnason NH, 2001, OSTEOPOROSIS INT, V12, P380, DOI 10.1007/s001980170106; Cannon CP, 2015, NEW ENGL J MED, V373, P1476, DOI 10.1056/NEJMc1509363; CENTRELLA M, 1987, J BIOL CHEM, V262, P2869; Chrysant SG, 2017, POSTGRAD MED, V129, P430, DOI 10.1080/00325481.2017.1292107; Erlandson KM, 2015, AIDS, V29, P175, DOI 10.1097/QAD.0000000000000526; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; Hatzigeorgiou C, 2005, OSTEOPOROSIS INT, V16, P990, DOI 10.1007/s00198-004-1793-0; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Helin-Salmivaara A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048095; Hughes A, 2007, CALCIFIED TISSUE INT, V81, P403, DOI 10.1007/s00223-007-9078-1; Jadhav SB, 2006, J PHARM PHARMACOL, V58, P1451, DOI 10.1211/jpp.58.11.0005; LaCroix AZ, 2003, ANN INTERN MED, V139, P97, DOI 10.7326/0003-4819-139-2-200307150-00009; Liu J, 2013, BONE, V54, P151, DOI 10.1016/j.bone.2013.01.044; Majima T, 2007, INTERNAL MED, V46, P1967, DOI 10.2169/internalmedicine.46.0419; Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205; Monjo M, 2010, CELL PHYSIOL BIOCHEM, V26, P647, DOI 10.1159/000322332; Morse LR, 2016, OSTEOPOROSIS INT, V27, P3503, DOI 10.1007/s00198-016-3678-4; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2000, AM J CARDIOL, V86, P257, DOI 10.1016/S0002-9149(00)00910-3; Pena JM, 2015, JAMA INTERN MED, V175, P171, DOI 10.1001/jamainternmed.2014.6388; Reid IR, 2001, LANCET, V357, P509, DOI 10.1016/S0140-6736(00)04042-3; Rejnmark L, 2004, OSTEOPOROSIS INT, V15, P452, DOI 10.1007/s00198-003-1568-z; Ridker PM, 2010, AM J CARDIOL, V106, P1351, DOI 10.1016/j.amjcard.2010.08.025; Roy Satyajeet, 2017, J Clin Med Res, V9, P638, DOI 10.14740/jocmr3066w; Scranton RE, 2005, ARCH INTERN MED, V165, P2007, DOI 10.1001/archinte.165.17.2007; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Swiger KJ, 2013, MAYO CLIN PROC, V88, P1213, DOI 10.1016/j.mayocp.2013.07.013; Tsubaki M, 2012, MOL CELL ENDOCRINOL, V361, P219, DOI 10.1016/j.mce.2012.05.002; Uzzan B, 2007, BONE, V40, P1581, DOI 10.1016/j.bone.2007.02.019; Wada Y, 2000, ARCH INTERN MED, V160, P2865, DOI 10.1001/archinte.160.18.2865; Weivoda MM, 2011, J CELL BIOCHEM, V112, P1506, DOI 10.1002/jcb.23087; Yamashita M, 2008, J ENDOCRINOL, V196, P601, DOI 10.1677/JOE-07-0532	36	25	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196713	10.1371/journal.pone.0196713	http://dx.doi.org/10.1371/journal.pone.0196713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723231	Green Submitted, gold, Green Published			2022-12-26	WOS:000431305100057
J	Leung-Theung-Long, S; Coupet, CA; Gouanvic, M; Schmitt, D; Ray, A; Hoffmann, C; Schultz, H; Tyagi, S; Soni, H; Converse, PJ; Arias, L; Kleinpeter, P; Sansas, B; Mdluli, K; Vilaplana, C; Cardona, PJ; Nuermberger, E; Marchand, JB; Silvestre, N; Inchauspe, G				Leung-Theung-Long, Stephane; Coupet, Charles-Antoine; Gouanvic, Marie; Schmitt, Doris; Ray, Aurelie; Hoffmann, Chantal; Schultz, Huguette; Tyagi, Sandeep; Soni, Heena; Converse, Paul J.; Arias, Lilibeth; Kleinpeter, Patricia; Sansas, Benoit; Mdluli, Khisimuzi; Vilaplana, Cristina; Cardona, Pere-Joan; Nuermberger, Eric; Marchand, Jean-Baptiste; Silvestre, Nathalie; Inchauspe, Genevieve			A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis	PLOS ONE			English	Article							CD8(+) T-CELLS; MURINE MODEL; MOUSE MODEL; VIRUS; IMMUNOTHERAPY; INTERFERON; PERSPECTIVES; IMMUNIZATION; BEDAQUILINE; PROTECTION	Despite the existence of the prophylactic Bacille Calmette-Guerin (BCG) vaccine, infection by Mycobacterium tuberculosis (Mtb) remains a major public health issue causing up to 1.8 million annual deaths worldwide. Increasing prevalence of Mtb strains resistant to antibiotics represents an urgent threat for global health that has prompted a search for alternative treatment regimens not subject to development of resistance. Immunotherapy constitutes a promising approach to improving current antibiotic treatments through engagement of the host's immune system. We designed a multi-antigenic and multiphasic vaccine, based on the Modified Vaccinia Ankara (MVA) virus, denoted MVATG18598, which expresses ten antigens classically described as representative of each of different phases of Mtb infection. In vitro analysis coupled with multiple-passage evaluation demonstrated that this vaccine is genetically stable, i.e. fit for manufacturing. Using different mouse strains, we show that MVATG18598 vaccination results in both Th1-associated T-cell responses and cytolytic activity, targeting all 10 vaccine-expressed Mtb antigens. In chronic post-exposure mouse models, MVATG18598 vaccination in combination with an antibiotic regimen decreases the bacterial burden in the lungs of infected mice, compared with chemotherapy alone, and is associated with long-lasting antigen-specific Th1-type T cell and antibody responses. In one model, co-treatment with MVATG18598 prevented relapse of the disease after treatment completion, an important clinical goal. Overall, results demonstrate the capacity of the therapeutic MVATG18598 vaccine to improve efficacy of chemotherapy against TB. These data support further development of this novel immunotherapeutic in the treatment of Mtb infections.	[Leung-Theung-Long, Stephane; Coupet, Charles-Antoine; Gouanvic, Marie; Ray, Aurelie; Inchauspe, Genevieve] Transgene SA, Infect Dis Dept, Ctr Infectiol, Bat Domilyon, Lyon, France; [Schmitt, Doris; Hoffmann, Chantal; Schultz, Huguette; Kleinpeter, Patricia; Sansas, Benoit; Marchand, Jean-Baptiste; Silvestre, Nathalie] Transgene SA, Blvd Gonthier Dandernach,Parc Innovat, Illkirch Graffenstaden, France; [Tyagi, Sandeep; Soni, Heena; Converse, Paul J.; Nuermberger, Eric] Johns Hopkins Univ, Dept Med, Ctr TB Res, Baltimore, MD USA; [Arias, Lilibeth; Vilaplana, Cristina; Cardona, Pere-Joan] Univ Autanoma Barcelona, Unitat Tuberculosi Expt, Fundacio Inst Germans Trias & Pujol, CIBERES, Crta Badalona, Catalonia, Spain; [Mdluli, Khisimuzi] Global Alliance TB Drug Dev, New York, NY USA	Transgene SA; Transgene SA; Johns Hopkins University; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Leung-Theung-Long, S (corresponding author), Transgene SA, Infect Dis Dept, Ctr Infectiol, Bat Domilyon, Lyon, France.	leung_theung_long@transgene.fr	Cardona, Pere-Joan/A-5258-2011; Vilaplana, Cristina/K-7216-2012	Cardona, Pere-Joan/0000-0001-5623-7873; Vilaplana, Cristina/0000-0002-2808-7270; LEUNG-THEUNG-LONG, Stephane/0000-0001-5590-9666	National Institute of Allergy and Infectious Diseases [R01-A1098911]; European Union's Horizon research and innovation programme [643381]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098911] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Union's Horizon research and innovation programme; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported in part by Award Number R01-A1098911 from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 643381 (https://ec. europa.eu/programmes/horizon2020). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Transgene SA provided support in the form of salaries for authors SL, CC, MG, DS, AR, CH, HS, PK, BS, JM, NS, and GI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Abate G, 2016, IMMUNOTARGETS THER, V5, P37, DOI 10.2147/ITT.S81892; [Anonymous], 2016, 47 UN WORLD C LUNG H; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Beverley PCL, 2014, J IMMUNOL, V193, P2306, DOI 10.4049/jimmunol.1302523; Bloemberg GV, 2015, NEW ENGL J MED, V373, P1986, DOI 10.1056/NEJMc1505196; Boukhebza H, 2012, HUM VACC IMMUNOTHER, V8, P1746, DOI 10.4161/hv.21689; Cardona PJ, 2017, INT J INFECT DIS, V56, P268, DOI 10.1016/j.ijid.2017.01.030; Cardona PJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01536; Cardona PJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00354; Cardona PJ, 2005, VACCINE, V23, P1393, DOI 10.1016/j.vaccine.2004.09.008; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; COCHRAN MA, 1985, J VIROL, V54, P30, DOI 10.1128/JVI.54.1.30-37.1985; Coler RN, 2013, J INFECT DIS, V207, P1242, DOI 10.1093/infdis/jis425; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Coppola M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37793; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Di Bisceglie AM, 2014, GASTROENTEROLOGY, V147, P119, DOI 10.1053/j.gastro.2014.03.007; Fiorino F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00128; Gengenbacher M, 2016, MICROBES INFECT, V18, P364, DOI 10.1016/j.micinf.2016.03.005; Gilbert SC, 2013, VACCINE, V31, P4241, DOI 10.1016/j.vaccine.2013.03.020; Guirado E, 2008, CLIN VACCINE IMMUNOL, V15, P1229, DOI 10.1128/CVI.00094-08; Ilghari D, 2011, J BIOL CHEM, V286, P29993, DOI 10.1074/jbc.M111.248732; Izzo AA, 2017, CURR OPIN IMMUNOL, V47, P78, DOI 10.1016/j.coi.2017.07.008; Kaufmann SHE, 2014, CURR OPIN PULM MED, V20, P294, DOI 10.1097/MCP.0000000000000041; Leung-Theung-Long S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143552; Li SY, 2015, ANTIMICROB AGENTS CH, V59, P4026, DOI 10.1128/AAC.00105-15; Lu JB, 2015, J MICROBIOL IMMUNOL, V48, P597, DOI 10.1016/j.jmii.2014.03.005; Luke GA, 2012, TRANSLATING 2A RES P, DOI [10.5772/30091, DOI 10.5772/30091]; Mahon RN, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00688; Martin P, 2004, J MED VIROL, V74, P397, DOI 10.1002/jmv.20189; Marx FM, 2014, CLIN INFECT DIS, V58, P1676, DOI 10.1093/cid/ciu186; Mould RC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08665-9; Nuermberger EL, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TBTB2-0034-2017; Orme IM, 2015, NAT IMMUNOL, V16, P57, DOI 10.1038/ni.3048; Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76; Pitt JM, 2013, MICROB PATHOGENESIS, V58, P2, DOI 10.1016/j.micpath.2012.12.002; Prabowo SA, 2013, MED MICROBIOL IMMUN, V202, P95, DOI 10.1007/s00430-012-0278-6; Quoix E, 2016, LANCET ONCOL, V17, P212, DOI 10.1016/S1470-2045(15)00483-0; Remy-Ziller C, 2014, CLIN VACCINE IMMUNOL, V21, P147, DOI 10.1128/CVI.00678-13; ROSEL JL, 1986, J VIROL, V60, P436, DOI 10.1128/JVI.60.2.436-449.1986; Rosenthal IM, 2012, ANTIMICROB AGENTS CH, V56, P4331, DOI 10.1128/AAC.00912-12; Schiroli C, 2015, INFECTION, V10, P10; Schon T, 2013, J INTERN MED, V273, P368, DOI 10.1111/joim.12031; Smith SM, 2000, IMMUNOL CELL BIOL, V78, P325, DOI 10.1046/j.1440-1711.2000.00936.x; Tasneen R, 2016, ANTIMICROB AGENTS CH, V60, P270, DOI 10.1128/AAC.01691-15; Volz A, 2017, ADV VIRUS RES, V97, P187, DOI 10.1016/bs.aivir.2016.07.001; WHO, 2016, GLOB TUB REP; Williams K, 2012, ANTIMICROB AGENTS CH, V56, P3114, DOI 10.1128/AAC.00384-12; Woodworth JSM, 2006, CRIT REV IMMUNOL, V26, P317, DOI 10.1615/CritRevImmunol.v26.i4.30; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136; Zumla A, 2016, LANCET INFECT DIS, V16, pE47, DOI 10.1016/S1473-3099(16)00078-5	53	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196815	10.1371/journal.pone.0196815	http://dx.doi.org/10.1371/journal.pone.0196815			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718990	gold, Green Published, Green Submitted			2022-12-26	WOS:000431281900085
J	Hannibal, L; Bolisetty, K; Axhemi, A; DiBello, PM; Quadros, EV; Fedosov, S; Jacobsen, DW				Hannibal, Luciana; Bolisetty, Keerthana; Axhemi, Armend; DiBello, Patricia M.; Quadros, Edward V.; Fedosov, Sergey; Jacobsen, Donald W.			Transcellular transport of cobalamin in aortic endothelial cells	FASEB JOURNAL			English	Article						vitamin B-12; transcobalamin; vascular endothelium; MMACHC processing; exocytosis	SOLUBLE TRANSCOBALAMIN RECEPTOR; RESISTANCE-ASSOCIATED PROTEIN-1; INTRINSIC FACTOR-COBALAMIN; CELLULAR UPTAKE; HOLO-TRANSCOBALAMIN; VITAMIN-B-12 DEFICIENCY; METHYLMALONIC ACIDURIA; FUNCTIONAL EXPRESSION; CULTURED FIBROBLASTS; PROMOTER REGION	Cobalamin [Cbl (or B-12)] deficiency causes megaloblastic anemia and a variety of neuropathies. However, homeostatic mechanisms of cyanocobalamin (CNCbl) and other Cbls by vascular endothelial cells are poorly understood. Herein, we describe our investigation into whether cultured bovine aortic endothelial cells (BAECs) perform transcytosis of B-12, namely, the complex formed between serum transcobalamin and B-12, designated as holo-transcobalamin (holo-TC). We show that cultured BAECs endocytose [Co-57]-CNCbl-TC (source material) via the CD320 receptor. The bound Cbl is transported across the cell both via exocytosis in its free form, [Co-57]-CNCbl, and via transcytosis as [Co-57]-CNCbl-TC. Transcellular mobilization of Cbl occurred in a bidirectional manner. A portion of the endocytosed [Co-57]-CNCbl was enzymatically processed by methylmalonic aciduria combined with homocystinuria type C (cblC) with subsequent formation of hydroxocobalamin, methylcobalamin, and adenosylcobalamin, which were also transported across the cell in a bidirectional manner. This demonstrates that transport mechanisms for Cbl in vascular endothelial cells do not discriminate between various -axial ligands of the vitamin. Competition studies with apoprotein- and holo-TC and holo-intrinsic factor showed that only holo-TC was effective at inhibiting transcellular transport of Cbl. Incubation of BAECs with a blocking antibody against the extracellular domain of the CD320 receptor inhibited uptake and transcytosis by approximate to 40%. This study reveals that endothelial cells recycle uncommitted intracellular Cbl for downstream usage by other cell types and suggests that the endothelium is self-sufficient for the specific acquisition and subsequent distribution of circulating B(12)via the CD320 receptor. We posit that the endothelial lining of the vasculature is an essential component for the maintenance of serum-tissue homeostasis of B-12.Hannibal, L., Bolisetty, K., Axhemi, A., DiBello, P. M., Quadros, E. V., Fedosov, S., Jacobsen, D. W. Transcellular transport of cobalamin in aortic endothelial cells.	[Hannibal, Luciana] Univ Freiburg, Med Ctr, Dept Pediat, Lab Clin Biochem & Metab, Freiburg, Germany; [Hannibal, Luciana; Bolisetty, Keerthana; Axhemi, Armend; DiBello, Patricia M.; Jacobsen, Donald W.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Quadros, Edward V.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Fedosov, Sergey] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	University of Freiburg; Cleveland Clinic Foundation; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Aarhus University	Hannibal, L (corresponding author), Univ Freiburg, Med Ctr, Mathildenstr 1, D-79106 Freiburg, Germany.	luciana.hannibal@uniklinik-freiburg.de	Fedosov, Sergey N./J-2340-2019; Hannibal, Luciana/AAY-7689-2021	Fedosov, Sergey N./0000-0002-7016-2959; Hannibal, Luciana/0000-0002-0911-5758; Axhemi, Armend/0000-0001-5747-9380	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL71907]; Department of Pediatrics, University of Freiburg Medical Center	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Pediatrics, University of Freiburg Medical Center	This work was funded by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant HL71907 (to D.W.J.). L.H. acknowledges intramural funding support from the Department of Pediatrics, University of Freiburg Medical Center. The authors declare no conflicts of interest.	Abuyaman O, 2016, SCAND J CLIN LAB INV, V76, P641, DOI 10.1080/00365513.2016.1230885; Abuyaman O, 2015, SCAND J CLIN LAB INV, V75, P514, DOI 10.3109/00365513.2015.1057761; Abuyaman O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073110; Alam A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12100; Arendt JFB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045979; Arendt JFB, 2012, CLIN CHEM LAB MED, V50, P515, DOI 10.1515/CCLM.2011.810; Arora K, 2017, FASEB J, V31, P3098, DOI 10.1096/fj.201700025R; Arora K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177156; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Beedholm-Ebsen R, 2010, BLOOD, V115, P1632, DOI 10.1182/blood-2009-07-232587; BEGLEY JA, 1994, J NEUROL SCI, V122, P57, DOI 10.1016/0022-510X(94)90051-5; Bor MV, 2004, CLIN CHEM, V50, P1043, DOI 10.1373/clinchem.2003.027458; Bose S, 1997, J BIOL CHEM, V272, P3538, DOI 10.1074/jbc.272.6.3538; Bose S, 2007, J PHYSIOL-LONDON, V581, P457, DOI 10.1113/jphysiol.2007.129171; Brokner M, 2017, SCAND J CLIN LAB INV, V77, P433, DOI 10.1080/00365513.2017.1335881; CARMEL R, 1990, BLOOD, V75, P251; Carmel R, 2000, ANNU REV MED, V51, P357, DOI 10.1146/annurev.med.51.1.357; Chen P, 1999, ADV ENZYME REGUL, V39, P93, DOI 10.1016/S0065-2571(98)00029-6; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; DAN N, 1994, J BIOL CHEM, V269, P18849; Devalia V, 2014, BRIT J HAEMATOL, V166, P496, DOI 10.1111/bjh.12959; Fedosov Sergey N, 2012, Subcell Biochem, V56, P347, DOI 10.1007/978-94-007-2199-9_18; Fedosov SN, 1999, J BIOL CHEM, V274, P26015, DOI 10.1074/jbc.274.37.26015; FERNANDESCOSTA F, 1979, BRIT J HAEMATOL, V43, P625, DOI 10.1111/j.1365-2141.1979.tb03795.x; Fernandez-Roig S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-41; FRATERSCHRODER M, 1985, BIOCHIM BIOPHYS ACTA, V845, P421, DOI 10.1016/0167-4889(85)90207-1; Fyfe JC, 2004, BLOOD, V103, P1573, DOI 10.1182/blood-2003-08-2852; Gailus S, 2010, J INHERIT METAB DIS, V33, P17, DOI 10.1007/s10545-009-9032-7; Gherasim C, 2013, BIOCHIMIE, V95, P1023, DOI 10.1016/j.biochi.2013.02.003; GOTTLIEB C, 1965, BLOOD-J HEMATOL, V25, P875, DOI 10.1182/blood.V25.6.875.875; Green R, 2017, BLOOD, V129, P2603, DOI 10.1182/blood-2016-10-569186; GUEANT JL, 1988, GUT, V29, P1370, DOI 10.1136/gut.29.10.1370; Hannibal L, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00027; Hannibal L, 2013, CLIN CHEM LAB MED, V51, P477, DOI 10.1515/cclm-2012-0568; Hannibal L, 2011, MOL GENET METAB, V103, P226, DOI 10.1016/j.ymgme.2011.03.008; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; Hannibal L, 2008, CLIN CHEM LAB MED, V46, P1739, DOI 10.1515/CCLM.2008.356; Helliwell KE, 2011, MOL BIOL EVOL, V28, P2921, DOI 10.1093/molbev/msr124; HERBERT V, 1994, AM J CLIN NUTR, V59, p1213S, DOI 10.1093/ajcn/59.5.1213S; Hoffmann-Lucke E, 2013, CLIN CHEM LAB MED, V51, P677, DOI 10.1515/cclm-2012-0554; HOM BL, 1969, SCAND J CLIN LAB INV, V23, P201, DOI 10.3109/00365516909077650; Hygum K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020638; Jehle J, 2017, ARCH MED SCI, V13, P930, DOI 10.5114/aoms.2017.68239; Jiang WX, 2011, DRUG DELIV, V18, P74, DOI 10.3109/10717544.2010.509745; Jiang WX, 2010, GENE, V466, P49, DOI 10.1016/j.gene.2010.07.004; Kim JC, 2012, MOL GENET METAB, V107, P664, DOI 10.1016/j.ymgme.2012.10.005; Kim J, 2009, J BIOL CHEM, V284, P33418, DOI 10.1074/jbc.M109.057877; Kornerup LS, 2018, EUR J NUTR, V57, P1459, DOI 10.1007/s00394-017-1424-0; Lai SC, 2013, FASEB J, V27, P2468, DOI 10.1096/fj.12-219055; Lai SC, 2011, EXP CELL RES, V317, P1603, DOI 10.1016/j.yexcr.2011.02.016; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; LI N, 1994, BIOCHEM J, V301, P585, DOI 10.1042/bj3010585; Lysne V, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010026; Malinovskaya NA, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00599; Markel SF, 2017, J NEUROCHEM, V140, P216, DOI 10.1111/jnc.13861; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; Neuser J, 2016, J DIABETES COMPLICAT, V30, P623, DOI 10.1016/j.jdiacomp.2016.02.002; Nexo E, 2002, CLIN CHEM, V48, P1768; Nexo E, 2011, AM J CLIN NUTR, V94, DOI 10.3945/ajcn.111.013458; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Pangilinan F, 2010, J MED GENET, V47, P677, DOI 10.1136/jmg.2009.073775; Perez-D'Gregorio RE, 1998, J PEDIATR-US, V132, pS35, DOI 10.1016/S0022-3476(98)70526-8; Plesa M, 2011, MOL GENET METAB, V102, P139, DOI 10.1016/j.ymgme.2010.10.011; Pons L, 2000, CELL PHYSIOL BIOCHEM, V10, P135, DOI 10.1159/000016344; Quadros EV, 2010, HUM MUTAT, V31, P924, DOI 10.1002/humu.21297; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; QUADROS EV, 1995, BBA-GEN SUBJECTS, V1244, P395, DOI 10.1016/0304-4165(95)00037-C; Quadros EV, 2005, BIOCHEM BIOPH RES CO, V327, P1006, DOI 10.1016/j.bbrc.2004.12.103; QUADROS EV, 1986, J BIOL CHEM, V261, P5455; Quadros EV, 1999, AM J PHYSIOL-GASTR L, V277, pG161, DOI 10.1152/ajpgi.1999.277.1.G161; QUADROS EV, 1989, AM J PHYSIOL, V256, pC296, DOI 10.1152/ajpcell.1989.256.2.C296; QUADROS EV, 1994, ARCH BIOCHEM BIOPHYS, V308, P192, DOI 10.1006/abbi.1994.1027; RAMANUJAM KS, 1991, J BIOL CHEM, V266, P13135; RAMANUJAM KS, 1991, AM J PHYSIOL, V260, pG416, DOI 10.1152/ajpgi.1991.260.3.G416; RAMANUJAM KS, 1991, BIOCHEM BIOPH RES CO, V179, P543, DOI 10.1016/0006-291X(91)91405-2; RAMANUJAM KS, 1994, ARCH BIOCHEM BIOPHYS, V315, P8, DOI 10.1006/abbi.1994.1464; RAMANUJAM KS, 1992, BIOCHEM BIOPH RES CO, V182, P439, DOI 10.1016/0006-291X(92)91751-B; Regec AL, 2002, ARCH BIOCHEM BIOPHYS, V407, P202, DOI 10.1016/S0003-9861(02)00495-2; Rutsch F, 2011, J INHERIT METAB DIS, V34, P121, DOI 10.1007/s10545-010-9083-9; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Schneider H, 2010, INT J DEV BIOL, V54, P367, DOI 10.1387/ijdb.082773hs; SCHOHN H, 1991, BIOCHEM J, V280, P427, DOI 10.1042/bj2800427; SODA R, 1985, BLOOD, V65, P795; Solomon LR, 2005, BLOOD, V105, P978, DOI 10.1182/blood-2004-04-1641; Takahashi K, 2012, BIOL PHARM BULL, V35, P1269, DOI 10.1248/bpb.b12-00069; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; United States Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 1998, DIET REF INT THIAM R; von Castel-Roberts KM, 2007, AM J CLIN NUTR, V85, P1057, DOI 10.1093/ajcn/85.4.1057; Watkins D, 2013, BIOCHIMIE, V95, P1019, DOI 10.1016/j.biochi.2013.01.013; Weber-Adrian D, 2017, J NEUROCHEM, V140, P192, DOI 10.1111/jnc.13898; Yamani L, 2008, MOL GENET METAB, V95, P104, DOI 10.1016/j.ymgme.2008.05.007; Zhang WD, 2003, FASEB J, V17, P2085, DOI 10.1096/fj.02-1131fje; Zhao H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167044	98	7	7	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5506	5519		10.1096/fj.201701141RR	http://dx.doi.org/10.1096/fj.201701141RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29741927	Green Published, Bronze			2022-12-26	WOS:000447972500026
J	Cheng, BB; Chatzinoff, Y; Szczepanski, D; Bing, CC; Shaikh, S; Wyman, O; Perry, CE; Richardson, JA; Burns, DK; Evers, BM; Greenberg, DE; Chopra, R				Cheng, Bingbing; Chatzinoff, Yonatan; Szczepanski, Debby; Bing, Chenchen; Shaikh, Sumbul; Wyman, Omar; Perry, Cameron E.; Richardson, James A.; Burns, Dennis K.; Evers, Bret M.; Greenberg, David E.; Chopra, Rajiv			Remote acoustic sensing as a safety mechanism during exposure of metal implants to alternating magnetic fields	PLOS ONE			English	Article							JOINT INFECTION; BACTERIA; HIP	Treatment of prosthetic joint infections often involves multiple surgeries and prolonged antibiotic administration, resulting in a significant burden to patients and the healthcare system. We are exploring a non-invasive method to eradicate biofilm on metal implants utilizing high-frequency alternating magnetic fields (AMF) which can achieve surface induction heating. Although proof-of-concept studies demonstrate the ability of AMF to eradicate biofilm in vitro, there is a legitimate safety concern related to the potential for thermal damage to surrounding tissues when considering heating implanted metal objects. The goal of this study was to explore the feasibility of detecting acoustic emissions associated with boiling at the interface between a metal implant and surrounding soft tissue as a wireless safety sensing mechanism. Acoustic emissions generated during in vitro and in vivo AMF exposures were captured with a hydrophone, and the relationship with surface temperature analyzed. The effect of AMF exposure power, surrounding media composition, implant location within the AMF transmitter, and implant geometry on acoustic detection during AMF therapy was also evaluated. Acoustic emissions were reliably identified in both tissue-mimicking phantom and mouse studies, and their onset coincided with the implant temperature reaching the boiling threshold. The viscosity of the surrounding medium did not impact the production of acoustic emissions; however, emissions were not present when the medium was oil due to the higher boiling point. Results of simulations and in vivo studies suggest that short-duration, high-power AMF exposures combined with acoustic sensing can be used to minimize the amount of thermal damage in surrounding tissues. These studies support the hypothesis that detection of boiling associated acoustic emissions at a metal/tissue interface could serve as a real-time, wireless safety indicator during AMF treatment of biofilm on metallic implants.	[Cheng, Bingbing; Chatzinoff, Yonatan; Szczepanski, Debby; Bing, Chenchen; Shaikh, Sumbul; Wyman, Omar; Chopra, Rajiv] UT Southwestern Med Ctr, Dept Radiol, Dallas, TX 75390 USA; [Perry, Cameron E.; Greenberg, David E.] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA; [Perry, Cameron E.; Richardson, James A.; Burns, Dennis K.; Evers, Bret M.] UT Southwestern Med Ctr, Dept Pathol, Dallas, TX USA; [Greenberg, David E.] UT Southwestern Med Ctr, Dept Microbiol, Dallas, TX USA; [Chopra, Rajiv] UT Southwestern Med Ctr, Adv Imaging Res Ctr, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cheng, BB (corresponding author), UT Southwestern Med Ctr, Dept Radiol, Dallas, TX 75390 USA.	bingbing.cheng@utsouthwestern.edu	Chopra, Rajiv/A-8367-2013	Chopra, Rajiv/0000-0003-3605-6076; Evers, Bret/0000-0001-5686-0315; Cheng, Bingbing/0000-0002-1336-4781	M. R. and Evelyn Hudson Foundation	M. R. and Evelyn Hudson Foundation	RC received a research grant from the M. R. and Evelyn Hudson Foundation (http://thehudsonfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Al-Ahmad A, 2010, J BIOMED MATER RES B, V95B, P101, DOI 10.1002/jbm.b.31688; ASTM, 2011, F218211A ASTM; Chopra R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07321-6; Chung AH, 1999, MED PHYS, V26, P2017, DOI 10.1118/1.598707; Cui QJ, 2007, J BONE JOINT SURG AM, V89A, P871, DOI 10.2106/JBJS.E.01070; de Carvalho Carla C C R, 2012, Recent Pat Biotechnol, V6, P13; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Garrett TR, 2008, PROG NAT SCI-MATER, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001; Hasgall P. A., 2012, ITIS DATABASE THERMA; King RL, 2011, IEEE T ULTRASON FERR, V58, P1397, DOI 10.1109/TUFFC.2011.1959; Kohler MO, 2009, MED PHYS, V36, P3521, DOI 10.1118/1.3152112; Kremers HM, 2015, J BONE JOINT SURG AM, V97A, P1386, DOI 10.2106/JBJS.N.01141; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022; Larimer C, 2016, J BIOPHOTONICS, V9, P656, DOI 10.1002/jbio.201500212; O'Toole A, 2015, BIOFOULING, V31, P665, DOI 10.1080/08927014.2015.1083985; O'Toole P, 2016, J ARTHROPLASTY, V31, P7, DOI 10.1016/j.arth.2015.07.034; Osmon DR, 2013, CLIN INFECT DIS, V56, DOI [10.1093/cid/cis803, 10.1093/cid/cis966]; Pedersen AB, 2010, J BONE JOINT SURG BR, V92B, P929, DOI 10.1302/0301-620X.92B7.24461; Pijls BG, 2017, BONE JOINT RES, V6, P323, DOI 10.1302/2046-3758.65.BJR-2016-0308.R1; SAPARETO SA, 1984, INT J RADIAT ONCOL, V10, P787, DOI 10.1016/0360-3016(84)90379-1; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Zinn S., 1988, ELEMENTS INDUCTION H	23	10	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197380	10.1371/journal.pone.0197380	http://dx.doi.org/10.1371/journal.pone.0197380			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746579	Green Submitted, gold, Green Published			2022-12-26	WOS:000431851700107
J	Cho, C; Chande, AT; Gakhar, L; Hunt, J; Ketterer, MR; Apicella, MA				Cho, Christine; Chande, Aroon T.; Gakhar, Lokesh; Hunt, Jason; Ketterer, Margaret R.; Apicella, Michael A.			Characterization of a nontypeable Haemophilus influenzae thermonuclease	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; NEUTROPHIL EXTRACELLULAR TRAPS; RAY SOLUTION SCATTERING; STAPHYLOCOCCAL NUCLEASE; BIOLOGICAL MACROMOLECULES; ACTIVE-SITE; OMEGA-LOOP; BIOFILMS; STABILITY; NUCLEOTIDE	Nontypeable Haemophilus influenzae (NTHi) has been shown to form biofilms, comprised of extracellular DNA (eDNA), in the middle ear and bronchus during clinical infections. Studies in our laboratory have shown that NTHi possesses a homolog of Staphylococcus aureus thermonuclease (staphylococcal thermonuclease), NTHi nuclease (NTHiNuc, HI_1296). This enzyme had similar size, heat stability, and divalent cation requirements to those of the staphylococcal homolog as determined by light scattering and circular dichroism spectroscopy. Small angle X-ray scattering (SAXS) analysis suggested an overall shape and substrate-binding site comparable to those of staphylococcal nuclease. However, NTH/Nuc was approximately 25-fold more active in fluorescence resonance energy transfer (FRET) activity assay than staphylococcal thermonuclease. Homology modeling implicates shorter NTHiNuc loops near the active site for this enhanced activity.	[Cho, Christine] Univ Iowa, Iowa Inflammat Program, Iowa City, IA USA; [Cho, Christine] Univ Iowa Hosp, Dept Infect Dis, Iowa City, IA USA; [Cho, Christine] Univ Iowa, Carver Coll Med, Phys Scientist Training Pathway, Iowa City, IA USA; [Chande, Aroon T.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Chande, Aroon T.] IHRC Georgia Tech Appl Bioinformat Lab, Atlanta, GA USA; [Chande, Aroon T.] PanAmer Bioinformat Inst, Cali, Valle Del Cauca, Colombia; [Gakhar, Lokesh] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Gakhar, Lokesh] Univ Iowa, Prot Crystallog Facil, Iowa City, IA USA; [Hunt, Jason] Western Illinois Univ, Inst Environm Studies, Macomb, IL 61455 USA; [Ketterer, Margaret R.; Apicella, Michael A.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University System of Georgia; Georgia Institute of Technology; University of Iowa; University of Iowa; Western Illinois University; University of Iowa	Apicella, MA (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	michael-apicella@uiowa.edu	Gakhar, Lokesh/F-2113-2010	Gakhar, Lokesh/0000-0002-3319-1902; Chande, Aroon/0000-0001-5260-3135	National Institute of Allergy and Infectious Diseases [AI024616]; Howard Hughes Medical Institute: Medical Research Fellows Program; NIAID [AI024616]; Howard Hughes Medical Student Fellowship; National Institute of Health project MINOS [R01GM105404];  [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM124169] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute: Medical Research Fellows Program(Howard Hughes Medical Institute); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Student Fellowship; National Institute of Health project MINOS; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Allergy and Infectious Diseases (https:// www.niaid.nih.gov), grant number AI024616 to MAA; and by the Howard Hughes Medical Institute: Medical Research Fellows Program (https://www.hhmi.org/developing-scientists/medical-research-fellows-program), year 2009-2010 to CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIAID grant AI024616 (MAA). CC was supported to perform this work by a Howard Hughes Medical Student Fellowship. This research used resources of the Advanced Light Source (ALS), which is a DOE Office of Science User Facility operated by the Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231. We thank the staff at the SIBYLS 12.3.1 ALS beamline supported through the Integrated Diffraction Analysis Technologies program (DOE Office of Biological and Environmental Research) and the National Institute of Health project MINOS (R01GM105404) for SAXS data collection.	BALDISSERI DM, 1991, BIOCHEMISTRY-US, V30, P3628, DOI 10.1021/bi00229a006; Caceres SM, 2014, ANTIMICROB AGENTS CH, V58, P6851, DOI 10.1128/AAC.03514-14; Cairoli P, 2008, J AGR FOOD CHEM, V56, P1043, DOI 10.1021/jf072803c; CALDERON RO, 1985, BIOCHEMISTRY-US, V24, P6044, DOI 10.1021/bi00343a004; Cavaliere R, 2014, MICROBIOLOGYOPEN, V3, P557, DOI 10.1002/mbo3.187; Chin CL, 2005, AM J RESP CRIT CARE, V172, P85, DOI 10.1164/rccm.200412-1687OC; Cho C, 2015, INFECT IMMUN, V83, P950, DOI 10.1128/IAI.02601-14; Cunningham L, 1958, ANN NY ACAD SCI, V3, P27; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guinier A., 1955, SMALL ANGLE SCATTERI; Juneau RA, 2015, J INFECT DIS, V212, P316, DOI 10.1093/infdis/jiv031; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGRAP, V34, P1; LEE SP, 1994, ANAL BIOCHEM, V220, P377, DOI 10.1006/abio.1994.1353; LOLL PJ, 1995, BIOCHEMISTRY-US, V34, P4316, DOI 10.1021/bi00013a021; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Maunders E, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx120; Morita C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103125; MURPHY TF, 1987, REV INFECT DIS, V9, P1; Olson ME, 2013, INFECT IMMUN, V81, P1316, DOI 10.1128/IAI.01242-12; POOLE LB, 1991, BIOCHEMISTRY-US, V30, P3621, DOI 10.1021/bi00229a005; Post JC, 2001, LARYNGOSCOPE, V111, P2083, DOI 10.1097/00005537-200112000-00001; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Starner TD, 2006, AM J RESP CRIT CARE, V174, P213, DOI 10.1164/rccm.200509-1459OC; Steichen CT, 2011, INFECT IMMUNITY; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Su ZD, 2005, FEBS J, V272, P3960, DOI 10.1111/j.1742-4658.2005.04814.x; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thammavongsa V, 2013, SCIENCE, V342, P863, DOI 10.1126/science.1242255; Truckses DM, 1996, PROTEIN SCI, V5, P1907, DOI 10.1002/pro.5560050917; TUCKER PW, 1979, MOL CELL BIOCHEM, V23, P3; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Zetzmann M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00989; Zhou ZX, 2012, ANAL CHIM ACTA, V740, P88, DOI 10.1016/j.aca.2012.06.032	37	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197010	10.1371/journal.pone.0197010	http://dx.doi.org/10.1371/journal.pone.0197010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746527	Green Submitted, Green Published, gold			2022-12-26	WOS:000431851700055
J	Vromans, RD; Jongman, SR				Vromans, Ruben D.; Jongman, Suzanne R.			The interplay between selective and nonselective inhibition during single word production	PLOS ONE			English	Article							STOP-SIGNAL PARADIGM; RESPONSE-INHIBITION; LEXICAL SELECTION; STROOP TASK; INDIVIDUAL-DIFFERENCES; SEMANTIC INTERFERENCE; LANGUAGE IMPAIRMENT; ATTENTIONAL CONTROL; SENTENCE PRODUCTION; EXECUTIVE CONTROL	The present study investigated the interplay between selective inhibition (the ability to suppress specific competing responses) and nonselective inhibition (the ability to suppress any inappropriate response) during single word production. To this end, we combined two well-established research paradigms: the picture-word interference task and the stop-signal task. Selective inhibition was assessed by instructing participants to name target pictures (e.g., dog) in the presence of semantically related (e.g., cat) or unrelated (e.g., window) distractor words. Nonselective inhibition was tested by occasionally presenting a visual stop-signal, indicating that participants should withhold their verbal response. The stop-signal was presented early (250 ms) aimed at interrupting the lexical selection stage, and late (325 ms) to influence the word-encoding stage of the speech production process. We found longer naming latencies for pictures with semantically related distractors than with unrelated distractors (semantic interference effect). The results further showed that, at both delays, stopping latencies (i.e., stop-signal RTs) were prolonged for naming pictures with semantically related distractors compared to pictures with unrelated distractors. Taken together, our findings suggest that selective and nonselective inhibition, at least partly, share a common inhibitory mechanism during different stages of the speech production process.	[Vromans, Ruben D.] Tilburg Univ, Tilburg Ctr Cognit & Commun TiCC, Tilburg, Netherlands; [Jongman, Suzanne R.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Tilburg University; Max Planck Society	Vromans, RD (corresponding author), Tilburg Univ, Tilburg Ctr Cognit & Commun TiCC, Tilburg, Netherlands.	R.D.Vromans@uvt.nl		Vromans, Ruben/0000-0001-8040-1207; Jongman, Suzanne/0000-0003-1987-2215				Baayen RH, 2008, ANAL LINGUISTIC DATA, V505; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2013, J MEM LANG, DOI DOI 10.1016/J.JML.2007.11.007; Cai WD, 2011, J NEUROSCI, V31, P5965, DOI 10.1523/JNEUROSCI.6292-10.2011; Castro-Meneses LJ, 2016, EXP BRAIN RES, V234, P185, DOI 10.1007/s00221-015-4452-0; Castro-Meneses LJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00529; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Eagle DM, 2003, BEHAV NEUROSCI, V117, P1302, DOI 10.1037/0735-7044.117.6.1302; Eggers K, 2013, J FLUENCY DISORD, V38, P1, DOI 10.1016/j.jfludis.2012.10.001; Etchell AC, 2012, NEUROPSYCHOLOGIA, V50, P129, DOI 10.1016/j.neuropsychologia.2011.11.009; Fargier R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168358; Finkbeiner M, 2006, CORTEX, V42, P1032, DOI 10.1016/S0010-9452(08)70210-7; Forstmann BU, 2008, J NEUROSCI, V28, P9790, DOI 10.1523/JNEUROSCI.1465-08.2008; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Henry LA, 2012, J CHILD PSYCHOL PSYC, V53, P37, DOI 10.1111/j.1469-7610.2011.02430.x; Im-Bolter N, 2006, CHILD DEV, V77, P1822, DOI 10.1111/j.1467-8624.2006.00976.x; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Kalanthroff E, 2013, J EXP PSYCHOL HUMAN, V39, P579, DOI 10.1037/a0027429; Kalsi N, 2015, J EXP NEUROSCI, V9, P57, DOI 10.4137/JEN.S25095; LA HEIJ W, 1988, MEM COGNITION, V16, P400, DOI 10.3758/BF03214220; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Mahon BZ, 2007, J EXP PSYCHOL LEARN, V33, P503, DOI 10.1037/0278-7393.33.3.503; Momma S, 2016, J EXP PSYCHOL LEARN, V42, P813, DOI 10.1037/xlm0000195; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Novick JM, 2010, LANG LINGUIST COMPAS, V4, P906, DOI 10.1111/j.1749-818x.2010.00244.x; Piai V, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00549; R Core Team, 2012, R LANG ENV STAT COMP; Rastle K, 2002, J EXP PSYCHOL HUMAN, V28, P307, DOI 10.1037//0096-1523.28.2.307; Ridderinkhof KR, 1999, ACTA PSYCHOL, V101, P315; Roelofs A, 2003, PSYCHOL REV, V110, P88, DOI 10.1037/0033-295X.110.1.88; Roelofs A, 2008, J EXP PSYCHOL GEN, V137, P303, DOI 10.1037/0096-3445.137.2.303; Roelofs A, 2017, Q J EXP PSYCHOL, V70, P782, DOI 10.1080/17470218.2016.1165264; SCHRIEFERS H, 1990, J MEM LANG, V29, P86, DOI 10.1016/0749-596X(90)90011-N; Severens E, 2005, ACTA PSYCHOL, V119, P159, DOI 10.1016/j.actpsy.2005.01.002; Shao Z, 2018, RES METHODS PSYCHOLI, P111; Shao Z, 2015, J EXP PSYCHOL LEARN, V41, P1806, DOI 10.1037/a0039363; Shao ZS, 2014, BRAIN RES, V1586, P130, DOI 10.1016/j.brainres.2014.07.009; Shao ZS, 2013, MEM COGNITION, V41, P1200, DOI 10.3758/s13421-013-0332-7; Shao ZS, 2012, Q J EXP PSYCHOL, V65, P1927, DOI 10.1080/17470218.2012.670252; Sikora K, 2016, Q J EXP PSYCHOL, V69, P1719, DOI 10.1080/17470218.2015.1093007; Tydgat I, 2011, J MEM LANG, V64, P359, DOI 10.1016/j.jml.2011.02.002; van Casteren M, 2006, BEHAV RES METHODS, V38, P584, DOI 10.3758/BF03193889; VANDAM WO, 2010, FRONT PSYCHOL, V1, P1, DOI DOI 10.3389/FPSYG.2010.00145; Verbruggen F, 2006, Q J EXP PSYCHOL, V59, P190, DOI 10.1080/17470210500151386; Verbruggen F, 2004, ACTA PSYCHOL, V116, P21, DOI 10.1016/j.actpsy.2003.12.011; Verbruggen F, 2005, THESIS; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Verbruggen F, 2008, BEHAV RES METHODS, V40, P479, DOI 10.3758/BRM.40.2.479; Verbruggen F, 2013, PSYCHOL SCI, V24, P352, DOI 10.1177/0956797612457390; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Wylie SA, 2016, J NEUROPSYCH CLIN N, V28, P306, DOI 10.1176/appi.neuropsych.15110387; Xue G, 2008, CEREB CORTEX, V18, P1923, DOI 10.1093/cercor/bhm220	56	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197313	10.1371/journal.pone.0197313	http://dx.doi.org/10.1371/journal.pone.0197313			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF3JM	29746594	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700100
J	Jorstad, MD; Marijani, M; Dyrhol-Riise, AM; Sviland, L; Mustafa, T				Jorstad, Melissa Davidsen; Marijani, Msafiri; Dyrhol-Riise, Anne Ma; Sviland, Lisbet; Mustafa, Tehmina			MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar	PLOS ONE			English	Article							ACID AMPLIFICATION TESTS; COMPLEX SPECIFIC ANTIGEN; FINE-NEEDLE-ASPIRATION; MYCOBACTERIUM-BOVIS BCG; XPERT MTB/RIF ASSAY; IMMUNOCYTOCHEMICAL DETECTION; RAPID DIAGNOSIS; ENDEMIC AREA; LYMPHADENITIS; METAANALYSIS	Background Extrapulmonary tuberculosis (EPTB) is a diagnostic challenge. An immunochemistry-based MPT64 antigen detection test (MPT64 test) has reported higher sensitivity in the diagnosis of EPTB compared with conventional methods. The objective of this study was to implement and evaluate the MPT64 test in routine diagnostics in a low-resource setting. Methods Patients with presumptive EPTB were prospectively enrolled at Mnazi Mmoja Hospital, Zanzibar, and followed to the end of treatment. Specimens collected were subjected to routine diagnostics, GeneXpert (R) MTB/RIF assay and the MPT64 test. The performance of the MPT64 test was assessed using a composite reference standard, defining the patients as tuberculosis (TB) cases or non-TB cases. Results Patients (n = 132) were classified as confirmed TB (n = 12), probable TB (n = 34), possible TB (n = 18), non-TB (n = 62) and uncategorized (n = 6) cases. Overall, in comparison to the composite reference standard for diagnosis, the sensitivity, specificity, positive predictive value, negative predictive value and accuracy of the MPT64 test was 69%, 95%, 94%, 75% and 82%, respectively. The MPT64 test performance was best in TB lymphadenitis cases (n = 67, sensitivity 79%, specificity 97%) and in paediatric TB (n = 41, sensitivity 100%, specificity 96%). Conclusions We show that the MPT64 test can be implemented in routine diagnostics in a low-resource setting and improves the diagnosis of EPTB, especially in TB lymphadenitis and in children.	[Jorstad, Melissa Davidsen; Mustafa, Tehmina] Haukeland Hosp, Dept Thorac Med, Bergen, Norway; [Jorstad, Melissa Davidsen; Mustafa, Tehmina] Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Marijani, Msafiri] Mnazi Mmoja Hosp, Dept Diagnost Serv, Zanzibar, Tanzania; [Dyrhol-Riise, Anne Ma] Univ Bergen, Fac Med, Dept Clin Sci, Bergen, Norway; [Dyrhol-Riise, Anne Ma] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway; [Dyrhol-Riise, Anne Ma] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Sviland, Lisbet] Univ Bergen, Fac Med, Dept Clin Med, Bergen, Norway; [Sviland, Lisbet] Haukeland Hosp, Dept Pathol, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Oslo; University of Oslo; University of Bergen; University of Bergen; Haukeland University Hospital	Mustafa, T (corresponding author), Haukeland Hosp, Dept Thorac Med, Bergen, Norway.; Mustafa, T (corresponding author), Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	Tehmina.Mustafa@uib.no		Davidsen Jorstad, Melissa/0000-0003-3516-5297	Research Council of Norway through the Global Health and Vaccination Programme [234457]; European Union; Department of International Collaboration (DIC), Haukeland University Hospital, Norway	Research Council of Norway through the Global Health and Vaccination Programme(Research Council of Norway); European Union(European Commission); Department of International Collaboration (DIC), Haukeland University Hospital, Norway	This work was partly supported by the Research Council of Norway through the Global Health and Vaccination Programme [project number 234457]. This project is part of the EDCTP2 programme supported by the European Union. The Department of International Collaboration (DIC), Haukeland University Hospital, Norway, provided logistic and financial support for relocation of the first author and her family in Zanzibar during the study period. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljafari AS, 2004, CYTOPATHOLOGY, V15, P44, DOI 10.1111/j.1365-2303.2003.00119.x; Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; [Anonymous], 2013, 2012 TANZ POP HOUS C; Baba K, 2008, APPL IMMUNOHISTO M M, V16, P554, DOI 10.1097/PAI.0b013e31816c3f79; Chakravorty S, 2005, J CLIN MICROBIOL, V43, P4357, DOI 10.1128/JCM.43.9.4357-4362.2005; Daley P, 2007, INT J TUBERC LUNG D, V11, P1166; Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814; Elhay MJ, 1998, INFECT IMMUN, V66, P3454, DOI 10.1128/IAI.66.7.3454-3456.1998; HARBOE M, 1986, INFECT IMMUN, V52, P293, DOI 10.1128/IAI.52.1.293-302.1986; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Jenkins HE, 2016, PNEUMONIA, V8, DOI 10.1186/s41479-016-0018-6; Kumar V, 2013, ROBBINS BASIC PATHOL, P472; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Malbruny B, 2011, INT J TUBERC LUNG D, V15, P553, DOI 10.5588/ijtld.10.0497; Marais BJ, 2006, INT J TUBERC LUNG D, V10, P732; Ministry of Health, 2014, ZANZ ZANZ INT HIV TU; Moure R, 2012, J CLIN MICROBIOL, V50, P513, DOI 10.1128/JCM.06467-11; Mustafa T, 2006, MODERN PATHOL, V19, P1606, DOI 10.1038/modpathol.3800697; National Bureau of Statistics Ministry of Finance Dar es Salaam, 2013, POP DISTR AG SEX; Pai M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-6; Pai M, 2003, LANCET INFECT DIS, V3, P633, DOI 10.1016/S1473-3099(03)00772-2; Pai M, 2008, FUTURE MICROBIOL, V3, P1, DOI 10.2217/17460913.3.1.1; Purohit MR, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-36; Purohit MR, 2012, DIAGN CYTOPATHOL, V40, P782, DOI 10.1002/dc.21637; Senkoro M, 2016, INT J TUBERC LUNG D, V20, P1014, DOI 10.5588/ijtld.15.0340; Tadele A, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0585-1; Thomas JO, 1999, DIAGN CYTOPATHOL, V21, P159, DOI 10.1002/(SICI)1097-0339(199909)21:3<159::AID-DC2>3.0.CO;2-2; Tortoli E, 2012, EUR RESPIR J, V40, P442, DOI 10.1183/09031936.00176311; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; World Health Organization, 2014, XPERTMTB RIF IMPL MA; Wright CA, 2008, ANN TROP PAEDIATR, V28, P65, DOI 10.1179/146532808X270707; Wright CA, 2009, INT J TUBERC LUNG D, V13, P1467	33	14	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196723	10.1371/journal.pone.0196723	http://dx.doi.org/10.1371/journal.pone.0196723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742144	Green Submitted, Green Published, gold			2022-12-26	WOS:000431757400037
J	Wither, JE; Prokopec, SD; Noamani, B; Chang, NH; Bonilla, D; Touma, Z; Avila-Casado, C; Reich, HN; Scholey, J; Fortin, PR; Boutros, PC; Landolt-Marticorena, C				Wither, Joan E.; Prokopec, Stephenie D.; Noamani, Babak; Chang, Nan-Hua; Bonilla, Dennisse; Touma, Zahi; Avila-Casado, Carmen; Reich, Heather N.; Scholey, James; Fortin, Paul R.; Boutros, Paul C.; Landolt-Marticorena, Carolina			Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms	PLOS ONE			English	Article							DISEASE-ACTIVITY; INDUCED GRANULOCYTOSIS; MESSENGER-RNA; PROBE LEVEL; INTERFERON; BLOOD; CELLS; CLASSIFICATION; FEATURES	Both a lack of biomarkers and relatively ineffective treatments constitute impediments to management of lupus nephritis (LN). Here we used gene expression microarrays to contrast the transcriptomic profiles of active SLE patients with and without LN to identify potential biomarkers for this condition. RNA isolated from whole peripheral blood of active SLE patients was used for transcriptomic profiling and the data analyzed by linear modeling, with corrections for multiple testing. Results were validated in a second cohort of SLE patients, using NanoString technology. The majority of genes demonstrating altered transcript abundance between patients with and without LN were neutrophil-related. Findings in the validation cohort confirmed this observation and showed that levels of RNA abundance in renal remission were similar to active patients without LN. In secondary analyses, RNA abundance correlated with disease activity, hematuria and proteinuria, but not renal biopsy changes. As abundance levels of the individual transcripts correlated strongly with each other, a composite neutrophil score was generated by summing all levels before examining additional correlations. There was a modest correlation between the neutrophil score and the blood neutrophil count, which was largely driven by the dose of glucocorticosteroids and not the proportion of low density and/or activated neutrophils. Analysis of longitudinal data revealed no correlation between baseline neutrophil score or changes over the first year of follow-up with subsequent renal flare or treatment outcomes, respectively. The findings argue that although the neutrophil score is associated with LN, its clinical utility as a biomarker may be limited.	[Wither, Joan E.; Noamani, Babak; Chang, Nan-Hua; Bonilla, Dennisse; Landolt-Marticorena, Carolina] Univ Hlth Network, Arthrit Ctr Excellence, Krembil Res Inst, Toronto, ON, Canada; [Wither, Joan E.; Touma, Zahi] Univ Hlth Network, Div Rheumatol, Toronto, ON, Canada; [Wither, Joan E.; Touma, Zahi; Reich, Heather N.; Scholey, James] Univ Toronto, Dept Med, Toronto, ON, Canada; [Prokopec, Stephenie D.; Boutros, Paul C.] Ontario Inst Canc Res, Informat & Biocomp Program, Toronto, ON, Canada; [Avila-Casado, Carmen] Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, Dept Pathol, Toronto, ON, Canada; [Reich, Heather N.; Scholey, James] Univ Hlth Network, Div Nephrol, Toronto, ON, Canada; [Fortin, Paul R.] Univ Laval, Ctr Rech, CHU Quebec, Div Rheumatol,Dept Med, Quebec City, PQ, Canada; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Boutros, Paul C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Laval University; University of Toronto; University of Toronto	Wither, JE (corresponding author), Univ Hlth Network, Arthrit Ctr Excellence, Krembil Res Inst, Toronto, ON, Canada.; Wither, JE (corresponding author), Univ Hlth Network, Div Rheumatol, Toronto, ON, Canada.; Wither, JE (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	jwither@uhnres.utoronto.ca	Touma, Zahi/ABE-7431-2021	Touma, Zahi/0000-0001-5177-2076; Wither, Joan/0000-0001-5961-9228; Boutros, Paul/0000-0003-0553-7520; Fortin, Paul R./0000-0002-7278-2596	Arthritis and Autoimm unity Research Centre of the University Health Network; Distinguished Senior Investigator of The Arthritis Society; Arthritis Centre of Excellence, University of Toronto; Canada Research Chair on systemic autoimmune rheumatic diseases at University Laval; Gabor Zellerman Chair in Nephrology Research at the University of Toronto; CIHR New Investigator Award; Government of Ontario; Arthritis Centre of Excellence of the University of Toronto; Eli Lilly Company; Canadian Institutes of Health Research (CIHR QNT) [78341]; Arthritis and Autoimmunity Research Centre of the University Health Network; Canada Research Chair on systemic autoimmune rheumatic diseases at Universite Laval	Arthritis and Autoimm unity Research Centre of the University Health Network; Distinguished Senior Investigator of The Arthritis Society; Arthritis Centre of Excellence, University of Toronto(University of Toronto); Canada Research Chair on systemic autoimmune rheumatic diseases at University Laval; Gabor Zellerman Chair in Nephrology Research at the University of Toronto; CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Government of Ontario; Arthritis Centre of Excellence of the University of Toronto(University of Toronto); Eli Lilly Company(Eli Lilly); Canadian Institutes of Health Research (CIHR QNT); Arthritis and Autoimmunity Research Centre of the University Health Network; Canada Research Chair on systemic autoimmune rheumatic diseases at Universite Laval	Dr. Landolt-Marticorena was the recipient of a Clinician-Scientist Salary Award from the Arthritis and Autoimm unity Research Centre of the University Health Network. Dr. Fortin was the recipient of a Distinguished Senior Investigator of The Arthritis Society and was supported by the Arthritis Centre of Excellence, University of Toronto. He is currently supported by a tenured Professorship of Medicine and a Canada Research Chair on systemic autoimmune rheumatic diseases at University Laval. Dr. Reich's work is supported by the Gabor Zellerman Chair in Nephrology Research at the University of Toronto. Dr. Boutros was supported by a CIHR New Investigator Award and has ongoing support from the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. Dr. Wither is funded by The Arthritis Centre of Excellence of the University of Toronto. The work outlined in this manuscript was partially supported by Eli Lilly Company who paid for the microarrays that were performed by Asurgen Services. The study was also partially funded by a New Emerging Team grant from the Canadian Institutes of Health Research (CIHR QNT #78341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Murray B. Urowitz, Dafna D. Gladman, Jorge Sanchez-Guerrero, Arthur Bookman, for provision and care of study patients. Dr. Landolt-Marticorena was the recipient of a Clinician -Scientist Salary Award from the Arthritis and Autoimmunity Research Centre of the University Health Network. Dr. Fortin was the recipient of a Distinguished Senior Investigator of The Arthritis Society and was supported by the Arthritis Centre of Excellence, University of Toronto. He is currently supported by a tenured Professorship of Medicine and a Canada Research Chair on systemic autoimmune rheumatic diseases at Universite Laval. Dr. Reich's work is supported by the Gabor Zellerman Chair in Nephrology Research at the University of Toronto. Dr. Boutros was supported by a CIHR New Investigator Award and has ongoing support from the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. Dr. Wither is funded by The Arthritis Centre of Excellence of the University of Toronto.	AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; AUSTIN HA, 1983, AM J MED, V75, P382, DOI 10.1016/0002-9343(83)90338-8; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; BISHOP CR, 1968, J CLIN INVEST, V47, P249, DOI 10.1172/JCI105721; CERVERA R, 1993, MEDICINE, V72, P113, DOI 10.1097/00005792-199303000-00005; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Cowland JB, 1999, J LEUKOCYTE BIOL, V66, P989, DOI 10.1002/jlb.66.6.989; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gladman DD, 2002, J RHEUMATOL, V29, P288; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jourde-Chiche N, 2017, RHEUMATOLOGY, V56, P477, DOI 10.1093/rheumatology/kew439; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Krainer EC, 2013, CYTOSKELETON, V70, P424, DOI 10.1002/cm.21113; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Landolt-Marticorena C, 2009, ANN RHEUM DIS, V68, P1440, DOI 10.1136/ard.2008.093146; Leonard D, 2016, ANN RHEUM DIS, V75, P1728, DOI 10.1136/annrheumdis-2015-208055; LILES WC, 1995, BLOOD, V86, P3181; Nakagawa M, 1998, CIRCULATION, V98, P2307, DOI 10.1161/01.CIR.98.21.2307; Nikpour M, 2008, ANN RHEUM DIS, V67, P1069, DOI 10.1136/ard.2007.074765; Rovin BH, 2007, BULL HOSP JT DIS, V65, P187; Saito K, 1998, INT J HEMATOL, V67, P145; Singh S, 2009, AM J MED SCI, V337, P451, DOI 10.1097/MAJ.0b013e3181907b3d; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Steiman AJ, 2015, J RHEUMATOL, V42, P2318, DOI 10.3899/jrheum.150040; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; VLACHOYIANNOPOULOS PG, 1993, LUPUS, V2, P303, DOI 10.1177/096120339300200505; Waggott D, 2012, BIOINFORMATICS, V28, P1546, DOI 10.1093/bioinformatics/bts188; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Wofsy D, 2013, ARTHRITIS RHEUM-US, V65, P1586, DOI 10.1002/art.37940; Xiong W, 2014, NAT REV RHEUMATOL, V10, P97, DOI 10.1038/nrrheum.2013.157	41	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196117	10.1371/journal.pone.0196117	http://dx.doi.org/10.1371/journal.pone.0196117			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742110	Green Published, gold			2022-12-26	WOS:000431757400019
J	Ahn, J; Park, J; Park, D; Paek, J; Ko, J				Ahn, Jungmo; Park, JaeYeon; Park, Donghwan; Paek, Jeongyeup; Ko, JeongGil			Convolutional neural network-based classification system design with compressed wireless sensor network images	PLOS ONE			English	Article							ALGORITHM	With the introduction of various advanced deep learning algorithms, initiatives for image classification systems have transitioned over from traditional machine learning algorithms (e.g., SVM) to Convolutional Neural Networks (CNNs) using deep learning software tools. A prerequisite in applying CNN to real world applications is a system that collects meaningful and useful data. For such purposes, Wireless Image Sensor Networks (WISNs), that are capable of monitoring natural environment phenomena using tiny and low-power cameras on resource-limited embedded devices, can be considered as an effective means of data collection. However, with limited battery resources, sending high-resolution raw images to the backend server is a burdensome task that has direct impact on network lifetime. To address this problem, we propose an energy-efficient pre- and post- processing mechanism using image resizing and color quantization that can significantly reduce the amount of data transferred while maintaining the classification accuracy in the CNN at the backend server. We show that, if well designed, an image in its highly compressed form can be well-classified with a CNN model trained in advance using adequately compressed data. Our evaluation using a real image dataset shows that an embedded device can reduce the amount of transmitted data by similar to 71% while maintaining a classification accuracy of similar to 98%. Under the same conditions, this process naturally reduces energy consumption by similar to 71% compared to a WISN that sends the original uncompressed images.	[Ahn, Jungmo; Park, JaeYeon; Ko, JeongGil] Ajou Univ, Dept Comp Engn, Suwon, South Korea; [Park, Donghwan] Elect & Telecommun Res Inst, Daejeon, South Korea; [Paek, Jeongyeup] Chung Ang Univ, Sch Comp Sci & Engn, Seoul, South Korea	Ajou University; Electronics & Telecommunications Research Institute - Korea (ETRI); Chung Ang University	Ko, J (corresponding author), Ajou Univ, Dept Comp Engn, Suwon, South Korea.	jgko@ajou.ac.kr	Paek, Jeongyeup/T-4780-2018; Ko, JeongGil/CAF-8134-2022	Paek, Jeongyeup/0000-0001-5177-4936; 	Institute for Information & communications Technology Promotion (IITP) grant - Korea government (MSIT) [2017-0-00501]	Institute for Information & communications Technology Promotion (IITP) grant - Korea government (MSIT)(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	Authors J.Paek and J.Ko were supported by the Institute for Information & communications Technology Promotion (IITP) grant funded by the Korea government (MSIT - previously MSIP) (Ministry of Science, ICT and Future Planning No.2017-0-00501, Development of Self -learnable common IoT SW Engine).; This work was supported by Institute for Information & communications Technology Promotion (IITP) grant funded by the Korea government (MSIT) (No.2017-0-00501, Development of Self-learnable common IoT SW Engine).	Amanatiadis A, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/104015; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Corporation A, 2016, SAM R21 XPLAIN PRO; Crossbow Technology Inc, TELOSB SPECS; Downes I., 2006, P COGN SYST INT SENS; Gu JX, 2018, PATTERN RECOGN, V77, P354, DOI 10.1016/j.patcog.2017.10.013; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hill JL, 2002, IEEE MICRO, V22, P12, DOI 10.1109/MM.2002.1134340; Hwang J, 2010, SENSORS-BASEL, V10, P11189, DOI 10.3390/s101211189; Inc MS, 2017, MONS POW MON; Jia Y., 2014, ARXIV14085093, P675; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Ko T, 2010, ACM T SENSOR NETWORK, V6, DOI 10.1145/1754414.1754415; Krishnaveni S, 2017, ICT EXPRESS, V3, P148, DOI 10.1016/j.icte.2017.04.006; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lee DU, 2009, IEEE T IMAGE PROCESS, V18, P2100, DOI 10.1109/TIP.2009.2022438; Lin TY, 2014, LECT NOTES COMPUT SC, V8693, P740, DOI 10.1007/978-3-319-10602-1_48; LINDE Y, 1980, IEEE T COMMUN, V28, P84, DOI 10.1109/TCOM.1980.1094577; Lloret J, 2011, SENSORS-BASEL, V11, P6165, DOI 10.3390/s110606165; Mohanty SP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01419; Mostefa B, 2016, IEEE INT C INT TECHN; ORCHARD MT, 1991, IEEE T SIGNAL PROCES, V39, P2677, DOI 10.1109/78.107417; Paek J., 2018, BIRD NEST IMAGE DATA, DOI [10.6084/m9.figshare.5853651.v2, DOI 10.6084/M9.FIGSHARE.5853651.V2]; Paek J, 2017, IEEE SYST J, V11, P2652, DOI 10.1109/JSYST.2015.2491359; Paek J, 2014, SENSORS-BASEL, V14, P15981, DOI 10.3390/s140915981; Park J, 2017, PROCEEDINGS OF THE 15TH ACM CONFERENCE ON EMBEDDED NETWORKED SENSOR SYSTEMS (SENSYS'17), DOI 10.1145/3131672.3131690; Pham C., 2015, IEEE INT C NETW SENS; Polastre J, 2005, IEEE INT S INF PROC; Polastre J, 2003, THESIS; Rahimi M, 2005, ACM INT C EMB NETW S; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Rowe A., 2007, IEEE INT REAL TIM SY; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Sharp C, 2005, EUR WORKSH WIR SENS; Sogaard J., 2016, ELECT IMAG, V2016, P1, DOI [10.2352/ISSN.2470-1173.2016.13.IQSP-206, DOI 10.2352/ISSN.2470-1173.2016.13.IQSP-206]; Srbinovska M, 2015, J CLEAN PROD, V88, P297, DOI 10.1016/j.jclepro.2014.04.036; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Taubman DS, 2002, P IEEE, V90, P1336, DOI 10.1109/JPROC.2002.800725; Virmani D, 2017, ICT EXPRESS, V3, P128, DOI 10.1016/j.icte.2017.04.004; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Werner-Allen G, 2006, IEEE INTERNET COMPUT; Yoon HJ, 2017, ACM T SENSOR NETWORK, V13, DOI 10.1145/3079764; Yosinski Jason, 2014, NIPS, DOI DOI 10.1109/IJCNN.2016.7727519	43	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196251	10.1371/journal.pone.0196251	http://dx.doi.org/10.1371/journal.pone.0196251			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738564	Green Published, gold, Green Submitted			2022-12-26	WOS:000431724900007
J	Elizalde, MM; Perez, PS; Sevic, I; Grasso, D; Ropolo, A; Barbini, L; Campos, RH; Vaccaro, MI; Flichman, DM				Mercedes Elizalde, Maria; Soledad Perez, Paula; Sevic, Ina; Grasso, Daniel; Ropolo, Alejandro; Barbini, Luciana; Hector Campos, Rodolfo; Ines Vaccaro, Maria; Martin Flichman, Diego			HBV subgenotypes F1b and F4 replication induces an incomplete autophagic process in hepatocytes: Role of BCP and preCore mutations	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; BASAL CORE-PROMOTER; ALASKA NATIVE PEOPLE; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; GENETIC-VARIABILITY; E-ANTIGEN; GENOTYPES; P62; INFECTION	Hepatitis B virus (HBV) genotypes and mutants have been associated with differences in clinical and virological characteristics. Autophagy is a cellular process that degrades long-lived proteins and damaged organelles. Viruses have evolved mechanisms to alter this process to survive in host cells. In this work, we studied the modulation of autophagy by the replication of HBV subgenotypes F1b and F4, and the naturally occurring mutants BCP and preCore. HBV subgenotypes F1b and F4 replication induced accumulation of autophago-somes in hepatoma cells. However, no autophagic protein degradation was observed, indicating a blockage of autophagic flux at later stages. This inhibition of autophagy flux might be due to an impairment of lysosomal acidification in hepatoma cells. Moreover, HBV-mediated autophagy modulation was independent of the viral subgenotypes and enhanced in viruses with BCP and preCore naturally occurring mutations. These results contribute to understand the mechanisms by which different HBV variants contribute to the pathogenesis of HBV infections. In addition, this study is the first to describe the role that two highly prevalent naturally occurring mutations exert on the modulation of HBV-induced autophagy.	[Mercedes Elizalde, Maria; Soledad Perez, Paula; Sevic, Ina; Hector Campos, Rodolfo; Martin Flichman, Diego] Univ Buenos Aires, Fac Farm & Bioquim, Dept Microbiol Inmunol Biotecnol & Genet, Catedra Virol, Buenos Aires, DF, Argentina; [Mercedes Elizalde, Maria; Soledad Perez, Paula; Sevic, Ina; Grasso, Daniel; Ropolo, Alejandro; Barbini, Luciana; Hector Campos, Rodolfo; Ines Vaccaro, Maria; Martin Flichman, Diego] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Grasso, Daniel; Ropolo, Alejandro; Ines Vaccaro, Maria] Univ Buenos Aires, Fac Farm & Bioquim, Inst Bioquim & Med Mol, Dept Fisiopatol, Buenos Aires, DF, Argentina; [Barbini, Luciana] Univ Nacl Mar del Plata, Fac Ciencias Exactas & Nat, Dept Quim, Mar Del Plata, Buenos Aires, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; National University of Mar del Plata	Elizalde, MM (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Dept Microbiol Inmunol Biotecnol & Genet, Catedra Virol, Buenos Aires, DF, Argentina.; Elizalde, MM (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	melizalde@docente.ffyb.uba.ar	Vaccaro, Maria I./L-8348-2017; Sevic, Ina/ABF-2898-2021	Sevic, Ina/0000-0002-4920-5096; GRASSO, DANIEL/0000-0002-8932-716X; Elizalde, Maria Mercedes/0000-0002-0533-4283	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP1122015010095CO]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT2014-1672]; UBACyT [20020130100505BA]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); UBACyT	This work was supported by grants from: Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP1122015010095CO]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT2014-1672] and UBACyT [20020130100505BA 2014-2017] to RHC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Rodrigo MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159509; Chen CJ, 2011, J GASTROEN HEPATOL, V26, P628, DOI 10.1111/j.1440-1746.2011.06695.x; Ching LK, 2016, LIVER INT, V36, P1507, DOI 10.1111/liv.13129; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Desai M, 2015, IMMUNOTARGETS THER, V4, P13, DOI 10.2147/ITT.S76720; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; Gounder PP, 2016, J PEDIATR-US, V178, P206, DOI 10.1016/j.jpeds.2016.08.017; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Iloeje UH, 2012, LIVER INT, V32, P1333, DOI 10.1111/j.1478-3231.2012.02805.x; Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947; Kunanopparat A, 2016, ASIAN PAC J ALLERGY, V34, P77, DOI 10.12932/AP0636.34.1.2016; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li JH, 2011, J VIROL, V85, P6319, DOI 10.1128/JVI.02627-10; Lin CL, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021436; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Lin CL, 2005, LIVER INT, V25, P564, DOI 10.1111/j.1478-3231.2005.01041.x; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Liu B, 2014, AUTOPHAGY, V10, P416, DOI 10.4161/auto.27286; Liu CJ, 2011, J VIRAL HEPATITIS, V18, pE482, DOI 10.1111/j.1365-2893.2011.01480.x; Liu CJ, 2013, SEMIN LIVER DIS, V33, P97, DOI 10.1055/s-0033-1345716; Livingston SE, 2007, J INFECT DIS, V195, P5, DOI 10.1086/509894; Ledesma MMGL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121436; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Elizalde MM, 2018, VIROLOGY, V513, P160, DOI 10.1016/j.virol.2017.10.016; Milich D, 2003, HEPATOLOGY, V38, P1075, DOI 10.1053/jhep.2003.50453; Pezzano SC, 2011, CLIN MICROBIOL INFEC, V17, P223, DOI 10.1111/j.1469-0691.2010.03283.x; Sevic I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175543; Sir D, 2010, AUTOPHAGY, V6, P548, DOI 10.4161/auto.6.4.11669; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Sunbul M, 2014, WORLD J GASTROENTERO, V20, P5427, DOI 10.3748/wjg.v20.i18.5427; Tian YJ, 2011, J VIROL, V85, P13453, DOI 10.1128/JVI.06064-11; Tong SP, 2016, J HEPATOL, V64, pS4, DOI 10.1016/j.jhep.2016.01.027; Wei FF, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006835, 10.1097/md.0000000000006835]; WHO, 2017, HEP B WHO; Xiang X, 2017, CANCER MED-US, V6, P2357, DOI 10.1002/cam4.1176; Yang ZG, 2016, ONCOTARGET, V7, P12525, DOI 10.18632/oncotarget.7123; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; Zhang ZH, 2016, WORLD J GASTROENTERO, V22, P126, DOI 10.3748/wjg.v22.i1.126; Zhong L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.136; Zhou TH, 2016, BIOSCI TRENDS, V10, P244, DOI 10.5582/bst.2016.01049	44	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0197109	10.1371/journal.pone.0197109	http://dx.doi.org/10.1371/journal.pone.0197109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738548	gold, Green Submitted, Green Published			2022-12-26	WOS:000431724900051
J	Leyhr, D; Kelava, A; Raabe, J; Honer, O				Leyhr, Daniel; Kelava, Augustin; Raabe, Johannes; Hoener, Oliver			Longitudinal motor performance development in early adolescence and its relationship to adult success: An 8-year prospective study of highly talented soccer players	PLOS ONE			English	Article							SKILL DEVELOPMENT; IDENTIFICATION; MATURITY; MODELS; SPORT; WORK	Several talent identification and development (TID) programs in soccer have implemented diagnostics to measure players' motor performance. Yet, there is a lack of research investigating the relationship between motor development in adolescence and future, adult performance. This longitudinal study analyzed the three-year development of highly talented young soccer players' speed abilities and technical skills and examined the relevance of this development to their adult success. The current research sample consisted of N = 1,134 players born between 1993 and 1995 who were selected for the German Soccer Association's TID program and participated in nationwide motor diagnostics (sprinting, agility, dribbling, ball control, shooting) four times between the Under 12 (U12) and Under 15 (U15) age class. Relative age (RA) was assessed for all players, and a total motor score was calculated based on performances in the individual tests. In order to investigate players' future success, participants were divided into two groups according to their adult performance level (APL) in the 2014/2015 season: Elite (1st-5th German division; N = 145, 12.8%) and non-elite players (lower divisions; N = 989, 87.2%). Using multilevel regression analyses each motor performance was predicted by Time, Time 2 (level-1 predictors), APL, and RA (level-2 covariates) with simultaneous consideration for interaction effects between the respective variables. Time and Time 2 were significant predictors for each test performance. A predictive value for RA was confirmed for sprinting and the total motor score. A significant relationship between APL and the motor score as well as between APL and agility, dribbling, ball control, and shooting emerged. Interaction effects distinctly failed to reach significance. The study found a non-linear improvement in players' performance for all considered motor performance factors over a three-year period from early to middle adolescence. While their predictive value for future success was confirmed by a significant relationship between APL and most of the considered factors, there was no significant interaction between APL and Time. These findings indicate that future elite players had already been better at the beginning of the TID program and maintained this high level throughout their promotion from U12 to U15.	[Leyhr, Daniel; Raabe, Johannes; Hoener, Oliver] Eberhard Karls Univ Tubingen, Inst Sports Sci, Tubingen, Germany; [Kelava, Augustin] Eberhard Karls Univ Tubingen, Hector Res Inst Educ Sci & Psychol, Tubingen, Germany; [Raabe, Johannes] Penn State Altoona, Dept Kinesiol, Altoona, PA USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Leyhr, D (corresponding author), Eberhard Karls Univ Tubingen, Inst Sports Sci, Tubingen, Germany.	daniel.leyhr@uni-tuebingen.de	Leyhr, Daniel/AAW-5081-2021; Höner, Oliver/AAC-3051-2021	Leyhr, Daniel/0000-0003-0436-0866; Kelava, Augustin/0000-0001-6053-0415; Honer, Oliver/0000-0002-3108-1531	DFB; DFBs Talent Development Program - DFB; German Football Association (Deutscher Fussball-Bund, DFB); Deutsche Forschungsgemeinschaft; University of Tubingen	DFB; DFBs Talent Development Program - DFB; German Football Association (Deutscher Fussball-Bund, DFB); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tubingen	This study is part of the research project "Scientific support of the DFB's Talent Development Program" which is funded by the DFB. We would like to thank DFB Director Ulf Schott, Thomas Hauser from the DFB's Science Department, and the staff of the DFB's Department for Talent Development (in particular Jorg Daniel, Claus Junginger, Thorsten Becht, and Tobias Kiess) for the provision of data and their valuable support.; This study is part of the research project Scientific support of the DFBs Talent Development Program, which is funded by the DFB and was granted by the German Football Association (Deutscher Fussball-Bund, DFB, http://www.dfb.de). DFB staff members conducted the data collection and the DFB provided the authors with players data. The DFB had no role in study design, data analysis, decision to publish, or preparation of the manuscript. We acknowledge support by Deutsche Forschungsgemeinschaft (http://www.dfg.de) and Open Access Publishing Fund of University of Tubingen (https://www.unituebingen.de/en/facilities/university-library/researching-publishing/open-accesspublikationsfonds.html). This funding supported the payment of the publication fee. The DFG and the Open Access Publishing Fund of University of Tubingen had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2002, HIGH ABIL STUD, V13, P157, DOI 10.1080/1359813022000048798; Brink MS, 2012, SCAND J MED SCI SPOR, V22, P285, DOI 10.1111/j.1600-0838.2010.01237.x; Buekers M., 2015, MOV SPORT SCI SCI MO, V12, P3, DOI [10.3917/sm.088.0003, DOI 10.3917/SM.088.0003, DOI 10.1051/SM/2014002]; Deprez D, 2015, MED SCI SPORT EXER, V47, P1408, DOI 10.1249/MSS.0000000000000541; Deprez DN, 2015, J STRENGTH COND RES, V29, P1692, DOI 10.1519/JSC.0000000000000806; Deutscher Fuuball Bund, 2009, TALENTFORDERPROGRAM; Elferink-Gemser MT, 2012, J SPORT SCI, V30, P1581, DOI 10.1080/02640414.2012.725854; Feichtinger P, 2015, EUROPEAN J SPORT SCI, P1; Figueiredo AJ, 2009, ANN HUM BIOL, V36, P60, DOI 10.1080/03014460802570584; Forsman H, 2016, J SPORT SCI, V34, P1311, DOI 10.1080/02640414.2015.1127401; Fransen J, 2017, SCI MED FOOTBALL, V1, P203, DOI 10.1080/24733938.2017.1366039; Gonaus C, 2012, J SPORT SCI, V30, P1673, DOI 10.1080/02640414.2012.713980; Hill LG, 2013, PREV SCI, V14, P557, DOI 10.1007/s11121-012-0342-x; Honer O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182211; Honer O, 2016, J SPORT SCI, V34, P2269, DOI 10.1080/02640414.2016.1177658; Honer O, 2016, PSYCHOL SPORT EXERC, V25, P17, DOI 10.1016/j.psychsport.2016.03.004; Honer O, 2015, J SPORT SCI, V33, P145, DOI 10.1080/02640414.2014.928416; Hohmann A., 2009, ENTWICKLUNG SPORTLIC; Huijgen BCH, 2013, INT J SPORTS MED, V34, P720, DOI 10.1055/s-0032-1323781; Huijgen BCH, 2009, INT J SPORTS MED, V30, P585, DOI 10.1055/s-0029-1202354; Huijgen BCH, 2010, J SPORT SCI, V28, P689, DOI 10.1080/02640411003645679; Huijgen BCH, 2013, TECHNICAL SKILLS KEY; Kannekens R, 2011, SCAND J MED SCI SPOR, V21, P846, DOI 10.1111/j.1600-0838.2010.01104.x; Kannekens R, 2009, PERCEPT MOTOR SKILL, V109, P459, DOI 10.2466/PMS.109.2.459-472; Kreft I. G., 1998, INTRO MULTILEVEL MOD, DOI DOI 10.4135/9781849209366; Maddala G.S., 1986, LTD DEPENDENT QUALIT; Malina R, 2004, GROWTH MATURATION PH, VXIV; Malina RM, 2005, J SPORT SCI, V23, P515, DOI 10.1080/02640410410001729928; Malina RM, 2012, J SPORT SCI, V30, P1705, DOI 10.1080/02640414.2011.639382; Meylan C, 2010, INT J SPORTS SCI COA, V5, P571, DOI 10.1260/1747-9541.5.4.571; Murr D, 2017, EUROPEAN J SPORT SCI, P1; Park S, 2005, NURS RES, V54, P406, DOI 10.1097/00006199-200511000-00007; Philippaerts RM, 2006, J SPORT SCI, V24, P221, DOI 10.1080/02640410500189371; Poczwardowski A, 2002, INT J SPORT PSYCHOL, V33, P116; Renshaw I., 2012, TALENT IDENTIFICATIO, P64; Saward C, 2016, SCAND J MED SCI SPOR, V26, P933, DOI 10.1111/sms.12534; Schott U., 2011, FUSSBALLTRAINING, V41, P47; Statistisches Bundesamt, 2017, AKT FUSS DEN EINZ TE; TANNER JM, 1981, NUTR REV, V39, P43, DOI 10.1111/j.1753-4887.1981.tb06734.x; Teachman J, 2002, J MARRIAGE FAM, V64, P280, DOI 10.1111/j.1741-3737.2002.00280.x; The Premier League, 2011, ELITE PERFORMANCE; Transfermarkt, 2017, WETTBEWERBE; Transfermarkt, 2015, WETTBEWERBE; Twisk JWR, 2003, APPL LONGITUDINAL DA; Vaeyens R, 2008, SPORTS MED, V38, P703, DOI 10.2165/00007256-200838090-00001; Valente-dos-Santos J, 2012, PEDIATR EXERC SCI, V24, P603, DOI 10.1123/pes.24.4.603; Votteler A, 2017, GER J EXERC SPORT RE, V47, P194, DOI 10.1007/s12662-017-0457-0; Williams AM, 1998, SPORTS EXERC INJURY, V4, P159; Williams AM, 2000, J SPORT SCI, V18, P657, DOI 10.1080/02640410050120041; Willimczik K, 1999, SPORTWISSENSCHAFT, V29, P42; Wilson RS, 2016, J SPORT SCI, V34, P2074, DOI 10.1080/02640414.2016.1151544; Wormhoudt R., 2018, ATHLETIC SKILLS MODE; Zuber C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01088	54	34	35	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196324	10.1371/journal.pone.0196324	http://dx.doi.org/10.1371/journal.pone.0196324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE6AF	29723200	gold, Green Published, Green Submitted			2022-12-26	WOS:000431305100022
J	Miranda, GE; Wilkinson, C; Roughley, M; Beaini, TL; Melani, RFH				Miranda, Geraldo Elias; Wilkinson, Caroline; Roughley, Mark; Beaini, Thiago Leite; Haltenhoff Melani, Rodolfo Francisco			Assessment of accuracy and recognition of three-dimensional computerized forensic craniofacial reconstruction	PLOS ONE			English	Article							TOMOGRAPHY	Facial reconstruction is a technique that aims to reproduce the individual facial characteristics based on interpretation of the skull, with the objective of recognition leading to identification. The aim of this paper was to evaluate the accuracy and recognition level of three-dimensional (3D) computerized forensic craniofacial reconstruction (CCFR) performed in a blind test on open-source software using computed tomography (CT) data from live subjects. Four CCFRs were produced by one of the researchers, who was provided with information concerning the age, sex, and ethnic group of each subject. The CCFRs were produced using Blender (R) with 3D models obtained from the CT data and templates from the MakeHuman (R) program. The evaluation of accuracy was carried out in CloudCompare, by geometric comparison of the CCFR to the subject 3D face model (obtained from the CT data). A recognition level was performed using the Picasa (R) recognition tool with a frontal standardized photography, images of the subject CT face model and the CCFR. Soft-tissue depth and nose, ears and mouth were based on published data, observing Brazilian facial parameters. The results were presented from all the points that form the CCFR model, with an average for each comparison between 63% and 74% with a distance -2.5 <= x <= 2.5 mm from the skin surface. The average distances were 1.66 to 0.33 mm and greater distances were observed around the eyes, cheeks, mental and zygomatic regions. Two of the four CCFRs were correctly matched by the Picasa (R) tool. Free software programs are capable of producing 3D CCFRs with plausible levels of accuracy and recognition and therefore indicate their value for use in forensic applications.	[Miranda, Geraldo Elias; Haltenhoff Melani, Rodolfo Francisco] Univ Sao Paulo, Sch Dent, Dept Social Dent, Lab Forens Anthropol & Odontol OFLAB, Sao Paulo, Brazil; [Wilkinson, Caroline; Roughley, Mark] Liverpool John Moores Univ, Face Lab, Liverpool, Merseyside, England; [Beaini, Thiago Leite] Univ Fed Uberlandia, Dept Prevent & Social Dent, Uberlandia, MG, Brazil	Universidade de Sao Paulo; Liverpool John Moores University; Universidade Federal de Uberlandia	Miranda, GE (corresponding author), Univ Sao Paulo, Sch Dent, Dept Social Dent, Lab Forens Anthropol & Odontol OFLAB, Sao Paulo, Brazil.	geraldoelias@usp.br	Melani, Rodolfo Francisco Haltenhoff/B-7205-2013; Beaini, Thiago/AAK-9658-2020; MIRANDA, GERALDO/D-1704-2015	Melani, Rodolfo Francisco Haltenhoff/0000-0001-7148-3503; Beaini, Thiago/0000-0003-0034-624X; MIRANDA, GERALDO/0000-0003-1240-3256; Wilkinson, Caroline/0000-0002-4603-5554; Yuquilema Miranda, Elias/0000-0002-1760-747X; Roughley, Mark/0000-0002-7483-859X				[Anonymous], 2010, J FORENSIC SCI; [Anonymous], 2016, FORENSIC SCI INT; [Anonymous], 1986, PLOS ONE; [Anonymous], 2004, FORENSIC SCI INT; Claes P, 2006, FORENSIC SCI INT, V159, pS147, DOI 10.1016/j.forsciint.2006.02.035; Claes P, 2010, FORENSIC SCI INT, V201, P138, DOI 10.1016/j.forsciint.2010.03.008; Clement J.G., 2005, COMPUTER GRAPHIC FAC; Decker S, 2013, FORENSIC SCI INT, V229, DOI 10.1016/j.forsciint.2013.03.028; Guyomarc'h P, 2014, J FORENSIC SCI, V59, P1502, DOI 10.1111/1556-4029.12547; Hamre SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180277; Lee WJ, 2012, J FORENSIC SCI, V57, P318, DOI 10.1111/j.1556-4029.2011.01971.x; Dias PEM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162732; Morales CA da C, 2014, J RES DENT, V2, P77; Parks CL, 2014, FORENSIC SCI INT, V237, DOI 10.1016/j.forsciint.2013.12.043; Parks CL, 2013, FORENSIC SCI INT, V233, P133, DOI 10.1016/j.forsciint.2013.08.031; Richard AH, 2014, FORENSIC SCI INT, V242, P283, DOI 10.1016/j.forsciint.2014.06.014; Short LJ, 2014, FORENSIC SCI INT, V237, DOI 10.1016/j.forsciint.2013.12.042; Tedeschi-Oliveira S.V., 2009, FORENSIC SCI INT, V193, pe1, DOI DOI 10.1016/J.F0RSCIINT.2009.09.002; Tedeschi-Oliveira SV, 2016, FORENSIC SCI INT, V266, P123, DOI 10.1016/j.forsciint.2016.05.004; Tilotta F, 2009, FORENSIC SCI INT, V191, P112, DOI 10.1016/j.forsciint.2009.06.017; Whitnall S. E., 1932, ANATOMY HUMAN ORBIT; Wilkinson C, 2012, CRANIOFACIAL IDENTIFICATION, P1, DOI 10.1017/CBO9781139049566; Wilkinson C., 2004, FORENSIC FACIAL RECO; Wilkinson Caroline, 2005, Forensic Sci Med Pathol, V1, P173, DOI 10.1385/FSMP:1:3:173; Wilkinson C, 2015, WILEY SER PSYCH CR, P93; Wilkinson Caroline, 2006, Forensic Sci Med Pathol, V2, P179, DOI 10.1007/s12024-006-0007-9; Wilkinson CM, 2003, J FORENSIC SCI, V48, P12; Zhao JL, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/943647	28	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196770	10.1371/journal.pone.0196770	http://dx.doi.org/10.1371/journal.pone.0196770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718983	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000431281900081
J	Pipan, T; Culver, DC; Papi, F; Kozel, P				Pipan, Tanja; Culver, David C.; Papi, Federica; Kozel, Peter			Partitioning diversity in subterranean invertebrates: The epikarst fauna of Slovenia	PLOS ONE			English	Article							SPECIES RICHNESS PATTERNS; HYPOGEAN WATERS; SPATIAL SCALES; BETA-DIVERSITY; CAVE; BIODIVERSITY; KARST; COMMUNITIES; CRUSTACEANS; HABITATS	The decomposition of diversity into within site (alpha) and between site (beta) components is especially interesting in subterranean communities because of their isolated nature and limited dispersal potential The aquatic epikarst fauna, sampled from water drips in caves affords a unique opportunity to provide comparable, quantitative samples of a portion of the obligate subterranean dwelling fauna in multiple hierarchical levels. We focused on three interrelated questions-(1) what is the spatial pattern of epikarst species diversity; (2) how does species diversity partition between local, and regional components (nested and replacement); and (3) whether epikarst hotspots are subterranean hotspots in general. We analyzed the geographic pattern of species richness of 30 species of obligate subterranean copepods found in 81 drips in Slovenian caves in three karst regions-Alpine, Dinaric, and Isolated. Comparison of Chao1 and observed (Mao-tau) estimates of species richness indicated sampling in most drips was complete, but species accumulation curves indicated roughly half of the sites in the Dinaric karst had not reached an asymptote. Overall, within drip diversity accounted for three species, different drips in a cave another three, different caves in a region six species, and different regions accounted for the remaining 18 species. Sites in the Dinaric karst had much higher species richness than the other sites, which is in agreement with studies of other components of the subterranean fauna. The fauna associated with drips in Zupanova jama (jama = cave), in the east-central Dinaric karst was the richest found. While turnover explained the majority of beta-diversity, nestedness in the form of hotspot drips was important as well. A consequence is that a small number of drips largely determine cave and regional species diversity.	[Pipan, Tanja; Kozel, Peter] Slovenian Acad Sci & Arts, Karst Res Inst, Sci Res Ctr, Postojna, Slovenia; [Pipan, Tanja; Papi, Federica] Univ Nova Gorica, Karstol Study Program, Nova Gorica, Slovenia; [Culver, David C.] Amer Univ, Dept Environm Sci, Washington, DC 20016 USA	Slovenian Academy of Sciences & Arts (SASA); Karst Research Institute, SASA; University of Nova Gorica; American University	Culver, DC (corresponding author), Amer Univ, Dept Environm Sci, Washington, DC 20016 USA.	dculver@american.edu		Pipan, Tanja/0000-0001-9786-3870; Culver, David/0000-0002-8866-9053	Slovenian Research Agency [P6-0119, BI-US/15-16-077]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The research was supported by grants from the Slovenian Research Agency to Tanja Pipan (P6-0119 and BI-US/15-16-077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], 2005, EPIKARST PROMISING H; Bakalowicz M., 2012, ENCY CAVES, P284; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Botosaneanu L., 1986, STYGOFAUNA MUNDI; Bradley C, 2010, QUATERNARY SCI REV, V29, P2301; Brancelj A, 2004, BALKAN BIODIVERSITY: PATTERN AND PROCESS IN THE EUROPEAN HOTSPOT, P323; Brancelj A, 2002, HYDROBIOLOGIA, V477, P59, DOI 10.1023/A:1021043014879; Brancelj A., 2015, VELIKA PASICA CAVE H; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Christman MC, 2005, J BIOGEOGR, V32, P1441, DOI 10.1111/j.1365-2699.2005.01263.x; Colwell RK, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Culver David C., 2004, Subterranean Biology, V2, P27; Culver David C., 2000, Journal of Caves and Karst Studies, V62, P11; Culver DC, 2006, ECOGRAPHY, V29, P120; Culver DC, 2014, Shallow Subterranean Habitats: Ecology, Evolution, and Conservation, P1, DOI 10.1093/acprof:oso/9780199646173.001.0001; Culver DC, 2004, BIODIVERS CONSERV, V13, P1209, DOI 10.1023/B:BIOC.0000018153.49280.89; Culver DC., 2013, ENCY BIODIVERSITY, P49, DOI [10.1016/B978-0-12-384719-5.00224-0, DOI 10.1016/B978-0-12-384719-5.00224-0]; Deharveng L, 2009, FRESHWATER BIOL, V54, P709, DOI 10.1111/j.1365-2427.2008.01972.x; Deharveng L, 2012, ENCY CAVES, P38; Eme D, 2015, ECOGRAPHY, V38, P531, DOI 10.1111/ecog.01092; Fairchild I.J., 2012, SPELEOTHEM SCI PROCE; Gams I, 2004, KRAS SLOVENIJI PROST; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; HOLSINGER JR, 1980, CAN J ZOOL, V58, P290, DOI 10.1139/z80-034; Jones W. K., 2004, EPIKARST; Kluge T, 2010, J HYDROL, V394, P396, DOI 10.1016/j.jhydrol.2010.09.015; Kogovsek J., 2010, CHARACTERISTIC PERCO; Kresic N, 2010, GROUNDWATER HYDROLOGY OF SPRINGS: ENGINEERING, THEORY, MANAGEMENT, AND SUSTAINABILITY, P1; Kresic N, 2013, WATER IN KARST; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; MacArthur RH, 1967, ISLAND THEORY BIOGEO; Malard F, 2009, FRESHWATER BIOL, V54, P756, DOI 10.1111/j.1365-2427.2009.02180.x; Meleg Ioana N., 2011, Subterranean Biology, V9, P103, DOI 10.3897/subtbiol.9.2513; Meleg IN, 2011, ANN LIMNOL-INT J LIM, V47, P185, DOI 10.1051/limn/2011014; Novak Tone, 2005, Acta Carsologica, V34, P169; Pipan T, 2006, HYDROBIOLOGIA, V559, P213, DOI 10.1007/s10750-005-0920-z; Pipan T., 2003, THESIS; Pipan T, 2008, ACTA CARSOLOGICA, V37, P141; Pipan T, 2007, ENVIRON GEOL, V53, P265, DOI 10.1007/s00254-007-0640-y; Pipan T, 2007, HYDROGEOL J, V15, P817, DOI 10.1007/s10040-006-0114-4; Pipan T, 2007, J BIOGEOGR, V34, P854, DOI 10.1111/j.1365-2699.2006.01667.x; Pipan T, 2006, AM MIDL NAT, V156, P75, DOI 10.1674/0003-0031(2006)156[75:DOECMP]2.0.CO;2; Pipan T, 2013, INT J SPELEOL, V42, P215, DOI 10.5038/1827-806X.42.3.5; Pipan T, 2010, AQUAT CONSERV, V20, P748, DOI 10.1002/aqc.1148; POULSON TL, 1969, SCIENCE, V165, P971; Simon KS, 2010, FUND APPL LIMNOL, V177, P81, DOI 10.1127/1863-9135/2010/0177-0081; Sket B, 2004, BALKAN BIODIVERSITY: PATTERN AND PROCESS IN THE EUROPEAN HOTSPOT, P309; Sket B, 1999, BIODIVERS CONSERV, V8, P1319, DOI 10.1023/A:1008916601121; Sket B, 1999, CRUSTACEANA, V72, P767, DOI 10.1163/156854099503951; Sket B., 2004, EP P S, V1, P104; Stoch F, 2010, HYDROBIOLOGIA, V653, P217, DOI 10.1007/s10750-010-0356-y; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; Williams PW, 2008, INT J SPELEOL, V37, P1, DOI 10.5038/1827-806x.37.1.1; Zagmajster M, 2008, DIVERS DISTRIB, V14, P95, DOI 10.1111/j.1472-4642.2007.00423.x; Zagmajster M, 2014, GLOBAL ECOL BIOGEOGR, V23, P1135, DOI 10.1111/geb.12200; Zagmajster M, 2010, BIODIVERS CONSERV, V19, P3035, DOI 10.1007/s10531-010-9873-2	63	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195991	10.1371/journal.pone.0195991	http://dx.doi.org/10.1371/journal.pone.0195991			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718938	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900040
J	Rostila, M; Maki, N; Martikainen, P				Rostila, Mikael; Maki, Netta; Martikainen, Pekka			Does the death of a child influence parental use of psychotropic medication? A follow-up register study from Finland	PLOS ONE			English	Article							BEREAVEMENT; MORTALITY; GRIEF; HEALTH; DISTRESS; DISORDER; INFANT; SPOUSE; RISK	Background Several studies have found that the loss of a child is associated with psychiatric health problems, yet few studies examined whether child loss influences psychotropic medication use. This study examined short-and long-term use of psychotropic medication, both before and after the death of a child, and its potential effect modifiers. Methodology/Principal findings A random sample of 205,456 parents, including 902 bereaved parents, were selected from a Finnish total population registry. The analyses were based on linear regressions using generalised estimation equations (GEE) and adjusted for sociodemographic factors. Annual psychotropic use was defined as having purchased prescribed psychotropic medication between 1996 and 2012. Bereaved parents were followed for four years prior to and up to four years after the death of their child. An increase in the use of antidepressants and anxiolytics was found in parents following their loss. The highest percentage of use was found around one year after bereavement, followed by a steady decrease although this remained higher than the level of use among non-bereaved four years after the death. Between 20-25% of bereaved mothers and 10-15% of bereaved fathers used antidepressants or anxiolytics one year after bereavement while the corresponding number in non-bereaved was 5-10%. An increase in psychotropic medication was also found several years before the disease-related loss of a child. Conclusions/Significance The use of psychotropic medication is markedly higher among parents after losing a child. Patterns of use leading up to and following the death of a child should be further examined in relation to clinical risk factors so as to identify at risk populations.	[Rostila, Mikael] Stockholm Univ, Dept Publ Hlth Sci, Stockholm, Sweden; [Rostila, Mikael; Martikainen, Pekka] Stockholm Univ, Ctr Hlth Equ Studies, Karolinska Inst, Stockholm, Sweden; [Maki, Netta] City Helsinki Urban Facts, Helsinki, Finland; [Martikainen, Pekka] Univ Helsinki, Fac Social Sci, Populat Res Unit, Helsinki, Finland; [Martikainen, Pekka] Max Planck Inst Demog Res, Rostock, Germany	Stockholm University; Karolinska Institutet; Stockholm University; University of Helsinki; Max Planck Society	Rostila, M (corresponding author), Stockholm Univ, Dept Publ Hlth Sci, Stockholm, Sweden.; Rostila, M (corresponding author), Stockholm Univ, Ctr Hlth Equ Studies, Karolinska Inst, Stockholm, Sweden.	mikael.rostila@su.se		Martikainen, Pekka/0000-0001-9374-1438	Swedish Research Council [2017-03266]; Academy of Finland	Swedish Research Council(Swedish Research CouncilEuropean Commission); Academy of Finland(Academy of Finland)	This work received support from The Swedish Research Council, 2017-03266, to Professor Mikael Rostila and the Academy of Finland, to Professor Pekka Martikainen.	Arnold J, 2005, ARCH PSYCHIAT NURS, V19, P245, DOI 10.1016/j.apnu.2005.07.008; Blekesaune M, 2008, J MARRIAGE FAM, V70, P879, DOI 10.1111/j.1741-3737.2008.00533.x; Bowlby J, 1970, ATTACHMENT LOSS, V1; Chen JH, 1999, PSYCHOL MED, V29, P367, DOI 10.1017/S0033291798008137; DYREGROV A, 1991, SCAND J PSYCHOL, V32, P193, DOI 10.1111/j.1467-9450.1991.tb00869.x; Fava GA, 2011, PROG NEURO-PSYCHOPH, V35, P1593, DOI 10.1016/j.pnpbp.2010.07.026; Gardarsdottir H, 2007, J AFFECT DISORDERS, V98, P109, DOI 10.1016/j.jad.2006.07.003; Gold KJ, 2016, J WOMENS HEALTH, V25, P263, DOI 10.1089/jwh.2015.5284; Hamalainen J, 2009, DEPRESS ANXIETY, V26, P1049, DOI 10.1002/da.20524; Hardison Heather Gaines, 2005, Behav Sleep Med, V3, P99, DOI 10.1207/s15402010bsm0302_4; James L, 1997, J Pediatr Oncol Nurs, V14, P83, DOI 10.1177/104345429701400207; King M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052561; Kreicbergs U, 2004, PSYCHOL MED, V34, P1431, DOI 10.1017/S0033291704002740; Laaksonen M, 2012, SCAND J WORK ENV HEA, V38, P409, DOI 10.5271/sjweh.3290; Lacasse JR, 2014, DEATH STUD, V38, P589, DOI 10.1080/07481187.2013.820229; Latham AE, 2004, SUICIDE LIFE-THREAT, V34, P350, DOI 10.1521/suli.34.4.350.53737; Li J, 2005, NEW ENGL J MED, V352, P1190, DOI 10.1056/NEJMoa033160; Li J, 2003, LANCET, V361, P363, DOI 10.1016/S0140-6736(03)12387-2; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; Martikainen P, 1996, J EPIDEMIOL COMMUN H, V50, P264, DOI 10.1136/jech.50.3.264; Merlevede E, 2004, RESUSCITATION, V61, P341, DOI 10.1016/j.resuscitation.2004.01.024; Metsa-Simola N, 2014, SOC SCI MED, V121, P10, DOI 10.1016/j.socscimed.2014.09.043; Moller J, 2011, AGING MENT HEALTH, V15, P259, DOI 10.1080/13607863.2010.513041; Oksuzyan Anna, 2011, J Aging Res, V2011, P678289, DOI 10.4061/2011/678289; Parkes CM, 1998, BRIT MED J, V316, P856, DOI 10.1136/bmj.316.7134.856; Qin P, 2003, ARCH GEN PSYCHIAT, V60, P797, DOI 10.1001/archpsyc.60.8.797; Rossi AS., 1990, HUMAN BONDING PARENT; Rostila M, 2012, J EPIDEMIOL COMMUN H, V66, P927, DOI 10.1136/jech-2011-200339; Roy A, 2001, J AFFECT DISORDERS, V66, P71, DOI 10.1016/S0165-0327(00)00275-5; Rubin S. S., 1993, DEATH CHILD IS FOREV; Sihvo S, 2008, J AFFECT DISORDERS, V110, P94, DOI 10.1016/j.jad.2008.01.012; Stroebe M, 2005, AM J PSYCHIAT, V162, P2178, DOI 10.1176/appi.ajp.162.11.2178; Stroebe M., 2001, REV GEN PSYCHOL, V5, P62, DOI [DOI 10.1037/1089-2680.5.1.62, 10.1037/1089-2680.5.1.62]; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Twisk JWR, 2003, APPL LONGITUDINAL DA; UMBERSON D, 1994, AM SOCIOL REV, V59, P152, DOI 10.2307/2096138; VANCE JC, 1995, PEDIATRICS, V96, P933; Wall-Wieler E, 2018, DEPRESS ANX IN PRESS; Zisook S, 2009, WORLD PSYCHIATRY, V8, P67	39	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195500	10.1371/journal.pone.0195500	http://dx.doi.org/10.1371/journal.pone.0195500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5SH	29718925	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900018
J	Schulte, DM; Lipcius, RN; Burke, RP				Schulte, David M.; Lipcius, Romuald N.; Burke, Russell P.			Gear and survey efficiency of patent tongs for oyster populations on restoration reefs	PLOS ONE			English	Article							CRASSOSTREA-VIRGINICA; EASTERN OYSTER; DREDGE EFFICIENCY; DELAWARE BAY; JAMES RIVER; FISHERY; STOCK; CATCH	Surveys of restored oyster reefs need to produce accurate population estimates to assess the efficacy of restoration. Due to the complex structure of subtidal oyster reefs, one effective and efficient means to sample is by patent tongs, rather than SCUBA, dredges, or bottom cores. Restored reefs vary in relief and oyster density, either of which could affect survey efficiency. This study is the first to evaluate gear (the first full grab) and survey (which includes selecting a specific half portion of the first grab for further processing) efficiencies of hand-operated patent tongs as a function of reef height and oyster density on subtidal restoration reefs. In the Great Wicomico River, a tributary of lower Chesapeake Bay, restored reefs of high-and low-relief (25 +/- 45 cm, and 8 +/- 12 cm, respectively) were constructed throughout the river as the first large-scale oyster sanctuary reef restoration effort (sanctuary acreage > 20 ha at one site) in Chesapeake Bay. We designed a metal frame to guide a non-hydraulic mechanical patent tong repeatedly into the same plot on a restored reef until all oysters within the grab area were captured. Full capture was verified by an underwater remotely-operated vehicle. Samples (n = 19) were taken on nine different reefs, including five low-(n = 8) and four high-relief reefs (n = 11), over a two-year period. The gear efficiency of the patent tong was estimated to be 76% (+/- 5% standard error), whereas survey efficiency increased to 81% (+/- 10%) due to processing. Neither efficiency differed significantly between young-of-the-year oysters (spat) and adults, high-and low-relief reefs, or years. As this type of patent tong is a common and cost-effective tool to evaluate oyster restoration projects as well as population density on fished habitat, knowing the gear and survey efficiencies allows for accurate and precise population estimates.	[Schulte, David M.] US Army Corps Engineer, Norfolk, VA 23510 USA; [Schulte, David M.; Lipcius, Romuald N.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; [Burke, Russell P.] Christopher Newport Univ, Dept Organismal & Environm Biol, Newport News, VA 23606 USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; William & Mary; Virginia Institute of Marine Science	Schulte, DM (corresponding author), US Army Corps Engineer, Norfolk, VA 23510 USA.; Schulte, DM (corresponding author), Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA.	david.m.schulte@usace.army.mil		schulte, david/0000-0003-2141-1776	National Science Foundation [DMS-1313093]; National Oceanic and Atmospheric Administration (NOAA), Chesapeake Bay Offic [NA13NMF4570205]	National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration (NOAA), Chesapeake Bay Offic	National Science Foundation - grant number: DMS-1313093, url: https://www.nsf.gov/ recipient: RNL National Oceanic and Atmospheric Administration (NOAA), Chesapeake Bay Office, grant number: NA13NMF4570205 url: https://chesapeakebay.noaa.gov/ recipient: RNL	Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], 2014, R LANG ENV STAT COMP; Baggett L. P., 2014, OYSTER HABITAT RESTO; Baggett LP, 2015, RESTOR ECOL, V23, P737, DOI 10.1111/rec.12262; Banta SE, 2003, N AM J FISH MANAGE, V23, P732, DOI 10.1577/M01-074; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Beck SL, 2012, THESIS; Burnham K.P., 2008, MODEL SELECTION MULT; CADDY JF, 1968, J FISH RES BOARD CAN, V25, P2123, DOI 10.1139/f68-189; Chai Ai-Ling, 1992, North American Journal of Fisheries Management, V12, P825, DOI 10.1577/1548-8675(1992)012<0825:EOOSEO>2.3.CO;2; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Gaspar MB, 1999, ICES J MAR SCI, V56, P103, DOI 10.1006/jmsc.1998.0423; Grabowski JH, 2012, BIOSCIENCE, V62, P900, DOI 10.1525/bio.2012.62.10.10; Grizzle RE, 2008, J COASTAL RES, V24, P103, DOI 10.2112/06-0672.1; Harding JM, 2008, J SHELLFISH RES, V27, P1109, DOI 10.2983/0730-8000-27.5.1109; Kennedy RJ, 1999, BIOL ENVIRON, V99B, P79; Kennedy VS, 2011, J SHELLFISH RES, V30, P719, DOI 10.2983/035.030.0312; Kent B, 1988, MAKING DEAD OYSTERS; Lenihan HS, 1999, ECOL MONOGR, V69, P251, DOI 10.1890/0012-9615(1999)069[0251:PBCOOR]2.0.CO;2; Lenihan HS, 1999, LIMNOL OCEANOGR, V44, P910, DOI 10.4319/lo.1999.44.3_part_2.0910; Lenihan HS, 1998, ECOL APPL, V8, P128, DOI 10.2307/2641316; Lipcius RN, 2015, FRONT MAR SCI, V2, P1; Lockwood R, 2014, PALEONTOL SOC SPEC P, V13, P81; Mann R, 2004, J SHELLFISH RES, V23, P387; Mann R, 2009, J SHELLFISH RES, V28, P193, DOI 10.2983/035.028.0203; Marenghi F, 2017, FISH RES, V186, P292, DOI 10.1016/j.fishres.2016.10.007; Moore HF, 1909, 729 US BUR FISH; Pezzuto PR, 2010, J MAR BIOL ASSOC UK, V90, P1455, DOI 10.1017/S0025315410000317; Powell EN, 2007, N AM J FISH MANAGE, V27, P492, DOI 10.1577/M04-205.1; Powers SP, 2009, MAR ECOL PROG SER, V389, P159, DOI 10.3354/meps08164; Rick TC, 2016, P NATL ACAD SCI USA, V113, P6568, DOI 10.1073/pnas.1600019113; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; RStudio Team, 2016, R STUD INT DEV R R S; Schulte DM, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00127; Schulte DM, 2009, SCIENCE, V325, P1124, DOI 10.1126/science.1176516; Theuerkauf SJ, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00064; Waldbusser GG, 2011, J SHELLFISH RES, V30, P659, DOI 10.2983/035.030.0308; Walker ND, 2017, ICES J MAR SCI, V74, P1448, DOI 10.1093/icesjms/fsw250; Winslow F, 1882, COAST GEODETIC SURVE; ZIMMERFAUST RK, 1994, LIMNOL OCEANOGR, V39, P1075, DOI 10.4319/lo.1994.39.5.1075	40	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196725	10.1371/journal.pone.0196725	http://dx.doi.org/10.1371/journal.pone.0196725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29719007	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900074
J	Le Billan, F; Amazit, L; Bleakley, K; Xue, QY; Pussard, E; Lhadj, C; Kolkhof, P; Viengchareun, S; Fagart, J; Lombes, M				Le Billan, Florian; Amazit, Larbi; Bleakley, Kevin; Xue, Qiong-Yao; Pussard, Eric; Lhadj, Christophe; Kolkhof, Peter; Viengchareun, Say; Fagart, Jerome; Lombes, Marc			Corticosteroid receptors adopt distinct cyclical transcriptional signatures	FASEB JOURNAL			English	Article						<bold>c</bold>hromatin immunoprecipitation; kinetics; nuclear receptors; aldosterone signaling; cortisol	HUMAN MINERALOCORTICOID RECEPTOR; RNA-POLYMERASE-II; GLUCOCORTICOID-RECEPTOR; CIRCADIAN CLOCK; STEROID-RECEPTORS; ER-ALPHA; BINDING; ALDOSTERONE; SPECIFICITY; MECHANISMS	Mineralocorticoid receptors (MRs) and glucocorticoid receptors (GRs) are two closely related hormone-activated transcription factors that regulate major pathophysiologic functions. High homology between these receptors accounts for the crossbinding of their corresponding ligands, MR being activated by both aldosterone and cortisol and GR essentially activated by cortisol. Their coexpression and ability to bind similar DNA motifs highlight the need to investigate their respective contributions to overall corticosteroid signaling. Here, we decipher the transcriptional regulatory mechanisms that underlie selective effects of MRs and GRs on shared genomic targets in a human renal cellular model. Kinetic, serial, and sequential chromatin immunoprecipitation approaches were performed on the period circadian protein 1 (PER1) target gene, providing evidence that both receptors dynamically and cyclically interact at the same target promoter in a specific and distinct transcriptional signature. During this process, both receptors regulate PER1 gene by binding as homo- or heterodimers to the same promoter region. Our results suggest a novel level of MR-GR target gene regulation, which should be considered for a better and integrated understanding of corticosteroid-related pathophysiology.Le Billan, F., Amazit, L., Bleakley, K., Xue, Q.-Y., Pussard, E., Lhadj, C., Kolkhof, P., Viengchareun, S., Fagart, J., Lombes, M. Corticosteroid receptors adopt distinct cyclical transcriptional signatures.	[Le Billan, Florian; Amazit, Larbi; Xue, Qiong-Yao; Pussard, Eric; Lhadj, Christophe; Viengchareun, Say; Fagart, Jerome; Lombes, Marc] INSERM, U1185, Le Kremlin Bicetre, France; [Le Billan, Florian; Amazit, Larbi; Lhadj, Christophe; Viengchareun, Say; Fagart, Jerome; Lombes, Marc] Univ Paris Saclay, Univ Paris Sud, Fac Med Paris Sud, Unite Mixte Rech S1185, Le Kremlin Bicetre, France; [Amazit, Larbi] Inst Biomed Bicetre, Unite Mixte Serv 32, Le Kremlin Bicetre, France; [Bleakley, Kevin] Inst Natl Rech Informat & Automat Saclay, Palaiseau, France; [Bleakley, Kevin] Dept Math Orsay, Orsay, France; [Xue, Qiong-Yao; Pussard, Eric] Hop Bicetre, AP HP, Serv Genet Mol Pharmacogen & Hormonol, Le Kremlin Bicetre, France; [Kolkhof, Peter] Bayer AG, Global Drug Discovery, Dept Cardiol Res, Wuppertal, Germany; [Lombes, Marc] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Bayer AG; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Fagart, J; Lombes, M (corresponding author), Univ Paris Sud, Fac Med Paris Sud, INERM, U1185, 63 Rue Gabriel Peri, F-94276 Le Kremlin Bicetre, France.	jerome.fagart@inserm.fr; marc.lombes@u-psud.fr	Lombes, Marc/L-5933-2018; PUSSARD, Eric/S-6059-2018; Viengchareun, Say/M-6612-2017; Fagart, Jerome/S-4581-2018; Viengchareun, Say/GOV-6812-2022	Lombes, Marc/0000-0003-3189-023X; Fagart, Jerome/0000-0002-7965-0553; Le Billan, Florian/0000-0002-3400-9295; viengchareun, say/0000-0003-4280-3250	Bayer AG [P1155.0]; HAC Pharma [P1156.0]; Ministere de l'Enseignement Superieur et de la Recherche; INSERM; Universite Paris-Sud; Agence Nationale de la Recherche (ANR Calsignaldo) [ANR-15-CE14-0005]	Bayer AG(Bayer AG); HAC Pharma; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris-Sud; Agence Nationale de la Recherche (ANR Calsignaldo)(French National Research Agency (ANR))	The authors acknowledge funding from Bayer AG (P1155.0) and HAC Pharma (P1156.0). F.L.B. is the recipient of a doctoral fellowship from the Ministere de l'Enseignement Superieur et de la Recherche. This work was supported by INSERM, Universite Paris-Sud, and the Agence Nationale de la Recherche (ANR Calsignaldo; ANR-15-CE14-0005). P.K. is a full-time employee of Bayer AG. The authors declare no conflicts of interest.	Amazit L, 2015, J BIOL CHEM, V290, P21876, DOI 10.1074/jbc.M115.657957; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Auwerx J, 1999, CELL, V97, P161; Barfacker L, 2012, CHEMMEDCHEM, V7, P1385, DOI 10.1002/cmdc.201200081; Berger S, 1998, P NATL ACAD SCI USA, V95, P9424, DOI 10.1073/pnas.95.16.9424; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cheon S, 2013, NUCLEIC ACIDS RES, V41, P6161, DOI 10.1093/nar/gkt307; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Conway-Campbell BL, 2012, MOL CELL ENDOCRINOL, V348, P383, DOI 10.1016/j.mce.2011.08.014; Denker A, 2015, CELL, V162, P942, DOI 10.1016/j.cell.2015.08.022; Deppe CE, 2002, ENDOCRINOLOGY, V143, P1932, DOI 10.1210/en.143.5.1932; Fagart J, 1998, EMBO J, V17, P3317, DOI 10.1093/emboj/17.12.3317; Fagart J, 2005, NAT STRUCT MOL BIOL, V12, P554, DOI 10.1038/nsmb939; Fagart J, 2005, MOL PHARMACOL, V67, P1714, DOI 10.1124/mol.104.010710; Fujihara Y, 2014, BONE, V61, P1, DOI 10.1016/j.bone.2013.12.026; Fuller PJ, 2000, KIDNEY INT, V57, P1256, DOI 10.1046/j.1523-1755.2000.00959.x; Funder J, 1996, ENDOCRINOLOGY, V137, P5264, DOI 10.1210/en.137.12.5264; Funder JW, 2007, HYPERTENSION, V50, P840, DOI 10.1161/HYPERTENSIONAHA.107.098012; Funder JW, 2017, J ENDOCRINOL, V234, pT17, DOI 10.1530/JOE-17-0119; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; Grossmann C, 2012, CHEM BIOL, V19, P742, DOI 10.1016/j.chembiol.2012.04.014; GUIOCHONMANTEL A, 1989, CELL, V57, P1147, DOI 10.1016/0092-8674(89)90052-4; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Hellal-Levy C, 1999, FEBS LETT, V464, P9, DOI 10.1016/S0014-5793(99)01667-1; Jaisser F, 2016, PHARMACOL REV, V68, P49, DOI 10.1124/pr.115.011106; Le Billan F, 2015, FASEB J, V29, P3977, DOI 10.1096/fj.15-274266; LOMBES M, 1994, BIOCHEM J, V302, P191, DOI 10.1042/bj3020191; LOMBES M, 1994, ENDOCRINOLOGY, V135, P834, DOI 10.1210/en.135.3.834; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mifsud KR, 2016, P NATL ACAD SCI USA, V113, P11336, DOI 10.1073/pnas.1605246113; Morris DJ, 2009, STEROIDS, V74, P1, DOI 10.1016/j.steroids.2008.10.005; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Odermatt A, 2009, STEROIDS, V74, P163, DOI 10.1016/j.steroids.2008.10.010; Ou XM, 2001, J BIOL CHEM, V276, P14299, DOI 10.1074/jbc.M005363200; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P1158, DOI 10.1210/me.2004-0331; Petit-Topin I, 2014, J STEROID BIOCHEM, V144, P427, DOI 10.1016/j.jsbmb.2014.08.008; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pippal JB, 2009, MOL ENDOCRINOL, V23, P1360, DOI 10.1210/me.2009-0032; Presman DM, 2016, P NATL ACAD SCI USA, V113, P8236, DOI 10.1073/pnas.1606774113; PRIE D, 1995, KIDNEY INT, V47, P1310, DOI 10.1038/ki.1995.186; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Richards J, 2014, J BIOL CHEM, V289, P11791, DOI 10.1074/jbc.M113.531095; Richards J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00253; Rowley MJ, 2016, CURR OPIN CELL BIOL, V40, P8, DOI 10.1016/j.ceb.2016.01.009; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; SCHREIBER JR, 1983, CONTRACEPTION, V28, P77, DOI 10.1016/S0010-7824(83)80008-0; Stortz M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06676-0; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Terker AS, 2015, AM J PHYSIOL-REG I, V309, pR1068, DOI 10.1152/ajpregu.00135.2015; Travers S, 2017, J STEROID BIOCHEM, V165, P202, DOI 10.1016/j.jsbmb.2016.06.005; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Viengchareun S, 2014, J AM SOC NEPHROL, V25, P2213, DOI 10.1681/ASN.2013091023; Viengchareun S, 2009, MOL ENDOCRINOL, V23, P1948, DOI 10.1210/me.2009-0095; Watson LC, 2013, NAT STRUCT MOL BIOL, V20, P876, DOI 10.1038/nsmb.2595; Weikum ER, 2017, NAT REV MOL CELL BIO, V18, P159, DOI 10.1038/nrm.2016.152; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Zhang SM, 2007, STEROIDS, V72, P600, DOI 10.1016/j.steroids.2007.03.012	60	13	13	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5626	5639		10.1096/fj.201800391RR	http://dx.doi.org/10.1096/fj.201800391RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29733691	Green Submitted, Bronze			2022-12-26	WOS:000447972500035
J	Weeden, CE; Ah-Cann, C; Holik, AZ; Pasquet, J; Garnier, JM; Merino, D; Lessene, G; Asselin-Labat, ML				Weeden, Clare E.; Ah-Cann, Casey; Holik, Aliaksei Z.; Pasquet, Julie; Garnier, Jean-Marc; Merino, Delphine; Lessene, Guillaume; Asselin-Labat, Marie-Liesse			Dual inhibition of BCL-XL and MCL-1 is required to induce tumour regression in lung squamous cell carcinomas sensitive to FGFR inhibition	ONCOGENE			English	Article							GENETIC ALTERATIONS; KINASE INHIBITOR; FAMILY PROTEINS; DOWN-REGULATION; CANCER; ABT-737; RESISTANCE; PREDICT; NVP-BGJ398; OVERCOME	Genetic alterations in the fibroblast growth factor receptors (FGFRs) have been described in multiple solid tumours including bladder cancer, head and neck and lung squamous cell carcinoma (SqCC). However, recent clinical trials showed limited efficacy of FGFR-targeted therapy in lung SqCC, suggesting combination therapy may be necessary to improve patient outcomes. Here we demonstrate that FGFR therapy primes SqCC for cell death by increasing the expression of the pro-apoptotic protein BIM. We therefore hypothesised that combining BH3-mimetics, potent inhibitors of pro-survival proteins, with FGFR-targeted therapy may enhance the killing of SqCC cells. Using patient-derived xenografts and specific inhibitors of BCL-2, BCL-XL, and MCL-1, we identified a greater reliance of lung SqCC cells on BCL-XL and MCL-1 compared to BCL-2 for survival. However, neither BCL-XL nor MCL-1 inhibitors alone provided a survival benefit in combination FGFR therapy in vivo. Only triple BCL-XL, MCL-1, and FGFR inhibition resulted in tumour volume regression and prolonged survival in vivo, demonstrating the ability of BCL-XL and MCL-1 proteins to compensate for each other in lung SqCC. Our work therefore provides a rationale for the inhibition of MCL-1, BCL-XL, and FGFR1 to maximize therapeutic response in FGFR1 -expressing lung SqCC.	[Weeden, Clare E.; Ah-Cann, Casey; Holik, Aliaksei Z.; Pasquet, Julie; Asselin-Labat, Marie-Liesse] Walter & Eliza Hall Inst Med Res, ACRF Stem Cells & Canc Div, Parkville, Vic, Australia; [Weeden, Clare E.; Ah-Cann, Casey; Holik, Aliaksei Z.; Garnier, Jean-Marc; Lessene, Guillaume; Asselin-Labat, Marie-Liesse] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Garnier, Jean-Marc; Lessene, Guillaume] Walter & Eliza Hall Inst Med Res, ACRF Chem Biol Div, Parkville, Vic, Australia; [Merino, Delphine] Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia; [Merino, Delphine] La Trobe Univ, Sch Canc Med, Melbourne, Vic, Australia; [Merino, Delphine] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Lessene, Guillaume] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne; Walter & Eliza Hall Institute; La Trobe University; Olivia Newton-John Cancer Research Institute; La Trobe University; Walter & Eliza Hall Institute; University of Melbourne	Asselin-Labat, ML (corresponding author), Walter & Eliza Hall Inst Med Res, ACRF Stem Cells & Canc Div, Parkville, Vic, Australia.; Asselin-Labat, ML (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.	labat@wehi.edu.au	Holik, Aliaksei Z/H-5828-2015; Holik, Aliaksei/GYA-2218-2022; Merino, Delphine/L-9159-2017	Holik, Aliaksei Z/0000-0002-3555-8587; Merino, Delphine/0000-0002-8075-6275; Ah-Cann, Casey/0000-0001-9210-3776; Weeden, Clare/0000-0002-1561-1416	Viertel Foundation Senior Medical Researcher Fellowship; Australian Postgraduate Award; Cancer Therapeutics CRC top-up scholarship; Deep Manchanda Lung Foundation Australia Early Career Fellowship; Lung Foundation Australia PhD Scholarship; NBCF Early Career Fellowship; NHMRC Project grant [1101378]; Servier; Cancer Therapeutics CRC; Harry Secomb Foundation; Ian Potter Foundation; Leukemia and Lymphoma Society; Australian Cancer Research Foundation; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS; Victorian Cancer Agency	Viertel Foundation Senior Medical Researcher Fellowship; Australian Postgraduate Award(Australian Government); Cancer Therapeutics CRC top-up scholarship(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Deep Manchanda Lung Foundation Australia Early Career Fellowship; Lung Foundation Australia PhD Scholarship; NBCF Early Career Fellowship; NHMRC Project grant(National Health and Medical Research Council (NHMRC) of Australia); Servier(Servier); Cancer Therapeutics CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Harry Secomb Foundation; Ian Potter Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Australian Cancer Research Foundation; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cancer Agency	M-LA-L is supported by a Viertel Foundation Senior Medical Researcher Fellowship. CEW is supported by an Australian Postgraduate Award, a Cancer Therapeutics CRC top-up scholarship, and a Deep Manchanda Lung Foundation Australia Early Career Fellowship. CA is supported by a Lung Foundation Australia PhD Scholarship. DM is supported by an NBCF Early Career Fellowship and NHMRC Project grant (1101378). This work was made possible through financial support from Servier, grants from the Victorian Cancer Agency, the Cancer Therapeutics CRC, the Harry Secomb Foundation, the Ian Potter Foundation, the Leukemia and Lymphoma Society, the Australian Cancer Research Foundation, the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS.	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Fan WW, 2011, CANCER RES, V71, P4494, DOI 10.1158/0008-5472.CAN-10-2668; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Gardner EE, 2014, CANCER RES, V74, P2846, DOI 10.1158/0008-5472.CAN-13-3460; Gong JN, 2016, BLOOD, V128, P1834, DOI 10.1182/blood-2016-03-704908; Greenberg EF, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.355; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Lam LT, 2017, MOL CANCER THER, V16, P1511, DOI 10.1158/1535-7163.MCT-16-0459; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Merino D, 2012, BLOOD, V119, P5807, DOI 10.1182/blood-2011-12-400929; Merino D, 2009, APOPTOSIS, V14, P570, DOI 10.1007/s10495-008-0308-4; Nogova L, 2017, J CLIN ONCOL, V35, P157, DOI 10.1200/JCO.2016.67.2048; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Potter DS, 2016, COLD SH Q B, V81, P131, DOI 10.1101/sqb.2016.81.030841; PRICHARD MN, 1991, ANTIMICROB AGENTS CH, V35, P1060, DOI 10.1128/AAC.35.6.1060; Rahman M, 2015, BIOINFORMATICS, V31, P3666, DOI 10.1093/bioinformatics/btv377; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; Roberts AW, 2016, NEW ENGL J MED, V374, P311, DOI 10.1056/NEJMoa1513257; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thiagarajan PS, 2016, ONCOTARGET, V7, P82013, DOI 10.18632/oncotarget.13307; Vaillant F, 2013, CANCER CELL, V24, P120, DOI 10.1016/j.ccr.2013.06.002; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vick B, 2009, HEPATOLOGY, V49, P627, DOI 10.1002/hep.22664; Weeden CE, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.49; Weeden CE, 2017, MOL CANCER THER, V16, P1610, DOI 10.1158/1535-7163.MCT-17-0174; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wykosky J, 2015, CANCER RES, V75, P394, DOI 10.1158/0008-5472.CAN-14-2004; Wynes MW, 2014, CLIN CANCER RES, V20, P3299, DOI 10.1158/1078-0432.CCR-13-3060; Ye MX, 2017, CANCER RES, V77, P3527, DOI 10.1158/0008-5472.CAN-16-3470; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Zeuner A, 2014, CELL DEATH DIFFER, V21, P1877, DOI 10.1038/cdd.2014.105	47	59	60	1	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 9	2018	37	32					4475	4488		10.1038/s41388-018-0268-2	http://dx.doi.org/10.1038/s41388-018-0268-2			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP8FA	29743589				2022-12-26	WOS:000441144300010
J	Ro, SY; Ross, MO; Deng, YW; Batelu, S; Lawton, TJ; Hurley, JD; Stemmler, TL; Hoffman, BM; Rosenzweig, AC				Ro, Soo Y.; Ross, Matthew O.; Deng, Yue Wen; Batelu, Sharon; Lawton, Thomas J.; Hurley, Joseph D.; Stemmler, Timothy L.; Hoffman, Brian M.; Rosenzweig, Amy C.			From micelles to bicelles: Effect of the membrane on particulate methane monooxygenase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper monooxygenase; metalloenzyme; crystal structure; biofuel; biotechnology; protein-lipid interaction; membrane protein; bicelle; copper metalloenzyme; methane oxidation; methanotroph; particulate methane monooxygenase	CRYSTAL-STRUCTURE; METAL CENTERS; PROTEIN; OXIDATION; COPPER; LIPIDS; PURIFICATION; DETERGENTS; BACTERIA; COMPLEX	Particulate methane monooxygenase (pMMO) is a copper-dependent integral membrane metalloenzyme that converts methane to methanol in methanotrophic bacteria. Studies of isolated pMMO have been hindered by loss of enzymatic activity upon its removal from the native membrane. To characterize pMMO in a membrane-like environment, we reconstituted pMMOs from Methylococcus (Mcc.) capsulatus (Bath) and Methylomicrobium (Mm.) alcaliphilum 20Z into bicelles. Reconstitution into bicelles recovers methane oxidation activity lost upon detergent solubilization and purification without substantial alterations to copper content or copper electronic structure, as observed by electron paramagnetic resonance (EPR) spectroscopy. These findings suggest that loss of pMMO activity upon isolation is due to removal from the membranes rather than caused by loss of the catalytic copper ions. A 2.7 resolution crystal structure of pMMO from Mm. alcaliphilum 20Z reveals a mononuclear copper center in the PmoB subunit and indicates that the transmembrane PmoC subunit may be conformationally flexible. Finally, results from extended X-ray absorption fine structure (EXAFS) analysis of pMMO from Mm. alcaliphilum 20Z were consistent with the observed monocopper center in the PmoB subunit. These results underscore the importance of studying membrane proteins in a membrane-like environment and provide valuable insight into pMMO function.	[Ro, Soo Y.; Ross, Matthew O.; Deng, Yue Wen; Lawton, Thomas J.; Hurley, Joseph D.; Hoffman, Brian M.; Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Ro, Soo Y.; Ross, Matthew O.; Deng, Yue Wen; Lawton, Thomas J.; Hurley, Joseph D.; Hoffman, Brian M.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Batelu, Sharon; Stemmler, Timothy L.] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA	Northwestern University; Northwestern University; Wayne State University	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.; Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.	amyr@northwestern.edu		Rosenzweig, Amy/0000-0001-8472-4134; Deng, Yue Wen/0000-0003-3344-6837; Hurley, Joseph/0000-0002-3903-318X; Stemmler, Timothy/0000-0002-6298-088X	Department of Energy Office of Science [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118035, R01GM111097, R01GM070473, T32GM008382, P41GM103393] Funding Source: NIH RePORTER	Department of Energy Office of Science(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work used the Advanced Photon Source, a Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor (grant 085P1000817). Data were collected at the LS-CAT beamline 21-ID-D. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the NIGMS, National Institutes of Health (including P41GM103393). We also thank Dr. Marina Kalyuzhnaya at San Diego State University for providing Mm. alcaliphilum 20Z cultures.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agah Sayeh, 2012, Methods Mol Biol, V914, P3, DOI 10.1007/978-1-62703-023-6_1; Ankudinov AL, 1997, PHYS REV B, V56, pR1712, DOI 10.1103/PhysRevB.56.R1712; Balasubramanian R, 2010, NATURE, V465, P115, DOI 10.1038/nature08992; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Blanchette CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11900; Cao LL, 2018, ANGEW CHEM INT EDIT, V57, P162, DOI 10.1002/anie.201708977; Chan SI, 2008, ACCOUNTS CHEM RES, V41, P969, DOI 10.1021/ar700277n; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi DW, 2003, J BACTERIOL, V185, P5755, DOI 10.1128/JB.185.19.5755-5764.2003; Cotelesage JJH, 2012, J INORG BIOCHEM, V115, P127, DOI 10.1016/j.jinorgbio.2012.06.019; Culpepper MA, 2014, J AM CHEM SOC, V136, P11767, DOI 10.1021/ja5053126; Czerski L, 2000, ANAL BIOCHEM, V284, P327, DOI 10.1006/abio.2000.4720; Durr UHN, 2012, CHEM REV, V112, P6054, DOI 10.1021/cr300061w; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fei Q, 2014, BIOTECHNOL ADV, V32, P596, DOI 10.1016/j.biotechadv.2014.03.011; Frandsen KEH, 2016, IUCRJ, V3, P448, DOI 10.1107/S2052252516014147; Frey L, 2017, ANGEW CHEM INT EDIT, V56, P380, DOI 10.1002/anie.201608246; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; George G. N., 2001, EXAFSPAK; Gruss F, 2015, METHODS MOL BIOL, V1329, P259, DOI 10.1007/978-1-4939-2871-2_20; Hakemian AS, 2008, BIOCHEMISTRY-US, V47, P6793, DOI 10.1021/bi800598h; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Jiang H, 2010, BIOCHEM ENG J, V49, P277, DOI 10.1016/j.bej.2010.01.003; Kaluzhnaya M, 2001, SYST APPL MICROBIOL, V24, P166, DOI 10.1078/0723-2020-00028; Kalyuzhnaya MG, 2015, METAB ENG, V29, P142, DOI 10.1016/j.ymben.2015.03.010; Khmelenina VN, 1997, CURR MICROBIOL, V35, P257, DOI 10.1007/s002849900249; Lawton TJ, 2016, J AM CHEM SOC, V138, P9327, DOI 10.1021/jacs.6b04568; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; LEE MH, 1993, PROTEIN SCI, V2, P1042, DOI 10.1002/pro.5560020617; Lieberman RL, 2006, INORG CHEM, V45, P8372, DOI 10.1021/ic060739v; Lieberman RL, 2003, P NATL ACAD SCI USA, V100, P3820, DOI 10.1073/pnas.0536703100; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; Liew EF, 2014, MICROBIOL-SGM, V160, P1267, DOI 10.1099/mic.0.078584-0; MAKULA RA, 1978, J BACTERIOL, V134, P771, DOI 10.1128/JB.134.3.771-777.1978; Ojala DS, 2011, METHOD ENZYMOL, P99, DOI 10.1016/B978-0-12-386905-0.00007-3; Orwick-Rydmark Marcella, 2016, Curr Protoc Protein Sci, V84, DOI 10.1002/0471140864.ps0408s84; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Puri AW, 2015, APPL ENVIRON MICROB, V81, P1766, DOI 10.1128/AEM.03795-14; RIGGSGELASCO PJ, 1995, COORDIN CHEM REV, V144, P245, DOI 10.1016/0010-8545(95)01144-E; Ross MO, 2017, J BIOL INORG CHEM, V22, P307, DOI 10.1007/s00775-016-1419-y; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Shen HH, 2013, INT J MOL SCI, V14, P1589, DOI 10.3390/ijms14011589; Simmons TJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01247-3; Sirajuddin S, 2015, BIOCHEMISTRY-US, V54, P2283, DOI 10.1021/acs.biochem.5b00198; Sirajuddin S, 2014, J BIOL CHEM, V289, P21782, DOI 10.1074/jbc.M114.581363; Smith SM, 2011, BIOCHEMISTRY-US, V50, P10231, DOI 10.1021/bi200801z; Stemmler TL, 1997, BIOCHEMISTRY-US, V36, P9847, DOI 10.1021/bi9702795; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; United States Environmental Protection Agency, 2017, 430P17001 EPA US ENV; Walton PH, 2016, CURR OPIN CHEM BIOL, V31, P195, DOI 10.1016/j.cbpa.2016.04.001; Wang VCC, 2017, CHEM REV, V117, P8574, DOI 10.1021/acs.chemrev.6b00624; Yang ZR, 2014, PROTEIN SCI, V23, P769, DOI 10.1002/pro.2460	55	31	31	4	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10457	10465		10.1074/jbc.RA118.003348	http://dx.doi.org/10.1074/jbc.RA118.003348			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29739854	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000437828400007
J	Gurzau, AD; Chen, KL; Xue, SF; Dai, WW; Lucet, IS; Ly, TTN; Reversade, B; Blewitt, ME; Murphy, JM				Gurzau, Alexandra D.; Chen, Kelan; Xue, Shifeng; Dai, Weiwen; Lucet, Isabelle S.; Thanh Thao Nguyen Ly; Reversade, Bruno; Blewitt, Marnie E.; Murphy, James M.			FSHD2-and BAMS-associated mutations confer opposing effects on SMCHD1 function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; small-angle X-ray scattering (SAXS); epigenetics; Xenopus; muscular dystrophy; craniofacial development; SMC; hinge domain	FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; ARHINIA MICROPHTHALMIA SYNDROME; EPIGENETIC REGULATOR SMCHD1; INACTIVE X-CHROMOSOME; DISEASE SEVERITY; GENE-EXPRESSION; HSP90 CHAPERONE; HINGE DOMAIN; ARCHITECTURE; BINDING	Structural maintenance of chromosomes flexible hinge domain-containing 1 (Smchd1) plays important roles in epigenetic silencing and normal mammalian development. Recently, heterozygous mutations in SMCHD1 have been reported in two disparate disorders: facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS). FSHD2-associated mutations lead to loss of function; however, whether BAMS is associated with loss- or gain-of-function mutations in SMCHD1 is unclear. Here, we have assessed the effect of SMCHD1 missense mutations from FSHD2 and BAMS patients on ATP hydrolysis activity and protein conformation and the effect of BAMS mutations on craniofacial development in a Xenopus model. These data demonstrated that FSHD2 mutations only result in decreased ATP hydrolysis, whereas many BAMS mutations can result in elevated ATPase activity and decreased eye size in Xenopus. Interestingly, a mutation reported in both an FSHD2 patient and a BAMS patient results in increased ATPase activity and a smaller Xenopus eye size. Mutations in the extended ATPase domain increased catalytic activity, suggesting critical regulatory intramolecular interactions and the possibility of targeting this region therapeutically to boost SMCHD1's activity to counter FSHD.	[Gurzau, Alexandra D.; Chen, Kelan; Dai, Weiwen; Lucet, Isabelle S.; Blewitt, Marnie E.; Murphy, James M.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Gurzau, Alexandra D.; Chen, Kelan; Lucet, Isabelle S.; Blewitt, Marnie E.; Murphy, James M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Blewitt, Marnie E.] Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia; [Xue, Shifeng; Thanh Thao Nguyen Ly; Reversade, Bruno] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Xue, Shifeng; Thanh Thao Nguyen Ly; Reversade, Bruno] ASTAR, Human Genet & Embryol Lab, Inst Med Biol, Singapore, Singapore; [Reversade, Bruno] Koc Univ, Sch Med KUSoM, Dept Med Genet, TR-34450 Sariyer, Turkey; [Reversade, Bruno] Natl Univ Singapore, Sch Med, Dept Paediat, Singapore, Singapore; [Reversade, Bruno] Acad Med Ctr, Amsterdam Reprod & Dev, NL-1105 AZ Amsterdam, Netherlands; [Reversade, Bruno] Vrije Univ Amsterdam, Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Koc University; National University of Singapore; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Blewitt, ME; Murphy, JM (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	blewitt@wehi.edu.au; jamesm@wehi.edu.au	Murphy, James/B-4863-2017	Murphy, James/0000-0003-0195-3949; Blewitt, Marnie/0000-0002-2984-1474; Gurzau, Alexandra/0000-0001-8664-0698; Xue, Shifeng/0000-0002-4668-5952; Chen, Kelan/0000-0003-1973-5405; REVERSADE, Bruno/0000-0002-4070-7997	Australian Research Training Program scholarship; Cancer Council Victoria fellowship; Bellberry-Viertel Senior Medical Research Fellowship; Australian National Health and Medical Research Council Fellowship [1105754, 1098290]; A*STAR BMRC YIG; NMRC YIRG; BMRC, A*STAR, Singapore; Victorian State Government Operational Infrastructure Support; Australian National Health and Medical Research Council IRIISS Grant [9000433]; Australian Cancer Research Foundation	Australian Research Training Program scholarship; Cancer Council Victoria fellowship(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Bellberry-Viertel Senior Medical Research Fellowship; Australian National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia); A*STAR BMRC YIG(Agency for Science Technology & Research (A*STAR)); NMRC YIRG; BMRC, A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); Victorian State Government Operational Infrastructure Support; Australian National Health and Medical Research Council IRIISS Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation	This study was supported by an Australian Research Training Program scholarship (to A. D. G.), a Cancer Council Victoria fellowship (to K. C.), the Bellberry-Viertel Senior Medical Research Fellowship (to M. E. B.), Australian National Health and Medical Research Council Fellowship 1105754 (to J. M. M.) and Grant 1098290 (to M. E. B. and J. M. M.), A*STAR BMRC YIG (to S. X.), NMRC YIRG (to S. X.), and a Strategic Positioning Fund on Genetic Orphan Diseases from the BMRC, A*STAR, Singapore (to B. R.). Additional support was provided by Victorian State Government Operational Infrastructure Support, Australian National Health and Medical Research Council IRIISS Grant 9000433, and the Australian Cancer Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Achilleos A, 2015, CURR TOP DEV BIOL, V115, P413, DOI 10.1016/bs.ctdb.2015.07.011; Babon Jeffrey J, 2013, Methods Mol Biol, V967, P39, DOI 10.1007/978-1-62703-242-1_3; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; Brideau NJ, 2015, MOL CELL BIOL, V35, P4053, DOI 10.1128/MCB.00432-15; Chen KL, 2016, BIOCHEM J, V473, P1733, DOI 10.1042/BCJ20160189; Chen K, 2016, BIOCHEM J, V473, P733, DOI 10.1042/BJ20151049; Chen KL, 2015, P NATL ACAD SCI USA, V112, pE3535, DOI 10.1073/pnas.1504232112; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; Diebold-Durand ML, 2017, MOL CELL, V67, P334, DOI 10.1016/j.molcel.2017.06.010; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Ganji M, 2018, SCIENCE, V360, P102, DOI 10.1126/science.aar7831; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Gordon CT, 2017, NAT GENET, V49, P249, DOI 10.1038/ng.3765; Graham JM, 2006, AM J MED GENET A, V140A, P189, DOI 10.1002/ajmg.a.31039; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Hu B, 2011, CURR BIOL, V21, P12, DOI 10.1016/j.cub.2010.12.004; Jansz N, 2017, TRENDS GENET, V33, P233, DOI 10.1016/j.tig.2017.01.007; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Larsen M, 2015, EUR J HUM GENET, V23, P808, DOI 10.1038/ejhg.2014.191; Leidenroth A, 2012, EUR J HUM GENET, V20, P999, DOI 10.1038/ejhg.2012.42; Lemmers RJLF, 2015, HUM MOL GENET, V24, P659, DOI 10.1093/hmg/ddu486; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Minnen A, 2016, CELL REP, V14, P2003, DOI 10.1016/j.celrep.2016.01.066; Nozawa RS, 2013, NAT STRUCT MOL BIOL, V20, P566, DOI 10.1038/nsmb.2532; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Piper PW, 2003, EUR J BIOCHEM, V270, P4689, DOI 10.1046/j.1432-1033.2003.03866.x; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Retzlaff M, 2009, EMBO REP, V10, P1147, DOI 10.1038/embor.2009.153; Sacconi S, 2013, AM J HUM GENET, V93, P744, DOI 10.1016/j.ajhg.2013.08.004; Shaw ND, 2017, NAT GENET, V49, P238, DOI 10.1038/ng.3743; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Soh YM, 2015, MOL CELL, V57, P290, DOI 10.1016/j.molcel.2014.11.023; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Tsutsumi S, 2012, P NATL ACAD SCI USA, V109, P2937, DOI 10.1073/pnas.1114414109; van der Maarel SM, 2005, AM J HUM GENET, V76, P375, DOI 10.1086/428361; Yao ZZ, 2014, HUM MOL GENET, V23, P5342, DOI 10.1093/hmg/ddu251; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	44	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9841	9853		10.1074/jbc.RA118.003104	http://dx.doi.org/10.1074/jbc.RA118.003104			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29748383	Green Published, hybrid			2022-12-26	WOS:000436102300026
J	Kasetti, RB; Maddineni, P; Patel, PD; Searby, C; Sheffield, VC; Zode, GS				Kasetti, Ramesh B.; Maddineni, Prabhavathi; Patel, Pinkal D.; Searby, Charles; Sheffield, Val C.; Zode, Gulab S.			Transforming growth factor 2 (TGF2) signaling plays a key role in glucocorticoid-induced ocular hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); glucocorticoid; growth factor; SMAD transcription factor; extracellular matrix (ECM) protein; glucocorticoids; ocular hypertension; steroid-induced glaucoma; trabecular meshwork; transforming growth factor 2 (TGF2)	TRABECULAR MESHWORK CELLS; EXTRACELLULAR-MATRIX PROTEINS; ENDOPLASMIC-RETICULUM STRESS; PLASMINOGEN-ACTIVATOR INHIBITOR-1; OPEN-ANGLE GLAUCOMA; FACTOR-BETA; INTRAOCULAR-PRESSURE; AQUEOUS-HUMOR; TISSUE TRANSGLUTAMINASE; ULTRASTRUCTURAL-CHANGES	Elevation of intraocular pressure (IOP) is a serious adverse effect of glucocorticoid (GC) therapy. Increased extracellular matrix (ECM) accumulation and endoplasmic reticulum (ER) stress in the trabecular meshwork (TM) is associated with GC-induced IOP elevation. However, the molecular mechanisms by which GCs induce ECM accumulation and ER stress in the TM have not been determined. Here, we show that a potent GC, dexamethasone (Dex), activates transforming growth factor (TGF) signaling, leading to GC-induced ECM accumulation, ER stress, and IOP elevation. Dex increased both the precursor and bioactive forms of TGF2 in conditioned medium and activated TGF-induced SMAD signaling in primary human TM cells. Dex also activated TGF2 in the aqueous humor and TM of a mouse model of Dex-induced ocular hypertension. We further show that Smad3(-/-) mice are protected from Dex-induced ocular hypertension, ER stress, and ECM accumulation. Moreover, treating WT mice with a selective TGF receptor kinase I inhibitor, LY364947, significantly decreased Dex-induced ocular hypertension. Of note, knockdown of the ER stress-induced activating transcription factor 4 (ATF4), or C/EBP homologous protein (CHOP), completely prevented Dex-induced TGF2 activation and ECM accumulation in TM cells. These observations suggested that chronic ER stress promotes Dex-induced ocular hypertension via TGF signaling. Our results indicate that TGF2 signaling plays a central role in GC-induced ocular hypertension and provides therapeutic targets for GC-induced ocular hypertension.	[Kasetti, Ramesh B.; Maddineni, Prabhavathi; Patel, Pinkal D.; Zode, Gulab S.] Univ North Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Kasetti, Ramesh B.; Maddineni, Prabhavathi; Patel, Pinkal D.; Zode, Gulab S.] Univ North Texas, Hlth Sci Ctr, North Texas Eye Res Inst, CBH 413,3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA; [Searby, Charles; Sheffield, Val C.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; University of North Texas Health Science Center; University of Iowa	Zode, GS (corresponding author), Univ North Texas, Hlth Sci Ctr, North Texas Eye Res Inst, CBH 413,3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	gulab.zode@unthsc.edu	Patel, Pinkal D./GQP-2308-2022	Patel, Pinkal D./0000-0002-7704-4381; Maddineni, Prabhavathi/0000-0002-6928-254X; Sheffield, Val/0000-0002-6282-0835; KASETTI, RAMESH/0000-0001-7874-3988	National Institutes of Health from the NEI [EY022077, EY026177, EY024259]; North Texas Eye Research Institute in Fort Worth, TX; NATIONAL EYE INSTITUTE [K99EY022077, R01EY026177, R00EY022077, R01EY024259, R01EY028616] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; North Texas Eye Research Institute in Fort Worth, TX; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY022077, EY026177, and EY024259 from the NEI and by funding from the North Texas Eye Research Institute in Fort Worth, TX. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal P, 2015, MOL VIS, V21, P612; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; ARMALY MF, 1965, FED PROC, V24, P1274; Bolkenius U, 2004, BIOCHEM BIOPH RES CO, V325, P1264, DOI 10.1016/j.bbrc.2004.10.164; Bollinger KE, 2012, MOL VIS, V18, P2001; Clark AF, 2009, EXP EYE RES, V88, P752, DOI 10.1016/j.exer.2008.10.004; Clark AF, 2005, CELL MOTIL CYTOSKEL, V60, P83, DOI 10.1002/cm.20049; Clark AF, 2001, INVEST OPHTH VIS SCI, V42, P1769; CLARK AF, 1995, INVEST OPHTH VIS SCI, V36, P478; Dickerson JE, 1998, EXP EYE RES, V66, P731, DOI 10.1006/exer.1997.0470; El-Shabrawi Y, 2000, EYE, V14, P375, DOI 10.1038/eye.2000.92; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Flugel-Koch C, 2004, EXP EYE RES, V79, P649, DOI 10.1016/j.exer.2004.07.005; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Haddadin RI, 2012, INVEST OPHTH VIS SCI, V53, P6708, DOI 10.1167/iovs.11-9013; Inatani M, 2001, GRAEF ARCH CLIN EXP, V239, P109, DOI 10.1007/s004170000241; Jain A, 2014, J OCUL PHARMACOL TH, V30, P121, DOI 10.1089/jop.2013.0239; Johnson D, 1997, ARCH OPHTHALMOL-CHIC, V115, P375, DOI 10.1001/archopht.1997.01100150377011; Jones R, 2006, CURR OPIN OPHTHALMOL, V17, P163; Kasetti RB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14938-0; Kasetti RB, 2016, INVEST OPHTH VIS SCI, V57, P6058, DOI 10.1167/iovs.16-19610; Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2; Kimura H, 2011, CLIN EXP NEPHROL, V15, P34, DOI 10.1007/s10157-010-0351-7; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Lutjen-Drecoll E, 2005, EXP EYE RES, V81, P1, DOI 10.1016/j.exer.2005.02.008; LUTJENDRECOLL E, 1973, INVEST OPHTH VISUAL, V12, P280; MAEPEA O, 1992, EXP EYE RES, V54, P879, DOI 10.1016/0014-4835(92)90151-H; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mao WM, 2011, INVEST OPHTH VIS SCI, V52, P8068, DOI 10.1167/iovs.11-8133; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McDowell CM, 2013, EXP EYE RES, V116, P419, DOI 10.1016/j.exer.2013.10.017; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Overby DR, 2015, EXP EYE RES, V141, P15, DOI 10.1016/j.exer.2015.06.002; Overby DR, 2014, INVEST OPHTH VIS SCI, V55, P4922, DOI 10.1167/iovs.14-14429; Pan XY, 2015, MOL CELL ENDOCRINOL, V407, P37, DOI 10.1016/j.mce.2015.03.005; PANG IH, 1994, CURR EYE RES, V13, P51, DOI 10.3109/02713689409042398; Patel GC, 2017, AM J PATHOL, V187, P713, DOI 10.1016/j.ajpath.2016.12.003; Peters JC, 2015, INVEST OPHTH VIS SCI, V56, P3860, DOI 10.1167/iovs.14-16220; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; ROHEN JW, 1973, EXP EYE RES, V17, P19, DOI 10.1016/0014-4835(73)90164-4; ROSENTHAL J, 1980, J AM OPTOM ASSOC, V51, P1017; SAMPLES JR, 1993, INVEST OPHTH VIS SCI, V34, P3386; Schwartze JT, 2014, J BIOL CHEM, V289, P3262, DOI 10.1074/jbc.M113.541052; Sethi A, 2011, INVEST OPHTH VIS SCI, V52, P5251, DOI 10.1167/iovs.11-7587; Shepard AR, 2010, INVEST OPHTH VIS SCI, V51, P2067, DOI 10.1167/iovs.09-4567; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; SNYDER RW, 1993, EXP EYE RES, V57, P461, DOI 10.1006/exer.1993.1148; Song CZ, 1999, P NATL ACAD SCI USA, V96, P11776, DOI 10.1073/pnas.96.21.11776; Stamer WD, 2017, EXP EYE RES, V158, P112, DOI 10.1016/j.exer.2016.07.009; STEELY HT, 1992, INVEST OPHTH VIS SCI, V33, P2242; Tanjore H, 2013, BBA-MOL BASIS DIS, V1832, P940, DOI 10.1016/j.bbadis.2012.11.011; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tovar-Vidales T, 2016, EXP EYE RES, V147, P156, DOI 10.1016/j.exer.2016.05.004; Tovar-Vidales T, 2013, INVEST OPHTH VIS SCI, V54, P4741, DOI 10.1167/iovs.13-12203; Tovar-Vidales T, 2011, EXP EYE RES, V93, P442, DOI 10.1016/j.exer.2011.06.011; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Wang WH, 2005, INVEST OPHTH VIS SCI, V46, P4617, DOI 10.1167/iovs.05-0781; Welge-Lussen U, 2000, INVEST OPHTH VIS SCI, V41, P2229; Wen FQ, 2003, INFLAMMATION, V27, P9, DOI 10.1023/A:1022683010976; Wickert Lucia, 2007, Comp Hepatol, V6, P5; Wordinger RJ, 1999, PROG RETIN EYE RES, V18, P629, DOI 10.1016/S1350-9462(98)00035-4; Wordinger RJ, 2007, INVEST OPHTH VIS SCI, V48, P1191, DOI 10.1167/iovs.06-0296; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; YUN AJ, 1989, INVEST OPHTH VIS SCI, V30, P2012; Zhang XY, 2005, INVEST OPHTH VIS SCI, V46, P4607, DOI 10.1167/iovs.05-0571; Zhou LL, 1998, INT J MOL MED, V1, P339; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4; Zimmerman KA, 2013, J BIOL CHEM, V288, P14584, DOI 10.1074/jbc.M112.447243; Zode GS, 2014, J CLIN INVEST, V124, P1956, DOI 10.1172/JCI69774	70	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9854	9868		10.1074/jbc.RA118.002540	http://dx.doi.org/10.1074/jbc.RA118.002540			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29743238	hybrid, Green Published			2022-12-26	WOS:000436102300027
J	Joo, CH				Joo, Chang Hwa			The effects of short term detraining and retraining on physical fitness in elite soccer players	PLOS ONE			English	Article							FOOTBALL PLAYERS; PERFORMANCE; SEASON; FATIGUE; PRESEASON; RESPONSES; STRENGTH; SPORTS	Purpose The aim of this study was to examine the effects of aerobic high-intensity training with reduced volume and training cessation on body composition and physical fitness after the end of season and the time required to recapture physical fitness with intensified retraining following two weeks of detraining in elite soccer players. Method Twenty male semi-professional soccer players participated in this study. The soccer players were assigned to either a group that completed high-intensity aerobic training (HAT, n = 10) or to a detraining and retraining group (DHAT, n = 10) for a 5-week period immediately after the end of the season. The first 2 weeks of the period, members of the HAT group performed high-intensity aerobic exercise (80-90% of HRmax, 12 min x 3, three times per week), whereas members of the DHAT group abstained from any physical activity. During the subsequent 3 weeks, members of both the HAT and DHAT groups completed high-intensity aerobic exercise. Exercise performance testing and body composition analysis were performed before; after 2 weeks of detraining; and at 1, 2 and 3 weeks of retraining. Results Intensified high-intensity training for 5 weeks maintained the performance in the Yo-Yo Intermittent Recovery level 2 test (Yo-Yo IR2) and repeated sprints at any time point (P > 0.05). However 2 weeks of detraining resulted in significant decreases in the performance on the Yo-Yo IR2 (P < 0.01) and repeated sprints test (P < 0.05). Performance on the Yo-Yo IR2 enhanced after 2 weeks of retraining and was maintained up to 3 weeks after retraining, with no significant differences between conditions (P > 0.05). In addition, repeated sprint performance markedly decreased after the detraining period (P < 0.05) and was continuously lower compared to the baseline at 2 weeks after retraining (P < 0.05). Furthermore, this value reached baseline level at the end of the experimental period (P > 0.05). There were no significant differences between conditions in body composition, performance of agility, or sprint ability throughout the 5-week experimental period (P > 0.05). Conclusions The present data suggest that short-term detraining after the competitive season can markedly decrease performances in the Yo-Yo IR2 test and repeated sprints. To return to a previous level of ability on the Yo-Yo IR2 and/or sprint test with retraining through high-intensity aerobic training after a period of detraining, a similar or longer period of retraining is required. However, the high-intensity training with reduced amount of training after competitive season can prevent reductions in physical fitness.	[Joo, Chang Hwa] Honam Univ, Dept Football Sci, Gwangju, South Korea	Honam University	Joo, CH (corresponding author), Honam Univ, Dept Football Sci, Gwangju, South Korea.	footballer@honam.ac.kr						Abrantes C, 2004, J SPORT SCI MED, V3, P44; Aguiar M, 2008, OPEN SPORTS SCI J, V1, P15; Bangsbo J., 1988, MORPHOLOGICAL METABO; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; Buchheit M, 2013, J SCI MED SPORT, V16, P550, DOI 10.1016/j.jsams.2012.12.003; Buchheit M, 2015, INT J SPORT PHYSIOL, V10, P120, DOI 10.1123/ijspp.2014-0082; Carling C, 2016, J SPORT SCI, V34, P2215, DOI 10.1080/02640414.2016.1176228; Christensen PM, 2011, MED SCI SPORT EXER, V43, P1716, DOI 10.1249/MSS.0b013e318211c01a; Di Salvo V, 2009, INT J SPORTS MED, V30, P205, DOI 10.1055/s-0028-1105950; Godfrey RJ, 2005, J SCI MED SPORT, V8, P314, DOI 10.1016/S1440-2440(05)80042-8; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; HORTOBAGYI T, 1993, MED SCI SPORT EXER, V25, P929; Impellizzeri FM, 2006, INT J SPORTS MED, V27, P483, DOI 10.1055/s-2005-865839; Izquierdo M, 2007, J STRENGTH COND RES, V21, P768; Jeong TS, 2011, J SPORT SCI, V29, P1161, DOI 10.1080/02640414.2011.583671; Kilinc BE, 2015, J EXERC REHABIL, V11, P95, DOI 10.12965/jer.150100; Kotzamanidis C, 2005, J STRENGTH COND RES, V19, P369; Koundourakis NE, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087803, 10.1371/journal.pone.0101659]; Krustrup P, 2006, MED SCI SPORT EXER, V38, P1666, DOI 10.1249/01.mss.0000227538.20799.08; Mara JK, 2015, INT J SPORT PHYSIOL, V10, P664, DOI 10.1123/ijspp.2014-0345; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Mohr M, 2016, J HUM KINET, V51, P183, DOI 10.1515/hukin-2015-0181; MOORE RL, 1987, J APPL PHYSIOL, V63, P1719, DOI 10.1152/jappl.1987.63.5.1719; Mujika I, 2000, SPORTS MED, V30, P79, DOI 10.2165/00007256-200030020-00002; Nakamura D, 2012, J STRENGTH COND RES, V26, P3392, DOI 10.1519/JSC.0b013e3182474356; Noon MR, 2015, J SPORT SCI, V33, P2106, DOI 10.1080/02640414.2015.1081393; Oliver JL, 2015, EUR J SPORT SCI, V15, P514, DOI 10.1080/17461391.2015.1063700; Ostojic SM, 2003, J EXERCISE PHYSL ONL, V6; Teixeira AS, 2019, J STRENGTH COND RES, V33, P1416, DOI 10.1519/JSC.0000000000002186; Thomassen M, 2010, J APPL PHYSIOL, V108, P898, DOI 10.1152/japplphysiol.01015.2009	31	47	47	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196212	10.1371/journal.pone.0196212	http://dx.doi.org/10.1371/journal.pone.0196212			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746505	Green Submitted, Green Published, gold			2022-12-26	WOS:000431851700011
J	Manana, PN; Kuonza, L; Musekiwa, A; Koornhof, H; Nanoo, A; Ismail, N				Manana, Pinky N.; Kuonza, Lazarus; Musekiwa, Alfred; Koornhof, Hendrik; Nanoo, Ananta; Ismail, Nazir			ONE Feasibility of using postal and web-based surveys to estimate the prevalence of tuberculosis among health care workers in South Africa	PLOS ONE			English	Article							INFLUENZA VACCINATION; COVERAGE; CANADA; BURDEN	Introduction Health Care Workers (HCWs) are among the highest risk groups for contracting tuberculosis (TB), which is ranked the third most common occupational health disease in South Africa. Little is known about the true extent of the burden of TB among South African HCWs and current surveillance approaches are inadequate. The study aimed to determine the feasibility of using postal and web-based surveys accessed through registries of registered professionals to estimate the prevalence of TB among HCWs in South Africa. Materials and methods We conducted a cross sectional survey on a sample of professional nurses and doctors (general practitioners) registered on the Medpages database platform; a subscription based registry for practising health care professionals. The survey included professionals who were actively involved in the clinical management of patients, either in public or private health care facilities. The paper based survey, including pre-paid return envelopes, was distributed via the post office and web-based surveys were distributed via e-mail through a hyperlink. Descriptive statistics were used to summarize the data and the Chi-square test to determine associations between categorical variables. Active TB was defined as any history of TB Results Out of a total of 3,400 health care professionals contacted, 596 (18%) responses were received: 401 (67%) web-based and 195 (33%) postal. A significantly higher percentage of complete forms were from postal compared to web-based (97% [189/195] versus 87% [348/ 401], p<0.001). Younger (<60 years) professionals were more likely to use the web-based compared to postal (87% [236/270] versus 71% [134/189], p<0.001). Overall, the prevalence of active TB infection was 8.7%, (95%CI: 6.3%-11.7%) and there was no difference observed between doctors and nurses (10.8% [18/167] versus 7.5% [22/292], p = 0.236). Conclusion This novel approach demonstrated the feasibility of using an existing registry of professionals to conduct surveys to estimate the prevalence of TB. Our findings showed a high TB prevalence; however the estimate might have been biased by the low response rate. Further research to optimise our approach could lead to a viable option in improving surveillance among health care professionals.	[Manana, Pinky N.; Kuonza, Lazarus; Musekiwa, Alfred] Natl Inst Communicable Dis, South African Field Epidemiol Training Programme, Johannesburg, South Africa; [Manana, Pinky N.; Kuonza, Lazarus; Musekiwa, Alfred] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Fac Hlth Sci, Pretoria, South Africa; [Koornhof, Hendrik; Nanoo, Ananta; Ismail, Nazir] Natl Inst Communicable Dis, Ctr TB, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); University of Pretoria; National Institute for Communicable Diseases (NICD)	Manana, PN (corresponding author), Natl Inst Communicable Dis, South African Field Epidemiol Training Programme, Johannesburg, South Africa.; Manana, PN (corresponding author), Univ Pretoria, Sch Hlth Syst & Publ Hlth, Fac Hlth Sci, Pretoria, South Africa.	pinkym@nicd.ac.za		Kuonza, Lazarus/0000-0001-5338-320X; Musekiwa, Alfred/0000-0001-5880-3680				Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Black CL, 2014, MMWR-MORBID MORTAL W, V63, P805; Casas EC, 2011, TROP MED INT HEALTH, V16, P1450, DOI 10.1111/j.1365-3156.2011.02853.x; Centers for Disease Control and Prevention, 2016, NAT I OCC SAF HLTH N; Dillender M, 2015, J HEALTH ECON, V43, P204, DOI 10.1016/j.jhealeco.2015.07.004; Drobniewski F, 2007, PLOS MED, V4, P273, DOI 10.1371/journal.pmed.0040055; Edwards JP, 2015, CAN J SURG, V58, P212, DOI 10.1503/cjs.011414; Garcia- prats AJ, 2014, SYSTEMATIC REV EPIDE, P1; Grobler L, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1601-5; He GX, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-313; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; LaVela SL, 2004, INFECT CONT HOSP EP, V25, P933, DOI 10.1086/502323; Lowe SR, 2015, SOC SCI MED, V130, P125, DOI 10.1016/j.socscimed.2015.02.009; Mukinda FK, 2014, SYSTEMATIC REV EPIDE; Norton J, 2015, CAN J SURG, V58, pE4, DOI 10.1503/cjs.014215; O'Hara LM, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2659-3; Schablon Anja, 2009, J Occup Med Toxicol, V4, P1, DOI 10.1186/1745-6673-4-1; Tudor C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-891; University Research Co. LCC (URC) and the Desmond Tutu Tuberculosis Centre (DTTC), 2008, TUB HLTH CAR WORK FI; WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; Wiysonge CS, 2014, SYSTEMATIC REV EPIDE; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2010, GLOB TUB CONTR WHO R; World Health Organization, 2013, WHO GLOB TUB REP 201; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, HLTH WORK 2018	26	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197022	10.1371/journal.pone.0197022	http://dx.doi.org/10.1371/journal.pone.0197022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746507	Green Submitted, Green Published, gold			2022-12-26	WOS:000431851700057
J	Mavroudis, PD; DuBois, DC; Almon, RR; Jusko, WJ				Mavroudis, Panteleimon D.; DuBois, Debra C.; Almon, Richard R.; Jusko, William J.			Daily variation of gene expression in diverse rat tissues	PLOS ONE			English	Article							PERIPHERAL CIRCADIAN OSCILLATORS; ADIPOSE-TISSUE; INDIVIDUAL FIBROBLASTS; SKELETAL-MUSCLE; TIMING SYSTEM; CLOCK GENES; TIME; TRANSCRIPTION; MICROARRAY; RHYTHMS	Circadian information is maintained in mammalian tissues by a cell-autonomous network of transcriptional feedback loops that have evolved to optimally regulate tissue-specific functions. An analysis of daily gene expression in different tissues, as well as an evaluation of inter-tissue circadian variability, is crucial for a systems-level understanding of this transcriptional circuitry. Affymetrix gene chip measurements of liver, muscle, adipose, and lung tissues were obtained from a rich time series light/dark experiment, involving 54 normal rats sacrificed at 18 time points within the 24-hr cycle. Our analysis revealed a high degree of circadian regulation with a variable distribution of phases among the four tissues. Interestingly, only a small number of common genes maintain circadian activity in all tissues, with many of them consisting of "core-clock" components with synchronous rhythms. Our results suggest that inter-tissue circadian variability is a critical component of homeostatic body function and is mediated by diverse signaling pathways that ultimately lead to highly tissue-specific transcription regulation.	[Mavroudis, Panteleimon D.; DuBois, Debra C.; Almon, Richard R.; Jusko, William J.] SUNY Buffalo, Dept Pharmaceut Sci, Sch Pharm & Pharmaceut Sci, Buffalo, NY 14222 USA; [DuBois, Debra C.; Almon, Richard R.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Jusko, WJ (corresponding author), SUNY Buffalo, Dept Pharmaceut Sci, Sch Pharm & Pharmaceut Sci, Buffalo, NY 14222 USA.	wjjusko@buffalo.edu	Mavroudis, Panteleimon/P-8546-2018	Mavroudis, Panteleimon/0000-0002-0512-4147	National Institute of General Medical Sciences [GM-24211]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024211] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences, Grant GM-24211 to WJJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Almon RR, 2008, AM J PHYSIOL-REG I, V295, pR1031, DOI 10.1152/ajpregu.90399.2008; Almon RR, 2008, J PHARMACOL EXP THER, V326, P700, DOI 10.1124/jpet.108.140186; Almon RR, 2007, PHYSIOL GENOMICS, V30, P282, DOI 10.1152/physiolgenomics.00242.2006; Atwood A, 2011, P NATL ACAD SCI USA, V108, P18560, DOI 10.1073/pnas.1115753108; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Boer F, 2003, BRIT J ANAESTH, V91, P50, DOI 10.1093/bja/aeg117; Buchman TG, 2002, NATURE, V420, P246, DOI 10.1038/nature01260; Deckard A, 2013, BIOINFORMATICS, V29, P3174, DOI 10.1093/bioinformatics/btt541; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Frayn KN, 2010, ACTA PHYSIOL, V199, P509, DOI 10.1111/j.1748-1716.2010.02128.x; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Godin PJ, 1996, CRIT CARE MED, V24, P1107, DOI 10.1097/00003246-199607000-00008; Harbour VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103309; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hui XY, 2016, J MOL CELL BIOL, V8, P110, DOI 10.1093/jmcb/mjw013; Jammalamadaka SR, 2001, WORLD SCI, Vxi; Korencic A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05782; Korencic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046835; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lemmer B, 1996, PHARMACOL RES, V33, P107, DOI 10.1006/phrs.1996.0016; Liu S, 2007, CHRONOBIOL INT, V24, P793, DOI 10.1080/07420520701672556; Mavroudi M, 2018, SLEEP BREATH, V22, P393, DOI 10.1007/s11325-017-1579-1; Mavroudis PD, 2013, J INNATE IMMUN, V5, P153, DOI 10.1159/000342427; Mavroudis PD, 2015, MATH BIOSCI, V260, P54, DOI 10.1016/j.mbs.2014.10.006; Mavroudis PD, 2014, PHYSIOL GENOMICS, V46, P766, DOI 10.1152/physiolgenomics.00026.2014; Mavroudis PD, 2012, PHYSIOL GENOMICS, V44, P607, DOI 10.1152/physiolgenomics.00001.2012; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Relogio A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002309; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Scheff JD, 2011, PHYSIOL GENOMICS, V43, P951, DOI 10.1152/physiolgenomics.00040.2011; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Straume M, 2004, METHOD ENZYMOL, V383, P149; Sukumaran S, 2011, J APPL PHYSIOL, V110, P1732, DOI 10.1152/japplphysiol.00079.2011; Sukumaran S, 2010, PHYSIOL GENOMICS, V42A, P141, DOI 10.1152/physiolgenomics.00106.2010; Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2007, COLD SPRING HARB SYM, V72, P365, DOI 10.1101/sqb.2007.72.047; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Ye DW, 2017, CHIN J INTEGR MED, V23, P410, DOI 10.1007/s11655-017-2810-4; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	54	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197258	10.1371/journal.pone.0197258	http://dx.doi.org/10.1371/journal.pone.0197258			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746605	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700092
J	Pinder, LF; Nzayisenga, JB; Shibemba, A; Kusweje, V; Chiboola, H; Amuyunzu-Nyamongo, M; Kapambwe, S; Mwaba, C; Lermontov, P; Mumba, C; Henry-Tillman, R; Parham, GP				Pinder, Leeya F.; Nzayisenga, Jean-Baptiste; Shibemba, Aaron; Kusweje, Victor; Chiboola, Hector; Amuyunzu-Nyamongo, Mary; Kapambwe, Sharon; Mwaba, Catherine; Lermontov, Pavlo; Mumba, Chibamba; Henry-Tillman, Ronda; Parham, Groesbeck P.			Demonstration of an algorithm to overcome health system-related barriers to timely diagnosis of breast diseases in rural Zambia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MIDDLE-INCOME COUNTRIES; CANCER; OPPORTUNITIES	Background Long delays to diagnosis is a major cause of late presentation of breast diseases in sub-Saharan Africa. Aims We designed and implemented a single-visit breast care algorithm that overcomes health system-related barriers to timely diagnosis of breast diseases. Methods A multidisciplinary team of Zambian healthcare experts trained a team of mid- and high-level Zambian healthcare practitioners how to evaluate women for breast diseases, and train trainers to do likewise. Working collaboratively, the two teams then designed a clinical platform that provides multiple breast care services within a single visit. The service platform was implemented using a breast outreach camp format, during which breast self-awareness, psychosocial counseling, clinical breast examination, breast ultrasound, ultrasound-guided biopsy, imprint cytology of biopsy specimens and surgical treatment or referral, were offered within a single visit. Results Eleven hundred and twenty-nine (1129) women attended the camps for breast care. Mean age was 35.9 years. The majority were multiparous (79.4%), breast-fed (76.0%), and reported hormone use (50.4%). Abnormalities were detected on clinical breast examination in 122 (10.8%) women, 114 of whom required ultrasound. Of the 114 who underwent ultrasound, 48 had identifiable lesions and were evaluated with ultrasound-guided core needle biopsy (39) or fine-needle aspiration (9). The concordance between imprint cytology and histopathology was 100%, when breast specimens were classified as either benign or malignant. However, when specimens were classified by histopathologic subtype, the concordance between imprint cytology and histology was 85.7% for benign and 100% for malignant lesions. Six (6) women were diagnosed with invasive cancer. Eighteen (18) women with symptomatic breast lesions had next-day surgery. Significance Similar to its impact on cervical cancer prevention services, a single visit breast care algorithm has the potential to overcome health system-related barriers to timely diagnosis of breast diseases, including cancer, in rural African settings.	[Pinder, Leeya F.; Parham, Groesbeck P.] Univ North Carolina Chapel Hill, Div Global Womens Hlth, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA; [Pinder, Leeya F.; Nzayisenga, Jean-Baptiste; Shibemba, Aaron; Parham, Groesbeck P.] Women & Newborn Hosp, Dept Obstet & Gynecol, Lusaka, Zambia; [Kusweje, Victor; Lermontov, Pavlo; Mumba, Chibamba] Kabwe Gen Hosp, Dept Pathol, Kabwe, Zambia; [Chiboola, Hector] Chreso Univ, Dept Social Sci, Lusaka, Zambia; [Amuyunzu-Nyamongo, Mary] African Inst Hlth & Dev, Nairobi, Kenya; [Kapambwe, Sharon] Minist Hlth, Lusaka, Zambia; [Mwaba, Catherine] Canc Dis Hosp, Lusaka, Zambia; [Henry-Tillman, Ronda] Univ Arkansas Med Sci, Dept Surg, Little Rock, AR 72205 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Arkansas System; University of Arkansas Medical Sciences	Parham, GP (corresponding author), Univ North Carolina Chapel Hill, Div Global Womens Hlth, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA.; Parham, GP (corresponding author), Women & Newborn Hosp, Dept Obstet & Gynecol, Lusaka, Zambia.	professorparham@gmail.com		Mumba, Chibamba/0000-0002-0267-5656	Susan G. Komen Breast Cancer Foundation [GSP15UNC002]	Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation)	This work was supported by the Susan G. Komen Breast Cancer Foundation, GSP15UNC002 (GP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HG, 2010, INDIAN J CANCER, V47, P23, DOI 10.4103/0019-509X.58854; Akuoko CP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171024; Anderson BO, 2015, BREAST J, V21, P111, DOI 10.1111/tbj.12357; Anderson BO, 2014, J SURG ONCOL, V110, P901, DOI 10.1002/jso.23825; Bateman AC, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1558-5; Brinton LA, 2014, BREAST CANCER RES TR, V144, P467, DOI 10.1007/s10549-014-2868-z; Central Statistics Office Zambia, 2014, ZAMB DEM HLTH SURV 2; Corbex M, 2012, BREAST, V21, P428, DOI 10.1016/j.breast.2012.01.002; Denny L., 2016, LANCET; El Saghir NS, 2011, BREAST, V20, pS3, DOI 10.1016/j.breast.2011.02.006; Ezeome ER, 2010, NIGER J CLIN PRACT, V13, P311; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ginsburg O, 2017, LANCET, V389, P847, DOI [10.1016/S0140-6736(16)31392-7, 10.1]; International Agency for Research on Cancer, 2012, GLOBOCAN 2012 EST CA; Jedy-Agba E, 2016, LANCET GLOB HEALTH, V4, pE923, DOI 10.1016/s2214-109x(16)30259-5; Jeje E A, 2010, Nig Q J Hosp Med, V20, P38, DOI 10.4314/nqjhm.v20i1.58015; Kantelhardt EJ, 2016, LANCET GLOB HEALTH, V4, pE875, DOI 10.1016/S2214-109X(16)30283-2; Kohler RE, 2017, PATIENT EDUC COUNS, V100, P167, DOI 10.1016/j.pec.2016.08.012; MAGUIRE P, 1994, BRIT MED J, V309, P1649, DOI 10.1136/bmj.309.6969.1649; McKenzie F, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011390; Njeze Gabriel E, 2014, Niger J Surg, V20, P38, DOI 10.4103/1117-6806.127111; Ohene-Yeboah M, 2008, Ghana Med J, V42, P110; Okoth C, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-9; Pace LE, 2016, ONCOLOGIST, V21, P739, DOI 10.1634/theoncologist.2015-0429; Pace LE, 2016, ONCOLOGIST, V21, P571, DOI 10.1634/theoncologist.2015-0388; Parham GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122169; Pinder LF, 2017, LEVERAGING EXI UNPUB; Rayne S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-016-1959-4; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Stotland NL, 2001, PSYCHOL ASPECTS WOME, Vxviii; Vanderpuye V, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0124-y	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196985	10.1371/journal.pone.0196985	http://dx.doi.org/10.1371/journal.pone.0196985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746541	Green Published, gold, Green Submitted			2022-12-26	WOS:000431851700052
J	Sablik, KA; Clahsen-van Groningen, MC; Hesselink, DA; van Gelder, T; Betjes, MGH				Sablik, Kasia A.; Clahsen-van Groningen, Marian C.; Hesselink, Dennis A.; van Gelder, Teun; Betjes, Michiel G. H.			Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection	PLOS ONE			English	Article							HIGH INTRAPATIENT VARIABILITY; SOLID-ORGAN TRANSPLANTATION; TROUGH BLOOD-LEVELS; KIDNEY-TRANSPLANTATION; RENAL-TRANSPLANTATION; STANDARD-DEVIATION; RISK-FACTOR; GRAFT LOSS; RECIPIENTS; NONADHERENCE	Background Chronic active antibody mediated rejection (c-aABMR) is a major cause of long-term kidney allograft loss. It is hypothesized that frequent sub-therapeutic exposure to immunosuppressive drugs, in particular tacrolimus (Tac), is a risk factor for the development of c-aABMR. The intra-patient variability (IPV) in Tac exposure may serve as a substitute biomarker for underexposure and/or non-adherence. In this study, the association between Tac IPV and the development of c-aABMR was investigated. Methods We retrospectively included 59 patients diagnosed with c-aABMR and compared them to 189 control patients matched for age, year of transplantation and type of kidney donor. The Tac IPV was calculated from pre-dose tacrolimus concentrations measured over a 3 year period preceding the diagnosis of c-aABMR. The mean Tac predose concentrations (C-0), Tac IPV, renal allograft function and graft survival were compared between the groups. Results Tac IPV was 24.4% for the cases versus 23.6% for the controls (p = 0.47). The mean Tac C-0 was comparable for the cases (5.8 ng/mL) and control patients (6.1 ng/mL, p = 0.08). Only in the c-aABMR group a significant decline in both mean Tac C-0 and allograft function over the timespan of 3 years was observed (p = 0.03 and p<0.001). Additionally, in the group of c-aABMR patients a high IPV was associated with inferior graft survival (p = 0.03). Conclusions A high Tac IPV per se does not predispose to the development of c-aABMR but is associated with inferior graft survival once c-aABMR is diagnosed.	[Sablik, Kasia A.; Hesselink, Dennis A.; van Gelder, Teun; Betjes, Michiel G. H.] Univ Med Ctr, Erasmus MC, Dept Nephrol & Transplantat, Rotterdam, Netherlands; [Clahsen-van Groningen, Marian C.] Univ Med Ctr, Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [van Gelder, Teun] Univ Med Ctr, Erasmus MC, Dept Hosp Pharm, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Sablik, KA (corresponding author), Univ Med Ctr, Erasmus MC, Dept Nephrol & Transplantat, Rotterdam, Netherlands.	k.sablik@erasmusmc.nl	Groningen, Marian Clahsen-van/J-8250-2015	Groningen, Marian Clahsen-van/0000-0003-0565-9560				Borra LCP, 2010, NEPHROL DIAL TRANSPL, V25, P2757, DOI 10.1093/ndt/gfq096; Cosio FG, 2008, AM J TRANSPLANT, V8, P492, DOI 10.1111/j.1600-6143.2007.02104.x; El-Zoghby ZM, 2009, AM J TRANSPLANT, V9, P527, DOI 10.1111/j.1600-6143.2008.02519.x; Gallagher HM, 2015, J HEART LUNG TRANSPL, V34, P1442, DOI 10.1016/j.healun.2015.05.028; Gloor JM, 2007, AM J TRANSPLANT, V7, P2124, DOI 10.1111/j.1600-6143.2007.01895.x; Gourishankar S, 2010, AM J TRANSPLANT, V10, P324, DOI 10.1111/j.1600-6143.2009.02954.x; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; Halloran PF, 2016, AM J TRANSPLANT, V16, P908, DOI 10.1111/ajt.13551; Hsiau M, 2011, TRANSPLANTATION, V92, P918, DOI 10.1097/TP.0b013e31822dc34f; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lieber SR, 2013, DIGEST DIS SCI, V58, P824, DOI 10.1007/s10620-012-2412-0; Loupy A, 2017, AM J TRANSPLANT, V17, P28, DOI 10.1111/ajt.14107; Matas AJ, 2013, AM J TRANSPLANT, V13, P11, DOI 10.1111/ajt.12019; Mengel M, 2012, AM J TRANSPLANT, V12, P563, DOI 10.1111/j.1600-6143.2011.03926.x; O'Regan JA, 2016, J NEPHROL, V29, P269, DOI 10.1007/s40620-015-0230-0; Pollock-BarZiv SM, 2010, PEDIATR TRANSPLANT, V14, P968, DOI 10.1111/j.1399-3046.2010.01409.x; Prytula AA, 2012, PEDIATR TRANSPLANT, V16, P613, DOI 10.1111/j.1399-3046.2012.01727.x; Rodrigo E, 2016, TRANSPLANTATION, V100, P2479, DOI 10.1097/TP.0000000000001040; Sapir-Pichhadze R, 2014, KIDNEY INT, V85, P1404, DOI 10.1038/ki.2013.465; Sellares J, 2012, AM J TRANSPLANT, V12, P388, DOI 10.1111/j.1600-6143.2011.03840.x; Shemesh E, 2010, PEDIATR TRANSPLANT, V14, P940, DOI 10.1111/j.1399-3046.2010.01396.x; Shuker N, 2016, TRANSPL INT, V29, P1158, DOI 10.1111/tri.12798; Shuker N, 2015, TRANSPLANT REV-ORLAN, V29, P78, DOI 10.1016/j.trre.2015.01.002; Stifft F, 2013, TRANSPLANTATION; Taber DJ, 2017, TRANSPLANTATION, V101, P2931, DOI 10.1097/TP.0000000000001840; van Hooff J, 2012, THER DRUG MONIT, V34, P46, DOI 10.1097/FTD.0b013e318244a7fd; Vanhove T, 2016, AM J TRANSPLANT, V16, P2954, DOI 10.1111/ajt.13803; Wallemacq P, 2009, THER DRUG MONIT, V31, P139, DOI 10.1097/FTD.0b013e318198d092; Wehland M, 2011, PHARMACOGENET GENOM, V21, P179, DOI 10.1097/FPC.0b013e32833ea085; Whalen HR, 2017, TRANSPLANTATION, V101, P430, DOI 10.1097/TP.0000000000001129; Wu MJ, 2011, TRANSPLANTATION, V92, P648, DOI 10.1097/TP.0b013e3182292426	32	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196552	10.1371/journal.pone.0196552	http://dx.doi.org/10.1371/journal.pone.0196552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746495	gold, Green Published, Green Submitted			2022-12-26	WOS:000431851700024
J	Kovac, B; Makela, TP; Vallenius, T				Kovac, Bianca; Makela, Tomi P.; Vallenius, Tea			Increased alpha-actinin-1 destabilizes E-cadherin-based adhesions and associates with poor prognosis in basal-like breast cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CELL-CELL JUNCTIONS; ALPHA-ACTININ; GENE-EXPRESSION; MESENCHYMAL TRANSITION; ADHERENS JUNCTIONS; OVARIAN-CANCER; TGF-BETA; CATENIN; MOTILITY	The controlled formation and stabilization of E-cadherin-based adhesions is vital for epithelial integrity. This requires co-operation between the E-cadherin-based adhesions and the associated actin cytoskeleton. In cancer, this co-operation often fails, predisposing cells to migration through molecular mechanisms that have only been partially characterized. Here, we demonstrate that the actin filament cross-linker alpha-actinin-1 is frequently increased in human breast cancer. In mammary epithelial cells, the increased alpha-actinin-1 levels promote cell migration and induce disorganized acini-like structures in Matrigel. This is accompanied by a major reorganization of the actin cytoskeleton and the associated E-cadherin-based adhesions. Increased expression of alpha-actinin-1 is particularly noted in basal-like breast cancer cell lines, and in breast cancer patients it associates with poor prognosis in basal-like subtypes. Downregulation of alpha-actinin-1 in E-cadherin expressing basal-like breast cancer cells demonstrate that alpha-actinin-1-assembled actin fibers destabilize E-cadherin-based adhesions. Taken together, these results indicate that increased alpha-actinin-1 expression destabilizes E-cadherin-based adhesions, which is likely to promote the migratory potential of breast cancer cells. Furthermore, our results identify alpha-actinin-1 as a candidate prognostic biomarker in basal-like breast cancer.	[Vallenius, Tea] Univ Helsinki, Biomedicum Helsinki, Fac Med, Res Programs Unit, Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, Helsinki Inst Life Sci HiLIFE, Helsinki, Finland	University of Helsinki; University of Helsinki	Vallenius, T (corresponding author), Univ Helsinki, Biomedicum Helsinki, Fac Med, Res Programs Unit, Helsinki, Finland.	tea.vallenius@helsinki.fi	makela, tomi/B-3734-2009	makela, tomi/0000-0002-4869-8044	Academy of Finland [258837, 265170]; Integrative Life Science Graduate School, University of Helsinki; Instrumentarium Science Foundation; Maud Kuistila Memorial Foundation; Finnish Medical Foundation; Biocentrum Helsinki	Academy of Finland(Academy of Finland); Integrative Life Science Graduate School, University of Helsinki; Instrumentarium Science Foundation; Maud Kuistila Memorial Foundation; Finnish Medical Foundation; Biocentrum Helsinki	The authors acknowledge salary funding from the Academy of Finland (TM. and B.K., grant numbers 258837 and 265170); Integrative Life Science Graduate School, University of Helsinki (B.K.), Instrumentarium Science Foundation and The Maud Kuistila Memorial Foundation (B.K.). In addition, Finnish Medical Foundation and Biocentrum Helsinki supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; An HT, 2016, ONCOGENE, V35, P5893, DOI 10.1038/onc.2016.117; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Ayollo DV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008027; Bakin AV, 2004, MOL BIOL CELL, V15, P4682, DOI 10.1091/mbc.E04-04-0353; Band AM, 2011, J MAMMARY GLAND BIOL, V16, P109, DOI 10.1007/s10911-011-9203-7; Bertocchi C, 2017, NAT CELL BIOL, V19, P28, DOI 10.1038/ncb3456; Bertucci F, 2006, OMICS, V10, P429, DOI 10.1089/omi.2006.10.429; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; Cheung KJ, 2014, CURR OPIN CELL BIOL, V30, P99, DOI 10.1016/j.ceb.2014.07.003; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Craig DH, 2008, NEOPLASIA, V10, P217, DOI 10.1593/neo.07945; Craig DH, 2007, AM J PHYSIOL-CELL PH, V293, pC1862, DOI 10.1152/ajpcell.00118.2007; Fellenberg J, 2007, MODERN PATHOL, V20, P1085, DOI 10.1038/modpathol.3800937; Foley KS, 2014, BIOCHEM J, V459, P1, DOI 10.1042/BJ20131511; Foley KS, 2013, BIOCHEM J, V452, P477, DOI 10.1042/BJ20121824; Fournier MV, 2006, CANCER RES, V66, P7095, DOI 10.1158/0008-5472.CAN-06-0515; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Fuhrich DG, 2013, ANAL QUANT CYTOL, V35, P210; Gloushankova NA, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1356900; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Grikscheit K, 2015, J CELL BIOL, V209, P367, DOI 10.1083/jcb.201412015; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hallett RM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00227; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashida Y, 2005, CANCER RES, V65, P8836, DOI 10.1158/0008-5472.CAN-05-0718; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Ito I, 2010, J BIOL CHEM, V285, P14747, DOI 10.1074/jbc.M109.093039; Jolly MK, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00155; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; Koizumi T, 2010, UROLOGY, V75, P357, DOI 10.1016/j.urology.2009.09.037; Kovac B, 2013, J CELL SCI, V126, P263, DOI 10.1242/jcs.115063; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Malek D, 2006, EUR J PHARMACOL, V534, P39, DOI 10.1016/j.ejphar.2006.01.025; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuda T, 2001, J BIOL CHEM, V276, P42908, DOI 10.1074/jbc.M105316200; MCGREGOR A, 1994, BIOCHEM J, V301, P225, DOI 10.1042/bj3010225; Mihaly Zsuzsanna, 2013, Microarrays (Basel), V2, P228, DOI 10.3390/microarrays2030228; Milioli HH, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0250-9; Mroue Rana, 2013, Methods Mol Biol, V945, P221, DOI 10.1007/978-1-62703-125-7_14; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; NISHIYAMA M, 1990, CANCER RES, V50, P6291; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Rao MV, 2016, MOL BIOL CELL, V27, P2844, DOI 10.1091/mbc.E16-06-0429; Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026; Shamir ER, 2014, J CELL BIOL, V204, P839, DOI 10.1083/jcb.201306088; Shao HS, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.579185; Shipitsin M, 2014, BRIT J CANCER, V111, P1201, DOI 10.1038/bjc.2014.396; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Taguchi K, 2011, J CELL BIOL, V194, P643, DOI 10.1083/jcb.201104124; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Watabe Y, 2014, CANCER MED-US, V3, P613, DOI 10.1002/cam4.214; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Xie L, 2003, BREAST CANCER RES, V5, pR187, DOI 10.1186/bcr640; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Yamamoto S, 2007, MODERN PATHOL, V20, P1278, DOI 10.1038/modpathol.3800966; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zandy NL, 2008, CELL CYCLE, V7, P444, DOI 10.4161/cc.7.4.5452; Zhang JK, 2005, J CELL SCI, V118, P5549, DOI 10.1242/jcs.02639	73	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0196986	10.1371/journal.pone.0196986	http://dx.doi.org/10.1371/journal.pone.0196986			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742177	gold, Green Published, Green Submitted			2022-12-26	WOS:000431757400053
J	Morrison, MJ; Boriack-Sjodin, PA; Swinger, KK; Wigle, TJ; Sadalge, D; Kuntz, KW; Scott, MP; Janzen, WP; Chesworth, R; Duncan, KW; Harvey, DM; Lampe, JW; Mitchell, LH; Copeland, RA				Morrison, Michael J.; Boriack-Sjodin, P. Ann; Swinger, Kerren K.; Wigle, Tim J.; Sadalge, Dipti; Kuntz, Kevin W.; Scott, Margaret Porter; Janzen, William P.; Chesworth, Richard; Duncan, Kenneth W.; Harvey, Darren M.; Lampe, John W.; Mitchell, Lorna H.; Copeland, Robert A.			Identification of a peptide inhibitor for the histone methyltransferase WHSC1	PLOS ONE			English	Article							T(4/14) MULTIPLE-MYELOMA; LYSINE METHYLTRANSFERASE; PROTEIN METHYLTRANSFERASES; SELECTIVE INHIBITORS; H3K36 METHYLATION; STRUCTURAL BASIS; MOLECULAR-BASIS; DRUG DISCOVERY; CHEMICAL PROBE; POTENT	WHSC1 is a histone methyltransferase that is responsible for mono- and dimethylation of lysine 36 on histone H3 and has been implicated as a driver in a variety of hematological and solid tumors. Currently, there is a complete lack of validated chemical matter for this important drug discovery target. Herein we report on the first fully validated WHSC1 inhibitor, PTD2, a norleucine-containing peptide derived from the histone H4 sequence. This peptide exhibits micromolar affinity towards WHSC1 in biochemical and biophysical assays. Furthermore, a crystal structure was solved with the peptide in complex with SAM and the SET domain of WHSC1L1. This inhibitor is an important first step in creating potent, selective WHSC1 tool compounds for the purposes of understanding the complex biology in relation to human disease.	[Morrison, Michael J.; Boriack-Sjodin, P. Ann; Swinger, Kerren K.; Wigle, Tim J.; Sadalge, Dipti; Kuntz, Kevin W.; Scott, Margaret Porter; Janzen, William P.; Chesworth, Richard; Duncan, Kenneth W.; Harvey, Darren M.; Lampe, John W.; Mitchell, Lorna H.; Copeland, Robert A.] Epizyme Inc, Cambridge, MA 02139 USA		Morrison, MJ (corresponding author), Epizyme Inc, Cambridge, MA 02139 USA.	mmorrison@epizyme.com	Morrison, Mark/C-9707-2013	Morrison, Mark/0000-0001-9257-9133; Morrison, Michael/0000-0002-8948-1773	Epizyme, Inc.	Epizyme, Inc.	This work was funded by Epizyme, Inc. The funding entities had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Basavapathruni A, 2012, CHEM BIOL DRUG DES, V80, P971, DOI 10.1111/cbdd.12050; Cerveira N, 2003, LEUKEMIA, V17, P2244, DOI 10.1038/sj.leu.2403104; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Cowen SD, 2016, J MED CHEM, V59, P11079, DOI 10.1021/acs.jmedchem.6b01303; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Eggert E, 2016, J MED CHEM, V59, P4578, DOI 10.1021/acs.jmedchem.5b01890; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Huang Z, 2013, CANCER RES, V73, P6277, DOI 10.1158/0008-5472.CAN-13-1000; Hudlebusch HR, 2011, CLIN CANCER RES, V17, P2919, DOI 10.1158/1078-0432.CCR-10-1302; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Judge RA, 2016, ACS MED CHEM LETT, V7, P1102, DOI 10.1021/acsmedchemlett.6b00303; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kassambara A, 2009, BIOCHEM BIOPH RES CO, V379, P840, DOI 10.1016/j.bbrc.2008.12.093; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li J, 2008, NEURO-ONCOLOGY, V10, P45, DOI 10.1215/15228517-2007-036; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Liu F, 2013, J MED CHEM, V56, P8931, DOI 10.1021/jm401480r; Liu F, 2010, J MED CHEM, V53, P5844, DOI 10.1021/jm100478y; Liu F, 2009, J MED CHEM, V52, P7950, DOI 10.1021/jm901543m; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Mitchell LH, 2016, ACS MED CHEM LETT, V7, P134, DOI 10.1021/acsmedchemlett.5b00272; Mitchell LH, 2015, ACS MED CHEM LETT, V6, P655, DOI 10.1021/acsmedchemlett.5b00071; Morishita M, 2017, MED CHEM RES, V26, P2038, DOI 10.1007/s00044-017-1909-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen H, 2015, J BIOL CHEM, V290, P13641, DOI 10.1074/jbc.M114.626861; Oyer JA, 2014, LEUKEMIA, V28, P198, DOI 10.1038/leu.2013.204; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Rader AFB, 2018, BIOORGAN MED CHEM, V26, P2766, DOI 10.1016/j.bmc.2017.08.031; Ribich S, 2017, CELL CHEM BIOL, V24, P1120, DOI 10.1016/j.chembiol.2017.08.020; Richon VM, 2011, CHEM BIOL DRUG DES, V78, P199, DOI 10.1111/j.1747-0285.2011.01135.x; Rogawski DS, 2015, BIOCHEMISTRY-US, V54, P5401, DOI 10.1021/acs.biochem.5b00697; Rosati R, 2002, BLOOD, V99, P3857, DOI 10.1182/blood.V99.10.3857; Rubin S, 2016, CRIT REV EUKAR GENE, V26, P199, DOI 10.1615/CritRevEukaryotGeneExpr.2016016525; Sankaran SM, 2016, J BIOL CHEM, V291, P8465, DOI 10.1074/jbc.M116.720748; Schapira M, 2016, CELL CHEM BIOL, V23, P1067, DOI 10.1016/j.chembiol.2016.07.014; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Sweis RF, 2015, ACS MED CHEM LETT, V6, P695, DOI 10.1021/acsmedchemlett.5b00124; Sweis RF, 2014, ACS MED CHEM LETT, V5, P205, DOI 10.1021/ml400496h; Tisi D, 2016, ACS CHEM BIOL, V11, P3093, DOI 10.1021/acschembio.6b00308; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; White AM, 2016, EXPERT OPIN DRUG DIS, V11, P1151, DOI 10.1080/17460441.2016.1245720; Xiong Y, 2017, J MED CHEM, V60, P1876, DOI 10.1021/acs.jmedchem.6b01645; Yang S, 2016, GENE DEV, V30, P1611, DOI 10.1101/gad.284323.116; Yang ZQ, 2010, CANCER RES, V70, P8487, DOI 10.1158/0008-5472.CAN-10-1013; Yao Y, 2011, J AM CHEM SOC, V133, P16746, DOI 10.1021/ja206312b; Yu WY, 2013, BIOORGAN MED CHEM, V21, P1787, DOI 10.1016/j.bmc.2013.01.049; Yu WY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2304; Zhang YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep43906	55	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2018	13	5							e0197082	10.1371/journal.pone.0197082	http://dx.doi.org/10.1371/journal.pone.0197082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF2GV	29742153	Green Submitted, Green Published, gold			2022-12-26	WOS:000431757400060
J	Prendergast, EN; Fonseca, MAD; Dezem, FS; Lester, J; Karlan, BY; Noushmehr, H; Lin, XZ; Lawrenson, K				Prendergast, Emily N.; de Souza Fonseca, Marcos Abraao; Dezem, Felipe Segato; Lester, Jenny; Karlan, Beth Y.; Noushmehr, Houtan; Lin, Xianzhi; Lawrenson, Kate			Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens	PLOS ONE			English	Article							NONCODING RNAS; CIRCULAR RNA; CANCER; VESICLES; BIOMARKERS; SIGNATURE; PROTEINS; MICRORNA; CELLS	Exosomes are endosome-derived membrane vesicles that contain proteins, lipids, and nucleic acids. The exosomal transcriptome mediates intercellular communication, and represents an understudied reservoir of novel biomarkers for human diseases. Next-generation sequencing enables complex quantitative characterization of exosomal RNAs from diverse sources. However, detailed protocols describing exosome purification for preparation of exosomal RNA-sequence (RNA-Seq) libraries are lacking. Here we compared methods for isolation of exosomes and extraction of exosomal RNA from human cell-free serum, as well as strategies for attaining equal representation of samples within pooled RNA-Seq libraries. We compared commercial precipitation with ultracentrifugation for exosome purification and confirmed the presence of exosomes via both transmission electron microscopy and immunoblotting. Exosomal RNA extraction was compared using four different RNA purification methods. We determined the minimal starting volume of serum required for exosome preparation and showed that high quality exosomal RNA can be isolated from sera stored for over a decade. Finally, RNA-Seq libraries were successfully prepared with exosomal RNAs extracted from human cell-free serum, cataloguing both coding and non-coding exosomal transcripts. This method provides researchers with strategic options to prepare RNA-Seq libraries and compare RNA-Seq data quantitatively from minimal volumes of fresh and archival human cell-free serum for disease biomarker discovery.	[Prendergast, Emily N.; Lester, Jenny; Karlan, Beth Y.; Lin, Xianzhi; Lawrenson, Kate] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA; [de Souza Fonseca, Marcos Abraao; Dezem, Felipe Segato; Noushmehr, Houtan] Univ Sao Paulo, Dept Genet, Ribeirao Preto, SP, Brazil; [Noushmehr, Houtan] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI USA; [Lawrenson, Kate] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Ctr Bioinformat & Funct Genom, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Universidade de Sao Paulo; Henry Ford Health System; Henry Ford Hospital; Cedars Sinai Medical Center	Lin, XZ; Lawrenson, K (corresponding author), Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA.; Lawrenson, K (corresponding author), Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Ctr Bioinformat & Funct Genom, Los Angeles, CA 90048 USA.	xianzhi.lin@cshs.org; kate.lawrenson@cshs.org	Lin, Xianzhi/O-2130-2017; N, Houtan/C-9692-2013	Lin, Xianzhi/0000-0001-9802-9896; N, Houtan/0000-0003-4051-8114; Lawrenson, Kate/0000-0002-6469-2515	K99/R00 Pathway to Independence Award from the NIH [R00CA184415]; Ann and Sol Schreiber Mentored Investigator Award from Ovarian Cancer Research Fund Alliance [458799]; American Cancer Society Early Detection Professorship [SIOP-06-258-01-COUN]; National Center for Advancing Translational Sciences (NCATS) [UL1TR000124]; Sao Paulo Research Foundation (FAPESP) [2017/08211-1, 2016/06413-3, 2015/0725-5]; Henry Ford Hospital [A30935]; NATIONAL CANCER INSTITUTE [R00CA184415, K99CA184415] Funding Source: NIH RePORTER	K99/R00 Pathway to Independence Award from the NIH; Ann and Sol Schreiber Mentored Investigator Award from Ovarian Cancer Research Fund Alliance; American Cancer Society Early Detection Professorship(American Cancer Society); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Henry Ford Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	K.L. is supported in part by a K99/R00 Pathway to Independence Award from the NIH (R00CA184415) and an institutional grant. X.L. is supported in part by Ann and Sol Schreiber Mentored Investigator Award from Ovarian Cancer Research Fund Alliance (458799). B.Y.K. is funded by the American Cancer Society Early Detection Professorship (SIOP-06-258-01-COUN) and the National Center for Advancing Translational Sciences (NCATS) (UL1TR000124). M.A.S.F. and H.N. are supported by the Sao Paulo Research Foundation (FAPESP, 2017/08211-1, 2016/06413-3 & 2015/0725-5). H.N. is supported in part by an institutional startup grant provided by the Henry Ford Hospital (A30935).	Bahn JH, 2015, CLIN CHEM, V61, P221, DOI 10.1373/clinchem.2014.230433; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; Chen MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep38397; Conley A, 2017, RNA BIOL, V14, P305, DOI 10.1080/15476286.2016.1259061; Denzer K, 2000, J CELL SCI, V113, P3365; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Gezer U, 2014, CELL BIOL INT, V38, P1076, DOI 10.1002/cbin.10301; Graves LE, 2004, CANCER RES, V64, P7045, DOI 10.1158/0008-5472.CAN-04-1800; Grigor'eva A. E., 2016, Biomeditsinskaya Khimiya, V62, P99, DOI 10.18097/PBMC20166201099; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Im H, 2014, NAT BIOTECHNOL, V32, P490, DOI 10.1038/nbt.2886; Jenjaroenpun P, 2013, PEERJ, V1, DOI 10.7717/peerj.201; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kramer-Albers EM, 2007, PROTEOM CLIN APPL, V1, P1446, DOI 10.1002/prca.200700522; Kreuger F., 2017, TRIM GALORE; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Li Y, 2015, CELL RES, V25, P981, DOI 10.1038/cr.2015.82; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lin XZ, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00175; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Masyuk AI, 2010, AM J PHYSIOL-GASTR L, V299, pG990, DOI 10.1152/ajpgi.00093.2010; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Ogawa Y, 2008, BIOL PHARM BULL, V31, P1059, DOI 10.1248/bpb.31.1059; Qazi KR, 2010, THORAX, V65, P1016, DOI 10.1136/thx.2009.132027; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Tarazona S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv711; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tominaga N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7716; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vojtech L, 2014, NUCLEIC ACIDS RES, V42, P7290, DOI 10.1093/nar/gku347; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44	42	24	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196913	10.1371/journal.pone.0196913	http://dx.doi.org/10.1371/journal.pone.0196913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738525	Green Published, gold, Green Submitted			2022-12-26	WOS:000431724900027
J	Bradbury, K; Morton, K; Band, R; van Woezik, A; Grist, R; McManus, RJ; Little, P; Yardley, L				Bradbury, Katherine; Morton, Katherine; Band, Rebecca; van Woezik, Anne; Grist, Rebecca; McManus, Richard J.; Little, Paul; Yardley, Lucy			Using the Person-Based Approach to optimise a digital intervention for the management of hypertension	PLOS ONE			English	Article							BLOOD-PRESSURE; TRIAL; PATIENT; DISEASE; TRUST; RISK	Background For behaviour-change interventions to be successful they must be acceptable to users and overcome barriers to behaviour change. The Person-Based Approach can help to optimise interventions to maximise acceptability and engagement. This article presents a novel, efficient and systematic method that can be used as part of the Person-Based Approach to rapidly analyse data from development studies to inform intervention modifications. We describe how we used this approach to optimise a digital intervention for patients with hypertension (HOME BP), which aims to implement medication and lifestyle changes to optimise blood pressure control. Methods In study 1, hypertensive patients (N = 12) each participated in three think-aloud interviews, providing feedback on a prototype of HOME BP. In study 2 patients (N = 11) used HOME BP for three weeks and were then interviewed about their experiences. Studies 1 and 2 were used to identify detailed changes to the intervention content and potential barriers to engagement with HOME BP. In study 3 (N = 7) we interviewed hypertensive patients who were not interested in using an intervention like HOME BP to identify potential barriers to uptake, which informed modifications to our recruitment materials. Analysis in all three studies involved detailed tabulation of patient data and comparison to our modification criteria. Results Studies 1 and 2 indicated that the HOME BP procedures were generally viewed as acceptable and feasible, but also highlighted concerns about monitoring blood pressure correctly at home and making medication changes remotely. Patients in study 3 had additional concerns about the safety and security of the intervention. Modifications improved the acceptability of the intervention and recruitment materials. Conclusions This paper provides a detailed illustration of how to use the Person-Based Approach to refine a digital intervention for hypertension. The novel, efficient approach to analysis and criteria for deciding when to implement intervention modifications described here may be useful to others developing interventions.	[Bradbury, Katherine; Morton, Katherine; Band, Rebecca; Yardley, Lucy] Univ Southampton, Acad Unit Psychol, Southampton, Hants, England; [van Woezik, Anne] Rotterdam Univ Appl Sci, Healthcare Technol, Rotterdam, Netherlands; [Grist, Rebecca] Sch Appl Social Sci, Brighton, E Sussex, England; [McManus, Richard J.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Little, Paul] Univ Southampton, Fac Med, Primary Care & Populat Sci, Southampton, Hants, England	University of Southampton; University of Oxford; University of Southampton	Bradbury, K (corresponding author), Univ Southampton, Acad Unit Psychol, Southampton, Hants, England.	kjb1e08@soton.ac.uk	Band, Rebecca/AAJ-7937-2020	Yardley, Lucy/0000-0002-3853-883X; Bradbury, Katherine/0000-0001-5513-7571; Band, Rebecca/0000-0001-5403-1708; Little, Paul/0000-0003-3664-1873	National Institute for Health Research (NIHR) Programme Grants for Applied Research Programme [RP-PG-1211-20001]; ESRC [ES/F029624/1] Funding Source: UKRI	National Institute for Health Research (NIHR) Programme Grants for Applied Research Programme; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This independent research was funded by the National Institute for Health Research (NIHR) Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-1211 -20001). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health.	Abras C., 2004, BERKSHIRE ENCY HUMAN, P445; Amuzie R, 2012, BRIT J GEN PRACT, V62, P68, DOI [10.3399/bjgp12X625049, 10.3399/bjgp12X625201]; Andreassen HK, 2006, QUAL HEALTH RES, V16, P238, DOI 10.1177/1049732305284667; Band R, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0553-4; Band R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012684; Benson J, 2002, BRIT MED J, V325, P873, DOI 10.1136/bmj.325.7369.873; Bradbury K, 2014, EVIDENCE BASED COMPL, V2014; Bradbury K, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-016-0397-x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Crutzen Rik, 2014, BMC Res Notes, V7, P824, DOI 10.1186/1756-0500-7-824; Falaschetti E, 2014, LANCET, V383, P1912, DOI 10.1016/S0140-6736(14)60688-7; Fletcher BR, 2016, PATIENT EDUC COUNS, V99, P210, DOI 10.1016/j.pec.2015.08.026; Fletcher BR, 2015, AM J HYPERTENS; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Khatib R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084238; Kok G, 2004, HLTH PSYCHOL PRACTIC, P203; Kronish IM, 2011, CIRCULATION; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; McManus RJ, 2014, JAMA-J AM MED ASSOC, V312, P799, DOI 10.1001/jama.2014.10057; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Morton K, 2016, PATIENT ED COUNSELIN; National Institute for Health and Clinical Excellence, 2011, HYP CLIN MAN PRIM HY; Ogedegbe G, 2008, J CLIN HYPERTENS, V10, P644, DOI 10.1111/j.1751-7176.2008.08329.x; Okonofua EC, 2006, HYPERTENSION, V47, P345, DOI 10.1161/01.HYP.0000200702.76436.4b; Public Health England, 2017, HLTH MATT COMB HIGH; Rogers R.W., 1983, SOCIAL PSYCHOPHYSIOL; Schulz M, 2016, INT J CARDIOL, V220, P668, DOI 10.1016/j.ijcard.2016.06.263; Spinuzzi C, 2005, TECH COMMUN-STC, V52, P163; Van den Haak MJ, 2007, TECH COMMUN-STC, V54, P58; Vega LC, 2011, HEALTH TECHNOL-GER, V1, P71, DOI 10.1007/s12553-011-0010-3; Yardley L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4055	33	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196868	10.1371/journal.pone.0196868	http://dx.doi.org/10.1371/journal.pone.0196868			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723262	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000431305100082
J	Geberselassie, SB; Abebe, SM; Melsew, YA; Mutuku, SM; Wassie, MM				Geberselassie, Selamawit Bekele; Abebe, Solomon Mekonnen; Melsew, Yayehirad Alemu; Mutuku, Shadrack Mulinge; Wassie, Molla Mesele			Prevalence of stunting and its associated factors among children 6-59 months of age in Libo-Kemekem district, Northwest Ethiopia; A community based cross sectional study	PLOS ONE			English	Article							HEALTH	Background Children in developing countries are highly vulnerable to impaired physical growth because of poor dietary intake, lack of appropriate care, and repeated infections. This study aimed at assessing the prevalence of stunting and associated factors among children 6-59 months of age in Libo-kemekem district, northwest Ethiopia. Methods A community based cross sectional study was conducted in Libo-Kemekem from October 15 to December 15, 2015. The multistage sampling technique was employed to select 1,320 children aged 6-59months. Data were collected by trained community health extension workers under regular supervision. Data were entered into EPI-Info version 3.5.1, and height for age was converted to Z-score with ENA-SMART software. Data were then exported to SPSS version 20 for descriptive and binary logistic regression analysees. The significance of associations was determined at p<0.05. Results Out of 1287 children included in the analysis, 49.4% (95% CI: 46.7%-52.3%) were found to be stunted. In the multivariate analysis, increased child age [AOR = 6.31, 95% Cl: (3.65, 10.91)], family size of six and above [AOR = 1.77, 95% Cl: (1.35, 2.32)] were positively associated with stunting, while, fathers with secondary school education [AOR = 0.50, 95% Cl: (0.30, 0.81)], farmers as household heads [AOR = 0.56, 95% Cl: (0.38, 0.84)] and selfemployed parents as household head [AOR = 0.45, 95% CI: (0.28, 0.72)] were found to be preventive factors. Conclusion The prevalence of stunting was high in the study area. We found that stunting was significantly correlated with child age, occupational status of household head, family size, and fathers' education. Therefore, intervention focusing on supporting housewives, family planning, and education on child feeding and nutrition should be implemented.	[Geberselassie, Selamawit Bekele] World Vis Ethiopia, Program Dev Div, Addis Ababa, Ethiopia; [Abebe, Solomon Mekonnen; Wassie, Molla Mesele] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Human Nutr, Gondar, Ethiopia; [Melsew, Yayehirad Alemu] Univ Gondar, Dept Epidemiol & Biostat, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Mutuku, Shadrack Mulinge] Univ Adelaide, Adelaide Med Sch, Fac Hlth & Med Sci, Adelaide, SA, Australia	University of Gondar; University of Gondar; University of Adelaide	Wassie, MM (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Human Nutr, Gondar, Ethiopia.	molmesele@gmail.com	Wassie, Molla/S-1946-2019	Wassie, Molla/0000-0002-3565-2397; Mutuku, Shadrack/0000-0002-6285-9895	University of Gondar; Institute of Public Health, the University of Gondar, Libo-kemekem District Health Office	University of Gondar; Institute of Public Health, the University of Gondar, Libo-kemekem District Health Office	The thesis is supported by University of Gondar.; We would like to thank the Institute of Public Health, the University of Gondar, Libo-kemekem District Health Office for their support. We are also grateful to the study participants.	Afework M, 2005, FACTORS CONTRIBUTING, V1; Ali Waqar, 2015, J Ayub Med Coll Abbottabad, V27, P556; Asfaw M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1370-9; Ayalew E., 2015, PREVALENCE STUNTING; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; CSA, 2014, ETH MIN DEM HLTH SUR; CSA, 2005, ETH DEM HLTH SURV CA; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P142, DOI 10.1017/S1368980011001315; Demissie S., 2013, SCI J PUBLIC HLTH, V1, P175, DOI [10.11648/j.sjph.20130104.12, DOI 10.11648/J.SJPH.20130104.12]; Derso T, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0848-2; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Gelano TF., 2015, J HARMON RES MED HLT, V2, P163; Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112858; Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105880; Islam MM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-11; Jamro B., 2012, PAK J MED RES, V51, P111; Kadima YE, 2012, FACTORS INFLUENCING; Lopez-Perea N, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002799; Megabiaw B, 2013, INT J CHILD HEALTH N, V2, P230, DOI 10.6000/1929-4247.2013.02.03.5; Mengistu K, 2013, NUTR DISORDERS THERA; Mutua N, 2015, INT J ACAD RES REFLE, V3; Rajalakshmi J, 2015, INT J NURSING DIDACT, V15, P10; Ruwali D., 2011, HLTH PROSPECT, V10; Sisay Z, 2012, HARAR B HLTH SCI EXT, V4; UNICEF, 1998, FOC NUTR STAT WORLDS; WHO, 2011, CHILD GROWTH STAND A; WHO, 2015, GLOB NUTR REP 2015 A; WHO, 2014, WHONMHNHD143; World Health Organization, 2006, WHO CHILD GROWTH STA; World Health Organization, 1995, PHYS STAT US INT ANT; Yalew BM., 2014, J NUTR DISORD THER, V4, P2161, DOI DOI 10.4172/2161-0509.1000132; Yisak H, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0535-0	33	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0195361	10.1371/journal.pone.0195361	http://dx.doi.org/10.1371/journal.pone.0195361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723280	Green Submitted, Green Published, gold			2022-12-26	WOS:000431305100005
J	Mendoza-Sanchez, J; Silva, F; Rangel, L; Jaramillo, L; Mendoza, L; Garzon, J; Quiroga, A				Mendoza-Sanchez, Jose; Silva, Federico; Rangel, Lady; Jaramillo, Linda; Mendoza, Leidy; Garzon, Jenny; Quiroga, Andrea			Benefit, risk and cost of new oral anticoagulants and warfarin in atrial fibrillation; A multicriteria decision analysis	PLOS ONE			English	Article							PREFERENCES; DABIGATRAN; MEDICINES; IMPACT	Introduction Warfarin and new oral anticoagulants are effective in reducing stroke in atrial fibrillation; however, the benefits and risks rates in clinical trials show heterogeneity for each anticoagulant, and is unknown the cost influence on a model considering most of the treatment consequences. We designed a benefit-risk and cost assessment of oral anticoagulants. Design We followed the roadmap proposed by IMI-PROTECT and the considerations of emerged good practice to perform Multi-Criteria Decision Analysis (MCDA). The roadmap defines the following steps: (1) planning, (2) evidence gathering and data preparation, (3) analyses, (4) explorations, and (5) conclusions. We defined two reference points (0-100) to allocate numerical values for scores and weights, and used an analogue numeric scale to assess physicians' preferences. As benefits of the anticoagulant therapy, we included reductions in stroke and all-cause mortality; intracranial haemorrhage, gastrointestinal haemorrhage, minor bleeding and myocardial infarction were considered risks. We also made an estimation of the annual drug cost per person. Main results The scores were: Apixaban 33, Dabigatran 25, warfarin 18 and Rivaroxaban 14 this score reveals the most preferred up to the less preferred option, considering the benefit-risk ratio and drug costs altogether. The relative model weights were: 51.1% for risks, 40.4% for benefits and 8.5% for cost. The sensitivity analysis confirms the model robustness. Conclusions From this analysis, apixaban should be considered as the preferred anticoagulant option -due to a better benefit-risk balance and a minor cost influence-followed by dabigatran, warfarin and rivaroxaban.	[Mendoza-Sanchez, Jose; Silva, Federico; Jaramillo, Linda; Mendoza, Leidy; Garzon, Jenny; Quiroga, Andrea] Fdn Cardiovasc Colombia, Hosp Int, Inst Neurol, Grp Ciencias Neurovasc, Floridablanca, Santander, Spain; [Rangel, Lady] Univ Ind Santander, Bucaramanga, Santander, Colombia	Universidad Industrial de Santander	Mendoza-Sanchez, J (corresponding author), Fdn Cardiovasc Colombia, Hosp Int, Inst Neurol, Grp Ciencias Neurovasc, Floridablanca, Santander, Spain.	jmendoza45@msn.com	Garzón, Jenny/AGB-5345-2022	Garzón, Jenny/0000-0003-4734-3396; Mendoza, Jose/0000-0001-8990-3895; Mendoza Uribe, Leidy Viviana/0000-0002-1124-8031	Colciencias, Net Cardiecol [5020-53-731809]	Colciencias, Net Cardiecol	Colciencias, Net Cardiecol; Code: 5020-53-731809	Belton V, 2002, INTEGRATED APPROACH, P331; Cacciatore F, 2012, DEMENT GERIATR COGN, V34, P143, DOI 10.1159/000342195; Clark WM, 2004, NEW ENGL J MED, V351, P2159; Connections I, 2013, ISPOR CONECTIONS, V19, P9; Despres F, 2016, J MANAG CARE SPEC PH, V22, P539, DOI 10.18553/jmcp.2016.22.5.539; Dynamed, 2017, TIP DOC DYNAMISCSUMM; Ghijben P, 2014, PHARMACOECONOMICS, V32, P1115, DOI 10.1007/s40273-014-0188-0; Goldberger JJ, 2013, JAMA-J AM MED ASSOC, V309, P2559, DOI 10.1001/jama.2013.6629; Harrington AR, 2013, STROKE, V44, P1676, DOI 10.1161/STROKEAHA.111.000402; Hockley K, 2013, IMI PROTECT BENEFIT; Hsu JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124806; Huang C, 2013, J EVAL CLIN PRACT, V19, P938, DOI 10.1111/j.1365-2753.2012.01886.x; Hughes D, 2013, IMI PROTECT BENEFIT; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Marsh K, 2016, VALUE HEALTH, V19, P125, DOI 10.1016/j.jval.2015.12.016; Mussen F, 2007, PHARMACOEPIDEM DR S, V16, pS42, DOI 10.1002/pds.1436; Okumura Ken, 2015, Value Health Reg Issues, V6, P65, DOI 10.1016/j.vhri.2015.03.016; Palmer S, 1999, BRIT MED J, V318, P1551, DOI 10.1136/bmj.318.7197.1551; Puhan MA, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-173; Rubboli A, 2011, WORLD J CARDIOL, V3, P351, DOI 10.4330/wjc.v3.i11.351; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Sandham JD, 2005, CIE, P5; Schafheutle EI, 2002, HEALTH SOC CARE COMM, V10, P187, DOI 10.1046/j.1365-2524.2002.00356.x; Tervonen T, 2016, VALUE HEALTH, V19, pA349, DOI 10.1016/j.jval.2016.09.014; Thokala P, 2016, VALUE HEALTH, V19, P1, DOI 10.1016/j.jval.2015.12.003	27	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196361	10.1371/journal.pone.0196361	http://dx.doi.org/10.1371/journal.pone.0196361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723207	Green Submitted, Green Published, gold			2022-12-26	WOS:000431305100024
J	Crowcroft, NS; Johnson, C; Chen, C; Li, Y; Marchand-Austin, A; Bolotin, S; Schwartz, K; Deeks, SL; Jamieson, F; Drews, S; Russell, ML; Svenson, LW; Simmonds, K; Mahmud, SM; Kwong, JC				Crowcroft, Natasha S.; Johnson, Caitlin; Chen, Cynthia; Li, Ye; Marchand-Austin, Alex; Bolotin, Shelly; Schwartz, Kevin; Deeks, Shelley L.; Jamieson, Frances; Drews, Steven; Russell, Margaret L.; Svenson, Lawrence W.; Simmonds, Kimberley; Mahmud, Salaheddin M.; Kwong, Jeffrey C.			Under-reporting of pertussis in Ontario: A Canadian Immunization Research Network (CIRN) study using capture-recapture	PLOS ONE			English	Article							ENGLAND; INFECTION; INFANTS; DEATHS; WALES	Introduction Under-reporting of pertussis cases is a longstanding challenge. We estimated the true number of pertussis cases in Ontario using multiple data sources, and evaluated the completeness of each source. Methods We linked data from multiple sources for the period 2009 to 2015: public health reportable disease surveillance data, public health laboratory data, and health administrative data (hospitalizations, emergency department visits, and physician office visits). To estimate the total number of pertussis cases in Ontario, we used a three-source capture-recapture analysis stratified by age (infants, or aged one year and older) and adjusting for dependency between sources. We used the Bayesian Information Criterion to compare models. Results Using probable and confirmed reported cases, laboratory data, and combined hospitalizations/emergency department visits, the estimated total number of cases during the six-year period amongst infants was 924, compared with 545 unique observed cases from all sources. Using the same sources, the estimated total for those aged 1 year and older was 12,883, compared with 3,304 observed cases from all sources. Only 37% of infants and 11% for those aged 1 year and over admitted to hospital or seen in an emergency department for pertussis were reported to public health. Public health reporting sensitivity varied from 2% to 68% depending on age group and the combination of data sources included. Sensitivity of combined hospitalizations and emergency department visits varied from 37% to 49% and of laboratory data from 1% to 50%. Conclusions All data sources contribute cases and are complementary, suggesting that the incidence of pertussis is substantially higher than suggested by routine reports. The sensitivity of different data sources varies. Better case identification is required to improve pertussis control in Ontario.	[Crowcroft, Natasha S.; Johnson, Caitlin; Chen, Cynthia; Li, Ye; Marchand-Austin, Alex; Bolotin, Shelly; Schwartz, Kevin; Deeks, Shelley L.; Jamieson, Frances; Kwong, Jeffrey C.] Publ Hlth Ontario, Toronto, ON, Canada; [Crowcroft, Natasha S.; Jamieson, Frances] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Crowcroft, Natasha S.; Li, Ye; Bolotin, Shelly; Schwartz, Kevin; Deeks, Shelley L.; Kwong, Jeffrey C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Drews, Steven] ProvLab Alberta, Edmonton, AB, Canada; [Drews, Steven] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Russell, Margaret L.] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Svenson, Lawrence W.; Simmonds, Kimberley] Alberta Hlth, Edmonton, AB, Canada; [Svenson, Lawrence W.] Univ Alberta, Div Prevent Med, Edmonton, AB, Canada; [Svenson, Lawrence W.; Simmonds, Kimberley] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Svenson, Lawrence W.; Simmonds, Kimberley] Univ Calgary, Community Hlth Sci, Calgary, AB, Canada; [Mahmud, Salaheddin M.] Univ Manitoba, Max Rady Coll Med, Vaccine & Drug Evaluat Ctr, Winnipeg, MB, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Alberta; University of Calgary; Alberta Health Services (AHS); University of Alberta; University of Alberta; University of Calgary; University of Manitoba; University of Toronto; University of Toronto	Crowcroft, NS (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.; Crowcroft, NS (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Crowcroft, NS (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	natasha.crowcroft@oahpp.ca			Canadian Institutes of Health Research [137470, PC01 ON24]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research grant #137470 (Canadian Immunization Research Network sub grant #PC01 ON24), received by NSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Braeye T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165351; Campbell H, 2014, EMERG INFECT DIS, V20, P968, DOI 10.3201/eid2006.131069; CDC, 2014, PERT WHOOP COUGH BOR; Cherry JD, 2012, CLIN INFECT DIS, V54, P1756, DOI 10.1093/cid/cis302; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; Crowcroft NS, 2003, LANCET INFECT DIS, V3, P413, DOI 10.1016/S1473-3099(03)00669-8; Crowcroft NS, 2002, ARCH DIS CHILD, V86, P336, DOI 10.1136/adc.86.5.336; Deeks S, 1999, CLIN INFECT DIS, V28, P840, DOI 10.1086/515203; Fathima S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2321-1; Gilberg S, 2002, J INFECT DIS, V186, P415, DOI 10.1086/341511; Government of Ontario, 2014, APP B PROV CAS DEF R; Granerod J, 2013, EMERG INFECT DIS, V19, P1455, DOI 10.3201/eid1909.130064; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Jansson A, 2005, EPIDEMIOL INFECT, V133, P401, DOI 10.1017/S0950268804003632; Johnson C, 2018, CJPH IN PRESS, V109; Kara EO, 2017, PEDIATR INFECT DIS J, V36, P140, DOI 10.1097/INF.0000000000001378; McGirr AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083850; Pillsbury A, 2014, COMMUN DIS INTELL, V38, pE179; Public Health England, 2017, HLTH PROT REP LAB CO; Schwartz KL, 2016, CAN MED ASSOC J, V188, pE399, DOI 10.1503/cmaj.160193; Schwartz KL, 2015, HUM VACC IMMUNOTHER, V11, P1840, DOI 10.1080/21645515.2015.1043499; Shiff NJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-236; Smith T., 2014, PERTUSSIS SURVEILLAN, P40; van der Maas NAT, 2017, VACCINE; van Hoek AJ, 2013, EUROSURVEILLANCE, V18, P15; Wang K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3668; Winter K, 2014, MMWR-MORBID MORTAL W, V63, P1129; WITTES JT, 1974, J CHRON DIS, V27, P25, DOI 10.1016/0021-9681(74)90005-8; World Health Organization, 2003, WHO REC SURV STAND P	30	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195984	10.1371/journal.pone.0195984	http://dx.doi.org/10.1371/journal.pone.0195984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718945	Green Submitted, Green Published, gold			2022-12-26	WOS:000431281900039
J	Engel, N; Adamus, A; Frank, M; Kraft, K; Kuhn, J; Muller, P; Nebe, B; Kasten, A; Seitz, G				Engel, Nadja; Adamus, Anna; Frank, Marcus; Kraft, Karin; Kuehn, Juliane; Mueller, Petra; Nebe, Barbara; Kasten, Annika; Seitz, Guido			First evidence of SGPL1 expression in the cell membrane silencing the extracellular S1P siren in mammary epithelial cells	PLOS ONE			English	Article							SPHINGOSINE-PHOSPHATE LYASE; SPHINGOSINE-1-PHOSPHATE LYASE; CANCER CELL; 1-PHOSPHATE; APOPTOSIS; KINASE-1; TARGET; BLOOD	The bioactive lipid sphingosine-1-phosphate (S1P) is a main regulator of cell survival, proliferation, motility, and platelet aggregation, and it is essential for angiogenesis and lymphocyte trafficking. In that S1P acts as a second messenger intra-and extracellularly, it might promote cancer progression. The main cause is found in the high S1P concentration in the blood, which encourage cancer cells to migrate through the endothelial barrier into the blood vessels. The irreversible degradation of S1P is solely caused by the sphingosine-1-phosphate lyase (SGPL1). SGPL1 overexpression reduces cancer cell migration and therefore silences the endogenous S1P siren, which promotes cancer cell attraction-the main reason for metastasis. Since our previous metabolomics studies revealed an increased SGPL1 activity in association with successful breast cancer cell treatment in vitro, we further investigated expression and localization of SGPL1. Expression analyses confirmed a very low SGPL1 expression in all breast cancer samples, regardless of their subtype. Additionally, we were able to prove a novel SGPL expression in the cytoplasm membrane of non-tumorigenic breast cells by fusing three independent methods. The general SGPL1 downregulation and the loss of the plasma membrane expression resulted in S1P dependent stimulation of migration in the breast cancer cell lines MCF-7 and BT-20. Not only S1P stimulated migration could be repressed by overexpressing the natural SGPL1 variant not but also more general migratory activity was significantly reduced. Here, for the first time, we report on the SGPL1 plasma membrane location in human, non-malignant breast epithelial cell lines silencing the extracellular S1P siren in vitro, and thereby regulating pivotal cellular functions. Loss of this plasma membrane distribution as well as low SGPL1 expression levels could be a potential prognostic marker and a viable target for therapy. Therefore, the precise role of SGPL1 for cancer treatment should be evaluated.	[Engel, Nadja; Adamus, Anna; Seitz, Guido] Univ Hosp Marburg, Dept Pediat Surg, Baldingerstr, Marburg, Germany; [Engel, Nadja; Adamus, Anna; Kuehn, Juliane; Mueller, Petra; Nebe, Barbara] Univ Med Rostock, Dept Cell Biol, Schillingallee, Rostock, Germany; [Engel, Nadja; Kasten, Annika] Rostock Univ, Facial Plast Surg, Med Ctr, Dept Oral & Maxillofacial Surg, Schillingallee, Rostock, Germany; [Frank, Marcus] Univ Med Rostock, Med Biol & Electron Microscopy Ctr, Strempelstr, Rostock, Germany; [Kraft, Karin] Univ Med Rostock, Ctr Internal Med, Complementary Med, Ernst Heydemann Str, Rostock, Germany; [Kuehn, Juliane] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany	University Hospital of Giessen & Marburg; University of Rostock; University of Rostock; Friedrich Loeffler Institute	Engel, N (corresponding author), Univ Hosp Marburg, Dept Pediat Surg, Baldingerstr, Marburg, Germany.; Engel, N (corresponding author), Univ Med Rostock, Dept Cell Biol, Schillingallee, Rostock, Germany.; Engel, N (corresponding author), Rostock Univ, Facial Plast Surg, Med Ctr, Dept Oral & Maxillofacial Surg, Schillingallee, Rostock, Germany.	nadja.engel-lutz@gmx.de	Seitz, Guido/AAH-5460-2019	Seitz, Prof. Dr. Guido/0000-0001-9280-1451; Engel, Nadja/0000-0002-6362-9282; Adamus, Anna/0000-0001-9938-8903	BMBF habilitation scholarship program of the University of Rostock; FORUN program of the University Medical Center Rostock [889025]	BMBF habilitation scholarship program of the University of Rostock; FORUN program of the University Medical Center Rostock	This work is supported by fund from BMBF habilitation scholarship program of the University of Rostock and FORUN program of the University Medical Center Rostock (no. 889025) (NE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandhuvula P, 2005, J BIOL CHEM, V280, P33697, DOI 10.1074/jbc.C500294200; Bandhuvula P, 2007, TRENDS MOL MED, V13, P210, DOI 10.1016/j.molmed.2007.03.005; Cuvillier O, 2007, ANTI-CANCER DRUG, V18, P105, DOI 10.1097/CAD.0b013e328011334d; Dai L, 2014, CANCER INVEST, V32, P71, DOI 10.3109/07357907.2013.876646; den Hollander P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00250; Engel N., 2015, ADV MED PLANT RES, V3, P92; Engel N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169742; Engel N, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1215-9; Engel N, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-334; Engel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047833; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Kumar A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.3; Maxmen A, 2012, NATURE, V485, pS50, DOI 10.1038/485S50a; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Olivera A, 2010, J CLIN INVEST, V120, P1429, DOI 10.1172/JCI40659; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Pchejetski D, 2008, MOL CANCER THER, V7, P1836, DOI 10.1158/1535-7163.MCT-07-2322; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ratajczak MZ, 2010, LEUKEMIA, V24, P976, DOI 10.1038/leu.2010.53; Reiss U, 2004, J BIOL CHEM, V279, P1281, DOI 10.1074/jbc.M309646200; Skoura A, 2009, J LIPID RES, V50, pS293, DOI 10.1194/jlr.R800047-JLR200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Van Veldhoven PP, 2000, METHOD ENZYMOL, V311, P244; VANVELDHOVEN PP, 1993, ADV LIPID RES, V26, P69; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155	29	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196854	10.1371/journal.pone.0196854	http://dx.doi.org/10.1371/journal.pone.0196854			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718989	gold, Green Published, Green Submitted			2022-12-26	WOS:000431281900087
J	Gomez, BI; McIntyre, MK; Gurney, JM; Chung, KK; Cancio, LC; Dubick, MA; Burmeister, DM				Gomez, Belinda, I; McIntyre, Matthew K.; Gurney, Jennifer M.; Chung, Kevin K.; Cancio, Leopoldo C.; Dubick, Michael A.; Burmeister, David M.			Enteral resuscitation with oral rehydration solution to reduce acute kidney injury in burn victims: Evidence from a porcine model	PLOS ONE			English	Article							ABDOMINAL COMPARTMENT SYNDROME; SEVERE TRAUMA; FLUID RESUSCITATION; RENAL DYSFUNCTION; RANDOMIZED-TRIAL; END-POINTS; BLOOD; SHOCK; MORTALITY; THERAPY	Intravenous (IV) resuscitation of burn patients has greatly improved outcomes and become a cornerstone of modern burn care. However, the heavy fluids and vascular access required may not be feasible in austere environments, mass casualty, or delayed transport scenarios. Enteral resuscitation has been proposed for these situations; we sought to examine the effectiveness of this strategy on improving burn-induced kidney injury. Anesthetized Yorkshire swine sustaining 40% TBSA full-thickness contact burns were randomized to three groups (n = 6/group): fluid deprivation, ad libitum water access, or 70 mL/kg/d Oral Rehydration Salt solution (ORS). Urine and blood were collected at baseline (BL), 6, 12, 24, 32, and 48h post-burn, at which point tissue was harvested and CT angiography performed. Although fluid consumption by ad libitum and ORS groups were matched (132 +/- 54mL/kg versus 120 +/- 24mL/kg, respectively), ORS intake increased urine output compared with water and no water (47.3 +/- 9.0 mL/kg versus 16.1 +/- 2.5 mL/kg, and 24.5 +/- 1.7 mL/kg respectively). Plasma creatinine peaked 6h following burn (1.67 +/- 0.07mg/dL) in all animals, but at 48h was comparable to BL in animals receiving water (1.23 +/- 0.06mg/dL) and ORS (1.30 +/- 0.09mg/dL), but not fluid deprived animals (1.56 +/- 0.05mg/dL) (P<0.05). Circulating levels of blood urea nitrogen steadily increased, but also decreased by 48h in animals receiving enteral fluids (P<0.05). Water deprivation reduced renal artery diameter (-1.4 +/- 0.17mm), whereas resuscitation with water (-0.44 +/- 0.14 mm) or ORS maintained it (-0.63 +/- 0.20 mm; P<0.02). Circulating cytokines IL-1 beta, IL-6, IFN gamma, and GM-CSF were moderately elevated in the fluid-deprived group. Taken together, the data suggest that enteral resuscitation with ORS rescues kidney function following burn injury. Incorporating enteral fluids may improve outcomes in resource-poor environments and possibly reduce IV fluid requirements to prevent co-morbidities associated with over-resuscitation. Studies into different volumes/types of enteral fluids are warranted. While ORS has saved many lives in cholera-associated dehydration, it should be investigated further for use in burn patients.	[Gomez, Belinda, I; McIntyre, Matthew K.; Gurney, Jennifer M.; Cancio, Leopoldo C.; Dubick, Michael A.; Burmeister, David M.] US Army Inst Surg Res, Ft Sam Houston, TX 78234 USA; [Gurney, Jennifer M.; Chung, Kevin K.; Cancio, Leopoldo C.] Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA; [Chung, Kevin K.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	United States Department of Defense; United States Army; San Antonio Military Medical Center; United States Department of Defense; United States Army; Uniformed Services University of the Health Sciences - USA	Burmeister, DM (corresponding author), US Army Inst Surg Res, Ft Sam Houston, TX 78234 USA.	David.m.burmeister3.civ@mail.mil		Burmeister, David/0000-0002-1256-0158	CDMRP [W81XWH-16-2-0041]	CDMRP(United States Department of Defense)	CDMRP (http://cdmrp.army.mil/) award #W81XWH-16-2-0041 provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, DEATHS CAUS AG SEX C; Balogh Z, 2003, ARCH SURG-CHICAGO, V138, P637, DOI 10.1001/archsurg.138.6.637; Balogh Z, 2003, ARCH SURG-CHICAGO, V138, P42, DOI DOI 10.1001/ARCHSURG.138.6.637; Binder Henry J, 2014, Curr Gastroenterol Rep, V16, P376, DOI 10.1007/s11894-014-0376-2; BISHOP MH, 1995, J TRAUMA, V38, P780, DOI 10.1097/00005373-199505000-00018; Brakenridge SC, 2011, J TRAUMA, V71, P299, DOI 10.1097/TA.0b013e318224d328; Burmeister DM, 2017, BBA-MOL BASIS DIS, V1863, P2661, DOI 10.1016/j.bbadis.2017.04.011; Burmeister DM, 2017, BURNS, V43, P1295, DOI 10.1016/j.burns.2017.03.010; Burmeister DM, 2016, SHOCK, V46, P137, DOI 10.1097/SHK.0000000000000662; Burmeister DM, 2015, BURNS, V41, P1242, DOI 10.1016/j.burns.2015.03.001; Cancio LC, 2006, J BURN CARE RES, V27, P561, DOI 10.1097/01.BCR.0000235449.05828.B8; Cartotto R, 2017, J BURN CARE RES, V38, pE596, DOI 10.1097/BCR.0000000000000541; Cartotto R, 2016, CRIT CARE CLIN, V32, P507, DOI 10.1016/j.ccc.2016.06.002; Chrysopoulo MT, 1999, J TRAUMA, V46, P141, DOI 10.1097/00005373-199901000-00024; Coca SG, 2007, AM J KIDNEY DIS, V49, P517, DOI 10.1053/j.ajkd.2006.12.018; Earley ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129996; El-Sonbaty M., 1991, ANN MBC, V4, P29; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; FLEMING A, 1992, ARCH SURG-CHICAGO, V127, P1175; Fleming A, 1992, ARCH SURG CHICAGO IL, V127, P9; Fox CL, 1944, J AMER MED ASSOC, V124, P207, DOI 10.1001/jama.1944.02850040007002; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Hu S, 2014, BURNS, V40, P693, DOI 10.1016/j.burns.2013.09.030; Ivy ME, 2000, J TRAUMA, V49, P387, DOI 10.1097/00005373-200009000-00001; Ivy ME, 1999, J BURN CARE REHABIL, V20, P351, DOI 10.1097/00004630-199909000-00003; KELLEY KW, 1973, J ANIM SCI, V36, P927; Kramer GC, 2010, EPLASTY, V10; Liu LM, 2003, J TRAUMA, V54, pS159, DOI 10.1097/01.TA.0000054649.46525.A5; MARKLEY K, 1956, JAMA-J AM MED ASSOC, V161, P1465, DOI 10.1001/jama.1956.02970150033008; Michell MW, 2006, J BURN CARE RES, V27, P819, DOI 10.1097/01.BCR.0000245422.33787.18; Milner SM, 2011, J HEALTH POPUL NUTR, V29, P648; Moghazy A M, 2016, Ann Burns Fire Disasters, V29, P43; Mosier MJ, 2010, J BURN CARE RES, V31, P83, DOI 10.1097/BCR.0b013e3181cb8c87; Moyer CA, 1944, ANN SURG, V120, P367, DOI 10.1097/00000658-194409000-00008; Palmieri T, 2010, BURNS, V36, P205, DOI 10.1016/j.burns.2009.08.012; Peck MD, 2011, BURNS, V37, P1087, DOI 10.1016/j.burns.2011.06.005; Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x; Rex S, 2012, CURR OPIN CRIT CARE, V18, P671, DOI 10.1097/MCC.0b013e328359fd6e; RUXIN JN, 1994, MED HIST, V38, P363, DOI 10.1017/S0025727300036905; Shah SK, 2010, J TRAUMA, V68, P682, DOI 10.1097/TA.0b013e3181c453cb; Sondeen JL, 2011, TRANSFUSION, V51, P779, DOI 10.1111/j.1537-2995.2010.02928.x; SORENSEN B, 1968, ANN NY ACAD SCI, V150, P865, DOI 10.1111/j.1749-6632.1968.tb14737.x; Steinvall I, 2008, CRIT CARE, V12, DOI 10.1186/cc7032; Velmahos GC, 2000, ANN SURG, V232, P409, DOI 10.1097/00000658-200009000-00013; WILSON BJ, 1960, JAMA-J AM MED ASSOC, V173, P509, DOI 10.1001/jama.1960.73020230008008; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Yin LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37220; Yin LJ, 2014, HEALTH PHYS, V106, P734, DOI 10.1097/HP.0000000000000117	48	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195615	10.1371/journal.pone.0195615	http://dx.doi.org/10.1371/journal.pone.0195615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718928	Green Submitted, Green Published, gold			2022-12-26	WOS:000431281900024
J	Roberts, BM; Brown, JL; Kersey, DC; Snyder, RJ; Durrant, BS; Kouba, AJ				Roberts, Beth M.; Brown, Janine L.; Kersey, David C.; Snyder, Rebecca J.; Durrant, Barbara S.; Kouba, Andrew J.			Use of urinary 13,14, dihydro-15-keto-prostaglandin F-2 alpha (PGFM) concentrations to diagnose pregnancy and predict parturition in the giant panda (Ailuropoda melanolecua)	PLOS ONE			English	Article							13,14-DIHYDRO-15-KETO-PROSTAGLANDIN F2-ALPHA; ENZYME-IMMUNOASSAY; PROGESTERONE; OVULATION; ESTRUS; SERUM; PROSTAGLANDINS; ENDOCRINOLOGY; PGF(2-ALPHA); GONADOTROPIN	Pregnancy determination is difficult in the giant panda (Ailuropoda melanolecua), representing a challenge for ex situ conservation efforts. Research in other species experiencing pseudopregnancy indicates that urinary/fecal concentrations of 13,14, dihydro-15-keto-prostaglandin F-2 alpha (PGFM) can accurately determine pregnancy status. Our objective was to determine if urinary PGFM concentrations are associated with pregnancy status in the giant panda. Urinary PGFM concentrations were measured in female giant pandas (n = 4) throughout gestation (n = 6) and pseudopregnancy (n = 4) using a commercial enzyme immunoassay. Regardless of pregnancy status, PGFM excretion followed a predictable pattern: 1) baseline concentrations for 11-19 weeks following ovulation; 2) a modest, initial peak 14-36 days after the start of the secondary urinary progestagen rise; 3) a subsequent period of relatively low concentrations; and 4) a large, terminal peak at the end of the luteal phase. Pregnant profiles were distinguished by an earlier initial peak (P = 0.024), higher inter-peak concentrations (P < 0.001), and a larger terminal peak (P = 0.003) compared to pseudopregnancy profiles. Parturition occurred 23 to 25 days from the initial PGFM surge and within 24 hours of the start of the terminal increase. These pattern differences indicate that urinary PGFM monitoring can be used to predict pregnancy status and time parturition in the giant panda. Furthermore, this is the only species known to exhibit a significant PGFM increase during pseudopregnancy, suggesting a unique physiological mechanism for regulating the end of the luteal phase in the giant panda.	[Roberts, Beth M.; Kouba, Andrew J.] Memphis Zoo, Dept Res & Conservat, Memphis, TN 38112 USA; [Brown, Janine L.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Front Royal, VA USA; [Kersey, David C.] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA USA; [Snyder, Rebecca J.] Zoo Atlanta, Dept Mammals, Atlanta, GA USA; [Durrant, Barbara S.] San Diego Zoo Global, Inst Conservat Res, San Diego, CA USA; [Snyder, Rebecca J.] Oklahoma City Zoo & Bot Garden, Dept Conservat & Sci, Oklahoma City, OK USA; [Kouba, Andrew J.] Mississippi State Univ, Coll Forestry, Dept Wildlife Fisheries & Aquaculture, Starkville, MS USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Western University of Health Sciences; Mississippi State University	Roberts, BM (corresponding author), Memphis Zoo, Dept Res & Conservat, Memphis, TN 38112 USA.	broberts@memphiszoo.org	Durrant, Barbara/AAF-7451-2021		Memphis Zoo	Memphis Zoo	The authors received no specific funding for this work. The Memphis Zoo provided support in the form of the first author's salary (BR) and supplied PGFM assay kits. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG EG, 1984, J CLIN ENDOCR METAB, V59, P867, DOI 10.1210/jcem-59-5-867; Baan M, 2008, THERIOGENOLOGY, V69, P399, DOI 10.1016/j.theriogenology.2007.10.008; BATRA SK, 1982, BIOL REPROD, V27, P1055, DOI 10.1095/biolreprod27.5.1055; BAZER FW, 1992, P SOC EXP BIOL MED, V199, P373, DOI 10.3181/00379727-199-43371A; BERGSTROM S, 1968, PHARMACOL REV, V20, P1; CHAUDHURI M, 1988, J REPROD FERTIL, V84, P23; CONCANNON PW, 1988, J REPROD FERTIL, V84, P71, DOI 10.1530/jrf.0.0840071; Czekala N, 2003, ZOO BIOL, V22, P389, DOI 10.1002/zoo.10108; Czekala NM, 1997, INT S ENV PROT CIT D; Dehnhard M, 2014, THERIOGENOLOGY, V81, P733, DOI 10.1016/j.theriogenology.2013.12.007; Dehnhard M, 2013, WIEN TIERARZTL MONAT, V100, P227; Dehnhard M, 2012, THERIOGENOLOGY, V77, P1088, DOI 10.1016/j.theriogenology.2011.10.011; Dehnhard M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143958; Durrant B, 2002, THERIOGENOLOGY, V57, P1855, DOI 10.1016/S0093-691X(02)00678-7; Durrant BS, 2006, THERIOGENOLOGY, V66, P1729, DOI 10.1016/j.theriogenology.2006.02.046; Durrant BS, 2003, ZOO BIOL, V22, P313, DOI 10.1002/zoo.10110; Edwards MS, 2006, GIANT PANDAS: BIOLOGY, VETERINARY MEDICINE AND MANAGEMENT, P315, DOI 10.1017/CBO9780511542244.014; Farina M, 2004, J STEROID BIOCHEM, V91, P211, DOI 10.1016/j.jsbmb.2004.05.001; Finkenwirth C, 2010, THERIOGENOLOGY, V73, P530, DOI 10.1016/j.theriogenology.2009.10.008; Graham L, 2001, ZOO BIOL, V20, P227, DOI 10.1002/zoo.1022; Hildebrandt TB, 2006, GIANT PANDAS: BIOLOGY, VETERINARY MEDICINE AND MANAGEMENT, P410, DOI 10.1017/CBO9780511542244.018; HODGES JK, 1984, J ZOOL, V203, P253; Howard J.G., 2008, BIOL REPROD, V78, P203; Jewgenow K, 2012, REPROD DOMEST ANIM, V47, P25, DOI 10.1111/rda.12033; Kersey DC, 2016, THERIOGENOLOGY, V85, P671, DOI 10.1016/j.theriogenology.2015.10.005; Kersey DC, 2011, GEN COMP ENDOCR, V173, P364, DOI 10.1016/j.ygcen.2011.06.013; Kersey DC, 2010, REPROD FERT DEVELOP, V22, P901, DOI 10.1071/RD09178; Kersey DC, 2010, REPRODUCTION, V140, P183, DOI 10.1530/REP-10-0003; Lasano S, 2007, REPROD DOMESTIC ANIM, V42; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; Luz MR, 2006, THERIOGENOLOGY, V66, P1436, DOI 10.1016/j.theriogenology.2006.01.036; McCracken JA, 1999, PHYSIOL REV, V79, P263, DOI 10.1152/physrev.1999.79.2.263; McGeehan L, 2002, ZOO BIOL, V21, P449, DOI 10.1002/zoo.10047; MEAD RA, 1986, ANN NY ACAD SCI, V476, P25, DOI 10.1111/j.1749-6632.1986.tb20919.x; MITCHELL MD, 1995, REPROD FERT DEVELOP, V7, P623, DOI 10.1071/RD9950623; MONFORT SL, 1989, J REPROD FERTIL, V85, P203; MUNRO CJ, 1991, CLIN CHEM, V37, P838; PAYNE JH, 1994, J REPROD FERTIL, V101, P737, DOI 10.1530/jrf.0.1010737; PIPER PJ, 1970, NATURE, V225, P600, DOI 10.1038/225600a0; Schaller G.B., 1985, GIANT PANDAS WOLONG; Senger PL, 1999, PATHWAYS PREGNANCY P, P149; Snegovskikh V, 2006, ENDOCRIN METAB CLIN, V35, P173, DOI 10.1016/j.ecl.2005.09.012; Snyder Rebecca J., 2004, P125; Steinetz BG, 2005, ANN NY ACAD SCI, V1041, P367, DOI 10.1196/annals.1282.057; Steinman KJ, 2006, GIANT PANDAS: BIOLOGY, VETERINARY MEDICINE AND MANAGEMENT, P198, DOI 10.1017/CBO9780511542244.009; Sutherland-Smith M, 2004, ZOO BIOL, V23, P449, DOI 10.1002/zoo.20022; Swaisgood R, 2016, IUCN RED LIST THREAT; TAUSSKY HH, 1954, J BIOL CHEM, V208, P853; THORBURN GD, 1979, PHYSIOL REV, V59, P863, DOI 10.1152/physrev.1979.59.4.863; TSUTSUI T, 1993, J REPROD FERTIL, P29; Willis EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021159; Xie Z, 2015, 2015 INT STUDBOOK GI; Zhang HM, 2009, REPRODUCTION, V138, P979, DOI 10.1530/REP-09-0241	53	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195599	10.1371/journal.pone.0195599	http://dx.doi.org/10.1371/journal.pone.0195599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718929	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281900023
J	Wabnitz, CCC; Lam, VWY; Reygondeau, G; Teh, LCL; Al-Abdulrazzak, D; Khalfallah, M; Pauly, D; Palomares, MLD; Zeller, D; Cheung, WWL				Wabnitz, Colette C. C.; Lam, Vicky W. Y.; Reygondeau, Gabriel; Teh, Lydia C. L.; Al-Abdulrazzak, Dalal; Khalfallah, Myriam; Pauly, Daniel; Palomares, Maria L. Deng; Zeller, Dirk; Cheung, William W. L.			Climate change impacts on marine biodiversity, fisheries and society in the Arabian Gulf	PLOS ONE			English	Article							CORAL-REEFS; MULTIMODEL ENSEMBLE; GENETIC DIVERSITY; VULNERABILITY; ADAPTATION; COASTAL; SEA; COMMUNITIES; ECOLOGY; OCEAN	Climate change-reflected in significant environmental changes such as warming, sea level rise, shifts in salinity, oxygen and other ocean conditions-is expected to impact marine organisms and associated fisheries. This study provides an assessment of the potential impacts on, and the vulnerability of, marine biodiversity and fisheries catches in the Arabian Gulf under climate change. To this end, using three separate niche modelling approaches under a 'business-as-usual' climate change scenario, we projected the future habitat suitability of the Arabian Gulf (also known as the Persian Gulf) for 55 expert-identified priority species, including charismatic and non-fish species. Second, we conducted a vulnerability assessment of national economies to climate change impacts on fisheries. The modelling outputs suggested a high rate of local extinction (up to 35% of initial species richness) by 2090 relative to 2010. Spatially, projected local extinctions are highest in the southwestern part of the Gulf, off the coast of Saudi Arabia, Qatar and the United Arab Emirates (UAE). While the projected patterns provided useful indicators of potential climate change impacts on the region's diversity, the magnitude of changes in habitat suitability are more uncertain. Fisheries-specific results suggested reduced future catch potential for several countries on the western side of the Gulf, with projections differing only slightly among models. Qatar and the UAE were particularly affected, with more than a 26% drop in future fish catch potential. Integrating changes in catch potential with socio-economic indicators suggested the fisheries of Bahrain and Iran may be most vulnerable to climate change. We discuss limitations of the indicators and the methods used, as well as the implications of our overall findings for conservation and fisheries management policies in the region.	[Wabnitz, Colette C. C.; Lam, Vicky W. Y.; Reygondeau, Gabriel; Teh, Lydia C. L.; Cheung, William W. L.] Univ British Columbia, Inst Oceans & Fisheries, Nippon Fdn, Nereus Program, Vancouver, BC, Canada; [Wabnitz, Colette C. C.; Lam, Vicky W. Y.; Reygondeau, Gabriel; Teh, Lydia C. L.; Cheung, William W. L.] Univ British Columbia, Inst Oceans & Fisheries, Changing Ocean Res Unit, Vancouver, BC, Canada; [Al-Abdulrazzak, Dalal; Khalfallah, Myriam; Pauly, Daniel; Palomares, Maria L. Deng] Univ British Columbia, Inst Oceans & Fisheries, Sea Around Us, Vancouver, BC, Canada; [Zeller, Dirk] Univ Western Australia, Sch Biol Sci, Sea Around Us Indian Ocean, Crawley, WA, Australia	University of British Columbia; University of British Columbia; University of British Columbia; University of Western Australia	Cheung, WWL (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Nippon Fdn, Nereus Program, Vancouver, BC, Canada.; Cheung, WWL (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Changing Ocean Res Unit, Vancouver, BC, Canada.	w.cheung@oceans.ubc.ca	Pauly, Daniel Marc/AAY-2316-2021; Palomares, Maria Lourdes D./K-1641-2019; Lam, Vicky/AAX-1684-2020	Palomares, Maria Lourdes/0000-0001-5905-1556; Khalfallah, Myriam/0000-0003-4753-2170; Zeller, Dirk/0000-0001-7304-4125; Pauly, Daniel/0000-0003-3756-4793; Wabnitz, Colette C.C./0000-0002-5076-9163	Abu Dhabi Global Environmental Data Initiative (AGEDI); Nippon Foundation-University of British Columbia Nereus Program; Nippon Foundation; Natural Sciences and Engineering Research Council of Canada; Wellcome Trust; Oak Foundation; Marisla Foundation; Paul M. Angell Family Foundation; MAVA Foundation	Abu Dhabi Global Environmental Data Initiative (AGEDI); Nippon Foundation-University of British Columbia Nereus Program; Nippon Foundation(Nippon Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Wellcome Trust(Wellcome Trust); Oak Foundation; Marisla Foundation; Paul M. Angell Family Foundation; MAVA Foundation	The authors acknowledge support from The Abu Dhabi Global Environmental Data Initiative (AGEDI). WWLC, VWYL, GR and CCCW also acknowledge funding support from the Nippon Foundation-University of British Columbia Nereus Program, a collaborative initiative by the Nippon Foundation and partners. WWLC also acknowledges support from the Natural Sciences and Engineering Research Council of Canada; and VWYL funding support from the Wellcome Trust. DA, MK, MLDP, DP and DZ acknowledge the Sea Around Us and the Sea Around Us Indian Ocean, research initiatives at the University of British Columbia and University of Western Australia, respectively. Sea Around Us activities are supported by the Oak Foundation, Marisla Foundation, Paul M. Angell Family Foundation and the MAVA Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2005, CR GEOSCI, V337, P399, DOI 10.1016/j.crte.2004.11.004; AGEDI, 2016, EX SUMM REG DES CLIM; Al-Abdulrazzak D, 2013, ROAD JUL 2 DOC, V21; Al-Abdulrazzak D, 2015, REG STUD MAR SCI, V2, P28, DOI 10.1016/j.rsma.2015.08.003; Al-Farraj A, 2005, J ARID ENVIRON, V63, P740, DOI 10.1016/j.jaridenv.2005.01.025; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Barros VR, 2015, CLIMATE CHANGE 2014; Barton AD, 2016, P NATL ACAD SCI USA, V113, P2964, DOI 10.1073/pnas.1519080113; Beaugrand G, 2011, MAR ECOL PROG SER, V424, P175, DOI 10.3354/meps08939; Bento R, 2016, MAR POLLUT BULL, V105, P466, DOI 10.1016/j.marpolbul.2015.10.006; Blasiak R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179632; Buchanan JR, 2016, MAR POLLUT BULL, V105, P480, DOI 10.1016/j.marpolbul.2015.11.033; Burt J, 2008, MAR BIOL, V154, P27, DOI 10.1007/s00227-007-0892-9; Burt J.A., 2014, CITY, V18, P760, DOI [10.1080/13604813.2014.962889, DOI 10.1080/13604813.2014.962889]; Burt JA, 2013, MAR POLLUT BULL, V72, P357, DOI 10.1016/j.marpolbul.2012.08.022; Busby JR, 1991, PLANT PROTECTION Q, V6; Central Intelligence Agency (CIA), 2016, WORLD FACTBOOK 2016; Cheung WWL, 2016, SCIENCE, V354, P1591, DOI 10.1126/science.aag2331; Cheung WWL, 2011, ICES J MAR SCI, V68, P1008, DOI 10.1093/icesjms/fsr012; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cinner JE, 2012, GLOBAL ENVIRON CHANG, V22, P12, DOI 10.1016/j.gloenvcha.2011.09.018; Coles SL, 2003, ATOLL RES B, V507, P1, DOI [10.5479/si.00775630.507.1, DOI 10.5479/SI.00775630.507.1]; Coles SL, 2013, MAR POLLUT BULL, V72, P323, DOI 10.1016/j.marpolbul.2012.09.006; Demmke A., 2011, VULNERABILITY TROPIC, P733; Edson J, 2015, REGIONAL OCEAN MODEL; Ekstrom JA, 2015, NAT CLIM CHANGE, V5, P207, DOI 10.1038/NCLIMATE2508; El-Khoury G., 2013, CONT ARAB AFFAIRS, V6, P14, DOI [10.1080/17550912.2013.843741, DOI 10.1080/17550912.2013.843741]; Elhakeem A, 2015, MAR POLLUT BULL, V101, P667, DOI 10.1016/j.marpolbul.2015.10.032; Few R, 2007, CLIM POLICY, V7, P46, DOI 10.1080/14693062.2007.9685637; FishStat F., 2011, FISHSTATJ SOFTW FISH; Froese R., 2016, FISHBASE; Fussel HM, 2006, CLIMATIC CHANGE, V75, P301, DOI 10.1007/s10584-006-0329-3; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Gray JS, 2002, MAR ECOL PROG SER, V244, P285, DOI 10.3354/meps244285; Grizzle RE, 2016, MAR POLLUT BULL, V105, P515, DOI 10.1016/j.marpolbul.2015.10.005; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamza W, 2009, AQUAT ECOSYST HEALTH, V12, P429, DOI 10.1080/14634980903361580; Hirzel AH, 2003, ENVIRON MANAGE, V32, P614, DOI 10.1007/s00267-003-0040-3; Hume BCC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08562; Hume BCC, 2016, P NATL ACAD SCI USA, V113, P4416, DOI 10.1073/pnas.1601910113; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IUCN and UN Environment WCMC, 2016, WORLD DAT PROT AR WD; JONES DA, 1978, ESTUAR COAST MAR SCI, V6, P253, DOI 10.1016/0302-3524(78)90014-2; Jones MC, 2015, ICES J MAR SCI, V72, P741, DOI 10.1093/icesjms/fsu172; Kampf J, 2006, OCEAN SCI, V2, P27; Kasperson R. E., 2005, ECOSYSTEMS HUMAN WEL, V1, P143; Kaufman D, 2010, 5430 WORLD BANK; KINSMAN DJJ, 1964, NATURE, V202, P1280, DOI 10.1038/2021280a0; Krishnamurti TN, 2000, J CLIMATE, V13, P4196, DOI 10.1175/1520-0442(2000)013<4196:MEFFWA>2.0.CO;2; LABORSTA, 2016, LABORSTA DAT; Lam VWY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32607; Lasram FB, 2010, GLOBAL CHANGE BIOL, V16, P3233, DOI 10.1111/j.1365-2486.2010.02224.x; Legendre P., 1998, DEV ENV MODELLING, V20; Levy JS, 2013, MAR POLICY, V38, P16, DOI 10.1016/j.marpol.2012.05.015; MacNeil MA, 2010, PHILOS T R SOC B, V365, P3753, DOI 10.1098/rstb.2010.0289; Madin JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046637; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; MIT, EC COMPL RANK 2016; Mohammad Ali Zahed, 2010, Electronic Journal of Environmental, Agricultural and Food Chemistry, V9, P411; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Naser H.A., 2014, BIODIVERSITY DYNAMIC; NationMaster, POPULATION POVERTY L; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Palomares MLD, 2016, SEALIFEBASE; Parry ML, 2007, CLIMATE CHANGE 2007; Pauly D., 2010, GASPING FISH PANTING, V22; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Pilcher NJ, 2014, J EXP MAR BIOL ECOL, V460, P89, DOI 10.1016/j.jembe.2014.06.009; Pitcher TJ, 2013, MAR POLLUT BULL, V74, P506, DOI 10.1016/j.marpolbul.2013.05.045; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; Portner HO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P411; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Riegl B, 2010, CARBONATE DEPOSITIONAL SYSTEMS: ASSESSING DIMENSIONS AND CONTROLLING PARAMETERS, P145, DOI 10.1007/978-90-481-9364-6_4; Riegl Bernhard M., 2012, P95; Sale PF, 2011, AMBIO, V40, P4, DOI 10.1007/s13280-010-0092-6; Sheppard C, 2016, MAR POLLUT BULL, V105, P593, DOI 10.1016/j.marpolbul.2015.09.031; Sheppard C, 2010, MAR POLLUT BULL, V60, P13, DOI 10.1016/j.marpolbul.2009.10.017; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Sheppard SRJ, 2011, FUTURES, V43, P400, DOI 10.1016/j.futures.2011.01.009; Shirvani A, 2015, ARAB J GEOSCI, V8, P2121, DOI 10.1007/s12517-014-1278-1; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Subba Rao D.V., 1998, Plankton Biology and Ecology, V45, P101; Sullivan CA, 2002, REPORT DIALOGUE WATE; Sumaila U. Rashid, 2007, Journal of Bioeconomics, V9, P39, DOI 10.1007/s10818-007-9015-4; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Swartz W, 2013, ENVIRON RESOUR ECON, V56, P467, DOI 10.1007/s10640-012-9611-1; Tebaldi C, 2007, PHILOS T R SOC A, V365, P2053, DOI 10.1098/rsta.2007.2076; Teh LCL, 2013, FISH FISH, V14, P77, DOI 10.1111/j.1467-2979.2011.00450.x; The Worldbank Group, 2016, WORLD BANK OP DAT; Thiault L, 2018, CONSERV BIOL, V32, P447, DOI 10.1111/cobi.12989; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; UN Trade Statistics - United Nations, 2015, INT TRAD STAT YB; UNDP, 2020, HUM DEV DAT 1990 201; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; Watson RT, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, pIX; WHO, 2018, GLOBAL HLTH OBSERVAT; World Ocean Atlas, 2015, WORLD OCEAN ATLAS 20; Wright JL., 1974, HYDROGRAPHIC ACOUS 1; Zolgharnein H., 2010, Journal of Fisheries and Aquatic Science, V5, P223	102	62	64	7	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0194537	10.1371/journal.pone.0194537	http://dx.doi.org/10.1371/journal.pone.0194537			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5SH	29718919	gold, Green Published, Green Submitted			2022-12-26	WOS:000431281900007
J	Liu, GZ; Gong, YJ; Zhang, R; Piao, LJ; Li, XZ; Liu, Q; Yan, S; Shen, YJ; Guo, SM; Zhu, MJ; Yin, HY; Funk, CD; Zhang, J; Yu, Y				Liu, Guizhu; Gong, Yanjun; Zhang, Rui; Piao, Lingjuan; Li, Xinzhi; Liu, Qian; Yan, Shuai; Shen, Yujun; Guo, Shumin; Zhu, Mingjiang; Yin, Huiyong; Funk, Colin D.; Zhang, Jian; Yu, Ying			Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration	FASEB JOURNAL			English	Article						neointimal hyperplasia; inflammation; VSMC	LOW-DOSE ASPIRIN; NF-KAPPA-B; ARTERIAL INJURY; DEFICIENT MICE; P-SELECTIN; MACROPHAGE POLARIZATION; INDUCED ATHEROGENESIS; MONOCYTE RECRUITMENT; INTIMAL HYPERPLASIA; BIOACTIVE PRODUCTS	Mechanical insults, such as stent implantation, can induce endothelial injury, vascular inflammation, and ultimately lead to vascular neointimal hyperplasia. Resolvin E1 (RvE1), derived from the 3 fatty acid eicosapentaenoic acid, can facilitate the resolution of inflammation in many settings. We therefore aimed to determine if there was a role for RvE1 in preventing neointimal formation after arterial injury and to understand the underlying mechanisms. Vascular inflammation and neointimal hyperplasia were induced by wire injury in the femoral arteries of mice. Administration of exogenous RvE1 and endogenously generated RvE1 via dietary supplementation with eicosapentaenoic acid and aspirin markedly reduced vascular neointima formation in this model. Mechanistically, RvE1 was found to inhibit vascular neutrophil infiltration, promote macrophage polarization toward an M2-like phenotype, suppress T-cell trafficking by reducing RANTES secretion from vascular smooth muscle cells, and inhibit vascular smooth muscle cell migration. In summary, RvE1 demonstrated a protective role against vascular inflammation and remodeling in response to mechanical injury, suggesting that it may serve as an adjuvant therapeutic agent for percutaneous coronary interventions, such as stent implantation.Liu, G., Gong, Y., Zhang, R., Piao, L., Li, X., Liu, Q., Yan, S., Shen, Y., Guo, S., Zhu, M., Yin, H., Funk, C. D., Zhang, J., Yu, Y. Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration.	[Liu, Guizhu; Gong, Yanjun; Yan, Shuai; Guo, Shumin; Zhu, Mingjiang; Yin, Huiyong; Yu, Ying] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Shanghai Inst Biol Sci,CAS Key Lab Nutr Metab & F, Beijing, Peoples R China; [Liu, Guizhu; Zhang, Rui; Liu, Qian; Shen, Yujun; Zhang, Jian; Yu, Ying] Tianjin Med Univ, Dept Pharmacol, Coll Basic Med Sci, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China; [Piao, Lingjuan] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, Seoul, South Korea; [Li, Xinzhi; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Tianjin Medical University; Ewha Womans University; Queens University - Canada	Zhang, J; Yu, Y (corresponding author), Tianjin Med Univ, Dept Pharmacol, Coll Basic Med Sci, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	zhangjian_tina@163.com; yuying@tmu.edu.cn	Li, Xinzhi/X-2650-2019	yin, hui yong/0000-0001-7049-1560; Yan, Shuai/0000-0003-0650-1837	Ministry of Science and Technology of China [2017YFC1307402]; National Natural Science Foundation of China [91439204, 81525004, 81790623, 91639302, 81771513, 81400239, 31771269, 31200860]; Tianjin Committee of Science and Technology [17JCYBJC26800]; Canadian Institutes of Health Research (CIHR) [MOP142476]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Committee of Science and Technology; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Ministry of Science and Technology of China (2017YFC1307402), the National Natural Science Foundation of China (91439204, 81525004, 81790623, 91639302, 81771513, 81400239, 31771269, 31200860), and the Tianjin Committee of Science and Technology (17JCYBJC26800). Y.Y. is a fellow at the Jiangsu Collaborative Innovation Center for Cardiovascular Disease Translational Medicine. C.D.F. holds a Canada Research Chair position and is supported by the Canadian Institutes of Health Research (CIHR; MOP142476). The authors declare no conflicts of interest.	Aizik G., 2017, DRUG DELIV TRANSL RE; An GY, 2008, CIRCULATION, V117, P3227, DOI 10.1161/CIRCULATIONAHA.108.771048; Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Asztalos IB, 2016, METABOLISM, V65, P1636, DOI 10.1016/j.metabol.2016.07.010; Back M, 2005, P NATL ACAD SCI USA, V102, P17501, DOI 10.1073/pnas.0505845102; Bai L, 2017, ARTERIOSCL THROM VAS, V37, P1470, DOI 10.1161/ATVBAHA.117.309672; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Block RC, 2012, PROSTAG LEUKOTR ESS, V87, P143, DOI 10.1016/j.plefa.2012.08.007; Boehm M, 2004, J CLIN INVEST, V114, P419, DOI 10.1172/jci200420176; Campbell EL, 2007, FASEB J, V21, P3162, DOI 10.1096/fj.07-8473com; Chen JH, 2011, CIRCULATION, V123, P584, DOI 10.1161/CIRCULATIONAHA.110.971853; Cyrus T, 2002, CIRCULATION, V106, P1282, DOI 10.1161/01.CIR.0000027816.54430.96; Davis C, 2003, J THROMB HAEMOST, V1, P1699, DOI 10.1046/j.1538-7836.2003.00292.x; Dona M, 2008, BLOOD, V112, P848, DOI 10.1182/blood-2007-11-122598; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; Faggin E, 2000, ARTERIOSCL THROM VAS, V20, P152, DOI 10.1161/01.ATV.20.1.152; Flesher RP, 2014, CLIN SCI, V126, P805, DOI 10.1042/CS20130623; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Freire MO, 2017, J IMMUNOL, V198, P718, DOI 10.4049/jimmunol.1601543; Fu CH, 2012, ARTERIOSCL THROM VAS, V32, P2418, DOI 10.1161/ATVBAHA.112.255786; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Gobbetti T, 2017, P NATL ACAD SCI USA, V114, P3963, DOI 10.1073/pnas.1617290114; Gong YJ, 2015, BRIT J PHARMACOL, V172, P5647, DOI 10.1111/bph.12986; Hart R, 2010, J IMMUNOL, V185, P3728, DOI 10.4049/jimmunol.0902154; Hasturk H, 2015, ARTERIOSCL THROM VAS, V35, P1123, DOI 10.1161/ATVBAHA.115.305324; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Hayashi S, 2000, CIRCULATION, V102, P1710, DOI 10.1161/01.CIR.102.14.1710; Heller EA, 2005, CIRCULATION, V112, P578, DOI 10.1161/CIRCULATIONAHA.105.545616; Herova M, 2015, J IMMUNOL, V194, P2330, DOI 10.4049/jimmunol.1402166; Hiram R, 2015, AM J PHYSIOL-LUNG C, V309, pL776, DOI 10.1152/ajplung.00177.2015; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Hong S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00013; Inoue T, 2009, CIRC J, V73, P615, DOI 10.1253/circj.CJ-09-0059; Keyes KT, 2010, AM J PHYSIOL-HEART C, V299, pH153, DOI 10.1152/ajpheart.01057.2009; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016; Lavin B, 2014, ARTERIOSCL THROM VAS, V34, P1739, DOI 10.1161/ATVBAHA.114.303866; Li CC, 2014, J NUTR BIOCHEM, V25, P19, DOI 10.1016/j.jnutbio.2013.08.010; Li RC, 2011, AM J RESP CRIT CARE, V184, P124, DOI 10.1164/rccm.201012-2039OC; Liu GZ, 2018, BRIT J PHARMACOL, V175, P1205, DOI 10.1111/bph.14041; Maghazachi AA, 1996, EUR J IMMUNOL, V26, P315, DOI 10.1002/eji.1830260207; Makino Y, 2002, CLIN IMMUNOL, V102, P302, DOI 10.1006/clim.2001.5178; Manka DR, 1999, J VASC RES, V36, P372, DOI 10.1159/000025676; Mitroulis I, 2015, PHARMACOL THERAPEUT, V147, P123, DOI 10.1016/j.pharmthera.2014.11.008; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Ohira T, 2010, J BIOL CHEM, V285, P3451, DOI 10.1074/jbc.M109.044131; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Roy J, 2016, J PHARMACOL EXP THER, V359, P134, DOI 10.1124/jpet.116.234781; Salic K, 2016, ATHEROSCLEROSIS, V250, P158, DOI 10.1016/j.atherosclerosis.2016.05.001; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Shen YJ, 2016, CIRC RES, V118, P1194, DOI 10.1161/CIRCRESAHA.115.307853; Skarke C, 2015, J LIPID RES, V56, P1808, DOI 10.1194/jlr.M060392; Smirnova NF, 2014, J EXP MED, V211, P1779, DOI 10.1084/jem.20131276; Sulciner ML, 2018, J EXP MED, V215, P115, DOI 10.1084/jem.20170681; Suna G, 2018, CIRCULATION, V137, P166, DOI 10.1161/CIRCULATIONAHA.116.023381; Waksman R, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.004150; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yang HM, 2004, CIRCULATION, V110, P301, DOI 10.1161/01.CIR.0000135467.43430.16; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yoneda S, 2013, CORONARY ARTERY DIS, V24, P368, DOI 10.1097/MCA.0b013e32836222ec; Yun JJ, 2001, TRANSPLANTATION, V71, P1649, DOI 10.1097/00007890-200106150-00026; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011; Zhang J, 2013, CIRC RES, V113, P104, DOI 10.1161/CIRCRESAHA.113.301033	74	30	31	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5413	5425		10.1096/fj.201800173R	http://dx.doi.org/10.1096/fj.201800173R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29723062	Bronze			2022-12-26	WOS:000447972500018
J	Lee, JA; Wang, ZQ; Sambo, D; Bunting, KD; Pallas, DC				Lee, Jocelyn A.; Wang, Zhengqi; Sambo, Danielle; Bunting, Kevin D.; Pallas, David C.			Global loss of leucine carboxyl methyltransferase-1 causes severe defects in fetal liver hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein serine; threonine phosphatase (PSP); protein phosphatase 2 (PP2A); hematopoiesis; development; mouse; LCMT-1; protein phosphatase methyltransferase	PROTEIN PHOSPHATASE 2A; PP2A CATALYTIC SUBUNIT; BOVINE BRAIN; METHYL ESTERIFICATION; SELF-RENEWAL; IN-VIVO; SACCHAROMYCES-CEREVISIAE; NEUROBLASTOMA-CELLS; REGULATORY SUBUNITS; ERYTHROID-CELLS	Leucine carboxyl methyltransferase-1 (LCMT-1) methylates the C-terminal leucine -carboxyl group of the catalytic subunits of the protein phosphatase 2A (PP2A) subfamily of protein phosphatases, PP2Ac, PP4c, and PP6c. LCMT-1 differentially regulates the formation and function of a subset of the heterotrimeric complexes that PP2A and PP4 form with their regulatory subunits. Global LCMT-1 knockout causes embryonic lethality in mice, but LCMT-1 function in development is unknown. In this study, we analyzed the effects of global LCMT-1 loss on embryonic development. LCMT-1 knockout causes loss of PP2Ac methylation, indicating that LCMT-1 is the sole PP2Ac methyltransferase. PP2A heterotrimers containing the B and B B-type subunits are dramatically reduced in whole embryos, and the steady-state levels of PP2Ac and the PP2A structural A subunit are also down approximate to 30%. Strikingly, global loss of LCMT-1 causes severe defects in fetal hematopoiesis and usually death by embryonic day 16.5. Fetal livers of homozygous lcmt-1 knockout embryos display hypocellularity, elevated apoptosis, and greatly reduced numbers of hematopoietic stem and progenitor cell-enriched Kit(+)Lin(-)Sca1(+) cells. The percent cycling cells and mitotic indices of WT and lcmt-1 knockout fetal liver cells are similar, suggesting that hypocellularity may be due to a combination of apoptosis and/or defects in specification, self-renewal, or survival of stem cells. Indicative of a possible intrinsic defect in stem cells, noncompetitive and competitive transplantation experiments reveal that lcmt-1 loss causes a severe multilineage hematopoietic repopulating defect. Therefore, this study reveals a novel role for LCMT-1 as a key player in fetal liver hematopoiesis.	[Lee, Jocelyn A.; Sambo, Danielle; Pallas, David C.] Emory Univ, Sch Med, Winship Canc Inst, Biochem Cell & Dev Grad Program,Dept Biochem, Atlanta, GA 30322 USA; [Wang, Zhengqi; Bunting, Kevin D.] Emory Univ, Sch Med, Aflac Canc & Blood Disorders Ctr Childrens Hlth A, Dept Pediat,Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Pallas, DC (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	dpallas@emory.edu			National Institutes of Health from NCI [R01 CA57327, R01DK059380, P30CA138292]; University Research Committee at Emory University; Aflac Cancer and Blood Disorder Center; NATIONAL CANCER INSTITUTE [R01CA057327, F31CA123640, P30CA138292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059380] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University Research Committee at Emory University; Aflac Cancer and Blood Disorder Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant R01 CA57327 from NCI (to D.C.P.), National Institutes of Health Grant R01DK059380 (to K.D.B.), and National Institutes of Health P30CA138292 from NCI (Emory Winship Cancer Institute), and in part by the University Research Committee at Emory University (to D.C.P.) and the Aflac Cancer and Blood Disorder Center (to K.D.B. and Z.W.). Dr. David Pallas is entitled to royalty from the sale of products related to the research described in this paper by Millipore, Inc., Santa Cruz Biotechnologies, Inc., and Novus Biologicals, Inc. In addition, Dr. David Pallas serves as a consultant to Millipore. The terms of these arrangements have been reviewed and approved by Emory University in accordance with its conflict of interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Predoctoral Fellowship Grant F31CA123640 from NCI.	Baron MH, 2003, EXP HEMATOL, V31, P1160, DOI 10.1016/j.exphem.2003.08.019; Brechmann M, 2012, IMMUNITY, V37, P697, DOI 10.1016/j.immuni.2012.07.014; Chen WQ, 2011, AM J PATHOL, V178, P2333, DOI 10.1016/j.ajpath.2011.01.041; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; Dudiki T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141961; Espin-Palazon R, 2014, CELL, V159, P1070, DOI 10.1016/j.cell.2014.10.031; FAVRE B, 1994, J BIOL CHEM, V269, P16311; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; FLOER M, 1994, BIOCHEM BIOPH RES CO, V198, P372, DOI 10.1006/bbrc.1994.1052; Gentry MS, 2005, EUKARYOT CELL, V4, P1029, DOI 10.1128/EC.4.6.1029-1040.2005; Haesen D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00347; Harrison DE, 1997, BLOOD, V90, P174; He QP, 2015, BLOOD, V125, P1098, DOI 10.1182/blood-2014-09-601542; Hwang J, 2016, J BIOL CHEM, V291, P21008, DOI 10.1074/jbc.M116.739920; Ikehara T, 2007, BIOCHEM BIOPH RES CO, V354, P1052, DOI 10.1016/j.bbrc.2007.01.085; Jackson JB, 2012, NEOPLASIA, V14, P585, DOI 10.1593/neo.12768; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kalhor HR, 2001, ARCH BIOCHEM BIOPHYS, V395, P239, DOI 10.1006/abbi.2001.2558; Kauts ML, 2016, FEBS LETT, V590, P3975, DOI 10.1002/1873-3468.12372; LEE J, 1993, J BIOL CHEM, V268, P19192; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Lee J. A., 2006, AFCS NATURE MOL; Lee JA, 2007, J BIOL CHEM, V282, P30974, DOI 10.1074/jbc.M704861200; LI M, 1994, BIOCHEM BIOPH RES CO, V202, P1023, DOI 10.1006/bbrc.1994.2031; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Longman MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086234; MacKay KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065967; Morioka K, 1998, EXP CELL RES, V240, P206, DOI 10.1006/excr.1997.3927; Nunbhakdi-Craig V, 2007, J NEUROCHEM, V101, P959, DOI 10.1111/j.1471-4159.2007.04503.x; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Palis J, 2016, FEBS LETT, V590, P3965, DOI 10.1002/1873-3468.12459; Pan XY, 2015, REPRODUCTION, V149, P385, DOI 10.1530/REP-14-0231; Pontius J., 2003, NCBI HDB, P1; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Sontag JM, 2013, J BIOL CHEM, V288, P27396, DOI 10.1074/jbc.M113.490102; Sontag JM, 2010, J NEUROCHEM, V115, P1455, DOI 10.1111/j.1471-4159.2010.07049.x; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Stein SJ, 2013, BLOOD, V121, P5015, DOI 10.1182/blood-2013-02-486142; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Tikhonova A, 2012, IMMUNITY, V37, P594, DOI 10.1016/j.immuni.2012.10.006; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Wu JH, 2000, J OPT COMMUN, V21, P10, DOI 10.1515/JOC.2000.21.1.10; XIE HY, 1994, BIOCHEM BIOPH RES CO, V203, P1710, DOI 10.1006/bbrc.1994.2383; XIE HY, 1993, J BIOL CHEM, V268, P13364; XIE HY, 1994, J BIOL CHEM, V269, P1981; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Xiu Y, 2017, STEM CELLS, V35, P777, DOI 10.1002/stem.2523; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yoder MC, 2002, ACTA PAEDIATR, V91, P5, DOI 10.1080/080352502320764139; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zhao BB, 2016, DEV CELL, V36, P498, DOI 10.1016/j.devcel.2016.02.001; Zhao C, 2012, STEM CELLS, V30, P709, DOI 10.1002/stem.1050	58	8	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9636	9650		10.1074/jbc.RA118.002012	http://dx.doi.org/10.1074/jbc.RA118.002012			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29735529	hybrid, Green Published			2022-12-26	WOS:000436102300008
J	Sambathkumar, R; Akkerman, R; Dastidar, S; Roelandt, P; Kumar, M; Bajaj, M; Rosa, ARM; Helsen, N; Vanslembrouck, V; Kalo, E; Khurana, S; Laureys, J; Gysemans, C; Faas, MM; de Vos, P; Verfaillie, CM				Sambathkumar, Rangarajan; Akkerman, Renate; Dastidar, Sumitava; Roelandt, Philip; Kumar, Manoj; Bajaj, Manmohan; Rosa, Ana Rita Mestre; Helsen, Nicky; Vanslembrouck, Veerle; Kalo, Eric; Khurana, Satish; Laureys, Jos; Gysemans, Conny; Faas, Marijke M.; de Vos, Paul; Verfaillie, Catherine M.			Generation of hepatocyte- and endocrine pancreatic-like cells from human induced endodermal progenitor cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INSULIN-PRODUCING CELLS; IN-VITRO; HUMAN FIBROBLASTS; DEFINED FACTORS; EFFICIENT DIFFERENTIATION; SECRETING CELLS; HUMAN LIVER; EXPRESSION; VIVO	Multipotent Adult Progenitor Cells (MAPCs) are one potential stem cell source to generate functional hepatocytes or (3-cells. However, human MAPCs have less plasticity than pluripotent stem cells (PSCs), as their ability to generate endodermal cells is not robust. Here we studied the role of 14 transcription factors (TFs) in reprogramming MAPCs to induced endodermal progenitor cells (iENDO cells), defined as cells that can be long-term expanded and differentiated to both hepatocyte- and endocrine pancreatic-like cells. We demonstrated that 14 TF-iENDO cells can be expanded for at least 20 passages, differentiate spontaneously to hepatocyte-, endocrine pancreatic-, gut tube-like cells as well as endodermal tumor formation when grafted in immunodeficient mice. Furthermore, iENDO cells can be differentiated in vitro into hepatocyte- and endocrine pancreatic-like cells. However, the pluripotency TF OCT4, which is not silenced in iENDO cells, may contribute to the incomplete differentiation to mature cells in vitro and to endodermal tumor formation in vivo. Nevertheless, the studies presented here provide evidence that reprogramming of adult stem cells to an endodermal intermediate progenitor, which can be expanded and differentiate to multiple endodermal cell types, might be a valid alternative for the use of PSCs for creation of endodermal cell types.	[Sambathkumar, Rangarajan; Akkerman, Renate; Dastidar, Sumitava; Roelandt, Philip; Kumar, Manoj; Bajaj, Manmohan; Rosa, Ana Rita Mestre; Helsen, Nicky; Vanslembrouck, Veerle; Kalo, Eric; Verfaillie, Catherine M.] Katholieke Univ Leuven, Dept Dev & Regenerat, Interdept Stem Cell Inst, Stem Cell Biol & Embryol, Leuven, Belgium; [Akkerman, Renate; Faas, Marijke M.; de Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, Pathol & Med Biol, Div Med Biol,Sect Immunoendocrinol, Groningen, Netherlands; [Khurana, Satish] Indian Inst Sci Educ & Res, Sch Biol, Thiruvananthapuram, Kerala, India; [Laureys, Jos; Gysemans, Conny] Katholieke Univ Leuven, Clin & Expt Endocrinol Unit, Dept Clin & Expt Med, Leuven, Belgium; [Faas, Marijke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [Sambathkumar, Rangarajan] Univ Hlth Network, Toronto Gen Hosp, McEwen Ctr Regenerat Med, Res Inst, Toronto, ON, Canada; [Dastidar, Sumitava] Free Univ Brussels VUB, Fac Med & Pharm, Dept Gene Therapy & Regenerat Med GTRM, Jette Campus, Brussels, Belgium	KU Leuven; University of Groningen; Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram; KU Leuven; University of Groningen; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Vrije Universiteit Brussel	Sambathkumar, R; Verfaillie, CM (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Interdept Stem Cell Inst, Stem Cell Biol & Embryol, Leuven, Belgium.; Sambathkumar, R (corresponding author), Univ Hlth Network, Toronto Gen Hosp, McEwen Ctr Regenerat Med, Res Inst, Toronto, ON, Canada.	ranga.1987@hotmail.com; Catherine.Verfaillie@kuleuven.be	Akkerman, Renate/GZG-2270-2022; de Vos, Paul/A-3170-2013; Gautam, Manoj Kumar/AAV-2798-2021; Dastidar, Sumitava/AAE-1542-2022; Kalo, Eric/GMX-4070-2022; Verfaillie, Catherine/H-5148-2013; Khurana, Satish/H-9090-2016	Gautam, Manoj Kumar/0000-0002-0572-5786; Kalo, Eric/0000-0002-6770-3857; Verfaillie, Catherine/0000-0001-7564-4079; DASTIDAR, SUMITAVA/0000-0003-1901-6750; gysemans, conny/0000-0003-3559-6089; de vos, paul/0000-0001-9618-2408; SAMBATHKUMAR, RANGARAJAN/0000-0002-2751-3143; Akkerman, Renate/0000-0002-0188-9097; Khurana, Satish/0000-0001-5176-1510	Dutch Diabetes Foundation [2008.50.003]; KU Leuven; Research Foundation Flanders (FWO); IWT [SB-121396]; Wellcome Trust/DBT India Alliance Fellowship [IA/I/15/2/502061]; IISER TVM;  [H2020-MSCA- (IF)-657701]	Dutch Diabetes Foundation; KU Leuven(KU Leuven); Research Foundation Flanders (FWO)(FWO); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Wellcome Trust/DBT India Alliance Fellowship(Wellcome Trust DBT India Alliance); IISER TVM; 	R.S. was supported by the Dutch Diabetes Foundation (2008.50.003), the Netherlands and KU Leuven; S.D. was supported by pre-doctoral scholaship from KU Leuven; P.R. was supported by Research Foundation Flanders (FWO); M.K. was supported by H2020-MSCA- (IF)-657701; N.H. was Funded by IWT (SB-121396); S. K. is supported by the Wellcome Trust/DBT India Alliance Fellowship (IA/I/15/2/502061) and intramural grant from IISER TVM; and Centre of Excellence funding from the KU Leuven to C.M.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Aranguren XL, 2007, BLOOD, V109, P2634, DOI 10.1182/blood-2006-06-030411; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Baxter M, 2015, J HEPATOL, V62, P581, DOI 10.1016/j.jhep.2014.10.016; Cai Q, 2014, STEM CELL TRANSL MED, V3, P489, DOI 10.5966/sctm.2013-0078; Chen YJ, 2014, CELL REP, V6, P1046, DOI 10.1016/j.celrep.2014.02.013; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; Chetty S, 2013, NAT METHODS, V10, P553, DOI [10.1038/NMETH.2442, 10.1038/nmeth.2442]; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291; Funa NS, 2015, CELL STEM CELL, V16, P639, DOI 10.1016/j.stem.2015.03.008; Godoy P, 2015, J HEPATOL, V63, P934, DOI 10.1016/j.jhep.2015.05.013; Hannan NRF, 2013, STEM CELL REP, V1, P293, DOI 10.1016/j.stemcr.2013.09.003; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hay DC, 2007, CLONING STEM CELLS, V9, P51, DOI 10.1089/clo.2006.0045; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Jacobs SA, 2013, CELL TRANSPLANT, V22, P1915, DOI 10.3727/096368912X657369; Jacobs SA, 2013, IMMUNOL CELL BIOL, V91, P32, DOI 10.1038/icb.2012.64; Katz LS, 2013, STEM CELLS DEV, V22, P2551, DOI 10.1089/scd.2013.0134; Keeffe EB, 2001, GASTROENTEROLOGY, V120, P749, DOI 10.1053/gast.2001.22583; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kumar AHS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057230, 10.1371/journal.pone.0064972]; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844; Li AR, 2008, ALTEX-ALTERN TIEREXP, V25, P33; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li WL, 2013, CELL STEM CELL, V13, P270, DOI 10.1016/j.stem.2013.08.002; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Mauda-Havakuk M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026298; Mora-Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043683; Naftanel MA, 2004, PLOS MED, V1, P198, DOI 10.1371/journal.pmed.0010058; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pennarossa G, 2013, P NATL ACAD SCI USA, V110, P8948, DOI 10.1073/pnas.1220637110; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Richert L, 2006, DRUG METAB DISPOS, V34, P870, DOI 10.1124/dmd.105.007708; Rodriguez-Antona C, 2002, XENOBIOTICA, V32, P505, DOI 10.1080/00498250210128675; Roelandt P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012101; Roobrouck VD, 2011, STEM CELLS, V29, P871, DOI 10.1002/stem.633; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Siller R, 2015, STEM CELL REP, V4, P939, DOI 10.1016/j.stemcr.2015.04.001; Subramanian K, 2014, STEM CELLS DEV, V23, P124, DOI 10.1089/scd.2013.0097; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ulvestad M, 2013, BIOCHEM PHARMACOL, V86, P691, DOI 10.1016/j.bcp.2013.06.029; Ulvestad M, 2011, BIOCHEM PHARMACOL, V82, P1219, DOI 10.1016/j.bcp.2011.07.076; Vanhove J, 2016, STEM CELL REP, V7, P192, DOI 10.1016/j.stemcr.2016.06.013; Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017; Zalzman M, 2005, DIABETES, V54, P2568, DOI 10.2337/diabetes.54.9.2568; Zalzman M, 2003, P NATL ACAD SCI USA, V100, P7253, DOI 10.1073/pnas.1136854100; Zhu SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10080; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020	56	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							0197046	10.1371/journal.pone.0197046	http://dx.doi.org/10.1371/journal.pone.0197046			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750821	Green Published, gold, Green Submitted			2022-12-26	WOS:000431856300013
J	Albert, P; Varga, B; Zsibrita, N; Kiss, A				Albert, Pal; Varga, Bence; Zsibrita, Nikolett; Kiss, Antal			Circularly permuted variants of two CG-specific prokaryotic DNA methyltransferases	PLOS ONE			English	Article							ESCHERICHIA-COLI; CYTOSINE METHYLTRANSFERASES; SEQUENCE; METHYLASE; PROTEIN; RESTRICTION; MOTIFS; COMPLEMENTATION; PERMUTATIONS; EXPRESSION	The highly similar prokaryotic DNA (cytosine-5) methyltransferases (C5-MTases) M.Mpel and M.Sssl share the specificity of eukaryotic C5-MTases (5'-CG), and can be useful research tools in the study of eukaryotic DNA methylation and epigenetic regulation. In an effort to improve the stability and solubility of complementing fragments of the two MTases, genes encoding circularly permuted (CP) variants of M.Mpel and M.Sssl were created, and cloned in a plasmid vector downstream of an arabinose-inducible promoter. MTase activity of the CP variants was tested by digestion of the plasmids with methylation-sensitive restriction enzymes. Eleven of the fourteen M.Mpel permutants and six of the seven M.Sssl permutants had detectable MTase activity as indicated by the full or partial protection of the plasmid carrying the cpMTase gene. Permutants cp62M.Mpel and cp58M.Sssl, in which the new N-termini are located between conserved motifs II and III, had by far the highest activity. The activity of cp62M.Mpel was comparable to the activity of wild-type M.Mpel. Based on the location of the split sites, the permutants possessing MTase activity can be classified in ten types. Although most permutation sites were designed to fall outside of conserved motifs, and the MTase activity of the permutants measured in cell extracts was in most cases substantially lower than that of the wild-type enzyme, the high proportion of circular permutation topologies compatible with MTase activity is remarkable, and is a new evidence for the structural plasticity of C5-MTases. A computer search of the REBASE database identified putative C5-MTases with CP arrangement. Interestingly, all natural circularly permuted C5-MTases appear to represent only one of the ten types of permutation topology created in this work.	[Albert, Pal; Varga, Bence; Zsibrita, Nikolett; Kiss, Antal] Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, Szeged, Hungary; [Albert, Pal; Zsibrita, Nikolett] Univ Szeged, Fac Sci & Informat, Doctoral Sch Biol, Szeged, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University	Kiss, A (corresponding author), Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, Szeged, Hungary.	kiss.antal@brc.mta.hu	Kiss, Antal/A-1656-2008	Varga, Bence/0000-0001-7356-2264; Kiss, Antal/0000-0002-7975-3085	National Research, Development and Innovation Office [NN109787]	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	This work was supported by the NN109787 grant to AK from the National Research, Development and Innovation Office (https://nkfih.gov.hu/english). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALGANESH TS, 1987, EMBO J, V6, P3543, DOI 10.1002/j.1460-2075.1987.tb02681.x; Bitinaite J, 2002, MOL GENET GENOMICS, V267, P664, DOI 10.1007/s00438-002-0701-6; Bliven Spencer, 2012, PLoS Comput Biol, V8, pe1002445, DOI 10.1371/journal.pcbi.1002445; Bujnicki JM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-3; Bujnicki JM, 2000, INT J BIOL MACROMOL, V27, P195, DOI 10.1016/S0141-8130(00)00120-3; Chaikind B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096931; Chaikind B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044852; Chiang JJH, 2006, BIOTECHNOL LETT, V28, P471, DOI 10.1007/s10529-006-0007-6; Choe W, 2005, BIOCHEM BIOPH RES CO, V334, P1233, DOI 10.1016/j.bbrc.2005.07.017; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Darii MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1654, DOI 10.1016/j.bbapap.2009.07.016; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gong WM, 1997, NUCLEIC ACIDS RES, V25, P2702, DOI 10.1093/nar/25.14.2702; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Jeltsch A, 1999, J MOL EVOL, V49, P161, DOI 10.1007/PL00006529; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jurkowska RZ, 2016, ADV EXP MED BIOL, V945, P1, DOI 10.1007/978-3-319-43624-1_1; KARREMAN C, 1990, J BACTERIOL, V172, P266, DOI 10.1128/JB.172.1.266-272.1990; KLIMASAUSKAS S, 1991, NUCLEIC ACIDS RES, V19, P6183, DOI 10.1093/nar/19.22.6183; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Koudan EV, 2004, J BIOMOL STRUCT DYN, V22, P339, DOI 10.1080/07391102.2004.10507005; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lei Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16026; Lo WC, 2012, NUCLEIC ACIDS RES, V40, pW232, DOI 10.1093/nar/gks529; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; MATSUO K, 1994, NUCLEIC ACIDS RES, V22, P5354, DOI 10.1093/nar/22.24.5354; Peisajovich SG, 2006, NAT GENET, V38, P168, DOI 10.1038/ng1717; Pinarbasi H, 2002, J BIOCHEM MOL BIOL, V35, P348, DOI 10.5483/BMBRep.2002.35.3.348; POSFAI G, 1991, NUCLEIC ACIDS RES, V19, P4843, DOI 10.1093/nar/19.18.4843; POSFAI J, 1989, NUCLEIC ACIDS RES, V17, P2421, DOI 10.1093/nar/17.7.2421; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; RENBAUM P, 1995, J MOL BIOL, V248, P19, DOI 10.1006/jmbi.1995.0199; RENBAUM P, 1990, NUCLEIC ACIDS RES, V18, P1145, DOI 10.1093/nar/18.5.1145; RENBAUM P, 1992, FEBS LETT, V313, P243, DOI 10.1016/0014-5793(92)81201-V; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Sambrook J., 2006, CONDENSED PROTOCOLS; Sasaki Y, 2002, NUCLEIC ACIDS RES, V30, P5293, DOI 10.1093/nar/gkf667; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Slaska-Kiss K, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-17; Stier I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079003; Timar E, 2008, J BACTERIOL, V190, P8003, DOI 10.1128/JB.00754-08; WILSON GG, 1992, METHOD ENZYMOL, V216, P259; Wojciechowski M, 2013, P NATL ACAD SCI USA, V110, P105, DOI 10.1073/pnas.1207986110; Xiong TN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06757-0; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376; Xu SY, 1997, NUCLEIC ACIDS RES, V25, P3991, DOI 10.1093/nar/25.20.3991; Yamazaki T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177764; Yu Y, 2011, TRENDS BIOTECHNOL, V29, P18, DOI 10.1016/j.tibtech.2010.10.004	52	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197232	10.1371/journal.pone.0197232	http://dx.doi.org/10.1371/journal.pone.0197232			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746549	Green Submitted, Green Published, gold			2022-12-26	WOS:000431851700087
J	Hensel, KO; Roskopf, M; Wilke, L; Heusch, A				Hensel, Kai O.; Roskopf, Markus; Wilke, Lucia; Heusch, Andreas			Intraobserver and interobserver reproducibility of M-mode and B-mode acquired mitral annular plane systolic excursion (MAPSE) and its dependency on echocardiographic image quality in children	PLOS ONE			English	Article							SPECKLE-TRACKING ECHOCARDIOGRAPHY; VENTRICULAR EJECTION FRACTION; Z-SCORE VALUES; PEDIATRIC ECHOCARDIOGRAM; DILATED CARDIOMYOPATHY; AMERICAN-SOCIETY; USEFUL INDICATOR; AORTIC-STENOSIS; HEALTHY-ADULTS; HEART-FAILURE	Background Mitral annular plane systolic excursion (MAPSE) is an increasingly used echocardiography technique to assess left ventricular (LV) function. However, reproducibility and dependence on echocardiographic image quality for MAPSE in pediatric patients have not been studied to date. Methods We analyzed 284 transthoracic echocardiograms performed on consecutive normotensive children without structural heart disease (mean age 12.6 +/- 3.1 years, 50.4% female). B-mode and M-mode derived MAPSE measurements were performed and analyzed regarding inter-and intraobserver reliability and the influence of echocardiographic image quality. Results Overall, MAPSE measurements were highly reproducible with only minor bias. Both interand intraobserver reliability were significantly better for M-mode derived MAPSE (p<0.001). Echocardiographic image quality did not significantly influence M-mode MAPSE reproducibility (p>0.235). In contrast, B-mode lateral MAPSE was significantly better reproducible in optimal image quality (-0.07 +/- 1.04) when compared to suboptimal echocardiographic images (0.42 +/- 1.59, p<0.001). Moreover, poor quality images yielded significantly lower M-mode MAPSE values (14.3 +/- 2 mm) than near-optimal (15.2 +/- 1.9 mm, p<0.001) or optimal images (15.1 +/- 2.2 mm, p = 0.006). Conclusion Echocardiographic image quality essentially has a negligible effect on MAPSE reproducibility and measurements. Consequently, MAPSE is a robust echocardiographic parameter with convincing reproducibility for the assessment of LV function in children-even in patients with substandard imaging conditions.	[Hensel, Kai O.; Roskopf, Markus; Wilke, Lucia; Heusch, Andreas] Witten Herdecke Univ, Fac Hlth, HELIOS Univ Med Ctr Wuppertal, Childrens Hosp,Dept Pediat,CCTR,Ctr Biomed Educ &, Wuppertal, Germany; [Hensel, Kai O.] Univ Cambridge, Addenbrookes Univ Hosp, Dept Pediat, Cambridge, England	University of Cambridge	Hensel, KO (corresponding author), Witten Herdecke Univ, Fac Hlth, HELIOS Univ Med Ctr Wuppertal, Childrens Hosp,Dept Pediat,CCTR,Ctr Biomed Educ &, Wuppertal, Germany.; Hensel, KO (corresponding author), Univ Cambridge, Addenbrookes Univ Hosp, Dept Pediat, Cambridge, England.	Kai.Hensel@uni-wh.de	Hensel, Kai O./AAR-5689-2020	Hensel, Kai O./0000-0001-5826-6133	Stiftung KinderHerz NRW; Deutsche Herzstiftung e.V. (Kaltenbach scholarship)	Stiftung KinderHerz NRW; Deutsche Herzstiftung e.V. (Kaltenbach scholarship)	This work was supported with grants by Stiftung KinderHerz NRW and Deutsche Herzstiftung e.V. (Kaltenbach scholarship, assigned to Lucia Wilke).	Adel W, 2016, ECHOCARDIOGR-J CARD, V33, P179, DOI 10.1111/echo.13009; Agha H, 2016, PEDIATR CARDIOL, V37, P537, DOI 10.1007/s00246-015-1311-5; Arce OX, 2002, J AM SOC ECHOCARDIOG, V15, P906, DOI 10.1067/mje.2002.121436; Bergenzaun L, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-16; Carlsson M, 2007, AM J PHYSIOL-HEART C, V292, pH1452, DOI 10.1152/ajpheart.01148.2006; Chubb H, 2012, ANN PEDIAT CARDIOL, V5, P179, DOI 10.4103/0974-2069.99622; de Knegt MC, 2014, EUR HEART J-CARD IMG, V15, P62, DOI 10.1093/ehjci/jet119; FEIGENBAUM H, 1967, CIRCULATION, V35, P1092, DOI 10.1161/01.CIR.35.6.1092; Grue JF, 2018, ULTRASOUND MED BIOL, V44, P168, DOI 10.1016/j.ultrasmedbio.2017.09.002; Hashimoto I, 2017, PEDIATR CARDIOL, V38, P1057, DOI 10.1007/s00246-017-1619-4; Hashimoto I, 2016, ECHOCARDIOGR-J CARD, V33, P290, DOI 10.1111/echo.13016; Hu K, 2013, J AM SOC ECHOCARDIOG, V26, P105, DOI 10.1016/j.echo.2012.11.004; Johri AM, 2015, ECHOCARDIOGR-J CARD, V32, P496, DOI 10.1111/echo.12692; Johri AM, 2011, JACC-CARDIOVASC IMAG, V4, P821, DOI 10.1016/j.jcmg.2011.06.004; Kim SH, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/7402784; Koestenberger M, 2015, PEDIATR CARDIOL, V36, P20, DOI 10.1007/s00246-014-0959-6; Koestenberger M, 2014, ECHOCARDIOGR-J CARD, V31, P1122, DOI 10.1111/echo.12541; Koestenberger M, 2012, AM HEART J, V164, P125, DOI 10.1016/j.ahj.2012.05.004; Lai WW, 2006, J AM SOC ECHOCARDIOG, V19, P1413, DOI 10.1016/j.echo.2006.09.001; Lee CK, 2014, PEDIATR CARDIOL, V35, P658, DOI 10.1007/s00246-013-0835-9; Levy PT, 2016, J AM SOC ECHOCARDIOG, V29, P209, DOI 10.1016/j.echo.2015.11.016; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Luszczak J, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-45; Mahfouz RA, 2017, INT J CARDIOVAS IMAG, V33, P533, DOI 10.1007/s10554-016-1036-4; Matos J, 2012, J AM SOC ECHOCARDIOG, V25, P969, DOI 10.1016/j.echo.2012.06.011; Matos JD, 2017, AM J CARDIOL, V120, P2031, DOI 10.1016/j.amjcard.2017.08.021; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Natale M, 2017, EUR J MED RES, V22, DOI 10.1186/s40001-017-0281-x; Ochs MM, 2017, INT J CARDIOVAS IMAG, V33, P721, DOI 10.1007/s10554-016-1058-y; Oehler AC, 2017, J AM SOC ECHOCARDIOG, V30, P1028, DOI 10.1016/j.echo.2017.06.007; Ortiz JU, 2015, PRENATAL DIAG, V35, P1197, DOI 10.1002/pd.4671; Qin Jian Xin, 2004, Eur J Echocardiogr, V5, P407, DOI 10.1016/j.euje.2004.03.002; Simonson J S, 1989, J Am Soc Echocardiogr, V2, P25; Suzuki K, 2012, J CARDIOL, V60, P55, DOI 10.1016/j.jjcc.2012.01.014; Tasolar H, 2015, ANATOL J CARDIOL, V15, P558, DOI 10.5152/akd.2014.5561; Terada T, 2016, ECHOCARDIOGR-J CARD, V33, P1703, DOI 10.1111/echo.13325; Tsang W, 2010, J AM SOC ECHOCARDIOG, V23, P511, DOI 10.1016/j.echo.2010.03.003; Wenzelburger FWG, 2011, EUR J HEART FAIL, V13, P953, DOI 10.1093/eurjhf/hfr081; Willenheimer R, 1997, HEART, V78, P230, DOI 10.1136/hrt.78.3.230; ZAKY A., 1967, CARDIO VASC RES, V1, P121, DOI 10.1093/cvr/1.2.121; Zidan DH, 2016, J CRIT CARE, V34, P74, DOI 10.1016/j.jcrc.2016.03.022	41	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196614	10.1371/journal.pone.0196614	http://dx.doi.org/10.1371/journal.pone.0196614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746603	gold, Green Published, Green Submitted			2022-12-26	WOS:000431851700028
J	Kuznyetsov, V; Madjunkova, S; Antes, R; Abramov, R; Motamedi, G; Ibarrientos, Z; Librach, C				Kuznyetsov, Valeriy; Madjunkova, Svetlana; Antes, Ran; Abramov, Rine; Motamedi, Gelareh; Ibarrientos, Zenon; Librach, Clifford			Evaluation of a novel non-invasive preimplantation genetic screening approach	PLOS ONE			English	Article							CELL-FREE DNA; EMBRYO CULTURE-MEDIUM; BLASTOCOELE FLUID; TROPHECTODERM CELLS; ANEUPLOIDY; IMPLANTATION; BLASTOCYSTS; BIOPSY; AMPLIFICATION; MOSAICISM	Objective To assess whether embryonic DNA isolated from blastocyst culture conditioned medium (BCCM) combined with blastocoel fluid (BF) could be used for blastocyst stage non-invasive preimplantation genetic testing for chromosomal aneuploidy (non-invasive preimplantation genetic screening, NIPGS). Patients 47 embryos from 35 patients undergoing IVF. Interventions DNA analysis of combined BCCM plus BF in comparison with trophectoderm (TE) biopsy and/or whole blastocyst (WB)using next generation sequencing (NGS). Results Embryonic DNA was successfully amplified in 47/47 NIPGS samples (28 frozen-thawed and 19 fresh culture samples) ranging from 6.3 to 44.0 ng/mu l. For frozen-thawed embryos, the concordance rate for whole chromosome copy number per sample was equivalent between NIPGS vs. TE biopsy, NIPGS vs. WB and TE vs. WB samples taken from the same embryo was 87.5%; 96.4% and 91.7% respectively (P>0.05), and the rate of concordance per single chromosome was 99.3%, 99.7% and 99.7%, respectively (P>0.05). In fresh cases (Day 4 to Day 5/6 culture), the concordance rate for whole chromosome copy number per sample between NIPGS vs. TE samples taken from the same embryo was 100%, and the rate of concordance per single chromosome was 98.2% (P>0.05). Conclusions A combination of BCCM and BF contains sufficient embryonic DNA for whole genome amplification and accurate aneuploidy screening. Our findings suggest that aneuploidy screening using BCCM combined with BF could potentially serve as a novel NIPGS approach for use in human IVF.	[Kuznyetsov, Valeriy; Madjunkova, Svetlana; Antes, Ran; Abramov, Rine; Motamedi, Gelareh; Ibarrientos, Zenon; Librach, Clifford] CReATe Fertil Ctr, Toronto, ON, Canada; [Librach, Clifford] Univ Toronto, Fac Med, Dept Obstet & Gynecol, Toronto, ON, Canada; [Librach, Clifford] Univ Toronto, Dept Physiol, 1 Kings Coll Circle, Toronto, ON, Canada; [Librach, Clifford] Univ Toronto, Inst Med Sci, 1 Kings Coll Circle, Toronto, ON, Canada; [Librach, Clifford] Womens Coll Hosp, Dept Gynecol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital	Madjunkova, S; Librach, C (corresponding author), CReATe Fertil Ctr, Toronto, ON, Canada.; Librach, C (corresponding author), Univ Toronto, Fac Med, Dept Obstet & Gynecol, Toronto, ON, Canada.; Librach, C (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle, Toronto, ON, Canada.; Librach, C (corresponding author), Univ Toronto, Inst Med Sci, 1 Kings Coll Circle, Toronto, ON, Canada.; Librach, C (corresponding author), Womens Coll Hosp, Dept Gynecol, Toronto, ON, Canada.	svetlana@createivf.com; drlibrach@createivf.com	Madjunkova, Svetlana/AAV-2941-2020	Madjunkova, Svetlana/0000-0001-8233-6621	Ontario Centres of Excellence TalentEdge Fellowship Program [22717]	Ontario Centres of Excellence TalentEdge Fellowship Program	Ontario Centres of Excellence TalentEdge Fellowship Program (http://www.oce-ontario.org/programs/industry-academic-collaboration/talentedge/talentedge-fellowship-program) supported in part research activities related to this manuscript by grant #22717 awarded to Dr. Svetlana Madjunkova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cimadomo D, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7193075; Darwish E, 2016, J ASSIST REPROD GEN, V33, P467, DOI 10.1007/s10815-016-0662-z; Deleye L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11711; Fiorentino F, 2014, HUM REPROD, V29, P2802, DOI 10.1093/humrep/deu277; Galluzzi L, 2015, FUTUR SCI OA, V1, DOI [10.4155/fso.15.62, 10.4155/FSO.15.62]; Garrisi G, 2016, FERTIL STERIL, V106, pE151, DOI 10.1016/j.fertnstert.2016.07.447; Gianaroli L, 2014, FERTIL STERIL, V102, P1692, DOI 10.1016/j.fertnstert.2014.08.021; Greco E, 2015, NEW ENGL J MED, V373, P2089, DOI 10.1056/NEJMc1500421; Hammond ER, 2016, HUM REPROD, V31, P1653, DOI 10.1093/humrep/dew132; Hammond ER, 2017, FERTIL STERIL, V1, P220; Handyside AH, 2016, FERTIL STERIL, V106, P1324, DOI 10.1016/j.fertnstert.2016.08.046; Huang J, 2016, FERTIL STERIL, V105, P1532, DOI 10.1016/j.fertnstert.2016.01.040; Johnson DS, 2010, MOL HUM REPROD, V16, P944, DOI 10.1093/molehr/gaq062; Kuznyetsov V, 2016 2 M CONTR PREC; Lane M, 2017, FERTIL STERIL, V108, pE61, DOI 10.1016/j.fertnstert.2017.07.192; Liu JQ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103192; Liu WQ, 2017, ANN MED, V49, P319, DOI 10.1080/07853890.2016.1254816; Madjunkova S, 2016 66 ANN M AM SOC; Magli MC, 2016, FERTIL STERIL, V105, P676, DOI 10.1016/j.fertnstert.2015.11.018; Maxwell SM, 2016, FERTIL STERIL, V106, P1414, DOI 10.1016/j.fertnstert.2016.08.017; Munne S, 2016, FERTIL STERIL, V105, P1146, DOI 10.1016/j.fertnstert.2016.01.016; Orvieto R, 2016, GYNECOL ENDOCRINOL, V32, P506, DOI 10.3109/09513590.2016.1142962; Palini S, 2013, REPROD BIOMED ONLINE, V26, P603, DOI 10.1016/j.rbmo.2013.02.012; Scott Jr RT, 2016, FERTIL STERIL, V32, P337; Scott RT, 2013, FERTIL STERIL, V100, P697, DOI 10.1016/j.fertnstert.2013.04.035; Scott RT, 2013, FERTIL STERIL, V100, P624, DOI 10.1016/j.fertnstert.2013.04.039; Shamonki MI, 2016, FERTIL STERIL, V106, P1312, DOI 10.1016/j.fertnstert.2016.07.1112; Taglauer ES, 2014, PLACENTA, V35, pS64, DOI 10.1016/j.placenta.2013.11.014; Tobler KJ, 2015, FERTIL STERIL, V104, P418, DOI 10.1016/j.fertnstert.2015.04.028; Vera-Rodriguez M, 2018, HUM REPROD, V33, P745, DOI 10.1093/humrep/dey028; Vermeesch JR, 2016, NAT REV GENET, V17, P643, DOI 10.1038/nrg.2016.97; Viaggi CD, 2013, J APPL GENET, V54, P353, DOI 10.1007/s13353-013-0157-x; Wells D, 2014, J MED GENET, V51, P553, DOI 10.1136/jmedgenet-2014-102497; Werner MD, 2016, FERTIL STERIL, V105, P1215, DOI 10.1016/j.fertnstert.2016.01.005; Wu HT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000669; Xu JJ, 2016, P NATL ACAD SCI USA, V113, P11907, DOI 10.1073/pnas.1613294113; Xu XP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146997; Zhang SP, 2016, FERTIL STERIL, V105, P1222, DOI 10.1016/j.fertnstert.2016.01.011; Zhang YX, 2016, J ASSIST REPROD GEN, V33, P637, DOI 10.1007/s10815-016-0667-7	39	57	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0197262	10.1371/journal.pone.0197262	http://dx.doi.org/10.1371/journal.pone.0197262			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746572	gold, Green Published, Green Submitted			2022-12-26	WOS:000431851700093
J	Kurian, SM; Di Pietro, A; Read, ND				Kurian, Smija M.; Di Pietro, Antonio; Read, Nick D.			Live-cell imaging of conidial anastomosis tube fusion during colony initiation in Fusarium oxysporum	PLOS ONE			English	Article							HYPHAL FUSION; SPORE GERMINATION; NUCLEAR-DYNAMICS; HORIZONTAL GENE; FUNGUS; WILT; PATHOGEN; PH; ADHESION; IDENTIFICATION	Fusarium oxysporum exhibits conidial anastomosis tube (CAT) fusion during colony initiation to form networks of conidial germlings. Here we determined the optimal culture conditions for this fungus to undergo CAT fusion between microconidia in liquid medium. Extensive high resolution, confocal live-cell imaging was performed to characterise the different stages of CAT fusion, using genetically encoded fluorescent labelling and vital fluorescent organelle stains. CAT homing and fusion were found to be dependent on adhesion to the surface, in contrast to germ tube development which occurs in the absence of adhesion. Staining with fluorescently labelled concanavalin A indicated that the cell wall composition of CATs differs from that of microconidia and germ tubes. The movement of nuclei, mitochondria, vacuoles and lipid droplets through fused germlings was observed by live-cell imaging.	[Kurian, Smija M.; Read, Nick D.] Univ Manchester, Inst Inflammat & Repair, Manchester Fungal Infect Grp, Manchester, Lancs, England; [Di Pietro, Antonio] Univ Cordoba, Dept Genet, Campus Rabanales C5, Cordoba, Spain	University of Manchester; Universidad de Cordoba	Read, ND (corresponding author), Univ Manchester, Inst Inflammat & Repair, Manchester Fungal Infect Grp, Manchester, Lancs, England.	nick.read@manchester.ac.uk	Di Pietro, Antonio/K-9220-2014	Di Pietro, Antonio/0000-0001-5930-5763; Read, Nick/0000-0002-2286-2862	European Union [PITN-GA-2013-607963]; FUNGIBRAIN [FP7-PEOPLE-ITN-607963]	European Union(European Commission); FUNGIBRAIN	This work was supported by European Union grants PITN-GA-2013-607963 to N.D. Read and FUNGIBRAIN (FP7-PEOPLE-ITN-607963) to A. Di Pietro.	ALLEN PJ, 1965, ANNU REV PHYTOPATHOL, V3, P313, DOI 10.1146/annurev.py.03.090165.001525; Apoga D, 2001, MYCOL RES, V105, P1251, DOI 10.1016/S0953-7562(08)61997-8; Boutati EI, 1997, BLOOD, V90, P999, DOI 10.1182/blood.V90.3.999.999_999_1008; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Caracuel Z, 2003, MOL MICROBIOL, V48, P765, DOI 10.1046/j.1365-2958.2003.03465.x; Caracuel Z, 2003, EUKARYOT CELL, V2, P1246, DOI 10.1128/EC.2.6.1246-1252.2003; Ruiz-Roldan MC, 2010, EUKARYOT CELL, V9, P1216, DOI 10.1128/EC.00040-10; COOK RJ, 1976, PHYTOPATHOLOGY, V66, P193, DOI 10.1094/Phyto-66-193; Czymmek KJ, 2007, FUNGAL GENET BIOL, V44, P1011, DOI 10.1016/j.fgb.2007.01.012; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dementhon K, 2006, EUKARYOT CELL, V5, P2161, DOI 10.1128/EC.00253-06; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Fischer-Harman V, 2012, FUNGAL GENET BIOL, V49, P896, DOI 10.1016/j.fgb.2012.08.004; Fleissner A, 2016, SEMIN CELL DEV BIOL, V57, P76, DOI 10.1016/j.semcdb.2016.03.016; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; GARRETT MK, 1969, ARCH MIKROBIOL, V67, P370, DOI 10.1007/BF00412583; Glass NL, 2006, CURR OPIN MICROBIOL, V9, P553, DOI 10.1016/j.mib.2006.09.001; Glass NL, 2000, ANNU REV GENET, V34, P165, DOI 10.1146/annurev.genet.34.1.165; Gupta Vijai Kumar, 2010, Journal of Plant Protection Research, V50, P452, DOI 10.2478/v10045-010-0076-3; Harris SD, 2005, MYCOLOGIA, V97, P880, DOI 10.3852/mycologia.97.4.880; He CZ, 1998, GENETICS, V150, P1459; Hickey PC, 2005, METHOD MICROBIOL, V34, P63, DOI 10.1016/S0580-8517(04)3403-1; Ishikawa FH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031175; Ishikawa FH, 2010, FUNGAL BIOL-UK, V114, P2, DOI 10.1016/j.funbio.2009.11.006; Joshi M., 2013, J APPL NAT SCI, V5, P108, DOI 10.31018/jans.v5i1.290; Kistler H, 2013, FUSARIUM GENOMICS MO; Kistler HC, 1997, PHYTOPATHOLOGY, V87, P474, DOI 10.1094/PHYTO.1997.87.4.474; Kuo KC, 1996, FUNGAL GENET BIOL, V20, P18, DOI 10.1006/fgbi.1996.0005; KWON YH, 1993, MOL PLANT MICROBE IN, V6, P481, DOI 10.1094/MPMI-6-481; Landa BB, 2001, PHYTOPATHOLOGY, V91, P807, DOI 10.1094/PHYTO.2001.91.8.807; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Leeder AC, 2011, NAT REV MICROBIOL, V9, P440, DOI 10.1038/nrmicro2580; Lichius A, 2014, OPEN MYCOL J, V8, P28, DOI DOI 10.2174/1874437001408010028; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Meadows BRA, 2012, THESIS; Mehrabi R, 2011, FEMS MICROBIOL REV, V35, P542, DOI 10.1111/j.1574-6976.2010.00263.x; MESTERHA.A, 1973, MYCOLOGIA, V65, P916, DOI 10.2307/3758525; Michielse CB, 2009, MOL PLANT PATHOL, V10, P311, DOI [10.1111/J.1364-3703.2009.00538.X, 10.1111/j.1364-3703.2009.00538.x]; MOLNAR A, 1990, MYCOL RES, V94, P393, DOI 10.1016/S0953-7562(09)80364-X; Osherov N, 2010, CELLULAR MOL BIOL FI; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Peng HX, 1999, SOIL BIOL BIOCHEM, V31, P1363, DOI 10.1016/S0038-0717(99)00045-0; PONTECORVO G, 1956, ANNU REV MICROBIOL, V10, P393, DOI 10.1146/annurev.mi.10.100156.002141; Popovski S., 2013, Acta Agriculturae Slovenica, V101, P105, DOI 10.2478/acas-2013-0012; Rosales RCP, 2008, EUKARYOT CELL, V7, P162, DOI 10.1128/EC.00258-07; Rasconi S, 2009, APPL ENVIRON MICROB, V75, P2545, DOI 10.1128/AEM.02211-08; Read Nick D., 2012, Fungal Biology Reviews, V26, P1, DOI 10.1016/j.fbr.2012.02.003; Read ND, 2009, CURR OPIN MICROBIOL, V12, P608, DOI 10.1016/j.mib.2009.09.008; Rep M, 2010, CURR OPIN PLANT BIOL, V13, P420, DOI 10.1016/j.pbi.2010.04.004; Roca MG, 2010, EUKARYOT CELL, V9, P1171, DOI 10.1128/EC.00329-09; Roca MG, 2005, FEMS MICROBIOL LETT, V249, P191, DOI 10.1016/j.femsle.2005.06.048; Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005; Roca MG, 2003, FUNGAL GENET BIOL, V40, P138, DOI 10.1016/S1087-1845(03)00088-4; Schafer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089920; Schoffelmeer EAM, 1999, FUNGAL GENET BIOL, V27, P275, DOI 10.1006/fgbi.1999.1153; Shahi S, 2016, FUNGAL GENET BIOL, V95, P49, DOI 10.1016/j.fgb.2016.08.005; Shahi S, 2016, FUNGAL GENET BIOL, V91, P20, DOI 10.1016/j.fgb.2016.03.003; Soanes D, 2014, ANNU REV PHYTOPATHOL, V52, P583, DOI 10.1146/annurev-phyto-102313-050127; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tucker SL, 2001, ANNU REV PHYTOPATHOL, V39, P385, DOI 10.1146/annurev.phyto.39.1.385; Ugalde U, 2014, APPL MICROBIOL BIOT, V98, P8809, DOI 10.1007/s00253-014-6019-6; Vlaardingerbroek I, 2016, ENVIRON MICROBIOL, V18, P3702, DOI 10.1111/1462-2920.13281; Weichert M, 2015, FUNG BIOL-US, P3, DOI 10.1007/978-3-319-10503-1_1; WHEELER KA, 1991, INT J FOOD MICROBIOL, V12, P141, DOI 10.1016/0168-1605(91)90063-U; Woltz SS, 1971, FLORIDA AGR EXPT STA, V4126, P132; WOSTEN HAB, 1994, EMBO J, V13, P5848, DOI 10.1002/j.1460-2075.1994.tb06929.x	66	14	14	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2018	13	5							e0195634	10.1371/journal.pone.0195634	http://dx.doi.org/10.1371/journal.pone.0195634			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE8KX	29734342	Green Published, gold, Green Submitted			2022-12-26	WOS:000431481700003
J	Hussain-Alkhateeb, L; Kroeger, A; Olliaro, P; Rocklov, J; Sewe, MO; Tejeda, G; Benitez, D; Gill, B; Hakim, SL; Carvalho, RG; Bowman, L; Petzold, M				Hussain-Alkhateeb, Laith; Kroeger, Axel; Olliaro, Piero; Rockloev, Joacim; Sewe, Maquins Odhiambo; Tejeda, Gustavo; Benitez, David; Gill, Balvinder; Hakim, S. Lokman; Carvalho, Roberta Gomes; Bowman, Leigh; Petzold, Max			Early warning and response system (EWARS) for dengue outbreaks: Recent advancements towards widespread applications in critical settings	PLOS ONE			English	Article							MALARIA EPIDEMICS; SURVEILLANCE	Background Dengue outbreaks are increasing in frequency over space and time, affecting people's health and burdening resource-constrained health systems. The ability to detect early emerging outbreaks is key to mounting an effective response. The early warning and response system (EWARS) is a toolkit that provides countries with early-warning systems for efficient and cost-effective local responses. EWARS uses outbreak and alarm indicators to derive prediction models that can be used prospectively to predict a forthcoming dengue outbreak at district level. Methods We report on the development of the EWARS tool, based on users' recommendations into a convenient, user-friendly and reliable software aided by a user's workbook and its field testing in 30 health districts in Brazil, Malaysia and Mexico. Findings 34 Health officers from the 30 study districts who had used the original EWARS for 7 to 10 months responded to a questionnaire with mainly open-ended questions. Qualitative content analysis showed that participants were generally satisfied with the tool but preferred open-access vs. commercial software. EWARS users also stated that the geographical unit should be the district, while access to meteorological information should be improved. These recommendations were incorporated into the second-generation EWARS-R, using the free R software, combined with recent surveillance data and resulted in higher sensitivities and positive predictive values of alarm signals compared to the first-generation EWARS. Currently the use of satellite data for meteorological information is being tested and a dashboard is being developed to increase user-friendliness of the tool. The inclusion of other Aedes borne viral diseases is under discussion. Conclusion EWARS is a pragmatic and useful tool for detecting imminent dengue outbreaks to trigger early response activities.	[Hussain-Alkhateeb, Laith] Univ Gothenburg, Sahlgrenska Acad, Occupat & Environm Med, Gothenburg, Sweden; [Kroeger, Axel; Olliaro, Piero; Benitez, David] WHO, Special Programme Res & Training Trop Dis TDR, Geneva, Switzerland; [Kroeger, Axel] Uniklinikum Freiburg, Ctr Med & Soc Anthropol, Freiburg, Germany; [Rockloev, Joacim; Sewe, Maquins Odhiambo] Umea Univ, Dept Publ Hlth & Clin Med Epidemiol & Global Hlth, Umea, Sweden; [Rockloev, Joacim] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Tejeda, Gustavo] Minist Hlth, Mexico City, DF, Mexico; [Gill, Balvinder] Minist Hlth, Dis Control Div, Informat & Documentat Surveillance Sect, Putrajaya, Malaysia; [Hakim, S. Lokman] Minist Hlth, Publ Hlth, Off Deputy Director Gen Hlth, Level 12,Block E7,Fed Govt Adm Complex, Putrajaya, Malaysia; [Hakim, S. Lokman] Int Med Univ, Sch Med, Kuala Lumpur, Malaysia; [Carvalho, Roberta Gomes] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil; [Bowman, Leigh] Umea Univ, Umea Ctr Global Hlth Res, Umea, Sweden; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Hlth Metr Unit, Gothenburg, Sweden	University of Gothenburg; World Health Organization; University of Freiburg; Umea University; Ruprecht Karls University Heidelberg; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; International Medical University Malaysia; Umea University; University of Gothenburg	Hussain-Alkhateeb, L (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Occupat & Environm Med, Gothenburg, Sweden.	laith.hussain@gu.se	Bowman, Leigh/H-6880-2019; Hussain-Alkhateeb, Laith/P-4958-2019; Hussain-Alkhateeb, Laith/K-3485-2013	Bowman, Leigh/0000-0003-0657-7911; Hussain-Alkhateeb, Laith/0000-0001-9607-110X; Rocklov, Joacim/0000-0003-4030-0449; sewe, maquins/0000-0003-1267-649X	European Commission [m281803]; Special Programme for Research and Training in Tropical Diseases (TDR-WHO); Special Programme for Tropical Disease Research and Training (TDR-WHO)	European Commission(European CommissionEuropean Commission Joint Research Centre); Special Programme for Research and Training in Tropical Diseases (TDR-WHO)(World Health Organization); Special Programme for Tropical Disease Research and Training (TDR-WHO)	This work was supported by a grant from the European Commission (grant number m281803) to the IDAMS network (www.idams.eu) within the 7th Framework Programme and by the Special Programme for Research and Training in Tropical Diseases (TDR-WHO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the country teams in Brazil, Malaysia, and Mexico as well as in the Dominican Republic and Vietnam for their continuous collaboration and feedback of experiences. Likewise the national programme managers in the study countries played an important role in facilitating the implementation of the new tools. The Special Programme for Tropical Disease Research and Training (TDR-WHO) was instrumental in supporting the project financially and organizationally supported by the NTD Department in Geneva and the WHO Regional Offices (PAHO, WPRO and SEARO). Special thanks to Beat Schwegler and his team at Microsoft Company, Zurich, Switzerland for advising on the further development of the EWARS tool.	[Anonymous], 2016, Wkly Epidemiol Rec, V91, P349; Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106; Badurdeen S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-607; Bowman LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157971; Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551; Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848; Campbell KM, 2013, AM J TROP MED HYG, V89, P1066, DOI 10.4269/ajtmh.13-0321; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Duclos A, 2009, BRIT J SURG, V96, P171, DOI 10.1002/bjs.6418; El Centro Nacional de Programas Preventivos y Control de Enfermedades (CENAPRECE), 2017, GUIA MET VIG ENT CON; Gagnon AS, 2002, INT J BIOMETEOROL, V46, P81, DOI 10.1007/s00484-001-0119-6; Hay SI, 2002, EMERG INFECT DIS, V8, P555, DOI 10.3201/eid0806.010310; Kroeger AMP, 2014, WHO TDR M WHO TDR LI; Lowe R, 2017, LANCET PLANET HEALTH, V1, pE142, DOI 10.1016/S2542-5196(17)30064-5; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Olliaro P, 2017, PLOS NTD IN PRESS; Organization WH, 2017, OP GUID EARL WARN RE; Reiner RC, 2012, P NATL ACAD SCI USA, V109, P2033, DOI 10.1073/pnas.1108438109; Rigau-Perez JG, 1999, AM J PUBLIC HEALTH, V89, P374, DOI 10.2105/AJPH.89.3.374; Runge-Ranzinger S, 2014, TROP MED INT HEALTH, V19, P1116, DOI 10.1111/tmi.12333; Runge-Ranzinger S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004916; Shewhart WA., 1931, EC CONTROL QUALITY M; Vega T, 2013, INFLUENZA OTHER RESP, V7, P546, DOI 10.1111/j.1750-2659.2012.00422.x	23	25	26	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2018	13	5							e0196811	10.1371/journal.pone.0196811	http://dx.doi.org/10.1371/journal.pone.0196811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE7ZR	29727447	Green Published, gold, Green Submitted			2022-12-26	WOS:000431452100011
J	Kameyama, A; Dissanayake, SK; Tin, WWT				Kameyama, Akihiko; Dissanayake, Santha Kumara; Tin, Wai Wai Thet			Rapid chemical de-N-glycosylation and derivatization for liquid chromatography of immunoglobulin N-linked glycans	PLOS ONE			English	Article							MASS-SPECTROMETRY; CAPILLARY-ELECTROPHORESIS; REDUCTIVE AMINATION; GLYCOSIDASE F; HIGH-MANNOSE; OLIGOSACCHARIDES; GLYCOPROTEINS; ANTIBODIES; RELEASE; DEGLYCOSYLATION	Glycan analysis may result in exploitation of glycan biomarkers and evaluation of heterogeneity of glycosylation of biopharmaceuticals. For N-linked glycan analysis, we investigated alkaline hydrolysis of the asparagine glycosyl carboxamide of glycoproteins as a deglycosylation reaction. By adding hydroxylamine into alkaline de-N-glycosylation, we suppressed the degradation of released glycans and obtained a mixture of oximes, free glycans, and glycosylamines. The reaction was completed within 1 h, and the mixture containing oximes was easily tagged with 2-aminobenzamide by reductive amination. Here, we demonstrated N-linked glycan analysis using this method for a monoclonal antibody, and examined whether this method could liberate glycans without degradation from apo-transferrin containing NeuAc and NeuGc and horseradish peroxidase containing Fuc alpha 1-3 GIcNAc at the reducing end. Furthermore, we compared glycan recoveries between conventional enzymatic glycan release and this method. Increasing the reaction temperature and reaction duration led to degradation, whereas decreasing these parameters resulted in lower release. Considering this balance, we proposed to carry out the reaction at 80 degrees C for 1 h for asialo glycoproteins from mammals and at 50 degrees C for 1 h for sialoglycoproteins.	[Kameyama, Akihiko; Dissanayake, Santha Kumara; Tin, Wai Wai Thet] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Kameyama, A (corresponding author), Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki, Japan.	aki-kameyama@aist.go.jp	Kameyama, Akihiko/A-9641-2008	Kameyama, Akihiko/0000-0002-8229-4449	Ministry of Economy, Trade and Industry of Japan (METI); Japan Agency for Medical Research and Development (AMED) [17ae0101003h0005]	Ministry of Economy, Trade and Industry of Japan (METI); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was funded by the Ministry of Economy, Trade and Industry of Japan (METI: http://www.meti.go.jp/english/index.html) and Japan Agency for Medical Research and Development (AMED: https://www.arned.go.jp/en/index.html) under grant number 17ae0101003h0005. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A, 2005, J CHROMATOGR B, V819, P203, DOI 10.1016/j.jchromb.2004.06.052; Ciucanu I, 2003, J AM CHEM SOC, V125, P16213, DOI 10.1021/ja035660t; Dirksen A, 2006, J AM CHEM SOC, V128, P15602, DOI 10.1021/ja067189k; Dong WJ, 2013, ELECTROPHORESIS, V34, P2432, DOI 10.1002/elps.201300154; Du YM, 2015, J AGR FOOD CHEM, V63, P10550, DOI 10.1021/acs.jafc.5b03633; EVANGELISTA RA, 1995, ANAL CHEM, V67, P2239, DOI 10.1021/ac00109a051; Fang JJ, 2015, J CHROMATOGR A, V1414, P122, DOI 10.1016/j.chroma.2015.08.038; Ghaderi D, 2010, NAT BIOTECHNOL, V28, P863, DOI 10.1038/nbt.1651; HASE S, 1979, J BIOCHEM-TOKYO, V85, P989, DOI 10.1093/oxfordjournals.jbchem.a132431; Huang YP, 2001, ANAL CHEM, V73, P6063, DOI 10.1021/ac015534c; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Kanda Y, 2007, GLYCOBIOLOGY, V17, P104, DOI 10.1093/glycob/cwl057; Krenkova J, 2013, J CHROMATOGR A, V1322, P54, DOI 10.1016/j.chroma.2013.10.087; Krenkova J, 2009, J CHROMATOGR A, V1216, P3252, DOI 10.1016/j.chroma.2009.02.036; Liu YD, 2016, BIOLOGICALS, V44, P163, DOI 10.1016/j.biologicals.2016.02.003; Nakakita SI, 2007, BIOCHEM BIOPH RES CO, V362, P639, DOI 10.1016/j.bbrc.2007.08.032; NOGUCHI S, 1992, EUR J BIOCHEM, V209, P883, DOI 10.1111/j.1432-1033.1992.tb17361.x; Ruhaak LR, 2010, PROTEOMICS, V10, P2330, DOI 10.1002/pmic.200900804; Sandoval WN, 2007, INT J MASS SPECTROM, V259, P117, DOI 10.1016/j.ijms.2006.09.003; Sato S, 2004, TETRAHEDRON, V60, P7899, DOI 10.1016/j.tet.2004.06.045; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Schwarzinger C, 2003, J ANAL APPL PYROL, V68-9, P137, DOI 10.1016/S0165-2370(03)00035-4; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Szabo Z, 2010, ANAL CHEM, V82, P2588, DOI 10.1021/ac100098e; Toyoda M, 2008, ANAL CHEM, V80, P5211, DOI 10.1021/ac800457a; Triguero A, 2010, ANAL BIOCHEM, V400, P173, DOI 10.1016/j.ab.2010.01.027; Wang T, 2014, BIOSCIENCE REP, V34, P673, DOI 10.1042/BSR20140148; WING DR, 1992, GLYCOCONJUGATE J, V9, P293, DOI 10.1007/BF00731089; Yang BY, 1996, CARBOHYD RES, V287, P203, DOI 10.1016/0008-6215(96)00073-0	29	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196800	10.1371/journal.pone.0196800	http://dx.doi.org/10.1371/journal.pone.0196800			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723274	Green Submitted, Green Published, gold			2022-12-26	WOS:000431305100065
J	Puertas, RD; Jalabert, A; Meugnier, E; Euthine, V; Chevalier, P; Rome, S				Puertas, Rosa Donate; Jalabert, Audrey; Meugnier, Emmanuelle; Euthine, Vanessa; Chevalier, Philippe; Rome, Sophie			Analysis of the microRNA signature in left atrium from patients with valvular heart disease reveals their implications in atrial fibrillation	PLOS ONE			English	Article							OXIDATIVE STRESS; EXPRESSION PROFILES; DNA METHYLATION; MIRNAS; HYPERMETHYLATION; IDENTIFICATION; CONTRIBUTES; ACTIVATION; MUTATIONS; PROMOTES	Background Among the potential factors which may contribute to the development and perpetuation of atrial fibrillation, dysregulation of miRNAs has been suggested. Thus in this study, we have quantified the basal expressions of 662 mature human miRNAs in left atrium (LA) from patients undergoing cardiac surgery for valve repair, suffering or not from atrial fibrillation (AF) by using TaqMan (R) Low Density arrays (v2.0). Results Among the 299 miRNAs expressed in all patients, 42 miRNAs had altered basal expressions in patients with AF. Binding-site predictions with Targetscan (conserved sites among species) indicated that the up- and down-regulated miRNAs controlled respectively 3,310 and 5,868 genes. To identify the most relevant cellular functions under the control of the altered miRNAs, we focused on the 100 most targeted genes of each list and identified 5 functional protein-protein networks among these genes. Up-regulated networks were involved in synchronisation of circadian rythmicity and in the control of the AKT/PKC signaling pathway (i.e., proliferation/adhesion). Down-regulated networks were the IGF-1 pathway and TGF-beta signaling pathway and a network involved in RNA-mediated gene silencing, suggesting for the first time that alteration of miRNAs in AF would also perturbate the whole miRNA machinery. Then we crossed the list of miRNA predicted genes, and the list of mRNAs altered in similar patients suffering from AF and we found that respectively 44.5% and 55% of the up- and down-regulated mRNA are predicted to be conserved targets of the altered miRNAs (at least one binding site in 3'-UTR). As they were involved in the same biological processes mentioned above, these data demonstrated that a great part of the transcriptional defects previously published in LA from AF patients are likely due to defects at the post-transcriptional level and involved the miRNAs. Conclusions Our stringent analysis permitted us to identify highly targeted protein-protein networks under the control of miRNAs in LA and, among them, to highlight those specifically affected in AF patients with altered miRNA signature. Further studies are now required to determine whether alterations of miRNA levels in AF pathology are causal or represent an adaptation to prevent cardiac electrical and structural remodeling.	[Puertas, Rosa Donate; Chevalier, Philippe] Univ Lyon, Inst NeuroMyoGene INMG, UMR CNRS 5310, INSERM U1217, Lyon, France; [Jalabert, Audrey; Meugnier, Emmanuelle; Euthine, Vanessa; Rome, Sophie] Univ Lyon, Lyon Sud Fac Med, CarMeN Lab, UMR INSERM 1060,INRA 1397,INSA, Pierre Benite, France; [Chevalier, Philippe] Hosp Civils Lyon, Louis Pradel Cardiol Hosp, Rhythmol Unit, Bron, France	Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Chevalier, P (corresponding author), Univ Lyon, Inst NeuroMyoGene INMG, UMR CNRS 5310, INSERM U1217, Lyon, France.; Rome, S (corresponding author), Univ Lyon, Lyon Sud Fac Med, CarMeN Lab, UMR INSERM 1060,INRA 1397,INSA, Pierre Benite, France.; Chevalier, P (corresponding author), Hosp Civils Lyon, Louis Pradel Cardiol Hosp, Rhythmol Unit, Bron, France.	philippe.chevalier@chu-lyon.fr; srome@univ-lyon1.fr	Doñate Puertas, Rosa/ABC-1447-2021; Carmen, Team1/Y-7382-2019	Doñate Puertas, Rosa/0000-0002-9230-6765; Carmen, Team1/0000-0003-4234-1746; Lab, Carmen/0000-0002-5935-3236; ROME, SOPHIE/0000-0003-3986-5936; meugnier, emmanuelle/0000-0002-2291-7691	Fondation pour la Recherche Medicale grant [DRM20101220456]	Fondation pour la Recherche Medicale grant(Fondation pour la Recherche Medicale)	This work was supported by Fondation pour la Recherche Medicale grant number DRM20101220456 (awarded to SR); https://wwwfrn.org/chercheurs/accueil. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Akerman AW, 2013, HEART RHYTHM, V10, P1010, DOI 10.1016/j.hrthm.2013.03.021; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Bocchi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017750; Caglayan AO, 2010, INTERACT CARDIOV TH, V11, P779, DOI 10.1510/icvts.2010.245910; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castoldi G, 2012, J CELL PHYSIOL, V227, P850, DOI 10.1002/jcp.22939; Christophersen IE, 2016, J HUM GENET, V61, P61, DOI 10.1038/jhg.2015.44; Cooley N, 2012, PHYSIOL GENOMICS, V44, P211, DOI 10.1152/physiolgenomics.00111.2011; Cui HW, 2016, FAM CANCER, V15, P317, DOI 10.1007/s10689-015-9846-4; Dawson K, 2013, CIRCULATION, V127, P1466, DOI 10.1161/CIRCULATIONAHA.112.001207; Diehl F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009748; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Puertas RD, 2017, TRANSL RES, V184, P57, DOI 10.1016/j.trsl.2017.03.004; Duron E, 2014, J GERONTOL A-BIOL, V69, P1025, DOI 10.1093/gerona/glt206; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Guazzi M, 2009, HEART, V95, P102, DOI 10.1136/hrt.2007.135277; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gutierrez A, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0735-8; Harada M, 2012, CIRCULATION, V126, P2051, DOI 10.1161/CIRCULATIONAHA.112.121830; He XX, 2015, MOL BIOSYST, V11, P532, DOI 10.1039/c4mb00563e; Higashi Y, 2010, TRENDS ENDOCRIN MET, V21, P245, DOI 10.1016/j.tem.2009.12.005; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hu YF, 2015, NAT REV CARDIOL, V12, P230, DOI 10.1038/nrcardio.2015.2; Husse B, 2005, BIOCHEM BIOPH RES CO, V334, P1260, DOI 10.1016/j.bbrc.2005.06.206; Ivanovska I, 2008, CELL CYCLE, V7, P3137, DOI 10.4161/cc.7.20.6923; Iwakawa HO, 2015, TRENDS CELL BIOL, V25, P651, DOI 10.1016/j.tcb.2015.07.011; Kakkar AK, 2012, AM HEART J, V163, P13, DOI 10.1016/j.ahj.2011.09.011; Kao YH, 2013, CLIN EXP PHARMACOL P, V40, P379, DOI 10.1111/1440-1681.12089; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Kim NH, 2005, INT HEART J, V46, P383, DOI 10.1536/ihj.46.383; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuehn H., 2008, CURR PROTOC BIOINFOR, DOI [DOI 10.1002/0471250953.BI0712S22, 10.1002/0471250953.bi0712s22]; Lao Kaiqin, 2007, Biotechnology Journal, V2, P33, DOI 10.1002/biot.200600119; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HL, 2012, MOL MED REP, V5, P1457, DOI 10.3892/mmr.2012.831; Lin HH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40377; Ling TY, 2013, HEART RHYTHM, V10, P1001, DOI 10.1016/j.hrthm.2013.03.005; Liu H, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-90; Liu H, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-10; Liu ZD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050367; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lozano-Velasco E, 2015, MOL CELL BIOL, V35, P2892, DOI 10.1128/MCB.00536-15; Lu L, 2007, CANCER RES, V67, P10117, DOI 10.1158/0008-5472.CAN-07-2544; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Luo XB, 2013, J CLIN INVEST, V123, P1939, DOI 10.1172/JCI62185; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Nattel S, 2014, J AM COLL CARDIOL, V63, P2335, DOI 10.1016/j.jacc.2014.02.555; Orenes-Pinero E, 2015, ARCH CARDIOL MEX, V85, P225, DOI 10.1016/j.acmx.2015.01.005; Orenes-Pinero E, 2013, INT J CARDIOL, V167, P1651, DOI 10.1016/j.ijcard.2012.09.120; Perez-Serra A, 2017, CURR OPIN CARDIOL; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Poudel P, 2015, CARDIOLOGY, V131, P58, DOI 10.1159/000375403; Pregi N, 2017, MOL CELL BIOCHEM, V425, P9, DOI 10.1007/s11010-016-2858-z; Reamon-Buettner SM, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040907; Reamon-Buettner SM, 2004, J MED GENET, V41, P684, DOI 10.1136/jmg.2003.017483; Reamon-Buettner SM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-38; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Sago N, 2004, BIOCHEM BIOPH RES CO, V319, P50, DOI 10.1016/j.bbrc.2004.04.151; Sajjad A, 2014, BBA-MOL CELL RES, V1843, P2556, DOI 10.1016/j.bbamcr.2014.06.019; Sandesara PB, 2017, HEART RHYTHM; Schaaf M, 2017, EUR HEART J-CARD IMG, V18, P46, DOI 10.1093/ehjci/jew028; Shan HL, 2009, CARDIOVASC RES, V83, P465, DOI 10.1093/cvr/cvp130; Sharma D, 2011, CARDIOLOGY, V120, P111, DOI 10.1159/000334434; Sheward WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009783; Shi KH, 2013, CELL SIGNAL, V25, P2079, DOI 10.1016/j.cellsig.2013.06.009; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takeda N, 2011, J CARDIOL, V57, P249, DOI 10.1016/j.jjcc.2011.02.006; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Viskin S, 1999, EUR HEART J, V20, P1429, DOI 10.1053/euhj.1999.1632; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wakili R, 2012, HERZ, V37, P166, DOI 10.1007/s00059-012-3594-0; Wang F, 2017, ONCOL LETT, V13, P1048, DOI 10.3892/ol.2017.5593; Wang JG, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0085-2; Wang T, 2016, MOL MED REP, V13, P4535, DOI 10.3892/mmr.2016.5106; Wang ZG, 2011, CARDIOVASC RES, V89, P710, DOI 10.1093/cvr/cvq350; Xiao JJ, 2011, PHYSIOL GENOMICS, V43, P655, DOI 10.1152/physiolgenomics.00139.2010; Xu GJ, 2013, CHINESE MED J-PEKING, V126, P1458, DOI 10.3760/cma.j.issn.0366-6999.20121233; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Zhang DL, 2014, CIRCULATION, V129, P346, DOI 10.1161/CIRCULATIONAHA.113.005300	87	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196666	10.1371/journal.pone.0196666	http://dx.doi.org/10.1371/journal.pone.0196666			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723239	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100049
J	Troder, SE; Ebert, LK; Butt, L; Assenmacher, S; Schermer, B; Zevnik, B				Troeder, Simon E.; Ebert, Lena K.; Butt, Linus; Assenmacher, Sonja; Schermer, Bernhard; Zevnik, Branko			An optimized electroporation approach for efficient CRISPR/Cas9 genome editing in murine zygotes	PLOS ONE			English	Article							ONE-STEP GENERATION; MOUSE ZYGOTES; ZONA-PELLUCIDA; MICE; DELIVERY; RIBONUCLEOPROTEINS; KNOCKOUT; PROTEIN; EMBRYOS; CAS9	Electroporation of zygotes represents a rapid alternative to the elaborate pronuclear injection procedure for CRISPR/Cas9-mediated genome editing in mice. However, current protocols for electroporation either require the investment in specialized electroporators or corrosive pre-treatment of zygotes which compromises embryo viability. Here, we describe an easily adaptable approach for the introduction of specific mutations in C57BL/6 mice by electroporation of intact zygotes using a common electroporator with synthetic CRISPR/ Cas9 components and minimal technical requirement. Direct comparison to conventional pronuclear injection demonstrates significantly reduced physical damage and thus improved embryo development with successful genome editing in up to 100% of living offspring. Hence, our novel approach for Easy Electroporation of Zygotes (EEZy) allows highly efficient generation of CRISPR/Cas9 transgenic mice while reducing the numbers of animals required.	[Troeder, Simon E.; Ebert, Lena K.; Butt, Linus; Assenmacher, Sonja; Schermer, Bernhard; Zevnik, Branko] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Troeder, Simon E.; Assenmacher, Sonja; Zevnik, Branko] Univ Cologne, Med Fac, In Vivo Res Facil, Cologne, Germany; [Ebert, Lena K.; Butt, Linus; Schermer, Bernhard] Univ Cologne, Dept Internal Med 2, Cologne, Germany; [Ebert, Lena K.; Butt, Linus; Schermer, Bernhard] Univ Cologne, CMMC, Cologne, Germany; [Schermer, Bernhard] Univ Cologne, Syst Biol Aging Cologne Sybacol, Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne	Zevnik, B (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.; Zevnik, B (corresponding author), Univ Cologne, Med Fac, In Vivo Res Facil, Cologne, Germany.	branko.zevnik@uk-koeln.de	Schermer, Bernhard/E-9972-2014; Zevnik, Branko/AAB-7853-2020; Tröder, Simon E/ABD-4367-2021	Schermer, Bernhard/0000-0002-5194-9000; Zevnik, Branko/0000-0001-7845-9522; Tröder, Simon E/0000-0003-1156-2976	Koln Fortune Program (F01) of the University of Cologne; German Research Foundation [SCHE1562/6]; German Federal Ministry of Research and Education (BMBF) [01GM1515]	Koln Fortune Program (F01) of the University of Cologne; German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Koln Fortune Program (F01) of the University of Cologne (www.uni-koeln.de) to B.Z., and the German Research Foundation (SCHE1562/6; www.dfg.de) and the German Federal Ministry of Research and Education (BMBF grant 01GM1515; NEOCYST consortium; www.bmbf.de) to B.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0653-x; Behringer R, 2014, COLD SPRING HARBOR, pxxii; BRONSON RA, 1970, J REPROD FERTIL, V22, P129, DOI 10.1530/jrf.0.0220129; Chen SH, 2016, J BIOL CHEM, V291, P20779, DOI 10.1074/jbc.M116.736223; Chu V, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0234-4; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Grabarek JB, 2002, GENESIS, V32, P269, DOI 10.1002/gene.10076; GRAHAM CF, 1970, NATURE, V226, P165, DOI 10.1038/226165a0; Hashimoto M, 2016, DEV BIOL, V418, P1, DOI 10.1016/j.ydbio.2016.07.017; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; Horii T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08496-8; Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaneko T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06382; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MODLINSKI JA, 1970, J EMBRYOL EXP MORPH, V23, P539; Peng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043748; Peterson KA, 2017, MAMM GENOME, V28, P283, DOI 10.1007/s00335-017-9681-z; Qin WN, 2015, GENETICS, V200, P423, DOI 10.1534/genetics.115.176594; Quadros RM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1220-4; Remy S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16328-y; Russell WMS., 1959, MED J AUSTRALIA; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Teixeira M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18826-5; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang WB, 2016, J GENET GENOMICS, V43, P319, DOI 10.1016/j.jgg.2016.02.004; Wefers B, 2017, METHODS, V121, P55, DOI 10.1016/j.ymeth.2017.02.008	28	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196891	10.1371/journal.pone.0196891	http://dx.doi.org/10.1371/journal.pone.0196891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723268	gold, Green Published, Green Submitted			2022-12-26	WOS:000431305100085
J	Bertran, MA; Martinez, NL; Wang, Y; Dunson, D; Sapiro, G; Ringach, D				Bertran, Martin A.; Martinez, Natalia L.; Wang, Ye; Dunson, David; Sapiro, Guillermo; Ringach, Dario			Active learning of cortical connectivity from two-photon imaging data	PLOS ONE			English	Article							SMALL-WORLD; MULTIMODEL INFERENCE; RECEPTIVE-FIELDS; MODEL SELECTION; STIMULUS; LOCOMOTION; INTEGRATION; RESOLUTION; DYNAMICS	Understanding how groups of neurons interact within a network is a fundamental question in system neuroscience. Instead of passively observing the ongoing activity of a network, we can typically perturb its activity, either by external sensory stimulation or directly via techniques such as two-photon optogenetics. A natural question is how to use such perturbations to identify the connectivity of the network efficiently. Here we introduce a method to infer sparse connectivity graphs from in-vivo, two-photon imaging of population activity in response to external stimuli. A novel aspect of the work is the introduction of a recommended distribution, incrementally learned from the data, to optimally refine the inferred network. Unlike existing system identification techniques, this "active learning" method automatically focuses its attention on key undiscovered areas of the network, instead of targeting global uncertainty indicators like parameter variance. We show how active learning leads to faster inference while, at the same time, provides confidence intervals for the network parameters. We present simulations on artificial small-world networks to validate the methods and apply the method to real data. Analysis of frequency of motifs recovered show that cortical networks are consistent with a small-world topology model.	[Bertran, Martin A.; Martinez, Natalia L.; Sapiro, Guillermo] Duke Univ, Elect & Comp Engn, Durham, NC 27708 USA; [Wang, Ye; Dunson, David] Duke Univ, Stat Sci Program, Durham, NC USA; [Sapiro, Guillermo] Duke Univ, BME CS & Math, Durham, NC USA; [Ringach, Dario] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Biomed Engn Program,Neurobiol & Psychol, Los Angeles, CA 90095 USA	Duke University; Duke University; Duke University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bertran, MA (corresponding author), Duke Univ, Elect & Comp Engn, Durham, NC 27708 USA.	martin.bertran@duke.edu			National Institute of Neurological Disorders and Stroke (BRAIN Initiative project title: BAYESIAN ESTIMATION OF NETWORK CONNECTIVITY AND MOTIFS) [R01EB022915]; National Eye Institute [R01EY01832]; National Geospatial-Intelligence Agency [HM04761610001]; Office of Naval Research [N000141210839]; Army Research Office [W911NF-16-1-0088]; National Science Foundation [1712867, 1737744]; NATIONAL EYE INSTITUTE [R01EY018322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB022915] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (BRAIN Initiative project title: BAYESIAN ESTIMATION OF NETWORK CONNECTIVITY AND MOTIFS); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Geospatial-Intelligence Agency; Office of Naval Research(Office of Naval Research); Army Research Office; National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Author DR received funding from the following sources: National Institute of Neurological Disorders and Stroke (BRAIN Initiative project title: BAYESIAN ESTIMATION OF NETWORK CONNECTIVITY AND MOTIFS, Grant number: R01EB022915, https://www.ninds.nih.gov/); National Eye Institute (Grant number: R01EY01832, https://nei.nih.gov/. Author GS received funding from the following sources: National Geospatial-Intelligence Agency (Grant number: HM04761610001, https://www.nga.mil/); Office of Naval Research (Grant number: N000141210839, https://www.onr.navy.mil/); Army Research Office (Grant number: W911NF-16-1-0088, http://www.arl.army.mil/); National Science Foundation (Grant numbers: 1712867, 1737744 https://www.nsf.gov/). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Ayaz A, 2013, CURR BIOL, V23, P890, DOI 10.1016/j.cub.2013.04.012; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Benda J, 2007, CURR OPIN NEUROBIOL, V17, P430, DOI 10.1016/j.conb.2007.07.009; Berens P, 2017, BIORXIV; Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Bolinger D, 2012, NEURON, V73, P333, DOI 10.1016/j.neuron.2011.10.039; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Candes E, 2007, ANN STAT, V35, P2313, DOI 10.1214/009053606000001523; Cho H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150611; Cramer H., 2016, MATH METHODS STAT PM, V9; DiMattina C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00101; DiMattina C, 2011, NEURAL COMPUT, V23, P2242, DOI 10.1162/NECO_a_00167; Edin F, 2004, J COMPUT NEUROSCI, V17, P47, DOI 10.1023/B:JCNS.0000023868.18446.a2; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kim S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001110; Koch C., 1998, METHODS NEURONAL MOD, DOI 10.1016/s0898-1221(98)91179-8; Kohavi J., 1994, P 11 INT C MACH LEAR, P121, DOI [DOI 10.1016/B978-1-55860-335-6.50023-4, 10.1016/B978-1-55860-335-6.50023-4]; Lee AM, 2014, NEURON, V83, P455, DOI 10.1016/j.neuron.2014.06.031; Lewi J., 2007, P ADV NEUR INF PROC, V20, P857; Lewi J, 2009, NEURAL COMPUT, V21, P619, DOI 10.1162/neco.2008.08-07-594; Lewi Jeremy, 2007, AISTATS, P267; MACKAY DJC, 1992, NEURAL COMPUT, V4, P590, DOI 10.1162/neco.1992.4.4.590; Malone BJ, 2008, J NEUROPHYSIOL, V100, P239, DOI 10.1152/jn.90273.2008; MCCULLAGH P, 1984, EUR J OPER RES, V16, P285, DOI 10.1016/0377-2217(84)90282-0; Miller AJ, 2002, SUBSET SELECTION REG, DOI DOI 10.1201/9781420035933; Mineault PJ, 2016, J NEUROSCI, V36, P6382, DOI 10.1523/JNEUROSCI.0430-16.2016; Mishchenko Y, 2011, ANN APPL STAT, V5, P1229, DOI 10.1214/09-AOAS303; Natale JL, 2017, ARXIV170506370; Nauhaus I, 2012, J NEUROPHYSIOL, V107, P923, DOI 10.1152/jn.00725.2011; Nelder J. A., 1972, GEN LINEAR MODELS; Nykamp DQ, 2009, J MATH BIOL, V59, P147, DOI 10.1007/s00285-008-0224-9; Packer AM, 2015, NAT METHODS, V12, P140, DOI 10.1038/nmeth.3217; Packer AM, 2012, NAT METHODS, V9, P1202, DOI [10.1038/NMETH.2249, 10.1038/nmeth.2249]; Paninski L., 2013, ADV NEURAL INF PROCE, V26, P2391; Paninski L, 2007, PROG BRAIN RES, V165, P493, DOI 10.1016/S0079-6123(06)65031-0; Park IM, 2014, NAT NEUROSCI, V17, P1395, DOI 10.1038/nn.3800; Park Mijung, 2012, ADV NEURAL INF PROCE, V25, P2; Pearl J, 2009, CAUSALITY, DOI 10.1017/CBO9780511803161; Pillow JW, 2016, ADAPTIVE BAYESIAN ME; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Ramkumar P, 2017, PYGLMNET; Rao CR, 1992, BREAKTHROUGHS STAT, P235, DOI DOI 10.1007/978-1-4612-0919-5; Ringach DL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12270; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; Saleem AB, 2013, NAT NEUROSCI, V16, P1864, DOI 10.1038/nn.3567; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Simon H. A., 1991, FACETS SYSTEMS SCI, P457; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stevenson IH, 2008, CURR OPIN NEUROBIOL, V18, P582, DOI 10.1016/j.conb.2008.11.005; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang J, 2015, COMMUN STAT-SIMUL C, V44, P2264, DOI 10.1080/03610918.2013.815773; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047	64	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196527	10.1371/journal.pone.0196527	http://dx.doi.org/10.1371/journal.pone.0196527			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718955	Green Submitted, gold, Green Published			2022-12-26	WOS:000431281900058
J	Fujita, N; Aono, S; Karasaki, K; Sera, F; Kurose, T; Fujino, H; Urakawa, S				Fujita, Naoto; Aono, Saki; Karasaki, Kohei; Sera, Fumi; Kurose, Tomoyuki; Fujino, Hidemi; Urakawa, Susumu			Changes in lipid metabolism and capillary density of the skeletal muscle following low-intensity exercise training in a rat model of obesity with hyperinsulinemia	PLOS ONE			English	Article							TOKUSHIMA-FATTY RATS; INSULIN-RESISTANCE; INTERVAL SPRINT; OLETF RATS; VOLUNTARY EXERCISE; GLUCOSE-METABOLISM; DIABETES-MELLITUS; HEPATIC STEATOSIS; GENE-EXPRESSION; RODENT MODEL	Although exercise is effective in improving obesity and hyperinsulinemia, the exact influence of exercise on the capillary density of skeletal muscles remains unknown. The aim of this study was to investigate the effects of low-intensity exercise training on metabolism in obesity with hyperinsulinemia, focusing specifically on the capillary density within the skeletal muscle. Otsuka Long-Evans Tokushima fatty (OLETF) rats were used as animal models of obesity with hyperinsulinemia, whereas Long-Evans Tokushima Otsuka (LETO) rats served as controls (no obesity, no hyperinsulinemia). The animals were randomly assigned to either non-exercise or exercise groups (treadmill running for 60 min/day, for 4 weeks). The exercise groups were further divided into subgroups according to training mode: single bout (60 min, daily) vs. multiple bout (three bouts of 20 min, daily). Fasting insulin levels were significantly higher in OLETF than in LETO rats. Among OLETF rats, there were no significant differences in fasting glucose levels between the exercise and the non-exercise groups, but the fasting insulin levels were significantly lower in the exercise group. Body weight and triacylglycerol levels in the liver were significantly higher in OLETF than in LETO rats; however, among OLETF rats, these levels were significantly lower in the exercise than in the non-exercise group. The capillary-to-fiber ratio of the soleus muscle was significantly higher in OLETF than in LETO rats; however, among OLETF rats, the ratio was lower in the exercise group than in the non-exercise group. No significant differences in any of the studied parameters were noted between the single-bout and multiple-bout exercise training modes among either OLETF or LETO rats. These results suggest that low-intensity exercise training improves insulin sensitivity and fatty liver. Additionally, the fact that attenuation of excessive capillarization in the skeletal muscle of OLETF rats was accompanied by improvement in increased body weight.	[Fujita, Naoto; Aono, Saki; Karasaki, Kohei; Sera, Fumi; Kurose, Tomoyuki; Urakawa, Susumu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Musculoskeletal Funct Res & Regenerat, Minami Ku, Hiroshima, Japan; [Fujino, Hidemi] Kobe Univ, Hlth Sci Discipline, Life & Med Sci Area, Suma Ku, Kobe, Hyogo, Japan	Hiroshima University; Kobe University	Fujita, N (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Musculoskeletal Funct Res & Regenerat, Minami Ku, Hiroshima, Japan.	fujitan@hiroshima-u.ac.jp		Fujita, Naoto/0000-0001-9416-3502	Japanese Ministry of Education, Culture, Sports, and Technology [16K01505]	Japanese Ministry of Education, Culture, Sports, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, and Technology (16K01505). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine, 2017, ACSMS EX TEST PRESCR; Beaudry JL, 2015, J APPL PHYSIOL, V118, P1331, DOI 10.1152/japplphysiol.00467.2014; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Bender SB, 2011, AM J PHYSIOL-HEART C, V300, pH1434, DOI 10.1152/ajpheart.01093.2010; Botezelli JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep31106; Chadderdon SM, 2016, DIABETES, V65, P2249, DOI 10.2337/db15-1574; Clark MG, 2003, AM J PHYSIOL-ENDOC M, V284, pE241, DOI 10.1152/ajpendo.00408.2002; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Dunford EC, 2017, J APPL PHYSIOL, V122, P492, DOI 10.1152/japplphysiol.00762.2016; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujita N, 2012, SCI WORLD J, DOI 10.1100/2012/637978; Fulton DJR, 2009, CIRC RES, V104, P1035, DOI 10.1161/CIRCRESAHA.109.198028; Gavin TP, 2005, J APPL PHYSIOL, V98, P315, DOI 10.1152/japplphysiol.00353.2004; Hirabara SM, 2006, CELL BIOCHEM FUNCT, V24, P475, DOI 10.1002/cbf.1327; Holloway TM, 2015, AM J PHYSIOL-REG I, V308, pR927, DOI 10.1152/ajpregu.00048.2015; Ichinose E, 2008, ARCH HISTOL CYTOL, V71, P45, DOI 10.1679/aohc.71.45; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; Kivela R, 2006, FASEB J, V20, P1570, DOI 10.1096/fj.05-4780fje; Kowalski GM, 2014, AM J PHYSIOL-ENDOC M, V307, pE859, DOI 10.1152/ajpendo.00165.2014; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Laughlin MH, 2008, J PHYSIOL PHARMACOL, V59, P71; Laughlin MH, 2015, J APPL PHYSIOL, V119, P583, DOI 10.1152/japplphysiol.00316.2015; Linden MA, 2015, MED SCI SPORT EXER, V47, P556, DOI 10.1249/MSS.0000000000000430; Magkos F, 2009, PROG LIPID RES, V48, P171, DOI 10.1016/j.plipres.2009.02.003; Marcinko K, 2014, EXP PHYSIOL, V99, P1581, DOI 10.1113/expphysiol.2014.082255; Martin JS, 2012, J APPL PHYSIOL, V113, P1223, DOI 10.1152/japplphysiol.00823.2012; Mikus CR, 2012, MICROCIRCULATION, V19, P729, DOI 10.1111/j.1549-8719.2012.00210.x; Mikus CR, 2010, J APPL PHYSIOL, V109, P1203, DOI 10.1152/japplphysiol.00064.2010; Minami A, 2002, ATHEROSCLEROSIS, V162, P85, DOI 10.1016/S0021-9150(01)00685-2; Morris RT, 2008, J APPL PHYSIOL, V104, P708, DOI 10.1152/japplphysiol.01034.2007; Nagatomo F, 2011, ACTA HISTOCHEM CYTOC, V44, P73, DOI 10.1267/ahc.10041; Nascimento AR, 2013, OBESITY, V21, P2046, DOI 10.1002/oby.20358; Niimi M, 1999, J NEUROENDOCRINOL, V11, P605; Olver TD, 2016, AM J PHYSIOL-HEART C, V310, pH337, DOI 10.1152/ajpheart.00440.2015; Peddie MC, 2013, AM J CLIN NUTR, V98, P358, DOI 10.3945/ajcn.112.051763; Potenza MA, 2005, AM J PHYSIOL-HEART C, V289, pH813, DOI 10.1152/ajpheart.00092.2005; Rector RS, 2008, J PHYSIOL-LONDON, V586, P4241, DOI 10.1113/jphysiol.2008.156745; Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007; Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030; Rector RS, 2010, AM J PHYSIOL-ENDOC M, V298, pE1179, DOI 10.1152/ajpendo.00703.2009; Roberts CK, 2013, COMPR PHYSIOL, V3, P1, DOI 10.1002/cphy.c110062; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Roudier E, 2009, J PHYSIOL-LONDON, V587, P4105, DOI 10.1113/jphysiol.2009.175554; Scherrer U, 1997, CIRCULATION, V96, P4104; SHIMA K, 1993, METABOLISM, V42, P971, DOI 10.1016/0026-0495(93)90009-D; Shindo D, 2014, J APPL PHYSIOL, V116, P674, DOI 10.1152/japplphysiol.00405.2013; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Solomon TPJ, 2011, J CLIN ENDOCR METAB, V96, P1377, DOI 10.1210/jc.2010-2069; Stanford KI, 2014, ADV PHYSIOL EDUC, V38, P308, DOI 10.1152/advan.00080.2014; Taniguchi Y, 2006, DIABETES, V55, P2371, DOI 10.2337/db06-0268; van Hall G, 2015, SPORTS MED, V45, pS23, DOI 10.1007/s40279-015-0394-8; Wagenmakers AJM, 2016, J PHYSIOL-LONDON, V594, P2207, DOI 10.1113/jphysiol.2014.284513; Wang L, 2009, MED SCI SPORT EXER, V41, P2136, DOI 10.1249/MSS.0b013e3181abc1ec; Yan JL, 2009, J VASC SURG, V50, P1412, DOI 10.1016/j.jvs.2009.08.007; Younk LM, 2011, EXPERT REV ENDOCRINO, V6, P93, DOI 10.1586/EEM.10.78	56	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196895	10.1371/journal.pone.0196895	http://dx.doi.org/10.1371/journal.pone.0196895			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718998	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000431281900089
J	Nomura-Nakayama, K; Adachi, H; Miyatake, N; Hayashi, N; Fujimoto, K; Yamaya, H; Yokoyama, H				Nomura-Nakayama, Kanae; Adachi, Hiroki; Miyatake, Nobuhiko; Hayashi, Norifumi; Fujimoto, Keiji; Yamaya, Hideki; Yokoyama, Hitoshi			High molecular weight adiponectin inhibits vascular calcification in renal allograft recipients	PLOS ONE			English	Article							T-CADHERIN; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; TRANSPLANTATION; ASSOCIATION; STRATEGIES; RECEPTORS; PROTEIN; MICE	Background Adiponectin (ADPN) prevents the development/recurrence of cardiovascular events via its anti-atherogenic effects. However, few long-term studies have examined the changes in serum ADPN levels and arterial calcification seen in renal allograft recipients. Subjects and methods The effects of the serum ADPN level on arterial calcification were examined in 51 Japanese renal allograft recipients. Abdominal aorta calcification was evaluated on computed tomography using the aortic calcification area index (ACAI). The change in the ACAI and serum high-molecular-weight (HMW)-ADPN fractions were studied over an 8-year period. The arterial expression of ADPN, ADPN receptors (AdipoR)1 and 2, and T-cadherin (cadherin-13) were also examined by immunohistochemistry. Results 1. The change in the ACAI were grouped into quartiles and compared with the alterations in the serum levels of each ADPN fraction over an 8-year period. The change in the ACAI was much lower in the patients with highly elevated HMW-ADPN levels. 2. Multiple regression analysis demonstrated that an advanced age at transplant and a history of cardiovascular complications were associated with an increased change in the ACAI, while higher HMW-ADPN concentrations were associated with improvements in the ACAI. Serum HDL-C level was also identified as a positive factor to increase serum HMW-ADPN level. 3. In immunohistochemical examinations, ADPN was detected on CD31-positive arterial endothelial cells from renal allograft biopsy samples. ADPN co-localized with T-cadherin and AdipoR1, but only partially co-localized with AdipoR2. Conclusion Both HMW-ADPN and HDL-C might inhibit the progression of vascular calcification by promoting ADPN binding to vascular endothelial cells via T-cadherin and AdipoR in Japanese renal allograft recipients.	[Nomura-Nakayama, Kanae; Adachi, Hiroki; Miyatake, Nobuhiko; Hayashi, Norifumi; Fujimoto, Keiji; Yamaya, Hideki; Yokoyama, Hitoshi] Kanazawa Med Univ, Sch Med, Dept Nephrol, Uchinada, Ishikawa, Japan	Kanazawa Medical University	Yokoyama, H (corresponding author), Kanazawa Med Univ, Sch Med, Dept Nephrol, Uchinada, Ishikawa, Japan.	h-yoko@kanazawa-med.ac.jp			Japan Society for the Promotion of Science [25461237]; Grants for Intractable Renal Disease Research from the Ministry of Health, Labour, and Welfare of Japan; Grants for a Cooperative Study at Kanazawa Medical University [C2017-4]; Grants for Health and Labour Sciences Research from the Ministry of Health, Labour, and Welfare of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants for Intractable Renal Disease Research from the Ministry of Health, Labour, and Welfare of Japan; Grants for a Cooperative Study at Kanazawa Medical University; Grants for Health and Labour Sciences Research from the Ministry of Health, Labour, and Welfare of Japan	This study was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (C) (no. 25461237); Grants for Intractable Renal Disease Research and for Health and Labour Sciences Research from the Ministry of Health, Labour, and Welfare of Japan; and Grants for a Cooperative Study at Kanazawa Medical University (no. C2017-4) (HY).; This study was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (C) (No. 25461237); Grants for Intractable Renal Disease Research and for Health and Labour Sciences Research from the Ministry of Health, Labour, and Welfare of Japan; and Grants for a Cooperative Study at Kanazawa Medical University (No. C2017-4) (HY)."	Adachi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163899; Alam A, 2013, CLIN J AM SOC NEPHRO, V8, P460, DOI 10.2215/CJN.04370512; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chen ZM, 2017, EUR J CLIN INVEST, V47, P137, DOI 10.1111/eci.12718; Costacou T, 2008, KIDNEY INT, V74, P549, DOI 10.1038/ki.2008.262; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Fujishima Y, 2017, FASEB J, V31, P1571, DOI 10.1096/fj.201601064R; Heidari Maryam, 2015, J Nephropharmacol, V4, P63; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Liefeldt L, 2010, TRANSPL INT, V23, P1191, DOI 10.1111/j.1432-2277.2010.01159.x; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Matsuda K, 2015, ENDOCRINOLOGY, V156, P934, DOI 10.1210/en.2014-1618; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Menzaghi C, 2007, DIABETES, V56, P1198, DOI 10.2337/db06-0506; Morozumi K, 2000, CLIN EXP NEPHROL, V4, P87, DOI 10.1007/pl00012170; Ojo AO, 2006, TRANSPLANTATION, V82, P603, DOI 10.1097/01.tp.0000235527.81917.fe; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Rigatto C, 2009, CLIN J AM SOC NEPHRO, V4, P291, DOI 10.2215/CJN.01840408; Sedighi Omid, 2014, Nephrourol Mon, V6, pe11743, DOI 10.5812/numonthly.11743; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang ZV, 2008, HYPERTENSION, V51, P8, DOI 10.1161/HYPERTENSIONAHA.107.099424; Wanner C, 2016, LANCET, V388, P276, DOI 10.1016/S0140-6736(16)30508-6; Wissing KM, 2000, TRANSPLANTATION, V70, P464, DOI 10.1097/00007890-200008150-00012; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yoon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075535	33	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195066	10.1371/journal.pone.0195066	http://dx.doi.org/10.1371/journal.pone.0195066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718962	gold, Green Published, Green Submitted			2022-12-26	WOS:000431281900013
J	Segev, E; Pasternak, Z; Ben Sasson, T; Jurkevitch, E; Gonen, M				Segev, Elad; Pasternak, Zohar; Ben Sasson, Tom; Jurkevitch, Edouard; Gonen, Mira			Automatic identification of optimal marker genes for phenotypic and taxonomic groups of microorganisms	PLOS ONE			English	Article							MICROBIAL GENOME DATABASE; SIGNATURE GENES; SET; APPROXIMATION; ALGORITHM	Finding optimal markers for microorganisms important in the medical, agricultural, environmental or ecological fields is of great importance. Thousands of complete microbial genomes now available allow us, for the first time, to exhaustively identify marker proteins for groups of microbial organisms. In this work, we model the biological task as the well-known mathematical "hitting set" problem, solving it based on both greedy and randomized approximation algorithms. We identify unique markers for 17 phenotypic and taxonomic microbial groups, including proteins related to the nitrite reductase enzyme as markers for the non-anammox nitrifying bacteria group, and two transcription regulation proteins, nusG and yhiF, as markers for the Archaea and Escherichia/Shigella taxonomic groups, respectively. Additionally, we identify marker proteins for three subtypes of pathogenic E. coli, which previously had no known optimal markers. Practically, depending on the completeness of the database this algorithm can be used for identification of marker genes for any microbial group, these marker genes may be prime candidates for the understanding of the genetic basis of the group's phenotype or to help discover novel functions which are uniquely shared among a group of microbes. We show that our method is both theoretically and practically efficient, while establishing an upper bound on its time complexity and approximation ratio; thus, it promises to remain efficient and permit the identification of marker proteins that are specific to phenotypic or taxonomic groups, even as more and more bacterial genomes are being sequenced.	[Segev, Elad] Holon Inst Technol, Dept Math, Holon, Israel; [Pasternak, Zohar; Jurkevitch, Edouard] Hebrew Univ Jerusalem, Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, Rehovot, Israel; [Ben Sasson, Tom] Open Univ Israel, Dept Math & Comp Sci, Raanana, Israel; [Gonen, Mira] Ariel Univ, Dept Comp Sci, Ariel, Israel	Hebrew University of Jerusalem; Open University Israel; Ariel University	Segev, E (corresponding author), Holon Inst Technol, Dept Math, Holon, Israel.	elad1segev@gmail.com		Segev, Elad/0000-0002-2786-324X				Alhagamhmad MH, 2016, J MED MICROBIOL, V65, P1049, DOI 10.1099/jmm.0.000331; [Anonymous], 1970, GOOD IS SIMPL ALG; AUSIELLO G, 1980, J COMPUT SYST SCI, V21, P136, DOI 10.1016/0022-0000(80)90046-X; Brinkac LM, 2017, BIOINFORMATICS, V33, P1725, DOI 10.1093/bioinformatics/btx045; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Caprara A, 1999, OPER RES, V47, P730, DOI 10.1287/opre.47.5.730; Chu PC, 1998, J HEURISTICS, V4, P63, DOI 10.1023/A:1009642405419; Chvatal V., 1979, Mathematics of Operations Research, V4, P233, DOI 10.1287/moor.4.3.233; Cormode Graham, 2010, P 19 ACM INT C INFOR, DOI [10.1145/1871437.1871501, DOI 10.1145/1871437.1871501]; Dinur I, 2014, STOC'14: PROCEEDINGS OF THE 46TH ANNUAL 2014 ACM SYMPOSIUM ON THEORY OF COMPUTING, P624, DOI 10.1145/2591796.2591884; Dutilh BE, 2008, MOL BIOL EVOL, V25, P1659, DOI 10.1093/molbev/msn115; Feige U, 1998, J ACM, V45, P634, DOI 10.1145/285055.285059; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; GOLDSCHMIDT O, 1993, INFORM PROCESS LETT, V48, P305, DOI 10.1016/0020-0190(93)90173-7; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hassin R, 2005, SIAM J COMPUT, V35, P189, DOI 10.1137/S0097539704444750; Huang BX, 2013, DIAGN MICR INFEC DIS, V77, P312, DOI 10.1016/j.diagmicrobio.2013.09.005; Jason J, 2007, ARCH MICROBIOL, V188, P349, DOI 10.1007/s00203-007-0255-4; JOHNSON DS, 1974, J COMPUT SYST SCI, V9, P256, DOI 10.1016/S0022-0000(74)80044-9; Karp R. M., 1972, P COMPL COMP COMP, P85; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kersey PJ, 2014, NUCLEIC ACIDS RES, V42, pD546, DOI 10.1093/nar/gkt979; Kordalewski D., 2013, ARXIV13053584CS; Kristensen DM, 2013, J BACTERIOL, V195, P941, DOI 10.1128/JB.01801-12; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Leopold SR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-183; LOVASZ L, 1975, DISCRETE MATH, V13, P383, DOI 10.1016/0012-365X(75)90058-8; MURPHY MJ, 1974, P NATL ACAD SCI USA, V71, P612, DOI 10.1073/pnas.71.3.612; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Pasternak Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142933; Pasternak Z, 2013, ISME J, V7, P756, DOI 10.1038/ismej.2012.149; Peleg D, 1997, ALGORITHMICA, V18, P44, DOI 10.1007/BF02523687; Perez-Losada M, 2013, INFECT GENET EVOL, V16, P38, DOI 10.1016/j.meegid.2013.01.009; Rabus R., 2013, PROKARYOTES GAMMAPRO, DOI [10.1007/978-3-642-38922-1, DOI 10.1007/978-3-642-38922-1]; Raghavan P., 1986, 27th Annual Symposium on Foundations of Computer Science (Cat. No.86CH2354-9), P10, DOI 10.1109/SFCS.1986.45; RAGHAVAN P, 1987, COMBINATORICA, V7, P365, DOI 10.1007/BF02579324; Robins-Browne RM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/tcimb.2016.00141; ROBINSBROWNE RM, 1987, REV INFECT DIS, V9, P28; Spasovski S, 2013, P 10 C INF INF TECHN, P175; Stein S. K., 1974, Journal of Combinatorial Theory, Series A, V16, P391, DOI 10.1016/0097-3165(74)90062-4; Torres M, 2004, J BACTERIOL, V186, P1304, DOI 10.1128/JB.186.5.1304-1310.2004; Uchiyama I, 2006, NUCLEIC ACIDS RES, V34, P647, DOI 10.1093/nar/gkj448; Uchiyama I, 2015, NUCLEIC ACIDS RES, V43, pD270, DOI 10.1093/nar/gku1152; Uchiyama I, 2013, NUCLEIC ACIDS RES, V41, pD631, DOI 10.1093/nar/gks1006; Umetani S, 2007, J OPER RES SOC JPN, V50, P350, DOI 10.15807/jorsj.50.350; van Leeuwen J, 1998, ALGORITHMS COMPLEXIT; Vazirani V., APPROXIMATION ALGORI; Wu DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056624, 10.1371/journal.pone.0053932, 10.1371/journal.pone.0055431]; Yakhnin AV, 2014, CURR OPIN MICROBIOL, V18, P68, DOI 10.1016/j.mib.2014.02.005; Yoshida CE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147101; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	52	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0195537	10.1371/journal.pone.0195537	http://dx.doi.org/10.1371/journal.pone.0195537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718935	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900021
J	Robb, EL; Hall, AR; Prime, TA; Eaton, S; Szibor, M; Viscomi, C; James, AM; Murphy, MP				Robb, Ellen L.; Hall, Andrew R.; Prime, Tracy A.; Eaton, Simon; Szibor, Marten; Viscomi, Carlo; James, Andrew M.; Murphy, Michael P.			Control of mitochondrial superoxide production by reverse electron transport at complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; mitochondrial membrane potential; redox signaling; reactive oxygen species (ROS); respiration; complex I; reverse electron transport; RET; coenzyme Q; superoxide	TARGETED ANTIOXIDANT MITOQ; UBIQUINONE OXIDOREDUCTASE; HYDROGEN-PEROXIDE; OXIDATIVE-PHOSPHORYLATION; RESPIRATORY-CHAIN; SIGNAL-TRANSDUCTION; HEART-MITOCHONDRIA; REPERFUSION INJURY; BINDING SITE; NADH	The generation of mitochondrial superoxide (O2.) by reverse electron transport (RET) at complex I causes oxidative damage in pathologies such as ischemia reperfusion injury, but also provides the precursor to H2O2 production in physiological mitochondrial redox signaling. Here, we quantified the factors that determine mitochondrial O2. production by RET in isolated heart mitochondria. Measuring mitochondrial H2O2 production at a range of proton-motive force (p) values and for several coenzyme Q (CoQ) and NADH pool redox states obtained with the uncoupler p-trifluoromethoxyphenylhydrazone, we show that O2. production by RET responds to changes in O2 concentration, the magnitude of p, and the redox states of the CoQ andNADHpools. Moreover, we determined how expressing the alternative oxidase from the tunicate Ciona intestinalis to oxidize the CoQ pool affected RET-mediated O2. production at complex I, underscoring the importance of the CoQ pool for mitochondrialO2. production by RET. An analysis ofO2. production at complex I as a function of the thermodynamic forces driving RET at complex I revealed that many molecules that affect mitochondrial reactive oxygen species production do so by altering the overall thermodynamic driving forces of RET, rather than by directly acting on complex I. These findings clarify the factors controlling RET-mediated mitochondrial O2. production in both pathological and physiological conditions. We conclude that O2. production by RET is highly responsive to small changes in p and the CoQ redox state, indicating that complex I RET represents a major mode of mitochondrial redox signaling.	[Robb, Ellen L.; Hall, Andrew R.; Prime, Tracy A.; Viscomi, Carlo; James, Andrew M.; Murphy, Michael P.] Univ Cambridge, Med Res Council, Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England; [Eaton, Simon] UCL Great Ormond St Inst Child Hlth, London WC1N 1EH, England; [Szibor, Marten] Univ Tampere, Fac Med & Life Sci, FI-33014 Tampere, Finland; [Szibor, Marten] Max Planck Inst Heart & Lung Res, Ludwigstr 43, D-61231 Bad Nauheim, Germany	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of London; University College London; Tampere University; Max Planck Society	Murphy, MP (corresponding author), MRC Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.	mpm@mrc-mbu.cam.ac.uk	Eaton, Simon/C-4942-2008; viscomi, Carlo/R-1940-2016; James, Andrew M/A-2639-2015; Murphy, Michael/C-2120-2009	Eaton, Simon/0000-0003-0892-9204; James, Andrew M/0000-0002-0515-9649; Viscomi, Carlo/0000-0001-6050-0566; Murphy, Michael/0000-0003-1115-9618	Medical Research Council UK [MC_U105663142, MC_UU_00015/5]; Wellcome Trust Investigator award [110159/Z/15/Z]; Great Ormond Street Hospital Children's Charity; NIHR Biomedical Research Centre at Great Ormond Street Hospital; MRC [MC_UU_00015/8, MC_UU_00015/3, MC_U105663142, MC_UU_00015/5] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Investigator award(Wellcome Trust); Great Ormond Street Hospital Children's Charity; NIHR Biomedical Research Centre at Great Ormond Street Hospital; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council UK (Grants MC_U105663142 (to M. P. M.) and MC_UU_00015/5 (to C. V.)) and by a Wellcome Trust Investigator award (110159/Z/15/Z) (to M. P. M). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by the Great Ormond Street Hospital Children's Charity and the NIHR Biomedical Research Centre at Great Ormond Street Hospital.	Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Birrell JA, 2009, BIOCHEMISTRY-US, V48, P12005, DOI 10.1021/bi901706w; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Fernandez-Aguera MC, 2015, CELL METAB, V22, P825, DOI 10.1016/j.cmet.2015.09.004; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; DRY IB, 1989, ARCH BIOCHEM BIOPHYS, V273, P148, DOI 10.1016/0003-9861(89)90173-2; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; El-Khoury R, 2014, BRIT J PHARMACOL, V171, P2243, DOI 10.1111/bph.12570; El-Khoury R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003182; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Goncalves RLS, 2015, J BIOL CHEM, V290, P209, DOI 10.1074/jbc.M114.619072; Guaras A, 2016, CELL REP, V15, P197, DOI 10.1016/j.celrep.2016.03.009; HINKLE PC, 1967, J BIOL CHEM, V242, P5169; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; James AM, 2007, J BIOL CHEM, V282, P14708, DOI 10.1074/jbc.M611463200; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lambert AJ, 2008, FEBS LETT, V582, P1711, DOI 10.1016/j.febslet.2008.04.030; Lambert AJ, 2008, BBA-BIOENERGETICS, V1777, P397, DOI 10.1016/j.bbabio.2008.03.005; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Murphy MP, 2012, ANTIOXID REDOX SIGN, V16, P476, DOI 10.1089/ars.2011.4289; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nicholls DG, 2013, BIOENERGETICS 4, P1; Orr AL, 2013, FREE RADICAL BIO MED, V65, P1047, DOI 10.1016/j.freeradbiomed.2013.08.170; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009; Ross MF, 2008, BIOCHEM J, V411, P633, DOI 10.1042/BJ20080063; Scialo F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009; SLED VD, 1994, BIOCHEMISTRY-US, V33, P10069, DOI 10.1021/bi00199a034; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stepanova A, 2019, J CEREBR BLOOD F MET, V39, P1790, DOI 10.1177/0271678X18770331; Szeto HH, 2011, PHARM RES-DORDR, V28, P2669, DOI 10.1007/s11095-011-0476-8; Szibor M, 2017, DIS MODEL MECH, V10, P163, DOI 10.1242/dmm.027839; Vinogradov AD, 2005, BIOCHEMISTRY-MOSCOW+, V70, P120, DOI 10.1007/s10541-005-0090-7; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wikstrom M., 1981, CYTOCHROME OXIDASE S; Wong HS, 2017, J BIOL CHEM, V292, P16804, DOI 10.1074/jbc.R117.789271; Yang BX, 2006, J BIOL CHEM, V281, P16202, DOI 10.1074/jbc.M601864200; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095	53	137	137	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9869	9879		10.1074/jbc.RA118.003647	http://dx.doi.org/10.1074/jbc.RA118.003647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29743240	Green Published, hybrid			2022-12-26	WOS:000436102300028
J	Selvam, SP; Roth, BM; Nganga, R; Kim, J; Cooley, MA; Helke, K; Smith, CD; Ogretmen, B				Selvam, Shanmugam Panneer; Roth, Braden M.; Nganga, Rose; Kim, Jisun; Cooley, Marion A.; Helke, Kristi; Smith, Charles D.; Ogretmen, Besim			Balance between senescence and apoptosis is regulated by telomere damage-induced association between p16 and caspase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; signal transduction; sphingolipid; sphingosine-1-phosphate (S1P); telomerase reverse transcriptase (TERT); senescence	SPHINGOSINE KINASE 2; CERAMIDE-DEPENDENT MITOPHAGY; TERT PROMOTER MUTATIONS; CANCER-CELLS; STEM-CELLS; LIFE-SPAN; IN-VITRO; ACTIVATION; LUNG; RNA	Telomerase activation protects cells from telomere damage by delaying senescence and inducing cell immortalization, whereas telomerase inhibition mediates rapid senescence or apoptosis. However, the cellular mechanisms that determine telomere damage-dependent senescence versus apoptosis induction are largely unknown. Here, we demonstrate that telomerase instability mediated by silencing of sphingosine kinase 2 (SPHK2) and sphingosine 1-phosphate (S1P), which binds and stabilizes telomerase, induces telomere damage-dependent caspase-3 activation and apoptosis, but not senescence, in p16-deficient lung cancer cells or tumors. These outcomes were prevented by knockdown of a tumor-suppressor protein, transcription factor 21 (TCF21), or by ectopic expression of WT human telomerase reverse transcriptase (hTERT) but not mutant hTERT with altered S1P binding. Interestingly, SphK2-deficient mice exhibited accelerated aging and telomerase instability that increased telomere damage and senescence via p16 activation especially in testes tissues, but not in apoptosis. Moreover, p16 silencing in SphK2(-/-) mouse embryonic fibroblasts activated caspase-3 and apoptosis without inducing senescence. Furthermore, ectopic WT p16 expression in p16-deficient A549 lung cancer cells prevented TCF21 and caspase-3 activation and resulted in senescence in response to SphK2/S1P inhibition and telomere damage. Mechanistically, a p16 mutant with impaired caspase-3 association did not prevent telomere damage-induced apoptosis, indicating that an association between p16 and caspase-3 proteins forces senescence induction by inhibiting caspase-3 activation and apoptosis. These results suggest that p16 plays a direct role in telomere damage-dependent senescence by limiting apoptosis via binding to caspase-3, revealing a direct link between telomere damage-dependent senescence and apoptosis with regards to aging and cancer.	[Selvam, Shanmugam Panneer; Roth, Braden M.; Nganga, Rose; Kim, Jisun; Ogretmen, Besim] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 30912 USA; [Selvam, Shanmugam Panneer; Roth, Braden M.; Nganga, Rose; Kim, Jisun; Ogretmen, Besim] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 30912 USA; [Cooley, Marion A.] Med Univ South Carolina, Dept Regenerat Med, Charleston, SC 30912 USA; [Helke, Kristi] Med Univ South Carolina, Dept Comparat Med, Charleston, SC 30912 USA; [Smith, Charles D.] Penn State Univ, Dept Pharmacol, Hershey, PA 17033 USA; [Cooley, Marion A.] Augusta Univ, Dept Oral Biol, 86 Jonathan Lucas St, Augusta, GA 30912 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University System of Georgia; Augusta University	Ogretmen, B (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 30912 USA.; Ogretmen, B (corresponding author), Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 30912 USA.	ogretmen@musc.edu	Roth, Braden/L-9386-2015	Roth, Braden/0000-0001-7559-7671; Helke, Kris/0000-0001-9746-0764; Cooley, Marion A./0000-0002-4286-745X	National Institutes of Health Grant [C06 RR015455]; Hollings Cancer Center Support Grant [P30 CA138313]; Center of Biomedical Research Excellence (Cobre) in Lipidomics and Pathobiology [P30 GM103339]; NATIONAL CANCER INSTITUTE [R01CA088932, P01CA203628, R01CA173687, P30CA138313, R01CA214461] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103339] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hollings Cancer Center Support Grant; Center of Biomedical Research Excellence (Cobre) in Lipidomics and Pathobiology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Richard Flavell (Yale University) for providing us with the caspase-3/7 knockout MEFs. We thank Dr. Sarah Spiegel (Virginia Commonwealth University) for providing SphK2 plasmids. We also thank Dr. Elizabeth Garrett-Mayer (Medical University of South Carolina) for assistance with statistical analyses and discussions in this study. The core facilities utilized were constructed using support from National Institutes of Health Grant C06 RR015455, Hollings Cancer Center Support Grant P30 CA138313, or Center of Biomedical Research Excellence (Cobre) in Lipidomics and Pathobiology P30 GM103339.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Arab K, 2014, MOL CELL, V55, P604, DOI 10.1016/j.molcel.2014.06.031; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Balk B, 2013, NAT STRUCT MOL BIOL, V20, P1199, DOI 10.1038/nsmb.2662; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bose K, 2003, BIOCHEMISTRY-US, V42, P12298, DOI 10.1021/bi034998x; Britten CD, 2017, CLIN CANCER RES, V23, P4642, DOI 10.1158/1078-0432.CCR-16-2363; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Dany M, 2016, BLOOD, V128, P1944, DOI 10.1182/blood-2016-04-708750; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; Gencer S, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam7464; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Gunes C, 2013, CELL, V152, P390, DOI 10.1016/j.cell.2013.01.010; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Hwang D, 2016, PROTEIN EXPRES PURIF, V126, P104, DOI 10.1016/j.pep.2016.06.004; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Jacobs JJL, 2005, CELL CYCLE, V4, P1364, DOI 10.4161/cc.4.10.2104; Jiang JS, 2015, SCIENCE, V350, DOI 10.1126/science.aab4070; Montero JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12534; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lewis CS, 2016, ONCOTARGET, V7, P60181, DOI 10.18632/oncotarget.11112; Li YH, 2015, NAT CELL BIOL, V17, P1327, DOI 10.1038/ncb3240; Masterson JC, 2007, ANTI-CANCER DRUG, V18, P1053, DOI 10.1097/CAD.0b013e32825209f6; McGurn LD, 2016, BIOCHEM J, V473, P4559, DOI 10.1042/BCJ20160773; Mender Ilgen, 2015, Bio Protoc, V5; Neubauer Heidi A, 2016, F1000Res, V5, P2825, DOI 10.12688/f1000research.10336.2; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Parham KA, 2015, FASEB J, V29, P3638, DOI 10.1096/fj.14-261289; Ponnusamy S, 2012, EMBO MOL MED, V4, P761, DOI 10.1002/emmm.201200244; Pont AR, 2012, MOL CELL, V47, P5, DOI 10.1016/j.molcel.2012.04.019; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Rice C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14928; Richards KL, 2011, CANCER-AM CANCER SOC, V117, P606, DOI 10.1002/cncr.25472; Selvam SP, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa4998; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Shay JW, 2016, CANCER DISCOV, V6, P584, DOI 10.1158/2159-8290.CD-16-0062; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Tessema M, 2008, CANCER RES, V68, P1707, DOI 10.1158/0008-5472.CAN-07-6325; Thomas RJ, 2017, EMBO MOL MED, V9, P1030, DOI 10.15252/emmm.201607088; Timashev LA, 2017, GENE DEV, V31, P578, DOI 10.1101/gad.294108.116; Valentijn LJ, 2015, NAT GENET, V47, P1411, DOI 10.1038/ng.3438; Vega LR, 2003, NAT REV MOL CELL BIO, V4, P948, DOI 10.1038/nrm1256; Venant H, 2015, MOL CANCER THER, V14, P2744, DOI 10.1158/1535-7163.MCT-15-0279; Venkata JK, 2014, BLOOD, V124, P1915, DOI 10.1182/blood-2014-03559385; Walsh KM, 2014, NAT GENET, V46, P731, DOI 10.1038/ng.3004; Wang Y, 2013, J CLIN INVEST, V123, P4489, DOI 10.1172/JCI69574	60	17	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9784	9800		10.1074/jbc.RA118.003506	http://dx.doi.org/10.1074/jbc.RA118.003506			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29748384	hybrid, Green Published			2022-12-26	WOS:000436102300022
J	Dery, KJ; Silver, C; Yang, L; Shively, JE				Dery, Kenneth J.; Silver, Craig; Yang, Lu; Shively, John E.			Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin remodeling; translation regulation; alternative splicing; transcription; RNA; CEACAM1; hnRNP L; IFN-gamma; IRF1	BILIARY GLYCOPROTEIN CD66A; NF-KAPPA-B; CARCINOEMBRYONIC ANTIGEN; HNRNP-L; BREAST-CANCER; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; DNA METHYLATION; CARCINOMA CELLS; DOWN-REGULATION	The adhesion protein carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is widely expressed in epithelial cells as a short cytoplasmic isoform (S-iso) and in leukocytes as a long cytoplasmic isoform (L-iso) and is frequently silenced in cancer by unknown mechanisms. Previously, we reported that interferon response factor 1 (IRF1) biases alternative splicing (AS) to include the variable exon 7 (E7) in CEACAM1, generating long cytoplasmic isoforms. We now show that IRF1 and a variant of heterogeneous nuclear ribonucleoprotein L (Lv1) coordinately silence the CEACAM1 gene. RNAi-mediated Lv1 depletion in IRF1-treated HeLa and melanoma cells induced significant CEACAM1 protein expression, reversed by ectopic Lv1 expression. The Lv1-mediated CEACAM1 repression resided in residues Gly(71)-Gly(89) and Ala(38)-Gly(89) in Lv1's N-terminal extension. ChIP analysis of IRF1- and FLAG-tagged Lv1-treated HeLa cells and global treatment with the global epigenetic modifiers 5-aza-2-deoxycytidine and trichostatin A indicated that IRF1 and Lv1 together induce chromatin remodeling, restricting IRF1 access to the CEACAM1 promoter. In interferon -treated HeLa cells, the transcription factor SP1 did not associate with the CEACAM1 promoter, but binding by upstream transcription factor 1 (USF1), a known CEACAM1 regulator, was greatly enhanced. ChIP-sequencing revealed that Lv1 overexpression in IRF1-treated cells induces transcriptional silencing across many genes, including DCC (deleted in colorectal carcinoma), associated with CEACAM5 in colon cancer. Notably, IRF1, but not IRF3 and IRF7, affected CEACAM1 expression via translational repression. We conclude that IRF1 and Lv1 coordinately regulate CEACAM1 transcription, alternative splicing, and translation and may significantly contribute to CEACAM1 silencing in cancer.	[Dery, Kenneth J.; Shively, John E.] City Hope Natl Med Ctr, Dept Mol Immunol, Beckman Res Inst, Duarte, CA 91010 USA; [Silver, Craig] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA; [Yang, Lu] City Hope Natl Med Ctr, Integrat Genom & Bioinformat Core, Beckman Res Inst, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; California State University System; California State Polytechnic University Pomona; City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), City Hope Natl Med Ctr, Dept Mol Immunol, Beckman Res Inst, Duarte, CA 91010 USA.	jshively@coh.org			NCI NIH HHS [P30 CA033572] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bidwell BN, 2012, NAT MED, V18, P1224, DOI 10.1038/nm.2830; Bieberstein NI, 2016, SCI REP-UK, V6, DOI 10.1038/srep29961; Bodaghi S, 2009, VIROLOGY, V386, P32, DOI 10.1016/j.virol.2008.12.037; Busch C, 2002, HUM PATHOL, V33, P290, DOI 10.1053/hupa.2002.32218; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; D'Agostino L, 2010, CELL CYCLE, V9, P1131, DOI 10.4161/cc.9.6.10991; Dai P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010069; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; DANSKYULLMANN C, 1995, CYTOKINE, V7, P118, DOI 10.1006/cyto.1995.1016; Dery KJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-64; Dery KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.204057; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gaur S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-46; Gencheva M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-79; Goehe RW, 2010, J CLIN INVEST, V120, P3923, DOI 10.1172/JCI43552; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Hillebrand F, 2017, BBA-GENE REGUL MECH, V1860, P205, DOI 10.1016/j.bbagrm.2016.12.001; Hu SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182771; Huang Y, 2012, MOL CELL, V45, P459, DOI 10.1016/j.molcel.2011.12.022; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Jiang HW, 2015, GENET MOL RES, V14, P10273, DOI 10.4238/2015.August.28.12; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kammerer R, 1998, EUR J IMMUNOL, V28, P3664, DOI 10.1002/(SICI)1521-4141(199811)28:11<3664::AID-IMMU3664>3.0.CO;2-D; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; KLINGELHUTZ AJ, 1993, ONCOGENE, V8, P95; Koren R, 2003, BREAST CANCER RES TR, V80, P215, DOI 10.1023/A:1024581508474; Lai MC, 1999, J BIOL CHEM, V274, P11832, DOI 10.1074/jbc.274.17.11832; Li JP, 2012, J PROTEOMICS, V75, P2879, DOI 10.1016/j.jprot.2011.12.040; Liu C, 2016, ONCOTARGET, V7, P71556, DOI 10.18632/oncotarget.12253; Lu RZ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002597; Lu RZ, 2011, J BIOL CHEM, V286, P27528, DOI 10.1074/jbc.M111.235762; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Luo CL, 2017, CANCER RES, V77, P1168, DOI 10.1158/0008-5472.CAN-16-1919; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Mayeda A, 1998, RNA, V4, P1111, DOI 10.1017/S135583829898089X; Morales VM, 1999, J IMMUNOL, V163, P1363; Munoz MJ, 2010, TRENDS BIOCHEM SCI, V35, P497, DOI 10.1016/j.tibs.2010.03.010; NAJJAR SM, 1993, J BIOL CHEM, V268, P1201; Nishiyama A, 2016, J BIOCHEM, V159, P9, DOI 10.1093/jb/mvv113; NOLL M, 1974, NATURE, V251, P249, DOI 10.1038/251249a0; Nyati KK, 2017, NUCLEIC ACIDS RES, V45, P2687, DOI 10.1093/nar/gkx064; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; Rogelj B., 2011, RNA BINDING PROTEINS, P1; Rosonina E, 2004, RNA, V10, P581, DOI 10.1261/rna.5207204; Rossbach O, 2009, MOL CELL BIOL, V29, P1442, DOI 10.1128/MCB.01689-08; Ruan K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12720; Ruggiero T, 2003, NUCLEIC ACIDS RES, V31, P6561, DOI 10.1093/nar/gkg858; Shankarling G, 2013, BIOCHEM J, V453, P271, DOI 10.1042/BJ20130432; Shingler V, 1996, MOL MICROBIOL, V19, P409, DOI 10.1046/j.1365-2958.1996.388920.x; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Singer BB, 2000, CANCER RES, V60, P1236; TAKAHASHI H, 1993, CANCER RES, V53, P1612; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Tsompana M, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-33; TURLEY H, 1995, CANCER RES, V55, P5628; Vitenshtein A, 2016, CELL REP, V15, P2331, DOI 10.1016/j.celrep.2016.05.036; Wang Y, 2014, CANCER CELL, V26, P374, DOI 10.1016/j.ccr.2014.07.010; Yabas M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010003; Yang CC, 2015, ACTA BIOCH BIOPH SIN, V47, P788, DOI 10.1093/abbs/gmv075; Yim JH, 2003, J INTERF CYTOK RES, V23, P501, DOI 10.1089/10799900360708623; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhou XM, 2017, ONCOTARGET, V8, P19342, DOI 10.18632/oncotarget.14258; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	69	10	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9277	9291		10.1074/jbc.RA117.001507	http://dx.doi.org/10.1074/jbc.RA117.001507			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29720400	Green Published, hybrid			2022-12-26	WOS:000435441400014
J	Mulu, W; Yizengaw, E; Alemu, M; Mekonnen, D; Hailu, D; Ketemaw, K; Abera, B; Kibret, M				Mulu, Wondemagegn; Yizengaw, Endalew; Alemu, Megbaru; Mekonnen, Daniel; Hailu, Derese; Ketemaw, Kassaw; Abera, Bayeh; Kibret, Mulugeta			Pharyngeal colonization and drug resistance profiles of Morraxella catarrrhalis, Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae among HIV infected children attending ART Clinic of Felegehiwot Referral Hospital, Ethiopia	PLOS ONE			English	Article							NASOPHARYNGEAL CARRIAGE; ANTIBIOTIC SUSCEPTIBILITY; PNEUMOCOCCAL DISEASE; SOUTHWEST ETHIOPIA; POSITIVE CHILDREN; HEALTHY-CHILDREN; RISK-FACTORS; PREVALENCE; TANZANIA; SCHOOL	Background Asymptomatic pharyngeal colonization by potential bacteria is the primary reservoir for bacterial species within a population and is considered a prerequisite for development of major childhood diseases such as sinusitis, otitis media, pneumonia, bacteremia, and meningitis. However, there is dearth of data on the colonization and drug resistance pattern of the main bacterial pathogens in the pharynx of HIV infected children in Ethiopia. Therefore, this study determined the pharyngeal colonization and drug resistance profile of bacterial pathogens in HIV infected children attending ART clinic of Felegehiwot Referral Hospital (FHRH), Amhara Region, Ethiopia. Methods A hospital based cross-sectional study was conducted from May 2016 to June 2017 at the ART clinic of FHRH. A total of 300 HIV infected children were enrolled in the study. Data on socio-demographic characteristics of the study participants were collected with face-to-face interview and patient-card review using structured questionnaire. Bacterial species were identified using standard bacteriological techniques. Drug susceptibility testing was performed using disk diffusion technique. Chi-square test was done to determine associations among variables. Results The median age of the participants was 11 years. Overall, 153 (51%) of children were colonized by respiratory bacteria in their pharynx. Colonization rate was higher in children from mothers who had attained college and above levels of education than others (P = 0.04). It was also higher in children without the sign of malnutrition than others (P = 0.004). The colonization rate of S.aureus, M.catarrhalis, S.pneumoniae and H.influenzae were 88 (29%), 37 (12.3%), 31 (10.3%) and 6 (2%), respectively. S.aureus-M.catarrhalis concurrent colonization was found in 14 (4.7%) of children. Age (P = 0.03), schooling (P = 0.045) and history of running nose (P = 0.043) were significantly associated with S.aureus colonization. Living in urban setting (P = 0.042) and children from mothers with college and above levels of education (P = 0.002) were significantly associated with M.catarrhalis colonization. Majority of the isolates were resistant to penicillin (68.5%) and cotrimoxazole (52.5%).S.aureus isolates were resistant to penicillin (84.1%) and cotrimoxazole (51.1%). M.catarrhalis isolates were resistant to penicillin (94.6%), erythromycin (86.5%)and cotrimoxazole (78.4%). Overall, 99 (59.3%) of the isolates were multi-drug (MDR) resistant. The overall MDR rates among S.aureus, M.catarrhalis and S.pneumoniae isolates were 65.9%, 78.4% and 22.6%, respectively. Conclusions Pharyngeal colonization of respiratory bacteria in HIV infected children is a major public health problem. Single and multiple antibiotic resistant is alarmingly high among respiratory colonizers. Therefore, regular screening of HIV infected children for culture and antimicrobial susceptibility testing is recommended to prevent the development of severe opportunistic infections.	[Mulu, Wondemagegn; Yizengaw, Endalew; Alemu, Megbaru; Mekonnen, Daniel; Abera, Bayeh] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Microbiol Immunol & Parasitol, Bahir Dar, Ethiopia; [Hailu, Derese] AmharaPubl Hlth Inst, Bahir Dar, Ethiopia; [Ketemaw, Kassaw] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Ear Nose & Throat, Bahir Dar, Ethiopia; [Kibret, Mulugeta] Bahir Dar Univ, Sci Coll, Dept Biol, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University; Bahir Dar University	Mulu, W (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Med Microbiol Immunol & Parasitol, Bahir Dar, Ethiopia.	wodem_32@yahoo.com	Abera, Bayeh/AAU-8754-2020; Mulu, Wondemagegn/X-3190-2019	Alemu, Megbaru/0000-0002-4851-1366; Mulu, Wondemagegn/0000-0002-5966-9388	College of Medicine and Health Sciences of Bahir Dar University	College of Medicine and Health Sciences of Bahir Dar University	The research project was funded by College of Medicine and Health Sciences of Bahir Dar University. The fund was utilized for purchasing reagents, data collection, analysis and interpretation.	[Anonymous], 2015, M100S25 CLSI; Anthony L, 2012, INT J INFECT DIS, V16, pE753, DOI 10.1016/j.ijid.2012.05.1037; Assefa A, 2013, PEDIATR NEONATOL, V54, P315, DOI 10.1016/j.pedneo.2013.03.017; Bae S, 2012, J MED MICROBIOL, V61, P678, DOI 10.1099/jmm.0.040584-0; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bhuyan GS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174488; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brugger SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011638; Casey JR, 2010, PEDIATR INFECT DIS J, V29, P304, DOI 10.1097/INF.0b013e3181c1bc48; Cheesbourgh M, 2006, DISTRICT LAB PRACT 2; Chochua S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167725; Cotton MF, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-40; Bhattacharya S, 2011, INDIAN J PEDIATR, V78, P423, DOI 10.1007/s12098-010-0310-z; Dunne EM, 2012, J CLIN MICROBIOL, V50, P1034, DOI 10.1128/JCM.06589-11; Federal Ministry of Health Family Health Department, 2005, NAT STRAT CHILD SURV; Gebre T, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4040027; Gebremedhn G, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2613-7; Hidron Alicia I, 2010, Infect Drug Resist, V3, P73; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Huebner R E, 1998, Int J Infect Dis, V3, P18, DOI 10.1016/S1201-9712(98)90090-X; Johny Molly, 2010, J Infect Public Health, V3, P60, DOI 10.1016/j.jiph.2010.02.003; Kejela T, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-11; Kinabo GD, 2013, TROP MED INT HEALTH, V18, P286, DOI 10.1111/tmi.12057; Leibovitz E, 1999, Int J Infect Dis, V3, P211, DOI 10.1016/S1201-9712(99)90027-9; Marchisio P, 2001, J MED MICROBIOL, V50, P1095, DOI 10.1099/0022-1317-50-12-1095; Moyo SJ, 2012, J MED MICROBIOL, V61, P952, DOI 10.1099/jmm.0.042598-0; Mwenya DM, 2010, ANTIMICROB AGENTS CH, V54, P3756, DOI 10.1128/AAC.01409-09; Naaber P, 2000, CLIN MICROBIOL INFEC, V6, P675, DOI 10.1046/j.1469-0691.2000.00184.x; Nackers F, 2017, VACCINE, V35, P5271, DOI 10.1016/j.vaccine.2017.07.081; Ndip RN, 2008, J HEALTH POPUL NUTR, V26, P397; Paulino C, 2013, PEDIATR INFECT DIS J, V14, P24; Quintero B, 2011, EUR J CLIN MICROBIOL, V30, P7, DOI 10.1007/s10096-010-1044-6; Rodr o AguezL, 2011, INT J ENV RES PUB HE, V8; Rutebemberwa E, 2015, UPSALA J MED SCI, V120, P249, DOI 10.3109/03009734.2015.1072606; Safari D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110526; Sampane-Donkor E, 2017, MED J, V26, P60; Shariff M, 2013, J INFECT DEV COUNTR, V7, P101, DOI 10.3855/jidc.2553; Shiri T, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-483; Suvada J, 2016, CLIN SOC WORK HEALTH, V7, P35, DOI 10.22359/cswhi_7_3_09; Valenzuela MT, 2009, REV PANAM SALUD PUBL, V25, P270, DOI 10.1590/S1020-49892009000300011; Thummeepak R, 2015, J INFECT PUBLIC HEAL, V8, P274, DOI 10.1016/j.jiph.2014.11.002; Torun MM, 2017, INDIAN J MED MICROBI, V30, P86; World Health Organization, 2003, WKLY EPIDEMIOL REC, V78	43	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196722	10.1371/journal.pone.0196722	http://dx.doi.org/10.1371/journal.pone.0196722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746496	Green Published, Green Submitted, gold			2022-12-26	WOS:000431851700031
J	Primus, S; Akoolo, L; Schlachter, S; Gedroic, K; Rojtman, AD; Parveen, N				Primus, Shekerah; Akoolo, Lavoisier; Schlachter, Samantha; Gedroic, Kristine; Rojtman, Albert D.; Parveen, Nikhat			Efficient detection of symptomatic and asymptomatic patient samples for Babesia microti and Borrelia burgdorferi infection by multiplex qPCR	PLOS ONE			English	Article							LYME-DISEASE SYNDROME; REAL-TIME PCR; UNITED-STATES; DIAGNOSIS; ASSAY; DUNCANI; TESTS; COINFECTION; SEROLOGY; HUMANS	Background Tick-borne infections have been increasing steadily over the years, with co-infections with Borrelia burgdorferi and Babesia microti/divergens emerging as a serious health problem. B. burgdorferi is a spirochetal bacterium that causes Lyme disease while protozoan pathogens belonging to Babesia species are responsible for babesiosis. Currently used serological tests do not always detect acute Lyme disease or babesiosis, and fail to differentiate cured patients from those who get re-infected. This is a major problem for proper diagnosis particularly in regions endemic for tick-borne diseases. Microscopy based evaluation of babesiosis is confirmatory but is labor intensive and insensitive such that many asymptomatic patients remain undetected and donate blood resulting in transfusion transmitted babesiosis. Results We conducted multiplex qPCR for simultaneous diagnosis of active Lyme disease and babesiosis in 192 blood samples collected from a region endemic for both diseases. We document qPCR results obtained from testing of each sample three times to detect infection with each pathogen separately or together. Results for Lyme disease by qPCR were also compared with serological tests currently used for Lyme disease when available. Considering at least two out of three test results for consistency, 18.2% of patients tested positive for Lyme disease, 18.7% for co-infection with B. burgdorferiand B. microtiand 6.3% showed only babesiosis. Conclusions With an 80% sensitivity for detection of Lyme disease, and ability to detect co-infection with B. microti, multiplex qPCR can be employed for diagnosis of these diseases to start appropriate treatment in a timely manner.	[Primus, Shekerah; Akoolo, Lavoisier; Schlachter, Samantha; Parveen, Nikhat] Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Gedroic, Kristine] Gedroic Ctr, Morristown, NJ USA; [Rojtman, Albert D.] Jersey Shore Univ, Med Ctr, Meridian Hlth, Neptune, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Jersey Shore University Medical Center	Parveen, N (corresponding author), Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA.	parveeni@njms.rutgers.edu		Primus, Shekerah/0000-0001-9379-1865; Akoolo, Lavoisier/0000-0002-3770-3338; Parveen, Nikhat/0000-0003-0592-0693	National Institutes of Health [AI089921]; New Jersey Health Foundation; Rutgers Office of Research and Economic Development grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Health Foundation; Rutgers Office of Research and Economic Development grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by AI089921 grant from the National Institutes of Health, New Jersey Health Foundation grant, and Rutgers Office of Research and Economic Development grant to Nikhat Parveen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; Akoolo L, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0929-2; Aucott JN, 2013, INT J INFECT DIS, V17, pE443, DOI 10.1016/j.ijid.2013.01.008; Aucott JN, 2013, QUAL LIFE RES, V22, P75, DOI 10.1007/s11136-012-0126-6; Bakken Lori L, 2002, J Contin Educ Health Prof, V22, P131, DOI 10.1002/chp.1340220302; Bish EK, 2016, TRANSFUSION, V56, P775, DOI 10.1111/trf.13453; Bloch EM, 2012, TRANSFUSION, V52, P1517, DOI 10.1111/j.1537-2995.2011.03467.x; Brown SL, 1999, JAMA-J AM MED ASSOC, V282, P62, DOI 10.1001/jama.282.1.62; Burbelo PD, 2010, CLIN VACCINE IMMUNOL, V17, P904, DOI 10.1128/CVI.00476-09; Chan K, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-295; Conrad PA, 2006, INT J PARASITOL, V36, P779, DOI 10.1016/j.ijpara.2006.03.008; Crowder LA, 2014, PUBLIC HEALTH, V128, P784, DOI 10.1016/j.puhe.2014.06.016; Diuk-Wasser MA, 2014, EMERG INFECT DIS, V20, P225, DOI 10.3201/eid2002.130644; Dunn JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115494; Fang DC, 2016, TRANSFUS MED REV, V30, P132, DOI 10.1016/j.tmrv.2016.04.002; Genda J, 2016, J INVEST MED HIGH IM, V4, DOI 10.1177/2324709616663774; HAUTANEN A, 1989, J BIOL CHEM, V264, P1437; Hernandez-Novoa B, 2003, DIAGN MICR INFEC DIS, V47, P321, DOI 10.1016/S0732-8893(03)00111-1; Hersh MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099348; Herwaldt BL, 2011, ANN INTERN MED, V155, P509, DOI 10.7326/0003-4819-155-8-201110180-00362; Johnson ST, 2013, TRANSFUSION, V53, P2644, DOI 10.1111/trf.12125; Joss AWL, 2008, J CLIN PATHOL, V61, P221, DOI 10.1136/jcp.2007.048801; Krause PJ, 2003, AM J TROP MED HYG, V68, P431, DOI 10.4269/ajtmh.2003.68.431; Krause PJ, 1996, JAMA-J AM MED ASSOC, V275, P1657, DOI 10.1001/jama.275.21.1657; Krause PJ, 2002, CLIN INFECT DIS, V34, P1184, DOI 10.1086/339813; Krupp LB, 2003, NEUROLOGY, V60, P1923, DOI 10.1212/01.WNL.0000071227.23769.9E; Leeflang MMG, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1468-4; LINNAVUO M, 1987, PHARMACOL TOXICOL, V61, P142, DOI 10.1111/j.1600-0773.1987.tb01792.x; Mareedu N, 2017, AM J TROP MED HYG, V97, P1218, DOI 10.4269/ajtmh.17-0146; Martinez-Balzano C, 2015, QJM-INT J MED, V108, P141, DOI 10.1093/qjmed/hcs100; Mogilyansky E, 2004, CLIN DIAGN LAB IMMUN, V11, P924, DOI 10.1128/CDLI.11.5.924-929.2004; Moutailler S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004539; Ohmori S, 2016, PARASITOL INT, V65, P567, DOI 10.1016/j.parint.2016.03.003; PIESMAN J, 1986, J CLIN MICROBIOL, V24, P446, DOI 10.1128/JCM.24.3.446-447.1986; Rebman AW, 2015, CLIN RHEUMATOL, V34, P585, DOI 10.1007/s10067-014-2706-z; Rollend L, 2013, VECTOR-BORNE ZOONOT, V13, P784, DOI 10.1089/vbz.2011.0935; Schlachter S, 2017, METHODS MOL BIOL, V1616, P155, DOI 10.1007/978-1-4939-7037-7_10; Schulze TL, 2013, J MED ENTOMOL, V50, P379, DOI 10.1603/ME12088; Souza SS, 2016, AM J TROP MED HYG, V95, P1413, DOI 10.4269/ajtmh.16-0406; Steere AC, 2008, CLIN INFECT DIS, V47, P188, DOI 10.1086/589242; Steiner I, 2003, NEUROLOGY, V60, P1888, DOI 10.1212/01.WNL.0000077046.67754.60; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; TAKADA Y, 1987, Nippon Acta Radiologica, V47, P962; Teal AE, 2012, J CLIN MICROBIOL, V50, P903, DOI 10.1128/JCM.05848-11; Tokarz R, 2017, DETECTION ANAPLASMA; Tonnetti L, 2013, TRANSFUSION, V53, P1698, DOI 10.1111/j.1537-2995.2012.03948.x; Vermeersch P, 2009, DIAGN MICR INFEC DIS, V64, P347, DOI 10.1016/j.diagmicrobio.2009.03.013; Wang GQ, 2015, DIAGN MICR INFEC DIS, V82, P109, DOI 10.1016/j.diagmicrobio.2015.03.010; Wang GQ, 2015, TICKS TICK-BORNE DIS, V6, P376, DOI 10.1016/j.ttbdis.2015.03.001; Wilske B, 2007, FEMS IMMUNOL MED MIC, V49, P13, DOI 10.1111/j.1574-695X.2006.00139.x; Wilson M, 2015, EXP PARASITOL, V149, P24, DOI 10.1016/j.exppara.2014.12.003; Wormser GP, 2013, DIAGN MICR INFEC DIS, V75, P9, DOI 10.1016/j.diagmicrobio.2012.09.003; Wright WF, 2012, AM FAM PHYSICIAN, V85, P1086; Young C, 2012, TRANSFUSION, V52, P1523, DOI 10.1111/j.1537-2995.2012.03612.x	55	15	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196748	10.1371/journal.pone.0196748	http://dx.doi.org/10.1371/journal.pone.0196748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746483	Green Submitted, Green Published, gold			2022-12-26	WOS:000431851700034
J	Roh, M; Selivanova, A; Shin, HJ; Miller, JW; Jackson, ML				Roh, Miin; Selivanova, Alexandra; Shin, Hyun Joon; Miller, Joan W.; Jackson, Mary Lou			Visual acuity and contrast sensitivity are two important factors affecting vision-related quality of life in advanced age-related macular degeneration	PLOS ONE			English	Article							FUNCTION QUESTIONNAIRE; ASSOCIATION; DISABILITY; VALIDITY; THERAPY	Purpose Vision loss from age-related macular degeneration (AMD) has a profound effect on vision-related quality of life (VRQoL). The pupose of this study is to identify clinical factors associated with VRQoL using the Rasch- calibrated NEI VFQ-25 scales in bilateral advanced AMD patients. Methods We retrospectively reviewed 47 patients (mean age 83.2 years) with bilateral advanced AMD. Clinical assessment included age, gender, type of AMD, high contrast visual acuity (VA), history of medical conditions, contrast sensitivity (CS), central visual field loss, report of Charles Bonnet Syndrome, current treatment for AMD and Rasch-calibrated NEI VFQ-25 visual function and socioemotional function scales. The NEI VFQ visual function scale includes items of general vision, peripheral vision, distance vision and near vision-related activity while the socioemotional function scale includes items of vision related-social functioning, role difficulties, dependency, and mental health. Multiple regression analysis (structural regression model) was performed using fixed item parameters obtained from the one-parameter item response theory model. Results Multivariate analysis showed that high contrast VA and CS were two factors influencing VRQoL visual function scale (beta = -0.25, 95% CI-0.37 to -0.12, p<0.001 and beta = 0.35, 95% CI 0.25 to 0.46, p<0.001) and socioemontional functioning scale (beta = -0.2, 95% CI -0.37 to -0.03, p = 0.023, and beta = 0.3, 95% CI 0.18 to 0.43, p = 0.001). Central visual field loss was not assoicated with either VRQoL visual or socioemontional functioning scale (beta = -0.08, 95% CI-0.28 to 0.12,p = 0.44 and beta = -0.09, 95% CI -0.03 to 0.16, p = 0.50, respectively). Conclusion In patients with vision impairment secondary to bilateral advanced AMD, high contrast VA and CS are two important factors affecting VRQoL.	[Roh, Miin; Selivanova, Alexandra; Miller, Joan W.] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear, Boston, MA USA; [Shin, Hyun Joon] Harvard Med Sch, Dept Med, VA Boston Hlth Care syst, Div Aging,Brigham & Womens Hosp, Boston, MA USA; [Jackson, Mary Lou] VGH Univ British Coumbia, Eye Care Ctr, Vancouver, BC, Canada	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; University of British Columbia	Jackson, ML (corresponding author), VGH Univ British Coumbia, Eye Care Ctr, Vancouver, BC, Canada.	marylou.jackson@vch.ca		Shin, Hyun Joon/0000-0001-5781-0643; Roh, Miin/0000-0003-3346-754X	Eye Pharmaceutical; Ear/Valeant Pharmaceutical; ONL Therapeutics, LLC	Eye Pharmaceutical; Ear/Valeant Pharmaceutical(Johnson & Johnson); ONL Therapeutics, LLC	MR, SA, HS and MJ have nothing to disclose. JWM reports personal fees from Amgen, Inc., personal fees from KalVista Pharmaceuticals, Ltd., non-financial support from Maculogix, Inc., personal fees from Biogen Idec, Inc., personal fees from Alcon Research Council, grants from Lowy Medical Research Institute, Ltd., outside the submitted work; In addition, Dr. Miller has a patent Mass. Eye and Ear/Valeant Pharmaceuticals with royalties paid to Mass. Eye and Ear, and a patent ONL Therapeutics, LLC with royalties paid to ONL Therapeutics, LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansback N, 2007, QUAL LIFE RES, V16, P533, DOI 10.1007/s11136-006-9126-8; Bellmann C, 2003, GRAEF ARCH CLIN EXP, V241, P968, DOI 10.1007/s00417-003-0689-6; Berdeaux GH, 2005, AM J OPHTHALMOL, V139, P271, DOI 10.1016/j.ajo.2004.09.028; Bond T. G, 2015, APPLYING RASCH MODEL, V3rd, DOI DOI 10.4324/9781315814698; Brody BL, 2001, OPHTHALMOLOGY, V108, P1893, DOI 10.1016/S0161-6420(01)00754-0; Brody BL, 2001, OPHTHALMOLOGY, V108, P1901; Brown Gary C, 2005, Trans Am Ophthalmol Soc, V103, P173; Cahill MT, 2005, OPHTHALMOLOGY, V112, P152, DOI 10.1016/j.ophtha.2004.06.036; Chew EY, 2014, JAMA OPHTHALMOL, V132, P272, DOI 10.1001/jamaophthalmol.2013.6636; Cruess AF, 2008, PHARMACOECONOMICS, V26, P57, DOI 10.2165/00019053-200826010-00006; DeMars C, 2010, ITEM RESPONSE THEORY; Fleckenstein M, 2017, OPHTHALMOLOGY; Fletcher DC, 2006, OPTOMETRY VISION SCI, V83, P178, DOI 10.1097/01.opx.0000204510.08026.7f; Fujii GY, 2003, AM J OPHTHALMOL, V136, P1067, DOI 10.1016/S0002-9394(03)00663-9; Hochberg C, 2012, INVEST OPHTH VIS SCI, V53, P3201, DOI 10.1167/iovs.12-9469; Linacre J.M, 2016, RASCH MODEL COMPUTER; Lu IRR, 2005, STRUCT EQU MODELING, V12, P263, DOI 10.1207/s15328007sem1202_5; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mantyjarvi M, 2001, J CATARACT REFR SURG, V27, P261, DOI 10.1016/S0886-3350(00)00562-9; Marella M, 2010, INVEST OPHTH VIS SCI, V51, P2878, DOI 10.1167/iovs.09-4494; Maynard ML, 2016, ACTA OPHTHALMOL, DOI DOI 10.1111/AOS.12758; Midena E, 2007, EUR J OPHTHALMOL, V17, P63, DOI 10.1177/112067210701700109; Midena Edoardo, 2004, Semin Ophthalmol, V19, P55, DOI 10.1080/08820530490882896; Mitchell J, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-97; Pelli DG, 2013, VISION RES, V90, P10, DOI 10.1016/j.visres.2013.04.015; Pesudovs K, 2010, J CATARACT REFR SURG, V36, P718, DOI 10.1016/j.jcrs.2009.11.019; Revicki DA, 2010, INVEST OPHTH VIS SCI, V51, P712, DOI 10.1167/iovs.09-3766; Schmidt-Erfurth UM, 2004, OPHTHALMOLOGY, V111, P931, DOI 10.1016/j.ophtha.2003.12.025; Sunness JS, 1999, OPHTHALMOLOGY, V106, P1768, DOI 10.1016/S0161-6420(99)90340-8; World Health Organization, 2012, GLOB DAT VIS IMP 201; World Health Organization, PREV BLINDN VIS IMP; Yang K, 2011, OPHTHALMOLOGY, V118, P1395, DOI 10.1016/j.ophtha.2010.12.030	32	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2018	13	5							e0196481	10.1371/journal.pone.0196481	http://dx.doi.org/10.1371/journal.pone.0196481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3JM	29746512	gold, Green Published, Green Submitted			2022-12-26	WOS:000431851700020
J	Diaz, A; Baade, PD; Valery, PC; Whop, LJ; Moore, SP; Cunningham, J; Garvey, G; Brotherton, JML; O'Connell, DL; Canfell, K; Sarfati, D; Roder, D; Buckley, E; Condon, JR				Diaz, Abbey; Baade, Peter D.; Valery, Patricia C.; Whop, Lisa J.; Moore, Suzanne P.; Cunningham, Joan; Garvey, Gail; Brotherton, Julia M. L.; O'Connell, Dianne L.; Canfell, Karen; Sarfati, Diana; Roder, David; Buckley, Elizabeth; Condon, John R.			Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012)	PLOS ONE			English	Article							BREAST-CANCER; ADMINISTRATIVE DATA; IMPACT; DISPARITIES; POPULATION; VALIDATION; OUTCOMES; DEATH; WALES; STAGE	Background Little is known about the impact of comorbidity on cervical cancer survival in Australian women, including whether Indigenous women's higher prevalence of comorbidity contributes to their lower survival compared to non-Indigenous women. Methods Data for cervical cancers diagnosed in 2003-2012 were extracted from six Australian state-based cancer registries and linked to hospital inpatient records to identify comorbidity diagnoses. Five-year cause-specific and all-cause survival probabilities were estimated using the Kaplan-Meier method. Flexible parametric models were used to estimate excess cause-specific mortality by Charlson comorbidity index score (0,1,2+), for Indigenous women compared to non-Indigenous women. Results Of 4,467 women, Indigenous women (4.4%) compared to non-Indigenous women had more comorbidity at diagnosis (score >= 1: 24.2% vs. 10.0%) and lower five-year cause-specific survival (60.2% vs. 76.6%). Comorbidity was associated with increased cervical cancer mortality for non-Indigenous women, but there was no evidence of such a relationship for Indigenous women. There was an 18% reduction in the Indigenous: non-Indigenous hazard ratio (excess mortality) when comorbidity was included in the model, yet this reduction was not statistically significant. The excess mortality for Indigenous women was only evident among those without comorbidity (Indigenous: non-Indigenous HR 2.5, 95%CI 1.9-3.4), indicating that factors other than those measured in this study are contributing to the differential. In a subgroup of New South Wales women, comorbidity was associated with advanced-stage cancer, which in turn was associated with elevated cervical cancer mortality. Conclusion Survival was lowest for women with comorbidity. However, there wasn't a clear comorbidity-survival gradient for Indigenous women. Further investigation of potential drivers of the cervical cancer survival differentials is warranted. Impact The results highlight the need for cancer care guidelines and multidisciplinary care that can meet the needs of complex patients. Also, primary and acute care services may need to pay more attention to Indigenous Australian women who may not obviously need it (i.e. those without comorbidity).	[Diaz, Abbey; Valery, Patricia C.; Whop, Lisa J.; Moore, Suzanne P.; Cunningham, Joan; Garvey, Gail; Condon, John R.] Charles Darwin Univ, Menzies Sch Hlth Res, Casuarina, NT, Australia; [Baade, Peter D.] Canc Council Queensland, Spring Hill, Qld, Australia; [Valery, Patricia C.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Brotherton, Julia M. L.] Victorian Cytol Serv, Carlton, Vic, Australia; [Brotherton, Julia M. L.] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [O'Connell, Dianne L.; Canfell, Karen] Canc Council NSW, Canc Res Div, Kings Cross, NSW, Australia; [O'Connell, Dianne L.; Canfell, Karen] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Canfell, Karen] Univ NSW, Prince Wales Clin Sch, Sydney, NSW, Australia; [Sarfati, Diana] Univ Otago, Wellington, New Zealand; [Roder, David; Buckley, Elizabeth] Univ South Australia, Canc Epidemiol & Populat Hlth, Adelaide, SA, Australia	Charles Darwin University; Menzies School of Health Research; Cancer Council Queensland; QIMR Berghofer Medical Research Institute; University of Melbourne; Cancer Council New South Wales; University of Sydney; University of New South Wales Sydney; University of Otago; University of South Australia	Diaz, A (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Casuarina, NT, Australia.	abbey.diaz@menzies.edu.au	Condon, John R/N-2281-2013; Valery, Patricia/AAV-5448-2020; Buckley, Elizabeth/E-3878-2016; Baade, Peter/C-4113-2009; Roder, David/B-7038-2013; Moore, Suzanne/AAC-3801-2021	Condon, John R/0000-0003-4952-0990; Valery, Patricia/0000-0002-8823-3006; Buckley, Elizabeth/0000-0001-8980-1194; Roder, David/0000-0001-6442-4409; Diaz, Abbey/0000-0002-8637-311X; Whop, Lisa/0000-0003-4816-2933; Canfell, Karen/0000-0002-6443-6618; Garvey, Gail/0000-0001-5065-5716; Moore, Suzanne/0000-0002-8045-0305; Baade, Peter/0000-0001-8576-8868	National Health and Medical Research Council (NHMRC) [1045591, 1055587]; Centre of Research Excellence in Discovering Indigenous Strategies to improve Cancer Outcomes via Engagement, Research Translation & Training (DISCOVER-TT CRE) - NHMRC [1041111]; Cancer Council NSW [SRP 13-01]; Cancer Council WA; Lowitja Institute; Australia's National Institute for Aboriginal and Torres Strait Islander Health Research; Menzies Enhanced Living Top-up scholarship - DISCOVER-TT CRE; NHMRC [1083090, 1082989]; Sidney Myer Health Scholarship; Menzies Enhanced Living Top-up Scholarship; NHMRC Early Career Fellowship [1105399]; NHMRC Research Fellowship [1058244]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Centre of Research Excellence in Discovering Indigenous Strategies to improve Cancer Outcomes via Engagement, Research Translation & Training (DISCOVER-TT CRE) - NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); Cancer Council WA(Cancer Council Western Australia); Lowitja Institute; Australia's National Institute for Aboriginal and Torres Strait Islander Health Research; Menzies Enhanced Living Top-up scholarship - DISCOVER-TT CRE; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Sidney Myer Health Scholarship; Menzies Enhanced Living Top-up Scholarship; NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The National Indigenous Cervical Screening Project (NICSP) was funded by a National Health and Medical Research Council (NHMRC; https://www.nhmrc.gov.au/) Project Grant (#1045591). This project was conducted under the auspice of the Centre of Research Excellence in Discovering Indigenous Strategies to improve Cancer Outcomes via Engagement, Research Translation & Training (DISCOVER-TT CRE) funded by NHMRC (#1041111) & the Strategic Research Partnership to Improve Cancer Control for Indigenous Australians (STREP Ca-CIndA), funded by Cancer Council NSW (#SRP 13-01; https://www.cancercouncil.com.au/) with supplementary funding from Cancer Council WA (https://www.cancerwa.asn.au/). We also acknowledge the ongoing support of the Lowitja Institute (http://www.lowitja.org.au/), Australias National Institute for Aboriginal and Torres Strait Islander Health Research. A Diaz was supported by a National Health and Medical Research Council (NHMRC) Training Scholarship for Indigenous Australian Health Research (#1055587) and a Menzies Enhanced Living Top-up scholarship (www.menzies.edu.au) funded by the DISCOVER-TT CRE. PCV was supported by the NHMRC (Career Development Fellowship #1083090). LJW was supported by a Sidney Myer Health Scholarship (http://myerfoundation.org.au/), Menzies Enhanced Living Top-up Scholarship and a student scholarship funded by the Lowitja Institute. GG was supported by an NHMRC Early Career Fellowship (#1105399). JC was supported by an NHMRC Research Fellowship (#1058244). KC receives salary support from NHMRC (Career Development Fellowship #1082989). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are those of the authors and do not necessarily reflect the views of the funding agencies.	AIHW, 2017, CANC AUSTR 2017; [Anonymous], 2016, AUSTR DEM STAT; [Anonymous], 2013, IND ID HOSP SEP DAT; Australian Bureau of Statistics (ABS), 2006, STAT GEOGR; Australian Bureau of Statistics (ABS), 2008, CENS POP HOUS SOC IN; Australian Institute of Health and Welfare (AIHW), 2004, RUR REG REM HLTH GUI; Australian Institute of Health and Welfare (AIHW), 2010, CONTR CHRON DIS GAP; Australian Institute of Health and Welfare (AIHW), 2016, CERV SCREEN AUSTR 20; Australian Institute of Health and Welfare & Cancer Australia Cancer, 2012, GYN CANC AUSTR OV; Brewer N, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-132; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coker AL, 2009, INT J GYNECOL CANCER, V19, P13, DOI 10.1111/IGC.0b013e318197f343; Condon JR, 2012, INTERN MED J, V42, pE165, DOI 10.1111/j.1445-5994.2011.02539.x; Condon JR, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-1; Condon JR, 2005, MED J AUSTRALIA, V182, P277, DOI 10.5694/j.1326-5377.2005.tb06700.x; Cronin-Fenton DP, 2007, BRIT J CANCER, V96, P1462, DOI 10.1038/sj.bjc.6603717; Dasgupta P, 2012, BREAST CANCER RES TR, V132, P701, DOI 10.1007/s10549-011-1899-y; Diaz A, 2017, CANCER EPIDEMIOL, V47, P7, DOI 10.1016/j.canep.2016.12.010; Diaz A, 2015, INT J GYNECOL CANCER, V25, P542, DOI 10.1097/IGC.0000000000000375; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ferrandina G, 2012, EJSO-EUR J SURG ONC, V38, P238, DOI 10.1016/j.ejso.2011.12.001; Fleming ST, 2005, MED CARE, V43, P132, DOI 10.1097/00005650-200502000-00006; Flores-Luna L, 2001, INT J GYNECOL OBSTET, V75, P33, DOI 10.1016/S0020-7292(01)00471-4; Ghebre RG, 2011, GYNECOL ONCOL, V121, P595, DOI 10.1016/j.ygyno.2011.02.005; Gibberd A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2322-1; Gibberd A, 2015, MED J AUSTRALIA, V202, P195, DOI 10.5694/mja14.00701; Grann Anne Fia, 2013, Clin Epidemiol, V5, P57, DOI 10.2147/CLEP.S47205; GRULICH AE, 1995, INT J CANCER, V63, P164, DOI 10.1002/ijc.2910630203; He VYF, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-016-0118-9; Heathcote K, 2007, CANC FORUM, V31, P1; Hill S, 2010, J EPIDEMIOL COMMUN H, V64, P117, DOI 10.1136/jech.2008.083816; Jong KE, 2004, MED J AUSTRALIA, V180, P618, DOI 10.5694/j.1326-5377.2004.tb06123.x; Kim Kyoung Hoon, 2009, J Prev Med Public Health, V42, P267, DOI 10.3961/jpmph.2009.42.4.267; Ministry of Health (NZ), 2017, NCSP NZ ALL DISTR HL; Moore SP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-517; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Sarfati D, 2016, CA-CANCER J CLIN, V66, P338, DOI 10.3322/caac.21342; Sarfati D, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-821; Schaffar R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-609; Seamon LG, 2011, GYNECOL ONCOL, V123, P565, DOI 10.1016/j.ygyno.2011.09.008; Smith M, 2016, MED J AUSTRALIA, V205, P359, DOI 10.5694/mja16.00289; Sogaard Mette, 2013, Clin Epidemiol, V5, P3, DOI 10.2147/CLEP.S47150; Stanbury JF, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2065-z; Supramaniam R, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-163; Tammemagi CM, 2005, JAMA-J AM MED ASSOC, V294, P1765, DOI 10.1001/jama.294.14.1765; Threlfall Timothy, 2005, Popul Health Metr, V3, P9, DOI 10.1186/1478-7954-3-9; Unit NS, 2008, GUID CERV SCREEN NZ; Whop LJ, 2017, ASIA-PAC J CLIN ONCO, V13, pE224, DOI 10.1111/ajco.12463; Whop LJ, 2016, CANCER-AM CANCER SOC, V122, P1560, DOI 10.1002/cncr.29954; Whop LJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009540; Xu N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152463	51	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2018	13	5							e0196764	10.1371/journal.pone.0196764	http://dx.doi.org/10.1371/journal.pone.0196764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF1VY	29738533	gold, Green Published, Green Accepted			2022-12-26	WOS:000431724900017
J	Abegaz, TM; Birru, EM; Mekonnen, GB				Abegaz, Tadesse Melaku; Birru, Eshetie Melese; Mekonnen, Gashaw Binega			Potentially inappropriate prescribing in Ethiopian geriatric patients hospitalized with cardiovascular disorders using START/STOPP criteria	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITORS; VENTRICULAR SYSTOLIC DYSFUNCTION; RANDOMIZED CONTROLLED-TRIALS; ACUTE MYOCARDIAL-INFARCTION; HEART-FAILURE PATIENTS; ADVERSE DRUG-REACTIONS; ELDERLY-PATIENTS; STOPP/START CRITERIA; OLDER-ADULTS; STROKE PREVENTION	Background There was a paucity of data on the magnitude of potentially inappropriate prescriptions (PIPs) among Ethiopian elderly cardiovascular patients. Objective The aim of this study was to assess PIPs and associated factors in the elderly population with cardiovascular disorders using the START/STOPP screening criteria. Methods A hospital-based cross-sectional study was conducted at medical wards of a teaching hospital in Ethiopia from 1 December 2016-30 May 2017. Included patients were hospitalized elderly patients aged 65 years or older with cardiovascular disorders; their medications were evaluated using the START/STOPP screening criteria from admission to discharge. Multivariable logistic regression was applied to identify factors associated with inappropriate medications. One Way Analysis Of Variance (ANOVA) was carried out to test significant differences on the number of PIPs per individual diagnosis. Results Two hundred thirty-nine patients were included in the analysis. More-than a third of the patients were diagnosed with heart failure, 88 (36.82%). A total of 221 PIPs were identified in 147 patients, resulting in PIP prevalence of 61.5% in the elderly population. Of the total number of PIPs, occurrence of one, two and three PIPs accounted for 83 (56.4%), 52 (35.4%), and 12(8.2%) respectively. One way ANOVA test showed significant differences on the mean number of PIPs per individual diagnosis (f = 5.718, p<0.001). Angiotensin Converting Enzyme Inhibitors (ACEIs) were the most common inappropriately prescribed medications, 32(14.5%). Hospital stay, AOR: 1.086 (1.016-1.160), number of medications at discharge, AOR: 1.924 (1.217-3.041) and the presence of co-morbidities, AOR: 3.127 (1.706-5.733) increased the likelihood of PIP. Conclusion Approximately, two-thirds of elderly cardiovascular patients encountered potentially inappropriate prescriptions. ACEIs were the most commonly mis-prescribed medications. Longer hospital stay, presence of comorbidities and prescription of large number of medications at discharge have been correlated with the occurrence of inappropriate medication. It is essential to evaluate patients' medications during hospital stay using the STOPP and START tool to reduce PIPs.	[Abegaz, Tadesse Melaku; Mekonnen, Gashaw Binega] Univ Gondar, Sch Pharm, Dept Clin Pharm, Coll Med & Hlth Sci, Gondar, Ethiopia; [Birru, Eshetie Melese] Univ Gondar, Sch Pharm, Dept Pharmacol, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar	Abegaz, TM (corresponding author), Univ Gondar, Sch Pharm, Dept Clin Pharm, Coll Med & Hlth Sci, Gondar, Ethiopia.	abegaztadesse981@gmail.com	mekonnen, Gashaw Binega/AAO-3178-2020	mekonnen, Gashaw Binega/0000-0002-2650-8668				Abegaz TM, EPIDEMIOLOGY TARGET; Ahmed A, 2002, SOUTHERN MED J, V95, P703; Ahmed A, 2002, J GERONTOL A-BIOL, V57, pM138, DOI 10.1093/gerona/57.2.M138; Akao M, 2014, CIRC J, V78, P2166, DOI 10.1253/circj.CJ-14-0344; Ambrosio G, 2011, HEART, V97, P209, DOI 10.1136/hrt.2010.207365; Arif SA, 2010, ANN PHARMACOTHER, V44, P1604, DOI 10.1345/aph.1P128; Bajorek B., 2011, THERAPEUTIC ADV DRUG; Bangalore S, 2007, J AM COLL CARDIOL, V50, P563, DOI 10.1016/j.jacc.2007.04.060; Bauersachs J, 2003, Minerva Cardioangiol, V51, P155; Bejan-Angoulvant T, 2010, J HYPERTENS, V28, P1366, DOI 10.1097/HJH.0b013e328339f9c5; BRUGTS JJ, 2009, BMJ-BRIT MED J, V338, DOI DOI 10.1136/BMJ.B2376; Bucci C, 2008, CAN J CARDIOL, V24, P629, DOI 10.1016/S0828-282X(08)70651-2; Chang CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094350; Cheng JWM, 2009, AM J GERIATR PHARMAC, V7, P233, DOI 10.1016/j.amjopharm.2009.10.001; Chiatti C, 2012, DRUG SAFETY, V35, P73, DOI 10.1007/BF03319105; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Dalleur O, 2014, DRUG AGING, V31, P291, DOI 10.1007/s40266-014-0157-5; Danchin N, 2006, ARCH INTERN MED, V166, P787, DOI 10.1001/archinte.166.7.787; Desai AS, 2007, J AM COLL CARDIOL, V50, P1959, DOI 10.1016/j.jacc.2007.07.067; Flaker GC, 2006, AM HEART J, V152, P967, DOI 10.1016/j.ahj.2006.06.024; Fleg JL, 2011, NAT REV CARDIOL, V8, P13, DOI 10.1038/nrcardio.2010.162; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gallagher PF, 2011, CLIN PHARMACOL THER, V89, P845, DOI 10.1038/clpt.2011.44; Gallagher PF, 2008, AGE AGEING, V37, P96, DOI 10.1093/ageing/afm116; Galvin R, 2014, EUR J CLIN PHARMACOL, V70, P599, DOI 10.1007/s00228-014-1651-8; Getachew H, 2016, CLIN INTERV AGING, V11, P819, DOI 10.2147/CIA.S107394; Hamano J, 2014, J GEN FAM MED, V15, P117, DOI 10.14442/general.15.117; Hamilton H, 2011, ARCH INTERN MED, V171, P1013, DOI 10.1001/archinternmed.2011.215; Hedna K, 2015, EUR J CLIN PHARMACOL, V71, P1525, DOI 10.1007/s00228-015-1950-8; Holmes DR, 2009, J AM COLL CARDIOL, V54, P95, DOI 10.1016/j.jacc.2009.03.044; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Knijff-Dutmer EAJ, 2003, QJM-INT J MED, V96, P513, DOI 10.1093/qjmed/hcg090; Lahoud R, 2012, AM J CARDIOL, V109, P159, DOI 10.1016/j.amjcard.2011.08.024; Lang PO, 2010, AGE AGEING, V39, P373, DOI 10.1093/ageing/afq031; Laroche ML, 2007, BRIT J CLIN PHARMACO, V63, P177, DOI 10.1111/j.1365-2125.2006.02831.x; Mills E, 2010, QJM; Misganaw A, 2014, J HEALTH POPUL NUTR, V32, P1; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082359; O'Connor M., 2013, THESIS; O'Connor MN, 2012, DRUG AGING, V29, P437, DOI 10.2165/11632610-000000000-00000; O'Mahony D, 2015, AGE AGEING, V44, P213, DOI 10.1093/ageing/afu145; Onder G, 2005, EUR J CLIN PHARMACOL, V61, P453, DOI 10.1007/s00228-005-0928-3; Onder G, 2013, AGE AGEING, V42, P284, DOI 10.1093/ageing/aft038; Papademetriou V, 2004, J AM COLL CARDIOL, V44, P1175, DOI 10.1016/j.jacc.2004.06.034; Poggio R, 2010, POSTGRAD MED J, V86, P136, DOI 10.1136/pgmj.2008.072058; Marquez PHP, 2017, DRUG AGING, V34, P453, DOI 10.1007/s40266-017-0452-z; Rancourt Carol, 2004, BMC Geriatr, V4, P9, DOI 10.1186/1471-2318-4-9; Rasmussen JN, 2007, JAMA-J AM MED ASSOC, V297, P177, DOI 10.1001/jama.297.2.177; Rollason V, 2003, DRUG AGING, V20, P817, DOI 10.2165/00002512-200320110-00003; San-Jose A, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0038-8; Scott I, 2009, INTERN MED J, V39, P347, DOI 10.1111/j.1445-5994.2009.01966.x; Sehgal Vishal, 2013, J Family Med Prim Care, V2, P194, DOI 10.4103/2249-4863.117423; Shah Kartik Nitinbhai, 2016, J Basic Clin Pharm, V7, P110, DOI 10.4103/0976-0105.189434; Sonnerstam E, 2016, DRUG AGING, V33, P889, DOI 10.1007/s40266-016-0408-8; Soumeral SB, 1997, JAMA-J AM MED ASSOC, V277, P115, DOI 10.1001/jama.277.2.115; Tangeman HJ, 2003, ANN PHARMACOTHER, V37, P701, DOI 10.1345/aph.1C286; Tosato M, 2014, AGE AGEING, V43, P767, DOI 10.1093/ageing/afu029; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; Wright SP, 2003, EUR J HEART FAIL, V5, P201, DOI 10.1016/S1388-9842(02)00201-5; Yang P, 2016, THER CLIN RISK MANAG, V12, P1517, DOI 10.2147/TCRM.S116789; Yeomans ND, 2011, EXPERT REV GASTROENT, V5, P447, DOI [10.1586/egh.11.42, 10.1586/EGH.11.42]	61	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0195949	10.1371/journal.pone.0195949	http://dx.doi.org/10.1371/journal.pone.0195949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723249	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100011
J	Belden, D; Porporato, EMD; Pastres, R; Brigolin, D				Belden, Damiano; Porporato, Erika Maria Diletta; Pastres, Roberto; Brigolin, Daniele			An R package for simulating growth and organic wastage in aquaculture farms in response to environmental conditions and husbandry practices	PLOS ONE			English	Article							CLIMATE-CHANGE; TAPES-PHILIPPINARUM; IMPACT; LAGOON	A new R software package, RAC, is presented. RAC allows to simulate the rearing cycle of 4 species, finfish and shellfish, highly important in terms of production in the Mediterranean Sea. The package works both at the scale of the individual and of the farmed population. Mathematical models included in RAC were all validated in previous works, and account for growth and metabolism, based on input data characterizing the forcing functions water temperature, and food quality/quantity. The package provides a demo dataset of forcings for each species, as well as a typical set of husbandry parameters for Mediterranean conditions. The present work illustrates RAC main features, and its current capabilities/limitations. Three test cases are presented as a proof of concept of RAC applicability, and to demonstrate its potential for integrating different open products nowadays provided by remote sensing and operational oceanography.	[Belden, Damiano; Pastres, Roberto; Brigolin, Daniele] Bluefarm Srl, Venezia Marghera, Italy; [Porporato, Erika Maria Diletta; Pastres, Roberto; Brigolin, Daniele] Ca Foscari Univ Venice, Dept Environm Sci Informat & Stat, Venice, Italy	Universita Ca Foscari Venezia	Brigolin, D (corresponding author), Bluefarm Srl, Venezia Marghera, Italy.; Brigolin, D (corresponding author), Ca Foscari Univ Venice, Dept Environm Sci Informat & Stat, Venice, Italy.	brigo@unive.it	Porporato, Erika M. D./L-7797-2017; Baldan, Damiano/AAW-1545-2021	Porporato, Erika M. D./0000-0001-9650-0760; Brigolin, Daniele/0000-0002-4590-8616; Baldan, Damiano/0000-0001-9237-4883; PASTRES, Roberto/0000-0002-7572-3858	Bluefarm S.r.I.; DAIS	Bluefarm S.r.I.; DAIS	DBr, EMDP and RP are researchers employed at the Department of Environmental Sciences, Informatics and Statistics, University of Venice (DAIS). The study was partly financed by DAIS, as an individual research grant to DBr, within the IRIDE project "ADvances in Aquaculture MOdels: state of the art and perspectives (ADAMO). Bluefarm S.r.I., a DAIS spin-off company of which DBr and RP are co-founders and shareholders, provided support in the form of salary for the author DBa. There was no additional external funding received for this study. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; Bacher C, 2006, J SEA RES, V56, P140, DOI 10.1016/j.seares.2006.03.004; Brigolin D, 2017, ICES J MAR SCI, V74, P1540, DOI 10.1093/icesjms/fsx018; Brigolin D, 2015, OCEAN COAST MANAGE, V116, P89, DOI 10.1016/j.ocecoaman.2015.07.010; Brigolin D, 2014, AQUACULT ENV INTERAC, V5, P71, DOI 10.3354/aei00093; Brigolin D, 2010, AQUACULT INT, V18, P149, DOI 10.1007/s10499-008-9232-4; Brigolin D, 2009, ESTUAR COAST SHELF S, V82, P365, DOI 10.1016/j.ecss.2009.01.029; Callier MD, 2006, MAR ECOL PROG SER, V322, P129, DOI 10.3354/meps322129; Cochrane K., 2009, 530 FAO FISH AQ; FAO, 2013, COFIAQ720136; FAO World Bank., 2015, AQ ZON SIT SEL AR MA; Ferreira JG., 2012, FARMING WATERS PEOPL, P643; Jacob D, 2014, REG ENVIRON CHANGE, V14, P563, DOI 10.1007/s10113-013-0499-2; Kapetsky J. M., 2007, 458 FAO; MIPAAF, 2014, PIAN STRAT ACQ IT 20; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Pastres R, 2001, ECOL MODEL, V138, P231, DOI 10.1016/S0304-3800(00)00404-X; Rampazzo F, 2013, ESTUAR COAST SHELF S, V129, P49, DOI 10.1016/j.ecss.2013.06.001; Rosa R, 2012, REV AQUACULT, V4, P163, DOI 10.1111/j.1753-5131.2012.01071.x; Saitoh SI, 2011, ICES J MAR SCI, V68, P687, DOI 10.1093/icesjms/fsq190; Solidoro C, 2000, MAR ECOL PROG SER, V199, P137, DOI 10.3354/meps199137; Solidoro C, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004838; Soto D., 2008, FAO Fisheries and Aquaculture Proceedings, P15; ZOPPINI A, 1995, ESTUAR COAST SHELF S, V41, P493, DOI 10.1016/0272-7714(95)90024-1	24	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0195732	10.1371/journal.pone.0195732	http://dx.doi.org/10.1371/journal.pone.0195732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723208	Green Submitted, Green Published, gold			2022-12-26	WOS:000431305100008
J	Xu, YZ; Thuraisingam, T; Kanagaratham, C; Tao, S; Radzioch, D				Xu, Yong Zhong; Thuraisingam, Thusanth; Kanagaratham, Cynthia; Tao, Shao; Radzioch, Danuta			c-Src kinase is involved in the tyrosine phosphorylation and activity of SLC11A1 in differentiating macrophages	PLOS ONE			English	Article							MURINE PERITONEAL-MACROPHAGES; CLASS-II EXPRESSION; NITRIC-OXIDE; NATURAL-RESISTANCE; IRON TRANSPORT; IN-VITRO; INTRACELLULAR INFECTIONS; GENETIC SUSCEPTIBILITY; FAMILY KINASES; NRAMP1 SLC11A1	Studies have demonstrated that the solute carrier family 11 member 1 (SLC11A1) is heavily glycosylated and phosphorylated in macrophages. However, the mechanisms of SLC11A1 phosphorylation, and the effects of phosphorylation on SLC11A1 activity remain largely unknown. Here, the tyrosine phosphorylation of SLC11A1 is observed in SLC11A1-expressing U937 cells when differentiated into macrophages by phorbol myristate acetate (PMA). The phosphorylation of SLC11A1 is almost completely blocked by treatment with PP2, a selective inhibitor of Src family kinases. Furthermore, we found that SLC11A1 is a direct substrate for active c-Src kinase and siRNA-mediated knockdown of cellular Src (c-Src) expression results in a significant decrease in tyrosine phosphorylation. We found that PMA induces the interaction of SLC11A1 with c-Src kinase. We demonstrated that SLC11A1 is phosphorylated by Src family kinases at tyrosine 15 and this type of phosphorylation is required for SLC11A1-mediated modulation of NF-kappa B activation and nitric oxide (NO) production induced by LPS. Our results demonstrate important roles for c-Src tyrosine kinase in phosphorylation and activation of SLC11A1 in macrophages.	[Xu, Yong Zhong; Kanagaratham, Cynthia; Radzioch, Danuta] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Xu, Yong Zhong; Kanagaratham, Cynthia; Tao, Shao; Radzioch, Danuta] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada; [Thuraisingam, Thusanth] McGill Univ, Div Dermatol, Fac Med, Montreal, PQ, Canada; [Tao, Shao; Radzioch, Danuta] McGill Univ, Div Expt Med, Fac Med, Montreal, PQ, Canada; [Kanagaratham, Cynthia] Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Kanagaratham, Cynthia] Harvard Med Sch, Dept Med, Boston, MA USA	McGill University; McGill University; McGill University; McGill University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Radzioch, D (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; Radzioch, D (corresponding author), McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada.; Radzioch, D (corresponding author), McGill Univ, Div Expt Med, Fac Med, Montreal, PQ, Canada.	danuta.radzioch@mcgill.ca		Radzioch, Danuta/0000-0002-0213-987X	Canadian Institutes of Health Research (CIHR) [106544]; Fonds de Recherche du Quebec - Sante (FRSQ) [17734]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec - Sante (FRSQ)	This work was supported by the Canadian Institutes of Health Research (CIHR) grant no. 106544 to DR and Fonds de Recherche du Quebec - Sante (FRSQ) grant no. 17734 to YZX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Aitio O, 2010, P NATL ACAD SCI USA, V107, P21743, DOI 10.1073/pnas.1010243107; Akcakaya P, 2012, MOL BIOL REP, V39, P5009, DOI 10.1007/s11033-011-1297-x; Archer NS, 2015, GENES IMMUN, V16, P275, DOI 10.1038/gene.2015.8; Arias M, 1997, J INFECT DIS, V176, P1552, DOI 10.1086/514154; Arias-Salvatierra D, 2011, CELL SIGNAL, V23, P425, DOI 10.1016/j.cellsig.2010.10.017; ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; Ates O, 2010, J CLIN IMMUNOL, V30, P583, DOI 10.1007/s10875-010-9422-5; Ates O, 2009, RHEUMATOL INT, V29, P787, DOI 10.1007/s00296-008-0763-9; Authier H, 2008, INT J PARASITOL, V38, P341, DOI 10.1016/j.ijpara.2007.08.002; BARRERA LF, 1994, IMMUNOLOGY, V82, P457; BARTON CH, 1994, J EXP MED, V179, P1683, DOI 10.1084/jem.179.5.1683; BARTON CH, 1995, MOL MED, V1, P267, DOI 10.1007/BF03401551; Barton CH, 1999, J LEUKOCYTE BIOL, V66, P757, DOI 10.1002/jlb.66.5.757; Beacham D, 2007, J NEUROSCI, V27, P11543, DOI 10.1523/JNEUROSCI.1743-07.2007; Biggs TE, 2001, EUR J IMMUNOL, V31, P2060, DOI 10.1002/1521-4141(200107)31:7<2060::AID-IMMU2060>3.0.CO;2-L; Blackwell JM, 2003, IMMUNOL LETT, V85, P197, DOI 10.1016/S0165-2478(02)00231-6; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BOOCKVAR KS, 1994, INFECT IMMUN, V62, P1089, DOI 10.1128/IAI.62.3.1089-1100.1994; Brunton VG, 1997, ONCOGENE, V14, P283, DOI 10.1038/sj.onc.1200827; Canhamero T, 2011, INFLAMMATION, V34, P303, DOI 10.1007/s10753-010-9235-y; Canonne-Hergaux F, 2002, BLOOD, V100, P268, DOI 10.1182/blood.V100.1.268; Cellier M, 1997, J LEUKOCYTE BIOL, V61, P96, DOI 10.1002/jlb.61.1.96; CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995; Chen F, 1996, APMIS, V104, P176, DOI 10.1111/j.1699-0463.1996.tb00705.x; Cuellar-Mata P, 2002, J BIOL CHEM, V277, P2258, DOI 10.1074/jbc.M105508200; Dalgarno DC, 1997, BIOPOLYMERS, V43, P383; Edwards JC, 2006, J BIOL CHEM, V281, P28011, DOI 10.1074/jbc.M605865200; Fleming RYD, 1997, SURGERY, V122, P501, DOI 10.1016/S0039-6060(97)90044-1; FLESCH IEA, 1991, INFECT IMMUN, V59, P3213, DOI 10.1128/IAI.59.9.3213-3218.1991; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; FORMICA S, 1994, IMMUNOLOGY, V82, P42; Freudenburg W, 2010, J GEN VIROL, V91, P2278, DOI 10.1099/vir.0.022665-0; Fritsche G, 2003, J IMMUNOL, V171, P1994, DOI 10.4049/jimmunol.171.4.1994; Geahlen RL, 2004, ONCOGENE, V23, P8024, DOI 10.1038/sj.onc.1208078; Gomez MA, 2007, J BIOL CHEM, V282, P36190, DOI 10.1074/jbc.M703140200; Goswami T, 2001, BIOCHEM J, V354, P511, DOI 10.1042/0264-6021:3540511; Gotoh H, 2006, BIOCHEM BIOPH RES CO, V346, P600, DOI 10.1016/j.bbrc.2006.05.167; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Govoni G, 1999, INFECT IMMUN, V67, P2225, DOI 10.1128/IAI.67.5.2225-2232.1999; GREEN SJ, 1993, CURR OPIN INFECT DIS, V6, P384; Gruenheid S, 1997, J EXP MED, V185, P717, DOI 10.1084/jem.185.4.717; Hackam DJ, 1998, J EXP MED, V188, P351, DOI 10.1084/jem.188.2.351; Hayashi S, 1996, BRIT J OPHTHALMOL, V80, P644, DOI 10.1136/bjo.80.7.644; Hedges JF, 2013, J IMMUNOL, V190, P4263, DOI 10.4049/jimmunol.1200732; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237; Jalal DI, 2006, J AM SOC NEPHROL, V17, P99, DOI 10.1681/ASN.2005070693; Jones Edward, 2007, J Inflamm (Lond), V4, P23, DOI 10.1186/1476-9255-4-23; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kuhn DE, 1999, J LEUKOCYTE BIOL, V66, P113, DOI 10.1002/jlb.66.1.113; Kuhn DE, 2001, J LEUKOCYTE BIOL, V69, P43; Lahdenpera J, 2003, KIDNEY INT, V64, P404, DOI 10.1046/j.1523-1755.2003.00097.x; Lin XT, 2013, J IMMUNOL, V190, P3109, DOI 10.4049/jimmunol.1203422; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Liu BA, 2012, FEBS LETT, V586, P2597, DOI 10.1016/j.febslet.2012.04.054; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; MALO D, 1994, GENOMICS, V23, P51, DOI 10.1006/geno.1994.1458; Mayer BJ, 2001, J CELL SCI, V114, P1253; Mayer Bruce J., 1993, Trends in Cell Biology, V3, P8, DOI 10.1016/0962-8924(93)90194-6; Nairz M, 2009, CELL MICROBIOL, V11, P1365, DOI 10.1111/j.1462-5822.2009.01337.x; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; Nino-Moreno P, 2017, REV INVEST CLIN, V69, P5; Ogura M, 2014, FEBS LETT, V588, P2837, DOI 10.1016/j.febslet.2014.06.044; Owens DW, 2000, MOL BIOL CELL, V11, P51, DOI 10.1091/mbc.11.1.51; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Radha V, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-31; Remer KA, 2001, INFECT IMMUN, V69, P4086, DOI 10.1128/IAI.69.6.4086-4093.2001; Searle S, 1998, J CELL SCI, V111, P2855; Sen Banibrata, 2011, J Signal Transduct, V2011, P865819, DOI 10.1155/2011/865819; Smit JJ, 2003, FASEB J, V17, P958, DOI 10.1096/fj.02-0985fje; Soe-Lin S, 2008, EXP HEMATOL, V36, P929, DOI 10.1016/j.exphem.2008.02.013; Soe-Lin S, 2010, EXP HEMATOL, V38, P609, DOI 10.1016/j.exphem.2010.04.003; Soe-Lin S, 2009, P NATL ACAD SCI USA, V106, P5960, DOI 10.1073/pnas.0900808106; Stober CB, 2007, INFECT IMMUN, V75, P5059, DOI 10.1128/IAI.00153-07; Valdez Y, 2009, CELL MICROBIOL, V11, P351, DOI 10.1111/j.1462-5822.2008.01258.x; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Vidal SM, 1996, J IMMUNOL, V157, P3559; Wang GZ, 2015, J BIOL CHEM, V290, P21890, DOI 10.1074/jbc.M115.660621; Winberg ME, 2007, EXP PARASITOL, V117, P165, DOI 10.1016/j.exppara.2007.04.004; Wojciechowski W, 1999, J IMMUNOL, V163, P2688; Wu HC, 2011, AM J PHYSIOL-RENAL, V300, pF403, DOI 10.1152/ajprenal.00520.2010; XIE QW, 1994, J BIOL CHEM, V269, P4705; Xu YZ, 2005, MOL CELL BIOL, V25, P8139, DOI 10.1128/MCB.25.18.8139-8149.2005; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; ZIEGLER SF, 1988, J EXP MED, V168, P1801, DOI 10.1084/jem.168.5.1801; ZWILLING BS, 1987, J IMMUNOL, V138, P1372	89	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2018	13	5							e0196230	10.1371/journal.pone.0196230	http://dx.doi.org/10.1371/journal.pone.0196230			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE6AF	29723216	Green Published, gold, Green Submitted			2022-12-26	WOS:000431305100018
J	Kishor, R; Sharma, GJ				Kishor, Rajkumar; Sharma, G. J.			The use of the hypervariable P8 region of trnL (UAA) intron for identification of orchid species: Evidence from restriction site polymorphism analysis	PLOS ONE			English	Article							PCR-RFLP; MOLECULAR PHYLOGENY; EVOLUTION; DNA; SECONDARY; PSBC	The P8 stem-loop region of the trnL intron, which is known to be hypervariable in size with multiple repeat motifs and created difficulties in alignment, is always excluded in phylogenetic as well as barcode analyses. This region was investigated for species discrimination in 98 taxa of orchids belonging to the tribe Vandeae using in silico mapping of restriction site polymorphism. The length of the P8 regions varied from 200 nucleotides in Aerides rosea to 669 nucleotides in Dendrophylax sallei. Forty two taxa had unique lengths, while as many as eight shared a common length of 521 nucleotides. Of the 35 restriction endonucleases producing digestions in the P8 regions, three, viz., Agsl, Apol and TspDTl turned out to have recognition sites across all the 98 taxa being studied. When their restriction data were combined, 92 taxa could be discriminated leaving three taxon pairs. However, Acampe papillosa and Aeranthes arachnites despite having similar restriction sites differed in their P8 lengths. This is the first report on thorough investigation of the P8 region of trnL intron for search of species specific restriction sites and hence its use as a potential plant DNA barcode.	[Kishor, Rajkumar; Sharma, G. J.] Manipur Univ, Dept Life Sci, Imphal, Manipur, India; [Kishor, Rajkumar] Kwaklei & Khonggunmelei Orchids Pvt Ltd, Imphal, Manipur, India	Manipur University	Kishor, R (corresponding author), Manipur Univ, Dept Life Sci, Imphal, Manipur, India.; Kishor, R (corresponding author), Kwaklei & Khonggunmelei Orchids Pvt Ltd, Imphal, Manipur, India.	rajkumarkishor@yahoo.com		Rajkumar, Kishor/0000-0001-7217-0672	Council of Scientific and Industrial Research (CSIR), Government of India [SRA-8627A]	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research (CSIR), Government of India by granting Senior Research Associateship to Rajkumar Kishor (grant no. SRA-8627A).; This work was supported by the Council of Scientific and Industrial Research (CSIR), Government of India by granting Senior Research Associateship to Rajkumar Kishor (Grant No. SRA-8627A).	Borsch T, 2003, J EVOLUTION BIOL, V16, P558, DOI 10.1046/j.1420-9101.2003.00577.x; Borsch T, 2007, INT J PLANT SCI, V168, P639, DOI 10.1086/513476; Brunner I, 2001, MOL ECOL, V10, P2079, DOI 10.1046/j.1365-294X.2001.01325.x; Carlsward BS, 2006, AM J BOT, V93, P770, DOI 10.3732/ajb.93.5.770; CECH TR, 1994, NAT STRUCT BIOL, V1, P273, DOI 10.1038/nsb0594-273; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Christenson EA, 2001, PHALAENOPSIS, P330; DAVIES RW, 1982, NATURE, V300, P719, DOI 10.1038/300719a0; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Fowlie JA, 1969, ORCHID DIG, V33, P301; Gielly L, 1996, BOT J LINN SOC, V120, P57, DOI 10.1111/j.1095-8339.1996.tb00480.x; GIELLY L, 1994, MOL BIOL EVOL, V11, P769; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Kishor R, 2009, PLANT CELL TISS ORG, V97, P121, DOI 10.1007/s11240-009-9506-1; Kocyan A, 2008, MOL PHYLOGENET EVOL, V48, P422, DOI 10.1016/j.ympev.2008.02.017; Kojoma M, 2002, PLANTA MED, V68, P94, DOI 10.1055/s-2002-20051; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; KUHSEL MG, 1990, SCIENCE, V250, P1570, DOI 10.1126/science.2125748; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; MICHEL F, 1982, BIOCHIMIE, V64, P867, DOI 10.1016/S0300-9084(82)80349-0; Parani M, 2000, THEOR APPL GENET, V100, P454, DOI 10.1007/s001220050059; Parani M, 2001, GENOME, V44, P495, DOI 10.1139/gen-44-3-495; Peyachoknagul S, 2014, SCIENCEASIA, V40, P113, DOI 10.2306/scienceasia1513-1874.2014.40.113; Quandt D, 2005, MOL PHYLOGENET EVOL, V36, P429, DOI 10.1016/j.ympev.2005.03.014; Quandt D, 2004, MONOG SYST BOTAN, V98, P13; Ridgway Karyn P, 2003, BMC Ecol, V3, P8, DOI 10.1186/1472-6785-3-8; Rolf FJ, 1993, NTSYS PC NUMERICAL T; Schuiteman A, 2014, GENERA ORCHIDACEAR 3, V6; SWEET H. R., 1968, American Orchid Society Bulletin, V37, P1089; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tsai CC, 2010, PLANT SYST EVOL, V288, P77, DOI 10.1007/s00606-010-0314-1; Tsai CC, 2011, ORCHID BIOTECHNOLOGY; Van Droogenbroeck B, 2004, THEOR APPL GENET, V108, P1473, DOI 10.1007/s00122-003-1575-7	35	1	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196680	10.1371/journal.pone.0196680	http://dx.doi.org/10.1371/journal.pone.0196680			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718976	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900069
J	Mak, D; de Villiers, CB; Chasela, C; Urban, MI; Kramvis, A				Mak, Daniel; de Villiers, Chantal Babb; Chasela, Charles; Urban, Margaret, I; Kramvis, Anna			Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000-2012	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; VIRAL LOAD; INFECTION; HIV; CANCERS; JOHANNESBURG; POPULATION; AFLATOXIN	Objective The aims of this study were to determine the prevalence of risk factors associated with hepatocellular carcinoma (HCC) in black adult South Africans and to estimate the size of the associated risks. Methods A case-control analysis of 150 black South African patients (aged 18-75 years) with HCC-who were a subset of patients recruited for the Johannesburg Cancer Case Control Study 2000 to 2012-was undertaken. The association between this tumour and hepatitis B/C virus infections, and human immunodeficiency virus (HIV) mono-and co-infections was investigated. Odds ratios (ORs) and 95% confidence intervals (CI) adjusted for age, year of diagnosis, marital status, place of birth and selected modifiable risk factors were calculated. Results HCC was significantly associated with a rural birthplace (p<0.05), being male and living in an urban area for 14 years or less. The Odds Ratio (OR) for HCC increased significantly with HBV DNA+/HBsAg+ (OR 34.5; CI: 16.26-73.13), HBV DNA+/HBsAg-(OR 3.76; CI: 1.79-7.92), HBV DNA level > 2000 IU/ml (OR 8.55; CI: 3.00-24.54) to >= 200,000 (OR 16.93; CI: 8.65-33.13), anti-HCV (OR 8.98; CI: 3.59-22.46), HBV DNA+/HIV+ co-infection (OR 5.36; CI: 2.59-11.11), but not with HBV DNA-/HIV+ (OR 0.34; CI: 0.14-0.85). We did not find a synergistic interaction between HBV and HIV. Modifiable risk factors (alcohol consumption, tobacco smoking, number of sexual partners, diabetes and hormonal contraceptive use) were nonsignificant. Discussion A considerable portion of the HCC burden in Johannesburg and surrounding provinces falls on rural migrants to urban areas, most of whom are men. The HBV will continue to contribute to HCC incidence in older age-groups and in others who missed vaccination. Although we did not find an increased risk for HCC in HIV positive individuals this may change as life expectancy increases due to greater access to antiretroviral therapies, necessitating the addition of hepatitis virus screening to preventive medical care.	[Mak, Daniel; Kramvis, Anna] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, HVDRU,Dept Internal Med, Johannesburg, South Africa; [de Villiers, Chantal Babb; Urban, Margaret, I] Natl Hlth Lab Serv, Natl Canc Registry, Canc Epidemiol Res Grp, Johannesburg, South Africa; [de Villiers, Chantal Babb] Univ Witwatersrand, Fac Hlth Sci, Div Human Genet, Johannesburg, South Africa; [Chasela, Charles] Human Sci Res Council, HAST, ESI, Pretoria, South Africa; [Chasela, Charles] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Johannesburg, South Africa; [Chasela, Charles] EQUIP HLTH, Right Care, Centurion, South Africa; [de Villiers, Chantal Babb] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England	University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand; Human Sciences Research Council-South Africa; University of Witwatersrand; University of Cambridge	Kramvis, A (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, HVDRU,Dept Internal Med, Johannesburg, South Africa.	Anna.Kramvis@wits.ac.za	de Villiers, Chantal Babb/AAL-3787-2021	de Villiers, Chantal Babb/0000-0003-1334-1819; Kramvis, Anna/0000-0001-6006-3765	Cancer Association of South Africa	Cancer Association of South Africa	Funded by Cancer Association of South Africa.	Bell TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045750; Bhaijee F, 2011, S AFR J SURG, V49, P68; Burnett RJ, 2005, LIVER INT, V25, P201, DOI 10.1111/j.1478-3231.2005.01054.x; Burnett RJ, 2012, VACCINE, V30, pC45, DOI 10.1016/j.vaccine.2012.02.021; Centers for Disease Control and Prevention, 2012, FACT SHEETS ALC US H; Chemin I, 2005, J CLIN VIROL, V34, pS15, DOI 10.1016/S1386-6532(05)80005-8; Colin JF, 1999, HEPATOLOGY, V29, P1306, DOI 10.1002/hep.510290447; Colli A, 2006, AM J GASTROENTEROL, V101, P513, DOI 10.1111/j.1572-0241.2006.00467.x; Falade-Nwulia O, 2011, SEX HEALTH, V8, P512, DOI 10.1071/SH10163; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Health NDo, 2015, NAT CONS GUID PREV M; Herbst MC, 2017, FACT SHEET POSITION, P10; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Kew M. C., 2008, Southern African Journal of Epidemiology & Infection, V23, P4; KEW MC, 1986, BRIT MED J, V293, P1339, DOI 10.1136/bmj.293.6558.1339; KEW MC, 1983, HEPATOLOGY, V3, P65; Kew MC, 2003, LIVER INT, V23, P405, DOI 10.1111/j.1478-3231.2003.00869.x; Kew MC, 1997, GASTROENTEROLOGY, V112, P184, DOI 10.1016/S0016-5085(97)70233-6; KEW MC, 1985, CANCER, V56, P2315, DOI 10.1002/1097-0142(19851101)56:9<2315::AID-CNCR2820560929>3.0.CO;2-T; Kew MC, 2008, J GASTROEN HEPATOL, V23, P1426, DOI 10.1111/j.1440-1746.2008.05481.x; Kew MC, 2013, ANN HEPATOL, V12, P173, DOI 10.1016/S1665-2681(19)31354-7; Kew MC, 2012, WORLD J HEPATOL, V4, P99, DOI 10.4254/wjh.v4.i3.99; Kew MC, 2010, WORLD J HEPATOL, V2, P65, DOI 10.4254/wjh.v2.i2.65; Kew MC, 2009, CANCER LETT, V286, P38, DOI 10.1016/j.canlet.2008.11.001; Klausner JD, 2011, JAIDS-J ACQ IMM DEF, V56, P292, DOI 10.1097/QAI.0b013e3182067d99; Ladep NG, 2014, WORLD J HEPATOL, V6, P783, DOI 10.4254/wjh.v6.i11.783; Lu LG, 2014, J CLIN TRANSL HEPATO, V2, P197, DOI 10.14218/JCTH.2014.00022; Lukhwareni A, 2009, J MED VIROL, V81, P406, DOI 10.1002/jmv.21418; Mandishona E, 1998, HEPATOLOGY, V27, P1563, DOI 10.1002/hep.510270614; Mendy ME, 2010, J VIRAL HEPATITIS, V17, P115, DOI 10.1111/j.1365-2893.2009.01168.x; Cobucci RNO, 2015, J INFECT PUBLIC HEAL, V8, P1, DOI 10.1016/j.jiph.2014.08.003; Puoti M, 2006, J HEPATOL, V44, pS65, DOI 10.1016/j.jhep.2005.11.015; Sengayi M, 2016, INT J CANCER, V139, P1209, DOI 10.1002/ijc.30154; Sengayi M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1171-7; Shapatava E, 2006, DRUG ALCOHOL DEPEN, V82, pS35, DOI 10.1016/S0376-8716(06)80006-2; Shi Y, 2012, LIVER INT, V32, P231, DOI 10.1111/j.1478-3231.2011.02481.x; Shisana O, 2014, S AFRICAN NATL HIV P; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sinn DH, 2015, HEPATOLOGY, V62, P694, DOI 10.1002/hep.27889; Sitas F, 1997, BRIT J CANCER, V75, P1704, DOI 10.1038/bjc.1997.290; Skelton M, 2000, J VIRAL HEPATITIS, V7, P230; Spearman CWN, 2013, SAMJ S AFR MED J, V103, P337, DOI 10.7196/SAMJ.6452; Stein L, 2008, INT J CANCER, V122, P2260, DOI 10.1002/ijc.23391; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Urban M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001182; VANRENSBURG SJ, 1985, BRIT J CANCER, V51, P713, DOI 10.1038/bjc.1985.107; Viana R, 2009, J MED VIROL, V81, P1525, DOI 10.1002/jmv.21574; Viljoen JH, 2004, MYCOTOXINS GRAIN GRA; Wandeler G, 2013, J INFECT DIS, V208, P1454, DOI 10.1093/infdis/jit351; Weinberger KM, 2000, J VIROL METHODS, V85, P75, DOI 10.1016/S0166-0934(99)00154-8; WHO, 2017, WHO PUBLISHES LIST B; Zhou S, 2016, LIVER RELATED MORTAL	53	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2018	13	5							e0196057	10.1371/journal.pone.0196057	http://dx.doi.org/10.1371/journal.pone.0196057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5SH	29718992	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281900045
